PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bentivenha, JPF; Paula-Moraes, SV; Baldin, ELL; Specht, A; da Silva, IF; Hunt, TE				Bentivenha, Jose P. F.; Paula-Moraes, Silvana V.; Baldin, Edson L. L.; Specht, Alexandre; da Silva, Ivana F.; Hunt, Thomas E.			Battle in the New World: Helicoverpa armigera versus Helicoverpa zea (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							PUNCTIGERA WALLENGREN LEPIDOPTERA; HUBNER LEPIDOPTERA; HELIOTHIS-ZEA; RESISTANCE MANAGEMENT; PYRETHROID RESISTANCE; TRANSGENIC CORN; COTTON BOLLWORM; BT-COTTON; CANNIBALISM; AUSTRALIA	The corn earworm Helicoverpa zea (Boddie) and the old world bollworm Helicoverpa armigera (Hubner) (Lepidoptera: Noctuidae) are allopatric species and occur in important agricultural crops. In maize, both species tend to infest the ear. The introduction of H. armigera in Brazil has created a new scenario, where these Helicoverpa species might cohabit and interact with one another, affecting the prevalence of each species in the agroecosystem, integrated pest management, and insect resistance management. In this study, larval occurrence and proportion of these species in maize was assessed in three regions of Brazil during three crop seasons. Interaction between the species was evaluated in interspecific and intraspecific scenarios under laboratory and field conditions. Helicoverpa zea was predominant in Rio Grande do Sul and the Planaltina, DF (central Brazil). In western Bahia, H. zea was predominant in the first collection, but approximately equal in number to H armigera in the second crop season. Both species exhibit high cannibalism/predation rates, and larval size was the primary factor for larval survival in the interaction studies. Larva of H. zea had higher survival when interacting with H. armigera, indicating that H. zea has an advantage in intraguild interactions with H. armigera in maize. Overall, the results from this study indicate that maize might play a role as a source of infestation or a sink of insecticide or Bt protein unselected H. armigera populations, depending on the H. zea:H. armigera intraguild competition and adult movement in the landscape.	[Bentivenha, Jose P. F.] Univ Sao Paulo, Dept Entomol & Acarol, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [Paula-Moraes, Silvana V.] Univ Florida, Dept Entomol & Nematol, WFREC, Jay, FL USA; [Baldin, Edson L. L.; da Silva, Ivana F.] Sao Paulo State Univ, Dept Crop Protect, Coll Agron Sci, Botucatu, SP, Brazil; [Specht, Alexandre] Embrapa Cerrados, Planaltina, DF, Brazil; [Hunt, Thomas E.] Univ Nebraska, Haskell Agr Lab, Concord, NE USA	Universidade de Sao Paulo; State University System of Florida; University of Florida; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Nebraska System	Bentivenha, JPF (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.	jpgfdsilva@gmail.com	Specht, Alexandre/G-6007-2012; Bentivenha, José Paulo Franco/G-4015-2017; da Silva, Ivana Fernandes IFS/C-4605-2017; Baldin, Edson L L/F-3009-2013; Specht, Alexandre/P-8435-2019	Specht, Alexandre/0000-0002-8921-0340; Bentivenha, José Paulo Franco/0000-0002-6524-4714; da Silva, Ivana Fernandes IFS/0000-0003-3533-5508; Specht, Alexandre/0000-0002-8921-0340	National Council for Scientific and Technological Development (CNPq) [403376/2013-0]; Embrapa Project, MP2 [02.13.14.606.00.00 / 02.13.14.606.00.02]; Coordination for the Improvement of Higher Education Personnel (CAPES) [99999.002564/2014-09]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Embrapa Project, MP2(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Council for Scientific and Technological Development (CNPq: 403376/2013-0): AS, SVP; Embrapa Project, MP2 (PA: 02.13.14.606.00.00 / 02.13.14.606.00.02): AS, SVP; Coordination for the Improvement of Higher Education Personnel (CAPES: 99999.002564/2014-09): JPFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, 28 C BRAS ENT 9 C LA; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; Burkness EC, 2012, J ECON ENTOMOL, V105, P1773, DOI 10.1603/EC12128; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; BUTLER GD, 1976, ENVIRON ENTOMOL, V5, P520, DOI 10.1093/ee/5.3.520; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Chapman JW, 1999, BEHAV ECOL, V10, P298, DOI 10.1093/beheco/10.3.298; Chapman JW, 2000, BEHAV ECOL SOCIOBIOL, V48, P321, DOI 10.1007/s002650000237; Chapman JW, 1999, ECOL ENTOMOL, V24, P268, DOI 10.1046/j.1365-2311.1999.00224.x; Chilcutt CF, 2006, J ECON ENTOMOL, V99, P728, DOI 10.1603/0022-0493-99.3.728; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; DIAL CI, 1990, ANN ENTOMOL SOC AM, V83, P258, DOI 10.1093/aesa/83.2.258; Dorhout DL, 2010, J ECON ENTOMOL, V103, P54, DOI 10.1603/EC09247; Downes S, 2007, J INVERTEBR PATHOL, V95, P208, DOI 10.1016/j.jip.2007.03.010; Duffield SJ, 2001, AUST J ENTOMOL, V40, P151, DOI 10.1046/j.1440-6055.2001.00213.x; Embrapa, 2013, NOT TECN RES TRAB IN; FIREMPONG S, 1990, AUST J ZOOL, V37, P665, DOI 10.1071/ZO9890665; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Hardwick D. F., 1965, Mem ent Soc Canada Ottawa, Vno. 40, P1; HARDWICK DF, 1970, MEM ENTOMOL SOC CAN, P5; Hayden J. E, 2015, FDACS02039 DIV PLANT; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Hutchison W.D., 2007, PLANT HLTH PROGR; Jacobson A, 2009, J ECON ENTOMOL, V102, P2289, DOI 10.1603/029.102.0634; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; JOYNER K, 1985, ANN ENTOMOL SOC AM, V78, P24, DOI 10.1093/aesa/78.1.24; Kakimoto T, 2003, ANN ENTOMOL SOC AM, V96, P793, DOI 10.1603/0013-8746(2003)096[0793:ELPLDA]2.0.CO;2; Kao S. S, 1995, B TAIWAN AGR CHEM TO, V37, P1; Keszthelyi S, 2011, BIOLOGIA, V66, P340, DOI 10.2478/s11756-011-0013-6; Kitching IJ, 1998, HDB ZOOLOGY ARTHROPO, VIV, P355, DOI DOI 10.1515/9783110804744.355; Kranthi KR, 2001, J ECON ENTOMOL, V94, P253, DOI 10.1603/0022-0493-94.1.253; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Liu ZD, 2004, APPL ENTOMOL ZOOL, V39, P373, DOI 10.1303/aez.2004.373; Luo SD, 2007, J ECON ENTOMOL, V100, P909, DOI 10.1603/0022-0493(2007)100[909:CSOCSO]2.0.CO;2; Luz PMC, 1809, OCORRENCIA PARASITOI; Mally F. W., 1892, Bull Dept Agric Ent, Vxxvi, P45; Matthews M, 1991, 44 NAT RES I; Matthews M, 1999, HELIOTHINE MOTHS AUS; Mironidis GK, 2008, ENVIRON ENTOMOL, V37, P16, DOI 10.1603/0046-225X(2008)37[16:DSAROH]2.0.CO;2; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Montezano DG, 2013, AN ACAD BRAS CIENC, V85, P271, DOI 10.1590/S0001-37652013000100013; Barbosa TAN, 2016, FLA ENTOMOL, V99, P72, DOI 10.1653/024.099.0113; Pannuti LER, 2016, ENVIRON ENTOMOL, V45, P192, DOI 10.1093/ee/nvv159; Paula-Moraes S, 2013, J ECON ENTOMOL, V106, P1274, DOI 10.1603/EC12436; Paula-Moraes SV, 2012, ENVIRON ENTOMOL, V41, P1494, DOI 10.1603/EN12149; Perkins LE, 2008, ARTHROPOD-PLANT INTE, V2, P197, DOI 10.1007/s11829-008-9047-2; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Pierce Naomi E., 1995, Journal of the Lepidopterists' Society, V49, P412; Pimentel D., 2002, BIOL INVASIONS EC EN; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Pratissoli D, 2015, HORTIC BRAS, V33, P101, DOI 10.1590/S0102-053620150000100016; Reisig DD, 2015, ENVIRON ENTOMOL, V44, P1275, DOI 10.1093/ee/nvv076; Ritchie S.W., 1993, IOWA STATE U COOPERA, V48, P21; Rudolf VHW, 2007, P R SOC B, V274, P1205, DOI 10.1098/rspb.2006.0449; SAS Institute, 2001, SAS STAT US GGGUID V; Sharma H. C., 2001, CROP PROTECTION COMP; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Sosa-Gomez DR, 2016, REV BRAS ENTOMOL, V60, P101, DOI 10.1016/j.rbe.2015.09.008; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Torres-Vila LM, 2002, AGR ECOSYST ENVIRON, V93, P55, DOI 10.1016/S0167-8809(02)00003-8; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zhao XC, 2010, CHEM SENSES, V35, P511, DOI 10.1093/chemse/bjq043	73	22	23	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167182	10.1371/journal.pone.0167182	http://dx.doi.org/10.1371/journal.pone.0167182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907051	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700088
J	Fischer, A; Onur, S; Niklowitz, P; Menke, T; Laudes, M; Rimbach, G; Doring, F				Fischer, Alexandra; Onur, Simone; Niklowitz, Petra; Menke, Thomas; Laudes, Matthias; Rimbach, Gerald; Doering, Frank			Coenzyme Q(10) Status as a Determinant of Muscular Strength in Two Independent Cohorts	PLOS ONE			English	Article							SKELETAL-MUSCLE STRENGTH; BODY-MASS INDEX; GENE-EXPRESSION; PHYSICAL-DISABILITY; LIFELONG EXERCISE; OXIDATIVE DAMAGE; GRIP STRENGTH; SARCOPENIA; MEN; SUPPLEMENTATION	Aging is associated with sarcopenia, which is a loss of skeletal muscle mass and function. Coenzyme Q(10) (CoQ(10)) is involved in several important functions that are related to bioenergetics and protection against oxidative damage; however, the role of CoQ(10) as a determinant of muscular strength is not well documented. The aim of the present study was to evaluate the determinants of muscular strength by examining hand grip force in relation to CoQ(10) status, gender, age and body mass index (BMI) in two independent cohorts (n = 334, n = 967). Furthermore, peak flow as a function of respiratory muscle force was assessed. Spearman's correlation revealed a significant positive association between CoQ(10)/cholesterol level and hand grip in the basic study population (p<0.01) as well as in the validation population (p<0.001). In the latter, we also found a negative correlation with the CoQ(10) redox state (p<0.01), which represents a lower percentage of the reduced form of CoQ10 (ubiquinol) in subjects who exhibit a lower muscular strength. Furthermore, the age of the subjects showed a negative correlation with hand grip (p<0.001), whereas BMI was positively correlated with hand grip (p<0.01), although only in the normal weight subgroup (BMI <25 kg/m(2)). Analysis of the covariance (ANCOVA) with hand grip as the dependent variable revealed CoQ(10)/cholesterol as a determinant of muscular strength and gender as the strongest effector of hand grip. In conclusion, our data suggest that both a low CoQ(10)/cholesterol level and a low percentage of the reduced form of CoQ(10) could be an indicator of an increased risk of sarcopenia in humans due to their negative associations to upper body muscle strength, peak flow and muscle mass.	[Fischer, Alexandra; Onur, Simone; Doering, Frank] Christian Albrechts Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany; [Niklowitz, Petra; Menke, Thomas] Univ Witten Herdecke, Childrens Hosp Datteln, Datteln, Germany; [Laudes, Matthias] Univ Hosp Schleswig Holstein, Dept Internal Med, Campus Kiel, Kiel, Germany; [Rimbach, Gerald] Christian Albrechts Univ Kiel, Inst Human Nutr & Food Sci, Dept Food Sci, Kiel, Germany	University of Kiel; Witten Herdecke University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Doring, F (corresponding author), Christian Albrechts Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany.	sek@molprev.uni-kiel.de	Laudes, Matthias/C-8885-2011; Rimbach, Gerald/A-7178-2011	Rimbach, Gerald/0000-0001-7888-4684	Federal Ministry for Education and Research [01EY1103]; grant of the Federal Ministry for Education and Research [0315540A]; Kaneka Corporation, Japan	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); grant of the Federal Ministry for Education and Research; Kaneka Corporation, Japan	Data from the basic study population presented in this paper derived from the PopGen control cohort, a population-based sample of mainly Caucasian individuals, identified through official population registries in Kiel (Germany). Participants were recruited into the PopGen biobank between June 2005 and February 2006. The study was funded by the Federal Ministry for Education and Research (01EY1103). Subjects of the validation population were randomly recruited via registry office of Kiel, Germany or via the adiposity ambulance of UKSH, Kiel, Germany. Members are part of the Focus Cohort, which was supported by a grant of the Federal Ministry for Education and Research (0315540A). Determining and analyzing the CoQ10 status was financially supported by Kaneka Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta MJ, 2016, BIOCH BIOPHYSICA ACT; Alf D, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-24; Bahat G, 2014, AGING MALE, V17, P136, DOI 10.3109/13685538.2014.936001; Banerjee AK, 2003, MOL CELL BIOCHEM, V253, P307, DOI 10.1023/A:1026032404105; Bello RI, 2006, EXP GERONTOL, V41, P1174, DOI 10.1016/j.exger.2006.08.012; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Buchman AS, 2008, MECH AGEING DEV, V129, P625, DOI 10.1016/j.mad.2008.07.003; Chai WW, 2014, J AM COLL NUTR, V33, P192, DOI 10.1080/07315724.2013.862490; Corbi G, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/728547; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Del Pozo-Cruz J, 2014, EXP GERONTOL, V52, P46, DOI 10.1016/j.exger.2014.01.026; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; Fischer A, 2015, BIOFACTORS, V41, P166, DOI 10.1002/biof.1210; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Hosoe K, 2007, REGUL TOXICOL PHARM, V47, P19, DOI 10.1016/j.yrtph.2006.07.001; Kalyan S, 2014, J CLIN ENDOCR METAB, V99, P1307, DOI 10.1210/jc.2013-3648; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Littarru GP, 2007, MOL BIOTECHNOL, V37, P31, DOI 10.1007/s12033-007-0052-y; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Menke T, 2000, ANAL BIOCHEM, V282, P209, DOI 10.1006/abio.2000.4579; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Muller N, 2015, J LIPID RES, V56, P1034, DOI 10.1194/jlr.P052209; Navas P, 2004, METHOD ENZYMOL, V378, P200; Navas P, 2007, MITOCHONDRION, V7, pS34, DOI 10.1016/j.mito.2007.02.010; Nothlings U, 2012, BUNDESGESUNDHEITSBLA, V55, P831, DOI 10.1007/s00103-012-1487-2; Onur S, 2015, BIOFACTORS, V41, P211, DOI 10.1002/biof.1216; Onur S, 2014, BIOFACTORS, V40, P346, DOI 10.1002/biof.1160; PORTER DA, 1995, INT J SPORTS MED, V16, P421, DOI 10.1055/s-2007-973031; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rosenfeldt RL, 2002, ANN NY ACAD SCI, V959, P355, DOI 10.1111/j.1749-6632.2002.tb02106.x; Sarmiento A, 2016, CURR DRUG METAB, V17, P345, DOI 10.2174/1389200216666151103115654; Schmelzer C, 2011, IUBMB LIFE, V63, P42, DOI 10.1002/iub.413; Schmelzer C, 2010, MOL NUTR FOOD RES, V54, P805, DOI 10.1002/mnfr.200900155; Schmelzer C, 2010, BIOFACTORS, V36, P222, DOI 10.1002/biof.93; SCHUTTE JE, 1981, J APPL PHYSIOL, V51, P762, DOI 10.1152/jappl.1981.51.3.762; Sprenger K B, 1987, J Clin Apher, V3, P185, DOI 10.1002/jca.2920030313; Tian G, 2014, ANTIOXID REDOX SIGN, V20, P2606, DOI 10.1089/ars.2013.5406; TRAUT TW, 1980, BIOCHEMISTRY-US, V19, P6062, DOI 10.1021/bi00567a018; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Yoritaka A, 2015, PARKINSONISM RELAT D, V21, P911, DOI 10.1016/j.parkreldis.2015.05.022; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	49	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167124	10.1371/journal.pone.0167124	http://dx.doi.org/10.1371/journal.pone.0167124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907044	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700078
J	Kim, JS; Kwon, SH				Kim, Jong Seung; Kwon, Sam Hyun			Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis	PLOS ONE			English	Article							BACTERIAL BIOFILMS; CONFIDENCE-INTERVALS; PUBLICATION BIAS; SINUS SURGERY; AUREUS; SUPERANTIGENS; IRRIGATION; EFFICACY; AGENTS; SALINE	Background Saline irrigation of the nasal cavity is a classic and effective treatment for acute or chronic rhinosinusitis. Topical antibiotics such as mupirocin have been widely used for recalcitrant chronic rhinosinusitis. Therefore, the purpose of this study was to evaluate the effect of saline irrigation using mupirocin. Methods A systematic literature review and meta-analysis of mupirocin saline irrigation were performed using EMBASE, MEDLINE, and Cochrane library through December 2015. Data were analyzed with R 3.2.2 software. A random effects model was used because of the diversity of included studies. Sensitivity analysis of particular tested groups and single proportion tests were also performed. The main outcome measure was residual staphylococcal infection, as confirmed by culture or PCR. Results Two RCTs, two prospective studies and two retrospective studies were included. A random effects model meta-analysis of the pooled data identified a relative risk of residual infection of 0.13 (95% CI: 0.06-0.26, p<0.05) with low heterogeneity (I-2 = 0%). The proportion of residual staphylococcal infections after 1 month was 0.08 (95% Cl: 0.04-0.16). However, this proportion increased to 0.53 at 6 months (95% Cl: 0.27-0.78). Conclusions The short-term use of mupirocin has a strongly reductive effect on staphylococcal infection in chronic rhinosinusitis. Although there is currently a lack of clear evidence, future studies with well-designed inclusion criteria and randomized controlled trials are needed to examine mupirocin's long-term effect on chronic rhinosinusitis.	[Kim, Jong Seung; Kwon, Sam Hyun] Chonbuk Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Jeonju, South Korea; [Kim, Jong Seung; Kwon, Sam Hyun] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Chonbuk Natl Univ Hosp, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital	Kwon, SH (corresponding author), Chonbuk Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Jeonju, South Korea.; Kwon, SH (corresponding author), Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Chonbuk Natl Univ Hosp, Jeonju, South Korea.	shkwon@jbnu.ac.kr	Kim, Jong Seung/N-4504-2015	Kim, Jong Seung/0000-0003-3477-1172; Kim, Jong Seung/0000-0002-1384-6799	Biomedical Research Institute at Chonbuk National University Hospital	Biomedical Research Institute at Chonbuk National University Hospital	This paper was supported by a fund of the Biomedical Research Institute at Chonbuk National University Hospital.	Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781; Al-Mutairi D, 2011, CURR OPIN ALLERGY CL, V11, P18, DOI 10.1097/ACI.0b013e3283423376; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Barham HP, 2015, BRAZ J OTORHINOLAR, V81, P457, DOI 10.1016/j.bjorl.2015.07.002; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borenstein M., 2009, INTRO META ANAL, V77, P85, DOI [10.1002/9780470743386.ch13, DOI 10.1002/9780470743386.CH13]; Brown Christopher L, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P9, DOI 10.1097/00020840-200402000-00004; Brown CL, 2004, LARYNGOSCOPE, V114, P2021, DOI 10.1097/01.mlg.0000147939.90249.47; Conley DB, 2006, AM J RHINOL, V20, P451, DOI 10.2500/ajr.2006.20.2880; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOEBBELING BN, 1994, ARCH INTERN MED, V154, P1505, DOI 10.1001/archinte.154.13.1505; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edmundson SP, 2011, EUR J CLIN MICROBIOL, V30, P1063, DOI 10.1007/s10096-011-1192-3; Ezzat WF, 2015, EUR ARCH OTO-RHINO-L, V272, P2355, DOI 10.1007/s00405-014-3301-2; Grossman EM, 2012, J DRUGS DERMATOL, V11, P1490; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jervis-Bardy J, 2012, LARYNGOSCOPE, V122, P2148, DOI 10.1002/lary.23486; Jervis-Bardy J, 2012, INT FORUM ALLERGY RH, V2, P111, DOI 10.1002/alr.20106; Khalil Yaser, 2011, Ear Nose Throat J, V90, pE1; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Matthijs S, 2014, RES MICROBIOL, V165, P695, DOI 10.1016/j.resmic.2014.09.009; McConeghy KW, 2009, PHARMACOTHERAPY, V29, P263, DOI 10.1592/phco.29.3.263; Moore EJ, 2001, AM J RHINOL, V15, P355, DOI 10.1177/194589240101500601; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nikfar R, 2015, IRAN J MICROBIOL, V7, P67; Ou J, 2016, INT FORUM ALLERGY RH, V6, P792, DOI 10.1002/alr.21758; Park SH, 2015, ANN DERMATOL, V27, P551, DOI 10.5021/ad.2015.27.5.551; Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119; Rezai MS, 2016, CASP J INTERN MED, V7, P114; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rohrer JW, 2012, AM J RHINOL ALLERGY, V26, P197, DOI 10.2500/ajra.2012.26.3761; Rotenberg BW, 2011, LARYNGOSCOPE, V121, P2702, DOI 10.1002/lary.22396; Seiberling KA, 2013, INT FORUM ALLERGY RH, V3, P94, DOI 10.1002/alr.21076; Solares CA, 2006, AM J OTOLARYNG, V27, P161, DOI 10.1016/j.amjoto.2005.09.006; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Uren B, 2008, LARYNGOSCOPE, V118, P1677, DOI 10.1097/MLG.0b013e31817aec47; Xie S, 2015, CANCER MED-US, V4, P1639, DOI 10.1002/cam4.504; Zabner J, 2000, P NATL ACAD SCI USA, V97, P11614, DOI 10.1073/pnas.97.21.11614; Zhang N, 2005, RHINOLOGY, V43, P162	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167369	10.1371/journal.pone.0167369	http://dx.doi.org/10.1371/journal.pone.0167369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907108	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700132
J	Kong, F; Li, YG; Hu, EZ; Wang, R; Wang, JH; Liu, J; Zhang, JS; He, DC; Xiao, XY				Kong, Fei; Li, Yunguang; Hu, Enze; Wang, Rui; Wang, Junhao; Liu, Jin; Zhang, Jinsan; He, Dacheng; Xiao, Xueyuan			The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; CONTACT INHIBITION; GROWTH-CONTROL; PSORIASIN; PROLIFERATION; TRANSCRIPTION; DOMAIN; ACTS; TAZ; DIFFERENTIATION	S100A7 is expressed in many squamous cell carcinomas (SCCs). Our previous study revealed that S100A7 was dramatically induced in several SCC cells and activation of the Hippo pathway significantly promoted S100A7 in epidermoid carcinoma cells. However, whether the Hippo pathway regulates S100A7 expression in SCCs remains largely unknown. Here, we uncover that S100A7 induction by the Hippo-YAP pathway displays different characteristic in cervical and glossopharyngeal SCC. In well differentiated HCC94 cervical cells and FaDu pharyngeal cells, S100A7 is easily induced by both suspension and dense culture, which is accompanied by an increase in YAP phosphorylation and a decrease in nuclear YAP. Strikingly, these correlations of S100A7 and YAP reverse after recovery of cell attachment or relief from dense culture. Further examination finds that S100A7 induction is significantly repressed by nuclear YAP, which is validated by activation or inhibition of the Hippo pathway via loss-and/or gain-of-LATS1 and MST1 function. Subsequently, we prove that TEAD1 is required for YAP transcriptional repression of S100A7. However, S100A7 is hardly induced in poorly differentiated SiHa cervical cells and NCI-H226 pulmonary cells even in suspension or activation of the Hippo pathway. More importantly, cervical and lingual SCC tissues array analyses show that S100A7 expression displays the positive correlation with pYAP-S127 and the negative correlation with nuclear YAP in the majority of well differentiated but not in poorly differentiated tissues. Collectively, our findings demonstrate that the different induction of S100A7 toward activation of the Hippo pathway mainly depends on the degree of cell differentiation in cervical and glossopharyngeal SCC.	[Kong, Fei; Li, Yunguang; Hu, Enze; Wang, Rui; Wang, Junhao; Liu, Jin; He, Dacheng; Xiao, Xueyuan] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing, Peoples R China; [Zhang, Jinsan] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China; [Zhang, Jinsan] Wenzhou Med Univ, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou, Zhejiang, Peoples R China	Beijing Normal University; Wenzhou Medical University; Wenzhou Medical University	Xiao, XY (corresponding author), Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing, Peoples R China.	xyxiao@bnu.edu.cn			National Natural Science Foundation of China [81172216, 81272604]; Ministry of Science and Technology of China [2011CB915504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (81172216, 81272604), of the Ministry of Science and Technology of China (2011CB915504). The funder's website is www.nsfc.gov.cn. X.Y. Xiao and D.C. He are the authors who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Barbieri M, 2011, BIOSEMIOTICS-NETH, V4, P1, DOI 10.1007/s12304-010-9103-z; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Dey KK, 2015, CANCER CELL INT, V15, P1; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kulski JK, 2003, J MOL EVOL, V56, P397, DOI 10.1007/s00239-002-2410-5; Li T, 2015, EXP DERMATOL, V24, P342, DOI 10.1111/exd.12645; Li YJ, 2016, ONCOTARGET; Mandal S, 2007, EXP CELL RES, V313, P3016, DOI 10.1016/j.yexcr.2007.03.020; Martinsson H, 2005, EXP DERMATOL, V14, P161, DOI 10.1111/j.0906-6705.2005.00239.x; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Mullen AC, 2014, CELL STEM CELL, V14, P6, DOI 10.1016/j.stem.2013.12.009; Oh H, 2014, CELL REP, V8, P448, DOI 10.1016/j.celrep.2014.06.017; Peder M, 1991, J INVEST DERMATOL, V97, P701; Qi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128887; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhu Y, 2015, CELL SIGNAL, V27, P606, DOI 10.1016/j.cellsig.2014.12.002	37	6	8	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167080	10.1371/journal.pone.0167080	http://dx.doi.org/10.1371/journal.pone.0167080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907036	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700073
J	Szakmany, T; Lundin, RM; Sharif, B; Ellis, G; Morgan, P; Kopczynska, M; Dhadda, A; Mann, C; Donoghue, D; Rollason, S; Brownlow, E; Hill, F; Carr, G; Turley, H; Hassall, J; Lloyd, J; Davies, L; Atkinson, M; Jones, M; Jones, N; Martina, R; Ibrahim, Y; Hall, JE				Szakmany, Tamas; Lundin, Robert M.; Sharif, Ben; Ellis, Gemma; Morgan, Paul; Kopczynska, Maja; Dhadda, Amrit; Mann, Charlotte; Donoghue, Danielle; Rollason, Sarah; Brownlow, Emma; Hill, Francesca; Carr, Grace; Turley, Hannah; Hassall, James; Lloyd, James; Davies, Llywela; Atkinson, Michael; Jones, Molly; Jones, Nerys; Martina, Rhodri; Ibrahim, Yousef; Hall, Judith E.		Welsh Digital Data Collection Plat	Sepsis Prevalence and Outcome on the General Wards and Emergency Departments in Wales: Results of a Multi-Centre, Observational, Point Prevalence Study	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; EARLY WARNING SCORE; CAMPAIGN; RESUSCITATION; CRITERIA	Data on sepsis prevalence on the general wards is lacking on the UK and in the developed world. We conducted a multicentre, prospective, observational study of the prevalence of patients with sepsis or severe sepsis on the general wards and Emergency Departments (ED) in Wales. During the 24-hour study period all patients with NEWS >= 3 were screened for presence of 2 or more SIRS criteria. To be eligible for inclusion, patients had to have a high clinical suspicion of an infection, together with a systemic inflammatory response (sepsis) and evidence of acute organ dysfunction and/or shock (severe sepsis). There were 5317 in-patients in the 24-hour study period. Data were returned on 1198 digital data collection forms on patients with NEWS >= 3 of which 87 were removed, leaving 1111 for analysis. 146 patients had sepsis and 144 patients had severe sepsis. Combined prevalence of sepsis and severe sepsis was 5.5% amongst all in-patients. Patients with sepsis had significantly higher NEWS scores (3 IQR 3-4 for non-sepsis and 4 IQR 3-6 for sepsis patients, respectively). Common organ dysfunctions in severe sepsis were hypoxia (47%), hypoper-fusion (40%) and acute kidney injury (25%). Mortality at 90 days was 31% with a median (IQR) hospital free stay of 78 (36-85) days. Screening for sepsis, referral to Critical Care and completion of Sepsis 6 bundle was low: 26%, 16% and 12% in the sepsis group. Multivariable logistic regression analysis identified higher National Early Warning Score, diabetes, COPD, heart failure, malignancy and current or previous smoking habits as independent variables suggesting the diagnosis of sepsis. We observed that sepsis is more prevalent in the general ward and ED than previously suggested before and that screening and effective treatment for sepsis and severe sepsis is far from being operationalized in this environment, leading to high 90 days mortality.	[Szakmany, Tamas; Hall, Judith E.] Cardiff Univ, Div Populat Med, Dept Anaesthesia Intens Care & Pain Med, Cardiff, S Glam, Wales; [Szakmany, Tamas] Cwm Taf Univ Hlth Board, ACT Directorate, Llantrisant, Wales; [Lundin, Robert M.; Sharif, Ben; Kopczynska, Maja; Dhadda, Amrit; Mann, Charlotte; Donoghue, Danielle; Rollason, Sarah; Brownlow, Emma; Hill, Francesca; Carr, Grace; Turley, Hannah; Hassall, James; Lloyd, James; Davies, Llywela; Atkinson, Michael; Jones, Molly; Jones, Nerys; Martina, Rhodri; Ibrahim, Yousef] Cardiff Univ, Sch Med, Cardiff Univ Res Soc CUReS, Cardiff, S Glam, Wales; [Ellis, Gemma; Morgan, Paul] Cardiff & Vale Univ Hlth Board, Crit Care Directorate, Cardiff, S Glam, Wales; [Szakmany, Tamas] Aneurin Bevan Univ Hlth Board, Dept Anaesthet & Crit Care, Newport, Gwent, Wales	Cardiff University; Cardiff University	Szakmany, T (corresponding author), Cardiff Univ, Div Populat Med, Dept Anaesthesia Intens Care & Pain Med, Cardiff, S Glam, Wales.; Szakmany, T (corresponding author), Cwm Taf Univ Hlth Board, ACT Directorate, Llantrisant, Wales.; Szakmany, T (corresponding author), Aneurin Bevan Univ Hlth Board, Dept Anaesthet & Crit Care, Newport, Gwent, Wales.	szakmanyt1@cardiff.ac.uk	Smith, Gary B/A-8235-2013; Morgan, Paul/AAJ-7740-2021; Kopczynska, Maja/GRF-1459-2022; Szakmany, Tamas/I-5546-2019; Zixuan, Huang/ABI-3557-2020; Lundin, Robert Michael/Q-5362-2018	Szakmany, Tamas/0000-0003-3632-8844; Lundin, Robert Michael/0000-0002-5992-2822; Pugh, Richard/0000-0002-2848-4444; McEnhill, Paul/0000-0001-8913-212X	Welsh Intensive Care Society; UK Sepsis Trust; Cwm Taf University Health Board; Health and Care Research Wales	Welsh Intensive Care Society; UK Sepsis Trust; Cwm Taf University Health Board; Health and Care Research Wales	This study was funded from grants from the Welsh Intensive Care Society, the UK Sepsis Trust, Cwm Taf University Health Board and Health and Care Research Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Corfield AR, 2014, EMERG MED J, V31, P482, DOI 10.1136/emermed-2012-202186; Daniels R, 2011, EMERG MED J, V28, P507, DOI 10.1136/emj.2010.095067; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Hancock C, 2015, INTENS CRIT CARE NUR, V31, P100, DOI 10.1016/j.iccn.2014.11.004; Jones KH, 2014, J BIOMED INFORM, V50, P196, DOI 10.1016/j.jbi.2014.01.003; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; McGinley A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5310; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rhee C, 2015, CLIN INFECT DIS, V60, P88, DOI 10.1093/cid/ciu750; Rhodes A, 2015, INTENS CARE MED, V41, P1620, DOI 10.1007/s00134-015-3906-y; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shahin J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3394; Sharif B, 2016, J AM MED INFORM ASSN, V23, P1185, DOI 10.1093/jamia/ocv208; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Szakmany T, 2015, BRIT J ANAESTH, V114, P1000, DOI 10.1093/bja/aev133; Szakmany T, 2015, LANCET INFECT DIS, V15, P1260, DOI 10.1016/S1473-3099(15)00376-X; Szakmany T, 2014, CRIT CARE MED, V42; Westphal GA, 2011, J CRIT CARE, V26, P76, DOI 10.1016/j.jcrc.2010.08.001; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yu S, 2014, CRIT CARE, V18, DOI 10.1186/cc13947	25	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167230	10.1371/journal.pone.0167230	http://dx.doi.org/10.1371/journal.pone.0167230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907062	Green Published, Green Accepted, gold			2022-12-27	WOS:000389482700097
J	Wang, J; Lu, WW; Liu, LN; Li, L; Xia, CY				Wang, Juan; Lu, Wenwen; Liu, Lina; Li, Li; Xia, Chengyi			Utility Evaluation Based on One-To-N Mapping in the Prisoner's Dilemma Game for Interdependent Networks	PLOS ONE			English	Article							PUBLIC-GOODS GAME; EVOLUTIONARY GAMES; INDIRECT RECIPROCITY; COOPERATION; DIVERSITY; BEHAVIOR; IMPACT	In the field of evolutionary game theory, network reciprocity has become an important means to promote the level of promotion within the population system. Recently, the interdependency provides a novel perspective to understand the widespread cooperation behavior in many real-world systems. In previous works, interdependency is often built from the direct or indirect connections between two networks through the one-to-one mapping mode. However, under many realistic scenarios, players may need much more information from many neighboring agents so as to make a more rational decision. Thus, beyond the one-to-one mapping mode, we investigate the cooperation behavior on two interdependent lattices, in which the utility evaluation of a focal player on one lattice may not only concern himself, but also integrate the payoff information of several corresponding players on the other lattice. Large quantities of simulations indicate that the cooperation can be substantially promoted when compared to the traditionally spatial lattices. The cluster formation and phase transition are also analyzed in order to explore the role of interdependent utility coupling in the collective cooperation. Current results are beneficial to deeply understand various mechanisms to foster the cooperation exhibited inside natural, social and engineering systems.	[Wang, Juan; Lu, Wenwen; Liu, Lina; Li, Li] Tianjin Univ Technol, Tianjin Key Lab Control Theory & Complicated Ind, Tianjin 300384, Peoples R China; [Wang, Juan; Lu, Wenwen; Liu, Lina; Li, Li] Tianjin Univ Technol, Sch Elect Engn, Tianjin 300384, Peoples R China; [Xia, Chengyi] Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin 300384, Peoples R China; [Xia, Chengyi] Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin 300384, Peoples R China; [Wang, Juan] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	Tianjin University of Technology; Tianjin University of Technology; Tianjin University of Technology; Tianjin University of Technology; University of Guelph	Wang, J (corresponding author), Tianjin Univ Technol, Tianjin Key Lab Control Theory & Complicated Ind, Tianjin 300384, Peoples R China.; Wang, J (corresponding author), Tianjin Univ Technol, Sch Elect Engn, Tianjin 300384, Peoples R China.; Xia, CY (corresponding author), Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin 300384, Peoples R China.; Xia, CY (corresponding author), Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin 300384, Peoples R China.; Wang, J (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	juanwang75@163.com; xialooking@163.com	liu, li/HGC-0900-2022; Xia, Chengyi/A-2752-2012	Xia, Chengyi/0000-0003-2686-5072	National Natural Science Foundation of China (NSFC) [71401122, 61374169]; Overseas Training Project for the Young and Middle Teachers in Tianjin University of Technology	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Overseas Training Project for the Young and Middle Teachers in Tianjin University of Technology	This project is partially supported by the National Natural Science Foundation of China (NSFC) under Grant Nos. 71401122 and 61374169 (http://www.nsfc.gov.cn), and the Overseas Training Project for the Young and Middle Teachers in Tianjin University of Technology (http://www.tjut.edu.cn). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is partially supported by the National Natural Science Foundation of China (NSFC) under Grant Nos. 71401122 and 61374169, and the Overseas Training Project for the Young and Middle Teachers in Tianjin University of Technology.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; [Anonymous], 1877, DIFFERENT FORMS FLOW; Axelrod R., 2006, EVOLUTION COOPERATIO; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Coakley S, 2013, EVOLUTION GAMES GOD, DOI [10.1007/s12232-013-0184-2, DOI 10.1007/S12232-013-0184-2]; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fort H, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48008; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gintis H., 2000, GAME THEORY EVOLVING; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056113; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Masuda N, 2008, J THEOR BIOL, V251, P181, DOI 10.1016/j.jtbi.2007.11.010; Maynard Smith J., 1982, pi; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wu ZX, 2006, CHINESE PHYS LETT, V23, P531, DOI 10.1088/0256-307X/23/3/002; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003; Zhang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/68002; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	58	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167083	10.1371/journal.pone.0167083	http://dx.doi.org/10.1371/journal.pone.0167083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907024	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700074
J	Zhou, W; Gao, J; Liao, J; Shi, RG; Li, T; Guo, YJ; Long, AM				Zhou, Weihua; Gao, Jie; Liao, Jianzu; Shi, Ronggui; Li, Tao; Guo, Yajuan; Long, Aimin			Characteristics of Phytoplankton Biomass, Primary Production and Community Structure in the Modaomen Channel, Pearl River Estuary, with Special Reference to the Influence of Saltwater Intrusion during Neap and Spring Tides	PLOS ONE			English	Article							SWAN-CANNING ESTUARY; SALT WEDGE ESTUARY; HONG-KONG; DYNAMICS; WATERS; NUTRIENTS; DIVERSITY	In recent decades, increasing frequency and intensity of saltwater intrusion in the Modaomen Channel has threatened the freshwater supply in the surrounding cities of the Pearl River Estuary, and ulteriorly changed the environmental conditions of the estuarine waters. Phytoplankton biomass, primary production (PP) and species composition, as well as hydrological and chemical parameters were examined along a downstream transect in the Modaomen Channel during neap tide (NT) and spring tide (ST), when a strong saltwater intrusion event occurred in late September, 2011. A total of 46 species phytoplankton were identified, including Bacillariophyta (25 species), Dinoflagellate (14 species), Chlorophyta (4 species), Cyanophyta (2 species) and Euglenozoa (1 species). The dominant species were shifted from freshwater diatoms (e.g., Melosira granulata and Melosira granulata var. angustissima) in the upper reaches to saline water diatoms (e.g., Skeletonema costatum and Coscinodiscus sp.) in the river mouth. Generally, phytoplankton density, biomass (chla) and PP decreased from the upper to lower reaches along the channel, and were significantly higher in NT than those of ST. There was a shift from large-sized phytoplankton (>20 mu m) in the upper reaches to relative small-sized cells (5-20 mu m) in the lower reaches. Compared to NT, low discharge and flow velocity, coupled with strong easterly winds during ST specially aggravated saltwater intrusion further to the upstream (similar to 50 km from the estuary). The intruded saltwater diluted nutrients, N/P ratios, chl-a, and phytoplankton abundances, and thereby led to a decline in PP during ST.	[Zhou, Weihua; Liao, Jianzu; Li, Tao; Guo, Yajuan; Long, Aimin] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Zhou, Weihua; Liao, Jianzu; Li, Tao; Guo, Yajuan; Long, Aimin] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China; [Zhou, Weihua; Liao, Jianzu; Li, Tao; Guo, Yajuan] Chinese Acad Sci, South China Sea Inst Oceanol, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China; [Gao, Jie] Guangdong Univ Foreign Studies, South China Business Coll, Guangzhou, Guangdong, Peoples R China; [Shi, Ronggui] State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China; [Liao, Jianzu; Guo, Yajuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Guangdong University of Foreign Studies; State Oceanic Administration; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, W; Long, AM (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.; Zhou, W; Long, AM (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China.; Zhou, W (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China.	whzhou@scsio.ac.en; longam@sciso.ac.en			Global Change Scientific Research Program of China [2010CB951201]; National Natural Science Fundiation of China [31370500, 31370499]	Global Change Scientific Research Program of China; National Natural Science Fundiation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Global Change Scientific Research Program of China through grant No. 2010CB951201 (http://program.most.gov.ch/), and the National Natural Science Fundiation of China through grants No. 31370500 and 31370499 (http:// www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y., 2008, SHIP BUILD, V49, P441; [包芸 Bao Yun], 2009, [中国科学. G辑, 物理学，力学，天文学, Science in China. Series G, Physics, Mechanics & Astronomy], V39, P1527; Behbehani, 1986, COASTAL EUTROPHICATI, P97; Brockway R, 2006, ESTUAR COAST SHELF S, V66, P1, DOI 10.1016/j.ecss.2005.07.014; [陈荣力 CHEN Rongli], 2011, [水动力学研究与进展. A辑, Journal of Hydrodynomics], V26, P312; Gong WP, 2011, CONT SHELF RES, V31, P769, DOI 10.1016/j.csr.2011.01.011; Haralambidou K, 2010, ESTUAR COAST SHELF S, V90, P174, DOI 10.1016/j.ecss.2010.08.010; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; HAYWARD D, 1982, SCIENCE, V216, P1413, DOI 10.1126/science.216.4553.1413; Ho AYT, 2010, ESTUAR COAST, V33, P170, DOI 10.1007/s12237-009-9247-8; Hu X., 2010, THESIS; Huang Liangmin, 1997, Marine Environmental Science, V16, P1; Huang LM, 2004, MAR POLLUT BULL, V49, P588, DOI 10.1016/j.marpolbul.2004.03.015; Jing ZY, 2013, EVOLUTION CAUSE ANAL, P118; JUSTIC D, 1995, ESTUAR COAST SHELF S, V40, P339, DOI 10.1016/S0272-7714(05)80014-9; Kasai A, 2010, ESTUAR COAST SHELF S, V86, P408, DOI 10.1016/j.ecss.2009.06.001; Knap A., 1996, PROTOCOLS JOINT GLOB, V1994, P19; Lai YS, 2011, ZHONGSHAN DAILY 0926; Li Kai-zhi, 2010, JOURNAL OF TROPICAL OCEANOGRAPHY, V29, P62; Liu JB., 2008, ACTA SCIENTIARUMNATU, V47, P122; Liu XF, 2010, GUANGDONG METEOROL, V32, P11; Long AM, 2013, J COASTAL RES, V29, P1158, DOI 10.2112/JCOASTRES-D-12-00182.1; Lu A., 2006, GUANGDONG WATER RESO, V2006, P50; Luo Lin, 2010, Journal of Tropical Oceanography, V29, P22; Nassar M. Z., 2000, THESIS; Paerl HW, 2007, ECOL APPL, V17, pS88, DOI 10.1890/05-0840.1; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Qiu DJ, 2010, CONT SHELF RES, V30, P177, DOI 10.1016/j.csr.2009.10.015; Scully ME, 2005, ESTUARIES, V28, P321, DOI 10.1007/BF02693915; SEKI H, 1980, Journal of the Oceanographical Society of Japan, V36, P30, DOI 10.1007/BF02209352; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shen PP, 2011, CONT SHELF RES, V31, P1672, DOI 10.1016/j.csr.2011.07.002; [石荣贵 Shi Ronggui], 2012, [海洋科学, Marine Sciences], V36, P86; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Sierra JP, 2002, CONT SHELF RES, V22, P361, DOI 10.1016/S0278-4343(01)00061-9; Specification for Oceanographic Survey, 2007, GB1276342007; Stephens R, 1996, MAR FRESHWATER RES, V47, P517, DOI 10.1071/MF9960517; Thompson PA, 2001, HYDROL PROCESS, V15, P2617, DOI 10.1002/hyp.289; Thompson PA, 1998, ESTUARIES, V21, P801, DOI 10.2307/1353282; Thomson DM, 2001, GLOBAL PLANET CHANGE, V32, P49, DOI 10.1016/S0921-8181(01)00149-7; Twomey L, 2001, HYDROL PROCESS, V15, P2655, DOI 10.1002/hyp.287; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Wang B, 2012, SCI CHINA EARTH SCI, V55, P1901, DOI 10.1007/s11430-012-4371-x; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wen P., 2007, J CHINA HYDROL, V27, P65; Wong MW, 1999, MAR ECOL PROG SER, V178, P133, DOI 10.3354/meps178133; Xu Z.L., 1989, J ECOL, V8, P13; Yin KD, 2004, CONT SHELF RES, V24, P1909, DOI 10.1016/j.csr.2004.06.015; YIN KD, 1995, ESTUAR COAST SHELF S, V40, P505, DOI 10.1006/ecss.1995.0035; Yin KD, 2000, MAR ECOL PROG SER, V194, P295, DOI 10.3354/meps194295; Yin KD, 2001, MAR ECOL PROG SER, V221, P17, DOI 10.3354/meps221017; Zhang X, 2014, J OCEAN U CHINA, V13, P73, DOI 10.1007/s11802-014-1972-3; Zhou MR, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P113, DOI 10.1007/1-4020-3655-8_8	53	23	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167630	10.1371/journal.pone.0167630	http://dx.doi.org/10.1371/journal.pone.0167630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907178	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700215
J	Finlayson, K; Lampe, JF; Hintze, S; Wurbel, H; Melotti, L				Finlayson, Kathryn; Lampe, Jessica Frances; Hintze, Sara; Wurbel, Hanno; Melotti, Luca			Facial Indicators of Positive Emotions in Rats	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; ANIMAL EMOTION; COGNITIVE BIAS; EAR POSTURES; PLAY; REWARD; PAIN; EXPRESSIONS; BEHAVIOR; STRESS	Until recently, research in animal welfare science has mainly focused on negative experiences like pain and suffering, often neglecting the importance of assessing and promoting positive experiences. In rodents, specific facial expressions have been found to occur in situations thought to induce negatively valenced emotional states (e.g., pain, aggression and fear), but none have yet been identified for positive states. Thus, this study aimed to investigate if facial expressions indicative of positive emotional state are exhibited in rats. Adolescent male Lister Hooded rats (Rattus norvegicus, N = 15) were individually subjected to a Positive and a mildly aversive Contrast Treatment over two consecutive days in order to induce contrasting emotional states and to detect differences in facial expression. The Positive Treatment consisted of playful manual tickling administered by the experimenter, while the Contrast Treatment consisted of exposure to a novel test room with intermittent bursts of white noise. The number of positive ultrasonic vocalisations was greater in the Positive Treatment compared to the Contrast Treatment, indicating the experience of differentially valenced states in the two treatments. The main findings were that Ear Colour became significantly pinker and Ear Angle was wider (ears more relaxed) in the Positive Treatment compared to the Contrast Treatment. All other quantitative and qualitative measures of facial expression, which included Eyeball height to width Ratio, Eyebrow height to width Ratio, Eyebrow Angle, visibility of the Nictitating Membrane, and the established Rat Grimace Scale, did not show differences between treatments. This study contributes to the exploration of positive emotional states, and thus good welfare, in rats as it identified the first facial indicators of positive emotions following a positive heterospecific play treatment. Furthermore, it provides improvements to the photography technique and image analysis for the detection of fine differences in facial expression, and also adds to the refinement of the tickling procedure.	[Finlayson, Kathryn; Lampe, Jessica Frances; Hintze, Sara; Wurbel, Hanno; Melotti, Luca] Univ Bern, Div Anim Welf, Bern, Switzerland	University of Bern	Melotti, L (corresponding author), Univ Bern, Div Anim Welf, Bern, Switzerland.	luca.melotti@vetsuisse.unibe.ch	; Wuerbel, Hanno/D-6281-2012	Lampe, Jessica/0000-0002-9062-3089; Wuerbel, Hanno/0000-0002-2934-3010	Swiss National Science Foundation [31003A_144088]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (Project n. 31003A_144088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardal SK, 2010, APPL PHARM; Boissy A, 2011, ANIM WELFARE, V20, P47; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Briefer EF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09989; Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burn CC, 2008, APPL ANIM BEHAV SCI, V112, P1, DOI 10.1016/j.applanim.2008.02.007; Butler A.B., 2005, COMP VERTEBRATE NEUR, Vsecond; BUTTNER D, 1982, LAB ANIM, V16, P319, DOI 10.1258/002367782780935913; Church JS, 2009, INFRAMATION 2009; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; DEBOER SF, 1989, PHYSIOL BEHAV, V45, P789, DOI 10.1016/0031-9384(89)90296-5; Defensor EB, 2012, PHYSIOL BEHAV, V107, P680, DOI 10.1016/j.physbeh.2012.03.024; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; GRANT RT, 1963, J PHYSIOL-LONDON, V167, P311, DOI 10.1113/jphysiol.1963.sp007151; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Inagaki H, 2005, EXP ANIM TOKYO, V54, P61, DOI 10.1538/expanim.54.61; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Lampe JF, UNPUB; Landers R., 2015, COMPUTING INTRACLASS; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Langford DJ, 2010, SOC NEUROSCI-UK, V5, P163, DOI 10.1080/17470910903216609; Leach M., 2012, P MEAS BEH 2012 8 IN, P238; LIU YC, 1995, IEEE T CONSUM ELECTR, V41, P460, DOI 10.1109/30.468045; Mahler M, 2014, LAB ANIM; Makowska IJ, 2013, APPL ANIM BEHAV SCI, V148, P1, DOI 10.1016/j.applanim.2013.07.017; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; Melotti L, 2014, ANIMAL BEHAV COGNITI; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Panksepp J., 1999, SCI CONSCIOUSNESS, P231; Parr LA, 2007, EMOTION, V7, P172, DOI 10.1037/1528-3542.7.1.172; Pellis SM, 1997, NEUROSCI BIOBEHAV R, V21, P105, DOI 10.1016/0149-7634(95)00060-7; PELLIS SM, 1992, BEHAV BRAIN RES, V50, P135, DOI 10.1016/S0166-4328(05)80295-5; Pinney CC, 2000, COMPLETE HOME VET GU; Proctor HS, 2014, APPL ANIM BEHAV SCI, V161, P20, DOI 10.1016/j.applanim.2014.09.015; Reefmann N, 2009, PHYSIOL BEHAV, V98, P235, DOI 10.1016/j.physbeh.2009.05.017; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siddiqui A, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000170; SIVIY SM, 1987, DEV PSYCHOBIOL, V20, P39, DOI 10.1002/dev.420200108; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Susskind Joshua M, 2008, Commun Integr Biol, V1, P148; VANDERPOEL AM, 1991, BEHAVIOUR, V119, P127, DOI 10.1163/156853991X00409; Vanderschuren LJMJ, 2010, AM J PLAY, V2, P315; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; Zebunke M, 2011, ANIM BEHAV, V81, P481, DOI 10.1016/j.anbehav.2010.11.023	73	58	58	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166446	10.1371/journal.pone.0166446	http://dx.doi.org/10.1371/journal.pone.0166446			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902721	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100025
J	Kalyani, M; Hasselfeld, K; Janik, JM; Callahan, P; Shi, HF				Kalyani, Manu; Hasselfeld, Kathryn; Janik, James M.; Callahan, Phyllis; Shi, Haifei			Effects of High-Fat Diet on Stress Response in Male and Female Wildtype and Prolactin Knockout Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GENE-EXPRESSION; BRAIN PROLACTIN; BASAL ACTIVITY; MESSENGER-RNA; RECEPTOR GENE; LEPTIN; MOUSE; RAT; CORTICOSTERONE	Prolactin (PRL) is well characterized for its roles in initiation and maintenance of lactation, and it also suppresses stress-induced responses. Feeding a high-fat diet (HFD) disrupts activity of the hypothalamic-pituitary-adrenal (HPA) axis. Whether PRL regulates HPA axis activation under HFD feeding is not clear. Male and female wildtype (WT) and PRL knockout (KO) mice were fed either a standard low-fat diet (LFD) or HFD for 12 weeks. Circulating corticosterone (CORT) levels were measured before, during, and after mice were subjected to an acute restraint stress or remained in their home cages as no stress controls. HFD feeding increased leptin levels, but the increase was lower in KO than in WT mice. All stressed female groups and only LFD-fed stressed males had elevated CORT levels compared to their no stress same-sex counterparts regardless of genotype. These results indicated that HFD consumption blunted the HPA axis response to acute stress in males but not females. Additionally, basal hypothalamic CRH content was lower in HFD than LFD males, but was similar among female groups. Furthermore, although basal CORT levels were similar among KO and WT groups, CORT levels were higher in KO mice than their WT counterparts during stress, suggesting that loss of PRL led to greater HPA axis activation. Basal PRL receptor mRNA levels in the choroid plexus were higher in HFD than LFD same-sex counterparts, suggesting activation of central PRL's action by HFD feeding in both males and females. Current results confirmed PRL's roles in suppression of the stress-induced HPA axis activation. Although HFD feeding activated central PRL's action in both sexes, only the male HPA axis was dampened by HFD feeding.	[Kalyani, Manu; Hasselfeld, Kathryn; Janik, James M.; Callahan, Phyllis; Shi, Haifei] Miami Univ, Dept Biol Physiol & Neurosci, Oxford, OH 45056 USA; [Janik, James M.; Callahan, Phyllis; Shi, Haifei] Miami Univ, Cell Mol & Struct Biol, Oxford, OH 45056 USA	Miami University; Miami University	Kalyani, M; Shi, HF (corresponding author), Miami Univ, Dept Biol Physiol & Neurosci, Oxford, OH 45056 USA.; Shi, HF (corresponding author), Miami Univ, Cell Mol & Struct Biol, Oxford, OH 45056 USA.	kalyanm@miamioh.edu; shih@miamioh.edu		Shi, Haifei/0000-0002-9523-7742	National Institutes of Health [DK046479, DK090823]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD046479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health DK046479 (JJ and PC) and DK090823 (HS), https://www.niddk.nih.gov/Pages/defaultaspx.; We are thankful for support from Miami University Senate Committee on Faculty Research (HS).	Auvinen HE, 2011, HORM METAB RES, V43, P899, DOI 10.1055/s-0031-1291305; Auvinen HE, 2012, J ENDOCRINOL, V214, P191, DOI 10.1530/JOE-12-0056; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Brandebourg TD, 2007, BIOCHEM BIOPH RES CO, V357, P408, DOI 10.1016/j.bbrc.2007.03.168; Clark KA, 2006, AM J PHYSIOL-REG I, V290, pR306, DOI 10.1152/ajpregu.00350.2005; Clark KA, 2008, BRAIN RES, V1195, P89, DOI 10.1016/j.brainres.2007.12.009; DEMAREST KT, 1985, NEUROENDOCRINOLOGY, V41, P504, DOI 10.1159/000124227; Fernandez-Guasti A, 2012, HORM METAB RES, V44, P607, DOI 10.1055/s-0032-1312592; Ferrini M, 1999, NEUROENDOCRINOLOGY, V69, P129, DOI 10.1159/000054411; Fleenor D, 2005, ENDOCRINOLOGY, V146, P103, DOI 10.1210/en.2004-0744; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Fujikawa T, 2005, ENDOCRINOLOGY, V146, P3471, DOI 10.1210/en.2004-1528; Fujikawa T, 2004, ENDOCRINOLOGY, V145, P2006, DOI 10.1210/en.2003-1446; FUJIKAWA T, 1995, ENDOCRINOLOGY, V136, P5608, DOI 10.1210/en.136.12.5608; GARTHWAITE TL, 1980, ENDOCRINOLOGY, V107, P671, DOI 10.1210/endo-107-3-671; GonzalezParra S, 1996, J NEUROENDOCRINOL, V8, P211, DOI 10.1046/j.1365-2826.1996.04526.x; HANDA RJ, 1994, PHYSIOL BEHAV, V55, P117, DOI 10.1016/0031-9384(94)90018-3; Handa RJ, 2014, FRONT NEUROENDOCRIN, V35, P197, DOI 10.1016/j.yfrne.2013.11.001; Heiman ML, 1997, ENDOCRINOLOGY, V138, P3859, DOI 10.1210/en.138.9.3859; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hler KD, 1974, ENDOCRINOLOGY, V94, P1003, DOI 10.1210/endo-94-4-1003; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Hsu HT, 2006, J CLIN ENDOCR METAB, V91, P2761, DOI 10.1210/jc.2005-2383; KITAY JI, 1963, ENDOCRINOLOGY, V73, P253, DOI 10.1210/endo-73-2-253; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kruse M, 1998, ENDOCR RES, V24, P587, DOI 10.3109/07435809809032650; LaPensee CR, 2006, ENDOCRINOLOGY, V147, P4638, DOI 10.1210/en.2006-0487; Ling C, 2001, ENDOCRINOLOGY, V142, P4880, DOI 10.1210/en.142.11.4880; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; MANGURIAN LP, 1992, ENDOCRINOLOGY, V131, P698, DOI 10.1210/en.131.2.698; Miller WJS, 2004, J NEUROSCI, V24, P10628, DOI 10.1523/JNEUROSCI.5540-03.2004; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Pecoraro N, 2006, PHYSIOL BEHAV, V89, P598, DOI 10.1016/j.physbeh.2006.07.019; Pi XJ, 2003, NEUROENDOCRINOLOGY, V77, P187, DOI 10.1159/000069510; Pi XJ, 2002, MOL BRAIN RES, V103, P130, DOI 10.1016/S0169-328X(02)00194-8; Seale JV, 2004, J NEUROENDOCRINOL, V16, P989, DOI 10.1111/j.1365-2826.2004.01258.x; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Torner L, 2004, EUR J NEUROSCI, V19, P1601, DOI 10.1111/j.1460-9568.2004.03264.x; Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vachon P, 2001, CONTEMP TOP LAB ANIM, V40, P22; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166416	10.1371/journal.pone.0166416	http://dx.doi.org/10.1371/journal.pone.0166416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893788	gold, Green Submitted, Green Published			2022-12-27	WOS:000389472400025
J	Alfonso-Gordillo, G; Flores-Ortiz, CM; Morales-Barrera, L; Cristiani-Urbina, E				Alfonso-Gordillo, Guadalupe; Flores-Ortiz, Cesar Mateo; Morales-Barrera, Liliana; Cristiani-Urbina, Eliseo			Biodegradation of Methyl Tertiary Butyl Ether (MTBE) by a Microbial Consortium in a Continuous Up-Flow Packed-Bed Biofilm Reactor: Kinetic Study, Metabolite Identification and Toxicity Bioassays	PLOS ONE			English	Article							SERVICE OIL DISTRIBUTION; PHOTOCATALYTIC DEGRADATION; AEROBIC BIODEGRADATION; STORAGE STATION; WATER; BIOREMEDIATION; OPTIMIZATION; BACTERIA; REMOVAL; WASTE	This study investigated the aerobic biodegradation of methyl tertiary-butyl ether (MTBE) by a microbial consortium in a continuous up-flow packed-bed biofilm reactor using tezontle stone particles as a supporting material for the biofilm. Although MTBE is toxic for microbial communities, the microbial consortium used here was able to resist MTBE loading rates up to 128.3 mg L-1 h(-1), with removal efficiencies of MTBE and chemical oxygen demand (COD) higher than 90%. A linear relationship was observed between the MTBE loading rate and the MTBE removal rate, as well as between the COD loading rate and the COD removal rate, within the interval of MTBE loading rates from 11.98 to 183.71 mg L-1 h(-1). The metabolic intermediate tertiary butyl alcohol (TBA) was not detected in the effluent during all reactor runs, and the intermediate 2-hydroxy butyric acid (2-HIBA) was only detected at MTBE loading rates higher than 128.3 mg L-1 h(-1). The results of toxicity bioassays with organisms from two different trophic levels revealed that the toxicity of the influent was significantly reduced after treatment in the packed-bed reactor. The packed-bed reactor system used in this study was highly effective for the continuous biodegradation of MTBE and is therefore a promising alternative for detoxifying MTBE-laden wastewater and groundwater.	[Alfonso-Gordillo, Guadalupe; Morales-Barrera, Liliana; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Mexico City, DF, Mexico; [Flores-Ortiz, Cesar Mateo] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biotecnol & Prototipos, Tlalnepantla, Estado De Mexic, Mexico; [Flores-Ortiz, Cesar Mateo] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Lab Nacl Salud, Tlalnepantla, Estado De Mexic, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Mexico City, DF, Mexico.	ecristianiu@yahoo.com.mx	Morales-Barrera, Liliana/GSD-2373-2022; MORALES-BARRERA, LILIANA/GSD-2320-2022	Cristiani-Urbina, Eliseo/0000-0002-8470-0711; Flores, Cesar M./0000-0002-5837-799X				Abdel-Razek MARS, 2013, J ENVIRON SCI HEAL B, V48, P449, DOI 10.1080/03601234.2013.761863; Acuna-Askar K, 2000, WATER SCI TECHNOL, V42, P153, DOI 10.2166/wst.2000.0509; Aivalioti M, 2012, J HAZARD MATER, V207, P117, DOI 10.1016/j.jhazmat.2011.03.040; Alfonso-Gordillo G, 2016, ELECTRON J BIOTECHN, V23, P12, DOI 10.1016/j.ejbt.2016.06.006; [Anonymous], [No title captured]; Bianchi E, 2009, J CHEM TECHNOL BIOT, V84, P871, DOI 10.1002/jctb.2133; BITTON G, 1992, REV ENVIRON CONTAM T, V125, P1; CALOW P, 1989, HYDROBIOLOGIA, V188, P61, DOI 10.1007/BF00027771; Chen DZ, 2009, J HAZARD MATER, V167, P860, DOI 10.1016/j.jhazmat.2009.01.065; Chen SC, 2011, J HAZARD MATER, V186, P1744, DOI 10.1016/j.jhazmat.2010.12.079; Company Hach, 2008, HACH WAT AN HDB; DEBEER D, 2013, PROKARYOTES, P343; DUTKA BJ, 1982, ENVIRON POLLUT A, V29, P125, DOI 10.1016/0143-1471(82)90116-7; Eixarch H, 2010, PROCESS BIOCHEM, V45, P794, DOI 10.1016/j.procbio.2009.12.015; Ercan D, 2015, CRIT REV BIOTECHNOL, V35, P1, DOI 10.3109/07388551.2013.793170; Gomez-De-Jesus A, 2003, ENG LIFE SCI, V3, P306, DOI 10.1002/elsc.200300052; Guisado IM, 2015, INT BIODETER BIODEGR, V97, P67, DOI 10.1016/j.ibiod.2014.11.008; Gunasekaran V, 2014, PROCESS BIOCHEM, V49, P124, DOI 10.1016/j.procbio.2013.09.028; Hu C, 2004, WATER SCI TECHNOL, V49, P87, DOI 10.2166/wst.2004.0026; Israni SH, 2002, J CHEM TECHNOL BIOT, V77, P1050, DOI 10.1002/jctb.677; Iturbe R, 2003, ENVIRON GEOL, V44, P608, DOI 10.1007/s00254-003-0799-9; Iturbe R, 2003, WATER AIR SOIL POLL, V146, P261, DOI 10.1023/A:1023967325239; Young BJ, 2012, ECOTOX ENVIRON SAFE, V76, P182, DOI 10.1016/j.ecoenv.2011.09.019; Karimi M, 2010, J CHROMATOGR A, V1217, P7017, DOI 10.1016/j.chroma.2010.09.015; Kharoune M, 2001, WATER RES, V35, P1665, DOI 10.1016/S0043-1354(00)00448-6; Kwak Y, 2013, BIOREMEDIAT J, V17, P173, DOI 10.1080/10889868.2013.807773; Lechner U, 2007, INT J SYST EVOL MICR, V57, P1295, DOI 10.1099/ijs.0.64663-0; Lee WM, 2015, CHEMOSPHERE, V128, P191, DOI 10.1016/j.chemosphere.2015.01.023; Levchuk I, 2014, SCI TOTAL ENVIRON, V476, P415, DOI 10.1016/j.scitotenv.2014.01.037; Li SS, 2014, CURR MICROBIOL, V68, P317, DOI 10.1007/s00284-013-0480-9; Li SS, 2015, ENVIRON SCI POLLUT R, V22, P10196, DOI 10.1007/s11356-015-4211-6; Logar R.M., 2007, COMMUN CURR RES ED T, P577; Lopez-Lopez A, 2013, ENVIRON TECHNOL, V34, P1151, DOI 10.1080/09593330.2012.743588; Maciel H, 2008, J MOL MICROB BIOTECH, V15, P190, DOI 10.1159/000121330; Maksimova YG, 2014, APPL BIOCHEM MICRO+, V50, P750, DOI 10.1134/S0003683814080043; Manzanares L, 2001, P 94 ANN C EXH AIR W; Martienssen M, 2006, J CONTAM HYDROL, V87, P37, DOI 10.1016/j.jconhyd.2006.04.007; Muller RH, 2007, APPL ENVIRON MICROB, V73, P1783, DOI 10.1128/AEM.01899-06; Netzahuatl-Munoz AR, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0137086, DOI 10.1371/JOURNAL.PONE.0137086]; Nicolella C, 2000, TRENDS BIOTECHNOL, V18, P312, DOI 10.1016/S0167-7799(00)01461-X; Okeke BC, 2003, MICROBIOL RES, V158, P99, DOI 10.1078/0944-5013-00181; Perez-Lopez H, 2014, BIORESOURCES, V9, P3977; Pimentel-Gonzalez D, 2008, PROCESS BIOCHEM, V43, P1239, DOI 10.1016/j.procbio.2008.07.004; Pourreau DB, 2015, P 3 ANN FOR EXCH TEC; Raynal M, 2008, BIODEGRADATION, V19, P269, DOI 10.1007/s10532-007-9133-7; Razo-Flores E, 2004, STUD SURF SCI CATAL, V151, P513; Reyna G, 2001, P 94 ANN C EXH AIR W; Rodriguez-Medina IC, 2009, J SEP SCI, V32, P3441, DOI 10.1002/jssc.200900298; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Roslev P, 2015, CHEMOSPHERE, V120, P284, DOI 10.1016/j.chemosphere.2014.07.003; Seddigi ZS, 2015, PHOTOCHEM PHOTOBIOL, V91, P265, DOI 10.1111/php.12391; Seddigi ZS, 2014, J HAZARD MATER, V264, P71, DOI 10.1016/j.jhazmat.2013.10.070; Siddiqui MN, 2014, J ENVIRON SCI HEAL A, V49, P52, DOI 10.1080/10934529.2013.824298; Tawabini BS, 2015, DESALIN WATER TREAT, V55, P549, DOI 10.1080/19443994.2014.924035; USDA Foreign Agricultural Service, 2009, MEX BIOF REP 2009; van Wezel A, 2009, CHEMOSPHERE, V76, P672, DOI 10.1016/j.chemosphere.2009.03.073; Volpe A, 2009, CHEMOSPHERE, V75, P149, DOI 10.1016/j.chemosphere.2008.12.053; Waul Christopher Kevin, 2007, V5, P213, DOI 10.1007/698_5_087; Wedekind W, 2011, ENVIRON EARTH SCI, V63, P1787, DOI 10.1007/s12665-011-1075-z; Wieczerzak M, 2016, ENVIRON INT, V94, P341, DOI 10.1016/j.envint.2016.05.017; Yanez-Ocampo G, 2011, BIODEGRADATION, V22, P1203, DOI 10.1007/s10532-011-9475-z; Yanez-Ocampo G, 2009, J HAZARD MATER, V168, P1554, DOI 10.1016/j.jhazmat.2009.03.047; ZUCCONI F, 1981, BIOCYCLE, V22, P54	64	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167494	10.1371/journal.pone.0167494	http://dx.doi.org/10.1371/journal.pone.0167494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907122	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700169
J	Bahramali, E; Askari, A; Zakeri, H; Farjam, M; Dehghan, A; Zendehdel, K				Bahramali, Ehsan; Askari, Alireza; Zakeri, Habib; Farjam, Mojtaba; Dehghan, Azizallah; Zendehdel, Kazem			Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; MORTALITY; TRENDS; EVENTS	Background Myocardial infarction (MI) is the leading cause of death in Iran. Every attempt to improve treatment patterns and patient outcomes needs a surveillance system to both consider the efficacy and safety measures. Fasa Registry on Myocardial Infarction (FaRMI) is the first population-based registry for acute MI in Iran targeted to provide meticulous description of patients' characteristics, to explore the management patterns of these patients, to discover the degree of adherence to the practice guidelines, and to investigate the determinants of poor in-hospital and later outcomes. Methods A diagnosis of acute MI (type I, II and III) was made upon the accepted criteria by the attending cardiologists and types IV and V MI were excluded. Two registrar nurses gathered data on demographics, place of residence and ethnicity, past medical history, risk factors, and the clinical course. Management patterns in the pre-hospital setting, during the hospital stay and at the discharge time were recorded. Routine laboratory results and cardiac biomarkers on three consecutive days were registered. Results pilot phase included the first 95 patients, 63.5% of whom were men and 31.5% were women. With a mean age of 62.89 +/- 13.75 years among participants, the rate of premature MI was 31.8%. ST segment elevation MI accounted for 68.2% cases and inferior wall was the most prevalent region involved followed by anterior and posterior walls. Discussion Obtained data on the characteristics of patients suffering an MI event revealed the major determinants of delay in initiation of therapies and contributors of poor outcome. Completeness of data was guaranteed upon involvement of multiple checkpoints and data quality was secured by means of automatic validation processes in addition to weekly physicians' roundups. Conclusion Execution of FaRMI in the form presented is feasible and it will build up a comprehensive population-based registry for MI in the region.	[Bahramali, Ehsan] Fasa Univ Med Sci, Dept Cardiol, Fasa, Iran; [Bahramali, Ehsan; Zakeri, Habib; Farjam, Mojtaba; Dehghan, Azizallah] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Askari, Alireza] Shiraz Univ Med Sci, Fac Med, Shiraz, Iran; [Farjam, Mojtaba] Fasa Univ Med Sci, Sch Med, Dept Med Pharmacol, Fasa, Iran; [Zendehdel, Kazem] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran	Shiraz University of Medical Science; Tehran University of Medical Sciences	Bahramali, E (corresponding author), Fasa Univ Med Sci, Dept Cardiol, Fasa, Iran.; Bahramali, E (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	ebahramali@fums.ac.ir	Dehghan, Azizallah/ABG-3704-2020; Farjam, Mojtaba/O-3475-2017; Dehghan, Azizallah/S-9306-2018; Askari, Alireza/Z-2099-2019; bahramali, ehsan/M-2673-2017; Zakeri, Habib/N-2431-2017	Dehghan, Azizallah/0000-0002-7345-0796; Farjam, Mojtaba/0000-0003-4826-2846; Zakeri, Habib/0000-0003-2495-8507; Bahramali, Ehsan/0000-0001-5454-0406; Zendehdel, Kazem/0000-0002-0269-4945	Iranian ministry of health, national center [1290007/10516]	Iranian ministry of health, national center	This work was funded by Iranian ministry of health, national center for disease registries grant number 1290007/10516 (http://hbi.ir/Forms/Special.aspx?hbsld=774&category=1&templateid=1&hdlld=61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnasser SMA, 2015, AM J MED, V128, P766, DOI 10.1016/j.amjmed.2014.12.007; Brown TM, 2015, AM HEART J, V170, P249, DOI 10.1016/j.ahj.2015.04.027; Degano IR, 2015, HEART, V101, P1413, DOI 10.1136/heartjnl-2014-307310; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Khademi H, 2012, OPIUM USE MORTALITY; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Schmidt Morten, 2012, BMJ, V344, pe356, DOI 10.1136/bmj.e356; Smolina Kate, 2012, BMJ, V344, pd8059, DOI 10.1136/bmj.d8059; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001	11	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167579	10.1371/journal.pone.0167579	http://dx.doi.org/10.1371/journal.pone.0167579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907128	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700202
J	Bernardino, T; Tatemoto, P; Morrone, B; Rodrigues, PHM; Zanella, AJ				Bernardino, Thiago; Tatemoto, Patricia; Morrone, Beatrice; Mazza Rodrigues, Paulo Henrique; Zanella, Adroaldo Jose			Piglets Born from Sows Fed High Fibre Diets during Pregnancy Are Less Aggressive Prior to Weaning	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; PRENATAL STRESS; GROWING PIGS; FOOD RESTRICTION; GENE-EXPRESSION; BLOOD-GLUCOSE; SKIN-LESIONS; DOMESTIC PIG; BEHAVIOR; PERFORMANCE	Aggressive interactions, and their consequences, are the most important causes of poor welfare in piglets. Aggressive behaviour can be modulated by the prenatal and neonatal environment in several species. Commercially kept pregnant sows are often subjected to food restriction, which can compromise their welfare. Limited information is available on the consequences of sow hunger during pregnancy on welfare outcomes for their piglets. High fibre diets can mitigate the feeling of hunger and, consequently, it may improve welfare and productivity measures. The aim of this study was to assess the consequences of feeding pregnant gilts with high fibre diets (HFD) on agonistic behaviour, as manifested by skin lesions, and indicators of fear in their piglets at weaning. Twenty-two pregnant gilts were fed either HFD, 12.86% of crude fibre, 2.4 kg per day (N = 14), or low fibre diet (LFD), 2.53% of crude fibre, 2.0 kg per day (N = 8). During lactation, both treatments received the same diet, ad libitum. We investigated the impact of HFD on behaviour and performance measures (birth weight, average daily gain, weaning weight, see S3 File) in the offspring. Skin lesions were evaluated before and after weaning in 156 piglets (100 HFD and 56 LFD), and 142 piglets were subjected to an open field test and a novel object test (87 HFD and 55 LFD). We found no treatment effect on the performance measures. Piglets born from gilts that received HFD had fewer skin lesions before weaning (D28) than the offspring of LFD gilts, while no difference was found during days 29 and 30. In the open field and novel object tests, there was no treatment effect on the behaviour of piglets. The improved skin health at weaning in piglets of sows fed HFD suggests less agonistic interactions amongst these littermates than in piglets of sows fed LFD.	[Bernardino, Thiago; Tatemoto, Patricia; Morrone, Beatrice; Zanella, Adroaldo Jose] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Prevent Vet Med & Anim Hlth, Pirassununga, Brazil; [Mazza Rodrigues, Paulo Henrique] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Nutr & Prod, Pirassununga, Brazil; [Bernardino, Thiago; Tatemoto, Patricia; Morrone, Beatrice; Mazza Rodrigues, Paulo Henrique; Zanella, Adroaldo Jose] Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zanella, AJ (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Prevent Vet Med & Anim Hlth, Pirassununga, Brazil.; Zanella, AJ (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, Brazil.	adroaldo.zanella@usp.br	Bernardino, Thiago/I-2939-2016; Zanella, Adroaldo J/G-7775-2014; Rodrigues, Paulo HM/O-2689-2017	Bernardino, Thiago/0000-0002-2146-0669; Zanella, Adroaldo J/0000-0002-5505-1679; Rodrigues, Paulo HM/0000-0002-4646-6805	Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Science, University of Sao Paulo; CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [312985/2013-4]	Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Science, University of Sao Paulo; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funds were provided by the Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Science, University of Sao Paulo, with resources from CAPES, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (award 312985/2013-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algers B., 2007, EFSA J, V572, P1; Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; APPLEBY MC, 1987, ANIM PROD, V45, P103, DOI 10.1017/S0003356100036680; Bolhuis JE, 2010, APPL ANIM BEHAV SCI, V123, P77, DOI 10.1016/j.applanim.2010.01.010; BROUNS F, 1994, APPL ANIM BEHAV SCI, V39, P215, DOI 10.1016/0168-1591(94)90157-0; Brunton PJ, 2013, REPRODUCTION, P146; Camerlink I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113502; Coulon M, 2013, PSYCHONEUROENDOCRINO, V38, P1112, DOI 10.1016/j.psyneuen.2012.10.018; Couret D, 2009, PHYSIOL BEHAV, V98, P498, DOI 10.1016/j.physbeh.2009.08.003; de Leeuw JA, 2005, APPL ANIM BEHAV SCI, V94, P15, DOI 10.1016/j.applanim.2005.02.006; de Leeuw JA, 2004, J NUTR, V134, P1481, DOI 10.1093/jn/134.6.1481; DELL PA, 1987, PHYSIOL BEHAV, V39, P187, DOI 10.1016/0031-9384(87)90008-4; Gentilini FP, CIENCIA RURAL; Guy JH, 2009, ANIM WELFARE, V18, P249; Harris MJ, 2001, APPL ANIM BEHAV SCI, V74, P153, DOI 10.1016/S0168-1591(01)00160-5; Holt JP, 2006, J ANIM SCI, V84, P946, DOI 10.2527/2006.844946x; Janczak AM, 2003, APPL ANIM BEHAV SCI, V81, P13, DOI 10.1016/S0168-1591(02)00252-6; Jarvis S, 2006, HORM BEHAV, V49, P68, DOI 10.1016/j.yhbeh.2005.05.004; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; LAWRENCE AB, 1988, ANIM PROD, V47, P131, DOI 10.1017/S0003356100037132; Lepionka L, 1997, REPROD NUTR DEV, V37, P449, DOI 10.1051/rnd:19970406; Meunier-Salaun MC, 2001, ANIM FEED SCI TECH, V90, P53, DOI 10.1016/S0377-8401(01)00196-1; Morgan CA, 1998, APPL ANIM BEHAV SCI, V58, P23, DOI 10.1016/S0168-1591(97)00141-X; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Petit B, 2015, BEHAV BRAIN RES, V291, P155, DOI 10.1016/j.bbr.2015.05.025; Poltyrev T, 1996, DEV PSYCHOBIOL, V29, P453, DOI 10.1002/(SICI)1098-2302(199607)29:5<453::AID-DEV4>3.0.CO;2-N; Puppe B, 2007, APPL ANIM BEHAV SCI, V105, P75, DOI 10.1016/j.applanim.2006.05.016; Rerat A, 1996, REPROD NUTR DEV, V36, P3, DOI 10.1051/rnd:19960101; ROBERT S, 1993, APPL ANIM BEHAV SCI, V37, P297, DOI 10.1016/0168-1591(93)90119-A; Rutherford KMD, 2014, PHYSIOL BEHAV, V129, P255, DOI 10.1016/j.physbeh.2014.02.052; Souza AS, 2006, APPL ANIM BEHAV SCI, V99, P77, DOI 10.1016/j.applanim.2005.09.008; Tuchscherer M, 2002, VET IMMUNOL IMMUNOP, V86, P195, DOI 10.1016/S0165-2427(02)00035-1; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Veum TL, 2009, J ANIM SCI, V87, P1003, DOI 10.2527/jas.2008-1119; Yuan Y, 2004, APPL ANIM BEHAV SCI, V88, P39, DOI 10.1016/j.applanim.2004.01.012; Zonderland JJ, 2004, APPL ANIM BEHAV SCI, V87, P15, DOI 10.1016/j.applanim.2003.12.009	37	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167363	10.1371/journal.pone.0167363	http://dx.doi.org/10.1371/journal.pone.0167363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907173	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700129
J	Cheng, Y; Zhao, G; Zhang, SW; Nigim, F; Zhou, GT; Yu, ZY; Song, Y; Chen, Y; Li, YQ				Cheng, Ye; Zhao, Gang; Zhang, Siwen; Nigim, Fares; Zhou, Guangtong; Yu, Zhiyun; Song, Yang; Chen, Yong; Li, Yunqian			AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin	PLOS ONE			English	Article							MESSENGER-RNA; ADJUVANT TEMOZOLOMIDE; TUMOR-GROWTH; CANCER; PROTEIN; AS1411; DNA; APTAMER; GLIOBLASTOMA; EXPRESSION	AS1411 binds nucleolin (NCL) and is the first oligodeoxynucleotide aptamer to reach phase I and II clinical trials for the treatment of several cancers. However, the mechanisms by which AS1411 targets and kills glioma cells and tissues remain unclear. Here we report that AS1411 induces cell apoptosis and cycle arrest, and inhibits cell viability by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 in human glioma cells. NCL was overexpressed in both nucleus and cytoplasm in human glioma U87, U251 and SHG44 cells compared to normal human astrocytes (NHA). AS1411 bound NCL and inhibited the proliferation of glioma cells but not NHA, which was accompanied with up-regulation of p53 and down-regulation of Bcl-2 and Akt1. Moreover, AS1411 treatment resulted in the G2/M cell cycle arrest in glioma cells, which was however abolished by overexpression of NCL. Further, AS1411 induced cell apoptosis, which was prevented by silencing of p53 and overexpression of Bcl-2. In addition, AS1411 inhibited the migration and invasion of glioma cells in an Akt1-dependent manner. Importantly, AS1411 inhibited the growth of glioma xenograft and prolonged the survival time of glioma tumor-bearing mice. These results revealed a promising treatment of glioma by oligodeoxynucleotide aptamer.	[Cheng, Ye; Zhao, Gang; Zhou, Guangtong; Yu, Zhiyun; Song, Yang; Chen, Yong; Li, Yunqian] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Peoples R China; [Zhang, Siwen] Jilin Univ, Hosp 1, Dept Endocrine, Changchun, Peoples R China; [Cheng, Ye; Nigim, Fares] Harvard Med Sch, Dept Neurosurg, Boston, MA USA	Jilin University; Jilin University; Harvard University; Harvard Medical School	Chen, Y; Li, YQ (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Peoples R China.	chenyong_jdyy@163.com; liyunqian_jdyy@163.com		yu, zhiyun/0000-0002-9773-4769	National Natural Science Foundation of China [21401072, 81672505]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by grants from National Natural Science Foundation of China (Nos. 21401072 and 81672505). This work was supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Young Scientists Fund of the National Natural Science Foundation of China (No.21401072); This work was supported by China Scholarship Council.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Benedetti E, 2015, ONCOTARGET, V6, P42091, DOI 10.18632/oncotarget.5990; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Chen Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2091; Cheng Y, 2016, ONCOTARGET, V7, P12682, DOI 10.18632/oncotarget.7259; Galzio R, 2012, J CELL BIOCHEM, V113, P571, DOI 10.1002/jcb.23381; Gao HL, 2014, ACTA BIOMATER, V10, P858, DOI 10.1016/j.actbio.2013.11.003; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Gimenez M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1473-9; Ginisty H, 1999, J CELL SCI, V112, P761; Gleave ME, 2005, NAT REV CANCER, V5, P468, DOI 10.1038/nrc1631; Goldshmit Y, 2014, ONCOTARGET, V5, P8602, DOI 10.18632/oncotarget.2343; Griffin SV, 2006, J BIOL CHEM, V281, P28048, DOI 10.1074/jbc.M513336200; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Koutsioumpa M, 2014, RECENT PAT ANTI-CANC, V9, DOI 10.2174/1574892808666131119095953; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Ma HW, 2014, BIOCHEM BIOPH RES CO, V449, P44, DOI 10.1016/j.bbrc.2014.04.148; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; Mu QC, 2015, CANCER BIOL THER, V16, P623, DOI 10.1080/15384047.2015.1019185; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Perrone R, 2016, INT J ANTIMICROB AG, V47, P311, DOI 10.1016/j.ijantimicag.2016.01.016; Pich A, 2000, MICRON, V31, P133, DOI 10.1016/S0968-4328(99)00070-0; Pichiorri F, 2013, J EXP MED, V210, P951, DOI 10.1084/jem.20120950; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Seinsoth S, 2003, EMBO REP, V4, P263, DOI 10.1038/sj.embor.embor770; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vlatkovic N, 2014, CELL MOL LIFE SCI, V71, P771, DOI 10.1007/s00018-013-1361-x; Watanabe T, 2010, BIOL PHARM BULL, V33, P796, DOI 10.1248/bpb.33.796; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Xu ZQ, 2012, J NEURO-ONCOL, V108, P59, DOI 10.1007/s11060-012-0827-2; Zhang GQ, 2016, BIOCHEM BIOPH RES CO, V469, P189, DOI 10.1016/j.bbrc.2015.11.099; Zhang HJ, 2013, CURR PHARM BIOTECHNO, V14, P1105, DOI 10.2174/1389201015666140408123710	51	25	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167094	10.1371/journal.pone.0167094	http://dx.doi.org/10.1371/journal.pone.0167094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907160	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700076
J	Cortese, G; Gandasi, NR; Barge, S; Pedersen, MG				Cortese, Giuliana; Gandasi, Nikhil R.; Barge, Sebastian; Pedersen, Morten Gram			Statistical Frailty Modeling for Quantitative Analysis of Exocytotic Events Recorded by Live Cell Imaging: Rapid Release of Insulin-Containing Granules Is Impaired in Human Diabetic beta-cells	PLOS ONE			English	Article							SECRETORY GRANULES; CHROMAFFIN CELLS; CA2+ CHANNELS; PEPTIDE SECRETION; CALCIUM; DYNAMICS; DISSOCIATION; VESICLES; SYNTAXIN; DOCKING	Hormones and neurotransmitters are released when secretory granules or synaptic vesicles fuse with the cell membrane, a process denoted exocytosis. Modern imaging techniques, in particular total internal reflection fluorescence (TIRF) microscopy, allow the investigator to monitor secretory granules at the plasma membrane before and when they undergo exocytosis. However, rigorous statistical approaches for temporal analysis of such exocytosis data are still lacking. We propose here that statistical methods from time-to-event (also known as survival) analysis are well suited for the problem. These methods are typically used in clinical settings when individuals are followed over time to the occurrence of an event such as death, remission or conception. We model the rate of exocytosis in response to pulses of stimuli in insulin-secreting pancreatic beta-cell from healthy and diabetic human donors using piecewise-constant hazard modeling. To study heterogeneity in the granule population we exploit frailty modeling, which describe unobserved differences in the propensity to exocytosis. In particular, we insert a discrete frailty in our statistical model to account for the higher rate of exocytosis in an immediately releasable pool (IRP) of insulin-containing granules. Estimates of parameters are obtained from maximum-likelihood methods. Since granules within the same cell are correlated, i.e., the data are clustered, a modified likelihood function is used for log-likelihood ratio tests in order to perform valid inference. Our approach allows us for example to estimate the size of the IRP in the cells, and we find that the IRP is deficient in diabetic cells. This novel application of time-to-event analysis and frailty modeling should be useful also for the study of other well-defined temporal events at the cellular level.	[Cortese, Giuliana] Univ Padua, Dept Stat Sci, Padua, Italy; [Gandasi, Nikhil R.; Barge, Sebastian] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Pedersen, Morten Gram] Univ Padua, Dept Informat Engn, Padua, Italy	University of Padua; Uppsala University; University of Padua	Pedersen, MG (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	pedersen@dei.unipd.it	Cortese, Giuliana/AAA-1603-2020; Pedersen, Morten Gram/P-5247-2019; Barg, Sebastian/F-9523-2010; Pedersen, Morten/F-4134-2012; Gandasi, Nikhil R/F-2164-2018	Pedersen, Morten Gram/0000-0002-2639-2394; Barg, Sebastian/0000-0003-4661-5724; Pedersen, Morten/0000-0002-2639-2394; Gandasi, Nikhil R/0000-0001-9400-6494	University of Padova; Swedish Society for Medical Research; European Foundation for the Study of Diabetes; Swedish Science Council; Diabetes Wellness Network Sweden; Swedish Diabetes Society; Barndiabetesfonden; Hjarnfonden; NovoNordisk-foundation; Goran Gustafsson-foundation; Family Ernfors-foundation; OE&E Johanssons-foundation; European Foundation for the Study of Diabetes via the EFSD/Boehringer Ingelheim Basic Programme; University of Padua via the Strategic Project 'DYCENDI'; Novo Nordisk Fonden [NNF15OC0016260, NNF14OC0010001] Funding Source: researchfish; European Foundation for the Study of Diabetes [Lilly FS 2016_9, BI 2014_5] Funding Source: researchfish	University of Padova; Swedish Society for Medical Research; European Foundation for the Study of Diabetes; Swedish Science Council; Diabetes Wellness Network Sweden; Swedish Diabetes Society; Barndiabetesfonden; Hjarnfonden; NovoNordisk-foundation(Novo Nordisk Foundation); Goran Gustafsson-foundation; Family Ernfors-foundation; OE&E Johanssons-foundation; European Foundation for the Study of Diabetes via the EFSD/Boehringer Ingelheim Basic Programme; University of Padua via the Strategic Project 'DYCENDI'; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	This work was supported by the University of Padova to GC. NG received support from the Swedish Society for Medical Research and the European Foundation for the Study of Diabetes. SB acknowledges support from the Swedish Science Council, Diabetes Wellness Network Sweden, the Swedish Diabetes Society, the European Foundation for the Study of Diabetes, Barndiabetesfonden, Hjarnfonden, and the NovoNordisk-, Goran Gustafsson-, Family Ernfors-, and OE&E Johanssons-foundations. MGP was supported by the European Foundation for the Study of Diabetes via the EFSD/Boehringer Ingelheim Basic Programme, and the University of Padua via the Strategic Project 'DYCENDI'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arai Mahmood, 2015, CLUSTER ROBUST STAND; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bertuzzi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE396, DOI 10.1152/ajpendo.00647.2006; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chandler RE, 2007, BIOMETRIKA, V94, P167, DOI 10.1093/biomet/asm015; Claeskens G, 2008, TEST, V17, P69, DOI 10.1007/s11749-006-0023-9; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Cortese G, 2010, BIOMETRICAL J, V52, P138, DOI 10.1002/bimj.200900076; Cortese G, 2010, STAT METHODS MED RES, V19, P5, DOI 10.1177/0962280209105022; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Davison A., 2003, STAT MODELS; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Gandasi NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127801; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Gilbert P., 2016, NUMDERIV ACCURATE NU; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Karatekin E, 2008, BIOPHYS J, V94, P2891, DOI 10.1529/biophysj.107.116756; Klein JP, 2005, SURVIVAL ANAL TECHNI; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; Midorikawa M, 2015, NEURON, V88, P492, DOI 10.1016/j.neuron.2015.09.047; Montefusco F, 2015, J PHYSIOL-LONDON, V593, P4519, DOI 10.1113/JP270777; Moser T, 1997, J NEUROSCI, V17, P2314; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Pedersen MG, 2010, J NEUROENDOCRINOL, V22, P1315, DOI 10.1111/j.1365-2826.2010.02056.x; Pedersen MG, 2008, PHILOS T R SOC A, V366, P3525, DOI 10.1098/rsta.2008.0120; Pedersen MG, 2011, BIOPHYS J, V101, P793, DOI 10.1016/j.bpj.2011.06.061; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Rua SMH, 2016, STAT METHODS MED RES, V25, P167, DOI 10.1177/0962280212445658; Stabley DR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9307; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Toomre Derek, 2012, Cold Spring Harb Protoc, V2012, P439, DOI 10.1101/pdb.ip068676; Trexler AJ, 2016, MOL BIOL CELL, V27, P2423, DOI 10.1091/mbc.E16-01-0057; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Wienke A., 2010, FRAILTY MODELS SURVI, DOI [10.1201/9781420073911, DOI 10.1201/9781420073911]; Yu BB, 2008, COMPUT STAT DATA AN, V52, P1524, DOI 10.1016/j.csda.2007.04.018	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167282	10.1371/journal.pone.0167282	http://dx.doi.org/10.1371/journal.pone.0167282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907065	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700110
J	Ferraro, M; Masetti, M; Recanatini, M; Cavalli, A; Bottegoni, G				Ferraro, Mariarosaria; Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea; Bottegoni, Giovanni			Mapping Cholesterol Interaction Sites on Serotonin Transporter through Coarse Grained Molecular Dynamics	PLOS ONE			English	Article							X-RAY STRUCTURES; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; BINDING-SITE; SUBSTRATE-BINDING; BACTERIAL HOMOLOG; MEMBRANE-PROTEINS; LIPID RAFTS; MECHANISM; SIMULATIONS	Serotonin transporter (SERT) modulates serotonergic signaling via re-uptake of serotonin in pre-synaptic cells. The inclusion in cholesterol-enriched membrane domains is crucial for SERT activity, suggesting a cross-talk between the protein and the sterol. Here, we develop a protocol to identify potential cholesterol interaction sites coupling statistical analysis to multi-microsecond coarse-grained molecular dynamics simulations of SERT in a previously validated raft-like membrane model. Six putative sites were found, including a putative CRAC motif on TM4 and a CARC motif on TM10. Among them, four hot-spots near regions related to ion binding, transport, and inhibition were detected. Our results encourage prospective studies to unravel mechanistic features of the transporter and related drug discovery implications.	[Ferraro, Mariarosaria; Cavalli, Andrea; Bottegoni, Giovanni] Ist Italiano Tecnol, CompuNet, Genoa, Italy; [Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy; [Bottegoni, Giovanni] BiKi Technol Srl, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Bologna	Bottegoni, G (corresponding author), Ist Italiano Tecnol, CompuNet, Genoa, Italy.; Masetti, M (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy.; Bottegoni, G (corresponding author), BiKi Technol Srl, Genoa, Italy.	matteo.masetti4@unibo.it; giovanni.bottegoni@iit.it	Recanatini, Maurizio/AAU-3319-2021; Recanatini, Maurizio/GXH-1338-2022	Recanatini, Maurizio/0000-0002-0039-0518; Bottegoni, Giovanni/0000-0003-1251-583X; CAVALLI, ANDREA/0000-0002-6370-1176				Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bjerregaard H, 2015, J BIOL CHEM, V290, P7747, DOI 10.1074/jbc.M114.573477; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Cang XH, 2014, PROTEINS, V82, P760, DOI 10.1002/prot.24456; Cang XH, 2013, J PHYS CHEM B, V117, P1085, DOI 10.1021/jp3118192; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen FH, 2005, J NEUROCHEM, V92, P21, DOI 10.1111/j.1471-4159.2004.02835.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; de Jong DH, 2012, J CHEM THEORY COMPUT, V8, P1003, DOI 10.1021/ct200599d; Divito CB, 2009, MOL INTERV, V9, P252, DOI 10.1124/mi.9.5.8; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Ferraro M, 2015, RSC ADV, V5, P37102, DOI 10.1039/c5ra02196k; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Grouleff J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00235; Grouleff J, 2015, BBA-BIOMEMBRANES, V1848, P1783, DOI 10.1016/j.bbamem.2015.03.029; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Hedger G., 2016, BIOCH BIOPHYS ACTA; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2015, BBA-BIOMEMBRANES, V1848, P1765, DOI 10.1016/j.bbamem.2015.03.025; Koldso H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00208; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Koldso H, 2013, ACS CHEM NEUROSCI, V4, P295, DOI 10.1021/cn300148r; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Kortagere S, 2013, NEUROPHARMACOLOGY, V72, P282, DOI 10.1016/j.neuropharm.2013.04.026; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kufareva I, 2014, STRUCTURE, V22, P1120, DOI 10.1016/j.str.2014.06.012; Lee JY, 2012, J AM CHEM SOC, V134, P16512, DOI 10.1021/ja307532d; Loland CJ, 2015, BBA-GEN SUBJECTS, V1850, P500, DOI 10.1016/j.bbagen.2014.04.011; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Midzak AS, 2015, PHARMACOL RES, V99, P393, DOI 10.1016/j.phrs.2015.03.023; Mortensen OV, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00223; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Paila YD, 2009, BBA-BIOMEMBRANES, V1788, P295, DOI 10.1016/j.bbamem.2008.11.020; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Saliba AE, 2015, NAT REV MOL CELL BIO, V16, P753, DOI 10.1038/nrm4080; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Sengupta D, 2015, BBA-BIOMEMBRANES, V1848, P1775, DOI 10.1016/j.bbamem.2015.03.018; Sengupta D, 2012, J PHYS CHEM B, V116, P12991, DOI 10.1021/jp309888u; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sonnino S, 2013, CURR MED CHEM, V20, P4; Stockner T, 2014, SPRINGER SER BIOPHYS, V17, P99, DOI 10.1007/978-3-642-53839-1_5; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wenthur CJ, 2010, BIOCHEM PHARMACOL, V80, P1418, DOI 10.1016/j.bcp.2010.07.005; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	72	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166196	10.1371/journal.pone.0166196	http://dx.doi.org/10.1371/journal.pone.0166196			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907003	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700019
J	Koopman, C; Vaartjes, I; van Dis, I; Verschuren, WMM; Engelfriet, P; Heintjes, EM; Blokstra, A; Deeg, DJH; Visser, M; Bots, ML; O'Flaherty, M; Capewell, S				Koopman, Carla; Vaartjes, Ilonca; van Dis, Ineke; Verschuren, W. M. Monique; Engelfriet, Peter; Heintjes, Edith M.; Blokstra, Anneke; Deeg, Dorly J. H.; Visser, Marjolein; Bots, Michiel L.; O'Flaherty, Martin; Capewell, Simon			Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; COHORT PROFILE; RISK-FACTORS; DECREASE; IRELAND; RATES	Objective We set out to determine what proportion of the mortality decline from 1997 to 2007 in coronary heart disease (CHD) in the Netherlands could be attributed to advances in medical treatment and to improvements in population-wide cardiovascular risk factors. Methods We used the IMPACT-SEC model. Nationwide information was obtained on changes between 1997 and 2007 in the use of 42 treatments and in cardiovascular risk factor levels in adults, aged 25 or over. The primary outcome was the number of CHD deaths prevented or postponed. Results The age-standardized CHD mortality fell by 48% from 269 to 141 per 100.000, with remarkably similar relative declines across socioeconomic groups. This resulted in 11,200 fewer CHD deaths in 2007 than expected. The model was able to explain 72% of the mortality decline. Approximately 37% (95% CI: 10%-80%) of the decline was attributable to changes in acute phase and secondary prevention treatments: the largest contributions came from treating patients in the community with heart failure (11%) or chronic angina (9%). Approximately 36% (24%-67%) was attributable to decreases in risk factors: blood pressure (30%), total cholesterol levels (10%), smoking (5%) and physical inactivity (1%). Ten% more deaths could have been prevented if body mass index and diabetes would not have increased. Overall, these findings did not vary across socioeconomic groups, although within socioeconomic groups the contribution of risk factors differed. Conclusion CHD mortality has recently halved in The Netherlands. Equally large contributions have come from the increased use of acute and secondary prevention treatments and from improvements in population risk factors (including primary prevention treatments). Increases in obesity and diabetes represent a major challenge for future prevention policies.	[Koopman, Carla; Vaartjes, Ilonca; Verschuren, W. M. Monique; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Koopman, Carla; Vaartjes, Ilonca; van Dis, Ineke] Dutch Heart Fdn, The Hague, Netherlands; [Verschuren, W. M. Monique; Engelfriet, Peter; Blokstra, Anneke] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Heintjes, Edith M.] PHARMO Inst Drug Res, Utrecht, Netherlands; [Deeg, Dorly J. H.; Visser, Marjolein] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam Med Ctr, Dept Dietet & Nutr Sci, Internal Med, Amsterdam, Netherlands; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool, Merseyside, England	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Liverpool	Vaartjes, I (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Vaartjes, I (corresponding author), Dutch Heart Fdn, The Hague, Netherlands.	C.H.Vaartjes@umcutrecht.nl	Visser, Marjolein/AAP-3224-2020	Visser, Marjolein/0000-0002-5136-298X	Dutch Heart Foundation [2008T111]; MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: researchfish	Dutch Heart Foundation(Netherlands Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CK and IV are supported by a grant from the Dutch Heart Foundation (grant 2008T111, http://www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NM, 2012, BMJ OPEN, P2; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Bruggink JW, 2009, BEVOLK INGSTRENDS 4E; Bruthans J, 2014, EUR J PREV CARDIOL, V21, P829, DOI 10.1177/2047487312469476; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Herings R., 2012, PHARMACOEPIDEM DR S, P270, DOI [10.1002/9781119959946.ch18, DOI 10.1002/9781119959946.CH18]; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, P1088; Hughes J, 2013, EUR J PREV CARDIOL, V20, P310, DOI 10.1177/2047487312441725; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; Kabir Z, 2013, INT J CARDIOL, V168, P2462, DOI 10.1016/j.ijcard.2013.03.007; Knol F, 1998, HIGH LOW LOW HIGH DE; Knol FA, 1998, HIGH LOW LOW HIGH DE; Koopman C, 2013, EUR HEART J, V34, P3198, DOI 10.1093/eurheartj/eht368; Koopman C, 2013, INT J CARDIOL, V168, P993, DOI 10.1016/j.ijcard.2012.10.036; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Pereira M, 2013, CIRC-CARDIOVASC QUAL, V6, P634, DOI 10.1161/CIRCOUTCOMES.113.000264; Stjarne MK, 2006, EPIDEMIOLOGY, V17, P14, DOI 10.1097/01.ede.0000187178.51024.a7; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; van Herk-Sukel MPP, 2010, EUR J CANCER, V46, P395, DOI 10.1016/j.ejca.2009.09.010; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; *VOED, 1998, ZO EET NED RES VOEDS; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; World Health Organization, TOP 10 CAUS DEATH; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166139	10.1371/journal.pone.0166139	http://dx.doi.org/10.1371/journal.pone.0166139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906998	gold, Green Published			2022-12-27	WOS:000389482700017
J	Parand, A; Garfield, S; Vincent, C; Franklin, BD				Parand, Anam; Garfield, Sara; Vincent, Charles; Franklin, Bryony Dean			Carers' Medication Administration Errors in the Domiciliary Setting: A Systematic Review	PLOS ONE			English	Review							ADVERSE DRUG EVENTS; ACETAMINOPHEN OVERDOSE; RISK-FACTORS; CHILDREN; HOME; CAREGIVERS; HEALTH; MANAGEMENT; MEDICINES; PARENTS	Purpose Medications are mostly taken in patients' own homes, increasingly administered by carers, yet studies of medication safety have been largely conducted in the hospital setting. We aimed to review studies of how carers cause and/or prevent medication administration errors (MAEs) within the patient's home; to identify types, prevalence and causes of these MAEs and any interventions to prevent them. Methods A narrative systematic review of literature published between 1 Jan 1946 and 23 Sep 2013 was carried out across the databases EMBASE, MEDLINE, PSYCHINFO, COCHRANE and CINAHL. Empirical studies were included where carers were responsible for preventing/causing MAEs in the home and standardised tools used for data extraction and quality assessment. Results Thirty-six papers met the criteria for narrative review, 33 of which included parents caring for children, two predominantly comprised adult children and spouses caring for older parents/partners, and one focused on paid carers mostly looking after older adults. The carer administration error rate ranged from 1.9 to 33% of medications administered and from 12 to 92.7% of carers administering medication. These included dosage errors, omitted administration, wrong medication and wrong time or route of administration. Contributory factors included individual carer factors (e.g. carer age), environmental factors (e.g. storage), medication factors (e.g. number of medicines), prescription communication factors (e.g. comprehensibility of instructions), psychosocial factors (e.g. carer-to-carer communication), and care-recipient factors (e.g. recipient age). The few interventions effective in preventing MAEs involved carer training and tailored equipment. Conclusion This review shows that home medication administration errors made by carers are a potentially serious patient safety issue. Carers made similar errors to those made by professionals in other contexts and a wide variety of contributory factors were identified. The home care setting should be a priority for the development of patient safety interventions.	[Parand, Anam] London Sch Econ, Dept Social Psychol, London, England; [Parand, Anam] Imperial Coll London, Natl Inst Hlth Res, Imperial Patient Safety Translat Res Ctr, London, England; [Garfield, Sara] Imperial Coll Healthcare NHS Trust, UCL Sch Pharm London, Res Dept Practice & Policy, Ctr Medicat Safety & Serv Qual, London, England; [Vincent, Charles] Univ Oxford, Dept Expt Psychol, Oxford, England	University of London; London School Economics & Political Science; Imperial College London; Imperial College London; University of Oxford	Parand, A (corresponding author), London Sch Econ, Dept Social Psychol, London, England.; Parand, A (corresponding author), Imperial Coll London, Natl Inst Hlth Res, Imperial Patient Safety Translat Res Ctr, London, England.	a.parand@lse.ac.uk	; Garfield, Sara/F-9941-2019	Parand, Anam/0000-0003-2031-5416; Garfield, Sara/0000-0002-9980-0520	National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre; National Institute for Health Research [NF-SI-0510-10193] Funding Source: researchfish	National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper represents independent research supported by the National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Absulem S, 2011, REHABIL NURS, V36, P98, DOI 10.1002/j.2048-7940.2011.tb00073.x; Alander SW, 2000, ARCH PEDIAT ADOL MED, V154, P346, DOI 10.1001/archpedi.154.4.346; Algahtani F, 2013, SAUDI PHARM J, V21, P165, DOI 10.1016/j.jsps.2012.05.008; Alomar M, 2011, ANN SAUDI MED, V31, P513, DOI 10.4103/0256-4947.84630; Alsulami Z, 2013, EUR J CLIN PHARMACOL, V69, P995, DOI 10.1007/s00228-012-1435-y; Axelsson Johan, 2002, Lakartidningen, V99, P1178; Azkunaga B, 2013, AN PEDIATR, V78, P355, DOI 10.1016/j.anpedi.2012.09.016; Barber ND, 2009, QUAL SAF HEALTH CARE, V18, P341, DOI 10.1136/qshc.2009.034231; Cameli D, 2013, JBI DATABASE SYSTEMA, V11, P1; Carers Trust, 2014, KEY FACTS CAR 2014; Cassidy N, 2011, CLIN TOXICOL, V49, P485, DOI 10.3109/15563650.2011.587193; Central Statistics Office, 2009, Q NAT HOUS SURV CAR; Choo J, 2010, J NURS MANAGE, V18, P853, DOI 10.1111/j.1365-2834.2010.01164.x; Cohen AL, 2008, J PEDIATR-US, V152, P416, DOI 10.1016/j.jpeds.2007.07.041; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CONROY S, 2003, PHARM J, V271, P209; Costa LL, 2011, J NURS CARE QUAL, V26, P243, DOI 10.1097/NCQ.0b013e31820e1543; Dean B, 2001, AM J HEALTH-SYST PH, V58, P54, DOI 10.1093/ajhp/58.1.54; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Ecker L, 2013, PEDIATRICS, V131, pE1771, DOI 10.1542/peds.2012-1970; Erlen JA, 2013, J GERONTOL NURS, V39, P30, DOI 10.3928/00989134-20130220-91; Family caregiver alliance, 2014, CAR 2014; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Frush KS, 2004, ARCH PEDIAT ADOL MED, V158, P620, DOI 10.1001/archpedi.158.7.620; Ghaleb MA, 2006, ANN PHARMACOTHER, V40, P1766, DOI 10.1345/aph.1G717; Godfrey C, 2013, JBI DATABASE SYSTEM, V11, P82, DOI DOI 10.11124/jbisrir-2013-959; Goldman RD, 2004, PEDIATR EMERG CARE, V20, P89, DOI 10.1097/01.pec.0000113877.10140.d2; GRIBETZ B, 1987, PEDIATRICS, V80, P630; Griffith R., 2011, NURSE PRESCRIBING, V9, P94; GUBERMAN D, 1990, Harefuah, V118, P17; Hain Debra J, 2012, Home Healthc Nurse, V30, P246, DOI 10.1097/NHH.0b013e31824c28bd; Health & Social Care Information Centre, 2010, SURV CAR HOUS ENGL 2; Heubi JE, 1998, J PEDIATR-US, V132, P22, DOI 10.1016/S0022-3476(98)70479-2; HYAM E, 1989, FAM PRACT, V6, P221, DOI 10.1093/fampra/6.3.221; International Alliance of Carer Organizations, 2015, GLOB CAR FACTS 2015; JONVILLE APE, 1991, DICP ANN PHARMAC, V25, P1113; Kaushal R, 2007, AMBUL PEDIATR, V7, P383, DOI 10.1016/j.ambp.2007.05.005; Keers RN, 2013, DRUG SAFETY, V36, P1045, DOI 10.1007/s40264-013-0090-2; Kmet LM, 2004, STANDARD QUALITY ASS; Knudsen P, 2007, QUAL SAF HEALTH CARE, V16, P291, DOI 10.1136/qshc.2006.018770; Lemer Claire, 2009, J Patient Saf, V5, P168, DOI 10.1097/PTS.0b013e3181b3a9b0; Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003; Lifshitz M, 2000, ISR MED ASSOC J, V2, P504; Lindquist LA, 2011, J GEN INTERN MED, V26, P474, DOI 10.1007/s11606-010-1596-2; Llewellyn G, 2003, RES DEV DISABIL, V24, P405, DOI 10.1016/j.ridd.2003.06.001; Loganathan M, 2011, AGE AGEING, V40, P150, DOI 10.1093/ageing/afq161; Madigan Elizabeth A, 2007, Home Healthc Nurse, V25, P191, DOI 10.1097/01.NHH.0000263437.08062.cc; Masotti Paul, 2009, Healthc Q, V12, P69; Masotti P, 2010, INT J QUAL HEALTH C, V22, P115, DOI 10.1093/intqhc/mzq003; MATTAR ME, 1975, J PEDIATR-US, V87, P137, DOI 10.1016/S0022-3476(75)80090-4; McCann JJ, 2000, J AM GERIATR SOC, V48, P1612, DOI 10.1111/j.1532-5415.2000.tb03872.x; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Mcerlean MA, 2001, PEDIATR EMERG CARE, V17, P249, DOI 10.1097/00006565-200108000-00005; McGraw Caroline, 2008, Qual Prim Care, V16, P239; McLeod MC, 2013, BMJ QUAL SAF, V22, P278, DOI 10.1136/bmjqs-2012-001330; McMahon SR, 1997, PEDIATRICS, V100, P330, DOI 10.1542/peds.100.3.330; Meredith S, 2001, J AM GERIATR SOC, V49, P719, DOI 10.1046/j.1532-5415.2001.49147.x; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Moretti R, 2013, ANN FR MED URGENCE, V3, P205, DOI 10.1007/s13341-013-0316-z; [倪韶青 Ni Shaoqing], 2013, [中国药学杂志, Chinese Pharmaceutical Journal], V48, P1419; Oshikoya KA, 2010, ANN AFR MED, V9, P203, DOI 10.4103/1596-3519.70954; Pelissier-Delour L, 2007, ARCH PEDIATRIE, V14, P1403, DOI 10.1016/j.arcped.2007.08.012; RANELLI PL, 1997, RES SOCIOL HEALTH CA, V14, P233; Reinhard S., 2012, HOME ALONE FAMILY CA; RiveraPenera T, 1997, J PEDIATR-US, V130, P300, DOI 10.1016/S0022-3476(97)70359-7; Ryu GS, 2012, J MANAGE CARE PHARM, V18, P439, DOI 10.18553/jmcp.2012.18.6.439; Sandars J, 2003, FAM PRACT, V20, P231, DOI 10.1093/fampra/cmg301; Schaefer MK, 2008, PEDIATRICS, V121, P783, DOI 10.1542/peds.2007-3638; Sears N, 2013, INT J QUAL HEALTH C, V25, P16, DOI 10.1093/intqhc/mzs075; Slatter Amanda, 2004, Br J Nurs, V13, P1135; Smith MD, 2014, PEDIATRICS, V134, P867, DOI 10.1542/peds.2014-0309; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Statistics ABo, 2012, SURV DIS AG CAR SDAC; Taylor DM, 2009, J PAEDIATR CHILD H, V45, P304, DOI 10.1111/j.1440-1754.2008.01462.x; Taylor JA, 2006, CANCER-AM CANCER SOC, V107, P1400, DOI 10.1002/cncr.22131; Tomkvist L, 2006, NORDIC J NURSING RES, V26, P52; Travis SS, 2000, J GERONTOL A-BIOL, V55, pM412, DOI 10.1093/gerona/55.7.M412; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Walsh KE, 2013, PEDIATRICS, V131, pE1405, DOI 10.1542/peds.2012-2434; Walsh KE, 2011, ARCH DIS CHILD, V96, P581, DOI 10.1136/adc.2010.204479; Walsh KE, 2008, ADV PATIENT SAFETY N, V4; Woodward C, 2002, MEASURING CONSISTENC; Yin HS, 2014, PEDIATRICS, V134, pE354, DOI 10.1542/peds.2014-0395; Zandieh SO, 2008, J PEDIATR-US, V152, P225, DOI 10.1016/j.jpeds.2007.09.054	84	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167204	10.1371/journal.pone.0167204	http://dx.doi.org/10.1371/journal.pone.0167204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907072	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000389482700090
J	Stroman, PW; Bosma, RL; Cotoi, AI; Leung, RH; Kornelsen, J; Lawrence-Dewar, JM; Pukall, CF; Staud, R				Stroman, Patrick W.; Bosma, Rachael L.; Cotoi, Andreea I.; Leung, Roxanne H.; Kornelsen, Jennifer; Lawrence-Dewar, Jane M.; Pukall, Caroline F.; Staud, Roland			Continuous Descending Modulation of the Spinal Cord Revealed by Functional MRI	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TEMPORAL SUMMATION; BRAIN-STEM; 2ND PAIN; EFFECTIVE CONNECTIVITY; IMAGE REGISTRATION; FMRI; ANTICIPATION; ACTIVATION; INTENSITY	Spontaneous variations in spinal cord activity may arise from regulation of any of a number of functions including sensory, motor, and autonomic control. Here, we use functional MRI (fMRI) of healthy participants to identify properties of blood oxygenation-level dependent (BOLD) variations in the spinal cord in response to knowledge that either a noxious stimulus is impending, or that no stimulus is to be expected. Expectation of a noxious stimulus, or no stimulus, is shown to have a significant effect on wide-spread BOLD signal variations in the spinal cord over the entire time period of the fMRI acquisition. Coordination of BOLD responses between/within spinal cord and brainstem regions are also influenced by this knowledge. We provide evidence that such signal variations are the result of continuous descending modulation of spinal cord function. BOLD signal variations in response to noxious stimulation of the hand are also shown, as in previous studies. The observation of both continuous and reactive BOLD responses to emotional/cognitive factors and noxious peripheral stimulation may have important implications, not only for our understanding of endogenous pain modulation, but also in showing that spinal cord activity is under continuous regulatory control.	[Stroman, Patrick W.; Bosma, Rachael L.; Cotoi, Andreea I.; Leung, Roxanne H.; Pukall, Caroline F.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Phys, Kingston, ON, Canada; [Kornelsen, Jennifer] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Lawrence-Dewar, Jane M.] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Pukall, Caroline F.] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Staud, Roland] Univ Florida, Dept Med, Gainesville, FL USA	Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Manitoba; Northern Ontario School of Medicine; Queens University - Canada; State University System of Florida; University of Florida	Stroman, PW (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Stroman, PW (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.; Stroman, PW (corresponding author), Queens Univ, Dept Phys, Kingston, ON, Canada.	stromanp@queensu.ca	Staud, Roland/A-8442-2008	Stroman, Patrick/0000-0002-9814-260X; Lawrence-Dewar, Jane/0000-0003-1529-5748; Kornelsen, Jennifer/0000-0003-0658-5321	NIH [NR014049-01]; Harry S. Botterell Foundation; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry S. Botterell Foundation; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding was provided by the Harry S. Botterell Foundation. Dr. Staud's effort was partially funded by NIH grant NR014049-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Harry S. Botterell Foundation for project funding support. We would also like to thank Don Brien for his help with acquiring the data, and Janet Mirtle-Stroman for her help with participant recruitment. Dr. Staud's effort was partially funded by NIH grant NR014049-01. All authors confirm that they have no conflicts of interest to declare.	Barry RL, 2014, ELIFE, V3, DOI 10.7554/eLife.02812; Beynon M, 2013, 4 INT C NEUR PAIN MA; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bosma RL, 2014, MAGN RESON IMAGING, V32, P473, DOI 10.1016/j.mri.2014.01.007; Bosma R.L., 2015, HUM BRAIN MAPP; Bosma RL, 2016, HUM BRAIN MAPP, V37, P1349, DOI 10.1002/hbm.23106; Bosma RL, 2015, HUM BRAIN MAPP, V36, P5038, DOI 10.1002/hbm.22993; Bosma RL, 2014, J MAGN RESON IMAGING; Bosma RL, 2014, SOC NEUROSCIENCE; Craggs JG, 2012, J PAIN, V13, P390, DOI 10.1016/j.jpain.2012.01.002; Dobek CE, 2014, J PAIN, V15, P1057, DOI 10.1016/j.jpain.2014.07.006; Dunckley P, 2007, NEUROGASTROENT MOTIL, V19, P569, DOI 10.1111/j.1365-2982.2007.00908.x; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Figley CR, 2009, NEUROIMAGE, V44, P421, DOI 10.1016/j.neuroimage.2008.08.040; Figley CR, 2006, P INT SOC MAGN RES M; Heinricher M.M., 2013, WALL MELZACKS TXB PA, P129; Ikeda H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-14; Khan HS, 2015, NEUROSCIENCE, V307, P231, DOI 10.1016/j.neuroscience.2015.08.059; Khan HS, 2015, NEUROSCIENC IN PRESS; Kong YZ, 2014, P NATL ACAD SCI USA, V111, P18067, DOI 10.1073/pnas.1414293111; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MCARDLE JJ, 1984, BRIT J MATH STAT PSY, V37, P234, DOI 10.1111/j.2044-8317.1984.tb00802.x; McIver TA, 2014, SOC NEUROSCIENCE; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Myronenko A, 2010, IEEE T MED IMAGING, V29, P1882, DOI 10.1109/TMI.2010.2053043; Myronenko A, 2009, PROC CVPR IEEE, P49, DOI 10.1109/CVPRW.2009.5206571; Palermo S, 2015, HUM BRAIN MAPP, V36, P1648, DOI 10.1002/hbm.22727; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rempe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112325; Rhudy JL, 2003, PAIN MED, V4, P244, DOI 10.1046/j.1526-4637.2003.03028.x; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Smith SD, 2011, NEUROIMAGE, V58, P269, DOI 10.1016/j.neuroimage.2011.06.004; Sousa MAS, 2014, B REAL SOC IN PRESS, V1, P1, DOI DOI 10.1152/JN.00440.2013; Sprenger C, 2015, J NEUROSCI, V35, P4248, DOI 10.1523/JNEUROSCI.4897-14.2015; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Staud R, 2006, J PAIN, V7, P575, DOI 10.1016/j.jpain.2006.02.005; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Stroman PW, 2016, J NEUROTRAUMA; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360; Zhang L, 2005, EUR J NEUROSCI, V22, P1141, DOI 10.1111/j.1460-9568.2005.04302.x	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167317	10.1371/journal.pone.0167317	http://dx.doi.org/10.1371/journal.pone.0167317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907094	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700118
J	Yin, CM; Xiang, L; Wang, GS; Wang, YF; Shen, X; Chen, XS; Mao, ZQ				Yin, Chengmiao; Xiang, Li; Wang, Gongshuai; Wang, Yanfang; Shen, Xiang; Chen, Xuesen; Mao, Zhiquan			How to Plant Apple Trees to Reduce Replant Disease in Apple Orchard: A Study on the Phenolic Acid of the Replanted Apple Orchard	PLOS ONE			English	Article							SOIL; GROWTH; SEEDLINGS; CUCUMBER	Apple replant disease (ARD) is an important problem in the production of apple. The phenolic acid is one of the causes of ARD. How phenolic acid affects the ARD was not well known. In this study, we analyzed the type, concentration and annual dynamic variation of phenolic acid in soil from three replanted apple orchards using an accelerated solvent extraction system with high performance liquid chromatography (ASE-HPLC). We found that the type and concentration of phenolic acid were significantly differed among different seasons, different sampling positions and different soil layers. Major types of phenolic acid in three replanted apple orchards were phlorizin, benzoic acid and vanillic aldehyde. The concentration of phenolic acid was highest in the soil of the previous tree holes and it was increased from the spring to autumn. Moreover, phenolic acid was primarily distributed in 30-60 cm soil layer in the autumn, while it was most abundant in 0-30 cm soil layer in the spring. Our results suggest that phlorizin, benzoic acid and vanillic aldehyde may be the key phenolic acid that brought about ARD in the replanted apple orchard.	[Yin, Chengmiao; Xiang, Li; Wang, Gongshuai; Wang, Yanfang; Shen, Xiang; Chen, Xuesen; Mao, Zhiquan] Shandong Agr Univ, Coll Hort Sci & Engn, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Yanfang] Shandong Agr Univ, Coll Chem & Mat Sci, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Mao, ZQ (corresponding author), Shandong Agr Univ, Coll Hort Sci & Engn, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	mzhiquan@sdau.edu.cn			earmarked fund for National Modern Agro-industry Technology Research System [CARS-28]; National Natural Science Foundation of China [31501720]; Shandong Province, China [SDAIT-06-07]; Shandong Natural Science Foundation, China [ZR2014CL024]	earmarked fund for National Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province, China; Shandong Natural Science Foundation, China	The research was supported by the earmarked fund for National Modern Agro-industry Technology Research System (CARS-28), the National Natural Science Foundation of China (31501720), Fruit innovation team in Shandong Province, China (SDAIT-06-07), and joint project of Shandong Natural Science Foundation, China (ZR2014CL024).; The research was supported by the earmarked fund for National Modern Agro-industry Technology Research System (CARS-28), the National Natural Science Foundation of China (31501720), Fruit innovation team in Shandong Province, China (SDAIT-06-07), and joint project of Shandong Natural Science Foundation, China (ZR2014CL024).	Baerson SR, 2008, J BIOL CHEM, V283, P3231, DOI 10.1074/jbc.M706587200; Bai R, 2009, J CHEM ECOL, V35, P488, DOI 10.1007/s10886-009-9615-7; Chen LiXin, 2005, Agricultural Sciences in China, V4, P747; David I., 2005, Novenyvdelem, V41, P397; Ding J, 2007, J EXP BOT, V58, P3765, DOI 10.1093/jxb/erm227; Gao XB, 2010, AGR SCI CHINA, V9, P833, DOI 10.1016/S1671-2927(09)60161-9; Han CM, 2008, SCI HORTIC-AMSTERDAM, V116, P330, DOI 10.1016/j.scienta.2008.01.005; Hiradate S, 2005, J CHEM ECOL, V31, P591, DOI 10.1007/s10886-005-2047-0; Hofmann A, 2009, J APPL BOT FOOD QUAL, V82, P193; Jilani G, 2008, ANN MICROBIOL, V58, P351, DOI 10.1007/BF03175528; KUITERS AT, 1990, ACTA BOT NEERL, V39, P329, DOI 10.1111/j.1438-8677.1990.tb01412.x; Kummeler M., 1981, Erwerbsobstbau, V23; 24, P162; Laurent AS, 2008, PLANT SOIL, V304, P209, DOI 10.1007/s11104-008-9541-4; Macias FA, 2000, PHYTOCHEMISTRY, V54, P165, DOI 10.1016/S0031-9422(00)00070-4; Manici LM, 2003, PLANT SOIL, V256, P315, DOI 10.1023/A:1026103001592; Mazzola M, 1998, PHYTOPATHOLOGY, V88, P930, DOI 10.1094/PHYTO.1998.88.9.930; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; Narwal SS, 2010, ALLELOPATHY J, V25, P51; Ogweno JO, 2006, ALLELOPATHY J, V18, P93; Politycka B, 2003, POL J ENVIRON STUD, V12, P95; Rumberger A, 2004, PLANT SOIL, V264, P247, DOI 10.1023/B:PLSO.0000047760.13004.94; Tewoldemedhin YT, 2011, SOIL BIOL BIOCHEM, V43, P1917, DOI 10.1016/j.soilbio.2011.05.014; Tewoldemedhin YT, 2011, EUR J PLANT PATHOL, V130, P215, DOI 10.1007/s10658-011-9747-9; van Schoor L, 2009, SCI HORTIC-AMSTERDAM, V119, P153, DOI 10.1016/j.scienta.2008.07.032; Wu FZ, 2006, ALLELOPATHY J, V18, P287; Wu HW, 2001, J CHEM ECOL, V27, P125, DOI 10.1023/A:1005676218582; Yang CM, 2004, BOT BULL ACAD SINICA, V45, P119; [尹承苗 Yin Chengmiao], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P4612; Zhang JH, 2007, J INTEGR PLANT BIOL, V49, P257, DOI 10.1111/j.1744-7909.2007.00307.x	29	31	36	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167347	10.1371/journal.pone.0167347	http://dx.doi.org/10.1371/journal.pone.0167347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907081	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700125
J	Qiao, PP; Liu, HY; Yan, XP; Jia, ZR; Pi, XT				Qiao, Panpan; Liu, Hongying; Yan, Xueping; Jia, Ziru; Pi, Xitian			A Smart Capsule System for Automated Detection of Intestinal Bleeding Using HSL Color Recognition	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; WIRELESS CAPSULE; PUSH ENTEROSCOPY; DIAGNOSTIC YIELD; ENDOSCOPY; HEMOGLOBIN; FUSION; BOVINE; IMAGES	There are no ideal means for the diagnosis of intestinal bleeding diseases as of now, particularly in the small intestine. This study investigated an intelligent intestinal bleeding detection capsule system based on color recognition. After the capsule is swallowed, the bleeding detection module (containing a color-sensitive adsorptive film that changes color when absorbing intestinal juice,) is used to identify intestinal bleeding features. A hue-saturation-light color space method can be applied to detect bleeding according to the range of H and S values of the film color. Once bleeding features are recognized, a wireless transmission module is activated immediately to send an alarm signal to the outside; an in vitro module receives the signal and sends an alarm. The average power consumption of the entire capsule system is estimated to be about 2.1mW. Owing to its simplicity, reliability, and effectiveness, this system represents a new approach to the clinical diagnosis of intestinal bleeding diseases.	[Qiao, Panpan; Liu, Hongying; Yan, Xueping; Jia, Ziru; Pi, Xitian] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China; [Pi, Xitian] Chongqing Univ, Key Labs Natl Def Sci & Technol Innovat Micronano, Chongqing, Peoples R China; [Liu, Hongying] Chongqing Engn Res Ctr Med Elect, Chongqing, Peoples R China	Chongqing University; Chongqing University	Liu, HY; Pi, XT (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China.; Pi, XT (corresponding author), Chongqing Univ, Key Labs Natl Def Sci & Technol Innovat Micronano, Chongqing, Peoples R China.; Liu, HY (corresponding author), Chongqing Engn Res Ctr Med Elect, Chongqing, Peoples R China.	liuhongying@cqu.edu.cn; pixitian@cqu.edu.cn			National Key Technology Support Program [2015BA101613]; Medical Instrument Key Project of Chongqing [cstc2015zdcy-zta10002]; National Natural Science Foundation of China [81671850]; Fundamental Research Funds for the Central Universities [106112016CDJXY230004]	National Key Technology Support Program(National Key Technology R&D Program); Medical Instrument Key Project of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Technology Support Program (2015BA101613), http://program.most.gov.cn/; The Medical Instrument Key Project of Chongqing (No. cstc2015zdcy-zta10002), http://www.cstc.gov.cn/; National Natural Science Foundation of China (81671850, http://www.nsfc.gov.cn/; and the Fundamental Research Funds for the Central Universities (106112016CDJXY230004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; Al-Rawhani MA, 2013, SENSOR ACTUAT B-CHEM, V189, P203, DOI 10.1016/j.snb.2013.03.037; Amin U., DETECTION DISTINCTIO; Appleyard M, 2000, GASTROENTEROLOGY, V119, P1431, DOI 10.1053/gast.2000.20844; Chen YT, 2014, WORLD J GASTROENTERO, V20, P17955, DOI 10.3748/wjg.v20.i47.17955; Chien CL, 2014, IEEE T GEOSCI REMOTE, V52, P651, DOI 10.1109/TGRS.2013.2243157; Chou PH, 2005, IEEE IC CAD, P913, DOI 10.1109/ICCAD.2005.1560192; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Dimino ML, 2007, J CHROMATOGR B, V856, P353, DOI 10.1016/j.jchromb.2007.05.040; Du H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089740; Eliakim R, 2004, ALIMENT PHARM THER, V20, P1083, DOI 10.1111/j.1365-2036.2004.02206.x; Ell C, 2002, ENDOSCOPY, V34, P685, DOI 10.1055/s-2002-33446; Erenas MM, 2012, SENSOR ACTUAT B-CHEM, V174, P10, DOI 10.1016/j.snb.2012.07.100; Haase S, 2013, CURR MED IMAGING, V9, P113, DOI 10.2174/1573405611309020006; Hayat M, 2000, ENDOSCOPY, V32, P369, DOI 10.1055/s-2000-9003; Herzig SJ, 2013, J GEN INTERN MED, V28, P978, DOI 10.1007/s11606-013-2425-1; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Jiang Y, 2017, IEEE T IND INFORM, V13, P1900, DOI 10.1109/TII.2016.2573762; Kapsoritakis AN, 2001, AM J GASTROENTEROL, V96, P776; Li BP, 2009, IMAGE VISION COMPUT, V27, P1336, DOI 10.1016/j.imavis.2008.12.003; Li BP, 2009, COMPUT BIOL MED, V39, P141, DOI 10.1016/j.compbiomed.2008.11.007; Lin TF, 2015, 2015 8TH INTERNATIONAL CONFERENCE ON UBI-MEDIA COMPUTING (UMEDIA) CONFERENCE PROCEEDINGS, P268, DOI 10.1109/UMEDIA.2015.7297467; Liu HY, 2010, J ZHEJIANG UNIV-SC B, V11, P937, DOI 10.1631/jzus.B1000047; Liu HY, 2013, INT J BIOMED ENG TEC, V13, P105, DOI 10.1504/IJBET.2013.057925; Longacre AV, 2003, AM J GASTROENTEROL, V98, P59; Meng M. Q.-H., 2004, Fifth World Congress on Intelligent Control and Automation (IEEE Cat. No.04EX788), P5561; Miraglia R, 2015, ABDOM IMAGING, V40, P1808, DOI 10.1007/s00261-014-0313-8; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Ramaswamy RS, 2014, WORLD J RADIOL, V6, P82, DOI 10.4329/wjr.v6.i4.82; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Sun B, 2006, AM J GASTROENTEROL, V101, P2011, DOI 10.1111/j.1572-0241.2006.00664.x; Sun GY, 2008, J CHROMATOGR B, V867, P1, DOI 10.1016/j.jchromb.2008.02.014; WEEKS AR, 1995, P SOC PHOTO-OPT INS, V2424, P291, DOI 10.1117/12.205231; Xie ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090286; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17	36	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166488	10.1371/journal.pone.0166488	http://dx.doi.org/10.1371/journal.pone.0166488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902728	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474100026
J	Fairbairn, NS; Walley, AY; Cheng, DM; Quinn, E; Bridden, C; Chaisson, C; Blokhina, E; Lioznov, D; Krupitsky, E; Raj, A; Samet, JH				Fairbairn, Nadia S.; Walley, Alexander Y.; Cheng, Debbie M.; Quinn, Emily; Bridden, Carly; Chaisson, Christine; Blokhina, Elena; Lioznov, Dmitry; Krupitsky, Evgeny; Raj, Anita; Samet, Jeffrey H.			Mortality in HIV-Infected Alcohol and Drug Users in St. Petersburg, Russia	PLoS One			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; NEW-YORK-CITY; SUBSTANCE-USE; ANTIRETROVIRAL TREATMENT; DEPRESSIVE SYMPTOMS; EASTERN-EUROPE; INJECT DRUGS; RISK-FACTOR; SEX WORK; COHORT	In Russia, up to half of premature deaths are attributed to hazardous drinking. The respective roles of alcohol and drug use in premature death among people with HIV in Russia have not been described. Criminalization and stigmatization of substance use in Russia may also contribute to mortality. We explored whether alcohol, drug use and risk environment factors are associated with short-term mortality in HIV-infected Russians who use substances. Secondary analyses were conducted using prospective data collected at baseline, 6 and 12months from HIV-infected people who use substances recruited between 2007-2010 from addiction and HIV care settings in a single urban setting of St. Petersburg, Russia. We used Cox proportional hazards models to explore associations between 30-day alcohol hazardous drinking, injection drug use, polysubstance use and environmental risk exposures (i.e. past incarceration, police involvement, selling sex, and HIV stigma) with mortality. Among 700 participants, 59% were male and the mean age was 30 years. There were 40 deaths after a median follow-up of 12 months (crude mortality rate 5.9 per 100 person-years). In adjusted analyses, 30-day NIAAA hazardous drinking was significantly associated with mortality compared to no drinking [adjusted Hazard Ratio (aHR) 2.60, 95% Confidence Interval (CI): 1.24-5.44] but moderate drinking was not (aHR 0.95, 95% CI: 0.35-2.59). No other factors were significantly associated with mortality. The high rates of short-term mortality and the strong association with hazardous drinking suggest a need to integrate evidence-based alcohol interventions into treatment strategies for HIV-infected Russians.	[Fairbairn, Nadia S.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Walley, Alexander Y.; Samet, Jeffrey H.] Boston Univ, Sch Med, Dept Med,Boston Med Ctr, Sect Gen Internal Med,Clin Addict Res & Educ Unit, Boston, MA 02118 USA; [Cheng, Debbie M.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Quinn, Emily; Chaisson, Christine] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Bridden, Carly] Boston Med Ctr, Dept Med, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston, MA USA; [Blokhina, Elena; Lioznov, Dmitry; Krupitsky, Evgeny] First Pavlov State Med Univ, St Petersburg, Russia; [Lioznov, Dmitry] North West Reg AIDS Ctr, St Petersburg, Russia; [Krupitsky, Evgeny] Bekhterev Res Psychoneurol Inst, St Petersburg, Russia; [Raj, Anita] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, La Jolla, CA 92093 USA	University of British Columbia; Boston Medical Center; Boston University; Boston University; Boston University; Boston Medical Center; Pavlov First Saint Petersburg State Medical University; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; University of California System; University of California San Diego	Walley, AY (corresponding author), Boston Univ, Sch Med, Dept Med,Boston Med Ctr, Sect Gen Internal Med,Clin Addict Res & Educ Unit, Boston, MA 02118 USA.	awalley@bu.edu	Lioznov, Dmitry/J-2539-2013; Blokhina, Elena A/V-6040-2018; Krupitsky, Evgeny/M-5935-2016	Lioznov, Dmitry/0000-0003-3643-7354; Blokhina, Elena A/0000-0001-5811-9897; Krupitsky, Evgeny/0000-0002-0529-4525; Samet, Jeffrey/0000-0002-0897-3400	National Institute on Alcohol Abuse and Alcoholism [R01 AA016059, U24AA020778, U24AA020779]; National Institute on Drug Abuse [R25DA013582, R25DA033211]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016059, U24AA020778, U24AA020779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA033211, R25DA037756, R25DA013582] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute on Alcohol Abuse and Alcoholism (R01 AA016059 - PI J.Samet, U24AA020778, U24AA020779) and the National Institute on Drug Abuse (R25DA013582, R25DA033211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all HERMITAGE subjects for their participation, and colleagues at Boston University and Pavlov State Medical University for their support. This study was funded by the National Institute on Alcohol Abuse and Alcoholism (R01AA016059 - PI J. Samet, U24AA020778, U24AA020779) and the National Institute on Drug Abuse (R25DA013582, R25DA03 3211).	Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Amirkhanian YA, 2011, AIDS BEHAV, V15, P767, DOI 10.1007/s10461-010-9793-x; [Anonymous], 2007, HELP PAT WHO DRINK T; [Anonymous], 2013, WORLD POP PROSP 2012; Aral SO, 2005, SOC SCI MED, V60, P2181, DOI 10.1016/j.socscimed.2004.10.009; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bernstein KT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-31; Coffin PO, 2003, ADDICTION, V98, P739, DOI 10.1046/j.1360-0443.2003.00376.x; Cooper H, 2004, AM J PUBLIC HEALTH, V94, P1109, DOI 10.2105/AJPH.94.7.1109; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Dissing AS, 2013, ADDICTION, V108, P1905, DOI 10.1111/add.12257; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Evans JL, 2012, AM J EPIDEMIOL, V175, P302, DOI 10.1093/aje/kwr318; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Fillmore KM, 1998, ADDICTION, V93, P183, DOI 10.1046/j.1360-0443.1998.9321834.x; Gossop M, 2002, ADDICTION, V97, P39, DOI 10.1046/j.1360-0443.2002.00079.x; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; HIV/ AIDS, 2013, HIV AIDS SURV EUR 20; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Larsen MV, 2010, SCAND J INFECT DIS, V42, P917, DOI 10.3109/00365548.2010.511258; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Liem M, 2013, INT J LAW PSYCHIAT, V36, P333, DOI 10.1016/j.ijlp.2013.04.012; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McKee M, 1999, ALCOHOL ALCOHOLISM, V34, P824, DOI 10.1093/alcalc/34.6.824; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Muga R, 2007, CLIN INFECT DIS, V45, P370, DOI 10.1086/519385; Nemstov AV, 2011, CONT HIST ALCOHOL RU; Odinokova V, 2014, INT J DRUG POLICY, V25, P96, DOI 10.1016/j.drugpo.2013.06.008; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Radaev V, 2015, ALCOHOL ALCOHOLISM, V50, P365, DOI 10.1093/alcalc/agv008; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Samet JH, 2015, ADDICTION, V110, P80, DOI 10.1111/add.12716; Samet JH, 2011, ADDICTION, V106, P1883, DOI 10.1111/j.1360-0443.2011.03523.x; Schiavini M, 2006, HIV MED, V7, P331, DOI 10.1111/j.1468-1293.2006.00384.x; Shacham E, 2011, AIDS BEHAV, V15, P209, DOI 10.1007/s10461-009-9652-9; Sobell L. C., 1995, ALCOHOL TIMELINE FOL; Solomon SS, 2009, AIDS, V23, P997, DOI 10.1097/QAD.0b013e32832a594e; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Sullivan LE, 2008, ADDICTION, V103, P1461, DOI 10.1111/j.1360-0443.2008.02245.x; UNAIDS, 2010, GLOB REP UNAIDS REP; Walley AY, 2008, AIDS, V22, P415, DOI 10.1097/QAD.0b013e3282f423f8; Ware JE, 2001, SF 36 PHYS MENTAL HL; Weber R, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12184; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Yuvaraj A., 2008, 17 INT AIDS C AUG 3; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	57	9	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166539	10.1371/journal.pone.0166539	http://dx.doi.org/10.1371/journal.pone.0166539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898683	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000010
J	Messina, F; Finocchio, A; Akar, N; Loutradis, A; Michalodimitrakis, EI; Brdicka, R; Jodice, C; Novelletto, A				Messina, Francesco; Finocchio, Andrea; Akar, Nejat; Loutradis, Aphrodite; Michalodimitrakis, Emmanuel I.; Brdicka, Radim; Jodice, Carla; Novelletto, Andrea			Spatially Explicit Models to Investigate Geographic Patterns in the Distribution of Forensic STRs: Application to the North-Eastern Mediterranean	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-STRUCTURE; HAPLOGROUP-J; DIVERSITY; COLONIZATION; EUROPE; SIGNATURE; DIFFUSION; INFERENCE; ANCESTRY	Human forensic STRs used for individual identification have been reported to have little power for inter-population analyses. Several methods have been developed which incorporate information on the spatial distribution of individuals to arrive at a description of the arrangement of diversity. We genotyped at 16 forensic STRs a large population sample obtained from many locations in Italy, Greece and Turkey, i.e. three countries crucial to the understanding of discontinuities at the European/Asian junction and the genetic legacy of ancient migrations, but seldom represented together in previous studies. Using spatial PCA on the full dataset, we detected patterns of population affinities in the area. Additionally, we devised objective criteria to reduce the overall complexity into reduced datasets. Independent spatially explicit methods applied to these latter datasets converged in showing that the extraction of information on long- to medium-range geographical trends and structuring from the overall diversity is possible. All analyses returned the picture of a background clinal variation, with regional discontinuities captured by each of the reduced datasets. Several aspects of our results are confirmed on external STR datasets and replicate those of genome-wide SNP typings. High levels of gene flow were inferred within the main continental areas by coalescent simulations. These results are promising from a microevolutionary perspective, in view of the fast pace at which forensic data are being accumulated for many locales. It is foreseeable that this will allow the exploitation of an invaluable genotypic resource, assembled for other (forensic) purposes, to clarify important aspects in the formation of local gene pools.	[Messina, Francesco; Finocchio, Andrea; Jodice, Carla; Novelletto, Andrea] Univ Tor Vergata, Dept Biol, Rome, Italy; [Akar, Nejat] TOBB Econ & Technol Univ Hosp, Dept Pediat, Ankara, Turkey; [Loutradis, Aphrodite] Natl Ctr Thalassemias, Athens, Greece; [Michalodimitrakis, Emmanuel I.] Univ Crete, Dept Forens Sci, Sch Med, Iraklion, Crete, Greece; [Brdicka, Radim] Inst Hematol & Blood Transfus, Prague, Czech Republic	University of Rome Tor Vergata; TOBB Ekonomi ve Teknoloji University; University of Crete; Institute of Hematology Prague	Novelletto, A (corresponding author), Univ Tor Vergata, Dept Biol, Rome, Italy.	novelletto@bio.uniroma2.it	Messina, Francesco/AAC-1675-2019; Akar, Nejat/H-2949-2019; Messina, Francesco/AAC-1816-2019; Messina, Francesco/AAB-5363-2022	Messina, Francesco/0000-0001-8076-7217; Novelletto, Andrea/0000-0002-1146-7680	Italian Ministry of Justice [CUP E81J10001270005]; Italian Ministry of Education [PRIN-MIUR 2012JA4BTY]	Italian Ministry of Justice; Italian Ministry of Education	This work was supported by grants of the Italian Ministry of Justice (grant number CUP E81J10001270005) to C.J. and of the Italian Ministry of Education (grant number PRIN-MIUR 2012JA4BTY) to A.N. F.M. was supported by a fellowship from the Italian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Algee-Hewitt BFB, 2016, CURR BIOL, V26, P935, DOI 10.1016/j.cub.2016.01.065; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Bradburd GS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005703; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Cann HM, 2002, SCIENCE, V296, P261; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Capocasa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056371; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Davis C, 2012, FORENSIC SCI INT-GEN, V6, P494, DOI 10.1016/j.fsigen.2011.12.002; Di Gaetano C, 2008, EUR J HUM GENET, V17, P1; Di Gaetano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043759; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Fix A.G ., 1999, MIGRATION COLONIZATI; Gazal S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17453; Green RL, 2013, FORENSIC SCI INT-GEN, V7, P41, DOI 10.1016/j.fsigen.2012.05.012; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Haining R, 2003, SPATIAL DATA ANAL; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; King RJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-69; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; Malaspina P, 2001, ANN HUM GENET, V65, P339, DOI 10.1017/S0003480001008727; Malone C, 2003, J WORLD PREHIST, V17, P235, DOI 10.1023/B:JOWO.0000012729.36053.42; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; Mellars P, 2011, NATURE, V479, P483, DOI 10.1038/479483a; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Paschou P, 2014, P NATL ACAD SCI USA, V111, P9211, DOI 10.1073/pnas.1320811111; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pemberton TJ, 2014, HUM HERED, V77, P37, DOI 10.1159/000362878; Pemberton TJ, 2013, G3-GENES GENOM GENET, V3, P891, DOI 10.1534/g3.113.005728; Petkova D, 2016, NAT GENET, V48, P94, DOI 10.1038/ng.3464; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Pritchard JK, 2000, GENETICS, V155, P945; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Rowold DJ, 2003, FORENSIC SCI INT, V133, P260, DOI 10.1016/S0379-0738(03)00073-2; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Sarno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096074; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Silva NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049666; Steele CD, 2014, ANN HUM GENET, V78, P468, DOI 10.1111/ahg.12081; Tagarelli G, 2007, COLLEGIUM ANTROPOL, V31, P331; Tofanelli S, 2016, EUR J HUM GENET, V24, P429, DOI 10.1038/ejhg.2015.124; Wang CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002886; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	84	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167065	10.1371/journal.pone.0167065	http://dx.doi.org/10.1371/journal.pone.0167065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898725	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000032
J	Drechsler, R; Chen, SW; Dancy, BCR; Mehrabkhani, L; Olsen, CP				Drechsler, Robin; Chen, Shaw-Wen; Dancy, Blair C. R.; Mehrabkhani, Lena; Olsen, Carissa Perez			HPLC-Based Mass Spectrometry Characterizes the Phospholipid Alterations in Ether-Linked Lipid Deficiency Models Following Oxidative Stress	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LC-MS; PLASMALOGENS; HOMEOSTASIS; REVEALS	Despite the fact that the discovery of ether-linked phospholipids occurred nearly a century ago, many unanswered questions remain concerning these unique lipids. Here, we characterize the ether-linked lipids of the nematode with HPLC-MS/MS and find that more than half of the phosphoethanolamine-containing lipids are ether-linked, a distribution similar to that found in mammalian membranes. To explore the biological role of ether lipids in vivo, we target fatty acyl-CoA reductase (fard-1), an essential enzyme in ether lipid synthesis, with two distinct RNAi strategies. First, when fard-1 RNAi is initiated at the start of development, the treated animals have severely reduced ether lipid abundance, resulting in a shift in the phosphatidylethanolamine lipid population to include more saturated fatty acid chains. Thus, the absence of ether lipids during development drives a significant remodeling of the membrane landscape. A later initiation of fard-1 RNAi in adulthood results in a dramatic reduction of new ether lipid synthesis as quantified with N-15-tracers; however, there is only a slight decrease in total ether lipid abundance with this adult-only fard-1 RNAi. The two RNAi strategies permit the examination of synthesis and ether lipid abundance to reveal a relationship between the amount of ether lipids and stress survival. We tested whether these species function as sacrificial antioxidants by directly examining the phospholipid population with HPLC-MS/MS after oxidative stress treatment. While there are significant changes in other phospholipids, including polyunsaturated fatty acid-containing species, we did not find any change in ether-linked lipids, suggesting that the role of ether lipids in stress resistance is not through their general consumption as free radical sinks. Our work shows that the nematode will be a useful model for future interrogation of ether lipid biosynthesis and the characterization of phospholipid changes in various stress conditions.	[Drechsler, Robin; Chen, Shaw-Wen; Dancy, Blair C. R.; Mehrabkhani, Lena; Olsen, Carissa Perez] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Dancy, Blair C. R.] US Army, Ctr Environm Hlth Res, Ft Detrick, MD USA	Fred Hutchinson Cancer Center	Olsen, CP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	cpolsen@fredhutch.org		Olsen, Carissa/0000-0003-1261-9364	NIH Early Independence Award from the Office of the Director [5 DP5 OD009189]; National Institute of Dental and Craniofacial Research; University of Washington's Nathan Shock Center for Excellence in Aging [P30AG013280]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009189] Funding Source: NIH RePORTER	NIH Early Independence Award from the Office of the Director; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Washington's Nathan Shock Center for Excellence in Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by an NIH Early Independence Award (5 DP5 OD009189) from the Office of the Director and the National Institute of Dental and Craniofacial Research (www.nih.gov) and funding (P30AG013280) from the University of Washington's Nathan Shock Center for Excellence in Aging (uwaging.org/shock-center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini G, 2006, CHEMMEDCHEM, V1, P1045, DOI 10.1002/cmdc.200600075; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Dancy BCR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141850; Donovan EL, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-24; Dorninger F, 2015, BBA-MOL CELL BIOL L, V1851, P117, DOI 10.1016/j.bbalip.2014.11.005; Gaposchkin DP, 2008, BBA-MOL CELL BIOL L, V1781, P213, DOI 10.1016/j.bbalip.2008.01.007; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Kaddurah-Daouk R, 2012, PSYCHIAT RES, V198, P347, DOI 10.1016/j.psychres.2012.02.019; Kou JQ, 2011, ACTA NEUROPATHOL, V122, P271, DOI 10.1007/s00401-011-0836-9; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shi X, 2016, J LIPID RES, V57, P265, DOI 10.1194/jlr.M064808; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stadelmann-Ingrand S, 2001, FREE RADICAL BIO MED, V31, P1263, DOI 10.1016/S0891-5849(01)00720-1; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Wanders Ronald J A, 2013, Subcell Biochem, V69, P23, DOI 10.1007/978-94-007-6889-5_2; Watschinger K, 2013, BIOCHIMIE, V95, P59, DOI 10.1016/j.biochi.2012.06.027; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	27	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167229	10.1371/journal.pone.0167229	http://dx.doi.org/10.1371/journal.pone.0167229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893806	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400105
J	Saldivar-Lucio, R; Di Lorenzo, E; Nakamura, M; Villalobos, H; Lluch-Cota, D; Del Monte-Luna, P				Saldivar-Lucio, Romeo; Di Lorenzo, Emanuele; Nakamura, Miguel; Villalobos, Hector; Lluch-Cota, Daniel; Del Monte-Luna, Pablo			Macro-Scale Patterns in Upwelling/Downwelling Activity at North American West Coast	PLOS ONE			English	Article							SEA-LEVEL; INTERANNUAL VARIABILITY; CLIMATE; CALIFORNIA; SARDINE; REGIME; FLUCTUATIONS; OSCILLATION; TEMPERATURE; CIRCULATION	The seasonal and interannual variability of vertical transport (upwelling/downwelling) has been relatively well studied, mainly for the California Current System, including low-frequency changes and latitudinal heterogeneity. The aim of this work was to identify potentially predictable patterns in upwelling/downwelling activity along the North American west coast and discuss their plausible mechanisms. To this purpose we applied the min/max Autocorrelation Factor technique and time series analysis. We found that spatial co-variation of seawater vertical movements present three dominant low-frequency signals in the range of 33, 19 and 11 years, resembling periodicities of: atmospheric circulation, nodal moon tides and solar activity. Those periodicities might be related to the variability of vertical transport through their influence on dominant wind patterns, the position/intensity of pressure centers and the strength of atmospheric circulation cells (wind stress). The low-frequency signals identified in upwelling/downwelling are coherent with temporal patterns previously reported at the study region: sea surface temperature along the Pacific coast of North America, catch fluctuations of anchovy Engraulis mordax and sardine Sardinops sagax, the Pacific Decadal Oscillation, changes in abundance and distribution of salmon populations, and variations in the position and intensity of the Aleutian low. Since the vertical transport is an oceanographic process with strong biological relevance, the recognition of their spatio-temporal patterns might allow for some reasonable forecasting capacity, potentially useful for marine resources management of the region.	[Saldivar-Lucio, Romeo; Del Monte-Luna, Pablo] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas CICIMAR, La Paz, Baja Calif Sur, Mexico; [Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Nakamura, Miguel] Ctr Invest Matemat AC, Area Probabilidad & Estadist, Guanajuato, Mexico; [Saldivar-Lucio, Romeo; Lluch-Cota, Daniel] Ctr Invest Biol Noroeste, La Paz, Baja Calif Sur, Mexico	Instituto Politecnico Nacional - Mexico; University System of Georgia; Georgia Institute of Technology; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Saldivar-Lucio, R; Del Monte-Luna, P (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas CICIMAR, La Paz, Baja Calif Sur, Mexico.; Saldivar-Lucio, R (corresponding author), Ctr Invest Biol Noroeste, La Paz, Baja Calif Sur, Mexico.	romeo26_1979@yahoo.com; pdelmontel@ipn.mx	Villalobos, Héctor/I-9440-2019; Saldívar-Lucio, Romeo/T-6275-2019; Lluch-Cota, Daniel B./AEU-0658-2022; Di Lorenzo, Emanuele/E-9107-2012	Villalobos, Héctor/0000-0002-6424-4050; Saldívar-Lucio, Romeo/0000-0002-9893-3540; Di Lorenzo, Emanuele/0000-0002-1935-7363; Lluch-Cota, Daniel Bernardo/0000-0002-9045-9821; Del Monte, Pablo/0000-0002-9526-0846	SEP-CONACYT [101550]; IPN-SIP [20121079, 20130517]; COFAA scholarship of the Instituto Politecnico Nacional; EDI scholarship of the Institute Politecnico Nacional; Directorate For Geosciences [1356924] Funding Source: National Science Foundation; Division Of Ocean Sciences [1026607] Funding Source: National Science Foundation	SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IPN-SIP; COFAA scholarship of the Instituto Politecnico Nacional; EDI scholarship of the Institute Politecnico Nacional; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We want to thank partial financial supports from SEP-CONACYT 101550, IPN-SIP 20121079 and 20130517. We also thank COFAA and EDI scholarships of the Institute Politecnico Nacional for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In honor to Dr. Daniel Lluch-Belda (1942-2014). We want to thank partial financial supports from SEP-CONACYT 101550, IPN-SIP 20121079 and 20130517. We also thank COFAA and EDI scholarships of the Instituto Politecnico Nacional for financial support. Special thanks for advice to enhance the present work: Dr. German Ponce Diaz, MC. Gustavo De la Cruz, Dr. Adriano Mazzarella, Dr. Jose Luis Castro Ortiz, Dr. Christian Salvadeo, Dr. Francisco Arreguin Sanchez and three anonimous reviewers.	Aravena G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090276; Baart F, 2012, J COASTAL RES, V28, P511, DOI 10.2112/JCOASTRES-D-11-00169.1; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BAKUN A, 1991, J PHYS OCEANOGR, V21, P1815, DOI 10.1175/1520-0485(1991)021<1815:TSCOWS>2.0.CO;2; Barth JA, 2000, DEEP-SEA RES PT II, V47, P783, DOI 10.1016/S0967-0645(99)00127-7; Bates JR, 1974, GEN CIRCULATION TROP; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; Beer J, 2000, QUATERNARY SCI REV, V19, P403, DOI 10.1016/S0277-3791(99)00072-4; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Bliss CI, 1958, CONN AES B; Bloomfield P, 2004, WILEY SERIES PROBABI; Bograd S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013790; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2355, DOI 10.1016/S0967-0645(03)00131-0; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Camuffo D, 2001, EARTH MOON PLANETS, V85-6, P99, DOI 10.1023/A:1017099427908; Cayan D.R., 1990, P 7 ANN PAC CLIM PAC, P115; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chen JY, 2002, SCIENCE, V295, P838, DOI 10.1126/science.1065835; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; CORNEJOGARRIDO AG, 1977, J ATMOS SCI, V34, P1155, DOI 10.1175/1520-0469(1977)034<1155:OTHBOT>2.0.CO;2; Cummins PF, 2007, PROG OCEANOGR, V75, P253, DOI 10.1016/j.pocean.2007.08.006; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Diffenbaugh NS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000865; DiLorenzo E, 2008, GEOPHYS RES LETT, V35, P6; Erzini K, 2005, ICES J MAR SCI, V62, P353, DOI 10.1016/j.icesjms.2004.12.009; Filonov AE, 2000, CIENC MAR, V26, P303; FILONOV AE, 2003, GEOFIS INT, V42, P307; Garcia-Reyes M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007629; Gonzalez-Rodriguez E., 2015, OPEN J SYSTEMS, V5, P604, DOI 10.4236/ojs.2015.56062; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hempel G, 2003, LARGE MARINE ECOSYTE; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; HOLLOWED AB, 1992, ICES MAR SC, V195, P433; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; HUYER A, 1991, J GEOPHYS RES-OCEANS, V96, P14809, DOI 10.1029/91JC00641; Jenkins G., 1968, SPECTRAL ANAL ITS AP; King JR, 1998, 318 N PAC AN FISH CO; Klyashtorin LB., 2007, CYCLIC CLIMATE CHANG; Laws E., MATH METHODS OCEANOG; Lindegren M, 2013, P NATL ACAD SCI USA, V110, P13672, DOI 10.1073/pnas.1305733110; Lluch-Belda D, 2003, J OCEANOGR, V59, P503, DOI 10.1023/A:1025596717470; Lluch-Belda D, 2001, CAL COOP OCEAN FISH, V42, P129; LLUCHBELDA D, 1992, CAL COOP OCEAN FISH, V33, P50; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; LLUCHCOTA SE, 2000, COLECCION INFORM AMB; Lohmann G, 2004, INT J CLIMATOL, V24, P1045, DOI 10.1002/joc.1054; Macias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030436; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mazzarella A, 2007, THEOR APPL CLIMATOL, V88, P193, DOI 10.1007/s00704-005-0219-z; McClatchie S, 2014, REGIONAL FISHERIES O; McFarlane GA, 2000, PROG OCEANOGR, V47, P147, DOI 10.1016/S0079-6611(00)00034-3; Mendes HC, 2015, ADV COMPLEX SYST, V18, DOI 10.1142/S0219525915500174; Mendoza B, 2001, J ATMOS SOL-TERR PHY, V63, P1891, DOI 10.1016/S1364-6826(01)00075-X; Munk W, 2007, J PHYS OCEANOGR, V37, P135, DOI 10.1175/JPO3002.1; Navrotsky V.V., 2013, AM J CLIM CHAN, V2, P183; Norton JG, 2013, QUATERN INT, V310, P7, DOI 10.1016/j.quaint.2011.10.041; Norton JG, 1985, PACIFIC OCEAN; Overland JE, 1978, 140 NOAAOCSEAP RU; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; Pearce KF, 1999, J MAR BIOL ASSOC UK, V79, P183, DOI 10.1017/S0025315498000216; PINEDA J, 1995, CONT SHELF RES, V15, P1023, DOI 10.1016/0278-4343(94)00046-P; Pizarro O, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020998; Pugh D. T., 1987, SURGES MEAN SEA LEVE; R Core Team, 2013, R LANG ENV STAT COMP; Ray RD, 2007, GEOPHYS J INT, V168, P999, DOI 10.1111/j.1365-246X.2006.03293.x; REBERT JP, 1985, J GEOPHYS RES-OCEANS, V90, P1719, DOI 10.1029/JC090iC06p11719; REID JL, 1988, CAL COOP OCEAN FISH, V29, P42; Royer TC, 1983, COASTAL OCEANOGRAPHY, V11; Samorodnitsky G, 2006, ANN FACULTE SCI TOUL, V15, P107; Scafetta N, 2010, J ATMOS SOL-TERR PHY, V72, P951, DOI 10.1016/j.jastp.2010.04.015; Schwing FB, 2002, PROG OCEANOGR, V53, P115, DOI 10.1016/S0079-6611(02)00027-7; Shapiro DE, 1989, 132 STANF U DEP STAT; Sharma S., 1996, APPL MULTIVARIATE TE; SOLOW AR, 1994, BIOMETRICS, V50, P556, DOI 10.2307/2533401; Stewart R., 2008, INTRO PHYS OCEANOGRA; Strub PT, 1987, J GEOPHYS RES, V92, P6445; Susanto RD, 2001, GEOPHYS RES LETT, V28, P1599, DOI 10.1029/2000GL011844; Switzer P, 1984, 6 STANF U DEP STAT S; Trenary LL, 2012, J PHYS OCEANOGR, V42, P602, DOI 10.1175/JPO-D-11-084.1; Vargas G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028812; WAHR JM, 1988, ANNU REV EARTH PL SC, V16, P231; Ware DM, 1995, FISH OCEANOGR, V4, P267, DOI 10.1111/j.1365-2419.1995.tb00072.x; Wooster Warren S., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P81; Wooster WS, 1985, EFFECTS E SUBARTIC P; Xue Y, 2003, J CLIMATE, V16, P1601, DOI 10.1175/1520-0442-16.10.1601; Yndestad H, 2006, ICES J MAR SCI, V63, P401, DOI 10.1016/j.icesjms.2005.07.015; Zhang A, 2006, 24 NOAA NOS CS US DE; [No title captured]	88	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166962	10.1371/journal.pone.0166962	http://dx.doi.org/10.1371/journal.pone.0166962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893826	Green Published, gold			2022-12-27	WOS:000389472400063
J	van Maanen, L; Couto, J; Lebreton, M				van Maanen, Leendert; Couto, Joaquina; Lebreton, Mael			Three Boundary Conditions for Computing the Fixed-Point Property in Binary Mixture Data	PLOS ONE			English	Article							ACCURACY TRADE-OFF; TO-ENGAGE THEORY; TIME; MODEL; SPEED; ACCOUNTS	The notion of "mixtures" has become pervasive in behavioral and cognitive sciences, due to the success of dual-process theories of cognition. However, providing support for such dual-process theories is not trivial, as it crucially requires properties in the data that are specific to mixture of cognitive processes. In theory, one such property could be the fixed-point property of binary mixture data, applied-for instance- to response times. In that case, the fixed-point property entails that response time distributions obtained in an experiment in which the mixture proportion is manipulated would have a common density point. In the current article, we discuss the application of the fixed-point property and identify three boundary conditions under which the fixed-point property will not be interpretable. In Boundary condition 1, a finding in support of the fixed-point will be mute because of a lack of difference between conditions. Boundary condition 2 refers to the case in which the extreme conditions are so different that a mixture may display bimodality. In this case, a mixture hypothesis is clearly supported, yet the fixed-point may not be found. In Boundary condition 3 the fixed-point may also not be present, yet a mixture might still exist but is occluded due to additional changes in behavior. Finding the fixed-property provides strong support for a dual-process account, yet the boundary conditions that we identify should be considered before making inferences about underlying psychological processes.	[van Maanen, Leendert] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [van Maanen, Leendert; Couto, Joaquina; Lebreton, Mael] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Couto, Joaquina; Lebreton, Mael] Univ Amsterdam, FEB, ASE, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	van Maanen, L (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.; van Maanen, L (corresponding author), Univ Amsterdam, ABC, Amsterdam, Netherlands.	lvmaanen@gmail.com	Lebreton, Maël/J-3179-2019; Van Maanen, Leendert/Z-5637-2019	Lebreton, Maël/0000-0002-2071-4890; Van Maanen, Leendert/0000-0001-9120-1075	EU [657904]; Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant; Bettencourt-Schueller Foundation	EU(European Commission); Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant; Bettencourt-Schueller Foundation	ML is supported by an EU Marie Sklodowska-Curie Individual Fellowship (IF-2015 Grant nr 657904, http://ec.europa.eu/research/mariecurieactions/about-msca/actions/if/index_en.htm), a Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant (http://abc.uva.nl/abc-grants/abc-talent-grant/abc-talent-grant.html), and acknowledges the support of the Bettencourt-Schueller Foundation (http://www.fondationbs.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML is supported by an EU Marie Sklodowska-Curie Individual Fellowship (IF-2015 Grant 657904), a Universiteit van Amsterdam-Amsterdam Brain and Cognition Talent Grant, and acknowledges the support of the Bettencourt-Schueller Foundation.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boehm U, 2014, NEUROIMAGE, V96, P95, DOI 10.1016/j.neuroimage.2014.03.063; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brown S, 2006, PSYCHON B REV, V13, P152, DOI 10.3758/BF03193827; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Burnham P., 2000, MODEL SELECTION MULT; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Dixon P, 2012, BEHAV RES METHODS, V44, P706, DOI 10.3758/s13428-012-0244-7; Dolan CV, 2002, BEHAV RES METH INS C, V34, P304, DOI 10.3758/BF03195458; Donkin C, 2014, J MATH PSYCHOL, V62-63, P22, DOI 10.1016/j.jmp.2014.09.006; Dutilh G, 2011, COGNITIVE SCI, V35, P211, DOI 10.1111/j.1551-6709.2010.01147.x; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; FALMAGNE JC, 1968, BRIT J MATH STAT PSY, V21, P131, DOI 10.1111/j.2044-8317.1968.tb00403.x; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2012, TECHNICAL REPORT; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Grange JA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00251; Hartelman PAI, 1998, BRIT J DEV PSYCHOL, V16, P97, DOI 10.1111/j.2044-835X.1998.tb00751.x; Kahneman D., 2013, THINKING FAST SLOW; Krajbich I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8455; Meijering B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045961; Mulder MJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1048, DOI 10.3758/s13414-013-0447-8; Ollman R., 1966, PSYCHON SCI, V6, P155, DOI [10.3758/BF03328004, DOI 10.3758/BF03328004]; Poboka D, 2014, COGNITIVE PSYCHOL, V72, P108, DOI 10.1016/j.cogpsych.2014.02.003; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Roberts S, 2000, PSYCHOL REV, P107; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Sprenger SA, 2013, MENT LEX, V8, P1, DOI 10.1075/ml.8.1.01spr; van Maanen L, 2016, TOP COGN SCI, V8, P279, DOI 10.1111/tops.12182; van Maanen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106113; VANDERMAAS HLJ, 1992, PSYCHOL REV, V99, P395, DOI 10.1037/0033-295X.99.3.395	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167377	10.1371/journal.pone.0167377	http://dx.doi.org/10.1371/journal.pone.0167377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893868	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400115
J	Chen, JH; Chung, CH; Wang, YC; Hsu, SN; Huang, WY; Chien, WC				Chen, Jia-Hong; Chung, Chi-Hsiang; Wang, Yung-Chih; Hsu, Shun-Neng; Huang, Wen-Yen; Chien, Wu-Chien			Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan	PLOS ONE			English	Article							TRANSPLANTATION; EXPERIENCE	In this retrospective cohort study based in Taiwan, we reported the current epidemiology of patients with multiple myeloma and analyzed the factors affecting mortality. We identified 7285 patients with newly diagnosed multiple myeloma (MM) between 1997 and 2013 in Taiwan. Privileges data from the National Health Institute Research Database was used, as it is made readily available to the public in electronic format for research purposes. From 1997 to 2013, the average incidence of MM per 100,000 people was 1.83. The mortality accounted for an average of 0.44 per 100,000 deaths. In all 7285 inpatients with MM, the proportion of male patients was greater than that of female (59.90% vs. 40.10%); the mean age was 68.71 years with the proportion of those >55 years of age was 85.11%; and the proportion of a catastrophic illness was 66.51%. The death risk of the inpatient dialysis group was 3.044 times that of patients without dialysis (P <0.001). Moreover, the risk of death to men in the hospital setting was 1.162 times that of women (P = 0.012), and in the group of patients aged >55 years, the risk of in-hospital death was 1.511 times more than that in those aged <= 55 years (P <0.001). The risk of hospital death due to catastrophic illness was 1.347 times that of a non-catastrophic illness (P <0.001). Male patients and those >55 years of age had the most common prevalence of MM in Taiwan. Hemodialysis treatment, male sex, old age, and catastrophic illness were independent predictors of hospital mortality in patients with MM.	[Chen, Jia-Hong] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Wang, Yung-Chih] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Wang, Yung-Chih; Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Hsu, Shun-Neng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, Taipei, Taiwan; [Huang, Wen-Yen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	chienwu@mail.ndmctsgh.eciu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Wang, Yung-Chih/ABE-9069-2020; huang, wen/GXW-0661-2022; Hsu, Shun-Neng/A-3602-2014	Wang, Yung-Chih/0000-0002-8491-8972; Hsu, Shun-Neng/0000-0002-8014-6311				[Anonymous], 2014, MYEL NCI SURV EP END; Barlogie B, 2006, WILLIAMS HEMATOLOGY, P1501; Bensinger WI, 2009, LEUKEMIA, V23, P442, DOI 10.1038/leu.2008.396; Cartwright RA, 1999, BRIT J HAEMATOL, V106, P281, DOI 10.1046/j.1365-2141.1999.01480.x; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Friese CR, 2009, LEUKEMIA LYMPHOMA, V50, P392, DOI 10.1080/10428190902741471; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Huang TC, 2015, ANN HEMATOL, V94, P107, DOI 10.1007/s00277-014-2165-2; IGLEHART JK, 1989, NEW ENGL J MED, V320, P329, DOI 10.1056/NEJM198902023200536; Kim K, 2014, AM J HEMATOL, V89, P751, DOI 10.1002/ajh.23731; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lee JH, 2010, INT J HEMATOL, V92, P52, DOI 10.1007/s12185-010-0617-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Palumbo A, 2009, LEUKEMIA, V23, P449, DOI 10.1038/leu.2008.325; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkumar SV, 2016, AM J HEMATOL, V91, P90, DOI 10.1002/ajh.24236; Yoshimi I, 2004, JPN J CLIN ONCOL, V34, P218	17	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167227	10.1371/journal.pone.0167227	http://dx.doi.org/10.1371/journal.pone.0167227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907052	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700095
J	Dreiss, AN; Chatelain, PG; Roulin, A; Richner, H				Dreiss, Amelie N.; Chatelain, Philippe G.; Roulin, Alexandre; Richner, Heinz			Prosody Predicts Contest Outcome in Non-Verbal Dialogs	PLOS ONE			English	Article							CONFLICT; ORGANIZATION; DOMINANCE; EVOLUTION; BEHAVIOR	Non-verbal communication has important implications for inter-individual relationships and negotiation success. However, to what extent humans can spontaneously use rhythm and prosody as a sole communication tool is largely unknown. We analysed human ability to resolve a conflict without verbal dialogs, independently of semantics. We invited pairs of subjects to communicate non-verbally using whistle sounds. Along with the production of more whistles, participants unwittingly used a subtle prosodic feature to compete over a resource (ice-cream scoops). Winners can be identified by their propensity to accentuate the first whistles blown when replying to their partner, compared to the following whistles. Naive listeners correctly identified this prosodic feature as a key determinant of which whistler won the interaction. These results suggest that in the absence of other communication channels, individuals spontaneously use a subtle variation of sound accentuation (prosody), instead of merely producing exuberant sounds, to impose themselves in a conflict of interest. We discuss the biological and cultural bases of this ability and their link with verbal communication. Our results highlight the human ability to use non-verbal communication in a negotiation process.	[Dreiss, Amelie N.; Chatelain, Philippe G.; Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Dreiss, Amelie N.; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Chatelain, Philippe G.] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany	University of Lausanne; University of Bern; Eberhard Karls University of Tubingen	Dreiss, AN (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.; Dreiss, AN (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	Amelie.n.dreiss@gmail.com	Richner, Heinz/B-1659-2008	Richner, Heinz/0000-0001-7390-0526; Dreiss, Amelie/0000-0001-7154-4783				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bradbury Jack W., 1998, pi; COOPER VW, 1986, J NONVERBAL BEHAV, V10, P134, DOI 10.1007/BF01000009; Curhan JR, 2007, J APPL PSYCHOL, V92, P802, DOI 10.1037/0021-9010.92.3.802; DePaulo B M, 1997, Pers Soc Psychol Rev, V1, P346, DOI 10.1207/s15327957pspr0104_5; DEPAULO BM, 1992, PSYCHOL BULL, V111, P203, DOI 10.1037/0033-2909.111.2.203; Gatica-Perez D, 2009, IMAGE VISION COMPUT, V27, P1775, DOI 10.1016/j.imavis.2009.01.004; GoldinMeadow S, 1996, PSYCHOL REV, V103, P34, DOI 10.1037/0033-295X.103.1.34; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hall JA, 2005, PSYCHOL BULL, V131, P898, DOI 10.1037/0033-2909.131.6.898; HALLE PA, 1991, LANG SPEECH, V34, P299, DOI 10.1177/002383099103400401; Iversen JR, 2008, J ACOUST SOC AM, V124, P2263, DOI 10.1121/1.2973189; Jayagopi DB, 2009, IEEE T AUDIO SPEECH, V17, P501, DOI 10.1109/TASL.2008.2008238; Kim S, 2012, INT CONF ACOUST SPEE, P5089, DOI 10.1109/ICASSP.2012.6289065; Ko SJ, 2015, PSYCHOL SCI, V26, P3, DOI 10.1177/0956797614553009; Kose-Bagci H, 2010, CONNECT SCI, V22, P103, DOI 10.1080/09540090903383189; KRAUSS RM, 1981, J PERS SOC PSYCHOL, V40, P312, DOI 10.1037/0022-3514.40.2.312; LEINONEN L, 1991, LANG COMMUN, V11, P241, DOI 10.1016/0271-5309(91)90031-P; MANDEL DR, 1994, COGNITION, V53, P155, DOI 10.1016/0010-0277(94)90069-8; Nass C, 2004, VOICE ACTIVATED PEOP; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Patterson ML, 2001, J NONVERBAL BEHAV, V25, P207, DOI 10.1023/A:1010675210696; Perlman M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150152; Pesarin A, 2012, COGN PROCESS, V13, P533, DOI 10.1007/s10339-011-0417-9; Rienks R, 2005, LECT NOTES COMPUT SC, V3869, P76; Saarni T, 2006, LECT NOTES ARTIF INT, V4139, P576; Sanchez-Cortes D, 2012, IEEE T MULTIMEDIA, V14, P816, DOI 10.1109/TMM.2011.2181941; Scheumann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091192; SILLARS AL, 1982, HUM COMMUN RES, V9, P83, DOI 10.1111/j.1468-2958.1982.tb00685.x; SMITH JM, 1982, J THEOR BIOL, V97, P1, DOI 10.1016/0022-5193(82)90271-5; Soderstrom M, 2003, J MEM LANG, V49, P249, DOI 10.1016/S0749-596X(03)00024-X; Steels L, 2006, TRENDS COGN SCI, V10, P347, DOI 10.1016/j.tics.2006.06.002; Sternglanz RW, 2004, J NONVERBAL BEHAV, V28, P245, DOI 10.1007/s10919-004-4158-7; Tusing KJ, 2000, HUM COMMUN RES, V26, P148, DOI 10.1093/hcr/26.1.148; Vinciarelli A, 2009, IMAGE VISION COMPUT, V27, P1743, DOI 10.1016/j.imavis.2008.11.007; WALL JA, 1995, J MANAGE, V21, P515, DOI 10.1016/0149-2063(95)90018-7; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	37	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166953	10.1371/journal.pone.0166953	http://dx.doi.org/10.1371/journal.pone.0166953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907039	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700055
J	Gorski, L; Parker, CT; Liang, AS; Walker, S; Romanolo, KF				Gorski, Lisa; Parker, Craig T.; Liang, Anita S.; Walker, Samarpita; Romanolo, Kelly F.			The Majority of Genotypes of the Virulence Gene inlA Are Intact among Natural Watershed Isolates of Listeria monocytogenes from the Central California Coast	PLOS ONE			English	Article							PREMATURE STOP CODON; TO-EAT FOODS; PHENOTYPIC CHARACTERIZATION; MUTATIONS; EVOLUTION; STRAINS; ENVIRONMENTS; INTERNALIN; IDENTIFICATION; PREVALENCE	Internalin A is an essential virulence gene involved in the uptake of the foodborne pathogen Listeria monocytogenes into host cells. It is intact in clinical strains and often truncated due to Premature Stop Codons (PMSCs) in isolates from processed foods and processing facilities. Less information is known about environmental isolates. We sequenced the inlA alleles and did Multi Locus Variable Number Tandem Repeat Analysis (MLVA) on 112 L. monocytogenes isolates from a 3-year period from naturally contaminated watersheds near a leafy green growing area in Central California. The collection contained 14 serotype 1/2a, 12 serotype 1/2b, and 86 serotype 4b strains. Twenty-seven different inlA alleles were found. Twenty-three of the alleles are predicted to encode intact copies of InlA, while three contain PMSCs. Another allele has a 9-nucleotide deletion, previously described for a clinical strain, indicating that it is still functional. Intact inlA genes were found in 101 isolates, and 8 isolates contained the allele predicted to contain the 3-amino acid deletion. Both allele types were found throughout the 3-year sampling period. Three strains contained inlA alleles with PMSCs, and these were found only during the first 3 months of the study. SNP analysis of the intact alleles indicated clustering of alleles based on serotype and lineage with serotypes 1/2b and 4b (lineage I strains) clustering together, and serotype 1/2a (lineage II strains) clustering separately. The combination of serotype, MLVA types, and inlA allele types indicate that the 112 isolates reflect at least 49 different strains of L. monocytogenes. The finding that 90% of environmental L. monocytogenes isolates contain intact inlA alleles varies significantly from isolates found in processing plants. This information is important to public health labs and growers as to the varieties of L. monocytogenes that could potentially contaminate fresh produce in the field by various means.	[Gorski, Lisa; Parker, Craig T.; Liang, Anita S.; Walker, Samarpita; Romanolo, Kelly F.] ARS, Prod Safety & Microbiol Res Unit, USDA, Albany, CA 94710 USA; [Romanolo, Kelly F.] USDA, Food Safety Inspect Serv, Alameda, CA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Gorski, L (corresponding author), ARS, Prod Safety & Microbiol Res Unit, USDA, Albany, CA 94710 USA.	lisa.gorski@ars.usda.gov		Gorski, Lisa/0000-0003-2387-1012; Parker, Craig/0000-0002-7719-8882	Agricultural Research Service CRIS project [5325-42000-050-00D]; Food and Drug Administration [224-11-2044]; FDA [224-11-2044]	Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Food and Drug Administration(United States Department of Health & Human Services); FDA(United States Department of Health & Human Services)	This work was funded through Agricultural Research Service CRIS project 5325-42000-050-00D and Food and Drug Administration grant #224-11-2044. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank M. Cooley for information and advice. This work was funded through Agricultural Research Service CRIS project 5325-42000-050-00D and FDA grant #224-11-2044.	Association LGM, 2013, COMMODITY SPECIFIC F; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Chen Y, 2011, J BACTERIOL, V193, P3424, DOI 10.1128/JB.05048-11; Cooley MB, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00030; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Felicio MTS, 2007, APPL ENVIRON MICROB, V73, P3887, DOI 10.1128/AEM.02912-06; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gorski L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00058; Gorski L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092467; Gudmundsdottir S, 2006, J FOOD PROTECT, V69, P2157; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Jonquieres R, 1998, INFECT IMMUN, V66, P3420; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kovacevic J, 2013, APPL ENVIRON MICROB, V79, P1915, DOI 10.1128/AEM.03341-12; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P8339, DOI 10.1128/AEM.02752-15; MCLAUCHLIN J, 1990, EUR J CLIN MICROBIOL, V9, P210, DOI 10.1007/BF01963840; Nightingale KK, 2008, APPL ENVIRON MICROB, V74, P6570, DOI 10.1128/AEM.00997-08; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Oliveira M, 2011, FOOD MICROBIOL, V28, P590, DOI 10.1016/j.fm.2010.11.004; Orsi RH, 2007, MICROBIOL-SGM, V153, P2666, DOI 10.1099/mic.0.2007/007310-0; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; Roche SM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-304; Sauders BD, 2006, J FOOD PROTECT, V69, P93, DOI 10.4315/0362-028X-69.1.93; Sauders BD, 2004, J FOOD PROTECT, V67, P1417, DOI 10.4315/0362-028X-67.7.1417; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sperry KEV, 2008, J CLIN MICROBIOL, V46, P1435, DOI 10.1128/JCM.02207-07; Sperry KEV, 2009, J CLIN MICROBIOL, V47, P1984, DOI 10.1128/JCM.00730-09; Stea EC, 2015, APPL ENVIRON MICROB, V81, P3812, DOI 10.1128/AEM.00416-15; Van Stelten A, 2008, APPL ENVIRON MICROB, V74, P7365, DOI 10.1128/AEM.01138-08; Van Stelten A, 2010, APPL ENVIRON MICROB, V76, P2783, DOI 10.1128/AEM.02651-09; Walters SP, 2011, WATER RES, V45, P1752, DOI 10.1016/j.watres.2010.11.032; Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004; Ward TJ, 2010, J FOOD PROTECT, V73, P861, DOI 10.4315/0362-028X-73.5.861	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167566	10.1371/journal.pone.0167566	http://dx.doi.org/10.1371/journal.pone.0167566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907153	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700196
J	Llano-Diez, M; Sinclair, J; Yamada, T; Zong, M; Fauconnier, J; Zhang, SJ; Katz, A; Jardemark, K; Westerblad, H; Andersson, DC; Lanner, JT				Llano-Diez, Monica; Sinclair, Jon; Yamada, Takashi; Zong, Mei; Fauconnier, Jeremy; Zhang, Shi-Jin; Katz, Abram; Jardemark, Kent; Westerblad, Hakan; Andersson, Daniel C.; Lanner, Johanna T.			The Role of Reactive Oxygen Species in beta-Adrenergic Signaling in Cardiomyocytes from Mice with the Metabolic Syndrome	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; HEART-FAILURE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CA2+ CHANNEL; CARDIAC CONTRACTILITY; RECEPTOR STIMULATION; HIGH-FAT; INSULIN; OB/OB	The metabolic syndrome is associated with prolonged stress and hyperactivity of the sympathetic nervous system and afflicted subjects are prone to develop cardiovascular disease. Under normal conditions, the cardiomyocyte response to acute beta-adrenergic stimulation partly depends on increased production of reactive oxygen species (ROS). Here we investigated the interplay between beta-adrenergic signaling, ROS and cardiac contractility using freshly isolated cardiomyocytes and whole hearts from two mouse models with the metabolic syndrome (high-fat diet and ob/ob mice). We hypothesized that cardiomyocytes of mice with the metabolic syndrome would experience excessive ROS levels that trigger cellular dysfunctions. Fluorescent dyes and confocal microscopy were used to assess mitochondrial ROS production, cellular Ca2+ handling and contractile function in freshly isolated adult cardiomyocytes. Immunofluorescence, western blot and enzyme assay were used to study protein biochemistry. Unexpectedly, our results point towards decreased cardiac ROS signaling in a stable, chronic phase of the metabolic syndrome because: beta-adrenergic-induced increases in the amplitude of intracellular Ca2+ signals were insensitive to antioxidant treatment; mitochondrial ROS production showed decreased basal rate and smaller response to beta-adrenergic stimulation. Moreover, control hearts and hearts with the metabolic syndrome showed similar basal levels of ROS-mediated protein modification, but only control hearts showed increases after beta-adrenergic stimulation. In conclusion, in contrast to the situation in control hearts, the cardiomyocyte response to acute beta-adrenergic stimulation does not involve increased mitochondrial ROS production in a stable, chronic phase of the metabolic syndrome. This can be seen as a beneficial adaptation to prevent excessive ROS levels.	[Llano-Diez, Monica; Sinclair, Jon; Yamada, Takashi; Fauconnier, Jeremy; Zhang, Shi-Jin; Katz, Abram; Jardemark, Kent; Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Zong, Mei] Karolinska Univ Hosp, Rheumatol Unit, CMM, Stockholm, Sweden; [Andersson, Daniel C.] Karolinska Inst, Dept Med, Stockholm, Sweden; [Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Fauconnier, Jeremy] Univ Montpellier, INSERM, U1046, Montpellier, France; [Katz, Abram] Ariel Univ, Sch Hlth Sci, Dept Phys Therapy, Ariel, Israel	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sapporo Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ariel University	Lanner, JT (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	Johanna.Lanner@ki.se	Andersson, Daniel/AAE-9968-2019; Katz, Abram/AAL-2244-2020; Yamada, Takashi/U-8443-2019; Yamada, Takashi/AAZ-6212-2021; Jeremy, Jeremy/N-6233-2018	Andersson, Daniel/0000-0003-4548-702X; Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Westerblad, Hakan/0000-0002-8180-3029; Jeremy, Jeremy/0000-0003-2748-0983	Swedish Research Council; Swedish Heart-Lung Foundation; KI fonds; Ake Wiberg foundation; Stockholm County Council; Karolinska Institutet; Lars Hierta foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); KI fonds; Ake Wiberg foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Lars Hierta foundation	This study was supported by The Swedish Research Council (JTL, HW), the Swedish Heart-Lung Foundation (DCA, HW), KI fonds (JTL), Ake Wiberg foundation (JTL, DCA), Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet (DCA) and Lars Hierta foundation (ML-D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Andersson DC, 2011, J PHYSIOL-LONDON, V589, P1791, DOI 10.1113/jphysiol.2010.202838; Aydin J, 2009, HUMAN MOL GENET; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bovo E, 2012, J PHYSIOL-LONDON, V590, P3291, DOI 10.1113/jphysiol.2012.230748; Bruton JD, 2008, J PHYSIOL-LONDON, V586, P175, DOI 10.1113/jphysiol.2007.147470; Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166; Callow AD, 2006, VASC PHARMACOL, V45, P302, DOI 10.1016/j.vph.2006.08.010; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Cheng AJ, 2015, J PHYSIOL-LONDON, V593, P457, DOI 10.1113/jphysiol.2014.279398; Chu G., 2002, BASIC RES CARDIOL S1, V97, pI43, DOI [10.1007/s003950200028, DOI 10.1007/S003950200028]; Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007; Crocini C, 2014, P NATL ACAD SCI USA, V111, P15196, DOI 10.1073/pnas.1411557111; Diniz YS, 2008, EUR J PHARMACOL, V579, P318, DOI 10.1016/j.ejphar.2007.11.008; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fauconnier J, 2005, DIABETES, V54, P2375, DOI 10.2337/diabetes.54.8.2375; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Fauconnier J, 2007, CARDIOVASC RES, V73, P376, DOI 10.1016/j.cardiores.2006.10.018; Findlay I, 2002, J PHYSIOL-LONDON, V541, P731, DOI 10.1113/jphysiol.2002.019729; Fu Q, 2014, DIABETES, V63, P2676, DOI 10.2337/db13-1763; Fu Y, 2014, P NATL ACAD SCI USA, V111, P16598, DOI 10.1073/pnas.1419129111; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Halseth AE, 2002, BIOCHEM BIOPH RES CO, V294, P798, DOI 10.1016/S0006-291X(02)00557-0; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Harper JM, 2005, EXP GERONTOL, V40, P303, DOI 10.1016/j.exger.2005.01.002; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Hool LC, 2002, CIRC RES, V91, P601, DOI 10.1161/01.RES.0000035528.00678.D5; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Jeong EM, 2016, J AM HEART ASSOC, P5; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kowluru RA, 2000, FREE RADICAL RES, V32, P67, DOI 10.1080/10715760000300071; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Mellor KM, 2010, CLIN EXP PHARMACOL P, V37, P222, DOI 10.1111/j.1440-1681.2009.05274.x; Mulligan C., 2016, ENVIRON TOXICOL; Nagasaka S, 2007, CIRC J, V71, P429, DOI 10.1253/circj.71.429; Nandhini A. T. A., 2005, SMJ Singapore Medical Journal, V46, P82; Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008; Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Panchenko PE, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0188-3; Patriarchi T, 2016, EMBO J, V35, P1330, DOI 10.15252/embj.201593409; Pironti G, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0551-8; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Spooner PM, 2008, DIABETES OBES METAB, V10, P523, DOI 10.1111/j.1463-1326.2007.00723.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sverdlov AL, 2015, J MOL CELL CARDIOL, V78, P165, DOI 10.1016/j.yjmcc.2014.07.018; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Thirunavukkarasu V, 2004, NUTR METAB CARDIOVAS, V14, P351, DOI 10.1016/S0939-4753(04)80025-5; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tu VC, 2002, J PHARMACOL EXP THER, V300, P1101, DOI 10.1124/jpet.300.3.1101; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Yamada T, 2015, ANN RHEUM DIS, V74, P1907, DOI 10.1136/annrheumdis-2013-205007; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Zhang YX, 2012, FREE RADICAL BIO MED, V53, P1531, DOI 10.1016/j.freeradbiomed.2012.07.010; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	64	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167090	10.1371/journal.pone.0167090	http://dx.doi.org/10.1371/journal.pone.0167090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907040	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700075
J	Shayeghian, Z; Hassanabadi, H; Aguilar-Vafaie, ME; Amiri, P; Besharat, MA				Shayeghian, Zeinab; Hassanabadi, Hamidreza; Aguilar-Vafaie, Maria E.; Amiri, Parise; Besharat, Mohammad Ali			A Randomized Controlled Trial of Acceptance and Commitment Therapy for Type 2 Diabetes Management: The Moderating Role of Coping Styles	PLOS ONE			English	Article							SELF-MANAGEMENT; GLYCEMIC CONTROL; STRESS; INTERVENTION; MINDFULNESS; ADOLESCENTS; STRATEGIES; ADHERENCE; MELLITUS; OUTCOMES	Background and Aim Evidence of the efficacy of existing psychological interventions for self-management in diabetes is limited. The current study aimed at assessing the effects of group-based ACT on self-management of patients with T2DM, considering the moderating role of coping styles. Methods One hundred and six patients with type 2 diabetes were randomly assigned either to the education alone (n = 53) or to a combination of education and group-based acceptance and commitment therapy (n = 53) over a period of 10 sessions. In each group, 50 participants completed a 3 month follow-up assessment. Results After 3 months, compared to patients who received education alone, those in the group based acceptance and commitment therapy condition were more likely to use effective coping strategies, reported better diabetes self-care, and optimum glycated hemoglobin (HbA1C) levels in the target range. Conclusions Consideration of the role of coping style for a more accurate evaluation of the effects of acceptance and commitment therapy may be a useful addition to services provided for patients with type 2 diabetes.	[Shayeghian, Zeinab; Amiri, Parise] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Endocrine Hlth, Tehran, Iran; [Shayeghian, Zeinab; Amiri, Parise] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Hassanabadi, Hamidreza] Kharazmi Univ, Dept Psychol, Tehran, Iran; [Aguilar-Vafaie, Maria E.] Tarbiat Modares Univ, Dept Psychol, Tehran, Iran; [Besharat, Mohammad Ali] Univ Tehran, Dept Psychol, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Kharazmi University; Tarbiat Modares University; University of Tehran	Amiri, P (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Endocrine Hlth, Tehran, Iran.; Amiri, P (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran.	amiri@endocrine.ac.ir	amiri, parisa/K-1575-2017; Hassanabadi, Hamidreza/CAJ-2673-2022	amiri, parisa/0000-0002-6693-1057; 				Asche C, 2011, CLIN THER, V33, P74, DOI 10.1016/j.clinthera.2011.01.019; ASSOCIATION AD, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011; Bastiaens H, 2009, PRIM CARE DIABETES, V3, P103, DOI 10.1016/j.pcd.2009.02.001; Besharat M, 2006, CONTEMP PSYCHOL, V1, P48; BROWN SA, 1990, PATIENT EDUC COUNS, V16, P189, DOI 10.1016/0738-3991(90)90070-2; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Ciarrochi J., 2010, ASSESSING MINDFULNES, P51; Coelho R, 2003, PSYCHOSOMATICS, V44, P312, DOI 10.1176/appi.psy.44.4.312; Fillion L, 2002, CURR PSYCHOL, V21, P17, DOI 10.1007/BF02903157; Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808; Gafvels C, 2006, DIABETES RES CLIN PR, V71, P280, DOI 10.1016/j.diabres.2005.07.001; Gillibrand R, 2006, BRIT J HEALTH PSYCH, V11, P155, DOI 10.1348/135910705X39485; Graue M, 2004, DIABETES CARE, V27, P1313, DOI 10.2337/diacare.27.6.1313; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Hadlandsmyth K., 2013, INT J BEHAV CONSULT, V7, P12, DOI [10.1037/h0100960, DOI 10.1037/H0100960]; Hayes SC, 2004, BEHAV THER, V35, P667, DOI 10.1016/S0005-7894(04)80014-5; Hayes SC, 2003, ACCEPTANCE COMMITMEN; Jadad A.R., 1998, HLTH TECHNOLOGY ASSE, V2, P214; Jaser SS, 2011, CHILD CARE HLTH DEV, V37, P335, DOI 10.1111/j.1365-2214.2010.01184.x; Jaser SS, 2012, ANN BEHAV MED, V43, P311, DOI 10.1007/s12160-012-9343-z; Kirk RE, 1995, EXPT DESIGN; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kumar V, 2014, ROBBINS COTRAN PATHO; Lloyd C., 2005, Diabetes Spectrum, V18, P121, DOI 10.2337/diaspect.18.2.121; Lustman PJ, 1995, DIABETES AM NIH PUBL, V95-1468, P507; Ng DM, 2003, HEALTH PSYCHOL, V22, P638, DOI 10.1037/0278-6133.22.6.638; Niemeier HM, 2012, BEHAV THER, V43, P427, DOI 10.1016/j.beth.2011.10.005; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370; PEYROT MF, 1992, DIABETES CARE, V15, P842, DOI 10.2337/diacare.15.7.842; Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36; Rubin R, 2001, CORE CURRICULUM DIAB; Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041; Thoolen B, 2008, HEALTH EDUC RES, V23, P53, DOI 10.1093/her/cyl160; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001; Van den Broucke S, 2014, HORM METAB RES, V46, P933, DOI 10.1055/s-0034-1389952; Vickers AJ, 2005, PSYCHOSOM MED, V67, P652, DOI 10.1097/01.psy.0000172624.52957.a8; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Yancura LA, 2006, J GERONTOL B-PSYCHOL, V61, pP295, DOI 10.1093/geronb/61.5.P295	42	32	33	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166599	10.1371/journal.pone.0166599	http://dx.doi.org/10.1371/journal.pone.0166599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907074	Green Published, gold			2022-12-27	WOS:000389482700030
J	Stankovic, S; Dimkic, I; Vujisic, L; Pavkovic-Lucic, S; Jovanovic, Z; Stevic, T; Sofrenic, I; Mitic, B; Tomic, V				Stankovic, Slavisa; Dimkic, Ivica; Vujisic, Ljubodrag; Pavkovic-Lucic, Sofija; Jovanovic, Zvezdana; Stevic, Tatjana; Sofrenic, Ivana; Mitic, Bojan; Tomic, Vladimir			Chemical Defence in a Millipede: Evaluation and Characterization of Antimicrobial Activity of the Defensive Secretion from Pachyiulus hungaricus (Karsch, 1881) (Diplopoda, Julida, Julidae)	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; LABOULBENIALES	The chemical defence of the millipede Pachyiulus hungaricus is reported in the present paper, in which a chemical characterization is given and antimicrobial activity is determined. In total, independently of sex, 44 compounds were identified. All compounds belong to two groups: quinones and pentyl and hexyl esters of long-chain fatty acids. The relative abundances of quinones and non-quinones were 94.7% vs. 5.3% (males) and 87.3% vs. 12.7% (females), respectively. The two dominant quinones in both sexes were 2-methyl-1,4,-benzoquinone and 2-methoxy-3-methyl-1,4-benzoquinone. Antibacterial and antifungal activity of the defensive secretion was evaluated in vitro against seven bacterial strains and eight fungal species. With the aid of a dilution technique, the antimicrobial potential of the secretion and high sensitivity of all tested strains were confirmed. The lowest minimum concentrations of these compounds (0.20-0.25 mg/mL) were sufficient for inhibition of Aeromonas hydrophila, Listeria monocytogenes and Methicillin resistant Staphylococcus aureus (MRSA). The growth of eight tested fungal species was inhibited by slightly lower concentrations of the secretion, with Fusarium equisetias the most sensitive fungus and Aspergillus flavus as the most resistant. Values of MIC and MFC in the employed microdilution assay ranged from 0.10 to above 0.35 mg/m L. The given extract contains antimicrobial components potentially useful as therapeutic agents in the pharmaceutical and agricultural industries.	[Stankovic, Slavisa; Dimkic, Ivica] Univ Belgrade, Dept Microbiol, Fac Biol, Belgrade, Serbia; [Vujisic, Ljubodrag; Sofrenic, Ivana] Univ Belgrade, Dept Organ Chem, Fac Chem, Belgrade, Serbia; [Pavkovic-Lucic, Sofija] Univ Belgrade, Dept Genet & Evolut, Fac Biol, Belgrade, Serbia; [Jovanovic, Zvezdana; Mitic, Bojan; Tomic, Vladimir] Univ Belgrade, Dept Anim Dev, Fac Biol, Belgrade, Serbia; [Stevic, Tatjana] Inst Med Plants Res Dr Josif Pancic, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Stankovic, S (corresponding author), Univ Belgrade, Dept Microbiol, Fac Biol, Belgrade, Serbia.	slavisas@bio.bg.ac.rs	Sofrenić, Ivana/W-2421-2018; Dimkic, Ivica/GWR-2445-2022; Stanković, Slaviša/S-6273-2018; Pavković-Lučić, Sofija/E-7668-2018; Mitic, Bojan/AAD-4235-2019; Dimkić, Ivica/AAE-1508-2019; Vujisic, Ljubodrag/Q-5913-2016	Sofrenić, Ivana/0000-0002-9799-670X; Stanković, Slaviša/0000-0003-0527-8741; Pavković-Lučić, Sofija/0000-0003-2415-7160; Vujisic, Ljubodrag/0000-0001-7625-7484; Dimkic, Ivica/0000-0002-0425-5938; Mitic, Bojan/0000-0003-4507-7629	Ministry of Education, Science and Technological Development of the Republic of Serbia [173026, 173038, 172053]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grants Nos. 173026, 173038 and 172053 - http://www./mpn.gov.rs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157097, DOI 10.1371/JOURNAL.PONE.0157097]; Arab Alberto, 2003, Entomotropica, V18, P79; Beheshti A, 2012, INT J ELECTROCHEM SC, V7, P4811; Bodner M, 2016, J CHEM ECOL, V42, P249, DOI 10.1007/s10886-016-0680-4; Bodner M, 2012, J CHEM ECOL, V38, P547, DOI 10.1007/s10886-012-0127-5; DAOUK RK, 1995, J FOOD PROTECT, V58, P1147, DOI 10.4315/0362-028X-58.10.1147; Drewes SE, 2005, PHYTOCHEMISTRY, V66, P1812, DOI 10.1016/j.phytochem.2005.05.024; Eisner O, 1978, ARTHROPOD VENOMS, P41; EISNER T, 1963, SCIENCE, V139, P1218, DOI 10.1126/science.139.3560.1218; Enghoff H, 2011, FAUNA EUROPAEA; Enghoff H, 2015, ORG DIVERS EVOL, V15, P249, DOI 10.1007/s13127-015-0208-8; HARRIS LJ, 1989, J FOOD PROTECT, V52, P384, DOI 10.4315/0362-028X-52.6.384; Jayaraman SS, 2014, ARCH BIOL SCI, V66, P385; KUWAHARA Y, 2002, JPN J ENV ENTOMOL ZO, V13, P117; Kuwahara Yasumasa, 2007, Japanese Journal of Environmental Entomology and Zoology, V18, P91; Makarov SE, 2015, THE MYRIAPODA, V2, P69, DOI DOI 10.1163/9789004188273; Makarov SE, 2010, J CHEM ECOL, V36, P978, DOI 10.1007/s10886-010-9847-6; McNicholl BP, 2007, WATER RES, V41, P127, DOI 10.1016/j.watres.2006.10.002; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Rakholiya K, 2014, INDIAN J PHARM SCI, V76, P148; Rocha DFO, 2013, MOLECULES, V18, P11429, DOI 10.3390/molecules180911429; RONCADORI RW, 1985, MYCOLOGIA, V77, P185, DOI 10.2307/3793067; Santamaria S, 2016, PHYTOTAXA, V243, P101, DOI 10.11646/phytotaxa.243.2.1; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Savikin K, 2015, BIOL CONTROL, V87, P6; Sekulic TL, 2013, BIOL CONTROL, V65, P312; Sen A., 2012, INT J CURRENT PHARM, V4, P67; Shimizu N, 2012, J CHEM ECOL, V38, P23, DOI 10.1007/s10886-012-0063-4; Stevic T, 2012, ARCH BIOL SCI, V64, P49, DOI 10.2298/ABS1201049S; Tatjana L., 2011, CHEM BIODIVERS, V8, P1284, DOI [10.1002/cbdv.201000377, DOI 10.1002/CBDV.201000377]; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; Vujisic LV, 2011, J CHEM ECOL, V37, P1358, DOI 10.1007/s10886-011-0040-3; WEATHERS.J, 1969, CAN J ZOOLOG, V47, P1389, DOI 10.1139/z69-214; Williams LAD, 1997, NATURWISSENSCHAFTEN, V84, P143, DOI 10.1007/s001140050364; Wu XG, 2007, CHEMOECOLOGY, V17, P131, DOI 10.1007/s00049-007-0372-1; Xylander Willi E. R., 2009, Soil Organisms, V81, P413; Yadav P. R., 2005, IND BIOTECHNOLOGY	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167249	10.1371/journal.pone.0167249	http://dx.doi.org/10.1371/journal.pone.0167249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907048	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700103
J	Li, QY; Chang, R; Sun, YJ; Li, BS				Li, Qingye; Chang, Rong; Sun, Yijun; Li, Bosheng			iTRAQ-Based Quantitative Proteomic Analysis of Spirulina platensis in Response to Low Temperature Stress	PLOS ONE			English	Article							ACYL-LIPID DESATURASES; SEDOHEPTULOSE-1,7-BISPHOSPHATASE ACTIVITY; PHOTOSYNTHETIC CAPACITY; ARABIDOPSIS-THALIANA; COLD; PROTEINS; GROWTH; EXPRESSION; PLANTS; ACID	Low temperature (LT) is one of the most important abiotic stresses that can significantly reduce crop yield. To gain insight into how Spirulina responds to LT stress, comprehensive physiological and proteomic analyses were conducted in this study. Significant decreases in growth and pigment levels as well as excessive accumulation of compatible osmolytes were observed in response to LT stress. An isobaric tag for relative and absolute quantitation (iTRAQ)-based quantitative proteomics approach was used to identify changes in protein abundance in Spirulina under LT. A total of 3,782 proteins were identified, of which 1,062 showed differential expression. Bioinformatics analysis indicated that differentially expressed proteins that were enriched in photosynthesis, carbohydrate metabolism, amino acid biosynthesis, and translation are important for the maintenance of cellular homeostasis and metabolic balance in Spirulina when subjected to LT stress. The up-regulation of proteins involved in gluconeogenesis, starch and sucrose metabolism, and amino acid biosynthesis served as coping mechanisms of Spirulina in response to LT stress. Moreover, the down-regulated expression of proteins involved in glycolysis, TCA cycle, pentose phosphate pathway, photosynthesis, and translation were associated with reduced energy consumption. The findings of the present study allow a better understanding of the response of Spirulina to LT stress and may facilitate in the elucidation of mechanisms underlying LT tolerance.	[Li, Qingye; Chang, Rong; Li, Bosheng] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Sun, Yijun] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Li, Bosheng] Beijing Forestry Univ, Inst Spirulina Res, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Li, BS (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Li, BS (corresponding author), Beijing Forestry Univ, Inst Spirulina Res, Beijing, Peoples R China.	libs3721@bjfu.edu.cn			State Public Forest Research Grant [201304605]	State Public Forest Research Grant	This study is funded by the State Public Forest Research Grant (NO. 201304605) (http://www.forestry.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Daim MM, 2015, IMMUNOPHARM IMMUNOT, V37, P126, DOI 10.3109/08923973.2014.998368; Aleksandrov A, 2014, J PHYS CHEM B, V118, P4505, DOI 10.1021/jp412346g; Aseev L V, 2011, Mol Biol (Mosk), V45, P805; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chen WP, 2002, PLANT CELL ENVIRON, V25, P955, DOI 10.1046/j.1365-3040.2002.00874.x; Chien L.-F., 2000, Journal of Phycology, V36, P12, DOI 10.1046/j.1529-8817.1999.00001-36.x; Chien LF, 2011, J APPL PHYCOL, V23, P887, DOI 10.1007/s10811-010-9607-6; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; COSSINS AR, 1994, PORTL PR P, P63; COSTA G, 1994, PLANT PHYSIOL BIOCH, V32, P561; Crosatti C, 2008, ENVIRON EXP BOT, V62, P93, DOI 10.1016/j.envexpbot.2007.07.008; Deshnium P, 2000, FEMS MICROBIOL LETT, V184, P207, DOI 10.1111/j.1574-6968.2000.tb09015.x; Fan PX, 2011, PROTEOMICS, V11, P4346, DOI 10.1002/pmic.201100054; Ge P, 2013, PROTEOMICS, V13, P3046, DOI 10.1002/pmic.201300042; Gharechahi J, 2014, MOL BIOL REP, V41, P3897, DOI 10.1007/s11033-014-3257-8; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gong B, 2014, BIOCHEM BIOPH RES CO, V446, P417, DOI 10.1016/j.bbrc.2014.03.005; Guo ZW, 1996, CHINESE J CHEM, V14, P279; Harris EH., 2009, CHLAMYDOMONAS SOURCE; Harrison EP, 1998, PLANTA, V204, P27, DOI 10.1007/s004250050226; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Hongsthong A, 2003, J BIOSCI BIOENG, V96, P519, DOI 10.1016/S1389-1723(04)70143-7; Hongsthong A, 2008, FEMS MICROBIOL LETT, V288, P92, DOI 10.1111/j.1574-6968.2008.01330.x; Hosseini SM, 2013, CURR NUTR FOOD SCI, V9, P189, DOI 10.2174/1573401311309030003; Huang Y, 2015, PLANT BIOTECHNOLOGY, V32, P159; Ibrahem M. D., 2013, Journal of Agricultural Science (Toronto), V5, P109; Kant S, 2014, INDIANAPOLIS BUSINES, V9, P83; Klotke J, 2004, PLANT CELL ENVIRON, V27, P1395, DOI 10.1111/j.1365-3040.2004.01242.x; Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111; Kumar D, 2005, BIOTECHNOL ADV, V23, P41, DOI 10.1016/j.biotechadv.2004.08.005; Kurdrid P, 2012, BIOCHEM CELL BIOL, V90, P621, DOI [10.1139/O2012-017, 10.1139/o2012-017]; Kurdrid P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-39; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Liu XL, 2012, MOL PLANT, V5, P1082, DOI 10.1093/mp/sss012; Lu C, 1999, J APPL PHYCOL, V11, P355, DOI 10.1023/A:1008195927725; Mackey KRM, 2013, PLANT PHYSIOL, V163, P815, DOI 10.1104/pp.113.221937; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Martinez-Esteso MJ, 2014, METHODS MOL BIOL, V1072, P155, DOI 10.1007/978-1-62703-631-3_12; MURATA N, 1995, BIOCHEM J, V308, P1; Murata Norio, 1996, P22; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Nogueira FCS, 2012, J PROTEOME RES, V11, P3046, DOI 10.1021/pr300192f; Olcer H, 2001, PLANT PHYSIOL, V125, P982, DOI 10.1104/pp.125.2.982; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Qian P-Y, 2009, HUMAN GENOMICS PROTE, V2009, P239; Rinalducci S, 2011, ELECTROPHORESIS, V32, P1807, DOI 10.1002/elps.201000663; Rocco M, 2013, MOL BIOSYST, V9, P1257, DOI 10.1039/c3mb70137a; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Shingaki-Wells RN, 2011, PLANT PHYSIOL, V156, P1706, DOI 10.1104/pp.111.175570; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamoi M, 2006, PLANT CELL PHYSIOL, V47, P380, DOI 10.1093/pcp/pcj004; Tang RS, 2008, PLANT GROWTH REGUL, V54, P37, DOI 10.1007/s10725-007-9225-8; Teets NM, 2013, J COMP PHYSIOL B, V183, P189, DOI 10.1007/s00360-012-0707-2; THEODOROU ME, 1992, J BIOL CHEM, V267, P21901; Vonshak A, 2001, PLANT CELL ENVIRON, V24, P1113, DOI 10.1046/j.0016-8025.2001.00759.x; Vonshak A, 2008, J PHYCOL, V44, P1071, DOI 10.1111/j.1529-8817.2008.00546.x; Walker RP, 2015, PLANT PHYSIOL BIOCH, V97, P62, DOI 10.1016/j.plaphy.2015.09.004; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083485; Wang LX, 2013, J PROTEOME RES, V12, P5124, DOI 10.1021/pr4006469; Wang XC, 2013, MOL CELL PROTEOMICS, V12, P2174, DOI 10.1074/mcp.M112.022475; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNOCK DW, 1988, J ANTIMICROB CHEMOTH, V21, P93, DOI 10.1093/jac/21.1.93; Wienkoop S, 2006, J EXP BOT, V57, P1529, DOI 10.1093/jxb/erj157; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu J, 2013, PLANT BIOLOGY, V15, P292, DOI 10.1111/j.1438-8677.2012.00639.x; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhao N, 2014, MOL BIOL REP, V41, P9, DOI 10.1007/s11033-013-2764-3	75	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166876	10.1371/journal.pone.0166876	http://dx.doi.org/10.1371/journal.pone.0166876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902743	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100040
J	Manhica, H; Gauffin, K; Almqvist, YB; Rostila, M; Hjern, A				Manhica, Helio; Gauffin, Karl; Almqvist, Ylva B.; Rostila, Mikael; Hjern, Anders			Hospital Admission and Criminality Associated with Substance Misuse in Young Refugees - A Swedish National Cohort Study	PLOS ONE			English	Article							MENTAL-HEALTH; USE DISORDERS; DRUG-ABUSE; GENDER-DIFFERENCES; PUBLIC-HEALTH; UNITED-STATES; CHILDREN; CARE; NEIGHBORHOOD; EXPERIENCES	Background High rates of mental health problems have been described in young refugees, but few studies have been conducted on substance misuse. This study aimed to investigate the patterns of hospital care and criminality associated with substance misuse in refugees who settled in Sweden as teenagers. Methods Gender stratified Cox regression models were used to estimate the risks of criminal convictions and hospital care associated with substance misuse from national Swedish data for 2005-2012. We focused on 22,992 accompanied and 5,686 unaccompanied refugees who were aged 13-19 years when they settled in Sweden and compared them with 1 million native Swedish youths from the same birth cohort. Results The risks of criminal conviction associated with substance misuse increased with the length of residency in male refugees, after adjustment for age and domicile. The hazard ratios (HRs) were 5.21 (4.39-6.19) for unaccompanied and 3.85 (3.42-4.18) for accompanied refugees after more than 10 years of residency, compared with the native population. The risks were slightly lower for hospital care, at 2.88 (2.18-3.79) and 2.52(2.01-3.01) respectively. Risks were particularly pronounced for male refugees from the Horn of Africa and Iran. The risks for all male refugees decreased substantially when income was adjusted for. Young female refugees had similar risks to the general population. Conclusion The risks of criminality and hospital care associated with substance misuse in young male refugees increased with time of residency in Sweden and were associated with a low level of income compared with the native Swedish population. Risks were similar in accompanied and unaccompanied refugees.	[Manhica, Helio; Gauffin, Karl; Almqvist, Ylva B.; Rostila, Mikael; Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden; [Hjern, Anders] Karolinska Inst, Dept Med, Clin Epidemiol, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Manhica, H (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden.	helio.manhica@chess.su.se	MANHICA, Helio/ABG-2029-2021	Gauffin, Karl/0000-0001-9349-9936	Swedish Research Council for Health, Working Life and Welfare (Forte); Nordforsk	Swedish Research Council for Health, Working Life and Welfare (Forte); Nordforsk	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (Forte), and Nordforsk.	Bean T, 2007, J NERV MENT DIS, V195, P288, DOI 10.1097/01.nmd.0000243751.49499.93; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Beckett K, 2006, CRIMINOLOGY, V44, P105, DOI 10.1111/j.1745-9125.2006.00044.x; Bhugra D, 2011, WORLD PSYCHIATRY, V10, P2; Brady KT, 1999, PSYCHIAT CLIN N AM, V22, P241, DOI 10.1016/S0193-953X(05)70074-5; Brady KT, 2004, CURR DIR PSYCHOL SCI, V13, P206, DOI 10.1111/j.0963-7214.2004.00309.x; Brama A, 2010, J HOUS BUILT ENVIRON, V25, P331, DOI 10.1007/s10901-010-9179-4; Brendler-Lindqvist M, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0122-2; Byqvist S, 2006, J PSYCHOACTIVE DRUGS, V38, P427, DOI 10.1080/02791072.2006.10400582; Chilcoat HD, 1998, ADDICT BEHAV, V23, P827, DOI 10.1016/S0306-4603(98)00069-0; Crum RM, 1996, DRUG ALCOHOL DEPEN, V43, P155, DOI 10.1016/S0376-8716(96)01298-7; Dupont HJBHM, 2005, INT J DRUG POLICY, V16, P27, DOI 10.1016/j.drugpo.2004.06.002; Eide K, 2013, ACTA PAEDIATR, V102, P666, DOI 10.1111/apa.12258; Medina-Mora ME, 2008, ISSUES CHILD FAM LIV, P73, DOI 10.1007/978-0-387-78512-7_4; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Fellner, 2009, STANFORD LAW REV, V20, P257; Gauffin K, 2013, ADDICTION, V108, P1441, DOI 10.1111/add.12169; Grella CE, 1999, AM J DRUG ALCOHOL AB, V25, P385, DOI 10.1081/ADA-100101868; Hjern A, 2000, ACTA PAEDIATR, V89, P722, DOI 10.1080/080352500750044089; Hjern A, 2004, SCAND J PUBLIC HEALT, V32, P40, DOI 10.1080/14034940310001677; Hjern A, 2013, EUROPEAN J PUBLIC HL; Hjern A, 2012, SCAND J PUBLIC HEALT, V40, P255, DOI 10.1177/1403494812459610; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Lappalainen Paul., 2005, BLAGULA GLASHUSET ST; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Little M, 2006, J RES CRIME DELINQ, V43, P357, DOI 10.1177/0022427806291260; Manhica H, EPIDEMIOLOG IN PRESS; Manhica H, 2015, NORD J MIGR RES, V5, P194, DOI 10.1515/njmr-2015-0024; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Martinez R, 2008, URBAN AFF REV, V43, P846, DOI 10.1177/1078087408314774; Matheson K, 2008, J IMMIGR MINOR HEALT, V10, P291, DOI 10.1007/s10903-007-9086-2; Momtazi S, 2010, CURR OPIN PSYCHIATR, V23, P221, DOI 10.1097/YCO.0b013e328338630d; Montgomery E, 2011, ACTA PSYCHIAT SCAND, V124, P1, DOI 10.1111/j.1600-0447.2011.01740.x; Norredam ML, 2007, DAN MED BULL, V54, P48; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Pfeiffer-Gerschel T, 2013 NATL REPORT 20; Pickering S., 2014, ROUTLEDGE HDB CRIME; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Salas-Wright CP, 2014, DRUG ALCOHOL DEPEN, V142, P345, DOI 10.1016/j.drugalcdep.2014.06.008; Samecki J, 2006, AR RETTVISAN RATTVIS; Sellstrom E, 2011, HEALTH PLACE, V17, P551, DOI 10.1016/j.healthplace.2010.12.013; Sellstrom E, 2008, HEALTH PLACE, V14, P155, DOI 10.1016/j.healthplace.2007.05.007; UBA L, 1992, PUBLIC HEALTH REP, V107, P544; Vega WA, 2003, AM J PUBLIC HEALTH, V93, P1057, DOI 10.2105/AJPH.93.7.1057; Weitoft GR, 1999, INT J EPIDEMIOL, V28, P756, DOI 10.1093/ije/28.4.756; YEE BWK, 1987, J PSYCHOACTIVE DRUGS, V19, P77, DOI 10.1080/02791072.1987.10472382; Zanchetta MS, 2006, CAN J PUBLIC HEALTH, V97, pS26	48	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166066	10.1371/journal.pone.0166066	http://dx.doi.org/10.1371/journal.pone.0166066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902694	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100010
J	Ye, LP; Zhang, C; Zhu, QX				Ye, Liang-ping; Zhang, Cheng; Zhu, Qi-xing			The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis	PLOS ONE			English	Article							CHRONIC OCULAR COMPLICATIONS; ADVERSE DRUG-REACTIONS; RETROSPECTIVE ANALYSIS; CLINICAL-COURSE; SCORTEN; MORTALITY; EFFICACY; COMBINATION; INHIBITION; APOPTOSIS	Background Intravenous immunoglobulin (IVIG) treatment is commonly used to treat Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) with controversial therapeutic effect. Methods We conducted a comprehensive meta-analysis through combining the published eligible studies to evaluate the effectiveness of IVIG on SJS and TEN treatment. Results A total of 26 studies were selected from public available databases. The combination of IVIG and corticosteroid markedly reduced the recovery time (by 1.63 days, 95% CI: 0.83-2.43, P<0.001), compared with solo corticosteroid group. The favorable effects were greater in Asian (2.19, 95% CI: 1.41-2.97, P<0.001), TEN (2.56, 95% CI: 0.35-4.77, P=0.023) and high-dose IVIG treated individuals (1.78, 95% CI: 0.42-3.14, P=0.010). The hospitalization length reduced by 3.19 days (95% CI: 0.08-6.30, P=0.045), though the outcome was proven to be unstable. We found heterogeneities, which sources were probably regional factors. Besides, IVIG was inclined to decrease SJS/TEN mortality (SMR: 0.84, 95% CI: 0.66-1.08, P=0.178). This impact was possibly more profound when patients were treated with high dose IVIG (SMR: 0.74, 95% CI: 0.50-1.08, P=0.116), or when patients were diagnosed as TEN (SMR: 0.68, 95% CI: 0.45-1.01, P=0.058). Conclusions Our current meta-analysis suggests that IVIG combined with corticosteroid could reduce recovery time for SJS and TEN. This effect is greater among Asian patients. Whereas, its impact on reducing mortality is not significant.	[Ye, Liang-ping; Zhu, Qi-xing] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Ye, Liang-ping; Zhu, Qi-xing] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Ye, Liang-ping] Anhui Med Univ, Affiliated Hosp 1, Phys Examinat Ctr, Hefei, Anhui, Peoples R China; [Zhang, Cheng; Zhu, Qi-xing] Anhui Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhu, QX (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.; Zhu, QX (corresponding author), Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China.; Zhu, QX (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Hefei, Anhui, Peoples R China.	zqxing@yeah.net	Zhu, Qixing/AAM-4214-2020	zhang, cheng/0000-0001-7665-8675	National Natural Science Foundation of China [81371730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by National Natural Science Foundation of China (81371730).	Ahluwalia J, 2014, PEDIATR DERMATOL, V31, P664, DOI 10.1111/pde.12481; Alejandria MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001090.pub2; Aubin E, 2010, BLOOD, V115, P1727, DOI 10.1182/blood-2009-06-225417; Bachot N, 2003, ARCH DERMATOL, V139, P33, DOI 10.1001/archderm.139.1.33; Bansal S, 2015, INT J DERMATOL, V54, pE18, DOI 10.1111/ijd.12466; Barron SJ, 2015, INT J DERMATOL, V54, P108, DOI 10.1111/ijd.12423; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Borchers AT, 2008, AUTOIMMUN REV, V7, P598, DOI 10.1016/j.autrev.2008.06.004; Brown KM, 2004, J BURN CARE REHABIL, V25, P81, DOI 10.1097/01.BCR.0000105096.93526.27; Campione E, 2003, ACTA DERM-VENEREOL, V83, P430, DOI 10.1080/00015550310005852; Cartotto R, 2008, J BURN CARE RES, V29, P141, DOI 10.1097/BCR.0b013e31815f3865; Chang VS, 2016, SEMIN OPHTHALMOL, V31, P178, DOI 10.3109/08820538.2015.1114841; Chen JB, 2010, EUR J DERMATOL, V20, P743, DOI 10.1684/ejd.2010.1077; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Creamer D, 2016, BRIT J DERMATOL, V174, P1194, DOI 10.1111/bjd.14530; Dai Z, 2012, J FRONT MED, V23, P30; de Prost N, 2014, CRIT CARE MED, V42, P118, DOI 10.1097/CCM.0b013e31829eb94f; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duong TA, 2015, BRIT J DERMATOL, V172, P400, DOI 10.1111/bjd.13505; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045516; Guegan S, 2006, J INVEST DERMATOL, V126, P272, DOI 10.1038/sj.jid.5700068; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang YC, 2012, BRIT J DERMATOL, V167, P424, DOI 10.1111/j.1365-2133.2012.10965.x; Jacobi C, 2009, CLIN IMMUNOL, V133, P393, DOI 10.1016/j.clim.2009.09.006; Jagadeesan S, 2013, INDIAN J DERMATOL VE, V79, P506, DOI 10.4103/0378-6323.113080; Jiang TF, 2007, ZHEJIANG CLIN MED, V9, P634; Jin LH, 2011, CHIN PRACT MED, V6, P139; Kim DH, 2015, OPHTHALMOLOGY, V122, P254, DOI 10.1016/j.ophtha.2014.08.013; Kim JD, 2014, TRANSPL P, V46, P754, DOI 10.1016/j.transproceed.2013.11.100; Kim KJ, 2005, ACTA DERM-VENEREOL, V85, P497, DOI 10.1080/00015550510038232; Kim Kyeong Hwan, 2013, Korean J Ophthalmol, V27, P331, DOI 10.3341/kjo.2013.27.5.331; Kohanim S, 2016, OCUL SURF, V14, P2, DOI 10.1016/j.jtos.2015.10.002; Lalosevic J, 2014, INT J DERMATOL; Lee HY, 2013, BRIT J DERMATOL, V169, P1304, DOI 10.1111/bjd.12607; Lee HY, 2012, BRIT J DERMATOL, V167, P555, DOI 10.1111/j.1365-2133.2012.11074.x; Lissia M, 2005, BRIT J PLAST SURG, V58, P504, DOI 10.1016/j.bjps.2004.12.007; Liu RR, 2012, J CHIN PRACT DIAGN T, V26, P698; Lu WS, 2013, CHIN J CLIN HEALTHC, V16, P133, DOI 10.1016/j.bjps.2004.12.007; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Rajaratnam R, 2010, CLIN EXP DERMATOL, V35, P853, DOI 10.1111/j.1365-2230.2010.03826.x; Roujeau JC, 2011, THER ADV DRUG SAF, V2, P87, DOI 10.1177/2042098611404094; Saeed H, 2016, BURNS, V42, P20, DOI 10.1016/j.burns.2015.03.012; Schwartz RA, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.05.002; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Stella M, 2007, BURNS, V33, P452, DOI 10.1016/j.burns.2006.08.014; Tan SK, 2012, ACTA DERM-VENEREOL, V92, P62, DOI 10.2340/00015555-1169; Teo L, 2009, SINGAP MED J, V50, P29; Trent JT, 2003, ARCH DERMATOL, V139, P39, DOI 10.1001/archderm.139.1.39; Trepanier P, 2014, IMMUNOLOGY, V141, P233, DOI 10.1111/imm.12189; Trepanier P, 2012, BLOOD, V120, P2769, DOI 10.1182/blood-2012-07-445007; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Viard-Leveugle I, 2013, J INVEST DERMATOL, V133, P489, DOI 10.1038/jid.2012.330; Wang M, 2010, CHIN J LEPR SKIN DIS, V26, P529; Woo T, 2011, INTERNAL MED, V50, P2823, DOI 10.2169/internalmedicine.50.5582; Xia ZH, 2012, CLIN ED GEN PRACT, V10, P670; Yang YS, 2009, INT J DERMATOL, V48, P1122, DOI 10.1111/j.1365-4632.2009.04166.x; Yeung CK, 2005, CLIN EXP DERMATOL, V30, P600, DOI 10.1111/j.1365-2230.2005.01863.x; Yeung CK, 2005, CLIN EXP DERMATOL, V30, P203, DOI [10.1016/j.jaad.2013.05.002, DOI 10.1016/J.JAAD.2013.05.002]; Yip LW, 2005, EYE, V19, P846, DOI 10.1038/sj.eye.6701653; Yip VLM, 2015, CLIN REV ALLERG IMMU, V48, P165, DOI 10.1007/s12016-014-8418-y; Zhang X., 2013, WORLD HLTH DIGEST, V10, P69; Zhu QY, 2012, J BURN CARE RES, V33, pE295, DOI 10.1097/BCR.0b013e318254d2ec	66	25	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167120	10.1371/journal.pone.0167120	http://dx.doi.org/10.1371/journal.pone.0167120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902746	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100052
J	Briceno, O; Pinto-Cardoso, S; Rodriguez-Bernabe, N; Murakami-Ogasawara, A; Reyes-Teran, G				Briceno, Olivia; Pinto-Cardoso, Sandra; Rodriguez-Bernabe, Nataly; Murakami-Ogasawara, Akio; Reyes-Teran, Gustavo			Gut Homing CD4+and CD8+T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment	PLoS One			English	Article							CD8(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; MUCOSAL IMMUNE RECONSTITUTION; HUMAN TH17 CELLS; INTEGRIN ALPHA(4)BETA(7); GASTROINTESTINAL-TRACT; TYPE-1 INFECTION; ACTIVATION; DEPLETION; SUBSET	The depletion of mucosal CD4+ T-cells occurs early in HIV infection and despite years on antiretroviral treatment (ART), this population never reconstitutes to pre-HIV infection levels. In an effort to understand the effect of ART initiation and different ART regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue (GALT), we quantified the frequency of CD4+ and CD8+ T cells expressing the gut homing receptors CCR9 and eta 7 in peripheral blood (PB) of HIV infected individuals naive to ART and treated individuals on both short-term (less than a year) and long-term ART (more than 2 years). We found that the gut homing CD4+ T cells were depleted in ART-naive individuals and increased after ART initiation but levels were not comparable to HIV uninfected individuals. Gut homing CD4+ T cell activation decreased after ART initiation whilst gut homing CD8+ T cell activation remained elevated in ART experienced individuals, especially in those individuals taking protease inhibitors. Our findings provide new insights into the effects of ART initiation and ART regimens on the frequency and immune status of gut homing CD4+ and CD8+ T cells.	[Briceno, Olivia; Pinto-Cardoso, Sandra; Rodriguez-Bernabe, Nataly; Murakami-Ogasawara, Akio; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico		Pinto-Cardoso, S; Reyes-Teran, G (corresponding author), Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	sandra.pinto@cieni.org.mx; gustavo.reyesteran@gmail.com		Reyes-Teran, Gustavo/0000-0002-4115-4888	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana)	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI); Mexican Government (Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana)	This work was supported by grants from the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI and Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Ciccone EJ, 2011, J VIROL, V85, P5880, DOI 10.1128/JVI.02643-10; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Greathead L, 2014, AIDS, V28, P1690, DOI 10.1097/QAD.0000000000000351; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Peng QL, 2013, JAIDS-J ACQ IMM DEF, V64, P25, DOI 10.1097/QAI.0b013e318293a114; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166496	10.1371/journal.pone.0166496	http://dx.doi.org/10.1371/journal.pone.0166496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898686	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000009
J	Noinarin, P; Chareonsudjai, P; Wangsomnuk, P; Wongratanacheewin, S; Chareonsudjai, S				Noinarin, Parumon; Chareonsudjai, Pisit; Wangsomnuk, Pinich; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri			Environmental Free-Living Amoebae Isolated from Soil in Khon Kaen, Thailand, Antagonize Burkholderia pseudomallei	PLOS ONE			English	Article							LONG-TERM SURVIVAL; ACANTHAMOEBA-CASTELLANII; LEGIONELLA-PNEUMOPHILA; LISTERIA-MONOCYTOGENES; BACTERIAL PATHOGENS; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; WATER AMEBAS; MELIOIDOSIS; POLYPHAGA	Presence of Burkholderia pseudomallei in soil and water is correlated with endemicity of melioidosis in Southeast Asia and northern Australia. Several biological and physicochemical factors have been shown to influence persistence of B. pseudomallei in the environment of endemic areas. This study was the first to evaluate the interaction of B. pseudomallei with soil amoebae isolated from B. pseudomallei-positive soil site in Khon Kaen, Thailand. Four species of amoebae, Paravahlkampfia ustiana, Acanthamoeba sp., Naegleria pagei, and isolate A-ST39-E1, were isolated, cultured and identified based on morphology, movement and 18S rRNA gene sequence. Co-cultivation combined with a kanamycin-protection assay of B. pseudomallei with these amoebae at MOI 20 at 30 degrees C were evaluated during 0-6 h using the plate count technique on Ashdown's agar. The fate of intracellular B. pseudomallei in these amoebae was also monitored by confocal laser scanning microscopy (CLSM) observation of the CellTracker (TM) Orange-B. pseudomallei stained cells. The results demonstrated the ability of P. ustiana, Acanthamoeba sp. and isolate A-ST39-E1 to graze B. pseudomallei. However, the number of internalized B. pseudomallei substantially decreased and the bacterial cells disappeared during the observation period, suggesting they had been digested. We found that B. pseudomallei promoted the growth of Acanthamoeba sp. and isolate A-ST39-E1 in co-cultures at MOI 100 at 30 degrees C, 24 h. These findings indicated that P. ustiana, Acanthamoeba sp. and isolate A-ST39-E1 may prey upon B. pseudomallei rather than representing potential environmental reservoirs in which the bacteria can persist.	[Noinarin, Parumon; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Chareonsudjai, Pisit] Khon Kaen Univ, Dept Environm Sci, Fac Sci, Khon Kaen, Thailand; [Wangsomnuk, Pinich] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand; [Noinarin, Parumon; Chareonsudjai, Pisit; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Chareonsudjai, Pisit; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chareonsudjai, S (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand.	sorujsr@kku.ac.th	Chareonsudjai, Pisit/AAC-5390-2021; Chareonsudjai, Pisit/AAC-6695-2021; Chareonsudjai, Sorujsiri/AFM-5607-2022	Chareonsudjai, Pisit/0000-0002-3717-5889; Chareonsudjai, Pisit/0000-0002-3717-5889; Chareonsudjai, Sorujsiri/0000-0001-7176-2924	Office of the Higher Education Commission, Thailand; CHE Ph.D. Scholarship The Office of the Higher Education Commission, Thailand	Office of the Higher Education Commission, Thailand; CHE Ph.D. Scholarship The Office of the Higher Education Commission, Thailand	This work was supported by the Office of the Higher Education Commission, Thailand. Parumon Noinarin was supported by CHE Ph.D. Scholarship The Office of the Higher Education Commission, Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Office of the Higher Education Commission. Parumon Noinarin was supported by CHE Ph.D. Scholarship. We would like to acknowledge Prof. David Blair for editing the manuscript via the Publication Clinic of KKU, Thailand.	Abd H, 2005, ENVIRON MICROBIOL, V7, P1003, DOI 10.1111/j.1462-2920.2005.00771.x; Akya A, 2010, MICROBIOL-SGM, V156, P809, DOI 10.1099/mic.0.031146-0; [Anonymous], 1988, NEW KEY FRESHWATER S; BAMFORTH SS, 1995, METHODS APPL SOIL MI, P174; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Chekabab SM, 2012, MICROBIOLOGYOPEN, V1, P427, DOI 10.1002/mbo3.40; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Dey R, 2009, FEMS MICROBIOL LETT, V290, P10, DOI 10.1111/j.1574-6968.2008.01387.x; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Greub, 2004, J EUKARYOT MICROBIOL, V51, P509; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Inglis TJJ, 2000, INFECT IMMUN, V68, P1681, DOI 10.1128/IAI.68.3.1681-1686.2000; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kamjumphol W, 2015, AM J TROP MED HYG, V93, P1058, DOI 10.4269/ajtmh.15-0177; Levy A, 2003, APPL ENVIRON MICROB, V69, P6250, DOI 10.1128/AEM.69.10.6250-6256.2003; Lin HH, 2011, MICROBIOL IMMUNOL, V55, P616, DOI 10.1111/j.1348-0421.2011.00365.x; Liu XY, 2006, MICROB ECOL, V51, P315, DOI 10.1007/s00248-006-9031-2; Mardare C, 2013, J APPL MICROBIOL, V114, P1388, DOI 10.1111/jam.12166; Marshall K, 2010, SE ASIAN J TROP MED, V41, P904; Matin A, 2011, KOREAN J PARASITOL, V49, P349, DOI 10.3347/kjp.2011.49.4.349; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Michel R, 1997, ZBL BAKT-INT J MED M, V285, P541; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; POSTMA J, 1990, MICROB ECOL, V19, P149, DOI 10.1007/BF02012096; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Saeed A, 2009, ARCH MICROBIOL, V191, P83, DOI 10.1007/s00203-008-0422-2; Smith CD, 2012, CURR MICROBIOL, V65, P805, DOI 10.1007/s00284-012-0232-2; Suebrasri T., 2013, African Journal of Microbiology Research, V7, P1940; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Techawiwattanaboon T, 2015, J MICROBIOL, V53, P134, DOI 10.1007/s12275-015-4522-9; THOM S, 1992, J MED MICROBIOL, V36, P303, DOI 10.1099/00222615-36-5-303; Thomas V, 2010, FEMS MICROBIOL REV, V34, P231, DOI 10.1111/j.1574-6976.2009.00190.x; Wang-Ngarm S, 2014, AM J TROP MED HYG, V90, P480, DOI 10.4269/ajtmh.13-0446; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; Wuthiekanun V, 2002, AM J TROP MED HYG, V66, P759, DOI 10.4269/ajtmh.2002.66.759; Bui XT, 2012, ENVIRON MICROBIOL, V14, P2034, DOI 10.1111/j.1462-2920.2011.02655.x; Zhou XH, 2007, ENVIRON MICROBIOL, V9, P913, DOI 10.1111/j.1462-2920.2006.01213.x	44	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167355	10.1371/journal.pone.0167355	http://dx.doi.org/10.1371/journal.pone.0167355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898739	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000057
J	Yokota, J; Ogawa, Y; Yamanaka, S; Takahashi, Y; Fujita, H; Yamaguchi, N; Onoue, N; Ishizuka, T; Shinozaki, T; Kohzuki, M				Yokota, Junichi; Ogawa, Yoshiko; Yamanaka, Shinsuke; Takahashi, Yoshimi; Fujita, Hiroshi; Yamaguchi, Nobuhiro; Onoue, Noriko; Ishizuka, Takeshi; Shinozaki, Tsuyoshi; Kohzuki, Masahiro			Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OROPHARYNGEAL DYSPHAGIA; DEMENTIA; PREVALENCE; ASPIRATION; JAPAN	Early detection and intervention for dysphagia is important in patients with congestive heart failure (CHF). However, previous studies have focused on how many patients with dysphagia develop CHF. Studies focusing on the comorbidity of dysphagia in patients with CHF are rare. Additionally, risk factors for dysphagia in patients with CHF are unclear. Thus, the aim of this study was to clarify risk factors for dysphagia in patients with acute exacerbation of CHF. A total of 105 patients, who were admitted with acute exacerbation of CHF, were enrolled. Clinical interviews, blood chemistry analysis, electrocardiography, echocardiography, Mini-Mental State Examination (MMSE), exercise tolerance tests, phonatory function tests, and evaluation of activities of daily living (ADL) and nutrition were conducted on admission. After attending physicians permitted the drinking of water, swallowing screening tests were performed. Patients were divided into a dysphagia group (DG) or a non-dysphagia group (non-DG) based on Functional Oral Intake Scale level. Among the 105 patients, 38 had dysphagia. A greater number of patients had history of aspiration pneumonia and dementia, and there was a higher age, N-terminal pro-B-type natriuretic peptide level in the DG compared with the non-DG. MMSE scores, exercise tolerance, phonatory function, status of ADL, nutrition, albumin, and transthyretin were lower in the DG compared with the non-DG. In multivariate analysis, after adjusting for age and sex, MMSE, BI score, and transthyretin was independently associated with dysphagia. Comorbidity of dysphagia was 36.1% in patients with acute exacerbation of CHF, and cognitive dysfunction and malnutrition may be an independent predictor of dysphagia.	[Yokota, Junichi; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan; [Yokota, Junichi] Sendai Med Ctr, Dept Rehabil, Sendai, Miyagi, Japan; [Ogawa, Yoshiko] Teikyo Univ, Fac Med Technol, Dept Sport & Med Sci, Tokyo, Japan; [Yamanaka, Shinsuke; Takahashi, Yoshimi; Fujita, Hiroshi; Yamaguchi, Nobuhiro; Onoue, Noriko; Ishizuka, Takeshi; Shinozaki, Tsuyoshi] Sendai Med Ctr, Dept Cardiol, Sendai, Miyagi, Japan	Tohoku University; Teikyo University	Kohzuki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan.	kohzuki@med.tohoku.ac.jp		Yokota, Junichi/0000-0002-9725-6322				Alagiakrishnan K, 2013, ARCH GERONTOL GERIAT, V56, P1, DOI 10.1016/j.archger.2012.04.011; Altman KW, 2010, ARCH OTOLARYNGOL, V136, P784, DOI 10.1001/archoto.2010.129; Anker SD, 2009, CLIN NUTR, V28, P455, DOI 10.1016/j.clnu.2009.04.023; [Anonymous], MED REV S; ARORA NS, 1982, AM REV RESPIR DIS, V126, P5; Bassi D, 2014, CODAS, V26, P17, DOI 10.1590/s2317-17822014000100004; Choi BR, 2006, AM J CARDIOL, V97, P1365, DOI 10.1016/j.amjcard.2005.11.059; Coates C, 1997, EUR NEUROL, V38, P49, DOI 10.1159/000112902; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glantz S. A., 2001, APPL REGRESSION ANAL; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Good-Fratturelli MD, 2000, J COMMUN DISORD, V33, P93, DOI 10.1016/S0021-9924(99)00026-X; Goto Y., 2009, JJCR, V14, P115; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; HILLEL AD, 1989, ARCH PHYS MED REHAB, V70, P618; Hudson HM, 2000, DYSPHAGIA, V15, P31, DOI 10.1007/s004559910007; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Izawa K, 2004, CIRC J, V68, P315, DOI 10.1253/circj.68.315; Katsura H, 1998, Nihon Ronen Igakkai Zasshi, V35, P363; Kim Y, 2015, ARCH PHYS MED REHAB, V96, P1269, DOI 10.1016/j.apmr.2015.02.026; Maeda K, 2015, DYSPHAGIA, V30, P80, DOI 10.1007/s00455-014-9577-y; MAHONEY F I, 1965, Md State Med J, V14, P61; Mirza SS, 2015, J NEUROL NEUROSUR PS, P27; Mirzakhani H, 2013, ANESTHESIOLOGY, V119, P389, DOI 10.1097/ALN.0b013e31829373fe; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Oguchi K., 2000, JPN J REHABIL MED, V37, P375, DOI [10.2490/jjrm1963.37.375, DOI 10.2490/JJRM1963.37.375]; Oguchi K., 2000, JPN J REHAB MED, V38, P383, DOI [10.2490/jjrm1963.37.383, DOI 10.2490/jjrm1963.37.383, DOI 10.2490/JJRM1963.37.383]; Oh JE, 2012, J CLIN NEUROL, V8, P123, DOI 10.3988/jcn.2012.8.2.123; Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Serra-Prat M, 2012, AGE AGEING, V41, P376, DOI 10.1093/ageing/afs006; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; SHIZGAL HM, 1986, AM J CLIN NUTR, V44, P761, DOI 10.1093/ajcn/44.6.761; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Speyer R, 2010, J VOICE, V24, P281, DOI 10.1016/j.jvoice.2008.10.004; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; VELDEE M S, 1992, Dysphagia, V7, P86, DOI 10.1007/BF02493439; Wakahara T, 2007, NUTRITION, V23, P634, DOI 10.1016/j.nut.2007.06.005; Wojkowska-Mach J, 2013, INT J INFECT DIS, V17, pE37, DOI 10.1016/j.ijid.2012.07.020; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782; Zuccala G, 1997, J NEUROL NEUROSUR PS, V63, P509, DOI 10.1136/jnnp.63.4.509	43	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167326	10.1371/journal.pone.0167326	http://dx.doi.org/10.1371/journal.pone.0167326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898735	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000053
J	Krupkova, S; Aguete, GP; Kocmanova, L; Volna, T; Grepl, M; Novakova, L; Miller, MJ; Hlavac, J				Krupkova, Sona; Aguete, Gonzalo Pazos; Kocmanova, Leona; Volna, Tereza; Grepl, Martin; Novakova, Lucie; Miller, Marvin John; Hlavac, Jan			Solid-Phase Synthesis of gamma-Lactone and 1,2-Oxazine Derivatives and Their Efficient Chiral Analysis	PLOS ONE			English	Article							DIELS-ALDER REACTIONS; SESQUITERPENE LACTONES; REDUCTIVE CLEAVAGE; O BONDS; BUTENOLIDES; ACIDS	Derivatives of 3-methyl-3,6-dihydro-2H-1,2-oxazine-6-carboxylic acid prepared by regioselective hetero Diels-Alder reaction of arylnitroso compounds with sorbic acid were used for solid-phase synthesis of a library of derivatives that included modification of carboxylic group, dihydroxylation of double bond and cleavage of N-O bond. Derivatives of 2,3,4-trihydroxyhexanoic acid obtained from 3,6-dihydro-2H-1,2-oxazines after double bond dihydroxylation and N-O cleavage were used for simple and stereoselective formation of chiral lactones derived from 3,4-dihydroxydihydrofuran-2(3H)-one. The final compounds obtained as a mixture of stereoisomers were analyzed with use of chiral HPLC and SFC. HPLC analyses were not successful for all derivatives or required lengthy chromatography. On the other hand SFC afforded much shorter analyses and was effective for all studied derivatives. The method of synthesis and analysis is thus suitable for future study of stereoselective synthesis of lactones and other derivatives from single oxazine derivatives and application of high-throughput synthesis on solid-support and combinatorial chemistry.	[Krupkova, Sona; Aguete, Gonzalo Pazos; Kocmanova, Leona; Volna, Tereza; Hlavac, Jan] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic; [Grepl, Martin] Palacky Univ, Dept Organ Chem, Fac Sci, Olomouc, Czech Republic; [Novakova, Lucie] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Analyt Chem, Prague, Czech Republic; [Miller, Marvin John] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Palacky University Olomouc; Palacky University Olomouc; Charles University Prague; University of Notre Dame	Hlavac, J (corresponding author), Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.	hlavac@orgchem.upol.cz	Novakova, Lucie/S-6604-2017	Novakova, Lucie/0000-0003-3570-5871; Kratka, Leona/0000-0002-9210-9788	Ministry of Education, Youth and Sport of the Czech Republic [IGA_PrF_2016_020]; European Social Fund [CZ.1.07/2.3.00/20.0009]; National Program of Sustainability [L01304]	Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Social Fund(European Social Fund (ESF)); National Program of Sustainability	This work was supported by Ministry of Education, Youth and Sport of the Czech Republic; IGA_PrF_2016_020; http://www.msmt.cz/, the European Social Fund; CZ.1.07/2.3.00/20.0009; http://ec.europleu/esf/home.jsp, National Program of Sustainability; L01304; http://www.msrnt.cz/.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2011, EUR J ORG CHEM, V2011, P2747, DOI 10.1002/ejoc.201001486; Amaral PA, 2008, TETRAHEDRON LETT, V49, P6607, DOI 10.1016/j.tetlet.2008.07.102; Bodnar BS, 2011, ANGEW CHEM INT EDIT, V50, P5629, DOI 10.1002/anie.201005764; Boucard V, 2007, EUR J ORG CHEM, V2007, P225, DOI 10.1002/ejoc.200600570; Calvet G, 2007, ORG LETT, V9, P1485, DOI 10.1021/ol0702066; Cesario C, 2009, J ORG CHEM, V74, P448, DOI 10.1021/jo802184y; CICCHI S, 1990, TETRAHEDRON LETT, V31, P3351, DOI 10.1016/S0040-4039(00)89062-0; Collins I, 1999, J CHEM SOC PERK T 1, P1377, DOI 10.1039/a808137i; DEFOIN A, 1994, TETRAHEDRON LETT, V35, P5653, DOI 10.1016/S0040-4039(00)77271-6; Dekaris V, 2011, EUR J ORG CHEM, V2011, P3210, DOI 10.1002/ejoc.201100230; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; GRIECO PA, 1975, SYNTHESIS-STUTTGART, P67; Harrison A, 2014, NEW J CHEM, V38, P5491, DOI 10.1039/c4nj00974f; Hwang DR, 2006, BIOORGAN MED CHEM, V14, P83, DOI 10.1016/j.bmc.2005.07.055; Jimenez V, 2014, PHYTOMEDICINE, V21, P1411, DOI 10.1016/j.phymed.2014.06.005; Keck GE, 1999, TETRAHEDRON, V55, P11755, DOI 10.1016/S0040-4020(99)00486-X; Krchanak V, 2008, J COMB CHEM, V10, P112, DOI 10.1021/cc700142d; Krchnak V, 2008, J ORG CHEM, V73, P4559, DOI 10.1021/jo8004827; Krchnak V, 2008, J COMB CHEM, V10, P104, DOI 10.1021/cc7001414; KRESZE G, 1969, TETRAHEDRON, V25, P4481, DOI 10.1016/S0040-4020(01)82990-2; Ma SM, 2000, ORG LETT, V2, P1419, DOI 10.1021/ol0057481; PETRAGNANI N, 1986, SYNTHESIS-STUTTGART, P157; RIEDIKER M, 1979, HELV CHIM ACTA, V62, P1586, DOI 10.1002/hlca.19790620524; RUTTIMANN A, 1975, HELV CHIM ACTA, V58, P2237, DOI 10.1002/hlca.19750580802; Shao LD, 2014, NAT PRODUCT BIOPROSP, V4, P181, DOI 10.1007/s13659-014-0022-6; Sheng SR, 2006, J COMB CHEM, V8, P805, DOI 10.1021/cc060104r; Wang CL, 2012, SYNTHETIC COMMUN, V42, P320, DOI 10.1080/00397911.2010.524064; Werner L, TETRAHEDRON; Yekta S, 2007, SYNLETT, P2069, DOI 10.1055/s-2007-984907	29	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166558	10.1371/journal.pone.0166558	http://dx.doi.org/10.1371/journal.pone.0166558			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893812	Green Submitted, gold, Green Published			2022-12-27	WOS:000389472400031
J	Bar-Ephraim, YE; Konijn, T; Gonultas, M; Mebius, RE; Reijmers, RM				Bar-Ephraim, Yotam E.; Konijn, Tanja; Gonultas, Mehmet; Mebius, Reina E.; Reijmers, Rogier M.			A Reproducible Method for Isolation and In Vitro Culture of Functional Human Lymphoid Stromal Cells from Tonsils	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; TISSUE-INDUCER CELLS; DENDRITIC CELLS; ENDOTHELIAL-CELLS; T-CELLS; INNATE; NODE; ANTIGEN; LIGANDS; ORGANS	The stromal compartment of secondary lymphoid organs is classicaly known for providing a mechanical scaffold for the complex interactions between hematopoietic cells during immune activation as well as for providing a niche which is favorable for survival of lymphocytes. In recent years, it became increasingly clear that these cells also play an active role during such a response. Currently, knowledge of the interactions between human lymphoid stroma and hematopoietic cells is still lacking and most insight is based on murine systems. Although methods to isolate stromal cells from tonsils have been reported, data on stability in culture, characterization, and functional properties are lacking. Here, we describe a reproducible and easy method for isolation and in vitro culture of functional human lymphoid stromal cells from palatine tonsils. The cells isolated express markers and characteristics of T cell zone fibroblastic reticular cells (FRCs) and react to inflammatory stimuli by upregulating inflammatory cytokines and chemokines as well as adhesion molecules, as previously described for mouse lymphoid stroma. Also, cultured tonsil stromal cells support survival of human innate lymphoid cells, showing that these stromal cells can function as bone fide FRCs, providing a favorable microenvironment for hematopoietic cells.	[Bar-Ephraim, Yotam E.; Konijn, Tanja; Mebius, Reina E.; Reijmers, Rogier M.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Gonultas, Mehmet] MC Hosp, Dept Otolaryngol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Reijmers, RM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	r.reijmers@vumc.nl	Reijmers, Rogier/M-2620-2019	Reijmers, Rogier/0000-0001-7471-7715; Mebius, Reina/0000-0003-0451-7464	Netherlands Organization for Scientific Research (NWO), VENI grant [916.13.011]; VUmc/CCA proof-of-concept grant [CCA2015-5-23]; Landsteiner Foundation for Blood Transfusion Research (LSBR) grant	Netherlands Organization for Scientific Research (NWO), VENI grant(Netherlands Organization for Scientific Research (NWO)); VUmc/CCA proof-of-concept grant; Landsteiner Foundation for Blood Transfusion Research (LSBR) grant	This study was supported by the Netherlands Organization for Scientific Research (NWO), VENI grant (916.13.011) to RMR, http://www.nwo.nl/; VUmc/CCA proof-of-concept grant (CCA2015-5-23) to RMR, http://www.vumc.nl; Landsteiner Foundation for Blood Transfusion Research (LSBR) grant to REM, http://www.lsbr.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DSJ, 2015, MUCOSAL IMMUNOL, V8, P340, DOI 10.1038/mi.2014.71; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Baptista AP, 2014, ELIFE, V3, DOI 10.7554/eLife.04433; Bar-Ephraim YE, 2016, IMMUNOL REV, V271, P185, DOI 10.1111/imr.12407; Barone F, 2015, P NATL ACAD SCI USA, V112, P11024, DOI 10.1073/pnas.1503315112; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; Christensen JR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-215; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Cornelissen F, 2011, CURR OPIN IMMUNOL, V23, P361, DOI 10.1016/j.coi.2011.03.002; Corneth OBJ, 2016, EUR J IMMUNOL, V46, P1404, DOI 10.1002/eji.201546241; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Fujisaka M, 1996, ARCH HISTOL CYTOL, V59, P273, DOI 10.1679/aohc.59.273; Garrafa E, 2006, J CELL PHYSIOL, V207, P107, DOI 10.1002/jcp.20537; Grzywacz B, 2006, BLOOD, V108, P3824, DOI 10.1182/blood-2006-04-020198; Hoorweg K, 2015, J IMMUNOL, V195, P4257, DOI 10.4049/jimmunol.1402584; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Hou TZ, 2010, EUR J IMMUNOL, V40, P359, DOI 10.1002/eji.200939776; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kim MY, 2007, BLOOD, V109, P1602, DOI 10.1182/blood-2006-04-018465; Koning JJ, 2012, TRENDS IMMUNOL, V33, P264, DOI 10.1016/j.it.2011.10.006; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lee TV, 2000, J INTERF CYTOK RES, V20, P391, DOI 10.1089/107999000312333; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Magnusson FC, 2008, GASTROENTEROLOGY, V134, P1028, DOI 10.1053/j.gastro.2008.01.070; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mogoanta CA, 2013, ROM J MORPHOL EMBRYO, V54, P179; MOST J, 1992, J IMMUNOL, V148, P1635; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Siegert S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00285; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Tang Q, 2011, BLOOD, V117, P4052, DOI 10.1182/blood-2010-09-303081; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167555	10.1371/journal.pone.0167555	http://dx.doi.org/10.1371/journal.pone.0167555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907202	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700193
J	d'Azy, CB; Pereira, B; Chiambaretta, F; Dutheil, F				d'Azy, Ceadric Benoist; Pereira, Bruno; Chiambaretta, Frederic; Dutheil, Frederic			Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OPEN-ANGLE GLAUCOMA; VITAMIN-E SUPPLEMENTATION; AQUEOUS-HUMOR; TRABECULAR MESHWORK; PSEUDOEXFOLIATION SYNDROME; INTRAOCULAR-PRESSURE; CLOSURE GLAUCOMA; RISK-FACTORS; AGE; MECHANISM	Chronic glaucoma is a multifactorial disease among which oxidative stress may play a major pathophysiological role. We conducted a systematic review and meta-analysis to evaluate the levels of oxidative and antioxidative stress markers in chronic glaucoma compared with a control group. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies reporting oxidative and antioxidative stress markers in chronic glaucoma and in healthy controls using the following keywords: "oxidative stress" or "oxidant stress" or "nitrative stress" or "oxidative damage" or "nitrative damage" or "antioxidative stress" or "antioxidant stress" or "antinitrative stress" and "glaucoma ". We stratified our meta-analysis on the type of biomarkers, the type of glaucoma, and the origin of the sample (serum or aqueous humor). We included 22 case-control studies with a total of 2913 patients: 1614 with glaucoma and 1319 healthy controls. We included 12 studies in the meta-analysis on oxidative stress markers and 19 on antioxidative stress markers. We demonstrated an overall increase in oxidative stress markers in glaucoma (effect size = 1.64; 95% CI 1.20-2.09), ranging from an effect size of 1.29 in serum (95% CI 0.84-1.74) to 2.62 in aqueous humor (95% CI 1.60-3.65). Despite a decrease in antioxidative stress marker in serum (effect size = -0.41; 95% CI -0.72 to - 0.11), some increased in aqueous humor (superoxide dismutase, effect size = 3.53; 95% CI 1.20-5.85 and glutathione peroxidase, effect size = 6.60; 95% CI 3.88-9.31). The differences in the serum levels of oxidative stress markers between glaucoma patients and controls were significantly higher in primary open angle glaucoma vs primary angle closed glaucoma (effect size = 12.7; 95% CI 8.78-16.6, P < 0.001), and higher in pseudo-exfoliative glaucoma vs primary angle closed glaucoma (effect size = 12.2; 95% CI 8.96-15.5, P < 0.001). In conclusion, oxidative stress increased in glaucoma, both in serum and aqueous humor. Malonyldialdehyde seemed the best biomarkers of oxidative stress in serum. The increase of some antioxidant markers could be a protective response of the eye against oxidative stress.	[d'Azy, Ceadric Benoist; Chiambaretta, Frederic] Univ Hosp Clermont Ferrand CHU, Ophthalmol, Clermont Ferrand, France; [d'Azy, Ceadric Benoist; Dutheil, Frederic] Univ Hosp Clermont Ferrand CHU, Prevent & Occupat Med, Clermont Ferrand, France; [Pereira, Bruno] Univ Hosp Clermont Ferrand CHU, Clin Res Direct, Clermont Ferrand, France; [Dutheil, Frederic] Univ Clermont Auvergne, LAPSCO, CNRS Physiol & Psychosocial Stress, Clermont Ferrand, France; [Dutheil, Frederic] Australian Catholic Univ, Fac Hlth, Sch Exercise Sci, Melbourne, Vic, Australia; [Dutheil, Frederic] Univ Clermont Auvergne, Lab Metab Adaptat Exercise Physiol & Pathol Condi, Clermont Ferrand, France; [Dutheil, Frederic] Res Ctr Human Nutr CRNH Auvergne, Clermont Ferrand, France	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Australian Catholic University; Universite Clermont Auvergne (UCA)	Dutheil, F (corresponding author), Univ Hosp Clermont Ferrand CHU, Prevent & Occupat Med, Clermont Ferrand, France.; Dutheil, F (corresponding author), Univ Clermont Auvergne, LAPSCO, CNRS Physiol & Psychosocial Stress, Clermont Ferrand, France.; Dutheil, F (corresponding author), Australian Catholic Univ, Fac Hlth, Sch Exercise Sci, Melbourne, Vic, Australia.; Dutheil, F (corresponding author), Univ Clermont Auvergne, Lab Metab Adaptat Exercise Physiol & Pathol Condi, Clermont Ferrand, France.; Dutheil, F (corresponding author), Res Ctr Human Nutr CRNH Auvergne, Clermont Ferrand, France.	frederic.dutheil@acu.edu.au						Abu-Amero Khaled K, 2014, BMC Res Notes, V7, P163, DOI 10.1186/1756-0500-7-163; Abu-Amero KK, 2013, CURR EYE RES, V38, P959, DOI 10.3109/02713683.2013.794246; Abu-Amero KK, 2011, MOL VIS, V17, P2769; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Ashor AW, 2015, BRIT J NUTR, V113, P1182, DOI 10.1017/S0007114515000227; Aslan M, 2008, FREE RADICAL BIO MED, V45, P367, DOI 10.1016/j.freeradbiomed.2008.04.026; Awodele O, 2015, MIDDLE EAST AFR J OP, V22, P489, DOI 10.4103/0974-9233.167811; Bagnis A, 2012, EXP EYE RES, V103, P55, DOI 10.1016/j.exer.2012.07.011; Borchman D, 1998, INVEST OPHTH VIS SCI, V39, P1053; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x; Chang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027218; Chua J, 2015, JAMA OPHTHALMOL, V133, P938, DOI 10.1001/jamaophthalmol.2015.1478; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Citrome L, 2014, INT J CLIN PRACT, V68, P533, DOI 10.1111/ijcp.12435; Courtin R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009675; d'Azy CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156431; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; DelaPaz MA, 1996, INVEST OPHTH VIS SCI, V37, P1849; Demirdogen BC, 2014, CLIN LAB, V60, P79, DOI 10.7754/Clin.Lab.2013.121229; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dursan F, 2015, INT J OPHTHALMOL-CHI, V8, P985, DOI 10.3980/j.issn.2222-3959.2015.05.24; Engin KN, 2010, MOL VIS, V16, P1260; Erdurmus M, 2011, CURR EYE RES, V36, P713, DOI 10.3109/02713683.2011.584370; Ferreira SM, 2009, EYE, V23, P1691, DOI 10.1038/eye.2008.352; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Ghanem AA, 2010, CURR EYE RES, V35, P295, DOI 10.3109/02713680903548970; Giaconi JA, 2012, AM J OPHTHALMOL, V154, P635, DOI 10.1016/j.ajo.2012.03.048; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Grover AK, 2014, MOL CELL BIOCHEM, V388, P173, DOI 10.1007/s11010-013-1908-z; Hirooka K, 2016, J GLAUCOMA; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Garcia-Medina JJ, 2015, ACTA OPHTHALMOL, V93, P546, DOI 10.1111/aos.12629; Ji HF, 2014, NUTRITION, V30, P986, DOI 10.1016/j.nut.2014.01.016; Jiang S, 2014, J NUTR SCI VITAMINOL, V60, P194, DOI 10.3177/jnsv.60.194; Kim KY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.180; Kruk J, 2016, MINI-REV MED CHEM, V16, P241, DOI 10.2174/1389557516666151120114605; Kumar DM, 2007, J GLAUCOMA, V16, P334; Lanhers C, 2015, SPORTS MED, V45, P1285, DOI 10.1007/s40279-015-0337-4; Le A, 2003, INVEST OPHTH VIS SCI, V44, P3783, DOI 10.1167/iovs.03-0077; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Miller AA, 2007, CLIN EXP PHARMACOL P, V34, P1037, DOI 10.1111/j.1440-1681.2007.04732.x; Morales RC, 2015, REDOX BIOL, V4, P226, DOI 10.1016/j.redox.2015.01.007; Mousa Ahmed, 2015, Saudi Med J, V36, P671, DOI 10.15537/smj.2015.6.10697; Nita Malgorzata, 2016, Oxid Med Cell Longev, V2016, P3164734, DOI 10.1155/2016/3164734; Nucci C, 2013, MOL VIS, V19, P1841; Ollier M, 2014, CHEST, V145, P1339, DOI 10.1378/chest.13-2181; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Ozdemir G, 2009, J GLAUCOMA, V18, P662, DOI 10.1097/IJG.0b013e31819c46b1; PRYOR WA, 1975, J ORG CHEM, V40, P3615, DOI 10.1021/jo00912a038; PRYOR WA, 1991, FREE RADICAL BIO MED, V10, P177, DOI 10.1016/0891-5849(91)90073-C; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Rokicki W, 2016, CLIN HEMORHEOL MICRO; Russo Mark W, 2007, Gastroenterol Hepatol (N Y), V3, P637; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Sacca SC, 2015, J CELL PHYSIOL, V230, P510, DOI 10.1002/jcp.24826; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Schmidtmann G, 2011, GRAEF ARCH CLIN EXP, V249, P895, DOI 10.1007/s00417-010-1600-x; Schottker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111; Sorkhabi R, 2011, MOL VIS, V17, P41; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Srour MA, 2000, CLIN HEMORHEOL MICRO, V23, P23; Tanito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049680; Thomas R, 2011, CLIN EXP OPHTHALMOL, V39, P593, DOI 10.1111/j.1442-9071.2011.02663.x; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Wang SY, 2013, EYE, V27, P487, DOI 10.1038/eye.2013.10; Wiggs JL, 2015, PROG MOL BIOL TRANSL, V134, P315, DOI 10.1016/bs.pmbts.2015.04.008; Xu Liang, 2004, Zhonghua Yan Ke Za Zhi, V40, P726; Xu P, 2014, J OCUL PHARMACOL TH, V30, P246, DOI 10.1089/jop.2013.0183; Yildirim O, 2005, EYE, V19, P580, DOI 10.1038/sj.eye.6701565; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zhao J, 2016, INT J MOL MED, V38, P995, DOI 10.3892/ijmm.2016.2714	78	73	73	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166915	10.1371/journal.pone.0166915	http://dx.doi.org/10.1371/journal.pone.0166915			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907028	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700054
J	Guan, XY; Chen, C; Work, D				Guan, Xiangyang; Chen, Cynthia; Work, Dan			Tracking the Evolution of Infrastructure Systems and Mass Responses Using Publically Available Data	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; SOCIAL MEDIA; NETWORKS; DISASTER; EARTHQUAKE; PATTERNS	Networks can evolve even on a short-term basis. This phenomenon is well understood by network scientists, but receive little attention in empirical literature involving real-world networks. On one hand, this is due to the deceitfully fixed topology of some networks such as many physical infrastructures, whose evolution is often deemed unlikely to occur in short term; on the other hand, the lack of data prohibits scientists from studying subjects such as social networks that seem likely to evolve on a short-term basis. We show that both networks the infrastructure network and social network are able to demonstrate evolutionary dynamics at the system level even in the short-term, characterized by shifting between different phases as predicted in network science. We develop a methodology of tracking the evolutionary dynamics of the two networks by incorporating flows and the microstructure of networks such as motifs. This approach is applied to the human interaction network and two transportation networks (subway and taxi) in the context of Hurricane Sandy, using publically available Twitter data and transportation data. Our result shows that significant changes in the system-level structure of networks can be detected on a continuous basis. This result provides a promising channel for real-time tracking in the future.	[Guan, Xiangyang; Chen, Cynthia] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Work, Dan] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL USA	University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Urbana-Champaign	Chen, C (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	qzchen@uw.edu		Work, Daniel/0000-0003-0565-2158	National Science Foundation [1200275, 1536340, CMMI 1200275]	National Science Foundation(National Science Foundation (NSF))	This work is performed under the funding from the National Science Foundation to Cynthia Chen (CMMI #1200275 and CMMI #1536340). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding support from the National Science Foundation (CMMI 1200275 and 1536340) is greatly appreciated. We sincerely thank Bill Howe, the eScience Institute of University of Washington and Twitter Inc. for providing us the Twitter data used in this study. We thank Rochelle Starrett and Raymond Hsu for comments on the manuscript and coding the Twitter dataset.	Abramson DM, 2012, DISASTER MED PUBLIC, V6, P328, DOI 10.1001/dmp.2012.76; Acar Adam, 2011, International Journal of Web Based Communities, V7, P392, DOI 10.1504/IJWBC.2011.041206; Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; [Anonymous], 2015, TRANSP RES BOARD 94; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Battiston S, 2016, SCIENCE, V351, P818, DOI 10.1126/science.aad0299; Berkoune D., 2012, SOCIO-ECON PLAN SCI, V46, P23, DOI DOI 10.1016/J.SEPS.2011.05.002; Bernatsky S, 2007, J TRAUMA STRESS, V20, P263, DOI [10.1002/jts.20207, DOI 10.1002/JTS.20207]; Blaikie P., 2014, RISK NATURAL HAZARDS, DOI DOI 10.4324/9780203714775; Bocchini P, 2011, PROBABILIST ENG MECH, V26, P182, DOI 10.1016/j.probengmech.2010.11.007; Brown J, 2007, J INTERACT MARK, V21, P2, DOI 10.1002/dir.20082; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Chang SE, 2001, TRANSPORT RES A-POL, V35, P475, DOI 10.1016/S0965-8564(00)00003-3; Chen C, 2013, NAT HAZARDS, V65, P407, DOI 10.1007/s11069-012-0371-6; De Domenico M, 2014, P NATL ACAD SCI USA, V111, P8351, DOI 10.1073/pnas.1318469111; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Donovan B, 2010, NEW YORK CITY TAXI T; Dorogovtsev S. N., 2013, EVOLUTION NETWORKS B; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Drabek T. E, 2012, HUMAN SYSTEM RESPONS; Duenas-Osorio L, 2009, STRUCT SAF, V31, P157, DOI 10.1016/j.strusafe.2008.06.007; Elliott JR, 2006, SOC SCI RES, V35, P295, DOI 10.1016/j.ssresearch.2006.02.003; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fresno V, 2015, PROCES LENG NAT, P85; Ganin AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19540; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gao L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03997; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guan XY, 2014, NAT HAZARDS, V74, P837, DOI 10.1007/s11069-014-1217-1; Heller K, 2005, J APPL SOC PSYCHOL, V35, P399, DOI 10.1111/j.1559-1816.2005.tb02127.x; Howard PN, 2012, J COMMUN, V62, P359, DOI 10.1111/j.1460-2466.2012.01626.x; Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Kryvasheyeu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117288; Kumar R, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P337, DOI 10.1007/978-1-4419-6515-8_13; Lambert JH, 2013, ACCIDENT ANAL PREV, V50, P645, DOI 10.1016/j.aap.2012.06.015; Lu X, 2014, SCI REP-UK, V4, DOI 10.1038/srep06773; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Massaro E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052817; Matsumaru R, 2012, IATSS RES, V36, P11, DOI 10.1016/j.iatssr.2012.07.001; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Newman M., 2011, STRUCTURE DYNAMICS N; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Norris FH, 2006, J TRAUMA STRESS, V19, P173, DOI 10.1002/jts.20109; Parshani R, 2011, P NATL ACAD SCI USA, V108, P1007, DOI 10.1073/pnas.1008404108; Phan TQ, 2015, P NATL ACAD SCI USA, V112, P6595, DOI 10.1073/pnas.1404770112; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Rinaldi SA, 2001, IEEE CONTR SYST MAG, V21, P11, DOI 10.1109/37.969131; Santora M, 2013, NY TIMES; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Silva R, 2015, P NATL ACAD SCI USA, V112, P5643, DOI 10.1073/pnas.1412908112; Spiro E, 2012, C NEUR INF PROC SYST, V12; Squartini T, 2012, TRIADIC MOTIFS DYADI, P24; Squartini T, 2015, J COMPLEX NETW, V3, P1, DOI 10.1093/comnet/cnu012; Squartini T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03357; Squartini T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083001; Starbird K., 2010, P 7 INT ISCRAM C SEA, V1; Starbird K, 2015, HUM ECOL RISK ASSESS, V21, P605, DOI 10.1080/10807039.2014.947866; Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241; Sullivan KD, 2012, SERVICE ASSESSMENT H; Sun LJ, 2013, P NATL ACAD SCI USA, V110, P13774, DOI 10.1073/pnas.1306440110; Sutton Jeannette, 2013, International Journal of Information Systems for Crisis Response and Management, V5, P58, DOI 10.4018/jiscrm.2013010104; Sutton J, 2014, INFORM COMMUN SOC, V17, P765, DOI 10.1080/1369118X.2013.862561; Tierney K.J., 2001, FACING UNEXPECTED DI; USCB, 2012, TABL B08301 MEANS TR; Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486; Wachinger G, 2013, RISK ANAL, V33, P1049, DOI 10.1111/j.1539-6924.2012.01942.x	73	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167267	10.1371/journal.pone.0167267	http://dx.doi.org/10.1371/journal.pone.0167267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907061	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700105
J	Jary, H; Simpson, H; Havens, D; Manda, G; Pope, D; Bruce, N; Mortimer, K				Jary, Hannah; Simpson, Hope; Havens, Deborah; Manda, Geoffrey; Pope, Daniel; Bruce, Nigel; Mortimer, Kevin			Household Air Pollution and Acute Lower Respiratory Infections in Adults: A Systematic Review	PLOS ONE			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; BIOMASS COMBUSTION; RISK-FACTORS; EXPOSURE; PREVALENCE; MORTALITY; CHILDREN; HEALTH; WOMEN; HIV	Introduction Household air pollution from solid fuel burning kills over 4 million people every year including half a million children from acute lower respiratory infections. Although biologically plausible, it is not clear whether household air pollution is also associated with acute lower respiratory infections in adults. We systematically reviewed the literature on household air pollution and acute lower respiratory infection in adults to identify knowledge gaps and research opportunities. Methods Ten bibliographic databases were searched to identify studies of household air pollution and adult acute lower respiratory infection. Data were extracted from eligible studies using standardised forms. Results From 4617 titles, 513 abstracts and 72 full-text articles were reviewed. Eight studies met the inclusion criteria of which 2 found a significant adjusted increased risk of acute lower respiratory infection, 2 identified a univariate association whilst 4 found no significant association. Study quality was generally limited. Heterogeneity in methods and findings precluded meta-analysis. Discussion A systematic review of the literature found limited evidence for an association between household air pollution and risk of acute lower respiratory infection in adults. Additional research, with carefully defined exposure and outcome measures, is required to complete the risk profile caused by household air pollution in adults.	[Jary, Hannah; Simpson, Hope; Havens, Deborah; Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Jary, Hannah; Mortimer, Kevin] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Manda, Geoffrey] Univ Malawi, Coll Med, Blantyre, Malawi; [Pope, Daniel; Bruce, Nigel] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; University of Malawi; University of Malawi; University of Liverpool	Mortimer, K (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.; Mortimer, K (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	kevin.mortimer@istmed.ac.uk	Simpson, Hope/ADW-8396-2022	Mortimer, Kevin/0000-0002-8118-8871; Manda, Geoffrey/0000-0001-8104-5021; Pope, Daniel/0000-0003-2694-5478; Simpson, Hope/0000-0002-2956-5342	Wellcome Trust (Hannah Jary Wellcome Trust Clinical PhD Fellow) [099929/B/12/Z]; UK Medical Research Council; UK Department for International Development (BREATHE-Africa MRC Partnership Grant) [MR/L009242/1]; MRC [MR/L002515/1, MR/L009242/1] Funding Source: UKRI; Medical Research Council [MR/L009242/1] Funding Source: researchfish	Wellcome Trust (Hannah Jary Wellcome Trust Clinical PhD Fellow); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (BREATHE-Africa MRC Partnership Grant); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (Hannah Jary Wellcome Trust Clinical PhD Fellow, 099929/B/12/Z, https:// wellcome.ac.uk) and the UK Medical Research Council and UK Department for International Development (BREATHE-Africa MRC Partnership Grant, MR/L009242/1, http://www.mrc.ac.uk/ funding/how-we-fund-research/partnership-grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, RESP CARE, V50, P1469; [Anonymous], 2002, RESP CARE, V47, P1032; [Anonymous], 2005, ANN EMERG MED, V46, pS1; Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA111, DOI 10.1289/ehp.122-A111; Benguigui Y, OPS SERIE HCT AIEPI, P241; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Bush A, 2016, THORAX, V71, P393, DOI 10.1136/thoraxjnl-2015-208241; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Ezzati M, 2002, ENERG POLICY, V30, P815, DOI 10.1016/S0301-4215(01)00125-2; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Ezzati M, 2001, ENVIRON HEALTH PERSP, V109, P481, DOI 10.2307/3454706; Figueroa CGS, 2012, REV I NAC ENF RESP, V71, P11; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Jary H, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0090-3; Jin Y, 2001, Wei Sheng Yan Jiu, V30, P241; Kilabuko James H, 2007, Int J Environ Res Public Health, V4, P39, DOI 10.3390/ijerph2007010007; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; LIND T, 1981, ARCH INTERN MED, V141, P1749, DOI 10.1001/archinte.141.13.1749; Loeb M, 2009, J AM GERIATR SOC, V57, P1036, DOI 10.1111/j.1532-5415.2009.02259.x; Ma L, ASSESSING HLTH BENEF; Mortimer K., 2016, THORAX; Puzzolo E, 2013, FACTORS INFLUENCING; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Shen M, 2009, ENVIRON HEALTH PERSP, V117, P261, DOI 10.1289/ehp.11521; Shrestha IL, 2005, INT J OCCUP ENV HEAL, V11, P150, DOI 10.1179/oeh.2005.11.2.150; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Sow O, 1996, THORAX, V51, P385, DOI 10.1136/thx.51.4.385; Stankovic A, 2011, MULTIDISCIP RESP MED, V6, P351, DOI 10.1186/2049-6958-6-6-351; Taylor ET, 2012, INT J ENV RES PUB HE, V9, P2252, DOI 10.3390/ijerph9062252; U.S. EPA, 2009, EPA600R08139F; Yone EWP, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-46	32	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167656	10.1371/journal.pone.0167656	http://dx.doi.org/10.1371/journal.pone.0167656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907205	Green Published, Green Accepted, gold			2022-12-27	WOS:000389482700218
J	Tayi, L; Maku, RV; Patel, HK; Sonti, RV				Tayi, Lavanya; Maku, Roshan V.; Patel, Hitendra Kumar; Sonti, Ramesh V.			Identification of Pectin Degrading Enzymes Secreted by Xanthomonas oryzae pv. oryzae and Determination of Their Role in Virulence on Rice	PLOS ONE			English	Article							PECTATE LYASE GENE; RALSTONIA-SOLANACEARUM; CELL-WALL; CAMPESTRIS; INDUCTION; SEQUENCE; CLONING; ACID; METHYLESTERASE; PATHOGENICITY	Xanthomonas oryzae pv.oryzae (Xoo) causes the serious bacterial blight disease of rice. Xoo secretes a repertoire of plant cell wall degrading enzymes (CWDEs) like cellulases, xylanases, esterases etc., which act on various components of the rice cell wall. The major cellulases and xylanases secreted by Xoo have been identified and their role in virulence has been determined. In this study, we have identified some of the pectin degrading enzymes of Xoo and assessed their role in virulence. Bioinformatics analysis indicated the presence of four pectin homogalacturonan (HG) degrading genes in the genome of Xoo. The four HG degrading genes include one polygalacturonase (pg/A), one pectin methyl esterase (pmt) and two pectate lyases (pel/and pelL). There was no difference in the expression of pg/A, pmtand pe/genes by laboratory wild type Xoo strain (BXO43) grown in either nutrient rich PS medium or in plant mimic XOM2 medium whereas the expression of pelL gene was induced in XOM2 medium as indicated by qRT-PCR experiments. Gene disruption mutations were generated in each of these four genes. The polygalacturonase mutant pglyet-was completely deficient in degrading the substrate Na-polygalacturonicacid (PGA). Strains carrying mutations in the pmt, pe/and pelL genes were as efficient as wild type Xoo (BXO43) in cleaving PGA. These observations clearly indicate that PgIA is the major pectin degrading enzyme produced by Xoo. The pectin methyl esterase, Pmt, is the pectin deesterifying enzyme secreted by Xoo as evident from the enzymatic activity assay performed using pectin as the substrate. Mutations in the pg/A, pmt, pe/and pelL genes have minimal effects on virulence. This suggests that, as compared to cellulases and xylanases, the HG degrading enzymes may not have a major role in the pathogenicity of Xoo.	[Tayi, Lavanya; Maku, Roshan V.; Patel, Hitendra Kumar; Sonti, Ramesh V.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sonti, RV (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana State, India.	sonti@ccmb.res.in			Indian Council of Medical Research ICMR India; XIIth five year plan project, Plant-Microbe and soil Interactions of the Council of Scientific and Industrial research [BSC0117]; Department of Science and Technology India	Indian Council of Medical Research ICMR India(Indian Council of Medical Research (ICMR)); XIIth five year plan project, Plant-Microbe and soil Interactions of the Council of Scientific and Industrial research; Department of Science and Technology India(Department of Science & Technology (India))	Support was provided by: Fellowship from Indian Council of Medical Research ICMR India [http://www.icmr.nic.in/]to LT; XIIth five year plan project, Plant-Microbe and soil Interactions (BSC0117) of the Council of Scientific and Industrial research [http://www.csir.res.in/] to RVS; and a JC Bose fellowship from the Department of Science and Technology India [www.dst.gov.in/] to RVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LT acknowledges a fellowship from the Indian Council of Medical Research (ICMR), India. This work was supported by the XIIth five year plan project, Plant-Microbe and soil Interactions (BSC0117) of the Council of Scientific and Industrial research. RVS is also supported by a JC Bose fellowship from the Department of Science and Technology, Government of India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annis SL, 1997, EUR J PLANT PATHOL, V103, P1, DOI 10.1023/A:1008656013255; BEAULIEU C, 1991, MOL PLANT MICROBE IN, V4, P446, DOI 10.1094/MPMI-4-446; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DOW JM, 1989, PHYSIOL MOL PLANT P, V35, P113, DOI 10.1016/0885-5765(89)90081-7; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; DURRANDS PK, 1988, PHYSIOL MOL PLANT P, V32, P363, DOI 10.1016/S0885-5765(88)80030-4; Gonzalez ET, 2003, MOL PLANT MICROBE IN, V16, P536, DOI 10.1094/MPMI.2003.16.6.536; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hsiao YM, 2008, MICROBIOL-SGM, V154, P705, DOI 10.1099/mic.0.2007/012930-0; Hsiao YM, 2009, J AGR FOOD CHEM, V57, P6207, DOI 10.1021/jf900701n; Huang Q, 1997, J BACTERIOL, V179, P7369, DOI 10.1128/jb.179.23.7369-7378.1997; Huang Q, 2000, PHYSIOL MOL PLANT P, V57, P77, DOI 10.1006/pmpp.2000.0283; INNES RW, 1988, J BACTERIOL, V170, P3793, DOI 10.1128/jb.170.9.3793-3802.1988; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Kaewnum S, 2006, PHYTOPATHOLOGY, V96, P1230, DOI 10.1094/PHYTO-96-1230; LEACH JE, 1990, MOL PLANT MICROBE IN, V3, P238, DOI 10.1094/MPMI-3-238; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Liao CH, 1996, MOL PLANT MICROBE IN, V9, P14, DOI 10.1094/MPMI-9-0014; Lin HC, 2010, J PLANT PATHOL, V92, P149; Liu HL, 2005, MOL PLANT MICROBE IN, V18, P1296, DOI 10.1094/MPMI-18-1296; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Ried J. L., 1988, Molecular Plant-Microbe Interactions, V1, P32, DOI 10.1094/MPMI-1-032; Sambrook J, 1989, MOL CLONING; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shevchik VE, 1998, MOL MICROBIOL, V29, P1459, DOI 10.1046/j.1365-2958.1998.01028.x; Subramoni S, 2005, MOL PLANT MICROBE IN, V18, P644, DOI 10.1094/MPMI-18-0644; Tans-Kersten J, 1998, APPL ENVIRON MICROB, V64, P4918; Tayi L, 2016, MOL PLANT MICROBE IN; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113	32	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166396	10.1371/journal.pone.0166396	http://dx.doi.org/10.1371/journal.pone.0166396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907079	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700025
J	Fitzsimmons, CM; Fujimori, DG				Fitzsimmons, Christina M.; Fujimori, Danica Galonic			Determinants of tRNA Recognition by the Radical SAM Enzyme RlmN	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; PSEUDOURIDINE SYNTHASE RLUA; ESCHERICHIA-COLI; M(5)C967 METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE SELECTIVITY; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; NASCENT PEPTIDE; METHYL TRANSFER	RlmN, a bacterial radical SAM methylating enzyme, has the unusual ability to modify two distinct types of RNA: 23S rRNA and tRNA. In rRNA, RlmN installs a methyl group at the C2 position of A2503 of 23S rRNA, while in tRNA the modification occurs at nucleotide A37, immediately adjacent to the anticodon triplet. Intriguingly, only a subset of tRNAs that contain an adenosine at position 37 are substrates for RlmN, suggesting that the enzyme carefully probes the highly conserved tRNA fold and sequence features to identify its targets. Over the past several years, multiple studies have addressed rRNA modification by RlmN, while relatively few investigations have focused on the ability of this enzyme to modify tRNAs. In this study, we utilized in vitro transcribed tRNAs as model substrates to interrogate RNA recognition by RlmN. Using chimeras and point mutations, we probed how the structure and sequence of RNA influences methylation, identifying position 38 of tRNAs as a critical determinant of substrate recognition. We further demonstrate that, analogous to previous mechanistic studies with fragments of 23S rRNA, tRNA methylation requirements are consistent with radical SAM reactivity. Together, our findings provide detailed insight into tRNA recognition by a radical SAM methylating enzyme.	[Fitzsimmons, Christina M.] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA; [Fujimori, Danica Galonic] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Fujimori, Danica Galonic] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fujimori, DG (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Fujimori, DG (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	Danica.Fujimori@ucsf.edu		Fitzsimmons, Christina/0000-0002-6743-2671	National Institutes of Health, NIAID [R01A1095393]; Genentech Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genentech Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, NIAID R01A1095393 (DGF); https://www.niaid.nih.gov/, Genentech Predoctoral Fellowship (CMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwalla S, 2002, J BIOL CHEM, V277, P8835, DOI 10.1074/jbc.M111825200; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; ARNEZ JG, 1994, BIOCHEMISTRY-US, V33, P7560, DOI 10.1021/bi00190a008; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Benitez-Paez A, 2010, RNA, V16, P2131, DOI 10.1261/rna.2245910; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Golovina AY, 2012, RNA, V18, P1725, DOI 10.1261/rna.034207.112; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; GU XG, 1994, BIOCHEMISTRY-US, V33, P2255, DOI 10.1021/bi00174a036; Gu XR, 1999, BIOCHEMISTRY-US, V38, P4053, DOI 10.1021/bi982364y; Hamilton CS, 2006, BIOCHEMISTRY-US, V45, P12029, DOI 10.1021/bi061293x; HARTMANN RK, 2005, HANDBOOK OF RNA BIOC; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; KEALEY JT, 1995, BIOCHEMISTRY-US, V34, P2441, DOI 10.1021/bi00008a006; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; McCusker KP, 2012, J AM CHEM SOC, V134, P18074, DOI 10.1021/ja307855d; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; OHASHI Z, 1972, FEBS LETT, V20, P239, DOI 10.1016/0014-5793(72)80804-4; Purta E, 2009, MOL MICROBIOL, V72, P1147, DOI 10.1111/j.1365-2958.2009.06709.x; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Ranaei-Siadat E, 2013, RNA BIOL, V10, P572, DOI 10.4161/rna.24327; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Saneyoshi M, 1972, BIOCHIM BIOPHYS ACTA, V1, P1; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P5428, DOI 10.1093/nar/gkt195; Silakov A, 2014, J AM CHEM SOC, V136, P8221, DOI 10.1021/ja410560p; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stojkovic V, 2016, NUCLEIC ACIDS RES, V44, P8897, DOI 10.1093/nar/gkw699; Stojkovic V, 2015, METHOD ENZYMOL, V560, P355, DOI 10.1016/bs.mie.2015.03.002; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Tscherne JS, 1999, BIOCHEMISTRY-US, V38, P1884, DOI 10.1021/bi981880l; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Villsen ID, 1999, J MOL BIOL, V286, P365, DOI 10.1006/jmbi.1998.2504; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WRZESINSKI J, 1995, RNA, V1, P437; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	55	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167298	10.1371/journal.pone.0167298	http://dx.doi.org/10.1371/journal.pone.0167298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902775	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100070
J	Grosset, AA; Poirier, F; Gaboury, L; St-Pierre, Y				Grosset, Andree-Anne; Poirier, Francoise; Gaboury, Louis; St-Pierre, Yves			Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer	PLOS ONE			English	Article							MYOEPITHELIAL CELL; MAMMARY-TUMORS; NEU ONCOGENE; T-CELLS; PROGRESSION; MICE; OVEREXPRESSION; CARCINOMAS; INDUCTION; LECTINS	HER-2 positive tumors are among the most aggressive subtypes of breast cancer and are frequently associated with metastasis and poor outcome. As with other aggressive subtypes of breast cancer, these tumors are associated with abnormally high expression of galectin-7 (gal-7), which confers metastatic breast tumor cells with increased invasive behavior. Although previous studies in the rat model of breast tumorigenesis have shown that gal-7 is also increased in primary breast tumor, its contribution to the development of the primary breast tumors remains unclear. In the present work, we have used genetically-engineered gal-7-deficient mice to examine the role of gal-7 in the development of the mammary gland and of breast cancer. Using histological and immunohistological analysis of whole mammary glands at different stages of development, we detected no significant changes between normal and gal-7-deficient mice. To test the involvement of gal-7 in breast cancer, we next examined the effects of loss of gal-7 on mammary tumor development by crossing gal-7-deficient mice with the mammary tumor transgenic mouse strain FVB-Tg(MMTV-Erbb2) NK1Mul/J. Finally, assessment of mice survival and tumor volume showed a delay of mammary tumor growth in the absence of systemic gal-7. These data suggest that gal-7 could potentiate the phenotype of HER-2 positive primary breast cancer.	[Grosset, Andree-Anne; St-Pierre, Yves] Inst Armand Frappier, INRS, Laval, PQ, Canada; [Grosset, Andree-Anne; Gaboury, Louis] Univ Montreal, IRIC, Montreal, PQ, Canada; [Poirier, Francoise] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod, Paris, France	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	St-Pierre, Y (corresponding author), Inst Armand Frappier, INRS, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041	Canadian Institutes for Health Research [MOP-89697]; CIHR; FRQS; GEFLUC (groupement des entreprises francaises contre le cancer)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS; GEFLUC (groupement des entreprises francaises contre le cancer)	This work was supported by a grant from the Canadian Institutes for Health Research (Grant No. MOP-89697) the CIHR (http://www.cihr-irsc.gc.ca), and FRQS (http://www.frqs.gouv.qc.ca). This work was supported by GEFLUC (groupement des entreprises francaises contre le cancer) (www.gefluc.org/paris-ile-de-france.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2014, CAN CANC STAT 2014; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; De Oliveira JT, 2014, ANTICANCER RES, V34, P2211; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Fernandez-Aguilar S, 2008, APMIS, V116, P33, DOI 10.1111/j.1600-0463.2008.00753.x; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Gendronneau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119031; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Grosset A. A, 2016, ONCOTARGET; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Koo JS, 2011, YONSEI MED J, V52, P89, DOI 10.3349/ymj.2011.52.1.89; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Lu CH, 2003, J NATL CANCER I, V95, P1825, DOI 10.1093/jnci/djg117; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; Miwa HE, 2013, GLYCOBIOLOGY, V23, P1477, DOI 10.1093/glycob/cwt075; Moisa A, 2007, ANTICANCER RES, V27, P2131; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Zhang H, 2014, MATH PROBL ENG, V2014, DOI [10.1155/2014/183580, 10.1007/978-3-319-07200-5_1]	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166731	10.1371/journal.pone.0166731	http://dx.doi.org/10.1371/journal.pone.0166731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902734	Green Published, Green Accepted, gold			2022-12-27	WOS:000389474100036
J	Monsuur, HN; Weijers, EM; Niessen, FB; Gefen, A; Koolwijk, P; Gibbs, S; van den Broek, LJ				Monsuur, Hanneke N.; Weijers, Ester M.; Niessen, Frank B.; Gefen, Amit; Koolwijk, Pieter; Gibbs, Susan; van den Broek, Lenie J.			Extensive Characterization and Comparison of Endothelial Cells Derived from Dermis and Adipose Tissue: Potential Use in Tissue Engineering	PLOS ONE			English	Article							CHEMOKINE RECEPTORS; STEM-CELLS; IN-VITRO; RECONSTRUCTIVE SURGERY; REGENERATION TEMPLATE; SKIN SUBSTITUTE; EXPRESSION; VASCULARIZATION; ANGIOGENESIS; MIGRATION	Tissue-engineered constructs need to become quickly vascularized in order to ensure graft take. One way of achieving this is to incorporate endothelial cells (EC) into the construct. The adipose tissue stromal vascular fraction (adipose-SVF) might provide an alternative source for endothelial cells as adipose tissue can easily be obtained by liposuction. Since adipose-EC are now gaining more interest in tissue engineering, we aimed to extensively characterize endothelial cells from adipose tissue (adipose-EC) and compare them with endothelial cells from dermis (dermal-EC). The amount of endothelial cells before purification varied between 4-16% of the total stromal population. After MACS selection for CD31 positive cells, a >99% pure population of endothelial cells was obtained within two weeks of culture. Adipose-and dermal-EC expressed the typical endothelial markers PECAM-1, ICAM-1, Endoglin, VE-cadherin and VEGFR2 to a similar extent, with 80-99% of the cell population staining positive. With the exception of CXCR4, which was expressed on 29% of endothelial cells, all other chemokine receptors (CXCR1, 2, 3, and CCR2) were expressed on less than 5% of the endothelial cell populations. Adipose-EC proliferated similar to dermal-EC, but responded less to the mitogens bFGF and VEGF. A similar migration rate was found for both adipose-EC and dermal-EC in response to bFGF. Sprouting of adipose-EC and dermal-EC was induced by bFGF and VEGF in a 3D fibrin matrix. After stimulation of adipose-EC and dermal-EC with TNF-alpha an increased secretion was seen for PDGF-BB, but not uPA, PAI-1 or Angiopoietin-2. Furthermore, secretion of cytokines and chemokines (IL-6, CCL2, CCL5, CCL20, CXCL1, CXCL8 and CXCL10) was also upregulated by both adipose- and dermal-EC. The similar characteristics of adipose-EC compared to their dermal-derived counterpart make them particularly interesting for skin tissue engineering. In conclusion, we show here that adipose tissue provides for an excellent source of endothelial cells	[Monsuur, Hanneke N.; Weijers, Ester M.; Gibbs, Susan; van den Broek, Lenie J.] Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Monsuur, Hanneke N.; van den Broek, Lenie J.] Res Inst MOVE, Amsterdam, Netherlands; [Niessen, Frank B.] Vrije Univ Amsterdam, Med Ctr, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands; [Gefen, Amit] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel; [Koolwijk, Pieter] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [Gibbs, Susan] Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Gibbs, Susan] Vrije Univ Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Tel Aviv University; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Gibbs, S (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, Amsterdam, Netherlands.; Gibbs, S (corresponding author), Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands.; Gibbs, S (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	s.gibbs@vumc.nl		Niessen, Frank/0000-0001-8479-7755	Dutch Burns Foundation (Nederlandse Brandwonden stichting) grant [13-101]; Netherlands Institute of Regenerative Medicine (NIRM); Eurostar [E8855]	Dutch Burns Foundation (Nederlandse Brandwonden stichting) grant; Netherlands Institute of Regenerative Medicine (NIRM); Eurostar	This work has been financed by the Dutch Burns Foundation (Nederlandse Brandwonden stichting) grant 13-101, the Netherlands Institute of Regenerative Medicine (NIRM) and Eurostar project number E8855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auxenfans C, 2012, J TISSUE ENG REGEN M, V6, P512, DOI 10.1002/term.454; Blok CS, 2013, WOUND REPAIR REGEN; Bodnar RJ, 2015, ADV WOUND CARE, V4, P641, DOI 10.1089/wound.2014.0594; Broek van den LJ, 2013, TISSUE ENG A; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Freiman A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0251-6; Gibbs S, 2006, BRIT J DERMATOL, V155, P267, DOI 10.1111/j.1365-2133.2006.07266.x; Groeber F, 2011, ADV DRUG DELIVER REV, V63, P352, DOI 10.1016/j.addr.2011.01.005; Guo R, 2014, WOUND REPAIR REGEN, V22, P390, DOI 10.1111/wrr.12171; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hatse S, 2006, BIOCHEM BIOPH RES CO, V348, P192, DOI 10.1016/j.bbrc.2006.07.030; Hendrickx B, 2010, STEM CELLS, V28, P1165, DOI 10.1002/stem.445; Herzog DPE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/320123; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Kim Y.-S., 2014, J MAT, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083901; Klar AS, 2016, PEDIATR SURG INT, V32, P17, DOI 10.1007/s00383-015-3808-7; Klar AS, 2014, BIOMATERIALS, V35, P5065, DOI 10.1016/j.biomaterials.2014.02.049; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Kroeze KL, 2009, J INVEST DERMATOL, V129, P1569, DOI 10.1038/jid.2008.405; Latham AM, 2012, BRIT J PHARMACOL, V165, P245, DOI 10.1111/j.1476-5381.2011.01545.x; Lauder H, 1998, Angiogenesis, V2, P67, DOI 10.1023/A:1009006527462; Liu Q., 2015, J TISSUE ENG REGEN M; Luo X, 2015, J CRANIOFAC SURG, V26, P358, DOI 10.1097/SCS.0000000000001470; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mantovani A, 1998, TRANSPLANT P, V30, P4239, DOI 10.1016/S0041-1345(98)01402-X; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; McFadden TM, 2013, ACTA BIOMATER, V9, P9303, DOI 10.1016/j.actbio.2013.08.014; Moiemen NS, 2006, PLAST RECONSTR SURG, V117, p160S, DOI 10.1097/01.prs.0000222609.40461.68; Montano I, 2010, TISSUE ENG PT A, V16, P269, DOI [10.1089/ten.tea.2008.0550, 10.1089/ten.TEA.2008.0550]; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x; Palao R, 2003, BRIT J PLAST SURG, V56, P252, DOI 10.1016/S0007-1226(03)00101-2; Pirayesh A, 2015, BURNS, V41, P132, DOI 10.1016/j.burns.2014.05.013; Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74; Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77; Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419; Sahota PS, 2003, WOUND REPAIR REGEN, V11, P275, DOI 10.1046/j.1524-475X.2003.11407.x; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; Shahrokhi S, 2014, WOUND REPAIR REGEN, V22, P14, DOI 10.1111/wrr.12119; Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com; Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7; Topman G, 2012, MED ENG PHYS, V34, P225, DOI 10.1016/j.medengphy.2011.07.014; Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x; VANHINSBERGH VWM, 1986, EUR J CELL BIOL, V42, P101; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Weijers EM, 2010, J THROMB HAEMOST, V8, P2800, DOI 10.1111/j.1538-7836.2010.04096.x; Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93; Zhang J, 2010, TOXICOL PATHOL, V38, P856, DOI 10.1177/0192623310378866	52	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167056	10.1371/journal.pone.0167056	http://dx.doi.org/10.1371/journal.pone.0167056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902740	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100047
J	Schibler, J; Tomanek-Chalkley, AM; Reedy, JL; Zhan, FH; Spitz, DR; Schultz, MK; Goel, A				Schibler, Jeanine; Tomanek-Chalkley, Ann M.; Reedy, Jessica L.; Zhan, Fenghuang; Spitz, Douglas R.; Schultz, Michael K.; Goel, Apollina			Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; CANCER STEM-CELLS; THERAPEUTIC TARGET; RETICULUM STRESS; REDOX REGULATION; PROSTATE-CANCER; DRUG-RESISTANCE; PLASMA-CELLS; HYPOXIA; METABOLISM	Therapeutic advances have markedly prolonged overall survival in multiple myeloma (MM) but the disease currently remains incurable. In a panel of MM cell lines (MM. 1S, OPM-2, H929, and U266), using CD138 immunophenotyping, side population staining, and stem cell-related gene expression, we demonstrate the presence of stem-like tumor cells. Hypoxic culture conditions further increased CD138 low stem-like cells with upregulated expression of OCT4 and NANOG. Compared to MM cells, these stem-like cells maintained lower steady-state pro-oxidant levels with increased uptake of the fluorescent deoxyglucose analog. In primary human MM samples, increased glycolytic gene expression correlated with poorer overall and event-free survival outcomes. Notably, stem-like cells showed increased mitochondrial mass, rhodamine 123 accumulation, and orthodox mitochondrial configuration while more condensed mitochondria were noted in the CD138 high cells. Glycolytic inhibitor 2-deoxyglucose (2-DG) induced ER stress as detected by qPCR (BiP, ATF4) and immunoblotting (BiP, CHOP) and increased dihydroethidium probe oxidation both CD138(low) and CD138(high) cells. Treatment with a mitochondrial-targeting agent decyl-triphenylphosphonium (10-TPP) increased intracellular steady-state pro-oxidant levels in stem-like and mature MM cells. Furthermore, 10-TPP mediated increases in mitochondrial oxidant production were suppressed by ectopic expression of manganese superoxide dismutase. Relative to 2-DG or 10-TPP alone, 2-DG plus 10-TPP combination showed increased caspase 3 activation in MM cells with minimal toxicity to the normal hematopoietic progenitor cells. Notably, treatment with polyethylene glycol conjugated catalase significantly reduced 2-DG and/or 10-TPP-induced apoptosis of MM cells. Also, the combination of 2-DG with 10-TPP decreased clonogenic survival of MM cells. Taken together, this study provides a novel strategy of metabolic oxidative stress-induced cytotoxicity of MM cells via 2-DG and 10-TPP combination therapy.	[Schibler, Jeanine; Zhan, Fenghuang; Goel, Apollina] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Tomanek-Chalkley, Ann M.; Reedy, Jessica L.; Spitz, Douglas R.; Schultz, Michael K.; Goel, Apollina] Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Zhan, Fenghuang] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Schultz, Michael K.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Goel, A (corresponding author), Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA.; Goel, A (corresponding author), Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA.	apollina-goel@uiowa.edu	Schultz, Michael/ABC-9890-2020	Schultz, Michael/0000-0002-4554-2212; Zhan, Fenghuang/0000-0001-6208-1676; Spitz, Douglas/0000-0002-1254-8765	NIH [R21-CA186040, R01-CA182804, K25-CA172218]; Cancer Center grant [P30-CA086862]; NATIONAL CANCER INSTITUTE [R21CA186040, P30CA086862, R01CA182804, K25CA172218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	study was supported by NIH Grants R21-CA186040 (Dr. Apollina Goel), R01-CA182804 (Dr. Douglas R. Spitz), and K25-CA172218 (Dr. Michael K. Schultz). The Holden Comprehensive Cancer Center cores facilities are supported by the Cancer Center grant P30-CA086862.	Asosingh K, 2005, HAEMATOLOGICA, V90, P810; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Bera S, 2010, NEOPLASIA, V12, P980, DOI 10.1593/neo.101146; Borsi E, 2015, TRANSL RES, V165, P641, DOI 10.1016/j.trsl.2014.12.001; Boutrid H, 2008, INVEST OPHTH VIS SCI, V49, P2799, DOI 10.1167/iovs.08-1751; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown CO, 2012, BIOCHEM J, V444, P515, DOI 10.1042/BJ20112019; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Charruyer A, 2012, J INVEST DERMATOL, V132, P2522, DOI 10.1038/jid.2012.196; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Colla S, 2010, LEUKEMIA, V24, P1967, DOI 10.1038/leu.2010.193; Dela Cruz R, 2011, AM J BLOOD RES, V1, P135; Dezorella N, 2009, EXP CELL RES, V315, P1904, DOI 10.1016/j.yexcr.2009.03.016; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Elliott BM, 2011, EUR J HAEMATOL, V86, P289, DOI 10.1111/j.1600-0609.2010.01575.x; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Feng W, 2014, STEM CELLS; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Fujiwara S, 2013, BRIT J CANCER, V108, P170, DOI 10.1038/bjc.2012.527; Gabr MT, 2015, RSC ADV, V5, P90226, DOI 10.1039/c5ra18724a; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Gao M, 2016, ONCOTARGET; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Goel A, 2005, EXP HEMATOL, V33, P784, DOI 10.1016/j.exphem.2005.04.005; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goto M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-76; Green DR, 2010, CELL, V142, P200, DOI 10.1016/j.cell.2010.07.007; Hajek R, 2013, BRIT J HAEMATOL, V163, P551, DOI 10.1111/bjh.12563; Han M, 2014, MOL PHARMACEUT, V11, P2640, DOI 10.1021/mp500038g; Herault O, 2012, J EXP MED, V209, P895, DOI 10.1084/jem.20102386; Hosen N, 2012, LEUKEMIA, V26, P2135, DOI 10.1038/leu.2012.80; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jara JA, 2014, J MED CHEM, V57, P2440, DOI 10.1021/jm500174v; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Kawano Y, 2013, INT J ONCOL, V43, P1809, DOI 10.3892/ijo.2013.2134; Kawano Y, 2012, INT J ONCOL, V41, P876, DOI 10.3892/ijo.2012.1545; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim YS, 2013, ANTICANCER RES, V33, P4469; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Kurtoglu M, 2010, CANCER CHEMOTH PHARM, V66, P129, DOI 10.1007/s00280-009-1143-1; Lagadec C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034545; Leung CWT, 2013, J AM CHEM SOC, V135, P62, DOI 10.1021/ja310324q; Li L, 2015, REDOX BIOL, V4, P127, DOI 10.1016/j.redox.2014.12.001; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Liu HP, 2002, BIOCHEM PHARMACOL, V64, P1745, DOI 10.1016/S0006-2952(02)01456-9; Liu JH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/294303; Loureiro R, 2013, RECENT PATENTS ENDOC, V7, P102, DOI 10.2174/18722148113079990006; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Majithia N, 2015, AM J HEMATOL, V90, P981, DOI 10.1002/ajh.24131; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreno-Sanchez R, 2016, FEBS J, V283, P54, DOI 10.1111/febs.13535; Morfouace M, 2012, J BIOL CHEM, V287, P33664, DOI 10.1074/jbc.M111.320028; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Muz B, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.82; Nakano A, 2012, J BIOENERG BIOMEMBR, V44, P31, DOI 10.1007/s10863-012-9412-9; Nara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056954; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]; Orlowski RZ, 2013, CANCER CELL, V24, P275, DOI 10.1016/j.ccr.2013.08.014; Paino T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092378; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Ramani VC, 2014, MATRIX BIOL, V35, P215, DOI 10.1016/j.matbio.2013.10.005; Reedy JL, 2016, BIOCONJUG CHEM; Reid S, 2010, INT J LAB HEMATOL, V32, pE190, DOI 10.1111/j.1751-553X.2010.01222.x; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Ria R, 2014, CLIN CANCER RES, V20, P847, DOI 10.1158/1078-0432.CCR-13-1950; Salaun PY, 2008, HAEMATOL-HEMATOL J, V93, P1269, DOI 10.3324/haematol.12654; Salem K, 2015, REDOX BIOL, V4, P23, DOI 10.1016/j.redox.2014.11.002; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Sattler UGA, 2009, INT J RADIAT BIOL, V85, P963, DOI 10.3109/09553000903258889; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shanmugam M, 2009, J BIOL CHEM, V284, P26816, DOI 10.1074/jbc.M109.000646; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shaughnessy JD, 2011, BLOOD, V118, P3512, DOI 10.1182/blood-2010-12-328252; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Van Valckenborgh E, 2012, LEUKEMIA, V26, P1436, DOI 10.1038/leu.2011.373; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vayalil PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120460; Victorino VJ, 2014, CURRENT MED CHEM; Vlashi E, 2014, BREAST CANCER RES TR, V146, P525, DOI 10.1007/s10549-014-3051-2; Wang XH, 2007, ACTA MATER, V55, P5304, DOI 10.1016/j.actamat.2007.04.041; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wen JG, 2015, INT J CANCER, V136, P991, DOI 10.1002/ijc.29078; White-Gilbertson Shai, 2013, Frontiers in Genetics, V4, P109, DOI 10.3389/fgene.2013.00109; WICK AN, 1957, J BIOL CHEM, V224, P963; Xi HB, 2014, IUBMB LIFE, V66, P110, DOI 10.1002/iub.1251; Yan B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1394-7; Yang Y, 2015, CANCER RES, V75, P594, DOI 10.1158/0008-5472.CAN-14-2362; Yang Y, 2013, BLOOD, V122, P1437, DOI 10.1182/blood-2013-02-482919; Ye F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080397; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Ye XQ, 2011, STEM CELL REV REP, V7, P153, DOI 10.1007/s12015-010-9122-9; Zamagni E, 2011, BLOOD, V118, P5989, DOI 10.1182/blood-2011-06-361386; Zhang BB, 2015, FAM CANCER, V14, P19, DOI 10.1007/s10689-014-9757-9; Zhang GC, 2013, BBA-REV CANCER, V1836, P49, DOI 10.1016/j.bbcan.2013.03.001; Zhu YM, 2009, FREE RADICAL BIO MED, V47, P1762, DOI 10.1016/j.freeradbiomed.2009.09.024; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	119	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167323	10.1371/journal.pone.0167323	http://dx.doi.org/10.1371/journal.pone.0167323			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902770	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100071
J	Simoes, EAF; Anderson, EJ; Wu, XH; Ambrose, CS				Simoes, Eric A. F.; Anderson, Evan J.; Wu, Xionghua; Ambrose, Christopher S.			Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation	PLOS ONE			English	Article							REQUIRING HOSPITALIZATION; INFECTION; IMMUNOPROPHYLAXIS; BRONCHIOLITIS; RISK	Objective To estimate the incidence of respiratory syncytial virus (RSV) disease as a function of chronologic age and exposure to young children in US preterm infants. Methods In the RSV Respiratory Events among Preterm Infants Outcomes and Risk Tracking (REPORT) study, preterm infants born at 32-35 weeks gestational age (wGA) were enrolled from 188 US clinics and followed September-May of 2009-2010 or 2010-2011. Infants with medically-attended acute respiratory illness had nasal/pharyngeal swabs collected for viral testing. Results of RSV tests conducted during routine clinical care were also collected. Event rates during November-March were modeled as a function of chronologic age and birth month using Poisson regression and adjusting for other covariates. Rates were calculated overall and for infants with and without exposure to young siblings or daycare attendance. Of 3317 infants screened, 1646 were enrolled as a consecutive sample. Infants with chronic lung disease of prematurity, hemodynamically significant congenital heart disease, life expectancy < 6 months, or receiving or being considered for RSV immunoprophylaxis were excluded. 84% of patients completed the study. Demographics of the enrolled cohort were generally similar to those of US infants born at 32-35 wGA; infants 32-34 wGA, Hispanic infants, and infants of less-educated mothers were under-represented. Results Among 1642 evaluable infants, outpatient RSV lower respiratory illness incidence was highest at older ages, whereas RSV hospitalization and intensive care unit (ICU) admission were highest at younger ages. In all instances, young child exposure was associated with higher RSV incidence. The highest RSV hospitalization and ICU rates occurred among February-born infants with young child exposure, at 19.0 (95% CI, 13.5-27.0) and 6.5 (95% CI, 5.6-7.6) per 100 infant-seasons, respectively. Conclusions Preterm infants have a substantially elevated risk of RSV disease. Young age and exposure to other young children identify those at greatest risk of severe RSV disease.	[Simoes, Eric A. F.] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Aurora, CO 80045 USA; [Simoes, Eric A. F.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Anderson, Evan J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Anderson, Evan J.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Wu, Xionghua] MedImmune, Dept Biostat, Gaithersburg, MD USA; [Ambrose, Christopher S.] AstraZeneca, Gaithersburg, MD 20878 USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Emory University; Emory University; AstraZeneca; Medimmune; AstraZeneca	Simoes, EAF (corresponding author), Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Aurora, CO 80045 USA.; Simoes, EAF (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.; Ambrose, CS (corresponding author), AstraZeneca, Gaithersburg, MD 20878 USA.	Eric.Simoes@ucdenver.edu; AmbroseC@medimmune.com		Ambrose, Christopher/0000-0003-4175-7336	AstraZeneca; MedImmune; AbbVie	AstraZeneca(AstraZeneca); MedImmune(AstraZenecaMedimmune); AbbVie(AbbVie)	This study was sponsored by AstraZeneca, the parent company of MedImmune. ES has received grant support through his institution from AstraZeneca and AbbVie. EA has received research funding to his institution on his behalf from AstraZeneca and is a consultant to AbbVie. XW was an employee of Medlmmune when the study was conducted and is currently an independent contractor to AstraZeneca. CSA is an employee of AstraZeneca and holds stock or stock options. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; Editorial assistance was provided by Java Solis, MS, CMPP, an agent of The Lockwood Group, and supported by AstraZeneca.	Ambrose CS, 2014, PEDIATR INFECT DIS J, V33, P576, DOI 10.1097/INF.0000000000000219; Blanken MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059161; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Carbonell X, 2012, J PERINAT MED, V40, P685, DOI 10.1515/jpm-2011-0248; Figueras-Aloy J, 2004, PEDIATR INFECT DIS J, V23, P815, DOI 10.1097/01.inf.0000136869.21397.6b; Figueras-Aloy J, 2009, AN PEDIATR, V71, P47, DOI 10.1016/j.anpedi.2009.04.010; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Helfrich AM, 2015, EARLY HUM DEV, V91, P541, DOI 10.1016/j.earlhumdev.2015.06.009; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Mauskopf J, 2016, PEDIATR INFECT DIS J, V35, pE229, DOI 10.1097/INF.0000000000001163; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Pickering LK, 2012, RED BOOK 2012 REPORT, P607; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Winterstein AG, 2013, JAMA PEDIATR, V167, P1118, DOI 10.1001/jamapediatrics.2013.2636	20	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166226	10.1371/journal.pone.0166226	http://dx.doi.org/10.1371/journal.pone.0166226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898687	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000005
J	Rahman, S; Rollison, DE; Campbell, CMP; Waterboer, T; Michel, A; Pawlita, M; Villa, LL; Ponce, EL; Wang, W; Borenstein, AR; Giuliano, AR				Rahman, Shams; Rollison, Dana E.; Campbell, Christine M. Pierce; Waterboer, Tim; Michel, Angelika; Pawlita, Michael; Villa, Luisa L.; Lazcano Ponce, Eduardo; Wang, Wei; Borenstein, Amy R.; Giuliano, Anna R.			Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GLUTATHIONE-S-TRANSFERASE; PENILE INTRAEPITHELIAL NEOPLASIA; NONMELANOMA SKIN-CANCER; IMMUNOCOMPETENT INDIVIDUALS; UNITED-STATES; BASAL-CELL; INFECTION; HPV; ASSOCIATION	Background A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men. Objectives To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs. Methods A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (beta types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), a type 27,. type 4, mu type 1, and. type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated. Results Overall, seropositivity to >= 1 cutaneous HPV type (any-HPV) and >= 1 beta types (any-beta) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for gamma-HPV 4, mu-HPV 1, and beta-HPV 8. No statistically significant association was observed between any-HPV, any-beta, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses. Conclusions Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men.	[Rahman, Shams; Rollison, Dana E.; Campbell, Christine M. Pierce; Giuliano, Anna R.] H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL USA; [Rahman, Shams; Wang, Wei; Borenstein, Amy R.] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Waterboer, Tim; Michel, Angelika; Pawlita, Michael] German Canc Res Ctr, Infect Inflammat & Canc Res Program, Heidelberg, Germany; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Lazcano Ponce, Eduardo] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade de Sao Paulo; Instituto Nacional de Salud Publica	Giuliano, AR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL USA.	anna.giuliano@moffitt.org	Borenstein, Amy/AAN-8884-2021; VILLA, LUISA/AAH-4761-2019	VILLA, LUISA/0000-0003-4074-2335; Pawlita, Michael/0000-0002-4720-8306; Rahman, Shams/0000-0001-5856-7753	National Cancer Institute, National Institutes of Health [R03: CA176743, R01: CA098803]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (R03: CA176743, PI: Anna R. Giuliano), and the HIM Study cohort infrastructure was supported through a grant from the National Cancer Institute, National Institutes of Health (R01: CA098803, PI: Anna R. Giuliano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2014, PRESSE MED, V43, pE435, DOI 10.1016/j.lpm.2014.08.008; Aldabagh B, 2013, DERMATOL SURG, V39, P1, DOI 10.1111/j.1524-4725.2012.02558.x; Andersson K, 2008, CANCER EPIDEM BIOMAR, V17, P189, DOI 10.1158/1055-9965.EPI-07-0405; Anic GM, 2013, J MED VIROL, V85, P1561, DOI 10.1002/jmv.23635; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arya M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1149; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Baldur-Felskov B, 2012, CANCER CAUSE CONTROL, V23, P273, DOI 10.1007/s10552-011-9876-7; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Campbell CMP, 2013, J CLIN VIROL, V58, P652, DOI 10.1016/j.jcv.2013.10.011; Casabonne D, 2007, INT J CANCER, V121, P1862, DOI 10.1002/ijc.22885; Chouhy D, 2013, J GEN VIROL, V94, P2480, DOI 10.1099/vir.0.055137-0; Cubilla AL, 2004, INT J SURG PATHOL, V12, P351, DOI 10.1177/106689690401200408; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; Feltkamp MCW, 2003, CANCER RES, V63, P2695; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Graafland NM, 2011, INT J CANCER, V128, P426, DOI 10.1002/ijc.25355; Hannigan GD, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015362; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Hernandez BY, 2008, CANCER-AM CANCER SOC, V113, P2883, DOI 10.1002/cncr.23743; Humbey O, 2003, EUR J CANCER, V39, P684, DOI 10.1016/S0959-8049(02)00835-3; Iannacone MR, 2012, CANCER EPIDEM BIOMAR, V21, P1303, DOI 10.1158/1055-9965.EPI-12-0032; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, HUM PAP, V90, P1; Ingles DJ, 2015, J INFECT DIS, V211, P1060, DOI 10.1093/infdis/jiu587; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Kreuter A, 2008, J INVEST DERMATOL, V128, P2316, DOI 10.1038/jid.2008.72; Majewski S, 1997, CANCER RES, V57, P4214; Masini C, 2003, ARCH DERMATOL, V139, P890, DOI 10.1001/archderm.139.7.890; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; Misra S, 2004, LANCET ONCOL, V5, P240, DOI 10.1016/S1470-2045(04)01427-5; Plasmeijer Elsemieke I., 2009, V146, P143, DOI 10.1007/978-0-387-78574-5_13; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Quint KD, 2015, J PATHOL, V235, P342, DOI 10.1002/path.4425; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Sudenga SL, 2015, EUR UROL; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Waterboer T, 2009, J GEN VIROL, V90, P1986, DOI 10.1099/vir.0.010637-0; Wieland U, 2000, J INVEST DERMATOL, V115, P396, DOI 10.1046/j.1523-1747.2000.00069.x	47	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167174	10.1371/journal.pone.0167174	http://dx.doi.org/10.1371/journal.pone.0167174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893841	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400095
J	Tschinkel, WR; Kwapich, CL				Tschinkel, Walter R.; Kwapich, Christina L.			The Florida Harvester Ant, Pogonomyrmex badius, Relies on Germination to Consume Large Seeds	PLOS ONE			English	Article							VEROMESSOR-PERGANDEI; COLONY SIZE; SOCIOGENESIS; SOCIOMETRY; DESERT; HYMENOPTERA; ALLOCATION; BEHAVIOR; GARDENS	The Florida harvester ant, Pogonomyrmex badius, is one of many ant species and genera that stores large numbers of seeds in damp, underground chambers for later consumption. A comparison of the sizes of seeds recovered from storage chambers with those of seed husks discarded following consumption revealed that the used seeds are far smaller than stored seeds. This difference in use-rate was confirmed in field and laboratory colonies by offering marked seeds of various sizes and monitoring the appearance of size-specific chaff. Because foragers collect a range of seed sizes but only open small seeds, large seeds accumulate, forming 70% or more of the weight of seed stores. Major workers increase the rates at which small and medium seeds are opened, but do not increase the size range of opened seeds. Experiments limiting ant access to portions of natural seed chambers showed that seeds germinate during storage, but that the ants rapidly remove them. When offered alongside non germinating seeds, germinating seeds were preferentially fed to larvae. The rate of germination during the annual cycle was determined by both burial in artificial chambers at various depths and under four laboratory temperatures. The germination rate depends upon the species of seed, the soil/laboratory temperature and/or the elapsed time. The seasonal soil temperature cycle generated germination patterns that vary with the mix of locally-available seeds. Taken together, exploitation of germination greatly increases the resources available to the ants in space and time. While the largest seeds may have the nutritional value of 15 small seeds, the inability of workers to open large seeds at will precludes them from rapid use during catastrophic events. The harvester ant's approach to seed harvesting is therefore two-pronged, with both immediate and delayed payoffs arising from the tendency to forage for a wide variety of seeds sizes.	[Tschinkel, Walter R.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Kwapich, Christina L.] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ USA	State University System of Florida; Florida State University; Arizona State University; Arizona State University-Tempe	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu		Kwapich, Christina/0000-0001-5141-7605	National Science Foundation (US) [IOS 1021632]	National Science Foundation (US)(National Science Foundation (NSF))	This work was funded by National Science Foundation (US) grant IOS 1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the competent and enthusiastic technical help of Nicholas Hanley and Daniel Dominguez. We thank Nichole Ramirez and Danielle Taylor for allowing us to use the results of their student research. Kent Perkins of the University of Florida Herbarium kindly gave us access to their seed collection. Loran Anderson of the Florida State University Herbarium greatly helped with seed identification. This work was carried out under US Forest Service permit APA56302, and was partially supported by National Science Foundation grant IOS 1021632.	CHEW AE, 1980, INSECT SOC, V27, P189, DOI 10.1007/BF02223663; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; Davison E.A., 1982, Geobotany, V4, P1; Eddy TA, 1970, THESIS; Ferster B, 2006, ETHOL ECOL EVOL, V18, P19, DOI 10.1080/08927014.2006.9522723; FEWELL JH, 1991, BEHAV ECOL SOCIOBIOL, V28, P377, DOI 10.1007/BF00164118; Goetsch W, 1957, STAATEN AMEISEN; HANSEN SR, 1978, OECOLOGIA, V35, P109, DOI 10.1007/BF00345544; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Pirk GI, 2010, ECOL RES, V25, P439, DOI 10.1007/s11284-009-0673-7; INOUYE RS, 1980, OECOLOGIA, V46, P235, DOI 10.1007/BF00540131; Jerdon TC, 1851, MADRAS J LIT SCI, V17, P103, DOI DOI 10.1080/03745485709496303; Jones CR, 1927, J COLORADO WYOMING A, V1; Kaufmann E, 2001, INSECT SOC, V48, P125, DOI 10.1007/PL00001754; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; Kwapich CL, 2016, BEHAV ECOL SOCIOBIOL, V70, P221, DOI 10.1007/s00265-015-2039-1; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; Landers JLJ, 1976, TALL TIMBERS MISCELL, V4; LAVIGNE RJ, 1969, ANN ENTOMOL SOC AM, V62, P1166, DOI 10.1093/aesa/62.5.1166; MacGown JA, 2007, MISSISSIPPI NATIVE P, V25, p[1, 4]; MACKAY W P, 1981, Psyche (Cambridge), V88, P25, DOI 10.1155/1981/78635; MACKAY WP, 1984, SOCIOBIOLOGY, V9, P31; Moggridge J.T., 1873, HARVESTING ANTS TRAP; Oettler J, 2009, J INSECT BEHAV, V22, P217, DOI 10.1007/s10905-008-9167-7; Oster G.F., 1978, Monographs in Population Biology, pi; RISSING SW, 1981, BEHAV ECOL SOCIOBIOL, V9, P149, DOI 10.1007/BF00293586; RISSING SW, 1976, PAN-PAC ENTOMOL, V52, P63; Rosene WF, 1988, GUIDE CULTURE FLOWER; Skyes WH, 1835, T ROY; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Smith CR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1479, DOI 10.1007/s00265-007-0380-8; TEVIS L, 1958, ECOLOGY, V39, P695, DOI 10.2307/1931610; TEVIS L, 1958, ECOLOGY, V39, P681, DOI 10.2307/1931608; Treat M, 1879, HARPERS HALF HOUR SE, V123, P5; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120407; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; TSCHINKEL WR, 2004, J INSECT SCI, V0004; WENT FW, 1972, BIOSCIENCE, V22, P82, DOI 10.2307/1296037; Wheeler W, 1910, AM NAT, V91, P5927; WHITFORD WG, 1979, ECOLOGY, V60, P686, DOI 10.2307/1936605; Willard JRA, 1964, THESIS; WILSON E O, 1978, Journal of the Kansas Entomological Society, V51, P615	46	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166907	10.1371/journal.pone.0166907	http://dx.doi.org/10.1371/journal.pone.0166907			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893844	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400054
J	Gourmelon, V; Maggia, L; Powell, JR; Gigante, S; Hortal, S; Gueunier, C; Letellier, K; Carriconde, F				Gourmelon, Veronique; Maggia, Laurent; Powell, Jeff R.; Gigante, Sarah; Hortal, Sara; Gueunier, Claire; Letellier, Kelly; Carriconde, Fabian			Environmental and Geographical Factors Structure Soil Microbial Diversity in New Caledonian Ultramafic Substrates: A Metagenomic Approach	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; TROPICAL RAIN-FORESTS; SPECIES RICHNESS; ECTOMYCORRHIZAL FUNGI; PYROSEQUENCING ANALYSES; LITTER DECOMPOSITION; FUNCTIONAL DIVERSITY; MYCORRHIZAL STATUS; PRIMARY SUCCESSION; HOST PREFERENCE	Soil microorganisms play key roles in ecosystem functioning and are known to be influenced by biotic and abiotic factors, such as plant cover or edaphic parameters. New Caledonia, a biodiversity hotspot located in the southwest Pacific, is one-third covered by ultramafic substrates. These types of soils are notably characterised by low nutrient content and high heavy metal concentrations. Ultramafic outcrops harbour diverse vegetation types and remarkable plant diversity. In this study, we aimed to assess soil bacterial and fungal diversity in New Caledonian ultramafic substrates and to determine whether floristic composition, edaphic parameters and geographical factors affect this microbial diversity. Therefore, four plant formation types at two distinct sites were studied. These formations represent different stages in a potential chronosequence. Soil cores, according to a given sampling procedure, were collected to assess microbial diversity using a metagenomic approach, and to characterise the physico-chemical parameters. A botanical inventory was also performed. Our results indicated that microbial richness, composition and abundance were linked to the plant cover type and the dominant plant species. Furthermore, a large proportion of Ascomycota phylum (fungi), mostly in non-rainforest formations, and Planctomycetes phylum (bacteria) in all formations were observed. Interestingly, such patterns could be indicators of past disturbances that occurred on different time scales. Furthermore, the bacteria and fungi were influenced by diverse edaphic parameters as well as by the interplay between these two soil communities. Another striking finding was the existence of a site effect. Differences in microbial communities between geographical locations may be explained by dispersal limitation in the context of the biogeographical island theory. In conclusion, each plant formation at each site possesses is own microbial community resulting from multiple interactions between abiotic and biotic factors.	[Gourmelon, Veronique; Maggia, Laurent; Gigante, Sarah; Letellier, Kelly; Carriconde, Fabian] Inst Agron Neocaledonien IAC, Axe Diversites Biol & Fonct Ecosyst Terrestres 2, Noumea, New Caledonia; [Maggia, Laurent] CIRAD, UMR AGAP, Noumea, New Caledonia; [Powell, Jeff R.; Hortal, Sara] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW, Australia; [Gueunier, Claire] Soc Nickel SLN, Dept Environm, Grp ERAMET, Noumea, New Caledonia	CIRAD; Western Sydney University	Gourmelon, V; Carriconde, F (corresponding author), Inst Agron Neocaledonien IAC, Axe Diversites Biol & Fonct Ecosyst Terrestres 2, Noumea, New Caledonia.	gourmelon@iac.nc; carriconde@iac.nc	Powell, Jeff R/A-5076-2010	Powell, Jeff R/0000-0003-1091-2452	Societe Le Nickel (SLN - Groupe ERAMET) [DE2013-041]	Societe Le Nickel (SLN - Groupe ERAMET)	This project was funded by the Societe Le Nickel (SLN - Groupe ERAMET) through a research collaboration agreement (agreement IAC-SLN no DE2013-041). The SLN provided support in the form of salaries for authors [CG] and contributed to the study design, the project administration, the access to the field and the decision to publish.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Alexander I, 2009, NEW PHYTOL, V182, P14, DOI 10.1111/j.1469-8137.2009.02798.x; Amir H, 2007, PLANT SOIL, V293, P23, DOI 10.1007/s11104-007-9238-0; Amir H., 2010, MINES ENV NOUVELLE C, P129; Amir H, 2013, MYCORRHIZA, V23, P585, DOI 10.1007/s00572-013-0499-6; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Bequette F., 1997, UNESCO COURIER, V50, P38; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bonito G, 2014, MOL ECOL, V23, P3356, DOI 10.1111/mec.12821; Bordez L, 2016, MOL ECOL, V25, P2258, DOI 10.1111/mec.13621; Branco S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011757; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chatain A, 2009, PLANT ECOL, V201, P51, DOI 10.1007/s11258-008-9477-z; Clarke KR, 2015, PRIMER V7 USER MANUA; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; Corneo PE, 2014, MICROB ECOL, V67, P659, DOI 10.1007/s00248-013-0357-2; DANELL E, 1993, MYCOL RES, V97, P1148, DOI 10.1016/S0953-7562(09)80519-4; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; DeGrood SH, 2005, SOIL BIOL BIOCHEM, V37, P1427, DOI 10.1016/j.soilbio.2004.12.013; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dickie IA, 2007, NEW PHYTOL, V174, P230, DOI 10.1111/j.1469-8137.2007.02055.x; Duponnois R, 2003, MYCORRHIZA, V13, P85, DOI 10.1007/s00572-002-0204-7; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELLIOTT WM, 1993, AM MIDL NAT, V129, P87, DOI 10.2307/2426438; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fitzsimons MS, 2010, PLANT SOIL, V330, P393, DOI 10.1007/s11104-009-0213-9; Frey P, 1997, APPL ENVIRON MICROB, V63, P1852, DOI 10.1128/AEM.63.5.1852-1860.1997; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Gobat J.-M., 2010, SOL VIVANT BASES PED; Gomoryova E, 2009, APPL SOIL ECOL, V43, P191, DOI 10.1016/j.apsoil.2009.07.007; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hartnett DC, 2002, PLANT SOIL, V244, P319, DOI 10.1023/A:1020287726382; He XH, 2008, FRANKIA NODULATION M, P767; Herrera A, 2007, EUR J SOIL BIOL, V43, P130, DOI 10.1016/j.ejsobi.2006.12.001; Hery M, 2003, ENVIRON MICROBIOL, V5, P3, DOI 10.1046/j.1462-2920.2003.00380.x; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Isnard S, 2016, PLANT SOIL, V403, P53, DOI 10.1007/s11104-016-2910-5; Jaffre A T, 2001, IRD DOC SCI TECH, P1; Jaffre T., 2010, MINES ENV NOUVELLE C, P45; Jaffre T, 2009, FLORA, V162, P54; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lagrange A, 2011, CAN J MICROBIOL, V57, P21, DOI [10.1139/W10-096, 10.1139/w10-096]; Lejon DPH, 2005, MICROB ECOL, V50, P614, DOI 10.1007/s00248-005-5130-8; Lenczewski M, 2009, AUSTRAL ECOL, V34, P567, DOI 10.1111/j.1442-9993.2009.01962.x; Li JJ, 2013, J SOIL SEDIMENT, V13, P760, DOI 10.1007/s11368-013-0652-z; Lisitskaya TB, 2013, RUSS J GEN CHEM+, V83, P2765, DOI 10.1134/S1070363213130252; lvarez-Lopez V, PLANT SOIL, V480, DOI [10.1111/j.1461-0248.2007.01035.x, DOI 10.1111/J.1461-0248.2007.01035.X]; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Majorel C, 2012, MOL ECOL, V21, P2208, DOI 10.1111/j.1365-294X.2012.05527.x; Mansfeld-Giese K, 2002, FEMS MICROBIOL ECOL, V41, P133, DOI 10.1111/j.1574-6941.2002.tb00974.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mengoni A, 2010, PLANT SOIL, V331, P5, DOI 10.1007/s11104-009-0242-4; Miyashita NT, 2013, GENES GENET SYST, V88, P93, DOI 10.1266/ggs.88.93; Morat P, 2012, ADANSONIA; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Ohtonen R, 1999, OECOLOGIA, V119, P239, DOI 10.1007/s004420050782; Oline DK, 2006, APPL ENVIRON MICROB, V72, P6965, DOI 10.1128/AEM.00690-06; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Pansu M, 2006, HDB SOIL ANAL, DOI 10.1007/978-3-540-31211-6; Pearson K., PHILIOSOPHICAL MAG, V2, P559; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1; Perrier N, 2006, MYCORRHIZA, V16, P449, DOI 10.1007/s00572-006-0057-6; Pessoa M, 2015, ANTON LEEUW INT J G, V107, P935, DOI 10.1007/s10482-015-0386-6; Pfeiffer B, 2013, APPL SOIL ECOL, V72, P150, DOI 10.1016/j.apsoil.2013.06.008; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Porter SS, 2013, EVOLUTION, V67, P599, DOI 10.1111/j.1558-5646.2012.01788.x; Puga-Freitas R, ENV EXP BOT; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Read J, 1996, ECOLOGY BIOGEOGRAPHY; Roy M, 2013, NEW PHYTOL, V198, P1228, DOI 10.1111/nph.12212; SCHLEGEL HG, 1991, BOT ACTA, V104, P18, DOI 10.1111/j.1438-8677.1991.tb00189.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; schmidt M., 1982, CR HEBD ACAD SCI, V48, P52; Schulz S, 2013, BIOGEOSCIENCES, V10, P3983, DOI 10.5194/bg-10-3983-2013; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sourkova M, 2005, GEODERMA, V129, P73, DOI 10.1016/j.geoderma.2004.12.032; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; TISDALL JM, 1994, PLANT SOIL, V159, P115, DOI 10.1007/BF00000100; Urbanova M, 2015, SOIL BIOL BIOCHEM, V84, P53, DOI 10.1016/j.soilbio.2015.02.011; White C, 2005, SOIL BIOL BIOCHEM, V37, P1359, DOI 10.1016/j.soilbio.2004.12.007; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZHANG XP, 1991, INT J SYST BACTERIOL, V41, P104, DOI 10.1099/00207713-41-1-104; 2010, APPL ENVIRON MICROB, V76, P3936, DOI DOI 10.1128/AEM.03085-09	106	36	36	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167405	10.1371/journal.pone.0167405	http://dx.doi.org/10.1371/journal.pone.0167405			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907121	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700147
J	Kamiza, AB; Hsieh, LL; Tang, R; Chien, HT; Lai, CH; Chiu, LL; Lo, TP; Hung, KY; You, JF; Wang, WC; Hsiung, CA; Yeh, CC				Kamiza, Abram Bunya; Hsieh, Ling-Ling; Tang, Reiping; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling; Lo, Tsai-Ping; Hung, Kuan-Yi; You, Jeng-Fu; Wang, Wen-Chang; Hsiung, Chao A.; Yeh, Chih-Ching			TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study	PLOS ONE			English	Article							CODON 72 POLYMORPHISM; AGE-OF-ONSET; P53 CODON-72; GENETIC POLYMORPHISMS; HAPLOTYPE ANALYSIS; ASSOCIATION; POPULATION; GENOTYPE; ADENOCARCINOMAS; SUSCEPTIBILITY	Background and Aim TP53 encodes p53, which has a crucial role in modulating genes that regulate defense against cancer development. This study investigated whether TP53 polymorphisms are associated with colorectal cancer (CRC) in patients with Lynch syndrome and whether TP53 interacts with lifestyle factors to modify CRC risk. Methods We identified 260 MLH1 and MSH2 germline mutation carriers from the Taiwan Hereditary Nonpolyposis Colorectal Cancer Consortium. A weighted Cox proportional hazard model was used to calculate hazard ratios (HRs) and 95% confidence intervals (Cis) to determine the association of TP53 polymorphisms with CRC development. Results The carriers of the variant C allele of rs1042522 were associated with a decreased CRC risk (GC genotype: HR = 0.35, 95% CI = 0.14-0.86; CC genotype: HR = 0.28, 95% CI = 0.13-0.57). In addition, the dominant model of rs1042522 was associated with a decreased CRC risk (HR = 0.32, 95% CI = 0.15-0.67). The CRC risk was decreased in carriers with the CT and TT genotypes of rs12947788 (HR = 0.20, 95% CI = 0.08-0.46 and HR = 0.25, 95% CI = 0.09-0.65, respectively). Moreover, the dominant model of rs12947788 was significantly associated with a decreased CRC risk (HR = 0.21, 95% CI = 0.09-0.46). A haplotype analysis indicated that compared with the most common GC haplotype, the CT haplotype was associated with a decreased CRC risk (HR = 0.26, 95% CI = 0.11-0.59). However, no significant interaction was observed between TP53 polymorphisms and lifestyle factors. Conclusion The study results revealed that the rs1042522 genotype with the C allele and the rs12947788 genotype with the T allele in TP53 were associated with a decreased CRC risk in patients with Lynch syndrome in Taiwan.	[Kamiza, Abram Bunya; Yeh, Chih-Ching] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Hsieh, Ling-Ling; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling] Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan, Taiwan; [Tang, Reiping; You, Jeng-Fu] Chang Gung Mem Hosp, Colorectal Sect, Dept Surg, Taoyuan, Taiwan; [Tang, Reiping; You, Jeng-Fu] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Chiu, Li-Ling] Chang Gung Univ Sci & Technol, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Lo, Tsai-Ping; Hung, Kuan-Yi; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Wang, Wen-Chang] Taipei Med Univ, Coll Med Sci & Technol, Ph Program Translat Med, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; National Health Research Institutes - Taiwan; Taipei Medical University; China Medical University Taiwan	Yeh, CC (corresponding author), Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan.; Hsiung, CA (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Yeh, CC (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	hsiung@nhri.org.tw; ccyeh@tmu.edu.tw		Kamiza, Abram Bunya/0000-0002-3919-7651; Wang, Wen-Chang/0000-0003-3124-2136	National Science Council, Executive Yuan, Taiwan [NSC 101-2314-B-038-057]; Ministry of Science and Technology, Taiwan [MOST 104-2314-B-038-009]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Executive Yuan, Taiwan (grant NSC 101-2314-B-038-057) and by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-038-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Science Council, Executive Yuan, Taiwan (grant NSC 101-2314-B-038-057) and by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-038-009). We would like to thank all patients and their families who participated in this study. We also thank the staff from Chang Gung University and Chang Gung Memorial Hospital.	Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Bartkowiak K, 2012, CANCER MICROENVIRON, V5, P59, DOI 10.1007/s12307-011-0067-6; Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Berggren P, 2001, MUTAGENESIS, V16, P475, DOI 10.1093/mutage/16.6.475; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JY, 2009, CANCER CAUSE CONTROL, V20, P1769, DOI 10.1007/s10552-009-9416-x; Dahabreh IJ, 2010, CANCER EPIDEM BIOMAR, V19, P1840, DOI 10.1158/1055-9965.EPI-10-0156; Dakouras A, 2008, ANTICANCER RES, V28, P1039; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Fu L, 2013, CELL ONCOL, V36, P225, DOI 10.1007/s13402-013-0130-z; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Ihsan R, 2011, DNA CELL BIOL, V30, P163, DOI 10.1089/dna.2010.1119; Jones JS, 2004, CLIN CANCER RES, V10, P5845, DOI 10.1158/1078-0432.CCR-03-0590; Kamiza AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130018; Kruger S, 2005, J MED GENET, V42, P769, DOI 10.1136/jmg.2004.028506; Li YL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-607; Malakar M, 2014, ASIAN PAC J CANCER P, V15, P717, DOI 10.7314/APJCP.2014.15.2.717; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Perez LO, 2006, WORLD J GASTROENTERO, V12, P1426, DOI 10.3748/wjg.v12.i9.1426; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931; Sayhan N, 2001, RES COMMUN MOL PATH, V109, P25; SJALANDER A, 1995, CARCINOGENESIS, V16, P1461, DOI 10.1093/carcin/16.7.1461; Song HR, 2011, GASTRIC CANCER, V14, P242, DOI 10.1007/s10120-011-0034-4; Sotamaa K, 2005, CLIN CANCER RES, V11, P6840, DOI 10.1158/1078-0432.CCR-05-1139; Sprague BL, 2007, CARCINOGENESIS, V28, P1680, DOI 10.1093/carcin/bgm097; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Talseth BA, 2006, INT J CANCER, V118, P2479, DOI 10.1002/ijc.21661; Tan XL, 2007, PHARMACOGENET GENOM, V17, P639, DOI 10.1097/FPC.0b013e3280d5121c; Tang NP, 2010, EJSO-EUR J SURG ONC, V36, P431, DOI 10.1016/j.ejso.2010.03.010; Tang R, 2009, CLIN GENET, V75, P334, DOI 10.1111/j.1399-0004.2009.01162.x; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Xu H, 2001, Biotechnol Annu Rev, V7, P131, DOI 10.1016/S1387-2656(01)07035-1; Zahary MN, 2015, ONCOL LETT, V10, P3216, DOI 10.3892/ol.2015.3728; Zhu ZZ, 2007, JPN J CLIN ONCOL, V37, P385, DOI 10.1093/jjco/hym034	41	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167354	10.1371/journal.pone.0167354	http://dx.doi.org/10.1371/journal.pone.0167354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907203	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700126
J	Reis, ST; Viana, NI; Leite, KRM; Diogenes, E; Antunes, AA; Iscaife, A; Nesrallah, AJ; Passerotti, CC; Srougi, V; Pontes, J; Salles, ME; Nahas, WC; Srougi, M				Reis, Sabrina T.; Viana, Nayara I.; Leite, Katia R. M.; Diogenes, Erico; Antunes, Alberto A.; Iscaife, Alexandre; Nesrallah, Adriano J.; Passerotti, Carlo C.; Srougi, Victor; Pontes-Junior, Jose; Salles, Mary Ellen; Nahas, William C.; Srougi, Miguel			Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer	PLOS ONE			English	Article							GENOME-WIDE; ASSOCIATION; MULTIPLE; LOCI; RISK; VARIANTS	Backgrounds Our aim was to evaluate the role of 20 genetic polymorphisms in the development and prognosis of sporadic and familial PC. A case-control study of 185 patients who underwent radical prostatectomy from 1997 to 2011. These patients were divided into two groups based on their family history. Gleason grade, PSA value and pathological TNM 2002 stage were used as prognostic factors. Blood samples from 70 men without PC were used as controls. The SNPs were genotyped using a TaqMan SNP Genotyping Assay Kit. Results Considering susceptibility, the polymorphic allele in the SNP rs2660753 on chromosome 3 was significantly more prevalent in controls (p = 0.01). For familial clustering, the polymorphic homozygote genotype of the SNP rs7931342 was five times more frequent in patients with familial PC compared to sporadic PC (p = 0.01). Regarding the SNP 1447295, the polymorphic homozygote genotype was more prevalent in patients with organ-confined PC (p = 0.05), and most importantly, the polymorphic allele occurred more frequently in patients without biochemical recurrence (p = 0.01). Kaplan-Meier analysis showed a median biochemical recurrence free survival of 124.2 compared to 85.6 months for patients with the wild-type allele (p = 0.007). Conclusion Our findings provide the evidence for the association of 20 recently highlighted SNPs and their susceptibility, familial clustering, staging, Gleason score and biochemical recurrence of PC. We believe that the association between these SNPs and PC may contribute to the development of alternative tools that can facilitate the early detection and prognosis of this disease.	[Reis, Sabrina T.; Viana, Nayara I.; Leite, Katia R. M.; Diogenes, Erico; Antunes, Alberto A.; Iscaife, Alexandre; Passerotti, Carlo C.; Srougi, Victor; Pontes-Junior, Jose; Salles, Mary Ellen; Srougi, Miguel] Univ Sao Paulo, Sch Med, Dept Urol, Lab Med Invest LIM55, Sao Paulo, Brazil; [Nesrallah, Adriano J.; Pontes-Junior, Jose; Nahas, William C.] Univ Sao Paulo, Sch Med, Dept Urol, Urooncol Grp, Sao Paulo, Brazil; [Nesrallah, Adriano J.; Pontes-Junior, Jose; Nahas, William C.] ICESP, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Reis, ST (corresponding author), Univ Sao Paulo, Sch Med, Dept Urol, Lab Med Invest LIM55, Sao Paulo, Brazil.	sasareis@gmail.com	Pontes Junior, Jose/GOH-2262-2022; Antunes, Alberto Azoubel/AAT-2023-2020; Srougi, Miguel/AAT-8625-2021; Srougi, Miguel Srougi/AEV-2674-2022; Iscaife, Alexandre/I-8536-2012; LEITE, KATIA RM/C-2055-2008; Viana, Nayara I/P-6868-2015	Iscaife, Alexandre/0000-0001-6388-8228; LEITE, KATIA RM/0000-0002-2615-7730; Reis, Sabrina Thalita dos/0000-0002-3564-3597; Viana, Nayara/0000-0003-4505-8508	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/19258-5]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) under protocol number 2012/19258-5.	Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cody NAL, 2009, MOL CARCINOGEN, V48, P1077, DOI 10.1002/mc.20535; Cussenot O, 1996, PATHOL BIOL, V44, P737; Du MJ, 2015, HUM MOL GENET, V24, P154, DOI 10.1093/hmg/ddu426; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Liu H, 2011, PROSTATE, V71, P209, DOI 10.1002/pros.21235; MEIKLE AW, 1985, PROSTATE, V6, P121; Siegel RL, 2015, CA-CANCER J CLIN, V65, P457, DOI 10.3322/caac.21314; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simard J, 2002, ENDOCRINOLOGY, V143, P2029, DOI 10.1210/en.143.6.2029; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Teerlink CC, 2014, HUM GENET, V133, P347, DOI 10.1007/s00439-013-1384-2; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Zhang YR, 2012, ASIAN PAC J CANCER P, V13, P6273, DOI 10.7314/APJCP.2012.13.12.6273; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zhou Lin, 2011, Zhonghua Nan Ke Xue, V17, P682	21	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166380	10.1371/journal.pone.0166380	http://dx.doi.org/10.1371/journal.pone.0166380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906997	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700024
J	Rosso, OA; Ospina, R; Frery, AC				Rosso, Osvaldo A.; Ospina, Raydonal; Frery, Alejandro C.			Classification and Verification of Handwritten Signatures with Time Causal Information Theory Quantifiers	PLOS ONE			English	Article							COMPLEX NETWORK; DIVERGENCE; ENTROPY; SERIES; STATE	We present a new approach for handwritten signature classification and verification based on descriptors stemming from time causal information theory. The proposal uses the Shannon entropy, the statistical complexity, and the Fisher information evaluated over the Bandt and Pompe symbolization of the horizontal and vertical coordinates of signatures. These six features are easy and fast to compute, and they are the input to an One-Class Support Vector Machine classifier. The results are better than state-of-the-art online techniques that employ higher-dimensional feature spaces which often require specialized software and hardware. We assess the consistency of our proposal with respect to the size of the training sample, and we also use it to classify the signatures into meaningful groups.	[Rosso, Osvaldo A.] Univ Fed Alagoas UFAL, Inst Fis, Maceio, AL, Brazil; [Rosso, Osvaldo A.] ITBA, Buenos Aires, DF, Argentina; [Rosso, Osvaldo A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rosso, Osvaldo A.] Univ Los Andes, Fac Ingn & Ciencias Aplicadas, Santiago, Chile; [Ospina, Raydonal] Univ Fed Pernambuco UFPE, Dept Estatist, Ctr Ciencias Exatas & Nat, Recife, PE, Brazil; [Frery, Alejandro C.] Univ Fed Alagoas UFAL, Lab Comp Cient & Anal Numer, Maceio, AL, Brazil	Universidade Federal de Alagoas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de los Andes - Chile; Universidade Federal de Pernambuco; Universidade Federal de Alagoas	Rosso, OA (corresponding author), Univ Fed Alagoas UFAL, Inst Fis, Maceio, AL, Brazil.; Rosso, OA (corresponding author), ITBA, Buenos Aires, DF, Argentina.; Rosso, OA (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Rosso, OA (corresponding author), Univ Los Andes, Fac Ingn & Ciencias Aplicadas, Santiago, Chile.	oarosso@gmail.com	Ospina, Raydonal/I-8878-2012; Frery, Alejandro C./A-8855-2008; Rosso, Osvaldo/O-4929-2019	Ospina, Raydonal/0000-0002-9884-9090; Frery, Alejandro C./0000-0002-8002-5341; Rosso, Osvaldo/0000-0002-1288-2528	CONICET (Argentina); CNPq (Brazil) [447229/2014-1]; FACEPE (Brazil)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE (Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	The authors are grateful to CONICET (Argentina, OAR), CNPq (447229/2014-1, Brazil, ACF) and FACEPE (Brazil, RO) for partial funding of this research. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors are grateful to CONICET (Argentina), CNPq and FACEPE (Brazil) for partial funding of this research. The Biometrics Research Lab (ATVS), Universidad Autonoma de Madrid, provided the MCYT-100 signature corpus employed in this work.	Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; BARON R, 1989, IEEE T INSTRUM MEAS, V38, P1132, DOI 10.1109/19.46414; Bohner M., 2009, P 14 INT C DIFF EQ A, P291; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bouletreau V, 1998, INT C PATT RECOG, P1758, DOI 10.1109/ICPR.1998.712067; Campbell C., 2011, SYNTH, V5, P1, DOI [10.2200/S00324ED1V01Y201102AIM010, DOI 10.2200/S00324ED1V01Y201102AIM010]; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; El-Henawy I., 2013, INT J COMPUT TECHNOL, V4, P664; Fierrez J, 2007, PATTERN RECOGN LETT, V28, P2325, DOI 10.1016/j.patrec.2007.07.012; Fierrez-Aguilar J, 2005, LECT NOTES COMPUT SC, V3546, P523; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Garcia-Salicetti S, 2009, GUIDE BIOMETRIC REFE, P125; Ravetti MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108004; Goncalves BA, 2016, PHYSICA A IN PRESS; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; HILTON O, 1992, J FORENSIC SCI, V37, P125; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Houmani N., 2014, SIGNAL IMAGE PROCESS, P255, DOI [10.1007/978-3-642-54080-6_10, DOI 10.1007/978-3-642-54080-6_10]; Impedovo D, 2008, IEEE T SYST MAN CY C, V38, P609, DOI 10.1109/TSMCC.2008.923866; Leclerc F., 1994, International Journal of Pattern Recognition and Artificial Intelligence, V8, P643, DOI 10.1142/S0218001494000346; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Longstaff MG, 1999, HUM MOVEMENT SCI, V18, P485, DOI 10.1016/S0167-9457(99)00028-7; McCabe A., 1997, REV DYNAMIC HANDWRIT; Nalwa VS, 1997, P IEEE, V85, P215, DOI 10.1109/5.554220; Ortega-Garcia J, 2004, IEEE SIGNAL PROC MAG, V21, P50, DOI 10.1109/MSP.2004.1276113; Ortega-Garcia J, 2003, IEE P-VIS IMAGE SIGN, V150, P395, DOI 10.1049/ip-vis:20031078; Pascual-Gaspar JM, 2009, LECT NOTES COMPUT SC, V5558, P1180, DOI 10.1007/978-3-642-01793-3_119; PLAMONDON R, 1989, PATTERN RECOGN, V22, P107, DOI 10.1016/0031-3203(89)90059-9; Re MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093532; Richards J. A., 2006, REMOTE SENSING DIGIT, P439, DOI DOI 10.1007/3-540-29711-1; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2015, PAP PHYS-LA PLATA, V7, DOI 10.4279/PIP.070006; Sanchez-Moreno P, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/12/125305; Schieber TA, 2016, PHYS LETT A, V380, P359, DOI 10.1016/j.physleta.2015.10.055; VANDERGON JJ, 1965, KYBERNETIK, V2, P145; Vincent N, 2000, FRACTALS, V8, P85, DOI 10.1142/S0218348X0000010X; Zhang LP, 2016, IEEE GEOSC REM SEN M, V4, P22, DOI 10.1109/MGRS.2016.2540798; Zunino L, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/10005	43	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166868	10.1371/journal.pone.0166868	http://dx.doi.org/10.1371/journal.pone.0166868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907014	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700046
J	Roszko, ML; Karninska, M; Szymczyk, K; Jedrzejczak, R				Roszko, Marek Lukasz; Karninska, Marta; Szymczyk, Krystyna; Jedrzejczak, Renata			Levels of Selected Persistent Organic Pollutants (PCB, PBDE) and Pesticides in Honey Bee Pollen Sampled in Poland	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; NEONICOTINOID INSECTICIDES; APIS-MELLIFERA; POLYCHLORINATED-BIPHENYLS; GAS-CHROMATOGRAPHY; ORGANOCHLORINE PESTICIDES; EXPOSURE; RESIDUES; COLONY; IMPACT	Chemical plant protection is a commonly discussed factor potentially responsible for decline in pollinators and other beneficial insect populations. Various groups of chemicals including persistent organic pollutants could impact a bee colony's welfare and are reported to be present in bee tissue and apiary products. The aim of this work was to evaluate the presence of selected persistent organic pollutant and pesticide residues in bee pollen originating from different geographical regions of Poland. Pesticide residues were identified in 60% of tested bee pollen samples. The compounds identified were mainly active ingredients of fungicide preparations. Insecticide active ingredients were up to 30% of the identified residues. The triazole fungicide tebuconazole and the neonicotinoid insecticide thiacloprid were the most frequently found pesticides in pollen. The highest pesticide concentration was determined for prothioconazole (356 mu g kg(-1)). Mean concentrations of chlorinated biphenyls-EC6 and EC12 were 194 pg g(-1) and 74 pg g(-1), respectively. CB #28 has the greatest share in the EC6 profile (mean 61 pg g(-1), 31% contribution). Relatively high contributions were also observed for CBs # 101 (35 pg g(-1), 18%), # 138 (36 pg g(-1), 19%) and # 153 (33 pg g(-1), 17%). CB # 114 and 118 have the highest share in the dioxin-like biphenyls fraction with mean concentrations of 17.6 and 37.6 pg g(-1) (respectively 23 and 50%). Mean calculated concentrations of 39 polybrominated diphenyl ether congeners (S39 BDE) were 20 +/- 27.7 pg g(-1). High variability was observed between maximal and minimal determined concentration values. Individual BDEs were found at different frequencies and varying concentration levels. BDEs # 47, 75 and 99 dominated the profile with average concentrations of 3 pg g(-1), 3.1 pg g(-1), and 2.9 pg g(-1), respectively.	[Roszko, Marek Lukasz; Karninska, Marta; Szymczyk, Krystyna; Jedrzejczak, Renata] Inst Agr & Food Biotechnol, Dept Food Anal, Warsaw, Poland	Warsaw University of Life Sciences	Roszko, ML (corresponding author), Inst Agr & Food Biotechnol, Dept Food Anal, Warsaw, Poland.	roszko@ibprs.pl	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Szymczyk, Krystyna/0000-0001-6486-2660; Roszko, Marek/0000-0003-1848-2100				[Anonymous], 2013, SCIENCE, V340, P924, DOI 10.1126/science.340.6135.924-a; [Anonymous], 2013, OFFICIAL J EUROPEAN, V139, P12; [Anonymous], 2005, OFF J EUR UNION L, V70, P1; Balayannis PG, 2001, J APICULT RES, V40, P71, DOI 10.1080/00218839.2001.11101054; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; BROMENSHENK JJ, 1986, ENVIRON MONIT ASSESS, V6, P35, DOI 10.1007/BF00394286; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Codling G, 2016, CHEMOSPHERE, V144, P2321, DOI 10.1016/j.chemosphere.2015.10.135; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEST MANAG SCI, V70, P779, DOI 10.1002/ps.3613; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DEVILLERS J, 2002, HONEY BEES ESTIMATIN; Eckert JE, 1942, J ECON ENTOMOL, V35, P309, DOI 10.1093/jee/35.3.309; Elliott JE, 2015, SCI TOTAL ENVIRON, V524, P157, DOI 10.1016/j.scitotenv.2015.04.008; EP European Parliament, 2012, EXISTING SCIENTIFIC; EPA Environmental Protection Agency Health Canada Pest Management Regulatory Agency California Department of Pesticide Regulation, 2014, GUIDANCE FOR ASSESSI; Erdogrul O, 2007, FOOD CONTROL, V18, P866, DOI 10.1016/j.foodcont.2006.05.001; Europe Parlament and Council of European Union, 2009, OFF J EUR UNION, V309, P1; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Gekeler W, 2014, PORADNIK HODOWCY; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Giroud B, 2013, J CHROMATOGR A, V1316, P53, DOI 10.1016/j.chroma.2013.09.088; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; HC Health Canada, 2014, UPDATE ON NEONICOTIN; Herrera A, 2005, ANAL BIOANAL CHEM, V381, P695, DOI 10.1007/s00216-004-2924-3; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Jones-Otazo HA, 2005, ENVIRON SCI TECHNOL, V39, P5121, DOI 10.1021/es048267b; Kasiotis KM, 2014, SCI TOTAL ENVIRON, V485, P633, DOI 10.1016/j.scitotenv.2014.03.042; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kujawski MW, 2012, EUR FOOD RES TECHNOL, V234, P223, DOI 10.1007/s00217-011-1635-1; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Maini S, 2010, B INSECTOL, V63, P153; Medrzycki P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.14; Mohr S, 2014, SCI TOTAL ENVIRON, V472, P741, DOI 10.1016/j.scitotenv.2013.11.035; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; OPERA, 2013, BEE HLTH GROUP BEE H; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Porrini C., 2003, APIACTA, V38, P63, DOI DOI 10.1080/10942912.2015.1107578; Raeymaekers B, 2006, ENVIRON MONIT ASSESS, V116, P233, DOI 10.1007/s10661-006-7389-8; Rennich K, 2013, 2011 2012 NATIONAL H; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Roszko M, 2013, FOOD ADDIT CONTAM A, V30, P181, DOI 10.1080/19440049.2012.721012; Roszko M, 2015, ENVIRON SCI POLLUT R, V22, P18381, DOI 10.1007/s11356-015-5065-7; Roszko M, 2015, TALANTA, V144, P171, DOI 10.1016/j.talanta.2015.04.070; Roszko M, 2014, SCI TOTAL ENVIRON, V466, P136, DOI [10.1015/j.scitotenv.2013.07.016, 10.1016/j.scitotenv.2013.07.016]; Roszko M, 2013, ANAL CHIM ACTA, V799, P88, DOI 10.1016/j.aca.2013.08.053; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Sgolastra F, 2012, B INSECTOL, V65, P273; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Thompson H, 2013, FOOD AND ENVIRONMENT; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Tylianakis JM, 2013, SCIENCE, V339, P1532, DOI 10.1126/science.1235464; Wang J, 2010, FOOD RES INT, V43, P2329, DOI 10.1016/j.foodres.2010.08.006; Wang J, 2010, J AGR FOOD CHEM, V58, P3495, DOI 10.1021/jf904490g; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; WHO World Health Organization, 2009, CHLORPYRIFOS; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931	79	37	37	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167487	10.1371/journal.pone.0167487	http://dx.doi.org/10.1371/journal.pone.0167487			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907097	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700167
J	Meehan, TD; Gratton, C				Meehan, Timothy D.; Gratton, Claudio			A Landscape View of Agricultural Insecticide Use across the Conterminous US from 1997 through 2012	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; SPATIAL AUTOCORRELATION; NATURAL ENEMIES; SOYBEAN APHID; CROP PEST; SIMPLIFICATION; MODELS; BIODIVERSITY; MANAGEMENT; DIVERSITY	Simplification of agricultural landscapes is expected to have positive effects on many crop pests and negative effects on their natural enemies, potentially leading to increased pest pressure, decreased crop yield, and increased insecticide use. While many intermediate links in this causal chain have empirical support, there is mixed evidence for ultimate relationships between landscape simplification, crop yield, and insecticide use, especially at large spatial and temporal scales. We explored relationships between landscape simplification (proportion of a county in harvested cropland) and insecticide use (proportion of harvested cropland treated with insecticides), using county-level data from the US Census of Agriculture and a variety of standard and spatiotemporal regression techniques. The best model indicated that insecticide use across the US has increased between 1997 and 2012, was strongly dependent on the crops grown in a county, increased with average farm income and size, and increased with annual growing degree days. After accounting for those variables, and other unidentified spatial and temporal structure in the data, there remained a statistically significant, moderate, positive relationship between insecticide use and landscape simplification. These results lend general support to the causal chain outlined above, and to the notion that a landscape perspective is useful for managing ecosystem services that are provided by mobile organisms and valuable to agriculture.	[Meehan, Timothy D.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Meehan, Timothy D.] Natl Audubon Soc, Div Sci, Boulder, CO 80302 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Meehan, TD (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.; Meehan, TD (corresponding author), Natl Audubon Soc, Div Sci, Boulder, CO 80302 USA.	tmeehan@audubon.org		Gratton, Claudio/0000-0001-6262-9670	US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; US DOE OBP Office of Energy and Renewable Energy [DE-AC05-76RL01830]	US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); US DOE OBP Office of Energy and Renewable Energy(United States Department of Energy (DOE))	This work was funded by the US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) and by the US DOE OBP Office of Energy and Renewable Energy (DE-AC05-76RL01830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136580; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Altieri M. A., 1984, REV PLANT SCI, V2, P131, DOI DOI 10.1080/07352688409382193; [Anonymous], 2014, R LANG ENV STAT COMP; Anselin L, 1998, STAT TEXTB MONOG, V155, P237; Anselin L., 1988, PAP REG SCI ASSOC, V65, P34, DOI 10.1111/j.1435-5597.1988.tb01155.x; Bahlai CA, 2010, ENVIRON ENTOMOL, V39, P50, DOI 10.1603/EN09127; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Banerjee S., 2014, HIERARCHICAL MODELIN; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Bhar R., 1998, CONSERV ECOL, V2, P3; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bianchi FJJA, 2005, AGR ECOSYST ENVIRON, V107, P145, DOI 10.1016/j.agee.2004.11.007; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI [10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001]; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Burnham K. P., 1998, MODEL SELECTION INFE; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Congdon P., 2014, APPL BAYESIAN MODELL; Dale M.R.T., 2014, SPATIAL ANAL GUIDE E; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Ehler LE, 2006, PEST MANAG SCI, V62, P787, DOI 10.1002/ps.1247; Fausti SW, 2012, RENEW AGR FOOD SYST, V27, P295, DOI 10.1017/S1742170511000561; FLORAX R, 1992, REG SCI URBAN ECON, V22, P405, DOI 10.1016/0166-0462(92)90037-2; Franzese RJ, 2007, POLIT ANAL, V15, P140, DOI 10.1093/pan/mpm005; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x; Heimpel GE, 2010, BIOL INVASIONS, V12, P2913, DOI 10.1007/s10530-010-9736-5; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E, DOI DOI 10.1007/S13398-014-0173-7.2; Kuminoff NV, 2010, J ENVIRON ECON MANAG, V60, P145, DOI 10.1016/j.jeem.2010.06.001; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Larsen AE, 2015, ECOL APPL, V25, P1976, DOI 10.1890/14-1283.1; Larsen AE, 2013, P NATL ACAD SCI USA, V110, P15330, DOI 10.1073/pnas.1301900110; Leung Y, 2000, ENVIRON PLANN A, V32, P9, DOI 10.1068/a3162; Liere H, 2015, ECOL APPL, V25, P652, DOI 10.1890/14-0570.1; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lunn D., 2012, BUGS BOOK PRACTICAL; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Marino PC, 1996, ECOL APPL, V6, P276, DOI 10.2307/2269571; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Meehan TD, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114001; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Norris RF, 2000, WEED SCI, V48, P94, DOI 10.1614/0043-1745(2000)048[0094:IBWAPA]2.0.CO;2; PRICE PW, 1994, INTRO INSECT PEST MA, P35; PRISM Climate Group, 2012, US PREC NORM 1981 20; RUE H., 2005, GAUSSIAN MARKOV RAND; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Rusch A, 2016, AGR ECOSYST ENVIRON, V221, P198, DOI 10.1016/j.agee.2016.01.039; Saas Y, 2014, ECOGRAPHY, V37, P476, DOI 10.1111/j.1600-0587.2013.00279.x; Sexton SE, 2007, INT REV ENVIRON RESO, V1, P270, DOI 10.1561/101.00000007; Simpson D, 2011, ARXIV11052982; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; USDA CSREES, 2010, N CENTR REG SOYB APH; USDA-NASS, 2007, CENS AGR; Van Buskirk J, 2004, CONSERV BIOL, V18, P987, DOI 10.1111/j.1523-1739.2004.00359.x; Veres A, 2013, AGR ECOSYST ENVIRON, V166, P110, DOI 10.1016/j.agee.2011.05.027; Waller L.A., 2004, APPL SPATIAL STAT PU; Waller LA, 2007, STOCH ENV RES RISK A, V21, P573, DOI 10.1007/s00477-007-0139-9; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Yang W. R., 2015, Journal of Agricultural Science (Toronto), V7, P1	70	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166724	10.1371/journal.pone.0166724	http://dx.doi.org/10.1371/journal.pone.0166724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902726	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100034
J	Nosova, EY; Zimenkov, DV; Khakhalina, AA; Isakova, AI; Krylova, LY; Makarova, MV; Galkina, KY; Krasnova, MA; Safonova, SG; Litvinov, VI; Gryadunov, DA; Bogorodskaya, EM				Nosova, Elena Y.; Zimenkov, Danila V.; Khakhalina, Anastasia A.; Isakova, Alexandra I.; Krylova, Ludmila Y.; Makarova, Marina V.; Galkina, Ksenia Y.; Krasnova, Maria A.; Safonova, Svetlana G.; Litvinov, Vitaly I.; Gryadunov, Dmitry A.; Bogorodskaya, Elena M.			A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia	PLOS ONE			English	Article							RPOB MUTATIONS; MODERN SUBLINEAGE; SUSCEPTIBILITY; RIFAMPIN; STRAINS; COMPLEX; EPIDEMIOLOGY; BREAKPOINTS; DIAGNOSIS; THERAPY	Background The goal of this study was to compare the consistency of three assays for the determination of the drug resistance of Mycobacterium tuberculosis (MTB) strains with various resistance profiles isolated from the Moscow region. Methods A total of 144 MTB clinical isolates with a strong bias toward drug resistance were examined using Bactec MGIT 960, Sensititre MycoTB, and a microarray-based molecular assay TB-TEST to detect substitutions in the rpoB, katG, inhA, ahpC, gyrA, gyrB, rrs, eis, and embB genes that are associated with resistance to rifampin, isoniazid, fluoroquinolones, second-line injectable drugs and ethambutol. Results The average correlation for the identification of resistant and susceptible isolates using the three methods was approximately 94%. An association of mutations detected with variable resistance levels was shown. We propose a change in the breakpoint minimal inhibitory concentration for kanamycin to less than 5 mu g/ml in the Sensititre MycoTB system. A pairwise comparison of the minimal inhibitory concentrations (MICs) of two different drugs revealed an increased correlation in the first-line drug group and a partial correlation in the second-line drug group, reflecting the history of the preferential simultaneous use of drugs from these groups. An increased correlation with the MICs was also observed for drugs sharing common resistance mechanisms. Conclusions The quantitative measures of phenotypic drug resistance produced by the Sensititre MycoTB and the timely detection of mutations using the TB-TEST assay provide guidance for clinicians for the choice of the appropriate drug regimen.	[Nosova, Elena Y.; Khakhalina, Anastasia A.; Isakova, Alexandra I.; Krylova, Ludmila Y.; Makarova, Marina V.; Galkina, Ksenia Y.; Krasnova, Maria A.; Safonova, Svetlana G.; Litvinov, Vitaly I.; Bogorodskaya, Elena M.] Moscow Govt Hlth Dept, Moscow Res & Clin Ctr TB Control, Moscow, Russia; [Zimenkov, Danila V.; Gryadunov, Dmitry A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Zimenkov, DV (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	z@biochip.ru	Bogorodskaya, Elena/AAE-7936-2022; Gryadunov, Dmitry A/F-5251-2014; Zimenkov, Danila/S-3097-2019; Zimenkov, Danila/G-8151-2014	Bogorodskaya, Elena/0000-0003-4552-5022; Gryadunov, Dmitry A/0000-0003-3183-318X; Zimenkov, Danila/0000-0002-2040-0904; Zimenkov, Danila/0000-0002-2040-0904	Russian Science Foundation [14-50-00060]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (grant no. 14-50-00060).	Abuali MM, 2012, EUR J CLIN MICROBIOL, V31, P835, DOI 10.1007/s10096-011-1382-z; Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; BODMER T, 1995, J ANTIMICROB CHEMOTH, V35, P345, DOI 10.1093/jac/35.2.345; Bottger EC, 2011, CLIN MICROBIOL INFEC, V17, P1128, DOI 10.1111/j.1469-0691.2011.03551.x; Chen HY, 2012, J CLIN MICROBIOL, V50, P2085, DOI 10.1128/JCM.00652-12; Cynamon MH, 1999, ANTIMICROB AGENTS CH, V43, P2922, DOI 10.1128/AAC.43.12.2922; de Keijzer J, 2014, MOL CELL PROTEOMICS, V13, P2632, DOI 10.1074/mcp.M114.038380; Dominguez J, 2016, INT J TUBERC LUNG D, V20, P24, DOI 10.5588/ijtld.15.0221; Engstrom A, 2011, J ANTIMICROB CHEMOTH, V66, P1247, DOI 10.1093/jac/dkr109; Fillion A, 2013, ANTIMICROB AGENTS CH, V57, P4496, DOI 10.1128/AAC.00506-13; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09; Hall L, 2012, J CLIN MICROBIOL, V50, P3732, DOI 10.1128/JCM.02048-12; Haydel SE, 2010, PHARMACEUTICALS-BASE, V3, P2268, DOI 10.3390/ph3072268; Heysell SK, 2015, ANTIMICROB AGENTS CH, V59, P7104, DOI 10.1128/AAC.01117-15; Ho J, 2013, J ANTIMICROB CHEMOTH, V68, P2915, DOI 10.1093/jac/dkt284; Jagielski T, 2016, CLIN MICROBIOL REV, V29, P239, DOI 10.1128/CMR.00055-15; Joshi KR, 2014, DATABASE-OXFORD, DOI 10.1093/database/bat083; Kambli P, 2015, DIAGN MICR INFEC DIS, V82, P49, DOI 10.1016/j.diagmicrobio.2015.01.009; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Lee J, 2014, ANTIMICROB AGENTS CH, V58, P11, DOI 10.1128/AAC.01209-13; Malik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039754; McGrath M, 2014, J ANTIMICROB CHEMOTH, V69, P292, DOI 10.1093/jac/dkt364; Mokrousov I, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0613-3; Niward K, 2016, J ANTIMICROB CHEMOTH, V71, P333, DOI 10.1093/jac/dkv353; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Sampson SL, 2016, TRENDS MICROBIOL, V24, P82, DOI 10.1016/j.tim.2015.12.006; Sarathy JP, 2016, ACS INFECT DIS, V2, P552, DOI 10.1021/acsinfecdis.6b00051; Shah NS, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw150; Sharma M, 2011, J CLIN MICROBIOL, V49, P4112, DOI 10.1128/JCM.05195-11; Smith J, 2006, ANTIMICROB AGENTS CH, V50, P1570, DOI 10.1128/AAC.50.4.1570-1572.2006; Springer B, 2008, J CLIN MICROBIOL, V46, P4064, DOI 10.1128/JCM.01114-08; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Trauner A, 2014, DRUGS, V74, P1063, DOI 10.1007/s40265-014-0248-y; Van Deun A, 2015, INT J TUBERC LUNG D, V19, P185, DOI 10.5588/ijtld.14.0651; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; van Ingen J, 2011, INT J TUBERC LUNG D, V15, P990, DOI 10.5588/ijtld.10.0127; van Klingeren B, 2007, J CLIN MICROBIOL, V45, P2662, DOI 10.1128/JCM.00244-07; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Williamson DA, 2012, INT J TUBERC LUNG D, V16, P216, DOI 10.5588/ijtld.11.0178; World Health Organization, GLOB TUB REP 2014 WH; World Health organization, 2008, POL GUID DRUG SUSC T; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Yakrus MA, 2014, J CLIN MICROBIOL, V52, P1932, DOI 10.1128/JCM.00417-14; Yuen LKW, 1999, J CLIN MICROBIOL, V37, P3844, DOI 10.1128/JCM.37.12.3844-3850.1999; Zhang ZJ, 2014, ANTIMICROB AGENTS CH, V58, P5632, DOI 10.1128/AAC.02778-14; Zhang ZJ, 2014, J CLIN MICROBIOL, V52, P638, DOI 10.1128/JCM.02713-13; Zimenkov DV, 2016, J ANTIMICROB CHEMOTH, V71, P1520, DOI 10.1093/jac/dkw015	53	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167093	10.1371/journal.pone.0167093	http://dx.doi.org/10.1371/journal.pone.0167093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902737	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100050
J	Davidson, R; Pontasch, JA; Wu, JQ				Davidson, Reshma; Pontasch, Josef A.; Wu, Jian-Qiu			Sbg1 Is a Novel Regulator for the Localization of the beta-Glucan Synthase Bgs1 in Fission Yeast	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SCHIZOSACCHAROMYCES-POMBE; CONTRACTILE-RING; CELL-WALL; SACCHAROMYCES-CEREVISIAE; 1,3-BETA-GLUCAN SYNTHASE; CANDIDA-ALBICANS; POLARIZED GROWTH; SEPTUM FORMATION; ACTOMYOSIN RING	Glucan synthases synthesize glucans, complex polysaccharides that are the major components in fungal cell walls and division septa. Studying regulation of glucan synthases is important as they are essential for fungal cell survival and thus popular targets for anti-fungal drugs. Linear 1,3-beta-glucan is the main component of primary septum and is synthesized by the conserved beta-glucan synthase Bgs1 in fission yeast cytokinesis. It is known that Rho1 GTPase regulates Bgs1 catalytic activity and the F-BAR protein Cdc15 plays a role in Bgs1 delivery to the plasma membrane. Here we characterize a novel protein Sbg1 that is present in a complex with Bgs1 and regulates its protein levels and localization. Sbg1 is essential for contractile-ring constriction and septum formation during cytokinesis. Sbg1 and Bgs1 physically interact and are interdependent for localization to the plasma membrane. Bgs1 is less stable and/or mis-targeted to vacuoles in sbg1 mutants. Moreover, Sbg1 plays an earlier and more important role in Bgs1 trafficking and localization than Cdc15. Together, our data reveal a new mode of regulation for the essential beta-glucan synthase Bgs1 by the novel protein Sbg1.	[Davidson, Reshma; Pontasch, Josef A.; Wu, Jian-Qiu] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Wu, Jian-Qiu] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, JQ (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.; Wu, JQ (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	wu.620@osu.edu	Wu, Jian-qiu/G-6835-2012		National Institutes of Health [GM118746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (https://www.nih.gov/) grant GM118746 to J-QW.	Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Arasada R, 2015, J CELL SCI, V128, P2259, DOI 10.1242/jcs.162974; Arasada R, 2014, CELL REP, V8, P1533, DOI 10.1016/j.celrep.2014.07.048; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Basha A, 2013, CURR MED CHEM, V20, P4859, DOI 10.2174/092986732038131128102220; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; BROWN JL, 1993, GENETICS, V133, P837; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Coffman VC, 2013, J CELL BIOL, V203, P101, DOI 10.1083/jcb.201305022; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Cortes JCG, 2012, J CELL BIOL, V198, P637, DOI 10.1083/jcb.201202015; Davidson R, 2016, METHODS MOL BIOL, V1369, P9, DOI 10.1007/978-1-4939-3145-3_2; Davidson R, 2015, MOL BIOL CELL, V26, P453, DOI 10.1091/mbc.E14-07-1252; de Leon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071510; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Estravis Miguel, 2012, Commun Integr Biol, V5, P370, DOI 10.4161/cib.19977; Hayat M.A., 1986, BASIC TECHNIQUES TRA, V1st ed.; Hayat MA, 2000, PRINCIPLES TECHNIQUE, Vxix; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; Kurita T, 2012, THESIS, V287, P17415, DOI [10.1074/jbc.M111.321018, DOI 10.1074/JBC.M111.321018]; Lackner M, 2014, ANTIMICROB AGENTS CH, V58, P3626, DOI 10.1128/AAC.00123-14; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Lee DW, 1999, BBA-MOL CELL RES, V1450, P145, DOI 10.1016/S0167-4889(99)00041-5; Lee HH, 2002, FEMS MICROBIOL LETT, V208, P253, DOI 10.1016/S0378-1097(02)00463-9; Lee IJ, 2014, MOL BIOL CELL, V25, P2735, DOI 10.1091/mbc.E13-11-0699; Lee IJ, 2012, J CELL SCI, V125, P2973, DOI 10.1242/jcs.102574; Liu JH, 1999, GENETICS, V153, P1193; Liu JH, 2002, MOL BIOL CELL, V13, P989, DOI 10.1091/mbc.01-12-0581; Liu YJ, 2016, MOL BIOL CELL, V27, P2528, DOI 10.1091/mbc.E16-03-0156; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MANNERS DJ, 1973, BIOCHEM J, V135, P31, DOI 10.1042/bj1350031; Martins IM, 2011, J BIOL CHEM, V286, P3484, DOI 10.1074/jbc.M110.174300; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Munoz J, 2013, J CELL BIOL, V203, P265, DOI 10.1083/jcb.201304132; Nakamata K, 2007, J BIOL CHEM, V282, P34315, DOI 10.1074/jbc.M706486200; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Perez P, 2016, CELL MICROBIOL, V18, P1201, DOI 10.1111/cmi.12611; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Proctor SA, 2012, CURR BIOL, V22, P1601, DOI 10.1016/j.cub.2012.06.042; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sethi K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006383; SIETSMA JH, 1981, J GEN MICROBIOL, V125, P209; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Tang X, 2011, YEAST, V28, P205, DOI 10.1002/yea.1831; Thiyagarajan S, 2015, J CELL SCI, V128, P3672, DOI 10.1242/jcs.166926; Wang N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002437; Wang N, 2015, MOL BIOL CELL, V26, P238, DOI 10.1091/mbc.E14-07-1196; WATANABE S, 1988, J ELECTRON MICROSC, V37, P89; Wloka C, 2012, CYTOSKELETON, V69, P710, DOI 10.1002/cm.21046; WOODS A, 1989, J CELL SCI, V93, P491; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Ye YF, 2012, MOL BIOL CELL, V23, P1181, DOI 10.1091/mbc.E11-09-0800; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045324; Zhou Z, 2015, MOL BIOL CELL, V26, P78, DOI 10.1091/mbc.E14-10-1441; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167043	10.1371/journal.pone.0167043	http://dx.doi.org/10.1371/journal.pone.0167043			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898700	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000031
J	Jeurissen, MLJ; Walenbergh, SMA; Houben, T; Hendrikx, T; Li, JY; Oligschlaeger, Y; van Gorp, PJ; Gijbels, MJJ; Bitorina, A; Nessel, I; Radtke, F; Vooijs, M; Theys, J; Shiri-Sverdlov, R				Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Radtke, Freddy; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit			Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in LdIr(-/-) Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DELTA-LIKE 4; NOTCH LIGAND; MACROPHAGE ACTIVATION; ADAPTIVE IMMUNITY; QUANTITATIVE PCR; ATHEROSCLEROSIS; EXPRESSION; RECEPTORS; REGULATOR	Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (LdIr(-/-) mice reduces hepatic inflammation. Irradiated LdIr(-/-) mice were transplanted (tp) with bone marrow from wild type (Wt) or DLL4(f/f)LysMCre(+0) (DLL4(del)) mice and fed either chow or high fat, high cholesterol (HFC) diet for 11 weeks. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) of DLL4(f/f)LysM-Cre(WT) and DLL(f/f)LysMCre(+/0) mice. In contrast to our hypothesis, inflammation was not decreased in HFC-fed DLL4(del)-transplanted mice. In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrow derived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.	[Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Mol Genet, Maastricht, Netherlands; [Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Pathol, Maastricht, Netherlands; [Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Radiotherapy, Maastricht, Netherlands; [Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; Houben, Tom; Hendrikx, Tim; Li, Jieyi; Oligschlaeger, Yvonne; van Gorp, Patrick J.; Gijbels, Marion J. J.; Bitorina, Albert; Nessel, Isabell; Vooijs, Marc; Theys, Jan; Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, MAASTRO Sch Dev Biol & Oncol GROW, Maastricht, Netherlands; [Gijbels, Marion J. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Expt Vasc Biol, Amsterdam, Netherlands; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Expt Canc Res Inst, Lausanne, Switzerland	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Mol Genet, Maastricht, Netherlands.; Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Pathol, Maastricht, Netherlands.; Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Sch Cardiovasc Dis CARIM,Dept Radiotherapy, Maastricht, Netherlands.; Shiri-Sverdlov, R (corresponding author), Maastricht Univ, Med Ctr, MAASTRO Sch Dev Biol & Oncol GROW, Maastricht, Netherlands.	r.sverdlov@maastrichtuniversity.nl	Radtke, Freddy/Q-3198-2017; Hendrikx, Tim/AAI-8252-2021; Vooijs, Marc/K-3522-2019; Shiri-Sverdlov, Ronit/X-2642-2019; Theys, Jan/K-6685-2015; Hendrikx, Tim/AAE-2329-2020; Houben, Tom/T-1083-2017; van Gorp, Patrick/S-3892-2019; Theys, Jan/AAI-9211-2021; van Gorp, Patrick/L-9580-2018; Shiri-Sverdlov, Ronit/E-5571-2017	Radtke, Freddy/0000-0003-4315-4045; Hendrikx, Tim/0000-0002-3381-2107; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Houben, Tom/0000-0002-0441-3166; van Gorp, Patrick/0000-0002-0355-5349; Theys, Jan/0000-0002-9718-8251; van Gorp, Patrick/0000-0002-0355-5349; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Nessel, Isabell/0000-0001-6621-4149	Maag Lever Darm Stichting (MLDS) [WO 08-16, WO 11-35]; Netherlands Organisation for Scientific Research (NWO) [016.126.327, 015.008.043]; Cardiovascular Research Netherlands (CVON) IN-CONTROL grant [CVON 2012-03]	Maag Lever Darm Stichting (MLDS); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Cardiovascular Research Netherlands (CVON) IN-CONTROL grant	This research was supported by the Maag Lever Darm Stichting (MLDS) (WO 08-16 and WO 11-35), the Netherlands Organisation for Scientific Research (NWO) (Vidi grant number: 016.126.327) and (ASPASIA grant number:015.008.043), and by the Cardiovascular Research Netherlands (CVON) IN-CONTROL grant (CVON 2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Bi PP, 2015, TRENDS ENDOCRIN MET, V26, P248, DOI 10.1016/j.tem.2015.02.006; Bieghs V, 2013, GASTROENTEROLOGY, V144, P167, DOI 10.1053/j.gastro.2012.09.062; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hoebe KHN, 2001, AM J PHYSIOL-GASTR L, V280, pG720, DOI 10.1152/ajpgi.2001.280.4.G720; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopec KL, 2011, NUTR CLIN PRACT, V26, P565, DOI 10.1177/0884533611419668; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Lu RC, 2013, ONCOL LETT, V5, P845, DOI 10.3892/ol.2013.1113; Martinez JC, 2009, HISTOPATHOLOGY, V54, P598, DOI 10.1111/j.1365-2559.2009.03279.x; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Niida T, 2013, CIRCULATION, V128; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Portincasa Piero, 2005, Rom J Gastroenterol, V14, P43; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Shutter JR, 2000, GENE DEV, V14, P1313; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Valenti L, 2013, DIABETES, V62, P4052, DOI 10.2337/db13-0769; Yoshida T, 2013, CIRCULATION, V128; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167199	10.1371/journal.pone.0167199	http://dx.doi.org/10.1371/journal.pone.0167199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898698	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000037
J	Yao, W; Gan, Y; Myers, KM; Vink, JY; Wapner, RJ; Hendon, CP				Yao, Wang; Gan, Yu; Myers, Kristin M.; Vink, Joy Y.; Wapner, Ronald J.; Hendon, Christine P.			Collagen Fiber Orientation and Dispersion in the Upper Cervix of Non-Pregnant and Pregnant Women	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MECHANICAL-PROPERTIES; CONSTITUENTS; STROMA; MODEL	The structural integrity of the cervix in pregnancy is necessary for carrying a pregnancy until term, and the organization of human cervical tissue collagen likely plays an important role in the tissue's structural function. Collagen fibers in the cervical extracellular matrix exhibit preferential directionality, and this collagen network ultrastructure is hypothesized to reorient and remodel during cervical softening and dilation at time of parturition. Within the cervix, the upper half is substantially loaded during pregnancy and is where the premature funneling starts to happen. To characterize the cervical collagen ultrastructure for the upper half of the human cervix, we imaged whole axial tissue slices from non-pregnant and pregnant women undergoing hysterectomy or cesarean hysterectomy respectively using optical coherence tomography (OCT) and implemented a pixel-wise fiber orientation tracking method to measure the distribution of fiber orientation. The collagen fiber orientation maps show that there are two radial zones and the preferential fiber direction is circumferential in a dominant outer radial zone. The OCT data also reveal that there are two anatomic regions with distinct fiber orientation and dispersion properties. These regions are labeled: Region 1 the posterior and anterior quadrants in the outer radial zone and Region 2 the left and right quadrants in the outer radial zone and all quadrants in the inner radial zone. When comparing samples from nulliparous vs multiparous women, no differences in these fiber properties were noted. Pregnant tissue samples exhibit an overall higher fiber dispersion and more heterogeneous fiber properties within the sample than non-pregnant tissue. Collectively, these OCT data suggest that collagen fiber dispersion and directionality may play a role in cervical remodeling during pregnancy, where distinct remodeling properties exist according to anatomical quadrant.	[Yao, Wang; Myers, Kristin M.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Gan, Yu; Hendon, Christine P.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Vink, Joy Y.; Wapner, Ronald J.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY USA	Columbia University; Columbia University; Columbia University	Hendon, CP (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	cpf2115@columbia.edu	Myers, Kristin M/E-5689-2017	Myers, Kristin M/0000-0002-5989-0242; Wapner, Ronald/0000-0003-0727-1244; Gan, Yu/0000-0003-3409-3412	National Science Foundation [CMMI 1454412]; National Institutes of Health [1DP2HL127776-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD040485, K08HD088758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL127776] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was supported by the National Science Foundation CAREER award CMMI 1454412 (http://nsf.gov/awardsearch/showAward? AWD_1D=1454412) to KMM, National Institutes of Health 1DP2HL127776-01 (https://projectreporter nih.gov/project_description.cfm?projectnurnberz= 1DP2HL127776-01) to CPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by the National Science Foundation CAREER award (CMMI 1454412) to KMM and the National Institutes of Health (DP2) to CPH (1DP2HL127776-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation nor the National Institutes of Health.	ASPDEN RM, 1988, COLLAGEN REL RES, V8, P103; Bauer M, 2007, ANN NY ACAD SCI, V1101, P186, DOI 10.1196/annals.1389.004; Chue-Sang J, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.7.071109; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Feltovich H, 2013, ULTRASOUND OBST GYN, V41, P121, DOI 10.1002/uog.12383; Feltovich H, 2012, AM J OBSTET GYNECOL, V207, P345, DOI 10.1016/j.ajog.2012.05.015; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Fernandez M, 2016, COMPUT METHOD BIOMEC, V19, P404, DOI 10.1080/10255842.2015.1033163; Fleming CP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937470; Gan Y, 2014, ENG MED BIOL SOC EMB; Gan Y, 2015, BIOMED OPT EXPRESS, V6, P1090, DOI 10.1364/BOE.6.001090; Gan Y, 2013, BIOMED OPT EXPRESS, V4, P2150, DOI 10.1364/BOE.4.002150; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; House M, 2009, SEMIN PERINATOL, V33, P300, DOI 10.1053/j.semperi.2009.06.002; House M, 2009, EUR J OBSTET GYN R B, V144, pS65, DOI 10.1016/j.ejogrb.2009.02.027; Kang W, 2011, MED PHYS, V38, P107, DOI 10.1118/1.3523098; Karlon WJ, 1998, ANAT RECORD, V252, P612, DOI 10.1002/(SICI)1097-0185(199812)252:4<612::AID-AR12>3.0.CO;2-1; KIRBY MC, 1988, J APPL CRYSTALLOGR, V21, P929, DOI 10.1107/S0021889888008040; Lee SW, 2008, OPT EXPRESS, V16, P2709, DOI 10.1364/OE.16.002709; Liu ZY, 2015, BIOMED OPT EXPRESS, V6, P2294, DOI 10.1364/BOE.6.002294; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; Myers KM, 2015, J BIOMECH, V48, P1511, DOI 10.1016/j.jbiomech.2015.02.065; Myers KM, 2015, J BIOMECH, V48, P1533, DOI 10.1016/j.jbiomech.2015.02.060; Orfanoudaki IM, 2011, ARCH GYNECOL OBSTET, V284, P1197, DOI 10.1007/s00404-011-2009-4; Quinn KP, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046003; Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845; Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508; Sacks MS, 1998, J BIOMED MATER RES, V41, P131, DOI 10.1002/(SICI)1097-4636(199807)41:1<131::AID-JBM16>3.0.CO;2-Q; Stoff S, 2016, CERVICAL COLLAGEN IM; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Weiss S, 2006, ANAT REC PART A, V288A, P84, DOI 10.1002/ar.a.20274; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; WOLMAN M, 1975, J HISTOCHEM CYTOCHEM, V23, P21, DOI 10.1177/23.1.1090645; Yao W, 2014, J MECH BEHAV BIOMED, V34, P18, DOI 10.1016/j.jmbbm.2014.01.016; Yao XW, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.061006; Yaqoob Z, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2400214; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109; Zork NM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.09.036; Zysk AM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793736	39	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166709	10.1371/journal.pone.0166709	http://dx.doi.org/10.1371/journal.pone.0166709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898677	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000015
J	Dong, JS; Li, JW; Zhou, GC; Peng, Z; Li, JJ; Lin, SZ; Liu, HH; Wu, CL; Huang, YJ; Lv, XL; Dai, SM				Dong, Jiashu; Li, Jinwan; Zhou, Gechen; Peng, Zheng; Li, Jingjing; Lin, Shengzhang; Liu, Haihua; Wu, Chunlin; Huang, Yujie; Lv, Xiaolan; Dai, Shengming			No Association between TNF-alpha-308G/A Polymorphism and Idiopathic Recurrent Miscarriage: A Systematic Review with Meta-Analysis and Trial Sequential Analysis	PLOS ONE			English	Review							TUMOR-NECROSIS-FACTOR; CYTOKINE GENE POLYMORPHISMS; PREGNANCY LOSS; FACTOR-ALPHA; SPONTANEOUS-ABORTION; TNF-ALPHA; PROMOTER POLYMORPHISMS; MATERNAL AGE; WOMEN; POPULATION	Background Conflicting results were reported on the association between the TNF-alpha-308G/A polymorphism and idiopathic recurrent miscarriage (IRM). Though three meta-analyses have been conducted on this topic, the conclusions were contradictory, and the results may be unreliable as certain crucial conditions were neglected. Method A complete search was conducted in PubMed, Cochrane Library, and Embase, other sources like Google Scholar, ClinicalTrial.gov and reference lists of relevant articles were also retrieved. All candidate articles were accessed and screened using specific inclusion and exclusion criteria. Statistical analyses were performed on data extracted from eligible studies using the STATA 12.0 software and the TSA 0.9 beta software. Results Eventually, 12 case-control studies from 11 publications (with 1,807 cases and 2,012 controls) were included in this meta-analysis, and no evidence of any significant association was found in the overall analyses between the TNF-alpha-308G/A polymorphism and IRM risk. However, significant association was shown in Asian population (four studies from three publications) in the dominant model (AA + GA vs. GG), the allelic model (A vs. G), and the heterozygote model (GA vs. GG). Conclusions TNF-alpha-308G/A polymorphism is not associated with IRM risk. Though significant association was found in Asian population, the result needs further confirmation from more studies.	[Dong, Jiashu; Li, Jinwan; Zhou, Gechen; Peng, Zheng; Lin, Shengzhang; Liu, Haihua; Wu, Chunlin; Huang, Yujie; Dai, Shengming] Guangxi Med Univ, Affiliated Hosp 4, Dept Clin Lab, Guangxi, Liuzhou, Peoples R China; [Li, Jingjing] Guangxi Med Univ, Affiliated Hosp 4, Dept Obstet & Gynaecol, Liuzhou, Guangxi, Peoples R China; [Lv, Xiaolan] Liuzhou Matern & Child Hlth Care Hosp, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Dai, SM (corresponding author), Guangxi Med Univ, Affiliated Hosp 4, Dept Clin Lab, Guangxi, Liuzhou, Peoples R China.	daishm@sina.com	Peng, Zheng/ABH-3205-2021	Peng, Zheng/0000-0001-9117-840X				Alkhuriji AE, 2013, SAUDI MED J, V34, P484; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Babbage SJ, 2001, J REPROD IMMUNOL, V51, P21, DOI 10.1016/S0165-0378(01)00069-9; Baxter N, 2001, CLIN EXP IMMUNOL, V126, P529, DOI 10.1046/j.1365-2249.2001.01663.x; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Bompeixe EP, 2013, INT J IMMUNOGENET, V40, P186, DOI 10.1111/j.1744-313X.2012.01155.x; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P825, DOI 10.1016/j.jclinepi.2008.08.010; Brigham SA, 1999, HUM REPROD, V14, P2868, DOI 10.1093/humrep/14.11.2868; Carrington B, 2005, CURR OPIN OBSTET GYN, V17, P591, DOI 10.1097/01.gco.0000194112.86051.26; Choi YK, 2008, AM J REPROD IMMUNOL, V60, P91, DOI 10.1111/j.1600-0897.2008.00602.x; Daher S, 2003, J REPROD IMMUNOL, V58, P69, DOI 10.1016/S0165-0378(02)00059-1; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Finan RR, 2010, J REPROD IMMUNOL, V84, P186, DOI 10.1016/j.jri.2009.12.005; FRIEDMAN T, 1989, BRIT J PSYCHIAT, V155, P810, DOI 10.1192/bjp.155.6.810; Gupta R, 2012, CYTOKINE, V60, P456, DOI 10.1016/j.cyto.2012.05.018; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Kamali-Sarvestani B, 2005, J REPROD IMMUNOL, V65, P171, DOI 10.1016/j.jri.2005.01.008; Kaur Amrit, 2011, J Hum Reprod Sci, V4, P91, DOI 10.4103/0974-1208.86090; Kulinskaya E, 2014, RES SYNTH METHODS, V5, P212, DOI 10.1002/jrsm.1104; Kwak-Kim JYH, 2005, CHEM IMMUNOL ALLERGY, V88, P64, DOI 10.1159/000087821; Lee BE, 2013, REPROD SCI, V20, P408, DOI 10.1177/1933719112459237; Li HH, 2016, REPROD BIOL ENDOCRIN, V14, P1, DOI 10.1186/s12958-016-0140-6; Liu CM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-114; Liu RX, 2015, INT J CLIN EXP MED, V8, P9786; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Makhseed M, 2001, HUM REPROD, V16, P2219, DOI 10.1093/humrep/16.10.2219; MALLMANN P, 1991, ARCH GYNECOL OBSTET, V249, P73, DOI 10.1007/BF02390365; Medica I, 2009, REPROD BIOMED ONLINE, V19, P406, DOI 10.1016/S1472-6483(10)60176-9; Mekinian A, 2011, EUR CYTOKINE NETW, V22, P88, DOI 10.1684/ecn.2011.0285; MILLER J, 1980, LANCET, V316, P554; Namipashaki A, 2015, CELL J, V17, P187; Palmirotta R, 2010, REPROD SCI, V17, P659, DOI 10.1177/1933719110366603; Peng Z, 2016, AM J REPROD IMMUNOL, V75, P162, DOI 10.1111/aji.12467; Pietrowski D, 2004, J REPROD IMMUNOL, V61, P51, DOI 10.1016/j.jri.2003.12.001; Prigoshin N, 2004, AM J REPROD IMMUNOL, V52, P36, DOI 10.1111/j.1600-0897.2004.00179.x; Quintero-Ramos Antonio, 2006, Gac Med Mex, V142, P95; Raghupathy R., 2001, PREGNANCY SUCCESS FA, P219; Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Reid JG, 2001, AM J REPROD IMMUNOL, V45, P35, DOI 10.1111/j.8755-8920.2001.450106.x; Saini V, 2011, CLIN CHIM ACTA, V412, P702, DOI 10.1016/j.cca.2011.01.002; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Sudhir Neha, 2016, J Hum Reprod Sci, V9, P86, DOI 10.4103/0974-1208.183516; Vitoratos N, 2006, MEDIATORS INFLAMMATI, V2006; Walia GK, 2008, INT J HUM GENET, V8, P227, DOI 10.1080/09723757.2008.11886033; Wilcox A J, 1990, Epidemiology, V1, P382, DOI 10.1097/00001648-199009000-00008; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilczynski JR, 2005, EUR J OBSTET GYN R B, V122, P136, DOI 10.1016/j.ejogrb.2005.03.008; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; YUI J, 1994, PLACENTA, V15, P819, DOI 10.1016/S0143-4004(05)80184-5; Zammiti W, 2008, REPRODUCTION, V135, P397, DOI 10.1530/REP-07-0322; Zammiti W, 2009, FERTIL STERIL, V91, P1903, DOI 10.1016/j.fertnstert.2008.01.090; Zhang BZ, 2012, HUM IMMUNOL, V73, P574, DOI 10.1016/j.humimm.2012.01.008	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166892	10.1371/journal.pone.0166892	http://dx.doi.org/10.1371/journal.pone.0166892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893839	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400052
J	Bruske, EI; Dimonte, S; Enderes, C; Tschan, S; Flotenmeyer, M; Koch, I; Berger, J; Kremsner, P; Frank, M				Bruske, Ellen Inga; Dimonte, Sandra; Enderes, Corinna; Tschan, Serena; Floetenmeyer, Matthias; Koch, Iris; Berger, Juergen; Kremsner, Peter; Frank, Matthias			In Vitro Variant Surface Antigen Expression in Plasmodium falciparum Parasites from a Semi-Immune Individual Is Not Correlated with Var Gene Transcription	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; FREQUENT RECOMBINATION EVENTS; SEVERE CHILDHOOD MALARIA; BRAIN ENDOTHELIAL-CELLS; INFECTED ERYTHROCYTES; ACQUIRED-IMMUNITY; DIFFERENTIAL EXPRESSION; ANTIBODY RECOGNITION; EPIGENETIC MEMORY; VIRULENCE GENES	Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is considered to be the main variant surface antigen (VSA) of Plasmodium falciparum and is mainly localized on electron-dense knobs in the membrane of the infected erythrocyte. Switches in PfEMP1 expression provide the basis for antigenic variation and are thought to be critical for parasite persistence during chronic infections. Recently, strain transcending anti-PfEMP1 immunity has been shown to develop early in life, challenging the role of PfEMP1 in antigenic variation during chronic infections. In this work we investigate how P. falciparum achieves persistence during a chronic asymptomatic infection. The infected individual (MOA) was parasitemic for 42 days and multilocus vargene genotyping showed persistence of the same parasite population throughout the infection. Parasites from the beginning of the infection were adapted to tissue culture and cloned by limiting dilution. Flow cytometry using convalescent serum detected a variable surface recognition signal on isogenic clonal parasites. Quantitative real-time PCR with a field isolate specific vargene primer set showed that the surface recognition signal was not correlated with transcription of individual vargenes. Strain transcending anti-PfEMP1 immunity of the convalescent serum was demonstrated with CD36 selected and PfEMP1 knock-down NF54 clones. In contrast, knock-down of PfEMP1 did not have an effect on the antibody recognition signal in MOA clones. Trypsinisation of the membrane surface proteins abolished the surface recognition signal and immune electron microscopy revealed that antibodies from the convalescent serum bound to membrane areas without knobs and with knobs. Together the data indicate that PfEMP1 is not the main variable surface antigen during a chronic infection and suggest a role for trypsin sensitive non-PfEMP1 VSAs for parasite persistence in chronic infections.	[Bruske, Ellen Inga; Dimonte, Sandra; Enderes, Corinna; Tschan, Serena; Kremsner, Peter; Frank, Matthias] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Kremsner, Peter; Frank, Matthias] CERMEL Ctr Rech Med Lambarene, Lambarene, Gabon; [Floetenmeyer, Matthias; Koch, Iris; Berger, Juergen] Max Planck Inst Dev Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Frank, M (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.; Frank, M (corresponding author), CERMEL Ctr Rech Med Lambarene, Lambarene, Gabon.	Matthias.Frank@praxis-frank-tuebingen.de	Mordmuller, Benjamin/A-5749-2010	Mordmuller, Benjamin/0000-0001-9101-2768; Floetenmeyer, Matthias/0000-0002-0133-1632; Dimonte, Sandra/0000-0002-4612-4979	BMBF of the German ministry for education and research (BMBF) [01KA110]; GIF of the German Israeli Foundation [997/2008]; BMBF [01KA1101]; Landesgraduiertenforderung Baden-Wurtemberg; GIF [997/2008]	BMBF of the German ministry for education and research (BMBF); GIF of the German Israeli Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); Landesgraduiertenforderung Baden-Wurtemberg; GIF(German-Israeli Foundation for Scientific Research and Development)	his work was funded by BMBF-grant 01KA110 of the German ministry for education and research (BMBF) and GIF-Research Project No. 997/2008 of the German Israeli Foundation to MFrank. SD, EB and MFrank received salary support through the BMBF-grant 01KA1101. CE was the recipient of a PhD scholarship by the Landesgraduiertenforderung Baden-Wurtemberg. CE and SD received additional salary support through GIF-Research Project No. 997/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MS, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.2.0700179; Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; Abdi AI, 2016, SCI REP, P6; Avraham I, 2012, P NATL ACAD SCI USA, V109, pE3678, DOI 10.1073/pnas.1214572109; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Bachmann A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005538; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barry AE, 2007, PLOS PATHOG, P3; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Chan JA, 2016, CELL MOL LIFE SCI, V73, P4141, DOI 10.1007/s00018-016-2267-1; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Claessens A, 2014, PLOS GENET, P10; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Dimonte S, 2016, J INFECT DIS, V214, P884, DOI 10.1093/infdis/jiw225; Dzikowski R, 2006, PLOS PATHOG, P2; Dzikowski R, 2008, J MOL BIOL, V382, P288, DOI 10.1016/j.jmb.2008.07.015; EDOZIEN JC, 1962, LANCET, V280, P951; Enderes C, 2011, J INFECT DIS, V204, P1620, DOI 10.1093/infdis/jir594; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Frank M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-304; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gannoun-Zaki L, 2005, EUKARYOT CELL, V4, P490, DOI 10.1128/EC.4.2.490-492.2005; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lau CKY, 2015, CELL HOST MICROBE, V17, P118, DOI 10.1016/j.chom.2014.11.007; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Mordmuller B, 2015, MALARIA J, P14; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Niang M, 2009, PLOS PATHOG, P5; Niang M, 2014, CELL HOST MICROBE, V16, P81, DOI 10.1016/j.chom.2014.06.004; Nielsen MA, 2004, INFECT IMMUN, V72, P3531, DOI 10.1128/IAI.72.6.3531-3535.2004; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; R Development Core Team, 2009, R A LANGUAGE AND ENV; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001306; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rupp I, 2011, CELL RES, V21, P683, DOI 10.1038/cr.2010.176; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Smith JD, 2013, CELL MICROBIOL, P15; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Stanisic DI, 2016, INFECT IMMUN; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Tonkin CJ, 2009, PLOS BIOL, P7; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	90	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166135	10.1371/journal.pone.0166135	http://dx.doi.org/10.1371/journal.pone.0166135			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907004	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700016
J	De Gasperi, R; Graham, ZA; Harlow, LM; Bauman, WA; Qin, WP; Cardozo, CP				De Gasperi, Rita; Graham, Zachary A.; Harlow, Lauren M.; Bauman, William A.; Qin, Weiping; Cardozo, Christopher P.			The Signature of MicroRNA Dysregulation in Muscle Paralyzed by Spinal Cord Injury Includes Downregulation of MicroRNAs that Target Myostatin Signaling	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SKELETAL-MUSCLE; GENE-EXPRESSION; ATROPHY; CITED2; MIR-145; PROTEIN; IDENTIFICATION; RECEPTOR; DISUSE	Spinal cord injury (SCI) results in muscle atrophy, reduced force generation and an oxidative-to-glycolytic fiber type shift. The mechanisms responsible for these alterations remain incompletely understood. To gain new insights regarding mechanisms involved in deterioration of muscle after SCI, global expression profiles of miRs in paralyzed gastrocnemius muscle were compared between sham-operated (Sham) and spinal cord-transected (SCI) rats. Ingenuity Pathways Analysis of the altered miRs identified signaling via insulin, IGF-1, integrins and TGF-beta as being significantly enriched for target genes. By qPCR, miRs 23a, 23b, 27b, 145, and 206, were downregulated in skeletal muscle 56 days after SCI. Using FISH, miR-145, a miR not previously implicated in the function of skeletal muscle, was found to be localized to skeletal muscle fibers. One predicted target of miR-145 was Cited2, a transcriptional regulator that modulates signaling through NF-KB, Smad3 and other transcription factors. The 3' UTR of Cited2 mRNA contained a highly conserved miR-145 seed sequence. Luciferase reporter assays confirmed that miR-145 interacts with this seed sequence. However, Cited2 protein levels were similar between Sham and SCI groups, indicating a biochemical interaction that was not involved in the context of adaptations after SCI. Taken together, the findings indicate dysregulation of several highly expressed miRs in skeletal muscle after SCI and suggest that reduced expression of miR-23a, 145 and 206 may have roles in alteration in skeletal muscle mass and insulin responsiveness in muscle paralyzed by upper motor neuron injuries.	[De Gasperi, Rita; Graham, Zachary A.; Harlow, Lauren M.; Bauman, William A.; Qin, Weiping; Cardozo, Christopher P.] James J Peters Med Ctr, VA RR&D Serv Natl Ctr Med Consequences Spinal Cor, Bronx, NY 10468 USA; [De Gasperi, Rita] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Graham, Zachary A.; Bauman, William A.; Qin, Weiping; Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Bauman, William A.; Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [De Gasperi, Rita] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cardozo, CP (corresponding author), James J Peters Med Ctr, VA RR&D Serv Natl Ctr Med Consequences Spinal Cor, Bronx, NY 10468 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	chris.cardozo@mssm.edu	Cardozo, Christopher/R-6021-2019	Cardozo, Christopher/0000-0003-4013-2537; Graham, Zachary/0000-0002-6506-7025	VA Rehabilitation and Research Development Grant [B9212C]	VA Rehabilitation and Research Development Grant	VA Rehabilitation and Research Development Grant B9212C to WAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by Veterans Affairs RR&D Service National Center Grant B9212-C to W.A.B.	Adams CM, 2011, MUSCLE NERVE, V43, P65, DOI 10.1002/mus.21831; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Biering-Sorensen B, 2009, MUSCLE NERVE, V40, P499, DOI 10.1002/mus.21391; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Cea LA, 2013, P NATL ACAD SCI USA, V110, P16229, DOI 10.1073/pnas.1312331110; Cha MJ, 2013, BIOCHEM BIOPH RES CO, V435, P720, DOI 10.1016/j.bbrc.2013.05.050; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Dudley-Javoroski S, 2008, J REHABIL RES DEV, V45, P283, DOI 10.1682/JRRD.2007.02.0031; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Graham ZA, 2015, SPINAL CORD; Hitachi K, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00408; Huang HP, 2015, TUMOR BIOL, V36, P4123, DOI 10.1007/s13277-015-3046-6; Huang QK, 2016, MED SCI MONITOR, V22, P1161, DOI 10.12659/MSM.897909; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Kirby TJ, 2015, FRONT BIOSCI-LANDMRK, V20, P37, DOI 10.2741/4298; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lee JY, 2009, BIOCHEM BIOPH RES CO, V387, P641, DOI 10.1016/j.bbrc.2009.07.029; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leong DJ, 2011, FASEB J, V25, P182, DOI 10.1096/fj.10-164277; Li Q, 2014, J BIOL CHEM, V289, P251, DOI 10.1074/jbc.M113.497594; Li Q, 2012, J BIOL CHEM, V287, P29088, DOI 10.1074/jbc.M112.378034; Li Rong, 2012, J WUHAN U SCI EDIT S, VS2, P145, DOI DOI 10.1371/J0URNAL.P0NE.0044907; Li RT, 2013, FEBS LETT, V587, P1754, DOI 10.1016/j.febslet.2013.04.018; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2011, J APPL PHYSIOL, V110, P1204, DOI 10.1152/japplphysiol.00686.2010; Lou XW, 2011, J IMMUNOL, V186, P539, DOI 10.4049/jimmunol.1001650; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Megiorni F, 2013, J CYST FIBROS, V12, P797, DOI 10.1016/j.jcf.2013.03.007; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Raychaudhuri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034596; Rezen T, 2014, ACTA PHYSIOL, V210, P655, DOI 10.1111/apha.12228; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Sato S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00018; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Tobimatsu K, 2009, BIOCHEM BIOPH RES CO, V378, P399, DOI 10.1016/j.bbrc.2008.11.062; Urso ML, 2007, J PHYSIOL-LONDON, V579, P877, DOI 10.1113/jphysiol.2006.118042; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wiberg R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142699; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wu Y, 2011, SPINAL CORD, V49, P867, DOI 10.1038/sc.2011.28; Wu Y, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-81; Wu Y, 2012, J NEUROTRAUM, V29, P1663, DOI 10.1089/neu.2011.2203; Xu B, 2008, DEV BIOL, V317, P95, DOI 10.1016/j.ydbio.2008.02.019; Yan GJ, 2012, FEBS LETT, V586, P3263, DOI 10.1016/j.febslet.2012.06.048; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5	63	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166189	10.1371/journal.pone.0166189	http://dx.doi.org/10.1371/journal.pone.0166189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907012	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700018
J	Liu, XJ; Qian, WS; Jin, RC; Li, X; Luk, KDK; Wu, EX; Hu, Y				Liu, Xiaojia; Qian, Wenshu; Jin, Richu; Li, Xiang; Luk, Keith D. K.; Wu, Ed. X.; Hu, Yong			Amplitude of Low Frequency Fluctuation (ALFF) in the Cervical Spinal Cord with Stenosis: A Resting State fMRI Study	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; LINE BRAIN ACTIVITY; SPONDYLOTIC MYELOPATHY; SIGNAL INTENSITY; NEURONAL-ACTIVITY; COMPRESSION; PLASTICITY; PROGNOSIS; DIAGNOSIS; SURGERY	Cervical spondylotic myelopathy (CSM) is a common spinal cord dysfunction disease with complex symptoms in clinical presentation. Resting state fMRI (rsfMRl) has been introduced to study the mechanism of neural development of CSM. However, most of those studies focused on intrinsic functional connectivity rather than intrinsic regional neural activity level which is also frequently analyzed in rsfMRl studies. Thus, this study aims to explore whether the level of neural activity changes on the myelopathic cervical cord and evaluate the possible relationship between this change and clinical symptoms through amplitude of low frequency fluctuation (ALFF). Eighteen CSM patients and twenty five healthy subjects participated in rsfMRl scanning. ALFF was investigated on each patient and subject. The results suggested that ALFF values were higher in the CSM patients at all cervical segments, compared to the healthy controls. The severity of myelopathy was associated with the increase of ALFF. This finding would enrich our understanding on the neural development mechanism of CSM.	[Liu, Xiaojia; Qian, Wenshu; Jin, Richu; Li, Xiang; Luk, Keith D. K.; Hu, Yong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Liu, Xiaojia; Wu, Ed. X.] Univ Hong Kong, Fac Engn, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China; [Hu, Yong] Guangdong Med Univ, Affiliated Hosp, Dept Orthopaed, Spinal Div, Zhanjiang, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Guangdong Medical University	Hu, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.; Hu, Y (corresponding author), Guangdong Med Univ, Affiliated Hosp, Dept Orthopaed, Spinal Div, Zhanjiang, Guangdong, Peoples R China.	yhud@hku.hk	; Hu, Yong/C-4276-2009; Wu, Ed Xuekui/C-1579-2009	Jin, Richu/0000-0002-7015-5302; Hu, Yong/0000-0003-0305-5616; Wu, Ed Xuekui/0000-0001-5581-1546	Research Grants Council of Hong Kong [HKU 774211M]; National Science Foundation of China [81572193]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Research Grants Council of Hong Kong (HKU 774211M) and the National Science Foundation of China (81572193). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avadhani A, 2010, SPINE J, V10, P475, DOI 10.1016/j.spinee.2010.03.024; Barry RL, 2014, ELIFE, V3, DOI 10.7554/eLife.02812; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Chen CJ, 2001, RADIOLOGY, V221, P789, DOI 10.1148/radiol.2213010365; Chen LM, 2015, P NATL ACAD SCI USA, V112, P5991, DOI 10.1073/pnas.1424106112; COOPER PR, 1985, J NEUROSURG, V63, P492, DOI 10.3171/jns.1985.63.4.0492; Dalitz K, 2008, SPINE J; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Dong MH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00099; Ganzetti M, 2013, NEUROSCIENCE, V240, P297, DOI 10.1016/j.neuroscience.2013.02.032; Giove F, 2004, MAGN RESON IMAGING, V22, P1505, DOI 10.1016/j.mri.2004.10.015; HARSH GR, 1987, J NEUROSURG, V67, P349, DOI 10.3171/jns.1987.67.3.0349; Henson JW, 2010, NEUROLOGY, V74, pE53, DOI 10.1212/WNL.0b013e3181d7b472; HERDMANN J, 1994, ADV NEUROS, V22, P266; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kim HJ, 2013, SPINE, V38, pS78, DOI 10.1097/BRS.0b013e3182a7eb06; Kong YZ, 2014, P NATL ACAD SCI USA, V111, P18067, DOI 10.1073/pnas.1414293111; LAW MD, 1993, YALE J BIOL MED, V66, P165; Li JF, 2013, ARCH ORTHOP TRAUM SU, V133, P745, DOI 10.1007/s00402-013-1719-4; Li X, 2014, SPINE, V39, pE615, DOI 10.1097/BRS.0000000000000288; Madi S, 2001, AM J NEURORADIOL, V22, P1768; MEHALIC TF, 1990, NEUROSURGERY, V26, P217, DOI 10.1227/00006123-199002000-00006; Meier J, 2016, BRAIN CONNECT, V6, P298, DOI 10.1089/brain.2015.0408; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nakashima H, 2015, SPINE PHILA PA 1976, V40, P392; Nateras OSE, 2016, RADIOLOGY, V279, P262, DOI 10.1148/radiol.2015150768; NURICK S, 1972, BRAIN, V95, P87; OGINO H, 1983, SPINE, V8, P1, DOI 10.1097/00007632-198301000-00001; OKADA Y, 1993, SPINE, V18, P2024, DOI 10.1097/00007632-199310001-00016; PANJABI M, 1988, SPINE, V13, P838, DOI 10.1097/00007632-198807000-00024; PROLO DJ, 1986, SPINE, V11, P601, DOI 10.1097/00007632-198607000-00012; Rhee JM, 2013, SPINE, V38, pS55, DOI 10.1097/BRS.0b013e3182a7f41d; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Shin JJ, 2010, ACTA NEUROCHIR, V152, P1687, DOI 10.1007/s00701-010-0692-8; Stracke CP, 2005, NEURORADIOLOGY, V47, P127, DOI 10.1007/s00234-004-1318-8; Stroman PW, 1999, MAGNET RESON MED, V42, P571, DOI 10.1002/(SICI)1522-2594(199909)42:3<571::AID-MRM20>3.0.CO;2-N; Summers PE, 2010, MAGN RESON IMAGING, V28, P1216, DOI 10.1016/j.mri.2010.05.001; TAKAHASHI M, 1989, RADIOLOGY, V173, P219, DOI 10.1148/radiology.173.1.2781011; Tetreault L, 2015, NEUROSURGERY, V77, pS51, DOI 10.1227/NEU.0000000000000951; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; Turner JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00137; Uchida K, 2005, J ORTHOP SCI, V10, P564, DOI 10.1007/s00776-005-0953-1; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Xu J, 2014, NEUROSCIENCE, V263, P181, DOI 10.1016/j.neuroscience.2014.01.020; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou FQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09975; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	49	23	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167279	10.1371/journal.pone.0167279	http://dx.doi.org/10.1371/journal.pone.0167279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907060	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700109
J	Miftahussurur, M; Syam, AF; Nusi, IA; Makmun, D; Waskito, LA; Zein, LH; Akil, F; Uwan, WB; Simanjuntak, D; Wibawa, IDN; Waleleng, JB; Saudale, AMJ; Yusuf, F; Mustika, S; Adi, P; Maimunah, U; Maulahela, H; Rezkitha, YAA; Subsomwong, P; Nasronudin; Rahardjo, D; Suzuki, R; Akada, J; Yamaoka, Y				Miftahussurur, Muhammad; Syam, Ari Fahrial; Nusi, Iswan Abbas; Makmun, Dadang; Waskito, Langgeng Agung; Zein, Lukman Hakim; Akil, Fardah; Uwan, Willy Brodus; Simanjuntak, David; Wibawa, I. Dewa Nyoman; Waleleng, Jimmy Bradley; Saudale, Alexander Michael Joseph; Yusuf, Fauzi; Mustika, Syifa; Adi, Pangestu; Maimunah, Ummi; Maulahela, Hasan; Rezkitha, Yudith Annisa Ayu; Subsomwong, Phawinee; Nasronudin; Rahardjo, Dadik; Suzuki, Rumiko; Akada, Junko; Yamaoka, Yoshio			Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations	PLOS ONE			English	Article							GASTRIC-CANCER; ANTIMICROBIAL SUSCEPTIBILITY; CLARITHROMYCIN RESISTANCE; METRONIDAZOLE RESISTANCE; VIRULENCE FACTORS; CONSENSUS REPORT; POINT MUTATIONS; GYRA MUTATIONS; INFECTION; IDENTIFICATION	Information regarding Helicobacter pylori antibiotic resistance in Indonesia was previously inadequate. We assessed antibiotic susceptibility for H. pylori in Indonesia, and determined the association between virulence genes or genetic mutations and antibiotic resistance. We recruited 849 dyspeptic patients who underwent endoscopy in 11 cities in Indonesia. E-test was used to determine the minimum inhibitory concentration of five antibiotics. PCR-based sequencing assessed mutations in 23S rRNA, rdxA, gyrA, gyrB, and virulence genes. Next generation sequencing was used to obtain full-length sequences of 23S rRNA, infB, and rp122. We cultured 77 strains and identified 9.1% with clarithromycin resistance. Low prevalence was also found for amoxicillin and tetracycline resistance (5.2% and 2.6%, respectively). In contrast, high resistance rates to metronidazole (46.7%) and levofloxacin (31.2%) were demonstrated. Strains isolated from Sumatera Island had significantly higher metronidazole resistance than those from other locations. Metronidazole resistant strains had highly distributed rdxA amino acid substitutions and the 23S rRNA A2143G mutation was associated with clarithromycin resistance (42.9%). However, one strain with the highest MIC value had a novel mutation in rp122 without an A2143G mutation. Mutation at Asn-87 and/or Asp 91 of gyrA was associated with levofloxacin-resistance and was related to gyrB mutations. In conclusions, although this is a pilot study for a larger survey, our current data show that Indonesian strains had the high prevalence of metronidazole and levofloxacin resistance with low prevalence of clarithromycin, amoxicillin, and tetracycline resistance. Nevertheless, clarithromycin-or metronidazole-based triple therapy should be administered with caution in some regions of Indonesia.	[Miftahussurur, Muhammad; Waskito, Langgeng Agung; Subsomwong, Phawinee; Suzuki, Rumiko; Akada, Junko; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA; [Miftahussurur, Muhammad; Nusi, Iswan Abbas; Maimunah, Ummi] Univ Airlangga, Fac Med, Dept Internal Med, Div Gastroenterohepatol, Surabaya, Indonesia; [Miftahussurur, Muhammad; Waskito, Langgeng Agung; Adi, Pangestu; Rezkitha, Yudith Annisa Ayu; Nasronudin; Rahardjo, Dadik] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Syam, Ari Fahrial; Makmun, Dadang; Maulahela, Hasan] Univ Indonesia, Div Gastroenterol, Dept Internal Med, Fac Med, Jakarta, Indonesia; [Zein, Lukman Hakim] Univ Sumatera Utara, Div Gastroenterohepatol, Dept Internal Med, Fac Med, Medan, Indonesia; [Akil, Fardah] Hasanuddin Univ, Dept Internal Med, Ctr Gastroenterohepatol, Fac Med, Makassar, Indonesia; [Uwan, Willy Brodus] Santo Antonius Hosp, Dept Internal Med, Pontianak, Indonesia; [Simanjuntak, David] Yowari Hosp, Dept Internal Med, Jayapura, Indonesia; [Wibawa, I. Dewa Nyoman] Univ Udayana, Fac Med, Dept Internal Med, Div Gastroenterohepatol, Denpasar, Indonesia; [Waleleng, Jimmy Bradley] Univ Sam Ratulangi, Prof Dr RD Kandou Hosp, Fac Med, Div Gastroenterohepatol,Dept Internal Med, Manado, Indonesia; [Saudale, Alexander Michael Joseph] Prof Dr WZ Johannes Gen Hosp, Div Gastroenterohepatol, Kupang, Indonesia; [Yusuf, Fauzi] Dr Zainoel Abidin Gen Hosp, Dept Internal Med, Div Gastroenterohepatol, Banda Aceh, Indonesia; [Mustika, Syifa] Dr Saiful Anwar Gen Hosp, Dept Internal Med, Div Gastroenterohepatol, Malang, Indonesia	Oita University; Baylor College of Medicine; Airlangga University; Airlangga University; University of Indonesia; University of North Sumatra; Universitas Hasanuddin; Universitas Udayana; Universitas Sam Ratulangi	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021; Syam, Ari Fahrial/ABI-4994-2020; MAIMUNAH, UMMI/GQH-0117-2022	maulahela, hasan/0000-0002-0396-4433; Mustika, Syifa/0000-0003-4831-2719; Miftahussurur, Muhammad/0000-0003-1415-6033; Syam, Ari Fahrial/0000-0003-0041-3553; Maimunah, Ummi/0000-0002-2496-4336; Rezkitha, Yudith Annisa Ayu/0000-0001-7600-9114; Akil, Fardah/0000-0002-4222-6011; effendi, wiwin is/0000-0003-3716-2452; Subsomwong, Phawinee/0000-0002-9961-9350; Yamaoka, Yoshio/0000-0002-1222-5819; nasronudin, nasronudin/0000-0001-7882-9992; Yusuf, Fauzi/0000-0002-5822-300X	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 15H02657, 221S0002]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST)	This study was funded by grants from the National Institutes of Health (DK62813) and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (24406015, 24659200, 25293104, 26640114,15H02657 and 221S0002) (YY). It was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY) and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST) (YY).	Abdullah Arman A, 2012, Acta Med Indones, V44, P298; Ang TL, 2016, CHANGING PROFILE HEL; Asaka M, 2013, INT J CANCER, V132, P1272, DOI 10.1002/ijc.27965; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Binh TT, 2015, ANTIMICROB AGENTS CH; Cambau E, 2009, J CLIN MICROBIOL, V47, P3600, DOI 10.1128/JCM.00744-09; Cammarota G, 2000, ALIMENT PHARM THER, V14, P1339, DOI 10.1046/j.1365-2036.2000.00846.x; Cuadrado-Lavin A, 2012, J ANTIMICROB CHEMOTH, V67, P170, DOI 10.1093/jac/dkr410; De Francesco V, 2006, ANN INTERN MED, V144, P94, DOI 10.7326/0003-4819-144-2-200601170-00006; De Francesco V, 2010, J GASTROINTEST LIVER, V19, P409; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Francesco Vincenzo De, 2011, World J Gastrointest Pathophysiol, V2, P35, DOI 10.4291/wjgp.v2.i3.35; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Gerrits MM, 2004, J MED MICROBIOL, V53, P1123, DOI 10.1099/jmm.0.45701-0; Glocker E, 2007, ANTIMICROB AGENTS CH, V51, P346, DOI 10.1128/AAC.00614-06; Ho SL, 2010, J DIGEST DIS, V11, P101, DOI 10.1111/j.1751-2980.2010.00423.x; Ierardi E, 2013, WORLD J GASTROENTERO, V19, P8168, DOI 10.3748/wjg.v19.i45.8168; Khan A, 2012, WORLD J GASTROENTERO, V18, P2245, DOI 10.3748/wjg.v18.i18.2245; Kim Sang Gyun, 2013, Korean J Gastroenterol, V62, P3; Kobayashi I, 2007, J CLIN MICROBIOL, V45, P4006, DOI 10.1128/JCM.00740-07; Kumala Widyasari, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P970; Kwon DH, 2000, J ANTIMICROB CHEMOTH, V46, P793, DOI 10.1093/jac/46.5.793; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Li AQ, 2007, WORLD J GASTROENTERO, V13, P1847, DOI 10.3748/wjg.v13.i12.1847; Liu WZ, 2013, J DIGEST DIS, V14, P211, DOI 10.1111/1751-2980.12034; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Matsumoto Y, 2005, DIGEST LIVER DIS, V37, P821, DOI 10.1016/j.dld.2005.06.002; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Megraud F, 1998, GASTROENTEROLOGY, V115, P1278, DOI 10.1016/S0016-5085(98)70101-5; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Megraud F, 2012, THER ADV GASTROENTER, V5, P103, DOI 10.1177/1756283X11432492; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0072-2; Miftahussurur M, 2015, MOLECULES, V20, P6068, DOI 10.3390/molecules20046068; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Nishizawa T, 2009, J CLIN BIOCHEM NUTR, V44, P119, DOI 10.3164/jcbn.08-220R; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Oleastro M, 2003, J CLIN MICROBIOL, V41, P397, DOI 10.1128/JCM.41.1.397-402.2003; Pandya HB, 2014, INDIAN J MED MICROBI, V32, P408, DOI 10.4103/0255-0857.142256; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Rimbara E, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2011.00912.x; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Syam AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140186; Takahashi A, 2012, INTACT LONG TYPE DUP; Teh X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101481; Binh TT, 2014, J ANTIMICROB CHEMOTH, V69, P1796, DOI 10.1093/jac/dku050; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, DIAGN MICR INFEC DIS, V77, P346, DOI 10.1016/j.diagmicrobio.2013.08.010; Wang LH, 2010, WORLD J GASTROENTERO, V16, P2272, DOI 10.3748/wjg.v16.i18.2272; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781	56	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166199	10.1371/journal.pone.0166199	http://dx.doi.org/10.1371/journal.pone.0166199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906990	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000389482700020
J	Takahashi, S; Yonekura, Y; Sasaki, R; Yokoyama, Y; Tanno, K; Sakata, K; Ogawa, A; Kobayashi, S; Yamamoto, T				Takahashi, Shuko; Yonekura, Yuki; Sasaki, Ryohei; Yokoyama, Yukari; Tanno, Kozo; Sakata, Kiyomi; Ogawa, Akira; Kobayashi, Seichiro; Yamamoto, Taro			Weight Gain in Survivors Living in Temporary Housing in the Tsunami-Stricken Area during the Recovery Phase following the Great East Japan Earthquake and Tsunami	PLOS ONE			English	Article							BODY-MASS INDEX; ATHENS-INSOMNIA-SCALE; RISK-FACTORS; DIETARY PATTERNS; OBESITY; STRESS; ENVIRONMENT; POPULATION; PREVALENCE; VALIDATION	Introduction Survivors who lost their homes in the Great East Japan Earthquake and Tsunami were forced to live in difficult conditions in temporary housing several months after the disaster. Body weights of survivors living in temporary housing for a long period might increase due to changes in their life style and psychosocial state during the medium-term and long-term recovery phases. The aim of this study was to determine whether there were differences between body weight changes of people living in temporary housing and those not living in temporary housing in a tsunami-stricken area during the medium-term and long-term recovery phases. Materials and methods Health check-ups were performed about 7 months after the disaster (in 2011) and about 18 months after the disaster (in 2012) for people living in a tsunami-stricken area (n = 6,601, mean age = 62.3 y). We compared the changes in body weight in people living in temporary housing (TH group, n = 2,002) and those not living in temporary housing (NTH group, n = 4,599) using a multiple linear regression model. Results While there was no significant difference between body weights in the TH and NTH groups in the 2011 survey, there was a significant difference between the mean changes in body weight in both sexes. We found that the changes in body weight were significantly greater in the TH group than in the NTH group in both sexes. The partial regression coefficients of mean change in body weight were +0.52 kg (P-value < 0.001) in males in the TH group and +0.56 kg (P-value < 0.001) in females in the TH group (reference: NTH group). Conclusion Analysis after adjustment for life style, psychosocial factors and cardiovascular risk factors found that people living in temporary housing in the tsunami-stricken area had a significant increase in body weight.	[Takahashi, Shuko; Yamamoto, Taro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Int Hlth, Nagasaki, Japan; [Yonekura, Yuki; Tanno, Kozo; Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Yahaba, Iwate, Japan; [Sasaki, Ryohei] Iwate Tohoku Med Megabank Org, Yahaba, Iwate, Japan; [Yokoyama, Yukari] Nihon Fukushi Univ, Dept Social Welf, Mihama, Aichi, Japan; [Ogawa, Akira] Iwate Med Univ, Morioka, Iwate, Japan; [Kobayashi, Seichiro] Iwate Med Univ, Sch Med, Dept Plast & Reconstruct Surg, Morioka, Iwate, Japan; [Takahashi, Shuko; Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki, Japan	Nagasaki University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Nagasaki University	Takahashi, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Int Hlth, Nagasaki, Japan.; Takahashi, S (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki, Japan.	shutakahashi-iwt@umin.ac.jp	Tanno, Kozo/ABE-5165-2020; Tanno, Kozo/HDM-5952-2022; Yonekura, Yuki/C-5973-2013	Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Yonekura, Yuki/0000-0002-2590-2022	Ministry of Health, Labour, and Welfare of Japan [H23-Tokubetsu-Shitei-002, H24-kenki-sitei-001]; Research Institute for Humanity and Nature, Japan; Environment Research and Technology Development Fund of Ministry of the Environment, Japan [S-11-3]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Institute for Humanity and Nature, Japan; Environment Research and Technology Development Fund of Ministry of the Environment, Japan	The study was supported by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan (H23-Tokubetsu-Shitei-002; H24-kenki-sitei-001). This work was partly conducted at the Joint Usage / Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University (http://www.mext.go.jp/a_menu/kyoten/). This study is a part of the incubation study "Exploratory Studies on Human Adaptation Mechanism to Modern Plague" funded by the Research Institute for Humanity and Nature, Japan. This research was in part supported by Environment Research and Technology Development Fund (S-11-3) of Ministry of the Environment, Japan.	Arai H, 2012, GUIDELINES PRIMARY P; Aranceta J, 2001, EUR J CLIN NUTR, V55, P430, DOI 10.1038/sj.ejcn.1601189; Aranceta J, 2007, PUBLIC HEALTH NUTR, V10, P1187, DOI 10.1017/S1368980007000699; Arbeeny CM, 2004, OBES RES, V12, P1191, DOI 10.1038/oby.2004.150; Arcaya M, 2014, PREV MED, V65, P40, DOI 10.1016/j.ypmed.2014.04.006; Cabinet Office Government of Japan, 2011, NUMB VICT EV SHELT G; Centers for Disease Control and Prevention, 2015, AD OB CAUS CONS; Centers for Disease Control and Prevention, 2015, OTH FACT WEIGHT GAIN; Chapman IM, 2011, MED CLIN N AM, V95, P579, DOI 10.1016/j.mcna.2011.02.004; Chiriboga DE, 2008, OBESITY, V16, P137, DOI 10.1038/oby.2007.38; Division of Consumer and Environmental Protection Reconstruction bureau Iwate prefecture, 2015, SIT VICT EM TEMP HOU; Drewnowski A, 2014, INT J OBESITY, V38, P306, DOI 10.1038/ijo.2013.97; Economic Research Bureau The Cabinet Office Government of Japan, 2011, AM CAP STOCK DAM EST; Geospatial Information Authority of Japan Ministry of Land Infrastructure Transport and Tourism, 2011, AR IN RANG CAUS TSUN; Goff DC, 2013, CIRCULATION, V2014, P129, DOI DOI 10.1161/01.CIR.0000437741.48606; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Harsha DW, 2008, HYPERTENSION, V51, P1420, DOI 10.1161/HYPERTENSIONAHA.107.094011; Ishii Takeaki, 2015, Prev Med Rep, V2, P916, DOI 10.1016/j.pmedr.2015.10.009; Ishiki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147025; Japan Science and Technology Agency, 2014, GREAT E JAP EARTHQ I; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; Koyama S, 2014, TOHOKU J EXP MED, V234, P241, DOI 10.1620/tjem.234.241; Martikainen PT, 1999, AM J CLIN NUTR, V69, P719; Ministry of health labor and welfare Japan, 2015, EX GUID GOOD HLTH 20; Ministry of Internal Affairs and Communications, 2015, 2011 PAC COAST TOH E; Moore CJ, 2012, J ACAD NUTR DIET, V112, P518, DOI 10.1016/j.jand.2011.12.001; Murakami Haruka, 2013, Nihon Koshu Eisei Zasshi, V60, P222; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580; Nishi N, 2013, J EPIDEMIOL, V23, P376, DOI 10.2188/jea.JE20130025; Office of Disease Prevention and Health Promotion, 2016, DIET PATT BOD WEIGHT; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Panagiotakos DB, 2004, OBES RES, V12, P1914, DOI 10.1038/oby.2004.239; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Research and Survey Division Department of Policy and Regional Affairs Iwate Prefectural Government, 2011, MONTHL EST IWATE PRE; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2005, SLEEP MED, V6, P5, DOI 10.1016/j.sleep.2004.10.006; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Sone T, 2016, SOC SCI MED, V152, P96, DOI 10.1016/j.socscimed.2016.01.037; Takahashi S, 2015, DISASTER MED PUBLIC, V9, P103, DOI 10.1017/dmp.2015.6; The National Police Agency, 2014, DAM SIT POL MEAS 201; TREVISAN M, 1986, ARTERIOSCLEROSIS, V6, P491, DOI 10.1161/01.ATV.6.5.491; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267; Tsuboyama-Kasaoka N, 2014, ASIA PAC J CLIN NUTR, V23, P159, DOI 10.6133/apjcn.2014.23.1.17; Ueda S, 2012, TOHOKU J EXP MED, V227, P199, DOI 10.1620/tjem.227.199; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102497; Yoshimura E., 2014, IWATE KOSHU EISEI ZA, V25, p7.	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166817	10.1371/journal.pone.0166817	http://dx.doi.org/10.1371/journal.pone.0166817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907015	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700043
J	Verburgh, L; Scherder, EJA; Van Lange, PAM; Oosterlaan, J				Verburgh, Lot; Scherder, Erik J. A.; Van Lange, Paul A. M.; Oosterlaan, Jaap			Do Elite and Amateur Soccer Players Outperform Non-Athletes on Neurocognitive Functioning? A Study Among 8-12 Year Old Children	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; WORKING-MEMORY; INTERVENTION; ASSOCIATIONS; ACHIEVEMENT; EXERCISE; FITNESS; OBESITY	Aim Research suggested a positive association between physical fitness and neurocognitive functioning in children. Aim of the present study is to investigate possible dose-response relationships between diverse daily physical activities and a broad range of neurocognitive functions in preadolescent children. Furthermore, the relationship between several sedentary behaviours, including TV-watching, gaming and computer time, and neurocognitive functioning will be investigated in this group of children. Methods A total of 168 preadolescent boys, aged 8 to 12 years, were recruited from various locations, including primary schools, an amateur soccer club, and a professional soccer club, to increase variability in the amount of participation in sports. All children performed neurocognitive tasks measuring inhibition, short term memory, working memory, attention and information processing speed. Regression analyses examined the predictive power of a broad range of physical activities, including sports, active transport to school, physical education (PE), outdoor play, and sedentary behaviour such as TV-watching and gaming, for neurocognitive functioning. Results Time spent in sports significantly accounted for the variance in inhibition, short term memory, working memory and lapses of attention, where more time spent in sports was associated with better performance. Outdoor play was also positively associated with working memory. In contrast, time spent on the computer was negatively associated with inhibition. Conclusions Results of the current study suggest a positive relationship between participation in sports and several important neurocognitive functions. Interventions are recommended to increase sports participation and to reduce sedentary behaviour in preadolescent children.	[Verburgh, Lot; Scherder, Erik J. A.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands; [Van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Oosterlaan, J (corresponding author), Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands.	j.oosterlaan@vu.nl		Van Lange, Paul/0000-0001-7774-6984				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anobile G, 2013, J EXP CHILD PSYCHOL, V116, P380, DOI 10.1016/j.jecp.2013.06.006; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ballester R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123898; Biddle SJH, 2004, J R SOC PROMO HEALTH, V124, P29, DOI 10.1177/146642400312400110; Brockman R, 2010, PREV MED, V51, P144, DOI 10.1016/j.ypmed.2010.05.012; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Carlson JA, 2013, PREV MED, V57, P591, DOI 10.1016/j.ypmed.2013.08.003; Chen AG, 2014, PSYCHOL SPORT EXERC, V15, P627, DOI 10.1016/j.psychsport.2014.06.004; Chin A, 2015, PREV MED, V70, P1, DOI [10.1016/j.ypmed.2014.10.029, DOI 10.1016/J.YPMED.2014.10.029]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Dollman J, 2009, J SCI MED SPORT, V12, P518, DOI 10.1016/j.jsams.2008.09.007; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Friedman SL, 2003, ARCH PEDIAT ADOL MED, V157, P185; Guagliano JM, 2013, MED SCI SPORT EXER, V45, P116, DOI 10.1249/MSS.0b013e31826a0a73; Hamer M, 2014, MED SCI SPORT EXER, V46, P718, DOI 10.1249/MSS.0000000000000156; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Kesse-Guyot E, 2012, PLOS ONE; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Littel M, 2012, ADDICT BIOL, V17, P934, DOI 10.1111/j.1369-1600.2012.00467.x; Ljach V, 2012, PERCEPT MOTOR SKILL, V114, P485, DOI 10.2466/05.10.25.PMS.114.2.485-506; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Nevo E, 2011, J EXP CHILD PSYCHOL, V109, P73, DOI 10.1016/j.jecp.2010.09.010; Nutley SB, 2010, DEV NEUROPSYCHOL, V35, P81, DOI 10.1080/87565640903325741; Ooijendijk W, 2007, CONSENSUS VRAGENLIJS; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Pearson N, 2014, OBES REV, V15, P666, DOI 10.1111/obr.12188; Pulles I, 2014, JEUGDBELEID, V8, P21; Schaeffer DJ, 2014, PSYCHOPHYSIOLOGY, V51, P728, DOI 10.1111/psyp.12227; Silva G, 2013, J SPORT SCI, V31, P1359, DOI 10.1080/02640414.2013.781666; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Soga K., 2016, J PHYS FITNESS SPORT, V5, P57, DOI [10.7600/jpfsm.5.57, DOI 10.7600/JPFSM.5.57]; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tabachnick BG, 2001, USING MULTIVARIATE S, P62; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; van der Niet AG, 2016, PEDIATR EXERC SCI, V28, P64, DOI 10.1123/pes.2015-0084; Verburgh L., 2013, BR J SPORTS MED; Verburgh L, 2016, J SPORTS SCI, P1; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Voss MW, 2014, MENT HEALTH PHYS ACT, V7, P9, DOI 10.1016/j.mhpa.2014.01.001; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Whelan R, 2008, PSYCHOL RECORD, V58; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a	53	36	37	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165741	10.1371/journal.pone.0165741	http://dx.doi.org/10.1371/journal.pone.0165741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906965	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700010
J	Zhou, LT; Lv, LL; Pan, MM; Cao, YH; Liu, H; Feng, Y; Ni, HF; Liu, BC				Zhou, Le-Ting; Lv, Lin-Li; Pan, Ming-Ming; Cao, Yu-Han; Liu, Hong; Feng, Ye; Ni, Hai-Feng; Liu, Bi-Cheng			Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis	PLOS ONE			English	Review							GELATINASE-ASSOCIATED LIPOCALIN; ATHEROSCLEROSIS RISK; MOLECULE-1 KIM-1; DECLINE; NGAL; CKD; PROGRESSION; PREDICTION; BIOMARKERS	Background Adverse outcome of chronic kidney disease, such as end stage renal disease, is a significant burden on personal health and healthcare costs. Urinary tubular injury markers, such as NGAL, KIM-1 and NAG, could provide useful prognostic value for the early identification of high-risk patients. However, discrepancies between recent large prospective studies have resulted in controversy regarding the potential clinical value of these markers. Therefore, we conducted the first meta-analysis to provide a more persuasive argument to this debate. Methods In the current meta-analysis, based on ten prospective studies involving 29366 participants, we evaluated the role of urinary tubular injury markers (NGAL, KIM-1 and NAG) in predicting clinical outcomes including CKD stage 3, end stage renal disease and mortality. The prognostic values of these biomarkers were estimated using relative risks and 95% confidence interval in adjusted models. All risk estimates were normalized to those of 1 standard deviation increase in log-scale concentrations to minimize heterogeneity. Fixed-effects models were adopted to combine risk estimates. The quality of the research and between-study heterogeneity were evaluated. The level of research evidence was identified according to the GRADE profiler. Results uNGAL was identified as an independent risk predictor of ESRD (pooled adjusted relative risk: 1.40[1.21 to 1.61], p<0.001) and of overall mortality (pooled adjusted relative risk: 1.10 [1.03 to 1.18], p = 0.001) in patients with chronic kidney disease. A borderline significance of uKIM-1 in predicting CKD stage 3 independently in the community-based population was observed (pooled adjusted relative risk: 1.13[1.00 to 1.27], p = 0.057). Only the prognostic value of uNGAL for ESRD was supported by a grade B level of evidence. Conclusion The concentration of uNGAL can be used in practice as an independent predictor of end stage renal disease among patients with chronic kidney disease, but it may be not useful in predicting disease progression to CKD stage 3 among community-based population.	[Zhou, Le-Ting; Lv, Lin-Li; Pan, Ming-Ming; Cao, Yu-Han; Liu, Hong; Feng, Ye; Ni, Hai-Feng; Liu, Bi-Cheng] Southeast Univ, Inst Nephrol, Zhong Da Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Liu, BC (corresponding author), Southeast Univ, Inst Nephrol, Zhong Da Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	liubc64@163.com	, 乐汀/AAN-9636-2020		National Natural Scientific Foundation [81130010]; Major State Basic Research Development Program ("973") [2012CB517706]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program ("973")(National Basic Research Program of China)	This study was supported by the National Natural Scientific Foundation grant 81130010, http://www.nsfc.gov.cn/publish/portal1/, and Major State Basic Research Development Program ("973") grant 2012CB517706, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aregger F, 2014, KIDNEY INT, V85, P909, DOI 10.1038/ki.2013.363; Bhavsar NA, 2012, AM J KIDNEY DIS, V60, P233, DOI 10.1053/j.ajkd.2012.02.336; Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; El Karoui K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10330; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Foster MC, 2015, CLIN J AM SOC NEPHRO, V10, P1956, DOI 10.2215/CJN.02590315; Fufaa GD, 2015, DIABETOLOGIA, V58, P188, DOI 10.1007/s00125-014-3389-3; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kim SS, 2013, DIABETES CARE, V36, P656, DOI 10.2337/dc12-0849; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Lim AI, 2013, J CELL PHYSIOL, V228, P917, DOI 10.1002/jcp.24267; Lin HYH, 2015, CLIN CHEM LAB MED, V53, P73, DOI 10.1515/cclm-2014-0647; Liu KD, 2015, AM J KIDNEY DIS, V65, P267, DOI 10.1053/j.ajkd.2014.07.025; Liu KD, 2013, KIDNEY INT, V83, P909, DOI 10.1038/ki.2012.458; Mise K, 2016, CLIN J AM SOC NEPHRO, V11, P593, DOI 10.2215/CJN.04980515; O'Seaghdha CM, 2013, J AM SOC NEPHROL, V24, P1880, DOI 10.1681/ASN.2013010019; Panduru NM, 2015, DIABETES CARE, V38, P1130, DOI 10.2337/dc14-2330; Patel M L, 2016, Indian J Nephrol, V26, P125, DOI 10.4103/0971-4065.157799; Peralta CA, 2012, AM J KIDNEY DIS, V60, P904, DOI 10.1053/j.ajkd.2012.05.014; Smith ER, 2013, NEPHROL DIAL TRANSPL, V28, P1569, DOI 10.1093/ndt/gfs586; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004	25	22	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167334	10.1371/journal.pone.0167334	http://dx.doi.org/10.1371/journal.pone.0167334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907168	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700122
J	Biswas, T; Islam, MS; Linton, N; Rawal, LB				Biswas, Tuhin; Islam, Md. Saimul; Linton, Natalie; Rawal, Lal B.			Socio-Economic Inequality of Chronic Non Communicable Diseases in Bangladesh	PLOS ONE			English	Article							HEALTH INEQUALITIES; NONCOMMUNICABLE DISEASES	Introduction Chronic non-communicable diseases (NCDs) are a major public health challenge, and undermine social and economic development in much of the developing world, including Bangladesh. Epidemiologic evidence on the socioeconomic status (SES)-related pattern of NCDs remains limited in Bangladesh. This study assessed the relationship between three chronic NCDs and SES among the Bangladeshi population, paying particular attention to the differences between urban and rural areas. Materials and Method Data from the 2011 Bangladesh Demographic and Health Survey were used for this study. Using a concentration index (CI), we measured relative inequality across pre-diabetes, diabetes, pre-hypertension, hypertension, and BMI (underweight, normal weight, and overweight/obese) in urban and rural areas in Bangladesh. A CI and its associated curve can be used to identify whether socioeconomic inequality exists for a given health variable. In addition, we estimated the health achievement index, integrating mean coverage and the distribution of coverage by rural and urban populations. Results Socioeconomic inequalities were observed across diseases and risk factors. Using CI, significant inequalities observed for pre-hypertension (CI = 0.09, p = 0.001), hypertension (CI = 0.10, p = 0.001), pre-diabetes (CI = -0.01, p = 0.005), diabetes (CI = 0.19, p<0.001), and overweight/obesity (CI = 0.45, p<0.001). In contrast to the high prevalence of the chronic health conditions among the urban richest, a significant difference in CI was observed for pre-hypertension (CI = -0.20, p = 0.001), hypertension (CI = -0.20, p = 0.005), pre-diabetes (CI = -0.15, p = 0.005), diabetes (CI = -0.26, p = 0.004) and overweight/obesity (CI = 0.25, p = 0.004) were observed more among the low wealth quintiles of rural population. In the same vein, the poorest rural households had more co-morbidities compared to the richest rural households (p = 0.003), and prevalence of co-morbidities was much higher for the richest urban households compared to the poorest urban households. On the other hand in that no competing interests exist. rural the "disachievement" of health indicators is more noticeable than the urban ones. Conclusion The findings indicate the high burden of selected NCDs among the low wealth quintile populations in rural areas and wealthy populations in urban areas. Particular attentions may be necessary to address the problem of NCDs among these groups.	[Biswas, Tuhin; Islam, Md. Saimul; Rawal, Lal B.] Icddr B, Hlth Syst & Populat Studies Div, Mohakhali, Bangladesh; [Linton, Natalie] Oregon State Univ, Corvallis, OR 97331 USA; [Rawal, Lal B.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Oregon State University; Bangladesh Rural Advancement Committee BRAC; BRAC University	Biswas, T (corresponding author), Icddr B, Hlth Syst & Populat Studies Div, Mohakhali, Bangladesh.	tuhin.biswas@icddrb.org	Linton, Natalie/AGY-8116-2022	Linton, Natalie/0000-0002-5464-0076; Rawal, Lal/0000-0003-1106-0108; Biswas, Tuhin/0000-0002-7837-0306				ABUSAYEED M, 1995, DIABETES CARE, V18, P555, DOI 10.2337/diacare.18.4.555; Ahmed S., 2013, J NUTR HLTH, V1, P18, DOI [10.12691/jnh-1-1-3, DOI 10.12691/JNH-1-1-3]; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; [Anonymous], 2008, ANAL HLTH EQUITY USI; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Baker J, 1993, EQUITY FINANCE DELIV; Baker J. L., 2007, DHAKA IMPROVING LIVI; BBS, 2011, TAT POCK BANGL 2010; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Chalasani S, 2012, SOC SCI MED, V75, P2160, DOI 10.1016/j.socscimed.2012.08.012; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Commission BP, 2013, MILL DEV GOALS BANGL; D'Orazio P, 2005, CLIN CHEM, V51, P1573, DOI 10.1373/clinchem.2005.051979; Demographic B, 2013, HLTH SURV BDHS 2011; Demographic B, 2012, HLTH SURV 2011; DHS M, 2012, DEM HLTH SURV; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Giashuddin M. S., 2005, Indian Journal of Pediatrics, V72, P481, DOI 10.1007/BF02724424; Gupta R, 2003, J Assoc Physicians India, V51, P470; Gupta R, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-8; Gupta R, 2010, PREV MED, V51, P408, DOI 10.1016/j.ypmed.2010.08.014; Gwatkin D. R., 2009, SOCIOECONOMIC DIFFER; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-198, 10.1186/1471-2458-12-912]; Islam A., 2014, AM J HLTH RES, V6, P366, DOI [10.11648/j.ajhr.20140206.18, DOI 10.11648/J.AJHR.20140206.18]; Islam A, HLTH SYSTEM BOTTLENE; Islam A, 2015, EUROPEAN J PREVENTIV, V3, P63; Islam A, HLTH SYSTEM FINANCIN; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; Kakwani NC, 1980, INCOME INEQUALITY PO; Le Gales-Camus C, 2005, PREVENTING CHRONIC D; Mackintosh M., 2001, POVERTY INEQUALITY H; Organization WH, 2009, GLOB HLTH RISKS MORT; Organization WH, 2011, NONC DIS RISK FACT S; Rahman MM, 2014, J HYPERTENSION; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Ruger JP, 2006, J EPIDEMIOL COMMUN H, V60, P928, DOI 10.1136/jech.2005.041954; Siegel KR, 2014, BRIT MED BULL, V111, P31, DOI 10.1093/bmb/ldu018; Sommer I, 2015, BMC PUBLIC HEALTH, V15, P1; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; WAGSTAFF A, 1994, HEALTH ECON, V3, P281, DOI 10.1002/hec.4730030409; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Wagstaff A, 2002, J HEALTH ECON, V21, P627, DOI 10.1016/S0167-6296(02)00006-1; Wagstaff A., 2000, RES EQUITY POVERTY H; Wagstaff A., 2002, INEQUALITIES HLTH DE; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zaman MJ, 2012, INT J EPIDEMIOL	50	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167140	10.1371/journal.pone.0167140	http://dx.doi.org/10.1371/journal.pone.0167140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902760	Green Published, gold			2022-12-27	WOS:000389474100056
J	Chan, H; Tang, YL; Lv, XH; Zhang, GF; Wang, M; Yang, HP; Li, Q				Chan, Han; Tang, Yan-Ling; Lv, Xiao-Hang; Zhang, Gao-Fu; Wang, Mo; Yang, Hai-Ping; Li, Qiu			Risk Factors Associated with Renal Involvement in Childhood Henoch-Schonlein Purpura: A Meta-Analysis	PLOS ONE			English	Article							CHILDREN; CLASSIFICATION; EPIDEMIOLOGY; NEPHRITIS; CRITERIA; DISEASE	Background and objective Henoch-Schonlein purpura (HSP) is an important cause of chronic kidney disease in children. This meta-analysis identified risk factors associated with renal involvement in childhood HSP. Methods PubMed, Embase, and Web of Science were searched. The quality of all eligible studies was assessed using the Newcastle-Ottawa scale criteria. An analysis of possible risk factors was conducted to report the odds ratio (OR) and weighted mean difference (WMD). Results Thirteen studies (2398 children) revealed 20 possible and 13 significant risk factors associated with renal involvement in HSP, with the following meta-analysis estimates of OR and WMD, with 95% confidence intervals: older age (0.90, 0.61-1.19); age > 10 y (3.13, 1.39-7.07); male gender (1.36, 1.07-1.74); abdominal pain (1.94,1.24-3.04); gastrointestinal bleeding (1.86, 1.30-2.65); severe bowel angina (3.38, 1.17-9.80); persistent purpura (4.02, 1.22-13.25); relapse (4.70, 2.42-9.14); WBC > 15 x 10(9)/L (2.42, 1.39-4.22); platelets > 500 x 10(9)/L (2.98, 1.22-7.25); elevated antistreptolysin O (ASO) (2.17, 1.29-3.64); and decreased complement component 3 (C3) (3.13, 1.62-6.05). Factors not significantly associated with renal involvement were: blood pressure; orchitis; elevated C-reactive protein; elevated erythrocyte sedimentation rate (ESR); and elevated serum IgA/IgE or IgG. Arthritis/arthralgia may be a risk factor according to the criteria of the American College of Rheumatology (1.41, 1.01-1.96). Conclusion The following are associated with renal involvement in pediatric HSP: male gender; > 10 y old; severe gastrointestinal symptoms (abdominal pain, gastrointestinal bleeding, and severe bowel angina); arthritis/arthralgia; persistent purpura or relapse; WBC > 15 x 10(9)/L; platelets > 500 x 10(9)/L; elevated ASO; and low C3. Relevant clinical interventions for these risk factors may exert positive effects on the prevention of kidney disease during the early stages of HSP. However, the results should be interpreted cautiously due to the limitations of the studies.	[Chan, Han; Tang, Yan-Ling; Lv, Xiao-Hang; Zhang, Gao-Fu; Wang, Mo; Yang, Hai-Ping; Li, Qiu] Chongqing Med Univ, Dept Nephrol, Key Lab, Minist Educ,Childrens Hosp, Chongqing, Peoples R China	Chongqing Medical University	Yang, HP; Li, Q (corresponding author), Chongqing Med Univ, Dept Nephrol, Key Lab, Minist Educ,Childrens Hosp, Chongqing, Peoples R China.	oyhp0708@163.com; liqiu809@126.com		chen, han/0000-0002-1819-702X	National Natural Science Foundation of China [81270802, 81470946, 81200520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant numbers 81270802, 81470946, 81200520), https//isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Alfredo CS, 2007, J PEDIAT-BRAZIL, V83, P177, DOI [10.1590/S0021-75572007000200013, 10.2223/JPED.1595]; ALLEN DM, 1960, AMA J DIS CHILD, V99, P833, DOI 10.1001/archpedi.1960.02070030835021; AlSheyyab M, 1996, J TROP PEDIATRICS, V42, P200, DOI 10.1093/tropej/42.4.200; Anil M, 2009, TURKISH J PEDIATR, V51, P429; Audemard Verger A, AUTOIMMUN REV, V14, P579, DOI [10.1016/j.autrev.2015.02.003, DOI 10.1016/J.AUTREV.2015.02.003]; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Butani L, 2007, CLIN PEDIATR, V46, P505, DOI 10.1177/0009922806298896; Cakir M, 2006, ANN TROP PAEDIATR, V26, P59, DOI 10.1179/146532806X90628; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; Chan SM, 2001, CHINESE J PRACTICAL, V4, P193, DOI [10.1007/s00296-004-0452-2, DOI 10.1007/S00296-004-0452-2]; Chartapisak W, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005128.pub2; Davin JC, 2001, EUR J PEDIATR, V160, P689, DOI 10.1007/s004310100841; Davin JC, 2014, NAT REV NEPHROL, V10, P563, DOI 10.1038/nrneph.2014.126; Davin JC, 2011, CLIN J AM SOC NEPHRO, V6, P679, DOI 10.2215/CJN.06710810; de Almeida JLJ, 2007, J PEDIAT-BRAZIL, V83, P259, DOI [10.2223/JPED.1638, 10.1590/S0021-75572007000400012]; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elmas AT, 2014, ASME J DYNAMIC SYSTE, P1; FARINE M, 1986, CLIN PEDIATR, V25, P257, DOI 10.1177/000992288602500505; FARLEY TA, 1989, AM J DIS CHILD, V143, P798, DOI 10.1001/archpedi.1989.02150190048019; Fretzayas A, 2008, JCR-J CLIN RHEUMATOL, V14, P324, DOI 10.1097/RHU.0b013e31817a240a; Garcia-Porrua C, 2002, SEMIN ARTHRITIS RHEU, V32, P149, DOI 10.1053/sarh.2002.33980; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Ghrahani R, 2014, ASIA PAC ALLERGY, V4, P42, DOI 10.5415/apallergy.2014.4.1.42; Gonzalez-Gay MA, 2004, CLIN EXP RHEUMATOL, V22, P781; Hahn D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005128.pub3; [何艳燕 He Yanyan], 2002, [中华儿科杂志, Chinese Journal of Pediatrics], V40, P99; Jauhola O, 2010, ARCH DIS CHILD, V95, P877, DOI 10.1136/adc.2009.182394; Jiang JH, 2008, SKIN VENEREAL DIS, V30, P3; Kawasaki Y, 2003, CLIN NEPHROL, V60, P153; Limpongsanurak W., 2011, J MED ASS THAILAND C, V94 Suppl 3, P204; Mao S, 2016, INT J CLIN EXP MED, V9, P3607; Mao YY, 2014, J INT MED RES, V42, P1043, DOI 10.1177/0300060514530879; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Nickavar A, 2012, IRAN J KIDNEY DIS, V6, P437; Nishiyama R, 2008, DIGESTION, V77, P236, DOI 10.1159/000150697; Oki E, 2008, RHEUMATOL INT, V28, P1181, DOI 10.1007/s00296-008-0610-z; Ozen S, 2006, ANN RHEUM DIS, V65, P936, DOI 10.1136/ard.2005.046300; Ozen S, 2002, BEST PRACT RES CL RH, V16, P411, DOI 10.1053/berh.2002.0237; Rigante D, 2005, RHEUMATOL INT, V25, P45, DOI 10.1007/s00296-004-0452-2; Ronkainen J, 2002, LANCET, V360, P666, DOI 10.1016/S0140-6736(02)09835-5; Sanders JT, 2008, CURR OPIN PEDIATR, V20, P163, DOI 10.1097/MOP.0b013e3282f4308b; Sano H, 2002, EUR J PEDIATR, V161, P196, DOI 10.1007/s00431-002-0922-z; Shin JI, 2006, SCAND J RHEUMATOL, V35, P56, DOI 10.1080/03009740510026841; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; StataCorp, 2011, STAT STAT SOFTW REL; STEWART M, 1988, EUR J PEDIATR, V147, P113, DOI 10.1007/BF00442205; Trapani S, 2005, SEMIN ARTHRITIS RHEU, V35, P143, DOI 10.1016/j.semarthrit.2005.08.007; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wakaki H, 2011, PEDIATR NEPHROL, V26, P921, DOI 10.1007/s00467-011-1827-8; Wang XH, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0080-x; Zhao YL, 2015, J EUROPEAN J PEDIAT, P1; [朱建建 Zhu Jianjian], 2014, [临床皮肤科杂志, Journal of Clinical Dermatology], V43, P336	52	60	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167346	10.1371/journal.pone.0167346	http://dx.doi.org/10.1371/journal.pone.0167346			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902749	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100076
J	Leung, JM; Malagoli, A; Santoro, A; Besutti, G; Ligabue, G; Scaglioni, R; Dai, D; Hague, C; Leipsic, J; Sin, DD; Man, SFP; Guaraldi, G				Leung, Janice M.; Malagoli, Andrea; Santoro, Antonella; Besutti, Giulia; Ligabue, Guido; Scaglioni, Riccardo; Dai, Darlene; Hague, Cameron; Leipsic, Jonathon; Sin, Don D.; Man, S. F. Paul; Guaraldi, Giovanni			Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ANTIRETROVIRAL THERAPY; HIV; COPD; CT; RISK; INFLAMMATION; SYMPTOMS; SMOKERS; LUNG	Background Chronic obstructive pulmonary disease (COPD) and emphysema are common amongst patients with human immunodeficiency virus (HIV). We sought to determine the clinical factors that are associated with emphysema progression in HIV. Methods 345 HIV-infected patients enrolled in an outpatient HIV metabolic clinic with >= 2 chest computed tomography scans made up the study cohort. Images were qualitatively scored for emphysema based on percentage involvement of the lung. Emphysema progression was defined as any increase in emphysema score over the study period. Univariate analyses of clinical, respiratory, and laboratory data, as well as multivariable logistic regression models, were performed to determine clinical features significantly associated with emphysema progression. Results 17.4% of the cohort were emphysema progressors. Emphysema progression was most strongly associated with having a low baseline diffusion capacity of carbon monoxide (DLCO) and having combination centrilobular and paraseptal emphysema distribution. In adjusted models, the odds ratio (OR) for emphysema progression for every 10% increase in DLCO percent predicted was 0.58 (95% confidence interval [CI] 0.41-0.81). The equivalent OR (95% CI) for centrilobular and paraseptal emphysema distribution was 10.60 (2.93-48.98). Together, these variables had an area under the curve (AUC) statistic of 0.85 for predicting emphysema progression. This was an improvement over the performance of spirometry (forced expiratory volume in 1 second to forced vital capacity ratio), which predicted emphysema progression with an AUC of only 0.65. Conclusion Combined paraseptal and centrilobular emphysema distribution and low DLCO could identify HIV patients who may experience emphysema progression.	[Leung, Janice M.; Sin, Don D.; Man, S. F. Paul] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Leung, Janice M.; Sin, Don D.; Man, S. F. Paul] St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada; [Malagoli, Andrea; Santoro, Antonella; Besutti, Giulia; Ligabue, Guido; Scaglioni, Riccardo; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Modena HIV Metab Clin, Modena, Italy; [Dai, Darlene] Univ British Columbia, PROOF Ctr Excellence, Vancouver, BC, Canada; [Hague, Cameron; Leipsic, Jonathon] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; Universita di Modena e Reggio Emilia; University of British Columbia; University of British Columbia	Guaraldi, G (corresponding author), Univ Modena & Reggio Emilia, Modena HIV Metab Clin, Modena, Italy.	Giovanni.guaraldi@unimore.it	Leipsic, Jonathon/ABE-6194-2020; Sin, Don/AAC-2219-2021; Guaraldi, Giovanni/J-9467-2018; Besutti, Giulia/K-5453-2018; Malagoli, Andrea/I-7744-2015	Besutti, Giulia/0000-0001-5319-5495; Malagoli, Andrea/0000-0001-7857-4133; Santoro, Antonella/0000-0002-2345-9135	RICERCA FINALIZZATA, Ministry of Health [GR-2011-0230596]	RICERCA FINALIZZATA, Ministry of Health	This work was supported by RICERCA FINALIZZATA 2011-2012, Ministry of Health (Project code: GR-2011-0230596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by RICERCA FINALIZZATA 2011-2012, Ministry of Health (Project code: GR-2011-0230596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron CP, 2015, RESP MED, V109, P255, DOI 10.1016/j.rmed.2014.10.004; Attia EF, 2014, CHEST, V146, P1543, DOI 10.1378/chest.14-0543; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bhavani S, 2015, AM J RESP CRIT CARE, V192, P1171, DOI 10.1164/rccm.201504-0736OC; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; Clausen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112237; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Drummond MB, 2013, AIDS, V27, P1303, DOI 10.1097/QAD.0b013e32835e395d; Edge J, 1966, BR J DIS CHEST, V60, P10; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gietema HA, 2013, RESP MED, V107, P1201, DOI 10.1016/j.rmed.2013.04.016; Gingo MR, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-75; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Leung JM, 2014, AIDS PATIENT CARE ST, V28, P240, DOI 10.1089/apc.2013.0373; Liu JCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124426; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Norris KA, 2006, IMMUNOL RES, V36, P175, DOI 10.1385/IR:36:1:175; Norris KA, 2011, IMMUNOL RES, V50, P175, DOI 10.1007/s12026-011-8218-x; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Sigel K, 2014, AIDS LONDON ENGLAND; Smith BM, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2013.09.020; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167247	10.1371/journal.pone.0167247	http://dx.doi.org/10.1371/journal.pone.0167247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902753	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100063
J	Malatesta, L; Tardella, FM; Piermarteri, K; Catorci, A				Malatesta, Luca; Tardella, Federico Maria; Piermarteri, Karina; Catorci, Andrea			Evidence of Facilitation Cascade Processes as Drivers of Successional Patterns of Ecosystem Engineers at the Upper Altitudinal Limit of the Dry Puna	PLOS ONE			English	Article							PLANT-PLANT INTERACTIONS; STRESS-GRADIENT HYPOTHESIS; SPECIES RICHNESS; PHYLOGENETIC DIVERSITY; COMMUNITY ORGANIZATION; POSITIVE INTERACTIONS; SPATIAL INTERACTIONS; CUSHION PLANTS; NURSE PLANTS; SOIL	Facilitation processes constitute basic elements of vegetation dynamics in harsh systems. Recent studies in tropical alpine environments demonstrated how pioneer plant species defined as "ecosystem engineers" are capable of enhancing landscape-level richness by adding new species to the community through the modification of microhabitats, and also provided hints about the alternation of different ecosystem engineers over time. Nevertheless, most of the existing works analysed different ecosystem engineers separately, without considering the interaction of different ecosystem engineers. Focusing on the altitudinal limit of Peruvian Dry Puna vegetation, we hypothesized that positive interactions structure plant communities by facilitation cascades involving different ecosystem engineers, determining the evolution of the microhabitat patches in terms of abiotic resources and beneficiary species hosted. To analyze successional mechanisms, we used a "space-for-time" substitution to account for changes over time, and analyzed data on soil texture, composition, and temperature, facilitated species and their interaction with nurse species, and surface area of engineered patches by means of chemical analyses, indicator species analysis, and rarefaction curves. A successional process, resulting from the dynamic interaction of different ecosystem engineers, which determined a progressive amelioration of soil conditions (e.g. nitrogen and organic matter content, and temperature), was the main driver of species assemblage at the community scale, enhancing species richness. Cushion plants act as pioneers, by starting the successional processes that continue with shrubs and tussocks. Tussock grasses have sometimes been found to be capable of creating microhabitat patches independently. The dynamics of species assemblage seem to follow the nested assemblage mechanism, in which the first foundation species to colonize a habitat provides a novel substrate for colonization by other foundation species through a facilitation cascade process.	[Malatesta, Luca; Piermarteri, Karina] Univ Camerino, Sch Adv Studies, Camerino, Macerata, Italy; [Tardella, Federico Maria; Catorci, Andrea] Univ Camerino, Sch Biosci & Vet Med, Camerino, Macerata, Italy	University of Camerino; University of Camerino	Tardella, FM (corresponding author), Univ Camerino, Sch Biosci & Vet Med, Camerino, Macerata, Italy.	dtfederico.tardella@unicam.it		Malatesta, Luca/0000-0003-1887-4163	University Research Funds (FAR); School of Advanced Studies PhD Course in Environmental Sciences and Public Health, University of Camerino (Italy)	University Research Funds (FAR); School of Advanced Studies PhD Course in Environmental Sciences and Public Health, University of Camerino (Italy)	The research was funded by University Research Funds (FAR 2012) assigned by the University of Camerino (Italy) to AC (http://www. unicam.it/) and a grant of the School of Advanced Studies PhD Course in Environmental Sciences and Public Health, University of Camerino (Italy) assigned to LM (http://isas.unicamit/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; Anthelme F, 2012, PERSPECT PLANT ECOL, V14, P363, DOI 10.1016/j.ppees.2012.05.002; Anthelme F, 2012, J VEG SCI, V23, P62, DOI 10.1111/j.1654-1103.2011.01333.x; Armas C, 2013, NEW PHYTOL, V200, P7, DOI 10.1111/nph.12460; Arredondo-Nunez A, 2009, COMMUNITY ECOL, V10, P1, DOI 10.1556/ComEc.10.2009.1.1; Badano EI, 2002, REV CHIL HIST NAT, V75, P757; Badano EI, 2006, OIKOS, V115, P369, DOI 10.1111/j.2006.0030-1299.15132.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brack Egg A, 2000, ECOLOGIA DEL PERU; Brako L, 1993, MONOGRAPHS SYSTEMATI, P45; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Caceres Y, 2015, PLANT ECOL DIVERS, V8, P147, DOI 10.1080/17550874.2014.960173; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Callaway RM, 2005, ECOLOGY, V86, P1856, DOI 10.1890/04-0784; Carteni F, 2012, J THEOR BIOL, V313, P153, DOI 10.1016/j.jtbi.2012.08.008; Catorci A, 2012, COMMUNITY ECOL, V13, P253, DOI 10.1556/ComEc.13.2012.2.16; Catorci A, 2016, J PLANT ECOL, V9, P296, DOI 10.1093/jpe/rtv062; Catorci A, 2014, POL J ECOL, V62, P385, DOI 10.3161/104.062.0201; Catorci A, 2014, PHYTOCOENOLOGIA, V44, P103, DOI 10.1127/0340-269X/2014/0044-0577; Catorci A, 2011, ALPINE BOT, V121, P113, DOI 10.1007/s00035-011-0097-1; Cavieres LA, 2007, ARCT ANTARCT ALP RES, V39, P229, DOI 10.1657/1523-0430(2007)39[229:MMOCPA]2.0.CO;2; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; El-Keblawy A, 2016, J ARID ENVIRON, V125, P127, DOI 10.1016/j.jaridenv.2015.10.007; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; HALVORSON JJ, 1995, SOIL SCI SOC AM J, V59, P1476, DOI 10.2136/sssaj1995.03615995005900050038x; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Badano EI, 2010, ACTA OECOL, V36, P46, DOI 10.1016/j.actao.2009.09.008; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kleier C, 2009, PLANT BIOLOGY, V11, P351, DOI 10.1111/j.1438-8677.2008.00115.x; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Li XR, 2007, PLANT SOIL, V300, P221, DOI 10.1007/s11104-007-9407-1; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; McCune B, 2002, ANAL ECOLOGICAL COMM; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Michalet R, 2015, J VEG SCI, V26, P207, DOI 10.1111/jvs.12226; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Molina-Montenegro Marco A, 2005, Ecol. austral, V15, P49; Molina-Montenegro Marco A., 2000, Gayana Botanica, V57, P161; Monteiro JAF, 2011, FLORA, V206, P387, DOI 10.1016/j.flora.2011.01.001; Moro MJ, 1997, FUNCT ECOL, V11, P425, DOI 10.1046/j.1365-2435.1997.00106.x; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Piston N, 2016, PERSPECT PLANT ECOL, V19, P30, DOI 10.1016/j.ppees.2016.02.002; Ramirez L, 2013, THESIS; Ramirez LA, 2015, PLANT ECOL, V216, P213, DOI 10.1007/s11258-014-0429-5; Schob C, 2013, J ECOL, V101, P753, DOI 10.1111/1365-2745.12062; Schob C, 2012, NEW PHYTOL, V196, P824, DOI 10.1111/j.1469-8137.2012.04306.x; SCOTTWENDT J, 1988, SOIL SCI, V145, P414, DOI 10.1097/00010694-198806000-00002; Sklenar P, 2009, FLORA, V204, P270, DOI 10.1016/j.flora.2008.04.001; Soil Laboratory Staff, 1984, AN METH SERV LAB SOI, P63; Soliveres S, 2014, PERSPECT PLANT ECOL, V16, P154, DOI 10.1016/j.ppees.2014.04.001; Sparling G, 2003, SOIL BIOL BIOCHEM, V35, P1575, DOI 10.1016/j.soilbio.2003.08.002; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Tighe M, 2009, AGR ECOSYST ENVIRON, V132, P212, DOI 10.1016/j.agee.2009.04.001; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; VALIENTEBANUET A, 1991, J VEG SCI, V2, P11, DOI 10.2307/3235892; Van Reeuwijk L.P., 2006, PROCEDURES SOIL ANAL, V7th ed.; Vuille M, 1998, J GEOPHYS RES-ATMOS, V103, P11191, DOI 10.1029/98JD00681; Wilson BR, 2007, AUST J SOIL RES, V45, P199, DOI 10.1071/SR07019; Xiao S, 2009, OIKOS, V118, P1343, DOI 10.1111/j.1600-0706.2009.17588.x; Yakovis EL, 2008, OECOLOGIA, V155, P785, DOI 10.1007/s00442-007-0945-2	67	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167265	10.1371/journal.pone.0167265	http://dx.doi.org/10.1371/journal.pone.0167265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902757	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100066
J	Mayeur, S; Veilleux, A; Pouliot, Y; Lamarche, B; Beaulieu, JF; Hould, FS; Richard, D; Tchernof, A; Levy, E				Mayeur, Sylvain; Veilleux, Alain; Pouliot, Yves; Lamarche, Benoit; Beaulieu, Jean-Francois; Hould, Frederic S.; Richard, Denis; Tchernof, Andre; Levy, Emile			Plasma Lactoferrin Levels Positively Correlate with Insulin Resistance despite an Inverse Association with Total Adiposity in Lean and Severely Obese Patients	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-DISEASE; CACO-2 CELLS; VISCERAL FAT; WEIGHT-LOSS; IN-VIVO; WOMEN; TISSUE; MEN; METABOLISM	Context Lactoferrin (Lf) is an important protein found on mucosal surfaces, within neutrophils and various cells, and in biological fluids. It displays multiple functions, including iron-binding as well as antimicrobial, immunomodulatory and anti-inflammatory activities. Although Lf ingestion has been suggested to cause adiposity reduction in murine models and humans, its relationship with insulin resistance (IR) has not been studied thoroughly. Objective To establish the association between circulating Lf levels, glucose status and blood lipid/lipoprotein profile. Methods Two independent cohorts were examined: lean to moderately obese women admitted for gynecological surgery (n = 53) and severely obese subjects undergoing biliopancreatic diversion (n = 62). Results Although body mass index (BMI) and total body fat mass were negatively associated with Lf, IR (assessed by the HOMA-IR index) was positively and independently associated with plasma Lf concentrations of the first cohort of lean to moderately obese women. These observations were validated in the second cohort in view of the positive correlation between plasma Lf concentrations and the HOMA-IR index, but without a significant association with the body mass index (BMI) of severely obese subjects. In subsamples of severely obese subjects matched for sex, age and BMI, but with either relatively low (1.89 +/- 0.73) or high (13.77 +/- 8.81) IR states (according to HOMA-IR), higher plasma Lf levels were noted in insulin- resistant vs insulin-sensitive subjects (P<0.05). Finally, Lf levels were significantly higher in lean to moderately obese women than in severely obese subjects (P<0.05). Conclusion Our findings revealed that plasma Lf levels are strongly associated with IR independently of total adiposity, which suggests an intriguing Lf regulation mechanism in conditions of obesity and IR.	[Mayeur, Sylvain; Veilleux, Alain; Levy, Emile] Univ Montreal, Res Ctr CHU St Justine, Montreal, PQ, Canada; [Pouliot, Yves; Lamarche, Benoit; Tchernof, Andre; Levy, Emile] Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ, Canada; [Beaulieu, Jean-Francois] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cellular Biol, Sherbrooke, PQ, Canada; [Hould, Frederic S.; Richard, Denis] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Laval University; University of Sherbrooke; Universite de Montreal	Levy, E (corresponding author), Univ Montreal, Res Ctr CHU St Justine, Montreal, PQ, Canada.; Levy, E (corresponding author), Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ, Canada.; Levy, E (corresponding author), Univ Montreal, Dept Nutr, Montreal, PQ, Canada.	emile.levy@recherche-ste-justine.qc.ca	Veilleux, Alain/I-5028-2019; Lamarche, Benoit/ABA-4785-2021; Pouliot, Yves/AAD-5836-2020	Veilleux, Alain/0000-0003-4078-1908; Lamarche, Benoit/0000-0002-4443-5378; Tchernof, Andre/0000-0002-2587-1000				Abrink M, 2000, KIDNEY INT, V57, P2004, DOI 10.1046/j.1523-1755.2000.00050.x; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Baveye S, 2000, INFECT IMMUN, V68, P6519, DOI 10.1128/IAI.68.12.6519-6525.2000; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Blanchette S, 2005, J CLIN ENDOCR METAB, V90, P264, DOI 10.1210/jc.2004-0583; Brock JH, 2012, BIOCHEM CELL BIOL, V90, P245, DOI [10.1139/O2012-018, 10.1139/o2012-018]; Denis MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053725; Doursout MF, 2013, INT IMMUNOPHARMACOL, V15, P227, DOI 10.1016/j.intimp.2012.12.009; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garcia-Rios A, 2013, CURR OPIN CARDIOL, V28, P475, DOI 10.1097/HCO.0b013e32836081a5; Hirotani Y, 2008, YAKUGAKU ZASSHI, V128, P1363, DOI 10.1248/yakushi.128.1363; Hu WP, 2012, BIOCHEM CELL BIOL, V90, P485, DOI [10.1139/o2012-003, 10.1139/O2012-003]; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Kim JY, 2014, PEDIAT OBESITY; Kruzel ML, 2010, INNATE IMMUN-LONDON, V16, P67, DOI 10.1177/1753425909105317; Latorre D, 2012, BIOCHEM CELL BIOL, V90, P269, DOI [10.1139/O11-059, 10.1139/o11-059]; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Moreno-Navarrete JM, 2008, CLIN CHEM, V54, P301, DOI 10.1373/clinchem.2007.095943; Moreno-Navarrete JM, 2014, J CELL MOL MED, V18, P391, DOI 10.1111/jcmm.12234; Moreno-Navarrete JM, 2013, J NUTR BIOCHEM, V24, P1266, DOI 10.1016/j.jnutbio.2012.10.002; Mastromarino P, 2014, BIOMETALS INT J ROLE; MOORJANI S, 1987, METABOLISM, V36, P244, DOI 10.1016/0026-0495(87)90183-1; Moreno-Navarrete JM, 2009, J CLIN ENDOCR METAB, V94, P4036, DOI 10.1210/jc.2009-0215; Moreno-Navarrete JM, 2009, INT J OBESITY, V33, P991, DOI 10.1038/ijo.2009.143; Morishita S, 2013, J OLEO SCI, V62, P97, DOI 10.5650/jos.62.97; Oda H, 2014, BIOMETALS INT J ROLE; Ono T, 2010, BRIT J NUTR, V104, P1688, DOI 10.1017/S0007114510002734; Pilvi TK, 2009, BRIT J NUTR, V102, P337, DOI 10.1017/S0007114508199445; Poddar K, 2011, NUTR CLIN PRACT, V26, P539, DOI 10.1177/0884533611419859; Suzuki YA, 2001, BIOCHEMISTRY-US, V40, P15771, DOI 10.1021/bi0155899; Takeuchi T, 2004, EXP PHYSIOL, V89, P263, DOI 10.1113/expphysiol.2003.026633; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Troost FJ, 2002, J NUTR, V132, P2597, DOI 10.1093/jn/132.9.2597; Troost FJ, 2001, J NUTR, V131, P2101, DOI 10.1093/jn/131.8.2101; Veilleux A, 2014, ARTERIOSCLEROSIS THR; Vengen IT, 2010, ATHEROSCLEROSIS, V212, P614, DOI 10.1016/j.atherosclerosis.2010.06.008; Wang YZ, 2006, ARCH ANIM NUTR, V60, P1, DOI 10.1080/17450390500468255; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; Yagi Motohiko, 2008, J Oral Sci, V50, P419; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166138	10.1371/journal.pone.0166138	http://dx.doi.org/10.1371/journal.pone.0166138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902700	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100014
J	Meier, JS; Goring-Morris, AN; Munro, ND				Meier, Jacqueline S.; Goring-Morris, A. Nigel; Munro, Natalie D.			Provisioning the Ritual Neolithic Site of Kfar HaHoresh, Israel at the Dawn of Animal Management	PLOS ONE			English	Article							BROAD-SPECTRUM REVOLUTION; EL-WAD TERRACE; GAZELLE EXPLOITATION; FORAGING EFFICIENCY; SOUTHERN LEVANT; DNA ANALYSIS; NEAR-EAST; DOMESTICATION; ORIGINS; WILD	It is widely agreed that a pivotal shift from wild animal hunting to herd animal management, at least of goats, began in the southern Levant by the Middle Pre-Pottery Neolithic B period (10,000-9,500 cal. BP) when evidence of ritual activities flourished in the region. As our knowledge of this critical change grows, sites that represent different functions and multiple time periods are needed to refine the timing, pace and character of changing human-animal relationships within the geographically variable southern Levant. In particular, we investigate how a ritual site was provisioned with animals at the time when herd management first began in the region. We utilize fauna from the 2010-2012 excavations at the mortuary site of Kfar HaHoresh-the longest continuous Pre-Pottery Neolithic B faunal sequence in the south Levantine Mediterranean Hills (Early-Late periods, 10,600-8,700 cal. BP). We investigate the trade-off between wild and domestic progenitor taxa and classic demographic indicators of management to detect changes in hunted animal selection and control over herd animal movement and reproduction. We find that ungulate selection at Kfar HaHoresh differs from neighboring sites, although changes in dietary breadth, herd demographics and body-size data fit the regional pattern of emerging management. Notably, wild ungulates including aurochs and gazelle are preferentially selected to provision Kfar HaHoresh in the PPNB, despite evidence that goat management was underway in the Mediterranean Hills. The preference for wild animals at this important site likely reflects their symbolic significance in ritual and mortuary practice.	[Meier, Jacqueline S.; Munro, Natalie D.] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Goring-Morris, A. Nigel] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University of Connecticut; Hebrew University of Jerusalem	Meier, JS (corresponding author), Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA.	jacqueline.meier@uconn.edu		Munro, Natalie/0000-0003-1690-6133; Goring-Morris, Adrian Nigel/0000-0003-1673-7747; Meier, Jacqueline/0000-0003-2003-9482	National Science Foundation Dissertation Improvement Grant [1355608]; The Irene Levi Sala CARE Foundation; University of Connecticut Department of Anthropology Summer Research Fellowships; University of Connecticut Department of Anthropology Dissertation Writing Fellowship; Israel Science Foundation - Israel Academy of Sciences and Humanities [840/01, 558/04, 755/07, 1161/10]; National Geographic Society [8625/09]; Irene Levi Sala CARE Foundation	National Science Foundation Dissertation Improvement Grant(National Science Foundation (NSF)); The Irene Levi Sala CARE Foundation; University of Connecticut Department of Anthropology Summer Research Fellowships; University of Connecticut Department of Anthropology Dissertation Writing Fellowship; Israel Science Foundation - Israel Academy of Sciences and Humanities(Israel Science Foundation); National Geographic Society(National Geographic Society); Irene Levi Sala CARE Foundation	This research was completed as part of a dissertation project supported by a National Science Foundation Dissertation Improvement Grant to JM (Award 1355608, PI-NM) [http://www.nsf.gov/pubs/2014/nsf14566/nsf14566.htm]. Preliminary data collection was funded by the The Irene Levi Sala CARE Foundation (Awarded to NM) [http://prehistory.org.il/?page_id=894]. Fieldwork of JM was supported by the University of Connecticut Department of Anthropology Summer Research Fellowships. Analysis and writing was made possible by the University of Connecticut Department of Anthropology Dissertation Writing Fellowship. Investigations at Kfar HaHoresh have been supported by generous grants (to ANG-M) from the Israel Science Foundation funded by the Israel Academy of Sciences and Humanities (Grants 840/01, 558/04, 755/07, and 1161/10) [http://www.academy.ac.il/english.htm], The National Geographic Society (Grant 8625/09) [http://www.nationalgeographic.com/explorers/be-an-explorer/] and The Irene Levi Sala CARE Foundation (grant to ANG-M).	[Anonymous], [No title captured]; Arbuckle B. S., 2014, BIOARCHAEOL NEAR E, V8, P53; Arbuckle BS, 2013, J ARCHAEOL SCI, V40, P1805, DOI 10.1016/j.jas.2012.12.008; Arbuckle BS, 2009, ANTIQUITY, V83, P669, DOI 10.1017/S0003598X00098902; Arbuckle Benjamin S., 2009, Anthropozoologica, V44, P129, DOI 10.5252/az2009n1a6; Bar-Gal GK, 2003, INT J OSTEOARCHAEOL, V13, P120, DOI 10.1002/oa.666; Bar-Oz G, 2004, J ARCHAEOL SCI, V31, P217, DOI 10.1016/j.jas.2003.08.003; Bar-Yosef O., 2000, ARCHAEOZOOLOGY NEAR, P185; Becker C., 2002, ARCHAEOZOOLOGY NEAR, P112; Bell Catherine, 1997, RITUAL PERSPECTIVES; Birkenfeld M, 2014, DEBATING SPATIAL ARC, P65; Birkenfeld M, 2015, ARCHAEOLOGICAL REV C, P7; Bokonyi Sandor, 1969, DOMEST EXPLOIT PLANT, P607; Bonogofsky Michelle, 2003, B AM SCH ORIENT RES, V331, P1, DOI DOI 10.2307/1357755; BROUGHTON JM, 1994, J ANTHROPOL ARCHAEOL, V13, P371, DOI 10.1006/jaar.1994.1019; Cauvin J., 1994, NAISSANCE DIVINITE N; Clutton-Brock J., 1979, Proceedings of the Prehistoric Society, V45, P135; Clutton-Brock J., 1987, NATURAL HIST DOMESTI; Conolly J, 2011, J ARCHAEOL SCI, V38, P538, DOI 10.1016/j.jas.2010.10.008; Davis S., 1982, PALEORIENT, V8, P5; Davis SJM, 2005, J ARCHAEOL SCI, V32, P1408, DOI 10.1016/j.jas.2005.03.018; DAVIS SJM, 1981, PALEOBIOLOGY, V7, P101, DOI 10.1017/S0094837300003821; DAVIS SJM, 1980, ISRAEL J ZOOL, V29, P129; Davis SJM, 1982, PALEORIENT, V8, P87, DOI [10.3406/paleo.1982.4313, DOI 10.3406/PALEO.1982.4313]; Davis SJM, 1985, PRELIMINARY REPORT F, V1, P71; deFrance SD, 2009, J ARCHAEOL RES, V17, P105, DOI 10.1007/s10814-008-9027-1; Doane DP, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889611; Ducos P., 1998, Paleorient, V23, P229; Ducos P, 1978, A GOSH BEISAMOUN 2 G, P107; Ducos P., 2003, NEOLITHIC SITE ABU G, P103; EDGE WD, 1990, J MAMMAL, V71, P156, DOI 10.2307/1382162; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Getzov N., 2009, J ISRAEL PREHISTORIC, V39, P81; Goring-Morris A. N., 1998, NEOLITHICS, V3, P1; Goring-Morris A.N., 2000, LIFE NEOLITHIC FARMI, P103, DOI DOI 10.1007/0-306-47166-3_5; Goring-Morris A. Nigel, 2002, MAGIC PRACTICES RITU, P67; Goring-Morris AN, 2008, ANTIQUITY, V82, P314; Goring-Morris AN, 2008, HORIZONS, V12, P20; Goring-Morris N, 2007, ANTIQUITY, V81, P902, DOI 10.1017/S0003598X00095995; Grigson C., 1989, BAR International Series, P77; Harper DAT, PALEONTOLOGICAL DATA; Hayden B, 2009, CURR ANTHROPOL, V50, P597, DOI 10.1086/605110; Herrero J, 2008, ACTA THERIOL, V53, P355, DOI 10.1007/BF03195196; Hodder I, 2004, AM ANTIQUITY, V69, P17, DOI 10.2307/4128346; Hodder I, 2011, CURR ANTHROPOL, V52, P235, DOI 10.1086/659250; Hongo Hitomi, 2009, Anthropozoologica, V44, P63, DOI 10.5252/az2009n1a3; Hongo Hitomi, 2000, ARCHAEOZOOLOGY NEAR, P121; Horwitz L.K., 2003, Paleorient, V29, P19, DOI 10.3406/paleo.2003.4753; Horwitz L.K., 2010, GILGAL EARLY NEOLITH, P263; Horwitz Liora Kolska, 2004, Anthropozoologica, V39, P165; Horwitz Liora Kolska, 2000, Paleorient, V25, P63; Horwitz Liora Kolska, 1997, Archaeozoologia, V8, P53; Horwitz LK, 2006, REV PALEOBIOLOGIE, V24, P209; Horwitz LK, 1998, MAN ANIMAL WORLD, P307; Ibanez JJ, 2010, ANTIQUITY, P84; Khalaily H, 2007, PALEORIENT, V33, P5, DOI DOI 10.3406/PALE0.2007.5218; Kuijt I, 2002, J WORLD PREHIST, V16, P361, DOI 10.1023/A:1022973114090; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Legge AJ, 1973, P PREHIST SOC, V39, P75; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Makarewicz CA, 2016, ENVIRON ARCHAEOL, V21, P199, DOI 10.1179/1749631415Y.0000000024; Manning K, 2013, ANTIQUITY, V87, P1046, DOI 10.1017/S0003598X00049851; Marom N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055958; Martin L, 2013, PUBL INST ARCHAEOL, V59, P49; Meadow RH., 1999, HISTORICI ANIMALIUM, P285; Meier JS, AUROCHS BONE D UNPUB; Mendelssohn H., 1999, MAMMALIA OF ISRAEL; Migowski C, 2006, QUATERNARY RES, V66, P421, DOI 10.1016/j.yqres.2006.06.010; Munro N.D., 2003, MITTEILUNGEN GESELLS, V12, P47; Munro N, 2009, VERTEBR PALEOBIOL PA, P141, DOI 10.1007/978-1-4020-9699-0_10; Munro ND, 2009, J ARCHAEOL SCI, V36, P752, DOI 10.1016/j.jas.2008.10.020; Munro ND, 2004, CURR ANTHROPOL, V45, pS5, DOI 10.1086/422084; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Ozdogan M, 1999, ANCIENT ANATOLIANS C; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Paz Y, 2008, HADASHOT ARKHEOLOGIY, V49, P119; Peters Joris, 2004, Anthropozoologica, V39, P179; Peters Joris, 2000, Paleorient, V25, P27; Rappaport Roy., 1999, RITUAL RELIG MAKING, DOI DOI 10.1017/CBO9780511814686; Redding RW, 1981, THESIS; Rollefson G. O., 1998, BAR INT SER-US, V705, P102; Rowley-Conwy P, 2012, J WORLD PREHIST, V25, P1, DOI 10.1007/s10963-012-9055-0; Russell N, 2002, SOC ANIM, V10, P285, DOI 10.1163/156853002320770083; Russell Nerissa, 2009, Anthropozoologica, V44, P103, DOI 10.5252/az2009n1a5; Sapir-Hen L, IAA REPORTS IN PRESS; Sapir-Hen L, 2016, PLOS ONE, P11; Sapir-Hen L, 2009, J ARCHAEOL SCI, V36, P1538, DOI 10.1016/j.jas.2009.03.015; SHANKLIN E, 1985, ANNU REV ANTHROPOL, V14, P375, DOI 10.1146/annurev.an.14.100185.002111; Simmons AH., 2011, NEOLITHIC REVOLUTION; Slon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089242; Spielmann KA, 2002, AM ANTHROPOL, V104, P195, DOI 10.1525/aa.2002.104.1.195; Stiner MC, 2014, P NATL ACAD SCI USA, V111, P8404, DOI 10.1073/pnas.1322723111; Stiner MC, 2002, J ARCHAEOL METHOD TH, V9, P181, DOI 10.1023/A:1016530308865; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Tchernov E, 1994, EARLY NEOLITHIC VILL; Tchernov Eitan, 1993, P10; Twiss KC, 2008, J ANTHROPOL ARCHAEOL, V27, P418, DOI 10.1016/j.jaa.2008.06.002; Twiss Kathryn C., 2009, Paleorient, V35, P19; Uerpmann M., 1994, QALAAT AL BAHRAIN TH, V30(1), P417; Verhoeven M, 2002, CAMB ARCHAEOL J, V12, P233, DOI 10.1017/S0959774302000124; von den Driesch A., 1997, PREHISTORY JORDAN 2, P511; Waheeb M, 1997, AYN EL JAMMAM NEOLIT, P215; Watkins T, 2005, ARCHAEOLOGICAL PERSP, P84; Whitcher Kansa S., 2004, BEHAV BONES ZOOARCHA, P2; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; WINTERHALDER B, 1993, CURR ANTHROPOL, V34, P710, DOI 10.1086/204214; Wolverton S, 2008, AM ANTIQUITY, V73, P179, DOI 10.2307/25470475; Yeshurun R, 2014, J HUM EVOL, V70, P16, DOI 10.1016/j.jhevol.2014.02.011; Zeder MA, 2001, J ARCHAEOL SCI, V28, P61, DOI 10.1006/jasc.1999.0555; Zeder Melinda A., 2006, P87; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P181; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307; [No title captured]	115	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166573	10.1371/journal.pone.0166573	http://dx.doi.org/10.1371/journal.pone.0166573			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EE3FV	27902736	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100029
J	Broad, KD; Hassell, J; Fleiss, B; Kawano, G; Ezzati, M; Rocha-Ferreira, E; Hristova, M; Bennett, K; Fierens, I; Burnett, R; Chaban, B; Alonso-Alconada, D; Oliver-Taylor, A; Tachsidis, I; Rostami, J; Gressens, P; Sanders, RD; Robertson, NJ				Broad, Kevin D.; Hassell, Jane; Fleiss, Bobbi; Kawano, Go; Ezzati, Mojgan; Rocha-Ferreira, Eridan; Hristova, Mariya; Bennett, Kate; Fierens, Igor; Burnett, Ryan; Chaban, Badr; Alonso-Alconada, Daniel; Oliver-Taylor, Aaron; Tachsidis, Ilias; Rostami, Jamshid; Gressens, Pierre; Sanders, Robert D.; Robertson, Nicola J.			Isoflurane Exposure Induces Cell Death, Microglial Activation and Modifies the Expression of Genes Supporting Neurodevelopment and Cognitive Function in the Male Newborn Piglet Brain	PLoS One			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEVELOPING RAT-BRAIN; DEVELOPMENTAL PLASTICITY; NEURONAL APOPTOSIS; CHILDHOOD EXPOSURE; NEURAL CIRCUITS; NERVOUS-SYSTEM; ADULT RATS; ANESTHESIA; MEMORY	Exposure of the brain to general anesthesia during early infancy may adversely affect its neural and cognitive development. The mechanisms mediating this are complex, incompletely understood and may be sexually dimorphic, but include developmentally inappropriate apoptosis, inflammation and a disruption to cognitively salient gene expression. We investigated the effects of a 6h isoflurane exposure on cell death, microglial activation and gene expression in the male neonatal piglet brain. Piglets (n = 6) were randomised to: (i) naive controls or (ii) 6h isoflurane. Cell death (TUNEL and caspase-3) and microglial activation were recorded in 7 brain regions. Changes in gene expression (microarray and qPCR) were assessed in the cingulate cortex. Electroencephalography (EEG) was recorded throughout. Isoflurane anesthesia induced significant increases in cell death in the cingulate and insular cortices, caudate nucleus, thalamus, putamen, internal capsule, periventricular white matter and hippocampus. Dying cells included both neurons and oligodendrocytes. Significantly, microglial activation was observed in the insula, pyriform, hippocampus, internal capsule, caudate and thalamus. Isoflurane induced significant disruption to the expression of 79 gene transcripts, of these 26 are important for the control of transcription and 23 are important for the mediation of neural plasticity, memory formation and recall. Our observations confirm that isoflurane increases apoptosis and inflammatory responses in the neonatal piglet brain but also suggests novel additional mechanisms by which isoflurane may induce adverse neural and cognitive development by disrupting the expression of genes mediating activity dependent development of neural circuits, the predictive adaptive responses of the brain, memory formation and recall.	[Broad, Kevin D.; Hassell, Jane; Kawano, Go; Ezzati, Mojgan; Rocha-Ferreira, Eridan; Hristova, Mariya; Bennett, Kate; Fierens, Igor; Burnett, Ryan; Chaban, Badr; Alonso-Alconada, Daniel; Oliver-Taylor, Aaron; Rostami, Jamshid; Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England; [Fleiss, Bobbi; Gressens, Pierre] Kings Coll London, Ctr Developing Brain, St Thomass Campus, London, England; [Fleiss, Bobbi; Gressens, Pierre] INSERM, Paris, France; [Fleiss, Bobbi; Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tachsidis, Ilias] UCL, Dept Med Phys & Biomed Engn, London, England; [Sanders, Robert D.] Univ Wisconsin, Dept Anesthesiol, Madison, WI USA; [Sanders, Robert D.] UCL, Wellcome Dept Imaging Neurosci, London, England; [Sanders, Robert D.] Univ Coll London Hosp, Surg Outcomes Res Ctr, London, England	University of London; University College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Robertson, NJ (corresponding author), UCL, Inst Womens Hlth, London, England.	n.robertson@ucl.ac.uk	Robertson, Nicola/GWR-2021-2022; Kawano, Go/AAI-5080-2021; gressens, pierre/M-7557-2017; Fleiss, Bobbi/F-9899-2011	Kawano, Go/0000-0003-2962-0556; gressens, pierre/0000-0002-0909-4221; Fleiss, Bobbi/0000-0001-7828-673X; Alonso-Alconada, Daniel/0000-0002-9874-2947; Sanders, Robert/0000-0003-0113-0328; Rocha Ferreira, Eridan/0000-0002-9342-4691	UK Department of Health's National Institute for Health Research Biomedical Research Centre; MRC Medical Research Council UK [MR/J00457X/1]; Basque Government Postdoctoral Program [POS_2013_1_191]; MRC [MR/M006743/1] Funding Source: UKRI; Medical Research Council [MR/M006743/1] Funding Source: researchfish	UK Department of Health's National Institute for Health Research Biomedical Research Centre; MRC Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basque Government Postdoctoral Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme. This study was funded by the MRC Medical Research Council UK (Grant: MR/J00457X/1 URL: http://www.mrc.ac.uk) as part of a larger project. DAA was funded by the Basque Government Postdoctoral Program (POS_2013_1_191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2007, J NUTR, V137, P1060, DOI 10.1093/jn/137.4.1060; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Broad KD, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6827135; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Cao WY, 2014, BEHAV BRAIN RES, V265, P76, DOI 10.1016/j.bbr.2014.02.022; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Crawford Charles, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P39; Creeley CE, 2014, ANESTHESIOLOGY, V120, P626, DOI 10.1097/ALN.0000000000000037; Culley DJ, 2013, BRIT J ANAESTH, V110, P19, DOI 10.1093/bja/aet169; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Edmonds H L Jr, 1985, Int J Clin Monit Comput, V1, P201, DOI 10.1007/BF01720184; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Glenn AL, 2009, INT J LAW PSYCHIAT, V32, P253, DOI 10.1016/j.ijlp.2009.04.002; Gluckman PD, 2005, FETAL MATRIX EVOLUTI; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Gordon KA, 2011, BRAIN TOPOGR, V24, P204, DOI 10.1007/s10548-011-0181-2; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Hayashi K, 2012, NEUROSCI LETT, V517, P87, DOI 10.1016/j.neulet.2012.04.028; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Hewitson TD, 2010, METHODS MOL BIOL, V611, P161, DOI 10.1007/978-1-60327-345-9_13; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Ji MH, 2014, MOL NEUROBIOL, V50, P937, DOI 10.1007/s12035-014-8659-z; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kalenka A, 2010, J NEUROSURG ANESTH, V22, P144, DOI 10.1097/ANA.0b013e3181cb7cb8; Kargaran P, 2015, EUR J ANAESTH, V32, P336, DOI 10.1097/EJA.0000000000000128; Kotani N, 1999, ANESTH ANALG, V89, P1250, DOI 10.1213/00000539-199911000-00032; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; LERMAN J, 1990, ANESTHESIOLOGY, V73, P717, DOI 10.1097/00000542-199010000-00018; Li H, 2013, NEUROBIOL DIS, V54, P216, DOI 10.1016/j.nbd.2012.12.014; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lunardi N, 2010, NEUROTOX RES, V17, P179, DOI 10.1007/s12640-009-9088-z; Ma DQ, 2007, ANESTHESIOLOGY, V106, P746, DOI 10.1097/01.anes.0000264762.48920.80; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Pilge S, 2014, BRIT J ANAESTH, V112, P1067, DOI 10.1093/bja/aeu016; Priebe NJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI [10.3389/fncir.2014.00123, 10.3389/tncir.2014.00123]; Rizzi S, 2010, ANN NY ACAD SCI, V1199, P43, DOI 10.1111/j.1749-6632.2009.05173.x; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; Sabir H, 2013, ANESTHESIOLOGY, V119, P345, DOI 10.1097/ALN.0b013e318294934d; Schubert H, 2012, INTENS CARE MED, V38, P1205, DOI 10.1007/s00134-012-2576-2; Senhadji L, 2000, ACTA BIOTHEOR, V48, P289, DOI 10.1023/A:1010233615281; Seubert CN, 2013, ANESTHESIOLOGY, V119, P358, DOI 10.1097/ALN.0b013e318291c04e; ShelleyTremblay JF, 1996, J GENET PSYCHOL, V157, P443, DOI 10.1080/00221325.1996.9914877; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Shu Y, 2012, NEUROBIOL DIS, V45, P743, DOI 10.1016/j.nbd.2011.10.021; Shulha HP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003433; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Sponheim S, 2003, ACTA ANAESTH SCAND, V47, P932, DOI 10.1034/j.1399-6576.2003.00199.x; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tropea D, 2009, PHILOS T R SOC B, V364, P341, DOI 10.1098/rstb.2008.0269; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; WILKINSON LS, 1994, NEUROPSYCHOPHARMACOL, V10, P61, DOI 10.1038/npp.1994.8; Wu J, 2016, ANESTHESIOLOGY, V124, P624, DOI 10.1097/ALN.0000000000000981; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang F, 2014, EXP THER MED, V8, P471, DOI 10.3892/etm.2014.1769; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	75	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166784	10.1371/journal.pone.0166784	http://dx.doi.org/10.1371/journal.pone.0166784			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898690	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000017
J	Pino, JV; Rohli, RV; DeLong, KL; Harley, GL; Trepanier, JC				Pino, Jordan V.; Rohli, Robert V.; DeLong, Kristine L.; Harley, Grant L.; Trepanier, Jill C.			Using Proxy Records to Document Gulf of Mexico Tropical Cyclones from 1820-1915	PLoS One			English	Article							HURRICANE	Observations of pre-1950 tropical cyclones are sparse due to observational limitations; therefore, the hurricane database HURDAT2 (1851-present) maintained by the National Oceanic and Atmospheric Administration may be incomplete. Here we provide additional documentation for HURDAT2 from historical United States Army fort records (1820-1915) and other archived documents for 28 landfalling tropical cyclones, 20 of which are included in HURDAT2, along the northern Gulf of Mexico coast. One event that occurred in May 1863 is not currently documented in the HURDAT2 database but has been noted in other studies. We identify seven tropical cyclones that occurred before 1851, three of which are potential tropical cyclones. We corroborate the pre-HURDAT2 storms with a tree-ring reconstruction of hurricane impacts from the Florida Keys (1707-2009). Using this information, we suggest landfall locations for the July 1822 hurricane just west of Mobile, Alabama and 1831 hurricane near Last Island, Louisiana on 18 August. Furthermore, we model the probable track of the August 1831 hurricane using the weighted average distance grid method that incorporates historical tropical cyclone tracks to supplement report locations.	[Pino, Jordan V.; Rohli, Robert V.; DeLong, Kristine L.; Trepanier, Jill C.] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA; [Harley, Grant L.] Univ Southern Mississippi, Dept Geog & Geol, Hattiesburg, MS USA; [Pino, Jordan V.] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA	Louisiana State University System; Louisiana State University; University of Southern Mississippi; University System of Ohio; Ohio State University	Pino, JV (corresponding author), Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA.; Pino, JV (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.	pino.17@osu.edu	DeLong, Kristine L/B-7500-2008	DeLong, Kristine L/0000-0001-6320-421X; Rohli, Robert/0000-0003-2198-5606; Harley, Grant/0000-0003-1557-8465; Pino, Jordan/0000-0003-3082-6535	South Central Climate Science Center of the US Geological Survey	South Central Climate Science Center of the US Geological Survey	This work is supported by the South Central Climate Science Center of the US Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Michael Chenoweth for sharing his knowledge on accessing the NOAA EV2 database, and the NOAA Climate Database Modernization Program for making these historical documents available to researchers. This work is supported by the South Central Climate Science Center of the US Geological Survey.	Chenoweth M, 2013, B AM METEOROL SOC, V94, P1735, DOI 10.1175/BAMS-D-12-00171.1; Chenoweth M, 2006, CLIMATIC CHANGE, V76, P169, DOI 10.1007/s10584-005-9005-2; Chenoweth M, 2014, J CLIMATE, V27, P8674, DOI 10.1175/JCLI-D-13-00771.1; Chenoweth M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002066; Fraser W. J., 2009, LOW COUNTRY HURRICAN; Garcia-Herrera, 2003, EVK2CT200000090 UE; Hagen AB, 2012, J CLIMATE, V25, P4461, DOI 10.1175/JCLI-D-11-00420.1; Jarvinen BR, 1984, 22 NOAA NWS NHC, V22, P21; Keim BD, 2009, HURRICANES OF THE GULF OF MEXICO, P1; Landsea CW, 2013, MON WEATHER REV, V141, P3576, DOI 10.1175/MWR-D-12-00254.1; Landsea CW, 2010, J CLIMATE, V23, P2508, DOI 10.1175/2009JCLI3034.1; Marx, 1987, SHIPWRECKS AM; Mock CJ, 2010, B AM METEOROL SOC, V91, P1653, DOI 10.1175/2010BAMS2937.1; Poey A., 1855, J ROYAL GEOGRAPHICAL, V25, P291, DOI [https://doi.org/10.2307/1798124, DOI 10.2307/1798124]; Sallenger Abby, 2009, ISLAND STORM RISING; Scheitlin KN, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012424; Swanson G., HIST PRESERVATION SO; Trouet V, 2016, P NATL ACAD SCI USA, V113, P3169, DOI 10.1073/pnas.1519566113; Vecchi GA, 2011, J CLIMATE, V24, P1736, DOI 10.1175/2010JCLI3810.1; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2	20	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167482	10.1371/journal.pone.0167482	http://dx.doi.org/10.1371/journal.pone.0167482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898726	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000065
J	van Gemst, JJ; Loeven, MA; de Graaf, MJJ; Berden, JHM; Rabelink, TJ; Smit, CH; van der Vlag, J				van Gemst, Jasper J.; Loeven, Markus A.; de Graaf, Mark J. J.; Berden, Jo H. M.; Rabelink, Ton J.; Smit, Cornelis H.; van der Vlag, Johan			RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues	PLoS One			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GLOMERULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; MAC-1 CD11B/CD18; SKELETAL-MUSCLE; MICRO-ASSAY; IN-VITRO; ADHESION; RAT; QUANTIFICATION	Glycosaminoglycans (GAGs) are linear negatively charged polysaccharides and important components of extracellular matrices and cell surface glycan layers such as the endothelial glycocalyx. The GAG family includes sulfated heparin, heparan sulfate (HS), dermatan sulfate (DS), chondroitin sulfate (CS), keratan sulfate, and non-sulfated hyaluronan. Because relative expression of GAGs is dependent on cell-type and niche, isolating GAGs from cell cultures and tissues may provide insight into cell- and tissue-specific GAG structure and functions. In our objective to obtain structural information about the GAGs expressed on a specialized mouse glomerular endothelial cell culture (mGEnC-1) we adapted a recently published GAG isolation protocol, based on cell lysis, proteinase K and DNase I digestion. Analysis of the GAGs contributing to the mGEnC-1 glycocalyx indicated a large HS and a minor CS content on barium acetate gel. However, isolated GAGs appeared resistant to enzymatic digestion by heparinases. We found that these GAG extracts were heavily contaminated with RNA, which co-migrated with HS in barium acetate gel electrophoresis and interfered with 1,9-dimethylmethylene blue (DMMB) assays, resulting in an overestimation of GAG yields. We hypothesized that RNA may be contaminating GAG extracts from other cell cultures and possibly tissue, and therefore investigated potential RNA contaminations in GAG extracts from two additional cell lines, human umbilical vein endothelial cells and retinal pigmental epithelial cells, and mouse kidney, liver, spleen and heart tissue. GAG extracts from all examined cell lines and tissues contained varying amounts of contaminating RNA, which interfered with GAG quantification using DMMB assays and characterization of GAGs by barium acetate gel electrophoresis. We therefore recommend routinely evaluating the RNA content of GAG extracts and propose a robust protocol for GAG isolation that includes an RNA digestion step.	[van Gemst, Jasper J.; Loeven, Markus A.; de Graaf, Mark J. J.; Berden, Jo H. M.; Smit, Cornelis H.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Einthoven Lab Vasc Med, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	Johan.vanderVlag@radboudumc.nl	Loeven, Markus/F-7863-2016; Van der Vlag, Johan/E-4636-2010; Rabelink, Ton J./A-5316-2008	Van der Vlag, Johan/0000-0001-7843-5918; Rabelink, Ton J./0000-0001-6780-5186	Dutch Kidney Foundation [CP09.03]; Radboud university medical center	Dutch Kidney Foundation; Radboud university medical center	Research was supported by the Dutch Kidney Foundation (www.nierstichting.nl), Consortium Grant CP09.03 (GLYCOREN) (received by JvdV), and the Radboud university medical center (www.radboudurric.nl), PhD project grant (received by MAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviezer D, 1999, BIOCHEM BIOPH RES CO, V263, P621, DOI 10.1006/bbrc.1999.1434; Bahrom NA, 2013, FOOD SCI NUTR, V1, P83, DOI 10.1002/fsn3.10; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; BEATY NB, 1987, J CHROMATOGR-BIOMED, V418, P187, DOI 10.1016/0378-4347(87)80009-9; Brito AS, 2008, BIOORGAN MED CHEM, V16, P9588, DOI 10.1016/j.bmc.2008.09.020; Cahu TB, 2012, PROCESS BIOCHEM, V47, P570, DOI 10.1016/j.procbio.2011.12.012; Canals I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13654; COHN RH, 1976, J CELL BIOL, V71, P280, DOI 10.1083/jcb.71.1.280; COOMBE DR, 1994, BLOOD, V84, P739; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; DEY P, 1992, CONNECT TISSUE RES, V28, P317, DOI 10.3109/03008209209016823; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Esko J.D., 2001, CURR PROTOC MOL BIOL, DOI 10.1002/0471142727.mb1702s22; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fedarko N S, 1994, EXS, V70, P9; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Goulas A, 2000, INT J BIOCHEM CELL B, V32, P975, DOI 10.1016/S1357-2725(00)00038-8; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; LARSSON SE, 1974, CALC TISS RES, V14, P49, DOI 10.1007/BF02060282; LEBARON RG, 1988, J CELL BIOL, V106, P945, DOI 10.1083/jcb.106.3.945; Lehri-Boufala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116641; Malavaki CJ, 2008, ANAL BIOCHEM, V374, P213, DOI 10.1016/j.ab.2007.11.006; Matalonga L, 2015, NEUROTHERAPEUTICS, V12, P874, DOI 10.1007/s13311-015-0368-4; MERRILEES MJ, 1981, ATHEROSCLEROSIS, V38, P19, DOI 10.1016/0021-9150(81)90099-X; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Mitropoulos D, 2007, EUR UROL, V51, P447, DOI 10.1016/j.eururo.2006.06.028; NISHINAGA M, 1993, J CLIN INVEST, V92, P1381, DOI 10.1172/JCI116712; OGURI K, 1987, BLOOD, V70, P501; Oivanen M, 1998, CHEM REV, V98, P961, DOI 10.1021/cr960425x; Papakonstantinou E, 1999, ARCH BIOCHEM BIOPHYS, V370, P250, DOI 10.1006/abbi.1999.1405; PAPAKONSTANTINOU E, 1995, P NATL ACAD SCI USA, V92, P9881, DOI 10.1073/pnas.92.21.9881; Papakonstantinou E, 2003, ARCH DERMATOL RES, V295, P138, DOI 10.1007/s00403-003-0413-8; Puvirajesinghe TM, 2012, METABOLITES, V2, P1060, DOI 10.3390/metabo2041060; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; ROLLINS BJ, 1979, BIOCHEMISTRY-US, V18, P141, DOI 10.1021/bi00568a022; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rops AL, 2007, NEPHROL DIAL TRANSPL, V22, P1070, DOI 10.1093/ndt/gfl801; Rops ALWMM, 2014, KIDNEY INT, V86, P932, DOI 10.1038/ki.2014.115; Tipson RS, 1985, ADV CARBOHYD CHEM, V43, P84; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; van Wijk XMR, 2010, EXP CELL RES, V316, P2504, DOI 10.1016/j.yexcr.2010.04.025; VANDELEST CHA, 1994, ANAL BIOCHEM, V221, P356, DOI 10.1006/abio.1994.1425; Wassenaar JW, 2015, BIOMATERIALS, V64, P108, DOI 10.1016/j.biomaterials.2015.06.033; WIGHT TN, 1975, J CELL BIOL, V67, P675, DOI 10.1083/jcb.67.3.675; Zheng CH, 2015, EUR CELLS MATER, V29, P224, DOI 10.22203/eCM.v029a17	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167336	10.1371/journal.pone.0167336	http://dx.doi.org/10.1371/journal.pone.0167336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898729	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000054
J	Averos, X; de Heredia, IB; Ruiz, R; Estevez, I				Averos, Xavier; Beltran de Heredia, Ignacia; Ruiz, Roberto; Estevez, Inma			The Impact of Group Size on Welfare Indicators of Ewes during Pregnancy	PLOS ONE			English	Article							TERM MOVEMENT PATTERNS; CONFINED ENVIRONMENTS; BROILER-CHICKENS; CONDITION SCORE; BLOOD VALUES; SPACE; SHEEP; BEHAVIOR; RESPONSES; DENSITY	Group size (GS) and space allowance have major implications for the welfare of production species, however their effects are often confounded. In a previous study we investigated the impact of varying space allowance at constant GS. In the present work we report the consequences of varying GS on pregnant ewes while controlling space allowance. We housed ewes at 6 (GS6) or 12 ewes/enclosure (GS12), while controlling space allowance to 1.5 m(2) /ewe (3 enclosures/treatment), and necessarily varying enclosure size. Therefore, when indicating GS effects we implicitly reflect a confounding effect with that of enclosure size. Movement, use of space, behaviour, serum cortisol concentration and body condition score (BCS) were collected during the last 12 gestation weeks. Movement, use of space, and behaviour were collected every other week, during 2 days/week, using 10 minute continuous scan samplings. Blood was collected during weeks 10, 13, 17, and 21 of gestation, and BCS during weeks 15 and 21. Data were analysed using repeated measures, generalized linear mixed models, with GS, week, and their interaction as fixed effects, and enclosure as random effect. GS mainly affected movement and use of space. GS12 ewes walked longer distances using longer steps (P<0.001). An interaction GS by week was observed for angular dispersion (P<0.0001), which was smaller for GS12 from week 10 onwards. Initial restlessness levels were lower for GS12, as shown by the reduced frequency of location changes (P<0.0001). Furthest and mean neighbour distances increased with GS (P<0.0001). The effect of GS on behaviour was only evident for eating behaviour as an interaction with gestation week (P<0.05). Changes in behaviour, movement and use of space along the study indicated an activity peak during weeks 3 to 5. Cortisol changes during gestation (P<0.01) also reflected this activity peak, while BCS (P<0.001) reflected normal physical condition changes during pregnancy. Although the separate effects of GS and enclosure size cannot be disentangled, we conclude that if enough space/ewe is given during gestation, larger GS will result in larger effective space, and no major implications for the welfare of ewes should be expected as GS increases. Ewes will adapt their movement patterns and use of space to enclosure size, and no further behavioural, physiological and physical consequences should be expected.	[Averos, Xavier; Beltran de Heredia, Ignacia; Ruiz, Roberto; Estevez, Inma] Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain; [Estevez, Inma] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Basque Foundation for Science	Estevez, I (corresponding author), Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain.; Estevez, I (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	iestevez@neiker.eus	Santos, Roberto J. Ruiz/F-3352-2019; Averos, Xavier/K-1185-2014	Santos, Roberto J. Ruiz/0000-0002-3074-7362; Averos, Xavier/0000-0002-7279-3420; Estevez, Inma/0000-0002-9054-9528	European Union [FP7-414 KBBE-2010-4]	European Union(European Commission)	The authors gratefully acknowledge the European Union financial support for conducting the experiments and the salary for X. Averos under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, of the Project Animal Welfare Indicators (AWIN; FP7-414 KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the European Union financial support for conducting the experiments and the salary for X. Averos under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, of the Project Animal Welfare Indicators (AWIN; FP7-KBBE-2010-4). The authors are grateful to Josune Arranz for her invaluable help in the preparation of the experimental setup, and to Imanol Etxebarria and Juan Carlos Ochoa de Zuazola for the excellent care of ewes during the study.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Averos X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094767; Averos X, 2014, APPL ANIM BEHAV SCI, V150, P17, DOI 10.1016/j.applanim.2013.11.002; BELL ME, 1991, DOMEST ANIM ENDOCRIN, V8, P245, DOI 10.1016/0739-7240(91)90060-W; Boyazoglu J, 2001, SMALL RUMINANT RES, V40, P1, DOI 10.1016/S0921-4488(00)00203-0; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Christman MC, 2007, APPL ANIM BEHAV SCI, V103, P265, DOI 10.1016/j.applanim.2006.05.020; Leme TMD, 2013, SMALL RUMINANT RES, V115, P1, DOI 10.1016/j.smallrumres.2013.07.010; DELVALLE J, 1983, ARCH MED VET, V15, P65; Estevez I, 2006, APPL ANIM BEHAV SCI, V97, P221, DOI 10.1016/j.applanim.2005.01.013; Estevez I, 2010, POULTRY SCI, V89, P643, DOI 10.3382/ps.2009-00433; Estevez I, 1997, BROILER CHICKENS TOL; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Gonzalez M, 2013, APPL ANIM BEHAV SCI, V149, P13, DOI 10.1016/j.applanim.2013.09.011; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Jorgensen GHM, 2009, APPL ANIM BEHAV SCI, V116, P198, DOI 10.1016/j.applanim.2008.08.014; Leone EH, 2008, POULTRY SCI, V87, P3, DOI 10.3382/ps.2007-00026; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; Leone EH, 2010, BEHAV PROCESS, V83, P16, DOI 10.1016/j.beproc.2009.08.009; Mallapur A, 2009, APPL ANIM BEHAV SCI, V117, P28, DOI 10.1016/j.applanim.2008.11.005; MCGLONE JJ, 1994, APPL ANIM BEHAV SCI, V39, P331, DOI 10.1016/0168-1591(94)90166-X; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; Michelena P, 2009, BEHAV ECOL, V20, P145, DOI 10.1093/beheco/arn126; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Roche JR, 2009, J DAIRY SCI, V92, P5769, DOI 10.3168/jds.2009-2431; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sanchez C., 1998, CHICKITIZER SOFTWARE; Shrestha JNB, 2011, ENCY DAIRY SCI, P67; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; TADICH N, 1994, ARCH MED VET, V26, P43; Turchin Peter, 1998	36	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167061	10.1371/journal.pone.0167061	http://dx.doi.org/10.1371/journal.pone.0167061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893817	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400078
J	Tehrani, S; Davis, L; Cepurna, WO; Choe, TE; Lozano, DC; Monfared, A; Cooper, L; Cheng, J; Johnson, EC; Morrison, JC				Tehrani, Shandiz; Davis, Lauren; Cepurna, William O.; Choe, Tiffany E.; Lozano, Diana C.; Monfared, Ashley; Cooper, Lauren; Cheng, Joshua; Johnson, Elaine C.; Morrison, John C.			Astrocyte Structural and Molecular Response to Elevated Intraocular Pressure Occurs Rapidly and Precedes Axonal Tubulin Rearrangement within the Optic Nerve Head in a Rat Model	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; TYROSINE PHOSPHORYLATION; OCULAR HYPERTENSION; FIBER LAYER; MOUSE MODEL; F-ACTIN; CORTACTIN; REACTIVITY; MIGRATION	Glaucomatous axon injury occurs at the level of the optic nerve head (ONH) in response to uncontrolled intraocular pressure (IOP). The temporal response of ONH astrocytes (glial cells responsible for axonal support) to elevated IOP remains unknown. Here, we evaluate the response of actin-based astrocyte extensions and integrin-based signaling within the ONH to 8 hours of IOP elevation in a rat model. IOP elevation of 60 mm Hg was achieved under isoflurane anesthesia using anterior chamber cannulation connected to a saline reservoir. ONH astrocytic extension orientation was significantly and regionally rearranged immediately after IOP elevation (inferior ONH, 43.2 degrees +/- 13.3 degrees with respect to the anterior-posterior axis versus 84.1 degrees +/- 1.3 degrees in controls, p<0.05), and re-orientated back to baseline orientation 1 day post IOP normalization. ONH axonal microtubule filament label intensity was significantly reduced 1 and 3 days post IOP normalization, and returned to control levels on day 5. Phosphorylated focal adhesion kinase (FAK) levels steadily decreased after IOP normalization, while levels of phosphorylated paxillin (a downstream target of FAK involved in focal adhesion dynamics) were significantly elevated 5 days post IOP normalization. The levels of phosphorylated cortactin (a downstream target of Src kinase involved in actin polymerization) were significantly elevated 1 and 3 days post IOP normalization and returned to control levels by day 5. No significant axon degeneration was noted by morphologic assessment up to 5 days post IOP normalization. Actin-based astrocyte structure and signaling within the ONH are significantly altered within hours after IOP elevation and prior to axonal cytoskeletal rearrangement, producing some responses that recover rapidly and others that persist for days despite IOP normalization.	[Tehrani, Shandiz; Davis, Lauren; Cepurna, William O.; Choe, Tiffany E.; Lozano, Diana C.; Monfared, Ashley; Cooper, Lauren; Cheng, Joshua; Johnson, Elaine C.; Morrison, John C.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University	Tehrani, S (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA.	tehrani@ohsu.edu		Tehrani, Shandiz/0000-0001-6083-3336	American Glaucoma Society Young Clinician Scientist Award; Glaucoma Research Foundation Shaffer Grant; Research to Prevent Blindness (RPB); RPB; National Institute of Health [K08EY024025, R01EY010145, P30EY010572]; NATIONAL EYE INSTITUTE [P30EY010572, R01EY010145, K08EY024025] Funding Source: NIH RePORTER	American Glaucoma Society Young Clinician Scientist Award; Glaucoma Research Foundation Shaffer Grant; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); RPB(Research to Prevent Blindness (RPB)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by the American Glaucoma Society Young Clinician Scientist Award (ST), the Glaucoma Research Foundation Shaffer Grant (ST), the Research to Prevent Blindness (RPB) Career Development Award (ST), an unrestricted grant from RPB (CEI/OHSU), and the National Institute of Health (K08EY024025 to ST, R01EY010145 to JCM, P30EY010572 to OHSU). The funders agove had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5; Beckel JM, 2014, GLIA; Brubaker RF, 1996, AM J OPHTHALMOL, V121, P473, DOI 10.1016/S0002-9394(14)75421-2; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Camassa LM., 2015, GLIA; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chen A, 2002, GLIA, V38, P115, DOI 10.1002/glia.10061; Choi HJ, 2015, MOL VIS, V21; Dai C, 2012, GLIA, V60, P13, DOI 10.1002/glia.21242; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Dong JM, 2009, BIOCHEM J, V418, P173, DOI 10.1042/BJ20080170; Fahy ET, 2016, EXP EYE RES, V146, P289, DOI 10.1016/j.exer.2016.03.001; Fang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107134; Feng J, 2016, J CELL SCI; Feola AJ, 2016, INVEST OPHTH VIS SCI, V57, P1901, DOI 10.1167/iovs.15-17573; Feuer WJ, 2002, AM J OPHTHALMOL, V133, P19, DOI 10.1016/S0002-9394(01)01338-1; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; Fujikawa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119361; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Giralt A, 2015, GLIA; Gnanaguru G, 2013, DEVELOPMENT, V140, P2050, DOI 10.1242/dev.087817; GRANT WM, 1982, OPHTHALMOLOGY, V89, P991; Ho KW, 2014, GLIA; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang XR, 2009, EXP EYE RES, V88, P1107, DOI 10.1016/j.exer.2009.01.014; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Ito A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0667; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; Jo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091582; Johnson E, 2006, INVEST OPHTHALMOL VI; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Katiyar KS, 2016, J TISSUE ENG REGEN M, P104, DOI 10.1242/jcs.053850; Koke Joseph R, 2010, BMC Res Notes, V3, P50, DOI 10.1186/1756-0500-3-50; Konopka A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155053; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Kwong JMK, 2013, EXP EYE RES, V112, P21, DOI 10.1016/j.exer.2013.04.008; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Maruyama S, 1996, J BIOL CHEM, V271, P6631, DOI 10.1074/jbc.271.12.6631; Mierke CT, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065005; Mills EA, 2015, P NATL ACAD SCI US; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Morrison JC, 2002, INVEST OPHTH VIS SCI, V43, pU813; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Morrison John C, 2006, Trans Am Ophthalmol Soc, V104, P453; Morrison JC, 2011, EXP EYE RES, V93, P156, DOI 10.1016/j.exer.2010.08.005; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nguyen TD, 2015, EXP EYE RES, V141, P125, DOI 10.1016/j.exer.2015.05.024; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Pazos M, 2015, EXP EYE RES, V139, P1, DOI 10.1016/j.exer.2015.05.011; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Posada-Duque RA, 2015, MOL CELL NEUROSCI; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Romanova LY, 2011, CELL ADHES MIGR, V5, P457, DOI 10.4161/cam.5.6.18219; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigal IA, 2007, EXP EYE RES, V85, P312, DOI 10.1016/j.exer.2007.05.005; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Smith MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069378; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; St-Pierre J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071531; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Tamm ER, 2007, SURV OPHTHALMOL, V52, pS101, DOI 10.1016/j.survophthal.2007.08.002; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Tehrani S, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14969; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thi MM, 2013, P NATL ACAD SCI USA, V110, P21012, DOI 10.1073/pnas.1321210110; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Wang JT, 2015, NEUROSCIENCE, V292, P90, DOI 10.1016/j.neuroscience.2015.02.025; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012; YANG H, 2009, INVEST OPHTHALMOL VI; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	94	38	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167364	10.1371/journal.pone.0167364	http://dx.doi.org/10.1371/journal.pone.0167364			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893827	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400113
J	Bai, WK; Zhang, FJ; He, TJ; Su, PW; Ying, XZ; Zhang, LL; Wang, T				Bai, Wen Kai; Zhang, Fei Jing; He, Tian Jin; Su, Peng Wei; Ying, Xiong Zhi; Zhang, Li Li; Wang, Tian			Dietary Probiotic Bacillus subtilis Strain fmbj Increases Antioxidant Capacity and Oxidative Stability of Chicken Breast Meat during Storage	PLOS ONE			English	Article							PROTEIN OXIDATION; GROWTH-PERFORMANCE; FREE-RADICALS; ORGAN WEIGHT; QUALITY; EXTRACTS; FOOD; SUPPLEMENTATION; SUPEROXIDE; PRODUCTS	This study was aimed to measure the dietary effects of probiotic Bacillus subtilis strain fmbj (BS fmbj) on antioxidant capacity and oxidative stability of chicken breast meat during storage. Treatment groups were fed the basal diet with BS fmbj at 0 g/kg (CON), 0.2 g/kg (BS 1), 0.3 g/kg (BS-2), or 0.4 g/kg (BS-3) doses without antibiotics. During 8 days of storage at 4 degrees C, BS-2 group showed a significant improvement (P < 0.05) on meat quality (pH, Drip loss, Cooking loss, Shear force, color L*, a*, b*), free radical scavenging activity (DPPH, ABTS(+), H2O2), tissues antioxidant enzyme capacity (SOD, CAT, GSH-Px, GSH, T-SH), mitochondria antioxidant enzyme capacity (MnSOD, GPx, GSH), mRNA expression of antioxidant genes (Nrf2, HO-1, SOD, CAT, GSH-Px) and mitochondrial function genes (avUCP, NRF1, NRF2, TFAM, PGC-1 alpha), oxidative damage index (MDA, ROS, PC, 8-OHdG), and MMP level in chicken breast meat as compared to the CON group. These results indicate that dietary BS fmbj in broiler diets can protect breast meat against the storage-induced oxidative stress by improving their free radical scavenging capacity and antioxidant activity during 8 days of storage at 4 degrees C.	[Bai, Wen Kai; Zhang, Fei Jing; He, Tian Jin; Su, Peng Wei; Ying, Xiong Zhi; Zhang, Li Li; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com						Ahmed ST, 2014, BRIT POULTRY SCI, V55, P540, DOI 10.1080/00071668.2014.938021; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Ananthi S, 2010, FOOD CHEM TOXICOL, V48, P187, DOI 10.1016/j.fct.2009.09.036; Baboota RK, 2013, J FUNCT FOODS, V5, P997, DOI 10.1016/j.jff.2013.04.014; Bai KW, 2017, POULTRY SCI, V96, P74, DOI 10.3382/ps/pew246; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; Butterfield DA, 2002, J NUTR BIOCHEM, V13, P444, DOI 10.1016/S0955-2863(02)00205-X; Capcarova M, 2010, J ANIM PHYSIOL AN N, V94, pe215, DOI 10.1111/j.1439-0396.2010.01010.x; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Dean RT, 1997, BIOCHEM J, V324, P1; Decker E.A., 2000, ANTIOXIDANTMUSCLE; Delles RM, 2014, POULTRY SCI, V93, P1561, DOI 10.3382/ps.2013-03682; Dridi S, 2004, COMP BIOCHEM PHYS A, V139, P273, DOI 10.1016/j.cbpb.2004.09.010; Endo Tsuyoshi, 1999, Animal Science Journal, V70, P207; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Fuentes V, 2010, MEAT SCI, V85, P506, DOI 10.1016/j.meatsci.2010.02.024; Gray JI, 1996, MEAT SCI, V43, pS111, DOI 10.1016/0309-1740(96)84583-9; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; Hosainzadeh A, 2012, J BIOMOL STRUCT DYN, V29, P1013, DOI 10.1080/073911012010525029; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; Housaindokht MR, 2001, B KOR CHEM SOC, V22, P145; Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P105, DOI 10.1016/j.fct.2007.07.003; Kayali R, 2007, BIOGERONTOLOGY, V8, P653, DOI 10.1007/s10522-007-9107-5; Kazemi S, 2011, FOOD BIOPROCESS TECH, V4, P102, DOI 10.1007/s11947-009-0201-3; Kikusato M, 2005, NUCLEIC ACIDS RES, V33, P6953; Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108; Leygonie C, 2011, FOOD CHEM, V127, P1659, DOI 10.1016/j.foodchem.2011.02.033; Li WF, 2012, PAK VET J, V32, P530; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049916; Liu XL, 2012, ASIAN AUSTRAL J ANIM, V25, P682, DOI 10.5713/ajas.2011.11334; Mahajan P, 2000, J FOOD SCI TECH MYS, V37, P67; Mercier Y, 1998, MEAT SCI, V48, P301, DOI 10.1016/S0309-1740(97)00113-7; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Park JH, 2015, J ANIM PHYSIOL AN N, V99, P326, DOI 10.1111/jpn.12248; Park JH, 2014, POULTRY SCI, V93, P2054, DOI 10.3382/ps.2013-03818; Pelicano ERL, 2003, Braz. J. Poult. Sci., V5, P207, DOI 10.1590/S1516-635X2003000300009; Perez-Granados AM, 2010, J NUTR BIOCHEM, V21, P948, DOI 10.1016/j.jnutbio.2009.07.010; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Pilger A, 2001, FREE RADICAL RES, V35, P273, DOI 10.1080/10715760100300811; Rajput IR, 2013, INT J AGRIC BIOL, V15, P231; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; SANDERS ME, 1993, J DAIRY SCI, V76, P1819, DOI 10.3168/jds.S0022-0302(93)77514-1; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Siddhuraju P, 2007, FOOD CHEM, V105, P950, DOI 10.1016/j.foodchem.2007.04.040; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Takahashi M, 2004, J GASTROENTEROL, V39, P1210, DOI 10.1007/s00535-004-1474-y; Tang XH, 2006, J NUTR BIOCHEM, V17, P177, DOI 10.1016/j.jnutbio.2005.06.008; Tornberg E, 2005, MEAT SCI, V70, P493, DOI 10.1016/j.meatsci.2004.11.021; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Ventanas S, 2006, MEAT SCI, V72, P647, DOI 10.1016/j.meatsci.2005.09.011; Wei QY, 2006, BBA-GEN SUBJECTS, V1760, P70, DOI 10.1016/j.bbagen.2005.09.008; Wen Jing, 2011, Acta Agriculturae Zhejiangensis, V23, P70; Wettasinghe M, 2000, FOOD CHEM, V70, P17, DOI 10.1016/S0308-8146(99)00269-1; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xiong Y. L., 2000, Antioxidants in muscle foods: nutritional strategies to improve quality, P85; Zhang AW, 2005, POULTRY SCI, V84, P1015, DOI 10.1093/ps/84.7.1015; Zhou X, 2010, POULTRY SCI, V89, P588, DOI 10.3382/ps.2009-00319	62	40	42	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167339	10.1371/journal.pone.0167339	http://dx.doi.org/10.1371/journal.pone.0167339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907152	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700123
J	Bossange, AV; Knudson, KM; Shrestha, A; Harben, R; Mitchell, JP				Bossange, Anne V.; Knudson, Kandace M.; Shrestha, Anil; Harben, Ronald; Mitchell, Jeffrey P.			The Potential for Conservation Tillage Adoption in the San Joaquin Valley, California: A Qualitative Study of Farmer Perspectives and Opportunities for Extension	PLOS ONE			English	Article							NO-TILLAGE; AGRICULTURAL INNOVATION; CARBON SEQUESTRATION; UNITED-STATES; SOIL CARBON; SYSTEMS; MANAGEMENT; INFILTRATION; ROTATIONS; EVOLUTION	Conservation tillage (CT) systems have a number of potential benefits including lower crop production costs and the ability to reduce soil erosion that have made them common in several regions of the world. Although CT systems have been researched and successfully implemented on some farms in California's San Joaquin Valley (SJV), overall adoption is low and the reasons for the region's comparatively low rates of adoption are not known. In 2011, we conducted written surveys and interviews with SJV farmers to identify characteristics of farmers who adopt or do not adopt CT, to determine reasons for non-adoption of CT, and to learn how successful CT adoption takes place in the SJV. We found that a universally acceptable definition of CT needs to be developed in order for effective research, outreach and communication on CT. Our research, which examined CT adoption within the expected progression of the diffusion of innovation model, suggested that larger and less diverse farms were more likely to use CT. Most farmers expressed transition to CT as a continuous learning process. Further, we conclude that gaining meaningful experience with CT practices by researchers in the local context is also a large component of successful adoption.	[Bossange, Anne V.] Univ Calif Davis, Dept Land Air & Water Resources Dept, Davis, CA 95616 USA; [Knudson, Kandace M.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Shrestha, Anil] Calif State Univ Fresno, Dept Plant Sci, Fresno, CA 93740 USA; [Harben, Ronald] Calif Assoc Resource Conservat Dist, Arroyo Grande, CA USA; [Mitchell, Jeffrey P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State University Fresno; University of California System; University of California Davis	Mitchell, JP (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jpmitchell@ucdavis.edu			California Department of Food and Agriculture Specialty Crop Block Grant Program [SCB09011]	California Department of Food and Agriculture Specialty Crop Block Grant Program	This work was supported by the California Department of Food and Agriculture Specialty Crop Block Grant Program under Grant SCB09011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMARAS RR, 1985, SOIL TILL RES, V5, P197, DOI 10.1016/0167-1987(85)90030-3; [Anonymous], 2000, CONSERVATION TILLAGE; [Anonymous], 1989, JPM VERRS 10; [Anonymous], EXPRESSSCRIBE; Awada L, 2014, INT SOIL WATER CONSE, V2, P47, DOI 10.1016/S2095-6339(15)30013-7; Aziz I, 2013, SOIL TILL RES, V131, P28, DOI 10.1016/j.still.2013.03.002; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball E. V., 2015, APPL ECON PERSPECT P, P30; Bell M.M., 2004, FARMING US ALL PRACT; Bernoux M, 2006, AGRON SUSTAIN DEV, V26, P1, DOI 10.1051/agro:2005055; Bettner T., 2012, EXP CAL OPT M ITS WA; Bitsch V., 2005, Journal of Agribusiness, V23, P75; BULTENA GL, 1983, J SOIL WATER CONSERV, V38, P281; Busscher WJ, 1996, J SOIL WATER CONSERV, V51, P188; California Department of Food and Agriculture, 2015, CAL AGR STAT REV 201; Corbin J, 1998, BASICS QUALITATIVE R; Crabtree B., 2010, SEARCH SUSTAINABILIT; De Vita P, 2007, SOIL TILL RES, V92, P69, DOI 10.1016/j.still.2006.01.012; Derpsch R, 2014, SOIL TILL RES, V137, P16, DOI 10.1016/j.still.2013.10.002; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Derpsch R., 2009, 4 WORLD C CONS AGR N 4 WORLD C CONS AGR N; Dumanski J., 2009, P MARCH 24 25 C SASK; Eckert E., 2005, J EXTENSION, V43; FEDER G, 1993, TECHNOL FORECAST SOC, V43, P215, DOI 10.1016/0040-1625(93)90053-A; Fleming Aysha., 2009, EXTENSION FARMING SY, V5, P1; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Ghadim AKA, 1999, AGR ECON-BLACKWELL, V21, P145, DOI 10.1016/S0169-5150(99)00023-7; Ghadim AKA, 2005, AGR ECON-BLACKWELL, V33, P1, DOI 10.1111/j.1574-0862.2005.00433.x; Junior R.C., 2012, NO TILL AGR SO BRAZI, P1; Kassam A, 2014, INT SOIL WATER CONSE, V2, P5, DOI 10.1016/S2095-6339(15)30009-5; Klerkx L, 2010, AGR SYST, V103, P390, DOI 10.1016/j.agsy.2010.03.012; Knowler D, 2007, FOOD POLICY, V32, P25, DOI 10.1016/j.foodpol.2006.01.003; KORSCHING PF, 1983, J SOIL WATER CONSERV, V38, P428; Lal R, 2007, SOIL TILL RES, V93, P1, DOI 10.1016/j.still.2006.11.004; Licht MA, 2005, SOIL TILL RES, V80, P233, DOI 10.1016/j.still.2004.03.017; Lindwall W, 2009, P LANDSCAPES TRANSFO; Llewellyn RS, 2007, FIELD CROP RES, V104, P148, DOI 10.1016/j.fcr.2007.03.022; Llewellyn RS, 2012, FIELD CROP RES, V132, P204, DOI 10.1016/j.fcr.2012.03.013; Madden NM, 2008, ATMOS ENVIRON, V42, P3795, DOI 10.1016/j.atmosenv.2007.12.058; Medellin-Azuara J, 2015, ARE UPDATE, V18, P6; Mitchell JP, 2007, AUST J EXP AGR, V47, P1383, DOI 10.1071/EA07044; Mitchell JP, 2016, SOIL TILL RES, V157, P52, DOI 10.1016/j.still.2015.10.015; Mitchell J.P., 2009, U CAL DIV AGR NAT RE, P8; Mitchell J. P, 2009, UC ANR COMMUNICATION, V8330; Mitchell JP, 2015, AGRON J, V107, P588, DOI 10.2134/agronj14.0415; Mitchell JP, 2012, HORTTECHNOLOGY, V22, P617, DOI 10.21273/HORTTECH.22.5.617; Mitchell JP, 2012, CALIF AGR, V66, P108, DOI 10.3733/ca.v066n03p108; Mitchell JR, 2008, CALIF AGR, V62, P74, DOI 10.3733/ca.v062n02p74; Morrison J.E., 2000, CHIN INT C DRYL WAT; Muhr Thomas, 2016, ATLAS TI COMPUTER SO; NAPIER TL, 1984, J SOIL WATER CONSERV, V39, P205; NOWAK P, 1992, J SOIL WATER CONSERV, V47, P14; NRCS USDA, 2005, 329 NRCS USDA; Pannell DJ, 2006, AUST J EXP AGR, V46, P1407, DOI 10.1071/EA05037; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Prokopy LS, 2008, J SOIL WATER CONSERV, V63, P300, DOI 10.2489/63.5.300; Reicosky DC, 2015, J SOIL WATER CONSERV, V70, P103, DOI 10.2489/jswc.70.5.103A; Rodriguez JM, 2009, RENEW AGR FOOD SYST, V24, P60, DOI 10.1017/S1742170508002421; Rogers E. M., 1961, RES B, V882, P1; Roling N.G., 2000, FACILITATING SUSTAIN; Rollins T, 1993, J AGR ED, V34, P46, DOI DOI 10.5032/JAE.1993.04046; Siebert R, 2006, SOCIOL RURALIS, V46, P318, DOI 10.1111/j.1467-9523.2006.00420.x; Uri ND, 2000, AGR ECOSYST ENVIRON, V77, P263, DOI 10.1016/S0167-8809(99)00085-7; Vanclay F, 2004, AUST J EXP AGR, V44, P213, DOI 10.1071/EA02139; Vitale JD, 2011, J SOIL WATER CONSERV, V66, P250, DOI 10.2489/jswc.66.4.250	65	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167612	10.1371/journal.pone.0167612	http://dx.doi.org/10.1371/journal.pone.0167612			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907196	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700212
J	Guo, YN; Dreier, JR; Cao, JX; Du, H; Granter, SR; Kwiatkowski, DJ				Guo, Yanan; Dreier, John R.; Cao, Juxiang; Du, Heng; Granter, Scott R.; Kwiatkowski, David J.			Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex	PLOS ONE			English	Article							SPORADIC PULMONARY LYMPHANGIOLEIOMYOMATOSIS; STROMAL FIBROBLASTS; ANGIOMYOLIPOMA; EXPRESSION; MUTATIONS; SURVIVAL; MARKERS; TUMORS; CELLS; TSC2	Tuberous Sclerosis Complex (TSC) is an autosomal dominant tumor suppressor gene syndrome in which patients develop several types of tumors, including facial angiofibroma, subungual fibroma, Shagreen patch, angiomyolipomas, and lymphangioleiomyomatosis. It is due to inactivating mutations in TSC1 or TSC2. We sought to generate a mouse model of one or more of these tumor types by targeting deletion of the Tsc1 gene to fibroblasts using the Fsp-Cre allele. Mutant, Tsc1(cc)Fsp-Cre+ mice survived a median of nearly a year, and developed tumors in multiple sites but did not develop angiomyolipoma or lymphangioleiomyomatosis. They did develop a prominent skin phenotype with marked thickening of the dermis with accumulation of mast cells, that was minimally responsive to systemic rapamycin therapy, and was quite different from the pathology seen in human TSC skin lesions. Recombination and loss of Tsc1 was demonstrated in skin fibroblasts in vivo and in cultured skin fibroblasts. Loss of Tsc1 in fibroblasts in mice does not lead to a model of angiomyolipoma or lymphangioleiomyomatosis.	[Guo, Yanan; Dreier, John R.; Cao, Juxiang; Du, Heng; Granter, Scott R.; Kwiatkowski, David J.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kwiatkowski, DJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.	dk@rics.bwh.harvard.edu			NIH NCI [1P01CA120964]	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant NIH NCI 1P01CA120964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Bonetti F, 1996, EUR RESPIR J, V9, P399, DOI 10.1183/09031936.96.09030399; Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chilosi M, 2009, MODERN PATHOL, V22, P161, DOI 10.1038/modpathol.2008.189; Darling TN, 2010, TUBEROUS SCLEROSIS C, P285; Giannikou K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006242; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Henske EP, 1997, AM J PATHOL, V151, P1639; KERR LA, 1993, UROLOGY, V41, P440, DOI 10.1016/0090-4295(93)90504-4; Koenig MK, 2012, DRUGS R&D, V12, P121, DOI 10.2165/11634580-000000000-00000; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lim SD, 2007, MOL MED, V13, P160, DOI 10.2119/2006-00070.Lim; Matsumoto Y, 1999, AM J RESP CELL MOL, V21, P327, DOI 10.1165/ajrcmb.21.3.3693; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; QinWB V, 2011, PLOS ONE IN PRESS; Seyama Kuniaki, 2006, Lymphatic Research and Biology, V4, P143, DOI 10.1089/lrb.2006.4.143; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tyburczy ME, 2014, HUM MOL GENET, V23, P2023, DOI 10.1093/hmg/ddt597; Urban T, 1999, MEDICINE, V78, P321, DOI 10.1097/00005792-199909000-00004; Yu SQ, 2012, PROSTATE, V72, P437, DOI 10.1002/pros.21445; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhang H, 2003, J CLIN INVEST, V112 54, P728, DOI [10.1165/rcmb.2015-0111OC, DOI 10.1172/JCI17222]; Zhe XN, 2004, J HISTOCHEM CYTOCHEM, V52, P1537, DOI 10.1369/jhc.4A6438.2004; Zhou QY, 2016, AM J RESP CELL MOL, V54, P728, DOI 10.1165/rcmb.2015-0111OC	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167384	10.1371/journal.pone.0167384	http://dx.doi.org/10.1371/journal.pone.0167384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907099	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700136
J	Jordan, S; Morris, JK; Davies, GI; Tucker, D; Thayer, DS; Luteijn, JM; Morgan, M; Garne, E; Hansen, AV; Klungsoyr, K; Engeland, A; Boyle, B; Dolk, H				Jordan, Sue; Morris, Joan K.; Davies, Gareth I.; Tucker, David; Thayer, Daniel S.; Luteijn, Johannes M.; Morgan, Margery; Garne, Ester; Hansen, Anne V.; Klungsoyr, Kari; Engeland, Anders; Boyle, Breidge; Dolk, Helen			Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark	PLOS ONE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; BIRTH-DEFECTS; HEART-DEFECTS; MATERNAL DEPRESSION; PRENATAL EXPOSURE; PRETERM BIRTH; CARDIAC-MALFORMATIONS; MEDICATION USE; RISK; WOMEN	Background Hypothesised associations between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and congenital anomalies, particularly congenital heart defects (CHD), remain controversial. We investigated the putative teratogenicity of SSRI prescription in the 91 days either side of first day of last menstrual period (LMP). Methods and Findings Three population-based EUROCAT congenital anomaly registries- Norway (2004-2010), Wales (2000-2010) and Funen, Denmark (2000-2010)-were linked to the electronic healthcare databases holding prospectively collected prescription information for all pregnancies in the timeframes available. We included 519,117 deliveries, including foetuses terminated for congenital anomalies, with data covering pregnancy and the preceding quarter, including 462,641 with data covering pregnancy and one year either side. For SSRI exposures 91 days either side of LMP, separately and together, odds ratios with 95% confidence intervals (ORs, 95% CI) for all major anomalies were estimated. We also explored: pausing or discontinuing SSRIs preconception, confounding, high dose regimens, and, in Wales, diagnosis of depression. Results were combined in meta-analyses. SSRI prescription 91 days either side of LMP was associated with increased prevalence of severe congenital heart defects (CHD) (as defined by EUROCAT guide 1.3, 2005) (34/12,962 [0.26%] vs. 865/506,155 [0.17%] OR 1.50, 1.06-2.11), and the composite adverse outcome of 'anomaly or stillbirth' (473/12962, 3.65% vs. 15829/ 506,155, 3.13%, OR 1.13, 1.03-1.24). The increased prevalence of all major anomalies combined did not reach statistical significance (3.09% [400/12,962] vs. 2.67% [13,536/506,155] OR 1.09, 0.99-1.21). Adjusting for socioeconomic status left ORs largely unchanged. The prevalence of anomalies and severe CHD was reduced when SSRI prescriptions were stopped or paused preconception, and increased when > 1 prescription was recorded, but differences were not statistically significant. The dose-response relationship between severe CHD and SSRI dose (meta-regression OR 1.49, 1.12-1.97) was consistent with SSRI-exposure related risk. Analyses in Wales suggested no associations between anomalies and diagnosed depression. Conclusion The additional absolute risk of teratogenesis associated with SSRIs, if causal, is small. However, the high prevalence of SSRI use augments its public health importance, justifying modifications to preconception care.	[Jordan, Sue; Davies, Gareth I.; Thayer, Daniel S.] Swansea Univ, Dept Nursing, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Morris, Joan K.; Luteijn, Johannes M.] Queen Mary Univ London, London, England; [Tucker, David; Morgan, Margery] Publ Hlth Wales, Swansea, W Glam, Wales; [Garne, Ester] Hosp Lillebaelt, Dept Paediat, Kolding, Denmark; [Hansen, Anne V.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Klungsoyr, Kari; Engeland, Anders] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Dept Hlth Registries, Bergen, Norway; [Engeland, Anders] Norwegian Inst Publ Hlth Bergen, Dept Pharmacoepidemiol, Bergen, Norway; [Boyle, Breidge; Dolk, Helen] Univ Ulster, Ctr Maternal Fetal & Infant Res, Newtownabbey, Co Antrim, North Ireland	Swansea University; University of London; Queen Mary University London; University of Copenhagen; University of Bergen; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Ulster University	Jordan, S (corresponding author), Swansea Univ, Dept Nursing, Coll Human & Hlth Sci, Swansea, W Glam, Wales.	S.E.Jordan@swansea.ac.uk	Engeland, Anders/AAG-7437-2021; Klungsøyr, Kari/ABC-6147-2020; Morris, Joan/AAT-9211-2020; jordan, sue/O-1297-2019	Klungsøyr, Kari/0000-0003-2482-1690; Morris, Joan/0000-0002-7164-612X; jordan, sue/0000-0002-5691-2987; Thayer, Dan/0000-0003-1847-4362; Davies, Gareth/0000-0001-9005-1618; Luteijn, Michiel/0000-0002-9526-9015; Hansen, Anne Vinkel/0000-0003-4523-3521	European Union under the 7th Framework Program [HEALTH-F5-2011-260598]	European Union under the 7th Framework Program	Financial support for the EUROmediCAT study was provided by the European Union under the 7th Framework Program (grant agreement HEALTH-F5-2011-260598). Start date: 1 March 2011. Duration: 48 months. Coordinator: Prof. Helen Dolk, University of Ulster, UK, Tel: +44 28 90368540, Email: h.dolk@ulster.ac.uk. Further information can be found at www.euromedicat.eu. The funder played no part in the study or production of the paper and the research report.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2015, BIRTH DEFECTS RES A, V103, P721, DOI 10.1002/bdra.23394; Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, P418, DOI 10.1097/AOG.0000000000001309; Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Angermeyer MC, 2014, SOC SCI MED, V103, P60, DOI 10.1016/j.socscimed.2013.11.014; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Bar-Oz B, 1999, LANCET, V354, P1700, DOI 10.1016/S0140-6736(99)04411-6; BEARDON PHG, 1993, BRIT MED J, V307, P846, DOI 10.1136/bmj.307.6908.846; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Berard A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.034; BNF, 2013, BRITISH MEDICAL ASSO; BNF, 2016, BRITISH NATIONAL FOR; Bradshaw PJ, CHANGING CHILDHOOD I; Bukowski R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001633; Burdan F, 2006, PHARMACOL RES, V53, P287, DOI 10.1016/j.phrs.2005.12.006; Byatt N, 2013, ACTA PSYCHIAT SCAND, V127, P94, DOI 10.1111/acps.12042; Carmichael SL, 2014, PAEDIATR PERINAT EP, V28, P338, DOI 10.1111/ppe.12123; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Charlton RA, 2014, PHARMACOEPIDEM DR S, V23, P586, DOI 10.1002/pds.3613; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P1075, DOI 10.1002/pds.1463; Colvin L, 2011, BIRTH DEFECTS RES A, V91, P142, DOI 10.1002/bdra.20773; Coughlin CG, 2015, OBSTET GYNECOL, V125, P1224, DOI 10.1097/AOG.0000000000000759; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; Daws LC, 2011, PHARMACOL THERAPEUT, V131, P61, DOI 10.1016/j.pharmthera.2011.03.013; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Dietz PM, 2011, AM J EPIDEMIOL, V173, P355, DOI 10.1093/aje/kwq381; Einarson A, 2012, J CLIN PSYCHIAT, V73, P1443, DOI 10.4088/JCP.12com08192; Eke AC, 2016, BJOG-INT J OBSTET GY, V123, P1900, DOI 10.1111/1471-0528.14144; EUROCAT, 2013, EUROCAT EUROPEAN SUR; EUROCAT, 2005, EUROCAT EUROPEAN SUR; EUROmediCAT. (EMC), 2015, SELECTIVE SEROTONIN; European Commission, 2008, OBJECTIVE 1 SUPPORTI; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Flower A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-238; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gadkari AS, 2010, CURR MED RES OPIN, V26, P683, DOI 10.1185/03007990903550586; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gentile S, 2011, ACTA PSYCHIAT SCAND, V123, P266, DOI 10.1111/j.1600-0447.2011.01673.x; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Golder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071813; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Greenlees R, 2011, BIRTH DEFECTS RES A, V91, pS51, DOI 10.1002/bdra.20775; Grigoriadis S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f6932; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE293, DOI 10.4088/JCP.12r07966; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; Hamer DM, 2013, CARDIFF WALES D CHIL; Handal M, 2016, BJOG-INT J OBSTET GY, V123, P1908, DOI 10.1111/1471-0528.13582; Hannerfors AK, 2015, PSYCHONEUROENDOCRINO, V58, P104, DOI 10.1016/j.psyneuen.2015.04.009; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hippocrates, 1923, THE HIPPOCRATIC CORP; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P13, DOI 10.1016/j.genhosppsych.2013.08.002; Hutton C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-71; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V314, P1294, DOI 10.1001/jama.2015.10048; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; IBM Corp, 2011, IBM SPSS STATISTICS; ICH, 1996, ICH HARMONISED TRIPA; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Jimenez-Solem E, 2013, AM J PSYCHIAT, V170, P299, DOI 10.1176/appi.ajp.2012.11081251; Jordan S, 2015, MARC SOC C ARCH WOM, V18, P269, DOI DOI 10.1007/S00737-014-0488-6.; Jordan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067912; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KLEMETTI A, 1967, AM J PUBLIC HEALTH N, V57, P2071, DOI 10.2105/AJPH.57.12.2071; Knudsen TM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-333; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Langhoff-Roos J, 2014, ACTA OBSTET GYN SCAN, V93, P132, DOI 10.1111/aogs.12302; Latendresse Gwen, 2013, Open J Obstet Gynecol, V3, P184; Lattimore Keri A, 2005, J Perinatol, V25, P595; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P942, DOI 10.1002/pds.3462; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; McDonagh M, 2014, ANTIDEPRESSANT TREAT; Menchetti M, 2014, BRIT J PSYCHIAT, V204, P144, DOI 10.1192/bjp.bp.112.122663; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Myles N, 2013, AUST NZ J PSYCHIAT, V47, P1002, DOI 10.1177/0004867413492219; NCCMH. (National Collaborating Centre for Mental Health), 2014, ANTENATAL AND POSTNA, P192; NCCMH. (National Collaborating Centre for Mental Health), 2007, ANTENATAL AND POSTNA; Nikfar S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-75; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Palmsten K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4877; Pearlstein T, 2015, BEST PRACT RES CL OB, V29, P754, DOI 10.1016/j.bpobgyn.2015.04.004; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Peters P, 2015, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 3RD EDITION, P1, DOI 10.1016/B978-0-12-408078-2.00001-9; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pop Anca, 2015, Clujul Med, V88, P381, DOI 10.15386/cjmed-474; Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883; Ramos E, 2008, BRIT J PSYCHIAT, V192, P344, DOI 10.1192/bjp.bp.107.042523; Ray S, 2014, BEST PRACT RES CL OB, V28, P71, DOI 10.1016/j.bpobgyn.2013.09.005; Reefhuis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3190; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Reis M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002166; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Salisbury AL, 2009, CLIN PERINATOL, V36, P595, DOI 10.1016/j.clp.2009.06.002; Santos-Silva AJ, 2009, REPROD SCI, V16, P1175, DOI 10.1177/1933719109343787; Schaefer C, 2007, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 2ND EDITION, P1; Schroll JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041174; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; Sljivic S, 2006, MED HYPOTHESES, V67, P57, DOI 10.1016/j.mehy.2005.07.037; StataCorp, 2011, STATA STATISTICAL SO; Stats Wales ELMS Welsh Government Cardiff Wales, 2014, Q REPORT; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Talbot J., 2012, STEPHENS DETECTION E, P215; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; United Nations, 2007, THE MILLENNIUM DEVEL; van Geffen ECG, 2009, BRIT J GEN PRACT, V59, P81, DOI 10.3399/bjgp09X395067; VANALLEN MI, 1981, PEDIATR ANN, V10, P219; Velasquez JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00047; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Wadhwa PD, 2002, REGUL PEPTIDES, V108, P149, DOI 10.1016/S0167-0115(02)00102-7; Wemakor A, 2015, EUR J EPIDEMIOL, V30, P1187, DOI 10.1007/s10654-015-0065-y; WERLER MM, 1992, TERATOLOGY, V45, P361, DOI 10.1002/tera.1420450407; Whitworth M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub3; WHO Collaborating Centre for Drug Statistics Methodology, 2016, GUIDELINES FOR ATC C; Wilffert B, 2011, PHARMACOGENOMICS, V12, P547, DOI [10.2217/pgs.10.201, 10.2217/PGS.10.201]; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Wisner K, 2015, DRUGS PREGNANCY LACT, P293; Wogelius P, 2005, INT J ANTIMICROB AG, V26, P323, DOI 10.1016/j.ijantimicag.2005.06.017; World Bank Group, 2014, THE WORLD BANK WORKI; Yazdy MM, 2014, EPIDEMIOLOGY, V25, P859, DOI 10.1097/EDE.0000000000000157; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	152	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165122	10.1371/journal.pone.0165122	http://dx.doi.org/10.1371/journal.pone.0165122			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906972	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000389482700008
J	Nalley, L; Tsiboe, F; Durand-Morat, A; Shew, A; Thoma, G				Nalley, Lawton; Tsiboe, Francis; Durand-Morat, Alvaro; Shew, Aaron; Thoma, Greg			Economic and Environmental Impact of Rice Blast Pathogen (Magnaporthe oryzae) Alleviation in the United States	PLOS ONE			English	Article							CISGENIC PLANTS; DISEASE; RESISTANCE; VARIETIES	Rice blast (Magnaporthe oryzae) is a key concern in combating global food insecurity given the disease is responsible for approximately 30% of rice production losses globally-the equivalent of feeding 60 million people. These losses increase the global rice price and reduce consumer welfare and food security. Rice is the staple crop for more than half the world's population so any reduction in rice blast would have substantial beneficial effects on consumer livelihoods. In 2012, researchers in the US began analyzing the feasibility of creating blast-resistant rice through cisgenic breeding. Correspondingly, our study evaluates the changes in producer, consumer, and environmental welfare, if all the rice produced in the Mid-South of the US were blast resistant through a process like cisgenics, using both international trade and environmental assessment modeling. Our results show that US rice producers would gain 69.34 million dollars annually and increase the rice supply to feed an additional one million consumers globally by eliminating blast from production in the Mid-South. These results suggest that blast alleviation could be even more significant in increasing global food security given that the US is a small rice producer by global standards and likely experiences lower losses from blast than other rice-producing countries because of its ongoing investment in production technology and management. Furthermore, results from our detailed life cycle assessment (LCA) show that producing blast-resistant rice has lower environmental (fossil fuel depletion, ecotoxicity, carcinogenics, eutrophication, acidification, global warming potential, and ozone depletion) impacts per unit of rice than non-blast resistant rice production. Our findings suggest that any reduction in blast via breeding will have significantly positive impacts on reducing global food insecurity through increased supply, as well as decreased price and environmental impacts in production.	[Nalley, Lawton; Tsiboe, Francis; Durand-Morat, Alvaro; Shew, Aaron] Univ Arkansas, Dept Agr Econ, Fayetteville, AR 72701 USA; [Thoma, Greg] Univ Arkansas, Dept Chem Engn, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Nalley, L (corresponding author), Univ Arkansas, Dept Agr Econ, Fayetteville, AR 72701 USA.	llnalley@uark.edu	Tsiboe, Francis/A-6485-2018; Thoma, Greg/W-8646-2019; Nalley, Lawton/AAN-7643-2021	Tsiboe, Francis/0000-0001-5984-1072; Thoma, Greg/0000-0001-8757-7635; Shew, Aaron/0000-0003-3788-7891	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2013-68004-20378]; National Science Foundation Research Fellowship Program [DGE-1450079]	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture; National Science Foundation Research Fellowship Program	This study was supported by the Agriculture and Food Research Initiative Competitive Grant no. 2013-68004-20378 from the United States Department of Agriculture National Institute of Food and Agriculture and the National Science Foundation Research Fellowship Program under grant no. (DGE-1450079).	Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; Arkansas Agricultural Experiment Station (AAES), 2002, ARK RIC PERF TRIALS; Bare J, 2006, ENVIRON SCI TECHNOL, V40, P5108, DOI 10.1021/es052494b; BASTIAANS L, 1993, NETH J PLANT PATHOL, V99, P205, DOI 10.1007/BF01974665; Blanchard T, 2016, BLAST OUTBREAK RICE; BONMAN JM, 1991, PLANT DIS, V75, P462, DOI 10.1094/PD-75-0462; Brennan JP, 1984, REV MARKETING AGR EC, V52; Briones RM, 2012, CLIMATE CHANGE PRICE; Falconer L, 2015, MISSISSIPPI RICE PLA; Flanders A, 2015, ARKANSAS CROP ENTERP; Ganesh N.R., 2012, J BIOSCI BIOTECHNOL, V1, P18; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Groth D, 2014, 105 ANN RES REP RIC; Groth D, 2014, RICE DIS CONTROL STU; High-Level Expert Forum, 2009, FEED WORLD 2050; INTERNATIONAL MONETARY FUND (IMF), 2015, INT FIN STAT IFS; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Koutroubas SD, 2008, AUSTRALAS PLANT PATH, V37, P53, DOI 10.1071/AP07078; Koutroubas SD, 2009, TURK J AGRIC FOR, V33, P487, DOI 10.3906/tar-0812-15; Louisiana State University Agricultural Center (LSU AgCenter), 2003, RIC VAR MAN TIPS; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Mississippi Agricultural and Forester Experiment Station (MAFES), 2002, MISS RIC VAR TRIALS; Nalley L. L., 2011, Journal of Agricultural and Applied Economics, V43, P131; Norman R, 2002, WELLS ARKANSAS RICE; Peng SB, 2010, FIELD CROP RES, V119, P342, DOI 10.1016/j.fcr.2010.08.003; Peter M, 2013, K STATE TODAY   0619; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rice Technical Working Group (RTWG), 2001, P RIC TECHN WORK GRO; Salassi M, 2015, PROJECTED COSTS RETU; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; University of Arkansas Cooperative Extension Service (UACES), 2015, RIC PROD HDB; University of Arkansas Cooperative Extension Service (UACES), 2016, 2016 CROP ENT BUDG A; USDA, 2015, QUICK STATS WORLD AG; Wailes E., 2010, RICEFLOW MULTIREGION; Wailes EJ, 2015, FRONT ECON GLOBAL, V15, P255, DOI 10.1108/S1574-871520150000015025; Wang G.-L., 2009, ADV GENETICS GENOMIC; Wang XY, 2015, MOL PLANT MICROBE IN, V28, P1383, DOI 10.1094/MPMI-06-15-0131-R; Zeigler R.S., 1994, RICE BLAST DIS; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	42	89	100	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167295	10.1371/journal.pone.0167295	http://dx.doi.org/10.1371/journal.pone.0167295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907101	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700112
J	Partridge, CG; MacManes, MD; Knapp, R; Neff, BD				Partridge, Charlyn G.; MacManes, Matthew D.; Knapp, Rosemary; Neff, Bryan D.			Brain Transcriptional Profiles of Male Alternative Reproductive Tactics and Females in Bluegill Sunfish	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; O-GLCNAC TRANSFERASE; LEPOMIS-MACROCHIRUS; PARENTAL CARE; SUBORDINATE RELATIONSHIPS; AROMATASE-ACTIVITY; SPERM COMPETITION; LIFE-HISTORIES; TELEOST FISH; PLASTICITY	Bluegill sunfish (Lepomis macrochirus) are one of the classic systems for studying male alternative reproductive tactics (ARTs) in teleost fishes. In this species, there are two distinct life histories: parental and cuckolder, encompassing three reproductive tactics, parental, satellite, and sneaker. The parental life history is fixed, whereas individuals who enter the cuckolder life history transition from sneaker to satellite tactic as they grow. For this study, we used RNAseq to characterize the brain transcriptome of the three male tactics and females during spawning to identify gene ontology (GO) categories and potential candidate genes associated with each tactic. We found that sneaker males had higher levels of gene expression differentiation compared to the other two male tactics. Sneaker males also had higher expression in ionotropic glutamate receptor genes, specifically AMPA receptors, compared to other males, which may be important for increased spatial working memory while attempting to cuckold parental males at their nests. Larger differences in gene expression also occurred among male tactics than between males and females. We found significant expression differences in several candidate genes that were previously identified in other species with ARTs and suggest a previously undescribed role for cAMP-responsive element modulator (crem) in influencing parental male behaviors during spawning.	[Partridge, Charlyn G.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI 49442 USA; [Partridge, Charlyn G.; Neff, Bryan D.] Univ Western Ontario, Dept Biol, London, ON, Canada; [MacManes, Matthew D.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Knapp, Rosemary] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	Grand Valley State University; Western University (University of Western Ontario); University System Of New Hampshire; University of New Hampshire; University of Oklahoma System; University of Oklahoma - Norman	Partridge, CG (corresponding author), Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI 49442 USA.; Partridge, CG (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	partridc@gvsu.edu		Knapp, Rosemary/0000-0001-6923-8410; Neff, Bryan/0000-0001-8499-250X	Natural Sciences and Engineering Research Council of Canada (NSERC) [250071-2012]; University of Oklahoma Department of Biology	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Oklahoma Department of Biology	Funding for this project was supported through the Natural Sciences and Engineering Research Council of Canada (NSERC) to B.D.N (#250071-2012) and the University of Oklahoma Department of Biology to R.K. The funders had no role in any study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Arslan T, 2004, AQUAC RES, V35, P397, DOI 10.1111/j.1365-2109.2004.01029.x; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; AVILA VL, 1976, AM MIDL NAT, V96, P195, DOI 10.2307/2424577; Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257; BLOCH GJ, 1993, PHYSIOL BEHAV, V54, P615, DOI 10.1016/0031-9384(93)90068-Q; Bloch GJ, 1996, PHYSIOL BEHAV, V59, P1147, DOI 10.1016/0031-9384(95)02087-X; Bolger AM, 2014, BIOINFORMATICS; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cardoso SD, 2015, BRIAN BEHAV EVOL, V85, P287; Churcher AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-799; COLGAN P W, 1979, Environmental Biology of Fishes, V4, P29, DOI 10.1007/BF00005925; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; DOMINEY WJ, 1980, NATURE, V284, P546, DOI 10.1038/284546a0; Fergus DJ, 2013, J COMP NEUROL, V521, P2850, DOI 10.1002/cne.23320; Foran CM, 1998, GEN COMP ENDOCR, V111, P271, DOI 10.1006/gcen.1998.7113; Forlano PM, 2005, J NEUROBIOL, V65, P37, DOI 10.1002/neu.20179; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; Fraser BA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2310; Frisch Ashley, 2004, Reviews in Fish Biology and Fisheries, V14, P481, DOI 10.1007/s11160-005-3586-8; Gao ZX, 2009, AQUACULTURE, V294, P138, DOI 10.1016/j.aquaculture.2009.05.024; Gomez Y, 2006, NEUROBIOL LEARN MEM, V85, P252, DOI 10.1016/j.nlm.2005.11.006; Goncalves D, 2008, HORM BEHAV, V54, P717, DOI 10.1016/j.yhbeh.2008.07.014; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenwood AK, 2008, P ROY SOC B-BIOL SCI, V275, P2393, DOI 10.1098/rspb.2008.0622; Grober MS, 2002, BRAIN RES BULL, V57, P423, DOI 10.1016/S0361-9230(01)00704-3; Gross MR, 1998, J THEOR BIOL, V192, P445, DOI 10.1006/jtbi.1998.0665; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; GROSS MR, 1981, BEHAV ECOL SOCIOBIOL, V8, P163, DOI 10.1007/BF00299826; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; GROSS MR, 1982, Z TIERPSYCHOL, V60, P1; GROSS MR, 1979, CAN J ZOOL, V57, P1507, DOI 10.1139/z79-197; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KINDLER PM, 1991, HORM BEHAV, V25, P410, DOI 10.1016/0018-506X(91)90011-6; KINDLER PM, 1989, GEN COMP ENDOCR, V75, P446, DOI 10.1016/0016-6480(89)90180-9; Knapp R, 2007, BIOL LETTERS, V3, P628, DOI 10.1098/rsbl.2007.0379; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Lepage O, 2005, HORM BEHAV, V48, P233, DOI 10.1016/j.yhbeh.2005.02.012; MacManes MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00013; Magee SE, 2006, HORM BEHAV, V49, P598, DOI 10.1016/j.yhbeh.2005.12.003; Marden JH, 2008, HEREDITY, V100, P111, DOI 10.1038/sj.hdy.6800904; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; MUNRO AD, 1986, J PINEAL RES, V3, P257, DOI 10.1111/j.1600-079X.1986.tb00748.x; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Neff BD, 2004, BEHAV ECOL, V15, P327, DOI 10.1093/beheco/arh016; Neff BD, 2001, J HERED, V92, P111, DOI 10.1093/jhered/92.2.111; Neff BD, 2001, P ROY SOC B-BIOL SCI, V268, P1559, DOI 10.1098/rspb.2001.1678; Neff BD, 2009, CENTRARCHID FISHES D, P96; Neff BD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0045; Oliveira Rui F., 2006, Fish Physiology, V24, P297; Ota Y, 1999, GEN COMP ENDOCR, V116, P40, DOI [10.1006/gcen.1999.7344, 10.1006/gcen.1999.7343]; Parsch J, 2013, NAT REV GENET, V14, P83, DOI 10.1038/nrg3376; Partridge C, 2015, CAN J ZOOL, V93, P9, DOI 10.1139/cjz-2014-0157; Paula JR, 2015, BEHAV ECOL, V26, P1005, DOI 10.1093/beheco/arv039; Piche A J, 2008, P ROY SOC LOND B BIO, V275, P1571; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Schlinger BA, 1999, P ROY SOC B-BIOL SCI, V266, P131, DOI 10.1098/rspb.1999.0612; Schunter C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-167; Shuster SM, 1997, NATURE, V388, P373, DOI 10.1038/41089; Sneddon LU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018181; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stiver KA, 2015, ETHOLOGY, V121, P152, DOI 10.1111/eth.12324; Stoltz JA, 2006, BEHAV ECOL SOCIOBIOL, V59, P811, DOI 10.1007/s00265-005-0127-3; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Taborsky M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P537, DOI 10.1007/978-3-642-02624-9_18; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602.002; Thomson JS, 2011, HORM BEHAV, V59, P67, DOI 10.1016/j.yhbeh.2010.10.010; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668	93	19	19	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167509	10.1371/journal.pone.0167509	http://dx.doi.org/10.1371/journal.pone.0167509			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907106	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700175
J	Robazza, C; Bertollo, M; Ruiz, MC; Bortoli, L				Robazza, Claudio; Bertollo, Maurizio; Ruiz, Montse C.; Bortoli, Laura			Measuring Psychobiosocial States in Sport: Initial Validation of a Trait Measure	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; CHANGING STUDENTS ATTITUDES; MOTIVATIONAL CLIMATE; NEGATIVE AFFECT; ATHLETIC PERFORMANCE; FREQUENCY DIMENSIONS; COMPETITIVE ANXIETY; FIT INDEXES; EMOTIONS; DIRECTION	We examined the item characteristics, the factor structure, and the concurrent validity of a trait measure of psychobiosocial states. In Study 1, Italian athletes (N = 342, 228 men, 114 women, M-age = 23.93, SD = 6.64) rated the intensity, the frequency, and the perceived impact dimensions of a psychobiosocial states scale, trait version (PBS-ST), which is composed of 20 items (10 functional and 10 dysfunctional) referring to how they usually felt before an important competition. In Study 2, the scale was cross validated in an independent sample (N = 251, 181 men, 70 women, M-age = 24.35, SD = 7.25). The concurrent validity of the PBS-ST scale scores were also examined in comparison with two sport-specific emotion-related measures and a general measure of affect. Exploratory structural equation modeling and confirmatory factor analysis of the data of Study 1 showed that a 2-factor, 15-item solution of the PBS-ST scale (8 functional items and 7 dysfunctional items) reached satisfactory fit indices for the three dimensions (i.e., intensity, frequency, and perceived impact). Results of Study 2 provided evidence of substantial measurement and structural invariance of all dimensions across samples. The low association of the PBS-ST scale with other measures suggests that the scale taps unique constructs. Findings of the two studies offer initial validity evidence for a sport-specific tool to measure psychobiosocial states.	[Robazza, Claudio; Bertollo, Maurizio; Bortoli, Laura] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, BIND Behav Imaging & Neural Dynam Ctr, Chieti, Italy; [Ruiz, Montse C.] Univ Jyvaskyla, Dept Sport Sci, Jyvaskyla, Finland	G d'Annunzio University of Chieti-Pescara; University of Jyvaskyla	Robazza, C (corresponding author), G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, BIND Behav Imaging & Neural Dynam Ctr, Chieti, Italy.	c.robazza@unich.it	Robazza, Claudio/AAS-1152-2020; Ruiz, Montse/F-4500-2016; Bertollo, Maurizio/K-5469-2013	Robazza, Claudio/0000-0002-3639-1539; Ruiz, Montse/0000-0002-1116-206X; Bertollo, Maurizio/0000-0002-0972-9178				Arnold R, 2015, J SPORT SCI, V33, P169, DOI 10.1080/02640414.2014.955520; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bertollo M, 2013, APPL PSYCHOPHYS BIOF, V38, P91, DOI 10.1007/s10484-013-9211-z; Blascovich J, 1996, ADV EXP SOC PSYCHOL, V28, P1, DOI 10.1016/S0065-2601(08)60235-X; Blascovich J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P431; Bortoli L., 2007, MOTIVATION EXERCISE, P119; Bortoli L, 2015, RES Q EXERCISE SPORT, V86, P196, DOI 10.1080/02701367.2014.999189; Bortoli L, 2014, J SPORT SCI, V32, P572, DOI 10.1080/02640414.2013.843017; Bortoli L, 2012, PSYCHOL SPORT EXERC, V13, P397, DOI 10.1016/j.psychsport.2012.01.001; Bortoli L, 2011, J SPORT SCI, V29, P171, DOI 10.1080/02640414.2010.530675; Bortoli L, 2009, PERS INDIV DIFFER, V47, P18, DOI 10.1016/j.paid.2009.01.042; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrne B.M., 2012, STRUCTURAL EQUATION; Campo M, 2012, SPORT PSYCHOL, V26, P62, DOI 10.1123/tsp.26.1.62; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Crocker PRE, 1997, J SPORT EXERCISE PSY, V19, P91, DOI 10.1123/jsep.19.1.91; Di Corrado D, 2015, PERCEPT MOTOR SKILL, V121, P14, DOI 10.2466/30.PMS.121c11x6; di Fronso S, 2016, J SPORT SCI MED, V15, P214; Farmer A. Y., 2014, RES DIVERSE GROUPS R; Fernandes MG, 2013, J APPL SPORT PSYCHOL, V25, P377, DOI 10.1080/10413200.2012.744780; Friesen AP, 2013, INT REV SPORT EXER P, V6, P139, DOI 10.1080/1750984X.2012.742921; Hanin J., 2014, ROUTLEDGE COMPANION, P83; Hanin Y.L., 2012, HDB SPORT PSYCHOL, P31, DOI [10.1002/9781118270011.ch2, DOI 10.1002/9781118270011.CH2]; Hanin YL, 2002, SPORT PSYCHOL, V16, P396, DOI 10.1123/tsp.16.4.396; Hanin YL, 2010, COPING SPORT THEORY, V159, P175; Hanton S, 2004, PSYCHOL SPORT EXERC, V5, P169, DOI 10.1016/S1469-0292(02)00042-0; Harmison RJ, 2006, PROF PSYCHOL-RES PR, V37, P233, DOI 10.1037/0735-7028.37.3.233; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang C., 2011, EDUC PSYCHOL REV, V23, P359, DOI [DOI 10.1007/s10648-011-9155-x, 10.1007/s10648-011-9155-x]; JONES G, 1995, BRIT J PSYCHOL, V86, P449, DOI 10.1111/j.2044-8295.1995.tb02565.x; Jones G, 2001, J SPORT SCI, V19, P385, DOI 10.1080/026404101300149348; Jones MV, 2005, J SPORT EXERCISE PSY, V27, P407, DOI 10.1123/jsep.27.4.407; Jones MV, 2003, SPORT PSYCHOL, V17, P471, DOI 10.1123/tsp.17.4.471; Lazarus RS, 2000, SPORT PSYCHOL, V14, P229, DOI 10.1123/tsp.14.3.229; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Martens R., 1990, COMPETITIVE ANXIETY, P117; Martinent G, 2015, PSYCHOL SPORT EXERC, V20, P29, DOI 10.1016/j.psychsport.2015.04.005; Martinent G, 2010, PSYCHOL SPORT EXERC, V11, P51, DOI 10.1016/j.psychsport.2009.05.001; Mellalieu S.D., 2006, LIT REV SPORT PSYCHO, P1; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nicolas M, 2014, PSYCHOL SPORT EXERC, V15, P227, DOI 10.1016/j.psychsport.2014.01.005; Nieuwenhuys A, 2008, PSYCHOL SPORT EXERC, V9, P61, DOI 10.1016/j.psychsport.2006.12.007; Nieuwenhuys A, 2011, PSYCHOL SPORT EXERC, V12, P135, DOI 10.1016/j.psychsport.2010.07.008; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; Pekrun R, 2011, CONTEMP EDUC PSYCHOL, V36, P36, DOI 10.1016/j.cedpsych.2010.10.002; Raglin J. S., 2000, EMOTIONS SPORT, P93; Robazza C, 2006, J SPORT MED PHYS FIT, V46, P501; Robazza C, 2005, J SPORT SCI, V23, P1075, DOI 10.1080/02640410500128205; Robazza C, 2004, PSYCHOL SPORT EXERC, V5, P379, DOI 10.1016/S1469-0292(03)00034-7; Robazza C., 2000, Psychology of Sport and Exercise, V1, P103, DOI 10.1016/S1469-0292(00)00007-8; Robazza C, 2009, GIORNALE ITALIANO PS, V4, P14, DOI DOI 10.1007/S40279-016-0492-2; Robazza C, 2007, PSYCHOL SPORT EXERC, V8, P875, DOI 10.1016/j.psychsport.2006.07.005; Robazza C, 2006, PERS INDIV DIFFER, V41, P767, DOI 10.1016/j.paid.2006.03.020; Robazza C, 2012, PSYCHOL SPORT EXERC, V13, P509, DOI 10.1016/j.psychsport.2012.02.011; Ruiz MC, 2004, J APPL SPORT PSYCHOL, V16, P258, DOI 10.1080/10413200490498366; Ruiz MC, 2016, INT J SPORT IN PRESS; RUIZ MC, 2004, REV PSICOL DEPORTE, V13, P229; Ruiz MC, 2016, SPORT PSYCH IN PRESS; Ruiz MC, 2011, PSYCHOL SPORT EXERC, V12, P242, DOI 10.1016/j.psychsport.2011.01.005; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; Smith R.E., 1990, ANXIETY RES, V2, P263, DOI [DOI 10.1080/08917779008248733, https://doi.org/10.1080/08917779008248733]; SWAIN A, 1993, J SPORT SCI, V11, P533, DOI 10.1080/02640419308730024; Thomas O, 2011, J SPORT SCI, V29, P495, DOI 10.1080/02640414.2010.541479; Uphill MA, 2012, PSYCHOL SPORT EXERC, V13, P761, DOI 10.1016/j.psychsport.2012.05.001; Wagstaff C. R., 2012, ROUTLEDGE ONLINE STU, P143, DOI DOI 10.4324/9780203852293; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiesner M, 2013, J SCHOOL PSYCHOL, V51, P751, DOI 10.1016/j.jsp.2013.09.001; Woodcock C, 2012, PSYCHOL SPORT EXERC, V13, P291, DOI 10.1016/j.psychsport.2011.11.011; Woodman T, 2009, J SPORT EXERCISE PSY, V31, P169, DOI 10.1123/jsep.31.2.169; ZEVON MA, 1982, J PERS SOC PSYCHOL, V43, P111, DOI 10.1037/0022-3514.43.1.111; Zhu WM, 2012, J SPORT HEALTH SCI, V1, P9, DOI 10.1016/j.jshs.2012.02.002	73	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167448	10.1371/journal.pone.0167448	http://dx.doi.org/10.1371/journal.pone.0167448			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907111	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700160
J	Roed, KH; Kvie, KS; Hasle, G; Gilbert, L; Leinaas, HP				Roed, Knut H.; Kvie, Kjersti S.; Hasle, Gunnar; Gilbert, Lucy; Leinaas, Hans Petter			Phylogenetic Lineages and Postglacial Dispersal Dynamics Characterize the Genetic Structure of the Tick, Ixodes ricinus, in Northwest Europe	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; BORRELIA-BURGDORFERI; POPULATION-GENETICS; STATISTICAL TESTS; PASSERINE BIRDS; LYME-DISEASE; WILD BOAR; COLONIZATION; PREVALENCE; DIVERGENCE	Dispersal and gene flow are important mechanisms affecting the dynamics of vectors and their pathogens. Here, patterns of genetic diversity were analyzed in many North European populations of the tick, Ixodes ricinus. Population sites were selected within and between areas separated by geographical barriers in order to evaluate the importance of tick transportation by birds in producing genetic connectivity across open sea and mountain ranges. The phylogenetic analyses of the mitochondrial control region and the cytochrome b gene revealed two distinct clades with supported sub-clades, with three genetic lineages: GB and WNo associated with Great Britain and western Norway respectively, and Eu with a wider distribution across continental Europe in agreement with much lower efficiency of tick dispersal by birds than by large mammals. The results suggest different ancestry of I. ricinus colonizing Britain and the rest of northern Europe, possibly from different glacial refuges, while ticks from western Norway and continental Europe share a more recent common ancestry. Demographic history modeling suggests a period of strong increase in tick abundance coincident with progression of the European Neolithic culture, long after their post-glacial colonization of NW Europe.	[Roed, Knut H.; Kvie, Kjersti S.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Hasle, Gunnar] Oslo Travel Clin, St Olays Plass 3, Oslo, Norway; [Gilbert, Lucy] James Hutton Inst, Macaulay Dr, Aberdeen, Scotland; [Leinaas, Hans Petter] Univ Oslo, Dept Biosci, Oslo, Norway	Norwegian University of Life Sciences; James Hutton Institute; University of Oslo	Leinaas, HP (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	h.p.leinaas@ibv.uio.no	Hasle, Gunnar/AAF-4863-2020		University of Oslo; Norwegian University if Life Sciences; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS)	University of Oslo; Norwegian University if Life Sciences; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS)	Support was provided by SAK 6-Fundings for Collaboration in Life Science between University of Oslo and Norwegian University if Life Sciences (to KHR and HPL) and the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-177; Araya-Anchetta A, 2015, INFECT GENET EVOL, V29, P164, DOI 10.1016/j.meegid.2014.11.008; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barrett PN, 2004, VACCINES, P773; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Casati S, 2008, INFECT GENET EVOL, V8, P152, DOI 10.1016/j.meegid.2007.11.007; Chomel B, 2015, REV SCI TECH OIE, V34, P569, DOI 10.20506/rst.34.2.2380; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; de Meeus T, 2002, EVOLUTION, V56, P1802, DOI 10.1111/j.0014-3820.2002.tb00194.x; Dietrich M, 2014, MOL ECOL, V23, P3292, DOI 10.1111/mec.12815; Dinnis RE, 2014, TICKS TICK-BORNE DIS, V5, P152, DOI 10.1016/j.ttbdis.2013.10.001; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Estrada-Pena A, 2013, EXP APPL ACAROL, V59, P351, DOI 10.1007/s10493-012-9600-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gilbert L, 2014, ECOL EVOL, V4, P1186, DOI 10.1002/ece3.1014; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Handeland K, 2013, VET PARASITOL, V195, P142, DOI 10.1016/j.vetpar.2013.02.012; Hasle G, 2011, TICKS TICK-BORNE DIS, V2, P37, DOI 10.1016/j.ttbdis.2010.10.004; Hasle G, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-55; Hasle G, 2009, J PARASITOL, V95, P1342, DOI 10.1645/GE-2146.1; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hillyard PD, 1996, SYNOPSES OF THE BRIT, V52; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hogestol M, 2006, ENVIRON ARCHAEOL, V11, P19, DOI 10.1179/174963106x97034; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; James MC, 2011, IBIS, V153, P293, DOI 10.1111/j.1474-919X.2011.01111.x; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kempf F, 2010, INFECT GENET EVOL, V10, P989, DOI 10.1016/j.meegid.2010.06.003; Kriz B, 2014, VECTOR-BORNE ZOONOT, V14, P801, DOI 10.1089/vbz.2013.1569; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; McCoy KD, 2003, EVOLUTION, V57, P288, DOI 10.1111/j.0014-3820.2003.tb00263.x; Montgomery WI, 2014, QUATERNARY SCI REV, V98, P144, DOI 10.1016/j.quascirev.2014.05.026; MOREL PC, 1978, ACAROLOGIA, V19, P579; Noureddine R, 2011, INT J PARASITOL, V41, P183, DOI 10.1016/j.ijpara.2010.08.010; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pietzsch ME, 2008, VET PARASITOL, V155, P328, DOI 10.1016/j.vetpar.2008.05.006; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V1 6; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Rosvold J, 2010, HOLOCENE, V20, P1113, DOI 10.1177/0959683610369505; Rowley-Conwy P, 2004, CURR ANTHROPOL, V45, pS83, DOI 10.1086/422083; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sparagano O, 2015, VET PARASITOL, V213, P61, DOI 10.1016/j.vetpar.2015.08.028; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Valarcher JF, 2015, REV SCI TECH OIE, V34, P453; Ytrehus B, 2013, VECTOR-BORNE ZOONOT, V13, P762, DOI 10.1089/vbz.2012.1023	57	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167450	10.1371/journal.pone.0167450	http://dx.doi.org/10.1371/journal.pone.0167450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907193	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000389482700161
J	Schaefer, B; Wurtinger, P; Finkenstedt, A; Braithwaite, V; Viveiros, A; Effenberger, M; Sulzbacher, I; Moschen, A; Griesmacher, A; Tilg, H; Vogel, W; Zoller, H				Schaefer, Benedikt; Wuertinger, Philipp; Finkenstedt, Armin; Braithwaite, Vickie; Viveiros, Andre; Effenberger, Maria; Sulzbacher, Irene; Moschen, Alexander; Griesmacher, Andrea; Tilg, Herbert; Vogel, Wolfgang; Zoller, Heinz			Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR 23; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; OSTEOMALACIA; MANAGEMENT; RICKETS	Background Ferric carboxymaltose (FCM) and iron isomaltoside 1000 (IIM) are increasingly used because they allow correction of severe iron deficiency in a single infusion. A transient decrease in serum phosphate concentrations is a frequent side effect of FCM. Aim To characterize this adverse event and search for its predictors in a gastroenterology clinic patient cohort. Methods Electronic medical records of patients attending the University Hospital of Innsbruck were searched for the keywords ferric carboxymaltose or iron isomaltoside. Eighty-one patients with documented administration of FCM or IIM with plasma phosphate concentrations before and after treatment were included. Results The prevalence of hypophosphatemia (<0.8 mmol/L) increased from 11% to 32.1% after treatment with i.v. iron. The hypophosphatemia risk was greater after FCM (45.5%) compared with IIM (4%). Severe hypophosphatemia (<0.6 mmol/L) occurred exclusively after FCM (32.7%). The odds for hypophosphatemia after i.v. iron treatment were independently determined by baseline phosphate and the choice of i.v. iron preparation (FCM vs. IIM-OR = 20.8; 95% CI, 2.6-166; p = 0.004). The median time with hypophosphatemia was 41 days, but prolonged hypophosphatemia of >= 2 months was documented in 13 of 17 patients in whom follow-up was available. A significant increase in the phosphaturic hormone intact FGF-23 in hypophosphatemic patients shows that this adverse event is caused by FCM-induced hormone dysregulation. Conclusion Treatment with FCM is associated with a high risk of developing severe and prolonged hypophosphatemia and should therefore be monitored. Hypophosphatemia risk appears to be substantially lower with IIM.	[Schaefer, Benedikt; Finkenstedt, Armin; Viveiros, Andre; Vogel, Wolfgang; Zoller, Heinz] Med Univ Innsbruck, Dept Med Gastroenterol & Hepatol 2, Anichstr, Innsbruck, Austria; [Wuertinger, Philipp; Griesmacher, Andrea] Univ Innsbruck Hosp, Cent Inst Med & Chem Lab Diag, Anichstr, Innsbruck, Austria; [Braithwaite, Vickie] Elsie Widdowson Labs, Med Res Council MRC Human Nutr Res, Fulbourn Rd, Cambridge, England; [Effenberger, Maria; Moschen, Alexander; Tilg, Herbert] Med Univ Innsbruck, Dept Med Gastroenterol Endocrinol & Metab 1, Anichstr, Innsbruck, Austria; [Sulzbacher, Irene] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Innsbruck; Medical University of Innsbruck; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Medical University of Innsbruck; Medical University of Vienna	Zoller, H (corresponding author), Med Univ Innsbruck, Dept Med Gastroenterol & Hepatol 2, Anichstr, Innsbruck, Austria.	heinz.zoller@i-med.ac.at	Zoller, Heinz/AAD-7225-2019; Schaefer, Benedikt/V-6096-2019; Moschen, Alexander/ABF-2267-2021	Moschen, Alexander R/0000-0003-3598-7848	Medical University of Innsbruck; Medical Research Council; Verein zur Foerderung der Wissenschaft in Gastroenterologie Hepatologie	Medical University of Innsbruck; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Verein zur Foerderung der Wissenschaft in Gastroenterologie Hepatologie	The study was funded by the Medical University of Innsbruck and the Medical Research Council. Benedikt Schaefer received a grant from the "Verein zur Foerderung der Wissenschaft in Gastroenterologie & Hepatologie." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mendoza JAB, 2014, MED CLIN-BARCELONA, V143, P284, DOI 10.1016/j.medcli.2013.11.030; Basha B, 2000, AM J MED, V108, P296, DOI 10.1016/S0002-9343(99)00460-X; Blazevic A, 2014, NETH J MED, V72, P49; David V, 2015, KIDNEY INT; Dignass AU, 2015, J CROHNS COLITIS, V9, P211, DOI 10.1093/ecco-jcc/jju009; Evstatiev R, 2011, GASTROENTEROLOGY, V141, P846, DOI 10.1053/j.gastro.2011.06.005; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Fierz YC, 2014, EUR J CLIN NUTR, V68, P531, DOI 10.1038/ejcn.2014.20; FINCH PJ, 1992, Q J MED, V83, P439; Keating GM, 2015, DRUGS, V75, P101, DOI 10.1007/s40265-014-0332-3; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Mani LY, 2010, TRANSPLANTATION, V90, P804, DOI 10.1097/TP.0b013e3181f00a18; Moore Kari Lenita Falck, 2013, Tidsskr Nor Laegeforen, V133, P165, DOI 10.4045/tidsskr.12.0494; National Cancer Institute, 2009, NIH PUBLICATION; New Drug Application (NDA), 2008, NEW DRUG APPL NDA 22; Onken JE, 2014, TRANSFUSION, V54, P306, DOI 10.1111/trf.12289; Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x; Poursac N., 2015, RHUMATOS, V12, P61; Reinisch W, 2015, SCAND J GASTROENTERO, V50, P1226, DOI 10.3109/00365521.2015.1031168; Sangros Sahun MJ, 2016, REV ESP MED NUCL IMA; Soeren AS, 2016, EUR IR CLUB M 2016 I; Van Wyck DB, 2009, TRANSFUSION, V49, P2719, DOI 10.1111/j.1537-2995.2009.02327.x; Vandemergel X, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/843689; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923	25	53	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167146	10.1371/journal.pone.0167146	http://dx.doi.org/10.1371/journal.pone.0167146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907058	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700081
J	Sibiya, HP; Mabandla, MV; Musabayane, CT				Sibiya, Happiness P.; Mabandla, Musa V.; Musabayane, Cephas T.			The Effects of Transdermally Delivered Oleanolic Acid on Malaria Parasites and Blood Glucose Homeostasis in P. berghei-Infected Male Sprague-Dawley Rats	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; IN-VITRO; ANTIOXIDANT; ARTEMISININ; CHLOROQUINE; FALCIPARUM; EXTRACT	The present study investigated the effects of transdermally delivered oleanolic acid (OA) monotherapy and in combination with chloroquine (CHQ) on malaria parasites and glucose homeostasis of P. berghei-infected male Sprague-Dawley rats. Oral glucose test (OGT) responses to OA-pectin patch and CHQ-OA combination matrix patch were monitored in non-infected and infected rats. To evaluate the short-term effects of treatment, percentage parasitaemia, blood glucose, glycogen and plasma insulin were monitored in separate groups of animals treated with either OA-patch monotherapy or CHQ-OA combination pectin patch over a 21-days period. Animals treated with drug-free pectin and CHQ acted as untreated and treated positive controls, respectively. Infected control rats exhibited significantly increased parasitaemia which was accompanied by hypoglycaemia. Both OA monotherapy and CHQ-OA combination therapy reduced and cleared the malaria parasites within a period of 4 and 3 days, respectively. Compared to respective controls groups, O-GT responses of animals treated with OA monotherapy or CHQ-OA combination therapy exhibited lower blood glucose levels at all time points. A once-off transdermal application of OApatch or CHQ-OA combination patch significantly improved blood glucose concentrations inducing any changes in insulin concentration. Transdermal OA used as a monotherapy or in combination with CHQ is able to clear and reduce the malaria parasites within a shorter period of time without eliciting any adverse effects on glucose homeostasis of P. berghei-infected rats.	[Sibiya, Happiness P.; Mabandla, Musa V.; Musabayane, Cephas T.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa	University of Kwazulu Natal	Sibiya, HP (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa.	208512883@stu.ukzn.ac.za		Sibiya, Happiness/0000-0001-9985-4759	NRF South Africa; University of KwaZulu-Natal Research Division	NRF South Africa(National Research Foundation - South Africa); University of KwaZulu-Natal Research Division	The authors are grateful to the NRF South Africa and the University of KwaZulu-Natal Research Division for financial support. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2001, ANT DRUG COMB THER; [Anonymous], 2013, EXPL PAT PART RED HL; Bai XP, 2007, ASIA PAC J CLIN NUTR, V16, P169; Barsoum RS, 2000, J AM SOC NEPHROL, V11, P2147, DOI 10.1681/ASN.V11112147; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bero J, 2013, J ETHNOPHARMACOL, V149, P176, DOI 10.1016/j.jep.2013.06.018; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; Das B. S., 2008, Journal of Vector Borne Diseases, V45, P83; Davis TME, 1997, BRIT J CLIN PHARMACO, V44, P1, DOI 10.1046/j.1365-2125.1997.00597.x; Dekker E, 1997, J CLIN ENDOCR METAB, V82, P2514, DOI 10.1210/jc.82.8.2514; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Gumede B, 2003, PARASITOL INT, V52, P53, DOI 10.1016/S1383-5769(02)00081-8; Hadebe SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101461; Horiuchi K, 2007, BIOL PHARM BULL, V30, P1147, DOI 10.1248/bpb.30.1147; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; Jarzyna R, 2001, EUR J PHARMACOL, V428, P381, DOI 10.1016/S0014-2999(01)01221-3; Jiang QK, 2016, EUR J PHARM BIOPHARM, V99, P65, DOI 10.1016/j.ejpb.2015.11.013; JONES RG, 1986, J ROY SOC MED, V79, P426, DOI 10.1177/014107688607900714; Khathi A, 2013, J DIABETES, V5, P80, DOI 10.1111/j.1753-0407.2012.00230.x; KNUTSON VP, 1985, J BIOL CHEM, V260, P4180; Krishna S, 1999, LANCET, V353, P546, DOI 10.1016/S0140-6736(98)06316-8; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Lu YF, 2013, MOLECULES, V18, P3060, DOI 10.3390/molecules18033060; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Madlala HP, 2012, EFFECTS SYZYGIUM ARO; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Mkhwanazi BN, 2014, RENAL FAILURE, V36, P419, DOI 10.3109/0886022X.2013.867799; Musabayane CT, 2007, RENAL FAILURE, V29, P389, DOI 10.1080/08860220701260735; Musabayane CT, 2003, RENAL FAILURE, V25, P525, DOI 10.1081/JDI-120022543; Ngubane PS, 2015, RENAL FAILURE, V37, P151, DOI 10.3109/0886022X.2014.970469; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Sairafianpour M, 2003, PLANTA MED, V69, P846, DOI 10.1055/s-2003-43212; Steele JCP, 1999, PHYTOTHER RES, V13, P115, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;115::AID-PTR404&gt;3.0.CO;2-1; Visser BJ, 2014, EXPERT OPIN PHARMACO, V15, P2219, DOI 10.1517/14656566.2014.944499; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHITE NJ, 1987, LANCET, V1, P708; World Health Organization, 2015, WORLD MAL REP 2015; Wu J, 2010, P NATL ACAD SCI USA, V107, P11698, DOI 10.1073/pnas.1004714107	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167132	10.1371/journal.pone.0167132	http://dx.doi.org/10.1371/journal.pone.0167132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907019	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700079
J	Cong, Y; Dyall, J; Hart, BJ; DeWald, LE; Johnson, JC; Postnikova, E; Zhou, H; Gross, R; Rojas, O; Alexander, I; Josleyn, N; Zhang, T; Michelotti, J; Janosko, K; Glass, PJ; Flint, M; McMullan, LK; Spiropoulou, CF; Mierzwa, T; Guha, R; Shinn, P; Michael, S; Klumpp-Thomas, C; McKnight, C; Thomas, C; Eakin, AE; O'Loughlin, KG; Green, CE; Catz, P; Mirsalis, JC; Honko, AN; Olinger, GG; Bennett, RS; Holbrook, MR; Hensley, LE; Jahrling, PB				Cong, Yu; Dyall, Julie; Hart, Brit J.; DeWald, Lisa Evans; Johnson, Joshua C.; Postnikova, Elena; Zhou, Huanying; Gross, Robin; Rojas, Oscar; Alexander, Isis; Josleyn, Nicole; Zhang, Tengfei; Michelotti, Julia; Janosko, Krisztina; Glass, Pamela J.; Flint, Mike; McMullan, Laura K.; Spiropoulou, Christina F.; Mierzwa, Tim; Guha, Rajarshi; Shinn, Paul; Michael, Sam; Klumpp-Thomas, Carleen; McKnight, Crystal; Thomas, Craig; Eakin, Ann E.; O'Loughlin, Kathleen G.; Green, Carol E.; Catz, Paul; Mirsalis, Jon C.; Honko, Anna N.; Olinger, Gene G., Jr.; Bennett, Richard S.; Holbrook, Michael R.; Hensley, Lisa E.; Jahrling, Peter B.			Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus	PLOS ONE			English	Article							CELL-LINES; 5'-TRIPHOSPHATE; GLYCOPROTEINS; PATHOGENESIS; MACROPHAGES; DIAGNOSIS; ENTRY	In the fall of 2014, an international news agency reported that patients suffering from Ebola virus disease (EVD) in Liberia were treated successfully with lamivudine, an antiviral drug used to treat human immunodeficiency virus-1 and hepatitis B virus infections. According to the report, 13 out of 15 patients treated with lamivudine survived and were declared free from Ebola virus disease. In this study, the anti-Ebola virus (EBOV) activity of lamivudine and another antiretroviral, zidovudine, were evaluated in a diverse set of cell lines against two variants of wild-type EBOV. Variable assay parameters were assessed to include different multiplicities of infection, lengths of inoculation times, and durations of dosing. At a multiplicity of infection of 1, lamivudine and zidovudine had no effect on EBOV propagation in Vero E6, Hep G2, or HeLa cells, or in primary human monocyte-derived macrophages. At a multiplicity of infection of 0.1, zidovudine demonstrated limited anti-EBOV activity in Huh 7 cells. Under certain conditions, lamivudine had low anti-EBOV activity at the maximum concentration tested (320 mu M). However, lamivudine never achieved greater than 30% viral inhibition, and the activity was not consistently reproducible. Combination of lamivudine and zidovudine showed no synergistic antiviral activity. Independently, a set of in vitro experiments testing lamivudine and zidovudine for antiviral activity against an Ebolaen-hanced green fluorescent protein reporter virus was performed at the Centers for Disease Control and Prevention. No antiviral activity was observed for either compound. A study evaluating the efficacy of lamivudine in a guinea pig model of EVD found no survival benefit. This lack of benefit was observed despite plasma lamivudine concentrations in guinea pig of about 4 mu g/ml obtained in a separately conducted pharmacokinetics study. These studies found no evidence to support the therapeutic use of lamivudine for the treatment of EVD.	[Cong, Yu; Dyall, Julie; Hart, Brit J.; DeWald, Lisa Evans; Johnson, Joshua C.; Postnikova, Elena; Zhou, Huanying; Gross, Robin; Rojas, Oscar; Alexander, Isis; Josleyn, Nicole; Zhang, Tengfei; Michelotti, Julia; Janosko, Krisztina; Honko, Anna N.; Olinger, Gene G., Jr.; Bennett, Richard S.; Holbrook, Michael R.; Hensley, Lisa E.; Jahrling, Peter B.] NIAID, Div Clin Res, Integrated Res Facil, NIH, Frederick, MD 21702 USA; [Josleyn, Nicole; Glass, Pamela J.] US Army, Med Res Inst Infect Dis, Frederick, MD USA; [Flint, Mike; McMullan, Laura K.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Mierzwa, Tim; Guha, Rajarshi; Shinn, Paul; Michael, Sam; Klumpp-Thomas, Carleen; McKnight, Crystal; Thomas, Craig] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Eakin, Ann E.] NIAID, Off Biodef Res Resources & Translat Res, Div Microbiol & Infect Dis, NIH, Rockville, MD USA; [O'Loughlin, Kathleen G.; Green, Carol E.; Catz, Paul; Mirsalis, Jon C.] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Jahrling, Peter B.] NIAID, Emerging Viral Pathogens Sect, NIH, Frederick, MD USA; [Hart, Brit J.] Assoc Publ Hlth Abstract Labs, Silver Spring, MD USA; [Zhang, Tengfei] Thermo Fisher Sci Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); SRI International; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Thermo Fisher Scientific	Dyall, J (corresponding author), NIAID, Div Clin Res, Integrated Res Facil, NIH, Frederick, MD 21702 USA.	dyallj@niaid.nih.gov	Flint, Mike/L-8355-2019; Holbrook, Michael/AAT-6865-2020; Honko, Anna/H-9539-2019; McMullan, Laura/AAI-1404-2021; Glass, Pamela/AAN-5555-2020	Holbrook, Michael/0000-0002-0824-2667; Honko, Anna/0000-0001-9165-148X; McMullan, Laura/0000-0003-2748-5151; Johnson, Joshua/0000-0002-5677-3841; Olinger, Gene/0000-0001-7338-0292; Thomas, Craig/0000-0001-9386-9001; Bennett, Richard/0000-0002-7227-4831; Hensley, Lisa/0000-0003-1188-4342	SRI International; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZICTR000242] Funding Source: NIH RePORTER	SRI International; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	SRI International provided support in the form of salaries for authors [KGO, PC, CEG, JCM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank IRF Cell Culture staff in preparing the cells used in this study. We appreciate the strong support from Will Sheffield from NCI-Frederick research donor program and Linda Coe (IRF) in obtaining fresh human blood from NIH blood bank (Bethesda, MD, USA). We thank Dr. Gary Kobinger (Public Health Agency of Canada, Winnipeg, CA) for the Makona variant of EBOV (GenBank accession no. KP096420). We thank Dr. Thomas Geisbert (University of Texas Medical Branch at Galveston, Galveston, TX, USA) for the Hartley guinea pig adapted variant of EBOV. We thank Dr. Atsunobu Hiraoka (SCGF Research Laboratory, Kyoto, JP) for the kind gift of conditioned medium from KPB-M15 cells. We thank Dr. Hideki Ebihara (NIAID, Rocky Mountain Laboratories, Hamilton, MT) for Huh 7 (human hepatocellular carcinoma) cells. We thank Dr. William Eugene Dowling (Division of Microbiology and Infectious Diseases, NIH) for providing resources for the pharmacokinetic study. We thank Linh Nguyen and Julie Nop for expert technical assistance in the conduct of the pharmacokinetics study. In addition, we acknowledge Laura Bollinger and Jiro Wada at the IRF for technical writing services and figure preparation, respectively, for this manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Cohen E., 2014, DOCTOR TREATS EBOLA; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Cong Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004709; Dahlmann F, 2015, J INFECT DIS; Dai CY, 2013, J ANTIMICROB CHEMOTH, V68, P2332, DOI 10.1093/jac/dkt193; Else LJ, 2012, ANTIMICROB AGENTS CH, V56, P1427, DOI 10.1128/AAC.05599-11; Feldmann H, 1996, ARCH VIROL, P77; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Georges A J, 1998, Med Trop (Mars), V58, P177; Gnirss K, 2012, VIROLOGY, V424, P3, DOI 10.1016/j.virol.2011.11.031; Grard G, 2011, J INFECT DIS, V204, pS776, DOI 10.1093/infdis/jir364; GRECO WR, 1995, PHARMACOL REV, V47, P331; Grygorczuk Sambor, 2003, Pol Merkur Lekarski, V14, P146; HART GJ, 1992, ANTIMICROB AGENTS CH, V36, P1688, DOI 10.1128/AAC.36.8.1688; Heeney JL, 2006, J INTERN MED, V260, P399, DOI 10.1111/j.1365-2796.2006.01711.x; Hensley LE, 2015, EMERG INFECT DIS, V21, P550, DOI 10.3201/eid2103.141862; Herrington CS, 2015, J PATHOL, V235, P149, DOI 10.1002/path.4476; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; KRUINING J, 1995, J HEPATOL, V22, P263, DOI 10.1016/0168-8278(95)80277-0; Langedijk J, 2015, DRUG DISCOV TODAY, V20, P1027, DOI 10.1016/j.drudis.2015.05.001; Martinez-Romero C, 2015, VIRUS RES, V209, P4, DOI 10.1016/j.virusres.2015.05.025; McCarthy SDS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004364; McMullan LK, 2016, ANTIVIR RES, V125, P71, DOI 10.1016/j.antiviral.2015.10.010; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schinazi RF, 2003, JAIDS-J ACQ IMM DEF, V34, P243, DOI 10.1097/00126334-200310010-00017; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Vogel P., 1997, CELL VISION, V4, P298; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI.79.4.2413-2419.2005; World Health Organization, 2016, EB SIT REP 10 JUN 20	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166318	10.1371/journal.pone.0166318	http://dx.doi.org/10.1371/journal.pone.0166318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902714	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474100019
J	Girard, LC; Cote, SM; de Lauzon-Guillain, B; Dubois, L; Falissard, B; Forhan, A; Doyle, O; Bernard, JY; Heude, B; Saurel-Cubizolles, MJ; Kaminski, M; Boivin, M; Tremblay, RE				Girard, Lisa-Christine; Cote, Sylvana M.; de lauzon-Guillain, Blandine; Dubois, Lise; Falissard, Bruno; Forhan, Anne; Doyle, Orla; Bernard, Jonathan Y.; Heude, Barbara; Saurel-Cubizolles, Marie-Josephe; Kaminski, Monique; Boivin, Michel; Tremblay, Richard E.		EDEN Mother-Child Cohort Study Grp	Factors Associated with Breastfeeding Initiation: A Comparison between France and French-Speaking Canada	PLOS ONE			English	Article							MOTHER-CHILD COHORT; COGNITIVE-DEVELOPMENT; DURATION	Background Breastfeeding is associated with multiple domains of health for both mothers and children. Nevertheless, breastfeeding initiation is low within certain developed countries. Furthermore, comparative studies of initiation rates using harmonised data across multiple regions is scarce. Objective The aim of the present study was to investigate and compare individual-level determinants of breastfeeding initiation using two French-speaking cohorts. Methods Participants included similar to 3,900 mothers enrolled in two cohort studies in Canada and France. Interviews, questionnaires, and medical records were utilised to collect information on maternal, family, and medical factors associated with breastfeeding initiation. Results Rates of breastfeeding initiation were similar across cohorts, slightly above 70%. Women in both Canada and France who had higher levels of maternal education, were born outside of their respective countries and who did not smoke during pregnancy were more likely to initiate breastfeeding with the cohort infant. Notably, cohort effects of maternal education at the university level were found, whereby having 'some university' was not statistically significant for mothers in France. Further, younger mothers in Canada, who delivered by caesarean section and who had previous children, had reduced odds of breastfeeding initiation. These results were not found for mothers in France. Conclusions and Implications for Practice While some similar determinants were observed, programming efforts to increase breastfeeding initiation should be tailored to the characteristics of specific geographical regions which may be heavily impacted by the social, cultural and political climate of the region, in addition to individual and family level factors.	[Girard, Lisa-Christine; Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth, Physiotherapy & Sports Sci, Dublin, Ireland; [Girard, Lisa-Christine; Doyle, Orla; Tremblay, Richard E.] Univ Coll Dublin, Geary Inst Publ Policy, Dublin, Ireland; [Cote, Sylvana M.] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Cote, Sylvana M.; Boivin, Michel] Tomsk State Univ, Inst Genet Neurobiol & Social Fdn Child Dev, Tomsk, Russia; [Cote, Sylvana M.; Boivin, Michel; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment GRI, Montreal, PQ, Canada; [de lauzon-Guillain, Blandine; Forhan, Anne; Bernard, Jonathan Y.; Heude, Barbara] INSERM, Early ORigin Childs Hlth & Dev Team ORCHAD, UMR 1153, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Villejuif, France; [de lauzon-Guillain, Blandine; Forhan, Anne; Bernard, Jonathan Y.; Heude, Barbara; Saurel-Cubizolles, Marie-Josephe; Kaminski, Monique] Paris Descartes Univ, Paris, France; [Dubois, Lise] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada; [Falissard, Bruno] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Paris, France; [Doyle, Orla] Univ Coll Dublin, Sch Econ, Dublin, Ireland; [Saurel-Cubizolles, Marie-Josephe; Kaminski, Monique] Ctr Epidemiol & Stat, Sorbonne Paris Cite, DHU Risks Pregnancy, INSERM,UMR 1153,Obstetr Perinatal & Pediat Epidem, Paris, France; [Boivin, Michel] Univ Laval, Sch Psychol, Quebec City, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada	University College Dublin; University College Dublin; Universite de Montreal; Tomsk State University; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Laval University; Universite de Montreal; Universite de Montreal	Girard, LC (corresponding author), Univ Coll Dublin, Sch Publ Hlth, Physiotherapy & Sports Sci, Dublin, Ireland.; Girard, LC (corresponding author), Univ Coll Dublin, Geary Inst Publ Policy, Dublin, Ireland.	lisa.girard@ucd.ie	Tremblay, Richard E./O-1360-2014; Cote, Silvana Maria/O-1356-2014; Girard, Lisa-Christine/ABD-6846-2020; Bernard, Jonathan/T-7064-2017; Heude, Barbara/GLU-9626-2022; de Lauzon-Guillain, Blandine/P-4659-2016; Côté, Sylvana M./T-4600-2019; Heude, Barbara/G-3095-2016; Saurel-Cubizolles, Marie-Josephe/D-1571-2014	Girard, Lisa-Christine/0000-0003-3817-034X; Bernard, Jonathan/0000-0002-6418-983X; Heude, Barbara/0000-0002-1565-1629; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; Côté, Sylvana M./0000-0001-7944-0647; Heude, Barbara/0000-0002-1565-1629; Doyle, Orla/0000-0001-7197-8012; Boivin, Michel/0000-0001-8621-9844; Saurel-Cubizolles, Marie-Josephe/0000-0002-2210-974X	Marie Curie International Incoming Fellowship; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [625014]; Foundation for medical research (FRM); National Agency for Research (ANR); National Institute for Research in Public health (IRESP: TGIR cohorte sante program); French Ministry of Health (DGS); French Ministry of Research; INSERM Bone; Joint Diseases National Research (PRO-A); Human Nutrition National Research Programs; Paris Sud University; Nestle; French National Institute for Population Health Surveillance (InVS); French National Institute for Health Education (INPES); European Union; Diabetes National Research Program through French Association of Diabetic Patients (AFD); French Agency for Environment Security (AFSSET); Mutuelle Generale de ('Education Nationale a complementary health insurance (MGEN); French national agency for food security; French speaking association for the study of diabetes and metabolism (ALFEDIAM); Quebec Ministry of Health and Social Services of the Quebec Longitudinal Study of Child Development [19982002]	Marie Curie International Incoming Fellowship(European Commission); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant; Foundation for medical research (FRM)(Fondation pour la Recherche Medicale); National Agency for Research (ANR)(French National Research Agency (ANR)); National Institute for Research in Public health (IRESP: TGIR cohorte sante program); French Ministry of Health (DGS); French Ministry of Research(Ministry of Research, FranceEuropean Commission); INSERM Bone; Joint Diseases National Research (PRO-A); Human Nutrition National Research Programs; Paris Sud University; Nestle(Nestle SA); French National Institute for Population Health Surveillance (InVS); French National Institute for Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Union(European Commission); Diabetes National Research Program through French Association of Diabetic Patients (AFD); French Agency for Environment Security (AFSSET)(French National Research Agency (ANR)); Mutuelle Generale de ('Education Nationale a complementary health insurance (MGEN); French national agency for food security; French speaking association for the study of diabetes and metabolism (ALFEDIAM); Quebec Ministry of Health and Social Services of the Quebec Longitudinal Study of Child Development	Dr. Girard is supported by a Marie Curie International Incoming Fellowship; the research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no [625014]. We would also like to acknowledge all funding sources for the EDEN study: Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte sante 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A) and Human Nutrition National Research Programs, Paris Sud University, Nestle, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), the European Union (FP7, MeDALL project), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environment Security (AFSSET), Mutuelle Generale de ('Education Nationale a complementary health insurance (MGEN), French national agency for food security, French speaking association for the study of diabetes and metabolism (ALFEDIAM). We also acknowledge the Quebec Ministry of Health and Social Services for their funding of the Quebec Longitudinal Study of Child Development (19982002) (QLSCD), conducted by Sante Quebec, a division of the Institut de la Statistique du Quebec. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; [Anonymous], 2003, SANT SERV SOC PRIOR; Association of Women's Health Obstetric and Neonatal Nurses (AWHONN), 2015, J OBSTET GYNECOL NEO, V44, P83; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; Bernard JY, 2013, J PEDIATR-US, V163, P36, DOI 10.1016/j.jpeds.2012.11.090; Blondel B, 2011, FRENCH NATL PERINATA, P1; Bonet M, 2007, ACTA PAEDIATR, V96, P1290, DOI 10.1111/j.1651-2227.2007.00410.x; Bonet M, 2013, MATERN CHILD HLTH J, V17, P714, DOI 10.1007/s10995-012-1053-4; Bonet M, 2010, PUBLIC HEALTH NUTR, V13, P1946, DOI 10.1017/S136898001000159X; Brion MJ, 2011, INT J EPIDEMIOL; Cattaneo A, 2010, PUBLIC HEALTH NUTR, V13, P751; Cattaneo A., 2004, 20042002359 EU SPC; Ceti AC, 2005, ARCH PEDIAT ADOL MED, V159, P255, DOI 10.1001/archpedi.159.3.255; Dennis CL, 2014, MATERN CHILD NUTR, V10, P527, DOI 10.1111/j.1740-8709.2012.00442.x; Dennis CL, 2002, JOGNN-J OBST GYN NEO, V31, P12, DOI 10.1111/j.1552-6909.2002.tb00019.x; Dubois L, 2003, CAN J PUBLIC HEALTH, V94, P300, DOI 10.1007/BF03403610; Guise Jeanne-Marie, 2003, Ann Fam Med, V1, P70, DOI 10.1370/afm.56; Guxens M, 2011, PEDIATRICS, V128, pE880, DOI 10.1542/peds.2010-1633; Health Canada, 2009, BREASTF IN CAN KEY S; Health Canada, 2003, CAN PER HLTH REP HLT; Heude B, 2016, INT J EPIDEMIOL, V45, P353, DOI 10.1093/ije/dyv151; Horta BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071548; IBM Corp, 2011, IBM SPSS STAT WIND V; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Japel C, 2000, TEMPERAMENT LONGITUD, P1; Jiang M, 2011, MATERN CHILD HLTH J, V15, P1296, DOI 10.1007/s10995-010-0677-5; Kersuzan C., 2014, B EPIDEMIOL HEBD, V27, P440; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Leahy-Warren P, 2014, MIDWIFERY, V30, P345, DOI 10.1016/j.midw.2013.01.008; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; OECD-Policy-Division, 2009, C01 5 BREASTF RAT; Public Health Agency of Canada, PROT PROM SUPP BREAS; Quigley MA, 2012, J PEDIATR-US, V160, P25, DOI 10.1016/j.jpeds.2011.06.035; Scott J A, 1999, Breastfeed Rev, V7, P5; Semenic S, EVALUATION MISE OEUV; Sheehan D, 2001, J Hum Lact, V17, P211, DOI 10.1177/089033440101700304; Simard I, 2005, J HUM LACT, V21, P327, DOI 10.1177/0890334405275831; Statistics Canada, 2009, BREASTFEEDING; Thorvaldsen G, 2008, HIST FAM, V13, P283, DOI 10.1016/j.hisfam.2008.08.001; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Weiser TM, 2009, PEDIATRICS, V124, P1603, DOI 10.1542/peds.2008-2711; World Health Organization, 2015, 10 FACTS BREASTF; World Health Organization, 2003, WHA55A5525 WHO	43	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166946	10.1371/journal.pone.0166946	http://dx.doi.org/10.1371/journal.pone.0166946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902741	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100041
J	Groeschel, S; Hagberg, GE; Schultz, T; Balla, DZ; Klose, U; Hauser, TK; Nagele, T; Bieri, O; Prasloski, T; MacKay, AL; Krageloh-Mann, I; Scheffler, K				Groeschel, Samuel; Hagberg, Gisela E.; Schultz, Thomas; Balla, David Z.; Klose, Uwe; Hauser, Till-Karsten; Naegele, Thomas; Bieri, Oliver; Prasloski, Thomas; MacKay, Alex L.; Kraegeloh-Mann, Ingeborg; Scheffler, Klaus			Assessing White Matter Microstructure in Brain Regions with Different Myelin Architecture Using MRI	PLoS One			English	Article							DIFFUSION-TENSOR MRI; GRADIENT-ECHO MRI; MAGNETIZATION-TRANSFER RATIO; TIME-DEPENDENT DIFFUSION; IN-VIVO QUANTIFICATION; L-ASPARTIC ACID; METABOLITE CONCENTRATIONS; CORTICOSPINAL TRACT; MULTIPLE-SCLEROSIS; FIBER ORIENTATION	Objective We investigate how known differences in myelin architecture between regions along the cortico-spinal tract and frontal white matter (WM) in 19 healthy adolescents are reflected in several quantitative MRI parameters that have been proposed to non-invasively probe WM microstructure. In a clinically feasible scan time, both conventional imaging sequences as well as microstructural MRI parameters were assessed in order to quantitatively characterise WM regions that are known to differ in the thickness of their myelin sheaths, and in the presence of crossing or parallel fibre organisation. Results We found that diffusion imaging, MR spectroscopy (MRS), myelin water fraction (MWF), Magnetization Transfer Imaging, and Quantitative Susceptibility Mapping were myelin-sensitive in different ways, giving complementary information for characterising WM microstructure with different underlying fibre architecture. From the diffusion parameters, neurite density (NODDI) was found to be more sensitive than fractional anisotropy ( FA), underlining the limitation of FA in WM crossing fibre regions. In terms of sensitivity to different myelin content, we found that MWF, the mean diffusivity and chemical-shift imaging based MRS yielded the best discrimination between areas. Conclusion Multimodal assessment of WM microstructure was possible within clinically feasible scan times using a broad combination of quantitative microstructural MRI sequences. By assessing new microstructural WM parameters we were able to provide normative data and discuss their interpretation in regions with different myelin architecture, as well as their possible application as biomarker for WM disorders.	[Groeschel, Samuel; Kraegeloh-Mann, Ingeborg] Univ Childrens Hosp Tubingen, Tubingen, Germany; [Hagberg, Gisela E.; Scheffler, Klaus] Max Planck Inst Biol Cybernet, High Field Magnet Resonance, Tubingen, Germany; [Hagberg, Gisela E.; Scheffler, Klaus] Univ Tubingen Hosp, Biomed Magnet Resonance, Tubingen, Germany; [Schultz, Thomas] Univ Bonn, Inst Comp Sci, Bonn, Germany; [Balla, David Z.] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Tubingen, Germany; [Klose, Uwe; Hauser, Till-Karsten; Naegele, Thomas] Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany; [Bieri, Oliver] Univ Basel, Radiol Phys, Basel, Switzerland; [Prasloski, Thomas; MacKay, Alex L.] Univ British Columbia, Vancouver, BC, Canada	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bonn; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; University of British Columbia	Groeschel, S (corresponding author), Univ Childrens Hosp Tubingen, Tubingen, Germany.	Samuel.groeschel@med.uni-tuebingen.de	Klose, Uwe/M-7110-2013; Hagberg, Gisela E/A-2134-2010	Klose, Uwe/0000-0001-5236-3450; Hagberg, Gisela E/0000-0003-2176-7086; Scheffler, Klaus/0000-0001-6316-8773	Medical Faculty of the University of Tubingen, Germany; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of the University of Tubingen, Germany; DFG [SCHU 3040/1-1]; Ministry of Science, Research and the Arts of Baden-Wurttemberg [Az: 32-771-8-1504.12/1/1]	Medical Faculty of the University of Tubingen, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen, Germany; DFG(German Research Foundation (DFG)); Ministry of Science, Research and the Arts of Baden-Wurttemberg	This study was funded by the Medical Faculty of the University of Tubingen, Germany. We also acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of the University of Tubingen, Germany. T.S. was funded by DFG grant SCHU 3040/1-1, G.E.H. by the Ministry of Science, Research and the Arts of Baden-Wurttemberg (Az: 32-771-8-1504.12/1/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Adluru G, 2014, IEEE ENG MED BIO, P742, DOI 10.1109/EMBC.2014.6943697; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ankele M, 2015, LECT NOTES COMPUT SC, V9349, P150, DOI 10.1007/978-3-319-24553-9_19; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Barth M, 2015, MAGN RESON MED; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bender B, 2010, NMR BIOMED, V23, P1071, DOI 10.1002/nbm.1534; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Billiet T, 2014, NEUROIMAGE-CLIN, V4, P649, DOI 10.1016/j.nicl.2014.04.005; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Bock NA, 2009, J NEUROSCI METH, V185, P15, DOI 10.1016/j.jneumeth.2009.08.022; BRENNER RE, 1993, MAGNET RESON MED, V29, P737, DOI 10.1002/mrm.1910290605; Burcaw LM, 2015, NEUROIMAGE, V114, P18, DOI 10.1016/j.neuroimage.2015.03.061; Callaghan MF, 2015, MAGN RESON MED, V73, P1309, DOI 10.1002/mrm.25210; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cercignani M, 2006, NEUROIMAGE, V31, P181, DOI 10.1016/j.neuroimage.2005.11.028; Chang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123656; Cherubini A, 2009, MAGN RESON MED, V61, P1066, DOI 10.1002/mrm.21978; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Concha L., 2013, NEUROSCIENCE, DOI 10.1016; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; de Rochefort L, 2008, MAGN RESON MED, V60, P1003, DOI 10.1002/mrm.21710; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Deoni SCL, 2008, NEUROIMAGE, V40, P662, DOI 10.1016/j.neuroimage.2007.11.052; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Dreha-Kulaczewski SF, 2012, J MAGN RESON IMAGING, V36, P1329, DOI 10.1002/jmri.23774; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Frahm J, 1996, NEUROPEDIATRICS, V27, P64, DOI 10.1055/s-2007-973751; Garcia M, 2011, NEURORADIOLOGY, V53, P159, DOI 10.1007/s00234-010-0714-5; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Gloor M, 2008, MAGN RESON MED, V60, P691, DOI 10.1002/mrm.21705; Gloor M, 2011, MAGN RESON MED, V65, P1113, DOI 10.1002/mrm.22694; Grinberg F, 2016, NEUROIMAGE; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Hagberg GE, 2010, MAGN RESON IMAGING, V28, P297, DOI 10.1016/j.mri.2009.06.001; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Helms G, 2010, MAGN RESON MED, V64, P177, DOI 10.1002/mrm.22379; Helms G, 2009, PHYS MED BIOL, V54, pN529, DOI 10.1088/0031-9155/54/23/N01; Herve PY, 2011, BRAIN STRUCT FUNCT, V216, P255, DOI 10.1007/s00429-011-0306-0; HIRAYAMA K, 1962, NEUROLOGY, V12, P337, DOI 10.1212/WNL.12.5.337; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaden E, 2016, NEUROIMAGE, V139, P346, DOI 10.1016/j.neuroimage.2016.06.002; Kaden E, 2016, MAGN RESON MED, V75, P1752, DOI 10.1002/mrm.25734; Kiselev VG, 2007, MAGN RESON MED, V57, P464, DOI 10.1002/mrm.21164; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; Kunz N, 2014, NEUROIMAGE; Labadie C, 2014, MAGN RESON MED, V71, P375, DOI 10.1002/mrm.24670; Langkammer C, 2015, NEUROIMAGE, V111, P622, DOI 10.1016/j.neuroimage.2015.02.041; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Liu C, 2014, J MAGN RESON IMAGING; Liu CL, 2012, NEUROIMAGE, V59, P1290, DOI 10.1016/j.neuroimage.2011.07.096; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Minati L, 2007, MAGN RESON MATER PHY, V20, P241, DOI 10.1007/s10334-007-0091-1; Moffett John R, 2006, Adv Exp Med Biol, V576, pvii; Mohammadi S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00441; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Panagiotaki E, 2014, CANCER RES, V74, P1902, DOI 10.1158/0008-5472.CAN-13-2511; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Pouwels PJW, 2014, ANN NEUROL, V76, P5, DOI 10.1002/ana.24194; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Prasloski T, 2012, MAGN RESON MED, V67, P1803, DOI 10.1002/mrm.23157; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raffelt D., 2012, P 20 ANN M ISMRM MEL, P3555; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Rioux JA, 2015, MAGN RESON MED; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Russell-Schulz B, 2013, MAGN RESON IMAGING, V31, P329, DOI 10.1016/j.mri.2012.07.003; Sati P, 2013, NEUROIMAGE, V77, P268, DOI 10.1016/j.neuroimage.2013.03.005; Schafer A, 2009, NEUROIMAGE, V48, P126, DOI 10.1016/j.neuroimage.2009.05.093; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schneider J, 2015, AJNR AM J NEURORADIO; Schweser F, 2016, Z MED PHYS, V26, P6, DOI 10.1016/j.zemedi.2015.10.002; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stikov N, 2015, NEUROIMAGE, V118, P397, DOI 10.1016/j.neuroimage.2015.05.023; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Sukstanskii AL, 2004, J MAGN RESON, V170, P56, DOI 10.1016/j.jmr.2004.05.020; Sun HF, 2014, MAGN RESON MED, V71, P1151, DOI 10.1002/mrm.24765; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tofts PS, 2006, MAGN RESON MATER PHY, V19, P209, DOI 10.1007/s10334-006-0049-8; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; Vos SB, 2016, MAGN RESON MED; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Weiskopf N, 2015, CURR OPIN NEUROL, V28, P313, DOI 10.1097/WCO.0000000000000222; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Wharton S, 2015, MAGN RESON MED, V73, P1258, DOI 10.1002/mrm.25189; Wharton S, 2013, NEUROIMAGE, V83, P1011, DOI 10.1016/j.neuroimage.2013.07.054; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; Yablonskiy DA, 2015, MAGN RESON MED, V73, P757, DOI 10.1002/mrm.25538; YAGISHITA A, 1994, RADIOLOGY, V191, P455, DOI 10.1148/radiology.191.2.8153321; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang J, 2015, MAGN RESON MED, V73, P223, DOI 10.1002/mrm.25125	135	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167274	10.1371/journal.pone.0167274	http://dx.doi.org/10.1371/journal.pone.0167274			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898701	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000044
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			Association between Alcohol Intake and Hemoglobin A1c in the Korean Adults: The 2011-2013 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							DIABETES-MELLITUS; CONSUMPTION; DRINKING; GLUCOSE; RISK; ACETALDEHYDE; DETERMINANTS; METAANALYSIS; POPULATION; HBA(1C)	Background Although alcohol consumption is commonly encountered in clinical practice, few studies have investigated the clinical significance of alcohol intake on the use of the hemoglobin A1c (HbA1c) level. Objectives This study was performed to investigate the association between alcohol intake and HbA1c level in the general population. Methods Among the 24,594 participants who participated in the 2011-2013 Korea National Health and Nutrition Examination Survey (KNHANES), 12,923 participants were analyzed in this study. We excluded diabetic patients currently taking antidiabetes medication. We compared the HbA1c level and proportions of patients with an HbA1c level of >= 5.7%, >= 6.1%, and >= 6.5% according to the fasting plasma glucose (FPG) concentration range and the amount of alcohol intake. The average amounts of daily alcohol intake were categorized into three groups: 0 g/day, <30 g/day, >= 30 g/day. Results The mean HbA1c level was 5.65%, and the mean FPG concentration was 95.3 mg/dl. The percentages of patients with an HbA1c level of >= 5.7%, >= 6.1%, and >= 6.5% were 42.6%, 13.4%, and 4.5%, respectively. The average amount of alcohol intake was 12.3 g/day. The percentages of subjects with alcohol intake 0, <30, and >= 30 g/day were 16.5%, 69.7%, and 13.8%, respectively. There was a significant positive relationship between alcohol intake and FPG concentration (P < 0.001), the prevalence of impaired fasting glucose (P < 0.001), and the prevalence of diabetes (P < 0.001). However, there was no significant relationship between the alcohol intake and HbA1c level. Overall, the adjusted HbA1c levels decreased across alcohol intake (5.70%+/- 0.01%, 5.66%+/- 0.01%, and 5.55%+/- 0.01%) after adjustment for confounding factors such as age, sex, FPG concentration, college graduation, smoking history, presence of hypertension, waist circumference, serum total cholesterol concentration, serum high density lipoprotein cholesterol concentration, serum triglyceride concentration, presence of anemia, serum white blood cell count, and serum alanine aminotransferase concentration (P < 0.001). The adjusted proportions (%) of patients with an HbA1c level of >= 5.7% (P < 0.001), >= 6.1% (P < 0.001), and >= 6.5% (P < 0.001) showed significant negative trends across alcohol intake after adjustment for confounders. Logistic regression analyses showed that, when using the group that abstained as the control, the group that consumed >= 30g/day was negatively associated with the risk of an HbA1c level of >= 5.7% (P < 0.001), >= 6.1% (P < 0.001), and >= 6.5% (P < 0.001), using the above-mentioned variables as covariates. Conclusions Higher alcohol intake was associated with lower HbA1c levels, even after adjusting for confounding factors, including the FPG concentration, in this nationally representative sample of Korean adults. These results suggest that excessive drinking shifts the HbA1c level downward, which might complicate use of the HbA1c level for the diagnosis of diabetes or prediabetes.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; da Costa JSD, 2004, REV SAUDE PUBL, V38, P284, DOI 10.1590/S0034-89102004000200019; ECKEY R, 1990, Z RECHTSMED, V103, P169; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; GOEDDE HW, 1987, ENZYME, V37, P29, DOI 10.1159/000469239; Gulliford MC, 2001, EUR J CLIN NUTR, V55, P615, DOI 10.1038/sj.ejcn.1601233; Harding AH, 2002, EUR J CLIN NUTR, V56, P882, DOI 10.1038/sj.ejcn.1601408; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Hong SW, 2015, ALCOHOL, V49, P275, DOI 10.1016/j.alcohol.2015.02.004; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; HUISMAN THJ, 1983, J LAB CLIN MED, V102, P163; Hyeon JH, 2016, ASIA PAC J CLIN NUTR, V25, P308, DOI 10.6133/apjcn.2016.25.2.17; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Koskinen LK, 1998, CLIN CHIM ACTA, V275, P53, DOI 10.1016/S0009-8981(98)00076-X; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Moreira LB, 1996, J STUD ALCOHOL, V57, P253, DOI 10.15288/jsa.1996.57.253; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Song DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163222; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043; TURPEINEN U, 1989, CLIN CHEM, V35, P33; World Health Organization, WORLDWIDE PREVALENCE; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Zilkens RR, 2003, J CARDIOVASC RISK, V10, P25, DOI 10.1097/00043798-200302000-00006	28	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167210	10.1371/journal.pone.0167210	http://dx.doi.org/10.1371/journal.pone.0167210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893805	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400101
J	Jutras, PV; Marusic, C; Lonoce, C; Deflers, C; Goulet, MC; Benvenuto, E; Michaud, D; Donini, M				Jutras, Philippe V.; Marusic, Carla; Lonoce, Chiara; Deflers, Carole; Goulet, Marie-Claire; Benvenuto, Eugenio; Michaud, Dominique; Donini, Marcello			An Accessory Protease Inhibitor to Increase the Yield and Quality of a Tumour-Targeting mAb in Nicotiana benthamiana Leaves	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; RECOMBINANT PROTEINS; PROTEOLYTIC DEGRADATION; HETEROLOGOUS PROTEINS; TRANSIENT EXPRESSION; PLANT PROTEASES; PROTECTION; PURIFICATION; CYSTATIN	The overall quality of recombinant IgG antibodies in plants is dramatically compromised by host endogenous proteases. Different approaches have been developed to reduce the impact of endogenous proteolysis on IgGs, notably involving site-directed mutagenesis to eliminate protease-susceptible sites or the in situ mitigation of host protease activities to minimize antibody processing in the cell secretory pathway. We here characterized the degradation profile of H10, a human tumour-targeting monoclonal IgG, in leaves of Nicotiana benthamiana also expressing the human serine protease inhibitor alpha(1)-antichymotrypsin or the cysteine protease inhibitor tomato cystatin S/CYS8. Leaf extracts revealed consistent fragmentation patterns for the recombinant antibody regardless of leaf age and a strong protective effect of S/CYS8 in specific regions of the heavy chain domains. As shown using an antigen-binding ELISA and LC-MS/MS analysis of antibody fragments, SlCYS8 had positive effects on both the amount of fully-assembled antibody purified from leaf tissue and the stability of biologically active antibody fragments containing the heavy chain Fc domain. Our data confirm the potential of Cys protease inhibitors as convenient antibody-stabilizing expression partners to increase the quality of therapeutic antibodies in plant protein biofactories.	[Jutras, Philippe V.; Deflers, Carole; Goulet, Marie-Claire; Michaud, Dominique] Univ Laval, Dept Phytol, Quebec City, PQ, Canada; [Marusic, Carla; Lonoce, Chiara; Benvenuto, Eugenio; Donini, Marcello] ENEA Res Ctr, Biotechnol Lab, Rome, Italy	Laval University; Italian National Agency New Technical Energy & Sustainable Economics Development	Michaud, D (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ, Canada.; Donini, M (corresponding author), ENEA Res Ctr, Biotechnol Lab, Rome, Italy.	dominique.michaud@fsaa.ulaval.ca; marcello.donini@enea.it	Donini, Marcello/AAJ-1079-2020	Deflers, Carole/0000-0001-7966-4114; Donini, Marcello/0000-0001-9183-0728; Goulet, Marie-Claire/0000-0001-7538-5783	Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione del Sistema Paese, Unita per la Cooperazione Scientifica e Tecnologica bilaterale e multilateral'; Natural Science and Engineering Research Council (NSERC) of Canada; AgroPhytoSciences NSERC-CREATE network; NSERC; Fonds de Recherche Quebec Nature et Technologies and Medicago inc	Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione del Sistema Paese, Unita per la Cooperazione Scientifica e Tecnologica bilaterale e multilateral'; Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); AgroPhytoSciences NSERC-CREATE network; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Quebec Nature et Technologies and Medicago inc	This work was supported by a Great Relevance collaborative grant from the Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione del Sistema Paese, Unita per la Cooperazione Scientifica e Tecnologica bilaterale e multilateral' to EB and MD, and by a Discovery grant from the Natural Science and Engineering Research Council (NSERC) of Canada to DM. PVJ was the recipient of a graduate scholarship from the AgroPhytoSciences NSERC-CREATE network and a BMP graduate scholarship funded by NSERC, the Fonds de Recherche Quebec Nature et Technologies and Medicago inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov V, 2010, PROTEIN EXPRES PURIF, V70, P158, DOI 10.1016/j.pep.2009.09.016; Benchabane M, 2009, PLANT BIOTECHNOL J, V7, P146, DOI 10.1111/j.1467-7652.2008.00382.x; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; Buyel JF, 2012, BIOTECHNOL BIOENG, V109, P2575, DOI 10.1002/bit.24523; D'Aoust Marc-Andre, 2009, V483, P41, DOI 10.1007/978-1-59745-407-0_3; De Meyer T, 2015, PLANT BIOTECHNOL J, V13, P938, DOI 10.1111/pbi.12330; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Donini M, 2015, BIOENGINEERED, V6, P299, DOI 10.1080/21655979.2015.1067740; Duwadi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130556; Fahad S, 2015, BIOTECHNOL LETT, V37, P265, DOI 10.1007/s10529-014-1699-7; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Fulton A, 2015, J CHROMATOGR A, V1389, P128, DOI 10.1016/j.chroma.2015.02.013; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goulet C, 2012, PLANT BIOTECHNOL J, V10, P83, DOI 10.1111/j.1467-7652.2011.00643.x; Goulet C, 2010, PLANT BIOTECHNOL J, V8, P142, DOI 10.1111/j.1467-7652.2009.00470.x; Goulet MC, 2008, PLANT PHYSIOL, V146, P1010, DOI 10.1104/pp.108.115741; Hehle VK, 2016, FASEB J, V30, P1590, DOI 10.1096/fj.15-283226; Hehle VK, 2015, PLANT BIOTECHNOL J, V13, P235, DOI 10.1111/pbi.12266; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; Huang C, 2013, FUSION PROTEIN TECHN, P123; Kim NS, 2008, PLANT MOL BIOL, V68, P263, DOI 10.1007/s11103-008-9367-8; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Krenek P, 2015, BIOTECHNOL ADV, V33, P1024, DOI 10.1016/j.biotechadv.2015.03.012; Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217; Lallemand J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00037; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521; Lombardi R, 2010, TRANSGENIC RES, V19, P1083, DOI 10.1007/s11248-010-9382-9; Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416; Mandal MK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00267; Mandal MK, 2014, BIOTECHNOL J, V9, P1065, DOI 10.1002/biot.201300424; Marusic C, 2015, PLANT BIOTECHNOL J, V8, P1; Mei B, 2013, FUSION PROTEIN TECHN, P107; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niemer M, 2014, BIOTECHNOL J, V9, P493, DOI 10.1002/biot.201300207; Outchkourov NS, 2003, PLANT PHYSIOL, V133, P379, DOI 10.1104/pp.102.017293; Pillay P, 2012, APPL BIOCHEM BIOTECH, V168, P1608, DOI 10.1007/s12010-012-9882-6; Pillay P, 2014, BIOENGINEERED, V5, P15, DOI 10.4161/bioe.25158; Rivard D, 2006, PLANT BIOTECHNOL J, V4, P359, DOI 10.1111/j.1467-7652.2006.00187.x; Robert S, 2016, METHODS MOL BIOL, V1385, P115, DOI 10.1007/978-1-4939-3289-4_8; Robert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070203; Sack M, 2015, CURR OPIN BIOTECH, V32, P163, DOI 10.1016/j.copbio.2014.12.008; Sainsbury F, 2013, PLANT BIOTECHNOL J, V11, P1058, DOI 10.1111/pbi.12098; Sainsbury F, 2012, J PROTEOME RES, V11, P5983, DOI 10.1021/pr300699n; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; SHORROSH BS, 1991, P NATL ACAD SCI USA, V88, P10941, DOI 10.1073/pnas.88.23.10941; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207; Zischewski J, 2016, BIOTECHNOL J, V11, P107, DOI 10.1002/biot.201500255	53	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167086	10.1371/journal.pone.0167086	http://dx.doi.org/10.1371/journal.pone.0167086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893815	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400081
J	Khachatryan, E; Camarrone, F; Fias, W; Van Hulle, MM				Khachatryan, Elvira; Camarrone, Flavio; Fias, Wim; Van Hulle, Marc M.			ERP Response Unveils Effect of Second Language Manipulation on First Language Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; LEXICAL ACCESS; PHONOLOGICAL REPRESENTATIONS; INTERLINGUAL HOMOGRAPHS; BILINGUALS; N400; TRANSLATION; ACTIVATION; BRAIN; RECOGNITION	Lexical access in bilinguals has been considered either selective or non-selective and evidence exists in favor of both hypotheses. We conducted a linguistic experiment to assess whether a bilingual's language mode influences the processing of first language information. We recorded event related potentials during a semantic priming paradigm with a covert manipulation of the second language (L2) using two types of stimulus presentations (short and long). We observed a significant facilitation of word pairs related in L2 in the short version reflected by a decrease in N400 amplitude in response to target words related to the English meaning of an inter-lingual homograph (homograph-unrelated group). This was absent in the long version, as the N400 amplitude for this group was similar to the one for the control-unrelated group. We also interviewed the participants whether they were aware of the importance of L2 in the experiment. We conclude that subjects participating in the long and short versions were in different language modes: closer to monolingual mode for the long and closer to bilingual mode for the short version; and that awareness about covert manipulation of L2 can influence the language mode, which in its turn influences the processing of the first language.	[Khachatryan, Elvira; Camarrone, Flavio; Van Hulle, Marc M.] Katholieke Univ Leuven, Dept Neurosci, Lab Neuro & Psychophysiol, Leuven, Belgium; [Khachatryan, Elvira] Yerevan State Med Univ, Dept Neurol, Yerevan, Armenia; [Fias, Wim] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	KU Leuven; Yerevan State Medical University; Ghent University	Khachatryan, E (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Lab Neuro & Psychophysiol, Leuven, Belgium.; Khachatryan, E (corresponding author), Yerevan State Med Univ, Dept Neurol, Yerevan, Armenia.	elvira.khachatryan@med.kuleuven.be	Fias, Wim/D-6861-2010	Fias, Wim/0000-0002-5788-7306; Van Hulle, Marc/0000-0003-1060-7044; Khachatryan, Elvira/0000-0003-1828-8324	Belgian Fund for Scientific Research - Flanders [GOA0914N, G088314N, G0A0914N]; Agency for Innovation by Science and Technology in Flanders (IWT); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Interuniversity Attraction Poles Program of the Belgian Federal Government [P7/11]; program Financing program [PFV/10/008]; interdisciplinary research project [IDO/12/007]; industrial research fund project of the KU Leuven [IOF/HB/12/021]; Interuniversity Attraction Poles Programme - Belgian Science Policy [IUAP P7/11]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Hercules Foundation [AKUL 043]	Belgian Fund for Scientific Research - Flanders(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Interuniversity Attraction Poles Program of the Belgian Federal Government(Belgian Federal Science Policy Office); program Financing program; interdisciplinary research project; industrial research fund project of the KU Leuven; Interuniversity Attraction Poles Programme - Belgian Science Policy(Belgian Federal Science Policy Office); Flemish Regional Ministry of Education (Belgium)(FWO); Hercules Foundation	EK is supported by the Belgian Fund for Scientific Research - Flanders (GOA0914N). FC is supported by the Agency for Innovation by Science and Technology in Flanders (IWT). WF is supported by Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; and by the Interuniversity Attraction Poles Program of the Belgian Federal Government [grant number P7/11]. MMVH is supported by research grants received from the program Financing program (PFV/10/008), an interdisciplinary research project (IDO/12/007), and an industrial research fund project (IOF/HB/12/021) of the KU Leuven, the Belgian Fund for Scientific Research - Flanders (G088314N, G0A0914N), the Interuniversity Attraction Poles Programme - Belgian Science Policy (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), and the Hercules Foundation (AKUL 043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou M, 2013, J ACOUST SOC AM, V133, P2397, DOI 10.1121/1.4792358; Antoniou M, 2012, J PHONETICS, V40, P582, DOI 10.1016/j.wocn.2012.05.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonfiglio L, 2015, ARCH ITAL BIOL, V153, P1, DOI 10.4449/aib.v153i1.3629; Bornkessel-Schlesewsky I., 2009, PROCESSING SYNTAX MO; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CARAMAZZA A, 1979, B PSYCHONOMIC SOC, V13, P212, DOI 10.3758/BF03335062; Carrasco-Ortiz H, 2012, PSYCHOPHYSIOLOGY, V49, P531, DOI 10.1111/j.1469-8986.2011.01333.x; Chauncey K, 2008, BRAIN LANG, V105, P161, DOI 10.1016/j.bandl.2007.11.006; Coe R., 2002, BRIT ED RES ASS ANN, P1214; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; De Bruijn E. R. A., 2001, BILING-LANG COGN, V4, P155, DOI [10.1017/S1366728901000256, DOI 10.1017/S1366728901000256]; De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213; de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891; Dewaele JM, 2014, INT J MULTILING, V11, P225, DOI 10.1080/14790718.2013.878347; Dijkstra T., 1998, BILING-LANG COGN, V1, P51, DOI [10.1017/S1366728998000121, DOI 10.1017/S1366728998000121]; Dunn a. L, 2012, INT J BILINGUAL, P1; Elston-Guttler KE, 2005, COGNITIVE BRAIN RES, V25, P57, DOI 10.1016/j.cogbrainres.2005.04.007; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; GERARD LD, 1989, J EXP PSYCHOL LEARN, V15, P305, DOI 10.1037/0278-7393.15.2.305; Grosjean F., 1994, ENCY LANG LINGUIST; Grosjean F., 1999, ONE MIND 2 LANGUAGES, P1; Hoffer B.L., 2005, INTERCULT COMMUN STU, V14, P53; Hoversten L, 2015, J COGNITIVE NEUROSCI, V23, P1; Jared D, 2001, J MEM LANG, V44, P2, DOI 10.1006/jmla.2000.2747; Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kiss GR, 1973, COMPUTER LIT STUDIES, P153; KOYAMA S, 1992, BRAIN LANG, V43, P668, DOI 10.1016/0093-934X(92)90089-W; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kutas M., 2009, SCHOLARPEDIA, V4, DOI [10.4249/scholarpedia.7790, DOI 10.4249/SCHOLARPEDIA.7790]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013; Luck SJ, 2005, MONOGRAPHS SOC RES C; Mari-Beffa P, 2007, BRAIN RES, V1147, P209, DOI 10.1016/j.brainres.2007.01.124; Martin CD, 2009, NEUROIMAGE, V47, P326, DOI 10.1016/j.neuroimage.2009.04.025; McKinney W., 2012, PYTHON DATA ANAL DAT; Midgley KJ, 2008, BRAIN RES, V1246, P123, DOI 10.1016/j.brainres.2008.09.078; Moon J, 2012, BILING-LANG COGN, V15, P173, DOI 10.1017/S1366728911000022; Moreno EM, 2008, J NEUROLINGUIST, V21, P477, DOI 10.1016/j.jneuroling.2008.01.003; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; Okita T, 1998, PSYCHOPHYSIOLOGY, V35, P260, DOI 10.1017/S0048577298961042; Paulmann S, 2006, NEUROREPORT, V17, P727, DOI 10.1097/01.wnr.0000214400.88845.fa; Proverbio AM, 2002, J COGNITIVE NEUROSCI, V14, P994, DOI 10.1162/089892902320474463; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Roelofs A, 2002, BILING-LANG COGN, V5, P214, DOI 10.1017/S1366728902263014; SOARES C, 1984, MEM COGNITION, V12, P380, DOI 10.3758/BF03198298; Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151; Team RDC, 2008, R LANG ENV STAT COMP; Thierry G, 2007, P NATL ACAD SCI USA, V104, P12530, DOI 10.1073/pnas.0609927104; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Van Petten C, 2014, INT J PSYCHOPHYSIOL, V94, P407, DOI 10.1016/j.ijpsycho.2014.10.012; Van Vliet M, 2014, PLOS ONE, P9; van Vliet M, 2016, IEEE T BIO-MED ENG, V63, P55, DOI 10.1109/TBME.2015.2468588; Wong B, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7069274; Wu Y., 2010, FRONTIERS LANGUAGE S, V1, P1; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zhou X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039011, 10.1371/journal.pone.0043230]	65	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167194	10.1371/journal.pone.0167194	http://dx.doi.org/10.1371/journal.pone.0167194			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893807	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400099
J	Kockelkoren, R; De Vis, JB; Mali, WPTM; Hendrikse, J; de Jong, PA; Rozemuller, AM; Koek, HL				Kockelkoren, Remko; De Vis, Jill B.; Mali, Willem P. Th. M.; Hendrikse, Jeroen; de Jong, Pim A.; Rozemuller, Annemieke M.; Koek, Huiberdina L.			Hippocampal Calcification on Computed Tomography in Relation to Cognitive Decline in Memory Clinic Patients: A Case-Control Study	PLOS ONE			English	Article							MRI; CT; SCLEROSIS; DEMENTIA; DISEASE	Background It was recently shown that calcification of the hippocampus can be detected on computed tomography (CT) images and these calcifications occur in up to 20% of people over 50 years of age. However, little is known about hippocampal calcification and its relation to cognition and cognitive decline. Therefore, the aim of this study was to (1) determine the prevalence of hippocampal calcification on CT in memory clinic patients controls, and (2) to assess its relation with cognitive decline. Methods 67 patients from a memory clinic (cases) were matched by age and gender to a control group. In both groups, hippocampal calcification was assessed by two raters on thin slice, non-contrast enhanced brain CT images. Calcifications were scored bilaterally on presence and severity (absent, mild, moderate, severe). Mini Mental State Exam (MMSE) score was determined in cases. Results Hippocampal calcification presence was significantly higher in cases (N = 26, 38.8%) compared to controls (N = 9, 13.4%) (P<.01) with an odds ratio of 4.40 (95% CI: 1.63-14.87). In cases, MMSE score was significantly lower in those with hippocampal calcification compared to those without (21.6 vs 24.5, p=.02). Conclusion In this case-control study we found significantly more hippocampal calcification in patients with cognitive decline as compared to controls. Furthermore, within the cases, MMSE score was significantly lower in those with hippocampal calcification.	[Kockelkoren, Remko; De Vis, Jill B.; Mali, Willem P. Th. M.; Hendrikse, Jeroen; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Rozemuller, Annemieke M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Koek, Huiberdina L.] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kockelkoren, R (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	r.kockelkoren@umcutrecht.nl	Rozemuller, Annemieke/C-2084-2008		Netherlands Organization for Scientific Research (NWO) [91712322]; European Research Council [637024]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	JH was supported by the Netherlands Organization for Scientific Research (NWO) under grant no 91712322 (JH), and the European Research Council under grant agreements no 637024 (JH) (http://www.nwo.nl/en); JH was supported by the Netherlands Organization for Scientific Research (NWO) under grant no 91712322 (JH), the European Research Council under grant agreements no 637024 (JH)."	Bos D, 2015, ALZHEIMERS DEMENT, V11, P639, DOI 10.1016/j.jalz.2014.05.1758; Bos D, 2014, JAMA NEUROL, V71, P405, DOI 10.1001/jamaneurol.2013.6223; Chew APT, 2012, RADIOLOGY, V265, P504, DOI 10.1148/radiol.12110636; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CoreyBloom J, 1997, NEUROLOGY, V48, P154, DOI 10.1212/WNL.48.1.154; DICKSON DW, 1994, ACTA NEUROPATHOL, V88, P212; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; SCHORNER W, 1991, ROFO FORTSCHR RONTG, V154, P430, DOI 10.1055/s-2008-1033162; SHANLEY DJ, 1995, NEURORADIOLOGY, V37, P331; Small SA, 2014, NEURON, V84, P32, DOI 10.1016/j.neuron.2014.08.030; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Wegiel J, 2002, ACTA NEUROPATHOL, V103, P333, DOI 10.1007/s00401-001-0471-y; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617	15	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167444	10.1371/journal.pone.0167444	http://dx.doi.org/10.1371/journal.pone.0167444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893859	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400118
J	Yuan, Q; Abdin, E; Picco, L; Vaingankar, JA; Shahwan, S; Jeyagurunathan, A; Sagayadevan, V; Shafie, S; Tay, J; Chong, SA; Subramaniam, M				Yuan, Qi; Abdin, Edimansyah; Picco, Louisa; Vaingankar, Janhavi Ajit; Shahwan, Shazana; Jeyagurunathan, Anitha; Sagayadevan, Vathsala; Shafie, Saleha; Tay, Jenny; Chong, Siow Ann; Subramaniam, Mythily			Attitudes to Mental Illness and Its Demographic Correlates among General Population in Singapore	PLOS ONE			English	Article							COMMUNITY ATTITUDES; NATIONAL-SURVEY; PEOPLE; DISORDERS; HEALTH; ILL	Background Public attitudes to mental illness could influence how the public interact with, provide opportunities for, and help people with mental illness. Aims This study aims to explore the underlying factors of the Attitudes to Mental Illness questionnaire among the general population in Singapore and the socio-demographic correlates of each factor. Methods From March 2014 to April 2015, a nation-wide cross-sectional survey on mental health literacy with 3,006 participants was conducted in Singapore. Results Factor analysis revealed a 4-factor structure for the Attitudes to Mental Illness questionnaire among the Singapore general population, namely social distancing, tolerance/support for community care, social restrictiveness, and prejudice and misconception. Older age, male gender, lower education and socio-economic status were associated with more negative attitudes towards the mentally ill. Chinese showed more negative attitudes than Indians and Malays (except for prejudice and misconception). Conclusions There is a need for culture-specific interventions, and the associated factors identified in this study should be considered for future attitude campaigns.	[Yuan, Qi; Abdin, Edimansyah; Picco, Louisa; Vaingankar, Janhavi Ajit; Shahwan, Shazana; Jeyagurunathan, Anitha; Sagayadevan, Vathsala; Shafie, Saleha; Tay, Jenny; Chong, Siow Ann; Subramaniam, Mythily] Inst Mental Hlth, Div Res, Singapore, Singapore		Yuan, Q (corresponding author), Inst Mental Hlth, Div Res, Singapore, Singapore.	Qi_YUAN@imh.com.sg	Abdin, Edimansyah/E-6451-2011; Picco, Louisa/AAD-6236-2022	Abdin, Edimansyah/0000-0002-1016-3298; Picco, Louisa/0000-0001-7593-3209; YUAN, Qi/0000-0002-5271-6954	Ministry of Health, Health Services Research Competitive Research Grant [HSRG/0036/2013]	Ministry of Health, Health Services Research Competitive Research Grant	This study was funded by Ministry of Health, Health Services Research Competitive Research Grant (HSRG/0036/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ras W, 2008, J MUSLIM MENT HEALTH, V3, P217, DOI 10.1080/15564900802487634; Angermeyer MC, 2011, BRIT J PSYCHIAT, V199, P367, DOI 10.1192/bjp.bp.110.085563; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Angermeyer MC, 1998, INT J SOC PSYCHIATR, V44, P107, DOI 10.1177/002076409804400203; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; BROCKINGTON IF, 1993, BRIT J PSYCHIAT, V162, P93, DOI 10.1192/bjp.162.1.93; Centers for Disease Control and Prevention Substance Abuse and Mental Health Services Administration National Association of County Behavioral Health & Developmental Disability Directors National Institute of Mental Health, 2012, ATT MENT ILLN RES BE; Chong SA, 2007, SOC PSYCH PSYCH EPID, V42, P734, DOI 10.1007/s00127-007-0213-0; Chong SA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0837-2; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Corrigan PW, 2010, CLIN PSYCHOL REV, V30, P907, DOI 10.1016/j.cpr.2010.06.004; Evans-Lacko S, 2013, BRIT J PSYCHIAT, V202, pS51, DOI 10.1192/bjp.bp.112.112979; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ilic N, ATTITUDES MENTAL ILL; Kermode M, 2009, SOC PSYCH PSYCH EPID, V44, P1087, DOI 10.1007/s00127-009-0031-7; L'Abate L., 2011, MENTAL ILLNESSES UND; Lauber C, 2004, COMMUNITY MENT HLT J, V40, P265, DOI 10.1023/B:COMH.0000026999.87728.2d; Lauber C, 2000, ACTA PSYCHIAT SCAND, V102, P26, DOI 10.1034/j.1600-0447.2000.00005.x; Link BG, 2001, PSYCHIAT SERVICES; Mehta N, 2009, BRIT J PSYCHIAT, V194, P278, DOI 10.1192/bjp.bp.108.052654; Nunnally J.C., 1961, POPULAR CONCEPTIONS; Padela AI, 2012, QUAL HEALTH RES, V22, P846, DOI 10.1177/1049732312438969; Parra F, 1985, Int J Soc Psychiatry, V31, P37, DOI 10.1177/002076408503100104; Picco L, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00547; RABKIN JG, 1981, HOSP COMMUNITY PSYCH, V32, P157; Rassool GH, 2000, J ADV NURS, V32, P1476, DOI 10.1046/j.1365-2648.2000.01614.x; Reavley NJ, 2011, AUST NZ J PSYCHIAT, V45, P1086, DOI 10.3109/00048674.2011.621061; Rusch N, 2011, PSYCHIAT SERVICES; Schnittker J, 2008, SOC SCI MED, V67, P1370, DOI 10.1016/j.socscimed.2008.07.007; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Smith AL., 2011, PROFESSIONAL COUNSEL, V1, P13, DOI DOI 10.15241/ALS.1.1.13; Song LY, 2005, INT J SOC PSYCHIATR, V51, P162, DOI 10.1177/0020764005056765; Subramaniam M, 2017, EPIDEMIOL PSYCH SCI, V26, P371, DOI 10.1017/S2045796016000159; Subramaniam M, 2012, INT J METH PSYCH RES, V21, P149, DOI 10.1002/mpr.1351; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; UK Department of Health, 2014, ATT MENT ILLN 2014 R; Willis GB, 2004, COGNITIVE INTERVIEWI; Youssef J, 2006, MENT HEALTH RELIG CU, V9, P43, DOI 10.1080/13674670512331335686	40	44	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167297	10.1371/journal.pone.0167297	http://dx.doi.org/10.1371/journal.pone.0167297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893796	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400109
J	Ballot, A; Cerasino, L; Hostyeva, V; Cires, S				Ballot, Andreas; Cerasino, Leonardo; Hostyeva, Vladyslava; Cires, Samuel			Variability in the sxt Gene Clusters of PSP Toxin Producing Aphanizomenon gracile Strains from Norway, Spain, Germany and North America	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; PARALYTIC SHELLFISH POISONS; IN-SILICO PCR; SAXITOXIN PRODUCTION; NOSTOCALES; CYLINDROSPERMOPSIN; PHYLOGENY; RELEASE; ROUTES; LAKES	Paralytic shellfish poisoning (PSP) toxin production has been detected worldwide in the cyanobacterial genera Anabaena, Lyngbya, Scytonema, Cuspidothrix and Aphanizomenon. In Europe Aphanizomenon gracile and Cuspidothrix issatschenkoi are the only known producers of PSP toxins and are found in Southwest and Central European freshwater bodies. In this study the PSP toxin producing Aphanizomenon sp. strain NIVA-CYA 851 was isolated from the Norwegian Lake Hillestadvannet. In a polyphasic approach NIVA-CYA 851 was morphologically and phylogenetically classified, and investigated for toxin production. The strain NIVA-CYA 851 was identified as A. gracile using 16S rRNA gene phylogeny and was confirmed to produce neosaxitoxin, saxitoxin and gonyautoxin 5 by LC-MS. The whole sxt gene clusters (circa 27.3 kb) of four A. gracile strains: NIVA-CYA 851 (Norway); NIVA-CYA 655 & NIVA-CYA 676 (Germany); and UAM 529 (Spain), all from latitudes between 40 degrees and 59 degrees North were sequenced and compared with the sxt gene cluster of reference strain A. gracile NH-5 from the USA. All five sxt gene clusters are highly conserved with similarities exceeding 99.4%, but they differ slightly in the number and presence of single nucleotide polymorphisms (SNPs) and insertions/deletions (In/Dels). Altogether 178 variable sites (44 SNPs and 4 In/Dels, comprising 134 nucleotides) were found in the sxt gene clusters of the Norwegian, German and Spanish strains compared to the reference strain. Thirty-nine SNPs were located in 16 of the 27 coding regions. The sxt gene clusters of NIVA-CYA 851, NIVA-CYA 655, NIVA-CYA 676 and UAM 529, were characterized by 15, 16, 19 and 23 SNPs respectively. Only the Norwegian strain NIVA-CYA 851 possessed an insertion of 126 base pairs (bp) in the noncoding area between the sxtA and sxtE genes and a deletion of 6 nucleotides in the sxtN gene. The sxtI gene showed the highest variability and is recommended as the best genetic marker for further phylogenetic studies of the sxt gene cluster of A. gracile. This study confirms for the first time the role of A. gracile as a PSP toxin producer in Norwegian waters, representing the northernmost occurrence of PSP toxin producing A. gracile in Europe known so far.	[Ballot, Andreas; Hostyeva, Vladyslava] Norwegian Inst Water Res, Oslo, Norway; [Cerasino, Leonardo] Fdn E Mach, IASMA Res & Innovat Ctr, Ist Agr S Michele Adige, San Michele All Adige, Trento, Italy; [Cires, Samuel] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Norwegian Institute for Water Research (NIVA); Fondazione Edmund Mach; Autonomous University of Madrid	Ballot, A (corresponding author), Norwegian Inst Water Res, Oslo, Norway.	andreas.ballot@niva.no	Ballot, Andreas/G-7752-2019; Cirés, Samuel/B-2508-2017; cerasino, leonardo/G-8466-2011	Ballot, Andreas/0000-0002-4088-0677; Cirés, Samuel/0000-0001-8272-5512; cerasino, leonardo/0000-0002-0839-9832				Al-Tebrineh J, 2010, APPL ENVIRON MICROB, V76, P7836, DOI 10.1128/AEM.00174-10; Ballot A, 2008, MICROB ECOL, V55, P608, DOI 10.1007/s00248-007-9304-4; Ballot A, 2014, MAR FRESHWATER RES, V65, P175, DOI 10.1071/MF13153; Ballot A, 2010, APPL ENVIRON MICROB, V76, P1173, DOI 10.1128/AEM.02285-09; Boopathi T, 2014, TOXINS, V6, P1951, DOI 10.3390/toxins6071951; Borges HLF, 2015, HARMFUL ALGAE, V43, P46, DOI 10.1016/j.hal.2015.01.003; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Carneiro RL, 2013, MAR DRUGS, V11, P2949, DOI 10.3390/md11082949; Cires S, 2016, HARMFUL ALGAE, V54, P21, DOI 10.1016/j.hal.2015.09.007; Cires S, 2014, APPL ENVIRON MICROB, V80, P1359, DOI 10.1128/AEM.03002-13; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; Casero MC, 2014, HARMFUL ALGAE, V37, P28, DOI 10.1016/j.hal.2014.05.006; D'Agostino PM, 2014, TOXINS AND BIOLOGICALLY ACTIVE COMPOUNDS FROM MICROALGAE, VOL 1: ORIGIN, CHEMISTRY AND DETECTION, P251; Dell'Aversano C, 2005, J CHROMATOGR A, V1081, P190, DOI 10.1016/j.chroma.2005.05.056; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gentile JH, 1971, MICROBIAL TOXINS, V7, P27; Gkelis S, 2005, MICROB ECOL, V49, P176, DOI 10.1007/s00248-003-2030-7; Gkelis S, 2014, TOXICON, V78, P1, DOI 10.1016/j.toxicon.2013.11.010; Hepperle D., 2008, ALIGN MANUAL DNA SEQ; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Jancula D, 2014, ENVIRON SCI POLLUT R, V21, P8006, DOI 10.1007/s11356-014-2699-9; Kaas H, 2000, WATER RES, V34, P2089, DOI 10.1016/S0043-1354(99)00372-3; Kalendar R, 2014, METHODS MOL BIOL, V1116, P271, DOI 10.1007/978-1-62703-764-8_18; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kokocinski M, 2013, ENVIRON SCI POLLUT R, V20, P5243, DOI 10.1007/s11356-012-1426-7; Komarek J., 2013, CYANOPROKARYOTA, V19; Komarek J., 2006, CZECH PHYCOL, V6, P1; Kotai J., 1972, PUBLICATION B; Ledreux A, 2010, HARMFUL ALGAE, V10, P88, DOI 10.1016/j.hal.2010.07.004; Li RH, 2000, HYDROBIOLOGIA, V438, P99, DOI 10.1023/A:1004166029866; Li RH, 2003, J PHYCOL, V39, P814, DOI 10.1046/j.1529-8817.2003.02199.x; Llewellyn LE, 2001, ENVIRON SCI TECHNOL, V35, P1445, DOI 10.1021/es001575z; MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Pereira P, 2004, EUR J PHYCOL, V39, P361, DOI 10.1080/09670260410001714723; Rapala J, 2005, ENVIRON TOXICOL, V20, P331, DOI 10.1002/tox.20109; Smith FMJ, 2012, PHYCOLOGIA, V51, P542, DOI 10.2216/11-84.1; Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001; Soto-Liebe K, 2010, TOXICON, V56, P1350, DOI 10.1016/j.toxicon.2010.07.022; Suikkanen S, 2013, HARMFUL ALGAE, V26, P52, DOI 10.1016/j.hal.2013.04.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185	48	21	21	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167552	10.1371/journal.pone.0167552	http://dx.doi.org/10.1371/journal.pone.0167552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907126	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700191
J	Benton, MA; Kenny, NJ; Conrads, KH; Roth, S; Lynch, JA				Benton, Matthew A.; Kenny, Nathan J.; Conrads, Kai H.; Roth, Siegfried; Lynch, Jeremy A.			Deep, Staged Transcriptomic Resources for the Novel Coleopteran Models Atrachya menetriesi and Callosobruchus maculatus	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE HOPKINS; MOUNTAIN PINE-BEETLE; SHORT-GERM; GENOME; ANNOTATION; TRIBOLIUM; PATTERNS; DIVERSIFICATION; SPECIFICATION; COMPONENTS	Despite recent efforts to sample broadly across metazoan and insect diversity, current sequence resources in the Coleoptera do not adequately describe the diversity of the clade. Here we present deep, staged transcriptomic data for two coleopteran species, Atrachya menetriesi (Faldermann 1835) and Callosobruchus maculatus (Fabricius 1775). Our sampling covered key stages in ovary and early embryonic development in each species. We utilized this data to build combined assemblies for each species which were then analysed in detail. The combined A. menetriesi assembly consists of 228,096 contigs with an N50 of 1,598 bp, while the combined C. maculatus assembly consists of 128,837 contigs with an N50 of 2,263 bp. For these assemblies, 34.6% and 32.4% of contigs were identified using Blast2GO, and 97% and 98.3% of the BUSCO set of metazoan orthologs were present, respectively. We also carried out manual annotation of developmental signalling pathways and found that nearly all expected genes were present in each transcriptome. Our analyses show that both transcriptomes are of high quality. Lastly, we performed read mapping utilising our timed, stage specific RNA samples to identify differentially expressed contigs. The resources presented here will provide a firm basis for a variety of experimentation, both in developmental biology and in comparative genomic studies.	[Benton, Matthew A.; Conrads, Kai H.; Roth, Siegfried] Univ Cologne, Inst Dev Biol, Cologne, Germany; [Kenny, Nathan J.] Chinese Univ Hong Kong, Simon FS Li Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Lynch, Jeremy A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Kenny, Nathan J.] Nat Hist Museum London, Dept Life Sci, London, England	University of Cologne; Chinese University of Hong Kong; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Natural History Museum London	Roth, S (corresponding author), Univ Cologne, Inst Dev Biol, Cologne, Germany.; Lynch, JA (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	siegfried.roth@uni-koeln.de; jlynch42@uic.edu	Roth, Siegfried/E-8241-2010; Kenny, Nathan/AAD-2391-2020	Roth, Siegfried/0000-0001-5772-3558; Kenny, Nathan/0000-0003-4816-4103; Benton, Matthew A./0000-0001-7953-0765	Alexander von Hum boldt; Deutsche Forschungsgemeinschaft [Collaborative Research Center Grant 680]	Alexander von Hum boldt(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MAB was supported by an Alexander von Hum boldt (https://www.humboldt-foundation.de/ web/home.html) Fellowship for Postdoctoral Researchers. KHC, SR and JAL were supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) Collaborative Research Center Grant 680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson D.T., 1972, pUnpaginated; ANDO Y, 1979, APPL ENTOMOL ZOOL, V14, P193, DOI 10.1303/aez.14.193; Ando Y, 1968, B FAC AGR IWATE U, V9, P87; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2015, 1KITE 1000 INSECT TR; Blumer LS, 2015, BEAN BEETLES MODEL O; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Chi YH, 2009, INSECT MOL BIOL, V18, P97, DOI 10.1111/j.1365-2583.2008.00854.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunningham CB, 2015, GENOME BIOL EVOL, V7, P3383, DOI 10.1093/gbe/evv194; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Flagel LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-195; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimaldi David, 2005, pi; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hegner RW, 1908, BIOL BULL-US, V16, P19, DOI 10.2307/1536121; Hegner RW, 1909, J MORPHOL, V20, P231, DOI 10.1002/jmor.1050200204; Hui JHL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-43; Hunt T, 2007, SCIENCE, V438, P1; Jacobs CGC, 2015, INSECT BIOCHEM MOLEC, V60, P7, DOI 10.1016/j.ibmb.2015.02.014; Jolivet PH, 1994, NOVEL ASPECTS BIOL C; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kenny NJ, 2015, GENOME BIOL EVOL, V7, P1280, DOI 10.1093/gbe/evv070; Kenny NJ, 2014, INT J DEV BIOL, V58, P533, DOI 10.1387/ijdb.140080nk; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; MIYA K, 1974, Journal of the Faculty of Agriculture Iwate University, V12, P39; Miya K., 1965, Journal of the Faculty of Agriculture Iwate University, V7, P155; Miya K, 1966, P 26 ANN M ENT SOC J, P9; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Oberhofer G, 2014, DEVELOPMENT, V141, P4740, DOI 10.1242/dev.112797; Ozuak O, 2014, DEV GENES EVOL, V224, P223, DOI 10.1007/s00427-014-0481-0; PATEL NH, 1994, NATURE, V367, P429, DOI 10.1038/367429a0; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schulz C, 1998, DEV GENES EVOL, V208, P283, DOI 10.1007/s004270050183; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stappert D, DEVELOPMENT IN PRESS; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Strauss AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098637; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tosar JP, 2014, RNA, V20, P754, DOI 10.1261/rna.044263.114; Tran BMD, 1995, BIOL J LINN SOC, V56, P483, DOI 10.1111/j.1095-8312.1995.tb01106.x; Van Der Meer JM, 1977, DROS INF SERV, V52; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Van der Zee M, 2008, DEV GENES EVOL, V218, P203, DOI 10.1007/s00427-007-0179-7; VANDERMEER JM, 1984, ROUX ARCH DEV BIOL, V193, P339, DOI 10.1007/BF00848161; VANDERMEER JM, 1979, J EMBRYOL EXP MORPH, V51, P1; Wilson MJ, 2009, DEV BIOL, V335, P276, DOI 10.1016/j.ydbio.2009.09.002; Yin A, 2015, INSECT SCI, V22, P65, DOI 10.1111/1744-7917.12092; Zhong YF, 2008, EVOL DEV, V10, P516, DOI 10.1111/j.1525-142X.2008.00266.x	66	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167431	10.1371/journal.pone.0167431	http://dx.doi.org/10.1371/journal.pone.0167431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907180	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700155
J	Deuschl, C; Goericke, S; Grueneisen, J; Sawicki, LM; Goebel, J; El Hindy, N; Wrede, K; Binse, I; Poeppel, T; Quick, H; Forsting, M; Hense, J; Umutlu, L; Schlamann, M				Deuschl, Cornelius; Goericke, Sophia; Grueneisen, Johannes; Sawicki, Lino Morris; Goebel, Juliane; El Hindy, Nicolai; Wrede, Karsten; Binse, Ina; Poeppel, Thorsten; Quick, Harald; Forsting, Michael; Hense, Joerg; Umutlu, Lale; Schlamann, Marc			Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; C-11-METHIONINE PET; F-18 FLUORODEOXYGLUCOSE; RESPONSE ASSESSMENT; INTEGRATED PET/MRI; VOLUME; TOOL; HISTOPATHOLOGY; NEUROONCOLOGY; EXPERIENCES	Introduction The objective of this study was to assess the diagnostic value of integrated 11C-methionine PET/MRI for suspected primary brain tumors, in comparison to MRI alone. Material and Methods Forty-eight consecutive patients with suspected primary brain tumor were prospectively enrolled for an integrated 11C-methionine PET/MRI. Two neuro-radiologists separately evaluated the MRI alone and the integrated PET/MRI data sets regarding most likely diagnosis and diagnostic confidence on a 5-point scale. Reference standard was histopathology or follow-up imaging. Results Fifty-one suspicious lesions were detected: 16 high-grade glioma and 25 low-grade glioma. Ten non-malignant cerebral lesions were described by the reference standard. MRI alone and integrated PET/MRI each correctly classified 42 of the 51 lesions (82.4%) as neoplastic lesions (WHO grade II, III and IV) or non-malignant lesions (infectious and neoplastic lesions). Diagnostic confidence for all lesions, low-grade astrocytoma and high-grade astrocytoma (3.7 vs. 4.2, 3,1 vs. 3.8, 4.0 vs. 4,7) were significantly (p < 0.05) better with integrated PET/MRI than in MRI alone. Conclusions The present study demonstrates the high potential of integrated 11C-methionine-PET/MRI for the assessment of suspected primary brain tumors. Although integrated methionine PET/MRI does not lead to an improvement of correct diagnoses, diagnostic confidence is significantly improved.	[Deuschl, Cornelius; Goericke, Sophia; Grueneisen, Johannes; Goebel, Juliane; Forsting, Michael; Umutlu, Lale; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Deuschl, Cornelius; Quick, Harald] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Sawicki, Lino Morris] Univ Hosp Duesseldorf, Inst Diagnost & Intervent Radiol, Dusseldorf, Germany; [El Hindy, Nicolai; Wrede, Karsten] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Binse, Ina; Poeppel, Thorsten] Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Quick, Harald] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Hense, Joerg] Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Schlamann, Marc] Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University Hospital of Giessen & Marburg	Deuschl, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.; Deuschl, C (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	cornelius.deuschl@uk-essen.de	Wrede, Karsten/AAZ-2154-2020	Wrede, Karsten/0000-0001-7076-3503; Hense, Jorg/0000-0003-4679-2026	University Duisburg-Essen	University Duisburg-Essen	An IFORES grant to CD from the University Duisburg-Essen supported the research [http://www.uni-due.de/med/forschun//forschungsfoerderung/ifores.shtml]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra A, 2004, Australas Radiol, V48, P324, DOI 10.1111/j.0004-8461.2004.01315.x; Becherer A, 2003, EUR J NUCL MED MOL I, V30, P1561, DOI 10.1007/s00259-003-1259-1; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Ceyssens S, 2006, AM J NEURORADIOL, V27, P1432; Chung JK, 2002, EUR J NUCL MED MOL I, V29, P176, DOI 10.1007/s00259-001-0690-4; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Fan GG, 2006, BRIT J RADIOL, V79, P652, DOI 10.1259/bjr/25349497; Gumprecht HK, 1999, NEUROSURGERY, V44, P97, DOI 10.1097/00006123-199901000-00056; Hatakeyama T, 2008, EUR J NUCL MED MOL I, V35, P2009, DOI 10.1007/s00259-008-0847-5; Herholz K, 1998, NEUROLOGY, V50, P1316, DOI 10.1212/WNL.50.5.1316; Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008; Kobayashi K, 2015, EUR J NUCL MED MOL I, V42, P1071, DOI 10.1007/s00259-015-3046-1; Kubota K, 2001, ANN NUCL MED, V15, P471, DOI 10.1007/BF02988499; LEE YY, 1989, AM J ROENTGENOL, V152, P361, DOI 10.2214/ajr.152.2.361; Liu X, 2011, NEURO-ONCOLOGY, V13, P447, DOI 10.1093/neuonc/noq197; Mabray Marc C, 2015, Brain Tumor Res Treat, V3, P8, DOI 10.14791/btrt.2015.3.1.8; Moulin-Romsee G, 2007, EUR J NUCL MED MOL I, V34, P2082, DOI 10.1007/s00259-007-0557-4; Nariai T, 2005, J NEUROSURG, V103, P498, DOI 10.3171/jns.2005.103.3.0498; Navarria P, 2014, RADIOTHER ONCOL, V112, P425, DOI 10.1016/j.radonc.2014.09.004; Nojiri T, 2009, J NEURO-ONCOL, V93, P233, DOI 10.1007/s11060-008-9767-2; Preuss M, 2014, CHILD NERV SYST, V30, P1399, DOI 10.1007/s00381-014-2412-9; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Sadeghi N, 2007, AM J NEURORADIOL, V28, P455; Sasaki M, 1998, EUR J NUCL MED, V25, P1261, DOI 10.1007/s002590050294; Shinozaki N, 2011, J NEUROSURG, V114, P1640, DOI 10.3171/2010.11.JNS10553; Singhal T, 2012, J NUCL MED, V53, P1709, DOI 10.2967/jnumed.111.102533; Takano K, 2016, AM J NEURORADIOL, V37, P44, DOI 10.3174/ajnr.A4460; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7; Voges J, 1997, STEREOT FUNCT NEUROS, V69, P129, DOI 10.1159/000099864; Watanabe A, 2016, J NEURO-ONCOL, V126, P577, DOI 10.1007/s11060-015-2004-x; Weckesser M, 2005, EUR J NUCL MED MOL I, V32, P422, DOI 10.1007/s00259-004-1705-8; Yamamoto Y, 2008, MOL IMAGING BIOL, V10, P281, DOI 10.1007/s11307-008-0152-5	33	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167596	10.1371/journal.pone.0167596	http://dx.doi.org/10.1371/journal.pone.0167596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907162	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700209
J	Diedhiou, AG; Mbaye, FK; Mbodj, D; Faye, MN; Pignoly, S; Ndoye, I; Djaman, K; Gaye, S; Kane, A; Laplaze, L; Manneh, B; Champion, A				Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Mbodj, Daouda; Faye, Mathieu Ndigue; Pignoly, Sarah; Ndoye, Ibrahima; Djaman, Koffi; Gaye, Souleymane; Kane, Aboubacry; Laplaze, Laurent; Manneh, Baboucarr; Champion, Antony			Field Trials Reveal Ecotype-Specific Responses to Mycorrhizal Inoculation in Rice	PLOS ONE			English	Article							PLANT-GROWTH; PHOSPHATE SOLUBILIZATION; FUNCTIONAL DIVERSITY; FUNGI; SOIL; ARCHITECTURE; ADAPTATION; ENDOPHYTES; INFECTION; NUTRIENT	The overuse of agricultural chemicals such as fertilizer and pesticides aimed at increasing crop yield results in environmental damage, particularly in the Sahelian zone where soils are fragile. Crop inoculation with beneficial soil microbes appears as a good alternative for reducing agricultural chemical needs, especially for small farmers. This, however, requires selecting optimal combinations of crop varieties and beneficial microbes tested in field conditions. In this study, we investigated the response of rice plants to inoculation with arbuscular mycorrhizal fungi (AMF) and plant growth promoting bacteria (PGPB) under screenhouse and field conditions in two consecutive seasons in Senegal. Evaluation of single and mixed inoculations with AMF and PGPB was conducted on rice (Oryza sativa) variety Sahel 202, on sterile soil under screenhouse conditions. We observed that inoculated plants, especially plants treated with AMF, grew taller, matured earlier and had higher grain yield than the non-inoculated plants. Mixed inoculation trials with two AMF strains were then conducted under irrigated field conditions with four O. sativa varieties, two O. glaberrima varieties and two interspecific NERICA varieties, belonging to 3 ecotypes (upland, irrigated, and rainfed lowland). We observed that the upland varieties had the best responses to inoculation, especially with regards to grain yield, harvest index and spikelet fertility. These results show the potential of using AMF to improve rice production with less chemical fertilizers and present new opportunities for the genetic improvement in rice to transfer the ability of forming beneficial rice-microbe associations into high yielding varieties in order to increase further rice yield potentials.	[Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Ndoye, Ibrahima; Kane, Aboubacry] Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Biol Vegetale, Dakar, Senegal; [Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Mbodj, Daouda; Faye, Mathieu Ndigue; Pignoly, Sarah; Ndoye, Ibrahima; Djaman, Koffi; Gaye, Souleymane; Kane, Aboubacry; Laplaze, Laurent; Manneh, Baboucarr; Champion, Antony] Ctr Rech Bel Air, Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal; [Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Faye, Mathieu Ndigue; Pignoly, Sarah; Ndoye, Ibrahima; Kane, Aboubacry; Laplaze, Laurent; Champion, Antony] Ctr Rech Bel Air, Lab Commun Microbiol, IRD ISRAU CAD, Dakar, Senegal; [Pignoly, Sarah; Laplaze, Laurent; Champion, Antony] IRD, UMR DIADE, Equipe CERES, Montpellier, France; [Mbodj, Daouda; Djaman, Koffi; Gaye, Souleymane; Manneh, Baboucarr] Africa Rice Ctr AfricaRice, St Louis, Senegal	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CGIAR; Africa Rice Center	Diedhiou, AG (corresponding author), Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Biol Vegetale, Dakar, Senegal.; Diedhiou, AG; Laplaze, L (corresponding author), Ctr Rech Bel Air, Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal.; Diedhiou, AG; Laplaze, L (corresponding author), Ctr Rech Bel Air, Lab Commun Microbiol, IRD ISRAU CAD, Dakar, Senegal.; Laplaze, L (corresponding author), IRD, UMR DIADE, Equipe CERES, Montpellier, France.	abdala.diedhiou@ucad.edu.sn; laurent.laplaze@ird.fr	Champion, Antony/E-4148-2015; Laplaze, Laurent/I-5435-2016; DIALLO, Sara/N-4362-2018	Champion, Antony/0000-0002-3731-1510; Laplaze, Laurent/0000-0002-6568-6504; DIALLO, Sara/0000-0003-1891-9982; DIEDHIOU, Abdala Gamby/0000-0002-1790-6883	IRD; Senegalese Ministere de l'Enseignement Superieur et de la Recherche from the Fonds d'Impulsion de la Recherche Scientifique et Technique	IRD; Senegalese Ministere de l'Enseignement Superieur et de la Recherche from the Fonds d'Impulsion de la Recherche Scientifique et Technique	This work was supported by IRD and the Senegalese Ministere de l'Enseignement Superieur et de la Recherche through a grant from the Fonds d'Impulsion de la Recherche Scientifique et Technique (FIRST 2014).	Ahmadi N, 2014, RICE, V7, DOI 10.1186/s12284-014-0029-y; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; BARBER DA, 1976, NEW PHYTOL, V76, P69, DOI 10.1111/j.1469-8137.1976.tb01439.x; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; BRYLA DR, 1990, OECOLOGIA, V84, P74, DOI 10.1007/BF00665598; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Cavagnaro TR, 2005, PLANT CELL ENVIRON, V28, P642, DOI 10.1111/j.1365-3040.2005.01310.x; Chaintreuil C, 2000, APPL ENVIRON MICROB, V66, P5437, DOI 10.1128/AEM.66.12.5437-5447.2000; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; Dobermann A, 2004, SCOPE SER, V65, P261; Dodd IC, 2012, CURR OPIN BIOTECH, V23, P236, DOI 10.1016/j.copbio.2011.09.005; Dupuy N, 1992, INTERACTIONS PLANTES, P371; Food and Agriculture Organization of the United Nations. FAOSTAT, 2013, FAOSTAT PRODUCTION I; Franche C, 2009, PLANT SOIL, V321, P35, DOI 10.1007/s11104-008-9833-8; Gamalero E, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P17, DOI 10.1007/978-3-642-21061-7_2; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; HETRICK BAD, 1991, CAN J BOT, V69, P112, DOI 10.1139/b91-016; Hrynkiewicz K, 2012, STRAT SUSTAIN, P35, DOI 10.1007/978-94-007-1591-2_2; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Koide RT, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P297, DOI 10.1007/978-90-481-9489-6_14; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lafitte HR, 2001, FIELD CROP RES, V71, P57, DOI 10.1016/S0378-4290(01)00150-2; Lioussanne L, 2010, SPAN J AGRIC RES, V8, pS51; LU XH, 1994, NEW PHYTOL, V128, P211, DOI 10.1111/j.1469-8137.1994.tb04004.x; Malakoff D, 1998, SCIENCE, V281, P190, DOI 10.1126/science.281.5374.190; McDowell RW, 2001, NUTR CYCL AGROECOSYS, V59, P269, DOI 10.1023/A:1014419206761; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Poulton JL, 2002, NEW PHYTOL, V154, P255, DOI 10.1046/j.1469-8137.2002.00366.x; Poussin JC, 2003, EUR J AGRON, V19, P341, DOI 10.1016/S1161-0301(02)00078-3; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Rodriguez H, 2004, NATURWISSENSCHAFTEN, V91, P552, DOI 10.1007/s00114-004-0566-0; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Rodriguez-Echeverria S, 2016, NEW PHYTOL; Rua MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0698-9; Ruiz-Sanchez M, 2011, J PLANT PHYSIOL, V168, P1031, DOI 10.1016/j.jplph.2010.12.019; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; Selosse MA, 2011, SCIENCE, V333, P828, DOI 10.1126/science.1210722; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Trebuil G, 2004, LE RIZ ENJEUX ECOLOG; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Verbruggen E, 2010, EVOL APPL, V3, P547, DOI 10.1111/j.1752-4571.2010.00145.x; WACEK TJ, 1976, CROP SCI, V16, P519, DOI 10.2135/cropsci1976.0011183X001600040020x; Wang L, 2012, ADV INTEL SOFT COMPU, V134, P935; Wopereis-Pura MM, 2002, EUR J AGRON, V17, P191, DOI 10.1016/S1161-0301(02)00009-6; Yoshida S., 1981, FUNDAMENTALS OF RICE	54	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167014	10.1371/journal.pone.0167014	http://dx.doi.org/10.1371/journal.pone.0167014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907023	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700063
J	Giles, C; Takechi, R; Mellett, NA; Meikle, PJ; Dhaliwal, S; Mamo, JC				Giles, Corey; Takechi, Ryusuke; Mellett, Natalie A.; Meikle, Peter J.; Dhaliwal, Satvinder; Mamo, John C.			The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WILD-TYPE MICE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; DOCOSAHEXAENOIC ACID; OXIDATIVE STRESS; BARRIER DYSFUNCTION; EPISODIC MEMORY; NERVOUS-SYSTEM; WHITE-MATTER	The brain is highly enriched in lipids, where they influence neurotransmission, synaptic plasticity and inflammation. Non-pathological modulation of the brain lipidome has not been previously reported and few studies have investigated the interplay between plasma lipid homeostasis relative to cerebral lipids. This study explored whether changes in plasma lipids induced by chronic consumption of a well-tolerated diet enriched in saturated fatty acids (SFA) was associated with parallel changes in cerebral lipid homeostasis. Male C57Bl/6 mice were fed regular chow or the SFA diet for six months. Plasma, hippocampus (HPF) and cerebral cortex (CTX) lipids were analysed by LC-ESI-MS/MS. A total of 348 lipid species were determined, comprising 25 lipid classes. The general abundance of HPF and CTX lipids was comparable in SFA fed mice versus controls, despite substantial differences in plasma lipid-class abundance. However, significant differences in 50 specific lipid species were identified as a consequence of SFA treatment, restricted to phosphatidylcholine (PC), phosphatidylethanolamine (PE), alkyl-PC, alkenyl-PC, alkyl-PE, alkenyl-PE, cholesterol ester (CE), diacylglycerol (DG), phosphatidylinositol (PI) and phosphatidylserine (PS) classes. Partial least squares regression of the HPF/CTX lipidome versus plasma lipidome revealed the plasma lipidome could account for a substantial proportion of variation. The findings demonstrate that cerebral abundance of specific lipid species is strongly associated with plasma lipid homeostasis.	[Giles, Corey; Takechi, Ryusuke; Mamo, John C.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Giles, Corey; Takechi, Ryusuke; Dhaliwal, Satvinder; Mamo, John C.] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia; [Mellett, Natalie A.; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Metabol Lab, Melbourne, Vic, Australia	Curtin University; Curtin University; Baker Heart and Diabetes Institute	Mamo, JC (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.; Mamo, JC (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia.	J.Mamo@curtin.edu.au	Giles, Corey/AAM-9003-2020; Takechi, Ryusuke/D-3692-2012; Takechi, Ryu/T-9970-2019	Giles, Corey/0000-0002-6050-1259; Takechi, Ryusuke/0000-0001-6359-3382; Takechi, Ryu/0000-0001-6359-3382; Mamo, John/0000-0002-5741-7849; Meikle, Peter/0000-0002-2593-4665	Australian National Health and Medical Research Council [1064567]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JM acknowledges the Australian National Health and Medical Research Council (www.nhmrc.gov.au) Project grant 1064567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alles B, 2012, NUTR RES REV, V25, P207, DOI 10.1017/S0954422412000133; Aung HH, 2016, J LIPID RES, V57, P955, DOI 10.1194/jlr.M061853; Bascoul-Colombo C, 2016, BBA-MOL CELL BIOL L, V1861, P524, DOI 10.1016/j.bbalip.2016.03.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Borg ML, 2012, J PHYSIOL-LONDON, V590, P4377, DOI 10.1113/jphysiol.2012.233288; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Carrie I, 2000, J LIPID RES, V41, P465; Cermenati G, 2015, BBA-MOL CELL BIOL L, V1851, P51, DOI 10.1016/j.bbalip.2014.08.011; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003; Cheng ML, 2016, J NUTR BIOCHEM, V31, P38, DOI 10.1016/j.jnutbio.2015.12.001; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; Folch-Fortuny A, 2015, CHEMOMETR INTELL LAB, V146, P77, DOI 10.1016/j.chemolab.2015.05.006; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Greenwood CE, 2001, NEUROBIOL LEARN MEM, V75, P179, DOI 10.1006/nlme.2000.3964; Guan ZQ, 2009, J CHROMATOGR B, V877, P2814, DOI 10.1016/j.jchromb.2009.03.002; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Hsu TM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00088; Kaduk M, 2014, J CHROMATOGR B, V966, P93, DOI 10.1016/j.jchromb.2014.04.048; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; Kramer JH, 2005, NEUROPSYCHOLOGY, V19, P799, DOI 10.1037/0894-4105.19.6.799; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Lam SM, 2014, NEUROBIOL AGING, V35, P2369, DOI 10.1016/j.neurobiolaging.2014.02.025; Le Cao K.-A., 2015, MIXOMICS OMICS DATA; Lepinay AL, 2015, PSYCHONEUROENDOCRINO, V53, P82, DOI 10.1016/j.psyneuen.2014.12.008; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lyn-Cook LE, 2009, J ALZHEIMERS DIS, V16, P715, DOI 10.3233/JAD-2009-0984; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Morris MC, 2014, NEUROBIOL AGING, V35, pS59, DOI 10.1016/j.neurobiolaging.2014.03.038; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; OBRIEN JS, 1965, J LIPID RES, V6, P537; Oh H, 2013, BRAIN RES, V1537, P191, DOI 10.1016/j.brainres.2013.09.025; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; R_Core_Team, 2015, R LANG ENV STAT COMP; Rabiei Z, 2013, CURR NEUROVASC RES, V10, P231, DOI 10.2174/15672026113109990007; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; Sprecher H, 2001, J MOL NEUROSCI, V16, P215; Stenvinkel P, 2004, NEPHROL DIAL TRANSPL, V19, P972, DOI 10.1093/ndt/gfh035; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Stranahan AM, 2011, J NEUROCHEM, V118, P611, DOI 10.1111/j.1471-4159.2011.07351.x; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Taha AY, 2016, PROSTAG LEUKOTR ESS, V105, P26, DOI 10.1016/j.plefa.2015.12.002; Takechi R, 2013, NEURODEGENER DIS, V12, P125, DOI 10.1159/000343211; Takechi R, 2013, CLIN EXP PHARMACOL P, V40, P45, DOI 10.1111/1440-1681.12032; Tu WC, 2013, PROSTAG LEUKOTR ESS, V88, P53, DOI 10.1016/j.plefa.2012.04.005; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wood PL, 2015, ACTA NEUROPSYCHIATR, V27, P270, DOI 10.1017/neu.2015.18; Wood PL, 2010, J PSYCHIATR NEUROSCI, V35, P59, DOI 10.1503/jpn.090059; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	76	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166964	10.1371/journal.pone.0166964	http://dx.doi.org/10.1371/journal.pone.0166964			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907021	gold, Green Published			2022-12-27	WOS:000389482700056
J	Kwon, D; Je, H; Kim, H; Ju, H; An, D				Kwon, Dongwoo; Je, Huigwang; Kim, Hyeonwoo; Ju, Hongtaek; An, Donghyeok			Scalable Video Streaming Relay for Smart Mobile Devices in Wireless Networks	PLOS ONE			English	Article							MAC PROTOCOL	Recently, smart mobile devices and wireless communication technologies such as WiFi, third generation (3G), and long-term evolution (LTE) have been rapidly deployed. Many smart mobile device users can access the Internet wirelessly, which has increased mobile traffic. In 2014, more than half of the mobile traffic around the world was devoted to satisfying the increased demand for the video streaming. In this paper, we propose a scalable video streaming relay scheme. Because many collisions degrade the scalability of video streaming, we first separate networks to prevent excessive contention between devices. In addition, the member device controls the video download rate in order to adapt to video playback. If the data are sufficiently buffered, the member device stops the download. If not, it requests additional video data. We implemented apps to evaluate the proposed scheme and conducted experiments with smart mobile devices. The results showed that our scheme improves the scalability of video streaming in a wireless local area network (WLAN).	[Kwon, Dongwoo; Kim, Hyeonwoo; Ju, Hongtaek; An, Donghyeok] Keimyung Univ, Dept Comp Engn, Daegu, South Korea; [Je, Huigwang] Med Device Dev Ctr, Prod R&D Div, Daegu, South Korea	Keimyung University	An, D (corresponding author), Keimyung Univ, Dept Comp Engn, Daegu, South Korea.	donghyeokan@kmu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01059786]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT & Future Planning) [2015R1C1A1A01052627]; Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP) [R0126-16-1009]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT & Future Planning); Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01059786). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korea government (Ministry of Science, ICT & Future Planning) (No. 2015R1C1A1A01052627). This work was supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIP) (R0126-16-1009, Development of Smart Mediator for Mashup Service and Information Sharing among ICBMS Platform).	Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; An D, 2014, WIRELESS PERS COMMUN, V79, P1511, DOI 10.1007/s11277-014-1943-4; [Anonymous], 2015, CISC VIS NETW IND GL; Bethanabhotla D, 2015, IEEE T COMMUN, V63, P268, DOI 10.1109/TCOMM.2014.2378774; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Chu YH, 2002, IEEE J SEL AREA COMM, V20, P1456, DOI 10.1109/JSAC.2002.803066; Deering S, 1989, REF1112; Do NM, 2011, MIDDLEWARE 2011; Guo QH, 2016, IEEE ACCESS, V4, P4310, DOI 10.1109/ACCESS.2016.2597189; Heusse M, 2005, ACM SIGCOMM COMP COM, V35, P121, DOI 10.1145/1090191.1080107; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Hwang T, 2011, IEEE T CONSUM ELECTR, V57, P120, DOI 10.1109/TCE.2011.5735491; Jacobson V, 2012, COMMUN ACM, V55, P117, DOI 10.1145/2063176.2063204; Jannotti J, 2000, 4 S OP SYST DES IMPL; Keller Lorenzo, 2012, P 10 INT C MOB SYST, P57, DOI DOI 10.1145/2307636.2307643; Kobayashi M, 2009, IEEE T MULTIMEDIA, V11, P166, DOI 10.1109/TMM.2008.2008933; Kwon Y, 2003, IEEE INFOCOM SER, P853; Lin YC, 2015, SENSORS-BASEL, V15, P20925, DOI 10.3390/s150820925; Lin YD, 2013, IEEE MULTIMEDIA, V20, P69, DOI 10.1109/MMUL.2013.3; Naranjo PGV, 2017, J SUPERCOMPUT, V73, P733, DOI 10.1007/s11227-016-1785-9; Pooranian Z., 2011, WORLD ACAD SCI ENG T, V73, P1080; Quinn B, 2001, IP MULTICAST APPL CH; Stockhammer T., 2011, P 2 ANN ACM C MULT S, P133, DOI [DOI 10.1145/1943552.1943572, 10.1145/1943552.1943572]; Tawalbeh LA, 2016, 2016 IEEE FIRST INTERNATIONAL CONFERENCE ON CONNECTED HEALTH: APPLICATIONS, SYSTEMS AND ENGINEERING TECHNOLOGIES (CHASE), P73, DOI 10.1109/CHASE.2016.40; Ting K-C, 2006, ACM MSWIM; Tran DA, 2003, IEEE INFOCOM SER, P1283; Umar MM, 2016, SECUR COMMUN NETW, V9, P3378, DOI 10.1002/sec.1544; Wi-Fi Alliance P2P Technical Group, 2014, WI FI PEER PEER P2P; Xiang S., 2012, P 3 MULT SYST C, P167, DOI [10.1145/2155555.2155583, DOI 10.1145/2155555.2155583]; Xing M, 2014, IEEE J SEL AREA COMM, V32, P795, DOI 10.1109/JSAC.2014.140411; Yang JC, 2016, IEEE ACCESS, V4, DOI 10.1109/ACCESS.2016.2601069; Yang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145800; Yang X, 2006, IEEE T MOBILE COMPUT, V5, P258, DOI 10.1109/TMC.2006.27; Yetgin Z., 2007, FUT GEN COMM NETW FG, V1, P289; Zhang LX, 2014, ACM SIGCOMM COMP COM, V44, P66, DOI 10.1145/2656877.2656887	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167403	10.1371/journal.pone.0167403	http://dx.doi.org/10.1371/journal.pone.0167403			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907113	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700145
J	Prasad, R; Hochmuth, GJ				Prasad, Rishi; Hochmuth, George J.			Environmental Nitrogen Losses from Commercial Crop Production Systems in the Suwannee River Basin of Florida	PLOS ONE			English	Article							NORTH CHINA PLAIN; AMMONIA VOLATILIZATION; SURFACE APPLICATION; GROUNDWATER; GRASSLAND; POTATO; MANAGEMENT; BUDGETS; SLURRY; MANURE	The springs and the Suwannee river of northern Florida in Middle Suwanee River Basin (MSRB) are among several examples in this planet that have shown a temporal trend of increasing nitrate concentration primarily due to the impacts of non-point sources such as agriculture. The rate of nitrate increase in the river as documented by Ham and Hatzell (1996) was 0.02 mg N L-1 y(-1). Best management practices (BMPs) for nutrients were adopted by the commercial farms in the MSRB region to reduce the amounts of pollutants entering the water bodies, however the effectiveness of BMPs remains a topic of interest and discussion among the researchers, environmental administrators and policy makers about the loads of nitrogen entering into groundwater and river systems. Through this study, an initiative was taken to estimate nitrogen losses into the environment from commercial production systems of row and vegetable crops that had adopted BMPs and were under a presumption of compliance with state water quality standards. Nitrogen mass budget was constructed by quantifying the N sources and sinks for three crops (potato (Solanum tuberosum L.), sweet corn (Zea mays L.) and silage corn (Zea mays L.)) over a four year period (2010-2013) on a large representative commercial farm in northern Florida. Fertilizer N was found to be the primary N input and represented 98.0 +/- 1.4, 91.0 +/- 13.9, 78.0 +/- 17.3% of the total N input for potato, sweet corn, and silage corn, respectively. Average crop N uptake represented 55.5%, 60.5%, and 65.2% of the mean total input N whereas average mineral N left in top 0.3 m soil layer at harvest represented 9.1%, 4.5%, and 2.6% of the mean total input N. Mean environmental N losses represented 35.3%, 34.3%, and 32.7% of the mean total input N for potato, sweet corn, and silage corn, respectively. Nitrogen losses showed a linear trend with increase in N inputs. Although, there is no quick fix for controlling N losses from crop production in MSRB, the strategies to reduce N losses must focus on managing the crop residues, using recommended fertilizer rates, and avoiding late-season application of nitrogen.	[Prasad, Rishi; Hochmuth, George J.] Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Prasad, R (corresponding author), Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	rprasad3@ufl.edu			Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District;  [015765]	Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District; 	Funding was provided by Grant no:015765. Funding agencies: Florida Department of Agriculture and Consumer Services, Florida Department of Environmental Protection, Suwannee River Water Management District. GH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraski TW, 1999, AGR ABSTR, P244; [Anonymous], 2000, EOS, DOI [DOI 10.1029/00E000244, DOI 10.1029/00EO00244]; Asci S, 2013, FLORIDA WATERSHED J, P104; Autry LP, 2003, EPA600R04003; BENNETT JM, 1989, FIELD CROP RES, V19, P297, DOI 10.1016/0378-4290(89)90100-7; Bundy LG, 2005, SOIL SCI SOC AM J, V69, P640, DOI 10.2136/sssaj2004.0216; Clean Air Status and Trends Network (CASTNET), 2014, WET DEP; Eichler F, 1998, ENVIRON POLLUT, V102, P609, DOI 10.1016/S0269-7491(98)80089-4; Errebhi M, 1998, AGRON J, V90, P10, DOI 10.2134/agronj1998.00021962009000010003x; Errebhi M, 1998, COMMUN SOIL SCI PLAN, V29, P23, DOI 10.1080/00103629809369926; Fernald E. A., 1998, WATER RESOURCES ATLA; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Ham LK, 1996, 964037 INV US GEOL S; Hellmuth R, 2013, THESIS; Hornsby D, 2007, THESIS; Huijsmans JFM, 2001, NETH J AGR SCI, V49, P323, DOI 10.1016/S1573-5214(01)80021-X; Institute of Food and Agricultural Sciences-University of Florida (IFAS-UF), 2006, CITR BMPS; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Katz BG, 1999, 994252 US GEO SURV; Katz BG, 2000, 004210  US GEOL SURV; Kraft GJ, 2003, AGR ECOSYST ENVIRON, V100, P63, DOI 10.1016/S0167-8809(03)00172-5; Li YC, 2002, COMMUN SOIL SCI PLAN, V33, P1671, DOI 10.1081/CSS-120004307; Liu GD, 2015, VEGETABLE PRODUCTION, pCV296; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Mylavarapu RS, 2009, 1248 COOP EXT SERV; Mylavarapu RS, 2015, UF FAS STAND FERT RE; National Atmospheric Deposition Program (NADP), 2011, NADP PROGR OFF ILL S; Obreza Tom, 2006, CHARACTERIZING AGR F; Oenema O, 2003, EUR J AGRON, V20, P3, DOI 10.1016/S1161-0301(03)00067-4; Peters J, 2003, PUBLICATION A U WISC; Pfluke PD, 2011, J ENVIRON QUAL, V40, P374, DOI 10.2134/jeq2010.0102; Pittman JR, 1997, 974152 US GEOL SURV; Prasad R., 2015, UNDERSTANDING NITROG; Prasad R., 2014, THESIS; Prasad R, 2014, CALCULATE PARTIAL NI; Prasad R, 2015, UNDERSTANDING AVAILA; Prasad R, 2015, ANAEROBIC DIGESTERS; Prasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117891; SAS Institute Incorporation, 2012, SAS 9 3 MICR WIND OP; Shrestha RK, 2010, AM J POTATO RES, V87, P229, DOI 10.1007/s12230-010-9131-x; Suwannee River Water Management District (SRWMD), 2010, POT SURF MAP; THOMPSON RB, 1990, PLANT SOIL, V125, P119, DOI 10.1007/BF00010751; THOMPSON RB, 1987, J SOIL SCI, V38, P689, DOI 10.1111/j.1365-2389.1987.tb02166.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Upchurch SB, 2007, 3017076 SD 2 GLOB CO	45	14	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167558	10.1371/journal.pone.0167558	http://dx.doi.org/10.1371/journal.pone.0167558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907130	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700194
J	Moyer-Horner, L; Beever, EA; Johnson, DH; Biel, M; Belt, J				Moyer-Horner, Lucas; Beever, Erik A.; Johnson, Douglas H.; Biel, Mark; Belt, Jami			Predictors of Current and Longer-Term Patterns of Abundance of American Pikas (Ochotona princeps) across a Leading- Edge Protected Area	PLOS ONE			English	Article							CLIMATE-CHANGE; BEHAVIORAL THERMOREGULATION; POPULATION-DENSITY; NATIONAL-PARK; RANGE SHIFTS; GREAT-BASIN; GENE FLOW; COMMUNITIES; RESPONSES; TRENDS	American pikas (Ochotona princeps) have been heralded as indicators of montane-mammal response to contemporary climate change. Pikas no longer occupy the driest and lowest-elevation sites in numerous parts of their geographic range. Conversely, pikas have exhibited higher rates of occupancy and persistence in Rocky Mountain and Sierra Nevada montane 'mainlands'. Research and monitoring efforts on pikas across the western USA have collectively shown the nuance and complexity with which climate will often act on species in diverse topographic and climatic contexts. However, to date no studies have investigated habitat, distribution, and abundance of pikas across hundreds of sites within a remote wilderness area. Additionally, relatively little is known about whether climate acts most strongly on pikas through direct or indirect (e.g., vegetation-mediated) mechanisms. During 2007-2009, we collectively hiked > 16,000 km throughout the 410,077-ha Glacier National Park, Montana, USA, in an effort to identify topographic, microrefugial, and vegetative characteristics predictive of pika abundance. We identified 411 apparently pika-suitable habitat patches with binoculars (in situ), and surveyed 314 of them for pika signs. Ranking of alternative logistic-regression models based on AIC(c) scores revealed that short-term pika abundances were positively associated with intermediate elevations, greater cover of mosses, and taller forbs, and decreased each year, for a total decline of 68% during the three-year study; whereas longer-term abundances were associated only with static variables (longitude, elevation, gradient) and were lower on north-facing slopes. Earlier Julian date and time of day of the survey (i.e., midday vs. not) were associated with lower observed pika abundance. We recommend that wildlife monitoring account for this seasonal and diel variation when surveying pikas. Broad-scale information on status and abundance determinants of montane mammals, especially for remote protected areas, is crucial for land and wildlife-resource managers trying to anticipate mammalian responses to climate change.	[Moyer-Horner, Lucas] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Beever, Erik A.] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT USA; [Beever, Erik A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Johnson, Douglas H.] US Geol Survey, Northern Prairie Wildlife Res Ctr, St Paul, MN USA; [Johnson, Douglas H.] Univ Minnesota, Fisheries Wildlife & Conservat Biol Dept, St Paul, MN 55108 USA; [Biel, Mark] Natl Pk Serv, Glacier Natl Pk, West Glacier, MT USA; [Belt, Jami] Natl Pk Serv, Klondike Gold Rush Natl Hist Pk, Skagway, AK USA	Utah System of Higher Education; University of Utah; United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Geological Survey; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Department of the Interior	Moyer-Horner, L (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	Lrmhorner@gmail.com	Beever, Erik/Q-3869-2019	Beever, Erik/0000-0002-9369-486X	Glacier National Park Conservancy	Glacier National Park Conservancy	LMH received funding in support of this work from the Glacier National Park Conservancy (https://www.glacierconservaocy.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancillotto L, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1334-7; [Anonymous], 2008, ESRI ARCGIS GIS SOFT; Barnard P, 2008, BIOL LETTERS, V4, P553, DOI 10.1098/rsbl.2008.0374; Beaugrand G, 2015, PHILOS T ROYAL SOC B, V370; Beever E. A, 2002, PARK SCI, V21, P23; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, J MAMMALOGY IN PRESS; Beever EA, 2008, WEST N AM NATURALIST, V68, P8, DOI 10.3398/1527-0904(2008)68[8:APOPIN]2.0.CO;2; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Beever EA, 2010, ECOL APPL, V20, P164, DOI 10.1890/08-1011.1; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; BROWN RN, 1989, J MAMMAL, V70, P622, DOI 10.2307/1381435; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cahill AE, 2012, P ROYAL SOC B, V280; Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x; Castillo JA, 2016, ECOL APPL, V26, P1660, DOI 10.1890/15-1452.1; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; CONNER DA, 1983, CAN J ZOOL, V61, P411, DOI 10.1139/z83-054; Dearing MD, 1997, J MAMMAL, V78, P1156, DOI 10.2307/1383058; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Erb LP, 2014, ECOL APPL, V24, P429, DOI 10.1890/13-1072.1; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; HAFNER DJ, 1993, QUATERNARY RES, V39, P373, DOI 10.1006/qres.1993.1044; HAFNER DJ, 1994, ARCTIC ALPINE RES, V26, P375, DOI 10.2307/1551799; Hall MHP, 2003, BIOSCIENCE, V53, P131, DOI 10.1641/0006-3568(2003)053[0131:MCIGCI]2.0.CO;2; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUNTLY NJ, 1987, ECOLOGY, V68, P274, DOI 10.2307/1939258; HUNTLY NJ, 1986, J MAMMAL, V67, P139, DOI 10.2307/1381010; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Krear H.R., 1965, ECOLOGICAL ETHOLOGIC; Kreuzer MP, 2003, OECOLOGIA, V134, P343, DOI 10.1007/s00442-002-1145-8; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; MACARTHUR RA, 1973, CAN J ZOOL, V51, P11, DOI 10.1139/z73-002; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manning T, 2011, WEST N AM NATURALIST, V71, P106, DOI 10.3398/064.071.0114; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; MILLAR J S, 1973, Canadian Field-Naturalist, V87, P457; MILLAR J S, 1972, Mammalia, V36, P657, DOI 10.1515/mamm.1972.36.4.657; Minder JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013493; Mori E, 2013, ITAL J ZOOL, V80, P469, DOI 10.1080/11250003.2013.857729; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morrison SF, 2007, J ANIM ECOL, V76, P899, DOI 10.1111/j.1365-2656.2007.01276.x; Mote PW, 2012, ECOLOGICAL CONSEQUEN; Moyer-Horner L, 2015, ECOL EVOL, V5, pS810, DOI 10.1002/ece3.1848; Moyer-Horner L, 2012, J WILDLIFE MANAGE, V76, P1472, DOI 10.1002/jwmg.373; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Peacock MM, 1997, MOL ECOL, V6, P801; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rapacciuolo G, 2014, GLOBAL CHANGE BIOL, V20, P2841, DOI 10.1111/gcb.12638; Raphael MG, 2001, FOREST ECOL MANAG, V153, P63, DOI 10.1016/S0378-1127(01)00454-6; Ray C., 2007, DISTRIBUTION ABUNDAN; Ray C, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1379; Rodhouse TJ, 2010, J MAMMAL, V91, P1287, DOI 10.1644/09-MAMM-A-334.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rowe KC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1857; Schwalm D, 2016, GLOBAL CHANGE BIOL, V22, P1572, DOI 10.1111/gcb.13189; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Simpson WG, 2009, WEST N AM NATURALIST, V69, P243, DOI 10.3398/064.069.0213; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; SMITH AT, 1978, ECOLOGY, V59, P133, DOI 10.2307/1936639; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; SMITH AT, 1980, ECOLOGY, V61, P8, DOI 10.2307/1937147; Smith JA, 2013, ARCT ANTARCT ALP RES, V45, P396, DOI 10.1657/1938-4246-45.3.396; SOUTHWICK CH, 1986, J MAMMAL, V67, P149, DOI 10.2307/1381011; Stewart JAE, 2015, J BIOGEOGR, V42, P880, DOI 10.1111/jbi.12466; Stewart JAE, 2012, WILDLIFE SOC B, V36, P759, DOI 10.1002/wsb.220; Stocker T. F., 2013, CLIMATE CHANGE 2013; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Trook J, 2009, EFFECTS CLIMATE CHAN; TYSER RW, 1980, AM MIDL NAT, V104, P32, DOI 10.2307/2424955; Varner J, 2016, BEHAV PROCESS, V125, P63, DOI 10.1016/j.beproc.2016.01.009; Varner J, 2015, INT J WILDLAND FIRE, V24, P921, DOI 10.1071/WF15038; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Walther GR, 2007, SCIENCE, V315, P606, DOI 10.1126/science.1138574; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; West EW, 1981, ADAPTIVE PATTERNS BE; Wilkening JL, 2011, QUATERN INT, V235, P77, DOI 10.1016/j.quaint.2010.05.004; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wilson R.J., 2012, ECOLOGICAL CONSEQUEN, P107; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Yandow LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131082; Yandow LH, 2012, DELINEATING LIMITING	96	5	5	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167051	10.1371/journal.pone.0167051	http://dx.doi.org/10.1371/journal.pone.0167051			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902732	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100046
J	Shimizu, T; Kitajima, A; Nonaka, K; Yoshioka, T; Ohta, S; Goto, S; Toyoda, A; Fujiyama, A; Mochizuki, T; Nagasaki, H; Kaminuma, E; Nakamura, Y				Shimizu, Tokurou; Kitajima, Akira; Nonaka, Keisuke; Yoshioka, Terutaka; Ohta, Satoshi; Goto, Shingo; Toyoda, Atsushi; Fujiyama, Asao; Mochizuki, Takako; Nagasaki, Hideki; Kaminuma, Eli; Nakamura, Yasukazu			Hybrid Origins of Citrus Varieties Inferred from DNA Marker Analysis of Nuclear and Organelle Genomes	PLOS ONE			English	Article							BAC END SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; GENETIC DIVERSITY; R-PACKAGE; MOLECULAR PHYLOGENY; POPULATION-GENETICS; CHLOROPLAST GENOMES; HARDY-WEINBERG; RFLP ANALYSIS; GENUS CITRUS	Most indigenous citrus varieties are assumed to be natural hybrids, but their parentage has so far been determined in only a few cases because of their wide genetic diversity and the low transferability of DNA markers. Here we infer the parentage of indigenous citrus varieties using simple sequence repeat and indel markers developed from various citrus genome sequence resources. Parentage tests with 122 known hybrids using the selected DNA markers certify their transferability among those hybrids. Identity tests confirm that most variant strains are selected mutants, but we find four types of kunenbo (Citrus nobilis) and three types of tachibana (Citrus tachibana) for which we suggest different origins. Structure analysis with DNA markers that are in Hardy-Weinberg equilibrium deduce three basic taxa coinciding with the current understanding of citrus ancestors. Genotyping analysis of 101 indigenous citrus varieties with 123 selected DNA markers infers the parentages of 22 indigenous citrus varieties including Satsuma, Temple, and iyo, and single parents of 45 indigenous citrus varieties, including kunenbo, C. ichangensis, and Ichang lemon by allele-sharing and parentage tests. Genotyping analysis of chloroplast and mitochondrial genomes using 11 DNA markers classifies their cytoplasmic genotypes into 18 categories and deduces the combination of seed and pollen parents. Likelihood ratio analysis verifies the inferred parentages with significant scores. The reconstructed genealogy identifies 12 types of varieties consisting of Kishu, kunenbo, yuzu, koji, sour orange, dancy, kobeni mikan, sweet orange, tachibana, Cleopatra, willowleaf mandarin, and pummelo, which have played pivotal roles in the occurrence of these indigenous varieties. The inferred parentage of the indigenous varieties confirms their hybrid origins, as found by recent studies.	[Shimizu, Tokurou; Nonaka, Keisuke; Yoshioka, Terutaka; Ohta, Satoshi; Goto, Shingo] NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shimizu, Shizuoka, Japan; [Kitajima, Akira] Kyoto Univ, Grad Sch Agr, Expt Farm, Kyoto, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka, Japan; [Mochizuki, Takako; Nagasaki, Hideki; Kaminuma, Eli; Nakamura, Yasukazu] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan; [Nagasaki, Hideki] Kazusa DNA Res Inst, Dept Frontier Res, Kisarazu, Chiba, Japan	National Agriculture & Food Research Organization - Japan; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kazusa DNA Research Institute	Shimizu, T (corresponding author), NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shimizu, Shizuoka, Japan.	tshimizu@affrc.go.jp	Goto, Shingo/AAU-4777-2021	Goto, Shingo/0000-0002-2298-7016; Nakamura, Yasukazu/0000-0002-6782-5715	Japanese Ministry of Agriculture, Forestry and Fisheries [NGB1006]; KAKEN [24405025]; Grants-in-Aid for Scientific Research [15K18643] Funding Source: KAKEN	Japanese Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); KAKEN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for Research Project "Genomics for Agricultural Innovation NGB1006" from Japanese Ministry of Agriculture, Forestry and Fisheries for TS. A part of this work was also supported by KAKEN (No. 24405025) for AK.	Abe K, 1904, CITRUS OF JAPAN; Abkenar AA, 2004, SCI HORTIC-AMSTERDAM, V102, P233, DOI 10.1016/j.scienta.2004.01.003; Ayres KL, 1998, HEREDITY, V80, P769, DOI 10.1046/j.1365-2540.1998.00360.x; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRENNER CH, 1993, TRANSFUSION, V33, P51, DOI 10.1046/j.1537-2995.1993.33193142310.x; Brenner CH, 2003, THEOR POPUL BIOL, V63, P173, DOI 10.1016/S0040-5809(03)00008-X; Brenner CH, 1983, INCLUSION PROBABILIT, P632; Breto MP, 2001, MOL PHYLOGENET EVOL, V21, P285, DOI 10.1006/mpev.2001.1008; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Close Timothy J., 2007, V406, P161; Coletta HD, 1998, EUPHYTICA, V102, P133, DOI 10.1023/A:1018300900275; Committee on Identifying the Needs of the Forensic Sciences Community: National Research Council, 2009, STRENGTH FOR SCI US; Corazza-Nunes MJ, 2002, EUPHYTICA, V126, P169, DOI 10.1023/A:1016332030738; Curk F, 2016, ANN BOT-LONDON, V117, P565, DOI 10.1093/aob/mcw005; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; de Araujo EF, 2003, ORG DIVERS EVOL, V3, P55, DOI 10.1078/1439-6092-00058; Deng Z, 1996, P INT SOC CITRIC, V2, P84; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elisiario PJ, 1999, SCI HORTIC-AMSTERDAM, V81, P287, DOI 10.1016/S0304-4238(99)00013-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang DQ, 1997, THEOR APPL GENET, V95, P408, DOI 10.1007/s001220050577; Foreign Agricultural Service/USDA O of GA, 2016, CITR WORLD MARK TRAD; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Fukuba H, 1882, RECORDS CITRUS KII P; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gmitter FG., 2010, ORIGIN EVOLUTION BRE, P345, DOI [10.1002/9780470650059.ch10, DOI 10.1002/9780470650059.CH10]; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Goodwin W, 2011, J CHEM INFORM MODELI; Goto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162408; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grattapaglia D, 2014, TREE GENET GENOMES, V10, P1631, DOI 10.1007/s11295-014-0784-3; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HANDA T, 1986, JPN J GENET, V61, P15, DOI 10.1266/jjg.61.15; HIRAI M, 1987, JPN J BREED, V37, P377; HIRAI M, 1990, J JPN SOC HORTIC SCI, V59, P1, DOI 10.2503/jjshs.59.1; Hodgson RW, 1967, CITRUS IND, V1, P431, DOI DOI 10.1016/J.FOODCHEM.2006.02.05910.1039/; Hui W, 2008, J STAT SOFTW, V28, P1; Iwamasa M, 1976, VARIETIES OF CITRUS; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jena SN, 2009, SCI HORTIC-AMSTERDAM, V119, P403, DOI 10.1016/j.scienta.2008.08.030; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jung YH, 2005, SCI HORTIC-AMSTERDAM, V104, P179, DOI 10.1016/j.scienta.2004.08.008; Kaibara E., 1709, YAMATO HONZO; Kepiro JL, 2010, TREE GENET GENOMES, V6, P1, DOI 10.1007/s11295-009-0223-z; Khan IA, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P1, DOI 10.1079/9780851990194.0000; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Kotoda N, 2017, HORTICULT J, V86, P183, DOI [10.2503/hortj.OKD-016, 10.2503/hortj.okd-016]; Kotoda N, 2016, HORTICULT J, V85, P128, DOI 10.2503/hortj.MI-085; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; Ladaniya MS, 2008, CITRUS FRUIT: BIOLOGY, TECHNOLOGY AND EVALUATION, pXIII, DOI 10.1016/B978-012374130-1.50001-2; Lassois L, 2016, PLANT MOL BIOL REP, V34, P827, DOI 10.1007/s11105-015-0966-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luro F., 1994, Fruits (Paris), V49, P404; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Ma L, 2015, CURR ZOOL, V61, P886, DOI 10.1093/czoolo/61.5.886; Mabberley D. J., 1997, Telopea, V7, P167; Mabberley DJ, 2004, BLUMEA, V49, P481; Machado M.A. Natividade Targon, 2000, ACTA HORTIC, V535, P51; Machado MA, 1996, EUPHYTICA, V92, P321, DOI 10.1007/BF00037115; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matsumoto R, 1985, B FRUIT TREE RES S D, V10, P1; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Nakano M, J JAPAN SOC HORT SCI; Nakano M, 2013, TREE GENET GENOMES, V9, P795, DOI 10.1007/s11295-013-0598-8; Nakano M, 2012, PLANT SCI, V183, P131, DOI 10.1016/j.plantsci.2011.08.002; Nakatani M., 1989, STUD CITROL, V15, P75; Nei M., 1987, MOL EVOLUTIONARY GEN, V512; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Nicolosi E, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P19, DOI 10.1079/9780851990194.0019; NISHIURA. M, 1967, Japan Agricultural Research Quarterly, V2, P15; Novelli VM, 2000, GENET MOL BIOL, V23, P163, DOI 10.1590/S1415-47572000000100030; Okamura S., 1848, KEIEN KIFFU; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Penjor Tshering, 2014, Horticultural Research (Japan), V13, P307, DOI 10.2503/hrj.13.307; Penjor T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062574; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; POTVIN C, 1983, SYST BOT, V8, P127, DOI 10.2307/2418689; Pritchard JK, 2000, GENETICS, V155, P945; Roose M, 2008, GENOMICS TROPICAL CR, DOI [10.1007/978-0-387-71219-2_8, DOI 10.1007/978-0-387-71219-2_8]; ROUSE RE, 1988, HORTSCIENCE, V23, P680; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunt J., 2000, CITRUS VARIETIES WOR; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Shaw PD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-259; Shimizu T, 2016, ACTA HORTIC, V1135, P23, DOI 10.17660/ActaHortic.2016.1135.4; Shimizu Tokurou, 2011, BMC Res Notes, V4, P161, DOI 10.1186/1756-0500-4-161; Siebert T, 2010, CITROGRAPH       MAR, P20; Sieberts SK, 2002, AM J HUM GENET, V70, P170, DOI 10.1086/338444; Staden R, 2000, Methods Mol Biol, V132, P115; Swingle W T, 1967, CITRUS IND, P190; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; TANAKA T., 1969, Bulletin of the University of Osaka Prefecture. Series B. Agriculture and Biology, V21, P139; Tanaka T., 1961, CITROLOGIA; Tanaka T., 1932, MEM FS AGR TAIHOKU U, V4, P1; TANAKA T, 1954, REVISIO AURANTIACEAR, V9; Tanaka Y., 1942, KANKITSU, V9, P5; Tanaka Y., 1941, KANKITSU, V8, P308; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; TORRES AM, 1978, AM J BOT, V65, P869, DOI 10.2307/2442183; Tripolitsiotis C, 2013, NOT BOT HORTI AGROBO, V41, P463; Uzun A, 2009, SCI HORTIC-AMSTERDAM, V121, P306, DOI 10.1016/j.scienta.2009.02.018; Uzun A, 2012, GENETIC DIVERSITY IN PLANTS, P213; Webber H.J., 1967, CITRUS IND, V1, P1; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; YAMAMOTO M, 1993, JPN J BREED, V43, P355; Yamamoto M, 2006, J JPN SOC HORTIC SCI, V75, P372, DOI 10.2503/jjshs.75.372; Yamamoto M, 2013, J JPN SOC HORTIC SCI, V82, P106, DOI 10.2503/jjshs1.82.106; Yang XM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0955-x	132	49	51	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166969	10.1371/journal.pone.0166969	http://dx.doi.org/10.1371/journal.pone.0166969			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902727	Green Published, gold			2022-12-27	WOS:000389474100042
J	Fatima, R; Qadeer, E; Yaqoob, A; Haq, MU; Majumdar, SS; Shewade, HD; Stevens, R; Creswell, J; Mahmood, N; Kumar, AMV				Fatima, Razia; Qadeer, Ejaz; Yaqoob, Aashifa; Haq, Mahboob Ul; Majumdar, Suman S.; Shewade, Hemant D.; Stevens, Robert; Creswell, Jacob; Mahmood, Nasir; Kumar, Ajay M. V.			Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; INFECTIOUS TUBERCULOSIS; PREVALENCE; BURDEN; IMPACT	Background Currently, only 62% of incident tuberculosis (TB) cases are reported to the national programme in Pakistan. Several innovative interventions are being recommended to detect the remaining 'missed' TB cases. One such intervention involved expanding contact investigation to the community using the Xpert MTB/RIF test. Methods This was a before and after intervention study involving retrospective record review. Passive case finding and household contact investigation was routinely done in the pre-intervention period July 2011-June 2013. Four districts with a high concentration of slums were selected as intervention areas; Lahore, Rawalpindi, Faisalabad and Islamabad. Here, in the intervention period, July 2013-June 2015, contact investigation beyond household was conducted: all people staying within a radius of 50 metres (using Geographical Information System) from the household of smear positive TB patients were screened for tuberculosis. Those with presumptive TB were investigated using smear microscopy and the Xpert MTB/RIF test was performed on smear negative patients. All the diagnosed TB patients were linked to TB treatment and care. Results A total of 783043 contacts were screened for tuberculosis: 23741(3.0%) presumptive TB patients were identified of whom, 4710 (19.8%) all forms and 4084(17.2%) bacteriologically confirmed TB patients were detected. The contribution of Xpert MTB/RIF to bacteriologically confirmed TB patients was 7.6%. The yield among investigated presumptive child TB patients was 5.1%. The overall yield of all forms TB patients among investigated was 22.3% among household and 19.1% in close community. The intervention contributed an increase of case detection of bacteriologically confirmed tuberculosis by 6.8% and all forms TB patients by 7.9%. Conclusion Community contact investigation beyond household not only detected additional TB patients but also increased TB case detection. However, further long term assessments and costeffectiveness studies are required before national scale-up.	[Fatima, Razia; Qadeer, Ejaz; Yaqoob, Aashifa; Haq, Mahboob Ul; Mahmood, Nasir] Natl TB Control Program, Islamabad, Pakistan; [Majumdar, Suman S.] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; [Shewade, Hemant D.] Mahatma Gandhi Inst Med Sci, Dept Community Med, Sevagram, Wardha, India; [Shewade, Hemant D.; Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Stevens, Robert] Mott MacDonald, London, England; [Creswell, Jacob] Stop TB Partnership, Geneva, Switzerland; [Kumar, Ajay M. V.] Int Union TB & Lung Dis, Paris, France	Burnet Institute; Mahatma Gandhi Institute of Medical Sciences, Sevagram; The Mott MacDonald Group	Yaqoob, A (corresponding author), Natl TB Control Program, Islamabad, Pakistan.	aashifa.yaqoob@gmail.com	Shewade MD PhD, Hemant Deepak/J-3907-2019; Majumdar, Suman/AAL-3070-2020	Shewade MD PhD, Hemant Deepak/0000-0002-8242-1911; Majumdar, Suman/0000-0002-9656-557X; Ul Haq, Mahboob/0000-0002-3709-3496; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Creswell, Jacob/0000-0002-4885-940X	TB REACH secretariat of Stop TB Partnership; Provincial TB Control Programme Pakistan	TB REACH secretariat of Stop TB Partnership; Provincial TB Control Programme Pakistan	Mott MacDonald was contracted by Stop TB to provide independent monitoring and evaluation of TB REACH projects. Robert Stevens receives a salary from Mott MacDonald. We gratefully acknowledge the support from the TB REACH secretariat of Stop TB Partnership for funding the study and the Provincial TB Control Programme Pakistan. The specific roles of these authors are articulated in the 'author contributions' section. Mott MacDonald contributed professional services and opinion independently of the funder, Stop TB and the grantee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT STRAT PLAN VIS 2; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Fatima R, 2014, INT J TUBERC LUNG D, V18, P1099, DOI 10.5588/ijtld.14.0001; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Kretzschmar M, 2004, EMERG INFECT DIS, V10, P832, DOI 10.3201/eid1005.030419; Lonnroth K, 2013, SYSTEMATIC REV NUMBE; Lorent N, 2014, PLOS ONE, P9; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P611; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; WHO, 2011, SCOP M DEV GUID SCRE; World Health Organization, 2013, WHO SYST SCREEN ACT; World Health Organization, 2015, GLOB TUB REP 2015	24	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0165813	10.1371/journal.pone.0165813	http://dx.doi.org/10.1371/journal.pone.0165813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898665	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000002
J	Wise, MJ				Wise, Michael J.			dCITE: Measuring Necessary Cladistic Information Can Help You Reduce Polytomy Artefacts in Trees	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PHYLOGENETIC INFERENCE; EXPERIMENTAL-DESIGN; POTENTIAL UTILITY; PROTEIN; INCONGRUENCE; SEARCH	Biologists regularly create phylogenetic trees to better understand the evolutionary origins of their species of interest, and often use genomes as their data source. However, as more and more incomplete genomes are published, in many cases it may not be possible to compute genome-based phylogenetic trees due to large gaps in the assembled sequences. In addition, comparison of complete genomes may not even be desirable due to the presence of horizontally acquired and homologous genes. A decision must therefore be made about which gene, or gene combinations, should be used to compute a tree. Deflated Cladistic Information based on Total Entropy (dCITE) is proposed as an easily computed metric for measuring the cladistic information in multiple sequence alignments representing a range of taxa, without the need to first compute the corresponding trees. dCITE scores can be used to rank candidate genes or decide whether input sequences provide insufficient cladistic information, making artefactual polytomies more likely. The dCITE method can be applied to protein, nucleotide or encoded phenotypic data, so can be used to select which data-type is most appropriate, given the choice. In a series of experiments the dCITE method was compared with related measures. Then, as a practical demonstration, the ideas developed in the paper were applied to a dataset representing species from the order Campylobacterales; trees based on sequence combinations, selected on the basis of their dCITE scores, were compared with a tree constructed to mimic Multi-Locus Sequence Typing (MLST) combinations of fragments. We see that the greater the dCITE score the more likely it is that the computed phylogenetic tree will be free of artefactual polytomies. Secondly, cladistic information saturates, beyond which little additional cladistic information can be obtained by adding additional sequences. Finally, sequences with high cladistic information produce more consistent trees for the same taxa.	[Wise, Michael J.] Univ Western Australia, Comp Sci & Software Engn, Perth, WA, Australia; [Wise, Michael J.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia	University of Western Australia; University of Western Australia	Wise, MJ (corresponding author), Univ Western Australia, Comp Sci & Software Engn, Perth, WA, Australia.; Wise, MJ (corresponding author), Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia.	Michael.Wise@uwa.edu.au	Wise, Michael J./B-5676-2012	Wise, Michael J./0000-0001-6559-4303				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bogdanowicz D, 2012, EVOL BIOINFORM, V8, P475, DOI 10.4137/EBO.S9657; COLLESS DH, 1980, SYST ZOOL, V29, P289; Cotton JA, 2008, TAXON, V57, P131, DOI 10.2307/25065954; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen JA, 1995, J MOL EVOL, V41, P1105; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glenner H, 2004, CURR BIOL, V14, P1644, DOI 10.1016/j.cub.2004.09.027; Gotelli Nicholas J., 2011, P39; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kallersjo M, 1999, CLADISTICS, V15, P91; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kroger A, 2005, BERGEYS MANUAL SYSTE, V2, P1191; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Massingham T, 2000, BIOINFORMATICS, V16, P294, DOI 10.1093/bioinformatics/16.3.294; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Nelson G, 1981, SYSTEMATICS BIOGEOGR, P169; On S. L. W., 2005, BERGEYS MANUAL SYS C, V2, P1169; Pal C, 2001, GENETICS, V158, P927; Park C, 2012, GENOME BIOL EVOL, V4, P523, DOI 10.1093/gbe/evs030; PENNY D, 1990, Australian Systematic Botany, V3, P21, DOI 10.1071/SB9900021; R Development Core Team, 2014, R LANG ENV STAT COMP; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Spielman SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139047; Steel Mike, 2005, P163; Strimmer K, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P111; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Thorley J. L, 2000, THESIS; Thorley JL, 1998, 6 C INT FED CLASS SO; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; Vandamme P., 2005, BERGEYS MANUAL SYSTE, P1161; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wise MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061276; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wortley AH, 2006, TAXON, V55, P431, DOI 10.2307/25065589; Zhang JZ, 2015, NAT REV GENET, V16, P409, DOI 10.1038/nrg3950	53	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166991	10.1371/journal.pone.0166991	http://dx.doi.org/10.1371/journal.pone.0166991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898695	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000029
J	Avrahami, I; Kersh, D; Liberzon, A				Avrahami, Idit; Kersh, Dikla; Liberzon, Alexander			Pulsatility Index as a Diagnostic Parameter of Reciprocating Wall Shear Stress Parameters in Physiological Pulsating Waveforms	PLOS ONE			English	Article							CEREBRAL ANEURYSM; RISK-FACTOR; HEART-RATE; IN-VIVO; FLOW; ULTRASOUND; BLOOD; ATHEROSCLEROSIS; ARTERIES; DISEASE	Arterial wall shear stress (WSS) parameters are widely used for prediction of the initiation and development of atherosclerosis and arterial pathologies. Traditional clinical evaluation of arterial condition relies on correlations of WSS parameters with average flow rate (Q) and heart rate (HR) measurements. We show that for pulsating flow waveforms in a straight tube with flow reversals that lead to significant reciprocating WSS, the measurements of HR and Q are not sufficient for prediction of WSS parameters. Therefore, we suggest adding a third quantity-known as the pulsatility index (PI)-which is defined as the peak-to-peak flow rate amplitude normalized by Q. We examine several pulsating flow waveforms with and without flow reversals using a simulation of a Womersley model in a straight rigid tube and validate the simulations through experimental study using particle image velocimetry (PIV). The results indicate that clinically relevant WSS parameters such as the percentage of negative WSS (P[%]), oscillating shear index (OSI) and the ratio of minimum to maximum shear stress rates (min/max), are better predicted when the PI is used in conjunction with HR and Q. Therefore, we propose to use PI as an additional and essential diagnostic quantity for improved predictability of the reciprocating WSS.	[Avrahami, Idit] Ariel Univ, Dept Mech Engn & Mechatron, Ariel, Israel; [Kersh, Dikla; Liberzon, Alexander] Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel	Ariel University; Tel Aviv University	Liberzon, A (corresponding author), Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel.	alexlib@eng.tau.ac.il	Avrahami, Idit/AAF-8175-2019; Liberzon, Alex/A-8596-2008	Avrahami, Idit/0000-0003-4927-3491; Liberzon, Alex/0000-0002-6882-4191	Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University; Israel Science Foundation [782/08]	Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University; Israel Science Foundation(Israel Science Foundation)	This study was supported in part by a grant from the Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University and partially by the Israel Science Foundation, under Grant no. 782/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake JR, 2008, ULTRASOUND MED BIOL, V34, P760, DOI 10.1016/j.ultrasmedbio.2007.11.003; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Bouillot P, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1746-0; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019; Cezeaux JL, 1997, ANN BIOMED ENG, V25, P536, DOI 10.1007/BF02684193; Daidzic NE, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4026481; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; EVANS DH, 1980, CIRC RES, V46, P470, DOI 10.1161/01.RES.46.4.470; Finol Ender A, 2002, Comput Methods Biomech Biomed Engin, V5, P319, DOI 10.1080/1025584021000009751; Formaggia L., 2010, CARDIOVASCULAR MATH; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Gharib M, 2003, ANN BIOMED ENG, V31, P678, DOI 10.1114/1.1574025; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hashimoto J, 2010, HYPERTENSION, V56, P926, DOI 10.1161/HYPERTENSIONAHA.110.159368; Kaspera W, 2014, STROKE, V45, P2906, DOI 10.1161/STROKEAHA.114.006055; Kawaguchi T, 2012, J NEUROSURG, V117, P774, DOI 10.3171/2012.7.JNS111991; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Le TB, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002702; Leguy CAD, 2009, MED BIOL ENG COMPUT, V47, P641, DOI 10.1007/s11517-009-0473-9; Leow CH, 2015, ULTRASOUND MED BIOL, V41, P2913, DOI 10.1016/j.ultrasmedbio.2015.06.012; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Marto A, 2003, NEUROLOGY, V61, P1051; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; Nichols W, 1998, MCDONALDS BLOOD FLOW; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Patti J, 2014, J NEUROINTERV SURG, V6, P103, DOI 10.1136/neurintsurg-2013-010660; Peiffer V., 2013, CARDIOVASCULAR RES; Poelma C, 2012, EUR J MECH B-FLUID, V35, P70, DOI 10.1016/j.euromechflu.2012.03.003; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Resnick N, 2003, ENDOTHELIUM-J ENDOTH, V10, P197, DOI 10.1080/713715231; Sahtout Wassila, 2012, Nonlinear Biomed Phys, V6, P2, DOI 10.1186/1753-4631-6-2; Shimogonya Y, 2009, J BIOMECH, V42, P550, DOI 10.1016/j.jbiomech.2008.10.006; Tang DL, 2014, J BIOMECH, V47, P834, DOI 10.1016/j.jbiomech.2014.01.012; Tarbell JM, 2014, ANNU REV FLUID MECH, V46, P591, DOI 10.1146/annurev-fluid-010313-141309; Taylor ZJ, 2010, IEEE T INSTRUM MEAS, V59, P3262, DOI 10.1109/TIM.2010.2047149; THURSTON GB, 1996, ADV HEMODY HEMORH, V1, P1; TSANGARIS S, 1988, J BIOMECH, V21, P263, DOI 10.1016/0021-9290(88)90176-5; van Grondelle A, 1990, BIOFLUID MECH, P545; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; YOMOSA S, 1987, J PHYS SOC JPN, V56, P506, DOI 10.1143/JPSJ.56.506; Zamir M., 2000, PHYS PULSATILE FLOW	45	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166426	10.1371/journal.pone.0166426	http://dx.doi.org/10.1371/journal.pone.0166426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893801	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400026
J	Silva, JLGD; Guitarte, CB; Valladares, PM; Noboa, JCR; Kestler, K; Millan, RD				de Veas Silva, Jose Luis Garcia; Guitarte, Carmen Bermudo; Valladares, Paloma Menendez; Rojas Noboa, Johanna Carolina; Kestler, Krysta; Millan, Rafael Duro			Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients	PLOS ONE			English	Article							INTERNATIONAL STAGING SYSTEM; INDEPENDENT RISK-FACTOR; RATIO; AGENTS; STRATIFICATION; PROGRESSION; DIAGNOSIS; CRITERIA	Background The outcome for patients with Multiple Myeloma (MM) is highly variable, therefore, the existence of robust and easy to determine prognostic markers is extremely important for an efficient management of these patients. Presently, there is a debate about the role of the serum free light chains (sFLC) in the prognosis of MM patients both at diagnosis and after treatment. The aim of this study is to evaluate in a cohort of newly diagnosed MM patients from the Southern area of Spain, the prognostic value of sFLC both at baseline and after treatment. Materials and Methods 180 patients with a median age of 69 years were followed-up for a median time of 35 (18-61) months. The sFLC ratio (sFLCR) was calculated using the monoclonal sFLC as numerator. Patients were divided in two groups according to a sFLCR cut-off based on ROC analysis. The primary endpoints were the Overall Survival (OS) and the Progression-free Survival (PFS). Additionally, thirty-six MM patients treated with novel agents (Bortezomib/Dexamethasone) that achieved Complete Response (CR) or stringent CR (sCR) before autologous stem cell transplantation were studied to assess the impact of sCR in Disease Free Survival (DFS) and OS. Results During follow-up there were 72 disease-related deaths. The 5-years OS for the whole group was 51%. However, separate analysis of patients with sFLCR above (group "high") or below (groups "low") the cut-off value of 47 shows an OS of 23% and 73%, respectively (HR = 5.03, 95% CI 2.99-8.50, p<0.001). In addition, analysis by ISS stage, showed that the presence of high sFLCR was always significantly associated with a worse OS. Multivariate analysis identified sFLCR (HR = 4.42, 95% CI 2.57-7.60, p<0.001) and beta-2-microglobulin (B2M) (HR = 3.04, 95%IC 1.75-5.31, p<0.001) as independent risk factors for adverse outcome. A new risk stratification model based on sFLCR >= 47 and B2M>3.5 mg/L provided a statistically more significant result for this cohort when compared with the conventional ISS system. The HR for the new model were 2.84 (95% CI, 1.39-5.79, p = 0.004) for patients in stage 2 and 15.39 (95% CI, 6.35-37.33, p<0.001) for those in stage 3. Finally, in the group of patients reaching CR (19/36) or sCR (17/36) after induction, the median DFS for CR patients was 29 months, and NR for sCR patients (HR = 3.73; 95% CI 1.15-12.13, p = 0.03). Importantly, achieving sCR also translated into a significantly longer OS (5y-OS: sCR-89% versus CR-49%; p = 0.003; OS: sCR-NR versus CR-52 months). Conclusions Our findings confirm the observations that the sFLCR has a major role in the survival of MM patients. A cut-off of sFLCR >= 47 was shown to have an independent prognostic value at diagnosis, and a proposed "New Staging System" allows an accurate and simple method to risk stratify MM patients. Furthermore, because achievement of sCR was shown to represent a response state deeper than conventional CR resulting in greater OS and DFS, our study supports the continuity of sFLC ratio as part of the response criteria for MM patients.	[de Veas Silva, Jose Luis Garcia; Guitarte, Carmen Bermudo; Valladares, Paloma Menendez] Hosp Univ Virgen Macarena, Dept Clin Biochem, Seville, Spain; [de Veas Silva, Jose Luis Garcia] Complejo Hosp Univ Granada, Dept Immunol, Granada, Spain; [Rojas Noboa, Johanna Carolina; Kestler, Krysta; Millan, Rafael Duro] Hosp Univ Virgen Macarena, Dept Hematol, Seville, Spain	Hospital Universitario Virgen Macarena; University of Granada; Hospital Universitario Virgen Macarena	Silva, JLGD (corresponding author), Hosp Univ Virgen Macarena, Dept Clin Biochem, Seville, Spain.; Silva, JLGD (corresponding author), Complejo Hosp Univ Granada, Dept Immunol, Granada, Spain.	jose6@outlook.com	Garcia de Veas Silva, Jose Luis/O-7786-2015; Valladares, Paloma Menéndez/D-9207-2015; de Veas Silva, Jose Luis Garcia/N-5765-2019	Garcia de Veas Silva, Jose Luis/0000-0001-8119-7842; Valladares, Paloma Menéndez/0000-0002-8313-8720; de Veas Silva, Jose Luis Garcia/0000-0001-8119-7842				Dingli D, 2006, BLOOD, V108, P1979, DOI 10.1182/blood-2006-04-015784; Dispenzieri A, 2008, BLOOD, V111, P785, DOI 10.1182/blood-2007-08-108357; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Iriuchishima H, 2015, EUR J HAEMATOL, V94, P145, DOI 10.1111/ejh.12407; Iwama K, 2013, EUR J HAEMATOL, V90, P134, DOI 10.1111/ejh.12050; Jekarl DW, 2013, ANN LAB MED, V33, P248, DOI 10.3343/alm.2013.33.4.248; Kapoor P, 2013, J CLIN ONCOL, V31, P4529, DOI 10.1200/JCO.2013.49.0086; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Katzmann JA, 2009, CLIN CHEM, V55, P1517, DOI 10.1373/clinchem.2009.126664; Kumar S, 2010, LEUKEMIA, V24, P1498, DOI 10.1038/leu.2010.128; Kyle RA, 2014, LEUKEMIA, V28, P980, DOI 10.1038/leu.2014.11; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyrtsonis MC, 2007, BRIT J HAEMATOL, V137, P240, DOI 10.1111/j.1365-2141.2007.06561.x; Maltezas D, 2013, HEMATOL ONCOL, V31, P356, DOI 10.1002/hon.2026; Moustafa MA, 2015, LEUKEMIA, V29, P2033, DOI 10.1038/leu.2015.118; Paiva B, 2011, J CLIN ONCOL, V29, P1627, DOI 10.1200/JCO.2010.33.1967; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Radocha J, EUR J HAEMATOL; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Snozek CLH, 2008, LEUKEMIA, V22, P1933, DOI 10.1038/leu.2008.171; Sthaneshwar P, 2009, CLIN CHEM LAB MED, V47, P1101, DOI 10.1515/CCLM.2009.260; van Rhee F, 2007, BLOOD, V110, P827, DOI 10.1182/blood-2007-01-067728; Xu Y, 2013, LEUKEMIA LYMPHOMA, V54, P123, DOI 10.3109/10428194.2012.704033	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166841	10.1371/journal.pone.0166841	http://dx.doi.org/10.1371/journal.pone.0166841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893836	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400047
J	Fu, Y; Zheng, ZY; Shi, HB; Xiao, R				Fu, Yang; Zheng, Zeyu; Shi, Haibo; Xiao, Rui			A Novel Large-Scale Temperature Dominated Model for Predicting the End of the Growing Season	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; LAND-SURFACE PHENOLOGY; VEGETATION PHENOLOGY; CARBON BALANCE; CLIMATE-CHANGE; WATER-BALANCE; FOREST; COVER; RESPONSES; ADAPTABILITY	Vegetation phenology regulates many ecosystem processes and is an indicator of the biological responses to climate change. It is important to model the timing of leaf senescence accurately, since the canopy duration and carbon assimilation are strongly determined by the timings of leaf senescence. However, the existing phenology models are unlikely to accurately predict the end of the growing season (EGS) on large scales, resulting in the misrepresentation of the seasonality and interannual variability of biosphere-atmosphere feedbacks and interactions in coupled global climate models. In this paper, we presented a novel large-scale temperature dominated model integrated with the physiological adaptation of plants to the local temperature to assess the spatial pattern and interannual variability of the EGS. Our model was validated in all temperate vegetation types over the Northern Hemisphere. The results indicated that our model showed better performance in representing the spatial and interannual variability of leaf senescence, compared with the original phenology model in the Integrated Biosphere Simulator (IBIS). Our model explained approximately 63% of the EGS variations, whereas the original model explained much lower variations (coefficient of determination R-2 = 0.01-0.18). In addition, the differences between the EGS reproduced by our model and the MODIS EGS at 71.3% of the pixels were within 10 days. For the original model, it is only 26.1%. We also found that the temperature threshold (TcritTm) of grassland was lower than that of woody species in the same latitudinal zone.	[Fu, Yang; Zheng, Zeyu; Shi, Haibo] Chinese Acad Sci, Shenyang Inst Automat, Shenyang, Peoples R China; [Fu, Yang; Zheng, Zeyu; Shi, Haibo] Chinese Acad Sci, Key Lab Network Control Syst, Shenyang, Peoples R China; [Xiao, Rui] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Pennsylvania; Pennsylvania Medicine	Zheng, ZY (corresponding author), Chinese Acad Sci, Shenyang Inst Automat, Shenyang, Peoples R China.; Zheng, ZY (corresponding author), Chinese Acad Sci, Key Lab Network Control Syst, Shenyang, Peoples R China.	zhengzeyu@sia.cn			Program for One-hundred Talent Program of the Chinese Academy of Sciences [Y5AA100A01]	Program for One-hundred Talent Program of the Chinese Academy of Sciences	This study was supported by the Program for One-hundred Talent Program of the Chinese Academy of Sciences (Y5AA100A01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT FT, 1968, PLANT PHYSIOL, V43, P1471; Ahrends HE, 2009, CLIM RES, V39, P261, DOI 10.3354/cr00811; Atkinson PM, 2012, REMOTE SENS ENVIRON, V123, P400, DOI 10.1016/j.rse.2012.04.001; Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Barr AG, 2007, GLOBAL CHANGE BIOL, V13, P561, DOI 10.1111/j.1365-2486.2006.01220.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Chuine I, 1999, NEW PHYTOL, V143, P339, DOI 10.1046/j.1469-8137.1999.00445.x; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; Davi H, 2006, AGR FOREST METEOROL, V141, P35, DOI 10.1016/j.agrformet.2006.09.003; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Ganguly S, 2010, REMOTE SENS ENVIRON, V114, P1805, DOI 10.1016/j.rse.2010.04.005; Hmimina G, 2013, REMOTE SENS ENVIRON, V132, P145, DOI 10.1016/j.rse.2013.01.010; Hunter P, 2013, EMBO REP, V14, P769, DOI 10.1038/embor.2013.122; Jeong S. J., 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI DOI 10.1111/J.1365-2486.2011.02397.X; Jordan NS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013777; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; KOIKE T, 1990, TREE PHYSIOL, V7, P21, DOI 10.1093/treephys/7.1-2-3-4.21; Kross A, 2011, REMOTE SENS ENVIRON, V115, P1564, DOI 10.1016/j.rse.2011.02.015; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; Joshi PKK, 2006, REMOTE SENS ENVIRON, V103, P190, DOI 10.1016/j.rse.2006.04.010; Lee DW, 2003, ECOL RES, V18, P677, DOI 10.1111/j.1440-1703.2003.00588.x; Li XL, 2013, ECOL MODEL, V261, P80, DOI 10.1016/j.ecolmodel.2013.03.024; Liang D, 2015, ISPRS INT J GEO-INF, V4, P2519, DOI 10.3390/ijgi4042519; Menzel A, 2003, CLIMATIC CHANGE, V57, P243, DOI 10.1023/A:1022880418362; Migliavacca M, 2008, INT J BIOMETEOROL, V52, P587, DOI 10.1007/s00484-008-0152-9; NASA LP DAAC, 2012, MCD12Q1 VERS 5; NASA LP DAAC, 2012, MCD12Q2 VERS 5; NunezOlivera E, 1996, FUNCT ECOL, V10, P636, DOI 10.2307/2390174; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Piao SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7911; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Schnase JL, 2014, COMPUTERS ENV URBAN; Shen MG, 2014, INT J REMOTE SENS, V35, P1162, DOI 10.1080/01431161.2013.875636; Verger A, 2015, REMOTE SENS ENVIRON, V166, P126, DOI 10.1016/j.rse.2015.05.027; Vicente-Serrano SM, 2004, ENVIRON MANAGE, V34, P802, DOI 10.1007/s00267-003-0022-5; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Vrbnicanin S, 2009, TURK J AGRIC FOR, V33, P325, DOI 10.3906/tar-0810-24; Wang YF, 2014, THEOR APPL CLIMATOL, V118, P569, DOI 10.1007/s00704-013-1078-7; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Xia JZ, 2014, REMOTE SENS-BASEL, V6, P1783, DOI 10.3390/rs6031783; Xiao W, 2013, J APPL REMOTE SENS, V7, P609; Yang X, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001977; Yi YH, 2011, J CLIMATE, V24, P3797, DOI 10.1175/2011JCLI4034.1; Yu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111056; [Yu Xinfang 于信芳], 2005, Journal of Geographical Sciences, V15, P239, DOI 10.1007/BF02872689; Yuan W, 2011, GLOBAL BIOGEOCHEMICA, V25, P1441; Yuan WP, 2012, WATER RESOUR MANAG, V26, P2147, DOI 10.1007/s11269-012-0007-3; Zhang HC, 2015, J GEOPHYS RES-BIOGEO, V120, P1658, DOI 10.1002/2015JG003112; Zhang HC, 2014, ECOL COMPLEX, V20, P240, DOI 10.1016/j.ecocom.2014.01.003; Zhang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/175940; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	63	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167302	10.1371/journal.pone.0167302	http://dx.doi.org/10.1371/journal.pone.0167302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893828	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400110
J	Hurtado-Alvarado, G; Dominguez-Salazar, E; Velazquez-Moctezuma, J; Gomez-Gonzalez, B				Hurtado-Alvarado, Gabriela; Dominguez-Salazar, Emilio; Velazquez-Moctezuma, Javier; Gomez-Gonzalez, Beatriz			A(2A) Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction	PLOS ONE			English	Article							INFLAMMATION; DEPRIVATION; PERMEABILITY; IMPAIRMENT; MODULATION; JUNCTIONS; CAFFEINE; DEFICITS; IMPROVES; MEMORY	Chronic sleep restriction induces blood-brain barrier disruption and increases pro-inflammatory mediators in rodents. Those inflammatory mediators may modulate the blood-brain barrier and constitute a link between sleep loss and blood-brain barrier physiology. We propose that adenosine action on its A(2A) receptor may be modulating the blood-brain barrier dynamics in sleep-restricted rats. We administrated a selective A(2A) adenosine receptor antagonist (SCH58261) in sleep-restricted rats at the 10(th) day of sleep restriction and evaluated the blood-brain barrier permeability to dextrans coupled to fluorescein (FITC-dextrans) and Evans blue. In addition, we evaluated by western blot the expression of tight junction proteins (claudin-5, occludin, ZO-1), adherens junction protein (E-cadherin), A(2A) adenosine receptor, adenosine-synthesizing enzyme (CD73), and neuroinflammatory markers (lba-1 and GFAP) in the cerebral cortex, hippocampus, basal nuclei and cerebellar vermis. Sleep restriction increased blood-brain barrier permeability to FITC-dextrans and Evans blue, and the effect was reverted by the administration of SCH58261 in almost all brain regions, excluding the cerebellum. Sleep restriction increased the expression of A(2A) adenosine receptor only in the hippocampus and basal nuclei without changing the expression of CD73 in all brain regions. Sleep restriction reduced the expression of tight junction proteins in all brain regions, except in the cerebellum; and SCH58261 restored the levels of tight junction proteins in the cortex, hippocampus and basal nuclei. Finally, sleep restriction induced GFAP and lba-1 overexpression that was attenuated with the administration of SCH58261. These data suggest that the action of adenosine on its A(2A) receptor may have a crucial role in blood-brain barrier dysfunction during sleep loss probably by direct modulation of brain endothelial cell permeability or through a mechanism that involves gliosis with subsequent inflammation and increased blood-brain barrier permeability.	[Hurtado-Alvarado, Gabriela; Dominguez-Salazar, Emilio; Velazquez-Moctezuma, Javier; Gomez-Gonzalez, Beatriz] Univ Autonoma Metropolitana, Area Neurosci, Dept Biol Reprod, CBS,Unidad Iztapalapa, Mexico City, DF, Mexico; [Hurtado-Alvarado, Gabriela] Univ Autonoma Metropolitana, Postgrad Program Expt Biol, CBS, Unidad Iztapalapa, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico	Gomez-Gonzalez, B (corresponding author), Univ Autonoma Metropolitana, Area Neurosci, Dept Biol Reprod, CBS,Unidad Iztapalapa, Mexico City, DF, Mexico.	bgomezglez@gmail.com	HURTADO-ALVARADO, GABRIELA/AAH-5979-2021	Dominguez-Salazar, Emilio/0000-0003-2145-0863; Gomez-Gonzalez, Beatriz/0000-0003-1388-0118; Hurtado-Alvarado, Gabriela/0000-0002-6137-663X	Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP) [CB 2012-180792, 371992]	Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP)	This work was supported by Grant CB 2012-180792 from Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP) to BGG and Fellowship 371992 from Consejo Nacional de Ciencia y Tecnologia (CONACyT-SEP) to GHA. URL: http://www.conacyt.mx. None of the funding sources had any role in the study design, analysis or interpretation of the data, nor in writing the report.	Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Bynoe MS, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0017-7; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Cheng CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23882; Christiansen SL, 2016, NEUROSCIENCE RESEARC; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; DeMet EM, 2002, N-S ARCH PHARMACOL, V366, P478, DOI 10.1007/s00210-002-0613-3; Dixon AK, 1996, BRIT J PHARMACOL, V118, P1461, DOI 10.1111/j.1476-5381.1996.tb15561.x; Dohadwala MM, 2008, CARDIOVASC THER, V26, P276, DOI 10.1111/j.1755-5922.2008.00059.x; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Gomez-Gonzalez B, 2013, CURR NEUROVASC RES, V10, P197, DOI 10.2174/15672026113109990002; Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; He JY, 2014, J NEUROSCI, V34, P14697, DOI 10.1523/JNEUROSCI.2111-14.2014; Hines DJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.136; Hoffmann A, 2011, TRANSL STROKE RES, V2, P106, DOI 10.1007/s12975-010-0049-x; Hurtado-Alvarado G, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4576012; Hurtado-Alvarado G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/801341; Jorg M, 2014, CURR MED CHEM, V21, P3188; Kahan V, 2010, BASIC CLIN PHARMACOL, V107, P598, DOI 10.1111/j.1742-7843.2010.00540.x; Killgore WDS, 2014, J CLIN PSYCHOPHARM, V34, P660, DOI 10.1097/JCP.0000000000000184; Kim DG, 2015, MOL NEUROBIOL, V52, P664, DOI 10.1007/s12035-014-8879-2; Kim Y, 2012, SLEEP, V35, P861, DOI 10.5665/sleep.1890; Leite MR, 2011, EXP GERONTOL, V46, P309, DOI 10.1016/j.exger.2010.11.034; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Mohamed RA, 2012, NEUROCHEM RES, V37, P538, DOI 10.1007/s11064-011-0640-x; MORII S, 1987, AM J PHYSIOL, V253, pH165, DOI 10.1152/ajpheart.1987.253.1.H165; Ng SK, 2015, EXP NEUROL, V267, P115, DOI 10.1016/j.expneurol.2015.03.004; Novati A, 2012, J SLEEP RES, V21, P3, DOI 10.1111/j.1365-2869.2011.00932.x; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Pezzola A, 1998, NEUROSCI LETT, V31, P251; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Porkka-Heiskanen T, 1999, ANN MED, V31, P125, DOI 10.3109/07853899908998788; Preti D, 2015, MED RES REV, V35, P790, DOI 10.1002/med.21344; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Rochfort KD, 2015, MICROVASC RES, V100, P48, DOI 10.1016/j.mvr.2015.04.010; Sanchez-Espinosa MP, 2014, NEUROIMAGE, V98, P395, DOI 10.1016/j.neuroimage.2014.05.027; Santiago AR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/465694; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Sumi N, 2010, CELL MOL NEUROBIOL, V30, P247, DOI 10.1007/s10571-009-9446-7; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Yang M, 2007, N-S ARCH PHARMACOL, V375, P133, DOI 10.1007/s00210-007-0135-0; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398	51	28	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167236	10.1371/journal.pone.0167236	http://dx.doi.org/10.1371/journal.pone.0167236			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893847	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400106
J	Andrienko, T; Pasdois, P; Rossbach, A; Halestrap, AP				Andrienko, Tatyana; Pasdois, Philippe; Rossbach, Andreas; Halestrap, Andrew P.			Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic/Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; INTRACELLULAR FREE CALCIUM; IMAGING HYDROGEN-PEROXIDE; OXYGEN SPECIES PRODUCTION; REPERFUSION INJURY; OXIDATIVE STRESS; HYPOXIA-REOXYGENATION; LIVER MITOCHONDRIA; CARDIAC ISCHEMIA; CYCLOSPORINE-A	Mitochondrial permeability transition pore (mPTP) opening is critical for ischemia / reperfusion (I/R) injury and is associated with increased [Ca2+] and reactive oxygen species (ROS). Here we employ surface fluorescence to establish the temporal sequence of these events in beating perfused hearts subject to global I/R. A bespoke fluorimeter was used to synchronously monitor surface fluorescence and reflectance of Langendorff-perfused rat hearts at multiple wavelengths, with simultaneous measurements of hemodynamic function. Potential interference by motion artefacts and internal filtering was assessed and minimised. Re-oxidation of NAD(P)H and flavoproteins on reperfusion (detected using autofluorescence) was rapid (t(0.5) < 15 s) and significantly slower following ischemic preconditioning (IP). This argues against superoxide production from reduced Complex 1 being a critical mediator of initial mPTP opening during early reperfusion. Furthermore, MitoPY1 (a mitochondria-targeted H2O2-sensitive fluorescent probe) and aconitase activity measurements failed to detect matrix ROS increases during early reperfusion. However, two different fluorescent cytosolic ROS probes did detect ROS increases after 2-3 min of reperfusion, which was shown to be after initiation of mPTP opening. Cyclosporin A (CsA) and IP attenuated these responses and reduced infarct size. [Ca2+](i) (monitored with Indo-1) increased progressively during ischemia, but dropped rapidly within 90 s of reperfusion when total mitochondrial [Ca2+] was shown to be increased. These early changes in [Ca2+] were not attenuated by IP, but substantial [Ca2+] increases were observed after 2-3 min reperfusion and these were prevented by both IP and CsA. Our data suggest that the major increases in ROS and [Ca2+] detected later in reperfusion are secondary to mPTP opening. If earlier IP-sensitive changes occur that might trigger initial mPTP opening they are below our limit of detection. Rather, we suggest that IP may inhibit initial mPTP opening by alternative mechanisms such as prevention of hexokinase 2 dissociation from mitochondria during ischemia.	[Andrienko, Tatyana; Pasdois, Philippe; Rossbach, Andreas; Halestrap, Andrew P.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol, Avon, England; [Andrienko, Tatyana; Pasdois, Philippe; Rossbach, Andreas; Halestrap, Andrew P.] Univ Bristol, Bristol Cardiovasc, Biomed Sci Bldg, Bristol, Avon, England; [Pasdois, Philippe] Univ Bordeaux, INSERM, U1045, Inst Rythmol & Modelisat Cardiaque LIRYC, Bordeaux, France	University of Bristol; University of Bristol; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Halestrap, AP (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol, Avon, England.; Halestrap, AP (corresponding author), Univ Bristol, Bristol Cardiovasc, Biomed Sci Bldg, Bristol, Avon, England.	a.halestrap@bristol.ac.uk	Pasdois, Philippe/AAH-9365-2020	Pasdois, Philippe/0000-0002-2385-4469; Rossbach, Andreas/0000-0002-6041-7348	Medical Research Council [G0801237]; British Heart Foundation [RG/08/001/24717, PG/12/40/29634]; MRC [G0801237] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (www.mrc.ac.uk/) grant number G0801237 to APH and PP and the British Heart Foundation (www.bhf.org.uk) grant numbers RG/08/001/24717 (to APH) and PG/12/40/29634 (to APH, PP and TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Arai AE, 1999, AM J PHYSIOL-HEART C, V277, pH683, DOI 10.1152/ajpheart.1999.277.2.H683; Assaly R, 2012, EUR J PHARMACOL, V675, P6, DOI 10.1016/j.ejphar.2011.11.036; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clarke SJ, 2008, CIRC RES, V102, P1082, DOI 10.1161/CIRCRESAHA.107.167072; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Cross HR, 1996, CIRC RES, V78, P482, DOI 10.1161/01.RES.78.3.482; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Fancelli D, 2014, J MED CHEM, V57, P5333, DOI 10.1021/jm500547c; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Griffiths EJ, 1997, AM J PHYSIOL-CELL PH, V273, pC37, DOI 10.1152/ajpcell.1997.273.1.C37; Halestrap AP, 2015, BRIT J PHARMACOL, V172, P2085, DOI 10.1111/bph.12899; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; HALESTRAP AP, 1982, BIOCHEM J, V204, P37, DOI 10.1042/bj2040037; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Hansson MJ, 2015, EUR J PHARMACOL, V760, P7, DOI 10.1016/j.ejphar.2015.04.009; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Karch J, 2014, P NATL ACAD SCI USA, V111, P10396, DOI 10.1073/pnas.1410104111; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Liimatta E, 2007, J BIOCHEM BIOPH METH, V70, P547, DOI 10.1016/j.jbbm.2007.01.006; Lu LS, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186321; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Murphy E, 2013, CIRC RES, V113, P852, DOI 10.1161/CIRCRESAHA.113.301950; Napankangas JP, 2012, J MOL CELL CARDIOL, V53, P906, DOI 10.1016/j.yjmcc.2012.09.011; Nederlof R, 2014, BRIT J PHARMACOL, V171, P2067, DOI 10.1111/bph.12363; Ong SB, 2015, BRIT J PHARMACOL, V172, P2074, DOI 10.1111/bph.13013; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; OWEN MR, 1993, BIOCHIM BIOPHYS ACTA, V1142, P11, DOI 10.1016/0005-2728(93)90079-U; Pagliaro P, 2015, BRIT J PHARMACOL, V172, P1974, DOI 10.1111/bph.12975; Pasdois P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005645; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pell VR, 2016, CARDIOVASC RES, V111, P134, DOI 10.1093/cvr/cvw100; SILVERMAN HS, 1994, CARDIOVASC RES, V28, P581, DOI 10.1093/cvr/28.5.581; STONE D, 1989, J MOL CELL CARDIOL, V21, P963, DOI 10.1016/0022-2828(89)90795-5; Varadarajan SG, 2001, AM J PHYSIOL-HEART C, V280, pH280, DOI 10.1152/ajpheart.2001.280.1.H280; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Vinten-Johansen J, 2005, CIRCULATION, V112, P2085, DOI 10.1161/CIRCULATIONAHA.105.569798; Ylitalo KV, 2000, J MOL CELL CARDIOL, V32, P1223, DOI 10.1006/jmcc.2000.1157; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	56	40	40	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167300	10.1371/journal.pone.0167300	http://dx.doi.org/10.1371/journal.pone.0167300			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907091	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700113
J	Haridy, Y; Macdougall, MJ; Scott, D; Reisz, RR				Haridy, Yara; Macdougall, Mark J.; Scott, Diane; Reisz, Robert R.			Ontogenetic Change in the Temporal Region of the Early Permian Parareptile Delorhynchus cifellii and the Implications for Closure of the Temporal Fenestra in Amniotes	PLOS ONE			English	Article							COLOBOMYCTER-PHOLETER; BONE ORNAMENTATION; SP-NOV; GROWTH; DIFFERENTIATION; OSTEOLOGY; OKLAHOMA; ANATOMY; REPTILE; SUTURES	A juvenile specimen of Delorhynchus cifellii, collected from the Early Permian fissure-fill deposits of Richards Spur, Oklahoma, permits the first detailed study of cranial ontogeny in this parareptile. The specimen, consisting of a partially articulated skull and mandible, exhibits several features that identify it as juvenile. The dermal tuberosities that ornament the dorsal side and lateral edges of the largest skull of D. cifellii specimens, are less prominent in the intermediate sized holotype, and are absent in the new specimen. This indicates that the new specimen represents an earlier ontogenetic stage than all previously described members of this species. In addition, the incomplete interdigitation of the sutures, most notably along the fronto-nasal contact, plus the proportionally larger sizes of the orbit and temporal fenestrae further support an early ontogenetic stage for this specimen. Comparisons between this juvenile and previously described specimens reveal that the size and shape of the temporal fenestra in Delorhynchus appear to vary through ontogeny, due to changes in the shape and size of the bordering cranial elements. The jugal of the juvenile specimen is tri-radiate and similar in outline with those found in other amniotes with temporal fenestrae. The available growth series of D. cifellii shows that the jugal gradually becomes a more robust, tetra-radiate element, as the proportionate size of the temporal fenestra is reduced. Ontogenetic changes of other elements that form the border of the fenestra also contribute to its reduction. This growth series provides valuable new information regarding the ontogenetic trajectory of the temporal fenestra in a Palaeozoic reptile, which may be applicable to the evolutionary event of loss of temporal fenestration in other amniotes.	[Haridy, Yara; Macdougall, Mark J.; Scott, Diane; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON, Canada	University of Toronto; University Toronto Mississauga	Haridy, Y (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON, Canada.	yara.hardy@mail.utoronta.ca	haridy, yara/AAT-3129-2021	haridy, yara/0000-0002-6908-5749	University of Toronto Mississauga; Natural Science and Engineering council of Canada; NSERC	University of Toronto Mississauga(University of Toronto); Natural Science and Engineering council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	R.R. - support by grants from the University of Toronto Mississauga, and a Discovery grant Natural Science and Engineering council of Canada.; We thank R. Cifelli and W. May of the Sam Noble Museum of Natural History for the loan of specimens. R.R.R is supported by grants from the University of Toronto Mississauga and NSERC Discovery Grant Program.	Bailleul AM, 2016, CR PALEVOL, V15, P49, DOI 10.1016/j.crpv.2014.12.004; Bailleul AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036112; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Cisneros JC, 2004, P ROY SOC B-BIOL SCI, V271, P1541, DOI 10.1098/rspb.2004.2748; Currie PJ, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1048348; de Buffrenil V, 2015, J MORPHOL, V276, P425, DOI 10.1002/jmor.20351; de Buffrenil V, 2016, J MORPHOL, V277, P634, DOI 10.1002/jmor.20525; Debraga M, 1996, J VERTEBR PALEONTOL, V16, P384, DOI 10.1080/02724634.1996.10011328; FOX RICHARD C., 1962, UNIV KANSAS PUBL MUS NAT HIST, V12, P297; GOW CE, 1972, J ZOOL, V167, P219; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; MacDougall MJ, 2014, ZOOL J LINN SOC-LOND, V172, P616, DOI 10.1111/zoj12180; MacDougall MJ, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1179641; Macdougall MJ, 2012, J VERTEBR PALEONTOL, V32, P1018, DOI 10.1080/02724634.2012.679757; MacDougall MJ, ZOOL J LINN IN PRESS; Modesto SP, 2008, J VERTEBR PALEONTOL, V28, P677, DOI 10.1671/0272-4634(2008)28[677:NMOCPA]2.0.CO;2; Modesto SP, 1999, J VERTEBR PALEONTOL, V19, P466, DOI 10.1080/02724634.1999.10011159; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Reisz R.R., 1984, Journal of Vertebrate Paleontology, V4, P57; Reisz RR, 2007, ZOOL J LINN SOC-LOND, V151, P191, DOI 10.1111/j.1096-3642.2007.00312.x; Reisz RR, 2002, J VERTEBR PALEONTOL, V22, P244, DOI 10.1671/0272-4634(2002)022[0244:OKSNAS]2.0.CO;2; RIEPPEL O, 1990, BIOL J LINN SOC, V39, P177, DOI 10.1111/j.1095-8312.1990.tb00510.x; Tsuji LA, 2006, J VERTEBR PALEONTOL, V26, P849, DOI 10.1671/0272-4634(2006)26[849:CAAPAO]2.0.CO;2; Tsuji LA, 2013, EARTH ENV SCI T R SO, V104, P81, DOI 10.1017/S1755691013000492; Tsuji LA, 2010, J SYST PALAEONTOL, V8, P245, DOI 10.1080/14772010903461099	26	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166819	10.1371/journal.pone.0166819	http://dx.doi.org/10.1371/journal.pone.0166819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907071	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700044
J	Hu, FW; Zhai, N; Gao, W; Wu, P; Luo, YY; Pan, DF; Liu, Y; Li, DY				Hu, Fengwang; Zhai, Nana; Gao, Wen; Wu, Pei; Luo, Yuanyuan; Pan, Defeng; Liu, Yang; Li, Dongye			Outer Balloon Ligation Increases Success Rate of Ischemia-Reperfusion Injury Model in Mice	PLOS ONE			English	Article							CORONARY COLLATERAL GROWTH; MYOCARDIAL-INFARCTION; INFLAMMATORY RESPONSE; ARTERY LIGATION; ANIMAL-MODELS; CLOSED-CHEST; MOUSE	Background Coronary artery disease is a growing public health problem and a major cause of morbidity and mortality. Experimental animal models provide valuable tools for studying myocardial ischemia reperfusion (I/R) injury in vivo. Objective The purpose of this study was to describe a new method (outer balloon ligation) to induce myocardial I/R injury in mice. Methods Ninety-nine male C57BL/6J mice were randomly divided into three groups: sham group, classic method group (I/R-C) and the new method group (I/R-N). The surgical procedure and recovery time were recorded. The levels of TNF-alpha, IL-6, cTnT and LDH were detected by ELISA kits. Hematoxylin-eosin staining was applied to assess neutrophil infiltration. Moreover, surgical survival, myocardial infarction areas, and cardiac function measurements were also recorded. Results The reperfusion operation time in the I/R-N group were markedly less than the I/R-C group (14.73 +/- 2.86 vs. 168.60 +/- 33.01 sec, p<0.0001). Similarly, the recovery time in I/R-N group was shorter than the I/R-C group (45.39 +/- 15.39 vs. 101.70 +/- 19.33 min, p<0.0001). The levels of TNF-a and IL-6 in I/R-N group were also markedly lower than in I/R-C group (136.5 +/- 22.21 vs. 170.5 +/- 24.79 pg/ml, p<0.05 and 100.3 +/- 23.74 vs. 144.40 +/- 22.24 pg/ml, p<0.001). Compared I/R-N group with I/R-C group, the levels of neutrophil infiltration, cTnT and LDH had no significant differences. Surgical survival rate was 96.7% in the I/R-N group, which was significantly improved compared to the rate of 80% in the I/R-C group. However, there were no significant differences in the areas of myocardial infarction and cardiac function between the two groups. Conclusions Compared with the classic method, our new method of inducing myocardial I/R injury has higher efficiency and less tissue damage in mice, but achieves the same modeling effects.	[Hu, Fengwang; Gao, Wen; Wu, Pei; Liu, Yang; Li, Dongye] Xuzhou Med Univ, Inst Cardiovasc Dis, Xuzhou, Jiangsu, Peoples R China; [Zhai, Nana; Luo, Yuanyuan; Pan, Defeng] Xuzhou Med Univ, Affiliated Hosp, Dept Cardiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Univ, Inst Cardiovasc Dis, Xuzhou, Jiangsu, Peoples R China.	ldy@xzmc.edu.cn	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020		National Natural Science Foundation of China [81570326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (81570326). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2010, J SURG RES, V162, P239, DOI 10.1016/j.jss.2009.06.021; Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Bian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144877; Borst O, 2011, CELL PHYSIOL BIOCHEM, V28, P1, DOI 10.1159/000331708; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eckle T, 2011, JOVE-J VIS EXP, DOI 10.3791/2526; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gehrmann J, 2001, BASIC RES CARDIOL, V96, P237, DOI 10.1007/s003950170054; H-Ici DO, 2016, RADIOLOGY, V278, P742, DOI 10.1148/radiol.2015151332; H-Ici DO, 2015, INT J CARDIOVAS IMAG, V31, P115, DOI 10.1007/s10554-014-0539-0; Hale SL, 1998, CARDIOVASC RES, V40, P502, DOI 10.1016/S0008-6363(98)00191-6; Hashmi S, 2015, INT J CLIN EXP PATHO, V8, P8786; Hattan N, 2007, BASIC RES CARDIOL, V102, P217, DOI 10.1007/s00395-007-0646-3; Jong WMC, 2014, INT J CARDIOL, V177, P41, DOI 10.1016/j.ijcard.2014.09.148; Jong WMC, 2003, COMPARATIVE MED, V53, P522; Kaiser RA, 2005, AM J PHYSIOL-HEART C, V289, pH2747, DOI 10.1152/ajpheart.01280.2004; Krombach GA, 2005, INVEST RADIOL, V40, P14; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Liao XL, 2013, J CARDIOVASC PHARM, V61, P430, DOI 10.1097/FJC.0b013e318288a68d; Lips DJ, 2004, BASIC RES CARDIOL, V99, P351, DOI 10.1007/s00395-004-0476-5; Lukacs E, 2012, ACTA PHYSIOL HUNG, V99, P365, DOI 10.1556/APhysiol.99.2012.4.1; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; NEELY JR, 1967, AM J PHYSIOL, V212, P804; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; Patten RD, 1998, AM J PHYSIOL, V274, P1812; Pung YF, 2012, ARTERIOSCL THROM VAS, V32, P325, DOI 10.1161/ATVBAHA.111.241802; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schultz JE, 2001, PHARMACOL THERAPEUT, V89, P123, DOI 10.1016/S0163-7258(00)00106-6; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; van Hout GPJ, 2015, J CELL MOL MED, V19, P2655, DOI 10.1111/jcmm.12656; Verdouw PD, 1998, CARDIOVASC RES, V39, P121, DOI 10.1016/S0008-6363(98)00069-8; Virag JAI, 2011, JOVE-J VIS EXP, DOI 10.3791/2581; Xu ZB, 2014, JOVE-J VIS EXP, DOI 10.3791/51329	37	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167631	10.1371/journal.pone.0167631	http://dx.doi.org/10.1371/journal.pone.0167631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907155	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700216
J	Janssens, GE; Veenhoff, LM				Janssens, Georges E.; Veenhoff, Liesbeth M.			The Natural Variation in Lifespans of Single Yeast Cells Is Related to Variation in Cell Size, Ribosomal Protein, and Division Time	PLOS ONE			English	Article							TOR; HYPERTROPHY; TRANSLATION; LONGEVITY; EXTENSION; GENETICS; KINASE; AGE	There is a large variability in lifespans of individuals even if they are genetically identical and raised under the same environmental conditions. Our recent system wide study of replicative aging in baker's yeast predicts that protein biogenesis is a driver of aging. Here, we address how the natural variation in replicative lifespan within wild-type populations of yeast cells correlates to three biogenesis-related parameters, namely cell size, ribosomal protein Rpl13A-GFP levels, and division times. Imaging wild type yeast cells in microfluidic devices we observe that in all cells and at all ages, the division times as well as the increase in cell size that single yeast undergo while aging negatively correlate to their lifespan. In the longer-lived cells Rpl13A-GFP levels also negatively correlate to lifespan. Interestingly however, at young ages in the population, ribosome concentration was lowest in the cells that increased the most in size and had shorter lifespans. The correlations between these molecular and cellular properties related to biogenesis and lifespan explain a small portion of the variation in lifespans of individual cells, consistent with the highly individual and multifactorial nature of aging.	[Janssens, Georges E.; Veenhoff, Liesbeth M.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands	University of Groningen	Veenhoff, LM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands.	lm.veenhoff@rug.nl		Veenhoff, Liesbeth/0000-0002-0158-4728; Janssens, Georges/0000-0003-2104-8145	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Netherlands Organization for Scientific Research (NWO), grant ID: Systems biology, SBC-EMA.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARTON AA, 1950, J GEN MICROBIOL, V4, P84, DOI 10.1099/00221287-4-1-84; Core Development Team R, 2014, R LANG ENV STAT COMP; Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660; Delaney JR, 2013, FEMS YEAST RES, V13, P267, DOI 10.1111/1567-1364.12030; Delaney JR, 2011, CELL CYCLE, V10, P156, DOI 10.4161/cc.10.1.14457; EGILMEZ NK, 1990, J GERONTOL, V45, pB9, DOI 10.1093/geronj/45.1.B9; Fehrmann S, 2013, CELL REP, V5, P1589, DOI 10.1016/j.celrep.2013.11.013; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Ganley ARD, 2012, FEMS YEAST RES, V12, P267, DOI 10.1111/j.1567-1364.2012.00796.x; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; He C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004860; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Huberts DHEW, 2014, P NATL ACAD SCI USA, V111, P11727, DOI 10.1073/pnas.1410024111; Huberts DHEW, 2013, JOVE-J VIS EXP, DOI 10.3791/50143; Huberts DHEW, 2013, NAT PROTOC, V8, P1019, DOI 10.1038/nprot.2013.060; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janssens GE, 2015, ELIFE, V4, DOI 10.7554/eLife.08527; Jo MC, 2015, P NATL ACAD SCI USA; Jo MC, 2015, P NATL ACAD SCI; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2012, FEMS YEAST RES, V12, P269, DOI 10.1111/j.1567-1364.2012.00798.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Lippuner AD, 2014, FEMS MICROBIOL REV, V38, P300, DOI 10.1111/1574-6976.12060; Maniere X, 2014, EXP GERONTOL, V60, P12, DOI 10.1016/j.exger.2014.09.005; Moretto F, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.60; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Therneau T, 2012, PACKAGE SURVIVAL ANA; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Warnes GR, 2012, J PHYCOL, DOI [10.1111/j.0022-3646.1997.00569.x, DOI 10.1111/J.0022-3646.1997.00569.X]; Xie ZW, 2015, CELL, V160, P928, DOI 10.1016/j.cell.2015.02.002; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Yang JY, 2011, CELL CYCLE, V10, P144, DOI 10.4161/cc.10.1.14455; Zadrag R, 2006, ACTA BIOCHIM POL, V53, P747, DOI 10.18388/abp.2006_3302; Zadrag-Tecza R, 2012, FEMS YEAST RES, P97; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	49	28	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167394	10.1371/journal.pone.0167394	http://dx.doi.org/10.1371/journal.pone.0167394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907085	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700142
J	Luo, XM; Liang, XJ; Li, JN; Shi, J; Zhang, WL; Chai, W; Wu, JP; Guo, SA; Fang, G; Zhou, XL; Zhang, JH; Xu, KC; Zeng, JY; Niu, LZ				Luo, Xiaomei; Liang, Xianjun; Li, Jiannan; Shi, Jian; Zhang, Wenlong; Chai, Wei; Wu, Jiuping; Guo, Shuai; Fang, Gang; Zhou, Xulong; Zhang, Jianhua; Xu, Kecheng; Zeng, Jianying; Niu, Lizhi			The Effects of Irreversible Electroporation on the Colon in a Porcine Model	PLOS ONE			English	Article							TISSUE ABLATION; CHEMOTHERAPY	Background and Aim Irreversible electroporation (IRE) is a method of targeted cell ablation which has been suggested as a potential cancer therapy as it leaves structures such as blood vessels and the extracellular matrix intact, thereby allowing the rapid recovery of healthy tissue. Here, we investigated the effects of IRE on the colon in vivo in a porcine model. Methods IRE ablation was performed on the colon walls of 12 female Tibet mini-pigs, creating a total of 24 lesions. Lesions were monitored periodically by endoscopy. The pigs were euthanized 7, 14, 21 or 28 days after IRE ablation and the colons harvested for gross and histological analysis. Sections were stained with hematoxylin and eosin (H&E), Masson's trichrome (MT) stain and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Results All pigs tolerated the ablation procedure without serious clinical symptoms or complications. There was no evidence of perforation by endoscopy or gross postmortem examination. All lesions were characterized by necrotic cell death with mild inflammation and hyperemia, with a sharp demarcation between ablated and adjacent normal tissue. A fibrous scar was observed in the ablated colon tissue. Histological analysis revealed damage to each layer of the colon. Histopathology findings also showed the preservation of extracellular structures and the recovery of the ablated colon. Conclusions The complete ablation of the target area, its rapid recovery and the lack of posttreatment symptoms suggest that IRE ablation may be a promising therapy for tumors located adjacent to or violating the colon wall.	[Luo, Xiaomei] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Liang, Xianjun] Taizhou Cent Hosp Zhejiang Prov, Dept Gastrointestinal Surg, Taizhou, Peoples R China; [Li, Jiannan; Shi, Jian] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun, Peoples R China; [Zhang, Wenlong] Jilin Univ, Dept Hematol & Oncol, China Japan Union Hosp, Changchun, Peoples R China; [Chai, Wei] Jilin Univ, Hosp 1, Dept Gynecol & Obstet, Changchun, Peoples R China; [Wu, Jiuping] Jilin Univ, Hosp 2, Orthopaed Hosp, Dept Spinal Surg, Changchun, Peoples R China; [Guo, Shuai] Taizhou Cent Hosp Zhejiang Prov, Dept Endocrinol, Taizhou, Peoples R China; [Fang, Gang; Xu, Kecheng; Niu, Lizhi] Jinan Univ, Sch Med, Dept Surg & Anesthesia, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zhou, Xulong] Jinan Univ, Sch Med, Dept Pathol, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zhang, Jianhua] Jinan Univ, Sch Med, Dept Endoscopy, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zeng, Jianying] Jinan Univ, Sch Med, Guangzhou Fuda Canc Inst, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China	Jinan University; Jilin University; Jilin University; Jilin University; Jilin University; Jinan University; Jinan University; Jinan University; Jinan University	Niu, LZ (corresponding author), Jinan Univ, Sch Med, Dept Surg & Anesthesia, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China.	lxm-vi-p@163.com	li, jn/ABH-3120-2021	Li, Jiannan/0000-0001-9744-7666	International Scientific Fund of Fuda Cancer Hospital, Guangzhou, China [Y2015-ZD-001]	International Scientific Fund of Fuda Cancer Hospital, Guangzhou, China	This work was supported by a grant from the International Scientific Fund of Fuda Cancer Hospital, Guangzhou (Y2015-ZD-001), China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JW, 2014, CARDIOVASC INTER RAD, V37, P224, DOI 10.1007/s00270-013-0731-y; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Han XD, 2011, BIOMED PHARMACOTHER, V65, P547, DOI 10.1016/j.biopha.2011.03.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Phillips MA, 2012, BRIT J CANCER, V106, P490, DOI 10.1038/bjc.2011.582; Phillips M, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001882; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Schoellnast H, 2013, CARDIOVASC INTER RAD, V36, P213, DOI 10.1007/s00270-012-0393-1; Srimathveeravalli G, 2013, J VASC INTERV RADIOL, V24, P1249, DOI 10.1016/j.jvir.2013.04.025; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Van Cutsem E, 2016, CLIN COLORECTAL CANC, V15, P91, DOI 10.1016/j.clcc.2015.09.005	18	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167275	10.1371/journal.pone.0167275	http://dx.doi.org/10.1371/journal.pone.0167275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907057	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700107
J	Mutenda, N; Bukowski, A; Nitschke, AM; Nakanyala, T; Hamunime, N; Mekonen, T; Tjituka, F; Mazibuko, G; Mwinga, S; Mabirizi, D; Sagwa, E; Indongo, R; Dean, N; Jordan, MR; Hong, SY				Mutenda, Nicholus; Bukowski, Alexandra; Nitschke, Anne-Marie; Nakanyala, Tuli; Hamunime, Ndapewa; Mekonen, Tadesse; Tjituka, Francina; Mazibuko, Greatjoy; Mwinga, Samson; Mabirizi, David; Sagwa, Evans; Indongo, Rosalia; Dean, Natalie; Jordan, Michael R.; Hong, Steven Y.			Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia	PLOS ONE			English	Article							VIROLOGICAL OUTCOMES; ADHERENCE; PROTEASE; PREDICTORS; MORTALITY	Background The World Health Organization (WHO) early warning indicators (EWIs) of HIV drug resistance (HIVDR) assess factors at individual ART sites that are known to create situations favourable to the emergence of HIVDR. Methods In 2014, the Namibia HIV care and treatment program abstracted the following adult and pediatric EWIs from all public ART sites (50 main sites and 143 outreach sites): On-time pill pick-up, Retention in care, Pharmacy stock-outs, Dispensing practices, and Viral load suppression. Comparisons were made between main and outreach sites and between 2014 and 2012 using the Wilcoxon signed-rank test in a matched analysis. Results The national estimates were: On-time pill pick-up 81.9% (95% CI 81.1-82.8) for adults and 82.4% (81.3-83.4) for pediatrics, Retention in care 79% retained on ART after 12 months for adults and 82% for pediatrics, Pharmacy stock-outs 94% of months without a stock-out for adults and 88% for pediatrics, and Dispensing practices 0.01% (0.001-0.056) dispensed mono-or dual-therapy for adults and 0.01% (0.001-0.069) for pediatrics. Viral load suppression was significantly affected by low rates of Viral load completion. Main sites had higher On-time pill pick-up than outreach sites for adults (p<0.001) and pediatrics (p<0.001), and no difference between main and outreach sites for Retention in care for adults (p = 0.761) or pediatrics (p = 0.214). From 2012 to 2014 in adult sites, On-time pill pick-up (p = 0.001), Retention in care (p<0.001), and Pharmacy stock-outs (p = 0.002) worsened. In pediatric sites, On-time pill pick-up (p<0.001) and Pharmacy stock-outs (p = 0.012) worsened. Conclusions Results of EWIs monitoring in Namibia provide evidence about ART programmatic functioning and contextualize results from national surveys of HIVDR. These results are worrisome as they show a decline in program performance over time. The national ART program is taking steps to minimize the emergence of HIVDR by strengthening adherence and retention of patients on ART, reducing stock-outs, and strengthening ART data quality.	[Mutenda, Nicholus; Nitschke, Anne-Marie; Nakanyala, Tuli; Hamunime, Ndapewa; Mekonen, Tadesse; Tjituka, Francina] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Bukowski, Alexandra; Jordan, Michael R.; Hong, Steven Y.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Mazibuko, Greatjoy; Mwinga, Samson; Mabirizi, David; Sagwa, Evans] Management Sci Hlth, SIAPS, Windhoek, Namibia; [Indongo, Rosalia] US Agcy Int Dev, Windhoek, Namibia; [Dean, Natalie] Univ Florida, Dept Biostat, Gainesville, FL USA; [Jordan, Michael R.; Hong, Steven Y.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University; United States Agency for International Development (USAID); State University System of Florida; University of Florida; Tufts Medical Center	Hong, SY (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.; Hong, SY (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA.	shong@tuftsmedicalcenter.org		Bukowski, Alexandra/0000-0001-7634-7340				[Anonymous], 2013, MINISTRY HLTH CHILD; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Central Intelligence Agency, WORLD FACTBOOK; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Fokam J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129210, 10.137]; Fokam J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-308; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2015, JAIDS-J ACQ IMM DEF, V68, P463, DOI 10.1097/QAI.0000000000000509; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jonas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100539; Jonas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065653; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Reidy William J, 2014, J Acquir Immune Defic Syndr, V67, pe34, DOI 10.1097/QAI.0000000000000264; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes Surveil-lance Report of the, 2014, REPUBLIC NAMIBIA MIN; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; UNAIDS, 2021, YOUNG PEOPL HIV; UNAIDS, 2014, AMB TREATM TARG WRIT; UNAIDS, FACT SHEET 2016; USAID, 2015, NAM PROGR PROF STREN; WHO, 2015, HIV DRUG RES SURV GU; WHO, 2016, GLOB REP EARL WARN I; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2011, EARL ADV IND PAN M 1	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166649	10.1371/journal.pone.0166649	http://dx.doi.org/10.1371/journal.pone.0166649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906995	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700031
J	Starha, P; Vanco, J; Travnicek, Z; Hosek, J; Klusakova, J; Dvorak, Z				Starha, Pavel; Vanco, Jan; Travnicek, Zdenek; Hosek, Jan; Klusakova, Jarmila; Dvorak, Zdenek			Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes	PLOS ONE			English	Article							IN-VITRO; PT(II) COMPLEXES; CISPLATIN; DNA; CIS; CYTOTOXICITY; FLUORESCENCE; DERIVATIVES; BINDING; REACTIVITY	A series of platinum(II) diiodido complexes containing 7-azaindole derivatives, having the general formula cis-[ PtI2(naza)(2)] (1-8), has been prepared and thoroughly characterized, including X-ray structure analysis of cis-[ PtI2(2Me4Claza)(2)].DMF (8.DMF; 2Me4Claza = 2-methyl-4-chloro-7-azaindole). Complexes showed high in vitro cytotoxicity against nine human cancer cell lines (IC50 ranging from 0.4 to 12.8 mu M), including the cisplatin-resistant ovarian cancer cell line (A2780R; IC50 = 1.0-3.5 mu M). The results of in vivo testing, using the L1210 lymphocytic leukaemia model, at the equimolar doses of Pt with cisplatin (2 mg/kg) confirmed the activity of complex 8 comparable to cisplatin. From the mechanistic point of view, evaluated ex vivo by Western blot analyses on the samples of isolated tumour tissues, the treatment of the animals with complex 8, contrary to cisplatin, decreased the levels of tumour suppressor p53 and increased significantly the amount of intracellular anti-apoptotic protein MCL-1(L) (37 kDa). Additionally, the active form of caspase 3 was significantly elevated in the sample of tumour tissues treated with complex 8, indicating that the activation of p53-independent cell-death pathway was initiated. The light and electron microscopy observations of the cancerous tissues revealed necrosis as a dominant mechanism of cell death, followed by scarce signs of apoptosis. The additional results (e.g. in vitro interaction experiments with selected biomolecules, cell cycle perturbations, gel electrophoretic studies on pUC19 plasmid DNA) supported the hypothesis that the complexes might be involved in the mechanism of action quite different from cisplatin.	[Starha, Pavel; Vanco, Jan; Travnicek, Zdenek; Hosek, Jan] Palacky Univ Olomouc, Dept Inorgan Chem, Fac Sci, Olomouc, Czech Republic; [Starha, Pavel; Vanco, Jan; Travnicek, Zdenek; Hosek, Jan] Palacky Univ Olomouc, Reg Ctr Adv Technol & Mat, Fac Sci, Olomouc, Czech Republic; [Klusakova, Jarmila] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic; [Dvorak, Zdenek] Palacky Univ Olomouc, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ Olomouc, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Veterinary Sciences Brno; Palacky University Olomouc; Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ Olomouc, Dept Inorgan Chem, Fac Sci, Olomouc, Czech Republic.; Travnicek, Z (corresponding author), Palacky Univ Olomouc, Reg Ctr Adv Technol & Mat, Fac Sci, Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009; Starha, Pavel/H-3902-2016	Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Ministry of Education, Youth and Sports (MEYS, MSMT in Czech) [L01305]	Ministry of Education, Youth and Sports (MEYS, MSMT in Czech)	This study was funded by the Ministry of Education, Youth and Sports (MEYS, MSMT in Czech), L01305, http://www.msmt.cz/index.php?lang=2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL SK, 1980, CANCER CHEMOTH PHARM, V4, P249; Arandjelovic S, 2002, J EXP CLIN CANC RES, V21, P519; Bartel C, 2012, J BIOL INORG CHEM, V17, P465, DOI 10.1007/s00775-011-0869-5; Berners-Price SJ, 2011, ANGEW CHEM INT EDIT, V50, P804, DOI 10.1002/anie.201004552; Brandenburg K., 2015, DIAMOND VERSION 4 0; BUTOUR JL, 1977, EUR J BIOCHEM, V78, P455, DOI 10.1111/j.1432-1033.1977.tb11758.x; Chardon E, 2012, ORGANOMETALLICS, V31, P7618, DOI 10.1021/om300806g; Chtchigrovsky M, 2013, J MED CHEM, V56, P2074, DOI 10.1021/jm301780s; Cleare, 1973, BIOINORG CHEM, V2, P187, DOI DOI 10.1016/S0006-3061(00)80249-5; de Mier-Vinue J, 2008, J INORG BIOCHEM, V102, P973, DOI 10.1016/j.jinorgbio.2007.12.026; Dhara S. C., 1970, IND J CHEM, P193; Gulyaeva N, 2002, EUR J PHARM SCI, V17, P81, DOI 10.1016/S0928-0987(02)00146-X; Hissler M, 2000, INORG CHEM, V39, P447, DOI 10.1021/ic991250n; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Margiotta N, 2006, J INORG BIOCHEM, V100, P1849, DOI 10.1016/j.jinorgbio.2006.07.010; Margiotta N, 2014, CHEMMEDCHEM, V9, P1161, DOI 10.1002/cmdc.201402028; Marzo T, 2015, DALTON T, V44, P14896, DOI 10.1039/c5dt01196e; Messori L, 2013, INORG CHEM, V52, P13827, DOI 10.1021/ic402611m; Messori L, 2012, INORG CHEM, V51, P1717, DOI 10.1021/ic202036c; Messori L, 2010, ACS MED CHEM LETT, V1, P381, DOI 10.1021/ml100081e; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; New EJ, 2009, J INORG BIOCHEM, V103, P1120, DOI 10.1016/j.jinorgbio.2009.05.005; Onoa GB, 1998, NUCLEIC ACIDS RES, V26, P1473, DOI 10.1093/nar/26.6.1473; Ormerod MG, 1996, CANCER CHEMOTH PHARM, V37, P463, DOI 10.1007/s002800050413; Ossipov K, 2014, J INORG BIOCHEM, V137, P40, DOI 10.1016/j.jinorgbio.2014.04.008; Oxford Diffraction, CRYSALIS RED CRYSALI; PASTERNACK RF, 1991, J AM CHEM SOC, V113, P6835, DOI 10.1021/ja00018a019; Ploner C, 2009, ONCOGENE, V27, P84; Pracharova J, 2015, J MED CHEM, V58, P847, DOI 10.1021/jm501420k; Roy S, 2009, DALTON T, P10846, DOI 10.1039/b911542k; Sakai K, 2007, ACTA CRYSTALLOGR E, V63, pM97, DOI 10.1107/S1600536806051610; Savic A, 2014, EUR J MED CHEM, V82, P372, DOI 10.1016/j.ejmech.2014.05.060; Sbovata SM, 2007, J MED CHEM, V50, P4775, DOI 10.1021/jm070426p; Sharp SY, 2002, EUR J CANCER, V38, P2309, DOI 10.1016/S0959-8049(02)00244-7; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Skander M, 2010, J MED CHEM, V53, P2146, DOI 10.1021/jm901693m; Starha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136338; Starha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123595; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; Suntharalingam K, 2014, METALLOMICS, V6, P437, DOI 10.1039/c3mt00364g; Tessier C, 1999, INORG CHIM ACTA, V295, P25, DOI 10.1016/S0020-1693(99)00303-5; Tetko IV, 2016, J INORG BIOCHEM, V156, P1, DOI 10.1016/j.jinorgbio.2015.12.006; Vardevanyan PO, 2003, EXP MOL MED, V35, P527, DOI 10.1038/emm.2003.68; Wang K, 2002, SPECTROCHIM ACTA A, V58, P2595, DOI 10.1016/S1386-1425(02)00004-5; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wu SN, 2014, J INORG BIOCHEM, V139, P77, DOI 10.1016/j.jinorgbio.2014.06.006	53	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165065	10.1371/journal.pone.0165062	http://dx.doi.org/10.1371/journal.pone.0165062			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906967	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700007
J	Vergni, D; Santoni, D				Vergni, Davide; Santoni, Daniele			Nullomers and High Order Nullomers in Genomic Sequences	PLOS ONE			English	Article							MINIMAL ABSENT WORDS; DNA	A nullomer is an oligomer that does not occur as a subsequence in a given DNA sequence, i.e. it is an absent word of that sequence. The importance of nullomers in several applications, from drug discovery to forensic practice, is now debated in the literature. Here, we investigated the nature of nullomers, whether their absence in genomes has just a statistical explanation or it is a peculiar feature of genomic sequences. We introduced an extension of the notion of nullomer, namely high order nullomers, which are nullomers whose mutated sequences are still nullomers. We studied different aspects of them: comparison with nullomers of random sequences, CpG distribution and mean helical rise. In agreement with previous results we found that the number of nullomers in the human genome is much larger than expected by chance. Nevertheless antithetical results were found when considering a random DNA sequence preserving dinucleotide frequencies. The analysis of CpG frequencies in nullomers and high order nullomers revealed, as expected, a high CpG content but it also highlighted a strong dependence of CpG frequencies on the dinucleotide position, suggesting that nullomers have their own peculiar structure and are not simply sequences whose CpG frequency is biased. Furthermore, phylogenetic trees were built on eleven species based on both the similarities between the dinucleotide frequencies and the number of nullomers two species share, showing that nullomers are fairly conserved among close species. Finally the study of mean helical rise of nullomers sequences revealed significantly high mean rise values, reinforcing the hypothesis that those sequences have some peculiar structural features. The obtained results show that nullomers are the consequence of the peculiar structure of DNA ( also including biased CpG frequency and CpGs islands), so that the hypermutability model, also taking into account CpG islands, seems to be not sufficient to explain nullomer phenomenon. Finally, high order nullomers could emphasize those features that already make simple nullomers useful in several applications.	[Vergni, Davide] CNR, Ist Applicaz Calcolo Mauro Picone, Via Taurini 19, I-00185 Rome, Italy; [Santoni, Daniele] CNR, Ist Analisi Sistemi Informat Antonio Ruberti, Via Taurini 19, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Santoni, D (corresponding author), CNR, Ist Analisi Sistemi Informat Antonio Ruberti, Via Taurini 19, I-00185 Rome, Italy.	daniele.santoni@iasi.cnr.it		SANTONI, DANIELE/0000-0003-1898-5285				Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; Alileche A, 2012, PEPTIDES, V38, P302, DOI 10.1016/j.peptides.2012.09.015; Chairungsee S, 2012, THEOR COMPUT SCI, V450, P109, DOI 10.1016/j.tcs.2012.04.031; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Goswami J, 2013, J FORENSIC LEG MED, V20, P513, DOI 10.1016/j.jflm.2013.02.003; GUIBAS LJ, 1981, J COMB THEORY A, V30, P183, DOI 10.1016/0097-3165(81)90005-4; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; JOSSE J, 1961, J BIOL CHEM, V236, P864; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Pedone F, 2012, DNA RES, P043; Pedone F, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-105; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Rahmann S, 2003, COMB PROBAB COMPUT, V12, P73, DOI 10.1017/S0963548302005473; Rahmann S, 2000, LECT NOTES COMPUT SC, V1848, P375; Silva RM, 2015, BIOINFORMATICS, V31, P2421, DOI 10.1093/bioinformatics/btv189; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e164540	10.1371/journal.pone.0164540	http://dx.doi.org/10.1371/journal.pone.0164540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906971	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700004
J	Young, I; Waddell, L				Young, Ian; Waddell, Lisa			Barriers and Facilitators to Safe Food Handling among Consumers: A Systematic Review and Thematic Synthesis of Qualitative Research Studies	PLOS ONE			English	Review							NUTRITION EDUCATION-PROGRAM; 30 SPECIFIED PATHOGENS; FOODBORNE ILLNESS; PLANNED BEHAVIOR; ENTERIC DISEASE; HEALTH-CARE; KNOWLEDGE; CANADA; HOME; PERCEPTIONS	Foodborne illness has a substantial health and economic burden on society, and most cases are believed to be due to unsafe food handling practices at home. Several qualitative research studies have been conducted to investigate consumers' perspectives, opinions, and experiences with safe food handling at home, and these studies provide insights into the underlying barriers and facilitators affecting their safe food handling behaviours. We conducted a systematic review of previously published qualitative studies in this area to synthesize the main across-study themes and to develop recommendations for future consumer interventions and research. The review was conducted using the following steps: comprehensive search strategy; relevance screening of abstracts; relevance confirmation of articles; study quality assessment; thematic synthesis of the results; and quality-of-evidence assessment. A total of 39 relevant articles reporting on 37 unique qualitative studies were identified. Twenty-one barriers and 10 facilitators to safe food handling were identified, grouped across six descriptive themes: confidence and perceived risk; knowledge-behaviour gap; habits and heuristics; practical and lifestyle constraints; food preferences; and societal and social influences. Our overall confidence that each barrier and facilitator represents the phenomenon of interest was rated as high (n = 1 1), moderate (11), and low (9). Overarching analytical themes included: 1) safe food handling behaviours occur as part of a complex interaction of everyday consumer practices and habituation; 2) most consumers are not concerned about food safety and are generally not motivated to change their behaviours based on new knowledge about food safety risks; and 3) consumers are amenable to changing their safe food handling habits through relevant social pressures. Key implications and recommendations for research, policy and practice are discussed.	[Young, Ian] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada; [Waddell, Lisa] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada	Toronto Metropolitan University; Public Health Agency of Canada	Young, I (corresponding author), Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada.	iyoung@ryerson.ca		waddell, lisa/0000-0003-4887-5124; Young, Ian/0000-0002-5575-5174				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Athearn PN, 2004, MATERN CHILD HLTH J, V8, P149, DOI 10.1023/B:MACI.0000037648.86387.1d; Boqvist S, 2015, INT J FOOD MICROBIOL, V215, P109, DOI 10.1016/j.ijfoodmicro.2015.08.023; Cates S. C., 2006, Food Protection Trends, V26, P774; Coleman HH, 2007, THESIS; Critical Appraisal Skills Programme, 2013, 10 QUEST HELP YOU MA; Dickinson Angela, 2014, Br J Community Nurs, V19, P228; Dixon-Woods M., 2006, QUAL RES, V6, P27, DOI [10.1177/1468794106058867, DOI 10.1177/1468794106058867]; Dollahite JS, 2014, J NUTR EDUC BEHAV, V46, P102, DOI 10.1016/j.jneb.2013.09.004; Dworkin M. S., 2015, Food Protection Trends, V35, P176; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; Evans EW, 2014, J FOOD PROTECT, V77, P510, DOI 10.4315/0362-028X.JFP-13-238; Fein SB, 2011, J FOOD PROTECT, V74, P1513, DOI 10.4315/0362-028X.JFP-11-017; Feng Y., 2015, THESIS; Fulham E, 2011, J FOOD PROTECT, V74, P925, DOI 10.4315/0362-028X.JFP-10-558; Gettings MA, 2001, J NUTR EDUC, V33, P148, DOI 10.1016/S1499-4046(06)60184-X; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Henley S. C., 2016, Food Protection Trends, V36, P43; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hoffman EW, 2005, J AM DIET ASSOC, V105, P1597, DOI 10.1016/j.jada.2005.07.035; House E, 2013, AUSTRALAS MED J, V6, P358, DOI 10.4066/AMJ.2013.1748; Keegan VA, 2009, CAN J INFECT DIS MED, V20, P79, DOI 10.1155/2009/978784; Kendall H, 2016, FOOD QUAL PREFER, V53, P105, DOI 10.1016/j.foodqual.2016.06.005; Koeppl P. T, 1998, FOCUS GROUPS BARRIER; Krueger R. A., 2015, FOCUS GROUPS PRACTIC; Lewin S, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001895; Lukacsovics A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1258; Lyon BG, 2000, J FOOD PROTECT, V63, P1389, DOI 10.4315/0362-028X-63.10.1389; Mari S, 2012, FOOD RES INT, V45, P1175, DOI 10.1016/j.foodres.2011.06.028; Mayer AB, 2012, J FOOD PROTECT, V75, P1453, DOI 10.4315/0362-028X.11-551; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Mazengia E., 2015, Food Protection Trends, V35, P8; McCurdy S. M., 2005, Food Protection Trends, V25, P826; McLinden T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-509; Meah A, 2014, CRIT PUBLIC HEALTH, V24, P88, DOI 10.1080/09581596.2013.791387; Medeiros L, 2001, J NUTR EDUC, V33, pS27, DOI 10.1016/S1499-4046(06)60067-5; Meysenburg R, 2014, APPETITE, V73, P121, DOI 10.1016/j.appet.2013.10.015; Milne R, 2011, CRIT PUBLIC HEALTH, V21, P485, DOI 10.1080/09581596.2011.616879; Mullan B, 2015, APPETITE, V90, P91, DOI 10.1016/j.appet.2015.02.033; Mullan BA, 2009, APPETITE, V52, P757, DOI 10.1016/j.appet.2009.01.007; Nesbitt A, 2014, FOOD CONTROL, V38, P157, DOI 10.1016/j.foodcont.2013.10.010; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Parra PA, 2014, FOOD CONTROL, V37, P115, DOI 10.1016/j.foodcont.2013.08.016; Patil SR, 2005, J FOOD PROTECT, V68, P1884, DOI 10.4315/0362-028X-68.9.1884; Porticella N., 2008, ANN M INT COMM ASS M; Quick V, 2013, BRIT FOOD J, V115, P686, DOI 10.1108/00070701311331481; Redmond EC, 2003, J FOOD PROTECT, V66, P130, DOI 10.4315/0362-028X-66.1.130; Redmond EC, 2002, THESIS; Research Triangle Institute, 2002, PR HACCP RUL EV REP; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shapiro MA, 2011, APPETITE, V56, P96, DOI 10.1016/j.appet.2010.11.148; Sivaramalingam B, 2015, FOODBORNE PATHOG DIS, V12, P561, DOI 10.1089/fpd.2014.1927; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Thomas MK, 2015, FOODBORNE PATHOG DIS, V12, P820, DOI 10.1089/fpd.2015.1966; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Townsend MS, 2006, J NUTR EDUC BEHAV, V38, P30, DOI 10.1016/j.jneb.2005.11.014; Trepka MJ, 2007, J FOOD PROTECT, V70, P1230, DOI 10.4315/0362-028X-70.5.1230; United States Department of Agriculture, 2016, EXP FOOD NUTR ED PRO; Vlasin-Marty KA, 2013, THESIS; Vrbova L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-970; Walsh D, 2006, MIDWIFERY, V22, P108, DOI 10.1016/j.midw.2005.05.004; Wang H, 2016, AM J PUBLIC HEALTH, V106, P1002, DOI 10.2105/AJPH.2016.303072; Warde A, 2014, J CONSUM CULT, V14, P279, DOI 10.1177/1469540514547828; Wills WJ, 2015, APPETITE, V85, P118, DOI 10.1016/j.appet.2014.11.022; Winter CK, 2009, J FOOD SCI EDUC, V8, P62, DOI 10.1111/j.1541-4329.2009.00075.x; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR; Yarrow L., 2008, Food Protection Trends, V28, P585; Young I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2171-x	71	53	54	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167695	10.1371/journal.pone.0167695	http://dx.doi.org/10.1371/journal.pone.0167695			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907161	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700224
J	Chandler, PD; Akinkuolie, AO; Tobias, DK; Lawler, PR; Li, CY; Moorthy, MV; Wang, L; Duprez, DA; Jacobs, DR; Glynn, RJ; Otvos, J; Connelly, MA; Post, WS; Ridker, PM; Manson, JE; Buring, JE; Lee, IM; Mora, S				Chandler, Paulette D.; Akinkuolie, Akintunde O.; Tobias, Deirdre K.; Lawler, Patrick R.; Li, Chungying; Moorthy, M. Vinayaga; Wang, Lu; Duprez, Daniel A.; Jacobs, David R.; Glynn, Robert J.; Otvos, James; Connelly, Margery A.; Post, Wendy S.; Ridker, Paul M.; Manson, Joann E.; Buring, Julie E.; Lee, I-Min; Mora, Samia			Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality	PLOS ONE			English	Article							PHASE REACTANT PROTEINS; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; TUMOR-MARKERS; CHRONIC INFLAMMATION; PRIMARY PREVENTION; WOMENS HEALTH; GLYCOSYLATION; BIOMARKER; RISK	Background Acute phase proteins highlight the dynamic interaction between inflammation and oncogenesis. GlycA, a novel nuclear magnetic resonance (NMR) inflammatory marker that identifies primarily circulating N-acetyl glycan groups attached to acute phase proteins, may be a future CRC risk biomarker. Methods We examined the association between GlycA and incident CRC and mortality in two prospective cohorts (N = 34,320); Discovery cohort: 27,495 participants from Women's Health Study (WHS); Replication cohort: 6,784 participants from Multi-Ethnic Study of Atherosclerosis (MESA). Multivariable Cox models were adjusted for clinical risk factors and compared GlycA to acute phase proteins (high-sensitivity C-reactive protein [hsCRP], fibrinogen, and soluble intercellular adhesion molecule-1 [sICAM-1]). Results In WHS (median follow-up 19 years, 337 cases, 103 deaths), adjusted HRs (95% CIs) per SD increment of GlycA for CRC incidence and mortality were 1.19 (1.06-1.35; p = 0.004) and 1.24 (1.00-1.55; p = 0.05), respectively. We replicated findings in MESA (median follow-up 11 years, 70 cases, 23 deaths); HRs (95% CIs) per SD of GlycA for CRC incidence and mortality were 1.32 (1.06-1.65; p = 0.01) and 1.54 (1.06-2.23; p = 0.02), respectively, adjusting for age, sex, and race. Pooled analysis, adjusted HR (95% CI) per SD of GlycA for CRC incidence and mortality was 1.26 (1.15-1.39; p = 1 x 10(-6)). Other acute phase proteins (hsCRP, fibrinogen, and sICAM-1) had weaker or no association with CRC incidence, while only fibrinogen and GlycA were associated with CRC mortality. Conclusions The clinical utility of GlycA to personalize CRC therapies or prevention warrants further study.	[Chandler, Paulette D.; Akinkuolie, Akintunde O.; Tobias, Deirdre K.; Lawler, Patrick R.; Li, Chungying; Moorthy, M. Vinayaga; Wang, Lu; Glynn, Robert J.; Ridker, Paul M.; Manson, Joann E.; Buring, Julie E.; Lee, I-Min; Mora, Samia] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Akinkuolie, Akintunde O.; Lawler, Patrick R.; Ridker, Paul M.; Mora, Samia] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Tobias, Deirdre K.; Lawler, Patrick R.; Wang, Lu; Glynn, Robert J.; Ridker, Paul M.; Manson, Joann E.; Buring, Julie E.; Lee, I-Min] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Duprez, Daniel A.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Jacobs, David R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Otvos, James; Connelly, Margery A.] LabCorp, Raleigh, NC USA; [Post, Wendy S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Post, Wendy S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chandler, PD; Mora, S (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA.; Mora, S (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.	pchandler@partners.org; smora@partners.org	Lee, I-Min/ABD-5409-2021	Venkatasubramanian, Siddharth/0000-0002-5860-0768; Jacobs, David/0000-0002-7232-0543; Chandler, Paulette/0000-0002-4213-1215; Mora, Samia/0000-0001-6283-0980; Lawler, Patrick/0000-0001-5155-5071	National Institutes of Health, Bethesda, MD [CA 047988, HL-043851, HL-530-080467, HL-099355, UM1 CM 82913]; National Heart, Lung, and Blood Institute (NHLBI); MESA [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-534-HC-95163, N01-HC-95164, N01-HC95165, N01-HC-95166, N01-HC-95167, N01-HC95168, N01-HC-95169]; CTSA [UL1-RR-024156]; American Cancer Society [127524-MRSG-15-012-01-CNE]; NIH T32 [HL007575]; Mentored Research Scientist Development Award from the NIH NIDDK [K01DK103720]; Donald W. Reynolds Foundation; Foundation Leducq; American Heart Association; NATIONAL CANCER INSTITUTE [UM1CA182913, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851, RC1HL099355, T32HL007575] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MESA; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Cancer Society(American Cancer Society); NIH T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Scientist Development Award from the NIH NIDDK; Donald W. Reynolds Foundation; Foundation Leducq(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The WHS 529 is supported by grants CA 047988, HL-043851, HL-530 080467, HL-099355, and UM1 CM 82913 from the National Institutes of Health, Bethesda, MD. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-534-HC-95163, N01-HC-95164, N01-HC95165, N01-HC-95166, N01-HC-95167, N01-HC95168, N01-HC-95169 and CTSA UL1-RR-024156. P.D. Chandler received support from grant 127524-MRSG-15-012-01-CNE from the American Cancer Society. A.O. Akinkoulie and P.R. Lawler received support from NIH T32 (HL007575). D.K. Tobias is supported by a Mentored Research Scientist Development Award from the NIH NIDDK (K01DK103720). The biomarker measurements were supported by the Donald W. Reynolds Foundation, the Foundation Leducq, and the American Heart Association. Margery A. Connolly and James D. Otvos are employees of LabCorp. LabCorp provided support in the form of salaries for authors MAC and JDO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. LipoScience (now LabCorp; Raleigh, NC) performed the analysis of GlycA based on LipoProfile-3 at no additional cost to the studies but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. These funding agencies had no role in the design and execution of the current study. The specific roles of these authors are articulated in the "author contributions" section.	Abu-Remaileh M, 2015, CANCER RES, V75, P2120, DOI 10.1158/0008-5472.CAN-14-3295; Akinkuolie AO, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001221; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Bernatsky S, 2002, J RHEUMATOL, V29, P2551; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brenner DR, 2014, CANCER EPIDEM BIOMAR, V23, P1729, DOI 10.1158/1055-9965.EPI-14-0064; BULLEN BR, 1977, MED PEDIATR ONCOL, V3, P289, DOI 10.1002/mpo.2950030311; Chan AOO, 2007, JAMA-J AM MED ASSOC, V298, P1412, DOI 10.1001/jama.298.12.1412; Chen CH, 2014, CARCINOGENESIS, V35, P1258, DOI 10.1093/carcin/bgu007; Chung CP, 2016, LUPUS, V25, P296, DOI 10.1177/0961203315617842; Cicatiello V, 2015, ONCOTARGET, V6, P10563, DOI 10.18632/oncotarget.3384; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Duffy MJ, 2001, CLIN CHEM, V47, P624; DURDEY P, 1984, BRIT J SURG, V71, P881, DOI 10.1002/bjs.1800711126; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Gruppen EG, 2015, EUR J CLIN INVEST, V45, P850, DOI 10.1111/eci.12481; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kristic J, 2014, J GERONTOL A-BIOL, V69, P779, DOI 10.1093/gerona/glt190; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; MULLER T, 1985, EUR J CANCER CLIN ON, V21, P1461, DOI 10.1016/0277-5379(85)90238-X; Nicastri A, 2014, J PROTEOME RES, V13, P4932, DOI 10.1021/pr500647y; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Ritchie SC, 2015, CELL SYST, V1, P293, DOI 10.1016/j.cels.2015.09.007; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; Solakidi S, 2004, CLIN BIOCHEM, V37, P56, DOI 10.1016/j.clinbiochem.2003.09.002; STAMATIADIS AP, 1990, CANCER, V65, P2055, DOI 10.1002/1097-0142(19900501)65:9<2055::AID-CNCR2820650927>3.0.CO;2-6; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Wahl LM, 1998, J NATL CANCER I, V90, P1583, DOI 10.1093/jnci/90.21.1583; WARD AM, 1977, BRIT J CANCER, V35, P170, DOI 10.1038/bjc.1977.24; Xu LY, 2015, TUMOR BIOL, V36, P669, DOI 10.1007/s13277-014-2670-x; Yuceyar S, 1996, INT SURG, V81, P136; Zhang SMM, 2005, ANN INTERN MED, V142, P425, DOI 10.7326/0003-4819-142-6-200503150-00008; Zhou B, 2014, CANCER CAUSE CONTROL, V25, P1397, DOI 10.1007/s10552-014-0445-8	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165615	10.1371/journal.pone.0165615	http://dx.doi.org/10.1371/journal.pone.0165615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902713	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100006
J	Koprich, JB; Johnston, TH; Reyes, G; Omana, V; Brotchie, JM				Koprich, James B.; Johnston, Tom H.; Reyes, Gabriela; Omana, Vanessa; Brotchie, Jonathan M.			Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque	PLOS ONE			English	Article							PATHOLOGY; OVEREXPRESSION; DYSFUNCTION; PROTEINS; MIDBRAIN; NEURONS; BRAIN	Recent failures in clinical trials for disease modification in Parkinson's disease have highlighted the need for a non-human primate model of the synucleinopathy underpinning dopaminergic neuron degeneration. The present study was defined to begin the development of such a model in cynomolgus macaque. We have validated surgical and vector parameters to define a means to provide a robust over-expression of alpha-synuclein which is associated with Lewy-like pathology and robust degeneration of the nigrostriatal pathway. Thus, an AAV1/2 vector incorporating strong transcription and transduction regulatory elements was used to deliver the gene for the human A53T mutation of alpha-synuclein. When injected into 4 sites within each substantia nigra (7 mu l per site, 1.7 x 10(12) gp/ml), this vector provided expression lasting at least 4 months, and a 50% loss of nigral dopaminergic neurons and a 60% reduction in striatal dopamine. Further studies will be required to develop this methodology into a validated model of value as a drug development platform.	[Koprich, James B.; Johnston, Tom H.; Brotchie, Jonathan M.] Atuka Inc, Toronto, ON, Canada; [Koprich, James B.; Johnston, Tom H.; Reyes, Gabriela; Omana, Vanessa; Brotchie, Jonathan M.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Koprich, JB (corresponding author), Atuka Inc, Toronto, ON, Canada.; Koprich, JB (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.	j.koprich@atuka.com	Johnston, Tom H/D-2531-2018	Johnston, Tom H/0000-0002-1537-8175; Brotchie, Jonathan/0000-0003-2337-0816	Atuka Inc.; Krembil Foundation	Atuka Inc.; Krembil Foundation	Funding was provided for by Atuka Inc. and the Krembil Foundation. There was no additional external funding received for this study. The funder (Atuka Inc.) provided support in the form of consultancies for authors [JBK, THJ, JMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bellucci A, 2016, NEUROPATH APPL NEURO, V42, P77, DOI 10.1111/nan.12297; Butler B, 2015, J BIOL CHEM; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; Chung CY, 2009, P NATL ACAD SCI USA, V106, P22474, DOI 10.1073/pnas.0912193106; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Koprich JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017698; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Roberts RF, 2015, BRAIN, V138, P1642, DOI 10.1093/brain/awv040; Ronzitti G, 2015, CHANNELS, V9, P169, DOI 10.1080/19336950.2015.1063285; Saito Y, 2016, MOVEMENT DISORD, V31, P135, DOI 10.1002/mds.26463; Tagliafierro L, 2016, NEUROGENETICS; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Xu W, 2015, NEUROBIOL AGING, V36, P1505, DOI 10.1016/j.neurobiolaging.2014.10.042; Yang WL, 2015, J NEUROSCI, V35, P8345, DOI 10.1523/JNEUROSCI.0772-15.2015	24	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167235	10.1371/journal.pone.0167235	http://dx.doi.org/10.1371/journal.pone.0167235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902767	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100061
J	Wajima, T; Anzai, Y; Yamada, T; Ikoshi, H; Noguchi, N				Wajima, Takeaki; Anzai, Yui; Yamada, Tetsuya; Ikoshi, Hideaki; Noguchi, Norihisa			Oldenlandia diffusa Extract Inhibits Biofilm Formation by Haemophilus influenzae Clinical Isolates	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; OTITIS-MEDIA; BETA; LUXS; CLARITHROMYCIN; AUTOINDUCER-2; RESISTANCE; CHILDREN; SYNTHASE; SURFACE	Oldenlandia diffusa has been empirically used as a therapeutic adjunct for the treatment of respiratory infections. To establish the basic evidence of its clinical usefulness, antimicrobial and biofilm inhibitory activities of an O. diffusa extract were examined against clinical isolates of Haemophilus influenzae, a major causative pathogen of respiratory and sensory organ infections. No significant growth inhibitory activity was observed during incubation for more than 6 h after the extract addition into a culture of H. influenzae. On the other hand, biofilm formation by H. influenzae, evaluated by a crystal violet method, was significantly and dose-dependently inhibited by the O. diffusa extract. Furthermore, the mRNA level of the biofilm-associated gene luxS of H. influenzae significantly decreased soon after the extract addition, and the suppressive effect continued for at least 2 h. At 2 h after the addition of the O. diffusa extract, the autoinducer in the culture supernatant was also significantly reduced by the O. diffusa extract in a dose-dependent manner. These results revealed that O. diffusa extract shows inhibitory activity against luxS-dependent biofilm formation but has no antimicrobial activity against planktonic cells of H. influenzae. Thus, O. diffusa extract might be useful as an adjunctive therapy for the treatment of respiratory infections caused by H. influenzae.	[Wajima, Takeaki; Anzai, Yui; Noguchi, Norihisa] Tokyo Univ Pharm & Life Sci, Dept Microbiol, Sch Pharm, Tokyo, Japan; [Yamada, Tetsuya; Ikoshi, Hideaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Tradit Chinese Med, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Noguchi, N (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Microbiol, Sch Pharm, Tokyo, Japan.	noguchin@toyaku.ac.jp	Wajma, Takeaki/AAF-4743-2020	Wajma, Takeaki/0000-0001-9506-707X; Noguchi, Norihisa/0000-0003-4710-7297				Armbruster CE, 2009, INFECT IMMUN, V77, P4081, DOI 10.1128/IAI.00320-09; Benninger MS, 2008, OTOLARYNG HEAD NECK, V138, P274, DOI 10.1016/j.otohns.2007.11.011; Chung HS, 2002, BIOL PHARM BULL, V25, P1142, DOI 10.1248/bpb.25.1142; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Gupta Salin, 2004, J Herb Pharmacother, V4, P21, DOI 10.1080/J157v04n01_03; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Iino Y, 2015, ACTA OTO-LARYNGOL, V135, P217, DOI 10.3109/00016489.2014.975893; Kalia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135495; Morozumi M, 2013, J INFECT CHEMOTHER, V19, P432, DOI 10.1007/s10156-012-0500-x; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Novotny LA, 2015, MOL MICROBIOL, V96, P276, DOI 10.1111/mmi.12934; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Sakaue Y, 2016, MICROBIOL IMMUNOL, V60, P10, DOI 10.1111/1348-0421.12343; Seyama S, 2016, ANTIMICROB AGENTS CH, V60, P3207, DOI 10.1128/AAC.00163-16; Song YH, 2012, BIOL PHARM BULL, V35, P1022, DOI 10.1248/bpb.b110660; Teng J, 2007, CHINESE MAT MED; Unal CM, 2012, INT J MED MICROBIOL, V302, P261, DOI 10.1016/j.ijmm.2012.07.013; Vilchez R, 2007, ANAL BIOANAL CHEM, V387, P489, DOI 10.1007/s00216-006-0824-4; Wajima T, 2016, J GLOB ANTIMICROB RE, V6, P22, DOI 10.1016/j.jgar.2016.01.014; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035	21	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167335	10.1371/journal.pone.0167335	http://dx.doi.org/10.1371/journal.pone.0167335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902758	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100074
J	Israyilova, A; Buroni, S; Forneris, F; Scoffone, VC; Shixaliyev, NQ; Riccardi, G; Chiarelli, LR				Israyilova, Aygun; Buroni, Silvia; Forneris, Federico; Scoffone, Viola Camilla; Shixaliyev, Namiq Q.; Riccardi, Giovanna; Chiarelli, Laurent Roberto			Biochemical Characterization of Glutamate Racemase - A New Candidate Drug Target against Burkholderia cenocepacia Infections	PLOS ONE			English	Article							KILL MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-ANTHRACIS; RESISTANCE; INHIBITORS; PURIFICATION; MURI; EXPRESSION; MECHANISM; DISCOVERY; HALOGEN	The greatest obstacle for the treatment of cystic fibrosis patients infected with the Burkholderia species is their intrinsic antibiotic resistance. For this reason, there is a need to develop new effective compounds. Glutamate racemase, an essential enzyme for the biosynthesis of the bacterial cell wall, is an excellent candidate target for the design of new antibacterial drugs. To this aim, we recombinantly produced and characterized glutamate racemase from Burkholderia cenocepacia J2315. From the screening of an in-house library of compounds, two Zn (II) and Mn (III) 1,3,5-triazapentadienate complexes were found to efficiently inhibit the glutamate racemase activity with IC50 values of 35.3 and 10.0 mu M, respectively. Using multiple biochemical approaches, the metal complexes have been shown to affect the enzyme activity by binding to the enzyme-substrate complex and promoting the formation of an inhibited dimeric form of the enzyme. Our results corroborate the value of glutamate racemase as a good target for the development of novel inhibitors against Burkholderia.	[Israyilova, Aygun; Buroni, Silvia; Forneris, Federico; Scoffone, Viola Camilla; Riccardi, Giovanna; Chiarelli, Laurent Roberto] Univ Pavia, Dipartimento Biol & Biotecnol, Pavia, Italy; [Israyilova, Aygun] Baku State Univ, Dept Microbiol, Baku, Azerbaijan; [Shixaliyev, Namiq Q.] Baku State Univ, Dept Organ Chem, Baku, Azerbaijan	University of Pavia; Ministry of Education of Azerbaijan Republic; Baku State University; Ministry of Education of Azerbaijan Republic; Baku State University	Chiarelli, LR (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol, Pavia, Italy.	laurent.chiarelli@unipv.it	Chiarelli, Laurent Roberto/J-8368-2016; Buroni, Silvia/AAX-5454-2020; Israilova, Aygun Israyilova/X-5353-2019; Shikhaliyev, Namig/P-8586-2019; Forneris, Federico/B-1145-2011; Forneris, Federico/AAL-5361-2020; Scoffone, Viola Camilla/F-7586-2017	Chiarelli, Laurent Roberto/0000-0003-0348-9764; Israilova, Aygun Israyilova/0000-0002-6526-132X; Shikhaliyev, Namig/0000-0002-6842-151X; Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; Buroni, Silvia/0000-0002-6979-2275; RICCARDI, Giovanna/0000-0003-3295-0070; Scoffone, Viola Camilla/0000-0001-9979-1655	Italian Cystic Fibrosis Foundation [19/2015]; Armenise-Harvard Foundation; "Rita Levi-Montalcini" award from the Italian Ministry of University and Education (MIUR)	Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Armenise-Harvard Foundation; "Rita Levi-Montalcini" award from the Italian Ministry of University and Education (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Cystic Fibrosis Foundation (FFC#19/2015 to G.R., adopted by Gruppo di Sostegno FFC di Como Dongo, Delegazione FFC di Olbia Tempio, Delegazione FFC di Reggio Calabria). F.F. is supported by a Career Development Award from the Armenise-Harvard Foundation and by the "Rita Levi-Montalcini" award from the Italian Ministry of University and Education (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa-Jove D, 2014, ACS CHEM BIOL, V9, P1567, DOI 10.1021/cb500149m; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bazzini S, 2014, BURKHOLDERIA GENOMES, P183, DOI [10.1186/1471-2180-9-200, DOI 10.1186/1471-2180-9-200]; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bohmer N, 2013, PROTEIN EXPRES PURIF, V88, P54, DOI 10.1016/j.pep.2012.11.012; Breault GA, 2008, BIOORG MED CHEM LETT, V18, P6100, DOI 10.1016/j.bmcl.2008.10.022; Buroni S, 2014, ANTIMICROB AGENTS CH, V58, P7424, DOI 10.1128/AAC.03800-14; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Conti P, 2011, CHEM REV, V111, P6919, DOI 10.1021/cr2000702; Copeland A.R, 2000, ENZYMES PRACTICAL IN, V2nd; de Dios A, 2002, J MED CHEM, V45, P4559, DOI 10.1021/jm020901d; Dodd D, 2007, J BACTERIOL, V189, P5265, DOI 10.1128/JB.00352-07; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Fisher SL, 2008, MICROB BIOTECHNOL, V1, P345, DOI 10.1111/j.1751-7915.2008.00031.x; Folescu TW, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0148-2; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; Geng B, 2009, BIOORG MED CHEM LETT, V19, P930, DOI 10.1016/j.bmcl.2008.11.113; Horsley A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub2; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; Israyilova A, 2015, J BIOTECHNOL, V208, pS27, DOI 10.1016/j.jbiotec.2015.06.072; Kim KH, 2007, J MOL BIOL, V372, P434, DOI 10.1016/j.jmb.2007.05.003; Kluger R, 2004, BIOORG CHEM, V32, P451, DOI 10.1016/j.bioorg.2004.08.002; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lundqvist T, 2007, NATURE, V447, P817, DOI 10.1038/nature05689; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Martin A, 2006, J ANTIMICROB CHEMOTH, V58, P327, DOI 10.1093/jac/dkl231; May M, 2007, J MOL BIOL, V371, P1219, DOI 10.1016/j.jmb.2007.05.093; Mehboob S, 2009, BIOCHEMISTRY-US, V48, P7045, DOI 10.1021/bi9005072; Mori G, 2015, CHEM BIOL, V22, P917, DOI 10.1016/j.chembiol.2015.05.016; Neres J, 2015, ACS CHEM BIOL, V10, P705, DOI 10.1021/cb5007163; Nzula S, 2002, J ANTIMICROB CHEMOTH, V50, P265, DOI 10.1093/jac/dkf137; Potrykus J, 2009, ARCH BIOCHEM BIOPHYS, V491, P16, DOI 10.1016/j.abb.2009.09.009; Ruzheinikov SN, 2005, STRUCTURE, V13, P1707, DOI 10.1016/j.str.2005.07.024; Sambrook J., 2001, MOL CLONING LAB MANU; Schrodinger L., 2020, PYMOL; Scoffone VC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00815; Scoffone VC, 2014, ANTIMICROB AGENTS CH, V58, P2415, DOI 10.1128/AAC.02438-13; Shixaliyev NQ, 2013, CATAL TODAY, V217, P76, DOI 10.1016/j.cattod.2013.06.013; Shixallyev NQ, 2014, NEW J CHEM, V38, P4807, DOI 10.1039/c4nj00797b; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sousa SA, 2011, INT J MICROBIOL, DOI [10.1155/2011/607575, DOI 10.1155/2011/607575]; Spies MA, 2009, J AM CHEM SOC, V131, P5274, DOI 10.1021/ja809660g; Taal MA, 2004, ACTA CRYSTALLOGR D, V60, P2031, DOI 10.1107/S0907444904021134; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whalen KL, 2013, CHEMMEDCHEM, V8, P1681, DOI 10.1002/cmdc.201300271; Whalen KL, 2011, MOL INFORM, V30, P459, DOI 10.1002/minf.201100014; Whalen KL, 2011, J PHYS CHEM B, V115, P3416, DOI 10.1021/jp201037t; Whalen KL, 2010, ACS MED CHEM LETT, V1, P9, DOI 10.1021/ml900005b; YAGASAKI M, 1995, BIOSCI BIOTECH BIOCH, V59, P610, DOI 10.1271/bbb.59.610	54	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167350	10.1371/journal.pone.0167350	http://dx.doi.org/10.1371/journal.pone.0167350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898711	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000056
J	Nagamitsu, T; Yasuda, M; Saito-Morooka, F; Inoue, MN; Nishiyama, M; Goka, K; Sugiura, S; Maeto, K; Okabe, K; Taki, H				Nagamitsu, Teruyoshi; Yasuda, Mika; Saito-Morooka, Fuki; Inoue, Maki N.; Nishiyama, Mio; Goka, Koichi; Sugiura, Shinji; Maeto, Kaoru; Okabe, Kimiko; Taki, Hisatomo			Genetic Structure and Potential Environmental Determinants of Local Genetic Diversity in Japanese Honeybees (Apis cerana japonica)	PLOS ONE			English	Article							BEES; MELLIFERA; HYMENOPTERA; RANGE; CONSERVATION; INFERENCE; RESPONSES; MARKERS	Declines in honeybee populations have been a recent concern. Although causes of the declines remain unclear, environmental factors may be responsible. We focused on the potential environmental determinants of local populations of wild honeybees, Apis cerana japonica, in Japan. This subspecies has little genetic variation in terms of its mitochondrial DNA sequences, and genetic variations at nuclear loci are as yet unknown. We estimated the genetic structure and environmental determinants of local genetic diversity in nuclear microsatellite genotypes of fathers and mothers, inferred from workers collected at 139 sites. The genotypes of fathers and mothers showed weak isolation by distance and negligible genetic structure. The local genetic diversity was high in central Japan, decreasing toward the peripheries, and depended on the climate and land use characteristics of the sites. The local genetic diversity decreased as the annual precipitation increased, and increased as the proportion of urban and paddy field areas increased. Positive effects of natural forest area, which have also been observed in terms of forager abundance in farms, were not detected with respect to the local genetic diversity. The findings suggest that A. cerana japonica forms a single population connected by gene flow in its main distributional range, and that climate and landscape properties potentially affect its local genetic diversity.	[Nagamitsu, Teruyoshi] FFPRI, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Yasuda, Mika; Okabe, Kimiko; Taki, Hisatomo] FFPRI, Dept Forest Entomol, Tsukuba, Ibaraki, Japan; [Saito-Morooka, Fuki] Ibaraki Univ, Fac Sci, Mito, Ibaraki, Japan; [Inoue, Maki N.] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Nishiyama, Mio; Goka, Koichi] NIES, Global Environm Div, Tsukuba, Ibaraki, Japan; [Sugiura, Shinji; Maeto, Kaoru] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Ibaraki University; Tokyo University of Agriculture & Technology; National Institute for Environmental Studies - Japan; Kobe University	Nagamitsu, T (corresponding author), FFPRI, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan.	nagamit@affrc.go.jp	Nagamitsu, Teruyoshi/J-7710-2015; INOUE, Maki/H-6581-2013; Maeto, Kaoru/AAB-7318-2019	Nagamitsu, Teruyoshi/0000-0003-3366-7197; INOUE, Maki/0000-0002-9815-3480; 	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25740051]; Ministry of the Environment, Japan [S-9, 5-1407]; Global Environment Research Funds	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of the Environment, Japan(Ministry of the Environment, Japan); Global Environment Research Funds	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI https://www.jsps.go.jp/english/e-grants/index.html, Grant Number 25740051 to HT and Global Environment Research Funds https://www.env.go.jp/en/earth/research/gerf_E/index2.htm, S-9 and 5-1407 from the Ministry of the Environment, Japan to HT.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; [Anonymous], 2015, NAT SURV NAT ENV 2 5; [Anonymous], 2014, NAT LAND NUM INF; Arthur AD, 2010, BASIC APPL ECOL, V11, P406, DOI 10.1016/j.baae.2010.05.001; Baum KA, 2005, ENVIRON ENTOMOL, V34, P610, DOI 10.1603/0046-225X-34.3.610; Baum KA, 2008, LANDSCAPE URBAN PLAN, V85, P123, DOI 10.1016/j.landurbplan.2007.10.005; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Chapman NC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1185, DOI 10.1007/s00265-006-0348-0; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FUJIWARA S, 1994, APIDOLOGIE, V25, P331, DOI 10.1051/apido:19940309; Gary N. E., 1963, Journal of Apicultural Research London, V2, P3; Goka K, 2001, MOL ECOL, V10, P2095, DOI 10.1046/j.0962-1083.2001.01323.x; Harpur BA, 2012, MOL ECOL, V21, P4414, DOI 10.1111/j.1365-294X.2012.05614.x; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kark S, 2008, EVOL ECOL RES, V10, P391; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Moritz RFA, 2007, J INSECT CONSERV, V11, P391, DOI 10.1007/s10841-006-9054-5; Nagamitsu T, 2015, J APICULT RES; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Oldroyd BP, 2009, APIDOLOGIE, V40, P296, DOI 10.1051/apido/2009021; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R Core Team, 2015, R LANG ENV STAT COMP; Rollin O, 2013, AGR ECOSYST ENVIRON, V179, P78, DOI 10.1016/j.agee.2013.07.007; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueppell O, 2011, INSECT SOC, V58, P445, DOI 10.1007/s00040-011-0161-2; Ruttner F., 1988, SPRINGER SCI BUSINES; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Smith DR, 1996, J KANSAS ENTOMOLOGIC; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Takahashi J, 2007, APIDOLOGIE, V38, P335, DOI 10.1051/apido:2007018; Takahashi JI, 2009, MOL ECOL RESOUR, V9, P819, DOI 10.1111/j.1755-0998.2009.02268.x; Taki H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00132; Taki H, 2010, BASIC APPL ECOL, V11, P594, DOI 10.1016/j.baae.2010.08.004; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; WILLIAMS JL, 1987, J ECON ENTOMOL, V80, P532, DOI 10.1093/jee/80.2.532; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	42	5	5	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167233	10.1371/journal.pone.0167233	http://dx.doi.org/10.1371/journal.pone.0167233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898704	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000041
J	Vioque, J; Gimenez-Monzo, D; Navarrete-Munoz, EM; Garcia-De-La-Hera, M; Gonzalez-Palacios, S; Rebagliato, M; Ballester, F; Murcia, M; Iniguez, C; Granado, F				Vioque, Jesus; Gimenez-Monzo, Daniel; Navarrete-Munoz, Eva Maria; Garcia-de-la-Hera, Manuela; Gonzalez-Palacios, Sandra; Rebagliato, Marisa; Ballester, Ferran; Murcia, Mario; Iniguez, Carmen; Granado, Fernando		Inma-Valencia Cohort Study	Reproducibility and Validity of a Food Frequency Questionnaire Designed to Assess Diet in Children Aged 4-5 Years	PLoS One			English	Article							ENERGY-INTAKE; MICRONUTRIENT INTAKE; PRESCHOOL-CHILDREN; RELATIVE VALIDITY; VALIDATION; ADOLESCENTS; OVERWEIGHT; PROFILE; CAROTENOIDS; POPULATION	Background The food frequency questionnaire (FFQ) is the most efficient and cost-effective method to investigate the relationship between usual diet and disease in epidemiologic studies. Although FFQs have been validated in many adult populations worldwide, the number of valid FFQ in preschool children is very scarce. The aim of this study was to evaluate the reproducibility and validity of a semi-quantitative FFQ designed for children aged 4 to 5 years. Materials and methods In this study, we have included 169 children aged 4-5 years from the INMA project in Valencia, a population-based prospective cohort study of mothers and children in Spain. The 105 items FFQ was administered twice to the parents or care-givers of children over a 9-month period. Reproducibility was explored by comparing intake of nutrients by the FFQs, while validity was examined by comparing the nutrient values from the FFQs with the average nutrient values of three 24 hour dietary recall (24hDR) taken in the period, and also, with the concentration in blood specimens for several vitamins (carotenoids, folate, vitamin B12, vitamin C and a-tocopherol). Pearson correlation coefficients and de-attenuated correlation coefficients were calculated and we also evaluated misclassification by quintile distribution. Results All correlation coefficients for reproducibility for nutrients and major food groups were statistically significant; the average correlation coefficients for daily intake were 0.43 for food groups and 0.41 for nutrients. The average correlation coefficients for validity for daily intakes against 24hDR was r = 0.30, and the average for de-attenuated correlation coefficients was r = 0.44. When evaluating validity against the blood concentration of vitamins, statistically significant correlations were observed for vitamin C (0.35), lycopene (0.31), beta-Cryptoxantin (0.40), and vitamin E (0.29); the average of correlation coefficients was r = 0.21. Conclusion Despite some low to moderate correlations for reproducibility and validity, overall this study suggests that the FFQ may be a good method for assessing a wide range of food groups and nutrients intake in children aged 4-5 years.	[Vioque, Jesus; Gimenez-Monzo, Daniel; Navarrete-Munoz, Eva Maria; Garcia-de-la-Hera, Manuela; Gonzalez-Palacios, Sandra] Univ Miguel Hernandez, Unidad Epidemiol Nutr, Alicante, Spain; [Vioque, Jesus; Gimenez-Monzo, Daniel; Navarrete-Munoz, Eva Maria; Garcia-de-la-Hera, Manuela; Gonzalez-Palacios, Sandra] ISABIAL FISABIO Fdn, Inst Hlth & Biomed Res, Alicante, Spain; [Vioque, Jesus; Navarrete-Munoz, Eva Maria; Garcia-de-la-Hera, Manuela; Rebagliato, Marisa; Ballester, Ferran; Murcia, Mario; Iniguez, Carmen] CIBERESP, Madrid, Spain; [Rebagliato, Marisa; Ballester, Ferran; Murcia, Mario; Iniguez, Carmen] Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Valencia, Spain; [Rebagliato, Marisa] Univ Jaume 1, Dept Med, Castellon De La Plana, Spain; [Granado, Fernando] Hosp Univ Puerta Hierro Majadahonda, Serv Bioquim Clin, Madrid, Spain	Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat Jaume I; Hospital Puerta de Hierro-Majadahonda	Vioque, J (corresponding author), Univ Miguel Hernandez, Unidad Epidemiol Nutr, Alicante, Spain.; Vioque, J (corresponding author), ISABIAL FISABIO Fdn, Inst Hlth & Biomed Res, Alicante, Spain.; Vioque, J (corresponding author), CIBERESP, Madrid, Spain.	vioque@umh.es	Gimenez-Monzo, Daniel/L-4528-2017; Palacios, Sandra González/AAA-9585-2021; de la Hera, Manuela Garcia/N-8908-2019; Navarrete-Muñoz, Eva Maria/F-1666-2011; GIMENEZ-MONZO, DANIEL/GXH-7993-2022; Iñiguez, Carmen/AAA-5866-2019; vioque, jesus/A-1066-2008; Murcia, Mario/B-5477-2019; Rebagliato, Marisa/L-6116-2018	Gimenez-Monzo, Daniel/0000-0002-6852-4922; Palacios, Sandra González/0000-0003-3358-472X; de la Hera, Manuela Garcia/0000-0001-5742-2704; Iñiguez, Carmen/0000-0003-3471-4928; vioque, jesus/0000-0002-2284-148X; Murcia, Mario/0000-0001-6996-1158; Iniguez, Carmen/0000-0002-5156-0732; Navarrete-Munoz, Eva Maria/0000-0002-1494-5676; Rebagliato, Marisa/0000-0001-5825-0190	Institute Salud Carlos III (Red INMA) [G03/176 CB06/02/0041]; Ministerio Sanidad y Fondos FEDER [FIS 03/1615, 04/1509, 04/1436, 05/1079, 06/1213, 06/0867, 07/0314, 11/01007]; Conselleria Sanitat, Generalitat Valenciana [ACOMP/2010/115, 084/2010]	Institute Salud Carlos III (Red INMA); Ministerio Sanidad y Fondos FEDER; Conselleria Sanitat, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Institute Salud Carlos III (Red INMA G03/176 CB06/02/0041), Ministerio Sanidad y Fondos FEDER (FIS 03/1615; 04/1509; 04/1436; 05/1079; 06/1213; 06/0867; 07/0314; 11/01007), Conselleria Sanitat, Generalitat Valenciana (ACOMP/2010/115; 084/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LF, 2004, PUBLIC HEALTH NUTR, V7, P757, DOI 10.1079/PHN2004613; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bingham SA, 2002, PUBLIC HEALTH NUTR, V5, P821, DOI 10.1079/PHN2002368; Blum R E, 1999, Matern Child Health J, V3, P167, DOI 10.1023/A:1022350023163; Buch-Andersen T, 2016, PUBLIC HEALTH NUTR, V19, P1184, DOI 10.1017/S136898001500275X; Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Field AE, 1999, PUBLIC HEALTH NUTR, V2, P293, DOI 10.1017/S1368980099000397; Fumagalli F, 2008, NUTRITION, V24, P427, DOI 10.1016/j.nut.2008.01.008; Granado-Lorencio F, 2010, ANAL BIOANAL CHEM, V397, P1389, DOI 10.1007/s00216-010-3655-2; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Henriquez-Sanchez P, 2009, BRIT J NUTR, V102, pS10, DOI 10.1017/S0007114509993126; Hunter D., 2012, NUTR EPIDEMIOLOGY, P174; Klohe DM, 2005, J AM DIET ASSOC, V105, P727, DOI 10.1016/j.jada.2005.02.008; Kobayashi T, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-27; Leventakou V, 2015, PUBLIC HEALTH NUTR, V18, P421, DOI 10.1017/S1368980014000445; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Matos SMA, 2012, NUTR HOSP, V27, P1114, DOI 10.3305/nh.2012.27.4.5883; McConahy KL, 2004, J AM DIET ASSOC, V104, P975, DOI 10.1016/j.jada.2004.03.027; Moghames P, 2016, NUTR J, V15, DOI 10.1186/s12937-015-0121-1; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Ortiz-Andrellucchi A, 2009, BRIT J NUTR, V102, pS87, DOI 10.1017/S0007114509993163; Palma I, 2008, TABLAS COMPOSICIO AL; Parrish LA, 2003, EPIDEMIOLOGY, V14, P213, DOI 10.1097/00001648-200303000-00016; Preston AM, 2011, P R HEALTH SCI J, V30, P58; Ramon R, 2009, J NUTR, V139, P561, DOI 10.3945/jn.108.095596; Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200; Rodriguez-Artalejo F, 2002, EUR J CLIN NUTR, V56, P141, DOI 10.1038/sj.ejcn.1601296; Rodriguez-Bernal CL, 2010, AM J CLIN NUTR, V91, P1659, DOI 10.3945/ajcn.2009.28866; Ruiz E, 2015, NUTRIENTS, V7, P4739, DOI 10.3390/nu7064739; Sahashi Y, 2011, J NUTR SCI VITAMINOL, V57, P372, DOI 10.3177/jnsv.57.372; Siusi FB, 2011, CAD SAUDE PUBLICA, V27, P2197; STEIN AD, 1992, AM J EPIDEMIOL, V135, P667, DOI 10.1093/oxfordjournals.aje.a116346; Tabacchi G, 2016, PUBLIC HEALTH NUTR, V19, P1168, DOI 10.1017/S1368980015002505; United States Department of Agriculture Agricultural Research Service, USDA NAT NUTR DAT ST; van der Pols JC, 2007, AM J CLIN NUTR, V86, P1722; van Het HK, 2000, J NUTR, V130, P503; Vicario IM, 2003, J AGR FOOD CHEM, V51, P134, DOI 10.1021/jf0258297; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vioque J, 2007, BRIT J NUTR, V97, P977, DOI 10.1017/S0007114507659017; Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26; Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62; Willett W, 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1983, AM J CLIN NUTR, V38, P631, DOI 10.1093/ajcn/38.4.631; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wrieden WL, 2008, BRIT J NUTR, V99, P1344, DOI 10.1017/S0007114507868516	48	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167338	10.1371/journal.pone.0167338	http://dx.doi.org/10.1371/journal.pone.0167338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898731	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000055
J	Zhu, S; Wang, YJ; Chen, WQ; Li, W; Wang, A; Wong, S; Bao, GQ; Li, JH; Yang, H; Tracey, KJ; D'Angelo, J; Wang, HC				Zhu, Shu; Wang, Yongjun; Chen, Weiqiang; Li, Wei; Wang, Angelina; Wong, Sarabeth; Bao, Guoqiang; Li, Jianhua; Yang, Huan; Tracey, Kevin J.; D'Angelo, John; Wang, Haichao			High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA(2)-IIE and sPLA(2)-V Expression in Macrophages	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); LETHAL SEPSIS; RESCUES MICE; SEPTIC SHOCK; PROTEIN SAA; RECEPTOR; RELEASE; MEDIATOR; INTERLEUKIN-1; INDUCTION	Human serum amyloid A (SAA) has been demonstrated as a chemoattractant and proinflammatory mediator of lethal systemic inflammatory diseases. In the circulation, it can be sequestered by a high-density lipoprotein, HDL, which carries cholesterol, triglycerides, phospholipids and apolipoproteins (Apo-AI). The capture of SAA by HDL results in the displacement of Apo-AI, and the consequent inhibition of SAA's chemoattractant activities. It was previously unknown whether HDL similarly inhibits SAA-induced sPLA(2) expression, as well as the resultant HMGB1 release, nitric oxide (NO) production and autophagy activation. Here we provided compelling evidence that human SAA effectively upregulated the expression and secretion of both sPLA(2)-IIE and sPLA(2)-V in murine macrophages, which were attenuated by HDL in a dose-dependent fashion. Similarly, HDL dose-dependently suppressed SAA-induced HMGB1 release, NO production, and autophagy activation. In both RAW 264.7 cells and primary macrophages, HDL inhibited SAAinduced secretion of several cytokines (e.g., IL-6) and chemokines (e. g., MCP-1 and RANTES) that were likely dependent on functional TLR4 signaling. Collectively, these findings suggest that HDL counter-regulates SAA-induced upregulation and secretion of sPLA2-IIE/V in addition to other TLR4-dependent cytokines and chemokines in macrophage cultures.	[Zhu, Shu; Chen, Weiqiang; Li, Wei; D'Angelo, John; Wang, Haichao] North Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA; [Zhu, Shu; Wang, Yongjun; Chen, Weiqiang; Li, Wei; Wang, Angelina; Wong, Sarabeth; Bao, Guoqiang; Li, Jianhua; Yang, Huan; Tracey, Kevin J.; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY USA; [Bao, Guoqiang] 4th Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian, Shaanxi, Peoples R China	Northwell Health; North Shore University Hospital; Northwell Health; Air Force Military Medical University	Wang, HC (corresponding author), North Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA.; Wang, HC (corresponding author), Feinstein Inst Med Res, Manhasset, NY USA.	hwang@northwell.edu	LI, JIAN/GRY-2197-2022; Wang, Haichao/AAU-2237-2021; li, jian/GSE-0245-2022	Wang, Haichao/0000-0002-0211-9000; Li, Wei/0000-0002-7941-7022; Wang, Yongjun/0000-0003-3515-9137; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences (NIGMS) [R01GM063075]; National Center of Complementary and Alternative Medicine (NCCAM) [R01AT05076]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118182, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center of Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (NIGMS, R01GM063075) and the National Center of Complementary and Alternative Medicine (NCCAM, R01AT05076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of General Medical Sciences (NIGMS, R01GM063075) and the National Center of Complementary and Alternative Medicine (NCCAM, R01AT05076).	BADOLATO R, 1995, J IMMUNOL, V155, P4004; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baek SH, 2000, J IMMUNOL, V164, P6359, DOI 10.4049/jimmunol.164.12.6359; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Dos Santos S, 2007, ANN NY ACAD SCI, V1096, P70, DOI 10.1196/annals.1397.071; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; HOFFMAN JS, 1982, J BIOL CHEM, V257, P518; Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200; Ito C, 2013, MOL CELL, V52, P794, DOI 10.1016/j.molcel.2013.10.024; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Kessen UA, 2005, J LIPID RES, V46, P2488, DOI 10.1194/jlr.M500325-JLR200; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Li B, 2013, ATHEROSCLEROSIS, V228, P370, DOI 10.1016/j.atherosclerosis.2013.03.023; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li W, 2015, MOL MED, V21, P515, DOI 10.2119/molmed.2015.00109; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MARSHALL LA, 1994, J LIPID MEDIAT CELL, V10, P295; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; Morin EE, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00244; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ohta S, 2009, CHEM PHYS LIPIDS, V162, P62, DOI 10.1016/j.chemphyslip.2009.07.008; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; Patel H, 1998, SCAND J IMMUNOL, V48, P410; RAMADORI G, 1985, J EXP MED, V162, P930, DOI 10.1084/jem.162.3.930; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sharifov OF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064486; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; STEINKASSERER A, 1990, BIOCHEM J, V268, P187, DOI 10.1042/bj2680187; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Sullivan CP, 2010, J BIOL CHEM, V285, P565, DOI 10.1074/jbc.M109.070565; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; VADAS P, 1991, IMMUNOL LETT, V28, P187, DOI 10.1016/0165-2478(91)90002-R; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang LM, 2004, BIOCHEM BIOPH RES CO, V317, P157, DOI 10.1016/j.bbrc.2004.03.027; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; XU LL, 1995, J IMMUNOL, V155, P1184; Yamamoto K, 2016, J BIOL CHEM, V291, P15602, DOI 10.1074/jbc.M116.734657; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Zhang YS, 2012, BIOCHEM PHARMACOL, V84, P1492, DOI 10.1016/j.bcp.2012.09.015; Zhang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH866, DOI 10.1152/ajpheart.01232.2008	51	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167468	10.1371/journal.pone.0167468	http://dx.doi.org/10.1371/journal.pone.0167468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898742	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000064
J	Pan, CH; Chang, CC; Su, CT; Tsai, PS				Pan, Chieh-Hsin; Chang, Chun-Chao; Su, Chien-Tien; Tsai, Pei-Shan			Trends in Irritable Bowel Syndrome Incidence among Taiwanese Adults during 2003-2013: A Population-Based Study of Sex and Age Differences	PLOS ONE			English	Article							CHINESE POPULATION; DISEASE; PREVALENCE; GENDER; METAANALYSIS; SYMPTOMS; QUESTIONNAIRE; COLONOSCOPY; DISORDERS; DIAGNOSIS	Background No population-based irritable bowel syndrome (IBS) incidence data among Taiwanese adults are available. Whether IBS is associated with risk of organic colonic diseases remains unanswered. We investigated 1) the sex-and age-stratified trends in the annual incidence of IBS, and 2) the risk of selected organic diseases in patients with IBS compared with those without IBS among Taiwanese adults during 2003-2013. Methods Medical claims data for 1 million randomly selected beneficiaries were obtained and analyzed. Patients with IBS were considered eligible for enrollment if they aged between 20 and 100 and had at least two medical encounters with IBS codes within 1 year. To test whether there was a linear secular trend in IBS incidence over time, multivariate Poisson regression with generalized estimating equation model was conducted. The risk of selected organic diseases associated with IBS was examined using multivariate Cox proportional hazard regression. Results From 2003 to 2013, the incidence of IBS significantly decreased over time [adjusted incidence rate ratio (IRR) = 0.97, p<0.001]; the incidence of IBS significantly increased with age (adjusted IRR = 1.03, p < 0.001) and was significantly higher in women than in men (adjusted IRR = 1.14, p<0.001). IBS significantly associated with increased risk of microscopic colitis, inflammatory bowel disease, and colorectal cancer during a 10-year follow-up period. Conclusions The incidence of IBS increased with age and was slightly higher in women than in men among Taiwanese adults. During 2003-2013, IBS incidence gradually decreased over time. IBS may increase risk of several colonic organic diseases.	[Pan, Chieh-Hsin; Tsai, Pei-Shan] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Pan, Chieh-Hsin] Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan; [Chang, Chun-Chao] Taipei Med Univ, Coll Med, Sch Med, Div Gastroenterol & Hepatol,Dept Internal Med, Taipei, Taiwan; [Chang, Chun-Chao] Taipei Med Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan; [Su, Chien-Tien] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth, Taipei, Taiwan; [Su, Chien-Tien] Taipei Med Univ, Sch Med, Div Family Med, Coll Med, Taipei, Taiwan; [Tsai, Pei-Shan] Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital	Tsai, PS (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Tsai, PS (corresponding author), Wan Fang Hosp, Dept Nursing, Taipei, Taiwan.; Tsai, PS (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	ptsai@tmu.edu.tw			Taipei Medical University Hospital, Taipei, Taiwan [105TMU-TMUH-22]	Taipei Medical University Hospital, Taipei, Taiwan	This study is supported by a grant from Taipei Medical University Hospital, Taipei, Taiwan (105TMU-TMUH-22).	Barbara G, 2014, CURR OPIN GASTROEN, V30, P352, DOI 10.1097/MOG.0000000000000070; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Canavan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106478; Chang FY, 2012, ASIA PAC J CLIN NUTR, V21, P594; Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; Ishihara S, 2012, J GASTROENTEROL, V47, P1084, DOI 10.1007/s00535-012-0573-4; Kamp EJCA, 2016, CLIN GASTROENTEROL H, V14, P659, DOI 10.1016/j.cgh.2015.09.031; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Lu CL, 2003, ALIMENT PHARM THERAP, V18, P1159, DOI 10.1046/j.1365-2036.2003.01711.x; Lu CL, 2005, ALIMENT PHARM THER, V21, P1497, DOI 10.1111/j.1365-2036.2005.02512.x; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Mulak A, 2014, WORLD J GASTROENTERO, V20, P2433, DOI 10.3748/wjg.v20.i10.2433; Patel P, 2015, SCAND J GASTROENTERO, V50, P816, DOI 10.3109/00365521.2015.1007079; Porter CK, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-55; Rodriguez LAG, 2000, SCAND J GASTROENTERO, V35, P306; Sperber AD, 2017, GUT, V66, P1075, DOI 10.1136/gutjnl-2015-311240; Thompson WG, 1999, GUT, V45, P43; Welch LC, 2012, J HEALTH SOC BEHAV, V53, P313, DOI 10.1177/0022146512456026	21	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166922	10.1371/journal.pone.0166922	http://dx.doi.org/10.1371/journal.pone.0166922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893818	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400058
J	Shin, JA; Kim, HS; Vargas, A; Yu, WQ; Eom, YS; Craft, CM; Lee, EJ				Shin, Jung-A; Kim, Hwa Sun; Vargas, Andrew; Yu, Wan-Qing; Eom, Yun Sung; Craft, Cheryl Mae; Lee, Eun-Jin			Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; MEDIATED GENE-TRANSFER; PHOTORECEPTOR DEGENERATION; RAT MODEL; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; TISSUE INHIBITORS; CELL-DEATH; RETINAL DEGENERATION; UP-REGULATION	Retinitis Pigmentosa (RP) is one of the most common forms of inherited visual loss with the initial degeneration of rod photoreceptors, followed by a progressive cone photoreceptor deterioration. Coinciding with this visual loss, the extracellular matrix (ECM) is reorganized, which alters matrix metalloproteinase (MMP) activity levels. A potential pathological role of MMPs, MMP-9 in particular, involves an excitotoxicity-mediated physiological response. In the current study, we examine the MMP-9 and MMP-2 expression levels in the rhodopsin S334ter-line3 RP rat model and investigate the impact of treatment with SB-3CT, a specific MMP-9 and MMP-2 inhibitor, on rod cell survival was tested. Retinal MMP-9 and MMP-2 expression levels were quantified by immunoblot analysis from S334ter-line3 rats compared to controls. Gelatinolytic activities of MMP-9 and MMP-2 by zymography were examined. The geometry of rod death was further evaluated using Voronoi analysis. Our results revealed that MMP-9 was elevated while MMP-2 was relatively unchanged when S334terline 3 retinas were compared to controls. With SB-3CT treatment, we observed gelatinolytic activity of both MMPs was decreased and diminished clustering associated with rod death, in addition to a robust preservation of rod photoreceptors. These results demonstrate that up-regulation of MMP-9 in retinas of S334ter-line3 are associated with rod death. The application of SB-3CT dramatically interferes with mechanisms leading to apoptosis in an MMP-9-dependent manner. Future studies will determine the feasibility of using SB-3CT as a potential therapeutic strategy to slow progression of vision loss in genetic inherited forms of human RP.	[Shin, Jung-A; Kim, Hwa Sun; Vargas, Andrew; Yu, Wan-Qing; Eom, Yun Sung; Craft, Cheryl Mae; Lee, Eun-Jin] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, USC Roski Eye Inst,Mary D Allen Lab Vis Res, Los Angeles, CA 90007 USA; [Shin, Jung-A] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Craft, Cheryl Mae] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA USA; [Yu, Wan-Qing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Craft, Cheryl Mae] Univ Southern Calif, Neurosci Grad Program, Los Angeles, CA USA; [Lee, Eun-Jin] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA USA	University of Southern California; Ewha Womans University; University of Southern California; University of Washington; University of Washington Seattle; University of Southern California; University of Southern California	Lee, EJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, USC Roski Eye Inst,Mary D Allen Lab Vis Res, Los Angeles, CA 90007 USA.; Lee, EJ (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA USA.	eunjinl@usc.edu		Yu, Wan-Qing/0000-0002-9275-391X	VSoE Research Innovation Fund; Ewha Womans University Research Grant; NEI [EY03040]; Research to Prevent Blindness (USC Ophthalmology); Mary D. Allen Foundation; William Hansen Sandberg Memorial Foundation;  [EY015851]	VSoE Research Innovation Fund; Ewha Womans University Research Grant; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (USC Ophthalmology)(Research to Prevent Blindness (RPB)); Mary D. Allen Foundation; William Hansen Sandberg Memorial Foundation; 	The work was supported by a VSoE Research Innovation Fund to E-JL, by Ewha Womans University Research Grant of 2015 to JAS, and by EY015851 to CMC. NEI core grant: EY03040 (Doheny Eye Institute), Research to Prevent Blindness (USC Ophthalmology), the Mary D. Allen Foundation (AV, HSK), and the William Hansen Sandberg Memorial Foundation (YSE). CMC is the inaugural Mary D. Allen Endowed Chair in Vision Research (Doheny Eye Institute).	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Ahuja S, 2006, OPHTHAL RES, V38, P125, DOI 10.1159/000090533; Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536; Anasagasti A, 2012, VISION RES, V75, P117, DOI 10.1016/j.visres.2012.09.012; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Berger AS, 2003, OPHTHALMOLOGY, V110, P383, DOI 10.1016/S0161-6420(02)01738-4; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Chabot V, 2006, J LEUKOCYTE BIOL, V79, P767, DOI 10.1189/jlb.0804464; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Conlon TJ, 2013, HUM GENE THER CL DEV, V24, P23, DOI 10.1089/humc.2013.037; Cusato K, 2003, BIOL BULL-US, V205, P197, DOI 10.2307/1543250; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; De Groef L, 2014, INVEST OPHTH VIS SCI, V55, P1953, DOI 10.1167/iovs.13-13630; Delyfer MN, 2005, MOL VIS, V11, P688; Deming JD, 2015, INVEST OPHTH VIS SCI, V56, P5407, DOI 10.1167/iovs.15-16647; Descamps FJ, 2002, LAB INVEST, V82, P1607, DOI 10.1097/01.LAB.0000038556.54069.73; Di Girolamo N, 2006, J IMMUNOL, V177, P2638, DOI 10.4049/jimmunol.177.4.2638; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guimaraes-Santos A, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/918174, 10.1155/2012/747969]; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Hu Xueyou, 2010, J Vis Exp, DOI 10.3791/2445; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Jacobsen FE, 2007, CHEMMEDCHEM, V2, P152, DOI 10.1002/cmdc.200600204; Ji Y, 2015, INVEST OPHTH VIS SCI, V56, P352, DOI 10.1167/iovs.14-15398; Ji Y, 2012, J COMP NEUROL, V520, P874, DOI 10.1002/cne.22800; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jung Young Suk, 2012, PLoS One, V7, pe38773, DOI 10.1371/journal.pone.0038773; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kowluru RA, 2010, INVEST OPHTH VIS SCI, V51, P4320, DOI 10.1167/iovs.09-4851; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lee EJ, 2011, GLIA, V59, P1107, DOI 10.1002/glia.21183; Lee M, 2015, ACS CHEM NEUROSCI, V6, P1658, DOI 10.1021/acschemneuro.5b00140; Lee SY, 2011, J CELL PHYSIOL, V226, P1843, DOI 10.1002/jcp.22508; Lheriteau E, 2014, MOL THER, V22, P265, DOI 10.1038/mt.2013.232; LILLIEN LE, 1990, J CELL BIOL, V111, P635, DOI 10.1083/jcb.111.2.635; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; Majka S, 2001, INVEST OPHTH VIS SCI, V42, P210; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Nagase H, 1999, ANN NY ACAD SCI, V878, P1, DOI 10.1111/j.1749-6632.1999.tb07670.x; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Pons M, 2011, AM J PATHOL, V178, P2665, DOI 10.1016/j.ajpath.2011.02.006; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Rhodes JM, 2007, J CELL MOL MED, V11, P176, DOI 10.1111/j.1582-4934.2007.00031.x; Ripps H, 2002, EXP EYE RES, V74, P327, DOI 10.1006/exer.2002.1155; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Sahel Jose-Alain, 2005, Retina, V25, pS38, DOI 10.1097/00006982-200512001-00015; Shin JA, 2015, EXP EYE RES, V140, P41, DOI 10.1016/j.exer.2015.08.005; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Siqueira RC, 2011, RETINA-J RET VIT DIS, V31, P1207, DOI 10.1097/IAE.0b013e3181f9c242; Tan HK, 2003, MOL CELL NEUROSCI, V22, P98, DOI 10.1016/S1044-7431(02)00024-6; Tanihara H, 1997, ARCH OPHTHALMOL-CHIC, V115, P752, DOI 10.1001/archopht.1997.01100150754011; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Woch G, 2001, INVEST OPHTH VIS SCI, V42, P1669; Woessner JF, 1999, ANN NY ACAD SCI, V878, P388, DOI 10.1111/j.1749-6632.1999.tb07697.x; Yong VW, 2007, NEUROTHERAPEUTICS, V4, P580, DOI 10.1016/j.nurt.2007.07.005; Yu WQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151668; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang X, 2004, EXP EYE RES, V78, P849, DOI 10.1016/j.exer.2003.10.018; Zhang X, 2002, EXP EYE RES, V74, P577, DOI 10.1006/exer.2001.1152; Zhu CL, 2013, CELL TISSUE RES, V351, P29, DOI 10.1007/s00441-012-1522-5	81	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167102	10.1371/journal.pone.0167102	http://dx.doi.org/10.1371/journal.pone.0167102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893855	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400086
J	Alsaleh, NB; Persaud, I; Brown, JM				Alsaleh, Nasser B.; Persaud, Indushekhar; Brown, Jared M.			Silver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE Receptor	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; B TYPE-I; SCAVENGER RECEPTORS; PHOSPHOINOSITIDE 3-KINASE; SELECTIVE INHIBITORS; HISTAMINE-SECRETION; OXIDE NANOPARTICLES; ACTIVATION; TOXICITY; MECHANISM	Engineered nanomaterial (ENM)-mediated toxicity often involves triggering immune responses. Mast cells can regulate both innate and adaptive immune responses and are key effectors in allergic diseases and inflammation. Silver nanoparticles (AgNPs) are one of the most prevalent nanomaterials used in consumer products due to their antimicrobial properties. We have previously shown that AgNPs induce mast cell degranulation that was dependent on nanoparticle physicochemical properties. Furthermore, we identified a role for scavenger receptor B1 (SR-B1) in AgNP-mediated mast cell degranulation. However, it is completely unknown how SR-B1 mediates mast cell degranulation and the intracellular signaling pathways involved. In the current study, we hypothesized that SR-B1 interaction with AgNPs directs mast cell degranulation through activation of signal transduction pathways that culminate in an increase in intracellular calcium signal leading to mast cell degranulation. For these studies, we utilized bone marrow-derived mast cells (BMMC) isolated from C57BI/6 mice and RBL-2H3 cells (rat basophilic leukemia cell line). Our data support our hypothesis and show that AgNP-directed mast cell degranulation involves activation of PI3K, PLC gamma and an increase in intracellular calcium levels. Moreover, we found that influx of extracellular calcium is required for the cells to degranulate in response to AgNP exposure and is mediated at least partially via the CRAC channels. Taken together, our results provide new insights into AgNP-induced mast cell activation that are key for designing novel ENMs that are devoid of immune system activation.	[Alsaleh, Nasser B.; Persaud, Indushekhar; Brown, Jared M.] Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Brown, JM (corresponding author), Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	jared.brown@ucdenver.edu	ALSALEH, NASSER/AAY-3067-2020	ALSALEH, NASSER/0000-0002-2650-5934	Saudi Arabian Cultural Mission (SACM); King Saud University(KSU); National Institute of Environmental Health Sciences [R01 ES019311]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019311] Funding Source: NIH RePORTER	Saudi Arabian Cultural Mission (SACM); King Saud University(KSU); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NBA is supported by Studentships from Saudi Arabian Cultural Mission (SACM) and King Saud University(KSU) (no grant number) (http:// ksu.edu.sa/en/). This work was supported by the National Institute of Environmental Health Sciences grant R01 ES019311 (JMB) (http://www.niehs.nih.gov/). The funders had no role in design, analysis, decision to publish or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Aldossari AA, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3116-0; Aldossari AA, 2015, TOXICOL IN VITRO, V29, P195, DOI 10.1016/j.tiv.2014.10.008; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bonner JC, 2013, ENVIRON HEALTH PERSP, V121, P676, DOI 10.1289/ehp.1205693; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chen EY, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-2; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006; Christensen FM, 2010, NANOTOXICOLOGY, V4, P284, DOI 10.3109/17435391003690549; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dobrovolskaia MA, 2016, TOXICOL APPL PHARM, V299, P78, DOI 10.1016/j.taap.2015.12.022; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Grundy S, 2014, CLIN SCI, V126, P223, DOI 10.1042/CS20130152; Guo DD, 2013, INT J BIOCHEM CELL B, V45, P1849, DOI 10.1016/j.biocel.2013.06.002; Guo H, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0133-9; Hamilton RF, 2014, INT J MOL SCI, V15, P6815, DOI 10.3390/ijms15046815; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Inoue T, 2009, J LEUKOCYTE BIOL, V86, P167, DOI [10.1189/JLB.1108691, 10.1189/jlb.1108691]; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kettiger H, 2013, INT J NANOMED, V8, P3255, DOI 10.2147/IJN.S49770; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Lam V, 2003, BLOOD, V102, P1405, DOI 10.1182/blood-2002-10-3176; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; MAEYAMA K, 1986, J BIOL CHEM, V261, P2583; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Nishanth RP, 2011, NANOTOXICOLOGY, V5, P502, DOI 10.3109/17435390.2010.541604; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Okayama Y, 2003, EUR J IMMUNOL, V33, P1450, DOI 10.1002/eji.200323563; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; OZAWA K, 1993, J BIOL CHEM, V268, P2280; Park EJ, 2010, ENVIRON TOXICOL PHAR, V30, P162, DOI 10.1016/j.etap.2010.05.004; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Patel PC, 2010, BIOCONJUGATE CHEM, V21, P2250, DOI 10.1021/bc1002423; Pernas-Sueiras O, 2006, J CELL BIOCHEM, V99, P1651, DOI 10.1002/jcb.21009; Rauch J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00868; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Recordati C, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0124-x; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Roy R, 2014, TOXICOL LETT, V230, P421, DOI 10.1016/j.toxlet.2014.08.008; Sabuncu AC, 2012, COLLOID SURFACE B, V95, P96, DOI 10.1016/j.colsurfb.2012.02.022; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Santoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00034; SCHILLING CG, 1988, AM J HOSP PHARM, V45, P313, DOI 10.1093/ajhp/45.2.313; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; SELDIN DC, 1985, P NATL ACAD SCI USA, V82, P3871, DOI 10.1073/pnas.82.11.3871; Shannahan JH, 2015, TOXICOL SCI, V143, P136, DOI 10.1093/toxsci/kfu217; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Suresh AK, 2010, ENVIRON SCI TECHNOL, V44, P5210, DOI 10.1021/es903684r; Suzuki Y, 2002, J IMMUNOL, V169, P3954, DOI 10.4049/jimmunol.169.7.3954; Sydlik U, 2006, AM J PHYSIOL-LUNG C, V291, pL725, DOI 10.1152/ajplung.00131.2006; Tang ML, 2008, ENVIRON HEALTH PERSP, V116, P915, DOI 10.1289/ehp.11225; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Tsou TC, 2013, TOXICOL APPL PHARM, V273, P492, DOI 10.1016/j.taap.2013.09.014; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Visnapuu M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/819252; Walczak-Drzewiecka A, 2003, ENVIRON HEALTH PERSP, V111, P708, DOI 10.1289/ehp.5960; Weldon BA, 2016, NANOTOXICOLOGY, V10, P945, DOI 10.3109/17435390.2016.1148793; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x; Yoshimaru T, 2006, FREE RADICAL BIO MED, V40, P1949, DOI 10.1016/j.freeradbiomed.2006.01.023; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zhu PM, 2009, J BIOL CHEM, V284, P22878, DOI 10.1074/jbc.M109.018580	83	39	41	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167366	10.1371/journal.pone.0167366	http://dx.doi.org/10.1371/journal.pone.0167366			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907088	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700131
J	Barnabas, K; Zhang, L; Wang, HY; Kirouac, G; Vrontakis, M				Barnabas, Karen; Zhang, Lin; Wang, Huiying; Kirouac, Gilbert; Vrontakis, Maria			Changes in Galanin Systems in a Rat Model of Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							PREPROGALANIN MESSENGER-RNA; CHRONIC RESTRAINT STRESS; LOCUS-COERULEUS; CENTRAL AMYGDALA; ANXIOLYTIC-LIKE; FOOT-SHOCKS; EXPRESSION; ANXIETY; DEPRESSION; RESPONSES	Post-traumatic stress disorder (PTSD) is a chronic syndrome triggered by exposure to trauma and a failure to recover from a normal negative emotional reaction to traumatic stress. The neurobiology of PTSD and the participation of neuropeptides in the neural systems and circuits that control fear and anxiety are not fully understood. The long-term dysregulation of neuropeptide systems contributes to the development of anxiety disorders, including PTSD. The neuropeptide galanin (Gal) and its receptors participate in anxiety-like and depression-related behaviors via the modulation of neuroendocrine and monoaminergic systems. The objective of this research was to investigate how Gal expression changes in the brain of rats 2 weeks after exposure to footshock. Rats exposed to footshocks were subdivided into high responders (HR; immobility>60%) and low responders (LR; immobility<40%) based on immobility elicited by a novel tone one day after exposure. On day 14, rats were anesthetized, and the amygdala, hypothalamus, pituitary and adrenal glands were removed for analysis using real-time polymerase chain reaction (RT-PCR). Gal mRNA levels were increased in the amygdala and hypothalamus of HR compared with the control and LR. In contrast, Gal mRNA levels were decreased in the adrenal and pituitary glands of HR compared with the control and LR. Thus, the differential regulation (dysregulation) of the neuropeptide Gal in these tissues may contribute to anxiety and PTSD development.	[Barnabas, Karen; Zhang, Lin; Vrontakis, Maria] Univ Manitoba, Fac Med, Winnipeg, MB, Canada; [Wang, Huiying; Kirouac, Gilbert] Univ Manitoba, Fac Dent, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Vrontakis, M (corresponding author), Univ Manitoba, Fac Med, Winnipeg, MB, Canada.	Maria.Vrontakis@umanitoba.ca		Wang, Huiying/0000-0001-7219-122X; Kirouac, Gilbert/0000-0002-3632-2189	University Res Grant Program (URGP) [UM44541]	University Res Grant Program (URGP)	This work was supported by the University Res Grant Program (URGP), grant UM44541 (https://umanitoba.ca/research/ors/media/Guidelines_URG.pdf). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera G, 2005, NEUROPEPTIDES, V39, P289, DOI 10.1016/j.npep.2004.12.008; Barrera G, 2006, SYNAPSE, V59, P27, DOI 10.1002/syn.20208; BING O, 1993, NEUROSCI LETT, V164, P17, DOI 10.1016/0304-3940(93)90846-D; Bonne O, 2004, NEUROSCI BIOBEHAV R, V28, P65, DOI 10.1016/j.neubiorev.2003.12.001; Bruijnzeel AW, 2001, PSYCHOPHARMACOLOGY, V158, P132; Bruijnzeel AW, 2001, EUR J PHARMACOL, V426, P77, DOI 10.1016/S0014-2999(01)01210-9; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen XY, 2014, BRAIN STRUCT FUNCT, V219, P2103, DOI 10.1007/s00429-013-0626-3; Chen XY, 2012, BEHAV BRAIN RES, V226, P112, DOI 10.1016/j.bbr.2011.09.004; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Davidson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2211, DOI 10.1038/npp.2011.93; Heim C, 2009, CNS SPECTRUMS, V14, P13; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Holmes A, 2013, TRENDS NEUROSCI, V36, P23, DOI 10.1016/j.tins.2012.11.003; HOLMES PV, 1995, PHARMACOL BIOCHEM BE, V50, P655, DOI 10.1016/0091-3057(94)00334-3; Karlsson RM, 2006, AMINO ACIDS, V31, P231, DOI 10.1007/s00726-006-0336-8; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; Khoshbouei H, 2002, NEUROPSYCHOPHARMACOL, V27, P25, DOI 10.1016/S0893-133X(01)00424-9; Kolakowski LF, 1998, J NEUROCHEM, V71, P2239; Kozlovsky N, 2009, BIOL PSYCHIAT, V65, P383, DOI 10.1016/j.biopsych.2008.10.034; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Louvart N, 2005, PSYCHONEUROENDOCRINO, V30, P316, DOI 10.1016/j.psyneuen.2004.09.003; Madaan V, 2009, DRUG NEWS PERSPECT, V22, P319, DOI 10.1358/dnp.2009.22.6.1395255; MALENDOWICZ LK, 1994, ENDOCR RES, V20, P307, DOI 10.1080/07435809409035866; Max MB, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-14; Mennicken F, 2002, J CHEM NEUROANAT, V24, P257, DOI 10.1016/S0891-0618(02)00068-6; Mikics E, 2008, PSYCHONEUROENDOCRINO, V33, P1198, DOI 10.1016/j.psyneuen.2008.06.006; Moller C, 1999, NEUROPSYCHOPHARMACOL, V21, P507, DOI 10.1016/S0893-133X(98)00102-X; Murck H, 2004, PSYCHONEUROENDOCRINO, V29, P1205, DOI 10.1016/j.psyneuen.2004.02.006; Narvaez M, 2015, BRAIN STRUCT FUNCT, V220, P2289, DOI 10.1007/s00429-014-0788-7; O'Neal HA, 2001, NEUROSCI LETT, V299, P69, DOI 10.1016/S0304-3940(00)01780-8; Palkovits M, 2000, EUR J PHARMACOL, V405, P161, DOI 10.1016/S0014-2999(00)00549-5; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sergeyev V, 2005, PSYCHOPHARMACOLOGY, V178, P115, DOI 10.1007/s00213-004-2015-3; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P558, DOI 10.1016/j.neubiorev.2007.01.001; Swanson CJ, 2005, P NATL ACAD SCI USA, V102, P17489, DOI 10.1073/pnas.0508970102; Sweerts BW, 2000, BRAIN RES, V873, P318, DOI 10.1016/S0006-8993(00)02558-0; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; Unschuld PG, 2008, J AFFECT DISORDERS, V105, P177, DOI 10.1016/j.jad.2007.05.006; Unschuld PG, 2010, NEUROPSYCHOPHARMACOL, V35, P1583, DOI 10.1038/npp.2010.30; Vermetten E, 2002, DEPRESS ANXIETY, V16, P14, DOI 10.1002/da.10017; Vrontakis ME, 2002, CNS NEUROL DISORD-DR, V1, P533, DOI 10.2174/1568007023338914; Wang YQ, 1999, GEN COMP ENDOCR, V113, P38, DOI 10.1006/gcen.1998.7174; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Xu ZQD, 2001, NEUROREPORT, V12, P1779, DOI 10.1097/00001756-200106130-00052; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033901	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167569	10.1371/journal.pone.0167569	http://dx.doi.org/10.1371/journal.pone.0167569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907151	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700198
J	Brailovskaia, J; Margraf, J				Brailovskaia, Julia; Margraf, Juergen			Comparing Facebook Users and Facebook Non-Users: Relationship between Personality Traits and Mental Health Variables - An Exploratory Study	PLOS ONE			English	Article							SOCIAL NETWORKING SITE; STRESS SCALES DASS-21; DUAL-FACTOR MODEL; SELF-ESTEEM; DEPRESSION ANXIETY; PSYCHOMETRIC PROPERTIES; LIFE SATISFACTION; COLLEGE-STUDENTS; SHORT VERSION; NARCISSISM	Over one billion people use Facebook as a platform for social interaction and self-presentation making it one of the most popular online sites. The aim of the present study was to investigate differences in various personality traits and mental health variables between Facebook users and people who do not use this platform. The data of 945 participants (790 Facebook users, 155 Facebook non-users) were collected. Results indicate that Facebook users score significantly higher on narcissism, self-esteem and extraversion than Facebook non-users. Furthermore, they have significantly higher values of social support, life satisfaction and subjective happiness. Facebook non-users have (marginally) significantly higher values of depression symptoms than Facebook users. In both groups, extraversion, self-esteem, happiness, life satisfaction, resilience and social support, on the one hand, and depression, anxiety and stress symptoms, on the other hand, are negatively correlated. Neuroticism is positively associated with depression, anxiety and stress symptoms. However, significant differences exist between Facebook users and Facebook non-users regarding some associations of personality traits and mental health variables. Compared to Facebook non-users, the present results indicate that Facebook users have higher values of certain personality traits and positive variables protecting mental health. These findings are of particular interest considering the high importance of social online-platforms in the daily life of many people.	[Brailovskaia, Julia; Margraf, Juergen] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany	Ruhr University Bochum	Brailovskaia, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany.	julia.brailovskaia@rub.de	Margraf, Jürgen/A-6873-2008; Brailovskaia, Julia/AAN-7333-2021	Margraf, Jürgen/0000-0001-5207-7016; Brailovskaia, Julia/0000-0001-7607-1305	Alexander von Humboldt Professorship; Open Access Publication Funds of the Ruhr-Universitat Bochum	Alexander von Humboldt Professorship(Alexander von Humboldt Foundation); Open Access Publication Funds of the Ruhr-Universitat Bochum	This study was supported by Alexander von Humboldt Professorship awarded to Jurgen Margraf by the Alexander von Humboldt Foundation. Furthermore, we acknowledge support by the Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichai-Hamburger Y, 2010, COMPUT HUM BEHAV, V26, P1289, DOI 10.1016/j.chb.2010.03.018; [Anonymous], 2012, J BUS MEDIA PSYCHOL; Antaramian SP, 2010, AM J ORTHOPSYCHIAT, V80, P462, DOI 10.1111/j.1939-0025.2010.01049.x; Bieda A, PSYCHOL ASSESS IN PR; Brailovskaia J., 2013, NARZISSTISCH UND SEN; Brailovskaia J, 2016, COMPUT HUM BEHAV, V55, P251, DOI 10.1016/j.chb.2015.09.018; Buffardi LE, 2008, PERS SOC PSYCHOL B, V34, P1303, DOI 10.1177/0146167208320061; Cabral, 2011, ELON J UNDERGRADUATE, V18, P5; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P358, DOI 10.1177/0146167202286007; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Collani G., 2003, Z DIFFERENTIELLE DIA, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Connor KM, 2006, CNS SPECTRUMS, V11, P5, DOI 10.1017/S1092852900025797; Constine J., 2016, TECHCRUNCH, V1, P27; Corp S., 2012, IBM SPSS STATISTICS; Correa T, 2010, COMPUT HUM BEHAV, V26, P247, DOI 10.1016/j.chb.2009.09.003; Davila J, 2012, PSYCHOL POP MEDIA CU, V1, P72, DOI 10.1037/a0027512; De Raad B, 1998, EUR PSYCHOL, V3, P113, DOI 10.1027/1016-9040.3.2.113; DeWall CN, 2011, PERS INDIV DIFFER, V51, P57, DOI 10.1016/j.paid.2011.03.011; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Ellison NB, 2011, NEW MEDIA SOC, V13, P873, DOI 10.1177/1461444810385389; Friborg O, 2006, J PSYCHOSOM RES, V61, P213, DOI 10.1016/j.jpsychores.2005.12.007; Fydrich T., 2009, Z MED PSYCHOL, V18, P43, DOI DOI 10.1026//0012-1924.45.4.212; Gentile B, 2013, PSYCHOL ASSESSMENT, V25, P1120, DOI 10.1037/a0033192; German Federal Statistical Office, 2016, STAT YB, P208; Glaesmer H, 2011, EUR J PSYCHOL ASSESS, V27, P127, DOI 10.1027/1015-5759/a000058; Hargittai E, 2007, J COMPUT-MEDIAT COMM, V13, P276, DOI 10.1111/j.1083-6101.2007.00396.x; Hayes M, 2015, COMPUT HUM BEHAV, V49, P507, DOI 10.1016/j.chb.2015.03.040; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hollenbaugh EE, 2014, COMPUT HUM BEHAV, V30, P50, DOI 10.1016/j.chb.2013.07.055; Hsu CW, 2011, CYBERPSYCH BEH SOC N, V14, P473, DOI 10.1089/cyber.2010.0267; Huang C, 2010, CYBERPSYCH BEH SOC N, V13, P241, DOI 10.1089/cyber.2009.0217; Iecovich E, 2004, J MARRIAGE FAM, V66, P306, DOI 10.1111/j.1741-3737.2004.00022.x; Jelenchick LA, 2013, J ADOLESCENT HEALTH, V52, P128, DOI 10.1016/j.jadohealth.2012.05.008; Kalpidou M, 2011, CYBERPSYCH BEH SOC N, V14, P183, DOI 10.1089/cyber.2010.0061; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Kim J, 2011, CYBERPSYCH BEH SOC N, V14, P359, DOI 10.1089/cyber.2010.0374; Kross E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069841; Kuo T, 2014, COMPUT HUM BEHAV, V31, P13, DOI 10.1016/j.chb.2013.10.019; Leppert K., 2003, DIAGNOSTISCHE VERFAH, V2, P295; Leppert K, 2003, DIAGNOSTISCHE VERFAH, V1, P295; Leppert K., 2008, KLIN DIAGNOSTIK EVAL, V1, P226; Lin RY, 2015, COMPUT HUM BEHAV, V52, P29, DOI 10.1016/j.chb.2015.04.064; Ljepava N, 2013, COMPUT HUM BEHAV, V29, P1602, DOI 10.1016/j.chb.2013.01.026; Lovibond SH, 1995, MANUAL DEPRESSION AN; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lyubomirsky S, 2006, SOC INDIC RES, V78, P363, DOI 10.1007/s11205-005-0213-y; Margraf J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150312; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mehdizadeh S, 2010, CYBERPSYCH BEH SOC N, V13, P357, DOI 10.1089/cyber.2009.0257; Meshi D, 2015, TRENDS COGN SCI, V19, P771, DOI 10.1016/j.tics.2015.09.004; Michikyan M, 2014, COMPUT HUM BEHAV, V33, P179, DOI 10.1016/j.chb.2014.01.010; Moore K, 2012, COMPUT HUM BEHAV, V28, P267, DOI 10.1016/j.chb.2011.09.009; Moreno MA, 2011, DEPRESS ANXIETY, V28, P447, DOI 10.1002/da.20805; Nadkarni A, 2012, PERS INDIV DIFFER, V52, P243, DOI 10.1016/j.paid.2011.11.007; Ng F, 2007, ACTA NEUROPSYCHIATR, V19, P304, DOI 10.1111/j.1601-5215.2007.00217.x; Norton PJ, 2007, ANXIETY STRESS COPIN, V20, P253, DOI 10.1080/10615800701309279; Okamoto J, 2011, RES HUM DEV, V8, P67, DOI 10.1080/15427609.2011.549711; Ong EYL, 2011, PERS INDIV DIFFER, V50, P180, DOI 10.1016/j.paid.2010.09.022; Orr ES, 2009, CYBERPSYCHOL BEHAV, V12, P337, DOI 10.1089/cpb.2008.0214; Pantic I, 2012, PSYCHIAT DANUB, V24, P90; Raacke J, 2008, CYBERPSYCHOL BEHAV, V11, P169, DOI 10.1089/cpb.2007.0056; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Renshaw TL, 2014, SOC INDIC RES, V117, P319, DOI 10.1007/s11205-013-0342-7; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rohmann E, 2012, EUR PSYCHOL, V17, P279, DOI 10.1027/1016-9040/a000100; Rosen L., 2012, IDISORDER UNDERSTAND; Rosen LD, 2013, COMPUT HUM BEHAV, V29, P1243, DOI 10.1016/j.chb.2012.11.012; Ross C, 2009, COMPUT HUM BEHAV, V25, P578, DOI 10.1016/j.chb.2008.12.024; Ryan T, 2011, COMPUT HUM BEHAV, V27, P1658, DOI 10.1016/j.chb.2011.02.004; SARASON BR, 2001, PERS RELATIONSHIP, P15; Schimmack U, 2003, J RES PERS, V37, P100, DOI 10.1016/S0092-6566(02)00532-9; Schonfeld P, 2016, INT J CLIN HLTH PSYC, V16, P1, DOI 10.1016/j.ijchp.2015.08.005; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Schutz A, 2004, DIAGNOSTICA, V50, P202, DOI 10.1026/0012-1924.50.4.202; Shteyn M, 2003, J COMMUNITY PSYCHOL, V31, P113, DOI 10.1002/jcop.10042; Smith BW, 2002, HEALTH PSYCHOL, V21, P81, DOI 10.1037//0278-6133.21.1.81; Steers MLN, 2014, J SOC CLIN PSYCHOL, V33, P701, DOI 10.1521/jscp.2014.33.8.701; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; STEVENS JP, 1980, PSYCHOL BULL, V88, P728, DOI 10.1037/0033-2909.88.3.728; Stewart J.B., 2016, IT WANTS MORE; Suldo SM, 2008, SCHOOL PSYCHOL REV, V37, P52; Tosun LP, 2012, COMPUT HUM BEHAV, V28, P1510, DOI 10.1016/j.chb.2012.03.018; Triandis H. C., 1988, PERSONALITY ATTITUDE, P60; Twenge JM, 2008, J PERS, V76, P875, DOI 10.1111/j.1467-6494.2008.00507.x; Twenge JM, 2009, THE NARCISSISM EPIDE; Twenge JM, 2012, MILLENNIALS THE GREA; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Valkenburg PM, 2006, CYBERPSYCHOL BEHAV, V9, P584, DOI 10.1089/cpb.2006.9.584; van der Aa N, 2009, J YOUTH ADOLESCENCE, V38, P765, DOI 10.1007/s10964-008-9298-3; Wang JL, 2012, COMPUT HUM BEHAV, V28, P2313, DOI 10.1016/j.chb.2012.07.001; World Health Organization, 2001, THE WORLD HEALTH REP; Zywica J, 2008, J COMPUT-MEDIAT COMM, V14, P1, DOI 10.1111/j.1083-6101.2008.01429.x	97	54	55	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166999	10.1371/journal.pone.0166999	http://dx.doi.org/10.1371/journal.pone.0166999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907020	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700061
J	Govindarajan, K; MacSharry, J; Casey, PG; Shanahan, F; Joyce, SA; Gahan, CGM				Govindarajan, Kalaimathi; MacSharry, John; Casey, Patrick G.; Shanahan, Fergus; Joyce, Susan A.; Gahan, Cormac G. M.			Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk	PLOS ONE			English	Article							DIURNAL-VARIATION; GUT; HOMEOSTASIS; CLOCK; ENTRAINMENT; METABOLISM; REGULATORS; PHYSIOLOGY; RECEPTORS; BACTERIA	Disruptions to circadian rhythm in mice and humans have been associated with an increased risk of obesity and metabolic syndrome. The gut microbiota is known to be essential for the maintenance of circadian rhythm in the host suggesting a role for microbe-host interactions in the regulation of the peripheral circadian clock. Previous work suggested a role for gut bacterial bile salt hydrolase (BSH) activity in the regulation of host circadian gene expression. Here we demonstrate that unconjugated bile acids, known to be generated through the BSH activity of the gut microbiota, are potentially chronobiological regulators of host circadian gene expression. We utilised a synchronised Caco-2 epithelial colorectal cell model and demonstrated that unconjugated bile acids, but not the equivalent tauro-conjugated bile salts, enhance the expression levels of genes involved in circadian rhythm. In addition oral administration of mice with unconjugated bile acids significantly altered expression levels of circadian clock genes in the ileum and colon as well as the liver with significant changes to expression of hepatic regulators of circadian rhythm (including Dbp) and associated genes (Per2, Per3 and Cry2). The data demonstrate a potential mechanism for microbe-host crosstalk that significantly impacts upon host circadian gene expression.	[Govindarajan, Kalaimathi; MacSharry, John; Casey, Patrick G.; Shanahan, Fergus; Joyce, Susan A.; Gahan, Cormac G. M.] Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [MacSharry, John; Gahan, Cormac G. M.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [MacSharry, John; Shanahan, Fergus] Univ Coll Cork, Sch Med, Cork, Ireland; [Joyce, Susan A.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Gahan, Cormac G. M.] Univ Coll Cork, Sch Pharm, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Joyce, SA; Gahan, CGM (corresponding author), Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.; Gahan, CGM (corresponding author), Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Joyce, SA (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.; Gahan, CGM (corresponding author), Univ Coll Cork, Sch Pharm, Cork, Ireland.	s.joyce@ucc.ie; c.gahan@ucc.ie	Joyce, Susan/ABE-2616-2020; Gahan, Cormac G/AAE-9346-2019; Sharry, John A Mac/M-7209-2017; Shanahan, Fergus/ABF-2390-2020	Joyce, Susan/0000-0003-4771-3123; Gahan, Cormac G/0000-0003-2385-8192; Sharry, John A Mac/0000-0002-9528-6261; Shanahan, Fergus/0000-0003-0467-0936	Health Research Board Ireland [HRA-POR-2013-296]; Science Foundation Ireland (SFI) [SFI/12/RC/2273]	Health Research Board Ireland; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was supported by Health Research Board Ireland (grant number HRA-POR-2013-296): http://www.hrb.ie/home/ and Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2273, http://www.sfi.ie/.	Ballesta A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002143; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Dey N, 2015, CELL, V163, P95, DOI 10.1016/j.cell.2015.08.059; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hu X, 2014, J INTERN MED, V275, P27, DOI 10.1111/joim.12140; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Joyce SA, 2014, GUT MICROBES, V5, P669, DOI 10.4161/19490976.2014.969986; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Mistlberger RE, 2011, ESSAYS BIOCHEM, V49, P119, DOI [10.1042/BSE0490119, 10.1042/bse0490119]; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Montagner A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20127; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048	31	64	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167319	10.1371/journal.pone.0167319	http://dx.doi.org/10.1371/journal.pone.0167319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907092	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700119
J	Ma, X; Guo, J; Sun, X				Ma, Xin; Guo, Jing; Sun, Xiao			DNABP: Identification of DNA-Binding Proteins Based on Feature Selection Using a Random Forest and Predicting Binding Residues	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; SEQUENCE-BASED PREDICTION; AMINO-ACID-COMPOSITION; MRMR FEATURE-SELECTION; RIBOSOMAL-RNA-BINDING; WEB SERVER; INFORMATION; SVM; REDUNDANCY; RELEVANCE	DNA-binding proteins are fundamentally important in cellular processes. Several computational -based methods have been developed to improve the prediction of DNA-binding proteins in previous years. However, insufficient work has been done on the prediction of DNA binding proteins from protein sequence information. In this paper, a novel predictor, DNABP (DNA-binding proteins), was designed to predict DNA-binding proteins using the random forest (RF) classifier with a hybrid feature. The hybrid feature contains two types of novel sequence features, which reflect information about the conservation of physicochemical properties of the amino acids, and the binding propensity of DNA-binding residues and nonbinding propensities of non-binding residues. The comparisons with each feature demonstrated that these two novel features contributed most to the improvement in predictive ability. Furthermore, to improve the prediction performance of the DNABP model, feature selection using the minimum redundancy maximum relevance (mRMR) method combined with incremental feature selection (IFS) was carried out during the model construction. The results showed that the DNABP model could achieve 86.90% accuracy, 83.76% sensitivity, 90.03% specificity and a Matthews correlation coefficient of 0.727. High prediction accuracy and performance comparisons with previous research suggested that DNABP could be a useful approach to identify DNA-binding proteins from sequence information.	[Ma, Xin] Nanjing Audit Univ, Sch Sci, Nanjing, Jiangsu, Peoples R China; [Guo, Jing; Sun, Xiao] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Nanjing Audit University; Southeast University - China	Ma, X (corresponding author), Nanjing Audit Univ, Sch Sci, Nanjing, Jiangsu, Peoples R China.	maxin@nau.edu.cn		Ma, Xin/0000-0002-8101-7271	National Natural Science Foundation of China [61305072]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [14KJB520020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 61305072) http://www.nsfc.gov.cn/ and had the data collection and analysis, decision to publish. This work was also supported by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 14KJB520020) and had study design and also by the Qing Lan Project and had preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bonchev D, 2001, J CHEM INF COMP SCI, V41, P582, DOI 10.1021/ci000104t; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19062; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Gao YF, 2013, MOL BIOSYST, V9, P61, DOI 10.1039/c2mb25327e; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Ho SY, 2007, BIOSYSTEMS, V90, P234, DOI 10.1016/j.biosystems.2006.08.007; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Imamova LR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1152; Kawashima Shuichi, 2000, NUCL ACIDS RES, V28, P374; KRAJEWSKA WM, 1992, INT J BIOCHEM, V24, P1885, DOI 10.1016/0020-711X(92)90284-8; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu B, 2016, IEEE T NANOBIOSCI, V15, P328, DOI 10.1109/TNB.2016.2555951; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15479; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Lou WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086703; Luscombe NM, 2000, GENOME BIOL, V1; Ma X, 2014, J THEOR BIOL, V360, P59, DOI 10.1016/j.jtbi.2014.06.037; Ma X, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/524502; Ma X, 2012, IEEE ACM T COMPUT BI, V9, P1766, DOI 10.1109/TCBB.2012.106; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Szaboova A, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-66; Vapnik Vladimir N., 1998, STATISICAL LEARNING; Veljkovic V, 2007, CURR MED CHEM, V14, P441, DOI 10.2174/092986707779941014; WANG J, 2002, BIOCH HIGHER ED; Wang J, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S9; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang LJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S1; Wang R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23934; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xu RF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/294279; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107464; Zhang YP, 2014, COMPUT BIOL CHEM, V52, P51, DOI 10.1016/j.compbiolchem.2014.09.002; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	56	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167345	10.1371/journal.pone.0167345	http://dx.doi.org/10.1371/journal.pone.0167345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907159	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700124
J	Meier, A; Higashigaito, K; Martini, K; Wurnig, M; Seifert, B; Keller, D; Frauenfelder, T; Alkadhi, H				Meier, Andreas; Higashigaito, Kai; Martini, Katharina; Wurnig, Moritz; Seifert, Burkhardt; Keller, Dagmar; Frauenfelder, Thomas; Alkadhi, Hatem			Dual Energy CT Pulmonary Angiography with 6g Iodine-A Propensity Score-Matched Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; DEEP-VEIN THROMBOSIS; CONTRAST-MEDIA; IMAGE QUALITY; TUBE VOLTAGE; CHEST CT; EMBOLISM; OPTIMIZATION; PROTOCOLS; NEPHROPATHY	Objective To evaluate the performance of low contrast media (CM) dose dual-energy computed tomography pulmonary angiography (CTPA) with advanced monoenergetic reconstructions in patients with suspected pulmonary embolism (PE). Materials and Methods The study had institutional review board approval; all patients gave written informed consent. Forty-one patients (25 men, 16 women, mean age 62.9 +/- 14.7 years) undergoing low CM dose (15ml, 6g iodine) dual-energy CTPA with advanced monoenergetic reconstructions were matched via propensity-scoring based on logistic regression analysis with a comparison group of 41 patients (24 men, 17 women, mean age 62.7 +/- 13.9 years) undergoing standard CM dose single-energy CTPA (80ml, 24g iodine). Subjective (noise, artifacts) and objective (attenuation, noise, contrast-to-noise ratio (CNR)) image quality was assessed by two blinded, independent readers. All patients underwent clinical follow-up after three months for evaluation of adverse events. Results Interrater agreement for subjective image quality in both groups ranged from fair to excellent (ICC: 0.46-0.84); agreement for objective image quality was excellent (ICC: 0.83-0.93). There was no significant difference regarding subjective noise (p = 0.15-0.72) and artifacts (p = 0.16-1) between the low and the standard CM dose group. There was no significant difference regarding CNR between the CM dose groups (p = 0.11-0.87). Seven of the 41 (17%) patients in the low and 5/41 (12%) in the standard CM dose group were diagnosed with PE (p = 0.32). No patient suffered from subsequent PE or PE-associated death during the follow-up period. Conclusion Dual-energy CTPA with advanced monoenergetic reconstruction is feasible with 6g iodine and allows for the diagnosis and safe exclusion of central, lobar, and segmental PE.	[Meier, Andreas; Higashigaito, Kai; Martini, Katharina; Wurnig, Moritz; Frauenfelder, Thomas; Alkadhi, Hatem] Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Dept Biostat, Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Keller, Dagmar] Univ Zurich, Univ Zurich Hosp, Interdisciplinary Emergency Dept, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Meier, A (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.	andreas.meier@usz.ch	Martini, Katharina/AAW-7995-2020; Frauenfelder, Thomas/O-1734-2016	Frauenfelder, Thomas/0000-0002-3295-6619; Seifert, Burkhardt/0000-0002-5829-2478; Wurnig, Moritz/0000-0001-7865-4010; Meier, Andreas/0000-0003-3669-8677				Bae KT, 2003, RADIOLOGY, V227, P809, DOI 10.1148/radiol.2273020102; Beckett KR, 2015, RADIOGRAPHICS, V35, P1738, DOI 10.1148/rg.2015150033; Belohlavek J, 2013, EXP CLIN CARDIOL, V18, P129; Davenport MS, 2013, RADIOLOGY, V267, P94, DOI 10.1148/radiol.12121394; Deinzer CKW, 2014, CONTRAST MEDIA MOL I, V9, P259, DOI 10.1002/cmmi.1567; Delesalle MA, 2013, RADIOLOGY, V267, P256, DOI 10.1148/radiol.12120195; Ghaye B, 2006, RADIOLOGY, V240, P256, DOI 10.1148/radiol.2401050350; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Gosselin MV, 2004, J THORAC IMAG, V19, P1, DOI 10.1097/00005382-200401000-00001; Grant KL, 2014, INVEST RADIOL, V49, P586, DOI 10.1097/RLI.0000000000000060; Hendriks BMF, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150850; Higashigaito K, 2016, INVEST RADIOL, V51, P241, DOI 10.1097/RLI.0000000000000233; Husarik DB, 2015, INVEST RADIOL, V50, P695, DOI 10.1097/RLI.0000000000000171; Jones SE, 2005, RADIOLOGY, V237, P329, DOI 10.1148/radiol.2371041520; Lell MM, 2015, INVEST RADIOL, V50, P161, DOI 10.1097/RLI.0000000000000119; Likert R, 1932, TECHNIQUE MEASUREMEN; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; McDonald JS, 2014, RADIOLOGY, V271, P65, DOI 10.1148/radiol.13130775; McDonald RJ, 2013, RADIOLOGY, V267, P106, DOI 10.1148/radiol.12121823; Mehran R, 2006, KIDNEY INT, V69, pS11, DOI 10.1038/sj.ki.5000368; Meier A, 2015, CLIN RADIOL, V70, P1244, DOI 10.1016/j.crad.2015.06.094; Meinel FG, 2014, EUR RADIOL, V24, P1643, DOI 10.1007/s00330-014-3194-x; Nance JW, 2012, INVEST RADIOL, V47, P78, DOI 10.1097/RLI.0b013e31821a2142; Odutayo A, 2012, CAN J ANESTH, V59, P934, DOI 10.1007/s12630-012-9761-1; Qanadli SD, 2000, RADIOLOGY, V217, P447, DOI 10.1148/radiology.217.2.r00nv01447; Quiroz R, 2005, JAMA-J AM MED ASSOC, V293, P2012, DOI 10.1001/jama.293.16.2012; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; Sabel BO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146949; Saltybaeva N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155722; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Streiff MB, 2016, J THROMB THROMBOLYS, V41, P32, DOI 10.1007/s11239-015-1317-0; Szucs-Farkas Z, 2008, INVEST RADIOL, V43, P871, DOI 10.1097/RLI.0b013e3181875e86; Thomsen HS, 2014, APPENDIX A ESUR GUID, P257; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Weininger M, 2011, AM J ROENTGENOL, V196, pW260, DOI 10.2214/AJR.10.5814; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Yu LF, 2009, MED PHYS, V36, P1019, DOI 10.1118/1.3077921	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167214	10.1371/journal.pone.0167214	http://dx.doi.org/10.1371/journal.pone.0167214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907049	gold, Green Published			2022-12-27	WOS:000389482700093
J	Pagan, I; Rojas, P; Ramos, JT; Holguin, A				Pagan, Israel; Rojas, Patricia; Ramos, Jose Tomas; Holguin, Africa			Clinical Determinants of HIV-1B Between-Host Evolution and their Association with Drug Resistance in Pediatric Patients	PLOS ONE			English	Article							NON-B SUBTYPES; DISEASE PROGRESSION; GENETIC DIVERSITY; PERINATAL TRANSMISSION; WITHIN-HOST; VIRUS; POPULATION; INDIVIDUALS; CHILDREN; RATES	Understanding the factors that modulate the evolution of virus populations is essential to design efficient control strategies. Mathematical models predict that factors affecting viral within-host evolution may also determine that at the between-host level. Although HIV-1 within-host evolution has been associated with clinical factors used to monitor AIDS progression, such as patient age, CD4 cells count, viral load, and antiretroviral experience, little is known about the role of these clinical factors in determining between-host HIV-1 evolution. Moreover, whether the relative importance of such factors in HIV-1 evolution vary in adult and children patients, in which the course of infection is different, has seldom been analysed. To address these questions, HIV-1 subtype B (HIV-1B) pol sequences of 163 infected children and 450 adults of Madrid, Spain, were used to estimate genetic diversity, rates of synonymous and non-synonymous mutations, selection pressures and frequency of drug-resistance mutations (DRMs). The role and relative importance of patient age, % CD4, CD4/mm(3), viral load, and antiretroviral experience in HIV-1B evolution was analysed. In the pediatric HIV-1B population, three clinical factors were primary predictors of virus evolution: Higher HIV-1B genetic diversity was observed with increasing children age, decreasing CD4/mm(3) and upon antiretroviral experience. This was mostly due to higher rates of non-synonymous mutations, which were associated with higher frequency of DRMs. Using this data, we have also constructed a simple multivariate model explaining between 55% and 66% of the variance in HIV-1B evolutionary parameters in pediatric populations. On the other hand, the analysed clinical factors had little effect in adult-infecting HIV-1B evolution. These findings highlight the different evolutionary dynamics of HIV-1B in children and adults, and contribute to understand the factors shaping HIV-1B evolution and the appearance of drug-resistance mutation in pediatric patients.	[Pagan, Israel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPMI NIA, Madrid, Spain; [Pagan, Israel] Univ Politecn Madrid, ETSI Agronomos, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] Hosp Ramon & Cajal, IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] CIBER ESP, Madrid, Spain; [Ramos, Jose Tomas] Univ Complutense Madrid, Hosp Clin San Carlos, Madrid, Spain; [Ramos, Jose Tomas] Univ Complutense Madrid, Fac Med, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid; Hospital Clinico San Carlos; Complutense University of Madrid	Pagan, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPMI NIA, Madrid, Spain.; Pagan, I (corresponding author), Univ Politecn Madrid, ETSI Agronomos, Madrid, Spain.; Holguin, A (corresponding author), Hosp Ramon & Cajal, IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol, Madrid, Spain.; Holguin, A (corresponding author), CIBER ESP, Madrid, Spain.	jesusisrael.pagan@upm.es; africa.holguin@salud.madrid.org	Holguín, Africa/AAF-9001-2021; Pagán, Israel/H-1843-2015	Holguín, Africa/0000-0002-1330-8050; Pagán, Israel/0000-0001-8876-1194; , Patricia/0000-0001-6935-0066	Plan Nacional de I+D+i; Institute de Salud Carlos III [FIS PI12/00240, FIS PI15/01005]; European Development Regional Fund "A way to achieve Europe (ERDF); GIBER [CB06/02/0053]; Ministerio de Economia y Competitividad [RYC-2011-08574]	Plan Nacional de I+D+i; Institute de Salud Carlos III(Instituto de Salud Carlos III); European Development Regional Fund "A way to achieve Europe (ERDF)(European Commission); GIBER; Ministerio de Economia y Competitividad(Spanish Government)	This work was supported in part by Plan Nacional de I+D+i 2008-2011, Institute de Salud Carlos III, FIS PI12/00240 and FIS PI15/01005, and co-financed by the European Development Regional Fund "A way to achieve Europe (ERDF) and GIBER (grant number CB06/02/0053) to AH, and Ramon y Cajal contract from Ministerio de Economia y Competitividad (grant number RYC-2011-08574) to IP. The Madrid cohort of HIV infected pediatric patients is part of CoRlspe, Red Tematica de Investigacion Cooperativa en SIDA (ISCIII-RETIC RD06/006), and Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RED RIS RD12-0017-0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Abrams EJ, 1998, J INFECT DIS, V178, P101, DOI 10.1086/515596; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; ANDERSON R M, 1991; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns DN, 1999, LANCET, V354, pS1, DOI 10.1016/S0140-6736(99)90249-0; Carvajal-Rodriguez A, 2008, INFECT GENET EVOL, V8, P110, DOI 10.1016/j.meegid.2007.10.009; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Ceballos A, 2008, J GEN VIROL, V89, P2773, DOI 10.1099/vir.0.83697-0; Chakraborty R, 2005, CURR HIV RES, V3, P31, DOI 10.2174/1570162052773022; Chen Xue-qing, 2011, Virologica Sinica, V26, P147, DOI 10.1007/s12250-011-3180-2; de Mulder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052155; de Mulder M, 2012, PEDIATR INFECT DIS J, V31, pE213, DOI 10.1097/INF.0b013e3182678c7c; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Einer-jensen K, 2004, J GEN VIROL, V85, P1167, DOI 10.1099/vir.0.79820-0; Gall A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-8; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gijsbers EF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05079; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; de Jose MI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-2; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kosakovsky Pond SL, 2005, BIOINFORMATICS, V21, P2531, DOI DOI 10.1093/BI0INF0RMATICS/BTI320; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2014, TRENDS ECOL EVOL, V29, P33, DOI 10.1016/j.tree.2013.09.009; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lorenzo E, 2004, VIROLOGY, V330, P116, DOI 10.1016/j.virol.2004.09.015; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Palladino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096307; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Resino S, 2006, CLIN INFECT DIS, V43, P243, DOI 10.1086/505213; Rojas P, 2015, CLIN MICROBIOL INFEC, V21; Sanchez PR, 2014, J ANTIMICROB CHEMOTH, V69, P2032, DOI 10.1093/jac/dku104; Ryland EG, 2010, J VIROL, V84, P12437, DOI 10.1128/JVI.01617-10; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Salemi M, 1999, P NATL ACAD SCI USA, V96, P13253, DOI 10.1073/pnas.96.23.13253; Scholle SO, 2013, AM NAT, V182, P494, DOI 10.1086/672000; Seo TK, 2002, BIOINFORMATICS, V18, P115, DOI 10.1093/bioinformatics/18.1.115; Shriner D, 2006, EVOLUTION, V60, P1165, DOI 10.1554/05-473.1; Sokal RR, 1995, BIOMETRY; Sundaravaradan V, 2006, P NATL ACAD SCI USA, V103, P11701, DOI 10.1073/pnas.0602185103; Tazi L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-62; UNAIDS, 2016, GLOB AIDS UPD; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Zhang Hongwei, 2010, Chin Med, V5, P1, DOI 10.1186/1749-8546-5-1	63	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167383	10.1371/journal.pone.0167383	http://dx.doi.org/10.1371/journal.pone.0167383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907076	Green Accepted, Green Published, gold			2022-12-27	WOS:000389482700135
J	Engel, NW; Neumann, JE; Ahlfeld, J; Wefers, AK; Merk, DJ; Ohli, J; Schuller, U				Engel, Nils W.; Neumann, Julia E.; Ahlfeld, Julia; Wefers, Annika K.; Merk, Daniel J.; Ohli, Jasmin; Schueller, Ulrich			Canonical Wnt Signaling Drives Tumor-Like Lesions from Sox2-Positive Precursors of the Murine Olfactory Epithelium	PLOS ONE			English	Article							BETA-CATENIN GENE; CONSTITUTIVE ACTIVATION; SINONASAL HEMANGIOPERICYTOMA; PROGENITOR CELLS; SMALL-INTESTINE; STEM-CELLS; MUTATIONS; PROLIFERATION; EXPRESSION; CARCINOMA	Canonical Wnt signaling is known to promote proliferation of olfactory stem cells. In order to investigate the effects of a constitutive activation of Wnt signaling in Sox2-positive precursor cells of the olfactory epithelium, we used transgenic mice that allowed an inducible deletion of exon 3 of the Ctnnb1 gene, which is responsible for the phosphorylation and degradation of Ctnnb1 protein. After induction of aberrant Wnt activation by Ctnnb1 deletion at embryonic day 14, such mice developed tumor-like lesions in upper parts of the nasal cavity. We still observed areas of epithelial hyperplasia within the olfactory epithelium following early postnatal Wnt activation, but the olfactory epithelial architecture remained unaffected in most parts when Wnt was activated at postnatal day 21 or later. In summary, our results suggest an age-dependent tumorigenic potential of aberrant Wnt signaling in the olfactory epithelium of mice.	[Engel, Nils W.; Neumann, Julia E.; Ahlfeld, Julia; Wefers, Annika K.; Merk, Daniel J.; Ohli, Jasmin; Schueller, Ulrich] Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany; [Engel, Nils W.] Univ Med Ctr, Dept Internal Med 2, Hamburg, Germany; [Neumann, Julia E.; Schueller, Ulrich] Univ Med Ctr, Inst Neuropathol, Hamburg, Germany; [Schueller, Ulrich] Res Inst Childrens Canc Ctr, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Ahlfeld, Julia] Ludwig Maximilians Univ Munchen, Dept Internal Med 4, Div Clin Pharmacol, Munich, Germany; [Wefers, Annika K.] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-69115 Heidelberg, Germany; [Merk, Daniel J.] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Ruprecht Karls University Heidelberg; Harvard University; Dana-Farber Cancer Institute	Schuller, U (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany.; Schuller, U (corresponding author), Univ Med Ctr, Inst Neuropathol, Hamburg, Germany.; Schuller, U (corresponding author), Res Inst Childrens Canc Ctr, Hamburg, Germany.; Schuller, U (corresponding author), Univ Med Ctr, Dept Pediat Hematol & Oncol, Hamburg, Germany.	u.schueller@uke.de	Wefers, Annika K./ABF-3832-2020	Wefers, Annika K./0000-0001-9394-8519; Schuller, Ulrich/0000-0002-8731-1121; Thorn-Seshold, Julia/0000-0002-4879-4159; Engel, Nils/0000-0002-3514-5686	Deutsche Krebshilfe [111630]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe, grant number 111630.	Agaimy A, 2014, HISTOPATHOLOGY, V65, P667, DOI 10.1111/his.12452; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bak M, 2012, HEMATOL ONCOL CLIN N, V26, P1185, DOI 10.1016/j.hoc.2012.08.005; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Bhutta MF, 2011, RHINOLOGY, V49, P185, DOI 10.4193/Rhino09.171; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; CARNEY ME, 1995, J NEURO-ONCOL, V26, P35, DOI 10.1007/BF01054767; Cau E, 1997, DEVELOPMENT, V124, P1611; Chen MF, 2014, J NEUROSCI, V34, P8268, DOI 10.1523/JNEUROSCI.0240-14.2014; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Faragalla H, 2009, ADV ANAT PATHOL, V16, P322, DOI 10.1097/PAP.0b013e3181b544cf; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fukuchi T, 1998, CANCER RES, V58, P3526; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; Haller F, 2015, AM J PATHOL, V185, P563, DOI 10.1016/j.ajpath.2014.10.019; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Knor M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141722; Kondo K, 2010, J COMP NEUROL, V518, P1962, DOI 10.1002/cne.22316; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lasota J, 2015, MODERN PATHOL, V28, P715, DOI 10.1038/modpathol.2014.161; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Loseva E, 2009, BRAIN RES REV, V59, P374, DOI 10.1016/j.brainresrev.2008.10.004; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Murdoch B, 2007, J MOL HISTOL, V38, P581, DOI 10.1007/s10735-007-9141-2; Ow TJ, 2013, NEUROSURG CLIN N AM, V24, P51, DOI 10.1016/j.nec.2012.08.005; Palacios J, 1998, CANCER RES, V58, P1344; Park WS, 1999, CANCER RES, V59, P4257; Poschl J, 2013, DEV BIOL, V374, P319, DOI 10.1016/j.ydbio.2012.12.001; Ralston J, 2008, MODERN PATHOL, V21, P1357, DOI 10.1038/modpathol.2008.118; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Swartling FJ, 2014, EXP NEUROL, V260, P56, DOI 10.1016/j.expneurol.2013.01.027; Tian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048997; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang YZ, 2011, J CELL SCI, V124, P1553, DOI 10.1242/jcs.080580; Wenig BM, 2005, WHO IARC CLASSIFICAT, V9, P65	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166690	10.1371/journal.pone.0166690	http://dx.doi.org/10.1371/journal.pone.0166690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902722	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100033
J	Hinduja, A; Limaye, K; Ravilla, R; Sasapu, A; Papanikolaou, X; Wei, L; Torbey, M; Waheed, S				Hinduja, Archana; Limaye, Kaustubh; Ravilla, Rahul; Sasapu, Appalnaidu; Papanikolaou, Xenofon; Wei, Lai; Torbey, Michel; Waheed, Sarah			Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study	PLOS ONE			English	Article							THALIDOMIDE PLUS DEXAMETHASONE; TRANSIENT ISCHEMIC ATTACK; PROGNOSTIC IMPLICATIONS; RECEIVING THALIDOMIDE; RENAL-FUNCTION; TOTAL THERAPY; YOUNG-ADULTS; STROKE RISK; SURVIVAL; KIDNEY	Objectives Patients with multiple myeloma (MM) are at increased risk of arterial thrombosis. Our aim was to determine the risk factors, mechanisms and outcome of strokes in these patients. Methods We conducted a retrospective matched case-control study from our database of MM patients enrolled in Total Therapy (TT) 2, TT3a and TT3b protocols who developed a vascular event (transient ischemic attack, ischemic stroke, or intracerebral hemorrhage) from October 1998 to January 2014. Cases were matched for age-matched selected controls. Baseline demographics, risk factors, MM characteristics, laboratory values, and mortality of cases were compared to those of controls. Multivariate logistic regression analysis identified risk factors associated with stroke. Ischemic strokes (IS) were classified with modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results Of 1,148 patients, 46 developed a vascular event (ischemic stroke, 33; transient ischemic attack, 11; hypertensive intracerebral hemorrhage, 2). Multivariate logistic regression analysis determined renal insufficiency (odds Ratio, 3.528; 95% CI, 1.36-9.14; P = 0.0094) and MM Stages I and II (odds Ratio, 2.770, 95% CI, 1.31-5.81; p = 0.0073) were independent predictors of stroke. In our study, strokes attributable to hypercoagulability, atrial fibrillation and small-vessel occlusion were common mechanisms. After a stroke, 78% of patients were discharged to home or a rehabilitation facility and 4% to a long-term nursing facility; in-hospital mortality was 15%. Despite suffering a stroke no significant differences in survival were observed. Conclusion In our cohort of multiple myeloma patients, renal failure and MM Stages I and II had increased risk of stroke.	[Hinduja, Archana; Limaye, Kaustubh] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA; [Ravilla, Rahul; Sasapu, Appalnaidu] Univ Arkansas Med Sci, Dept Hematol & Oncol, Little Rock, AR 72205 USA; [Papanikolaou, Xenofon; Waheed, Sarah] Univ Arkansas Med Sci, Multiple Myeloma Res & Therapy, Little Rock, AR 72205 USA; [Hinduja, Archana; Wei, Lai; Torbey, Michel] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Torbey, Michel] Ohio State Univ, Dept Neurosurg, Wexner Med Ctr, Columbus, OH 43210 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hinduja, A (corresponding author), Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA.; Hinduja, A (corresponding author), Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA.	archanahinduja@yahoo.com	Ravilla, Rahul/AFS-1497-2022	Ravilla, Rahul/0000-0001-8403-0386; Limaye, Kaustubh/0000-0002-7280-7407	 [U10NS080368]		This work was supported by grant U10NS080368.	Aarnio K, 2015, STROKE, V46, P1601, DOI 10.1161/STROKEAHA.115.008694; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2014, BLOOD, V124, P3043, DOI 10.1182/blood-2014-07-552059; Bejot Y, 2008, J NEUROL NEUROSUR PS, V79, P1344, DOI 10.1136/jnnp.2008.150318; Bennett CL, 2006, JAMA-J AM MED ASSOC, V296, P2558, DOI 10.1001/jama.296.21.2558-c; CATOVSKY D, 1970, BRIT MED J, V3, P438, DOI 10.1136/bmj.3.5720.438; Cestari DM, 2004, NEUROLOGY, V62, P2025, DOI 10.1212/01.WNL.0000129912.56486.2B; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Fernyhough LJ, 2013, INTERN MED J, V43, P130, DOI 10.1111/j.1445-5994.2012.02819.x; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hajat C, 2011, J NEUROL NEUROSUR PS, V82, P527, DOI 10.1136/jnnp.2010.222919; Holzmann MJ, 2012, ANN MED, V44, P607, DOI 10.3109/07853890.2011.582136; Hong KS, 2011, CIRCULATION, V123, P2111, DOI 10.1161/CIRCULATIONAHA.109.934786; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Jung SH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2645-y; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Khan R, 2015, LEUKEMIA, V29, P1195, DOI 10.1038/leu.2015.15; Khatri M, 2014, J STROKE CEREBROVASC, V23, P25, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.005; Knight R, 2006, NEW ENGL J MED, V354, P2079; KNUDSEN LM, 1994, EUR J HAEMATOL, V53, P207; Kristinsson SY, 2012, HAEMATOL-HEMATOL J, V97, P1603, DOI 10.3324/haematol.2012.064444; Kristinsson SY, 2010, BLOOD, V115, P4991, DOI 10.1182/blood-2009-11-252072; Kumai Y, 2012, Neurology, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Lau KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088283; Lee JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089386; Libourel EJ, 2010, BLOOD, V116, P22, DOI 10.1182/blood-2009-12-257519; Moe SM, 2012, CIRCULATION, V125, P2181, DOI 10.1161/CIRCULATIONAHA.112.104828; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/306189; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620; Navi BB, 2014, NEUROLOGY, V83, P26, DOI 10.1212/WNL.0000000000000539; Neben K, 2002, CLIN CANCER RES, V8, P3377; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ovbiagele B, 2013, STROKE, V44, P3223, DOI 10.1161/STROKEAHA.113.002463; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Rajkumar SV, 2002, J CLIN ONCOL, V20, P4319, DOI 10.1200/JCO.2002.02.116; Rios R, 2013, REV CLIN ESP, V213, P330, DOI 10.1016/j.rce.2013.02.014; Schlaich MP, 2011, HYPERTENSION, V57, P683, DOI 10.1161/HYPERTENSIONAHA.110.167189; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stefan O, 2009, J NEURO-ONCOL, V94, P221, DOI 10.1007/s11060-009-9818-3; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Tsukamoto Y, 2012, J STROKE CEREBROVASC, V21, P547, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.005; van Rhee F, 2010, BLOOD, V116, P1220, DOI 10.1182/blood-2010-01-264333; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Zangari M, 2002, BLOOD, V100, P1168, DOI 10.1182/blood-2002-01-0335; Zangari M, 2001, BLOOD, V98, P1614, DOI 10.1182/blood.V98.5.1614; Zhang YY, 2006, ACTA NEUROL SCAND, V114, P378, DOI 10.1111/j.1600-0404.2006.00709.x; Zonder JA, 2006, BLOOD, V108, P403, DOI 10.1182/blood-2006-01-0154	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166627	10.1371/journal.pone.0166627	http://dx.doi.org/10.1371/journal.pone.0166627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902730	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100030
J	Kaplan, JO; Pfeiffer, M; Kolen, JCA; Davis, BAS				Kaplan, Jed O.; Pfeiffer, Mirjam; Kolen, Jan C. A.; Davis, Basil A. S.			Large Scale Anthropogenic Reduction of Forest Cover in Last Glacial Maximum Europe	PLOS ONE			English	Article							SOUTHEASTERN EUROPE; GLOBAL VEGETATION; EARLIEST EVIDENCE; CHARCOAL RECORDS; MAMMOTH STEPPE; POLLEN RECORD; FIRE REGIMES; CLIMATE; SEA; AGE	Reconstructions of the vegetation of Europe during the Last Glacial Maximum (LGM) are an enigma. Pollen-based analyses have suggested that Europe was largely covered by steppe and tundra, and forests persisted only in small refugia. Climate-vegetation model simulations on the other hand have consistently suggested that broad areas of Europe would have been suitable for forest, even in the depths of the last glaciation. Here we reconcile models with data by demonstrating that the highly mobile groups of hunter-gatherers that inhabited Europe at the LGM could have substantially reduced forest cover through the ignition of wildfires. Similar to hunter-gatherers of the more recent past, Upper Paleolithic humans were masters of the use of fire, and preferred inhabiting semi-open landscapes to facilitate foraging, hunting and travel. Incorporating human agency into a dynamic vegetation-fire model and simulating forest cover shows that even small increases in wildfire frequency over natural background levels resulted in large changes in the forested area of Europe, in part because trees were already stressed by low atmospheric CO2 concentrations and the cold, dry, and highly variable climate. Our results suggest that the impact of humans on the glacial landscape of Europe may be one of the earliest large-scale anthropogenic modifications of the earth system.	[Kaplan, Jed O.; Davis, Basil A. S.] Univ Lausanne, Inst Earth Surface Dynam, Geopolis, Lausanne, Switzerland; [Pfeiffer, Mirjam] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Kolen, Jan C. A.] Leiden Univ, Fac Archaeol, Leiden, Netherlands	University of Lausanne; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Leiden University; Leiden University - Excl LUMC	Kaplan, JO (corresponding author), Univ Lausanne, Inst Earth Surface Dynam, Geopolis, Lausanne, Switzerland.	jed.kaplan@unil.ch	Kaplan, Jed O./P-1796-2015	Kaplan, Jed O./0000-0001-9919-7613	Swiss National Science Foundation [PP00P2_139193]; European Research Council [313797]; European Commission [603447]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	JOK, MP, and BASD were supported by the Swiss National Science Foundation (snf.ch; PP00P2_139193) and European Research Council (erc.eu; 313797) for project COEVOLVE. JCAK was supported by the European Commission's 7th Framework Programme for project HERCUES (ec.europa.eu/research/fp7; 603447).	Ammann B, 2013, PALAEOGEOGR PALAEOCL, V391, P111, DOI 10.1016/j.palaeo.2013.11.009; Aydin M, 2016, J GEOPHYS RES-ATMOS, V121, P1943, DOI 10.1002/2015JD024235; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Barton CM, 2011, HUM ECOL, V39, P705, DOI 10.1007/s10745-011-9433-8; Barton RNE, 2013, J HUM EVOL, V65, P266, DOI 10.1016/j.jhevol.2013.06.003; Beresford-Jones DG, 2010, J ARCHAEOL SCI, V37, P2799, DOI 10.1016/j.jas.2010.06.014; Binford L.R., 2001, CONSTRUCTING FRAMES; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; Birks HJB, 2005, TRENDS ECOL EVOL, V20, P154, DOI 10.1016/j.tree.2005.02.001; Blarquez O, 2014, COMPUT GEOSCI-UK, V72, P255, DOI 10.1016/j.cageo.2014.07.020; Bocquet-Appel JP, 2000, J ARCHAEOL SCI, V27, P551, DOI 10.1006/jasc.1999.0471; Boomer I, 2000, QUATERNARY SCI REV, V19, P1259, DOI 10.1016/S0277-3791(00)00002-0; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Carcaillet C, 2001, QUATERNARY RES, V55, P385, DOI 10.1006/qres.2001.2226; Clark CD, 2012, QUATERNARY SCI REV, V44, P112, DOI 10.1016/j.quascirev.2010.07.019; Collier REL, 2000, GEOLOGY, V28, P999; d'Errico F., 2011, PALEOANTHROPOLOGY, DOI [10.4207/PA.2011.ART40, DOI 10.4207/PA.2011.ART40]; Daniau AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009157; Davis BAS, 2015, VEG HIST ARCHAEOBOT, V24, P303, DOI 10.1007/s00334-014-0476-9; Dolukhanov PM, 2010, QUATERN INT, V225, P152, DOI 10.1016/j.quaint.2009.10.039; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Fao/Iiasa/Isric/Isscas/Jrc, 2012, HARM WORLD SOIL DAT; Feblot-Augustins J., 2009, REVISITING EUROPEAN, P25; Gamble C., 1993, TIMEWALKERS PREHISTO; Gibbard P. L, 2004, QUATERNARY GLACIAT 1; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; Haesaerts P, 2010, PALAEOGEOGR PALAEOCL, V291, P106, DOI 10.1016/j.palaeo.2010.03.034; Harrison SP, 2003, GLOBAL CHANGE BIOL, V9, P983, DOI 10.1046/j.1365-2486.2003.00640.x; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Huntley B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061963; Jurickova L, 2014, QUATERNARY RES, V82, P222, DOI 10.1016/j.yqres.2014.01.015; Kageyama M, 1999, J CLIMATE, V12, P742, DOI 10.1175/1520-0442(1999)012<0742:NHSTIP>2.0.CO;2; Kaltenrieder P, 2009, QUATERNARY SCI REV, V28, P2647, DOI 10.1016/j.quascirev.2009.05.025; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Karkanas P, 2004, ANTIQUITY, V78, P513, DOI 10.1017/S0003598X00113195; Kelly A, 2010, J QUATERNARY SCI, V25, P296, DOI 10.1002/jqs.1309; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lawson IT, 2013, J BIOGEOGR, V40, P2324, DOI 10.1111/jbi.12164; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; Livi-Bacci M., 2007, CONCISE HIST WORLD P; McHugh CMG, 2008, MAR GEOL, V255, P64, DOI 10.1016/j.margeo.2008.07.005; Mitchell FJG, 2005, J ECOL, V93, P168, DOI 10.1111/j.1365-2745.2004.00964.x; Molinari C, 2013, GLOBAL ECOL BIOGEOGR, V22, P1248, DOI 10.1111/geb.12090; Murray LT, 2014, ATMOS CHEM PHYS, V14, P3589, DOI 10.5194/acp-14-3589-2014; Mussi M., 2000, HUNTERS GOLDEN AGE M; Naughton F, 2015, MAR GEOL, V367, P118, DOI 10.1016/j.margeo.2015.06.003; Neugebauer-Maresch C., 2008, WISS MITT NIEDER STE, V19, P119; Nigst PR, 2011, SITE INTERNAL SPATIA, P11; Pachzelt A, 2015, GLOBAL ECOL BIOGEOGR, V24, P991, DOI 10.1111/geb.12313; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Peyron O, 1998, QUATERNARY RES, V49, P183, DOI 10.1006/qres.1997.1961; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; Pyne S., 2000, VESTAL FIRE ENV HIST; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Scherjon F, 2015, CURR ANTHROPOL, V56, P299, DOI 10.1086/681561; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Siddall M, 2004, EARTH PLANET SC LETT, V225, P421, DOI 10.1016/j.epsl.2004.06.008; Soffer O., 1985, UPPER PALEOLITHIC CE, DOI 10.1016/B978-0-12-654270-7.50010-0; Soffer O., 1993, LASCAUX COMPLEX RECO, P259; Song Y, 2009, PHOTOGRAMM ENG REM S, V75, P281, DOI 10.14358/PERS.75.3.281; Strandberg G, 2011, TELLUS A, V63, P107, DOI 10.1111/j.1600-0870.2010.00485.x; Sumegi P, 2001, QUATERN INT, V76-7, P165, DOI 10.1016/S1040-6182(00)00100-2; Svoboda JA, 2007, PALEO, V19, P203; Tallavaara M, 2015, P NATL ACAD SCI USA, V112, P8232, DOI 10.1073/pnas.1503784112; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Thonicke K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002278; Van Meerbeeck CJ, 2009, CLIM PAST, V5, P33, DOI 10.5194/cp-5-33-2009; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wang X, 2012, PALAEOGEOGR PALAEOCL, V315, P61, DOI 10.1016/j.palaeo.2011.11.008; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2001, QUATERNARY RES, V55, P388, DOI 10.1006/qres.2001.2225; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Winguth C, 2000, MAR GEOL, V167, P127, DOI 10.1016/S0025-3227(00)00024-4; Zimov SA, 2012, QUATERNARY SCI REV, V57, P26, DOI 10.1016/j.quascirev.2012.10.005	80	41	43	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166726	10.1371/journal.pone.0166726	http://dx.doi.org/10.1371/journal.pone.0166726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902716	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100035
J	Halperin, I; Hughes, S; Panchuk, D; Abbiss, C; Chapman, DW				Halperin, Israel; Hughes, Steven; Panchuk, Derek; Abbiss, Chris; Chapman, Dale W.			The Effects of Either a Mirror, Internal or External Focus Instructions on Single and Multi-Joint Tasks	PLOS ONE			English	Article							FORCE PRODUCTION; ATTENTIONAL FOCUS; MUSCULAR-ACTIVITY; SELF; PERFORMANCE; ENVIRONMENTS; FEEDBACK; LOCUS; WOMEN; BODY	Training in front of mirrors is common, yet little is known about how the use of mirrors effects muscle force production. Accordingly, we investigated how performing in front of a mirror influences performance in single and multi-joint tasks, and compared the mirror condition to the established performance effects of internal focus (IF) and external focus (EF) instructions in a two part experiment. In the single-joint experiment 28 resistance-trained participants (14 males and 14 females) completed two elbow flexion maximal voluntary isometric contractions under four conditions: mirror, IF, EF and neutral instructions. During these trials, surface EMG activity of the biceps and triceps were recorded. In the multi-joint experiment the same participants performed counter-movement jumps on a force plate under the same four conditions. Single-joint experiment: EF led to greater normalized force production compared to all conditions (P <= 0.02, effect-size range [ES] = 0.46-1.31). No differences were observed between neutral and mirror conditions (P=0.15, ES = 0.15), but both were greater than IF (P<0.01, ES = 0.79-1.84). Surface EMG activity was comparable across conditions (P >= 0.1, ES = 0.10-0.21). Multi-joint experiment: Despite no statistical difference (P=0.10), a moderate effect size was observed for jump height whereby EF was greater than IF (ES = 0.51). No differences were observed between neutral and mirror conditions (ES = 0.01), but both were greater than IF (ES = 0.20-22). The mirror condition led to superior performance compared to IF, inferior performance compared to EF, and was equal to a neutral condition in both tasks. These results provide novel and practical evidence concerning mirror training during resistance type training.	[Halperin, Israel; Hughes, Steven; Chapman, Dale W.] Australian Inst Sport, Discipline Physiol, Canberra, ACT, Australia; [Halperin, Israel; Hughes, Steven; Abbiss, Chris; Chapman, Dale W.] Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sport Sci Res, Joondalup, WA, Australia; [Panchuk, Derek] Victoria Univ, Inst Sport Exercise & Act Living, Coll Sport & Exercise Sci, Footscray, Vic, Australia; [Panchuk, Derek] Australian Inst Sport, Skill Acquisit Discipline, Canberra, ACT, Australia	Australian Institute of Sport; Edith Cowan University; Victoria University; Australian Institute of Sport	Halperin, I (corresponding author), Australian Inst Sport, Discipline Physiol, Canberra, ACT, Australia.; Halperin, I (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sport Sci Res, Joondalup, WA, Australia.	Israel.halperin@ausport.gov.au	Chapman, Dale Wilson/I-3125-2019	Chapman, Dale Wilson/0000-0002-3393-1261; Abbiss, Chris/0000-0003-3940-5542				BENNETT S, 1995, RES Q EXERCISE SPORT, V66, P210, DOI 10.1080/02701367.1995.10608835; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dearborn K., 2006, J DANCE ED, V6, P109, DOI [DOI 10.1080/15290824.2006.10387323, 10.1080/15290824.2006.10387323]; Eaves DL, 2008, MED SCI SPORT EXER, V40, P1506, DOI 10.1249/MSS.0b013e31817057a8; Ehrlenspiel F, 2004, PERCEPT MOTOR SKILL, V99, P127, DOI 10.2466/PMS.99.5.127-130; Ginis KAM, 2003, HEALTH PSYCHOL, V22, P354, DOI 10.1037/0278-6133.22.4.354; Greig M, 2014, HUM MOVEMENT SCI, V33, P135, DOI 10.1016/j.humov.2013.08.008; Halperin I, 2016, J STRENGTH COND RES, V30, P919, DOI 10.1519/JSC.0000000000001194; Ille A, 2013, J SPORT SCI, V31, P1705, DOI 10.1080/02640414.2013.797097; Katula JA, 2001, INT J BEHAV MED, V8, P319, DOI 10.1207/s15327558ijbm0804_6; Lamarche L, 2009, PSYCHOL SPORT EXERC, V10, P67, DOI 10.1016/j.psychsport.2008.06.006; Lynch JA, 2009, J BODYW MOV THER, V13, P283, DOI 10.1016/j.jbmt.2008.09.003; Marchant DC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00210; Marchant DC, 2009, INT J SPORT EXERC PS, V7, P488, DOI 10.1080/1612197X.2009.9671921; Marchant DC, 2009, J STRENGTH COND RES, V23, P2358, DOI 10.1519/JSC.0b013e3181b8d1e5; McKay B, 2015, Q J EXP PSYCHOL, V68, P1910, DOI 10.1080/17470218.2014.997765; Notarnicola Angela, 2014, BMC Res Notes, V7, P426, DOI 10.1186/1756-0500-7-426; Porter JM, 2013, J STRENGTH COND RES, V27, P2073, DOI 10.1519/JSC.0b013e31827e1521; Radell SA, 2003, PERCEPT MOTOR SKILL, V97, P960, DOI 10.2466/PMS.97.7.960-964; Radell SA, 2002, PERCEPT MOTOR SKILL, V95, P1239, DOI 10.2466/PMS.95.7.1239-1247; Radell SA, 2014, RES DANC EDUC, V15, P161, DOI 10.1080/14647893.2013.879256; Rougier P, 2002, ANN READAPTATION MED; SEWALL LP, 1988, PERCEPT MOTOR SKILL, V67, P715, DOI 10.2466/pms.1988.67.3.715; Vaillant J, 2004, ARCH PHYS MED REHAB, V85, P1962, DOI 10.1016/j.apmr.2004.02.019; Weiss SM, 2008, J SPORT SCI, V26, P1049, DOI 10.1080/02640410802098874; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166799	10.1371/journal.pone.0166799	http://dx.doi.org/10.1371/journal.pone.0166799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898743	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000389474000019
J	Jara, RF; Wydeven, AP; Samuel, MD				Jara, Rocio F.; Wydeven, Adrian P.; Samuel, Michael D.			Gray Wolf Exposure to Emerging Vector-Borne Diseases in Wisconsin with Comparison to Domestic Dogs and Humans	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; LYME-DISEASE; BORRELIA-BURGDORFERI; IXODES-SCAPULARIS; UNITED-STATES; ANAPLASMA-PHAGOCYTOPHILUM; RHIPICEPHALUS-SANGUINEUS; AMBLYOMMA-AMERICANUM; HUMAN INFECTION; CANIS-LUPUS	World-wide concern over emerging vector-borne diseases has increased in recent years for both animal and human health. In the United Sates, concern about vector-borne diseases in canines has focused on Lyme disease, anaplasmosis, ehrlichiosis, and heartworm which infect domestic and wild canids. Of these diseases, Lyme and anaplasmosis are also frequently diagnosed in humans. Gray wolves (Canis lupus) recolonized Wisconsin in the 1970s, and we evaluated their temporal and geographic patterns of exposure to these four vector-borne diseases in Wisconsin as the population expanded between 1985 and 2011. A high proportion of the Wisconsin wolves were exposed to the agents that cause Lyme (65.6%) and anaplasma (47.7%), and a smaller proportion to ehrlichiosis (5.7%) and infected with heartworm (9.2%). Wolf exposure to tick borne diseases was consistently higher in older animals. Wolf exposure was markedly higher than domestic dog (Canis familiaris) exposure for all 4 disease agents during 2001-2013. We found a cluster of wolf exposure to Borrelia burgdorferi in northwestern Wisconsin, which overlaps human and domestic dog clusters for the same pathogen. In addition, wolf exposure to Lyme disease in Wisconsin has increased, corresponding with the increasing human incidence of Lyme disease in a similar time period. Despite generally high prevalence of exposure none of these diseases appear to have slowed the growth of the Wisconsin wolf population.	[Jara, Rocio F.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI USA; [Wydeven, Adrian P.] Wisconsin Dept Nat Resources, Ashland, WI USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI 53706 USA; [Jara, Rocio F.] Univ North Texas, Subantarctic Biocultural Conservat Program, Dept Biol Sci, Denton, TX USA; [Wydeven, Adrian P.] Northland Coll, Timber Wolf Alliance, Ashland, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of North Texas System; University of North Texas Denton	Samuel, MD (corresponding author), Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI 53706 USA.	mdsamuel@wisc.edu	Jara, Rocio Fernanda/GOK-0262-2022	Jara, Rocio/0000-0001-7896-7885	Wisconsin Department of Natural Resources; U.S. Geological Survey; Chilean National Commission for Scientific and Technological Research (CONICYT - Spanish acronym); Department of Forest and Wildlife Ecology, University of Wisconsin-Madison	Wisconsin Department of Natural Resources; U.S. Geological Survey(United States Geological Survey); Chilean National Commission for Scientific and Technological Research (CONICYT - Spanish acronym); Department of Forest and Wildlife Ecology, University of Wisconsin-Madison	We thank the Wisconsin Department of Natural Resources for funding. This research was also funded by the U.S. Geological Survey and the Chilean National Commission for Scientific and Technological Research (CONICYT - Spanish acronym), which provided a graduate fellowship to RJ. The Department of Forest and Wildlife Ecology, University of Wisconsin-Madison, provided funds for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Veterinary Medical Association, 2013, US PET OWN STAT; ANDERSON BE, 1993, AM J TROP MED HYG, V49, P239, DOI 10.4269/ajtmh.1993.49.239; ANZIANI OS, 1990, AM J VET RES, V51, P929; Beheler-Amass K, 1999, WOLF HLTH MONITORING; Bowman D, 2009, VET PARASITOL, V160, P138, DOI 10.1016/j.vetpar.2008.10.093; Brown HE, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-245; Brown Richard N., 2001, P435, DOI 10.1002/9780470344880.ch26; Centers for Disease Control and Prevention, 2011, APPR DISTR LON STAR; Centers for Disease Control and Prevention, 2013, AN STAT EP; Centers for Disease Control and Prevention, 2012, LYM DIS DAT STAT; Curry PS, 2014, J WILDLIFE DIS, V50, P308, DOI 10.7589/2012-06-150; Dantas-Torres F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-26; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davidson William R., 2001, P455, DOI 10.1002/9780470344880.ch27; deCampos JRM, 1997, CHEST, V112, P729, DOI 10.1378/chest.112.3.729; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Gaunt SD, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-33; GENCHI C, 2001, HEARTWORM INFECT HUM, P121; GODSEY MS, 1987, AM J TROP MED HYG, V37, P180, DOI 10.4269/ajtmh.1987.37.180; GROVES MG, 1975, AM J VET RES, V36, P937; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; HARVEY JW, 1979, J AM VET MED ASSOC, V175, P901; Hegarty BC, 2012, J VET INTERN MED, V26, P1217, DOI 10.1111/j.1939-1676.2012.00968.x; Holden K, 2005, INFECT IMMUN, V73, P3440, DOI 10.1128/IAI.73.6.3440-3444.2005; IDEXX L, 2013, DIS YOUR AR; IDEXX L., 2013, SNAP 4DX TEST CLIN R; JACKSON JO, 1970, J MED ENTOMOL, V7, P124, DOI 10.1093/jmedent/7.1.124; Jara RF, 2013, THESIS; Johnson DKH, 2015, EMERG INFECT DIS, V21, P1794, DOI 10.3201/eid2110.150143; KAZMIERCZAK JJ, 1988, J WILDLIFE DIS, V24, P522, DOI 10.7589/0090-3558-24.3.522; Kohn B, 2008, J VET INTERN MED, V22, P1289, DOI 10.1111/j.1939-1676.2008.0180.x; Kreeger Terry J., 2003, P192; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lee X, 2013, J MED ENTOMOL, V50, P632, DOI 10.1603/ME12234; Leschnik M, 2012, J ZOO WILDLIFE MED, V43, P645, DOI 10.1638/2011-0224R.1; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; Littman MP, 2006, J VET INTERN MED, V20, P422, DOI 10.1892/0891-6640(2006)20[422:ASACSO]2.0.CO;2; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; McCall JW, 2008, ADV PARASIT, V66, P193, DOI 10.1016/S0065-308X(08)00204-2; Mladenoff DJ, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P119, DOI 10.1007/978-0-387-85952-1_8; Nieto NC, 2009, VECTOR-BORNE ZOONOT, V9, P93, DOI 10.1089/vbz.2008.0072; O'Connor TP, 2006, AM J VET RES, V67, P206, DOI 10.2460/ajvr.67.2.206; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI DOI 10.1056/NEJM0A1010493; RIKIHISA Y, 1991, CLIN MICROBIOL REV, V4, P286, DOI 10.1128/CMR.4.3.286-308.1991; Ruid DB, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P279, DOI 10.1007/978-0-387-85952-1_18; SIMPSON RM, 1991, AM J VET RES, V52, P1537; Stenglein J, 2014, CONSERV LETT, V8, P351; Telford Iii Sam R, 2011, Open Microbiol J, V5, P18, DOI 10.2174/1874285801105010018; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Theis JH, 2005, VET PARASITOL, V133, P157, DOI 10.1016/j.vetpar.2005.04.007; THIEKING A, 1992, J WILDLIFE DIS, V28, P177, DOI 10.7589/0090-3558-28.2.177; Thomas V, 2001, INFECT IMMUN, V69, P3359, DOI 10.1128/IAI.69.5.3359-3371.2001; Wisconsin Department of Health Services, 2013, LYM DIS BORR BURGD I; Wisconsin Department of Health Services, 2010, AN EHRL; Wisconsin Department of Health Services, 2012, EHRL CHAFF INF; WISCONSIN DEPARTMENT OF NATURAL RESOURCES, 1999, WISCONSIN WOLF MANAG, P3; Wisconsin Department of Natural Resources, 2012, FALL DEER POP DENS 2; Wydeven A. P., 2011, STATUS TIMBER WOLF W; Wydeven AP, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P87, DOI 10.1007/978-0-387-85952-1_6	64	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0165836	10.1371/journal.pone.0165836	http://dx.doi.org/10.1371/journal.pone.0165836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898670	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000003
J	Betekhtin, A; Rojek, M; Milewska-Hendel, A; Gawecki, R; Karcz, J; Kurczynska, E; Hasterok, R				Betekhtin, Alexander; Rojek, Magdalena; Milewska-Hendel, Anna; Gawecki, Robert; Karcz, Jagna; Kurczynska, Ewa; Hasterok, Robert			Spatial Distribution of Selected Chemical Cell Wall Components in the Embryogenic Callus of Brachypodium distachyon	PLOS ONE			English	Article							MATRIX SURFACE NETWORK; ARABINOGALACTAN-PROTEIN EPITOPE; SOMATIC EMBRYOGENESIS; EXTRACELLULAR-MATRIX; PLANT-REGENERATION; MODEL SYSTEM; PECTIN; POLYSACCHARIDES; LOCALIZATION; EXPRESSION	Brachypodium distachyon L. Beauv. (Brachypodium) is a species that has become an excellent model system for gaining a better understanding of various areas of grass biology and improving plant breeding. Although there are some studies of an in vitro Brachypodium culture including somatic embryogenesis, detailed knowledge of the composition of the main cell wall components in the embryogenic callus in this species is missing. Therefore, using the immunocytochemical approach, we targeted 17 different antigens of which five were against the arabinogalactan proteins (AGP), three were against extensins, six recognised pectic epitopes and two recognised hemicelluloses. These studies were complemented by histological and scanning electron microscopy (SEM) analyses. We revealed that the characteristic cell wall components of Brachypodium embryogenic calli are AGP epitopes that are recognised by the JIM16 and LM2 antibodies, an extensin epitope that is recognised by the JIM11 antibody and a pectic epitopes that is recognised by the LM6 antibody. Furthermore, we demonstrated that AGPs and pectins are the components of the extracellular matrix network in Brachypodium embryogenic culture. Additionally, SEM analysis demonstrated the presence of an extracellular matrix on the surface of the calli cells. In conclusion, the chemical compositions of the cell walls and ECMSN of Brachypodium callus show spatial differences that correlate with the embryogenic character of the cells. Thus, the distribution of pectins, AGPs and hemicelluloses can be used as molecular markers of embryogenic cells. The presented data extends the knowledge about the chemical composition of the embryogenic callus cells of Brachypodium.	[Betekhtin, Alexander; Rojek, Magdalena; Hasterok, Robert] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland; [Milewska-Hendel, Anna; Gawecki, Robert; Kurczynska, Ewa] Univ Silesia, Fac Biol & Environm Protect, Dept Cell Biol, Katowice, Poland; [Karcz, Jagna] Univ Silesia, Fac Biol & Environm Protect, Scanning Electron Microscopy Lab, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Betekhtin, A (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	alexander.betekhtin@us.edu.pl	Betekhtin, Alexander/O-4619-2018; Hasterok, Robert/A-1629-2008	Betekhtin, Alexander/0000-0001-6146-1669; Kurczynska, Ewa/0000-0003-0772-8961; Milewska-Hendel, Anna/0000-0002-9066-477X; Hasterok, Robert/0000-0001-6667-2721; Gawecki, Robert/0000-0002-7752-000X	National Science Centre, Poland [DEC-2014/14/M/NZ2/00519]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland [grant no. DEC-2014/14/M/NZ2/00519]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam J, 2011, SAUDI J BIOL SCI, V18, P369, DOI 10.1016/j.sjbs.2011.06.002; BABLAK P, 1995, PLANT CELL TISS ORG, V42, P97, DOI 10.1007/BF00037687; BRADLEY DJ, 1988, PLANTA, V173, P149, DOI 10.1007/BF00403006; Buckeridge MS, 2010, PLANT PHYSIOL, V154, P1017, DOI 10.1104/pp.110.158642; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chapman A, 2000, PLANTA, V211, P305, DOI 10.1007/s004250000299; [陈红伟 Chen Hongwei], 2014, [生物技术通报, Biotechnology Bulletin], P25; Christiansen P, 2005, PLANT CELL REP, V23, P751, DOI 10.1007/s00299-004-0889-5; Clausen MH, 2004, PLANTA, V219, P1036, DOI 10.1007/s00425-004-1309-3; Din AJM, 2016, SAUDI J BIOL SCI, V23, pS69, DOI 10.1016/j.sjbs.2015.10.022; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Eeckhout S, 2014, ANN BOT-LONDON, V114, P1295, DOI 10.1093/aob/mcu039; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Feher A, 2002, BIOLOGIA, V57, P5; Gaj MD, 2011, METHODS MOL BIOL, V710, P257, DOI 10.1007/978-1-61737-988-8_18; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Gonzalez-Perez L, 2014, MOL BIOL REP, V41, P6803, DOI 10.1007/s11033-014-3566-y; Hammami R, 2011, BIOL PLANTARUM, V55, P797, DOI 10.1007/s10535-011-0191-7; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hoch G, 2007, FUNCT ECOL, V21, P823, DOI 10.1111/j.1365-2435.2007.01305.x; International_Brachypodium_Initiative, 2014, TRENDS PLANT SCI, V19, P414, DOI [10.1016/j.tplants.2014.05.002, DOI 10.1016/J.TPLANTS.2014.05.002]; Jeon WoongBae, 2010, Korean Journal of Breeding Science, V42, P351; Jimenez VM, 2005, PLANT GROWTH REGUL, V47, P91, DOI 10.1007/s10725-005-3478-x; Jothi R, 2010, OPEN ACCESS BIOINFOR, V2, P157; KNOX JP, 1991, PLANT J, V1, P317, DOI 10.1046/j.1365-313X.1991.t01-9-00999.x; KNOX JP, 1989, DEVELOPMENT, V106, P47; Konieczny R, 2005, PLANT CELL TISS ORG, V83, P201, DOI 10.1007/s11240-005-5771-9; Konieczny R, 2007, PLANT CELL REP, V26, P355, DOI 10.1007/s00299-006-0222-6; Kurczynska E, 2012, EMBRYOGENESIS, P27; Kurczynska EU, 2007, PLANTA, V226, P619, DOI 10.1007/s00425-007-0510-6; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Lee YI, 2013, AM J BOT, V100, P2121, DOI 10.3732/ajb.1300193; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Mazarei M, 2011, PLANT SCI, V181, P712, DOI 10.1016/j.plantsci.2010.12.010; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moller I, 2007, GLYCOCONJUGATE J, V25; Ovecka M, 1999, ACTA PHYSIOL PLANT, V21, P117, DOI 10.1007/s11738-999-0065-1; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; PENNELL RI, 1989, J CELL BIOL, V108, P1967, DOI 10.1083/jcb.108.5.1967; Pilarska M, 2007, ACTA BIOL CRACOV BOT, V49, P69; Pilarska M, 2014, ACTA SOC BOT POL, V83, P67, DOI 10.5586/asbp.2014.009; Pilarska M, 2013, PLANT CELL TISS ORG, V115, P35, DOI 10.1007/s11240-013-0337-8; Popielarska-Konieczna M, 2010, PROTOPLASMA, V247, P121, DOI 10.1007/s00709-010-0149-1; Popielarska-Konieczna M, 2008, PLANT SIGNAL BEHAV, V3, P707, DOI 10.4161/psb.3.9.6433; Rancour DM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00266; Ribeiro JM, 2006, J EXP BOT, V57, P2025, DOI 10.1093/jxb/erj153; Rumyantseva N I, 2003, Dokl Biol Sci, V391, P375, DOI 10.1023/A:1025127323165; Samaj J, 1999, J MICROSC-OXFORD, V193, P150, DOI 10.1046/j.1365-2818.1999.00441.x; SAMAJ J, 1995, PROTOPLASMA, V186, P45, DOI 10.1007/BF01276934; Samaj J, 2008, PLANT CELL REP, V27, P221, DOI 10.1007/s00299-007-0429-1; Samaj J, 2006, PLANT CELL MONOGR, V2, P35, DOI 10.1007/7089_024; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seifert GJ, 2010, PLANT PHYSIOL, V153, P467, DOI 10.1104/pp.110.153940; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SMALLWOOD M, 1995, PLANTA, V196, P510, DOI 10.1007/BF00203651; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Smallwood M, 1996, PLANTA, V198, P452, DOI 10.1007/BF00620063; Toonen MAJ, 1997, PLANTA, V203, P188, DOI 10.1007/s004250050181; Trifunovi M., 2015, GENTIANACEAE VOLUME, V2, P113; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Verdeil JL, 2001, ANN BOT-LONDON, V88, P9, DOI 10.1006/anbo.2001.1408; Verhertbruggen Y, 2009, PLANT J, V59, P413, DOI 10.1111/j.1365-313X.2009.03876.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2015, GENETICS GENOMICS BR, P353; Wang JB, 2004, AQUAT BOT, V79, P163, DOI 10.1016/j.aquabot.2004.02.003; Wietholter N, 2003, CARBOHYD RES, V338, P423, DOI 10.1016/S0008-6215(02)00498-6; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022992; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Zagorchev L, 2011, BIOTECHNOL BIOTEC EQ, V25, P2321, DOI 10.5504/BBEQ.2011.0050; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411	77	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167426	10.1371/journal.pone.0167426	http://dx.doi.org/10.1371/journal.pone.0167426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893856	gold, Green Submitted, Green Published			2022-12-27	WOS:000389472400116
J	Inaoka, DK; Iida, M; Tabuchi, T; Honma, T; Lee, N; Hashimoto, S; Matsuoka, S; Kuranaga, T; Sato, K; Shiba, T; Sakamoto, K; Balogun, EO; Suzuki, S; Nara, T; da Rocha, JR; Montanari, CA; Tanaka, A; Inoue, M; Kita, K; Harada, S				Inaoka, Daniel Ken; Iida, Maiko; Tabuchi, Toshiyuki; Honma, Teruki; Lee, Nayoung; Hashimoto, Satoshi; Matsuoka, Shigeru; Kuranaga, Takefumi; Sato, Kazuhito; Shiba, Tomoo; Sakamoto, Kimitoshi; Balogun, Emmanuel Oluwadare; Suzuki, Shigeo; Nara, Takeshi; Rodrigues da Rocha, Josmar; Alberto Montanari, Carlos; Tanaka, Akiko; Inoue, Masayuki; Kita, Kiyoshi; Harada, Shigeharu			The Open Form Inducer Approach for Structure-Based Drug Design	PLOS ONE			English	Article							HUMAN DIHYDROOROTATE DEHYDROGENASE; NEMATODE ASCARIS-SUUM; TRYPANOSOMA-CRUZI; FUMARATE REDUCTASE; PYRIMIDINE BIOSYNTHESIS; RHEUMATOID-ARTHRITIS; ALTERNATIVE OXIDASE; COMPLEX-II; INHIBITOR; CHEMOTHERAPY	Many open form (OF) structures of drug targets were obtained a posteriori by analysis of co-crystals with inhibitors. Therefore, obtaining the OF structure of a drug target a priori will accelerate development of potent inhibitors. In addition to its small active site, Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH) is fully functional in its monomeric form, making drug design approaches targeting the active site and protein-protein interactions unrealistic. Therefore, a novel a priori approach was developed to determination the TcDHODH active site in OF. This approach consists of generating an "OF inducer" (predicted in silico) to bind the target and cause steric repulsion with flexible regions proximal to the active site that force it open. We provide the first proof-of-concept of this approach by predicting and crystallizing TcDHODH in complex with an OF inducer, thereby obtaining the OF a priori with its subsequent use in designing potent and selective inhibitors. Fourteen co-crystal structures of TcDHODH with the designed inhibitors are presented herein. This approach has potential to encourage drug design against diseases where the molecular targets are such difficult proteins possessing small AS volume. This approach can be extended to study open/close conformation of proteins in general, the identification of allosteric pockets and inhibitors for other drug targets where conventional drug design approaches are not applicable, as well as the effective exploitation of the increasing number of protein structures deposited in Protein Data Bank.	[Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Inaoka, Daniel Ken; Balogun, Emmanuel Oluwadare; Suzuki, Shigeo; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan; [Iida, Maiko; Tabuchi, Toshiyuki; Lee, Nayoung; Hashimoto, Satoshi; Matsuoka, Shigeru; Kuranaga, Takefumi; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Integrated Analyt Chem, Tokyo, Japan; [Honma, Teruki; Sato, Kazuhito; Tanaka, Akiko] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Shiba, Tomoo; Harada, Shigeharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Kyoto, Japan; [Sakamoto, Kimitoshi] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Aomori, Japan; [Nara, Takeshi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Rodrigues da Rocha, Josmar; Alberto Montanari, Carlos] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil	Nagasaki University; University of Tokyo; University of Tokyo; RIKEN; Kyoto Institute of Technology; Hirosaki University; Juntendo University; Universidade de Sao Paulo	Inaoka, DK (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.; Inaoka, DK (corresponding author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan.	danielken@nagasaki-u.ac.jp	Balogun, Emmanuel Oluwadare/AAF-3352-2020; Montanari, Carlos A/C-2799-2012; Sakamoto, Kimitoshi/G-4539-2014; Inaoka, Daniel Ken/GMX-4344-2022	Montanari, Carlos A/0000-0002-4963-0316; Inaoka, Daniel Ken/0000-0002-9791-927X; Balogun, Emmanuel/0000-0002-2092-0045	Japanese Society for the Promotion of Science [18GS0314, 18073004, 26253025, 26870119, 16K19114]; Targeted Proteins Research Program from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) [10000284, 1400738]; Grants-in-Aid for Scientific Research [26304041] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Creative Scientific Research Grant 18GS0314 (to K. K.), Grant-in-aid for Scientific Research 18073004 and 26253025 (to K.K.), 26870119 and 16K19114 (to D.K.I.) from the Japanese Society for the Promotion of Science, and Targeted Proteins Research Program (to K.K. and Sh.H.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT). The authors also acknowledge the support from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to K.K. and Sh.H.) and JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) 10000284 (to K.K.) and 1400738 (to D.K.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed using synchrotron beamlines BL44XU and BL41XU at Spring-8, and beamlines BL5A, BL17A, NE3A, and NW12A at Photon Factory. We thank all beamline staff members for their help with X-ray diffraction data collection. This work was supported in part by Creative Scientific Research Grant 18GS0314 (to K.K.), Grant-in-aid for Scientific Research 18073004 and 26253025 (to K.K.), 26870119 and 16K19114 (to D.K.I.) from the Japanese Society for the Promotion of Science, and Targeted Proteins Research Program (to K.K. and Sh.H.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT). We also acknowledge the support from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to K.K. and Sh.H.) and JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) 10000284 (to K.K.) and 1400738 (to D.K.I.).	Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Baumgartner R, 2006, J MED CHEM, V49, P1239, DOI 10.1021/jm0506975; Bedingfield PTP, 2012, J MED CHEM, V55, P5841, DOI 10.1021/jm300157n; Breedveld FC, 2000, ANN RHEUM DIS, V59, P841, DOI 10.1136/ard.59.11.841; Cheleski J, 2010, EUR J MED CHEM, V45, P5899, DOI 10.1016/j.ejmech.2010.09.055; Chemical Computing Group Inc, 2012, SSW SUIT 910; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fritzson I, 2010, CHEMMEDCHEM, V5, P608, DOI 10.1002/cmdc.200900454; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; Harada S, 2013, BBA-BIOENERGETICS, V1827, P658, DOI 10.1016/j.bbabio.2013.01.005; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; Heikkila T, 2007, J MED CHEM, V50, P186, DOI 10.1021/jm060687j; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Inaoka DK, 2008, BIOCHEMISTRY-US, V47, P10881, DOI 10.1021/bi800413r; Inaoka DK, 2015, INT J MOL SCI, V16, P15287, DOI 10.3390/ijms160715287; Inaoka DK, 2005, ACTA CRYSTALLOGR F, V61, P875, DOI 10.1107/S174430910502659X; Jensen KF, 1998, PATHS PYRIMIDINES, V6, P20; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; MacDonald FE., 2010, HDB BIOCH MOL BIOL; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ong HB, 2013, MOL MICROBIOL, V90, P443, DOI 10.1111/mmi.12376; Osanai A, 2009, ACTA CRYSTALLOGR F, V65, P941, DOI 10.1107/S1744309109031352; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips Margaret A., 2010, Infectious Disorders - Drug Targets, V10, P226; Pipeline Pilot, 2007, PIP PIL; Rowland P, 2000, STRUCTURE, V8, P1227, DOI 10.1016/S0969-2126(00)00530-X; ROZENCWEIG M, 1979, CANCER CHEMOTH PHARM, V3, P135, DOI 10.1007/BF00262414; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Shimizu H, 2012, J BIOCHEM, V151, P589, DOI 10.1093/jb/mvs051; Takashima E, 2002, MOL BIOCHEM PARASIT, V122, P189, DOI 10.1016/S0166-6851(02)00100-7; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Wilson ZN, 2012, J BIOL CHEM, V287, P12759, DOI 10.1074/jbc.M112.346502; Yabu Y, 2006, PARASITOL INT, V55, P39, DOI 10.1016/j.parint.2005.09.003; Yabu Y, 2003, PARASITOL INT, V52, P155, DOI 10.1016/S1383-5769(03)00012-6	57	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167078	10.1371/journal.pone.0167078	http://dx.doi.org/10.1371/journal.pone.0167078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893848	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400079
J	Munoz-Aguirrel, P; Denova-Gutierrez, E; Flores, M; Salazar-Martinez, E; Salmeron, J				Munoz-Aguirrel, Paloma; Denova-Gutierrez, Edgar; Flores, Mario; Salazar-Martinez, Eduardo; Salmeron, Jorge			High Vitamin D Consumption Is Inversely Associated with Cardiovascular Disease Risk in an Urban Mexican Population	PLOS ONE			English	Article							METABOLIC SYNDROME; D SUPPLEMENTATION; DIETARY PATTERNS; 25-HYDROXYVITAMIN-D; EXPRESSION; PREDICTION; NUTRITION; ARTERIES; CALCIUM; HEALTH	Background Vitamin D deficiency is a major global public health problem. Recent epidemiological studies have assessed the relationship between vitamin D and multiple outcomes, including cardiovascular disease. However, this evidence is limited and inconclusive. Our purpose in this study was to evaluate the association between dietary vitamin D intake and cardiovascular disease risk in adult Mexican population. Methods We conducted a cross-sectional analysis with the baseline data from 6294 men and women aged 20-80 years participating in the Health Workers Cohort Study. Data on sociodemographic, lifestyle, and medical history factors were collected with a self-administered questionnaire. Dietary intake was evaluated by using a semi-quantitative food-frequency questionnaire. Cardiovascular disease risk was calculated using a recalibration of the Framingham heart disease prediction score. To evaluate the association between vitamin D intake and 10-year cardiovascular disease risk, odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using multiple logistic regression analysis. Results A total of 6294 subjects (1820 men and 4474 women) with a mean age of 42 years, were included. Of these, subjects in the highest quintile of vitamin D intake presented lower levels of triglycerides 14.6 mg/dL (P for trend = 0.001); 2.0 cm less in waist circumference (P for trend = 0.001) and 0.8 points less in the Framingham cardiovascular disease risk score (P for trend = 0.002) compared with the subjects in the lower quintile of vitamin D intake. Additionally, participants in the highest quintile of vitamin D consumption were less likely to develop elevated 10-year cardiovascular disease risk, compared with those in the lowest quintile (OR = 0.51; 95% CI: 0.33, 0.77; P for trend = 0.007). Conclusion Our data suggest that higher consumption of vitamin D is associated with a reduced risk of cardiovascular disease in Mexican population.	[Munoz-Aguirrel, Paloma; Salmeron, Jorge] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Cuernavaca, Morelos, Mexico; [Denova-Gutierrez, Edgar] Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Epidemiol & Clin, Mexico City, DF, Mexico; [Flores, Mario] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico; [Salazar-Martinez, Eduardo; Salmeron, Jorge] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico	Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico Gomez; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Denova-Gutierrez, E (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Epidemiol & Clin, Mexico City, DF, Mexico.	edenovag@gmail.com	Gutierrez, Edgar Denova/E-4600-2011; Cardoso, Isadora/H-5757-2017	Gutierrez, Edgar Denova/0000-0001-9671-9682; Salmeron, Jorge/0000-0002-5113-299X; Flores, Mario/0000-0001-5522-6849	Consejo Nacional de Ciencia y Tecnologia Mexico City [87783, 7876]	Consejo Nacional de Ciencia y Tecnologia Mexico City(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was supported by Consejo Nacional de Ciencia y Tecnologia (grant: 87783, and grant: 7876) Mexico City.	American Heart Association, HEART ATT RISK ASS; [Anonymous], 2010, CAUS SEL MORT SEX 20, P93; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Borges ACR, 1999, BRIT J PHARMACOL, V127, P772, DOI 10.1038/sj.bjp.0702581; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Denova-Gutierrez E, 2016, NUTR HOSP, V33, P663, DOI 10.20960/nh.276; Denova-Gutierrez E, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/170680; Denova-Gutierrez E, 2011, J NUTR, V141, P921, DOI 10.3945/jn.110.132332; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Denova-Gutierrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145; Flores M., 2011, RESULTADOS ENSANUT 2; Getz GS, 2007, ARTERIOSCL THROM VAS, V27, P2499, DOI 10.1161/ATVBAHA.107.155853; Hernandez-Avila JE, 2003, USER MANUAL EVALUATI; Hernandez-Avila M, 1998, SALUD PUBLICA MEXICO, V40, P133, DOI 10.1590/S0036-36341998000200005; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jaimungal S, 2011, NUTR RES, V31, P805, DOI 10.1016/j.nutres.2011.09.005; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Lee DM, 2009, EUR J ENDOCRINOL, V161, P947, DOI 10.1530/EJE-09-0496; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; MACCARTHY EP, 1989, HYPERTENSION, V13, P954, DOI 10.1161/01.HYP.13.6.954; Maki KC, 2009, J CLIN LIPIDOL, V3, P289, DOI 10.1016/j.jacl.2009.07.003; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Michos ED, 2007, CIRCULATION, V115, P827, DOI 10.1161/CIRCULATIONAHA.106.686238; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Munoz-Aguirre P, 2015, CLIN NUTR, V34, P799, DOI 10.1016/j.clnu.2014.10.002; Norman A.W., 2006, PRESENT KNOWLEDGE NU; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; Ohsawa M, 2000, CIRCULATION, V102, P2867; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Poliquin S, 2009, CAN J DIET PRACT RES, V70, P21, DOI 10.3148/70.1.2009.21; Ramly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110476; Ross AC, 2006, MODERN NUTR HLTH DIS, V10th; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Sun Q, 2011, AM J CLIN NUTR, V94, P534, DOI 10.3945/ajcn.110.008763; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Willet W, 1998, NUTR EPIDEMIOLOGY; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolpowitz D, 2006, J AM ACAD DERMATOL, V54, P301, DOI 10.1016/j.jaad.2005.11.1057; World Health Organization (WHO), 2008, FRAM MON EV IMPL GLO; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zittermann A, 2014, ANTICANCER RES, V34, P4641; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166869	10.1371/journal.pone.0166869	http://dx.doi.org/10.1371/journal.pone.0166869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893863	gold, Green Submitted, Green Published			2022-12-27	WOS:000389472400051
J	Yu, J; Chen, RS; Tan, YF; Wu, JS; Qi, JY; Zhang, MZ; Gu, WW				Yu, Juan; Chen, Renshan; Tan, Yafang; Wu, Jiashin; Qi, Jianyong; Zhang, Minzhou; Gu, Weiwang			Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice	PLOS ONE			English	Article							CARDIOMYOCYTE HYPERTROPHY; CARDIAC-HYPERTROPHY; UP-REGULATION; ACTIVATION; PROTECTS; CELLS; GATA4; MILTIORRHIZA; DYSFUNCTION; INHIBITION	Background Heart failure(HF) is a dangerous disease that affects millions of patients. Radix Salvia is widely used in Chinese clinics to treat heart diseases. Salvianolic acid B(SalB) is the major active component of Radix Salvia. This study investigated the mechanisms of action and effects of SalB on HF in an experimental mouse model of HF. Methods We created a mouse model of HF by inducing pressure overload with transverse aortic constriction( TAC) surgery for 2 weeks and compared among 4 study groups: SHAM group (n = 10), TAC group (n = 9), TAC+MET group (metprolol, positive drug treatment, n = 9) and TAC+SalB group (SalB, 240 mg.kg(-1).day(-1), n = 9). Echocardiography was used to evaluate the dynamic changes in cardiac structure and function in vivo. Plasma brain natriuretic peptide (BNP) concentration was detected by Elisa method. In addition, H9C2 rat cardiomyocytes were cultured and Western blot were implemented to evaluate the phosphorylation of ERK1/2, AKT, and protein expression of GATA4. Results SalB significantly inhibited the phosphorylation of Thr202/Tyr204 sites of ERK1/2, but not Ser473 site of AKT, subsequently inhibited protein expression of GATA4 and plasma BNP (P < 0.001), and then inhibited HF at 2 weeks after TAC surgery. Conclusions Our data provide a mechanism of inactivating the ERK1/2/GATA4 signaling pathway for SalB inhibition of the TAC-induced HF.	[Yu, Juan; Gu, Weiwang] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Renshan; Tan, Yafang; Qi, Jianyong; Zhang, Minzhou] Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2,AMI Key Lab Chinese Med Guangzh, Guangzhou, Guangdong, Peoples R China; [Yu, Juan] Guangdong Prov Acad Chinese Med, Anim Lab, Guangzhou, Guangdong, Peoples R China; [Wu, Jiashin] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Coll Pharm, Rootstown, OH USA	Southern Medical University - China; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Northeast Ohio Medical University (NEOMED)	Gu, WW (corresponding author), Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China.; Qi, JY; Zhang, MZ (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Acad Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2,AMI Key Lab Chinese Med Guangzh, Guangzhou, Guangdong, Peoples R China.	drqjy@163.com; minzhouzhang8@163.com; guweiwang8@163.com			National Natural Science Foundation of China [81473471, 81603429]; National Natural Science Foundation of Guangdong [2014A030313402]; Guangdong Medical Research Fund [A2014271]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20134425110001]; Guangdong science and Technology Foundation [2016KT1170]; Special Funds of Guangdong hospital of Chinese Medicine [YK2013B2N11, YN2014ZH01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Guangdong Medical Research Fund; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong science and Technology Foundation; Special Funds of Guangdong hospital of Chinese Medicine	This study was supported by the National Natural Science Foundation of China (#81473471 to M.Z., #81603429 to J.Y.), of Guangdong (#2014A030313402 to J.Q.), Guangdong Medical Research Fund (#A2014271 to J.Q.), Specialized Research Fund for the Doctoral Program of Higher Education of China 20134425110001 (to M.Z.), Guangdong science and Technology Foundation 2016KT1170 (to J.Q.), Special Funds of Guangdong hospital of Chinese Medicine YK2013B2N11, YN2014ZH01 (to M.Z.),	Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Deng YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135435; Guo HD, 2014, INT J CARDIOL, V177, P538, DOI 10.1016/j.ijcard.2014.08.104; Huang MA, 2015, PHARM BIOL, V53, P1058, DOI 10.3109/13880209.2014.959611; Kovacs K, 2009, MOL CELL BIOCHEM, V321, P155, DOI 10.1007/s11010-008-9929-8; Li Q, 2015, J CARDIOVASC PHARM, V66, P196, DOI 10.1097/FJC.0000000000000265; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liu CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001321; Liu M, 2015, BIOCHEM BIOPH RES CO, V468, P214, DOI 10.1016/j.bbrc.2015.10.127; Lv HD, 2015, BRAIN RES BULL, V115, P30, DOI 10.1016/j.brainresbull.2015.05.002; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pan RH, 2008, CHIN J INTEGR TRADIT, V9, P779; Qi JY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/769515; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Tang YB, 2014, BIOCHEM PHARMACOL, V90, P34, DOI 10.1016/j.bcp.2014.04.008; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Ulm S, 2014, J MOL CELL CARDIOL, V72, P104, DOI 10.1016/j.yjmcc.2014.03.002; Wu YT, 2006, INT J PHARM, V326, P25, DOI 10.1016/j.ijpharm.2006.07.003; Xu X, 2013, MOL MED REP, V8, P385, DOI 10.3892/mmr.2013.1548; Yu FJ, 2015, J CELL MOL MED, V19, P2617, DOI 10.1111/jcmm.12655; Zeng WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16013; Zhang HS, 2006, J MOL CELL CARDIOL, V41, P138, DOI 10.1016/j.yjmcc.2006.03.007; Zhao Y, 2011, J ONCOL, V2011, DOI 10.1155/2011/534548	31	18	18	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166560	10.1371/journal.pone.0166560	http://dx.doi.org/10.1371/journal.pone.0166560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893819	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400032
J	Aurpibul, L; Tangmunkongvorakul, A; Musumari, PM; Srithanaviboonchai, K; Tarnkehard, S				Aurpibul, Linda; Tangmunkongvorakul, Arunrat; Musumari, Patou Masika; Srithanaviboonchai, Kriengkrai; Tarnkehard, Surapee			Patterns of Sexual Behavior in Lowland Thai Youth and Ethnic Minorities Attending High School in Rural Chiang Mai, Thailand	PLOS ONE			English	Article							HEALTH-SERVICES; HIV; ADOLESCENTS; INITIATION; STUDENTS; GENDER	Introduction The rural areas of Northern Thailand are home to a large cultural diversity of ethnic minority groups. Previous studies have shown that young people in rural Thailand have low levels of knowledge on HIV/AIDS and high sexual risks. We compared sexual behaviors between the lowland Thai youth and the youth from ethnic minority groups. Methods and findings This is a cross-sectional quantitative study conducted among high-school Thai and ethnic students in Chiang Mai. From a total 1215 participants, 487 (40.1%) were lowland Thai and 728 (59.9%) were from ethnic minorities. Overall, 17.9% of respondents reported "ever had sex." Lowland Thai adolescents were more likely to have ever had sex compared with ethnic minority adolescents (AOR, 1.61; CI, 1.06-2.45; P<0.01). A higher proportion of lowland Thai respondents reported having >= 2 lifetime sexual partners (51.9% vs. 33.3%, P= 0.003), or currently having a boy/girlfriend (59.9% vs. 45.3%, P< 0.001) compared to ethnic minority adolescents. Consistent condom use was low in both groups (22.6%). The common significant factors associated with "ever had sex" in both groups were "ever drunk alcohol in the past year" and "currently having a boy/girlfriend." Specifically, for lowland Thai youth, being around the age of 17 or 18 years and "ever used methamphetamine in the past year" were associated with increased odds of "ever had sex". For ethnic minority adolescents, being female and belonging to religions other than Buddhism were associated with decreased odds of "ever had sex". Conclusion A substantially higher proportion of lowland Thai engage in risky sexual behaviors when compared to ethnic minorities. However, both groups remained vulnerable to HIV and other sexually transmitted infections. To minimize sexual risks, education program and school-based interventions are warranted to increase awareness of young people about risky behaviors and to promote essential life skills.	[Aurpibul, Linda; Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai; Tarnkehard, Surapee] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Musumari, Patou Masika] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand	Chiang Mai University; Kyoto University; Chiang Mai University	Tangmunkongvorakul, A (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	arunrat@rihes.org	., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission; Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program"	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission; Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program"	The study was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research and the National Research University Project under Thailand's Office of the Higher Education Commission (Dr. Arunrat Tangmunkongvorakul). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was part of the HIV/AIDS Prevention Program among Ethnic Young People in Chiang Mai. It was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research. It was also supported by the National Research University Project under Thailand's Office of the Higher Education Commission. We thank the young people in rural Chiang Mai Province who contributed to this research. We also thank the Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program" for supporting the collaboration between Kyoto University and the Research Institute for Health Sciences, Chiang Mai University.	Baba S., 2010, INT C FUT IMP COMM I; Bozon M, 1998, SOC AS AIDS, P37; Chai Podhisita PX, 2001, POPULATION SERIES, V108-5; Dahlfred K., LIFE MINISTRY D MCGI; David Ross, 2006, UNAIDS INTERAGENCY T; Fongkaew W, 2007, J ASSOC NURSE AIDS C, V18, P60, DOI 10.1016/j.jana.2007.01.005; FRIEDMAN HL, 1992, J ADOLESCENT HEALTH, V13, P345, DOI 10.1016/1054-139X(92)90026-8; HalpernFelsher BL, 1996, J ADOLESCENT HEALTH, V19, P331, DOI 10.1016/S1054-139X(96)00024-9; Huguet A., 2011, APHICHAT CHAMRATRITH; Idele P, 1999, J ACQ IMMUN DEF SYND, V2014; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; Kumpirat P., SOCIAL CULTURAL FACT; Liebowitz J., 2002, IMPACT FAITH BASED O; Lindley LL, PUBLIC HLTH REP, V1, P12; Listman JB, 2011, AM J PHYS ANTHROPOL, V144, P300, DOI 10.1002/ajpa.21408; Liu A, 2006, INT FAM PLAN PERSPEC, V32, P126, DOI 10.1363/3212606; Liulan WC, 2006, SE ASIAN STUDIES, V44, P337; Ministry of Social Development and Human Security, 2010, PREGN THAI AD; Mulu W, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-84; Musumari PM, 2016, PLOS ONE, V11; National AIDS Prevention and Alleviation Committee, 2006, UNGASSCOUNTRY PROGR; Ngamprapasom N., 2001, THESIS; Pettifor A, 2013, JAIDS-J ACQ IMM DEF, V63, pS155, DOI 10.1097/QAI.0b013e31829871fb; Rongkavilit Chokechai, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.004; Sirinan Kittisuksathit, 2007, SEXUAL RISK BEHAV HI, P99; Srisuriyawet R, 2006, THESIS; Tangmunkongvorakul A, 2005, CULT HEALTH SEX, V7, P361, DOI 10.1080/13691050500100740; Tangmunkongvorakul A, SE ASIAN J TROPICAL, V45, P1437; Tangmunkongvorakul A, 2012, SE ASIAN J TROP MED, V43, P479; Tangmunkongvorakul A, 2012, ASIAN POPUL STUD, V8, P39, DOI 10.1080/17441730.2012.646837; Tangmunkongvorakul A, 2010, SE ASIAN J TROP MED, V41, P1475; Taywaditep KJ, 2004, CONTINUUM COMPLETE I, P1021; Techasrivichien T, 2014, ARCH SEXUAL BEHAV; UNAIDS, 2012, FACT SHEET; Wingood GM, 2013, AM J PUBLIC HEALTH, V103, P2226, DOI 10.2105/AJPH.2013.301386; World Health Organisation, 2013, TRAD FOR POL DIPL HL; Yongpanichkul S, REV SEXUALITY REPROD	37	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165866	10.1371/journal.pone.0165866	http://dx.doi.org/10.1371/journal.pone.0165866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906980	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700012
J	Bachelot, A; Nicolas, C; Gricourt, S; Dulon, J; Leban, M; Golmard, JL; Touraine, P				Bachelot, Anne; Nicolas, Carole; Gricourt, Solenne; Dulon, Jerome; Leban, Monique; Golmard, Jean Louis; Touraine, Philippe			Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency	PLOS ONE			English	Article							EARLY BILATERAL OOPHORECTOMY; YOUNG-WOMEN; TURNER-SYNDROME; EARLY MENOPAUSE; FAILURE; MORTALITY; REPLACEMENT; COHORT	Premature ovarian insufficiency leads to through infertility and estrogen deficiency. Optimal management encompasses estrogen replacement therapy. Long-term outcome of women with POI is not known. We design a study to evaluate the medical care, hormone replacement therapy compliance and bone mineral density (BMD) in POI women with at least a five-year follow-up after the first evaluation. One hundred and sixty-two patients (37.3 +/- 8.0 years) were evaluated (follow-up 7.9 +/- 2.8 years). Sixty-nine patients (42.6%) had stopped their hormone replacement therapy (HRT) for at least one year during the follow up period. BMD determination at initial evaluation and at follow-up visit was completed in 92 patients. At first evaluation, 28 patients (30%) had osteopenia and 7 (8%) had osteoporosis. At follow up, 31 women (34%) had BMD impairment with osteopenia in 61% and osteoporosis in 5%. In univariate analysis and multivariate analysis, there was a significant loss of femoral BMD in women who had stopped their HRT for over a year. In conclusion, this first study concerning long-term follow-up of POI patients shows the poor compliance to their HRT, despite its importance in the prevention of bone demineralization. This study reinforces the need for follow up and specific care for POI women.	[Bachelot, Anne; Nicolas, Carole; Gricourt, Solenne; Dulon, Jerome; Touraine, Philippe] Hop La Pitie Salpetriere, AP HP, IE3M,Dept Endocrinol & Reprod Med,Ctr Reference P, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France; [Bachelot, Anne; Nicolas, Carole; Golmard, Jean Louis; Touraine, Philippe] Univ Paris, Univ Pierre & Marie Curie, Paris, France; [Leban, Monique] Hop La Pitie Salpetriere, AP HP, Dept Hormonal Biochem, Paris, France; [Golmard, Jean Louis] Hop La Pitie Salpetriere, AP HP, Clin Res Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Touraine, P (corresponding author), Hop La Pitie Salpetriere, AP HP, IE3M,Dept Endocrinol & Reprod Med,Ctr Reference P, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France.; Touraine, P (corresponding author), Univ Paris, Univ Pierre & Marie Curie, Paris, France.	philippe.touraine@aphp.fr	Bachelot, Anne/GQZ-0551-2022					Amarante F, 2011, BRAZ J MED BIOL RES, V44, P78, DOI 10.1590/S0100-879X2011000100012; Anasti JN, 1998, OBSTET GYNECOL, V91, P12, DOI 10.1016/S0029-7844(97)00583-8; Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Bachelot A, 2016, CLIN ENDOCRINOL OXF; Bachelot A, 2009, EUR J ENDOCRINOL, V161, P179, DOI 10.1530/EJE-09-0231; Bakalov VK, 2003, J CLIN ENDOCR METAB, V88, P5717, DOI 10.1210/jc.2003-030913; Bidet M, 2011, J CLIN ENDOCR METAB, V96, P3864, DOI 10.1210/jc.2011-1038; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; DAVIES MC, 1990, BRIT MED J, V301, P790, DOI 10.1136/bmj.301.6755.790; Francucci C M, 2010, J Endocrinol Invest, V33, P39; Gallagher JC, 2007, MENOPAUSE, V14, P567, DOI 10.1097/gme.0b013e31804c793d; Hanton L, 2003, J WOMENS HEALTH, V12, P971, DOI 10.1089/154099903322643893; Jacobsen BK, 2003, AM J EPIDEMIOL, V157, P923, DOI 10.1093/aje/kwg066; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Langrish JP, 2009, HYPERTENSION, V53, P805, DOI 10.1161/HYPERTENSIONAHA.108.126516; Management of women with premature ovarian insufficiency, MANAGEMENT WOMEN PRE; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Popat VB, 2014, J CLIN ENDOCR METAB, V99, P3418, DOI 10.1210/jc.2013-4145; Popat VB, 2009, J CLIN ENDOCR METAB, V94, P2277, DOI 10.1210/jc.2008-1878; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rivera CM, 2009, NEUROEPIDEMIOLOGY, V33, P32, DOI 10.1159/000211951; Schoemaker MJ, 2008, J CLIN ENDOCR METAB, V93, P4735, DOI 10.1210/jc.2008-1049; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; Soares PM, 2010, SAO PAULO MED J, V128, P211, DOI 10.1590/S1516-31802010000400007; van Lennep JER, 2016, EUR J PREV CARDIOL, V23, P178, DOI 10.1177/2047487314556004; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4	27	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0164638	10.1371/journal.pone.0164638	http://dx.doi.org/10.1371/journal.pone.0164638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906970	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700005
J	Fjellman-Wiklundl, A; Nordin, E; Skelton, DA; Lundin-Olsson, L				Fjellman-Wiklundl, Anncristine; Nordin, Ellinor; Skelton, Dawn A.; Lundin-Olsson, Lillemor			Reach the Person behind the Dementia Physical Therapists' Reflections and Strategies when Composing Physical Training	PLOS ONE			English	Article							OLDER-PEOPLE; FOCUS GROUPS; CARE; COMORBIDITY; RESIDENTS; PROGRAM; DISEASE	Dementia is a disease characterized by cognitive impairment and physical decline that worsens over time. Exercise is one lifestyle factor that has been identified as a potential means of reducing or delaying progression of the symptoms of dementia, maximizing function and independence. The purpose of this study was to explore physical therapists' (PTs) experiences and reflections on facilitating high-intensity functional exercise with older people living with dementia, in residential care home settings. The study used a qualitative design based on interviews, individually or in small groups, with seven PTs engaged as leaders in the training of older people with dementia. The interviews were analyzed with a modified Grounded Theory method with focus on constant comparisons. To increase trustworthiness the study used triangulation within investigators and member checking. The core category "Discover and act in the moment-learn over time" reflects how the PTs continuously developed their own learning in an iterative process. They built on previous knowledge to communicate with residents and staff and to tailor the high intensity training in relation to each individual at that time point. The category "Be on your toes" highlights how the PTs searched for sufficient information about each individual, before and during training, by eliciting the person's current status from staff and by interpreting the person's body language. The category "Build a bond with a palette of strategies" describes the importance of confirmation to build up trust and the use of group members and the room to create an interplay between exercise and social interaction. These findings highlight the continuous iterative process of building on existing knowledge, sharing and reflecting, being alert to any alterations needed for individuals that day, communication skills (both with residents and staff) and building a relationship and trust with residents in the effective delivery of high intensity functional exercise to older people living with dementia in care settings.	[Fjellman-Wiklundl, Anncristine; Nordin, Ellinor; Skelton, Dawn A.; Lundin-Olsson, Lillemor] Umea Univ, Physiotherapy, Dept Community Hlth & Rehabil, Umea, Sweden; [Skelton, Dawn A.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland	Umea University; Glasgow Caledonian University	Fjellman-Wiklundl, A (corresponding author), Umea Univ, Physiotherapy, Dept Community Hlth & Rehabil, Umea, Sweden.	anncristinefielirron-wiklund@umu.se	Skelton, Dawn A/B-7552-2013	Skelton, Dawn A/0000-0001-6223-9840	Dementia Association - The National Association for the Rights of the Demented, in Sweden; Umea University	Dementia Association - The National Association for the Rights of the Demented, in Sweden; Umea University	This work received support from The Dementia Association - The National Association for the Rights of the Demented, in Sweden, http://www.demensforbundet.se/, to LLO and Umea University, http://www.umu.se/, to LLO.	Chartered Society of Physiotherapy United Kingdom, 2011, DEM CAR PHYS DEL PAR; Collin C, 1988, Int Disabil Stud, V10, P61; Dahlgren L, QUALITATIVE METHODOL; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173, DOI 10.1093/gerona/57.3.M173; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2013, COCHRANE DATABASE SY, V12; Fox C, 2014, AGE AGEING, V43, P741, DOI 10.1093/ageing/afu101; Galik EM, 2009, INT J NURS PRACT, V15, P48, DOI 10.1111/j.1440-172X.2008.01721.x; Guzman-Velez E, 2014, COGN BEHAV NEUROL, V27, P117, DOI 10.1097/WNN.0000000000000020; Johannessen A, 2014, SCAND J CARING SCI, V28, P749, DOI 10.1111/scs.12107; Kitwood T, 1997, AGING MENT HEALTH, V1, P13, DOI 10.1080/13607869757344; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kovach CR, 2010, AM J ALZHEIMERS DIS, V25, P317, DOI 10.1177/1533317510363471; Laventure B, 2010, J ACTIVE AGING   SEP, P63; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Littbrand H, 2006, PHYS THER, V86, P489, DOI 10.1093/ptj/86.4.489; Martin-Garcia S, 2013, INT PSYCHOGERIATR, V25, P1077, DOI 10.1017/S1041610213000458; Morgan D.L., 1998, PLANNING FOCUS GROUP; NICE, 2011, SUPP PEOPL DEM THEIR; Prince M., 2013, WORLD ALZHEIMER REPO; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Schon D. A, 1986, REFLECTIVE PRACTITIO; Schon D. A., 1983, REFLECTIVE PRACTITIO, DOI [10.2307/J.CTVPBNPJG.24, DOI 10.4324/9781315237473]; Scottish Intercollegiate Guideline Network (SIGN), 2006, MAN PAT DEM NAT CLIN; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL, V4th; Strauss A., 1998, BASICS QUALITATIVE R; Teri L, 2015, HDB PSYCHOL AGING; Toots A, 2015, J AM GER SO IN PRESS; Willemse BM, 2015, AGING MENT HEALTH, V19, P444, DOI 10.1080/13607863.2014.944088	31	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166686	10.1371/journal.pone.0166686	http://dx.doi.org/10.1371/journal.pone.0166686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906996	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700035
J	Camargos, AC; Mendonca, VA; de Andrade, CA; Oliveira, KSC; Tossige-Gomes, R; Rocha-Vieira, E; Neves, CDC; Vieira, EL; Leite, HR; Oliveira, MX; Teixeira, AL; Coimbra, CC; Lacerda, ACR				Resende Camargos, Ana Cristina; Mendonca, Vanessa Amaral; de Andrade, Camila Alves; Caires Oliveira, Katherine Simone; Tossige-Gomes, Rosalina; Rocha-Vieira, Etel; Cunha Neves, Camila Danielle; Marciano Vieira, Erica Leandro; Leite, Hercules Ribeiro; Oliveira, Murilo Xavier; Teixeira Junior, Antonio Lucio; Coimbra, Candido Celso; Lacerda, Ana Cristina Rodrigues			Neuroendocrine Inflammatory Responses in Overweight/Obese Infants	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ADIPOSE-TISSUE BIOLOGY; HIGH-MOLECULAR-WEIGHT; OBESE CHILDREN; OXIDATIVE STRESS; METABOLIC SYNDROME; NEUROTROPHIC FACTOR; CHILDHOOD OBESITY; BREAST-MILK; ADIPONECTIN	Childhood obesity is related to a cascade of neuroendocrine inflammatory changes. However, there remains a gap in the current literature regarding the possible occurrence of these changes in overweight/obese infants. The objective of this study was to evaluate adipokines, cortisol, brain-derived neurotrophic factor (BDNF) and redox status in overweight/obese infants versus normal-weight peers. A cross-sectional study was conducted with 50 infants (25 in the overweight/obese group and 25 in the normal-weight group) between 6 and 24 months. Plasma levels of leptin, adiponectin, resistin, soluble tumor necrosis factor (TNF) receptors, chemokines, BDNF, serum cortisol and redox status were measured. Unpaired Student's t-test was used to analyze the results and a probability of p<0.05 was acceptable for rejection of the null hypothesis. The Pearson correlation was used to verify the association between the biomarkers analyzed in each group. Plasma levels of leptin (p = 0.0001), adiponectin (p = 0.0007) and BDNF (p = 0.003), and serum cortisol (p = 0.048) were significantly higher in overweight/obese infants than normal-weight infants. In contrast, the concentration of thiobarbituric acid reactive substances (TBARS) (p = 0.004), and catalase (p = 0.045) and superoxide dismutase activity (p = 0.02) were lower in overweight/obese infants than normal-weight peers. All the results together indicate neuroendocrine inflammatory response changes in overweight/obese infants between 6 and 24 months. Although there is already an environment that predisposes for a subsequent pro-inflammatory response, neuroendocrine secretion changes that permit the control of the inflammatory process in this age interval can be observed.	[Resende Camargos, Ana Cristina; Mendonca, Vanessa Amaral; de Andrade, Camila Alves; Caires Oliveira, Katherine Simone; Leite, Hercules Ribeiro; Oliveira, Murilo Xavier; Lacerda, Ana Cristina Rodrigues] Univ Fed Vales Jequitinhonha & Mucuri, Dept Fisioterapia, Diamantina, MG, Brazil; [Resende Camargos, Ana Cristina; Mendonca, Vanessa Amaral; Tossige-Gomes, Rosalina; Rocha-Vieira, Etel; Cunha Neves, Camila Danielle; Leite, Hercules Ribeiro; Lacerda, Ana Cristina Rodrigues] Soc Brasileira Fisiol, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil; [Marciano Vieira, Erica Leandro; Teixeira Junior, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Coimbra, Candido Celso] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Sociedade Brasileira de Fisiologia; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Camargos, AC (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Dept Fisioterapia, Diamantina, MG, Brazil.; Camargos, AC (corresponding author), Soc Brasileira Fisiol, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil.	anacristinarcamargos@gmail.com	Teixeira, Antonio L/N-3315-2014; Lacerda, Ana Cristina/J-2181-2012; Mendonça, Vanessa Amaral/T-7958-2019; Oliveira, Murilo/I-7346-2013; Vieira, Erica L M/A-1976-2013; Camargos, Ana Cristina/O-5993-2016; Camargos, Ana Cristina/R-8436-2018; Leite, Hércules Ribeiro/GVT-1268-2022; Leite, Hércules Ribeiro/T-8366-2019; Rocha-Vieira, Etel/A-2524-2017	Teixeira, Antonio L/0000-0002-9621-5422; Lacerda, Ana Cristina/0000-0001-5366-3754; Mendonça, Vanessa Amaral/0000-0002-1696-6091; Oliveira, Murilo/0000-0001-6358-4910; Vieira, Erica L M/0000-0002-4147-5614; Camargos, Ana Cristina/0000-0003-2719-4231; Camargos, Ana Cristina/0000-0003-2719-4231; Leite, Hércules Ribeiro/0000-0001-8977-8131; Leite, Hércules Ribeiro/0000-0001-8977-8131; Rocha-Vieira, Etel/0000-0001-6908-7237	CNPq; FAPEMIG; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Universidade Federal dos Vales do Jequitinhonha e Mucuri for institutional support, the CNPq, FAPEMIG, and CAPES for financial support and scholarships. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Universidade Federal dos Vales do Jequitinhonha e Mucuri for institutional support, the CNPq, FAPEMIG, and CAPES for financial support and scholarships. The authors are in debt to David Lee Nelson for kindly reading the manuscript.	Adamska A, 2012, ACTA DIABETOL, V49, P17, DOI 10.1007/s00592-010-0252-y; Aprath-Husmann I, 2001, INT J OBESITY, V25, P1465, DOI 10.1038/sj.ijo.0801737; Araki S, 2014, OBES RES CLIN PRACT, V8, pE63, DOI 10.1016/j.orcp.2012.07.003; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Associacao Brasileira de Empresas de Pesquisa, 2008, CRIT CLASS EC BRAS; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catli G, 2014, J CLIN RES PEDIATR E, V6, P192, DOI [10.4274/Jcrpe.1531, 10.4274/jcrpe.1531]; Codoner-Franch P, 2014, CLIN BIOCHEM, V47, P44, DOI [10.1016/j.clinbiochem.2013.10.021, DOI 10.1016/J.CLINBIOCHEM.2013.10.021]; Codoner-Franch P, 2014, CLIN BIOCHEM, V47, P44, DOI 10.1016/j.clinbiochem.2013.10.021; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; Economou EV, 2004, J CARDIOVASC PHARM, V44, P310, DOI 10.1097/01.fjc.0000133587.01718.59; Faienza MF, 2012, HORM RES PAEDIAT, V78, P158, DOI 10.1159/000342642; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; GLASS GA, 1981, BIOCHEM BIOPH RES CO, V103, P1245, DOI 10.1016/0006-291X(81)90256-4; Guzzetti C, 2014, J ENDOCRINOL INVEST, V37, P51, DOI 10.1007/s40618-013-0014-0; Harris RBS, 2014, BBA-MOL BASIS DIS, V1842, P414, DOI 10.1016/j.bbadis.2013.05.009; Jeffery AN, 2008, INT J PEDIATR OBES, V3, P130, DOI 10.1080/17477160801954538; Jin YJ, 2015, NUTR NEUROSCI, V18, P376, DOI 10.1179/1476830515Y.0000000039; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Korner A, 2005, BIOCHEM BIOPH RES CO, V337, P540, DOI 10.1016/j.bbrc.2005.09.064; Kotani Y, 2004, CLIN ENDOCRINOL, V61, P418, DOI 10.1111/j.1365-2265.2004.02041.x; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Landgraf K, 2015, DIABETES, V64, P1249, DOI 10.2337/db14-0744; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee MJ, 2014, BBA-MOL BASIS DIS, V1842, P473, DOI 10.1016/j.bbadis.2013.05.029; Leoni MC, 2010, PEDIATRIC REP, V2, P62, DOI 10.4081/pr.2010.e19; Li SH, 2016, OBESITY, V24, P408, DOI 10.1002/oby.21378; Martos-Moreno GA, 2010, OBESITY, V18, P2288, DOI 10.1038/oby.2010.68; Martos-Moreno GA, 2013, VITAM HORM, V91, P107, DOI 10.1016/B978-0-12-407766-9.00006-7; Molgat ASD, 2012, J ENDOCRINOL, V214, P21, DOI 10.1530/JOE-12-0114; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Oliver SR, 2010, INT J PEDIATR OBES, V5, P436, DOI 10.3109/17477160903545163; Oyama C, 2006, TOHOKU J EXP MED, V209, P257, DOI 10.1620/tjem.209.257; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Prodam F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-44; Romacho T, 2015, NUTRIENTS, V7, P865, DOI 10.3390/nu7020865; Rosas-Vargas H, 2011, ARCH MED RES, V42, P482, DOI 10.1016/j.arcmed.2011.09.005; Roth CL, 2013, METABOLISM, V62, P226, DOI 10.1016/j.metabol.2012.08.001; Sabin MA, 2015, J PAEDIATR CHILD H, V51, P82, DOI 10.1111/jpc.12819; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Sorisky A, 2013, ADV NUTR, V4, P67, DOI 10.3945/an.112.003020; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tenenbaum-Gavish K, 2013, FETAL DIAGN THER, V34, P1, DOI 10.1159/000350170; Veldhorst MAB, 2014, J CLIN ENDOCR METAB, V99, P285, DOI 10.1210/jc.2013-2924; WHO, 2011, CHILD GROWTH STANDAR; Wosiski-Kuhn M, 2014, PSYCHONEUROENDOCRINO, V42, P165, DOI 10.1016/j.psyneuen.2014.01.020; Yoshinaga M, 2008, CIRC J, V72, P1874, DOI 10.1253/circj.CJ-08-0180; Zarban A, 2015, BREASTFEED MED, V10, P214, DOI 10.1089/bfm.2014.0143; Zhang MX, 2011, BIOMED ENVIRON SCI, V24, P12, DOI 10.3967/0895-3988.2011.01.002; Zhu YG, 2006, BIOMED ENVIRON SCI, V19, P353	60	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167593	10.1371/journal.pone.0167593	http://dx.doi.org/10.1371/journal.pone.0167593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907172	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700208
J	Samsiah, A; Othman, N; Jamshed, S; Hassali, MA				Samsiah, A.; Othman, Noordin; Jamshed, Shazia; Hassali, Mohamed Azmi			Perceptions and Attitudes towards Medication Error Reporting in Primary Care Clinics: A Qualitative Study in Malaysia	PLOS ONE			English	Article							ADMINISTRATION ERRORS; NURSING ERRORS; PATIENT SAFETY; BARRIERS; NURSES; SYSTEM; INFORMATION; MANAGEMENT; PHYSICIANS; INCIDENTS	Objective To explore and understand participants' perceptions and attitudes towards the reporting of medication errors (MEs). Methods A qualitative study using in-depth interviews of 31 healthcare practitioners from nine publicly funded, primary care clinics in three states in peninsular Malaysia was conducted for this study. The participants included family medicine specialists, doctors, pharmacists, pharmacist assistants, nurses and assistant medical officers. The interviews were audiotaped and transcribed verbatim. Analysis of the data was guided by the framework approach. Results Six themes and 28 codes were identified. Despite the availability of a reporting system, most of the participants agreed that MEs were underreported. The nature of the error plays an important role in determining the reporting. The reporting system, organisational factors, provider factors, reporter's burden and benefit of reporting also were identified. Conclusions Healthcare practitioners in primary care clinics understood the importance of reporting MEs to improve patient safety. Their perceptions and attitudes towards reporting of MEs were influenced by many factors which affect the decision-making process of whether or not to report. Although the process is complex, it primarily is determined by the severity of the outcome of the errors. The participants voluntarily report the errors if they are familiar with the reporting system, what error to report, when to report and what form to use.	[Samsiah, A.; Jamshed, Shazia] Int Islamic Univ Malaysia, Kulliyyah Pharm, Kuantan, Pahang, Malaysia; [Samsiah, A.] Minist Hlth, Inst Hlth Syst Res, Shah Alam, Selangor, Malaysia; [Othman, Noordin] Taibah Univ, Coll Pharm, Dept Clin & Hosp Pharm, Almadinah Almunawwarah, Saudi Arabia; [Hassali, Mohamed Azmi] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia	International Islamic University Malaysia; Kementerian Kesihatan Malaysia; Taibah University; Universiti Sains Malaysia	Othman, N (corresponding author), Taibah Univ, Coll Pharm, Dept Clin & Hosp Pharm, Almadinah Almunawwarah, Saudi Arabia.	noordin_uia@yahoo.com	Hassali, Mohamed Azmi/A-6895-2011; Jamshed, Shazia/AAF-6525-2020	Hassali, Mohamed Azmi/0000-0001-9575-403X; Jamshed, Shazia/0000-0003-0773-0463; Othman, Noordin/0000-0001-7672-9226				ABOSHAIQAH AE, 2013, MIDDLE EAST J SCI RE, V17, P130, DOI DOI 10.5829/idosi.mejsr.2013.17.02.76110; Ashcroft DM, 2006, QUAL SAF HEALTH CARE, V15, P48, DOI 10.1136/qshc.2005.014639; Bayazidi Snor, 2012, J Caring Sci, V1, P231, DOI 10.5681/jcs.2012.032; Beasley John W, 2004, WMJ, V103, P56; Benn J, 2009, QUAL SAF HEALTH CARE, V18, P11, DOI 10.1136/qshc.2007.024166; Boyle TA, 2011, RES SOC ADMIN PHARM, V7, P93, DOI 10.1016/j.sapharm.2009.12.001; Cheng Lan, 2011, J Evid Based Med, V4, P32, DOI 10.1111/j.1756-5391.2011.01119.x; Cheung KC, 2011, J AM MED INFORM ASSN, V18, P799, DOI 10.1136/amiajnl-2011-000191; Chiang HY, 2010, NURS OUTLOOK, V58, P17, DOI 10.1016/j.outlook.2009.06.001; Covell CL, 2009, J NURS CARE QUAL, V24, P287, DOI 10.1097/NCQ.0b013e3181a4d506; Elder NC, 2007, J AM BOARD FAM MED, V20, P115, DOI 10.3122/jabfm.2007.02.060081; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Furukawa H, 2003, ANN PHARMACOTHER, V37, P1716, DOI 10.1345/aph.1C330; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; GLADSTONE J, 1995, J ADV NURS, V22, P628, DOI 10.1046/j.1365-2648.1995.22040628.x; Handler SM, 2007, J AM MED DIR ASSOC, V8, P568, DOI 10.1016/j.jamda.2007.06.009; Hartnell N, 2012, BMJ QUAL SAF, V21, P361, DOI 10.1136/bmjqs-2011-000299; Hashemi F, 2012, BMC NURS, V11, DOI 10.1186/1472-6955-11-20; Hickner J, 2010, ANN FAM MED, V8, P517, DOI 10.1370/afm.1169; Holmstrom AR, 2012, J PATIENT SAF, V8, P165, DOI 10.1097/PTS.0b013e3182676cf3; Jeffe Donna B, 2004, Jt Comm J Qual Saf, V30, P471; Kaldjian LC, 2008, ARCH INTERN MED, V168, P40, DOI 10.1001/archinternmed.2007.12; Kennedy Amanda G, 2004, J Am Pharm Assoc (2003), V44, P434, DOI 10.1331/1544345041475724; Khoo EM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-127; Kreckler S, 2009, QUAL SAF HEALTH CARE, V18, P116, DOI 10.1136/qshc.2008.026534; Larizgoitia I, 2013, J PUBLIC HEALTH RES, V2, P168, DOI 10.4081/jphr.2013.e29; Lin YH, 2009, WORLDV EVID-BASED NU, V6, P237, DOI 10.1111/j.1741-6787.2009.00169.x; MOH, 2009, GUID MED ERR REP; Mrayyan Majd T, 2007, J Nurs Manag, V15, P659, DOI 10.1111/j.1365-2834.2007.00724.x; Patel I, 2010, INDIAN J PHARM SCI, V72, P539, DOI 10.4103/0250-474X.78518; Patrician PA, 2009, J NURS CARE QUAL, V24, P277, DOI 10.1097/NCQ.0b013e3181afa4cb; Petrova E, 2010, Nurs Stand, V24, P41; Pham Julius Cuong, 2013, J Public Health Res, V2, pe27, DOI 10.4081/jphr.2013.e27; Phillips MAS, 2002, AM J HEALTH-SYST PH, V59, P2326, DOI 10.1093/ajhp/59.23.2326; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Psuedonym Olgen R., 2008, SAGE ENCY QUALITATIV, P195; Rea D, 2016, HEALTH SOC CARE COMM, V24, P411, DOI 10.1111/hsc.12221; Roughead L., 2013, LIT REV MEDICATION S; Roulston KJ, 2008, SAGE ENCY QUALITATIV, P681; Runciman WB, 2006, QUAL SAF HEALTH CARE, V15, pI82, DOI 10.1136/qshc.2005.017467; Samsiah A, 2016, EUR J CLIN PHARM; Sanghera IS, 2007, ANAESTHESIA, V62, P53, DOI 10.1111/j.1365-2044.2006.04858.x; Sarvadikar A, 2010, EUR J CLIN PHARMACOL, V66, P843, DOI 10.1007/s00228-010-0838-x; Saumure K., 2008, SAGE ENCY QUALITATIV, P195; Schectman JM, 2006, JT COMM J QUAL PATIE, V32, P337, DOI 10.1016/S1553-7250(06)32043-0; Teoh BC, 2015, PHARMACOEPIDEMIOL AD, V4; Throckmorton Terry, 2007, J Perianesth Nurs, V22, P400, DOI 10.1016/j.jopan.2007.09.006; Toruner EK, 2012, AUST J ADV NURS, V29, P28; Ulanimo VM, 2007, J NURS CARE QUAL, V22, P28, DOI 10.1097/00001786-200701000-00007; Uribe CL, 2002, J HEALTHC MANAG, V47, P263, DOI 10.1097/00115514-200207000-00009; Wagner LM, 2013, J PATIENT SAF, V9, P1, DOI 10.1097/PTS.0b013e3182699919; Walker S B, 1998, Int J Nurs Pract, V4, P97, DOI 10.1046/j.1440-172X.1998.00058.x; Williams SD, 2013, RES SOC ADMIN PHARM, V9, P80, DOI 10.1016/j.sapharm.2012.02.002; World Health Organization, 2005, WHO DRAFT GUID ADV E; World Health Organization (WHO), 2014, REP LEARN SYST MED E	55	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166114	10.1371/journal.pone.0166114	http://dx.doi.org/10.1371/journal.pone.0166114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906960	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700015
J	Serra, MM; Alonso, AC; Peterson, M; Mochizuki, L; Greve, JMD; Garcez-Leme, LE				Serra, Marcos Mauricio; Alonso, Angelica Castilho; Peterson, Mark; Mochizuki, Luis; D'Andrea Greve, Julia Maria; Garcez-Leme, Luiz Eugenio			Balance and Muscle Strength in Elderly Women Who Dance Samba	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; PROGRAM	Considering the growth of the aging population, and the increasing risk for falls and related morbidity, it is vital to seek efficient, comprehensive, and culturally relevant prevention programs for elderly people to reduce risks for falls. The aim of the present study was to evaluate the postural balance and muscle strength among women participating in the "Wing of Baianas" in the carnival parades. One hundred and ten women, with an average age of 67.4 5.9 years, were divided into two groups: Baianas group elderly participants of the carnival parades in the "Wing of Baianas", and a Control group of women who do not dance samba. Assessments included a physical activity questionnaire, isokinetic muscle strength testing for the knee extensors and flexors, and a postural balance assessment completed on a force platform. There were no differences between groups, for postural balance outcomes, during the eyes open condition; however, with eyes closed, there was a significant effect between groups (Baianas vs Control) in all variables. The Baianas group showed less medio-lateral displacement (p < 0.04); and anteroposterior displacement (p < 0.007); larger amplitudes of medio-lateral displacement (p < 0.001); and anteroposterior displacement (p < 0.001); increased mean velocity (p < 0.01); and elliptical area (p < 0.01) There were no differences in the isokinetic peak torque corrected by body weight, total work and flexor/extensor ratio. Participation in the Wing of Baianas is associated with better balance with closed eyes, but there were no differences between dancers and non-dancers for muscle strength.	[Serra, Marcos Mauricio; Alonso, Angelica Castilho; Mochizuki, Luis; D'Andrea Greve, Julia Maria; Garcez-Leme, Luiz Eugenio] Univ Sao Paulo, Sch Med, Inst Orthoped & Traumatol, Lab Study Movement, Sao Paulo, Brazil; [Peterson, Mark] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Alonso, Angelica Castilho] Sao Judas Tadeu Univ USJT, Dept Pos Grad Program Aging Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Michigan System; University of Michigan; Universidade Sao Judas Tadeu	Alonso, AC (corresponding author), Univ Sao Paulo, Sch Med, Inst Orthoped & Traumatol, Lab Study Movement, Sao Paulo, Brazil.; Alonso, AC (corresponding author), Sao Judas Tadeu Univ USJT, Dept Pos Grad Program Aging Sci, Sao Paulo, Brazil.	angelicacastilho@msn.com	GREVE, JULIA/A-7849-2013; Peterson, Mark/ABD-3853-2020; Mochizuki, Luis/H-3044-2012; /J-7743-2012; Garcez Leme, Luiz/C-6759-2009	GREVE, JULIA/0000-0003-1778-0448; Peterson, Mark/0000-0002-9861-4275; Mochizuki, Luis/0000-0002-7550-2537; /0000-0002-9644-5068; Garcez Leme, Luiz/0000-0002-9738-5466				Alonso Angélica Castilho, 2014, MedicalExpress (São Paulo, online), V1, P298, DOI 10.5935/MedicalExpress.2014.06.03; Alonso AC, 2012, CLINICS, V67, P1433, DOI 10.6061/clinics/2012(12)14; Alpert PT, 2009, J AM ACAD NURSE PRAC, V21, P108, DOI 10.1111/j.1745-7599.2008.00392.x; Brech GC, 2011, MATURITAS, V70, P379, DOI 10.1016/j.maturitas.2011.09.004; Eyigor S, 2009, ARCH GERONTOL GERIAT, V48, P84, DOI 10.1016/j.archger.2007.10.008; Ferrufino L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00169; Garcez-Leme LE, 2005, J AM GERIATR SOC, V53, P2018, DOI 10.1111/j.1532-5415.2005.53557.x; Garcez-Leme Luiz E., 2014, MedicalExpress (São Paulo, online), V1, P3, DOI 10.5935/MedicalExpress.2014.01.02; Garcia Rosamaria, 2006, Clinics, V61, P539, DOI 10.1590/S1807-59322006000600009; Granacher U, 2012, GERONTOLOGY, V58, P305, DOI 10.1159/000334814; Gschwind YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-105; Hui E, 2009, ARCH GERONTOL GERIAT, V49, pE45, DOI 10.1016/j.archger.2008.08.006; Janyacharoen Taweesak, 2013, Clin Interv Aging, V8, P855, DOI 10.2147/CIA.S41076; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Krampe J, 2013, WESTERN J NURS RES, V35, P39, DOI 10.1177/0193945911423266; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Matsudo SM., 2002, REV BRAS CIENC MOV, V10, P41; Mochizuki L, 2006, J APPL BIOMECH, V22, P51, DOI 10.1123/jab.22.1.51; Muehlbauer T, 2012, GERONTOLOGY, V58, P504, DOI 10.1159/000341614; Pichierri G, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-74; Sofianidis G, 2009, J AGING PHYS ACTIV, V17, P167, DOI 10.1123/japa.17.2.167; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Zhang JG, 2008, GAIT POSTURE, V27, P697, DOI 10.1016/j.gaitpost.2007.09.004	24	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166105	10.1371/journal.pone.0166105	http://dx.doi.org/10.1371/journal.pone.0166105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906984	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700014
J	Yang, WC; Zhang, XZ; Wang, N; Tan, J; Fang, XH; Wang, Q; Tao, T; Li, WZ				Yang, Wanchao; Zhang, Xuezhong; Wang, Nan; Tan, Jing; Fang, Xianhai; Wang, Qi; Tao, Tao; Li, Wenzhi			Effects of Acute Systemic Hypoxia and Hypercapnia on Brain Damage in a Rat Model of Hypoxia-Ischemia	PLOS ONE			English	Article							FOCAL CEREBRAL ISCHEMIA/REPERFUSION; BLOOD-FLOW; THERAPEUTIC HYPERCAPNIA; BARRIER PERMEABILITY; PROTEIN EXPRESSION; PERINATAL-PERIOD; HEAD-INJURY; ADULT RATS; EDEMA; REOXYGENATION	Therapeutic hypercapnia has the potential for neuroprotection after global cerebral ischemia. Here we further investigated the effects of different degrees of acute systemic hypoxia in combination with hypercapnia on brain damage in a rat model of hypoxia and ischemia. Adult wistar rats underwent unilateral common carotid artery (CCA) ligation for 60 min followed by ventilation with normoxic or systemic hypoxic gas containing 11%O-2,13%O-2,15% O-2 and 18%O-2 (targeted to PaO2 30-39 mmHg, 40-49 mmHg, 50-59 mmHg, and 60-69 mmHg, respectively) or systemic hypoxic gas containing 8% carbon dioxide (targeted to PaCO2 60-80 mmHg) for 180 min. The mean artery pressure (MAP), blood gas, and cerebral blood flow (CBF) were evaluated. The cortical vascular permeability and brain edema were examined. The ipsilateral cortex damage and the percentage of hippocampal apoptotic neurons were evaluated by Nissl staining and terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling (TUNEL) assay as well as flow cytometry, respectively. Immunofluorescence and western blotting were performed to determine aquaporin-4 (AQP4) expression. In rats treated with severe hypoxia (PaO2 < 50 mmHg), hypercapnia augmented the decline of MAP with cortical CBF and damaged blood brain barrier permeability (p < 0.05). In contrast, in rats treated with mild to moderate hypoxia (PaO2 > 50 mmHg), hypercapnia protected against these pathophysiological changes. Moreover, hypercapnia treatment significantly reduced brain damage in the ischemic ipsilateral cortex and decreased the percentage of apoptotic neurons in the hippocampus after the CCA ligated rats were exposed to mild or moderate hypoxemia (PaO2 > 50 mmHg); especially under mild hypoxemia (PaO2 > 60 mmHg), hypercapnia significantly attenuated the expression of AQP4 protein with brain edema (p < 0.05). Hypercapnia exerts beneficial effects under mild to moderate hypoxemia and augments detrimental effects under severe hypoxemia on brain damage in a rat model of hypoxia-ischemia.	[Li, Wenzhi] Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang Sh, Peoples R China; Harbin Med Univ, Dept Educ, Anesthesiol Key Lab, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Li, WZ (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang Sh, Peoples R China.	Wenzhili9@126.com			National Natural Science Foundation of China [8140050107]; Educational Commission of Heilong Jiang Province of China [12541387]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Educational Commission of Heilong Jiang Province of China	This study was supported by the National Natural Science Foundation of China (grant no. 8140050107) and Educational Commission of Heilong Jiang Province of China (grant no. 12541387).; This study was supported by the National Natural Science Foundation of China (grant no. 8140050107) and Educational Commission of Heilong Jiang Province of China (grant no. 12541387). We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	ANDINE P, 1991, DEV BRAIN RES, V64, P115, DOI 10.1016/0165-3806(91)90214-4; Bogoslovsky T, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-46; Calvert JW, 2005, NEUROL RES, V27, P246, DOI 10.1179/016164105X25216; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; Chonghaile MN, 2008, ANESTHESIOLOGY, V109, P837, DOI 10.1097/ALN.0b013e3181895fb7; Chonghaile MN, 2008, CRIT CARE MED, V36, P3135, DOI 10.1097/CCM.0b013e31818f0d13; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; GOLD R, 1994, LAB INVEST, V71, P219; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Kempski O, 1999, ACT NEUR S, V73, P41; KOSTIC V, 1991, J NEUROCHEM, V57, P1962, DOI 10.1111/j.1471-4159.1991.tb06410.x; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; LEVINE S, 1960, AM J PATHOL, V36, P1; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Morita Yoko, 1997, Keio Journal of Medicine, V46, P120; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; Niatsetskaya ZV, 2012, J CEREBR BLOOD F MET, V32, P232, DOI 10.1038/jcbfm.2011.164; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; SALFORD LG, 1974, ACTA PHYSIOL SCAND, V92, P130, DOI 10.1111/j.1748-1716.1974.tb05729.x; SALFORD LG, 1973, ARCH NEUROL-CHICAGO, V29, P234, DOI 10.1001/archneur.1973.00490280046006; Shian W J, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P154; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Stavale LM, 2013, TOXICON, V66, P37, DOI 10.1016/j.toxicon.2013.01.026; SUTTER R, 1976, STROKE, V7, P500, DOI 10.1161/01.STR.7.5.500; Tao T, 2014, NEUROSCI LETT, V573, P1, DOI 10.1016/j.neulet.2014.04.051; Tao T, 2013, BRAIN RES, V1533, P52, DOI 10.1016/j.brainres.2013.08.014; TOWFIGHI J, 1994, BIOL NEONATE, V65, P108; Uekawa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163329; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Volpe J J, 1981, Major Probl Clin Pediatr, V22, P1; Willis CL, 2010, J CEREBR BLOOD F MET, V30, P1847, DOI 10.1038/jcbfm.2010.119; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Wuyam B, 2002, RESP PHYSIOL, V129, P375, DOI 10.1016/S0034-5687(01)00319-X; Yu LS, 2016, EXP THER MED, V11, P709, DOI 10.3892/etm.2016.3022; Zammit C, 2015, CURR PHARM DESIGN, V21, P1418, DOI 10.2174/1381612821666150105122008; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257	46	22	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167359	10.1371/journal.pone.0167359	http://dx.doi.org/10.1371/journal.pone.0167359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907083	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700127
J	Zhang, T; Hu, Q; Shi, LY; Qin, L; Zhang, QY; Mi, MT				Zhang, Ting; Hu, Qin; Shi, Linying; Qin, Li; Zhang, Qianyong; Mi, Mantian			Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; UNFOLDED PROTEIN RESPONSE; DEPENDENT ACTIVATION; DEATH; APOPTOSIS; PATHWAY; PERK; SOY; INVOLVEMENT; DYSFUNCTION	The development of atherosclerosis is closely related to excessive endoplasmic reticulum stress (ERs). Equol reportedly protects against cardiovascular disease; however, the underlying mechanism for this protection remains unknown. Herein, the mechanisms contributing to the atheroprotective effect of equol were addressed using apolipoprotein E knockout (apoE-/-) mice fed a high-fat diet (HFD) with or without equol. Equol intervention reduced atherosclerotic lesions in the aorta in HFD-fed apoE-/-mice. Plasma lipid analysis showed that equol intervention reduced triglycerides, total cholesterol and LDL-cholesterol and increased HDL-cholesterol. Additionally, equol administration decreased lipid accumulation in the liver. Simultaneously, equol treatment inhibited cell apoptosis induced by t-BHP and thapsigargin in human umbilical vein endothelial cells (HUVECs). Furthermore, equol treatment attenuated palmitate, t-BHP or thapsigargin-induced upregulation of ER stress markers, including p-PERK, p-eIF2 alpha, GRP78, ATF6 and CHOP proteins expression. The same tendency was also observed in aortic lysates in apoE-/-mice fed with equol plus HFD compared with HFD alone. Moreover, equol treatment dose dependently activated the Nrf2 signaling pathway under oxidative stress. Additionally, elevation of Nrf2 induction was found in aortic lysates in apoE-/-mice fed with a HFD diet containing equol compared with a HFD diet without equol. Importantly, Nrf2 siRNA interference induced CHOP and attenuated the effect of equol to inhibit t-BHP mediated CHOP induction, furthermore, abrogated cell apoptosis induced by t-BHP, suggesting a role for Nrf2 in the protective effect of equol in HUVECs. Collectively, these findings implicate that the improvement of atherosclerosis by equol through attenuation of ER stress is mediated, at least in part, by activating the Nrf2 signaling pathway.	[Zhang, Ting; Hu, Qin; Shi, Linying; Qin, Li; Zhang, Qianyong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China	Army Medical University	Zhang, QY; Mi, MT (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China.	248141998@qq.com; mantianmi@hotmail.com			National Natural Science Foundation of China [81102129, 81072288]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (No. 81102129; No. 81072288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The National Natural Science Foundation of China (No. 81102129; No. 81072288). The authors thank Xinyu Liang, Huiling Deng, Juan Huang and Changjun Zhao for assistance with experiment work. All authors contributed to the final version. M. T. M. had primary responsibility for final content. The authors state that there are no conflicts of interest.	Chen CY, 2010, CHEM-BIOL INTERACT, V183, P105, DOI 10.1016/j.cbi.2009.09.024; Chin-Dusting JPF, 2001, BRIT J PHARMACOL, V133, P595, DOI 10.1038/sj.bjp.0704088; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cominacini L, 2015, FREE RADICAL BIO MED, V88, P233, DOI 10.1016/j.freeradbiomed.2015.05.027; Cominacini L, 2015, CURR MED CHEM, V22, P1565, DOI 10.2174/0929867322666150311150829; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eyster K, 2014, NUTR METAB CARDIOVAS, V24, P423, DOI 10.1016/j.numecd.2013.09.014; Gao D, 2012, FREE RADICAL BIO MED, V53, P796, DOI 10.1016/j.freeradbiomed.2012.05.026; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim DS, 2010, J PHARM PHARMACOL, V62, P197, DOI [10.1211/jpp.62.02.0007, 10.1211/jpp/62.02.0007]; Krogmann A, 2011, MICROVASC RES, V81, P52, DOI 10.1016/j.mvr.2010.11.008; Lenna S, 2014, IUBMB LIFE, V66, P530, DOI 10.1002/iub.1292; Li X, 2013, ARTERIOSCL THROM VAS, V33, P232, DOI 10.1161/ATVBAHA.112.252239; Liang XL, 2014, ANTI-CANCER DRUG, V25, P633, DOI 10.1097/CAD.0000000000000085; Loutchanwoot P, 2015, LIFE SCI, V128, P1, DOI 10.1016/j.lfs.2015.02.002; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Myers L, 2014, J EPIDEMIOL GLOB HEA, V4, P23, DOI 10.1016/j.jegh.2013.09.007; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nagarajan S, 2008, J NUTR, V138, P332, DOI 10.1093/jn/138.2.332; Namgaladze D, 2014, DIABETOLOGIA, V57, P1067, DOI 10.1007/s00125-014-3173-4; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Obiorah IE, 2014, CANCER PREV RES, V7, P939, DOI 10.1158/1940-6207.CAPR-14-0061; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Palomer X, 2014, CLIN INVEST ARTERIOS, V26, P255, DOI 10.1016/j.arteri.2014.02.003; Park YJ, 2013, NEUROCHEM RES, V38, P1561, DOI 10.1007/s11064-013-1057-5; Park YJ, 2010, AMINO ACIDS, V39, P785, DOI 10.1007/s00726-010-0523-5; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/169405; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Yao ST, 2014, J BIOL CHEM, V289, P4032, DOI 10.1074/jbc.M113.524512; Yi N, 2012, ANAT REC, V295, P1462, DOI 10.1002/ar.22539; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079075; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	54	24	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167020	10.1371/journal.pone.0167020	http://dx.doi.org/10.1371/journal.pone.0167020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907038	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700065
J	Abrieux, A; Mhamdi, A; Rabhi, KK; Egon, J; Debernard, S; Duportets, L; Tricoire-Leignel, H; Anton, S; Gadenne, C				Abrieux, Antoine; Mhamdi, Amel; Rabhi, Kaouther K.; Egon, Julie; Debernard, Stephane; Duportets, Line; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe			An Insecticide Further Enhances Experience-Dependent Increased Behavioural Responses to Sex Pheromone in a Pest Insect	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BLACK CUTWORM MOTH; APIS-MELLIFERA; PLASTICITY; SUSCEPTIBILITY; SENSITIZATION; LEPIDOPTERA; SENSITIVITY; ATTRACTION; RESISTANCE	Neonicotinoid insecticides are widely used to protect plants against pest insects, and insecticide residues remaining in the environment affect both target and non-target organisms. Whereas low doses of neonicotinoids have been shown to disturb the behaviour of pollinating insects, recent studies have revealed that a low dose of the neonicotinoid clothianidin can improve behavioural and neuronal sex pheromone responses in a pest insect, the male moth Agrotis ipsilon, and thus potentially improve reproduction. As male moth behaviour depends also on its physiological state and previous experience with sensory signals, we wondered if insecticide effects would be dependent on plasticity of olfactory-guided behaviour. We investigated, using wind tunnel experiments, whether a brief pre-exposure to the sex pheromone could enhance the behavioural response to this important signal in the moth A. ipsilon at different ages (sexually immature and mature males) and after different delays (2 h and 24 h), and if the insecticide clothianidin would interfere with age effects or the potential pre-exposure-effects. Brief pre-exposure to the pheromone induced an age-independent significant increase of sex pheromone responses 24 h later, whereas sex pheromone responses did not increase significantly 2 h after exposure. However, response delays were significantly shorter compared to naive males already two hours after exposure. Oral treatment with clothianidin increased sex pheromone responses in sexually mature males, confirming previous results, but did not influence responses in young immature males. Males treated with clothianidin after pre-exposure at day 4 responded significantly more to the sex pheromone at day 5 than males treated with clothianidin only and than males pre-exposed only, revealing an additive effect of experience and the insecticide. Plasticity of sensory systems has thus to be taken into account when investigating the effects of sublethal doses of insecticides on behaviour.	[Abrieux, Antoine; Mhamdi, Amel; Rabhi, Kaouther K.; Egon, Julie; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe] Univ Angers, INRA, Neuroethol RCIM, Beaucouze, France; [Debernard, Stephane; Duportets, Line] IEES, Dept Ecol Sensorielle, Paris, France; [Duportets, Line] Univ Paris Saclay, Univ Paris Sud, Orsay, France; [Abrieux, Antoine] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	INRAE; Universite d'Angers; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Gadenne, C (corresponding author), Univ Angers, INRA, Neuroethol RCIM, Beaucouze, France.	christophe.gadenne@inra.fr	Tricoire-Leignel, Hélène/ABG-2320-2020	Tricoire-Leignel, Hélène/0000-0002-2881-2962; abrieux, antoine/0000-0002-2977-2034	Region Pays de la Loire; National French Funding Agency ANR [ANR-12-ADAP-0012-01]; Agronomy Institute Chott Meriem, Tunisia	Region Pays de la Loire(Region Pays de la Loire); National French Funding Agency ANR(French National Research Agency (ANR)); Agronomy Institute Chott Meriem, Tunisia	This work was supported by a PhD grant to A. A., and a research grant from Region Pays de la Loire to S. A. and C. G., as well as a grant from the National French Funding Agency ANR (ANR-12-ADAP-0012-01) to S. A., C. G. and H. T. -L. A. M. was supported by a grant from the Agronomy Institute Chott Meriem, Tunisia.; We thank C. Le Corre and L. Gamier for help in insect rearing. This work was supported by a PhD grant to A. A., and research grant from Region Pays de la Loire to S. A. and C. G., as well as a grant from the National French Funding Agency ANR (ANR-12 ADAP-0012-01) to S. A., C. G. and H. T. -L. A. M. was supported by a grant from the Agronomy Institute Chott Meriem, Tunisia.	Abrieux A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00312; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Anderson P, 2003, CHEM SENSES, V28, P285, DOI 10.1093/chemse/28.4.285; Anderson P, 2007, CHEM SENSES, V32, P483, DOI 10.1093/chemse/bjm017; Anton S, 1999, P NATL ACAD SCI USA, V96, P5764, DOI 10.1073/pnas.96.10.5764; Anton S, 2016, CELL TISSUE RES, V364, P59, DOI 10.1007/s00441-015-2299-0; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; BAKER TC, 1989, EXPERIENTIA, V45, P248, DOI 10.1007/BF01951811; Banken JAO, 1997, J ECON ENTOMOL, V90, P1102, DOI 10.1093/jee/90.5.1102; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Bouvier JC, 2002, ARCH INSECT BIOCHEM, V51, P55, DOI 10.1002/arch.10052; Bues R., 1974, ANN ZOOL ECOL ANIM, V2, P79; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Duportets L, 2013, GEN COMP ENDOCR, V186, P58, DOI 10.1016/j.ygcen.2013.02.024; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Fan RJ, 1997, J EXP BIOL, V200, P2969; GADENNE C, 1993, EXPERIENTIA, V49, P721, DOI 10.1007/BF01923960; Gadenne C, 2016, ANNU REV ENTOMOL, V61, P317, DOI 10.1146/annurev-ento-010715-023523; Gemeno C, 1998, J CHEM ECOL, V24, P999, DOI 10.1023/A:1022398318465; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guerrieri F, 2012, J EXP BIOL, V215, P2334, DOI 10.1242/jeb.060988; Hartlieb E, 1999, NATURWISSENSCHAFTEN, V86, P396, DOI 10.1007/s001140050640; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Jarriault D, 2009, HORM BEHAV, V56, P185, DOI 10.1016/j.yhbeh.2009.04.005; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jones CM, 2011, PESTIC BIOCHEM PHYS, V101, P53, DOI 10.1016/j.pestbp.2011.07.004; Leonova IN, 1996, ARCH INSECT BIOCHEM, V32, P157, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;157::AID-ARCH1&gt;3.0.CO;2-W; de Oliveira IM, 2010, TOXICOL LETT, V192, P294, DOI 10.1016/j.toxlet.2009.11.005; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 1996, J PHYSIOL-PARIS, V90, P395, DOI 10.1016/S0928-4257(97)87928-4; Minoli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034141; Oliveira EE, 2011, INSECT BIOCHEM MOLEC, V41, P872, DOI 10.1016/j.ibmb.2011.08.001; Picimbon JF, 1997, J CHEM ECOL, V23, P211, DOI 10.1023/B:JOEC.0000006355.13207.91; Rabhi KK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2987; Rabhi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114411; RAKITIN A, 1991, PHYSIOL BEHAV, V50, P477, DOI 10.1016/0031-9384(91)90533-T; Salgado VL, 2016, NEUROTOXICOLOGY, V56, P188, DOI 10.1016/j.neuro.2016.08.003; Sokal R.R., 2012, BIOMETRY; Vinson S.B., 1984, P205; Walters ET, 2001, J EXP BIOL, V204, P457; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	48	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167469	10.1371/journal.pone.0167469	http://dx.doi.org/10.1371/journal.pone.0167469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902778	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100083
J	Mentzel, CMJ; Alkan, F; Keinicke, H; Jacobsen, MJ; Gorodkin, J; Fredholm, M; Cirera, S				Mentzel, Caroline M. Junker; Alkan, Ferhat; Keinicke, Helle; Jacobsen, Mette J.; Gorodkin, Jan; Fredholm, Merete; Cirera, Susanna			Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene Regulation in the Gottingen Minipig Obesity Model	PLOS ONE			English	Article							HIGH-FAT-DIET; ADIPOSE-TISSUE; METABOLIC SYNDROME; LIPID-METABOLISM; EXPRESSION; LIVER; PROTEIN; MUSCLE; LEPTIN; CXCR4	Obesity and its comorbidities are an increasing challenge for both affected individuals and health care systems, worldwide. In obese individuals, perturbation of expression of both protein-coding genes and microRNAs (miRNA) are seen in obesity-relevant tissues (i.e. adipose tissue, liver and skeletal muscle). miRNAs are small non-coding RNA molecules which have important regulatory roles in a wide range of biological processes, including obesity. Rodents are widely used animal models for human diseases including obesity. However, not all research is applicable for human health or diseases. In contrast, pigs are emerging as an excellent animal model for obesity studies, due to their similarities in their metabolism, their digestive tract and their genetics, when compared to humans. The Gottingen minipig is a small sized easy-to-handle pig breed which has been extensively used for modeling human obesity, due to its capacity to develop severe obesity when fed ad libitum. The aim of this study was to identify differentially expressed of protein-coding genes and miRNAs in a Gottingen minipig obesity model. Liver, skeletal muscle and abdominal adipose tissue were sampled from 7 lean and 7 obese minipigs. Differential gene expression was investigated using high-throughput quantitative real-time PCR (qPCR) on 90 mRNAs and 72 miRNAs. The results revealed de-regulation of several obesity and inflammation-relevant protein-coding genes and miRNAs in all tissues examined. Many genes that are known to be de-regulated in obese humans were confirmed in the obese minipigs and several of these genes have target sites for miRNAs expressed in the opposing direction of the gene, confirming miRNA-mediated regulation in obesity. These results confirm the translational value of the pig for human obesity studies.	[Mentzel, Caroline M. Junker; Keinicke, Helle; Jacobsen, Mette J.; Fredholm, Merete; Cirera, Susanna] Univ Copenhagen, Dept Vet Clin & Anim Sci, Anim Genet, Fac Hlth Sci, Frederiksberg, Denmark; [Mentzel, Caroline M. Junker; Alkan, Ferhat; Gorodkin, Jan; Fredholm, Merete] Univ Copenhagen, Dept Vet Clin & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Computat Biol & Bioinformat,Fac Hlth Sci, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen	Cirera, S (corresponding author), Univ Copenhagen, Dept Vet Clin & Anim Sci, Anim Genet, Fac Hlth Sci, Frederiksberg, Denmark.	scs@sund.ku.dk	Alkan, Ferhat/U-4058-2019; Mentzel, Caroline/AAX-1577-2021; Cirera, Susanna/K-8540-2017	Alkan, Ferhat/0000-0001-6709-9605; Mentzel, Caroline/0000-0003-4688-7367; Cirera, Susanna/0000-0001-8105-1579; Gorodkin, Jan/0000-0001-5823-4000; Jacobsen, Mette Juul/0000-0001-9264-7554	Danish Independent Research Council [DFF-1335-00127]; Innovation Fund Denmark; Danish Center for Scientific Computing (DCSC, DeIC); SHARE foundation; Danielsen's Foundation	Danish Independent Research Council(Det Frie Forskningsrad (DFF)); Innovation Fund Denmark; Danish Center for Scientific Computing (DCSC, DeIC); SHARE foundation; Danielsen's Foundation	The project was funded by the Danish Independent Research Council (DFF-1335-00127), Innovation Fund Denmark, Danish Center for Scientific Computing (DCSC, DeIC). The lean minipigs were funded by the SHARE foundation and Danielsen's Foundation. The obese minipigs were donated by Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Auguet T, 2013, EXP CLIN ENDOCR DIAB, V121, P119, DOI 10.1055/s-0032-1331696; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Boonen HCM, 2014, PFLUG ARCH EUR J PHY, V466, P2167, DOI 10.1007/s00424-014-1486-2; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Celikbilek M, 2014, WORLD J HEPATOL, V6, P613, DOI 10.4254/wjh.v6.i8.613; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cirera S, 2014, ANIM GENET, V45, P59, DOI 10.1111/age.12082; Cirera S, 2014, METHODS MOL BIOL, V1182, P73, DOI 10.1007/978-1-4939-1062-5_7; Diawara MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091375; Enright AJ, 2004, GENOME BIOL, V5; Ersen BOC, 2007, COMPARATIVE MED, V57, P493; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Felipe F, 2003, INT J OBESITY, V27, P60, DOI 10.1038/sj.ijo.0802188; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Goossens GH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00055; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043; Jacobsen MJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8539057; Johansen T, 2001, COMPARATIVE MED, V51, P150; Jones BH, 1996, AM J PHYSIOL-ENDOC M, V271, pE44, DOI 10.1152/ajpendo.1996.271.1.E44; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978; Lu J, 2014, CARCINOGENESIS, V35, P554, DOI 10.1093/carcin/bgt354; Madeira MS, 2013, BRIT J NUTR, V110, P216, DOI 10.1017/S0007114512004916; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Mentzel Caroline M J, 2014, Microrna, V3, P174; Mentzel CMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131650; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mika A, 2015, EUR J LIPID SCI TECH, V117, P926, DOI 10.1002/ejlt.201400372; Musa CV, 2012, INT J OBESITY, V36, P207, DOI 10.1038/ijo.2011.81; Oliver P, 2012, INT J OBESITY, V36, P225, DOI 10.1038/ijo.2011.92; Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013; Pant SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137356; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Rennie W, 2014, NUCLEIC ACIDS RES, V42, pW114, DOI 10.1093/nar/gku376; Rodgaard T, 2014, ANIM GENET, V45, P67, DOI 10.1111/age.12090; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341; Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Vienberg S, 2016, ACTA PHYSL OXF; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519; World Health Organization,, 2015, OB OV; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yao LB, 2014, FASEB J, V28, P4534, DOI 10.1096/fj.14-249797; Yates A, 2015, NUCLEIC ACIDS RES; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2	70	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167285	10.1371/journal.pone.0167285	http://dx.doi.org/10.1371/journal.pone.0167285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902747	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100067
J	Rasool, M; Malik, A; Ashraf, MAB; Parveen, G; Iqbal, S; Ali, I; Qazi, MH; Asif, M; Kamran, K; Iqbal, A; Iram, S; Khan, SU; Mustafa, MZ; Zaheer, A; Shaikh, R; Choudhry, H; Jamal, MS				Rasool, Mahmood; Malik, Arif; Ashraf, Muhammad Abdul Basit; Parveen, Gulshan; Iqbal, Shazia; Ali, Irfan; Qazi, Mahmood Husain; Asif, Muhammad; Kamran, Kashif; Iqbal, Asim; Iram, Saima; Khan, Sami Ullah; Mustafa, Mohammad Zahid; Zaheer, Ahmad; Shaikh, Rozeena; Choudhry, Hani; Jamal, Mohammad Sarwar			Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LIPID-PEROXIDATION; VITAMIN-E; PROGNOSTIC-SIGNIFICANCE; ANTIOXIDANT STATUS; CAROTENOIDS; PROGRESSION; DISEASE; ADENOCARCINOMA; INTERLEUKIN-1	Background Ovarian cancer is the 5(th) most common cause of deaths in the women among gynecological tumors. There are many growing evidences that stress and other behavioral factors may affect cancer progression and patient survival. The purpose of this study is to determine the key role of matrix metalloproteinases (MMPs), and cytokines in the aggregation and progression of ovarian cancer. Methodology Stress variables (MDA, AGEs, AOPPs, NO), profile of antioxidants (SOD, Catalase, Vitamin E & A, GSH, GRx, GPx) and inflammatory biomarkers (MMP-9, MMP-2, MMP-11, IL-1 alpha and TNF-alpha) were biochemically assessed from venous blood of fifty ovarian cancer patients and twenty healthy control subjects. The results of all parameters were analyzed statistically by independent sample t-test. Results The results of the study demonstrated that the levels of stress variables like MDA (3.38 +/- 1.12nmol/ml), AGEs (2.72 +/- 0.22 ng/ml), AOPPs (128.48 +/- 27.23 ng/ml) and NO (58.71 +/- 8.67 ng/ml) were increased in the patients of ovarian cancer as compared to control individuals whereas the profile of antioxidants like SOD, Catalase, Vitamin E, Vitamin A, GSH andGRx were decreased in ovarian cancer patients (0.11 +/- 0.08 mu mol/mol, 2.41 +/- 1.01 mu mol/mol of protein, 0.22 +/- 0.04 mu g/ml, 45.84 +/- 9.07 mu g/ml, 4.88 +/- 1.18 mu g/ml, 5.33 +/- 1.26 mu mol/ml respectively). But the level of GPx antioxidant was increased in ovarian cancer patients (6.58 +/- 0.21 mu mol/ml). Moreover the levels of MMP-9 (64.87 +/- 5.35 ng/ml), MMP-2 (75.87 +/- 18.82 ng/ml) and MMP-11 (63.58 +/- 8.48 ng/ml) were elevated in the patients. Similarly, the levels of various cytokines TNF-alpha and IL-1 alpha were also increased in the patients of ovarian cancer (32.17 +/- 3.52 pg/mI and 7.04 +/- 0.85 pg/mI respectively). Conclusion MMPs are commonly expressed in ovarian cancer which are potential extrapolative biomarkers and have a major role in metastasis. Due to oxidative stress, different cytokines are released by tumor associated macrophages (TAMS) that result in the cancer progression. Consequently, tissue inhibitors of matrix metalloproteinases (TIMPs) are the valuable therapeutic approaches to complement conservative anticancer strategies.	[Rasool, Mahmood] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia; [Malik, Arif; Ashraf, Muhammad Abdul Basit; Parveen, Gulshan; Iqbal, Shazia] Univ Lahore, Inst Mol Biol & Biotechnol IMBB, Lahore, Pakistan; [Ali, Irfan] Akhuwat Faisalabad Inst Res Sci & Technol, Faisalabad, Pakistan; [Qazi, Mahmood Husain] Univ Lahore, CRIMM, Lahore, Pakistan; [Asif, Muhammad; Shaikh, Rozeena] BUITEMS, Dept Biotechnol, Quetta, Pakistan; [Kamran, Kashif; Iqbal, Asim] Univ Balochistan, Fac Life Sci, Quetta, Pakistan; [Iram, Saima] Bolan Med Hosp, Quetta, Pakistan; [Khan, Sami Ullah] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan; [Mustafa, Mohammad Zahid] Univ Balochistan, CASVAB, Quetta, Pakistan; [Zaheer, Ahmad] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Choudhry, Hani] King Abdulaziz Univ, Dept Biochem, Ctr Innovat Personalized Med, Fac Sci,King Fahd Ctr Med Res, Jeddah, Saudi Arabia; [Jamal, Mohammad Sarwar] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia	King Abdulaziz University; University of Lahore; University of Lahore; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; University of Balochistan; University of Balochistan; Pakistan Institute of Engineering & Applied Science; King Abdulaziz University; King Abdulaziz University	Jamal, MS (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	sarwar4u@gmail.com	Iqbal, Shazia/AAH-2282-2020; Rasool, Mahmood/H-9475-2012; Asif, Muhammad/AAF-3615-2020; Zaheer, Ahmad/H-4182-2013; Jamal, Mohammad Sarwar/K-3842-2013; Malik, Arif/A-5218-2016; Iqbal, Shazia/AAE-7042-2019	Iqbal, Shazia/0000-0003-4890-5864; Rasool, Mahmood/0000-0003-2997-5891; Asif, Muhammad/0000-0003-4761-837X; Zaheer, Ahmad/0000-0001-5131-3240; Malik, Arif/0000-0002-1894-6772; Choudhry, Hani/0000-0003-0401-6619	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	We are thankful to all participants of this study. This article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Abdalla M. Y., 2011, Jordan Journal of Biological Sciences (JJBS), V4, P119; Abei H, 1974, METHODS ENZYMATIC AN; Agnani D, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-18; Bhurgri Y, 2000, INT J CANCER, V85, P325, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;325::AID-IJC5&gt;3.0.CO;2-J; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Colvin EK, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00137; Cramer DW, 2001, INT J CANCER, V94, P128, DOI 10.1002/ijc.1435; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Goldberg DM., 1983, METHODS ENZYM ANAL, V3, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4; Heijst J. W., 2005, ANN NY ACAD SCI, V1043, P725; HEINONEN PK, 1987, ARCH GYNECOL OBSTET, V241, P151, DOI 10.1007/BF00931311; Herrera E, 2001, J PHYSIOL BIOCHEM, V57, P43, DOI 10.1007/BF03179812; Holschneider CH, 2000, OVARIAN CANC EPIDEMI; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kalousova M, 2002, PHYSIOL RES, V51, P597; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; KIKUGAWA K, 1984, ARCH BIOCHEM BIOPHYS, V229, P7, DOI 10.1016/0003-9861(84)90124-3; Korde S, 2012, ORAL ONCOL, V48, P475, DOI 10.1016/j.oraloncology.2012.01.003; Kumaraguruparan R, 2002, CLIN BIOCHEM, V35, P275, DOI 10.1016/S0009-9120(02)00310-7; Manju V, 2002, CLIN BIOCHEM, V35, P621, DOI 10.1016/S0009-9120(02)00376-4; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Nayak SB, 2004, INDIAN J PHYSL PHARM, V48; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Noel AC, 1996, J CLIN INVEST, V97, P1924, DOI 10.1172/JCI118624; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parveen S, 1999, SPECIALIST KARACHI, V16, P209; Peng HL, 2013, J BUON, V18, P202; Piwowar A., 2013, POSTEPY HIGIENY MEDY, V68, P179; POLLARD JW, 1991, CURR OPIN IMMUNOL, V3, P772, DOI 10.1016/0952-7915(91)90112-E; Rashid MU, 2006, INT J CANCER, V119, P2832, DOI 10.1002/ijc.22269; ROSENBERG HR, 1959, ARCH BIOCHEM BIOPHYS, V80, P86, DOI 10.1016/0003-9861(59)90345-5; Rutkowski M, 2007, ACTA SCI POLON-TECHN, V6, P17; Schweigert FJ, 2004, ANN NUTR METAB, V48, P241, DOI 10.1159/000080457; Skrzydlewska E, 2001, J TOXICOL ENV HEAL A, V64, P213, DOI 10.1080/15287390152543690; Srinivasan D, 2008, FENNEEMALS FOOD CHEM; Torng PL, 2004, GYNECOL ONCOL, V92, P559, DOI 10.1016/j.ygyno.2003.11.011; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Tung KH, 2005, CANCER EPIDEM BIOMAR, V14, P669, DOI 10.1158/1055-9965.EPI-04-0550; Zeisler H, 1998, EUR J CANCER, V34, P931	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167149	10.1371/journal.pone.0167149	http://dx.doi.org/10.1371/journal.pone.0167149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902750	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100057
J	Soyama, H; Miyamoto, M; Ishibashi, H; Takano, M; Sasa, H; Furuya, K				Soyama, Hiroaki; Miyamoto, Morikazu; Ishibashi, Hiroki; Takano, Masashi; Sasa, Hidenori; Furuya, Kenichi			Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; TRANSVAGINAL ULTRASONOGRAPHY; MASSIVE HEMORRHAGE; PRETERM DELIVERY; RISK; ACCRETA	Background Placenta previa, one of the most severe obstetric complications, carries an increased risk of intraoperative massive hemorrhage. Several risk factors for intraoperative hemorrhage have been identified to date. However, the correlation between birth weight and intraoperative hemorrhage has not been investigated. Here we estimate the correlation between birth weight and the occurrence of intraoperative massive hemorrhage in placenta previa. Materials and Methods We included all 256 singleton pregnancies delivered via cesarean section at our hospital because of placenta previa between 2003 and 2015. We calculated not only measured birth weights but also standard deviation values according to the Japanese standard growth curve to adjust for differences in gestational age. We assessed the correlation between birth weight and the occurrence of intraoperative massive hemorrhage (>1500 mL blood loss). Receiver operating characteristic curves were constructed to determine the cutoff value of intraoperative massive hemorrhage. Results Of 256 pregnant women with placenta previa, 96 (38%) developed intraoperative massive hemorrhage. Receiver-operating characteristic curves revealed that the area under the curve of the combination variables between the standard deviation of birth weight and intraoperative massive hemorrhage was 0.71. The cutoff value with a sensitivity of 81.3% and specificity of 55.6% was -0.33 standard deviation. The multivariate analysis revealed that a standard deviation of >-0.33 (odds ratio, 5.88; 95% confidence interval, 3.04-12.00), need for hemostatic procedures (odds ratio, 3.31; 95% confidence interval, 1.79-6.25), and placental adhesion (odds ratio, 12.68; 95% confidence interval, 2.85-92.13) were independent risk of intraoperative massive hemorrhage. Conclusion In patients with placenta previa, a birth weight >-0.33 standard deviation was a significant risk indicator of massive hemorrhage during cesarean section. Based on this result, further studies are required to investigate whether fetal weight estimated by ultrasonography can predict hemorrhage during cesarean section in patients with placental previa.	[Soyama, Hiroaki; Miyamoto, Morikazu; Ishibashi, Hiroki; Takano, Masashi; Sasa, Hidenori; Furuya, Kenichi] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan	Soyama, H (corresponding author), Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama, Japan.	h.soyama55@gmail.com						Ananth CV, 2003, AM J OBSTET GYNECOL, V188, P1299, DOI 10.1067/mob.2003.76; Ananth CV, 2001, OBSTET GYNECOL, V98, P299, DOI 10.1016/S0029-7844(01)01413-2; Baba Y, 2014, J OBSTET GYNAECOL RE, V40, P1243, DOI 10.1111/jog.12340; Cali G, 2013, ULTRASOUND OBST GYN, V41, P406, DOI 10.1002/uog.12385; Cresswell JA, 2013, TROP MED INT HEALTH, V18, P712, DOI 10.1111/tmi.12100; Ghourab S, 2001, ULTRASOUND OBST GYN, V18, P103, DOI 10.1046/j.1469-0705.2001.00420.x; Gregory KD, 1998, OBSTET GYNECOL, V92, P507, DOI 10.1016/S0029-7844(98)00224-5; Harper LM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.014; Hasegawa J, 2009, ULTRASOUND OBST GYN, V34, P80, DOI 10.1002/uog.6426; Hwu YM, 2005, BJOG-INT J OBSTET GY, V112, P1420, DOI 10.1111/j.1471-0528.2005.00666.x; Jang Dong Gyu, 2011, Int J Med Sci, V8, P439; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Raisanen S, 2014, OBSTET GYNECOL, V124, P285, DOI 10.1097/AOG.0000000000000368; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Sekiguchi A, 2013, INT J MED SCI, V10, P1683, DOI 10.7150/ijms.6416; Shinozuka N., 2002, ULTRASOUND REV OBSTE, V2, P156, DOI DOI 10.3109/14722240208500478; Smith RS, 1997, ULTRASOUND OBST GYN, V9, P22, DOI 10.1046/j.1469-0705.1997.09010022.x; Stafford IA, 2010, OBSTET GYNECOL, V116, P595, DOI 10.1097/AOG.0b013e3181ea2deb; Tuzovic L, 2006, INT J GYNECOL OBSTET, V93, P110, DOI 10.1016/j.ijgo.2006.02.006; Vergani P, 2007, OBSTET GYNECOL, V109, P410, DOI 10.1097/01.AOG.0000250470.78700.f0; Walfish M, 2009, BR J ANAESTH S1, V103, pi47, DOI [DOI 10.1093/BJA/AEP303, DOI 10.1093/bja/aep303]; Yeniel AO, 2012, ARCH GYNECOL OBSTET, V286, P295, DOI 10.1007/s00404-012-2296-4; Zaitoun MM, 2011, ARCH GYNECOL OBSTET, V284, P867, DOI 10.1007/s00404-010-1737-1; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360	25	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167332	10.1371/journal.pone.0167332	http://dx.doi.org/10.1371/journal.pone.0167332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902772	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100073
J	van Kooten, GC; Duan, J; Lynch, R				van Kooten, G. Cornelis; Duan, Jun; Lynch, Rachel			Is There a Future for Nuclear Power? Wind and Emission Reduction Targets in Fossil-Fuel Alberta	PLOS ONE			English	Article								This paper explores the viability of relying on wind power to replace upwards of 60% of electricity generation in Alberta that would be lost if coal-fired generation is phased out. Using hourly wind data from 17 locations across Alberta, we are able to simulate the potential wind power output available to the Alberta grid when modern, 3.5 MW-capacity wind turbines are spread across the province. Using wind regimes for the years 2006 through 2015, we find that available wind power is less than 60% of installed capacity 98% of the time, and below 30% of capacity 74% of the time. There is only a small amount of correlation between wind speeds at different locations, but yet it remains necessary to rely on fossil fuel generation. Then, based on the results from a grid allocation model, we find that CO2 emissions can be reduced by about 30%, but only through a combination of investment in wind energy and reliance on purchases of hydropower from British Columbia. Only if nuclear energy is permitted into the generation mix would Alberta be able to meet its CO2-emissions reduction target in the electricity sector. With nuclear power, emissions can be reduced by upwards of 85%.	[van Kooten, G. Cornelis; Duan, Jun; Lynch, Rachel] Univ Victoria, Dept Econ, Victoria, BC, Canada	University of Victoria	van Kooten, GC (corresponding author), Univ Victoria, Dept Econ, Victoria, BC, Canada.	kooten@uvic.ca	van Kooten, G. Cornelis/AAS-4867-2020		Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-03959]; NSERC (Canada) [RGPIN 2015-03959]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada. Grant #RGPIN-2015-03959. http://www. nserc-crsng.gc.ca/index_eng.asp to GCvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Subject to the usual qualifier, the authors would like to thank the Journal reviewers for helpful comments and suggestions. Funding for the research reported here was provided by NSERC (Canada) Discovery Grant RGPIN 2015-03959.	BP, 2021, UPD METH CONV NONF E; Government of Alberta, 2016, SUMM ALB NEW POL RES; Lovering JR, 2016, ENERG POLICY, V91, P371, DOI 10.1016/j.enpol.2016.01.011; Monahan K, 2010, ENV EC, V1, P92; Nordhaus W, 2014, J ASSOC ENVIRON RESO, V1, P273, DOI 10.1086/676035; Taylor G.S., 2015, LEVELIZED COST ELECT; Tol R.S.J., 2014, CLIMATE EC EC ANAL C; U.S. ENERGY INFO. ADMIN, 2021, LEV COSTS NEW GEN RE, P4; van Kooten GC, 2013, AM J AGR ECON, V95, P505, DOI 10.1093/ajae/aas094; van Kooten GC, 2016, ANN REV RESOURCE EC, V8; van Kooten GC, 2016, P CAN SOC MECH ENG I	11	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165822	10.1371/journal.pone.0165822	http://dx.doi.org/10.1371/journal.pone.0165822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902712	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100008
J	Chang, PY; Lo, PC; Chang, HC; Hsueh, KC; Tsai, YW				Chang, Po-Yin; Lo, Po-Ching; Chang, Hui-Chin; Hsueh, Kuang-Chieh; Tsai, Yi-Wen			Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; GENDER-DIFFERENCES; SEX-DIFFERENCES; VARENICLINE; POPULATION; SMOKERS; PLACEBO; PATCH	Background and objective Relative effectiveness of smoking cessation medications-varenicline, bupropion and nicotine replacement therapy (NRT)-remains unclear among smokers in real-world settings. Evidence in females and smokers with light/moderate nicotine dependence is particularly insufficient. This study compared the effectiveness of varenicline, bupropion or NRT gum relative to NRT patch, in achieving abstinence among recent quitters. Methods In a national smoking cessation program in Taiwan (2012-2015), a cohort of 11,968 participants received varenicline (n = 5,052), bupropion (n = 823), NRT gum (n = 1944) or NRT patch (n = 4,149). The 7-day, 1-month or 6-month point-prevalence was calculated based on self-reported last smoking event via telephone interview after 6 months. Logistic regression modellings estimated odds ratios (OR) and 95% confidence intervals (CI) for achieving abstinence using different modalities (NRT patch as referent). Models included age, sex, education, marital status, geographic region, smoke-years, nicotine-dependence level, medical institution, number of clinic visits and medication use duration. Analyses were further stratified by sex and dependence severity. Results Participants were predominantly male (83%) with a mean age of 43.7 +/- 12.6 years. Varenicline users were more likely than NRT patch users to achieve abstinence, based on 7-day point-prevalence (OR = 1.30, CI: 1.19-1.44), 1-month point-prevalence (OR = 1.36, CI: 1.24-1.50) or 6-month point-prevalence (OR = 1.30, CI: 1.14-1.47). Compared with NRT patch, varenicline was associated with greater odds of being abstinent in women (OR = 1.29, CI: 1.01-1.65), men (OR = 1.31, CI: 1.18-1.46), those with light/moderate dependence (OR = 1.42, CI: 1.24-1.63) or smokers with severe dependence (OR = 1.19, CI: 1.04-1.37), based on 7-day point-prevalence. Differences in effectiveness were not observed between users of bupropion, NRT gum and NRT patch. Conclusions In smoking cessation clinics in Taiwan, varenicline users reported higher abstinence rates than NRT patch users after 6 months. Women and smokers with light/moderate nicotine dependence may also benefit from varenicline in actual clinical practice.	[Chang, Po-Yin] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Lo, Po-Ching; Chang, Hui-Chin; Tsai, Yi-Wen] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei, Taiwan; [Hsueh, Kuang-Chieh] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Stanford University; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital	Tsai, YW (corresponding author), Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei, Taiwan.	ywtsai@ym.edu.tw			Health Promotion Administration, Ministry of Health and Welfare, Taiwan; Health Promotion Administration, Ministry of Health and Welfare, Taiwan [G1031227-105]	Health Promotion Administration, Ministry of Health and Welfare, Taiwan; Health Promotion Administration, Ministry of Health and Welfare, Taiwan	National Yang-Ming University received research funding from the revenues of tobacco health and welfare surcharges by the Health Promotion Administration, Ministry of Health and Welfare, Taiwan, for project, titled "International Collaborative Project for the Evaluation of Medical Services for Smoking Cessation." Yi-Wen Tsai (PI), Kuang-Chieh Hsueh (Co-PI), Po-Yin Chang, Po-Ching Lo and Hui-Chin Chang received grants (G1031227-105) from the Health Promotion Administration, Ministry of Health and Welfare, Taiwan (http://www.hpa.gov.tw/BHPNet/English/Index.aspx). Health Promotion Administration, Taiwan provided data for the current study; it had no role in study design, analysis, data interpretation, or manuscript writing.	Agaku IT, 2014, MMWR-MORBID MORTAL W, P63; Anthenelli RM, 2016, LANCET, V387, P2507, DOI 10.1016/S0140-6736(16)30272-0; Baha MY, 2010, EUR ADDICT RES, V16, P162, DOI 10.1159/000314360; Baker TB, 2016, JAMA-J AM MED ASSOC, V315, P371, DOI 10.1001/jama.2015.19284; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Cahill K, 2014, JAMA-J AM MED ASSOC, V311, P193, DOI 10.1001/jama.2013.283787; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hsueh SC, 2015, EVAL HEALTH PROF, V38, P115, DOI 10.1177/0163278712466868; Huang Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1024; Jarvis MJ, 2013, TOB CONTROL, V22, P356, DOI 10.1136/tobaccocontrol-2011-050279; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kotz D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1163; Kotz D, 2014, PSYCHOPHARMACOLOGY, V231, P37, DOI 10.1007/s00213-013-3202-x; McKee SA, 2015, OFFICIAL J SOC RES N; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Munafo M, 2004, NICOTINE TOB RES, V6, P769, DOI 10.1080/14622200410001696556; Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171; Perkins KA, 2008, NICOTINE TOB RES, V10, P1245, DOI 10.1080/14622200802097506; Scharf D, 2004, ADDICTION, V99, P1462, DOI 10.1111/j.1360-0443.2004.00845.x; Schauer GL, 2014, NICOTINE TOB RES, V16, P58, DOI 10.1093/ntr/ntt113; Smith PH, 2015, NICOTINE TOB RES, V17, P463, DOI 10.1093/ntr/ntu212; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Wu PC, 2016, EVAL HEALTH PROF, V39, P317, DOI 10.1177/0163278715616439	26	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166992	10.1371/journal.pone.0166992	http://dx.doi.org/10.1371/journal.pone.0166992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893843	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400066
J	Dai, L; Sun, CX; Wang, D; Gao, YX				Dai, Lei; Sun, Cuixia; Wang, Di; Gao, Yanxiang			The Interaction between Zein and Lecithin in Ethanol-Water Solution and Characterization of Zein-Lecithin Composite Colloidal Nanoparticles	PLOS ONE			English	Article							MORPHOLOGICAL-CHARACTERISTICS; ANTISOLVENT PRECIPITATION; PICKERING EMULSION; PROTEIN; FLUORESCENCE; STABILITY; COMPLEX; PH; PHOSPHOLIPIDS; LACTOGLOBULIN	Lecithin, a naturally small molecular surfactant, which is widely used in the food industry, can delay aging, enhance memory, prevent and treat diabetes. The interaction between zein and soy lecithin with different mass ratios (20:1, 10:1, 5:1, 3:1, 2:1, 1:1 and 1:2) in ethanol- water solution and characterisation of zein and lecithin composite colloidal nanoparticles prepared by antisolvent co-precipitation method were investigated. The mean size of zein-lecithin composite colloidal nanoparticles was firstly increased with the rise of lecithin concentration and then siginificantly decreased. The nanoparticles at the zein to lecithin mass ratio of 5: 1 had the largest particle size (263 nm), indicating that zein and lecithin formed composite colloidal nanoparticles, which might aggregate due to the enhanced interaction at a higher proportion of lecithin. Continuing to increase lecithin concentration, the zein-lecithin nanoparticles possibly formed a reverse micelle-like or a vesicle-like structure with zein in the core, which prevented the formation of nanoparticle aggregates and decreased the size of composite nanoparticles. The presence of lecithin significantly reduced the.-potential of zein-lecithin composite colloidal nanoparticles. The interaction between zein and lecithin enhanced the intensity of the fluorescence emission of zein in ethanol-water solution. The secondary structure of zein was also changed by the addition of lecithin. Differential scanning calorimetry thermograms revealed that the thermal stability of zein-lecithin nanoparticles was enhanced with the rise of lecithin level. The composite nanoparticles were relatively stable to elevated ionic strengths. Possible interaction mechanism between zein and lecithin was proposed. These findings would help further understand the theory of the interaction between the alcohol soluble protein and the natural small molecular surfactant. The composite colloidal nanoparticles formed in this study can broaden the application of zein and be suitable for incorporating water-insoluble bioactive components in functional food and beverage products.	[Dai, Lei; Sun, Cuixia; Wang, Di; Gao, Yanxiang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing Key Lab Funct Food Plant Resources, Coll Food Sci & Nutr Engn,Beijing Lab Food Qual &, Beijing, Peoples R China	China Agricultural University	Gao, YX (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing Key Lab Funct Food Plant Resources, Coll Food Sci & Nutr Engn,Beijing Lab Food Qual &, Beijing, Peoples R China.	gyxcau@126.com	Gao, Y./GWZ-3665-2022; Gao, Yu/HGE-1937-2022; Dai, Lei/HCH-4898-2022; gao, yi/HCI-8298-2022	Dai, Lei/0000-0002-9491-6567; 	National Natural Science Foundation of China [31371835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by the National Natural Science Foundation of China (No.31371835).	Alcantara ACS, 2010, J MAT CHEM, V20; Chen JJ, 2014, FOOD CHEM, V158, P466, DOI 10.1016/j.foodchem.2014.03.003; Comas DI, 2006, FOOD HYDROCOLLOID, V20, P990, DOI 10.1016/j.foodhyd.2005.11.006; Gao ZM, 2014, J AGR FOOD CHEM, V62, P2672, DOI 10.1021/jf500005y; Hu DD, 2012, J FOOD ENG, V109, P545, DOI 10.1016/j.jfoodeng.2011.10.025; Hu K, 2015, FOOD HYDROCOLLOID, V44, P101, DOI 10.1016/j.foodhyd.2014.09.015; Hu K, 2014, FOOD RES INT, V64, P329, DOI 10.1016/j.foodres.2014.07.004; Joye IJ, 2015, FOOD CHEM, V185, P261, DOI 10.1016/j.foodchem.2015.03.128; Kongsawat P., 2011, Proceedings of the 49th Kasetsart University Annual Conference, Kasetsart University, Thailand, 1-4 February, 2011. Volume 7. Subject: Agro-Industry, P406; Li JF, 2014, FOOD SCI BIOTECHNOL, V23, P1785, DOI 10.1007/s10068-014-0244-8; Luo YC, 2011, COLLOID SURFACE B, V85, P145, DOI 10.1016/j.colsurfb.2011.02.020; Maikokera R, 2007, COLLOID SURFACE B, V55, P173, DOI 10.1016/j.colsurfb.2006.11.029; Mantovani RA, 2016, FOOD HYDROCOLLOID, V60, P288, DOI 10.1016/j.foodhyd.2016.03.039; Mc Clements D.J., 2005, FOOD EMULSIONS PRINC, P269; Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p; Patel A, 2010, SOFT MATTER, V6, P6192, DOI 10.1039/c0sm00800a; Patel AR, 2012, FOOD CHEM, V133, P423, DOI 10.1016/j.foodchem.2012.01.054; Patel AR, 2010, J AGR FOOD CHEM, V58, P12497, DOI 10.1021/jf102959b; Podaralla S, 2012, AAPS PHARMSCITECH, V13, P919, DOI 10.1208/s12249-012-9816-1; Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9; Sun CX, 2016, INNOV FOOD SCI EMERG, V34, P161, DOI 10.1016/j.ifset.2016.01.016; Sun CX, 2016, FOOD HYDROCOLLOID, V58, P11, DOI 10.1016/j.foodhyd.2016.02.014; Sun CX, 2015, IND CROP PROD, V77, P476, DOI 10.1016/j.indcrop.2015.09.028; Surh J, 2008, J FOOD ENG, V89, P164, DOI 10.1016/j.jfoodeng.2008.04.023; van Nieuwenhuyzen W, 1998, FETT-LIPID, V100, P282; Wang Q., 2014, J APPL POLYM SCI, V131, P12; Wang XG, 2014, CARBOHYD POLYM, V101, P1027, DOI 10.1016/j.carbpol.2013.10.042; Wang YH, 2016, FOOD HYDROCOLLOID, V54, P40, DOI 10.1016/j.foodhyd.2015.09.020; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xue J, 2014, J AGR FOOD CHEM, V62, P2956, DOI 10.1021/jf405828s; Yin HY, 2015, INT J BIOL MACROMOL, V72, P480, DOI 10.1016/j.ijbiomac.2014.08.025; Yong YH, 2004, J AGR FOOD CHEM, V52, P7094, DOI 10.1021/jf040133u; Zhang Y, 2003, COLLOID SURFACE A, V223, P11, DOI 10.1016/S0927-7757(03)00099-2; Zhou CP, 2012, J PEPT SCI, V18, P541, DOI 10.1002/psc.2423; Zou LQ, 2016, FOOD RES INT, V81, P74, DOI 10.1016/j.foodres.2015.12.035; Zou Y, 2015, J AGR FOOD CHEM, V63, P7405, DOI 10.1021/acs.jafc.5b03113	36	62	68	14	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167172	10.1371/journal.pone.0167172	http://dx.doi.org/10.1371/journal.pone.0167172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893802	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400094
J	Gammelmark, A; Nielsen, MS; Lundbye-Christensen, S; Tjonneland, A; Schmidt, EB; Overvad, K				Gammelmark, Anders; Nielsen, Michael S.; Lundbye-Christensen, Soren; Tjonneland, Anne; Schmidt, Erik B.; Overvad, Kim			Common Polymorphisms in the 5-Lipoxygenase Pathway and Risk of Incident Myocardial Infarction: A Danish Case-Cohort Study	PLOS ONE			English	Article							LEUKOTRIENE BIOSYNTHESIS PATHWAY; ISCHEMIC-STROKE; REPEAT POLYMORPHISM; PROMOTER GENOTYPE; GENETIC-VARIATION; CONFERS RISK; C-4 SYNTHASE; ASSOCIATION; ATHEROSCLEROSIS; HAPLOTYPE	Background The 5-lipoxygenase pathway (5-LOX) has been implicated in the development of cardiovascular disease and studies have suggested that genetic polymorphisms related to key enzymes in this pathway may confer risk of myocardial infarction (MI). This study investigated the association of pre-selected genetic polymorphisms in four candidate genes of 5-LOX (arachidonate 5-lipoxygenase and its activating protein (ALOX-5 and FLAP), leukotriene A4 hydroxylase (LTA4-H) and leukotriene C4 synthase (LTC4-S)) with incident MI. Methods In a Danish cohort including 57,053 participants, aged 50-64 at enrolment and recruited from 1993-97, we conducted a case-cohort study including cases with incident MI and a randomly selected sub cohort of 3,000 participants. Cases were identified from national registries through July 2013. A total of 22 SNPs were selected and genotyped using the commercially available KASP (TM) assay. A tandem-repeat polymorphism, located in the ALOX-5 gene, was genotyped by multi-titre plate sequencing. Haplotypes were inferred using PHASE 2.1. Results During a median follow-up of 17.0 years we identified 3,089 cases of incident MI. In FLAP, two SNPs were negatively associated with incident MI (rs9551963 & rs17222842) while one SNP (rs2247570) located in LTA4-H, was associated with higher risk of MI when comparing subjects with two copies of the variant allele to homozygotes for the wild type. However, only rs17222842 remained significantly associated with MI after correcting for multiple testing. Furthermore, the promoter polymorphism rs59439148 was associated with risk of MI in men. For male carriers of two variant alleles we found a hazard ratio of 1.63 (95% CI: 1.06;2.52) compared to homozygotes for the wild type. Previously described haplotypes (Hap-A-B, -E and -K) were not associated with MI in our population. Conclusion In conclusion, some common polymorphisms in the 5-lipoxygenase pathway were modestly associated with incident MI, suggesting a potential role for this pathway in the development of cardiovascular disease.	[Gammelmark, Anders; Nielsen, Michael S.; Schmidt, Erik B.; Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Gammelmark, Anders; Schmidt, Erik B.] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Lundbye-Christensen, Soren] Aalborg Univ Hosp, Unit Clin Biostat & Bioinformat, Aalborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Danish Cancer Society; Aarhus University	Gammelmark, A (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.; Gammelmark, A (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	anders.gammelmark@rn.dk		Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921; Lundbye-Christensen, Soren/0000-0002-9420-2783	Danish Heart Association, Copenhagen, Denmark; Hertha Christensens Foundation, Aalborg, Denmark; Medical Specialist Heinrich Kopp's Grant; Danish Cancer Society	Danish Heart Association, Copenhagen, Denmark; Hertha Christensens Foundation, Aalborg, Denmark; Medical Specialist Heinrich Kopp's Grant; Danish Cancer Society(Danish Cancer Society)	The study was supported by a research grant from The Danish Heart Association (https://www.hjerteforeningen.dk), Copenhagen, Denmark, Hertha Christensens Foundation, Aalborg, Denmark and Medical Specialist Heinrich Kopp's Grant. The Diet, Cancer and Health study was funded by the Danish Cancer Society (https://www.cancer.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Allayee H, 2008, AM J CLIN NUTR, V88, P934, DOI 10.1093/ajcn/88.4.934; Assimes TL, 2008, HUM GENET, V123, P399, DOI 10.1007/s00439-008-0489-5; Bevan S, 2008, STROKE, V39, P1109, DOI 10.1161/STROKEAHA.107.491969; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; Crosslin DR, 2009, HUM GENET, V125, P217, DOI 10.1007/s00439-008-0619-0; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Domingues-Montanari S, 2010, CEREBROVASC DIS, V29, P528, DOI 10.1159/000302738; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Freiberg JJ, 2008, ARTERIOSCL THROM VAS, V28, P990, DOI 10.1161/ATVBAHA.107.158873; French B, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1764; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gonzalez P, 2007, INT J IMMUNOGENET, V34, P127, DOI 10.1111/j.1744-313X.2007.00671.x; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Hartiala J, 2011, HUM GENET, V129, P617, DOI 10.1007/s00439-011-0963-3; He CL, 2014, METHODS MOL BIOL, V1145, P75, DOI 10.1007/978-1-4939-0446-4_7; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Iovannisci DM, 2007, ARTERIOSCL THROM VAS, V27, P394, DOI 10.1161/01.ATV.0000252680.72734.10; Jawien J, 2006, EUR J CLIN INVEST, V36, P141, DOI 10.1111/j.1365-2362.2006.01606.x; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Koch W, 2007, GENET MED, V9, P123, DOI 10.1097/GIM.0b013e318030c9c5; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; Lohmussaar E, 2005, STROKE, V36, P731, DOI 10.1161/01.STR.0000157587.59821.87; Maznyczka A, 2008, ATHEROSCLEROSIS, V199, P328, DOI 10.1016/j.atherosclerosis.2007.11.027; Mehrabian M, 2003, CURR OPIN LIPIDOL, V14, P447, DOI 10.1097/00041433-200310000-00005; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Radmark O, 2007, PROSTAG OTH LIPID M, V83, P162, DOI 10.1016/j.prostaglandins.2007.01.003; Riccioni G, 2012, SCI WORLD J, DOI 10.1100/2012/490968; Sharma V, 2013, J NEUROL SCI, V331, P108, DOI 10.1016/j.jns.2013.05.024; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Todur SP, 2012, CTS-CLIN TRANSL SCI, V5, P408, DOI 10.1111/j.1752-8062.2011.00396.x; Tsai AK, 2009, ATHEROSCLEROSIS, V207, P487, DOI 10.1016/j.atherosclerosis.2009.06.018; Wang GN, 2012, PROSTAG LEUKOTR ESS, V87, P169, DOI 10.1016/j.plefa.2012.09.005; Zhao JY, 2014, ATHEROSCLEROSIS, V233, P165, DOI 10.1016/j.atherosclerosis.2013.12.007; Zhao JY, 2013, ATHEROSCLEROSIS, V226, P238, DOI 10.1016/j.atherosclerosis.2012.10.048	49	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167217	10.1371/journal.pone.0167217	http://dx.doi.org/10.1371/journal.pone.0167217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893808	Green Published, gold			2022-12-27	WOS:000389472400102
J	Romero-Brito, TP; Buckley, RC; Byrne, J				Romero-Brito, Tania P.; Buckley, Ralf C.; Byrne, Jason			NGO Partnerships in Using Ecotourism for Conservation: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMMUNITY-BASED ECOTOURISM; PROTECTED AREAS; GLOBAL BIODIVERSITY; NONGOVERNMENTAL ORGANIZATIONS; ECOSYSTEM SERVICES; POVERTY REDUCTION; NATIONAL-PARK; RAIN-FOREST; TOURISM; SUSTAINABILITY	We analyse 214 cases worldwide where non-governmental organisations (NGOs) use ecotourism for conservation. Other stakeholders in these initiatives include local communities, the private sector, and government agencies. Stakeholder relationships determine NGO roles and project management structures and governance. We classified cases into 10 structural categories based on the initiating stakeholder and the NGO role, and used these categories to analyze geographic patterns and success factors. Most of the 214 cases are community-based (similar to 170; 79%); most are in developing countries (190; 89%); and most are in protected areas (196; 91%). Frequencies of structural categories differ between continents. More cases in Latin America and Asia are initiated by NGOs and local communities, and more in Africa by the private sector. Case-study authors used a range of economic, socio-cultural and environmental criteria to judge whether projects were successful. At global scale, we found no significant association between project success and the involvement of private tourism entrepreneurs. Projects involving either local or international NGOs had higher success rates than those that involved both simultaneously. Future research could adopt political ecology approaches to examine: the factors that lead NGOs to adopt ecotourism enterprises; their internal decision-making processes and strategies; their interactions with the stakeholders involved; and their conservation goals and outcomes.	[Romero-Brito, Tania P.; Buckley, Ralf C.; Byrne, Jason] Griffith Univ, Griffith Sch Environm, Gold Coast, NSW, Australia; [Buckley, Ralf C.] Griffith Univ, Int Chair Ecotourism Res, Gold Coast, NSW, Australia	Griffith University; Griffith University	Buckley, RC (corresponding author), Griffith Univ, Griffith Sch Environm, Gold Coast, NSW, Australia.; Buckley, RC (corresponding author), Griffith Univ, Int Chair Ecotourism Res, Gold Coast, NSW, Australia.	r.buckley@griffith.edu.au	Byrne, Jason/AAC-6344-2019; Byrne, Jason/L-7140-2013; Buckley, Ralf/G-7032-2014	Byrne, Jason/0000-0001-8733-0333; Buckley, Ralf/0000-0003-0442-5818				Ahebwa W. M., 2012, Conservation and Society, V10, P305; Ashley C, 2003, TRANSFORMING ROLES N; Azcarate M. C., 2010, Tourist Studies, V10, P99, DOI 10.1177/1468797611403033; Balint PJ, 2006, GEOFORUM, V37, P805, DOI 10.1016/j.geoforum.2005.01.011; Balint PJ, 2006, ENVIRON MANAGE, V38, P137, DOI 10.1007/s00267-005-0100-y; Balmford Andrew, 2012, WILD HOPE FRONT LINE; Baral N, 2011, BIODIVERS CONSERV, V20, P2407, DOI 10.1007/s10531-011-9993-3; Barkin D., 2002, Current Issues in Tourism, V5, P245, DOI 10.1080/13683500208667921; Barkin David, 2003, Environment Development and Sustainability, V5, P371, DOI 10.1023/A:1025725012903; Barnett T, 2008, THIRD WORLD Q, V29, P995, DOI 10.1080/01436590802106213; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Belsky JM, 1999, RURAL SOCIOL, V64, P641, DOI 10.1111/j.1549-0831.1999.tb00382.x; BRATTON M, 1990, DEV CHANGE, V21, P87, DOI 10.1111/j.1467-7660.1990.tb00369.x; Brenner L, 2006, J LAT AM GEOGR, V5, P7, DOI 10.1353/lag.2006.0019; Brightsmith DJ, 2008, BIOL CONSERV, V141, P2832, DOI 10.1016/j.biocon.2008.08.020; Brightsmith DJ, 2008, ORNITOL NEOTROP, V19, P173; Buckley R, 2010, CONSERVATION TOURISM, P1, DOI 10.1079/9781845936655.0000; Buckley R., 2009, ECOTOURISM PRINCIPLE; Buckley R., 2003, CASE STUDIES ECOTOUR; Buckley R, 2014, SCIENCE, V346; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; Buckley R, 2009, J SUSTAIN TOUR, V17, P643, DOI 10.1080/09669580902999188; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Buckley RC, 2012, NATURE, V489, P33, DOI 10.1038/489033b; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butcher J, 2007, CONTEMP GEOGR LEIS T, P1; Celata F, 2012, LOCAL ENVIRON, V17, P977, DOI 10.1080/13549839.2012.688731; CI, 2015, VERD VENT INV SUST B; Cooley A, 2002, INT SECURITY, V27, P5, DOI 10.1162/016228802320231217; Coria J, 2012, ECOL ECON, V73, P47, DOI 10.1016/j.ecolecon.2011.10.024; Cousins JA, 2007, TOURISM MANAGE, V28, P1020, DOI 10.1016/j.tourman.2006.08.011; Cusack D., 2006, Journal of Sustainable Forestry, V22, P157, DOI 10.1300/J091v22n01_09; Di Minin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071788; Ebrahim A., 2005, NGOS ORG CHANGE DISC; Ferraro Paul J, 2014, Proc Natl Acad Sci U S A, V111, P4332, DOI 10.1073/pnas.1307712111; Finnetty S., 2001, THESIS; Foucat VSA, 2002, OCEAN COAST MANAGE, V45, P511, DOI 10.1016/S0964-5691(02)00083-2; Fowler A., 2010, NGO MANAGEMENT EARTH; GEF, 2012, GEF GEF SGP FUND BIR; Gray N. J., 2007, Journal of Sustainable Tourism, V15, P463, DOI 10.2167/jost725.0; Halpenny E. A., 2001, The encyclopedia of ecotourism, P479, DOI 10.1079/9780851993683.0479; Halpenny EA, 2003, NGOS CONSERVATION AG, P107; Halstead L., 2003, MAKING COMMUNITY BAS; Hamzah A., 2012, MALAYSIAN FORESTER, V75, P29; Harrison D., 2007, Pro-poor tourism: who benefits? Perspectives on tourism and poverty reduction., P84; Heher S., 2003, ECOTOURISM INVESTMEN; Hitchner S. L., 2009, Journal of Ecotourism, V8, P193, DOI 10.1080/14724040802696064; Hiwasaki L, 2006, SOC NATUR RESOUR, V19, P675, DOI 10.1080/08941920600801090; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hoole A.F., 2009, INT J COMMONS, V4, P78, DOI DOI 10.18352/IJC.112; Horochowski K., 1999, Tourism Recreation Research, V24, P19; Hummel J, 2012, ASIA PACIFIC J TOURI, V1, P1; Hummel J, 2012, J SUSTAIN TOUR, V20, P319, DOI 10.1080/09669582.2012.663381; Jamal T., 2007, International Journal of Tourism Policy, V1, P93, DOI 10.1504/IJTP.2007.015522; Jamal T, 2009, J SUSTAIN TOUR, V17, P169, DOI 10.1080/09669580802495741; Jepson P, 2005, ENVIRON SCI POLICY, V8, P515, DOI 10.1016/j.envsci.2005.06.006; Karanth KK, 2010, BIOL CONSERV, V143, P2865, DOI 10.1016/j.biocon.2010.05.002; Karkut J., 1999, Tourism Recreation Research, V24, P45; Kennedy K, 2009, ASIA PAC J TOUR RES, V14, P183, DOI 10.1080/10941660902847237; King DA, 1996, BIODIVERS CONSERV, V5, P293, DOI 10.1007/BF00051775; Ko TG, 2005, TOURISM MANAGE, V26, P431, DOI 10.1016/j.tourman.2003.12.003; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Lamers M, 2015, I ARRANGEMENTS CONSE, P219; Lamers M, 2014, ANN TOURISM RES, V48, P250, DOI 10.1016/j.annals.2014.07.004; Lamers M, 2014, TOURISM GEOGR, V16, P474, DOI 10.1080/14616688.2013.806583; Lapeyre R, 2010, DEV SO AFR, V27, P757, DOI 10.1080/0376835X.2010.522837; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leung Y., 2019, TURISMO GESTAO VISIT, P120, DOI [10.2305/IUCN.CH.2018.PAG.27.p, DOI 10.2305/IUCN.CH.2018.PAG.27.P]; Liburd J. J., 2004, Tourism Recreation Research, V29, P105; Lovelock B., 2005, Journal of Sustainable Tourism, V13, P529, DOI 10.1080/09669580508668580; Lovelock B., 2003, Asia Pacific Journal of Tourism Research, V8, P1, DOI 10.1080/10941660308725451; Lovelock B., 2002, Journal of Sustainable Tourism, V10, P5, DOI 10.1080/09669580208667150; Mahanty S, 2002, WORLD DEV, V30, P1369, DOI 10.1016/S0305-750X(02)00039-6; Manyara G., 2006, Tourism Culture & Communication, V7, P19, DOI 10.3727/109830406778493579; del Rio JMV, 2009, PASOS, V7, P179; McAlpin M, 2008, POLICY SCI, V41, P51, DOI 10.1007/s11077-007-9053-8; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Mohan G, 2002, POLIT GEOGR, V21, P125, DOI 10.1016/S0962-6298(01)00072-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Morrison C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043757; Ndlovu Joram, 2014, Journal of Human Ecology, V47, P229; Neves K, 2010, ANTIPODE, V42, P719, DOI 10.1111/j.1467-8330.2010.00770.x; Novelli M., 2007, Current Issues in Tourism, V10, P443, DOI 10.2167/cit332.0; Nthiga R, 2011, NEW ALLIANCES TOURIS, P107; Nthiga RW, 2015, DEV SO AFR, V32, P407, DOI 10.1080/0376835X.2015.1016217; Ntshona ZM, 2003, COMMUNITY BASED ECOT; Nyakaana J, 2011, NEW ALLIANCES TOURIS, P63; Ohl-Schacherer J, 2008, ENVIRON CONSERV, V35, P14, DOI 10.1017/S0376892908004517; Ong F., 2011, World Leisure Journal, V53, P296, DOI 10.1080/04419057.2011.630787; Pasquini L, 2011, ORYX, V45, P373, DOI 10.1017/S0030605310000876; Pegas F, 2010, BRAZIL CONSERVATION, V8, P15, DOI DOI 10.4103/0972-4923.62676; Pellis A., 2011, NEW ALLIANCES TOURIS, P127; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Princen T., 1994, ENV NGOS WORLD POLIT; Punch K. F., 2013, INTRO SOCIAL RES QUA, V3rd; Raymond E, 2008, JOURNEYS OF DISCOVERY IN VOLUNTEER TOURISM: INTERNATIONAL CASE STUDY PERSPECTIVES, P48, DOI 10.1079/9781845933807.0048; Reimer JK, 2013, TOURISM MANAGE, V34, P122, DOI 10.1016/j.tourman.2012.04.002; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sagar Singh, 1999, Tourism Recreation Research, V24, P92; Sanghamitra Mahanty, 2002, Economic and Political Weekly, V37, P3757; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; Schelhaas M, 2007, SUSTAINABLE NATURE T; Scheyvens R., 2002, TOURISM DEV EMPOWERI; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Segrado R, 2006, WIT TRANS ECOL ENVIR, V97, P311, DOI 10.2495/ST060281; Silverman D., 2010, QUALITATIVE RES, DOI [10.1177/1468794110362874, DOI 10.1177/1468794110362874]; Simpson MC, 2008, TOURISM MANAGE, V29, P1, DOI 10.1016/j.tourman.2007.06.005; Sirakaya E., 2001, The encyclopedia of ecotourism, P411, DOI 10.1079/9780851993683.0411; Sithole E., 2005, Journal of Sustainable Tourism, V13, P486, DOI 10.1080/09669580508668575; Snyman S, 2012, TOUR MANAG PERSPECT, V4, P127, DOI 10.1016/j.tmp.2012.07.004; Sparrowhawk J., 1999, Tourism Recreation Research, V24, P37; Spencer R, 2008, JOURNEYS OF DISCOVERY IN VOLUNTEER TOURISM: INTERNATIONAL CASE STUDY PERSPECTIVES, P36, DOI 10.1079/9781845933807.0036; Spencer R., 2010, DEV TOURISM LESSONS; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Stronza A., 2008, Human Dimensions of Wildlife, V13, P263, DOI 10.1080/10871200802187097; Sundberg J, 1998, GEOGR REV, V88, P388, DOI 10.2307/216016; Svoronou E., 2005, Journal of Sustainable Tourism, V13, P456, DOI 10.1080/09669580508668573; Timothy D. J., 1999, Current Issues in Tourism, V2, P226; TNC, 2015, TRAV CONN NAT WORLD; Trejos B, 2008, J RURAL TOURISM RES, V2, P63; Trejos B, 2008, OPEN AREA STUDIES J, V1, P16; Trejos B, 2009, SINGAPORE J TROP GEO, V30, P373, DOI 10.1111/j.1467-9493.2009.00375.x; van der Duim R, 2014, SOC NATUR RESOUR, V27, P588, DOI 10.1080/08941920.2014.901459; van Wijk J, 2015, PROMOTING CONSERVATI, P203; Van Wijk J, 2015, J SUSTAIN TOUR, V23, P104, DOI 10.1080/09669582.2014.927878; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Walter P, 2009, INT J LIFELONG EDUC, V28, P513, DOI 10.1080/02601370903031363; Walter PG, 2012, ASIA PAC J TOUR RES, V17, P551, DOI 10.1080/10941665.2011.627930; Warren C, 2005, DEV CHANGE, V36, P49, DOI 10.1111/j.0012-155X.2005.00402.x; Wearing S., 2005, Journal of Sustainable Tourism, V13, P424, DOI 10.1080/09669580508668571; Wearing S., 2002, Journal of Sustainable Tourism, V10, P191, DOI 10.1080/09669580208667162; Weaver DB, 2007, TOURISM MANAGE, V28, P1168, DOI 10.1016/j.tourman.2007.03.004; West P, 2004, CURR ANTHROPOL, V45, P483, DOI 10.1086/422082; Wood M. E., 1999, Tourism Recreation Research, V24, P119; Wood ME, 1998, M GLOB CHALL COMM PA; WWF, 2015, TRAV WITH WWF 2015; Zanotti L, 2008, TOURISM GEOGR, V10, P495, DOI 10.1080/14616680802434114; Zapata MJ, 2011, CURR ISSUES TOUR, V14, P725, DOI 10.1080/13683500.2011.559200; Zeppel HD, 2006, ECOTOUR BK SER, V3, P1, DOI 10.1079/9781845931247.0000; Zhong LS, 2015, BIOL CONSERV, V181, P219, DOI 10.1016/j.biocon.2014.11.007; Zhuang H., 2011, Journal of Ecotourism, V10, P46, DOI 10.1080/14724041003686813	145	19	20	8	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166919	10.1371/journal.pone.0166919	http://dx.doi.org/10.1371/journal.pone.0166919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893800	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400056
J	Shafiro, V; Sheft, S; Norris, M; Spanos, G; Radasevich, K; Formsma, P; Gygi, B				Shafiro, Valeriy; Sheft, Stanley; Norris, Molly; Spanos, George; Radasevich, Katherine; Formsma, Paige; Gygi, Brian			Toward a Nonspeech Test of Auditory Cognition: Semantic Context Effects in Environmental Sound Identification in Adults of Varying Age and Hearing Abilities	PLOS ONE			English	Article							SPEECH RECOGNITION; PERCEPTION; MEMORY; WORDS; CATEGORIZATION; DECLINE	Objective Sounds in everyday environments tend to follow one another as events unfold over time. The tacit knowledge of contextual relationships among environmental sounds can influence their perception. We examined the effect of semantic context on the identification of sequences of environmental sounds by adults of varying age and hearing abilities, with an aim to develop a nonspeech test of auditory cognition. Method The familiar environmental sound test (FEST) consisted of 25 individual sounds arranged into ten five-sound sequences: five contextually coherent and five incoherent. After hearing each sequence, listeners identified each sound and arranged them in the presentation order. FEST was administered to young normal-hearing, middle-to-older normal-hearing, and middle-to-older hearing-impaired adults (Experiment 1), and to postlingual cochlear-implant users and young normal-hearing adults tested through vocoder-simulated implants (Experiment 2). Results FEST scores revealed a strong positive effect of semantic context in all listener groups, with young normal-hearing listeners outperforming other groups. FEST scores also correlated with other measures of cognitive ability, and for CI users, with the intelligibility of speech-in-noise. Conclusions Being sensitive to semantic context effects, FEST can serve as a nonspeech test of auditory cognition for diverse listener populations to assess and potentially improve everyday listening skills.	[Shafiro, Valeriy; Sheft, Stanley; Norris, Molly; Spanos, George; Radasevich, Katherine; Formsma, Paige] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA; [Gygi, Brian] Vet Affairs Northern Calif Hlth Care Syst, Martinez, CA USA	Rush University	Shafiro, V (corresponding author), Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA.	Valeriy_Shafiro@rush.edu		Shafiro, Valeriy/0000-0002-5722-748X	Capita Foundation	Capita Foundation	This work was supported by Capita Foundation (http://www.capitafoundation.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva H, 2015, J AM GERIATR SOC, V63, P2099, DOI 10.1111/jgs.13649; BALLAS JA, 1987, ENVIRON BEHAV, V19, P91, DOI 10.1177/0013916587191005; Ballas JA, 1991, HUM PERFORM, V4, P199, DOI DOI 10.1207/S15327043HUP0403_3; Benichov J, 2012, EAR HEARING, V33, P262, DOI 10.1097/AUD.0b013e31822f680f; Berland A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115557; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Borg E, 1998, SCAND AUDIOL, V27, P195, DOI 10.1080/010503998420496; Bregman A.S., 1990, AUDITORY SCENE ANAL; Cabe PA, 2000, J EXP PSYCHOL HUMAN, V26, P313, DOI 10.1037/0096-1523.26.1.313; Carello C, 1998, PSYCHOL SCI, V9, P211, DOI 10.1111/1467-9280.00040; Crowder RG, 1993, THINKING SOUND COGNI, P113, DOI DOI 10.1093/ACPR0F:0S0/9780198522577.003.0005; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DEESE J, 1957, J EXP PSYCHOL, V54, P180, DOI 10.1037/h0040536; Dick F., 2016, NEUROBIOLOGY LANGUAG, P1121; Donaldson GS, 2009, EAR HEARING, V30, P401, DOI 10.1097/AUD.0b013e3181a16379; ELLIOTT LL, 1995, J SPEECH HEAR RES, V38, P1363, DOI 10.1044/jshr.3806.1363; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Gregg MK, 2009, ATTEN PERCEPT PSYCHO, V71, P607, DOI 10.3758/APP.71.3.607; Guastavino C, 2007, CAN J EXP PSYCHOL, V61, P54, DOI 10.1037/cjep2007006; Gygi B, 2015, J ACOUST SOC AM, V138, P457, DOI 10.1121/1.4923020; Gygi B, 2013, J SPEECH LANG HEAR R, V56, P1373, DOI 10.1044/1092-4388(2013/12-0283); Gygi B, 2011, J EXP PSYCHOL HUMAN, V37, P551, DOI 10.1037/a0020671; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hocking J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073382; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Inverso Y, 2010, EAR HEARING, V31, P505, DOI 10.1097/AUD.0b013e3181d99a52; Jenkins J. J., 1985, PERSISTENCE CHANGE, P115; Jenkins J. J., 1979, LEVELS PROCESSING HU, P429; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kidd GR, 2012, J ACOUST SOC AM, V131, P1434, DOI 10.1121/1.3675975; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Leech R, 2009, J ACOUST SOC AM, V126, P3147, DOI 10.1121/1.3238160; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Looi Valerie, 2010, Cochlear Implants Int, V11, P203, DOI 10.1002/cii.428; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Molis MR, 2015, J SPEECH LANG HEAR R, V58, P481, DOI 10.1044/2015_JSLHR-H-14-0098; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niessen ME, 2008, INT J SEMANT COMPUT, V2, P327, DOI 10.1142/S1793351X08000506; Nimon K., 2010, MULTIPLE LINEAR REGR, V36, P10, DOI DOI 10.2106/JBJS.M.00521; Nittrouer S, 2014, APPL PSYCHOLINGUIST, V35, P333, DOI 10.1017/S0142716412000410; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Orgs G, 2006, BRAIN COGNITION, V62, P267, DOI 10.1016/j.bandc.2006.05.003; Overath T, 2015, NAT NEUROSCI, V18, P903, DOI 10.1038/nn.4021; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Park D. C., 2000, COGNITIVE AGING PRIM, V11, P3; Pastore RE, 2008, PERCEPT PSYCHOPHYS, V70, P13, DOI 10.3758/PP.70.1.13; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS26; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Pisoni D. B., 2011, EAR HEARING, V32, P60, DOI DOI 10.1097/AUD.0B013E3181FFD58E; POIRIER M, 1995, Q J EXP PSYCHOL-A, V48, P384, DOI 10.1080/14640749508401396; Ramsdell D.A.., 1978, HEARING AND DEAFNESS, P499; Reed CM, 2005, EAR HEARING, V26, P48, DOI 10.1097/00003446-200502000-00005; Risley R, 2012, P MEET ACOUST, V15; Roediger HL, 2008, ANNU REV PSYCHOL, V59, P225, DOI 10.1146/annurev.psych.57.102904.190139; Ronnberg J., 1990, EUR J COGN PSYCHOL, V2, P253, DOI [10.1080/09541449008406207, DOI 10.1080/09541449008406207]; Shafiro V, 2004, BEHAV RES METH INS C, V36, P590, DOI 10.3758/BF03206539; Shafiro V, 2008, EAR HEARING, V29, P401, DOI 10.1097/AUD.0b013e31816a0cf1; Shafiro V, 2008, EAR HEARING, V29, P775, DOI 10.1097/AUD.0b013e31817e08ea; Shafiro V, 2015, J SPEECH LANG HEAR R, V58, P509, DOI 10.1044/2015_JSLHR-H-14-0312; Shafiro V, 2012, TRENDS AMPLIF, V16, P83, DOI 10.1177/1084713812454225; Shafiro V, 2011, EAR HEARING, V32, P511, DOI 10.1097/AUD.0b013e3182064a87; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sheft S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134330; Sheft S, 2015, J AM ACAD AUDIOL, V26, P572, DOI 10.3766/jaaa.14067; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; Van Engen KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043753; Wechsler D, WECHSLER ADULT INTEL; Wingfield A, 2007, J AM ACAD AUDIOL, V18, P548, DOI 10.3766/jaaa.18.7.3	75	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167030	10.1371/journal.pone.0167030	http://dx.doi.org/10.1371/journal.pone.0167030			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893791	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400071
J	Chang, TH; Chen, MC; Chang, JP; Huang, HD; Ho, WC; Lin, YS; Pan, KL; Huang, YK; Liu, WH; Wu, CC				Chang, Tzu-Hao; Chen, Mien-Cheng; Chang, Jen-Ping; Huang, Hsien-Da; Ho, Wan-Chun; Lin, Yu-Sheng; Pan, Kuo-Li; Huang, Yao-Kuang; Liu, Wen-Hao; Wu, Chia-Chen			Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy	PLOS ONE			English	Article							FIBRILLATION	Background Left atrial enlargement in mitral regurgitation (MR) predicts a poor prognosis. The regulatory mechanisms of atrial myocyte hypertrophy of MR patients remain unknown. Methods and Results This study comprised 14 patients with MR, 7 patients with aortic valve disease (AVD), and 6 purchased samples from normal subjects (NC). We used microarrays, enrichment analysis and quantitative RT-PCR to study the gene expression profiles in the left atria. Microarray results showed that 112 genes were differentially up-regulated and 132 genes were differentially down-regulated in the left atria between MR patients and NC. Enrichment analysis of differentially expressed genes demonstrated that "NFAT in cardiac hypertrophy" pathway was not only one of the significant associated canonical pathways, but also the only one predicted with a non-zero score of 1.34 (i.e. activated) through Ingenuity Pathway Analysis molecule activity predictor. Ingenuity Pathway Analysis Global Molecular Network analysis exhibited that the highest score network also showed high association with cardiac related pathways and functions. Therefore, 5 NFAT associated genes (PPP3R1, PPP3CB, CAMK1, MEF2C, PLCE1) were studies for validation. The mRNA expressions of PPP3CB and MEF2C were significantly up-regulated, and CAMK1 and PPP3R1 were significantly down-regulated in MR patients compared to NC. Moreover, MR patients had significantly increased mRNA levels of PPP3CB, MEF2C and PLCE1 compared to AVD patients. The atrial myocyte size of MR patients significantly exceeded that of the AVD patients and NC. Conclusions Differentially expressed genes in the "NFAT in cardiac hypertrophy" pathway may play a critical role in the atrial myocyte hypertrophy of MR patients.	[Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Chen, Mien-Cheng; Ho, Wan-Chun; Liu, Wen-Hao] Chang Gung Univ, Coll Med, Div Cardiol, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chen, Mien-Cheng; Ho, Wan-Chun; Liu, Wen-Hao] Chang Gung Univ, Coll Med, Dept Internal Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chang, Jen-Ping; Wu, Chia-Chen] Chang Gung Univ, Coll Med, Div Cardiovasc Surg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Lin, Yu-Sheng; Pan, Kuo-Li] Chang Gung Mem Hosp, Div Cardiol, Chiayi, Taiwan; [Huang, Yao-Kuang] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Chiayi, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, MC (corresponding author), Chang Gung Univ, Coll Med, Div Cardiol, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.; Chen, MC (corresponding author), Chang Gung Univ, Coll Med, Dept Internal Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.	chenmien@ms76.hinet.net	Huang, Hsien-Da/AAA-7376-2019; Huang, Yao-Kuang/AAK-5137-2021	Huang, Yao-Kuang/0000-0003-2699-2207	National Science Council; Chang Gung Memorial Hospital, Taiwan [NSC 101-2314-B-182A-096, NSC 102-2314-B-182A-107-MY2, CM RPG8A0571]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, and the Chang Gung Memorial Hospital, Taiwan (grant number NSC 101-2314-B-182A-096, NSC 102-2314-B-182A-107-MY2, CM RPG8A0571). MCC received all the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chang JP, 2011, INT J CARDIOL, V146, P44, DOI 10.1016/j.ijcard.2009.06.012; Chen HC, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0038-9; Chen MC, 2015, TRANSL RES, V165, P599, DOI 10.1016/j.trsl.2014.11.005; Corradi D, 2012, J CARDIOVASC ELECTR, V23, P271, DOI 10.1111/j.1540-8167.2011.02187.x; di Gioia CRT, 2000, BIOCHEM BIOPH RES CO, V279, P965, DOI 10.1006/bbrc.2000.4049; Gentleman R, GENEFILTER GENEFILTE; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; McWhinnie R, 2007, AM J PHYSIOL-LUNG C, V292, pL278, DOI 10.1152/ajplung.00111.2006; Otto CM, 2003, HEART, V89, P100, DOI 10.1136/heart.89.1.100; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Sun LL, 2013, MOL CELL BIOCHEM, V377, P151, DOI 10.1007/s11010-013-1581-2; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166791	10.1371/journal.pone.0166791	http://dx.doi.org/10.1371/journal.pone.0166791			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907007	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700040
J	Hsieh, YP; Chang, CC; Kor, CT; Yang, Y; Wen, YK; Chiu, PF				Hsieh, Yao-Peng; Chang, Chia-Chu; Kor, Chew-Teng; Yang, Yu; Wen, Yao-Ko; Chiu, Ping-Fang			The Predictive Role of Red Cell Distribution Width in Mortality among Chronic Kidney Disease Patients	PLOS ONE			English	Article							HEART-FAILURE; PERITONEAL-DIALYSIS; PROGNOSTIC MARKER; CRITICAL ILLNESS; ASSOCIATION; HEMOGLOBIN; COHORT; RISK; ERYTHROPOIESIS; DYSFUNCTION	Background Recently, accumulating evidence has demonstrated that RDW independently predicts clinically important outcomes in many populations. However, the role of RDW has not been elucidated in chronic kidney disease (CKD) patients. We conducted the present study with the aim to evaluate the predictive value of RDW in CKD patients. Methods A retrospective observational cohort study of 1075 stage 3-5 CKD patients was conducted in a medical center. The patients' baseline information included demographic data, laboratory values, medications, and comorbid conditions. The upper limit of normal RDW value (14.9%) was used to divide the whole population. Multivariate Cox regression analysis was used to determine the independent predictors of mortality. Results Of the 1075 participants, 158 patients (14.7%) died over a mean follow-up of approximately 2.35 years. The crude mortality rate was significantly higher in the high RDW group (high RDW group, 22.4%; low RDW group 11%, p <0.001). From the adjusted model, the high RDW group was correlated with a hazard ratio of 2.19 for overall mortality as compared with the low RDW group (95% CI = 1.53-3.09, p<0.001). In addition, the high RDW group was also associated with an increased risk for cardiovascular disease (HR = 2.28, 95% CI = 1.14-4.25, p = 0.019) and infection (HR = 1.9, 95% CI = 1.15-3.14, p = 0.012)) related mortality in comparison with the low RDW group. Conclusions In stage 3-5 CKD patients, RDW was associated with patient mortality of all-cause, cardiovascular disease and infection. RDW should be considered as a clinical predictor for mortality when providing healthcare to CKD patients.	[Hsieh, Yao-Peng; Chang, Chia-Chu; Kor, Chew-Teng; Yang, Yu; Wen, Yao-Ko; Chiu, Ping-Fang] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Hsieh, Yao-Peng] Natl Chung Hsing Univ, Coll Life Sci, PhD Program Translat Med, Taichung, Taiwan; [Hsieh, Yao-Peng] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Hsieh, Yao-Peng; Chang, Chia-Chu; Yang, Yu; Chiu, Ping-Fang] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsieh, Yao-Peng] Changhua Christian Hosp, Div Nephrol, Internal Med, Changhua, Taiwan	Changhua Christian Hospital; National Chung Hsing University; Kaohsiung Medical University; Chung Shan Medical University; Changhua Christian Hospital	Hsieh, YP (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Hsieh, YP (corresponding author), Natl Chung Hsing Univ, Coll Life Sci, PhD Program Translat Med, Taichung, Taiwan.; Hsieh, YP (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.; Hsieh, YP (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Hsieh, YP (corresponding author), Changhua Christian Hosp, Div Nephrol, Internal Med, Changhua, Taiwan.	102407@cch.org.tw						Akin F, 2015, CORONARY ARTERY DIS, V26, P289, DOI 10.1097/MCA.0000000000000223; Al-Najjar Y, 2009, EUR J HEART FAIL, V11, P1155, DOI 10.1093/eurjhf/hfp147; Bion JF, 2000, INTENS CARE MED, V26, pS57, DOI 10.1007/s001340051120; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Celik A, 2012, KAOHSIUNG J MED SCI, V28, P165, DOI 10.1016/j.kjms.2011.06.024; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Gromadzinski L, 2015, CLIN EXP NEPHROL, V19, P616, DOI 10.1007/s10157-014-1033-7; Kalay N, 2011, TURK KARDIYOL DERN A, V39, P463, DOI 10.5543/tkda.2011.01578; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; Lee JH, 2013, AM J EMERG MED, V31, P72, DOI 10.1016/j.ajem.2012.06.004; Lee WS, 2010, ARCH PATHOL LAB MED, V134, P505, DOI 10.1043/1543-2165-134.4.505.c; MCCLURE S, 1985, JAMA-J AM MED ASSOC, V253, P1021, DOI 10.1001/jama.253.7.1021; Molnar MZ, 2011, CLIN J AM SOC NEPHRO, V6, P1973, DOI 10.2215/CJN.01050211; Mucsi I, 2014, INT UROL NEPHROL, V46, P641, DOI 10.1007/s11255-013-0530-z; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; Pascual-Figal DA, 2012, INT J CARDIOL, V160, P196, DOI 10.1016/j.ijcard.2011.04.018; Patel KV, 2013, ADV EXP MED BIOL, V765, P211, DOI 10.1007/978-1-4614-4989-8_29; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Peng FF, 2014, INT J CARDIOL, V176, P1379, DOI 10.1016/j.ijcard.2014.08.030; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Solak Y, 2014, AM J MED SCI, V347, P118, DOI 10.1097/MAJ.0b013e3182996a96; Tekce H, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/754370; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zalawadiya SK, 2012, AM J CARDIOL, V109, P1664, DOI 10.1016/j.amjcard.2012.01.396; Zalawadiya SK, 2010, AM J CARDIOL, V106, P988, DOI 10.1016/j.amjcard.2010.06.006; Zorlu A, 2012, AM J CARDIOL, V109, P128, DOI 10.1016/j.amjcard.2011.08.015	32	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0162025	10.1371/journal.pone.0162025	http://dx.doi.org/10.1371/journal.pone.0162025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906969	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700002
J	Ribeiro, RS; Terry, SA; Sacramento, JP; Silveira, SRE; Bento, CBP; da Silva, EF; Mantovani, HC; da Gama, MAS; Pereira, LGR; Tomich, TR; Mauricio, RM; Chaves, AV				Ribeiro, Rafael Sandin; Terry, Stephanie Amelia; Sacramento, Joao Paulo; Rocha e Silveira, Sylvia; Pereira Bento, Claudia Braga; da Silva, Elsa Fernandes; Mantovani, Hilario Cuquetto; Sundfeld da Gama, Marco Antonio; Ribeiro Pereira, Luiz Gustavo; Tomich, Thierry Ribeiro; Mauricio, Rogerio Martins; Chaves, Alexandre Vieira			Tithonia diversifolia as a Supplementary Feed for Dairy Cows	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; NEUTRAL DETERGENT FIBER; METHANE PRODUCTION; TRACER TECHNIQUE; FATTY-ACIDS; IN-VITRO; MILK-FAT; CORN; DIET; BIOHYDROGENATION	The objective of this study was to examine the effects of Tithonia diversifolia as a supplementary forage on dairy cow performance and methane production. Nine lactating Holstein x Zebu dairy cows (519 +/- 53.3 kg of body weight and 66 +/- 13.3 d in milk) were paired by milk yield (21.3 +/- 2.34 kg/d) and body weight and randomly assigned to three dietary treatments in a Latin square design with 21-d experimental periods (14 d for diet adaptation and 7 d for measurements and sample collection). The dietary treatments included the control diet consisting of fresh sugar cane plus concentrate (44:56, % of diet DM), and two treatment diets containing different levels of fresh T. diversifolia (6.5 and 15.4%, DM basis) which partially replaced both sugarcane and concentrates. Methane production was measured using the sulphur hexafluoride (SF6) technique from d 16 to d 21 of each experimental period. Analysis of the gas samples was performed by gas chromatography. The inclusion of T. diversifolia at 15.4% DM had no effects on DM intake, milk production, nitrogen balance or methane production. There was no effect on the concentrations of total saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) in milk fat (P >= 0.28), though individual milk fatty acids were affected. Serum concentrations of glucose, urea nitrogen (BUN), triglycerides, P-hydroxybutyrate (BHBA), and cholesterol were unaffected by the dietary treatments (P >= 0.13). There was a time (2 and 6 h post-feeding) and dietary treatment effect (P < 0.01) on the acetate to propionate ratio in the rumen. A denaturing gradient gel electrophoresis analysis of the archaeal community showed distinct clustering of the archaea populations for control and treatment diets. Taken together, our results indicate the potential of T. diversifolia as a supplementary forage for dairy cattle in the tropics.	[Ribeiro, Rafael Sandin; Sacramento, Joao Paulo; Rocha e Silveira, Sylvia; Mauricio, Rogerio Martins] Univ Fed Sao Joao Del Rei, Bioengn Dept, Sao Joao Del Rei, MG, Brazil; [Terry, Stephanie Amelia; Chaves, Alexandre Vieira] Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia; [Pereira Bento, Claudia Braga; da Silva, Elsa Fernandes; Mantovani, Hilario Cuquetto] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Sundfeld da Gama, Marco Antonio; Ribeiro Pereira, Luiz Gustavo; Tomich, Thierry Ribeiro] Embrapa Gado Leite, Juiz De Fora, MG, Brazil	Universidade Federal de Sao Joao del-Rei; University of Sydney; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Chaves, AV (corresponding author), Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia.	alex.chaves@sydney.edu.au	Mantovani, Hilario C/J-5287-2012; Bento, Cláudia Braga Pereira/AAW-4415-2021; Mauricio, Rogerio M/G-3728-2013; Chaves, Alexandre Vieira/B-8843-2012	Mantovani, Hilario C/0000-0002-3481-5318; Chaves, Alexandre Vieira/0000-0001-5065-7367; Terry, Stephanie Amelia/0000-0003-2567-6368	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	All the funding of support received during this specific study came from CAPES, http://www.capes.gov.br/, proposal n#129089 (Funding from Feb 2014 to Feb 2016), title: "Adaptacao de bovinos leiteiros as mudancas climaticas e avancos tecnologicos para mensuracao de metano enterico". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alexandre V. Chaves received R$14,000/month during his stay in Brazil during this proposal. Dr Chaves spent 7 months in total during this 3 year period project (2014-2016) funded by CAPES.	Barros-Rodriguez MA, 2015, TROP ANIM HEALTH PRO, V47, P757, DOI 10.1007/s11250-015-0790-y; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Baldin M, 2013, J ANIM SCI, V91, P3305, DOI 10.2527/jas.2012-5766; Berends H, 2014, J THEOR BIOL, V353, P1, DOI 10.1016/j.jtbi.2014.02.040; Berndt A., 2014, GUIDELINES USE SULPH; Broderick GA, 2004, J DAIRY SCI, V87, P2997, DOI 10.3168/jds.S0022-0302(04)73431-1; Broucek J., 2014, Journal of Environmental Protection, V5, P1482, DOI 10.4236/jep.2014.515141; Delgado DC, 2012, TROP ANIM HEALTH PRO, V44, P1097, DOI 10.1007/s11250-011-0045-5; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chilliard Y, 2007, EUR J LIPID SCI TECH, V109, P828, DOI 10.1002/ejlt.200700080; Cruz-Hernandez C, 2007, J DAIRY SCI, V90, P3786, DOI 10.3168/jds.2006-698; Deighton MH, 2014, ANIM FEED SCI TECH, V197, P47, DOI 10.1016/j.anifeedsci.2014.08.003; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Holtshausen L, 2009, J DAIRY SCI, V92, P2809, DOI 10.3168/jds.2008-1843; Jayanegara A, 2011, ANIM PROD SCI, V51, P1127, DOI 10.1071/AN11059; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kay JK, 2004, J DAIRY SCI, V87, P369, DOI 10.3168/jds.S0022-0302(04)73176-8; Kratz M, 2013, EUR J NUTR, V52, P1, DOI 10.1007/s00394-012-0418-1; Lana RP, 1998, J ANIM SCI, V76, P2190; Lee C, 2013, J DAIRY SCI, V96, P5295, DOI 10.3168/jds.2012-6442; Mahecha L, 2007, LIVEST RES RURAL DEV, P19; Martin C, 2008, J ANIM SCI, V86, P2642, DOI 10.2527/jas.2007-0774; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; Moate PJ, 2016, ANIM PROD SCI, V56, P1017, DOI 10.1071/AN15222; Motta EF, 2014, 19 NAT M METH EMBR L; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Olabode O. S., 2007, World Journal of Agricultural Sciences, V3, P503; Palmquist DL, 2005, BIOSYNTHESIS CONJUGA, P179; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Ramirez-Rivera U, 2010, AGROFOREST SYST, V80, P295, DOI 10.1007/s10457-010-9320-0; Ruiz T. E., 2014, Cuban Journal of Agricultural Science, V48, P79; Sao VN, 2010, LIVEST RES RURAL DEV, P22; Shingfield KJ, 2008, ADV EXP MED BIOL, V606, P3, DOI 10.1007/978-0-387-74087-4_1; SIEGFRIED R, 1984, LANDWIRT FORSCH, V37, P298; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Tendonkeng F, 2014, TROP ANIM HEALTH PRO, V46, P981, DOI 10.1007/s11250-014-0597-2; Terry SA, 2016, ANIM PROD SCI, V56, P437, DOI 10.1071/AN15560; Valadares RFD, 1999, J DAIRY SCI, V82, P2686, DOI 10.3168/jds.S0022-0302(99)75525-6; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Waghorn G, 2008, ANIM FEED SCI TECH, V147, P116, DOI 10.1016/j.anifeedsci.2007.09.013; Wambui C. C., 2006, Livestock Research for Rural Development, V18, P64; Ward AT, 2003, J DAIRY SCI, V86, P1742, DOI 10.3168/jds.S0022-0302(03)73760-6; Wolff RL, 1995, J AM OIL CHEM SOC, V72, P1471, DOI 10.1007/BF02577840	45	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165751	10.1371/journal.pone.0165751	http://dx.doi.org/10.1371/journal.pone.0165751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906983	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700011
J	Seo, MH; Lee, J; Hong, SW; Rhee, EJ; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Seo, Mi Hae; Lee, Jinmi; Hong, Seok-Woo; Rhee, Eun-Jung; Park, Se Eun; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Lee, Won-Young			Exendin-4 Inhibits Hepatic Lipogenesis by Increasing beta-Catenin Signaling	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PPAR-GAMMA; INSULIN-RESISTANCE; GENETIC-VARIANTS; LIPID-METABOLISM; STEATOSIS; ADIPOGENESIS; ACTIVATION; PATHWAY; TCF7L2	The aim of this study is to investigate whether the beneficial effect of exendin-4 on hepatic steatosis is mediated by beta-catenin signaling. After the HepG2 human hepatoma cells were treated with PA for 24 hours, total triglycerides levels were increased in a dose-dependent manner, and the expression levels of perilipin family members were upregulated in cells treated with 400 mu M PA. For our in vitro model of hepatic steatosis, HepG2 cells were treated with 400 mu M palmitic acid (PA) in the presence or absence of 100 nM exendin-4 for 24 hours. PA increased the expression of lipogenic genes, such as sterol regulatory element- binding protein 1c (SREBP-1c), peroxisome proliferator-activated receptor gamma (PPAR.), stearoyl-CoA desaturase 1 (SCD1), fatty acid synthase (FAS), and acetyl-CoA carboxylase (ACC) and triglyceride synthesis-involved genes, such as diacylglycerol acyltransferase 1 (DGAT1) and diacylglycerol acyltransferase 2 (DGAT2) in HepG2 cells, whereas exendin-4 treatment significantly prevented the upregulation of SREBP-1c, PPAR gamma, SCD1, FAS, ACC, DGAT1 and DGAT2. Moreover, exendin-4 treatment increased the expression of phosphorylated glycogen synthase kinase-3 beta (GSK-3 beta) in the cytosolic fraction and the expression of beta-catenin and transcription factor 4 (TCF4) in the nuclear fraction. In addition, siRNA-mediated inhibition of beta-catenin upregulated the expression of lipogenic transcription factors. The protective effects of exendin-4 on intracellular triglyceride content and total triglyceride levels were not observed in cells treated with the beta-catenin inhibitor IWR-1. These data suggest that exendin-4 treatment improves hepatic steatosis by inhibiting lipogenesis via activation of Wnt/beta-catenin signaling.	[Seo, Mi Hae] Soonchunhyang Univ, Gumi Hosp, Dept Internal Med, Gumi, South Korea; [Lee, Jinmi; Hong, Seok-Woo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Inst Med Res, Seoul, South Korea; [Rhee, Eun-Jung; Park, Se Eun; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea	Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592	National Research Foundation (NRF) - funded by the Korean government [NRF2013R1A1A2063069]; Samsung Biomedical Research Institute (SBRI)	National Research Foundation (NRF) - funded by the Korean government; Samsung Biomedical Research Institute (SBRI)	This study was supported by a grant from the National Research Foundation (NRF), which is funded by the Korean government (NRF2013R1A1A2063069) (http:www.nrf.rekr), and Samsung Biomedical Research Institute (SBRI) (http://www.sbri.or.kr). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Cauchi S, 2008, CURR DIABETES REP, V8, P149, DOI 10.1007/s11892-008-0026-x; Cho YM, 2013, ENDOCRINOL METAB, V28, P262, DOI 10.3803/EnM.2013.28.4.262; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Hong SW, 2012, MOL CELL ENDOCRINOL, V362, P242, DOI 10.1016/j.mce.2012.07.004; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kallwitz ER, 2008, WORLD J GASTROENTERO, V14, P22, DOI 10.3748/wjg.14.22; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; Kim HY, 2014, ENDOCRINOL METAB, V29, P320, DOI 10.3803/EnM.2014.29.3.320; Lee J, 2014, METABOLISM, V63, P1041, DOI 10.1016/j.metabol.2014.04.011; Lee J, 2012, DIABETES METAB J, V36, P262, DOI 10.4093/dmj.2012.36.4.262; Lee J, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-32; Liu PH, 2009, J CLIN ENDOCR METAB, V94, P3575, DOI 10.1210/jc.2009-0609; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Wang CH, 2006, J FORMOS MED ASSOC, V105, P743, DOI 10.1016/S0929-6646(09)60202-3; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004	31	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166913	10.1371/journal.pone.0166913	http://dx.doi.org/10.1371/journal.pone.0166913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907035	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700053
J	Soler-Hurtado, MM; Sandoval-Sierra, JV; Machordom, A; Dieguez-Uribeondo, J				Soler-Hurtado, M. Mar; Sandoval-Sierra, Jose Vladimir; Machordom, Annie; Dieguez-Uribeondo, Javier			Aspergillus sydowii and Other Potential Fungal Pathogens in Gorgonian Octocorals of the Ecuadorian Pacific	PLOS ONE			English	Article							POPULATION-STRUCTURE; SEA FANS; VENTALINA; DISTURBANCE; HEALTHY; DISEASE; CORALS; DUST	Emerging fungal diseases are threatening ecosystems and have increased in recent decades. In corals, the prevalence and consequences of these infections have also increased in frequency and severity. Coral reefs are affected by an emerging fungal disease named aspergillosis, caused by Aspergillus sydowii. This disease and its pathogen have been reported along the Caribbean and Pacific coasts of Colombia. Despite this, an important number of coral reefs worldwide have not been investigated for the presence of this pathogen. In this work, we carried out the surveillance of the main coral reef of the Ecuadorian Pacific with a focus on the two most abundant and cosmopolitan species of this ecosystem, Leptogorgia sp. and Leptogorgia obscura. We collected 59 isolates and obtained the corresponding sequences of the Internal Transcribed Spacers (ITS) of the ribosomal DNA. These were phylogenetically analyzed using MrBayes, which indicated the presence of two isolates of the coral reef pathogen A. sydowii, as well as 16 additional species that are potentially pathogenic to corals. Although the analyzed gorgonian specimens appeared healthy, the presence of these pathogens, especially of A. sydowii, alert us to the potential risk to the health and future survival of the Pacific Ecuadorian coral ecosystem under the current scenario of increasing threats and stressors to coral reefs, such as habitat alterations by humans and global climate change.	[Soler-Hurtado, M. Mar; Machordom, Annie] CSIC, MNCN, Dept Biodiversidad & Biol Evolut, Madrid, Spain; [Soler-Hurtado, M. Mar] Univ Seville, Fac Biol, Dept Biodiversidad & Ecol Invertebrados Marinos, Seville, Spain; [Sandoval-Sierra, Jose Vladimir; Dieguez-Uribeondo, Javier] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Dieguez-Uribeondo, J (corresponding author), Real Jardin Bot CSIC, Dept Micol, Madrid, Spain.	dieguez@rjb.csic.es	Diéguez-Uribeondo, Javier/ABF-1130-2021; dieguez-uribeondo, javier/I-2178-2015; Sandoval, Vladimir/GYD-5018-2022; Machordom, Annie/K-1737-2014	Diéguez-Uribeondo, Javier/0000-0002-4488-0658; dieguez-uribeondo, javier/0000-0002-4488-0658; Sandoval, Vladimir/0000-0003-2007-6582; Machordom, Annie/0000-0003-0341-0809	Spanish Ministry of Economy and Competitiveness [CTM2014-57949-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was only partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CTM2014-57949-R). The authors have not had any additional funding and coauthors have supported the sampling and sequencing from other projects. Both author and coauthors have currently not funding to pay publication fees.; We thank the Museo Ecuatoriano de Ciencias Naturales, Machalilla National Park and Ministerio del Ambiente of Ecuador (Manabi) for participation and collection permits (No 016 RM-DPM-MA). Thanks to Michel Guerrero and his team (Exploramar Diving) for his special interest from the early stages of our research. Special thanks to Micaela Peria for unconditional help and support. This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CTM2014-57949-R).	Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrero-Canosa J, 2013, CORAL REEFS, V32, P35, DOI 10.1007/s00338-012-0972-2; Bielschowsky E., 1929, Zoologische Jahrbuecher Jena Supplement, V16, P63; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Contreras AC, 2011, 64 GULF CAR FISH I, P28; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Dieguez-Uribeondo J, 2011, PHYTOPATHOLOGY, V101, P1013, DOI 10.1094/PHYTO-07-10-0193; Enochs I, 2008, P 11 INT COR REEF S, V26, P1368; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GARZONFERREIRA J, 1992, B MAR SCI, V50, P522; Gates RD, 2011, J EXP MAR BIOL ECOL, V408, P94, DOI 10.1016/j.jembe.2011.07.029; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Hallegraeff G, 2014, APPL ENVIRON MICROB, V80, P3315, DOI 10.1128/AEM.04118-13; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Kim Kiho, 2002, P813; Klinch MA, 2002, IDENTIFICATION COMMO; Koh LL, 2000, P 9 INT COR REEF S, V1, P521; Landry E.T., 2006, MYCOLOGIST, V20, P15, DOI [DOI 10.1016/J.MYC0L.2005.11.010, 10.1016/j.mycol.2005.11.010]; Milne-Edwards H, 1857, HIST NATURELLE CORAL; Moree WJ, 2014, ACS CHEM BIOL, V9, P2300, DOI 10.1021/cb500432j; Nagarajan C, 2014, INT J CASE REPORTS I, V5, P13, DOI [10.5348/ijcri-2014-01-430-CS-3, DOI 10.5348/ijcri-2014-01-430-CS-3]; Nagelkerken I, 1997, MAR ECOL PROG SER, V160, P255, DOI 10.3354/meps160255; Nagelkerken I, 1997, P 8 INT COR REEF S S, V1, P679; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Petes LE, 2003, MAR ECOL PROG SER, V264, P167, DOI 10.3354/meps264167; Raper KB, 1965, GENUS ASPERGILLUS GE; Rivera KG, 2012, MYCOTAXON, V119, P315, DOI 10.5248/119.315; Rypien K., 2008, THE ORIGINS AND SPRE; Rypien KL, 2008, MAR ECOL PROG SER, V367, P125, DOI 10.3354/meps07600; Rypien KL, 2008, MOL ECOL, V17, P4068, DOI 10.1111/j.1365-294X.2008.03894.x; Sánchez Juan A., 2011, Bol. Invest. Mar. Cost., V40, P139; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; SODERHALL K, 1978, MYCOPATHOLOGIA, V64, P9, DOI 10.1007/BF00443081; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Toledo-Hernandez C, 2008, CORAL REEFS, V27, P707, DOI 10.1007/s00338-008-0387-2; Toledo-Hernandez C, 2007, CORAL REEFS, V26, P725, DOI 10.1007/s00338-007-0252-8; Tsounis G, 2006, MAR BIOL, V149, P1059, DOI 10.1007/s00227-006-0302-8; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilkinson C., 2008, STATUS CORAL REEFS W, V2008, P5; Yang KL, 2012, J NAT PROD, V75, P935, DOI 10.1021/np300103w; Zhang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109118; Zhang XY, 2013, CURR MICROBIOL, V67, P525, DOI 10.1007/s00284-013-0394-6; Zuluaga-Montero A, 2010, AQUAT BIOL, V8, P151, DOI 10.3354/ab00218	51	28	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165992	10.1371/journal.pone.0165992	http://dx.doi.org/10.1371/journal.pone.0165992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902710	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100009
J	Uytingco, CR; Puche, AC; Munger, SD				Uytingco, Cedric R.; Puche, Adam C.; Munger, Steven D.			Using Intrinsic Flavoprotein and NAD(P)H Imaging to Map Functional Circuitry in the Main Olfactory Bulb	PLOS ONE			English	Article							CORTEX IN-VIVO; EXTERNAL TUFTED CELLS; FLUORESCENCE TRANSIENTS; LASER PHOTOSTIMULATION; MITOCHONDRIAL-FUNCTION; NEURONAL ACTIVATION; SURROUND INHIBITION; LATERAL INHIBITION; SENSORY NEURONS; ENERGY BUDGET	Neurons exhibit strong coupling of electrochemical and metabolic activity. Increases in intrinsic fluorescence from either oxidized flavoproteins or reduced nicotinamide adenine dinucleotide (phosphate) [NAD(P)H] in the mitochondria have been used as an indicator of neuronal activity for the functional mapping of neural circuits. However, this technique has not been used to investigate the flow of olfactory information within the circuitry of the main olfactory bulb (MOB). We found that intrinsic flavoprotein fluorescence signals induced by electrical stimulation of single glomeruli displayed biphasic responses within both the glomerular (GL) and external plexiform layers (EPL) of the MOB. Pharmacological blockers of mitochondrial activity, voltage-gated Na+ channels, or ionotropic glutamate receptors abolished stimulus-dependent flavoprotein responses. Blockade of GABAA receptors enhanced the amplitude and spatiotemporal spread of the flavoprotein signals, indicating an important role for inhibitory neurotransmission in shaping the spread of neural activity in the MOB. Stimulus-dependent spread of fluorescence across the GL and EPL displayed a spatial distribution consistent with that of individual glomerular microcircuits mapped by neuroanatomic tract tracing. These findings demonstrated the feasibility of intrinsic fluorescence imaging in the olfactory systems and provided a new tool to examine the functional circuitry of the MOB.	[Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Munger, Steven D.] Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA; [Uytingco, Cedric R.] Univ Florida, Dept Pharmacol & Therapeut, POB 100267, Gainesville, FL 32610 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Munger, SD (corresponding author), Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA.	steven.munger@ufl.edu		Uytingco, Cedric/0000-0003-1625-3988	National Institute of Deafness and Other Communicative Disorders [R01-DC005633]; National Institute of Neurological Disorders and Stroke [T32-NS063391]; National Institute of General Medical Sciences [T32-GM008181, T32-GM55036]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005633] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grant R01-DC005633 (SDM) National Institute of Deafness and Other Communicative Disorders. CRU received training support from T32-NS063391 (National Institute of Neurological Disorders and Stroke), T32-GM008181 (National Institute of General Medical Sciences), and T32-GM55036 (National Institute of General Medical Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould S, 1997, BIOCHEMISTRY-US, V36, P10178, DOI 10.1021/bi970549j; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Brennan AM, 2007, J NEUROSCI RES, V85, P3233, DOI 10.1002/jnr.21288; Brennan AM, 2006, J CEREBR BLOOD F MET, V26, P1389, DOI 10.1038/sj.jcbfm.9600292; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chery R, 2011, JOVE-J VIS EXP, DOI 10.3791/3336; Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Husson TR, 2007, J NEUROSCI, V27, P8665, DOI 10.1523/JNEUROSCI.2156-07.2007; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kikuta S, 2013, NEURON, V77, P1122, DOI 10.1016/j.neuron.2013.01.022; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kosaka T, 2005, NEUROSCIENCE, V134, P757, DOI 10.1016/j.neuroscience.2005.04.057; Kosaka T, 2008, NEUROSCI RES, V60, P349, DOI 10.1016/j.neures.2007.11.012; L'Heureux B, 2009, OPT EXPRESS, V17, P9477, DOI 10.1364/OE.17.009477; Liu SL, 2008, J NEUROSCI, V28, P10311, DOI 10.1523/JNEUROSCI.2608-08.2008; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Llano DA, 2012, J NEUROSCI, V32, P16141, DOI 10.1523/JNEUROSCI.2499-12.2012; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Mallik AK, 2008, VISION RES, V48, P1545, DOI 10.1016/j.visres.2008.04.014; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Migliore M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00050; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Murakami H, 2004, EUR J NEUROSCI, V19, P1352, DOI 10.1111/j.1460-9568.2004.03237.x; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; Nawroth JC, 2007, J NEUROSCI, V27, P9790, DOI 10.1523/JNEUROSCI.1415-07.2007; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Ratz JD, 2000, J PHARMACOL EXP THER, V293, P569; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Reinert KC, 2007, J NEUROSCI RES, V85, P3221, DOI 10.1002/jnr.21348; Reinert KC, 2011, CEREBELLUM, V10, P585, DOI 10.1007/s12311-011-0278-x; Schuchmann S, 2001, BRAIN RES PROTOC, V7, P267, DOI 10.1016/S1385-299X(01)00080-0; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shirley CH, 2010, BRAIN RES BULL, V81, P406, DOI 10.1016/j.brainresbull.2009.10.022; Shuttleworth CW, 2010, NEUROCHEM INT, V56, P379, DOI 10.1016/j.neuint.2009.12.015; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Theyel BB, 2011, NAT PROTOC, V6, P502, DOI 10.1038/nprot.2011.315; Theyel BB, 2010, NEUROREPORT, V21, P861, DOI 10.1097/WNR.0b013e32833d7cec; Uytingco CR, PLOS ONE FORTHCOMING; Wang X, 2009, NEUROSCIENCE, V162, P713, DOI 10.1016/j.neuroscience.2009.01.071; Whitesell JD, 2013, J NEUROSCI, V33, P1552, DOI 10.1523/JNEUROSCI.3410-12.2013; Yaseen MA, 2013, BIOMED OPT EXPRESS, V4, P307, DOI 10.1364/BOE.4.000307; Yuan Q, 2004, LEARN MEMORY, V11, P406, DOI 10.1101/lm.75204; Zhou ZS, 2006, EUR J NEUROSCI, V24, P1623, DOI 10.1111/j.1460-9568.2006.05076.x	62	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165342	10.1371/journal.pone.0165342	http://dx.doi.org/10.1371/journal.pone.0165342			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902689	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100001
J	Uytingco, CR; Puche, AC; Munger, SD				Uytingco, Cedric R.; Puche, Adam C.; Munger, Steven D.			Interglomerular Connectivity within the Canonical and GC-D/Necklace Olfactory Subsystems	PLOS ONE			English	Article							COMMISSURAL FIBER SYSTEMS; EXTERNAL TUFTED CELLS; SHORT-AXON CELLS; LATERAL INHIBITION; CHOLINE-ACETYLTRANSFERASE; SURROUND INHIBITION; LOCUS-COERULEUS; BULB CIRCUITS; RAT; ORGANIZATION	The mammalian main olfactory system contains several subsystems that differ not only in the receptors they express and the glomerular targets they innervate within the main olfactory bulb (MOB), but also in the strategies they use to process odor information. The canonical main olfactory system employs a combinatorial coding strategy that represents odorant identity as a pattern of glomerular activity. By contrast, the "GC-D/necklace" olfactory subsystem D formed by olfactory sensory neurons expressing the receptor guanylyl cyclase GC-D and their target necklace glomeruli (NGs) encircling the caudal MOB D is critical for the detection of a small number of semiochemicals that promote the acquisition of food preferences. The formation of these socially-transmitted food preferences requires the animal to integrate information about two types of olfactory stimuli: these specialized social chemosignals and the food odors themselves. However, the neural mechanisms with which the GC-D/necklace subsystem processes this information are unclear. We used stimulus-induced increases in intrinsic fluorescence signals to map functional circuitry associated with NGs and canonical glomeruli (CGs) in the MOB. As expected, CG-associated activity spread laterally through both the glomerular and external plexiform layers associated with activated glomeruli. Activation of CGs or NGs resulted in activity spread between the two types of glomeruli; there was no evidence of preferential connectivity between individual necklace glomeruli. These results support previous anatomical findings that suggest the canonical and GC-D/necklace subsystems are functionally connected and may integrate general odor and semiochemical information in the MOB.	[Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Munger, Steven D.] Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA; [Uytingco, Cedric R.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Munger, SD (corresponding author), Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA.	steven.munger@ufl.edu		Uytingco, Cedric/0000-0003-1625-3988	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC005633]; National Institute of General Medical Sciences (NIGMS) [GM008181, GM55036]; National Institute of Neurological Disorders and Stroke (NINDS) [NS063391]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005633] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders (NIDCD) grant, R01 DC005633 (SDM). CRU was supported in part by the National Institute of General Medical Sciences (NIGMS) training grants, GM008181 and GM55036, and National Institute of Neurological Disorders and Stroke (NINDS) training grant, NS063391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2013, CHEM SENSES, V38, P391, DOI 10.1093/chemse/bjt015; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Buonviso N, 1996, J NEUROPHYSIOL, V76, P2393, DOI 10.1152/jn.1996.76.4.2393; Cockerham RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004657; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Hayar A, 2007, J NEUROPHYSIOL, V98, P1052, DOI 10.1152/jn.01214.2006; ICHIKAWA T, 1986, J NEUROSCI, V6, P281; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Ma XF, 2004, J NEUROPHYSIOL, V92, P3192, DOI 10.1152/jn.00301.2004; MCLEAN JH, 1989, J COMP NEUROL, V285, P339, DOI 10.1002/cne.902850305; MCLEAN JH, 1987, J NEUROSCI, V7, P3029; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nagayama S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00098; OJIMA H, 1988, ANAT EMBRYOL, V178, P481, DOI 10.1007/BF00305035; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Perez-Gomez A, 2015, CURR BIOL, V25, P1340, DOI 10.1016/j.cub.2015.03.026; PRICE JL, 1970, J ANAT, V107, P215; PRICE JL, 1970, J CELL SCI, V7, P157; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; SHINODA K, 1993, BRAIN RES, V618, P160, DOI 10.1016/0006-8993(93)90440-X; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; Shirley CH, 2010, BRAIN RES BULL, V81, P406, DOI 10.1016/j.brainresbull.2009.10.022; SUR M, 1980, BRAIN RES, V198, P465, DOI 10.1016/0006-8993(80)90762-3; Theyel BB, 2011, NAT PROTOC, V6, P502, DOI 10.1038/nprot.2011.315; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2007, DEVELOPMENT, V134, P4063, DOI 10.1242/dev.008722; Whitesell JD, 2013, J NEUROSCI, V33, P1552, DOI 10.1523/JNEUROSCI.3410-12.2013; Won MH, 1998, NEUROSCI LETT, V243, P53; Zufall F, 2010, MOL CELL BIOCHEM, V334, P191, DOI 10.1007/s11010-009-0325-9	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165343	10.1371/journal.pone.0165343	http://dx.doi.org/10.1371/journal.pone.0165343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902696	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100002
J	Staples, KJ; Taylor, S; Thomas, S; Leung, S; Cox, K; Pascal, TG; Ostridge, K; Welch, L; Tuck, AC; Clarke, SC; Gorringe, A; Wilkinson, TMA				Staples, Karl J.; Taylor, Stephen; Thomas, Steve; Leung, Stephanie; Cox, Karen; Pascal, Thierry G.; Ostridge, Kristoffer; Welch, Lindsay; Tuck, Andrew C.; Clarke, Stuart C.; Gorringe, Andrew; Wilkinson, Tom M. A.			Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IGA; BACTERIAL; FREQUENCY; PROTEASES; SERUM	Non-typeable Haemophilus influenzae (NTHi) is a key pathogen in COPD, being associated with airway inflammation and risk of exacerbation. Why some patients are susceptible to colonisation is not understood. We hypothesised that this susceptibility may be due to a deficiency in mucosal humoral immunity. The aim of our study (NCT01701869) was to quantify the amount and specificity of antibodies against NTHi in the lungs and the associated risk of infection and inflammation in health and COPD. Phlebotomy, sputum induction and bronchoscopy were performed on 24 mild-to-moderate COPD patients and 8 age and smoking-matched controls. BAL (Bronchoalveolar lavage) total IgG1, IgG2, IgG3, IgM and IgA concentrations were significantly increased in COPD patients compared to controls. NTHi was detected in the lungs of 7 of the COPD patients (NTHi+ve-29%) and these patients had a higher median number of previous exacerbations than NTHi-ve patients as well as evidence of increased systemic inflammation. When comparing NTHi+ve versus NTHi-ve patients we observed a decrease in the amount of both total IgG1 (p = 0.0068) and NTHi-specific IgG1 (p = 0.0433) in the BAL of NTHi+ve patients, but no differences in total IgA or IgM. We observed no evidence of decreased IgG1 in the serum of NTHi+ve patients, suggesting this phenomenon is restricted to the airway. Furthermore, the NTHi+ve patients had significantly greater levels of IL-1 beta (p = 0.0003), in BAL than NTHi-ve COPD patients. This study indicates that the presence of NTHi is associated with reduced levels and function of IgG1 in the airway of NTHi-colonised COPD patients. This decrease in total and NTHI-specific IgG1 was associated with greater systemic and airway inflammation and a history of more frequent exacerbations and may explain the susceptibility of some COPD patients to the impacts of NTHi.	[Staples, Karl J.; Cox, Karen; Tuck, Andrew C.; Clarke, Stuart C.; Wilkinson, Tom M. A.] Univ Southampton, Fac Med, Southampton Gen Hosp, Clin & Expt Sci, Tremona Rd, Southampton, Hants, England; [Staples, Karl J.; Clarke, Stuart C.; Wilkinson, Tom M. A.] Univ Southampton, Fac Med, Southampton Gen Hosp, Wessex Invest Sci Hub, Tremona Rd, Southampton, Hants, England; [Taylor, Stephen; Thomas, Steve; Leung, Stephanie; Gorringe, Andrew] Publ Hlth England, Salisbury, Wilts, England; [Pascal, Thierry G.] GSK Vaccines, Wavre, Belgium; [Ostridge, Kristoffer; Welch, Lindsay; Clarke, Stuart C.; Wilkinson, Tom M. A.] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Tremona Rd, Southampton, Hants, England	University of Southampton; University of Southampton; Public Health England; GlaxoSmithKline; University of Southampton	Staples, KJ (corresponding author), Univ Southampton, Fac Med, Southampton Gen Hosp, Clin & Expt Sci, Tremona Rd, Southampton, Hants, England.; Staples, KJ (corresponding author), Univ Southampton, Fac Med, Southampton Gen Hosp, Wessex Invest Sci Hub, Tremona Rd, Southampton, Hants, England.	k.staples@southampton.ac.uk	Gorringe, Andrew R/L-6022-2017	Gorringe, Andrew R/0000-0003-2193-7954; Ostridge, Kristoffer/0000-0001-8910-3900; Leung, Stephanie/0000-0002-8880-2977; Welch, Lindsay/0000-0001-5564-2252; Wilkinson, Tom/0000-0003-1771-3851; Thomas, Stephen/0000-0003-2368-8058; Staples, Karl/0000-0003-3844-6457; Osman, Karen/0000-0002-8095-3850; Taylor, Stephen/0000-0002-9936-8539; Clarke, Stuart/0000-0002-7009-1548	GlaxoSmithKline Biologicals, SA, Belgium via a Collaborative Research & Development Agreement (CRADA)	GlaxoSmithKline Biologicals, SA, Belgium via a Collaborative Research & Development Agreement (CRADA)	This work was supported by GlaxoSmithKline Biologicals, SA, Belgium via a Collaborative Research & Development Agreement (CRADA). The funder provided support in the form of salaries for TGP and project management but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of TGP are articulated in the 'author contributions' section. No restrictions were placed on authors regarding the statements made in the manuscript.	Bafadhel M, 2015, INT J CHRONIC OBSTR, V10, P1075, DOI 10.2147/COPD.S80091; Brandsma CA, 2012, EUR RESPIR J, V40, P313, DOI 10.1183/09031936.00011211; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16; Freeman CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096421; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; GROENEVELD K, 1990, AM REV RESPIR DIS, V141, P1316, DOI 10.1164/ajrccm/141.5_Pt_1.1316; Hawdon N, 2012, VACCINE, V30, P1235, DOI 10.1016/j.vaccine.2011.12.113; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jalalvand F, 2014, VACCINE, V32, P2261, DOI 10.1016/j.vaccine.2014.02.082; Jung Y, 2015, MUCOSAL IMMUNOL, V8, P930, DOI 10.1038/mi.2014.123; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Ladjemi MZ, 2015, EUR RESPIR J, V45, P980, DOI 10.1183/09031936.00063914; Lee J, 2016, FASEB J; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Lugade AA, 2014, J IMMUNOL, V192, P5226, DOI 10.4049/jimmunol.1302584; McKendry RT, 2015, AM J RESP CRITICAL C; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILLER RD, 1979, AM REV RESPIR DIS, V119, P229; Murphy TF, 2015, J INFECT DIS, V212, P1798, DOI 10.1093/infdis/jiv299; Ostridge K, 2016, THORAX, V71, P126, DOI 10.1136/thoraxjnl-2015-207428; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042664; Sandstedt SA, 2008, J MICROBIOL METH, V75, P369, DOI 10.1016/j.mimet.2008.06.023; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Singh R, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0114-1; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090	38	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167250	10.1371/journal.pone.0167250	http://dx.doi.org/10.1371/journal.pone.0167250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898728	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000389474000042
J	Nugent, G; Yockney, IJ; Whitford, EJ; Cross, ML; Aldwell, FE; Buddle, BM				Nugent, Graham; Yockney, Ivor J.; Whitford, E. Jackie; Cross, Martin L.; Aldwell, Frank E.; Buddle, Bryce M.			Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula)	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; CALMETTE-GUERIN VACCINATION; ORAL RABIES VACCINATION; LIPID-FORMULATED BCG; BADGERS MELES-MELES; NEW-ZEALAND; IMMUNE-RESPONSES; EFFICACY; EPIDEMIOLOGY; PROTECTION	Oral-delivery Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine in a lipid matrix has been shown to confer protection against M. bovis infection and reduce the severity of tuberculosis (TB) when fed to brushtail possums (Trichosurus vulpecula), the major wildlife vector of bovine TB in New Zealand. Here we demonstrate the feasibility of aerial delivery of this live vaccine in bait form to an M. bovis-infected wild possum population, and subsequently assess vaccine uptake and field efficacy. Pre-trial studies indicated a resident possum population at very low density (<0.6 possums/ha) at the field site, with a 5.1% prevalence of macroscopic TB lesions. Pilot studies indicated that flavoured lipid matrix baits in weather-proof sachets could be successfully sown aerially via helicopter and were palatable to, and likely to be consumed by, a majority of wild possums under free-choice conditions. Subsequently, sachet-held lipid baits containing live BCG vaccine were sown at 3 baits/ha over a 1360 ha area, equating to >5 baits available per possum. Blood sampling conducted two months later provided some evidence of vaccine uptake. A necropsy survey conducted one year later identified a lower prevalence of culture-confirmed M. bovis infection and/or gross TB lesions among adult possums in vaccinated areas (1.1% prevalence; 95% CI, 0-3.3%, n = 92) than in unvaccinated areas (5.6%; 0.7-10.5%, n = 89); P = 0.098. Although not statistically different, the 81% efficacy in protecting possums against natural infection calculated from these data is within the range of previous estimates of vaccine efficacy in trials where BCG vaccine was delivered manually. We conclude that, with further straightforward refinement to improve free-choice uptake, aerial delivery of oral BCG vaccine is likely to be effective in controlling TB in wild possums. We briefly discuss contexts in which this could potentially become an important complementary tool in achieving national eradication of TB from New Zealand wildlife.	[Nugent, Graham; Yockney, Ivor J.; Whitford, E. Jackie; Cross, Martin L.] Landcare Res Manaaki Whenua, Lincoln, New Zealand; [Aldwell, Frank E.] Univ Otago, Ctr Innovat, Dunedin, New Zealand; [Buddle, Bryce M.] AgResearch, Hopkirk Inst, Palmerston North, New Zealand	Landcare Research - New Zealand; University of Otago; AgResearch - New Zealand	Nugent, G (corresponding author), Landcare Res Manaaki Whenua, Lincoln, New Zealand.	nugentg@landcareresearch.co.nz		Buddle, Bryce/0000-0001-6197-6689; Nugent, Graham/0000-0001-6223-8450	New Zealand Ministry for Science and Innovation [C09X0803]; OSPRI (TBfree programme) (Wellington, New Zealand)	New Zealand Ministry for Science and Innovation; OSPRI (TBfree programme) (Wellington, New Zealand)	This work was funded by the New Zealand Ministry for Science and Innovation (Contract C09X0803) with co-funding from OSPRI (TBfree programme) (Wellington, New Zealand). Neither body had any role in the study design, acquisition or analysis of data, decision to publish or presentation of results.	Aldwell FE, 2003, VACCINE, V22, P70, DOI 10.1016/S0264-410X(03)00539-5; Aldwell FE, 2003, INFECT IMMUN, V71, P101, DOI 10.1128/IAI.71.1.101-108.2003; [Anonymous], 2002, ORAL VACCINATION FOX, P1; [Anonymous], 2016, OSPRI TBFREE INFORM, P1; Aznar I, 2011, VET MICROBIOL, V151, P104, DOI 10.1016/j.vetmic.2011.02.032; Barlow ND, 2000, J ANIM ECOL, V69, P703, DOI 10.1046/j.1365-2656.2000.00428.x; Blackwell BF, 2004, J WILDLIFE DIS, V40, P222, DOI 10.7589/0090-3558-40.2.222; Buddle BM, 2006, NEW ZEAL VET J, V54, P224, DOI 10.1080/00480169.2006.36701; Buddle BM, 2015, NEW ZEAL VET J, V63, P19, DOI 10.1080/00480169.2014.929518; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; BUDDLE BM, 1992, NEW ZEAL VET J, V40, P155, DOI 10.1080/00480169.1992.35721; Byrom AE, 2008, LC0708110, P1; Byrom AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145636; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Clark S, 2008, INFECT IMMUN, V76, P3771, DOI 10.1128/IAI.00052-08; Coleman J.D., 1980, New Zealand Journal of Ecology, V3, P69; Coleman Jim, 2000, P92; Collins DM, 2007, VACCINE, V25, P4659, DOI 10.1016/j.vaccine.2007.04.014; Corner LAL, 2009, J WILDLIFE DIS, V45, P1042, DOI 10.7589/0090-3558-45.4.1042; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Corner LAL, 2002, RES VET SCI, V73, P145, DOI 10.1016/S0034-5288(02)00038-3; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Cousins DV, 2001, REV SCI TECH OIE, V20, P71, DOI 10.20506/rst.20.1.1263; Cowan Phil, 2000, P24; Cross ML, 2007, VET J, V174, P472, DOI 10.1016/j.tvjl.2006.10.005; Cross ML, 2009, J WILDLIFE DIS, V45, P754, DOI 10.7589/0090-3558-45.3.754; Cross ML, 2016, VERTEBRATE PEST RES, V27, P8; DEFRA, 2014, DEP ENV FOOD RUR AFF; Farry SC, 1998, J WILDLIFE DIS, V34, P23, DOI 10.7589/0090-3558-34.1.23; Freuling CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0142; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; Kaden V, 2002, BERL MUNCH TIERARZTL, V115, P179; Kelly DJ, 2011, EUR J WILDLIFE RES, V57, P767, DOI 10.1007/s10344-010-0485-7; Livingstone PG, 2015, NEW ZEAL VET J, V63, P4, DOI 10.1080/00480169.2014.971082; Livingstone PG, 2015, NEW ZEAL VET J, V63, P98, DOI 10.1080/00480169.2015.1013581; Mainguy J, 2013, J WILDLIFE DIS, V49, P190, DOI 10.7589/2011-11-342; More SJ, 2015, VET REC, V177, P224, DOI 10.1136/vr.103163; Murphy D, 2014, VET J, V200, P362, DOI 10.1016/j.tvjl.2014.02.031; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Nugent G, 2015, NEW ZEAL VET J, V63, P28, DOI 10.1080/00480169.2014.963791; Nugent G, 2015, NEW ZEAL VET J, V63, P54, DOI 10.1080/00480169.2014.963792; Nugent G, 2013, J COMP PATHOL, V148, P33, DOI 10.1016/j.jcpa.2012.05.006; Nugent G, 2012, EPIDEMIOL INFECT, V140, P1036, DOI 10.1017/S0950268811001579; Nugent G, 2002, J WILDLIFE DIS, V38, P665, DOI 10.7589/0090-3558-38.4.665; Nugent G, 2013, PREV VET MED, V109, P168, DOI 10.1016/j.prevetmed.2012.09.008; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; OSPRI, 2015, OP SOL PRIM IND ANN, P1; Ramsey DSL, 2009, TUBERCULOSIS, V89, P163, DOI 10.1016/j.tube.2008.11.002; Ramsey DS, 2004, LC0304068 AN HLTH BO, P1; Rosatte RC, 2001, J WILDLIFE DIS, V37, P730, DOI 10.7589/0090-3558-37.4.730; Rouco C, 2013, NEW ZEAL J ECOL, V37, P12; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Shwiff SA, 2009, J WILDLIFE DIS, V45, P227, DOI 10.7589/0090-3558-45.1.227; Skinner MA, 2005, RES VET SCI, V78, P231, DOI 10.1016/j.rvsc.2004.07.007; Spencer A, 2011, POLITICS-OXFORD, V31, P91, DOI 10.1111/j.1467-9256.2011.01407.x; Sweetapple P, 2011, NEW ZEAL J ECOL, V32, P152; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Tompkins DM, 2013, VACCINE, V31, P893, DOI 10.1016/j.vaccine.2012.12.003; Warburton B, 2015, NEW ZEAL VET J, V63, P77, DOI 10.1080/00480169.2014.981315; Warburton B, 2009, MANY POSSUMS ARE NOW, P1; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; WINTER JW, 1980, AUST WILDLIFE RES, V7, P359, DOI 10.1071/WR9800359; Wright J., 2011, EVALUATING USE 1080, P1; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289; Yockney IJ, 2015, LC2485 OSPRI LANDC R, P1; Yockney IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121865	70	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167144	10.1371/journal.pone.0167144	http://dx.doi.org/10.1371/journal.pone.0167144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893793	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400092
J	Perea, S; Vukic, J; Sanda, R; Doadrio, I				Perea, Silvia; Vukic, Jasna; Sanda, Radek; Doadrio, Ignacio			Ancient Mitochondrial Capture as Factor Promoting Mitonuclear Discordance in Freshwater Fishes: A Case Study in the Genus Squalius (Actinopterygii, Cyprinidae) in Greece	PLOS ONE			English	Article							INCIPIENT SPECIATION; INTROGRESSIVE HYBRIDIZATION; HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC NETWORKS; EVOLUTIONARY HISTORY; ALBURNOIDES COMPLEX; POROUS GENOMES; DNA; PELOPONNESE; OSTEICHTHYES	Hybridization and incomplete lineage sorting are common confounding factors in phylogeny and speciation resulting in mitonuclear disparity. Mitochondrial introgression, a particular case of hybridization, may, in extreme cases, lead to replacement of the mitochondrial genome of one species with that of another (mitochondrial capture). We investigated mitochondrial introgression involving two species of the cyprinid genus Squalius in the western Peloponnese region of Greece using molecular and morphological data. We found evidence of complete mitochondrial introgression of Squalius keadicus into two populations recognized as Squalius peloponensis from the Miras and Pamissos River basins and a divergence of mitochondrial genomes of S. keadicus from the Evrotas basin from that of the introgressed populations dating from the Pleistocene. Secondary contact among basins is a possible factor in connection of the species and the introgression event. Morphological analyses support the hypothesis of mitochondrial introgression, as S. keadicus was different from the other three populations recognized as S. peloponensis, although significant differences were found among the four populations. Isolation by geographical barriers arose during Pleistocene in the western Peloponnese were the source of the evolution of the two reciprocally monophyletic subclades found in the S. keadicus mitochondrial Glade, and the morphological differences found among the four populations. Along with the lack of structure in the nuclear genome in the three populations ascribed to S. peloponensis, this suggests an incipient speciation process occurring in these Squalius species in the western Peloponnese.	[Perea, Silvia; Doadrio, Ignacio] Museo Nacl Ciencias Nat CSIC, Biodivers & Evolutionary Grp, C Jose Gutierrez Abascal, Madrid, Spain; [Vukic, Jasna] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Sanda, Radek] Natl Museum, Dept Zool, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Charles University Prague; National Museum	Perea, S (corresponding author), Museo Nacl Ciencias Nat CSIC, Biodivers & Evolutionary Grp, C Jose Gutierrez Abascal, Madrid, Spain.	sperea2@gmail.com	Perea, Silvia/A-7620-2018; Doadrio, Ignacio/F-8448-2016; Vukic, Jasna/D-2811-2015	Perea, Silvia/0000-0003-0436-8577; Doadrio, Ignacio/0000-0003-4863-9711; Vukic, Jasna/0000-0003-2243-0303	Spanish Ministry of Economy and Competitiveness [CGL2013-41375-P]; Czech Science Foundation [GM 5-19382S]; SYNTHESYS Programme at the Museo Nacional de Ciencias Naturales (CSIC) - European Community Research Infrastructure Action under the FP7 "Capacities" Programme [ES-TAF-5255]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Czech Science Foundation(Grant Agency of the Czech Republic); SYNTHESYS Programme at the Museo Nacional de Ciencias Naturales (CSIC) - European Community Research Infrastructure Action under the FP7 "Capacities" Programme	This study was financially sponsored by the Spanish Ministry of Economy and Competitiveness (project CGL2013-41375-P) to ID and SP, the Czech Science Foundation (project GM 5-19382S) to JV and RS, and by the SYNTHESYS Programme project ES-TAF-5255 at the Museo Nacional de Ciencias Naturales (CSIC), financed by European Community Research Infrastructure Action under the FP7 "Capacities" Programme to RS.	Aboim MA, 2010, J EVOLUTION BIOL, V23, P817, DOI 10.1111/j.1420-9101.2010.01953.x; Aguilar A, 2009, MOL PHYLOGENET EVOL, V51, P373, DOI 10.1016/j.ympev.2008.11.028; Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; [Anonymous], 2007, TRACER V 1 6; Athanassas C, 2010, THESIS; Athanassas C, 2013, J EARTH SCI-CHINA, V24, P410, DOI 10.1007/s12583-013-0334-1; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Bohme M., 2003, FOSFARBASE; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Broughton RE, 2011, GENETICA, V139, P699, DOI 10.1007/s10709-011-9578-9; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryson RW, 2014, ZOOL J LINN SOC-LOND, V172, P103, DOI 10.1111/zoj12169; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; CABRERA L, 1985, Acta Geologica Hispanica, V20, P219; Chan KMA, 2005, EVOLUTION, V59, P720; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Cunha C, 2004, MOL ECOL, V13, P2807, DOI 10.1111/j.1365-294X.2004.02283.x; Cunha C, 2004, J EVOLUTION BIOL, V22, P718; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Cuvier G, 1844, CYPRINOIDES, V17, P487; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doadrio I., 2007, Graellsia, V63, P89; Doadrio I, 1998, J FISH BIOL, V53, P591, DOI 10.1111/j.1095-8649.1998.tb01004.x; Durand JD, 2000, P ROY SOC B-BIOL SCI, V267, P1687; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Fountoulis I, 2014, B GEOFIS TEOR APPL, V55, P303, DOI 10.4430/bgta0074; Fountoulis I, 2008, Z DTSCH GES GEOWISS, V159, P485, DOI 10.1127/1860-1804/2008/0159-0485; Freyhof J, 2005, MOL PHYLOGENET EVOL, V37, P347, DOI 10.1016/j.ympev.2005.07.018; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaudant J, 1977, CIENCIAS TERRA, V3, P129; Geiger MF, 2016, J FISH BIOL, V88, P1038, DOI 10.1111/jfb.12871; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Harper DAT, 2001, PALEONTOLOGICAL ELEC, V41; HUDSON RR, 1987, GENETICS, V116, P153; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jan C. C., 2002, Helia, V25, P123, DOI 10.2298/HEL0236123J; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Knudsen R, 2006, P ROY SOC B-BIOL SCI, V273, P2291, DOI 10.1098/rspb.2006.3582; Kokkalas S, 2006, GEOL SOC AM SPEC PAP, V409, P97, DOI 10.1130/2006.2409(06); Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Koukouvelas IK, 2010, INT GEOL REV, V52, P249, DOI 10.1080/00206810802674329; Kumar S, 2015, MOL BIOL EVOL UNPUB; Leache AD, 2006, MOL PHYLOGENET EVOL, V39, P628, DOI 10.1016/j.ympev.2005.12.016; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Ludwig A, 2003, MOL ECOL, V12, P3253, DOI 10.1046/j.1365-294X.2003.01999.x; Machordom A, 1990, AQUAT LIVING RESOUR, V3, P295, DOI 10.1051/alr:1990030; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Magalhaes IS, 2009, J EVOLUTION BIOL, V22, P260, DOI 10.1111/j.1420-9101.2008.01637.x; Markova S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069497; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Ntageretzis K, 2015, Z GEOMORPHOL, V59, P253, DOI 10.1127/zfg_suppl/2015/S-00207; Papanikolaou D, 2007, QUATERN INT, V171-72, P14, DOI 10.1016/j.quaint.2007.04.005; Perdices A, 2003, MOL PHYLOGENET EVOL, V26, P289, DOI 10.1016/S1055-7903(02)00334-2; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Rabosky DL, 2009, MOL PHYLOGENET EVOL, V53, P368, DOI 10.1016/j.ympev.2009.06.020; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; ROHLF FJ, 1987, SYST ZOOL, V36, P356, DOI 10.2307/2413400; Rosenberg NA, 2013, MOL BIOL EVOL; Sanjur OI, 2003, MOL PHYLOGENET EVOL, V29, P20, DOI 10.1016/S1055-7903(03)00088-5; Sinama M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-22; Sousa-Santos C, 2006, J FISH BIOL, V68, P292, DOI 10.1111/j.0022-1112.2006.01081.x; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang QY, 2012, ZOOL SCR, V41, P233, DOI 10.1111/j.1463-6409.2011.00530.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vila M, 2005, MOL PHYLOGENET EVOL, V36, P249, DOI 10.1016/j.ympev.2005.02.019; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Willis SC, 2014, EVOLUTION, V68, P256, DOI 10.1111/evo.12230; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	86	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166292	10.1371/journal.pone.0166292	http://dx.doi.org/10.1371/journal.pone.0166292			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906993	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700022
J	Yang, JY; Yang, X; Li, Y; Xu, J; Zhou, Y; Wang, AX; Gao, X; Xu, L; Wu, SL; Wei, WB; Zhao, XQ; Jonas, JB				Yang, Jing Yan; Yang, Xuan; Li, Yang; Xu, Jie; Zhou, Yong; Wang, An Xin; Gao, Xiang; Xu, Liang; Wu, Shou Ling; Wei, Wen Bin; Zhao, Xing Quan; Jonas, Jost B.			Carotid Atherosclerosis, Cerebrospinal Fluid Pressure, and Retinal Vessel Diameters: The Asymptomatic Polyvascular Abnormalities in Community Study	PLOS ONE			English	Article							FIBER LAYER DEFECTS; MICROVASCULAR ABNORMALITIES; ARTERIAL-HYPERTENSION; BEIJING EYE; VENULAR DIAMETER; RISK; THICKNESS; STROKE	Purpose To assess relationships between carotid artery atherosclerosis and retinal arteriolar and venular diameters. Methods The community-based longitudinal Asymptomatic Polyvascular Abnormalities Community Study (APAC) included a sub-population of the Kailuan study which consisted of 101,510 employees and retirees of a coal mining industry. Based on the Chinese National Census 2010 and excluding individuals with history of cerebrovascular ischemic events, 4004 individuals were included into the APAC. All participants underwent a detailed clinical examination including blood laboratory tests and carotid artery duplex ultrasound examination. The cerebrospinal fluid pressure (CSFP) was estimated using the formula: CSFP[mmHg] = 0.44xBody Mass Index[kg/m(2)]+ 0.16xDiastolic Blood Pressure[mmHg]-0.18 x Age[Years]-1.91. Results In multivariable analysis (goodness of fit r(2) : 0.12), thicker retinal arteries were associated with a thinner common carotid artery intima-media thickness (IMT) (P = 0.002; standardized regression coefficient beta:-0.06; non-standardized regression coefficient B:-6.92; 95% confidence interval (CI):-11.2,-2.61) after adjusting for thicker retinal nerve fiber layer (P< 0.001; beta: 0.18; B: 0.35; 95% CI: 0.28,0.42), lower diastolic blood pressure (P<0.001; beta:-0.16; B:-0.17; 95% CI:-0.21,-0.3), younger age (P<0.001; beta:-0.08; B:-0.16; 95%; CI:-0.25,-0.08), and less abdominal circumference (P = 0.003; beta:-0.06; B:-0.11; 95% CI:-0.18,-0.03). Thicker retinal vein diameter was associated (r = 0.40) with higher estimated CSFP (P<0.001; beta: 0.09; B: 0.78; 95% CI: 0.47,1.08) after adjusting for wider retinal arteries (P<0.001; beta: 0.27; B: 0.36; 95% CI: 0.31,0.41), thicker retinal nerve fiber layer thickness (P = 0.03; beta: 0.22; B: 0.56; 95% CI: 0.46,0.65) and male gender (P<0.001; beta:-0.08; B:-3.98; 95% CI:-5.88,2.09). Conclusions Thinner retinal artery diameter was significantly, however weakly, associated with increased common carotid artery IMT. It suggests that retinal microvascular changes were only week indicators for an atherosclerotic carotid artery pathology. Thicker retinal vein diameter was associated with higher estimated CSFP, confirming associations between higher estimated CSFP and higher incidence of retinal vein occlusion.	[Yang, Jing Yan; Yang, Xuan; Li, Yang; Xu, Jie; Wei, Wen Bin] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Zhou, Yong; Wang, An Xin; Zhao, Xing Quan] Capital Med Univ, Beijing TianTan Hosp, Dept Neurol, Beijing, Peoples R China; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Med Sch, Boston, MA USA; [Gao, Xiang] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Ophthalmol & Visual Sci K, Beijing, Peoples R China; [Wu, Shou Ling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Capital Medical University; North China University of Science & Technology; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.; Zhao, XQ (corresponding author), Capital Med Univ, Beijing TianTan Hosp, Dept Neurol, Beijing, Peoples R China.; Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; tr_weiwenbin@163.com; zxq@vip.163.com	Xu, Jie/AIE-0524-2022; wei, wei/HHR-8613-2022; xu, jie/GQR-1913-2022	xu, jie/0000-0002-2039-7055; , Xiang/0000-0003-2617-6509	Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20150201]; Science & Technology Project of Beijing Municipal Science & Technology Commission [Z151100001615052]; National Natural Science Foundation of China [81570891, 81272981]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; Beijing Natural Science Foundation [7151003]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]	Beijing Municipal Administration of Hospitals' Ascent Plan; Science & Technology Project of Beijing Municipal Science & Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau	This work was supported by the Beijing Municipal Administration of Hospitals' Ascent Plan (code: DFL20150201); Science & Technology Project of Beijing Municipal Science & Technology Commission (code: Z151100001615052); National Natural Science Foundation of China (Nr. 81570891 and Nr. 81272981); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307); Beijing Natural Science Foundation (Nr.7151003); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuspidi C, 2004, J HYPERTENS, V22, P2095, DOI 10.1097/00004872-200411000-00010; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Hanff TC, 2014, STROKE, V45, P1012, DOI 10.1161/STROKEAHA.113.004166; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P178, DOI 10.1159/000309998; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; JONAS JB, 1993, INVEST OPHTH VIS SCI, V34, P2260; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1604; Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P361, DOI 10.1136/bjo.87.3.361-a; Jonas JB, 1997, AM J OPHTHALMOL, V124, P488, DOI 10.1016/S0002-9394(14)70864-5; Jonas JB, 2015, ACTA OPHTHALMOL, V93, pE522, DOI 10.1111/aos.12575; Jonas JB, 2014, INVEST OPHTH VIS SCI, V55, P1292, DOI 10.1167/iovs.13-13351; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Miller RG, 2009, AM J OPHTHALMOL, V147, P653, DOI 10.1016/j.ajo.2008.10.004; Myers CE, 2012, OPHTHALMOLOGY, V119, P2563, DOI 10.1016/j.ophtha.2012.06.038; Torres FS, 2013, ATHEROSCLEROSIS, V229, P134, DOI 10.1016/j.atherosclerosis.2013.04.019; Wang AX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113205; Wang DD, 2014, STROKE, V45, P1651, DOI 10.1161/STROKEAHA.113.004629; Wang S, 2012, OPHTHALMOLOGY, V119, P2592, DOI 10.1016/j.ophtha.2012.06.031; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Xu L, 2013, AM J HYPERTENS, V26, P511, DOI 10.1093/ajh/hps081; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685	23	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166993	10.1371/journal.pone.0166993	http://dx.doi.org/10.1371/journal.pone.0166993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907041	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700060
J	Zhang, HY; Sun, LL; Wang, K; Wu, D; Trappio, M; Witting, C; Cao, K				Zhang, Haoyue; Sun, Linlin; Wang, Kun; Wu, Di; Trappio, Mason; Witting, Celeste; Cao, Kan			Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; RADIATION SENSITIVITY; DEFECTIVE MATURATION; GENOMIC INSTABILITY; IONIZING-RADIATION; MOUSE MODEL; PRELAMIN-A; CELL-CYCLE	Compelling evidence suggests that defective DNA damage response (DDR) plays a key role in the premature aging phenotypes in Hutchinson-Gilford progeria syndrome (HGPS). Studies document widespread alterations in histone modifications in HGPS cells, especially, the global loss of histone H3 trimethylated on lysine 9 (H3K9me3). In this study, we explore the potential connection(s) between H3K9me3 loss and the impaired DDR in HGPS. When cells are exposed to a DNA-damaging agent Doxorubicin (Dox), double strand breaks (DSBs) are generated that result in the phosphorylation of histone H2A variant H2AX (gammaH2AX) within an hour. We find that the intensities of gammaH2AX foci appear significantly weaker in the G0/G1 phase HGPS cells compared to control cells. This reduction is associated with a delay in the recruitment of essential DDR factors. We further demonstrate that ataxia-telangiectasia mutated (ATM) is responsible for the amplification of gammaH2AX signals at DSBs during G0/G1 phase, and its activation is inhibited in the HGPS cells that display significant loss of H3K9me3. Moreover, methylene (MB) blue treatment, which is known to save heterochromatin loss in HGPS, restores H3K9me3, stimulates ATM activity, increases gammaH2AX signals and rescues deficient DDR. In summary, this study demonstrates an early DDR defect of attenuated gammaH2AX signals in G0/G1 phase HGPS cells and provides a plausible connection between H3K9me3 loss and DDR deficiency.	[Zhang, Haoyue; Sun, Linlin; Wang, Kun; Wu, Di; Trappio, Mason; Witting, Celeste; Cao, Kan] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Wang, Kun] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Cao, K (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	kcao@umd.edu			NIH/NHLBI [R01HL126784]; Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126784] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI Grant R01HL126784 (KC) and by an exploratory grant from the Maryland Stem Cell Research Fund (KC).	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Booth EA, 2015, SOFT MATTER, V11, P6412, DOI 10.1039/c5sm00521c; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Felgentreff K, 2014, P NATL ACAD SCI USA, V111, P8889, DOI 10.1073/pnas.1323649111; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Hartlerode AJ, 2015, NAT STRUCT MOL BIOL, V22, P736, DOI 10.1038/nsmb.3072; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lee Jong-Soo, 2007, Cancer Res Treat, V39, P125, DOI 10.4143/crt.2007.39.3.125; Liu BH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2885; Liu BH, 2013, AGING CELL, V12, P316, DOI 10.1111/acel.12035; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Musich PR, 2011, BIOCHEM SOC T, V39, P1764, DOI 10.1042/BST20110687; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xiong ZM, 2015, AGING CELL; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE2261, DOI 10.1073/pnas.1320843111; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	65	17	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167454	10.1371/journal.pone.0167454	http://dx.doi.org/10.1371/journal.pone.0167454			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907109	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700162
J	Zhao, XY; Jiang, ZZ; Yang, F; Wang, Y; Gao, XM; Wang, YF; Chai, X; Pan, GX; Zhu, Y				Zhao, Xiaoya; Jiang, Zhenzuo; Yang, Fan; Wang, Yan; Gao, Xiumei; Wang, Yuefei; Chai, Xin; Pan, Guixiang; Zhu, Yan			Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; BUTYRATE; METABOLITES; SPECTRUM; OLIGOSACCHARIDES; IDENTIFICATION; FERMENTATION; AZITHROMYCIN; SPECTROMETRY; PROPIONATE	Short-chain fatty acids (SCFAs), produced by anaerobic fermentation of mainly indigestible dietary carbohydrates by gut microbiota, have a profound influence on intestinal function and host energy metabolism. Antibiotics may seriously disturb the balance of fecal SCFAs. To evaluate the impacts of antibiotics on fecal SCFAs produced by gut microbiota, a simple, reproducible and accurate gas chromatography (GC) method, which can simultaneously analyze seven SCFAs in fecal samples, was developed and validated. The ranges of detection and quantitation of the SCFAs reached 0.0868 similar to 0.393 and 0.261 similar to 1.18 mu g.mL(-1) respectively, in an optimized protocol for SCFAs extraction and analysis that used 10 mL 75% ethanol aqueous solution containing 1% HCl, without ultrasonication. The technique exhibited excellent intra-day (relative standard deviation (RSD) <= 2.54%) and inter-day (RSD <= 4.33%) precisions for all the SCFAs. Later, we administered broad-spectrum antibiotics, cefdinir or azithromycin to rats and analyzed the alterations in fecal SCFAs. The total amount, types and distribution of nearly all fecal SCFAs were significantly altered during the administration and even after withdrawal of the antibiotics in rats. The effects of cefdinir on the SCFAs were more pronounced than those of azithromycin. Our findings suggest SCFAs may serve as sensitive indicators to monitor the influences of antibiotics on SCFAs originated by intestinal bacteria. Our improved SCFAs analysis method is a potential platform for a standard clinical test of the effects of new antibiotics on SCFAs.	[Zhao, Xiaoya; Jiang, Zhenzuo; Yang, Fan; Wang, Yan; Gao, Xiumei; Wang, Yuefei; Chai, Xin; Pan, Guixiang; Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Zhao, Xiaoya; Jiang, Zhenzuo; Yang, Fan; Wang, Yan; Wang, Yuefei; Chai, Xin; Pan, Guixiang; Zhu, Yan] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine	Wang, YF; Zhu, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Wang, YF; Zhu, Y (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China.	wangyuefei_2006@hotmail.com; yanzhu.harvard@icloud.com	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936	National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2015ZX09J15102-004-004, 2013ZX09201020]	National Science and Technology Major Projects for "Major New Drugs Innovation and Development"	This work was supported by grants from the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (No. 2015ZX09J15102-004-004 and 2013ZX09201020).	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arboleya S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050649; Arellano M, 2000, J CHROMATOGR B, V741, P89, DOI 10.1016/S0378-4347(00)00066-9; Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cheng HH, 2000, J NUTR, V130, P1991, DOI 10.1093/jn/130.8.1991; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Destandau E, 2005, J CHROMATOGR A, V1088, P49, DOI 10.1016/j.chroma.2005.01.002; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Guay DRP, 2002, CLIN THER, V24, P473, DOI 10.1016/S0149-2918(02)85125-6; HOVERSTAD T, 1986, SCAND J GASTROENTERO, V21, P621, DOI 10.3109/00365528609003109; Iraporda C, 2015, IMMUNOBIOLOGY, V220, P1161, DOI 10.1016/j.imbio.2015.06.004; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Ketabi A, 2011, J APPL MICROBIOL, V110, P1297, DOI 10.1111/j.1365-2672.2011.04984.x; Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136; Lagkouvardos I, 2015, MOL NUTR FOOD RES, V59, P1614, DOI 10.1002/mnfr.201500125; LEVISON ME, 1973, INFECT IMMUN, V8, P30, DOI 10.1128/IAI.8.1.30-35.1973; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Meyer D, 2009, EUR J CLIN NUTR, V63, P1277, DOI 10.1038/ejcn.2009.64; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Morrison DJ, 2004, RAPID COMMUN MASS SP, V18, P2593, DOI 10.1002/rcm.1662; MURASE M, 1995, J CHROMATOGR B, V664, P415, DOI 10.1016/0378-4347(94)00491-M; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; RASMUSSEN HS, 1988, SCAND J GASTROENTERO, V23, P178, DOI 10.3109/00365528809103964; RETSEMA J, 1987, ANTIMICROB AGENTS CH, V31, P1939, DOI 10.1128/AAC.31.12.1939; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; Ruuskanen O, 2004, PEDIATR INFECT DIS J, V23, pS135, DOI 10.1097/01.inf.0000112528.75956.41; Sako T, 1999, INT DAIRY J, V9, P69, DOI 10.1016/S0958-6946(99)00046-1; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; SCHEPPACH W, 1995, EUR J CANCER, V31A, P1077, DOI 10.1016/0959-8049(95)00165-F; Schneider SM, 2005, WORLD J GASTROENTERO, V11, P6165, DOI 10.3748/wjg.v11.i39.6165; Tangerman A, 1996, ANAL BIOCHEM, V236, P1, DOI 10.1006/abio.1996.0123; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; van Eijk HMH, 2009, J CHROMATOGR B, V877, P719, DOI 10.1016/j.jchromb.2009.01.039; Westerbeek EAM, 2013, EUR J CLIN MICROBIOL, V32, P269, DOI 10.1007/s10096-012-1739-y; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Zambell KL, 2003, J NUTR, V133, P3509, DOI 10.1093/jn/133.11.3509; Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	48	33	34	9	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167032	10.1371/journal.pone.0167032	http://dx.doi.org/10.1371/journal.pone.0167032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907030	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700067
J	Zimmermann, S; Klusmann, D; Hampe, W				Zimmermann, Stefan; Klusmann, Dietrich; Hampe, Wolfgang			Are Exam Questions Known in Advance? Using Local Dependence to Detect Cheating	PLOS ONE			English	Article							ITEM; PERFORMANCE; INDEXES	Cheating is a common phenomenon in high stakes admission, licensing and university exams and threatens their validity. To detect if some exam questions had been affected by cheating, we simulated how data would look like if some test takers possessed item pre knowledge: Responses to a small number of items were set to correct for 1-10% of test takers. Item difficulty, item discrimination, item fit, and local dependence were computed using an IRT 2PL model. Then changes in these item properties from the non-compromised to the compromised dataset were scrutinized for their sensitivity to item preknowledge. A decline in the discrimination parameter compared with previous test versions and an increase in local item dependence turned out to be the most sensitive indicators of item preknowledge. A multiplicative combination of shifts in item discrimination, item difficulty, and local item dependence detected item preknowledge with a sensitivity of 1.0 and a specificity of.95 if 11 of 80 items were preknown to 10% of the test takers. Cheating groups smaller than 5% of the test takers were not detected reliably. In the discussion, we outline an effective search for items affected by cheating, which would enable faculty staff without IRT knowledge to detect compromised items and exclude them from scoring.	[Zimmermann, Stefan; Klusmann, Dietrich; Hampe, Wolfgang] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Zimmermann, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	st.zimmermann@uke.de	Zimmermann, Stefan/M-4688-2018	Zimmermann, Stefan/0000-0002-8904-9024	Federal Ministry of Education and Research in Germany (BMBF) [01PL12033]	Federal Ministry of Education and Research in Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This project is funded by the Federal Ministry of Education and Research in Germany (BMBF), funding code 01PL12033. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN; [Anonymous], 1997, NY TIMES; [Anonymous], 2010, ETH PRINC PSYCH COD; Belov D.I., 2014, J COMPUTERIZED ADAPT, V2, P37, DOI DOI 10.7333/1410-0203037; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.2307/1165285; Colton GD, 1997, HIGH TECH APPROACHES; De Ayala R.J., 2009, THEORY PRACTICE ITEM; Embretson S, 2000, MULTIVARIATE APPL BO; Foster D., 2013, HDB TEST SECURITY, P39; HAINES VJ, 1986, RES HIGH EDUC, V25, P342, DOI 10.1007/BF00992130; Hissbach JC, 2011, BMC MED EDUC, P11; McCabe DL, 2001, ETHICS BEHAV, V11, P219, DOI 10.1207/S15327019EB1103_2; MCCORMICK WT, 1972, OPER RES, V20, P993, DOI 10.1287/opre.20.5.993; McLeod L, 2003, APPL PSYCH MEAS, V27, P121, DOI 10.1177/0146621602250534; McManus IC, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-204; Meade AW, 2012, J APPL PSYCHOL, V97, P1016, DOI 10.1037/a0027934; Meijer RR, 2015, ASSESSMENT; Michaelides MP, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00167; Murphy KL, 2015, J CHEM EDUC, V92, P1431, DOI 10.1021/acs.jchemed.5b00637; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Orlando M, 2000, APPL PSYCH MEAS, V24, P48; Shu Z, 2013, PSYCHOMETRIKA, V78, P481, DOI [10.1007/s11336-012-9311-3, 10.1007/S11336-012-9311-3]; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; Wood TJ, 2010, EVAL HEALTH PROF, V33, P96, DOI 10.1177/0163278709356192; YEN WM, 1993, J EDUC MEAS, V30, P187, DOI 10.1111/j.1745-3984.1993.tb00423.x	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167545	10.1371/journal.pone.0167545	http://dx.doi.org/10.1371/journal.pone.0167545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907190	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700188
J	Luo, W; Sandy, J; Trella, K; Gorski, D; Gao, SG; Li, J; Brounts, S; Galante, J; Plaas, A				Luo, Wei; Sandy, John; Trella, Katie; Gorski, Daniel; Gao, Shuguang; Li, Jun; Brounts, Sabrina; Galante, Jorge; Plaas, Anna			Degenerative Suspensory Ligament Desmitis (DSLD) in Peruvian Paso Horses Is Characterized by Altered Expression of TGF beta Signaling Components in Adipose-Derived Stromal Fibroblasts	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; AGGRECAN ACCUMULATION; TENDINOPATHY; RISK; ADAMTS5; GENES; CELLS; MODEL	Equine degenerative suspensory ligament desmitis (DSLD) in Peruvian Paso horses typically presents at 7-15 years and is characterized by lameness, focal disorganization of collagen fibrils, and chondroid deposition in the body of the ligament. With the aim of developing a test for disease risk (that can be used to screen horses before breeding) we have quantified the expression of 76 TGF beta-signaling target genes in adipose-derived stromal fibroblasts (ADSCs) from six DSLD-affected and five unaffected Paso horses. Remarkably, 35 of the genes showed lower expression (p<0.05) in cells from DSLD-affected animals and this differential was largely eliminated by addition of exogenous TGF beta 1. More-over, TGF beta 1-mediated effects on expression were prevented by the TGF beta R1/2 inhibitor LY2109761, showing that the signaling was via a TGF beta R1/2 complex. The genes affected by the pathology indicate that it is associated with a generalized metabolic disturbance, since some of those most markedly altered in DSLD cells (ATF3, MAPK14, ACVRL1 (ALK1), SMAD6, FOS, CREBBP, NFKBIA, and TGFBR2) represent master-regulators in a wide range of cellular metabolic responses.	[Luo, Wei; Gorski, Daniel; Gao, Shuguang; Li, Jun; Plaas, Anna] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Sandy, John; Galante, Jorge; Plaas, Anna] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Trella, Katie] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Sandy, John] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Brounts, Sabrina] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Luo, Wei] Cent S Univ, Dept Orthoped, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Trella, Katie] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Gorski, Daniel] Heinrich Heine Univers, Inst Pharmakol & Klin Pharmakol, Dusseldorf, Germany	Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Wisconsin System; University of Wisconsin Madison; Central South University; Colorado State University	Plaas, A (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.; Plaas, A (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	aplaas@gmail.com		Gorski, Daniel/0000-0001-9734-7008; Brounts, Sabrina/0000-0001-8748-7912	Rush Arthritis Institute; Katz/Rubschlager Endowed Chair	Rush Arthritis Institute; Katz/Rubschlager Endowed Chair	This study received funding from the Rush Arthritis Institute and the Katz/Rubschlager Endowed Chair. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbah SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20922; Ashley SL, 2016, MUCOSAL IMMUNOLOGY; Bell R, 2013, J BIOMECH, V46, P498, DOI 10.1016/j.jbiomech.2012.10.020; BROWN CT, 1995, J CELL BIOCHEM, V59, P57, DOI 10.1002/jcb.240590108; Danielpour D, 1989, GROWTH FACTORS, V2, P61, DOI 10.3109/08977198909069082; Fenwick SA, 2001, J ANAT, V199, P231, DOI 10.1046/j.1469-7580.2001.19930231.x; Gibson KT, 2002, EQUINE VET EDUC, V14, P39, DOI 10.1111/j.2042-3292.2002.tb00137.x; Gorski DJ, 2015, MATRIX BIOL J INT SO; Halper Jaroslava, 2006, BMC Vet Res, V2, P12, DOI 10.1186/1746-6148-2-12; Halper J, 2011, PAK VET J, V31, P1; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Kim B, 2010, ARCH BIOCHEM BIOPHYS, V501, P221, DOI 10.1016/j.abb.2010.06.017; Li C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157181; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Lombana KG, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00067; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mero JL, 2005, J EQUINE VET SCI, V25, P224, DOI 10.1016/j.jevs.2005.04.001; Monestier O, 2016, WFIKKN1 WFIKKN2 COMP; Trinh NT, 2016, STEM CELLS DEV, V25, P760, DOI 10.1089/scd.2015.0335; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; Prantl L, 2016, PLAST RECONSTR SURG, V137, P1181, DOI 10.1097/PRS.0000000000002013; Saunders CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19820; Saunders CJ, 2015, J ORTHOP RES, V33, P898, DOI 10.1002/jor.22820; Sayegh ET, 2015, RECENT SCI ADV DEV T, V4, P128, DOI [10.2174/2211542004666150713190231, DOI 10.2174/2211542004666150713190231]; Schenkman D, 2009, J EQUINE VET SCI, V29; Strong DI, 2005, USE WHOLE GENOME SCA; Taga Y, 2016, J BIOL CHEM, V291, P837, DOI 10.1074/jbc.M115.686105; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trella KJ, 2016, T ORTHOP RES; Tully LJ, 2014, EQUINE VET J, V46, P289, DOI 10.1111/evj.12134; Vandenberghe A, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00049; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Wang VM, 2012, J ORTHOP RES, V30, P620, DOI 10.1002/jor.21558; Wang WB, 2015, CONNECT TISSUE RES, V56, P288, DOI 10.3109/03008207.2015.1023433; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042	36	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167069	10.1371/journal.pone.0167069	http://dx.doi.org/10.1371/journal.pone.0167069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902739	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474100048
J	Eichenberger, PA; Scherer, TA; Spengler, CM				Eichenberger, Philipp A.; Scherer, Thomas A.; Spengler, Christina M.			Pre-Exercise Hyperpnea Attenuates Exercise Induced Bronchoconstriction Without Affecting Performance	PLOS ONE			English	Article							WARM-UP EXERCISE; INDUCED ASTHMA; REFRACTORY PERIOD; MUSCLE FATIGUE; INDOMETHACIN; RESISTANCE; TOLERANCE; SYMPTOMS; MANNITOL	Whole-body warm-up exercises were shown to attenuate exercise-induced bronchoconstriction (EIB). Whether intense pre-exercise hyperpnea offers similar protection and whether this might negatively affect exercise performance is unknown. Nine subjects with EIB (25 +/- 5 yrs; forced expiratory volume in 1s [FEV1], 104 +/- 15% predicted) performed an exercise challenge (ECh) followed after 30min by a constant-load cycling test to exhaustion. The ECh was preceded by one of four conditions: by i) control warm-up (CON) or by 10min of normocapnic hyperpnea with partial rebreathing at either ii) 50% (WU50) or iii) variable intensity (8x 30s-80%/45s-30%; WU80/30), or at iv) 70% (WU70) of maximal voluntary ventilation. FEVi was measured at baseline and in 5-min intervals until 15min after CON/ warm-up and 30min after ECh. None of the warm-up conditions induced EIB. The maximal post-ECh decrease in FEVi was-13.8 +/- 3.1% after CON,-9.3 +/- 5.0% after WU50 (p = 0.081 vs. CON),-8.6 +/- 7.5% after WU80/30 (p = 0.081 vs. CON) and-7.2 +/- 5.0% after WU70 (p = 0.006 vs. CON), and perception of respiratory exertion was significantly attenuated (all p <= 0.048), with no difference between warm-up conditions. Only after CON, FEVi remained significantly reduced up to the start of the cycling endurance test (-8.0 +/- 4.3%, p = 0.004). Cycling performance did not differ significantly between test days (CON: 13 +/- 7min; WU50: 14 +/- 9min; WU80/30: 13 +/- 9min; WU70: 14 +/- 7min; p = 0.582). These data indicate that intense hyperpnea warm-up is effective in attenuating EIB severity and accelerating lung function recovery while none of the warm-up condition do compromise cycling performance.	[Eichenberger, Philipp A.; Spengler, Christina M.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Exercise Physiol Lab, Zurich, Switzerland; [Scherer, Thomas A.] LungenZentrum Hirslanden, Zurich, Switzerland; [Spengler, Christina M.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Spengler, CM (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Exercise Physiol Lab, Zurich, Switzerland.; Spengler, CM (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	christina.spengler@hest.ethz.ch	Spengler, Christina M./E-9776-2012	Spengler, Christina M./0000-0002-4598-3595	Swiss Federal Office of Sport [12-07]	Swiss Federal Office of Sport	This work was supported by Swiss Federal Office of Sport (grant no. 12-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	BENDOV I, 1983, THORAX, V38, P849, DOI 10.1136/thx.38.11.849; Bolger C, 2011, J APPL PHYSIOL, V111, P1059, DOI 10.1152/japplphysiol.00113.2011; Bood JR, 2015, J APPL PHYSIOL, V119, P272, DOI 10.1152/japplphysiol.00301.2015; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Currie GP, 2003, CLIN EXP ALLERGY, V33, P783, DOI 10.1046/j.1365-2222.2003.01688.x; Dahlen B, 2001, EUR RESPIR J, V17, P581, DOI 10.1183/09031936.01.17405810; de Bisschop C, 1999, BRIT J SPORT MED, V33, P100, DOI 10.1136/bjsm.33.2.100; Eck R, 2001, MAINZER SPORTMEDIZIN, V3, P97; EDMUNDS AT, 1978, AM REV RESPIR DIS, V117, P247; Eichenberger PA, 2013, SPORTS MED, V43, P1157, DOI 10.1007/s40279-013-0077-2; Franca-Pinto A, 2015, THORAX, V70, P732, DOI 10.1136/thoraxjnl-2014-206070; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Hancox RJ, 2002, AM J RESP CRIT CARE, V165, P1068, DOI 10.1164/ajrccm.165.8.200111-091bc; How SC, 2009, RESP PHYSIOL NEUROBI, V166, P159, DOI 10.1016/j.resp.2009.03.003; Inman MD, 1996, AM J RESP CRIT CARE, V153, P65, DOI 10.1164/ajrccm.153.1.8542164; Larsson J, 2013, IMMUNOL ALLERGY CLIN, V33, P329, DOI 10.1016/j.iac.2013.02.004; Larsson J, 2011, J APPL PHYSIOL, V110, P1029, DOI 10.1152/japplphysiol.00978.2010; MARGOLSKEE DJ, 1988, AM REV RESPIR DIS, V137, P842, DOI 10.1164/ajrccm/137.4.842; MCKENZIE DC, 1994, MED SCI SPORT EXER, V26, P951; MCNEILL RS, 1966, Q J MED, V35, P55; MEAD J, 1978, J APPL PHYSIOL, V44, P156, DOI 10.1152/jappl.1978.44.2.156; Mickleborough TD, 2007, INT J SPORTS MED, V28, P456, DOI 10.1055/s-2006-924583; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MORTON AR, 1979, ANN ALLERGY, V42, P257; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Parsons JP, 2011, ALLERGY ASTHMA PROC, V32, P431, DOI 10.2500/aap.2011.32.3501; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; REIFF DB, 1989, AM REV RESPIR DIS, V139, P479, DOI 10.1164/ajrccm/139.2.479; Renggli AS, 2008, RESP PHYSIOL NEUROBI, V164, P366, DOI 10.1016/j.resp.2008.08.008; Romer LM, 2008, J APPL PHYSIOL, V104, P879, DOI 10.1152/japplphysiol.01157.2007; Rossman MJ, 2014, MED SCI SPORT EXER, V46, P1104, DOI 10.1249/MSS.0000000000000206; Rundell KW, 2001, MED SCI SPORT EXER, V33, P208; Savla U, 1997, AM J PHYSIOL-LUNG C, V273, pL1013, DOI 10.1152/ajplung.1997.273.5.L1013; SCHNALL RP, 1980, THORAX, V35, P828, DOI 10.1136/thx.35.11.828; Stickland MK, 2012, MED SCI SPORT EXER, V44, P383, DOI 10.1249/MSS.0b013e31822fb73a; TWEEDDALE PM, 1981, THORAX, V36, P596, DOI 10.1136/thx.36.8.596; Verges S, 2007, AM J PHYSIOL-REG I, V292, pR1246, DOI 10.1152/ajpregu.00409.2006; Weiler John M, 2010, Ann Allergy Asthma Immunol, V105, pS1, DOI 10.1016/j.anai.2010.09.021; Wilson B. A., 1996, Medicine and Science in Sports and Exercise, V28, pS181; WILSON BA, 1994, EUR RESPIR J, V7, P2174, DOI 10.1183/09031936.94.07122174; Wuthrich TU, 2013, EXP PHYSIOL, V98, P1705, DOI 10.1113/expphysiol.2013.073635	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167318	10.1371/journal.pone.0167318	http://dx.doi.org/10.1371/journal.pone.0167318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898744	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000389474000051
J	Herraiz-Adillo, A; Martinez-Vizcaino, V; Cavero-Redondo, I; Alvarez-Bueno, C; Garrido-Miguel, M; Notario-Pacheco, B				Herraiz-Adillo, Angel; Martinez-Vizcaino, Vicente; Cavero-Redondo, Ivan; Alvarez-Bueno, Celia; Garrido-Miguel, Miriam; Notario-Pacheco, Blanca			Diagnostic Accuracy Study of an Oscillometric Ankle-Brachial Index in Peripheral Arterial Disease: The Influence of Oscillometric Errors and Calcified Legs	PLOS ONE			English	Article							DIABETIC-PATIENTS; PRESSURE INDEX; DOPPLER; METAANALYSIS; RISK; ASSOCIATION; CONCORDANCE; STATEMENT; DEVICE	Background Peripheral arterial disease (PAD) is an indicator of widespread atherosclerosis. However, most individuals with PAD, in spite of being at high cardiovascular risk, are asymptomatic. This fact, together with the limitations of the Doppler ankle-brachial index (ABI), contributes to PAD underdiagnose. The aim of this study was to compare oscillometric ABI and Doppler ABI to diagnose peripheral arterial disease, and also to examine the influence of oscillometric errors and calcified legs on the PAD diagnoses. Methods and Findings We measured the ankle-brachial indexes of 90 volunteers (n = 180 legs, age 70 +/- 14 years, 43% diabetics) using both oscillometer OMRON-M3 and Doppler. For concordance analyses we used the Bland and Altman method, and also estimated the intraclass correlation coefficient. Receiver Operating Characteristic Curves were used to examine the diagnostic performance of both methods. The ABI means were 1.06 +/- 0.14 and 1.04 +/- 0.16 (p = 0.034) measured by oscillometer and Doppler ABIs respectively, with limits of agreement of +/- 0.20 and intraclass correlation coefficient = 0.769. Oscillometer yielded 23 "error" measurements, and also overestimated the measurements in low ankle pressures. Using Doppler as gold standard, oscillometer performance for diagnosis of PAD showed an Area Under Curve = 0.944 (sensitivity: 66.7%, specificity: 96.8%). Moreover, when considered calcified legs and oscillometric "error" readings as arteriopathy equivalents, sensitivity rose to 78.2%, maintaining specificity in 96%. The best oscillometer cutoff point was 0.96 (sensitivity: 87%, specificity: 91%, positive likelihood ratio: 9.66 and negative likelihood ratio: 0.14). Conclusion Despite its limitations, oscillometric ABI could be a useful tool for the diagnosis of PAD, particularly when considering calcified legs and oscillometric "errors" readings as peripheral arterial disease equivalents.	[Herraiz-Adillo, Angel] Hlth Serv Castilla La Mancha SESCAM, Dept Primary Care, Tragacete, Cuenca, Spain; [Martinez-Vizcaino, Vicente; Cavero-Redondo, Ivan; Alvarez-Bueno, Celia; Garrido-Miguel, Miriam; Notario-Pacheco, Blanca] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.; Martinez-Vizcaino, V (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	Vicente.Martinez@uclm.es	VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Alvarez-Bueno, Celia/R-4075-2019; Cavero-Redondo, Ivan/R-4818-2019; Cavero Redondo, Iván/HII-7855-2022; Notario Pacheco, Blanca/G-2583-2016	VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Alvarez-Bueno, Celia/0000-0002-6176-1618; Cavero Redondo, Iván/0000-0003-2617-0430; GARRIDO MIGUEL, MIRIAM/0000-0003-4617-616X; Herraiz-Adillo, Angel/0000-0002-2691-0315; Notario Pacheco, Blanca/0000-0001-8406-6952				Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Beckman JA, 2006, HYPERTENSION, V47, P35, DOI 10.1161/01.HYP.0000196686.85286.9c; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, CROAT MED J, V44, P639; Brooks B, 2001, DIABETIC MED, V18, P528, DOI 10.1046/j.1464-5491.2001.00493.x; Clairotte C, 2009, DIABETES CARE, V32, P1231, DOI [10.2337/dc08-2015, 10.2337/dc08-2230]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diehm C, 2004, ATHEROSCLEROSIS, V172, P95, DOI 10.1016/S0021-9150(03)00204-1; Diehm N, 2009, SWISS MED WKLY, V139, P357, DOI smw-12636; Raurell RF, 2010, MED CLIN-BARCELONA, V135, P306, DOI 10.1016/j.medcli.2009.11.046; Gomez-Huelgas R, 2010, DIABETES CARE, V33, DOI [10.2337/dc09-2059, DOI 10.2337/DC09-2059PMID:20190289]; Gomez-Huelgas Ricardo, 2010, Diabetes Care, V33, pe42, DOI 10.2337/dc09-2059; Hamel JF, 2010, ANGIOLOGY, V61, P487, DOI 10.1177/0003319709360522; Heald CL, 2006, ATHEROSCLEROSIS, V189, P61, DOI 10.1016/j.atherosclerosis.2006.03.011; Kollias A, 2011, HYPERTENS RES, V34, P825, DOI 10.1038/hr.2011.53; Korno M, 2009, EUR J VASC ENDOVASC, V38, P610, DOI 10.1016/j.ejvs.2009.07.004; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Rodriguez-Roca GC, 2014, BLOOD PRESSURE, V23, P270, DOI 10.3109/08037051.2013.876796; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simundic Ana-Maria, 2006, Acta Med Croatica, V60 Suppl 1, P93; Takahashi I, 2013, VASC HEALTH RISK MAN, V9, P89, DOI 10.2147/VHRM.S39785; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; Topouchian J, 2011, VASC HEALTH RISK MAN, V7, P709, DOI 10.2147/VHRM.S27193; Vega J, 2011, REV ESP CARDIOL, V64, P619, DOI [10.1016/j.recesp.2010.10.019, 10.1016/j.rec.2010.12.006]; Verberk WJ, 2012, HYPERTENS RES, V35, P883, DOI 10.1038/hr.2012.83; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125; Vinyoles E, 2007, MED CLIN-BARCELONA, V128, P92, DOI 10.1016/S0025-7753(07)72499-5; Wohlfahrt P, 2011, INT ANGIOL, V30, P256; Xu DC, 2013, CAN J CARDIOL, V29, P492, DOI 10.1016/j.cjca.2012.06.014	31	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167408	10.1371/journal.pone.0167408	http://dx.doi.org/10.1371/journal.pone.0167408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898734	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000061
J	Song, LL; Li, YM; Jia, J; Zhou, GP; Wang, JM; Kang, Q; Jin, P; Sheng, JQ; Cai, GX; Cai, SJ; Han, XL				Song, Lele; Li, Yuemin; Jia, Jia; Zhou, Guangpeng; Wang, Jianming; Kang, Qian; Jin, Peng; Sheng, Jianqiu; Cai, Guoxiang; Cai, Sanjun; Han, Xiaoliang			Algorithm Optimization in Methylation Detection with Multiple RT-qPCR	PLOS ONE			English	Article							COLORECTAL-CANCER; SEPT9 DNA; BIOMARKER; PLASMA; BLOOD; ASSAY	Epigenetic markers based on differential methylation of DNA sequences are used in cancer screening and diagnostics. Detection of abnormal methylation at specific loci by real-time quantitative polymerase chain reaction (RT-qPCR) has been developed to enable high-throughput cancer screening. For tests that combine the results of multiple PCR replicates into a single reportable result, both individual PCR cutoff and weighting of the individual PCR result are essential to test outcome. In this opportunistic screening study, we tested samples from 1133 patients using the triplicate Epi proColon assay with various algorithms and compared it with the newly developed single replicate SensiColon assay that measures methylation status of the same SEPT9 gene sequence. The Epi proColon test approved by the US FDA (1/3 algorithm) showed the highest sensitivity (82.4%) at a lower specificity (82.0%) compared with the Epi proColon 2.0 CE version with 2/3 algorithm (75.1% sensitivity, 97.1% specificity) or 1/1 algorithm (71.3% sensitivity, 92.7% specificity). No significant difference in performance was found between the Epi proColon 2.0 CE and the SensiColon assays. The choice of algorithm must depend on specific test usage, including screening and early detection. These considerations allow one to choose the optimal algorithm to maximize the test performance. We hope this study can help to optimize the methylation detection in cancer screening and early detection.	[Song, Lele; Li, Yuemin; Jia, Jia] Chinese PLA 309th Hosp, Beijing, Peoples R China; [Zhou, Guangpeng; Wang, Jianming; Han, Xiaoliang] BioChain Beijing Sci & Technol Inc, Beijing, Peoples R China; [Kang, Qian; Jin, Peng; Sheng, Jianqiu] Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Cai, Guoxiang; Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China	Fudan University	Song, LL (corresponding author), Chinese PLA 309th Hosp, Beijing, Peoples R China.; Han, XL (corresponding author), BioChain Beijing Sci & Technol Inc, Beijing, Peoples R China.	songlele@sina.com; shan@biochain.com		Han, Xiaoliang/0000-0002-3043-6353; Jin, Peng/0000-0001-6685-1906	BioChain (Beijing) Science and Technology, Inc.; Beijing Municipal Science and Technology Project (capital public health project) - Beijing Municipal Science and Technology Commission [Z151100003915092]	BioChain (Beijing) Science and Technology, Inc.; Beijing Municipal Science and Technology Project (capital public health project) - Beijing Municipal Science and Technology Commission	This study was supported by BioChain (Beijing) Science and Technology, Inc. The funder provided support in the form of salaries for authors [LS, GZ, JW, XH] and had an additional role in the study design, data analysis, preparation of the manuscript and publication of the study. The specific roles of these authors are articulated in the 'author contributions' section. This work was also supported by the Beijing Municipal Science and Technology Project (capital public health project) No. Z151100003915092, sponsored by the Beijing Municipal Science and Technology Commission.	American Cancer Society, 2011, COL CANC FACTS FIG 2; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Jin P, 2015, J GASTROEN HEPATOL, V30, P830, DOI 10.1111/jgh.12855; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Li YM, 2014, BIOMARK MED, V8, P755, DOI [10.2217/bmm.14.8, 10.2217/BMM.14.8]; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Potter NT, 2014, CLIN CHEM, V60, P1183, DOI 10.1373/clinchem.2013.221044; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Song LL, 2015, ADV CLIN CHEM, V72, P171, DOI 10.1016/bs.acc.2015.07.004; Wu D, 2016, J MOL DIAGN	12	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0163333	10.1371/journal.pone.0163333	http://dx.doi.org/10.1371/journal.pone.0163333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898666	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000001
J	Spilak, MP; Sigsgaard, T; Takai, H; Zhang, GQ				Spilak, Michal P.; Sigsgaard, Torben; Takai, Hisamitsu; Zhang, Guoqiang			A Comparison between Temperature-Controlled Laminar Airflow Device and a Room Air-Cleaner in Reducing Exposure to Particles While Asleep	PLOS ONE			English	Article							BREATHING ZONE; POLLUTANTS; ASTHMA; SLEEP; VENTILATION; MICROENVIRONMENT; RESUSPENSION; FILTRATION; INFECTION; CHILDREN	People spend approximately one third of their life sleeping. Exposure to pollutants in the sleep environment often leads to a variety of adverse health effects, such as development and exacerbation of asthma. Avoiding exposure to these pollutants by providing a sufficient air quality in the sleep environment might be a feasible method to alleviate these health symptoms. We performed full-scale laboratory measurements using a thermal manikin positioned on an experimental bed. Three ventilation settings were tested: with no filtration system operated, use of portable air cleaner and use of a temperature-controlled laminar airflow (TLA) device. The first part of the experiment investigated the air-flow characteristics in the breathing zone. In the second part, particle removal efficiency was estimated. Measured in the breathing zone, the room air cleaner demonstrated high turbulence intensity, high velocity and turbulence diffusivity level, with a particle reduction rate of 52% compared to baseline after 30 minutes. The TLA device delivered a laminar airflow to the breathing zone with a reduction rate of 99.5%. During a periodical duvet lifting mimicking a subject's movement in bed, the particle concentration was significantly lower with the TLA device compared to the room air cleaner. The TLA device provided a barrier which significantly reduced the introduction of airborne particles into the breathing zone. Further studies should be conducted for the understanding of the transport of resuspended particles between the duvet and the laying body.	[Spilak, Michal P.] Aalborg Univ, Danish Bldg Res Inst, Copenhagen, Denmark; [Sigsgaard, Torben] Aarhus Univ, Dept Publ Hlth, Inst Environm & Occupat Med, Aarhus C, Denmark; [Takai, Hisamitsu] Aarhus Univ, Dept Engn, Engn Ctr Bygholm, Horsens, Denmark; [Zhang, Guoqiang] Aarhus Univ, Dept Engn Fluid Dynam & Bldg Ventilat, Aarhus C, Denmark	Aalborg University; Aarhus University; Aarhus University; Aarhus University	Spilak, MP (corresponding author), Aalborg Univ, Danish Bldg Res Inst, Copenhagen, Denmark.	michal.p.spilak@gmail.com	Sigsgaard, Torben/AAC-1292-2020	Sigsgaard, Torben/0000-0002-2043-7571				AARONSON ST, 1982, ARCH GEN PSYCHIAT, V39, P330; Bin YS, 2012, SLEEP MED REV, V16, P223, DOI 10.1016/j.smrv.2011.07.003; Bolashikov Z, 2014, HVAC&R RES, V20, P238, DOI 10.1080/10789669.2013.864919; Bolashikov Z, 2013, HVAC&R RES, V19, P385, DOI 10.1080/10789669.2013.784645; Boor BE, 2015, INDOOR AIR, V25, P441, DOI 10.1111/ina.12148; Boyle RJ, 2012, THORAX, V67, P215, DOI 10.1136/thoraxjnl-2011-200665; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; CLARK RP, 1974, MED BIOL ENG, V12, P270, DOI 10.1007/BF02477790; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; De Koninck J., 1992, SLEEP POSITIONS POSI, V5, P143; Dorward A. J., 1988, EFFECT HOUSE DUST MI, P98; Goetzsche PC, 2008, COCHRANE DATABASE SY; Gore RB, 2015, INDOOR AIR, V25, P36, DOI 10.1111/ina.12122; Habbick BF, 1999, CAN MED ASSOC J, V160, P1824; Hinze J. O., 1975, TURBULENCE; IOM (Committee on the Assessment of Asthma and Indoor Air of the Institute of Medicine), 2000, CLEAR AIR ASTHM IND; Kanchongkittiphon W, 2015, ENVIRON HEALTH PERSP, V123, P6, DOI [10.1289/ehp.1307922, 10.1289/ehp.123-A6]; Kilburn S, 2003, COCHRANE DATABASE SY; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Laverge J, 2014, BUILD ENVIRON, V82, P258, DOI 10.1016/j.buildenv.2014.08.014; Liao W.I., 2008, PATT REC 2008 ICPR 2, P1, DOI DOI 10.1109/ICPR.2008.4761635; MARSHALL JD, 2006, EXPOSURE ANAL, P237, DOI DOI 10.1201/9781420012637.CH10; Melikov A., 1999, CABCLI SEM DISS RES, P41; MillerLeiden S, 1996, J AIR WASTE MANAGE, V46, P869, DOI 10.1080/10473289.1996.10467523; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Nazaroff WW, 2008, BUILD ENVIRON, V43, P269, DOI 10.1016/j.buildenv.2006.03.021; Ozcan O, 2005, J VISUAL-JAPAN, V8, P23, DOI 10.1007/BF03181599; Pedroletti C, 2009, RESP MED, V103, P1313, DOI 10.1016/j.rmed.2009.03.020; PLATTSMILLS TAE, 1982, LANCET, V2, P675; Rim D, 2010, J OCCUP ENVIRON HYG, V7, P683, DOI 10.1080/15459624.2010.526894; Rim D, 2009, BUILD ENVIRON, V44, P1840, DOI 10.1016/j.buildenv.2008.12.009; Ross RN, 2000, CLIN THER, V22, P329, DOI 10.1016/S0149-2918(00)80037-5; Schauer U., 2015, EUROPEAN CLIN RESP J; Spilak MP, 2014, BUILD ENVIRON, V81, P60, DOI 10.1016/j.buildenv.2014.06.010; Vincent James H., 1989, AEROSOL SAMPLING SCI; Warner J. O., 1988, CLIN IMMUNOL ALLERGY, P217	37	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166882	10.1371/journal.pone.0166882	http://dx.doi.org/10.1371/journal.pone.0166882			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898693	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000021
J	De Santis Puzzonia, M; Cozzolino, AM; Grassi, G; Bisceglia, F; Strippoli, R; Guarguaglini, G; Citarella, F; Sacchetti, B; Tripodi, M; Marchetti, A; Amicone, L				De Santis Puzzonia, Marco; Cozzolino, Angela Maria; Grassi, Germana; Bisceglia, Francesca; Strippoli, Raffaele; Guarguaglini, Giulia; Citarella, Franca; Sacchetti, Benedetto; Tripodi, Marco; Marchetti, Alessandra; Amicone, Laura			TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure	PLOS ONE			English	Article							TGF-BETA; AURORA-B; KINASE INHIBITOR; CLEAVAGE FURROW; RHOA ACTIVITY; LIVER; POLYPLOIDY; GROWTH; STRESS; PLOIDY	In all mammals, the adult liver shows binucleated as well as mononucleated polyploid hepatocytes. The hepatic polyploidization starts after birth with an extensive hepatocyte binucleation and generates hepatocytes of several ploidy classes. While the functional significance of hepatocyte polyploidy is becoming clearer, how it is triggered and maintained needs to be clarified. Aim of this study was to identify a major inducer of hepatocyte binucleation/polyploidization and the cellular and molecular mechanisms involved. We found that, among several cytokines analyzed, known to be involved in early liver development and/or mass control, TGFbeta1 was capable to induce, together with the expected morphological changes, binucleation in hepatocytes in culture. Most importantly, the pharmacological inhibition of TGFbeta signaling in healthy mice during weaning, when the physiological binucleation occurs, induced a significant decrease of hepatocyte binucleation rate, without affecting cell proliferation and hepatic index. The TGFbeta-induced hepatocyte binucleation resulted from a cytokinesis failure, as assessed by video microscopy, and is associated with a delocalization of the cytokinesis regulator RhoA-GTPase from the mid-body of dividing cells. The use of specific chemical inhibitors demonstrated that the observed events are Src-dependent. Finally, the restoration of a fully epithelial phenotype by TGFbeta withdrawal gave rise to a cell progeny capable to maintain the polyploid state. In conclusion, we identified TGFbeta as a major inducer of hepatocyte binucleation both in vitro and in vivo, thus ascribing a novel role to this pleiotropic cytokine. The production of binucleated/tetraploid hepatocytes is due to a cytokinesis failure controlled by the molecular axis TGFbeta/Src/RhoA.	[De Santis Puzzonia, Marco; Cozzolino, Angela Maria; Bisceglia, Francesca; Strippoli, Raffaele; Citarella, Franca; Tripodi, Marco; Marchetti, Alessandra; Amicone, Laura] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy; [Cozzolino, Angela Maria; Grassi, Germana; Tripodi, Marco] IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy; [Guarguaglini, Giulia] Univ Roma La Sapienza, Inst Mol Biol & Pathol, Dept Biol & Biotechnol, CNR,Natl Res Council, Rome, Italy; [Sacchetti, Benedetto] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Lazzaro Spallanzani; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome	Marchetti, A; Amicone, L (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy.	marchetti@bce.uniroma1.it; amicone@bce.uniroma1.it	Strippoli, Raffaele/J-2129-2018; Tripodi, Marco/F-1143-2011; Tripodi, Marco/ABO-1160-2022; COZZOLINO, ANGELA MARIA/ABD-2576-2020; Marchetti, Alessandra/AAD-5498-2019	Strippoli, Raffaele/0000-0003-3483-8381; Tripodi, Marco/0000-0001-6135-971X; Tripodi, Marco/0000-0001-6135-971X; COZZOLINO, ANGELA MARIA/0000-0002-3981-0639; De Santis Puzzonia, Marco/0000-0001-5691-1733; MARCHETTI, ALESSANDRA/0000-0001-9706-848X; Grassi, Germana/0000-0001-8168-8721	MT: Associazione Italiana Ricerca sul Cancro (AIRC) [IG-14114]; MT: Ministry for Health of Italy "Ricerca Corrente"; MT: Ministry of University and Research of Italy (PRIN); LA: Sapienza, Universita di ROMA "Progetti di Ateneo"	MT: Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); MT: Ministry for Health of Italy "Ricerca Corrente"; MT: Ministry of University and Research of Italy (PRIN)(Ministry of Education, Universities and Research (MIUR)); LA: Sapienza, Universita di ROMA "Progetti di Ateneo"	This work was supported by MT: Associazione Italiana Ricerca sul Cancro (AIRC IG-14114); MT: Ministry for Health of Italy "Ricerca Corrente"; MT: Ministry of University and Research of Italy (PRIN); LA: Sapienza, Universita di ROMA "Progetti di Ateneo".	Aiuti A, 1998, HEPATOLOGY, V28, P1645, DOI 10.1002/hep.510280626; Amicone L, 2002, ONCOGENE, V21, P1335, DOI 10.1038/sj.onc.1205199; Amicone L, 1997, EMBO J, V16, P495, DOI 10.1093/emboj/16.3.495; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Baek HA, 2012, AM J RESP CELL MOL, V46, P731, DOI 10.1165/rcmb.2011-0121OC; Bellovino D, 1998, EXP CELL RES, V243, P101, DOI 10.1006/excr.1998.4137; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bordoni V, 2004, HEPATOLOGY, V39, P1508, DOI 10.1002/hep.20234; Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Celton-Morizur S, 2010, CELL CYCLE, V9, P460, DOI 10.4161/cc.9.3.10542; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Cicchini C, 2006, J CELL PHYSIOL, V209, P230, DOI 10.1002/jcp.20730; Cicchini C, 2015, LIVER INT, V35, P302, DOI 10.1111/liv.12577; Cozzolino AM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5481493; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Flechsig P, 2012, CLIN CANCER RES, V18, P3616, DOI 10.1158/1078-0432.CCR-11-2855; Gentric G, 2015, J CLIN INVEST; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Giannelli G., 2014, CURRENT PHARM DESIGN, V18, P4071; Gorla GR, 2001, J CELL SCI, V114, P2943; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Guantario B, 2012, TOXICOL IN VITRO, V26, P7, DOI 10.1016/j.tiv.2011.09.020; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Houglum K, 1994, AM J PHYSIOL, V267, P908; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Napolitano M, 2001, FREE RADICAL BIO MED, V30, P506, DOI 10.1016/S0891-5849(00)00493-7; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Sacco MG, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-5; SAETER G, 1988, CARCINOGENESIS, V9, P939, DOI 10.1093/carcin/9.6.939; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Torres S, 1999, AM J PHYSIOL-GASTR L, V276, pG155, DOI 10.1152/ajpgi.1999.276.1.G155; Toyoda H, 2005, GUT, V54, P297, DOI 10.1136/gut.2004.043893; Troadec MB, 2006, J HEPATOL, V44, P391, DOI 10.1016/j.jhep.2005.07.033; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; WEBBER EM, 1994, AM J PATHOL, V145, P398; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	60	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167158	10.1371/journal.pone.0167158	http://dx.doi.org/10.1371/journal.pone.0167158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893804	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400093
J	Gaona-Lopez, C; Julian-Sanchez, A; Riveros-Rosas, H				Gaona-Lopez, Carlos; Julian-Sanchez, Adriana; Riveros-Rosas, Hector			Diversity and Evolutionary Analysis of Iron-Containing (Type-III) Alcohol Dehydrogenases in Eukaryotes	PLOS ONE			English	Article							HYDROXYACID-OXOACID TRANSHYDROGENASE; MALEYLACETATE-REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENE-CLUSTER; GLYCEROL DEHYDROGENASE; MOLECULAR CHARACTERIZATION; METHANOL DEHYDROGENASE; ENTAMOEBA-HISTOLYTICA; SEQUENCE-ANALYSIS	Background Alcohol dehydrogenase (ADH) activity is widely distributed in the three domains of life. Currently, there are three non-homologous NAD(P)(+)-dependent ADH families reported: Type I ADH comprises Zn-dependent ADHs; type II ADH comprises short-chain ADHs described first in Drosophila; and, type III ADH comprises iron-containing ADHs (FeADHs). These three families arose independently throughout evolution and possess different structures and mechanisms of reaction. While types I and II ADHs have been extensively studied, analyses about the evolution and diversity of (type III) FeADHs have not been published yet. Therefore in this work, a phylogenetic analysis of FeADHs was performed to get insights into the evolution of this protein family, as well as explore the diversity of FeADHs in eukaryotes. Principal Findings Results showed that FeADHs from eukaryotes are distributed in thirteen protein subfamilies, eight of them possessing protein sequences distributed in the three domains of life. Interestingly, none of these protein subfamilies possess protein sequences found simultaneously in animals, plants and fungi. Many FeADHs are activated by or contain Fe2+, but many others bind to a variety of metals, or even lack of metal cofactor. Animal FeADHs are found in just one protein subfamily, the hydroxyacid-oxoacid transhydrogenase (HOT) subfamily, which includes protein sequences widely distributed in fungi, but not in plants), and in several taxa from lower eukaryotes, bacteria and archaea. Fungi FeADHs are found mainly in two subfamilies: HOT and maleylacetate reductase (MAR), but some can be found also in other three different protein subfamilies. Plant FeADHs are found only in chlorophyta but not in higher plants, and are distributed in three different protein subfamilies. Conclusions/Significance FeADHs are a diverse and ancient protein family that shares a common 3D scaffold with a patchy distribution in eukaryotes. The majority of sequenced FeADHs from eukaryotes are distributed in just two subfamilies, HOT and MAR (found mainly in animals and fungi). These two subfamilies comprise almost 85% of all sequenced FeADHs in eukaryotes.	[Gaona-Lopez, Carlos; Julian-Sanchez, Adriana; Riveros-Rosas, Hector] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Riveros-Rosas, H (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico.	hriveros@unam.mx	Riveros-Rosas, Hector/B-6607-2008; Riveros-Rosas, Hector/ABD-6638-2020	Riveros-Rosas, Hector/0000-0003-0194-2537; Riveros-Rosas, Hector/0000-0003-0194-2537	Direccion General de Asuntos del Personal Academic; Universidad Nacional Autonoma de Mexico, PAPIIT [IN216513, IN225016]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [233791]; Programa de Doctorado en Ciencias, Universidad Nacional Autonoma de Mexico	Direccion General de Asuntos del Personal Academic; Universidad Nacional Autonoma de Mexico, PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Doctorado en Ciencias, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Direccion General de Asuntos del Personal Academic, Universidad Nacional Autonoma de Mexico, PAPIIT grants IN216513 and IN225016 to HRR, and Consejo Nacional de Ciencia y Tecnologia (Mexico), Ph.D. fellowship No. 233791, and Programa de Doctorado en Ciencias, Universidad Nacional Autonoma de Mexico, to CGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; Andersson B, 1934, H-S Z PHYSIOL CHEM, V225, P57, DOI 10.1515/bchm2.1934.225.2-3.57; Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Antoine E, 1999, EUR J BIOCHEM, V264, P880, DOI 10.1046/j.1432-1327.1999.00685.x; Arfman N, 1997, EUR J BIOCHEM, V244, P426, DOI 10.1111/j.1432-1033.1997.00426.x; Armengaud J, 1999, J BACTERIOL, V181, P3452, DOI 10.1128/JB.181.11.3452-3461.1999; Atteia A, 2003, PLANT MOL BIOL, V53, P175, DOI 10.1023/B:PLAN.0000009274.19340.36; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battelli F, 1910, BIOCHEM Z, V28, P145; Battelli F, 1909, CR SOC BIOL, V67, P419; Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; BONNICHSEN RK, 1948, ARCH BIOCHEM, V18, P361; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Borras E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-216; BRUCHHAUS I, 1994, BIOCHEM J, V303, P743, DOI 10.1042/bj3030743; Brzostowicz PC, 2002, APPL MICROBIOL BIOT, V58, P781, DOI 10.1007/s00253-002-0968-x; BUSWELL JA, 1979, FEBS LETT, V104, P258, DOI 10.1016/0014-5793(79)80827-3; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; Camara B, 2009, J BACTERIOL, V191, P4905, DOI 10.1128/JB.00331-09; Chan Cheong Xin, 2012, Mob Genet Elements, V2, P101; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Cheng SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047144; CONWAY T, 1989, J BACTERIOL, V171, P3754, DOI 10.1128/jb.171.7.3754-3759.1989; CONWAY T, 1987, J BACTERIOL, V169, P2591, DOI 10.1128/jb.169.6.2591-2597.1987; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dan MX, 2000, MOL BIOCHEM PARASIT, V109, P25, DOI 10.1016/S0166-6851(00)00233-4; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Daubaras DL, 1996, APPL ENVIRON MICROB, V62, P4276, DOI 10.1128/AEM.62.11.4276-4279.1996; DAUBARAS DL, 1995, APPL ENVIRON MICROB, V61, P1279, DOI 10.1128/AEM.61.4.1279-1289.1995; de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x; Deng YF, 2002, DNA SEQUENCE, V13, P301, DOI 10.1080/1042517021000011636; DEVRIES GE, 1992, J BACTERIOL, V174, P5346, DOI 10.1128/JB.174.16.5346-5353.1992; DREWKE C, 1988, BIOCHIM BIOPHYS ACTA, V950, P54, DOI 10.1016/0167-4781(88)90072-3; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; Elias M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-21; Elleuche S, 2014, APPL MICROBIOL BIOT, V98, P4041, DOI 10.1007/s00253-013-5374-z; Elleuche S, 2013, APPL MICROBIOL BIOT, V97, P8963, DOI 10.1007/s00253-013-4725-0; Endo R, 2005, J BACTERIOL, V187, P847, DOI 10.1128/JB.187.3.847-853.2005; Espinosa A, 2001, J BIOL CHEM, V276, P20136, DOI 10.1074/jbc.M101349200; Extance J, 2013, ACTA CRYSTALLOGR D, V69, P2104, DOI 10.1107/S0907444913020349; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fujii T, 2016, PROTEINS; GAAL AB, 1980, BIOCHEM J, V185, P783, DOI 10.1042/bj1850783; GANZHORN AJ, 1987, J BIOL CHEM, V262, P3754; Gattis SG, 2013, J BIOL CHEM, V288, P9216, DOI 10.1074/jbc.M113.453324; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; Gonzalez-Segura L, 2015, CHEM-BIOL INTERACT, V234, P59, DOI 10.1016/j.cbi.2014.12.039; Greco M, 2012, J EXP BOT, V63, P695, DOI 10.1093/jxb/err313; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han JS, 2002, EUR J BIOCHEM, V269, P969, DOI 10.1046/j.0014-2956.2001.02731.x; Hernandez-Tobias A, 2011, CHEM-BIOL INTERACT, V191, P14, DOI 10.1016/j.cbi.2011.02.008; HIU SF, 1987, APPL ENVIRON MICROB, V53, P697, DOI 10.1128/AEM.53.4.697-703.1987; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang Y, 2006, APPL ENVIRON MICROB, V72, P7238, DOI 10.1128/AEM.01494-06; Iwaki H, 2002, APPL ENVIRON MICROB, V68, P5671, DOI 10.1128/AEM.68.11.5671-5684.2002; JONES KH, 1995, ARCH MICROBIOL, V163, P176, DOI 10.1007/BF00305350; JORNVALL H, 1981, P NATL ACAD SCI-BIOL, V78, P4226, DOI 10.1073/pnas.78.7.4226; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; JORNVALL H, 1970, EUR J BIOCHEM, V16, P25, DOI 10.1111/j.1432-1033.1970.tb01049.x; JORNVALL H, 1977, EUR J BIOCHEM, V72, P443, DOI 10.1111/j.1432-1033.1977.tb11268.x; Jornvall H, 2015, CHEM-BIOL INTERACT, V234, P75, DOI 10.1016/j.cbi.2014.10.017; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; Kardon T, 2006, FEBS LETT, V580, P2347, DOI 10.1016/j.febslet.2006.02.082; KASCHABEK SR, 1993, J BACTERIOL, V175, P6075, DOI 10.1128/JB.175.19.6075-6081.1993; KAUFMAN EE, 1988, J BIOL CHEM, V263, P16872; KAUFMAN EE, 1991, NEUROCHEM RES, V16, P965, DOI 10.1007/BF00965839; KESSLER D, 1992, J BIOL CHEM, V267, P18073; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018; Koch Jason J, 2002, Pediatr Rev, V23, P310, DOI 10.1542/pir.23-9-310; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li DH, 1997, J BACTERIOL, V179, P4433, DOI 10.1128/jb.179.13.4433-4437.1997; Lia Yaoyao, 2013, Mycology, V4, P179, DOI 10.1080/21501203.2013.874540; Luers F, 1997, FEMS MICROBIOL LETT, V154, P337, DOI 10.1016/S0378-1097(97)00351-0; Lyon RC, 2009, CHEM-BIOL INTERACT, V178, P283, DOI 10.1016/j.cbi.2008.10.025; Ma F, 2014, J MICROBIOL BIOTECHN, V24, P748, DOI 10.4014/jmb.1312.12030; Ma KS, 2001, METHOD ENZYMOL, V331, P195; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Maitre M, 2016, MED RES REV, V36, P363, DOI 10.1002/med.21382; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Martin-Duran JM, 2013, GENOME BIOL EVOL, V5, P1435, DOI 10.1093/gbe/evt102; McGivney BA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-638; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Moon JH, 2011, J MOL BIOL, V407, P413, DOI 10.1016/j.jmb.2011.01.045; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Musille P, 2014, ACTA CRYSTALLOGR F, V70, P166, DOI 10.1107/S2053230X13034444; Negelein E, 1937, BIOCHEM Z, V293, P351; NELSON T, 1981, J NEUROCHEM, V37, P1345, DOI 10.1111/j.1471-4159.1981.tb04689.x; Nichols CE, 2004, J MOL BIOL, V343, P533, DOI 10.1016/j.jmb.2004.08.039; Obradors N, 1998, EUR J BIOCHEM, V258, P207, DOI 10.1046/j.1432-1327.1998.2580207.x; PAQUIN CE, 1986, MOL CELL BIOL, V6, P70, DOI 10.1128/MCB.6.1.70; PATEL TR, 1992, J BASIC MICROB, V32, P233, DOI 10.1002/jobm.3620320405; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Perez-Pantoja D, 2009, MICROBIOL-SGM, V155, P3641, DOI 10.1099/mic.0.032086-0; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; PERSSON B, 1994, EUR J BIOCHEM, V226, P15, DOI 10.1111/j.1432-1033.1994.tb20021.x; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pineda E, 2013, FEBS LETT, V587, P178, DOI 10.1016/j.febslet.2012.11.020; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Pundir Sangya, 2016, Curr Protoc Bioinformatics, V53, DOI 10.1002/0471250953.bi0129s53; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; RIEBLE S, 1994, J BACTERIOL, V176, P4838, DOI 10.1128/jb.176.16.4838-4844.1994; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Sakurai M, 2004, FEMS YEAST RES, V4, P649, DOI 10.1016/j.femsyr.2003.12.009; SCHWARTZ MF, 1976, EUR J BIOCHEM, V68, P159, DOI 10.1111/j.1432-1033.1976.tb10774.x; Schwarzenbacher R, 2004, PROTEINS, V54, P174, DOI 10.1002/prot.10594; SCOPES RK, 1983, FEBS LETT, V156, P303, DOI 10.1016/0014-5793(83)80517-1; Seibert V, 2004, MICROBIOL-SGM, V150, P463, DOI 10.1099/mic.0.26602-0; Seibert V, 1998, J BACTERIOL, V180, P3503, DOI 10.1128/JB.180.14.3503-3508.1998; SEIBERT V, 1993, J BACTERIOL, V175, P6745, DOI 10.1128/jb.175.21.6745-6754.1993; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; SHAILUBHAI K, 1983, EXPERIENTIA, V39, P70, DOI 10.1007/BF01960634; Shapiro JA, 2016, BIOLOGY, P5; Shasmal M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19936; SOFER W, 1968, J BIOL CHEM, V243, P3110; SPARNINS VL, 1979, J BACTERIOL, V138, P425, DOI 10.1128/JB.138.2.425-430.1979; SPENCER P, 1990, BIOCHIM BIOPHYS ACTA, V1040, P130, DOI 10.1016/0167-4838(90)90156-A; SPENCER P, 1989, BIOCHIM BIOPHYS ACTA, V994, P270, DOI 10.1016/0167-4838(89)90304-X; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Struys EA, 2005, J INHERIT METAB DIS, V28, P921, DOI 10.1007/s10545-005-0114-x; Sugahara M, 2005, PROTEINS, V58, P249, DOI 10.1002/prot.20281; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; Tae CH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-142; Tamarit J, 1997, J BACTERIOL, V179, P1102, DOI 10.1128/jb.179.4.1102-1104.1997; TRUNIGER V, 1994, J BACTERIOL, V176, P1796, DOI 10.1128/jb.176.6.1796-1800.1994; VALLEE BL, 1955, P NATL ACAD SCI USA, V41, P327, DOI 10.1073/pnas.41.6.327; VALLEE BL, 1957, J BIOL CHEM, V225, P185; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; VONCK J, 1991, J BIOL CHEM, V266, P3949; WALTER KA, 1992, J BACTERIOL, V174, P7149, DOI 10.1128/jb.174.22.7149-7158.1992; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; WILLIAMSON VM, 1987, MOL GEN GENET, V209, P374, DOI 10.1007/BF00329668; WILLS C, 1981, ARCH BIOCHEM BIOPHYS, V210, P775, DOI 10.1016/0003-9861(81)90245-9; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Ying XX, 2009, EXTREMOPHILES, V13, P299, DOI 10.1007/s00792-008-0217-z; Yoshida M, 2007, J BACTERIOL, V189, P1573, DOI 10.1128/JB.01675-06; YOUNGLESON JS, 1988, APPL ENVIRON MICROB, V54, P676, DOI 10.1128/AEM.54.3.676-682.1988; YOUNGLESON JS, 1989, GENE, V78, P355, DOI 10.1016/0378-1119(89)90238-2; Zheng YY, 2004, BIOTECHNOL LETT, V26, P251	156	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166851	10.1371/journal.pone.0166851	http://dx.doi.org/10.1371/journal.pone.0166851			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893862	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400048
J	Schroeders, U; Wilhelm, O; Olaru, G				Schroeders, Ulrich; Wilhelm, Oliver; Olaru, Gabriel			Meta-Heuristics in Short Scale Construction: Ant Colony Optimization and Genetic Algorithm	PLOS ONE			English	Article							COEFFICIENT ALPHA; PERSONALITY; SELECTION; RELIABILITY; INVENTORY; VALIDITY; PANEL	The advent of large-scale assessment, but also the more frequent use of longitudinal and multivariate approaches to measurement in psychological, educational, and sociological research, caused an increased demand for psychometrically sound short scales. Shortening scales economizes on valuable administration time, but might result in inadequate measures because reducing an item set could: a) change the internal structure of the measure, b) result in poorer reliability and measurement precision, c) deliver measures that cannot effectively discriminate between persons on the intended ability spectrum, and d) reduce test-criterion relations. Different approaches to abbreviate measures fare differently with respect to the above-mentioned problems. Therefore, we compare the quality and efficiency of three item selection strategies to derive short scales from an existing long version: a Step-wise COnfirmatory Factor Analytical approach (SCOFA) that maximizes factor loadings and two metaheuristics, specifically an Ant Colony Optimization (ACO) with a tailored user-defined optimization function and a Genetic Algorithm (GA) with an unspecific cost-reduction function. SCOFA compiled short versions were highly reliable, but had poor validity. In contrast, both metaheuristics outperformed SCOFA and produced efficient and psychometrically sound short versions (unidimensional, reliable, sensitive, and valid). We discuss under which circumstances ACO and GA produce equivalent results and provide recommendations for conditions in which it is advisable to use a metaheuristic with an unspecific out-of-the-box optimization function.	[Schroeders, Ulrich] Univ Bamberg, Dept Educ Sci, Bamberg, Germany; [Wilhelm, Oliver; Olaru, Gabriel] Univ Ulm, Dept Psychol & Educ, Ulm, Germany	Otto Friedrich University Bamberg; Ulm University	Schroeders, U (corresponding author), Univ Bamberg, Dept Educ Sci, Bamberg, Germany.	ulrich.schroeders@uni-bamberg.de	Schroeders, Ulrich/AAG-9800-2020; Olaru, Gabriel/AAL-5282-2020; Wilhelm, Oliver/K-6455-2012	Schroeders, Ulrich/0000-0002-5225-1122; Olaru, Gabriel/0000-0002-7430-7350; Wilhelm, Oliver/0000-0001-7980-1166				[Anonymous], 2010, IERI MONOGRAPH SERIE; Arendasy M, 2005, INT J TEST, V5, P197, DOI 10.1207/s15327574ijt0503_2; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Blossfeld HP, 2011, Z ERZIEHWISS, V14, P19, DOI 10.1007/s11618-011-0179-2; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Borsboom D, 2006, PSYCHOMETRIKA, V71, P425, DOI 10.1007/s11336-006-1447-6; Borsboom D, 2009, CONCEPT OF VALIDITY: REVISIONS, NEW DIRECTIONS AND APPLICATIONS, P135; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Costa PT, 2007, REVISED NEO PERSONAL; Courvoisier DS, 2012, PSYCHOL ASSESSMENT, V24, P713, DOI 10.1037/a0026733; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Dorigo M, 2010, INT SER OPER RES MAN, V146, P227, DOI 10.1007/978-1-4419-1665-5_8; Drezner Z, 1999, COMMUN STAT-SIMUL C, V28, P349, DOI 10.1080/03610919908813553; Duchhardt C, 2013, NEPS TECHNICAL REPOR, P1; Dunn L.M., 2007, PEABODY PICTURE VOCA, DOI [DOI 10.1037/T15144-000, 10.1037/t15144-000]; Eisenbarth H, 2015, PSYCHOL ASSESSMENT, V27, P194, DOI 10.1037/pas0000032; Embretson S, 2000, MULTIVARIATE APPL BO; Emons WHM, 2007, PSYCHOL METHODS, V12, P105, DOI 10.1037/1082-989X.12.1.105; Gehrer K., 2012, ASSESSMENT READING C; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; GREEN SB, 1977, EDUC PSYCHOL MEAS, V37, P827, DOI 10.1177/001316447703700403; Gulliksen H., 1945, PSYCHOMETRIKA, V10, P79, DOI [10.1007/BF02288877, DOI 10.1007/BF02288877]; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Heene M, 2011, PSYCHOL METHODS, V16, P319, DOI 10.1037/a0024917; Holland J. H., 1992, ADAPTATION NATURAL A; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Janssen AB, 2017, EUR J PSYCHOL ASSESS, V33, P409, DOI 10.1027/1015-5759/a000299; Kane M, 2002, J EDUC MEAS, V39, P165, DOI 10.1111/j.1745-3984.2002.tb01141.x; Kano Y, 2000, PSYCHOMETRIKA, V65, P7, DOI 10.1007/BF02294182; Kelley T. L., 1927, INTERPRETATION ED ME; Kruyen PM, 2013, INT J TEST, V13, P223, DOI 10.1080/15305058.2012.703734; Kruyen PM, 2012, INT J TEST, V12, P321, DOI 10.1080/15305058.2011.643517; Lang FR, 2014, ERFASSUNG FLUIDEN KO, P12; Leite WL, 2008, MULTIVAR BEHAV RES, V43, P411, DOI 10.1080/00273170802285743; LOEVINGER J, 1965, PSYCHOL REV, V72, P143, DOI 10.1037/h0021704; LOEVINGER J, 1954, PSYCHOL BULL, V51, P493, DOI 10.1037/h0058543; Marcoulides George A., 2001, NEW DEV TECHNIQUES S, P247; Markus K. A., 2013, MULTIVARIATE APPL SE, V341; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; McDonald R.P., 2003, ALTA J EDUC RES, V49, P212, DOI [10.11575/ajer.v49i3.54980, DOI 10.11575/AJER.V49I3.54980]; McDonald RP, 1999, TEST THEORY UNIFIED; Mellenbergh GJ, 1996, PSYCHOL METHODS, V1, P293, DOI 10.1037/1082-989X.1.3.293; Olaru G, 2015, J RES PERS, V59, P56, DOI 10.1016/j.jrp.2015.09.001; Olderbak S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01503; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sahdra BK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00189; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Schoeni RF, 2013, ANN AM ACAD POLIT SS, V645, P60, DOI 10.1177/0002716212456363; Schroeders U., 2016, METAHEURISTICS SCRIP; Schroeders U, 2016, INTELLIGENCE, V58, P22, DOI 10.1016/j.intell.2016.06.003; Scrucca L, 2016, GAABBREVIATE; Scrucca L, 2013, J STAT SOFTW, V53, P1; Sijtsma K, 2009, INT J TEST, V9, P167, DOI 10.1080/15305050903106883; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Thompson B, 2000, EDUC PSYCHOL MEAS, V60, P174, DOI 10.1177/00131640021970448; Van der Linden W.J., 1997, HDB MODERN ITEM RESP; Widaman K. F., 2011, SECONDARY DATA ANAL, P39, DOI [10.1037/12350-003, DOI 10.1037/12350-003]; Yarkoni T, 2010, J RES PERS, V44, P180, DOI 10.1016/j.jrp.2010.01.002; Ziegler M, 2014, J INDIVID DIFFER, V35, P185, DOI 10.1027/1614-0001/a000148; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	66	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167110	10.1371/journal.pone.0167110	http://dx.doi.org/10.1371/journal.pone.0167110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893845	Green Submitted, gold, Green Published			2022-12-27	WOS:000389472400087
J	Yitbarek, T; Nega, D; Tasew, G; Taye, B; Desta, K				Yitbarek, Tigist; Nega, Desalegn; Tasew, Geremew; Taye, Bineyam; Desta, Kassu			Performance Evaluation of Malaria Microscopists at Defense Health Facilities in Addis Ababa and Its Surrounding Areas, Ethiopia	PLOS ONE			English	Article							IMPROVE; ZAMBIA; FEVER	Background Blood film microscopy is the gold standard approach for malaria diagnosis, and preferred method for routine patient diagnosis in health facilities. However, the inability of laboratory professionals to correctly detect and identify malaria parasites microscopically leads to an inappropriate administration of anti-malarial drugs to the patients and incorrect findings in research areas. This study was carried out to evaluate the performance of laboratory professionals in malaria diagnosis in health facilities under the Defense Health Main Department in Addis Ababa and its surroundings, Ethiopia. Method A cross sectional study was conducted from June to July 2015. Totally, 60 laboratory professionals out of the selected 16 health facilities were included in the study. Data were collected by distributing standardized pre-validated malaria slide-panels and self-administered questionnaires among professionals, onsite in each study facility. Sensitivity, specificity, and strength of agreement (with kappa score) in performance among the study participants against WHO-certified expert malaria microscopists were calculated. Result Of the 60 study participants, 8.3% (5/60) correctly read all the distributed slides in terms of parasite detection, species identification and parasite counting; whereas, each of the remaining 55(91.7%) interpreted at least two slides incorrectly. The overall sensitivity and specificity of participants' performance in detection of malaria parasites were 65.7% and 100%, respectively. Overall, fair agreement (71.4%; Kappa: 0.4) in detection of malaria parasite was observed between the study subjects and expert readers. The overall sensitivity and specificity of participants in species identification of malaria parasites were respectively 41.3% and 100%. Overall, slight agreement (51.1%; kappa: 0.04) in identification of malaria species was observed. Generally, agreement was lower in parasite detection and species identification at low parasite density and mixed infection cases. Conclusion The general agreement between the study participants and expert microscopists in malaria parasite detection and species identification was very low, particularly in the cases of low-parasite density and mixed infections. Therefore, regular external quality assessments and further refreshment trainings are crucial to enhance the skill of professionals in malaria microscopy; particularly for those in non-malarious areas where exposure to malaria diagnosis is low.	[Yitbarek, Tigist] Emanuel Mental Specialized Hosp, Med Lab Serv, Addis Ababa, Ethiopia; [Nega, Desalegn; Tasew, Geremew] Ethiopian Publ Hlth Inst, Malaria Other Parasite & Vector Borne Parasit Dis, Addis Ababa, Ethiopia; [Taye, Bineyam] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Yitbarek, Tigist; Desta, Kassu] Univ Addis Ababa, Collage Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Colgate University; Addis Ababa University	Yitbarek, T (corresponding author), Emanuel Mental Specialized Hosp, Med Lab Serv, Addis Ababa, Ethiopia.; Yitbarek, T (corresponding author), Univ Addis Ababa, Collage Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia.	tigist.yitbarek@yahoo.com		Tasew, Geremew/0000-0002-2797-824X	Addis Ababa University	Addis Ababa University	This work was financially supported by the Addis Ababa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Addis Ababa University for financial support & Defense Health Main Department for allowing us to conduct this study. Our sincere gratitude also goes to data collectors and supervisors for their unreserved support, and the study participants for their participation.	Ayalew Freshwork, 2014, BMC Res Notes, V7, P839, DOI 10.1186/1756-0500-7-839; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Barnish G, 2004, BMJ-BRIT MED J, V328, P1511, DOI 10.1136/bmj.328.7455.1511; Desta KM, 2002, ETHIOP J HEALTH DEV, P53; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Ekawati LL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0746-8; Fernando SD, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-98; Haditsch M, 2004, Travel Med Infect Dis, V2, P149, DOI 10.1016/j.tmaid.2004.03.001; Kassahun Mitiku, 2003, Ethiopian Journal of Health Development, V17, P197; Leung WL, J HONG KONG INST MED, V11, P8; Msisuka C, 2011, SAHARA J-J SOC ASP H, V8, P204, DOI 10.1080/17290376.2011.9725005; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Pierre M, 2011, MALARIA J, V10, P308, DOI [10.1186/1475-2875-10-308, DOI 10.1186/1475-2875-10-308]; Prescott WR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-155; Rosas-Aguirre Ángel, 2010, Rev. perú. med. exp. salud publica, V27, P540, DOI 10.1590/s1726-46342010000400008; The malERA Consultative Group on Diagnoses and Diagnostics, 2011, PLOS MED, V8; Thomson S, 2000, ARCH PATHOL LAB MED, V124, P57; Viera AJ, 2005, FAM MED, V37, P360; WHO, 2009, MAL MICR QUAL ASS VE; Wilson ML, 2012, CLIN INFECT DIS, V54, P1637, DOI 10.1093/cid/cis228; World Health Organization, 2002, BENCH AIDS DIAGN MAL	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166170	10.1371/journal.pone.0166170	http://dx.doi.org/10.1371/journal.pone.0166170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893838	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400019
J	Bannerman, P; Burns, T; Xu, J; Miers, L; Pleasure, D				Bannerman, Peter; Burns, Travis; Xu, Jie; Miers, Laird; Pleasure, David			Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; MITOCHONDRIAL FUSION; SKELETAL-MUSCLE; MOUSE MODEL; MUTATIONS; MFN2; EXPRESSION; TRANSPORT; GENE; 2A	Charcot-Marie-Tooth disease type 2A (CMT2A), the most common axonal form of hereditary sensory motor neuropathy, is caused by mutations of mitofusin-2 (MFN2). Mitofusin-2 is a GTPase required for fusion of mitochondrial outer membranes, repair of damaged mitochondria, efficient mitochondrial energetics, regulation of mitochondrial-endoplasmic reticulum calcium coupling and axonal transport of mitochondria. We knocked T105M MFN2 preceded by a loxP-flanked STOP sequence into the mouse Rosa26 locus to permit cell type-specific expression of this pathogenic allele. Crossing these mice with nestin-Cre transgenic mice elicited T105M MFN2 expression in neuroectoderm, and resulted in diminished numbers of mitochondria in peripheral nerve axons, an alteration in skeletal muscle fiber type distribution, and a gait abnormality.	[Bannerman, Peter; Pleasure, David] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA; [Bannerman, Peter] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Burns, Travis; Xu, Jie; Miers, Laird; Pleasure, David] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bannerman, P (corresponding author), Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA.; Bannerman, P (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	pgbannerman@ucdavis.edu			Shriners Hospitals for Children; Hereditary Neuropathy Foundation	Shriners Hospitals for Children; Hereditary Neuropathy Foundation	This work was funded by Shriners Hospitals for Children and by a pilot grant from the Hereditary Neuropathy Foundation.	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Amiott EA, 2009, MOL BIOL CELL, V20, P5026, DOI 10.1091/mbc.E09-07-0622; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Chen G., 2015, J NANOMATER, V2015, P1, DOI DOI 10.18632/0NC0TARGET.4376; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Dubowitz V, 2013, EUROGENIC DISORDERS; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e; Feng HZ, AM J PHYSL CELL PHYS; Guo FZ, 2011, J NEUROSCI, V31, P11914, DOI 10.1523/JNEUROSCI.1759-11.2011; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Honda S, 2005, J CELL SCI, V118, P3153, DOI 10.1242/jcs.02449; Klein CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1295, DOI 10.1001/archneurol.2011.225; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; McCorquodale DS, 2011, J NEUROL, V258, P1234, DOI 10.1007/s00415-011-5910-7; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Moldovan M, 2016, EUR J NEUROSCI, V43, P388, DOI 10.1111/ejn.13047; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Saporta Mario A, 2014, Continuum (Minneap Minn), V20, P1208, DOI 10.1212/01.CON.0000455885.37169.4c; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strickland AV, 2014, J PERIPHER NERV SYST, V19, P152, DOI 10.1111/jns5.12066; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y; Vital A, 2012, NEUROMUSCULAR DISORD, V22, P735, DOI 10.1016/j.nmd.2012.04.001; Yu D, 2015, SURG RADIOL ANAT; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167573	10.1371/journal.pone.0167573	http://dx.doi.org/10.1371/journal.pone.0167573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907123	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700199
J	Chochua, S; D'Acremont, V; Hanke, C; Alfa, D; Shak, J; Kilowoko, M; Kyungu, E; Kaiser, L; Genton, B; Klugman, KP; Vidal, JE				Chochua, Sopio; D'Acremont, Valerie; Hanke, Christiane; Alfa, David; Shak, Joshua; Kilowoko, Mary; Kyungu, Esther; Kaiser, Laurent; Genton, Blaise; Klugman, Keith P.; Vidal, Jorge E.			Increased Nasopharyngeal Density and Concurrent Carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Are Associated with Pneumonia in Febrile Children	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; PNEUMOCOCCAL COLONIZATION; MICROBIAL INTERACTIONS; BACTERIAL INTERACTIONS; RESPIRATORY PATHOGENS; PCR; ACQUISITION; VACCINATION; INFECTIONS	Background We assessed nasopharyngeal (NP) carriage of five pathogens in febrile children with and without acute respiratory infection (ARI) of the upper (URTI) or lower tract, attending health facilities in Tanzania. Methods NP swabs collected from children (N = 960) aged 2 months to 10 years, and with a temperature >= 38 degrees C, were utilized to quantify bacterial density of S. pneumoniae (Sp), H. influenzae (Hi), M. catarrhalis (Mc), S. aureus (Sa), and N. meningitidis (Nm). We determined associations between presence of individual species, densities, or concurrent carriage of all species combination with respiratory diseases including clinical pneumonia, pneumonia with normal chest radiography (CXR) and endpoint pneumonia. Results Individual carriage, and NP density, of Sp, Hi, or Mc, but not Sa, or Nm, was significantly associated with febrile ARI and clinical pneumonia when compared to febrile non-ARI episodes. Density was also significantly increased in severe pneumonia when compared to mild URTI (Sp, p<0.002; Hi p<0.001; Mc, p = 0.014). Accordingly, concurrent carriage of sp(+), H1(+), and mc(+), in the absence of Sa-and Nm, was significantly more prevalent in children with ARI (p = 0.03), or clinical pneumonia (p<0.001) than non-ARI, and in children with clinical pneumonia (p = 0.0007) than URTI. Furthermore, sp(+), HI+, and Mc(+) differentiated children with pneumonia with normal CXR, or endpoint pneumonia, from those with URTI, and non-ARI cases. Conclusions Concurrent NP carriage of Sp, Hi, and Mc was a predictor of clinical pneumonia and identified children with pneumonia with normal CXR and endpoint pneumonia from those with febrile URTI, or non-ARI episodes.	[Chochua, Sopio; Hanke, Christiane; Alfa, David; Shak, Joshua; Klugman, Keith P.; Vidal, Jorge E.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [D'Acremont, Valerie; Genton, Blaise] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Basel, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Kilowoko, Mary] Amana Hosp, Dar Es Salaam, Tanzania; [Kyungu, Esther] St Francis Hosp, Ifakara, Tanzania; [Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Fac Med, Geneva, Switzerland; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland	Emory University; Rollins School Public Health; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Vidal, JE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jvidalg@emory.edu	Boillat-Blanco, Noémie/GLT-5579-2022	Kaiser, Laurent/0000-0002-0857-2252	National Institutes of Health NIH [R21AI112768-01A1]; Swiss National Science Foundation [3270B0-109696, IZ70Z0-124023, 32003B_127160]; Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation; National Institutes of Health (NIH) [R21AI112768-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health NIH) R21AI112768-01A1, Swiss National Science Foundation 3270B0-109696, IZ70Z0-124023 and 32003B_127160), the Commission for International Medicine of the University Hospital of Geneva, and the Bill and Melinda Gates Foundation. JEV was in part funded by a grant from the National Institutes of Health (NIH; R21AI112768-01A1). The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Grijalva CG, 2014, CLIN INFECT DIS, V58, P1369, DOI 10.1093/cid/ciu148; [Group WHOPVTI Biologicals DoVa], 2001, JCM, V39, P1021; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kaiser L, 2001, EUR J CLIN MICROBIOL, V20, P445, DOI 10.1007/s10096-001-8150-4; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Revai K, 2008, CLIN INFECT DIS, V46, pE34, DOI 10.1086/525856; Sakai F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067147; Sakal F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121064; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Xu QF, 2012, EMERG INFECT DIS, V18, P1738, DOI 10.3201/eid1811.111904	31	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167725	10.1371/journal.pone.0167725	http://dx.doi.org/10.1371/journal.pone.0167725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907156	Green Published, Green Accepted, gold			2022-12-27	WOS:000389482700226
J	Azevedo, APDS; Mezencio, B; Amadio, AC; Serrao, JC				da Silva Azevedo, Ana Paula; Mezencio, Bruno; Amadio, Alberto Carlos; Serrao, Julio Cerca			16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners	PLOS ONE			English	Article							FOOT-STRIKE PATTERNS; GROUND REACTION FORCES; NEUROMUSCULAR ADAPTATIONS; MINIMALIST FOOTWEAR; 1ST ATTEMPT; INJURIES; KNEE; BIOMECHANICS; KINEMATICS; EMG	Short-term effects of barefoot and simulated barefoot running have been widely discussed in recent years. Consequences of adopting barefoot running for a long period, including as a training approach, still remain unknown. The present study evaluated the influence of 16 weeks of progressive barefoot running training on impact force and muscle activation in habitual shod runners. Six habitual shod runners (3 men and 3 women, 29.5 +/- 7.3 years) were tested barefoot (BF) and shod (SH), before and after 16 weeks of progressive barefoot running training. Tests consisted of running on instrumented treadmill at 9 km/h, for 10 minutes in each experimental condition. Nine data acquisitions (10 s) of vertical ground reaction force (VGRF) and electromyographic (EMG) signal were conducted in each experimental condition for each test. BF training was effective to alter VGRF and EMG parameters of running in habitual shod runners, regardless of footwear condition (SH or BF). The magnitude of first peak of VGRF (Fy1) and the impulse of the first 50 ms decreased after training for BF and SH (p<0.01). The activation reduced from PRE to POST training for four muscles in BF running (p<0.001), whereas only muscle gastrocnemius lateralis decreased significantly its activation (p<0.01) in SH running. A 16-week progressive barefoot running training seems to be an effective training strategy to reduce impact force, improve shock attenuation and to decrease muscle activation intensity, not only in BF running, but also in SH running, although BF condition seems to be more influenced by BF training.	[da Silva Azevedo, Ana Paula; Mezencio, Bruno; Amadio, Alberto Carlos; Serrao, Julio Cerca] Univ Sao Paulo, Sch Phys Educ & Sport, Lab Biomech, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Azevedo, APDS (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Lab Biomech, Sao Paulo, SP, Brazil.	anaazevedo@usp.br	SERRÃO, JULIO CERCA/G-8499-2015; Azevedo, Ana P. S./E-9444-2016; Mezêncio, Bruno/AAX-3450-2020; Mezêncio, Bruno/W-4273-2019	SERRÃO, JULIO CERCA/0000-0002-3646-3387; Azevedo, Ana P. S./0000-0003-4866-145X; Mezêncio, Bruno/0000-0001-6293-5571; Mezêncio, Bruno/0000-0001-6293-5571	University of Sao Paulo (USP)	University of Sao Paulo (USP)	Authors would like to acknowledge the University of Sao Paulo (USP) which gave support to this research by the "USP in 2016 Olympic Games Program". Additionally, authors would like to thank the participants for their involvement in this study.	Altman AR, 2012, CURR SPORT MED REP, V11, P244, DOI 10.1249/JSR.0b013e31826c9bb9; An W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/240153; Bergstra S a, 2014, J SCI MED SPORT; Bonacci J, 2013, BRIT J SPORT MED, V47, P387, DOI 10.1136/bjsports-2012-091837; Bonacci J, 2009, SPORTS MED, V39, P903, DOI 10.2165/11317850-000000000-00000; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Cauthon David J, 2013, Foot (Edinb), V23, P100, DOI 10.1016/j.foot.2013.03.001; Cavanagh P.R., 1981, BIOMECHANICS 7, P151; Cheung RTH, 2014, HUM MOVEMENT SCI, V34, P120, DOI 10.1016/j.humov.2014.01.006; Cheung RT, 2016, SPORTS BIOMECH, V4, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1080/14763141.2016.1226381; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohler MH, 2015, SURVEY RUNNERS ATTIT; COOK SD, 1990, SPORTS MED, V10, P1, DOI 10.2165/00007256-199010010-00001; Azevedo APD, 2016, GAIT POSTURE, V46, P142, DOI [10.1016/j.gaitpost.2016.03.008, 10.1016/j.gaitpost.2016.03.003]; Daoud AI, 2012, MED SCI SPORT EXER, V44, P1325, DOI 10.1249/MSS.0b013e3182465115; Davis IS, 2016, BRIT J SPORT MED, V50, P887, DOI 10.1136/bjsports-2015-094579; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Divert C, 2008, INT J SPORTS MED, V29, P512, DOI 10.1055/s-2007-989233; Divert C, 2005, INT J SPORTS MED, V26, P593, DOI 10.1055/s-2004-821327; Ervilha UF, 2016, J SPORTS SCI, V414, P1; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fleming N, 2015, HUM MOVEMENT SCI, V42, P27, DOI 10.1016/j.humov.2015.04.008; Fredericson M, 2007, SPORTS MED, V37, P437, DOI 10.2165/00007256-200737040-00043; Gazendam MGJ, 2007, GAIT POSTURE, V25, P604, DOI 10.1016/j.gaitpost.2006.06.013; Hreljac A, 2004, MED SCI SPORT EXER, V36, P845, DOI 10.1249/01.MSS.0000126803.66636.DD; Khowailed IA, 2015, MED SCI MONITOR, V21, P2021, DOI 10.12659/MSM.893518; KOMI PV, 1987, INT J SPORTS MED, V8, P196, DOI 10.1055/s-2008-1025655; Lieberman DE, 2014, J SPORT HEALTH SCI, V3, P65, DOI 10.1016/j.jshs.2014.04.001; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Lohman EB, 2011, PHYS THER SPORT, V12, P151, DOI 10.1016/j.ptsp.2011.09.004; McCallion C, 2014, J SPORT SCI MED, V13, P280; McCarthy C, 2014, INT J SPORTS MED, V35, P443, DOI 10.1055/s-0033-1353215; McCarthy C, 2015, MED SCI SPORT EXER, V47, P1009, DOI 10.1249/MSS.0000000000000505; McLean L, 2003, J ELECTROMYOGR KINES, V13, P169, DOI 10.1016/S1050-6411(02)00051-2; Messier SP, 2008, MED SCI SPORT EXER, V40, P1873, DOI 10.1249/MSS.0b013e31817ed272; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; MONTGOMERY WH, 1994, AM J SPORT MED, V22, P272, DOI 10.1177/036354659402200220; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Olin ED, 2013, HUM MOVEMENT SCI, V32, P343, DOI 10.1016/j.humov.2012.11.005; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Rice HM, 2016, MED SCI SPORT EXER, P1; Ridge ST, 2013, MED SCI SPORT EXER, V45, P1363, DOI 10.1249/MSS.0b013e3182874769; ROBBINS SE, 1987, MED SCI SPORT EXER, V19, P148; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Rothschild CE, 2012, J STRENGTH COND RES, V26, P2021, DOI 10.1519/JSC.0b013e31823a3c54; Ryan M, 2014, BRIT J SPORT MED, V48, P1257, DOI 10.1136/bjsports-2012-092061; Sacco ICN, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-24; Sinclair J, 2014, CLIN BIOMECH, V29, P395, DOI 10.1016/j.clinbiomech.2014.02.004; Snow NJ, 2016, ACUTE BOUT BAREFOOT; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Squadrone R, 2015, J SPORT SCI, V33, P1196, DOI 10.1080/02640414.2014.989534; Strauts J, 2015, J SPORTS SCI, P1; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Trombini-Souza F, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-121; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Vibram, 2012, MIN RUNN, P1035, DOI [10.1016/j.jelekin.2010.07.004, DOI 10.1016/J.JELEKIN.2010.07.004]; Wakeling JM, 2002, MED SCI SPORT EXER, V34, P1529, DOI 10.1097/00005768-200209000-00021; Warne JP, 2014, SCAND J MED SCI SPOR, V24, P964, DOI 10.1111/sms.12121; Warne JP, 2014, SCAND J MED SCI SPOR, V24, P563, DOI 10.1111/sms.12032; Warne JP, 2015, HUM MOVEMENT SCI, V42, P183, DOI 10.1016/j.humov.2015.05.005; Willy RW, 2014, MED SCI SPORT EXER, V46, P318, DOI 10.1249/MSS.0b013e3182a595d2; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	65	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167234	10.1371/journal.pone.0167234	http://dx.doi.org/10.1371/journal.pone.0167234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907069	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700100
J	Li, ZG; Liu, BY; Yuan, MX; Zhang, FF; Guo, JQ				Li, Zhigang; Liu, Boying; Yuan, Mengxiong; Zhang, Feifei; Guo, Jiaqiang			Characterization of Initial Parameter Information for Lifetime Prediction of Electronic Devices	PLOS ONE			English	Article							FATIGUE LIFE; RESIDUAL LIFE; DEGRADATION; MODEL	Newly manufactured electronic devices are subject to different levels of potential defects existing among the initial parameter information of the devices. In this study, a characterization of electromagnetic relays that were operated at their optimal performance with appropriate and steady parameter values was performed to estimate the levels of their potential defects and to develop a lifetime prediction model. First, the initial parameter information value and stability were quantified to measure the performance of the electronics. In particular, the values of the initial parameter information were estimated using the probability-weighted average method, whereas the stability of the parameter information was determined by using the difference between the extrema and end points of the fitting curves for the initial parameter information. Second, a lifetime prediction model for small-sized samples was proposed on the basis of both measures. Finally, a model for the relationship of the initial contact resistance and stability over the lifetime of the sampled electromagnetic relays was proposed and verified. A comparison of the actual and predicted lifetimes of the relays revealed a 15.4% relative error, indicating that the lifetime of electronic devices can be predicted based on their initial parameter information.	[Li, Zhigang; Liu, Boying; Yuan, Mengxiong; Zhang, Feifei; Guo, Jiaqiang] Hebei Univ Technol, Dept Elect Engn, Tianjin, Peoples R China	Hebei University of Technology	Li, ZG (corresponding author), Hebei Univ Technol, Dept Elect Engn, Tianjin, Peoples R China.	zgli@hebut.edu.cn			National Key Technology Support Program [2015BAA091301]; Science and Technology Project of Hebei Province [14214503D]; Tianjin Science and Technology Commissioner Project [16JCTPJC50700]; National Natural Science Foundation of China [51475136]	National Key Technology Support Program(National Key Technology R&D Program); Science and Technology Project of Hebei Province; Tianjin Science and Technology Commissioner Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technology Support Program (Program No. 2015BAA091301), to Zhigang Li, (http://program.most.gov.cn/), Science and Technology Project of Hebei Province (Program No. 14214503D), to Zhigang Li, (http://zdsys.hebstd.gov.cn/), Tianjin Science and Technology Commissioner Project (Program No. 16JCTPJC50700), (http://www.tstc.gov.cn/), and National Natural Science Foundation of China (Program No. 51475136), (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2016, INT J FATIGUE, V85, P98, DOI 10.1016/j.ijfatigue.2015.12.002; Caesarendra W, 2010, EXPERT SYST APPL, V37, P2412, DOI 10.1016/j.eswa.2009.07.014; Deng YJ, 2016, IEEE T RELIAB, V65, P126, DOI 10.1109/TR.2015.2462353; Di MH, 2004, 39 INT U POW ENG C 2, P93; Fontana WJ, 1965, IEEE T PARTS MAT PAC, V1, P309; Gebraeel N, 2004, IEEE T IND ELECTRON, V51, P694, DOI 10.1109/TIE.2004.824875; Hammerschmidt M, 2004, IEEE T COMPON PACK T, V27, P12, DOI 10.1109/TCAPT.2004.825781; Jin G, 2013, RELIAB ENG SYST SAFE, V113, P7, DOI 10.1016/j.ress.2012.12.011; Lall P, 2015, J ELECTRON PACKAGING, V137, DOI 10.1115/1.4028957; Li WH, 2000, ELECTRICAL CONTACTS-2000: PROCEEDINGS OF THE FORTY-SIXTH IEEE HOLM CONFERENCE ON ELECTRICAL CONTACTS, P109, DOI 10.1109/HOLM.2000.889919; [李志刚 Li Zhigang], 2015, [电工技术学报, Transactions of China Electrotechnical Society], V30, P233; Lin ZH, 2010, HIGH VOLTAGE APPARAT, V46, P89; Liu Y, 2015, IEEE T RELIAB, V64, P1287, DOI 10.1109/TR.2015.2418294; [吕克洪 LV Ke-hong], 2009, [兵工学报, Acta Armamentarii], V30, P91; Madge JJ, 2007, WEAR, V262, P1159, DOI 10.1016/j.wear.2006.11.004; Neuhaus AR, 2011, P 50 IEEE C EL CONT, P3119; Pan ZQ, 2011, RELIAB ENG SYST SAFE, V96, P949, DOI 10.1016/j.ress.2011.03.014; RIEDER WF, 1991, IEEE T COMPON HYBR, V14, P109, DOI 10.1109/33.76518; Rivera DE, 2000, IEEE CONTR SYST MAG, V20, P25, DOI 10.1109/37.845036; Robinson Michael E, 2000, LIFETIME DATA ANAL; Rocco CM, 2013, IEEE T RELIAB, V62, P781, DOI 10.1109/TR.2013.2284737; Sharma A, 2003, PROCEEDINGS OF THE INTERNATIONAL 2003 SBMO/IEEE MTT-S INTERNATIONAL MICROWAVE AND OPTOELECTRONICS CONFERENCE - IMOC 2003, VOLS I AND II, P725; Sum WS, 2005, INT J FATIGUE, V27, P403, DOI 10.1016/j.ijfatigue.2004.08.001; Tian ZG, 2010, MECH SYST SIGNAL PR, V24, P1542, DOI 10.1016/j.ymssp.2009.11.005; Valentin R, 2008, MICROELECTRON RELIAB, V48, P1831, DOI 10.1016/j.microrel.2008.05.005; Wang W, 2010, PROGNOST SYST HEALT, P216; Wilkinson C, 2004, AEROSP CONF PROC, P3435, DOI 10.1109/AERO.2004.1368149; Yao F, 2004, ELECTRICAL CONTACTS-2004: PROCEEDINGS OF THE 50TH IEEE HOLM CONFERENCE ON ELECTRICAL CONTACTS/THE 22ND INTERNATIONAL CONFERENCE ON ELECTRICAL CONTACTS, P447, DOI 10.1109/HOLM.2004.1353155; Yao Fang, 2005, Proceedings of the CSEE, V25, P61; Yu Q, 2009, ICIEA: 2009 4TH IEEE CONFERENCE ON INDUSTRIAL ELECTRONICS AND APPLICATIONS, VOLS 1-6, P1266; Zhai GF, 2001, CHINESE SOC ELECT EN, V21, P91; Zhai Guo-fu, 2002, Proceedings of the CSEE, V22, P76; Zhang FS, 2012, SCI WORLD J, DOI 10.1100/2012/289896	33	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167429	10.1371/journal.pone.0167429	http://dx.doi.org/10.1371/journal.pone.0167429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907188	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700154
J	Nakajima, E; Shimaji, K; Umegawachi, T; Tomida, S; Yoshida, H; Yoshimoto, N; Izawa, S; Kimura, H; Yamaguchi, M				Nakajima, Ei; Shimaji, Kouhei; Umegawachi, Takanari; Tomida, Saki; Yoshida, Hideki; Yoshimoto, Nana; Izawa, Shingo; Kimura, Hiroshi; Yamaguchi, Masamitsu			The Histone Deacetylase Gene Rpd3 Is Required for Starvation Stress Resistance	PLOS ONE			English	Article							DROSOPHILA FAT-BODY; NUCLEOLAR STRUCTURE; MEDIATED REGULATION; AUTOPHAGY; ACETYLATION; EXPRESSION; TRANSLATION; TRANSCRIPTION; METHYLATION; METABOLISM	Epigenetic regulation in starvation is important but not fully understood yet. Here we identified the Rpd3 gene, a Drosophila homolog of histone deacetylase 1, as a critical epigenetic regulator for acquiring starvation stress resistance. Immunostaining analyses of Drosophila fat body revealed that the subcellular localization and levels of Rpd3 dynamically changed responding to starvation stress. In response to starvation stress, the level of Rpd3 rapidly increased, and it accumulated in the nucleolus in what appeared to be foci. These observations suggest that Rpd3 plays a role in regulation of rRNA synthesis in the nucleolus. The RT-qPCR and ChIP-qPCR analyses clarified that Rpd3 binds to the genomic region containing the rRNA promoters and activates rRNA synthesis in response to starvation stress. Polysome analyses revealed that the amount of polysomes was decreased in Rpd3 knockdown flies under starvation stress compared with the control flies. Since the autophagy-related proteins are known to be starvation stress tolerance proteins, we examined autophagy activity, and it was reduced in Rpd3 knockdown flies. Taken together, we conclude that Rpd3 accumulates in the nucleolus in the early stage of starvation, upregulates rRNA synthesis, maintains the polysome amount for translation, and finally increases stress tolerance proteins, such as autophagy-related proteins, to acquire starvation stress resistance.	[Nakajima, Ei; Shimaji, Kouhei; Umegawachi, Takanari; Tomida, Saki; Yoshida, Hideki; Yoshimoto, Nana; Izawa, Shingo; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan; [Nakajima, Ei; Shimaji, Kouhei; Umegawachi, Takanari; Tomida, Saki; Yoshida, Hideki; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; Tokyo Institute of Technology	Yamaguchi, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan.; Yamaguchi, M (corresponding author), Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto, Japan.	myamaguc@kit.ac.jp	Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X; Izawa, Shingo/0000-0002-4920-2450; Yamaguchi, Masamitsu/0000-0002-6321-9750	Japan Society for the Promotion of Science (JSPS); Asia-Africa Science Platforms; JSPS KAKENHI Grant [15J0948, 16K07346.]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asia-Africa Science Platforms; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by the Japan Society for the Promotion of Science (JSPS; https://www.jsps.go.jp/) Core-to-Core Program, Asia-Africa Science Platforms, JSPS KAKENHI Grant Number 15J0948 and 16K07346.	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barrio L, 2014, CELL REP, V8, P527, DOI 10.1016/j.celrep.2014.06.020; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cesarini E, 2012, MOL BIOL CELL, V23, P2770, DOI 10.1091/mbc.E12-02-0095; Darling N.J., 2014, SCI REP-UK, V1843, P2150, DOI DOI 10.1016/J.BBAMCR.2014.01.009; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Eng CH, 2011, ONCOGENE, V30, P4687, DOI 10.1038/onc.2011.220; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Jin M, 2014, AUTOPHAGY, V10, P1681, DOI 10.4161/auto.29641; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Koutsounas I, 2013, WORLD J GASTROENTERO, V19, P813, DOI 10.3748/wjg.v19.i6.813; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Li W, 2014, DEVELOPMENT, V141, P3910, DOI 10.1242/dev.109306; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MIAN A, 1990, NUCLEIC ACIDS RES, V18, P3795, DOI 10.1093/nar/18.13.3795; Mikawa T, 2010, GENES CELLS, V15, P229, DOI 10.1111/j.1365-2443.2009.01376.x; Musselman LP, 2013, J BIOL CHEM, V288, P8028, DOI 10.1074/jbc.M112.371047; Naveed Sidra, 2014, Oman Med J, V29, P391, DOI 10.5001/omj.2014.107; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; Pritchett TL, 2012, CELL DEATH DIFFER, V19, P1069, DOI 10.1038/cdd.2011.200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	45	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167554	10.1371/journal.pone.0167554	http://dx.doi.org/10.1371/journal.pone.0167554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907135	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700192
J	Nguyen, V; Rizzo, J; Sanii, B				Nguyen, Victoria; Rizzo, John; Sanii, Babak			An Assemblable, Multi-Angle Fluorescence and Ellipsometric Microscope	PLOS ONE			English	Article							IMAGING ELLIPSOMETRY; PHOSPHOLIPID-MEMBRANES; VISUALIZATION	We introduce a multi-functional microscope for research laboratories that have significant cost and space limitations. The microscope pivots around the sample, operating in upright, inverted, side-on and oblique geometries. At these geometries it is able to perform brightfield, fluorescence and qualitative ellipsometric imaging. It is the first single instrument in the literature to be able to perform all of these functionalities. The system can be assembled by two undergraduate students from a provided manual in less than a day, from off-the-shelf and 3D printed components, which together cost approximately $ 16k at 2016 market prices. We include a highly specified assembly manual, a summary of design methodologies, and all associated 3D-printing files in hopes that the utility of the design outlives the current component market. This open design approach prepares readers to customize the instrument to specific needs and applications. We also discuss how to select household LEDs as low-cost light sources for fluorescence microscopy. We demonstrate the utility of the microscope in varied geometries and functionalities, with particular emphasis on studying hydrated, solidsupported lipid films and wet biological samples.	[Nguyen, Victoria; Sanii, Babak] Scripps Coll, Keck Sci Dept, Claremont, CA 91711 USA; [Rizzo, John; Sanii, Babak] Claremont Mckenna Coll, Keck Sci Dept, Claremont, CA 91711 USA; [Sanii, Babak] Pitzer Coll, Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Scripps College; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Pitzer College	Sanii, B (corresponding author), Scripps Coll, Keck Sci Dept, Claremont, CA 91711 USA.; Sanii, B (corresponding author), Claremont Mckenna Coll, Keck Sci Dept, Claremont, CA 91711 USA.; Sanii, B (corresponding author), Pitzer Coll, Keck Sci Dept, Claremont, CA 91711 USA.	bsanii@kecksci.claremont.edu	Rizzo, J. Ricardo/N-5879-2014	Rizzo, J. Ricardo/0000-0002-8443-6631	Department of Keck Science; S.D. Bechtel, Jr. Foundation [5666]	Department of Keck Science; S.D. Bechtel, Jr. Foundation	This project was primarily funded through startup funds via the Department of Keck Science (https://www.kecksci.claremont.edu). Additionally, one of the co-authors (Victoria Nguyen, VN) was funded for a summer through the S.D. Bechtel, Jr. Foundation (http://sdbjrfoundation.org, Grant ID #5666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate advice and assistance from W. Cook and A. Schwartzberg, and spectrophotometer assistance from L. Schmitz. We thank J. Zehner and M. Swift who test-assembled the device from parts and the manual in a day, as well as T. Liu and C. Hu who prepared lipid-spreading samples for ellipsometry. Yeast and brain-tissue samples were generously provided by the laboratories of Z.I. Tang and R. Spence respectively. We gratefully acknowledge summer financial support of V.N. through the S.D. Bechtel Jr. Foundation (Grant ID 5666).	[Anonymous], COMMUNICATION; ASPNES DE, 1975, APPL OPTICS, V14, P220, DOI 10.1364/AO.14.000220; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azzam R.M., 1987, ELLIPSOMETRY POLARIZ, V3rd, DOI [10.1063/1.2994821, DOI 10.1063/1.2994821]; Baden T, 2015, PLOS COLLECTIONS; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Campbell RAA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088977; Carnahan RH, 2005, EUKARYOT CELL, V4, P577, DOI 10.1128/EC.4.3.577-587.2005; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781; Davis JL, 2014, THERM MECH MULT SIM, P1, DOI 10.1109/; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Dougherty Dale, 2012, DISPLAY DESIGN IDEAS, V27, P80, DOI [10.1162/INOV_a_00135, DOI 10.1162/INOV_A_00135]; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Faiss S, 2007, J PHYS CHEM B, V111, P13979, DOI 10.1021/jp073671t; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Greenbaum A, 2012, LAB CHIP, V12, P1242, DOI 10.1039/c2lc21072j; Hilfiker JN, 2003, J VAC SCI TECHNOL A, V21, P1103, DOI 10.1116/1.1569928; HONIG D, 1991, J PHYS CHEM-US, V95, P4590, DOI 10.1021/j100165a003; Howland MC, 2007, BIOPHYS J, V92, P1306, DOI 10.1529/biophysj.106.097071; Jin G, 1996, REV SCI INSTRUM, V67, P2930, DOI 10.1063/1.1147074; JIN G, 1995, ANAL BIOCHEM, V232, P69, DOI 10.1006/abio.1995.9959; Kintel M., 2011, OPENSCAD PROGRAMMERS; Kohler A., 1894, J R MICROSCOP SOC, V14, P261, DOI DOI 10.1111/J.1365-2818.1894; Kondoh E., SPREADSHEET ELLIPSOM; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Liu KN, 2015, SOFT MATTER, V11, P8217, DOI 10.1039/c5sm02013a; LOSCHE M, 1983, BER BUNSEN PHYS CHEM, V87, P848, DOI 10.1002/bbpc.19830871004; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Mota C., 2011, PROC 8 ACM C CREATIV, P279, DOI [10.1145/2069618.2069665, DOI 10.1145/2069618.2069665]; MULLER RH, 1969, SURF SCI, V16, P14, DOI 10.1016/0039-6028(69)90003-X; NADKARNI GD, 1992, EUROPHYS LETT, V20, P523, DOI 10.1209/0295-5075/20/6/009; NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1998, DOI 10.1143/JJAP.30.L1998; Nissen J, 1999, EUR PHYS J B, V10, P335, DOI 10.1007/s100510050862; Phillips ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124938; Rosenegger DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110475; Sharkey JP, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941068; Shin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011218; Smith JL, 1852, AM J SCI ARTS, VXIV; Stewart C, 2016, J CHEM EDUC, V93, P1310, DOI 10.1021/acs.jchemed.5b00984; Sung YL, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.4.047005; Tapley A, 2013, J CLIN MICROBIOL, V51, P1774, DOI 10.1128/JCM.03432-12; Tompkins H, 2005, HDB ELLIPSOMETRY; Tompkins HG, 2012, USERS GUIDE ELLIPSOM; Wilczynski V., 2015, P 2015 ASEE ANN C EX, DOI 10.18260/p.23477; Wirth M, 2014, P EUR C INF SYST ECI; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Young MD, 2015, ADV OPT PHOTONICS, V7, P276, DOI 10.1364/AOP.7.000276; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166735	10.1371/journal.pone.0166735	http://dx.doi.org/10.1371/journal.pone.0166735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907008	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700037
J	Steegen, K; Carmona, S; Bronze, M; Papathanasopoulos, MA; van Zyl, G; Goedhals, D; MacLeod, W; Sanne, I; Stevens, WS				Steegen, Kim; Carmona, Sergio; Bronze, Michelle; Papathanasopoulos, Maria A.; van Zyl, Gert; Goedhals, Dominique; MacLeod, William; Sanne, Ian; Stevens, Wendy S.			Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE PATIENTS; VIROLOGICAL FAILURE; SUBTYPE-B; MUTATIONS; THERAPY; SURVEILLANCE; TRANSMISSION; PREVALENCE; INDIVIDUALS	Background In order to assess the level of transmitted and/or pre-treatment antiretroviral drug resistance to HIV-1, the World Health Organization (WHO) recommends that regular surveys are conducted. This study's objective was to assess the frequency of HIV-1 antiretroviral drug resistance in patients initiating antiretroviral treatment (ART) in the public sector throughout South Africa. Methods A prospective cross-sectional survey was conducted using probability proportional to size sampling. This method ensured that samples from each province were proportionally collected, based on the number of patients receiving ART in each region. Samples were collected between March 2013 and October 2014. Po/sequences were obtained using RTPCR and Sanger sequencing and submitted to the Stanford Calibrated Population Resistance tool v6.0. Results A total of 277 sequences were available for analysis. Most participants were female (58.8%) and the median age was 34 years (IQR: 29-42). The median baseline CD4-count was 149 cells/mm3 (IQR: 62-249) and, based on self-reporting, participants had been diagnosed as HIV-positive approximately 44 days prior to sample collection (IQR: 23-179). Subtyping revealed that 98.2% were infected with HIV-1 subtype C. Overall, 25 out of 277 patients presented with >= 1 surveillance drug resistance mutation (SDRM, 9.0%, 95% CI: 6.1-13.0%). Non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations were the most numerous mutations detected (n = 23). Only two patients presented with a protease inhibitor (PI) mutation. In four patients >= 4 SDRMs were detected, which might indicate that these patients were not truly ART-naive or were infected with a multi-resistant virus. Conclusions These results show that the level of antiretroviral drug resistance in ART-na ve South Africans has reached moderate levels, as per the WHO classification. Therefore, regular surveys of pre-treatment drug resistance levels in all regions of South Africa is highly recommended to monitor the changing levels of pre-treatment antiretroviral drug resistance.	[Steegen, Kim; Carmona, Sergio; Papathanasopoulos, Maria A.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Carmona, Sergio; Bronze, Michelle; van Zyl, Gert; Goedhals, Dominique; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [van Zyl, Gert] Univ Stellenbosch, Div Med Virol, Stellenbosch, South Africa; [Goedhals, Dominique] Univ Free State, Dept Med Microbiol & Virol, Bloemfontein, South Africa; [MacLeod, William] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [MacLeod, William] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Sanne, Ian] Right Care, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; Stellenbosch University; University of the Free State; Boston University; University of Witwatersrand	Steegen, K (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa.	kim.steegen@nhls.ac.za	van Zyl, Gert/I-7357-2019; Steegen, Kim/ABH-4471-2020; Sanne, Ian/ABH-2231-2020; Steegen, K/AAF-6512-2020	van Zyl, Gert/0000-0003-3021-5101; Steegen, Kim/0000-0003-3226-7685; Carmona, Sergio/0000-0002-6792-4748; MacLeod, William/0000-0001-8003-8874	Global Fund to Fight AIDS, Tuberculosis and Malaria (SAF-H-RTC)	Global Fund to Fight AIDS, Tuberculosis and Malaria (SAF-H-RTC)	The survey was funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria (SAF-H-RTC, www.theglobalfund.org). The views described herein are the views of the researchers involved, and do not represent the views or opinions of the Global Fund to Fight AIDS, Tuberculosis & Malaria, nor is there any approval or authorisation of this material, express or implied, by the Global Fund to Fight AIDS, Tuberculosis and Malaria. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Bronze M., 1 INT C AFR SOC LAB; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Claassen M, 2008, IMPROVEMENT VALIDATI; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Jacobs GB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090845; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Lukhwareni A, 2012, PATHP C PATHP C CAP; Manasa J, 2016, AIDS RES HUMAN RETRO; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Nichols BE, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19164; Nwobegahay JM, 2011, J HEALTH POPUL NUTR, V29, P303, DOI 10.3329/jhpn.v29i4.8444; Orrell C, 2009, ANTIVIR THER, V14, P523; Parboosing R, 2011, J MED VIROL, V83, P1508, DOI 10.1002/jmv.22143; Parikh UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059787; Pillay V, 2008, ANTIVIR THER, V13, P101; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Richard N, 2004, AIDS RES HUM RETROV, V20, P355, DOI 10.1089/088922204323048104; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, UNAIDS ANN GOAL 15 M; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; World Health Organization, 2012, HIV DRUG RES REP 201	33	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166305	10.1371/journal.pone.0166305	http://dx.doi.org/10.1371/journal.pone.0166305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907009	Green Published, gold			2022-12-27	WOS:000389482700023
J	Tian, X; Patel, K; Ridpath, JR; Chen, YJ; Zhou, YH; Neo, D; Clement, J; Takata, M; Takeda, S; Sale, J; Wright, FA; Swenberg, JA; Nakamura, J				Tian, Xu; Patel, Keyur; Ridpath, John R.; Chen, Youjun; Zhou, Yi-Hui; Neo, Dayna; Clement, Jean; Takata, Minoru; Takeda, Shunichi; Sale, Julian; Wright, Fred A.; Swenberg, James A.; Nakamura, Jun			Homologous Recombination and Translesion DNA Synthesis Play Critical Roles on Tolerating DNA Damage Caused by Trace Levels of Hexavalent Chromium	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ACCESSORY SUBUNITS; CANCER-MORTALITY; MAMMALIAN-CELLS; POLYMERASE-ZETA; CR(VI) EXPOSURE; DRINKING-WATER; CROSS-LINKING	Contamination of potentially carcinogenic hexavalent chromium (Cr(VI)) in the drinking water is a major public health concern worldwide. However, little information is available regarding the biological effects of a nanomoler amount of Cr(VI). Here, we investigated the genotoxic effects of Cr(VI) at nanomoler levels and their repair pathways. We found that DNA damage response analyzed based on differential toxicity of isogenic cells deficient in various DNA repair proteins is observed after a three-day incubation with K2CrO4 in REV1-deficient DT40 cells at 19.2 mu g/L or higher as well as in TK6 cells deficient in polymerase delta subunit 3 (POLD3) at 9.8 mu g/L or higher. The genotoxicity of Cr(VI) decreased similar to 3000 times when the incubation time was reduced from three days to ten minutes. TK mutation rate also significantly decreased from 6 day to 1 day exposure to Cr(VI). The DNA damage response analysis suggest that DNA repair pathways, including the homologous recombination and REV1- and POLD3-mediated error-prone translesion synthesis pathways, are critical for the cells to tolerate to DNA damage caused by trace amount of Cr(VI).	[Tian, Xu; Patel, Keyur; Ridpath, John R.; Neo, Dayna; Clement, Jean; Swenberg, James A.; Nakamura, Jun] Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA; [Chen, Youjun] Univ North Carolina Chapel Hill, Dept Neurol, UNC Neurosci Ctr, Sch Med, Chapel Hill, NC USA; [Zhou, Yi-Hui; Wright, Fred A.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Zhou, Yi-Hui; Wright, Fred A.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Takata, Minoru] Kyoto Univ, Lab DNA Damage Signaling, Dept Late Effects Studies, Ctr Radiat Biol, Kyoto, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan; [Sale, Julian] MRC, Mol Biol Lab, Cambridge, England; [Wright, Fred A.] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Swenberg, James A.] Univ North Carolina Chapel Hill, Curriculum Toxicol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Kyoto University; Kyoto University; MRC Laboratory Molecular Biology; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Nakamura, J (corresponding author), Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA.; Wright, FA (corresponding author), North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.; Wright, FA (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Wright, FA (corresponding author), North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	fred_wright@ncsu.edu; ynakamur@ernail.unc.edu	Takata, Minoru/K-3772-2019	Neo, Dayna/0000-0001-7044-7260; Takata, Minoru/0000-0002-4926-3675; Nakamura, Jun/0000-0002-1756-7199; Takeda, Shunichi/0000-0002-7924-7991; Sale, Julian/0000-0002-5031-3780; Zhou, Yi-Hui/0000-0002-4092-7463	National Institutes of Health [P42 ES005948, P30 ES010126]; Medical Research Council [MC_U105178808] Funding Source: researchfish; MRC [MC_U105178808] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, T32ES007126, P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was fully supported by grants from the National Institutes of Health (P42 ES005948, P30 ES010126 to JAS and JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RA, 1989, SCI TOTAL ENVIRON, V86, P75, DOI 10.1016/0048-9697(89)90196-4; [Anonymous], 2012, U S EPA 100 R 12 001; [Anonymous], 2000, AG TOX SUBST DIS REG; Arakawa H, 2008, CHEM RES TOXICOL, V21, P1284, DOI 10.1021/tx800046y; Beaumont JJ, 2008, EPIDEMIOLOGY, V19, P12, DOI 10.1097/EDE.0b013e31815cea4c; BRIDGEWATER LC, 1994, CARCINOGENESIS, V15, P2421, DOI 10.1093/carcin/15.11.2421; Bryant HE, 2006, MUTAT RES-FUND MOL M, V599, P116, DOI 10.1016/j.mrfmmm.2006.02.001; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ha LN, 2004, CARCINOGENESIS, V25, P2265, DOI 10.1093/carcin/bgh242; Hu J, 2012, ENVIRON SCI TECHNOL, V46, P4607, DOI 10.1021/es300020e; Ishiai Masamichi, 2012, Methods Mol Biol, V920, P39, DOI 10.1007/978-1-61779-998-3_4; Ji K, 2011, ENVIRON SCI TECHNOL, V45, P7481, DOI 10.1021/es200724x; Johnson AJ, 2016, METALLOMICS, V8, P542, DOI 10.1039/c6mt00039h; Kerger BD, 2009, J TOXICOL ENV HEAL A, V72, P329, DOI 10.1080/15287390802529898; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Liu FJ, 2009, TOXICOL SCI, V110, P307, DOI 10.1093/toxsci/kfp104; Liu KJ, 2001, MOL CELL BIOCHEM, V222, P41, DOI 10.1023/A:1017994720562; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Messer J, 2006, FREE RADICAL BIO MED, V40, P1981, DOI 10.1016/j.freeradbiomed.2006.01.028; Morse JL, 2013, CHEM RES TOXICOL, V26, P1591, DOI 10.1021/tx400293s; National Toxicology P, 2008, NATL TOXICOLOGY PROG, P1; O'Brien TJ, 2005, MOL CELL BIOCHEM, V279, P85, DOI 10.1007/s11010-005-8225-0; O'Brien TJ, 2002, DNA REPAIR, V1, P617, DOI 10.1016/S1568-7864(02)00078-2; O'Brien TJ, 2009, MUTAT RES-FUND MOL M, V663, P77, DOI 10.1016/j.mrfmmm.2009.01.012; Reynolds M, 2004, J BIOL CHEM, V279, P30419, DOI 10.1074/jbc.M402486200; Reynolds M, 2007, NUCLEIC ACIDS RES, V35, P465, DOI 10.1093/nar/gkl1069; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Ridpath JR, 2011, ENVIRON MOL MUTAGEN, V52, P153, DOI 10.1002/em.20595; Santoyo G, 2008, MICROBIOL RES, V163, P113, DOI 10.1016/j.micres.2007.09.001; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Sugden KD, 1997, CHEM RES TOXICOL, V10, P1397, DOI 10.1021/tx970135r; Sugden KD, 2001, CHEM RES TOXICOL, V14, P1315, DOI 10.1021/tx010088+; Sutton R., 2010, CHROMIUM 6 US TAP WA, P1; Suzuki Aussie, 2011, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0807s50; USEPA, 2010, EPA635R10004A; Vilcheck SK, 2002, ENVIRON HEALTH PERSP, V110, P773, DOI 10.1289/ehp.02110s5773; Vilcheck SK, 2006, MUTAT RES-GEN TOX EN, V610, P21, DOI 10.1016/j.mrgentox.2006.06.009; VOITKUN V, 1994, ENVIRON HEALTH PERSP, V102, P251, DOI 10.2307/3431796; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Xie H, 2005, MUTAT RES-GEN TOX EN, V586, P160, DOI 10.1016/j.mrgentox.2005.06.002; Zecevic A, 2010, MUTAGENESIS, V25, P381, DOI 10.1093/mutage/geq017; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+; Zhitkovich A, 1996, BIOCHEMISTRY-US, V35, P7275, DOI 10.1021/bi960147w; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t	44	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167503	10.1371/journal.pone.0167503	http://dx.doi.org/10.1371/journal.pone.0167503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907204	Green Published, gold			2022-12-27	WOS:000389482700172
J	Wang, HS; Zhai, KL; Xue, YC; Yang, J; Yang, Q; Fu, Y; Hu, Y; Liu, F; Wang, WQ; Cui, LX; Chen, H; Zhang, JM; He, W				Wang, Huaishan; Zhai, Kangle; Xue, Yingchao; Yang, Jia; Yang, Qi; Fu, Yi; Hu, Yu; Liu, Fang; Wang, Weiqing; Cui, Lianxian; Chen, Hui; Zhang, Jianmin; He, Wei			Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile	PLOS ONE			English	Article							TRANSLOCATOR PROTEIN TSPO; POSITRON-EMISSION-TOMOGRAPHY; CELL-TARGETED DELETION; 18 KDA TSPO; BENZODIAZEPINE-RECEPTOR; MOUSE MODEL; CHOLESTEROL TRANSPORT; CRUCIAL ROLE; IN-VIVO; STEROIDOGENESIS	Translocator Protein (18kDa, TSPO) is a mitochondrial outer membrane transmembrane protein. Its expression is elevated during inflammation and injury. However, the function of TSPO in vivo is still controversial. Here, we constructed a TSPO global knockout (KO) mouse with a Cre-LoxP system that abolished TSPO protein expression in all tissues and showed normal phenotypes in the physiological condition. The birth rates of TSPO heterozygote (Het) x Het or KO x KO breeding were consistent with Mendel's Law, suggesting a normal viability of TSPO KO mice at birth. RNA-seq analysis showed no significant difference in the gene expression profile of lung tissues from TSPO KO mice compared with wild type mice, including the genes associated with bronchial alveoli immune homeostasis. The alveolar macrophage population was not affected by TSPO deletion in the physiological condition. Our findings contradict the results of Papadopoulos, but confirmed Selvaraj's findings. This study confirms TSPO deficiency does not affect viability and bronchial alveolar immune homeostasis.	[Wang, Huaishan; Zhai, Kangle; Xue, Yingchao; Yang, Jia; Yang, Qi; Fu, Yi; Hu, Yu; Cui, Lianxian; Chen, Hui; Zhang, Jianmin; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Res Ctr Pediat Dev & Dis, Dept Immunol, Beijing, Peoples R China; [Wang, Huaishan; Zhai, Kangle; Xue, Yingchao; Yang, Jia; Yang, Qi; Fu, Yi; Hu, Yu; Cui, Lianxian; Chen, Hui; Zhang, Jianmin; He, Wei] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Liu, Fang] Beijing Thorgene Med Lab, Yizhuang Biomed Pk, Beijing, Peoples R China; [Wang, Weiqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Wang, Weiqing] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JM; He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Res Ctr Pediat Dev & Dis, Dept Immunol, Beijing, Peoples R China.; Zhang, JM; He, W (corresponding author), Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing, Peoples R China.	jzhang42@163.com; heweingd@126.com	Wang, Huaishan/P-1882-2014; YANG, JIA/AAW-3653-2021	Wang, Huaishan/0000-0002-8686-4357; YANG, JIA/0000-0002-3992-4070; Xue, Yingchao/0000-0002-7830-3146; Wang, Weiqing/0000-0002-9440-1117	National Natural Science Foundation of China [31471016]; CAMS Initiative for Innovative Medicine [2016-I2M-1-008]; PUMC Scholarship [3332015109]; CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses [2016ZX310182-3]; Beijing Thorgene Medical Laboratory	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine; PUMC Scholarship; CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses; Beijing Thorgene Medical Laboratory	This study was supported by grants from National Natural Science Foundation of China to JZ (31471016), CAMS Initiative for Innovative Medicine to JZ (2016-I2M-1-008), PUMC Scholarship for Young Scientists to HW (3332015109) and CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses to HW (2016ZX310182-3). Beijing Thorgene Medical Laboratory provided support in the form of salaries for author FL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'Author Contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from National Natural Science Foundation of China to JZ (31471016), CAMS Initiative for Innovative Medicine to JZ (2016-I2M-1-008), PUMC Scholarship for Young Scientists to HW (3332015109) and CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses to HW (2016ZX310182-3). Beijing Thorgene Medical Laboratory provided support in the form of salary for FL, but did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. Austin Cape at ASJ Editors for careful review and feedback.	Anders S, 2012, DIFFERENTIAL EXPRESS; Anders S., 2010, MOL BIOL+, V43, P1, DOI DOI 10.1186/GB-2010-11-10-R106; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Daugherty DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22556; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Gavish M, 1999, PHARMACOL REV, V51, P629; Guilarte TR, 2016, TRENDS PHARMACOL SCI, V37, P334, DOI 10.1016/j.tips.2016.02.008; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Hatori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045065; Hatty CR, 2015, PHARMACOL RES, V100, P58, DOI 10.1016/j.phrs.2015.07.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Middleton RJ, 2015, BIOCHEM SOC T, V43, P553, DOI 10.1042/BST20150039; Mirzaei N, 2016, GLIA, V64, P993, DOI 10.1002/glia.22978; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Selvaraj V, 2016, P NATL ACAD SCI USA, V112, P7261; Selvaraj V, 2016, J ENDOCRINOL, V231, pR1, DOI 10.1530/JOE-16-0241; Selvaraj V, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00091; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Selvaraj V, 2015, MOL ENDOCRINOL, V29, P490, DOI 10.1210/me.2015-1033; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tu LN, 2016, ENDOCRINOLOGY, V157, P1110, DOI 10.1210/en.2015-1795; Tu LN, 2015, ENDOCRINOLOGY, V156, P1033, DOI 10.1210/en.2014-1707; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Wang WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26604; Yin SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14432; Yin SS, 2013, J BIOL CHEM, V288, P26448, DOI 10.1074/jbc.M113.484600; Zhao AH, 2016, J BIOL CHEM, V291, P1591, DOI 10.1074/jbc.M115.686360	51	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167307	10.1371/journal.pone.0167307	http://dx.doi.org/10.1371/journal.pone.0167307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907096	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700115
J	Richard, G; Cox, SL; Picard, B; Vacquie-Garcia, J; Guinet, C				Richard, Gaetan; Cox, Samantha L.; Picard, Baptiste; Vacquie-Garcia, Jade; Guinet, Christophe			Southern Elephant Seals Replenish Their Lipid Reserves at Different Rates According to Foraging Habitat	PLOS ONE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; ACCELERATION DATA LOGGERS; MIROUNGA-LEONINA; ENERGY-EXPENDITURE; STROKING PATTERNS; STABLE-ISOTOPES; MARINE PREDATOR; BODY CONDITION; OCEAN; BEHAVIOR	Assessing energy gain and expenditure in free ranging marine predators is difficult. However, such measurements are critical if we are to understand how variation in foraging efficiency, and in turn individual body condition, is impacted by environmentally driven changes in prey abundance and/or accessibility. To investigate the influence of oceanographic habitat type on foraging efficiency, ten post-breeding female southern elephant seals Mirounga leonina (SES) were equipped and tracked with bio-loggers to give continuous information of prey catch attempts, body density and body activity. Variations in these indices of foraging efficiency were then compared between three different oceanographic habitats, delineated by the main frontal structures of the Southern Ocean. Results show that changes in body density are related not only to the number of previous prey catch attempts and to the body activity (at a 6 day lag), but also foraging habitat type. For example, despite a lower daily prey catch attempt rate, SESs foraging north of the sub-Antarctic front improve their body density at a higher rate than individuals foraging south of the sub-Antarctic and polar fronts, suggesting that they may forage on easier to catch and/or more energetically rich prey in this area. Our study highlights a need to understand the influence of habitat type on top predator foraging behaviour and efficiency when attempting a better comprehension of marine ecosystems.	[Richard, Gaetan; Cox, Samantha L.; Picard, Baptiste; Vacquie-Garcia, Jade; Guinet, Christophe] CEBC CNRS, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Richard, G; Guinet, C (corresponding author), CEBC CNRS, Villiers En Bois, France.	gaetan-gs.richard@laposte.net; christophe.guinet@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020; Cox, S L/ABD-5059-2021; Cox, S L/AEX-9613-2022	Cox, S L/0000-0002-5409-4458; Cox, S L/0000-0002-5409-4458; Baptiste, Picard/0000-0001-9565-9446; VACQUIE GARCIA, Jade/0000-0002-3126-3423; Richard, Gaetan/0000-0003-3709-2909	IPEV program [109]; Total Foundation	IPEV program; Total Foundation(Total SA)	This study is part of Institut Paul Emile Victor; IPEV program no. 109 led by H. Weimerskirch and the national observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02. This work was carried out in the framework of the ANR Blanc MYCTO-3D-MAP and ANR VMC 07: IPSOS-SEAL programs and CNES-TOSCA program (Elephants de mer oceanographes'). The funder, Total Foundation, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all the Kerguelen fieldworkers involved in data collection. We are also grateful to Dr. Martin Biuw and two anonymous reviewers for their insightful comments. This study is part of the Institut Paul Emile Victor; IPEV program no. 109 led by H. Weimerskirch and the national observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02). This work was carried out in the framework of the ANR Blanc MYCTO-3D-MAP and ANR VMC 07: IPSOS-SEAL programs and CNES-TOSCA program ('Elephants de mer oceanographes'). The authors wish to additionally thank the Total Foundation for financial support.	Adachi T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2120; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Authier M, 2012, P ROY SOC B-BIOL SCI, V279, P2681, DOI 10.1098/rspb.2012.0199; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Daneri GA, 2002, POLAR BIOL, V25, P739, DOI 10.1007/s00300-002-0408-5; Davies NB, 2012, INTRO BEHAV ECOLOGY; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Field IC, 2007, MAR BIOL, V150, P1441, DOI 10.1007/s00227-006-0417-y; Gallon S, 2013, DEEP-SEA RES PT II, V88-89, P14, DOI 10.1016/j.dsr2.2012.09.002; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Hulley PA., 1981, RESULTS RES CRUISES; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kooyman G. L., 1965, Polar Record, V12, P391; McConnell BJ, 1992, ANTARCT SCI, V4, DOI [10.1017/S0954102092000590, DOI 10.1017/S0954102092000590]; McIntyre T, 2011, MAR ECOL PROG SER, V441, P257, DOI 10.3354/meps09383; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Mori Y, 1998, J ZOOL, V245, P279, DOI 10.1111/j.1469-7998.1998.tb00102.x; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Noren DP, 2002, PHYSIOL BIOCHEM ZOOL, V75, P513, DOI 10.1086/342254; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Park YH, 1998, J MARINE SYST, V17, P5, DOI 10.1016/S0924-7963(98)00026-8; PARK YH, 1991, MAR CHEM, V35, P45, DOI 10.1016/S0304-4203(09)90007-X; Pinheiro J., 2006, MIXED EFFECTS MODELS; Richard G, 2014, J EXP BIOL, V217, P2609, DOI 10.1242/jeb.088542; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Schick RS, 2013, J ANIM ECOL, V82, P1300, DOI 10.1111/1365-2656.12102; SLIP DJ, 1995, CAN J ZOOL, V73, P1519, DOI 10.1139/z95-180; Thums M, 2008, MAR ECOL PROG SER, V370, P249, DOI 10.3354/meps07613; Vacquie-Garcia J, 2015, MAR ECOL PROG SER, V541, P265, DOI 10.3354/meps11511; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; WHITWORTH T, 1987, J GEOPHYS RES-OCEANS, V92, P6462, DOI 10.1029/JC092iC06p06462; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28; Yoda K, 1999, J EXP BIOL, V202, P3121	44	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166747	10.1371/journal.pone.0166747	http://dx.doi.org/10.1371/journal.pone.0166747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902786	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100037
J	Lind, T; Ekebom, A; Kubler, KA; Ostensson, P; Bellander, T; Lohmus, M				Lind, Tomas; Ekebom, Agneta; Kubler, Kerstin Alm; Ostensson, Pia; Bellander, Tom; Lohmus, Mare			Pollen Season Trends (1973-2013) in Stockholm Area, Sweden	PLOS ONE			English	Article							BIRCH POLLEN; CLIMATE-CHANGE; AIRBORNE POLLEN; GRASS-POLLEN; ALLERGIC RHINITIS; BETULA POLLEN; START; PREVALENCE; QUANTITIES; EXPOSURE	In the present study, the phenological and quantitative changes in the pollen seasons between 1973 and 2013 in the Stockholm region of Sweden were studied for nine types of pollen (hazel, alder, elm, birch, oak, grass, mugwort, willow and pine). Linear regression models were used to estimate the long term trends in duration, start-and end-dates, peakvalues and the yearly accumulated pollen sums of the pollen seasons. The pollen seasons of several arboreal plant species (e.g. birch, oak and pine) were found to start significantly earlier today compared to 41 years earlier, and have an earlier peak-date, while the season of other species seemed largely unaffected. However, the long term trends in the end-dates of pollen seasons differed between arboreal and herbaceous species. For herbaceous species (grass and mugwort), a significant change towards later end-dates was observed and the duration of season was found to have increased. A significant trend towards an earlier end-date was found in the majority of the arboreal plant species (i.e. elm, oak, pine and birch), but the length of the season seemed unaffected. A trend towards an increase in yearly concentrations of pollen was observed for several species; however the reasons for this phenomenon cannot be explained unambiguously by the present study design. The trend of increasing yearly mean air temperatures in the Stockholm area may be the reason to changed phenological patterns of pollen seasons.	[Lind, Tomas; Bellander, Tom; Lohmus, Mare] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Lind, Tomas; Bellander, Tom; Lohmus, Mare] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Ekebom, Agneta; Kubler, Kerstin Alm; Ostensson, Pia] Swedish Museum Nat Hist, Dept Environm Res & Monitoring, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Swedish Museum of Natural History	Lohmus, M (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.; Lohmus, M (corresponding author), Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden.	mare.lohmus.sundstrom@ki.se		Lohmus, Mare/0000-0002-6619-9679				Bogawski P, 2014, INT J BIOMETEOROL, V58, P1759, DOI 10.1007/s00484-013-0781-5; Bonofiglio T, 2013, ENVIRON MONIT ASSESS, V185, P877, DOI 10.1007/s10661-012-2598-9; D'Amato G, 1998, ALLERGY, V53, P567, DOI 10.1111/j.1398-9995.1998.tb03932.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; D'Amato G, 2000, CLIN EXP ALLERGY, V30, P628; Djukanovic R, 1996, THORAX, V51, P575, DOI 10.1136/thx.51.6.575; Edenhofer O., 2014, CONTRIBUTION WORKING; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Emberlin J, 1997, GRANA, V36, P29, DOI 10.1080/00173139709362586; EMBERLIN J, 1994, GRANA, V33, P94, DOI 10.1080/00173139409427839; Estrella N, 2006, INT J BIOMETEOROL, V51, P49, DOI 10.1007/s00484-006-0038-7; Rodriguez SF, 2015, AEROBIOLOGIA, V31, P1, DOI 10.1007/s10453-014-9338-2; Fernandez-Llamazares A, 2014, INT J BIOMETEOROL, V58, P371, DOI 10.1007/s00484-013-0632-4; Frei T, 2008, INT J BIOMETEOROL, V52, P841, DOI 10.1007/s00484-008-0178-z; Frei T, 2008, INT J BIOMETEOROL, V52, P667, DOI 10.1007/s00484-008-0159-2; Galan C, 2016, SCI TOTAL ENVIRON, V550, P53, DOI 10.1016/j.scitotenv.2016.01.069; Gruzieva O, 2015, ALLERGY, V70, P1181, DOI 10.1111/all.12653; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; Jager S, 1996, GRANA, V35, P171, DOI 10.1080/00173139609429078; Jato V, 2015, INT J BIOMETEOROL, V59, P517, DOI 10.1007/s00484-014-0865-x; Karlsen SR, 2009, CLIM RES, V39, P275, DOI 10.3354/cr00828; Karolinska-Institutets-Folkhalsoakademi, 2009, MILJ STOCKH LAN 2009; Keiding L, 1997, ASTMA ALLERGI ANDEN; Linneberg A, 1999, ALLERGY, V54, P1194, DOI 10.1034/j.1398-9995.1999.00180.x; Newnham RM, 2013, INT J BIOMETEOROL, V57, P391, DOI 10.1007/s00484-012-0563-5; Puc M, 2003, ANN AGR ENV MED, V10, P143; Rasmussen Alix, 2002, Aerobiologia, V18, P253, DOI 10.1023/A:1021321615254; Rodriguez-Rajo FJ, 2011, CLIM RES, V48, P281, DOI 10.3354/cr00966; SPIEKSMA FTM, 1995, GRANA, V34, P51, DOI 10.1080/00173139509429033; Szema AM, 2014, RESPIR MED SER, V7, P155, DOI 10.1007/978-1-4614-8417-2_9; Van der Meer T, 2010, AM SOCIOL REV, V75, P173, DOI 10.1177/0003122409359166; Van Vliet AJH, 2002, INT J CLIMATOL, V22, P1757, DOI 10.1002/joc.820; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yli-Panula E, 2009, INT J ENV RES PUB HE, V6, P1706, DOI 10.3390/ijerph6061706; Zhang Y, 2014, INT J BIOMETEOROL, V58, P909, DOI 10.1007/s00484-013-0674-7; Zhang Y, 2013, ATMOS ENVIRON, V68, P64, DOI 10.1016/j.atmosenv.2012.11.028	36	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166887	10.1371/journal.pone.0166887	http://dx.doi.org/10.1371/journal.pone.0166887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898718	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000022
J	Alhaj, TA; Siraj, MM; Zainal, A; Elshoush, HT; Elhaj, F				Alhaj, Taqwa Ahmed; Siraj, Maheyzah Md; Zainal, Anazida; Elshoush, Huwaida Tagelsir; Elhaj, Fatin			Feature Selection Using Information Gain for Improved Structural-Based Alert Correlation	PLOS ONE			English	Article								Grouping and clustering alerts for intrusion detection based on the similarity of features is referred to as structurally base alert correlation and can discover a list of attack steps. Previous researchers selected different features and data sources manually based on their knowledge and experience, which lead to the less accurate identification of attack steps and inconsistent performance of clustering accuracy. Furthermore, the existing alert correlation systems deal with a huge amount of data that contains null values, incomplete information, and irrelevant features causing the analysis of the alerts to be tedious, time-consuming and error-prone. Therefore, this paper focuses on selecting accurate and significant features of alerts that are appropriate to represent the attack steps, thus, enhancing the structural-based alert correlation model. A two-tier feature selection method is proposed to obtain the significant features. The first tier aims at ranking the subset of features based on high information gain entropy in decreasing order. The second tier extends additional features with a better discriminative ability than the initially ranked features. Performance analysis results show the significance of the selected features in terms of the clustering accuracy using 2000 DARPA intrusion detection scenario-specific dataset.	[Alhaj, Taqwa Ahmed; Siraj, Maheyzah Md; Zainal, Anazida; Elhaj, Fatin] Univ Teknol Malaysia, Fac Comp, Informat Assurance & Secur Res Grp, Johor Baharu, Johor, Malaysia; [Elshoush, Huwaida Tagelsir] Univ Khartoum, Fac Math Sci, Khartoum, Sudan	Universiti Teknologi Malaysia; University of Khartoum	Alhaj, TA (corresponding author), Univ Teknol Malaysia, Fac Comp, Informat Assurance & Secur Res Grp, Johor Baharu, Johor, Malaysia.	taqwa-315@hotmail.com	Elhaj, Fatin Ahmed Mohammed/AAT-9967-2021; Elshoush, Huwaida Tagelsir/HGB-9342-2022	Elshoush, Huwaida Tagelsir/0000-0003-0142-393X; Ahmed, Taqwa/0000-0002-2366-0138	Ministry of Higher Education (MoHE); Universiti Teknologi Malaysia [PY/2014/02899]	Ministry of Higher Education (MoHE)(Ministry of Higher Education & Scientific Research (MHESR)); Universiti Teknologi Malaysia	We would like to thank Ministry of Higher Education (MoHE) and Universiti Teknologi Malaysia for funding this work under Potential Academic Staff research grant with reference number PY/2014/02899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ministry of Higher Education (MoHE) and Universiti Teknologi Malaysia for funding this work under Potential Academic Staff research grant with reference number PY/2014/02899.	Anderson D, 1993, TECHNICAL REPORT; Bolon-Canedo V, 2011, EXPERT SYST APPL, V38, P5947, DOI 10.1016/j.eswa.2010.11.028; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Debar H., 2001, P INT WORKSH REC ADV, P85; Elshoush H.T., 2012, P WORLD C ENG JUL LO, P1; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Lee W, 2001, AI REV, V4, P533; Man DP, 2012, PROCEDIA ENGINEER, V29, P3033, DOI 10.1016/j.proeng.2012.01.435; Mohamed A. B., 2012, Proceedings of the 2012 International Conference on Communication Systems and Network Technologies (CSNT 2012), P720, DOI 10.1109/CSNT.2012.212; Qin XZ, 2003, LECT NOTES COMPUT SC, V2820, P73; Ramaki AA, 2015, COMPUT SECUR, V49, P206, DOI 10.1016/j.cose.2014.10.006; Ren HL, 2010, LECT NOTES COMPUT SC, V6201, P153; Reuben S, 2008, ADV ARTIFICIAL INTEL, P308; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salim LF, 2007, INT J COMPUT SCI NET, V7, P210; Shittu R, 2015, COMPUT SECUR, V50, P1, DOI 10.1016/j.cose.2014.12.003; Siraj MM, THESIS; Srilatha C, 2005, FEATURE DEDUCTION EN; Tjhai GC, 2010, COMPUT SECUR, V29, P712, DOI 10.1016/j.cose.2010.02.001; Wang J-X, NEURAL INFORM PROCES, P217; Xing E.P., 2001, ICML CITESEER, V1, P601; Yang D., 2008, P 19 INT C PATT REC, P1, DOI DOI 10.1109/ICPR.2008.4761087; Yang Yiming, 1997, ICM 1997, P97; Zainal A, 2006, FEATURE SELECTION US	25	67	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166017	10.1371/journal.pone.0166017	http://dx.doi.org/10.1371/journal.pone.0166017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893821	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400015
J	Chen, PH; Cheng, CH; Shih, CM; Ho, KH; Lin, CW; Lee, CC; Liu, AJ; Chang, CK; Chen, KC				Chen, Peng-Hsu; Cheng, Chia-Hsiung; Shih, Chwen-Ming; Ho, Kuo-Hao; Lin, Cheng-Wei; Lee, Chin-Cheng; Liu, Ann-Jeng; Chang, Cheng-Kuei; Chen, Ku-Chung			The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; PROLIFERATION; P53; EXPRESSION; PATHWAYS; MIR-128; TARGETS; GENES	Temozolomide (TMZ), an alkylating agent of the imidazotetrazine series, is a first-line chemotherapeutic drug used in the clinical therapy of glioblastoma multiforme, the most common and high-grade primary glioma in adults. Micro (mi) RNAs, which are small noncoding RNAs, post-transcriptionally regulate gene expressions and are involved in gliomagenesis. However, no studies have reported relationships between TMZ and miRNA gene regulation. We investigated TMZ-mediated miRNA profiles and its molecular mechanisms underlying the induction of glioma cell death. By performing miRNA microarray and bioinformatics analyses, we observed that expression of 248 miRNAs was altered, including five significantly upregulated and 17 significantly downregulated miRNAs, in TMZ-treated U87MG cells. miR-128 expression levels were lower in different glioma cells and strongly associated with poor survival. TMZ treatment significantly upregulated miR-128 expression. TMZ significantly enhanced miR-128-1 promoter activity and transcriptionally regulated miR-128 levels through c-Jun N-terminal kinase 2/c-Jun pathways. The overexpression and knockdown of miR-128 expression significantly affected TMZ-mediated cell viability and apoptosis-related protein expression. Furthermore, the overexpression of miR-128 alone enhanced apoptotic death of glioma cells through caspase-3/9 activation, poly(ADP ribose) polymerase degradation, reactive oxygen species generation, mitochondrial membrane potential loss, and non-protective autophagy formation. Finally, we identified that key members in mammalian target of rapamycin (mTOR) signaling including mTOR, rapamycin-insensitive companion of mTOR, insulin-like growth factor 1, and PIK3R1, but not PDK1, were direct target genes of miR-128. TMZ inhibited mTOR signaling through miR-128 regulation. These results indicate that miR-128-inhibited mTOR signaling is involved in TMZ-mediated cytotoxicity. Our findings may provide a better understanding of cytotoxic mechanisms of TMZ involved in glioblastoma development.	[Chen, Peng-Hsu; Cheng, Chia-Hsiung; Shih, Chwen-Ming; Lin, Cheng-Wei; Chen, Ku-Chung] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Cheng, Chia-Hsiung; Shih, Chwen-Ming; Lin, Cheng-Wei; Chen, Ku-Chung] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan; [Ho, Kuo-Hao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Lee, Chin-Cheng] Shin Kong Wu Ho Su Mem Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Liu, Ann-Jeng] Taipei City Hosp, Ren Ai Branch, Dept Neurosurg, Taipei, Taiwan; [Chang, Cheng-Kuei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Chang, Cheng-Kuei] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei City Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan.	kuchung@tmu.edu.tw	Cheng, Chia-Hsiung/A-6044-2019	Cheng, Chia-Hsiung/0000-0003-0307-9650	Ministry of Science and Technology, Taiwan [MOST104-2320-B-038-046, MOST105-2320-B-038-019]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (nos. MOST104-2320-B-038-046 and MOST105-2320-B-038-019).	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Ananta JS, 2015, MOL PHARMACEUT, V12, P4509, DOI 10.1021/acs.molpharmaceut.5b00694; Bertucci A, 2015, SMALL, V11, P5687, DOI 10.1002/smll.201500540; Donzelli S, 2012, CELL DEATH DIFFER, V19, P1038, DOI 10.1038/cdd.2011.190; Duzgun Z, 2016, GENE, V575, P187, DOI 10.1016/j.gene.2015.08.060; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gratas C, 2014, ONCOTARGET, V5, P2428, DOI 10.18632/oncotarget.1642; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Hirose Y, 2004, J NEUROSURG, V100, P1060, DOI 10.3171/jns.2004.100.6.1060; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16422; Li ML, 2013, EXP CELL RES, V319, P3059, DOI 10.1016/j.yexcr.2013.07.031; Li X, 2016, ONCOTARGET; Li YP, 2015, CELL PROLIFERAT, V48, P643, DOI 10.1111/cpr.12223; Lin C.-L., 2012, COMPUTATIONAL INTELL, V2012, P7, DOI [DOI 10.1371/J0UMAL.P0NE.0038706, DOI 10.1371/J0URNAL.P0NE.0038706]; Lin CJ, 2012, FREE RADICAL BIO MED, V52, P377, DOI 10.1016/j.freeradbiomed.2011.10.487; Lin LN, 2013, ONCOL REP, V30, P1239, DOI 10.3892/or.2013.2596; Miao W, 2015, MOL MED REP, V11, P4165, DOI 10.3892/mmr.2015.3255; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Castro GN, 2015, CELL STRESS CHAPERON, V20, P253, DOI 10.1007/s12192-014-0537-0; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Persengiev S. P., 2012, CURR GERONTOL GERIAT, V2012, P359, DOI DOI 10.1155/2012/359369; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Rekers NH, 2011, J CHEMOTHERAPY, V23, P187, DOI 10.1179/joc.2011.23.4.187; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shang C, 2016, ONCOL LETT, V11, P904, DOI 10.3892/ol.2015.3927; Shea A, 2016, CANC MED; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Stavrovskaya AA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P91, DOI 10.1134/S0006297916020036; Sun J, 2015, INT J CLIN EXP MED, V8, P456; Tomicic MT, 2015, ONCOTARGET, V6, P33755, DOI 10.18632/oncotarget.5274; Urbanska K, 2014, WSPOLCZESNA ONKOL, V18, P307, DOI 10.5114/wo.2014.40559; Wang HT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1728-5; Wang J, 2013, CANCER CHEMOTH PHARM, V72, P147, DOI 10.1007/s00280-013-2180-3; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wilson Taylor A, 2014, Surg Neurol Int, V5, P64, DOI 10.4103/2152-7806.132138; Xie BH, 2016, CANCER BIOMARK, V16, P405, DOI 10.3233/CBM-160579; Yu ZY, 2015, CANCER LETT, V367, P58, DOI 10.1016/j.canlet.2015.07.007; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	43	35	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167096	10.1371/journal.pone.0167096	http://dx.doi.org/10.1371/journal.pone.0167096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893811	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400085
J	Daboval, T; Shidler, S; Thomas, D				Daboval, Thierry; Shidler, Sarah; Thomas, Daniel			Shared Decision Making at the Limit of Viability: A Blueprint for Physician Action	PLOS ONE			English	Article							PARENTS; CARE; COMMUNICATION; RESUSCITATION; PERCEPTIONS; INFORMATION; INFANTS; MOTHERS; ETHICS	Objective To document interactions during the antenatal consultation between parents and neonatologist that parents linked to their satisfaction with their participation in shared decision making for their infant at risk of being born at the limit of viability. Methods This multiple-case ethnomethodological qualitative research study, included mothers admitted for a threatened premature delivery between 20 0/7 and 26 6/7 weeks gestation, the father, and the staff neonatologist conducting the clinical antenatal consultation. Content analysis of an audiotaped post-antenatal consultation interview with parents obtained their satisfaction scores as well as their comments on physician actions that facilitated their desired participation. Results Five cases, each called a "system-infant at risk", included 10 parents and 6 neonatologists. From the interviews emerged a blueprint for action by physicians, including communication strategies that parents say facilitated their participation in decision making; such as building trustworthy physician-parent relationships, providing "balanced" information, offering choices, and allowing time to think. Conclusion Parent descriptions indicate that the opportunity to participate to their satisfaction in the clinical antenatal consultation depends on how the physician interacts with them. Practice implications The parent-identified communication strategies facilitate shared decision making regarding treatment in the best interest of the infant at risk to be born at the limit of viability.	[Daboval, Thierry] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Obstet & Gynecol, Ottawa Hosp,Dept Pediat, Ottawa, ON, Canada; [Shidler, Sarah] Univ Quebec Abitibi Temiscamingue, Dept Hlth Sci Sci, Rouyn Noranda, PQ, Canada; [Thomas, Daniel] Univ Quebec Abitibi Temiscamingue, Dept Human Sci, Rouyn Noranda, PQ, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; Ottawa Hospital Research Institute; University of Quebec; University Quebec Abitibi-Temiscamingue; University of Quebec; University Quebec Abitibi-Temiscamingue	Daboval, T (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Obstet & Gynecol, Ottawa Hosp,Dept Pediat, Ottawa, ON, Canada.	tdaboval@cheo.on.ca		Daboval, Thierry/0000-0002-5321-6193	Fonds Institutionnel de la Recherche (FIR), Universite du Quebec en Abitibi-Temiscamingue; Universite du Quebec en Abitibi-Temiscamingue	Fonds Institutionnel de la Recherche (FIR), Universite du Quebec en Abitibi-Temiscamingue; Universite du Quebec en Abitibi-Temiscamingue	This work was supported by the Fonds Institutionnel de la Recherche (FIR) 2011-2012, Universite du Quebec en Abitibi-Temiscamingue (April 2011). 3,500.00 $ CAN. Thierry Daboval received the funds mentioned above to complete the study. The remaining authors have no financial relationships relevant to this article to disclose. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the parents who participated to this study and shared their thoughts. We thank Jacques Charest, PhD, for his helpful and constructive suggestions that positively improved the quality of the manuscript. We also thank the Universite du Quebec en Abitibi-Temiscamingue who funded the study.	Anspach R.R, 1997, DECIDING WHO LIVES F; Audet M, 1995, ROLES DEFIS COMITES, P167; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Batton DG, 2009, PEDIATRICS, V124, P422, DOI 10.1542/peds.2009-1060; Bergeron V, 2008, MAY REAL SURROGATE S; Boss RD, 2008, PEDIATRICS, V122, P583, DOI 10.1542/peds.2007-1972; Caeymaex L, 2013, ARCH DIS CHILD-FETAL, V98, pF26, DOI 10.1136/archdischild-2011-301548; CHAREST J, 1996, REV QUEBECOISE PSYCH, V17, P43; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Coulon A, 1993, LETHNOMETHODOLOGIE, P127; Daboval T, NEONATAL ETHICS TEAC; Daboval T, PARTICIPATION PARENT, P1; Daboval T, 2014, PAED CHILD HEALT-CAN, V19, P302, DOI 10.1093/pch/19.6.302; Daboval T, 2013, MED TEACH, V35, P194, DOI 10.3109/0142159X.2012.733452; Daboval Thierry, 2005, Paediatr Child Health, V10, P87; Einarsdottir J, 2009, MED ANTHROPOL Q, V23, P34, DOI 10.1111/j.1548-1387.2009.01036.x; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Gaucher N, 2011, PAED CHILD HEALT-CAN, V16, P638, DOI 10.1093/pch/16.10.638; Geertz D, 1983, CONT FIELD RES COLLE, P37; Halamek LP, 2003, NEOREVIEWS, V4; HARRISON H, 1993, PEDIATRICS, V92, P643; Haward MF, 2011, CLIN PERINATOL, V38, P471, DOI 10.1016/j.clp.2011.06.004; Holstein J.A., 2006, HDB QUALITATIVE RES, P262; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P443; Kavanaugh Karen, 2005, J Pediatr Nurs, V20, P347, DOI 10.1016/j.pedn.2005.03.006; Keenan HT, 2005, PEDIATRICS, V116, P104, DOI 10.1542/peds.2004-1340; Kopelman AE, 2006, MT SINAI J MED, V73, P580; McHaffie HE, 2001, EUR J PEDIATR, V160, P339, DOI 10.1007/PL00008444; Miquel-Verges F, 2009, PEDIATRICS, V124, pE573, DOI 10.1542/peds.2008-2865; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Partridge J C, 2001, J Perinatol, V21, P27; Partridge JC, 2005, PEDIATRICS, V116, pE263, DOI 10.1542/peds.2004-2274; Payot A, 2007, SOC SCI MED, V64, P1487, DOI 10.1016/j.socscimed.2006.11.016; Stake R. E., 1995, ART CASE STUDY RES; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Watzlawick P., 1972, LOGIQUE COMMUNICATIO; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Yee WH, 2007, PAED CHILD HEALT-CAN, V12, P191, DOI 10.1093/pch/12.3.191; Young E, 2013, PAEDIAT CHILD HLTH, V17, P432; Zupancic JAF, 2002, ARCH DIS CHILD-FETAL, V87, pF113, DOI 10.1136/fn.87.2.F113	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166151	10.1371/journal.pone.0166151	http://dx.doi.org/10.1371/journal.pone.0166151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893823	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400018
J	Dai, LH; Ma, C; Zhang, ZS; Zeng, SX; Liu, AW; Tang, SJ; Ren, Q; Sun, YH; Xu, CL				Dai, Lihe; Ma, Chong; Zhang, Zhensheng; Zeng, Shuxiong; Liu, Anwei; Tang, Shijie; Ren, Qian; Sun, Yinghao; Xu, Chuanliang			DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TRANSITIONAL-CELL CARCINOMA; DNA METHYLATION; UROTHELIAL CARCINOMAS; MULTIPLE GENES; HYPERMETHYLATION; RECURRENCE; EXPRESSION; DEATH; ASSOCIATION; HISTORY	Background Methylation of tumor suppressor gene promoter leads to transcription inactivation and is involved in tumorigenesis. Several studies demonstrate a potential association between the Death-Associated Protein Kinase (DAPK) gene promoter methylation and bladder cancer risk, tumor stage and histological grade. Due to inconsistent results of these studies, we performed this meta-analysis to ascertain the association. Methods Studies were retrieved from the PubMed, Embase, Web of Science and the Cochrane Library databases. Study selection and data extraction were executed by two reviewers independently. Meta-analysis was performed using Stata 13.0 and Review Manager 5.3 software. Results A total of 21 articles involving 15 case control and 8 case series studies were included in this meta-analysis. DAPK promoter methylation was associated with bladder cancer risk (OR: 5.81; 95%CI = 3.83-8.82, P<0.00001). The frequency of DAPK promoter methylation was equal in bladder cancer tissue and paired adjacent normal tissue (OR: 0.87; 95%CI = 0.31- 2.48, P = 0.794). Furthermore, DAPK promoter methylation was associated with higher histological grade (OR: 1.52; 95%CI = 1.10-2.09, P = 0.011) but not associated with tumor stage (OR: 1.12; 95%CI = 0.67-1.87, P = 0.668). Conclusions The result suggests that DAPK promoter methylation is significantly increased in bladder cancer patients compared to normal controls. DAPK promoter methylation could serve as a biomarker for bladder cancer detection and management.	[Dai, Lihe; Ma, Chong; Zhang, Zhensheng; Zeng, Shuxiong; Liu, Anwei; Tang, Shijie; Ren, Qian; Sun, Yinghao; Xu, Chuanliang] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China	Naval Medical University	Xu, CL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	xuchuanliang@vip.126.com	TANG, Shi/GXH-5719-2022					Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Chai CY, 2007, TOXICOL LETT, V173, P48, DOI 10.1016/j.toxlet.2007.06.006; Chan MWY, 2002, CLIN CANCER RES, V8, P464; Chanda S, 2006, TOXICOL SCI, V89, P431, DOI 10.1093/toxsci/kfj030; Chen PC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-45; Chen WT, 2007, HISTOPATHOLOGY, V51, P785, DOI 10.1111/j.1365-2559.2007.02871.x; Christoph F, 2006, BRIT J CANCER, V95, P1701, DOI 10.1038/sj.bjc.6603482; Christoph F, 2006, INT J CANCER, V119, P1396, DOI 10.1002/ijc.21971; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellinger J, 2008, J UROLOGY, V179, P346, DOI 10.1016/j.juro.2007.08.091; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteller M, 2001, CANCER RES, V61, P3225; Friedrich MG, 2005, EUR J CANCER, V41, P2769, DOI 10.1016/j.ejca.2005.07.019; Friedrich MG, 2004, CLIN CANCER RES, V10, P7457, DOI 10.1158/1078-0432.CCR-04-0930; Gao TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048300; Guo SC, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-5; Hellwinkel OJC, 2008, BJU INT, V101, P753, DOI 10.1111/j.1464-410X.2007.07322.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jablonowski Z, 2011, ARCH MED SCI, V7, P512, DOI 10.5114/aoms.2011.23421; Jarmalaite S, 2008, ONCOLOGY-BASEL, V75, P145, DOI 10.1159/000158665; Jarmalaite S, 2010, J CANCER RES CLIN, V136, P847, DOI 10.1007/s00432-009-0725-y; Kandimalla R, 2013, NAT REV UROL, V10, P327, DOI 10.1038/nrurol.2013.89; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li Y, 2015, DRUG DES DEV THER, V9, P1785, DOI 10.2147/DDDT.S78012; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; Maruyama R, 2001, CANCER RES, V61, P8659; Motlagh FZ, 2013, J BIOL RES-THESSALON, V19, P56; Nakagawa T, 2005, J UROLOGY, V173, P1767, DOI 10.1097/01.ju.0000154632.11824.4d; Neuhausen A, 2006, CANCER BIOL THER, V5, P993, DOI 10.4161/cbt.5.8.2885; Park HJ, 2010, KOREAN J PATHOL, V44, P623, DOI 10.4132/KoreanJPathol.2010.44.6.623; PROUT GR, 1992, J UROLOGY, V148, P1413, DOI 10.1016/S0022-5347(17)36924-0; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Schulz WA, 2016, EPIGENOMICS; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sobti RC, 2010, BIOMARKERS, V15, P167, DOI 10.3109/13547500903395124; Soloway MS, 2013, NAT REV UROL, V10, P5, DOI 10.1038/nrurol.2012.219; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tada Y, 2002, CANCER RES, V62, P4048; Vinci S, 2011, UROL ONCOL-SEMIN ORI, V29, P150, DOI 10.1016/j.urolonc.2009.01.003; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Wolff EM, 2008, CANCER RES, V68, P6208, DOI 10.1158/0008-5472.CAN-07-6616; Xu Ning-ru, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1882; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209	50	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167228	10.1371/journal.pone.0167228	http://dx.doi.org/10.1371/journal.pone.0167228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907054	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700096
J	Hashimoto, K; Kurosawa, K; Murayama, A; Seo, H; Ohta, K				Hashimoto, Koji; Kurosawa, Kohei; Murayama, Akiho; Seo, Hidetaka; Ohta, Kunihiro			B Cell-Based Seamless Engineering of Antibody Fc Domains	PLOS ONE			English	Article							IMMUNOGLOBULIN GENE CONVERSION; CLASS SWITCH RECOMBINATION; EFFECTOR FUNCTIONS; RAPID GENERATION; HUMAN IGG1; FUSION PROTEINS; GAMMA-RIII; CHICKEN; BINDING; REGION	Engineering of monoclonal antibodies (mAbs) enables us to obtain mAbs with additional functions. In particular, modifications in antibody's Fc (fragment, crystallizable) region can provide multiple benefits such as added toxicity by drug conjugation, higher affinity to Fc receptors on immunocytes, or the addition of functional modules. However, the generation of recombinant antibodies requires multiple laborious bioengineering steps. We previously developed a technology that enables rapid in vitro screening and isolation of specific mAb-expressing cells from the libraries constructed with chicken B-cell line DT40 (referred to as the 'ADLib system'). To upgrade this ADLib system with the ability to generate customized mAbs, we developed a novel and rapid engineering technology that enables seamless exchanges of mAbs' Fc domains after initial selections of mAb-producing clones by the ADLib system, using a gene-replacement unit for recombinase-mediated cassette exchange (RMCE). In this system, Cre-recombinase recognition sites were inserted into the Fc region of the active DT40 IgM allele, allowing the replacement of the Fc domain by the sequences of interest upon co-transfection of a Cre recombinase and a donor DNA, enabling the rapid exchange of Fc regions. Combining this method with the ADLib system, we demonstrate rapid Fc engineering to generate fluorescent antibodies and to enhance affinity to Fc receptors.	[Hashimoto, Koji; Kurosawa, Kohei; Murayama, Akiho; Seo, Hidetaka; Ohta, Kunihiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Kurosawa, Kohei] NYU, Laura & Isaac Perlmutter Canc Ctr, Langone Med Ctr, New York, NY USA	University of Tokyo; New York University; NYU Langone Medical Center	Seo, H (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	hidetakaseo@bio.c.u-tokyo.ac.jp		Hashimoto, Koji/0000-0001-8024-0060	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan;  [3114003];  [21241046];  [26291018]	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan; ; ; 	Support was provided by the Japanese Society for the Promotion of Science Fellows (3114003, 21241046, 26291018) [https://www.isps.go.jp/english/] and The Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan [http//www/mext.go.jp/english/].; We thank Dr. Moritoshi Sato for use of cell counter. This work was supported by Japanese Society for the Promotion of Science Fellows [3114003, 21241046, 26291018 to K.O.] and the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Derer Stefanie, 2012, Methods Mol Biol, V907, P519, DOI 10.1007/978-1-61779-974-7_30; DiLillo DJ, 2015, CANCER IMMUNOL RES, V3, P704, DOI 10.1158/2326-6066.CIR-15-0120; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; Goodwin EC, 1992, BIOCHEMISTRY-US, P16330; Griep RA, 1999, PROTEIN EXPRES PURIF, V16, P63, DOI 10.1006/prep.1999.1041; Guy AT, 2015, SCIENCE, V349, P974, DOI 10.1126/science.aab3516; Haas AK, 2010, MABS-AUSTIN, V2, P648, DOI 10.4161/mabs.2.6.13179; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8; Kohler G, 1975, NATURE; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lin W, 2008, GENES CELLS, V13, P255, DOI 10.1111/j.1365-2443.2008.01166.x; Lin W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1122; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Menzel C, 2008, BLOOD, V111, P3830, DOI 10.1182/blood-2007-04-082768; Natsume A, 2008, DRUG DES DEV THER, V3, P7; Nimmerjahn F, 2015, TRENDS IMMUNOL, V36, P325, DOI 10.1016/j.it.2015.04.005; Omi K, 2015, CLIN CHEM, V61, P627, DOI 10.1373/clinchem.2014.232728; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Seo H, 2006, NAT PROTOC, V1, P1502, DOI 10.1038/nprot.2006.248; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vincent KJ, 2012, BIOTECHNOL J, P1; Yamashita N, 2015, INT IMMUNOL, V27, P459, DOI 10.1093/intimm/dxv014; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x	46	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167232	10.1371/journal.pone.0167232	http://dx.doi.org/10.1371/journal.pone.0167232			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907066	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700099
J	Menon, N; Rogers, CJ; Lukaszewicz, AI; Axtelle, J; Yadav, M; Song, FF; Chakravarti, A; Jacob, NK				Menon, Naresh; Rogers, Claude J.; Lukaszewicz, Agnes I.; Axtelle, James; Yadav, Marshleen; Song, Feifei; Chakravarti, Arnab; Jacob, Naduparambil K.			Detection of Acute Radiation Sickness: A Feasibility Study in Non-Human Primates Circulating miRNAs for Triage in Radiological Events	PLOS ONE			English	Article							BODY IRRADIATION MODEL; IONIZING-RADIATION; IN-VIVO; MICRORNA EXPRESSION; PERIPHERAL-BLOOD; CELLS; INJURY; RNA; MANAGEMENT; EXPOSURE	Development of biomarkers capable of estimating absorbed dose is critical for effective triage of affected individuals after radiological events. Levels of cell-free circulating miRNAs in plasma were compared for dose-response analysis in non-human primates (NHP) exposed to lethal (6.5 Gy) and sub-lethal (1 and 3 Gy) doses over a 7 day period. The doses and test time points were selected to mimic triage needs in the event of a mass casualty radiological event. Changes in miRNA abundance in irradiated animals were compared to a non-irradiated cohort and a cohort experiencing acute inflammation response from exposure to lipopolysaccharide (LPS). An amplification-free, hybridization-based direct digital counting method was used for evaluation of changes in microRNAs in plasma from all animals. Consistent with previous murine studies, circulating levels of miR-150-5p exhibited a dose-and time-dependent decrease in plasma. Furthermore, plasma miR-150-5p levels were found to correlate well with lymphocyte and neutrophil depletion kinetics. Additionally, plasma levels of several other evolutionarily and functionally conserved miRNAs were found altered as a function of dose and time. Interestingly, miR-574-5p exhibited a distinct, dose-dependent increase 24 h post irradiation in NHPs with lethal versus sub-lethal exposure before returning to the baseline level by day 3. This particular miRNA response was not detected in previous murine studies but was observed in animals exposed to LPS, indicating distinct molecular and inflammatory responses. Furthermore, an increase in low-abundant miR-126, miR-144, and miR-21 as well as high-abundant miR-1-3p and miR-206 was observed in irradiated animals on day 3 and/or day 7. The data from this study could be used to develop a multi-marker panel with known tissue-specific origin that could be used for developing rapid assays for dose assessment and evaluation of radiation injury on multiple organs. Furthermore this approach may be utilized to screen for tissue toxicity in patients who receive myeloablative and therapeutic radiation.	[Menon, Naresh; Rogers, Claude J.; Lukaszewicz, Agnes I.; Axtelle, James] ChromoLogic LLC, Monrovia, CA 91016 USA; [Yadav, Marshleen; Song, Feifei; Chakravarti, Arnab; Jacob, Naduparambil K.] Ohio State Univ, Comprehens Canc Ctr Columbus, Dept Radiat Oncol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Menon, N (corresponding author), ChromoLogic LLC, Monrovia, CA 91016 USA.; Jacob, NK (corresponding author), Ohio State Univ, Comprehens Canc Ctr Columbus, Dept Radiat Oncol, Columbus, OH 43210 USA.	nmenon@chromologic.com; naduparambil.jacob@osumc.edu	Yadav, Marshleen/J-8795-2019	Yadav, Marshleen/0000-0002-4778-8347; /0000-0002-4700-8064	Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services [HHS0100201000005C]; National Institute of Allergies and Infectious Disease (NIAID) [1R43AI108019-01 A1]; Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-15-2-0054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI108019] Funding Source: NIH RePORTER	Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services; National Institute of Allergies and Infectious Disease (NIAID); Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All NHP studies were performed at CiTox Laboratories (Laval, Canada). This project has been funded in whole or in part with Federal funds from the Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services (Contract No. HHS0100201000005C); the National Institute of Allergies and Infectious Disease (NIAID; Grant 1R43AI108019-01 A1); the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (Award No. W81XWH-15-2-0054). The Grants 1R43AI108019-01 A1 provided support in the form of salaries for authors [NJ, CR, AL, NM, JA], purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract W81XWH-15-2-0054 provided support in the form of salaries for authors [MY, FS, NJ], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract HHS0100201000005C provided support in the form of salaries for authors [NM, JA], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All NHP studies were performed at CiTox Laboratories (Laval, Canada). This project has been funded in whole or in part with Federal funds from the Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services (Contract No. HHS0100201000005C); the National Institute of Allergies and Infectious Disease (NIAID; Grant 1R43AI108019-01 A1); the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (Award No. W81XWH-15-2-0054).; The Grants 1R43AI108019-01 A1 provided support in the form of salaries for authors [NJ, CR, AIL, NM, JA], purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract W81XWH-15-2-0054 provided support in the form of salaries for authors [MY, FS, NJ], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract HHS0100201000005C provided support in the form of salaries for authors [NM, JA], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Only authors [CR, AIL, JA, NM] are full time employees of ChromoLogic LLC while authors [NJ, MY, AC] have no financial interest in ChromoLogic LLC. Grant 1R43AI108019-01 A1 and Contract HHS0100201000005C were awarded to ChromoLogic LLC. All ChromoLogic LLC staff adhere strictly to Ethical Scientific Conduct guidelines documented by the company in their Employee Agreement and, independently, those established by the National Institutes of Health. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abend M, 2016, RADIAT RES, V185, P109, DOI 10.1667/RR14221.1; ACHARYA SS, 2015, SCI TRANSL MED, V7; Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Blakely WF, 2014, RADIAT PROT DOSIM, V159, P46, DOI 10.1093/rpd/ncu127; Bolduc DL, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/685286; Buddemeir B. R., 2011, KEY RESPONSE PLANNIN; Carver JR, 2007, J CLIN ONCOL, V25, P3991, DOI 10.1200/JCO.2007.10.9777; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Christensen DM, 2014, J AM OSTEOPATH ASSOC, V114, P189, DOI 10.7556/jaoa.2014.037; Dainiak N, 2007, EXP HEMATOL, V35, P17, DOI 10.1016/j.exphem.2007.01.007; Dicarlo AL, 2011, DISASTER MED PUBLIC, P5; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Fliedner TM, 2005, BR J RADIOL S27, P1, DOI DOI 10.1259/BJR/77700378; Flynn DF, 2006, SURG CLIN N AM, V86, P601, DOI 10.1016/j.suc.2006.03.005; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; Girardi C, 2012, PLOS ONE, P7; GOANS RE, 1997, HLTH PHYS, V72; Graessle DH, 2015, HEALTH PHYS, V109, P493, DOI 10.1097/HP.0000000000000355; He Y, 2014, INFLAMMATION, V37, P71, DOI 10.1007/s10753-013-9713-0; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Jacob NK, 2013, PLOS ONE, P8; Jusufovic E, 2012, PLOS ONE, P7; Knebel AR, 2011, DISASTER MED PUBLIC, V5, pS20, DOI 10.1001/dmp.2011.25; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li Q., 2012, IACR CRYPTOL EPRINT, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0048278; Ludwig N, 2016, NUCLEIC ACIDS RES, P1; Ludwig N., 2016, NUCL ACIDS RES; LUSHBAUGH CC, 1987, BRIT J RADIOL, V60, P1159, DOI 10.1259/0007-1285-60-720-1159; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ossetrova NI, 2014, RADIAT PROT DOSIM, V159, P61, DOI 10.1093/rpd/ncu165; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Quesenberry PJ, 2014, STEM CELLS DEV, V23, P1429, DOI 10.1089/scd.2013.0594; Ranganathan P, 2015, AM J PHYSIOL-RENAL, V309, pF551, DOI 10.1152/ajprenal.00076.2015; Rothkamm K, 2013, RADIAT RES, V180, P111, DOI 10.1667/RR3231.1; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Simone N.L., 2009, PLOS ONE, P4; Sine R C, 2001, Mil Med, V166, P85; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Tano N, 2011, PLOS ONE, P6; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Templin T, 2011, INT J RADIAT ONCOL, V80, P549, DOI 10.1016/j.ijrobp.2010.12.061; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Van der Meeren A, 2005, RADIAT RES, V163, P144, DOI 10.1667/RR3293; Vincenti S, 2011, RADIAT RES, V175, P535, DOI 10.1667/RR2200.1; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Weber JM, 2010, BONE, P281; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	57	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167333	10.1371/journal.pone.0167333	http://dx.doi.org/10.1371/journal.pone.0167333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907140	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700121
J	Santos, UP; Campos, JF; Torquato, HFV; Paredes-Gamero, EJ; Carollo, CA; Estevinho, LM; Souza, KD; dos Santos, EL				Santos, Uilson P.; Campos, Jaqueline F.; Torquato, Heron Fernandes V.; Paredes-Gamero, Edgar Julian; Carollo, Carlos Alexandre; Estevinho, Leticia M.; Souza, Kely de Picoli; dos Santos, Edson Lucas			Antioxidant, Antimicrobial and Cytotoxic Properties as Well as the Phenolic Content of the Extract from Hancornia speciosa Gomes	PLOS ONE			English	Article							MEDICINAL-PLANTS; CELL-DEATH; OXIDATIVE DAMAGE; NATURAL-PRODUCTS; BLOOD-CELLS; APOPTOSIS; INHIBITION; RUTIN; ANTIBACTERIAL; PROPOLIS	Hancornia speciosa Gomes (Apocynaceae) is a fruit tree, popularly known as mangabeira, and it is widely distributed throughout Brazil. Several parts of the plant are used in folk medicine, and the leaf and bark extracts have anti-inflammatory, antihypertensive, antidiabetic, and antimicrobial properties. In this study, we investigated the chemical composition of the ethanolic extract of Hancornia speciosa leaves (EEHS) and its antioxidant, antimicrobial, and cytotoxic activities as well as the mechanisms involved in cell death. The chemical compounds were identified by liquid chromatography coupled to mass spectrometry (LC-MS/MS). The antioxidant activity of the EEHS was investigated using the method that involves the scavenging of 2,2-dipheny1-1-picrylhydrazyl free radicals as well as the inhibition of oxidative hemolysis and lipid peroxidation induced by 2,2'-azobis (2-amidinopropane) in human erythrocytes. The antimicrobial activity was determined by calculating the minimum inhibitory concentration, minimum bactericidal concentration, minimum fungicidal concentration, and zone of inhibition. Kasumi-1 leukemic cells were used to assess the cytotoxic activity and mechanisms involved in cell death promoted by the EEHS. The chemical compounds identified were quinic acid, chlorogenic acid, catechin, rutin, isoquercitrin, kaempferol-rutinoside, and catechin-pentoside. The EEHS demonstrated antioxidant activity via the sequestration of free radicals, inhibition of hemolysis, and inhibition of lipid peroxidation in human erythrocytes incubated with an oxidizing agent. The antimicrobial activity was observed against American Type Culture Collection (ATCC) and hospital strains of bacteria and fungi, filamentous fungi and dermatophytes. The cytotoxic activity of the EEHS was induced by apoptosis, reduction of the mitochondrial membrane potential, and activation of cathepsins. Together, these results indicate the presence of phenolic compounds and flavonoids in the EEHS and that their antioxidant, antimicrobial, and cytotoxic activities in acute myeloid leukemia cells are mediated by apoptosis.	[Santos, Uilson P.; Campos, Jaqueline F.; Souza, Kely de Picoli; dos Santos, Edson Lucas] Fed Univ Grande Dourados, Sch Environm & Biol Sci, Rodovia Dourados Ithaum, Dourados, MS, Brazil; [Torquato, Heron Fernandes V.; Paredes-Gamero, Edgar Julian] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil; [Paredes-Gamero, Edgar Julian] Univ Mogi Das Cruzes, Ctr Interdisciplinary Res Biochem, Av Dr Candido Xavier de Almeida Souza, Mogi Das Cruzes, SP, Brazil; [Carollo, Carlos Alexandre] Univ Fed Mato Grosso do Sul, Ctr Biol & Hlth Sci, Lab Nat Prod & Mass Spectrometry, Campo Grande, MS, Brazil; [Estevinho, Leticia M.] Polytech Inst Braganca, Agr Coll Braganca, Campus Santa Apolonia, Braganca, Portugal; [Estevinho, Leticia M.] Univ Minho, Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal	Universidade Federal da Grande Dourados; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Mogi das Cruzes; Universidade Federal de Mato Grosso do Sul; Instituto Politecnico de Braganca; Universidade do Minho	dos Santos, EL (corresponding author), Fed Univ Grande Dourados, Sch Environm & Biol Sci, Rodovia Dourados Ithaum, Dourados, MS, Brazil.	edson.lucas@pq.cnpq.br	de Picoli Souza, Kely/AAU-5978-2020; dos Santos, Edson Lucas/AAU-5857-2020; de Picoli Souza, Kely/I-1248-2015; Santos, Edson/C-6820-2014; Estevinho, Leticia M./L-2656-2017; Torquato, Heron/AAQ-2462-2020; Paredes-Gamero, Edgar J/C-4791-2012	de Picoli Souza, Kely/0000-0001-5764-2125; dos Santos, Edson Lucas/0000-0002-6557-7914; de Picoli Souza, Kely/0000-0001-5764-2125; Santos, Edson/0000-0002-6557-7914; Estevinho, Leticia M./0000-0002-9249-1948; Paredes-Gamero, Edgar J/0000-0003-3686-8402	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); PRODER [24.073]; CNPq, Brazil	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRODER; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and PRODER, (24.073 - A, Portugal). E.L.S.; E.J.P.G e C.A.L.C., were recipient of felowship from CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and PRODER, (24.073 - A Portugal). E.L.S.; E.J.P.G e C.A.L.C., were recipient of felowship from CNPq, Brazil.	Akintobi OA, 2013, REPORT OPINION, V5, P41; Al-Fatimi M, 2007, J ETHNOPHARMACOL, V111, P657, DOI 10.1016/j.jep.2007.01.018; Amin MU, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0580-0; Bardaweel SK, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/790838; Joray MB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/912484; Almeida MMB, 2011, FOOD RES INT, V44, P2155, DOI 10.1016/j.foodres.2011.03.051; Brown DG, 2014, BIOORG MED CHEM LETT, V24, P413, DOI 10.1016/j.bmcl.2013.12.059; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Casagrande JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112748; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; da Silva AO, 2014, J ETHNOPHARMACOL, V154, P319, DOI 10.1016/j.jep.2014.03.017; Marcondes DBD, 2014, J ETHNOPHARMACOL, V157, P243, DOI 10.1016/j.jep.2014.09.018; Pereira ABD, 2012, J CHROMATOGR B, V887, P133, DOI 10.1016/j.jchromb.2012.01.009; Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028; Endringer DC, 2007, ACTA CRYSTALLOGR E, V63, pO1067, DOI 10.1107/S1600536806037019; Endringer DC, 2010, PHYTOTHER RES, V24, P928, DOI 10.1002/ptr.3050; Endringer DC, 2009, PHYTOMEDICINE, V16, P1064, DOI 10.1016/j.phymed.2009.03.022; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Favela-Hernandez JMJ, 2015, MOLECULES, V20, P12450, DOI 10.3390/molecules200712450; Feas X, 2013, MOLECULES, V18, P4573, DOI 10.3390/molecules18044573; Ferreira HC, 2007, PHYTOMEDICINE, V14, P473, DOI 10.1016/j.phymed.2006.11.008; Ferreira HC, 2007, J ETHNOPHARMACOL, V109, P161, DOI 10.1016/j.jep.2006.06.009; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Geller FC, 2015, PHYTOTHER RES, V29, P1887, DOI 10.1002/ptr.5438; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Grandi TSM, 1989, ACTA BOT BRAS, V3, P185, DOI [10.1590/S0102-33061989000300018, DOI 10.1590/S0102-33061989000300018]; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Henneberg Railson, 2013, Rev. Bras. Hematol. Hemoter., V35, P52, DOI 10.5581/1516-8484.20130015; HIRSCHMANN GS, 1990, J ETHNOPHARMACOL, V29, P159, DOI 10.1016/0378-8741(90)90052-U; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Kesharwani Rajesh Kumar, 2012, Org Med Chem Lett, V2, P12, DOI 10.1186/2191-2858-2-12; Khan R, 2009, MOLECULES, V14, P586, DOI 10.3390/molecules14020586; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Li TY, 2016, FOOD FUNCT, V7, P1147, DOI 10.1039/c5fo01036e; Liberio SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-108; Marinho DG, 2011, J ETHNOPHARMACOL, V135, P530, DOI 10.1016/j.jep.2011.03.059; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moraes TDM, 2008, J ETHNOPHARMACOL, V120, P161, DOI 10.1016/j.jep.2008.08.001; Moraes VWR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.190; Morais M, 2011, FOOD CHEM TOXICOL, V49, P1096, DOI 10.1016/j.fct.2011.01.020; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Oliveira P. S., 2002, THE CERRADOS OF BRAZ; Owen S.O., 2006, HANDBOOK OF PHARMACE; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Pereira AC, 2015, J ETHNOPHARMACOL, V161, P30, DOI 10.1016/j.jep.2014.11.050; Pietkiewicz S, 2015, J IMMUNOL METHODS, V423, P99, DOI 10.1016/j.jim.2015.04.025; Plaper A, 2003, BIOCHEM BIOPH RES CO, V306, P530, DOI 10.1016/S0006-291X(03)01006-4; Ribeiro AB, 2015, PHARM BIOL, V53, P1691, DOI 10.3109/13880209.2014.1001407; Rizzo JA, 1990, C NAC BOT AN, V2, P691; Rodrigues V. E. G., 2001, Ciencia e Agrotecnologia, V25, P102; Roy S, 2014, ENVIRON TOXICOL PHAR, V37, P234, DOI 10.1016/j.etap.2013.11.008; Sahreen S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-372; Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Silva GC, 2011, J ETHNOPHARMACOL, V137, P709, DOI 10.1016/j.jep.2011.06.031; Sofi FR, 2016, J FOOD SCI TECH MYS, V53, P104, DOI 10.1007/s13197-015-1983-0; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; The Japanese Mycology Study Group, 2007, GUIDELINES FOR MANAG; Umarani V, 2015, TOXICOL MECH METHOD, V25, P143, DOI 10.3109/15376516.2014.1003359; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Wannes WA, 2010, FOOD CHEM TOXICOL, V48, P1362, DOI 10.1016/j.fct.2010.03.002; Williams GM, 1999, FOOD CHEM TOXICOL, V37, P1027, DOI 10.1016/S0278-6915(99)00085-X; Wintola OA, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0835-9; Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k; Zhao M, 2001, FEBS LETT, V509, P399, DOI 10.1016/S0014-5793(01)03184-2; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x; Zou CG, 2001, LIFE SCI, V69, P75, DOI 10.1016/S0024-3205(01)01112-2	77	28	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167531	10.1371/journal.pone.0167531	http://dx.doi.org/10.1371/journal.pone.0167531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907185	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700185
J	Sundberg, M; Strage, EM; Bergquist, J; Holst, BS; Ramstrom, M				Sundberg, Marten; Strage, Emma M.; Bergquist, Jonas; Holst, Bodil S.; Ramstrom, Margareta			Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry	PLOS ONE			English	Article							MULTIPLEXED ABSOLUTE QUANTIFICATION; CONCATENATED SIGNATURE PEPTIDES; FACTOR-I; LIQUID-CHROMATOGRAPHY; TARGETED PROTEOMICS; DIABETES-MELLITUS; PERFORMANCE; PLASMA; IDENTIFICATION; BIOMARKERS	Today immunoassays are widely used in veterinary medicine, but lack of species specific assays often necessitates the use of assays developed for human applications. Mass spectrometry (MS) is an attractive alternative due to high specificity and versatility, allowing for species-independent analysis. Targeted MS-based quantification methods are valuable complements to large scale shotgun analysis. A method referred to as parallel reaction monitoring (PRM), implemented on Orbitrap MS, has lately been presented as an excellent alternative to more traditional selected reaction monitoring/multiple reaction monitoring (SRM/MRM) methods. The insulin-like growth factor (IGF)-system is not well described in the cat but there are indications of important differences between cats and humans. In feline medicine IGF-I is mainly analyzed for diagnosis of growth hormone disorders but also for research, while the other proteins in the IGF-system are not routinely analyzed within clinical practice. Here, a PRM method for quantification of IGF-I, IGF-II, IGF binding protein (BP)-3 and IGFBP-5 in feline serum is presented. Selective quantification was supported by the use of a newly launched internal standard named QPrEST (TM). Homology searches demonstrated the possibility to use this standard of human origin for quantification of the targeted feline proteins. Excellent quantitative sensitivity at the attomol/mu L (pM) level and selectivity were obtained. As the presented approach is very generic we show that high resolution mass spectrometry in combination with PRM and nQPrEST (TM) internal standards is a versatile tool for protein quantitation across multispecies.	[Sundberg, Marten; Bergquist, Jonas; Ramstrom, Margareta] Uppsala Univ, Dept Chem BMC, Analyt Chem, Uppsala, Sweden; [Sundberg, Marten; Bergquist, Jonas; Ramstrom, Margareta] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Strage, Emma M.; Holst, Bodil S.] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Strage, Emma M.] Swedish Univ Agr Sci, Univ Anim Hosp, Clin Pathol Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Ramstrom, M (corresponding author), Uppsala Univ, Dept Chem BMC, Analyt Chem, Uppsala, Sweden.; Ramstrom, M (corresponding author), Uppsala Univ, Sci Life Lab, Uppsala, Sweden.	margareta.ramstrom@kemi.uu.se	Holst, Bodil Strom/D-4487-2014	Holst, Bodil Strom/0000-0001-7623-7141; Strage, Emma/0000-0003-4731-2960; Ramstrom, Margareta/0000-0003-1471-7291; Bergquist, Jonas/0000-0002-4597-041X	Swedish research council [621-2011-4423, 2015-4870]; Agria; Swedish Kennel Club Research Foundation; Michael Forsgren Foundation	Swedish research council(Swedish Research CouncilEuropean Commission); Agria; Swedish Kennel Club Research Foundation; Michael Forsgren Foundation	This work was supported by the Swedish research council (621-2011-4423), http://www.vr.se/; the Agria and Swedish Kennel Club Research Foundation, http://www.skk.se/sv/Agria-SKK-Forskningsfond/; and the Michael Forsgren Foundation, http://stiftelsemedel.se/michael-forsgrens-stiftelse/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Swedish research council (621-2011-4423, 2015-4870), the Agria and Swedish Kennel Club Research Foundation and the Michael Forsgren Foundation are acknowledged for financial support. We thank Anne Konzer and Katarina Hornaeus for valuable discussions and support. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [41] partner repository with the data set identifier PXD005337 and PXD005340.	Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Bredehoft M, 2008, RAPID COMMUN MASS SP, V22, P477, DOI 10.1002/rcm.3388; Bystrom C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043457; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; CLEMMONS DR, 1991, J CLIN ENDOCR METAB, V73, P727, DOI 10.1210/jcem-73-4-727; Cox HD, 2014, CLIN CHEM, V60, P541, DOI 10.1373/clinchem.2013.208538; de Kock SS, 2001, RAPID COMMUN MASS SP, V15, P1191, DOI 10.1002/rcm.363; Duriez E, 2015, J PROTEOME RES, V14, P728, DOI 10.1021/pr500764e; Edfors F, 2014, MOL CELL PROTEOMICS, V13, P1611, DOI 10.1074/mcp.M113.034140; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Gallien S, 2015, MOL CELL PROTEOMICS; Gallien S, 2015, METHODS; Gallien S, 2014, J PROTEOMICS, V100, P147, DOI 10.1016/j.jprot.2013.10.029; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kay RG, 2009, RAPID COMMUN MASS SP, V23, P3173, DOI 10.1002/rcm.4237; Kay R, 2013, CLIN ENDOCRINOL, V78, P424, DOI 10.1111/cen.12085; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kirsch S, 2007, J CHROMATOGR A, V1153, P300, DOI 10.1016/j.chroma.2007.03.058; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lewitt MS, 2000, J ENDOCRINOL, V166, P21, DOI 10.1677/joe.0.1660021; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Niederkofler EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081125; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Popot MA, 2001, CHROMATOGRAPHIA, V54, P737, DOI 10.1007/BF02492492; Pratt JM, 2006, NAT PROTOC, V1, P1029, DOI 10.1038/nprot.2006.129; Rezeli M, 2013, J PROTEOMICS, V87, P16, DOI 10.1016/j.jprot.2013.05.016; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rijnberk A., 2010, TIER RZTLICHE PRAXIS, V38, P105; Scott KB, 2015, ANAL CHEM, V87, P4429, DOI 10.1021/acs.analchem.5b00331; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Thomas A, 2011, ANALYST, V136, P1003, DOI 10.1039/c0an00632g; Tschuor F, 2012, AM J VET RES, V73, P1925, DOI 10.2460/ajvr.73.12.1925; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379; Zeiler M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.009613	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167138	10.1371/journal.pone.0167138	http://dx.doi.org/10.1371/journal.pone.0167138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907059	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700080
J	Tseng, CH				Tseng, Chin-Hsiao			Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up	PLOS ONE			English	Article							OBESITY PARADOX; BLADDER-CANCER; MORTALITY; POPULATION; HYPERTENSION; PREVALENCE; INSULIN; DISEASE; IMPACT	Objective A previous 12-year follow-up of a large diabetes cohort in Taiwan suggested a survival advantage in the patients with obesity. The present study further investigated additional determinants for cancer and non-cancer death in the cohort after a follow-up of 17 years. Methods A cohort of 92546 diabetes patients recruited since 1995 was followed for vital status by matching the National Death Certificate Database until 2011. Cox regression estimated the hazard ratios for the following variables: age at baseline, sex, diabetes type, screen-detected diabetes (diabetes diagnosed accidentally through epidemiological screening programs or during visits to medical settings without a history of diabetes), diabetes duration, body mass index, insulin use, hypertension, smoking, and living region. Fasting glucose and history of dyslipidemia were available for additional adjustment in a subcohort of the patients (n = 14559). Results A total of 40229 diabetes patients (43.5% of the cohort) died during follow-up and 10.9% died under the age of 60. Insulin use and smoking significantly predicted cancer and non-cancer death. The adjusted hazard ratio (95% confidence interval) associated with insulin use was 1.161 (1.052-1.281) for cancer death and 1.469 (1.413-1.526) for non-cancer death. Screen-detected diabetes and body mass index were consistently associated with a lower risk, but diabetes duration a higher risk, for non-cancer death, with adjusted hazard ratio of 0.683 (0.666-0.702), 0.955 (0.951-0.958) and 1.018 (1.017-1.020), respectively. Diabetes type had a null association disregarding the causes of death and living in rural areas was significantly associated with a higher mortality from non-cancer death. Hypertension, fasting glucose and dyslipidemia showed differential impacts on cancer and non-cancer death, and were significantly predictive for non-cancer death. Conclusions Screen-detected diabetes and a higher body mass index provide a survival advantage, especially for non-cancer death. However, insulin use is associated with a significantly higher risk of either cancer or non-cancer death.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan.; Tseng, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan.; Tseng, CH (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net			Department of Health [DOH89-TD-1035]; Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-187-MY3]	Department of Health; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the Department of Health (DOH89-TD-1035) and the Ministry of Science and Technology (MOST 103-2314-B-002-187-MY3) of Taiwan.	[Anonymous], 2015, IDF DIABETES ATLAS; Brun E, 2000, DIABETES CARE, V23, P1119, DOI 10.2337/diacare.23.8.1119; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Canchola AJ, COX REGRESSION USING; Carpenter CL, 2013, J OBES, V2013, DOI 10.1155/2013/790654; Chang HY, 2010, DIABETES RES CLIN PR, V90, P358, DOI 10.1016/j.diabres.2010.09.032; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Jones MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077941; Lavie CJ, 2011, CLIN PHARMACOL THER, V90, P23, DOI 10.1038/clpt.2011.87; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Rahman M, 2012, DIABETIC MED, V29, P886, DOI 10.1111/j.1464-5491.2012.03570.x; Rahman M, 2012, DIABETOLOGIA, V55, P1651, DOI 10.1007/s00125-011-2441-9; Rotella CM, 2013, INT J ENDOCRINOL MET, V11, P137, DOI 10.5812/ijem.7551; Simmons RK, 2011, DIABETOLOGIA, V54, P312, DOI 10.1007/s00125-010-1949-8; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2009, DIABETOLOGIA, V52, P240, DOI 10.1007/s00125-008-1204-8; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Tseng CH, 2009, OPEN DIABETES J, V2, P18; Tseng CH, 2008, CIRC J, V72, P1419, DOI 10.1253/circj.CJ-08-0009; Tseng CH, 2007, CIRC J, V71, P1749, DOI 10.1253/circj.71.1749; Tseng Chin-Hsiao, 2006, CMAJ, V174, P319, DOI 10.1503/cmaj.050680; Tseng CH, 2006, ARCH INTERN MED, V166, P1184, DOI 10.1001/archinte.166.11.1184; Tseng CH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1876-7; Tseng CH, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/678756; Tseng CH, 2015, J ENVIRON SCI HEAL C, V33, P67, DOI 10.1080/10590501.2015.1003496; Tseng CH, 2014, J ENVIRON SCI HEAL C, V32, P1, DOI 10.1080/10590501.2014.877645; Tseng CH, 2013, ATHEROSCLEROSIS, V226, P186, DOI 10.1016/j.atherosclerosis.2012.09.004; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Tseng CH, 2010, ATHEROSCLEROSIS, V210, P585, DOI 10.1016/j.atherosclerosis.2009.12.015; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 1985, TECHNICAL REPORT SER, V727; XU Y, 2010, JAMA-J AM MED ASSOC, V310, P948, DOI DOI 10.1001/JAMA.2013.168118	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0147916	10.1371/journal.pone.0147916	http://dx.doi.org/10.1371/journal.pone.0147916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906989	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700001
J	Zhang, DP; Lu, HY; Zhuang, MH; Wu, GH; Yan, HJ; Xu, J; Wei, XL; Li, CM; Meng, SN; Fu, XJ; Qi, JL; Wang, P; Luo, M; Dai, M; Yip, R; Sun, JP; Wu, ZY				Zhang, Dapeng; Lu, Hongyan; Zhuang, Minghua; Wu, Guohui; Yan, Hongjing; Xu, Jun; Wei, Xiaoli; Li, Chengmei; Meng, Sining; Fu, Xiaojing; Qi, Jinlei; Wang, Peng; Luo, Mei; Dai, Min; Yip, Ray; Sun, Jiangping; Wu, Zunyou			Enhancing HIV Testing and Treatment among Men Who Have Sex with Men in China: A Pilot Model with Two-Rapid Tests, Single Blood Draw Session, and Intensified Case Management in Six Cities in 2013	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; LINKAGE; TRANSMISSION; PREVENTION; INFECTION; IMPACT; POLICY; NO	Objectives To explore models to improve HIV testing, linkage to care and treatment among men who have sex with men (MSM) in cooperation with community-based organizations (CBOs) in China. Methods We introduced a new model for HIV testing services targeting MSM in six cities in 2013. These models introduced provision of rapid HIV testing by CBO staff and streamlined processes for HIV screening, confirmation of initial reactive screening results, and linkage to care among diagnosed people. We monitored attrition along each step of the continuum of care from screening to treatment and compared program performance between 2012 and 2013. According to the providers of two rapid tests (HIV screening), four different services delivery models were examined in 2013: Model A = first screen at CDC, second at CDC (Model A = CDC+CDC), Model B = first and second screens at CBOs (Model B = CBO + CBO), Model C = first screen at CBO, second at Hospital (Model C = CBO+Hosp), and Model D = first screen at CBO, second at CDC (Model D = CBO+CDC). Logistic regressions were performed to assess advantages of different screening models of case finding and case management. Results Compared to 2012, the number of HIV screening tests performed for MSM increased 35.8% in 2013 (72,577 in 2013 vs. 53,455 in 2012). We observed a 5.6% increase in proportion of cases screened reactive receiving HIV confirmatory tests (93.9% in 2013 vs. 89.2% in 2012, chi(2) = 48.52, p<0.001) and 65% reduction in loss to CD4 cell count tests (15% in 2013 vs. 43% in 2012, chi(2) = 628.85, p<0.001). Regarding linkage to care and treatment, the 2013 pilot showed that the Model D had the highest rate of loss between screening reactive and confirmatory test among the four models, with 18.1% fewer receiving a second screening test and a further 5.9% loss among those receiving HIV confirmatory tests. The Model B and the Model C showed lower losses (0.8% and 1.3%) for newly diagnosed HIV positives receiving CD4 cell count tests, and higher rates of HIV positives referred to designated ART hospitals (88.0% and 93.3%) than the Model A and Model D (4.6% and 5.7% for CD4 cell count test, and 68.9% and 64.4% for referring to designated ART hospitals). The proportion of cases where the screening test was reactive that were commenced on ART was highest in Model C; 52.8% of cases commenced on ART compared to 38.9%, 34.2% and 21.1% in Models A, B and D respectively. Using Model A as a reference group, the multivariate logistic regression results also showed the advantages of Models B, C and D, which increased CD4 cell count test, referral to designated ART hospitals and initiation of ART, when controlling for program city and other factors. Conclusions This study has demonstrated that involvement of CBOs in HIV rapid testing provision, streamlining testing and care procedures and early hospital case management can improve testing, linkage to, and retention in care and treatment among MSM in China.	[Zhang, Dapeng; Li, Chengmei; Meng, Sining; Fu, Xiaojing; Qi, Jinlei; Sun, Jiangping; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Lu, Hongyan] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhuang, Minghua] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wu, Guohui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Yan, Hongjing] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Xu, Jun] Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China; [Wei, Xiaoli] Xian Ctr Dis Control & Prevent, Xian, Peoples R China; [Wang, Peng] Chinese Prevent Med Assoc, Beijing, Peoples R China; [Luo, Mei] Chinese Assoc STD & AIDS Prevent & Control, Beijing, Peoples R China; [Dai, Min; Yip, Ray] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	DAI, M/GPS-8291-2022		China-Gates Foundation HIV Cooperation Program [Opp 49277]	China-Gates Foundation HIV Cooperation Program	This program was funded by the China-Gates Foundation HIV Cooperation Program (Opp 49277).	Andrews JR, 2012, J INFECT DIS, V206, P543, DOI 10.1093/infdis/jis401; [Anonymous], 2012, CHIN J BOOD TRANSFUS, P702; Bao Z, 2012, CHINA STD AIDS, P371; China Ministry of Health UNAIDS WHO, 2012, CHIN J AIDS STD, V18, P1; Chinese Center for Diseae Control and Prevention, 2009, NAT GUILD DET HIV AI; Clark HA, 2008, PUBLIC HEALTH REP, V123, P86, DOI 10.1177/00333549081230S311; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han J, 2009, CHIN J AIDS STD, V3, P311; Han M., 2011, INT J LAB MED, V32, P1185; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Li J, 2011, ZHEJING PREVENT MED, V23, P6; Liu Y, 2012, J APPL MATH, DOI 10.1155/2012/391372; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126893; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Millar R, 2016, J HEALTH ORGAN MANAG, V30, P324, DOI 10.1108/JHOM-12-2014-0200; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Qvist T, 2014, SEX TRANSM DIS, V41, P209, DOI 10.1097/OLQ.0000000000000096; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Shrestha RK, 2011, AIDS EDUC PREV, V23, P49, DOI 10.1521/aeap.2011.23.3_supp.49; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Tucker JD, 2012, SEX TRANSM DIS, V39, P182, DOI 10.1097/OLQ.0b013e318237b3b4; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wilcox Ronald D, 2012, HIV Clin, V24, P1; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, CONS GUID US ANT DRU; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Wu ZY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001874; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397; Zhang D, 2014, AIDS CARE, V31, P31; Zhang D, 2014, INT J STD AIDS, V15; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431; Zhang L, 2012, SEX HEALTH, V9, P261, DOI 10.1071/SH11104; Zou J, 2010, LAB MED CLIC, V7, P93	39	7	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166812	10.1371/journal.pone.0166812	http://dx.doi.org/10.1371/journal.pone.0166812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906994	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700042
J	Agus, DB; Gaudette, E; Goldman, DP; Messali, A				Agus, David B.; Gaudette, Etienne; Goldman, Dana P.; Messali, Andrew			The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older	PLOS ONE			English	Article							ATHEROSCLEROTIC VASCULAR-DISEASE; LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; AHA/ACC GUIDELINES; HEART-ASSOCIATION; HEALTH; UPDATE; METAANALYSIS; CORONARY	Background The usefulness of aspirin to defend against cardiovascular disease in both primary and secondary settings is well recognized by the medical profession. Multiple studies also have found that daily aspirin significantly reduces cancer incidence and mortality. Despite these proven health benefits, aspirin use remains low among populations targeted by cardiovascular prevention guidelines. This article seeks to determine the long-term economic and population-health impact of broader use of aspirin by older Americans at higher risk for cardiovascular disease. Methods and Findings We employ the Future Elderly Model, a dynamic microsimulation that follows Americans aged 50 and older, to project their lifetime health and spending under the status quo and in various scenarios of expanded aspirin use. The model is based primarily on data from the Health and Retirement Study, a large, representative, national survey that has been ongoing for more than two decades. Outcomes are chosen to provide a broad perspective of the individual and societal impacts of the interventions and include: heart disease, stroke, cancer, life expectancy, quality-adjusted life expectancy, disability-free life expectancy, and medical costs. Eligibility for increased aspirin use in simulations is based on the 2011-2012 questionnaire on preventive aspirin use of the National Health and Nutrition Examination Survey. These data reveal a large unmet need for daily aspirin, with over 40% of men and 10% of women aged 50 to 79 presenting high cardiovascular risk but not taking aspirin. We estimate that increased use by high-risk older Americans would improve national life expectancy at age 50 by 0.28 years (95% CI 0.08-0.50) and would add 900,000 people (95% CI 300,000- 1,400,000) to the American population by 2036. After valuing the quality-adjusted life-years appropriately, Americans could expect $692 billion (95% CI 345-975) in net health benefits over that period. Conclusions Expanded use of aspirin by older Americans with elevated risk of cardiovascular disease could generate substantial population health benefits over the next twenty years and do so very cost-effectively.	[Agus, David B.] Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Beverly Hills, CA 90211 USA; [Agus, David B.] Viterbi Sch Engn, Beverly Hills, CA 90089 USA; [Gaudette, Etienne; Goldman, Dana P.] Univ Southern Calif, Price Sch, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Gaudette, Etienne; Goldman, Dana P.] Sch Pharm, Los Angeles, CA USA; [Messali, Andrew] Anal Grp Inc, Boston, MA USA	University of Southern California; University of Southern California; Analysis Group Inc.	Agus, DB (corresponding author), Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Beverly Hills, CA 90211 USA.; Agus, DB (corresponding author), Viterbi Sch Engn, Beverly Hills, CA 90089 USA.	agus@usc.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; Agus, David B./0000-0002-7499-7822; Gaudette, Etienne/0000-0003-0359-2083	National Institute on Aging [P30AG024968]; Lawrence J. Ellison Institute for Transformative Medicine; Stephenson Family Personalized Medicine Center	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lawrence J. Ellison Institute for Transformative Medicine; Stephenson Family Personalized Medicine Center	The authors did not receive financial support for conducting this study. The authors are grateful to the National Institute on Aging for its support through the Robal Center for Health Policy Simulation (grant no. P30AG024968) and to the Lawrence J. Ellison Institute for Transformative Medicine and Stephenson Family Personalized Medicine Center. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Lawrence J. Ellison Institute for Transformative Medicine or the Stephenson Family Personalized Medicine Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bibbins-Domingo K, 2016, ANN INTERNAL MED; Calonge N, 2009, ANN INTERN MED, V150, P396; Cuzick J, 2014, ANN ONCOLOGY; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Frakt A, 2015, THE UPSHOT; Gaudette Etienne, 2015, Forum Health Econ Policy, V18, P75; Gaudette E, 2015, PHARMACOECONOMICS, V33, P723, DOI 10.1007/s40273-014-0234-y; Goldman DP, 2016, AM J PREV MED, V50, pS45, DOI 10.1016/j.amepre.2015.12.005; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Goldman DP, 2004, DTIC DOCUMENT; Health WBCoMa, 2001, MACR HLTH INV HLTH E; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kaestner R, 2014, J HEALTH ECON, V36, P151, DOI 10.1016/j.jhealeco.2014.04.006; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Michaud PC, 2012, J HEALTH ECON, V31, P630, DOI 10.1016/j.jhealeco.2012.04.006; Prevention CfDCa, 2015, CHRON DIS PREV HLTH; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Survey NHaNE, 2013, 2011 2012 DAT DOC CO; Zissimopoulos Julie, 2014, Forum Health Econ Policy, V18, P25	25	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166103	10.1371/journal.pone.0166103	http://dx.doi.org/10.1371/journal.pone.0166103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902693	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100013
J	Dugo, M; Cotroneo, CE; Lavoie-Charland, E; Incarbone, M; Santambrogio, L; Rosso, L; van den Berge, M; Nickle, D; Pare, PD; Bosse, Y; Dragani, TA; Colombo, F				Dugo, Matteo; Cotroneo, Chiara E.; Lavoie-Charland, Emilie; Incarbone, Matteo; Santambrogio, Luigi; Rosso, Lorenzo; van den Berge, Maarten; Nickle, David; Pare, Peter D.; Bosse, Yohan; Dragani, Tommaso A.; Colombo, Francesca			Human Lung Tissue Transcriptome: Influence of Sex and Age	PLOS ONE			English	Article							GENE-EXPRESSION; BLOOD; METAANALYSIS; SIGNATURE; EVOLUTION; PIPELINE; SURVIVAL; REVEALS; PROFILE; COPD	Background Sex and age strongly influence the pathophysiology of human lungs, but scarce information is available about their effects on pulmonary gene expression. Methods We followed a discovery-validation strategy to identify sex-and age-related transcriptional differences in lung. Results We identified transcriptional profiles significantly associated with sex (215 genes; FDR < 0.05) and age at surgery (217 genes) in non-involved lung tissue resected from 284 lung adenocarcinoma patients. When these profiles were tested in three independent series of non-tumor lung tissue from an additional 1,111 patients, we validated the association with sex and age for 25 and 22 genes, respectively. Among the 17 sex-biased genes mapping on chromosome X, 16 have been reported to escape X-chromosome inactivation in other tissues or cells, suggesting that this mechanism influences lung transcription too. Our 22 age-related genes partially overlap with genes modulated by age in other tissues, suggesting that the aging process has similar consequences on gene expression in different organs. Finally, seven genes whose expression was modulated by sex in non-tumor lung tissue, but no age-related gene, were also validated using publicly available data from 990 lung adenocarcinoma samples, suggesting that the physiological regulatory mechanisms are only partially active in neoplastic tissue. Conclusions Gene expression in non-tumor lung tissue is modulated by both sex and age. These findings represent a validated starting point for research on the molecular mechanisms underlying the observed differences in the course of lung diseases among men and women of different ages.	[Dugo, Matteo] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Cotroneo, Chiara E.; Dragani, Tommaso A.; Colombo, Francesca] Fdn IRCCS Ist Nazl Tumori, Dept Predict & Prevent Med, Milan, Italy; [Lavoie-Charland, Emilie; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Incarbone, Matteo] San Giuseppe Hosp MultiMed, Dept Surg, Milan, Italy; [Santambrogio, Luigi; Rosso, Lorenzo] Univ Milan, Fdn IRCCS Osped Maggiore Policlin, Milan, Italy; [van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC, Groningen, Netherlands; [Nickle, David] Merck & Co Inc, Rahway, NJ 07065 USA; [Pare, Peter D.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Pare, Peter D.] St Pauls Hosp, Inst Heart & Lung Hlth, Vancouver, BC, Canada; [Pare, Peter D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Cotroneo, Chiara E.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Groningen; Merck & Company; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Laval University; University College Dublin	Dragani, TA (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Predict & Prevent Med, Milan, Italy.	tommaso.dragani@istitutotumori.mi.it	Pare, Peter D/C-7425-2011; Rosso, Lorenzo Paolo/J-6815-2015; Rosso, Lorenzo/O-6063-2017; Santambrogio, Luigi/O-7335-2017; Nickle, David/ABF-2727-2020; Dugo, Matteo/H-6860-2014; Colombo, Francesca/B-4617-2013; Colombo, Francesca/Q-5292-2019	Rosso, Lorenzo Paolo/0000-0002-9809-7140; Rosso, Lorenzo/0000-0002-9809-7140; Santambrogio, Luigi/0000-0002-6192-8190; Dugo, Matteo/0000-0001-9786-2763; Colombo, Francesca/0000-0003-2015-4317; Colombo, Francesca/0000-0003-2015-4317; Cotroneo, Chiara Elisabetta/0000-0001-6648-2987; van den Berge, Maarten/0000-0002-9336-7340	Italian Association for Cancer Research (AIRC) [14714]; Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research [MOP 123369]; Cancer Research Society and Read for the Cure; Fonds de recherche Quebec Sante (FRQS)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society and Read for the Cure; Fonds de recherche Quebec Sante (FRQS)	This work was supported by grants from the Italian Association for Cancer Research (AIRC, grant no. 14714). One of the authors (D.N.) has an affiliation to a commercial funder of this research (Merck & Co. Inc.); the funder provided support in the form of salary for the author (D.N.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in the design or conduction of the study, in the collection, analysis or interpretation of the data, or in the preparation, review and approval of the manuscript. The collection of lung samples from Laval University was supported by the Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval, the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, the Respiratory Health Network of the FRQS, the Canadian Institutes of Health Research (MOP 123369), and the Cancer Research Society and Read for the Cure. Y. Bosse is the recipient of a Junior 2 Research Scholar award from the Fonds de recherche Quebec Sante (FRQS). The authors would like to thank the staff at the Respiratory Health Network Tissue Bank of the FRQS for their valuable assistance.	Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Bacalini MG, 2015, AGING-US, V7, P97, DOI 10.18632/aging.100718; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Galvan A, 2013, CARCINOGENESIS, V34, P2767, DOI 10.1093/carcin/bgt294; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito K, 2012, INT J CHRONIC OBSTR, V7, P641, DOI 10.2147/COPD.S28250; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Palma DA, 2010, J THORAC ONCOL, V5, P818, DOI 10.1097/JTO.0b013e3181d6e052; Papaioannou AI, 2013, CURR DRUG TARGETS, V14, P149; Renzoni Elisabetta, 2014, F1000Prime Rep, V6, P69, DOI 10.12703/P6-69; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singmann P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0035-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016; Tong BC, 2014, J THORAC CARDIOV SUR, V148, P13, DOI 10.1016/j.jtcvs.2014.03.012; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Xu HQ, 2014, HUM MOL GENET, V23, P1260, DOI 10.1093/hmg/ddt516; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167460	10.1371/journal.pone.0167460	http://dx.doi.org/10.1371/journal.pone.0167460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902768	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100082
J	Smith, IM; Baker, A; Christensen, JE; Boekhout, T; Frokiaer, H; Arneborg, N; Jespersen, L				Smith, Ida M.; Baker, Adam; Christensen, Jeffrey E.; Boekhout, Teun; Frokiaer, Hanne; Arneborg, Nils; Jespersen, Lene			Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; FUNGAL BETA-GLUCAN; CANDIDA-ALBICANS; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; IMMUNE RECOGNITION; MONONUCLEAR-CELLS; LECTIN RECEPTORS; INDUCED COLITIS; GUT MICROBIOTA	Interactions between members of the intestinal microbiota and the mucosal immune system can significantly impact human health, and in this context, fungi and food-related yeasts are known to influence intestinal inflammation through direct interactions with specialized immune cells in vivo. The aim of the present study was to characterize the immune modulating properties of the food-related yeast Kluyveromyces marxianus in terms of adaptive immune responses indicating inflammation versus tolerance and to explore the mechanisms behind the observed responses. Benchmarking against a Saccharomyces boulardii strain with probiotic effects documented in clinical trials, we evaluated the ability of K. marxianus to modulate human dendritic cell (DC) function in vitro. Further, we assessed yeast induced DC modulation of naive T cells toward effector responses dominated by secretion of IFN gamma and IL-17 versus induction of a Treg response characterized by robust IL-10 secretion. In addition, we blocked relevant DC surface receptors and investigated the stimulating properties of beta-glucan containing yeast cell wall extracts. K. marxianus and S. boulardii induced distinct levels of DC cytokine secretion, primarily driven by Dectin-1 recognition of beta-glucan components in their cell walls. Upon co-incubation of yeast exposed DCs and naive T cells, S. boulardii induced a potent IFN. response indicating T(H)1 mobilization. In contrast, K. marxianus induced a response dominated by Foxp3(+)T(reg) cells, a characteristic that may benefit human health in conditions characterized by excessive inflammation and positions K. marxianus as a strong candidate for further development as a novel yeast probiotic.	[Smith, Ida M.; Baker, Adam] Chr Hansen AS, Hlth & Nutr Div Discovery, Horsholm, Denmark; [Smith, Ida M.; Arneborg, Nils; Jespersen, Lene] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Christensen, Jeffrey E.] French Inst Hlth & Med Res INSERM, Inst Metab & Cardiovasc Dis, Toulouse, France; [Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Frokiaer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Smith, Ida M.] ALK AS, Global Clin Dev, Biometr Med Writing, Horsholm, Denmark	Chr Hansen; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Copenhagen; ALK-Abello AS	Smith, IM (corresponding author), Chr Hansen AS, Hlth & Nutr Div Discovery, Horsholm, Denmark.; Smith, IM (corresponding author), Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark.; Smith, IM (corresponding author), ALK AS, Global Clin Dev, Biometr Med Writing, Horsholm, Denmark.	ismdk@alk.net	Boekhout, Teunis/ABF-2538-2020; Jespersen, Lene/AAA-4230-2021	Boekhout, Teunis/0000-0002-0476-3609; Jespersen, Lene/0000-0002-2555-5948; Frokiaer, Hanne/0000-0003-1472-9698; Christensen, Jeffrey E./0000-0001-7357-7677	EU [PITN-GA-2010-264717]	EU(European Commission)	The research leading to these results was funded by the EU's Seventh Framework Programme (FP7) under grant agreement PITN-GA-2010-264717, in the form of a research fellowship for IMS. Thus, the funder provided support in the form of salary for IMS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034676; Batbayar S, 2012, BIOMOL THER, V20, P433, DOI 10.4062/biomolther.2012.20.5.433; Bazan SB, 2011, VACCINE, V29, P8165, DOI 10.1016/j.vaccine.2011.07.141; (BIOHAZ) EPoBH, 2010, EFSA J, V8; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Donkor ON, 2012, CLIN EXP IMMUNOL, V167, P282, DOI 10.1111/j.1365-2249.2011.04496.x; Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jespersen L, 2005, FEMS YEAST RES, V5, P441, DOI 10.1016/j.femsyr.2004.11.002; Justino PFC, 2014, BRIT J NUTR, V111, P1611, DOI 10.1017/S0007114513004248; Karumuthil-Melethil S, 2014, J IMMUNOL, V193, P3308, DOI 10.4049/jimmunol.1400186; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kuhle AVA, 2003, SYST APPL MICROBIOL, V26, P564, DOI 10.1078/072320203770865873; Kumura H, 2004, J DAIRY SCI, V87, P4050, DOI 10.3168/jds.S0022-0302(04)73546-8; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lang TJ, 2002, J IMMUNOL, V168, P3786, DOI 10.4049/jimmunol.168.8.3786; Lee SK, 2009, DIGEST DIS SCI, V54, P255, DOI 10.1007/s10620-008-0357-0; Liu YY, 2014, AM J PHYSIOL-GASTR L, V307, pG177, DOI 10.1152/ajpgi.00038.2014; Maccaferri S, 2012, APPL ENVIRON MICROB, V78, P956, DOI 10.1128/AEM.06385-11; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Marchesi JR, 2010, ADV APPL MICROBIOL, V72, P43, DOI 10.1016/S0065-2164(10)72002-5; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Martins FS, 2005, J GEN APPL MICROBIOL, V51, P83, DOI 10.2323/jgam.51.83; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Petersen ER, 2012, INFLAMM BOWEL DIS, V18, P131, DOI 10.1002/ibd.21709; Podojil JR, 2009, IMMUNOL REV, V229, P337, DOI 10.1111/j.1600-065X.2009.00773.x; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Romani L, 2004, INT IMMUNOL, V16, P149, DOI 10.1093/intimm/dxh012; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Seong Su Kyoung, 2010, Mycobiology, V38, P144, DOI 10.4489/MYCO.2010.38.2.144; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Smith IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096595; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Thomas S, 2009, CLIN EXP IMMUNOL, V156, P78, DOI 10.1111/j.1365-2249.2009.03878.x; Thomas S, 2011, AM J PHYSIOL-GASTR L, V301, pG1083, DOI 10.1152/ajpgi.00217.2011; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Wismar R, 2011, MOL NUTR FOOD RES, V55, P443, DOI 10.1002/mnfr.201000230; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441	63	14	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167410	10.1371/journal.pone.0167410	http://dx.doi.org/10.1371/journal.pone.0167410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898740	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000062
J	Zwicker, S; Bureik, D; Bosma, M; Martinez, GL; Almer, S; Bostrom, EA				Zwicker, Stephanie; Bureik, Daniela; Bosma, Madeleen; Martinez, Gisele Lago; Almer, Sven; Bostrom, Elisabeth A.			Receptor-Type Protein-Tyrosine Phosphatase zeta and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1	PLoS One			English	Article							INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; MICE DEFICIENT; MACROPHAGES; IL-34; ANTIBODY; BLOOD; CELLS; SERUM	Differential intestinal expression of the macrophage growth factors colony stimulating factor-1 (CSF-1), interleukin (IL)-34, and their shared CSF-1 receptor (CSF-1R) in inflammatory bowel disease (IBD) has been shown. Diverse expression between CSF-1 and IL-34, suggest that IL-34 may signal via an alternate receptor. Receptor-type protein-tyrosine phosphatase (PTPRZ1, RPTP-zeta), an additional IL-34 receptor, was recently identified. Here, we aimed to assess PTPRZ1 expression in IBD and non-IBD intestinal biopsies. Further, we aimed to investigate cellular PTPRZ1 and CSF-1R expression, and cytokine- and chemokine responses by IL-34 and CSF-1. The expression of PTPRZ1 was higher in nonIBD colon compared to ileum. PTPRZ1 expression was not altered with inflammation in IBD, however, correlated to 1L34, CSF1, and CSF1R. The expression patterns of PTPRZ1 and CSF-1R differed in peripheral blood mononuclear cells (PBMCs), monocytes, macrophages, and intestinal epithelial cell line. PBMCs and monocytes of the same donors responded differently to IL-34 and CSF-1 with altered expression of tumor-necrosis factor a (TNF-alpha), IL-1 beta, interferon gamma(IFN-gamma), IL-13, IL-8, and monocyte chemotactic protein-1 (MCP 1) levels. This study shows that PTPRZ1 was expressed in bowel tissue. Furthermore, CSF-1R protein was detected in an intestinal epithelial cell line and donor dependently in primary PBMCs, monocytes, and macrophages, and first hints also suggest an expression in these cells for PTPRZ1, which may mediate IL-34 and CSF-1 actions.	[Zwicker, Stephanie; Bureik, Daniela; Martinez, Gisele Lago; Bostrom, Elisabeth A.] Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden; [Bosma, Madeleen] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Almer, Sven] Karolinska Inst, Dept Med, Stockholm, Sweden; [Almer, Sven] Karolinska Univ Hosp, GastroCtr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Bostrom, EA (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden.	elisabeth.bostrom@ki.se		Almer Bostrom, Elisabeth/0000-0003-1788-7501; Almer, Sven/0000-0001-9334-1821	Swedish Research Council [523-2012-2480]; Stockholm County Council/ALF project [20140367]; Karolinska Institutet Funds; Ake Wiberg Foundation; Ihre Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council/ALF project(Stockholm County Council); Karolinska Institutet Funds; Ake Wiberg Foundation; Ihre Foundation	This work was supported by grants from the Swedish Research Council (523-2012-2480 to EAB), Stockholm County Council/ALF project (20140367 to EAB), Karolinska Institutet Funds (EAB), Ake Wiberg Foundation (EAB) and the Ihre Foundation (SA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Booker Burthia E, 2015, Int J Biochem Mol Biol, V6, P1; Bostrom EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081665; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Ciccia F, 2013, RHEUMATOLOGY, V52, P1009, DOI 10.1093/rheumatology/kes435; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Eda H, 2010, CYTOKINE, V52, P215, DOI 10.1016/j.cyto.2010.08.005; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Franze E, 2015, CLIN SCI; Franze E, 2015, J CROHNS COLITIS; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Herradon G, 2009, CURR MED CHEM, V16, P3322, DOI 10.2174/092986709788803240; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Krishnan K, 2011, INFLAMM BOWEL DIS, V17, P410, DOI 10.1002/ibd.21316; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Millard AL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00125; Moon SJ, 2013, J RHEUMATOL, V40, P1842, DOI 10.3899/jrheum.130356; Nagashima R, 1996, J HISTOCHEM CYTOCHEM, V44, P721, DOI 10.1177/44.7.8675993; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Nandi S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.442731; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Paniagua RT, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2940; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Segaliny AI, 2015, BBA-MOL CELL RES, V1853, P1010, DOI 10.1016/j.bbamcr.2015.01.023; Stanley ER, 2014, COLD SPRING HARBOR P, V6; Strack S, 2015, J MUSCLE RES CELL M, V36, P517, DOI 10.1007/s10974-015-9418-0; Sullivan AR, 2014, J MAMMARY GLAND BIOL, V19, P149, DOI 10.1007/s10911-014-9320-1; Tian Y, 2013, J INTERF CYTOK RES, V33, P398, DOI 10.1089/jir.2012.0122; Toh ML, 2014, ARTHRITIS RHEUMATOL, V66, P2989, DOI 10.1002/art.38624; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025; Zwicker S, 2015, CLIN SCI	43	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167324	10.1371/journal.pone.0167324	http://dx.doi.org/10.1371/journal.pone.0167324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898738	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000052
J	Bender, JK; Fleige, C; Klare, I; Fiedler, S; Mischnik, A; Mutters, NT; Dingle, KE; Werner, G				Bender, Jennifer K.; Fleige, Carola; Klare, Ingo; Fiedler, Stefan; Mischnik, Alexander; Mutters, Nico T.; Dingle, Kate E.; Werner, Guido			Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.	PLOS ONE			English	Article							MULTIRESISTANCE GENE CFR; CLOSTRIDIUM-DIFFICILE; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC-RESISTANCE; ANIMAL ORIGIN; RIBOSOMAL-RNA; 1ST REPORT; FAECALIS; MECHANISMS; OXAZOLIDINONES	The National Reference Centre for Staphylococci and Enterococci in Germany has received an increasing number of clinical linezolid-resistant E. faecium isolates in recent years. Five isolates harbored a cfr(B) variant gene locus the product of which is capable of conferring linezolid resistance. The cfr(B)-like methyltransferase gene was also detected in Clostridium difficile. Antimicrobial susceptibility was determined for cfr(B)-positive and linezolid-resistant E. faecium isolates and two isogenic C. difficile strains. All strains were subjected to whole genome sequencing and analyzed with respect to mutations in the 23S rDNA, rplC, rplD and rplV genes and integration sites of the cfr(B) variant locus. To evaluate methyltransferase function, the cfr(B) variant of Enterococcus and Clostridium was expressed in both E. coli and Enterococcus spp. Ribosomal target site mutations were detected in E. faecium strains but absent in clostridia. Sequencing revealed 99.9% identity between cfr(B) of Enterococcus and cfr of Clostridium. The methyltransferase gene is encoded by transposon Tn6218 which was present in C. difficile Ox3196, truncated in some E. faecium and absent in C. difficile Ox3206. The latter finding explains the lack of linezolid and chloramphenicol resistance in C. difficile Ox3206 and demonstrates for the first time a direct correlation of elevated linezolid MICs in C. difficile upon cfr acquisition. Tn6218 insertion sites revealed novel target loci for integration, both within the bacterial chromosome and as an integral part of plasmids. Importantly, the very first plasmid-association of a cfr(B) variant was observed. Although we failed to measure cfr(B)-mediated resistance in transformed laboratory strains the occurrence of the multidrug resistance gene cfr on putatively highly mobile and/or extrachromosomal DNA in clinical isolates is worrisome with respect to dissemination of antibiotic resistances.	[Bender, Jennifer K.; Fleige, Carola; Klare, Ingo; Fiedler, Stefan; Werner, Guido] Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistances, Natl Reference Ctr Staphylococci & Enterococci, Dept Infect Dis,Wernigerode Branch, Wernigerode, Germany; [Mischnik, Alexander] Univ Freiburg, Fac Med, Med Ctr, Div Infect Dis,Dept Med, Freiburg, Germany; [Mischnik, Alexander; Mutters, Nico T.] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany; [Mischnik, Alexander; Mutters, Nico T.] German Ctr Infect Res DZIF, Heidelberg, Germany; [Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, Oxon, England; [Dingle, Kate E.] John Radcliffe Hosp, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, Oxon, England	Robert Koch Institute; University of Freiburg; Ruprecht Karls University Heidelberg; German Center for Infection Research; University of Oxford; University of Oxford	Bender, JK (corresponding author), Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistances, Natl Reference Ctr Staphylococci & Enterococci, Dept Infect Dis,Wernigerode Branch, Wernigerode, Germany.	benderj@rki.de	Mutters, Nico/B-5287-2013	Mutters, Nico/0000-0002-0156-9595; Dingle, Kate/0000-0002-2303-5957; Bender, Jennifer/0000-0001-5167-3836	Federal Ministry of Health [1369-234]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre; Federal Ministry for Health, Germany	Federal Ministry of Health; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Federal Ministry for Health, Germany	The work of the National Reference Centre for Staphylococci and Enterococci is supported by a grant from the Federal Ministry of Health (1369-234). KED was supported by the Oxford Partnership Comprehensive Biomedical Research Centre, with funding from the Department of Health's NIHR Biomedical Research Centre funding scheme.; We would like to thank Sandra Stengel, Anja Greiner and Uta Geringer for excellent technical support and all laboratories which provided us with strains. Further, we would like to acknowledge the contribution of Dr. Franziska Layer and Dr. Roman Gerlach for critical reading of the manuscript. K.E.D. was supported by the Oxford Partnership Comprehensive Biomedical Research Centre, with funding from the Department of Health's NIHR Biomedical Research Centre funding scheme. We acknowledge funding received from the Federal Ministry for Health, Germany, for our work as a National Reference Centre for Staphylococci and Enterococci.	Adams V, 2002, CELL MOL LIFE SCI, V59, P2033, DOI 10.1007/s000180200003; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bender J, 2015, J ANTIMICROB CHEMOTH, V70, P1630, DOI 10.1093/jac/dkv025; Bonilla H, 2010, CLIN INFECT DIS, V51, P796, DOI 10.1086/656281; Brenciani A, 2016, J ANTIMICROB CHEMOTH, V71, P1118, DOI 10.1093/jac/dkv438; Cafini F, 2016, J ANTIMICROB CHEMOTH, V71, P587, DOI 10.1093/jac/dkv391; Cai J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.007; Chen HB, 2013, INT J ANTIMICROB AG, V42, P317, DOI 10.1016/j.ijantimicag.2013.06.008; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Deshpande LM, 2015, ANTIMICROB AGENTS CH, V59, P6256, DOI 10.1128/AAC.01473-15; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Dingle KE, 2014, GENOME BIOL EVOL, V6, P36, DOI 10.1093/gbe/evt204; Fiedler S, 2016, J ANTIMICROB CHEMOTH, V71, P871, DOI 10.1093/jac/dkv420; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; Gomez JAL, 2011, INT J MED MICROBIOL, V301, P165, DOI 10.1016/j.ijmm.2010.08.015; Hansen LH, 2015, ANTIMICROB AGENTS CH, V59, P5841, DOI 10.1128/AAC.01274-15; Huang YL, 2014, J THORAC DIS, V6, pE48, DOI 10.3978/j.issn.2072-1439.2014.02.13; Jasni AS, 2010, ANTIMICROB AGENTS CH, V54, P4924, DOI 10.1128/AAC.00496-10; Johanesen PA, 2015, GENES-BASEL, V6, P1347, DOI 10.3390/genes6041347; Johnson AP, 2002, EUR J CLIN MICROBIOL, V21, P751, DOI 10.1007/s10096-002-0807-0; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Klare I, 2015, J GLOB ANTIMICROB RE, V3, P128, DOI 10.1016/j.jgar.2015.02.007; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; LaMarre J, 2013, ANTIMICROB AGENTS CH, V57, P1173, DOI 10.1128/AAC.02047-12; Launay A, 2006, ANTIMICROB AGENTS CH, V50, P1054, DOI 10.1128/AAC.50.3.1054-1062.2006; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu Y, 2014, VET MICROBIOL, V170, P352, DOI 10.1016/j.vetmic.2014.02.037; Liu Y, 2014, J ANTIMICROB CHEMOTH, V69, P892, DOI 10.1093/jac/dkt459; Liu Y, 2013, ANTIMICROB AGENTS CH, V57, P42, DOI 10.1128/AAC.01605-12; Liu Y, 2012, ANTIMICROB AGENTS CH, V56, P1650, DOI 10.1128/AAC.06091-11; Livermore DM, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg249; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Long KS, 2012, ANTIMICROB AGENTS CH, V56, P603, DOI 10.1128/AAC.05702-11; Marin M, 2015, ANTIMICROB AGENTS CH, V59, P586, DOI 10.1128/AAC.04082-14; Mendes RE, 2016, J ANTIMICROB CHEMOTH, V71, P1860, DOI 10.1093/jac/dkw052; Mendes RE, 2010, J ANTIMICROB CHEMOTH, V65, P2329, DOI 10.1093/jac/dkq331; Penders J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00087; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; de Gopegui ER, 2012, ANTIMICROB AGENTS CH, V56, P2139, DOI 10.1128/AAC.06042-11; Seedat J, 2006, ANTIMICROB AGENTS CH, V50, P4217, DOI 10.1128/AAC.00518-06; Shen JZ, 2013, J ANTIMICROB CHEMOTH, V68, P1697, DOI 10.1093/jac/dkt092; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Wang Y, 2015, J ANTIMICROB CHEMOTH, V70, P2182, DOI 10.1093/jac/dkv116; Wasels F, 2014, MICROB DRUG RESIST, V20, P555, DOI 10.1089/mdr.2014.0015; Werner G, 2004, J CLIN MICROBIOL, V42, P5327, DOI 10.1128/JCM.42.11.5327-5331.2004; Werner G, 2011, J ANTIMICROB CHEMOTH, V66, P273, DOI 10.1093/jac/dkq455	47	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167042	10.1371/journal.pone.0167042	http://dx.doi.org/10.1371/journal.pone.0167042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893790	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400073
J	Afrooz, ARMN; Boehm, AB				Afrooz, A. R. M. Nabiul; Boehm, Alexandria B.			Escherichia coli Removal in Biochar-Modified Biofilters: Effects of Biofilm	PLOS ONE			English	Article							HETEROGENEOUS POROUS-MEDIA; FECAL INDICATOR BACTERIA; SECONDARY ENERGY MINIMUM; ATOMIC-FORCE MICROSCOPY; AERUGINOSA PAO1 BIOFILM; NATURAL ORGANIC-MATTER; PSEUDOMONAS-AERUGINOSA; STORMWATER BIOFILTERS; INTERMITTENT FLOW; COLLOID TRANSPORT	The presence of microbial contaminants in urban stormwater is a significant concern for public health; however, their removal by traditional stormwater biofilters has been reported as inconsistent and inadequate. Recent work has explored the use of biochar to improve performance of stormwater biofilters under simplified conditions that do not consider potential effects of biofilm development on filter media. The present study investigates the role of biofilm on microbial contaminant removal performance of stormwater biofilters. Pseudomonas aeruginosa biofilms were formed in laboratory-scale sand and biochar-modified sand packed columns, which were then challenged with Escherichia coli laden synthetic stormwater containing natural organic matter. Results suggests that the presence of biofilm influences the removal of E. coli. However, the nature of the influence depends on the specific surface area and the relative hydrophobicity of filter media. The distribution of attached bacteria within the columns indicates that removal by filter media varies along the length of the column: the inlet was the primary removal zone regardless of experimental conditions. Findings from this research inform the design of field-scale biofilters for better and consistent performance in removing microbial contaminants from urban stormwater.	[Afrooz, A. R. M. Nabiul; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Afrooz, A. R. M. Nabiul; Boehm, Alexandria B.] Engn Res Ctr ERC Reinventing Nations Urban Water, Stanford, CA USA	Stanford University	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.; Boehm, AB (corresponding author), Engn Res Ctr ERC Reinventing Nations Urban Water, Stanford, CA USA.	aboehm@stanford.edu	Afrooz, ARM/B-1701-2014	Afrooz, ARM/0000-0002-9141-9426; Boehm, Alexandria/0000-0002-8162-5090; Afrooz, Nabiul/0000-0002-0588-6942	United States National Science Foundation [EEC-1028968]; U.S. National Science Foundation [EEC-1028968]	United States National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by the United States National Science Foundation through EEC-1028968. (https://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Re-inventing Nations Urban Water Infrastructure (ReNUWIt), an Engineering Research Center (ERC) funded by the U.S. National Science Foundation (Grant#EEC-1028968). We thank Andrew Torkelson (University of California, Berkeley) for sharing the biofilm characterization protocol.	Abit SM, 2012, ENVIRON SCI TECHNOL, V46, P8097, DOI 10.1021/es300797z; Abu-Lail LI, 2007, ENVIRON SCI TECHNOL, V41, P8031, DOI 10.1021/es071047o; Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o; Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839; Atabek A, 2007, J BACTERIOL, V189, P8503, DOI 10.1128/JB.00769-07; Bauman WJ, 2009, BIOFOULING, V25, P229, DOI 10.1080/08927010802688566; BENNETT JM, 1981, APPL OPTICS, V20, P1785, DOI 10.1364/AO.20.001785; Bozorg A, 2015, J CONTAM HYDROL, V183, P109, DOI 10.1016/j.jconhyd.2015.10.008; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a; Chandrasena GI, 2014, J HYDROL, V519, P814, DOI 10.1016/j.jhydrol.2014.08.015; Chen GX, 2012, ENVIRON SCI TECHNOL, V46, P8782, DOI 10.1021/es301378q; Clement TP, 1996, GROUND WATER, V34, P934, DOI 10.1111/j.1745-6584.1996.tb02088.x; Cunningham A, 1997, BIOFILM PROCESSES PO, P325; CUNNINGHAM AB, 1991, ENVIRON SCI TECHNOL, V25, P1305, DOI 10.1021/es00019a013; Dai XJ, 2002, WATER RES, V36, P3523, DOI 10.1016/S0043-1354(02)00045-3; de Kerchove AJ, 2005, LANGMUIR, V21, P6462, DOI 10.1021/la047049t; Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; Elimelech M, 2000, ENVIRON SCI TECHNOL, V34, P2143, DOI 10.1021/es9910309; Fang QL, 2014, ENVIRON SCI TECHNOL, V48, P279, DOI 10.1021/es403711y; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Ghezzehei TA, 2014, SOLID EARTH, V5, P953, DOI 10.5194/se-5-953-2014; Janjaroen D, 2013, WATER RES, V47, P2531, DOI 10.1016/j.watres.2013.02.032; Johnson PR, 1996, ENVIRON SCI TECHNOL, V30, P3284, DOI 10.1021/es960053+; Johnson WP, 2007, ENVIRON SCI TECHNOL, V41, P1279, DOI 10.1021/es061301x; Johnson WP, 1996, WATER RES, V30, P923, DOI 10.1016/0043-1354(95)00225-1; Kobayashi H, 2009, CLIN ORTHOP RELAT R, V467, P1360, DOI 10.1007/s11999-008-0609-5; LECHEVALLIER MW, 1992, J AM WATER WORKS ASS, V84, P136; Liu Y, 2008, ENVIRON SCI TECHNOL, V42, P443, DOI 10.1021/es071861b; Lorite GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075247; Mitzel MR, 2014, ENVIRON SCI TECHNOL, V48, P2715, DOI 10.1021/es404598v; Moges ME, 2015, MANAGEMENT ENV QUALI, V26; Mohanty SK, 2014, ENVIRON SCI TECHNOL, V48, P11535, DOI 10.1021/es5033162; Mohanty SK, 2014, WATER RES, V61, P288, DOI 10.1016/j.watres.2014.05.026; Mohanty SK, 2013, ENVIRON SCI TECHNOL, V47, P10791, DOI 10.1021/es305136b; National Academies of Sciences E Medicine, 2016, US GRAYW STORMW ENH; Papineau I, 2013, J ENVIRON ENG, V139, P603, DOI 10.1061/(ASCE)EE.1943-7870.0000672; Pieper AP, 1997, ENVIRON SCI TECHNOL, V31, P1163, DOI 10.1021/es960670y; Reddy KR, 2014, J ENVIRON ENG, V140, DOI 10.1061/(ASCE)EE.1943-7870.0000872; Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es034887l; Rippy MA, 2015, WIRES WATER, V2, P577, DOI 10.1002/wat2.1096; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Smith DP, 2008, J IRRIG DRAIN ENG, V134, P624, DOI 10.1061/(ASCE)0733-9437(2008)134:5(624); STOODLEY P, 1994, APPL ENVIRON MICROB, V60, P2711, DOI 10.1128/AEM.60.8.2711-2716.1994; TAYLOR SW, 1990, WATER RESOUR RES, V26, P2153; Tian J, 2014, WORLD ENV WAT RES C, p197 ; Torkzaban S, 2007, LANGMUIR, V23, P9652, DOI 10.1021/la700995e; Tripathi S, 2012, ENVIRON SCI TECHNOL, V46, P6942, DOI 10.1021/es202833k; Truesdail SE, 1998, J COLLOID INTERF SCI, V203, P369, DOI 10.1006/jcis.1998.5541; Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g; Velten S, 2007, WATER RES, V41, P1973, DOI 10.1016/j.watres.2007.01.021; Wang AM, 2011, GROUND WATER, V49, P20, DOI 10.1111/j.1745-6584.2010.00690.x; Wang YG, 2010, J ENVIRON QUAL, V39, P1925, DOI 10.2134/jeq2009.0411; Waterboard, ATTACHMENT H BIORETE; YEH TCJ, 1995, ENVIRON HEALTH PERSP, V103, P41, DOI 10.2307/3432011	58	25	26	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167489	10.1371/journal.pone.0167489	http://dx.doi.org/10.1371/journal.pone.0167489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907127	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700168
J	Chevallier, C; Tonge, N; Safra, L; Kahn, D; Kohls, G; Miller, J; Schultz, RT				Chevallier, Coralie; Tonge, Natasha; Safra, Lou; Kahn, David; Kohls, Gregor; Miller, Judith; Schultz, Robert T.			Measuring Social Motivation Using Signal Detection and Reward Responsiveness	PLOS ONE			English	Article							ATTENTION; SCALES	Background Recent trends in psychiatry have emphasized the need for a shift from categorical to dimensional approaches. Of critical importance to this transformation is the availability of tools to objectively quantify behaviors dimensionally. The present study focuses on social motivation, a dimension of behavior that is central to a range of psychiatric conditions but for which a particularly small number of assays currently exist. Methods In Study 1 (N = 48), healthy adults completed a monetary reward task and a social reward task, followed by completion of the Chapman Physical and Social Anhedonia Scales. In Study 2 (N = 26), an independent sample was recruited to assess the robustness of Study 1's findings. Results The reward tasks were analyzed using signal detection theory to quantify how much reward cues bias participants' responses. In both Study 1 and Study 2, social anhedonia scores were negatively correlated with change in response bias in the social reward task but not in the monetary reward task. A median split on social anhedonia scores confirmed that participants with high social anhedonia showed less change in response bias in the social reward task compared to participants with low social anhedonia. Conclusions This study confirms that social anhedonia selectively affects how much an individual changes their behavior based on the presence of socially rewarding cues and establishes a tool to quantify social reward responsiveness dimensionally.	[Chevallier, Coralie; Tonge, Natasha; Kahn, David; Miller, Judith; Schultz, Robert T.] Childrens Hosp Philadelphia, Ctr Autism Res, Philadelphia, PA 19104 USA; [Chevallier, Coralie; Safra, Lou] ENS PSL, INSERM U960, LNC, Paris, France; [Kahn, David; Miller, Judith; Schultz, Robert T.] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA; [Kohls, Gregor] Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Child Neuropsychol Sect, Aachen, Germany; [Schultz, Robert T.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schultz, Robert T.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Pennsylvania; Pennsylvania Medicine; RWTH Aachen University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Chevallier, C (corresponding author), Childrens Hosp Philadelphia, Ctr Autism Res, Philadelphia, PA 19104 USA.; Chevallier, C (corresponding author), ENS PSL, INSERM U960, LNC, Paris, France.	coralie.chevallier@ens.fr	Tonge, Natasha April/ABI-1770-2020; Chevallier, Coralie/AAR-4748-2020; Kohls, Gregor/AAH-6429-2020; Chevallier, Coralie/L-3120-2017	Tonge, Natasha April/0000-0001-7670-7991; Chevallier, Coralie/0000-0002-7358-4962; 	Pennsylvania Department of Health [4100047863]; Fondation Roger de Spoelberch [ANR-11-0001-02 PSL*, ANR-10-LABX-0087]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088791] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Fondation Roger de Spoelberch; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from the Pennsylvania Department of Health (SAP # 4100047863) awarded to RTS. CC and LS were also supported by Fondation Roger de Spoelberch, ANR-11-0001-02 PSL*, ANR-10-LABX-0087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2013, NATURE, V496, P416, DOI 10.1038/496416a; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Chevallier C, 2012, TRENDS COGN SCI; Chevallier C, 2015, AUTISM RES, V8, P620, DOI 10.1002/aur.1479; Collet L, 1986, LENCEPHALE, V10, P77; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dubey I, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0031-2; Green DM, 1966, SIGNAL DETECTION THE; Happe F, 2003, ANN NY ACAD SCI, V1001, P134, DOI 10.1196/annals.1279.008; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Johnstone V, 2000, J EXP ANAL BEHAV, V73, P275, DOI 10.1901/jeab.2000.73-275; Kohls G, 2013, NEUROPSYCHOLOGIA, V51, P2062, DOI 10.1016/j.neuropsychologia.2013.07.020; Kosmadakis CS, 1995, ENCEPHALE, V21, P437; Macmillan N. A., 2004, DETECTION THEORY USE; McCarthy D. C., 1991, SIGNAL DETECTION MEC, P239; Mehrabian A, 1970, ED PSYCHOL MEAS; NIMH, SOC PROC WORKSH P; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rutter M, 2011, J CHILD PSYCHOL PSYC, V52, P647, DOI 10.1111/j.1469-7610.2011.02367.x; Silvia PJ, 2011, J PERS, V79, P1013, DOI 10.1111/j.1467-6494.2010.00702.x; Tripp G, 1999, J CLIN CHILD PSYCHOL, V28, P366, DOI 10.1207/S15374424jccp280309; Uziel L, 2010, PERSPECT PSYCHOL SCI, V5, P243, DOI 10.1177/1745691610369465; Watson KK, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00036	28	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167024	10.1371/journal.pone.0167024	http://dx.doi.org/10.1371/journal.pone.0167024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907025	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700066
J	Duan, YP; Feng, MS; Zhong, XY; Shang, RS; Huang, LH				Duan, Yiping; Feng, Mingshi; Zhong, Xinyan; Shang, Ruishu; Huang, Lihong			Thermodynamic Simulation of Carbonate Cements-Water-Carbon Dioxide Equilibrium in Sandstone for Prediction of Precipitation/Dissolution of Carbonate Cements	PLOS ONE			English	Article							EQUATION-OF-STATE; TAHE OIL-FIELD; CALCITE DISSOLUTION; TARIM BASIN; CO2; RESERVOIR; SEQUESTRATION; DIAGENESIS; PRESSURES; KINETICS	Carbonate cements, such as calcite, dolomite, ferrocalcite and ankerite, play important roles in the formation of pores in sandstones: precipitation of carbonate cements modifies pores and inhibits compaction, while dissolution creates secondary pores. This work proposed a precipitation- dissolution model for carbonate cements-CO2-H2O system by means of ion equilibrium concentration ([M2+], M = Ca, Mg, Fe or Mn) with different factors, such as temperature, depth, pH, P-CO2, variable rock composition and overpressure. Precipitation-dissolution reaction routes were also analyzed by minimization of the total Gibbs free energy (Delta G).Delta[M2+], the variation of [Ca2+], [Fe2+], [Mg2+] or [Mn2+] for every 100 m of burial depths, is used to predict precipitation or dissolution. The calculation results indicate that the increasing temperature results in decrease of equilibrium constant of reactions, while the increasing pressure results in a relatively smaller increase of equilibrium constant; As a result, with increasing burial depth, which brings about increase of both temperature and pressure, carbonate cements dissolve firstly and produces the maximal dissolved amounts, and then precipitation happens with further increasing depth; For example, calcite is dissolving from 0.0 km to 3.0 km with a maximal value of [Ca2+] at depth of 0.8 km, and then precipitates with depth deeper than 3.0 km. Meanwhile, with an increasing CO2 mole fraction in the gaseous phase from 0.1% to 10.0% in carbonate systems, the aqueous concentration of metal ions increases, e.g., dissolved amount of CaFe0.7Mg0.3(CO3)(2) increases and reaches maximum of 1.78 mmol.L-1 and 8.26 mmol.L-1 at burial depth of 0.7 km with CO2 mole fraction of 0.1% and 10.0%, respectively. For the influence of overpressure in the calcite system, with overpressure ranging from 36 MPa to 83 MPa, pH reaches a minimum of 6.8 at overpressure of 51 MPa; meanwhile, Delta[Ca2+] increases slightly from -2.24 mmol.L-1 to -2.17 mmol.L-1 and remains negative, indicating it is also a precipitation process at burial depth of 3.9 km where overpressure generated. The method used in this study can be applied in assessing burial precipitation-dissolution processes and predicting possible pores in reservoirs with carbonate cement-water-carbon dioxide.	[Duan, Yiping; Zhong, Xinyan; Shang, Ruishu; Huang, Lihong] Chengdu Univ Technol, Dept Chem & Pharmaceut Engn, Chengdu, Peoples R China; [Duan, Yiping; Feng, Mingshi] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Huang, Lihong] Indiana Univ Purdue Univ, Richard G Lugar Ctr Renewable Energy, Indianapolis, IN 46202 USA	Chengdu University of Technology; Chengdu University of Technology; Indiana University System; Indiana University-Purdue University Indianapolis	Huang, LH (corresponding author), Chengdu Univ Technol, Dept Chem & Pharmaceut Engn, Chengdu, Peoples R China.; Feng, MS (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.; Huang, LH (corresponding author), Indiana Univ Purdue Univ, Richard G Lugar Ctr Renewable Energy, Indianapolis, IN 46202 USA.	fengmingshi09@cdut.cn; huanglihong06@cdut.cn			Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology) [PLC201205]; National Natural Science Foundation of China [21276031]; Department of Science and Technology of Sichuan Province [2015HH0013]	Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province	This work was financially supported by the Open Fund (PLC201205) of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology), the National Natural Science Foundation of China (21276031), and by the Department of Science and Technology of Sichuan Province (2015HH0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achal V, 2015, EARTH-SCI REV, V148, P1, DOI 10.1016/j.earscirev.2015.05.008; Achal V, 2011, CURR MICROBIOL, V62, P894, DOI 10.1007/s00284-010-9801-4; Al-Najrani F., 2010, THESIS; Bateman K, 2005, OIL GAS SCI TECHNOL, V60, P161, DOI 10.2516/ogst:2005010; BELONOSHKO A, 1991, GEOCHIM COSMOCHIM AC, V55, P381, DOI 10.1016/0016-7037(91)90425-5; BHIRUD VL, 1978, AICHE J, V24, P880, DOI 10.1002/aic.690240514; Bloch S, 2002, AAPG BULL, V86, P301; BOLES JR, 1978, CONTRIB MINERAL PETR, V68, P13, DOI 10.1007/BF00375443; Camy S, 2003, J SUPERCRIT FLUID, V25, P19, DOI 10.1016/S0896-8446(02)00087-6; Chai L, 1996, AM MINERAL, V81, P1141; Delavar H, 2014, FLUID PHASE EQUILIBR, V369, P1, DOI 10.1016/j.fluid.2014.02.009; Fischer S, 2010, CHEM ERDE-GEOCHEM, V70, P155, DOI 10.1016/j.chemer.2010.06.001; Guimara L, 2007, CHEM PHYS, V333, P10; Guo XW, 2011, ORG GEOCHEM, V42, P1343, DOI 10.1016/j.orggeochem.2011.08.017; Haase C, 2013, APPL GEOCHEM, V33, P306, DOI 10.1016/j.apgeochem.2013.03.001; Hammes F, 2003, APPL MICROBIOL BIOT, V62, P191, DOI 10.1007/s00253-003-1287-6; HELGESON HC, 1978, AM J SCI, V278, P1; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; Huang S J, 2010, CARBONATE DIAGENSIS, P73; Huang SJ, 2000, CHIN J GEOCHEM, V19, P58; Jin ZJ, 2009, MAR PETROL GEOL, V26, P753, DOI 10.1016/j.marpetgeo.2008.08.005; Kaufmann G, 2007, GEOCHIM COSMOCHIM AC, V71, P1398, DOI 10.1016/j.gca.2006.10.024; Ketzer JM, 2009, APPL GEOCHEM, V24, P760, DOI 10.1016/j.apgeochem.2009.01.001; Li H, 2009, APPL ENERG, V86, P2760, DOI 10.1016/j.apenergy.2009.04.013; Lin CY, 2013, APPL GEOCHEM, V29, P13, DOI 10.1016/j.apgeochem.2012.10.029; LUNDEGARD PD, 1989, CHEM GEOL, V74, P277, DOI 10.1016/0009-2541(89)90038-7; Mandalaparty P., 2012, THESIS; Rossi C, 2001, J SEDIMENT RES, V71, P459, DOI 10.1306/2DC40955-0E47-11D7-8643000102C1865D; Ruan Z, 2013, CHEM ERDE-GEOCHEM, V73, P469, DOI 10.1016/j.chemer.2013.03.004; SHOCK EL, 1988, GEOCHIM COSMOCHIM AC, V52, P2009, DOI 10.1016/0016-7037(88)90181-0; Soli AL, 2002, MAR CHEM, V78, P65, DOI 10.1016/S0304-4203(02)00010-5; Sung RT, 2014, INT J GREENH GAS CON, V20, P168, DOI 10.1016/j.ijggc.2013.11.003; SVERJENSKY DA, 1984, GEOCHIM COSMOCHIM AC, V48, P1127, DOI 10.1016/0016-7037(84)90203-5; Sverjensky DA, 1997, GEOCHIM COSMOCHIM AC, V61, P1359, DOI 10.1016/S0016-7037(97)00009-4; Tempel RN, 2000, APPL GEOCHEM, V15, P1071, DOI 10.1016/S0883-2927(99)00108-0; Wang TY, 2013, MAR POLLUT BULL, V76, P307, DOI 10.1016/j.marpolbul.2013.08.014; Wunsch A, 2013, APPL GEOCHEM, V38, P33, DOI 10.1016/j.apgeochem.2013.08.005; Xu J, 2012, CHEM GEOL, V322, P11, DOI 10.1016/j.chemgeo.2012.04.019; Yao LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139117; Yu BS, 2008, SCI CHINA SER D, V51, P567, DOI 10.1007/s11430-008-0027-2; Zenger D.H., 1980, SEPM SPECIAL PUBLICA, V28, P320, DOI [10.2110/pec.80.28, DOI 10.2110/PEC.80.28]; Zhang Z J., 2007, J YANGLING VOCATIONA, V6, P9; Zhao L, 2014, MAR POLLUT BULL, V85, P78, DOI 10.1016/j.marpolbul.2014.06.019	44	3	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167035	10.1371/journal.pone.0167035	http://dx.doi.org/10.1371/journal.pone.0167035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907043	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700068
J	Gulzari, UA; Sajid, M; Anjum, S; Agha, S; Torres, FS				Gulzari, Usman Ali; Sajid, Muhammad; Anjum, Sheraz; Agha, Shahrukh; Torres, Frank Sill			A New Cross-By-Pass-Torus Architecture Based on CBP-Mesh and Torus Interconnection for On-Chip Communication	PLOS ONE			English	Article								A Mesh topology is one of the most promising architecture due to its regular and simple structure for on-chip communication. Performance of mesh topology degraded greatly by increasing the network size due to small bisection width and large network diameter. In order to overcome this limitation, many researchers presented modified Mesh design by adding some extra links to improve its performance in terms of network latency and power consumption. The Cross-By-Pass-Mesh was presented by us as an improved version of Mesh topology by intelligent addition of extra links. This paper presents an efficient topology named Cross-By-Pass-Torus for further increase in the performance of the Cross-By-Pass-Mesh topology. The proposed design merges the best features of the Cross-By-Pass-Mesh and Torus, to reduce the network diameter, minimize the average number of hops between nodes, increase the bisection width and to enhance the overall performance of the network. In this paper, the architectural design of the topology is presented and analyzed against similar kind of 2D topologies in terms of average latency, throughput and power consumption. In order to certify the actual behavior of proposed topology, the synthetic traffic trace and five different real embedded application workloads are applied to the proposed as well as other competitor network topologies. The simulation results indicate that Cross-By-Pass-Torus is an efficient candidate among its predecessor's and competitor topologies due to its less average latency and increased throughput at a slight cost in network power and energy for on-chip communication.	[Gulzari, Usman Ali; Sajid, Muhammad; Agha, Shahrukh] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan; [Anjum, Sheraz] COMSATS Inst Informat Technol, Dept Comp Sci, Wah Cantt, Pakistan; [Torres, Frank Sill] Univ Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); Universidade Federal de Minas Gerais	Gulzari, UA (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan.	usmangulzari2000@yahoo.com	Torres, Frank Sill/A-1634-2013; gulzari, usman/L-4289-2018	Sill Torres, Frank/0000-0002-4028-455X; gulzari, usman/0000-0002-9726-9254				Ahmadi A, 2014, EFFICIENT ROUTING AL; Arora LK, 2013, 2013 IEEE INT C; Bhardwaj M, 2015, AM J NETWORKS COMMUN; Bhat S., 2005, ENERGY MODELS NETWOR; Butun I, 2016, IEEE COMMUN; Dally W. J., 2004, PRINCIPLES PRACTICES; Du Q, 2015, PERS UBIQUITOUS COMP; Elmiligi H, 2009, MICROPROCESS; Goossens K, 2005, IEEE DES TEST COMPUT; Grecu C, 2007, NETWORKS CHIP; Gulzari U, 2015, 9 INT S; Hansson A, 2011, DES AUTOM EMBED SYST, V15, P159, DOI 10.1007/s10617-011-9073-7; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Jerger NE, 2009, SYNTH LECT COMPUT AR; Ju X, 2012, MICROPROCESS MICROSY; Ju XG, 2012, MICROPROCESS MICROSY, V36, P505, DOI 10.1016/j.micpro.2012.04.006; Kahng A, 2015, IEEE EMBED SYST LETT; Khawaja SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125230; Li W, 2016, FUTUR GENER; Lo'ai A, 2016, HEAL APPL SYST; Naranjo P, 2016, P PSE; Ogras U, 2005, P 3 IEEE ACM IFIP; Ouyang Y, 2009, COMPUT ENG; Rezaei A, 2016, 2016 24 EUROMICRO; Sehgal V, 2010, J SUPERCOMPUT; Song Houbing, 2003, COMPUTER COMMUNICATI, V4; Tang K, 1994, IEEE T COMPUT; Tran A. T., 2012, NOCTWEAK HIGHLY PARA; Wang Y, 2011, J CHINA U POSTS; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Zhang Y, 2015, A NEW MULTI SERVICE	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167590	10.1371/journal.pone.0167590	http://dx.doi.org/10.1371/journal.pone.0167590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907147	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700206
J	Jacobs, M; Cooper, SA; McGowan, R; Nelson, SM; Pell, JP				Jacobs, Myrthe; Cooper, Sally-Ann; McGowan, Ruth; Nelson, Scott M.; Pell, Jill P.			Pregnancy Outcome following Prenatal Diagnosis of Chromosomal Anomaly: A Record Linkage Study of 26,261 Pregnancies	PLOS ONE			English	Article							DOWN-SYNDROME; PARENTAL DECISIONS; ABNORMALITIES; TERMINATION; ABORT; DETERMINANTS; PREVALENCE; ANEUPLOIDY; TRENDS; IMPACT	Previous studies have demonstrated the influence of changes in the age at which women give birth, and of developments in prenatal screening and diagnosis on the number of pregnancies diagnosed and terminated with chromosomal anomalies. However, we are unaware of any population studies examining pregnancy terminations after diagnosis of chromosomal anomalies that has included all aneuploidies and the influence of maternal factors. The aims of this study were to examine the association between results of prenatal tests and pregnancy termination, and the proportion of foetuses with and without chromosomal anomalies referred for invasive diagnostic tests over time. Diagnostic information of 26,261 prenatal invasive tests from all genetic service laboratories in Scotland from 2000 to 2011 was linked to Scottish Morbidity Records to obtain details on pregnancy outcome. Binary logistic regression was carried out to test the associations of year and type of diagnosis with pregnancy termination, while controlling for maternal age, neighbourhood deprivation and parity. There were 24,155 (92.0%) with no chromosomal anomalies, 1,483 (5.6%) aneuploidy diagnoses, and 623 (2.4%) diagnoses of anomaly that was not aneuploidy (including translocations and single chromosome deletions). In comparison with negative test results, pregnancies diagnosed with trisomy were most likely to be terminated (adjusted OR 437.40, 95% CI 348.19-549.46) followed by other aneuploid anomalies (adjusted OR 95.94, 95% CI 69.21-133.01). During the study period, fewer pregnancies that were diagnosed with aneuploidy were terminated, including trisomy diagnoses (adjusted OR 0.44, 95% CI 0.26-0.73). Older women were less likely to terminate (OR 0.35, 95% CI 0.28, 0.42), and parity was also an independent predictor of termination. In keeping with previous findings, while the number of invasive diagnostic tests declined, the proportion of abnormal results increased from 6.09% to 10.88%. Systematic advances in prenatal screening have improved detection rates for aneuploidy. This has been accompanied by a reduction in the rate of termination for aneuploidy. This may reflect societal changes with acceptance of greater diversity, but this is speculation, and further research would be needed to test this.	[Jacobs, Myrthe; Cooper, Sally-Ann; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [McGowan, Ruth] West Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Cooper, SA (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Sally-Ann.Cooper@glasgow.ac.uk		Nelson, Scott/0000-0002-9099-3047; Pell, Jill/0000-0002-8898-7035; Jacobs, Myrthe/0000-0001-8301-2020	Scottish Government [60559]; Medical Research Council [MR/K007017/1, MC_PC_13040] Funding Source: researchfish; MRC [MR/K007017/1] Funding Source: UKRI	Scottish Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by a grant from the Scottish Government (http://www.gov.scot/) awarded to SAC; Grant number: 60559 (Scottish Learning Disabilities Observatory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkan M, 2010, J GENET COUNS, V19, P241, DOI 10.1007/s10897-009-9275-3; Burns H, 2011, CMO 2011 06 CHANGES; Carothers AD, 1999, GENET EPIDEMIOL, V16, P179, DOI 10.1002/(SICI)1098-2272(1999)16:2<179::AID-GEPI5>3.0.CO;2-7; Choi H, 2012, J MIDWIFERY WOM HEAL, V57, P156, DOI 10.1111/j.1542-2011.2011.00109.x; Collins VR, 2008, J PEDIATR-US, V152, P20, DOI 10.1016/j.jpeds.2007.07.045; DRUGAN A, 1990, PRENATAL DIAG, V10, P483, DOI 10.1002/pd.1970100802; Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547; Hawkins A, 2013, J GENET COUNS, V22, P238, DOI 10.1007/s10897-012-9539-1; Hecht CA, 1996, AM J MED GENET, V62, P376, DOI 10.1002/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L; Information Services Division, 2014, BIRTHS SCOTT HOSP NA; Irving C, 2008, EUR J HUM GENET, V16, P1336, DOI 10.1038/ejhg.2008.122; Jeon KC, 2012, GENET MED, V14, P27, DOI 10.1038/gim.0b013e31822e57a7; Khoshnood B, 2004, BJOG-INT J OBSTET GY, V111, P485, DOI 10.1111/j.1471-0528.2004.00117.x; Kramer RL, 1998, AM J MED GENET, V79, P172, DOI 10.1002/(SICI)1096-8628(19980923)79:3<172::AID-AJMG4>3.0.CO;2-P; Mezei G, 2004, OBSTET GYNECOL, V104, P94, DOI 10.1097/01.AOG.0000128171.14081.eb; Morris JK, 2014, NATL SYNDROME CYTOGE; Morris JK, 2009, BMJ-BRIT MED J, V339, pb3794, DOI DOI 10.1136/BMJ.B3794; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; National Records of Scotland, 2001, CENS AGGR DAT SCOTL; National Records of Scotland, 2011, CENS AGGR DAT SCOTL; National Statistics, 2012, SCOTT IND MULT DEPR; Natoli JL, 2012, PRENATAL DIAG, V32, P142, DOI 10.1002/pd.2910; Olsen CL, 2003, HUM BIOL, V75, P503, DOI 10.1353/hub.2003.0059; Robson G, 2001, HDL 2001 34 ANTENATA, P34; Shaffer BL, 2006, PRENATAL DIAG, V26, P667, DOI 10.1002/pd.1462; VINCENT VA, 1991, SOUTHERN MED J, V84, P1210, DOI 10.1097/00007611-199110000-00012; Whittle P., 2008, CEL31 2008 CHANGES P; Zlotogora J, 2002, PRENATAL DIAG, V22, P1102, DOI 10.1002/pd.472	28	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166909	10.1371/journal.pone.0166909	http://dx.doi.org/10.1371/journal.pone.0166909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907018	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000389482700052
J	Lardy, S; Fortin, D; Pays, O				Lardy, Sophie; Fortin, Daniel; Pays, Olivier			Increased Exploration Capacity Promotes Group Fission in Gregarious Foraging Herbivores	PLOS ONE			English	Article							FUSION DYNAMICS; GROUP-SIZE; SEARCHING BEHAVIOR; DECISION-MAKING; MAMMALIAN HERBIVORES; ORGANIZATION; SEGREGATION; POPULATION; STRATEGIES; LEADERSHIP	Many gregarious species display rapid fission-fusion dynamics with individuals frequently leaving their groups to reunite or to form new ones soon after. The adaptive value of such ephemeral associations might reflect a frequent tilt in the balance between the costs and benefits of maintaining group cohesion. The lack of information on the short-term advantages of group fission, however, hampers our understanding of group dynamics. We investigated the effect of group fission on area-restricted search, a search tactic that is commonly used when food distribution is spatially autocorrelated. Specifically, we determine if roe deer (Capreolus capreolus) improve key aspects of their extensive search mode immediately after fission. We found that groups indeed moved faster and farther over time immediately after than before fission. This gain was highest for the smallest group that resulted from fission, which was more likely to include the fission's initiator. Sex of group members further mediated the immediate gain in search capacity, as post-fission groups moved away at farthest rate when they were only comprised of males. Our study suggests that social conflicts during the extensive search mode can promote group fission and, as such, can be a key determinant of group fission-fusion dynamics that are commonly observed in gregarious herbivores.	[Lardy, Sophie] Univ Angers, Grp Ecol & Conservat Vertebras, Angers, France; [Fortin, Daniel] Univ Laval, CEF, Quebec City, PQ, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Pays, Olivier] Univ Angers, CNRS, UMR 6554, LETG Angers, Angers, France	Universite d'Angers; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite d'Angers	Pays, O (corresponding author), Univ Angers, CNRS, UMR 6554, LETG Angers, Angers, France.	olivier.pays@univ-angers.fr	Fortin, Daniel/ABG-3554-2020		Communaute de Communes de l'Argonne Ardennaise'; Conseil Regional de Champagne Ardenne; Universite d'Angers	Communaute de Communes de l'Argonne Ardennaise'(Region Grand-Est); Conseil Regional de Champagne Ardenne(Region Grand-Est); Universite d'Angers	The 'Communaute de Communes de l'Argonne Ardennaise', the 'Conseil Regional de Champagne Ardenne' and the 'Universite d'Angers' provided financial support to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados C.L., 1985, P134; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2012, BEHAV ECOL, V23, P1308, DOI 10.1093/beheco/ars122; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Body G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095618; CALDER WA, 1983, ANNU REV ECOL SYST, V14, P213, DOI 10.1146/annurev.es.14.110183.001241; Cezilly F, 1996, REV ECOL-TERRE VIE, V51, P43; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Farine DR, 2014, ANIM BEHAV, V89, P141, DOI 10.1016/j.anbehav.2014.01.001; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2003, BEHAV ECOL SOCIOBIOL, V54, P194, DOI 10.1007/s00265-003-0599-y; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; FRID A, 1994, BIOL CONSERV, V67, P13, DOI 10.1016/0006-3207(94)90003-5; Fryxell JM, 2004, ECOLOGY, V85, P2429, DOI 10.1890/04-0147; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; GETTY T, 1991, AM NAT, V138, P1459, DOI 10.1086/285296; Haskell DG, 1997, BEHAV ECOL, V8, P448, DOI 10.1093/beheco/8.4.448; HIGASHI M, 1993, AM NAT, V142, P553, DOI 10.1086/285555; Illius AW, 2002, OIKOS, V98, P558, DOI 10.1034/j.1600-0706.2002.980323.x; Krause J, 2002, LIVING GROUPS; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Marchal C, 1998, REV ECOL-TERRE VIE, V53, P59; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pays O, 2007, ANIM BEHAV, V74, P1429, DOI 10.1016/j.anbehav.2007.02.012; Pays O, 2013, BEHAV ECOL, V24, P1229, DOI 10.1093/beheco/art057; Pays O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034678; Pearson HC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1437, DOI 10.1007/s00265-009-0821-7; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramseyer A, 2009, BEHAVIOUR, V146, P351, DOI 10.1163/156853909X410955; RANNALA BH, 1994, TRENDS ECOL EVOL, V9, P117, DOI 10.1016/0169-5347(94)90172-4; Rubenstein DI, 2004, SEXUAL SELECTION PRI; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Shipley LA, 1996, FUNCT ECOL, V10, P234, DOI 10.2307/2389848; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Silk MJ, 2014, IBIS, V156, P701, DOI 10.1111/ibi.12191; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; SMITH JNM, 1974, BEHAVIOUR, V49, P1, DOI 10.1163/156853974X00390; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Uccheddu S, 2015, OECOLOGIA, V179, P711, DOI 10.1007/s00442-015-3392-5; VICKERY WL, 1991, AM NAT, V137, P847, DOI 10.1086/285197; Villerette N, 2006, CAN J ZOOL, V84, P787, DOI 10.1139/Z06-052; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; [No title captured]; [No title captured]	61	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167516	10.1371/journal.pone.0167516	http://dx.doi.org/10.1371/journal.pone.0167516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907143	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700179
J	Okonechnikov, K; Imai-Matsushima, A; Paul, L; Seitz, A; Meyer, TF; Garcia-Alcalde, F				Okonechnikov, Konstantin; Imai-Matsushima, Aki; Paul, Lukas; Seitz, Alexander; Meyer, Thomas F.; Garcia-Alcalde, Fernando			InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data	PLOS ONE			English	Article							SEQ DATA; CANCER; IDENTIFICATION; EXPRESSION; QUANTIFICATION; COMPLEXITY; ALGORITHM; ALIGNMENT; TUMOR	Analysis of fusion transcripts has become increasingly important due to their link with cancer development. Since high-throughput sequencing approaches survey fusion events exhaustively, several computational methods for the detection of gene fusions from RNA-seq data have been developed. This kind of analysis, however, is complicated by native trans-splicing events, the splicing-induced complexity of the transcriptome and biases and artefacts introduced in experiments and data analysis. There are a number of tools available for the detection of fusions from RNA-seq data; however, certain differences in specificity and sensitivity between commonly used approaches have been found. The ability to detect gene fusions of different types, including isoform fusions and fusions involving non-coding regions, has not been thoroughly studied yet. Here, we propose a novel computational toolkit called InFusion for fusion gene detection from RNA-seq data. InFusion introduces several unique features, such as discovery of fusions involving intergenic regions, and detection of anti-sense transcription in chimeric RNAs based on strand-specificity. Our approach demonstrates superior detection accuracy on simulated data and several public RNA-seq datasets. This improved performance was also evident when evaluating data from RNA deep-sequencing of two well-established prostate cancer cell lines. InFusion identified 26 novel fusion events that were validated in vitro, including alternatively spliced gene fusion isoforms and chimeric transcripts that include intergenic regions. The toolkit is freely available to download from httplbabucketorg/kokonechhnfusion.	[Okonechnikov, Konstantin; Imai-Matsushima, Aki; Meyer, Thomas F.; Garcia-Alcalde, Fernando] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Paul, Lukas; Seitz, Alexander] Lexogen GmbH, Bioctr 5, Campus Vienna, Vienna, Austria; [Okonechnikov, Konstantin] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Garcia-Alcalde, Fernando] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Inflammat & Infect Dis, Immunol, Basel, Switzerland	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Roche Holding	Meyer, TF; Garcia-Alcalde, F (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.; Garcia-Alcalde, F (corresponding author), Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Inflammat & Infect Dis, Immunol, Basel, Switzerland.	meyer@mpiib-berlin.mpg.de; fernando.garcia-alcalde@roche.com	Okonechnikov, Konstantin/AAD-4239-2019; Paul, Lukas/L-9231-2015; Meyer, Thomas F./J-2485-2013	Paul, Lukas/0000-0001-9410-4078; Meyer, Thomas F./0000-0002-6120-8679				Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Carrara M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340620; Chen K, 2012, BIOINFORMATICS, V28, P1923, DOI 10.1093/bioinformatics/bts272; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Di Segni G, 2008, P NATL ACAD SCI USA, V105, P6864, DOI 10.1073/pnas.0800420105; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Fernandez-Cuesta L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0558-0; Frenkel-Morgenstern M, 2015, NUCLEIC ACIDS RES, V43, pD68, DOI 10.1093/nar/gku1199; Frenkel-Morgenstern M, 2012, GENOME RES, V22, P1231, DOI 10.1101/gr.130062.111; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Holtgrewe M., 2010, TECH REP TB B 10 06; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Jividen K, 2014, GENE CHROMOSOME CANC, V53, P963, DOI 10.1002/gcc.22207; Kangaspeska S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048745; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim HP, 2014, ONCOGENE, V33, P5434, DOI 10.1038/onc.2013.490; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Li Y, 2011, BIOINFORMATICS, V27, P1708, DOI 10.1093/bioinformatics/btr265; Liu SQ, 2015, MOL CELL TOXICOL, V11, P11, DOI 10.1007/s13273-015-0002-x; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Mills JD, 2013, CURR GENOMICS, V14, P173, DOI 10.2174/1389202911314030003; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicorici, 2014, BIORXIV, DOI [10.1101/011650, DOI 10.1101/011650V1]; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P610, DOI 10.1002/gcc.22057; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Rubin BP, 1998, AM J PATHOL, V153, P1451, DOI 10.1016/S0002-9440(10)65732-X; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Shah N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818; Sheng WQ, 2001, AM J CLIN PATHOL, V115, P348; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Weirather JL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv562; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999	52	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167417	10.1371/journal.pone.0167417	http://dx.doi.org/10.1371/journal.pone.0167417			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907167	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700148
J	Dalem, A; Demeester, S; Balti, EV; Keymeulen, B; Gillard, P; Lapauw, B; De Blocks, C; Abrams, P; Weber, E; Vermeulen, I; De Pauw, P; Pipeleers, D; Weets, I; Gorus, FK				Van Dalem, Annelien; Demeester, Simke; Balti, Eric V.; Keymeulen, Bart; Gillard, Pieter; Lapauw, Bruno; De Blocks, Christophe; Abrams, Pascale; Weber, Eric; Vermeulen, Ilse; De Pauw, Pieter; Pipeleers, Daniel; Weets, Ilse; Gorus, Frans K.		Belgian Diabetes Registry	Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin: C-Peptide Ratio	PLOS ONE			English	Article							ACUTE INSULIN-RESPONSE; HYPERGLYCEMIC CLAMP; CLINICAL ONSET; ISLET AUTOANTIBODIES; PROGRESSION; SENSITIVITY; PREVENTION; RESISTANCE; APPEARANCE; ANTIBODIES	Background The hyperglycemic clamp test, the gold standard of beta cell function, predicts impending type 1 diabetes in islet autoantibody-positive individuals, but the latter may benefit from less invasive function tests such as the proinsulin: C-peptide ratio (PI:C). The present study aims to optimize precision of PI:C measurements by automating a dual-label trefoil-type time-resolved fluorescence immunoassay (TT-TRFIA), and to compare its diagnostic performance for predicting type 1 diabetes with that of clamp-derived C-peptide release. Methods Between-day imprecision (n = 20) and split-sample analysis (n = 95) were used to compare TT-TRFIA (Auto Delfia, Perkin-Elmer) with separate methods for proinsulin (in-house TRFIA) and C-peptide (Elecsys, Roche). High-risk multiple autoantibody-positive firstdegree relatives (n = 49; age 5-39) were tested for fasting PI:C, HOMA2-IR and hyperglycemic clamp and followed for 20-57 months (interquartile range). Results TT-TRFIA values for proinsulin, C-peptide and PI:C correlated significantly (r(2) = 0.96-0.99; P<0.001) with results obtained with separate methods. TT-TRFIA achieved better between-day % CV for PI:C at three different levels (4.5-7.1 vs 6.7-9.5 for separate methods). In high-risk relatives fasting PI:C was significantly and inversely correlated ( r(s) = -0.596; P<0.001) with first-phase C-peptide release during clamp ( also with second phase release, only available for age 12-39 years; n = 31), but only after normalization for HOMA2-IR. In ROC- and Cox regression analysis, HOMA2-IR-corrected PI:C predicted 2-year progression to diabetes equally well as clamp-derived C-peptide release. Conclusions The reproducibility of PI:C benefits from the automated simultaneous determination of both hormones. HOMA2-IR-corrected PI:C may serve as a minimally invasive alternative to the more tedious hyperglycemic clamp test.	[Van Dalem, Annelien; Demeester, Simke; Balti, Eric V.; Keymeulen, Bart; Gillard, Pieter; Vermeulen, Ilse; De Pauw, Pieter; Pipeleers, Daniel; Weets, Ilse; Gorus, Frans K.] Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium; [Van Dalem, Annelien; Demeester, Simke; Weets, Ilse; Gorus, Frans K.] Univ Ziekenhuis Brussel, Dept Clin Chem & Radioimmunol, Brussels, Belgium; [Keymeulen, Bart] Univ Ziekenhuis Brussel, Dept Diabetol, Brussels, Belgium; [Gillard, Pieter] Univ Ziekenhuis Leuven, Dept Endocrinol, Leuven, Belgium; [Lapauw, Bruno] Univ Ziekenhuis Gent, Dept Endocrinol, Ghent, Belgium; [De Blocks, Christophe] Univ Ziekenhuis Antwerpen, Dept Endocrinol Diabetol & Metab, Edegem, Belgium; [Abrams, Pascale] GZA Campus Sint Augustinus Sint Vincentius, Dept Endocrinol & Diabetol, Antwerp, Belgium; [Weber, Eric] Clin Sud Luxembourg, Dept Endocrinol & Diabetol, Arlon, Belgium; [Weber, Eric] Clin St Joseph, Arlon, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; University of Antwerp	Weets, I (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium.; Weets, I (corresponding author), Univ Ziekenhuis Brussel, Dept Clin Chem & Radioimmunol, Brussels, Belgium.	ilsa.weets@uzbrussel.be	Gillard, Pieter/AAY-1483-2020; Gillard, Pieter/AAA-9820-2020; Gillard, Pieter/GPX-1490-2022; Lapauw, Bruno/AAB-4463-2021	Gillard, Pieter/0000-0001-9111-4561; Gillard, Pieter/0000-0001-9111-4561; De Pauw, Pieter/0000-0002-6463-4585; Gorus, Frans/0000-0002-9007-6177; Van Dalem, Annelien/0000-0003-2304-5298; Keymeulen, Bart/0000-0002-8671-4527; Pipeleers, Daniel/0000-0002-6440-2485; Demeester, Simke/0000-0001-7179-1717; Weets, Ilse/0000-0002-9007-5203	Juvenile Diabetes Research Foundation (JDRF) [4-2005-1327, 17-2012-615]; European Union (FP-7) [241883]; Research Foundation Flanders (FWO Vlaanderen) [G.0868.11, 1880115N, G080009N, 11D1214N]; Flemish government [IWT 130138]; Research Council of the Brussels Free University-VUB [OZR 1615]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Union (FP-7)(European Commission); Research Foundation Flanders (FWO Vlaanderen)(FWO); Flemish government(European Commission); Research Council of the Brussels Free University-VUB	This work was supported by Juvenile Diabetes Research Foundation (JDRF Center Grant No. 4-2005-1327 to DGP and Project No. 17-2012-615 to FKG), the European Union (FP-7 Project No. 241883), the Research Foundation Flanders (FWO Vlaanderen Projects No. G.0868.11; senior clinical research fellowship for IW (1880115N) and BK (G080009N); junior research fellowship for AVD (11D1214N)), the Flemish government (Grant No. IWT 130138), and the Research Council of the Brussels Free University-VUB (Projects No. OZR 1615).	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bach JF, 2011, SEMIN IMMUNOL, V23, P174, DOI 10.1016/j.smim.2011.07.009; Balti EV, 2015, J CLIN ENDOCR METAB, V100, P551, DOI 10.1210/jc.2014-2035; BINGLEY PJ, 1993, DIABETES, V42, P213, DOI 10.2337/diabetes.42.2.213; Bingley PJ, 2008, DIABETES CARE, V31, P146, DOI 10.2337/dc07-0103; Carlsson A, 2010, ENDOCRINOLOGY, V151, P5048, DOI 10.1210/en.2010-0433; De Grijse J, 2010, DIABETOLOGIA, V53, P517, DOI 10.1007/s00125-009-1618-y; De Pauw PE, 2009, J CHROMATOGR B, V877, P2403, DOI 10.1016/j.jchromb.2008.11.024; De Pauw PEM, 2008, CLIN CHEM, V54, P1990, DOI 10.1373/clinchem.2008.109710; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dons RF, 2009, ENDOCRINE METABOLIC, pXXV; Elahl D, 1996, DIABETES CARE, V19, P278, DOI 10.2337/diacare.19.3.278; GARCIAWEBB P, 1983, CLIN CHIM ACTA, V129, P103, DOI 10.1016/0009-8981(83)90157-2; Gorus FK, 2013, CLIN EXP IMMUNOL, V171, P82, DOI 10.1111/j.1365-2249.2012.04675.x; Gorus FK, 2013, EXPERT REV CLIN IMMU, V9, P1173, DOI 10.1586/1744666X.2013.856757; Helminen O, 2015, DIABETES, V64, P1719, DOI 10.2337/db14-0497; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; KJEMS LL, 1993, CLIN CHEM, V39, P2146; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Mahon JL, 1997, DIABETES CARE, V20, P1027, DOI 10.2337/diacare.20.6.1027; Meah FA, 2016, DIABETOLOGIA, V59, P1186, DOI 10.1007/s00125-016-3924-5; Mykkanen L, 1997, DIABETES, V46, P1990, DOI 10.2337/diabetes.46.12.1990; Mykkanen L, 1999, DIABETOLOGIA, V42, P1060, DOI 10.1007/s001250051271; Petrie JR, 1996, CLIN SCI, V91, P65, DOI 10.1042/cs0910065; RODER ME, 1994, J CLIN ENDOCR METAB, V79, P1570, DOI 10.1210/jc.79.6.1570; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; Rodriguez-Cabaleiro D, 2006, CLIN CHEM, V52, P1193, DOI 10.1373/clinchem.2005.062505; Saisho Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050744; Selo I, 1996, J IMMUNOL METHODS, V199, P127, DOI 10.1016/S0022-1759(96)00173-1; Siljander HT, 2013, EUR J ENDOCRINOL, V169, P479, DOI 10.1530/EJE-13-0206; Sims EK, 2016, DIABETES CARE, V39, P1519, DOI 10.2337/dc15-2849; Skyler JS, 2013, DIABETIC MED, V30, P161, DOI 10.1111/dme.12100; Steck AK, 2015, DIABETES CARE, V38, P808, DOI 10.2337/dc14-2426; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Truyen I, 2005, DIABETOLOGIA, V48, P2322, DOI 10.1007/s00125-005-1959-0; Van Dalem A, 2015, DIABETOLOGIA, V58, P2753, DOI 10.1007/s00125-015-3761-y; Vandemeulebroucke E, 2010, DIABETOLOGIA, V53, P36, DOI 10.1007/s00125-009-1569-3; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	43	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166702	10.1371/journal.pone.0166702	http://dx.doi.org/10.1371/journal.pone.0166702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907006	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700036
J	Kanemoto, K; Fukuta, K; Kawai, N; Tozawa, K; Ochiai, M; Okamoto, K; Ohnami, S; Sakamoto, H; Yoshida, T; Kanai, Y; Katoh, M; Yasui, T; Kohri, K; Kakizoe, T; Nakagama, H				Kanemoto, Kazuhiro; Fukuta, Katsuhiro; Kawai, Noriyasu; Tozawa, Keiichi; Ochiai, Masako; Okamoto, Koji; Ohnami, Sumiko; Sakamoto, Hiromi; Yoshida, Teruhiko; Kanai, Yae; Katoh, Masaru; Yasui, Takahiro; Kohri, Kenjiro; Kakizoe, Tadao; Nakagama, Hitoshi			Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype	PLOS ONE			English	Article							CONFERS SUSCEPTIBILITY; SYNERGISTIC CYTOTOXICITY; URINARY METABOLITE; SEQUENCE VARIANT; WIDE ASSOCIATION; TUMOR INVASION; C-OXIDATION; COPY NUMBER; CYP2A6; INDUCTION	Non-muscle invasive (superficial) bladder cancer is a low-grade malignancy with good prognosis, while muscle invasive (invasive) bladder cancer is a high-grade malignancy with poor prognosis. N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) induces superficial bladder cancers with papillary morphology in rats and invasive bladder cancers with infiltrating phenotype in mice. In this study, we analyzed genomic landscapes of rodent BBN-induced bladder cancers using array-based comparative genomic hybridization (array CGH). While no significant copy number alterations were detected in superficial bladder tumors in rats, copy number gains in chromosomal regions 2D-E1, 7qA3, 9F2, and 11C-D were detected in invasive bladder tumors in mice. Amplification of representative genes located on 2D-E1 and 7qA3 chromosomal regions was confirmed by quantitative PCR. Cyp2a22 and Cyp2a5 genes but not Cyp2g1, Cyp2a12, and Rab4b genes on mouse chromosome 7qA3 were amplified in invasive bladder cancers. Although the human ortholog gene of Cyp2a22 has not been confirmed, the mouse Cyp2a5 gene is the ortholog of the human CYP2A6 gene located in chromosomal region 19q13.2, and CYP2A6 was identified by database search as one of the closest human homolog to mouse Cyp2a22. Considering a possibility that this region may be related to mouse 7qA3, we analyzed CYP2A6 copy number and expression in human bladder cancer using cell lines and resected tumor specimens. Although only one of eight cell lines showed more than one copy increase of the CYP2A6 gene, CYP2A6 amplification was detected in six out of 18 primary bladder tumors where it was associated with the invasive phenotype. Immunohistochemical analyses of 118 primary bladder tumors revealed that CYP2A6 protein expression was also higher in invasive tumors, especially in those of the scattered type. Together, these findings indicate that the amplification and overexpression of the CYP2A6 gene are characteristic of human bladder cancers with increased malignancy and that CYP2A6 can be a candidate prognostic biomarker in this type of cancer.	[Kanemoto, Kazuhiro; Ochiai, Masako; Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Res Inst, Tokyo, Japan; [Kanemoto, Kazuhiro; Fukuta, Katsuhiro; Kawai, Noriyasu; Tozawa, Keiichi; Yasui, Takahiro; Kohri, Kenjiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan; [Okamoto, Koji] Natl Canc Ctr, Div Canc Differentiat, Res Inst, Tokyo, Japan; [Ohnami, Sumiko; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Res Inst, Tokyo, Japan; [Kanai, Yae] Natl Canc Ctr, Div Mol Pathol, Res Inst, Tokyo, Japan; [Katoh, Masaru] Natl Canc Ctr, Dept Omics Network, Res Inst, Tokyo, Japan; [Kakizoe, Tadao] Natl Canc Ctr, Res Inst, Tokyo, Japan	National Cancer Center - Japan; Nagoya City University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Kanemoto, K; Nakagama, H (corresponding author), Natl Canc Ctr, Div Canc Dev Syst, Res Inst, Tokyo, Japan.; Kanemoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan.	k.kanemoto7@gmail.com; hnakagam@ncc.go.jp	Kanai, Yae/AAE-6987-2019; YASUI, Takahiro/E-6401-2018	YASUI, Takahiro/0000-0003-2197-2477; Katoh, Masaru/0000-0003-3274-4066				Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Chu HY, 2013, J BIOMED RES, V27, P170, DOI 10.7555/JBR.27.20130026; Edwards RJ, 2003, DRUG METAB DISPOS, V31, P1476, DOI 10.1124/dmd.31.12.1476; FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651; Figueroa JD, 2014, HUM MOL GENET, V23, P1387, DOI 10.1093/hmg/ddt519; Fujiwara K, 2004, CARCINOGENESIS, V25, P1495, DOI 10.1093/carcin/bgh155; HASHIMOTO Y, 1972, GANN, V63, P637; HASHIMOTO Y, 1974, GANN, V65, P69; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Kawanishi H, 2008, CLIN CANCER RES, V14, P2579, DOI 10.1158/1078-0432.CCR-07-1922; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; London SJ, 1999, LANCET, V353, P898, DOI 10.1016/S0140-6736(98)04984-8; Matsuda K, 2015, HUM MOL GENET, V24, P1177, DOI 10.1093/hmg/ddu512; Matsuda Y, 2007, CANCER SCI, V98, P1582, DOI 10.1111/j.1349-7006.2007.00572.x; Matsuda Y, 2007, ONCOL REP, V18, P53; Matsui Y, 2007, CANCER RES, V67, P1212, DOI 10.1158/0008-5472.CAN-06-3283; Messina ES, 1997, J PHARMACOL EXP THER, V282, P1608; Miyazaki M, 2005, CARCINOGENESIS, V26, P1947, DOI 10.1093/carcin/bgi156; Mizutani Y, 1999, CLIN CANCER RES, V5, P2605; Mizutani Y, 2002, J UROLOGY, V168, P2650, DOI 10.1016/S0022-5347(05)64237-1; Nakada T, 2012, J TOXICOL SCI, V37, P555; Nakagama H, 1997, P NATL ACAD SCI USA, V94, P10813, DOI 10.1073/pnas.94.20.10813; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Nishiyama N, 2011, CARCINOGENESIS, V32, P462, DOI 10.1093/carcin/bgq274; Ochiai M, 2003, AM J PATHOL, V163, P1607, DOI 10.1016/S0002-9440(10)63517-1; OKADA M, 1977, XENOBIOTICA, V7, P11, DOI 10.3109/00498257709036241; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Saito R, 2013, ONCOGENE, V32, P894, DOI 10.1038/onc.2012.101; Sampson JN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv279; Song DK, 2009, CANCER DETECT PREV, V32, P416, DOI 10.1016/j.cdp.2009.02.003; Sugano K, 2006, NAT CLIN PRACT UROL, V3, P642, DOI 10.1038/ncpuro0649; SUGIMURA T, 1992, SCIENCE, V258, P603, DOI 10.1126/science.1411570; Vedder MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096849; Veltman JA, 2003, CANCER RES, V63, P2872; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zeegers MPA, 2001, OCCUP ENVIRON MED, V58, P590, DOI 10.1136/oem.58.9.590; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167374	10.1371/journal.pone.0167374	http://dx.doi.org/10.1371/journal.pone.0167374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902773	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100079
J	Morici, P; Fais, R; Rizzato, C; Tavanti, A; Lupetti, A				Morici, Paola; Fais, Roberta; Rizzato, Cosmeri; Tavanti, Arianna; Lupetti, Antonella			Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; GROWTH; INFECTIONS; MECHANISMS; VIRULENCE; PATHWAYS; CELLS	The aim of this study was to evaluate the in vitro activity of the synthetic peptide hLF1-11 against biofilm produced by clinical isolates of Candida albicans with different fluconazole susceptibility. The antibiofilm activity of the peptide hLF1-11 was assessed in terms of reduction of biofilm cellular density, metabolic activity and sessile cell viability. The extent of morphogenesis in hLF1-11 treated and untreated biofilms was also investigated microscopically. Transcription levels of genes related to cell adhesion, hyphal development and extracellular matrix production were analysed by qRT-PCR in hLF1-11 treated and untreated biofilms. Exogenous dibutyryl-cAMP (db-cAMP) was used to rescue morphogenesis in cells exposed to the peptide. The results revealed that hLF1-11 exhibited an inhibitory effect on biofilm formation by all C. albicans isolates tested in a dose-dependent manner, regardless of their fluconazole susceptibility. Visual inspection of treated or untreated biofilm cells with an inverted microscope revealed a significant reduction in hyphal formation by hLF1-11 treated cells, as early as 3 hours of incubation. Moreover, hLF1-11 showed a reduced activity on preadherent cells. hLF1-11 induced the down-regulation of biofilm and hyphal-associated genes, which were predominantly regulated via the Ras1-cAMP-Efg1 pathway. Indeed, exogenous db-cAMP restored morphogenesis in hLF1-11 treated cells. The hLF1-11 peptide significantly inhibited biofilm formation by C. albicans mainly at early stages, interfering with biofilm cellular density and metabolic activity, and affected morphogenesis through the Ras1-cAMP-Efg1 pathway. Our findings provide the first evidence that hLF1-11 could represent a potential candidate for the prevention of biofilm formation by C. albicans.	[Morici, Paola; Fais, Roberta; Rizzato, Cosmeri; Lupetti, Antonella] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Tavanti, Arianna] Univ Pisa, Dept Biol, Pisa, Italy; [Morici, Paola] CNR, Inst Nanosci, NEST, Pisa, Italy; [Morici, Paola] Scuola Normale Super Pisa, Pisa, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa	Lupetti, A (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	antonella.lupetti@med.unipi.it	Rizzato, Cosmeri/AAI-1261-2020	Tavanti, Arianna/0000-0001-5791-686X	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2012WJSX8K_005]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), research grant number 2012WJSX8K_005.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bonhomme J, 2013, CURR OPIN MICROBIOL, V16, P398, DOI 10.1016/j.mib.2013.03.007; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Clinical LSI, 2008, M27A3 CLIN LSI; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasan F, 2009, MICROBES INFECT, V11, P753, DOI 10.1016/j.micinf.2009.04.018; Hogan DA, 2009, FUTURE MICROBIOL, V4, P1263, DOI 10.2217/FMB.09.106; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Li Y, 2009, BIOCHIMIE, V91, P58, DOI 10.1016/j.biochi.2008.04.014; Lupetti A, 2002, ANTIMICROB AGENTS CH, V46, P1634, DOI 10.1128/AAC.46.6.1634-1639.2002; Lupetti A, 2007, J INFECT DIS, V196, P1416, DOI 10.1086/522427; Nibbering PH, 2001, INFECT IMMUN, V69, P1469, DOI 10.1128/IAI.69.3.1469-1476.2001; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Nuijens JH, 1996, J MAMMARY GLAND BIOL, V1, P285, DOI 10.1007/BF02018081; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Raman N, 2015, PHARMACEUTICALS, V8, P483, DOI 10.3390/ph8030483; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Sun LM, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0117695, 10.1371/journal.pone.0143820]; Taff HT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002848; Tati S, 2014, ANTIMICROB AGENTS CH, V58, P756, DOI 10.1128/AAC.01851-13; Theberge S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-246; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; van der Does AM, 2012, J INNATE IMMUN, V4, P284, DOI 10.1159/000332941; van der Does AM, 2010, BIOMETALS, V23, P493, DOI 10.1007/s10534-010-9322-4; van der Velden WJFM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-44; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Vriens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132701; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079671	44	41	43	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167470	10.1371/journal.pone.0167470	http://dx.doi.org/10.1371/journal.pone.0167470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902776	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100084
J	Nelson, GD; Rae, A				Nelson, Garrett Dash; Rae, Alasdair			An Economic Geography of the United States: From Commutes to Megaregions	PLOS ONE			English	Article								The emergence in the United States of large-scale "megaregions" centered on major metropolitan areas is a phenomenon often taken for granted in both scholarly studies and popular accounts of contemporary economic geography. This paper uses a data set of more than 4,000,000 commuter flows as the basis for an empirical approach to the identification of such megaregions. We compare a method which uses a visual heuristic for understanding areal aggregation to a method which uses a computational partitioning algorithm, and we reflect upon the strengths and limitations of both. We discuss how choices about input parameters and scale of analysis can lead to different results, and stress the importance of comparing computational results with "common sense" interpretations of geographic coherence. The results provide a new perspective on the functional economic geography of the United States from a megaregion perspective, and shed light on the old geographic problem of the division of space into areal units.	[Nelson, Garrett Dash] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA; [Nelson, Garrett Dash] Dartmouth Coll, Soc Fellows, Hanover, NH 03755 USA; [Rae, Alasdair] Univ Sheffield, Dept Urban Studies & Planning, Sheffield, S Yorkshire, England	Dartmouth College; Dartmouth College; University of Sheffield	Rae, A (corresponding author), Univ Sheffield, Dept Urban Studies & Planning, Sheffield, S Yorkshire, England.	a.j.rae@sheffield.ac.uk		Rae, Alasdair/0000-0003-0136-7659	University of Sheffield	University of Sheffield	The publication fee for this article was provided by the University of Sheffield.	Agnew J, 1994, REV INT POLIT ECON, V1, P53, DOI 10.1080/09692299408434268; Amin Ash, 2004, GEOGR ANN B, V86, P33, DOI [10.1111/j.0435-3684.2004.00152.x, DOI 10.1111/j.0435-3684.2004.00152.x]; [Anonymous], 1954, BALKANIZATION LABOR; [Anonymous], [No title captured]; [Anonymous], 1974, PROG PLANN; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 1970, EC SCI; [Anonymous], [No title captured]; Bogart WT, 1999, URBAN STUD, V36, P2099, DOI 10.1080/0042098992566; Cervero R, 1998, URBAN STUD, V35, P1059, DOI 10.1080/0042098984484; Cervero R, 1997, ENVIRON PLANN A, V29, P865, DOI 10.1068/a290865; Christaller W., 1933, CENTRAL PLACES SO GE; Clark WAV, 2003, REG SCI URBAN ECON, V33, P199, DOI 10.1016/S0166-0462(02)00012-1; Cronon William., 1991, NATURES METROPOLIS C; Dewar M, 2007, J PLAN LIT, V22, P108, DOI 10.1177/0885412207306615; Dickinson RE, 1947, CITY REGION REGIONAL; Gaudart J, 2015, J STAT SOFTW, V63, P1; Gottmann J., 1961, MEGALOPOLIS URBANIZE; Hanson S, 2004, GEOGRAPHY URBAN TRAN, Vthird; Hartshorne R, 1939, ANN ASSOC AM GEOGR, V29, P173, DOI 10.2307/2561063; Innes JE, 2011, J AM PLANN ASSOC, V77, P55, DOI 10.1080/01944363.2011.533640; Jones Clarence F., 1954, AM GEOGRAPHY INVENTO, P19; Jones M, 2009, PROG HUM GEOG, V33, P487, DOI 10.1177/0309132508101599; Kallus Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126713; Khanna Parag., 2016, SEXUALNESS; MacEachren A.M., 1995, MAPS WORK REPRESENTA; McKenzie B., 2014, DESIGN COMP LODES AC, P14; McLafferty S, 1996, PROF GEOGR, V48, P420, DOI 10.1111/j.0033-0124.1996.00420.x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; PAASI A, 1991, ENVIRON PLANN A, V23, P239, DOI 10.1068/a230239; Papps K., 2002, 443 IZA; Peterson M., 1987, CARTOGR J, V24, P35; Polya G., 1945, AM MATH MON, DOI DOI 10.2307/2306109; Rae A, 2009, COMPUT ENVIRON URBAN, V33, P161, DOI 10.1016/j.compenvurbsys.2009.01.007; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; RICHARDSON HW, 1988, ANN REGIONAL SCI, V22, P1, DOI 10.1007/BF01287319; Royuela V, 2009, URBAN STUD, V46, P2381, DOI 10.1177/0042098009342600; Sauer CO, 1918, AM POLIT SCI REV, V12, P403, DOI 10.2307/1946093; SIMON HA, 1990, ANNU REV PSYCHOL, V41, P1, DOI 10.1146/annurev.ps.41.020190.000245; Smelcer JB, 1997, DECISION SCI, V28, P391, DOI 10.1111/j.1540-5915.1997.tb01316.x; Sobolevsky S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012811; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tolbert C., 1987, LABOR MARKET AREAS U; Tolbert C. M., 1996, 9614 ERS	50	80	81	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166083	10.1371/journal.pone.0166083	http://dx.doi.org/10.1371/journal.pone.0166083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902707	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000389474100011
J	Nam, SS; Alouini, MS; Choi, S				Nam, Sung Sik; Alouini, Mohamed-Slim; Choi, Seyeong			Modified Dynamic Decode-and-Forward Relaying Protocol for Type II Relay in LTE-Advanced and Beyond	PLOS ONE			English	Article							PHYSICAL IMPAIRMENTS; PERFORMANCE	In this paper, we propose a modified dynamic decode-and-forward (MoDDF) relaying protocol to meet the critical requirements for user equipment (UE) relays in next-generation cellular systems (e.g., LTE-Advanced and beyond). The proposed MoDDF realizes the fast jump-in relaying and the sequential decoding with an application of random codeset to encoding and re-encoding process at the source and the multiple UE relays, respectively. A subframe-by-subframe decoding based on the accumulated (or buffered) messages is employed to achieve energy, information, or mixed combining. Finally, possible early termination of decoding at the end user can lead to the higher spectral efficiency and more energy saving by reducing the frequency of redundant subframe transmission and decoding. These attractive features eliminate the need of directly exchanging control messages between multiple UE relays and the end user, which is an important prerequisite for the practical UE relay deployment.	[Nam, Sung Sik] Hanyang Univ, Dept Elect Engn, Seoul, South Korea; [Alouini, Mohamed-Slim] KAUST, Dept Elect Engn, Thuwal, Makkah Province, Saudi Arabia; [Choi, Seyeong] Wonkwang Univ, Dept Informat & Commun Engn, Jeonbuk, South Korea	Hanyang University; King Abdullah University of Science & Technology; Wonkwang University	Choi, S (corresponding author), Wonkwang Univ, Dept Informat & Commun Engn, Jeonbuk, South Korea.	sychoi@wku.ac.kr	Alouini, Mohamed-Slim/I-2658-2018	Alouini, Mohamed-Slim/0000-0003-4827-1793	Wonkwang University	Wonkwang University	This paper was supported by Wonkwang University in 2015.	3GPP, 2010, 36814 3GPP; Azarian K, 2005, IEEE T INFORM THEORY, V51, P4152, DOI 10.1109/TIT.2005.858920; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Bui T, 2007, P IEEE SIGN PROC ADV; Castura J, 2007, IEEE T WIREL COMMUN, V6, P1638, DOI 10.1109/TWC.2007.360364; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Dai G. Y, 2014, U.S. Patent, Patent No. [US8787428 B2, 8787428]; Davis P.J., 1972, HDB MATH FUNCTIONS F, V10; Du QH, 2014, 2014 10TH INTERNATIONAL CONFERENCE ON MOBILE AD-HOC AND SENSOR NETWORKS (MSN), P138, DOI 10.1109/MSN.2014.25; Erdelyi A., 1954, TABLES INTEGRAL TRAN, VI; Gradshteyn I. S., 2014, TABLE INTEGRALS SERI; He HL, 2015, IEEE ICC, P617, DOI 10.1109/ICC.2015.7248390; Hossain E, 2011, COOPERATIVE CELLULAR; L. Electronics, 2010, 3GPP TSGRAN WG1 M 59; Mehmood A, 2015, AD HOC SENS WIREL NE, V28, P1; Molisch AF, 2007, IEEE T WIREL COMMUN, V6, P4108, DOI 10.1109/TWC.2007.060232; Nam S. S, 2012, P IEEE WCNC FRANC AP, P1402; Nam SS, 2009, IEEE T WIREL COMMUN, V8, P2150, DOI 10.1109/TWC.2009.080784; Nam SS, 2009, IEEE T WIREL COMMUN, V8, P1744, DOI 10.1109/TWC.2009.071026; Papoulis A., 1991, PROBABILITY RANDOM V; Plainchault M, 2012, IEEE T WIREL COMMUN, V11, P732, DOI 10.1109/TWC.2011.122211.110355; Ravanshid A, 2009, IEEE INT SYMP INFO, P508, DOI 10.1109/ISIT.2009.5205721; Shojafar M, 2015, IEEE INT CONF COMM, P1800, DOI 10.1109/ICCW.2015.7247442; Song HB, 2012, IEEE GLOB COMM CONF, P2984, DOI 10.1109/GLOCOM.2012.6503571; Song HB, 2013, J LIGHTWAVE TECHNOL, V31, P846, DOI 10.1109/JLT.2012.2235409; Song HB, 2012, J LIGHTWAVE TECHNOL, V30, P713, DOI 10.1109/JLT.2011.2180360; XU DT, 2016, IET COMMUN, V10, P292, DOI DOI 10.1049/IET-C0M.2015.0229; Yuan Y., 2013, LTE ADV RELAY TECHNO, P39, DOI [10.1007/978-3-642-29676-5, DOI 10.1007/978-3-642-29676-5]	28	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167457	10.1371/journal.pone.0167457	http://dx.doi.org/10.1371/journal.pone.0167457			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898712	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000063
J	Lee, MJ; Son, JS; Lee, JH; Kim, SJ; Lyoo, CH; Lee, MS				Lee, M. J.; Son, J. S.; Lee, J. H.; Kim, S. J.; Lyoo, C. H.; Lee, M. S.			Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson's Disease	PLOS ONE			English	Article							SENSORY DYSFUNCTION; OBJECT MANIPULATION; SUBSTANTIA-NIGRA; CAUDATE-NUCLEUS; FEEDBACK; HUMANS; INFORMATION; PATHOLOGY; RESPONSES; CIRCUITS	Introduction Sensory information is essential for the precise control of movement. Patients with Parkinson's disease (PD) have higher-order sensory dysfunctions including prolonged temporal discrimination threshold (TDT). However, the impact of prolonged TDT on parkinsonian motor deficits is uncertain. Methods This study includes 33 PD patients and 24 healthy controls. TDT values were measured in the index finger. Using coin rotation task (CRT), dexterous finger movement was assessed. Using an inertial sensor, the speed, amplitude, and frequency of finger tapping were measured. The impact of prolonged index finger TDT on two different finger movements was analyzed using the general estimating equation. Results Compared to healthy controls, TDT was prolonged in the PD patients. There was no impact of TDT on mean values or decrement for amplitude and speed, as well as mean values, decrement and variability of tapping frequency. However, prolonged TDT had a significant impact on the variability in amplitude (B = 436.905 x 10(-4), Wald chi(2) = 9.140, p = 0.014) and speed (B = 425.655 x 10(-4), Wald chi(2) = 9.876, p = 0.014) of finger tapping. There was a marginal correlation between TDT and CRT. In addition, CRT correlated with variability in amplitude and speed of finger tapping. Conclusion In PD, cutaneous temporal discriminative sensory dysfunction appears to be related to increased variabilities in the speed and amplitude of fast repetitive finger movements and disturbed finger dexterity.	[Lee, M. J.] Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Neurol, Busan, South Korea; [Lee, M. J.] Biomed Res Inst, Busan, South Korea; [Son, J. S.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Lee, J. H.] Pusan Natl Univ, Sch Med, Yangsan Hosp, Dept Neurol, Yangsan, South Korea; [Lee, J. H.] Biomed Res Inst, Yangsan, South Korea; [Kim, S. J.] Inje Univ, Coll Med, Busan Baik Hosp, Dept Neurol, Busan, South Korea; [Lyoo, C. H.; Lee, M. S.] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea	Pusan National University; Pusan National University Hospital; Northwestern University; Pusan National University; Pusan National University Hospital; Inje University; Yonsei University; Yonsei University Health System	Lee, MS (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea.	mslee@yuhs.ac	Son, Jongsang/C-5178-2018	Son, Jongsang/0000-0002-6132-5058; Lee, Myung Sik/0000-0002-8413-1854; Lyoo, Chul Hyoung/0000-0003-2231-672X	Pusan National University	Pusan National University(Pusan National University)	The present study was supported by a clinical research grant, which was received by MJ Lee (first author of the study) from Pusan National University in 2015. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors have nothing to disclose.	AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Conte A, 2016, CLIN NEUROPHYSIOL, V127, P2985, DOI 10.1016/j.clinph.2016.06.026; Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224; Contreras-Vidal JL, 2004, PARKINSONISM RELAT D, V10, P501, DOI 10.1016/j.parkreldis.2004.06.002; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; GIBB WRG, 1988, NEUROLOGY, V38, P1402, DOI 10.1212/WNL.38.9.1402; Gordon AM, 1995, EXP BRAIN RES, V107, P281; Guigon E, 2008, EUR J NEUROSCI, V27, P1003, DOI 10.1111/j.1460-9568.2008.06028.x; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; JASPERS RMA, 1989, NEUROSCIENCE, V28, P159, DOI 10.1016/0306-4522(89)90240-6; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; KOLLER WC, 1984, NEUROLOGY, V34, P957, DOI 10.1212/WNL.34.7.957; Koop MM, 2013, NEUROSCIENCE, V243, P1, DOI 10.1016/j.neuroscience.2013.03.026; LACRUZ F, 1991, J NEUROL NEUROSUR PS, V54, P1077, DOI 10.1136/jnnp.54.12.1077; Lee MS, 2005, NEUROLOGY, V64, P670, DOI 10.1212/01.WNL.0000151961.14861.BA; Lee MJ, 2015, J NEURAL TRANSM, V122, P669, DOI 10.1007/s00702-014-1296-x; Lee MS, 2010, MOVEMENT DISORD, V25, P2531, DOI 10.1002/mds.23304; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lyoo CH, 2012, ACTA NEUROL SCAND, V126, P344, DOI 10.1111/j.1600-0404.2012.01657.x; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Nagy A, 2005, EUR J NEUROSCI, V22, P419, DOI 10.1111/j.1460-9568.2005.04211.x; Nowak DA, 2013, NEUROSCI BIOBEHAV R, V37, P1578, DOI 10.1016/j.neubiorev.2013.06.003; Rabin E, 2004, EXP BRAIN RES, V155, P362, DOI 10.1007/s00221-003-1736-6; Rammsayer TH, 2001, Q J EXP PSYCHOL-B, V54, P247, DOI 10.1080/02724990143000036; Schurr A, 1982, NEUROL RES, V5, P31; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wu T, 2016, BRAIN, V139, P144, DOI 10.1093/brain/awv319	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167034	10.1371/journal.pone.0167034	http://dx.doi.org/10.1371/journal.pone.0167034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893840	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400072
J	Wanninger, S; Donati, M; Di Francesco, A; Hassig, M; Hoffmann, K; Seth-Smith, HMB; Marti, H; Borel, N				Wanninger, Sabrina; Donati, Manuela; Di Francesco, Antonietta; Hassig, Michael; Hoffmann, Karolin; Seth-Smith, Helena M. B.; Marti, Hanna; Borel, Nicole			Selective Pressure Promotes Tetracycline Resistance of Chlamydia Suis in Fattening Pigs	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SAMPLES; INFECTIONS; VETERINARY; FAILURE	In pigs, Chlamydia suis has been associated with respiratory disease, diarrhea and conjunctivitis, but there is a high rate of inapparent C. suis infection found in the gastrointestinal tract of pigs. Tetracycline resistance in C. suis has been described in the USA, Italy, Switzerland, Belgium, Cyprus and Israel. Tetracyclines are commonly used in pig production due to their broad-spectrum activity and relatively low cost. The aim of this study was to isolate clinical C. suis samples in cell culture and to evaluate their antibiotic susceptibility in vitro under consideration of antibiotic treatment on herd level. Swab samples (n = 158) identified as C. suis originating from 24 farms were further processed for isolation, which was successful in 71% of attempts with a significantly higher success rate from fecal swabs compared to conjunctival swabs. The farms were divided into three treatment groups: A) farms without antibiotic treatment, B) farms with prophylactic oral antibiotic treatment of the whole herd consisting of trimethoprime, sulfadimidin and sulfathiazole (TSS), or C) farms giving herd treatment with chlortetracycline with or without tylosin and sulfadimidin (CTS). 59 isolates and their corresponding clinical samples were selected and tested for the presence or absence of the tetracycline resistance class C gene [tet(C)] by conventional PCR and isolates were further investigated for their antibiotic susceptibility in vitro. The phenotype of the investigated isolates was either classified as tetracycline sensitive (Minimum inhibitory concentration [MIC] < 2 mu g/ml), intermediate (2 mu g/ml <= MIC < 4 mu g/ml) or resistant (MIC >= 4 mu g/ml). Results of groups and individual pigs were correlated with antibiotic treatment and time of sampling (beginning/end of the fattening period). We found clear evidence for selective pressure as absence of antibiotics led to isolation of only tetracycline sensitive or intermediate strains whereas tetracycline treatment resulted in a greater number of tetracycline resistant isolates.	[Wanninger, Sabrina; Hoffmann, Karolin; Seth-Smith, Helena M. B.; Marti, Hanna; Borel, Nicole] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Donati, Manuela] Univ Bologna, Microbiol, DIMES, Policlin S Orsola, Bologna, Italy; [Di Francesco, Antonietta] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Hassig, Michael] Univ Zurich, Vetsuisse Fac, Dept Farm Anim, Zurich, Switzerland	University of Zurich; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Zurich	Borel, N (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland.	n.borel@access.uzh.ch	Borel, Nicole/M-6204-2016; Marti, Hanna/AAA-3955-2021; Borel, Nicole/GPP-1073-2022	Borel, Nicole/0000-0002-1556-9262; Marti, Hanna/0000-0002-8398-4708; Borel, Nicole/0000-0002-1556-9262	Federal Food Safety and Veterinary Office (FSVO) [1.13.03]	Federal Food Safety and Veterinary Office (FSVO)	This study was supported by the Federal Food Safety and Veterinary Office (FSVO), research grant number 1.13.03 (NB); http://www.blv.admin.ch//index.html?iang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874; Bachmann NL, 2015, J CLIN MICROBIOL, V53, P1573, DOI 10.1128/JCM.03534-14; Blumer S, 2011, VET MICROBIOL, V152, P385, DOI 10.1016/j.vetmic.2011.05.024; Borel N, 2016, CURR CLIN MICROBIOL, V3, P10, DOI 10.1007/s40588-016-0028-4; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Borges V, 2013, INFECT GENET EVOL, V17, P23, DOI 10.1016/j.meegid.2013.03.035; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; De Puysseleyr K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0560-x; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Donati M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149914; Donati M, 2010, ANTIMICROB AGENTS CH, V54, P5379, DOI 10.1128/AAC.00553-10; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Guscetti F, 2009, VET MICROBIOL, V135, P157, DOI 10.1016/j.vetmic.2008.09.038; Hoffmann K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143576; Kohlhoff SA, 2015, EXPERT OPIN PHARMACO, V16, P205, DOI 10.1517/14656566.2015.999041; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Pathak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034931; Petyaev IM, 2010, INT J MED SCI, V7, P181; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Regula G, 2009, J ANTIMICROB CHEMOTH, V63, P805, DOI 10.1093/jac/dkp009; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rodloff A, 2008, DTSCH ARZTEBL INT, V105, P657, DOI 10.3238/arztebl.2008.0657; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Schachter J., 1999, CHLAMYDIA, P156; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schautteet K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-29; Seth-Smith HMB, 2013, NAT PROTOC, V8, P2404, DOI 10.1038/nprot.2013.147; The Federal Council, 2015, STRAT ANT RES SWITZ, P11; US Food and Drug Administration, 2015, SUMM REP ANT SOLD DI, P15; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Vodstrcil LA, 2015, J INFECT DIS, V211, P1628, DOI 10.1093/infdis/jiu670	37	23	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166917	10.1371/journal.pone.0166917	http://dx.doi.org/10.1371/journal.pone.0166917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893834	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000389472400055
J	Xuan, SC; Yang, W; Dong, H; Zhang, JC				Xuan, Shichang; Yang, Wu; Dong, Hui; Zhang, Jiangchuan			Performance Evaluation Model for Application Layer Firewalls	PLOS ONE			English	Article								Application layer firewalls protect the trusted area network against information security risks. However, firewall performance may affect user experience. Therefore, performance analysis plays a significant role in the evaluation of application layer firewalls. This paper presents an analytic model of the application layer firewall, based on a system analysis to evaluate the capability of the firewall. In order to enable users to improve the performance of the application layer firewall with limited resources, resource allocation was evaluated to obtain the optimal resource allocation scheme in terms of throughput, delay, and packet loss rate. The proposed model employs the Erlangian queuing model to analyze the performance parameters of the system with regard to the three layers (network, transport, and application layers). Then, the analysis results of all the layers are combined to obtain the overall system performance indicators. A discrete event simulation method was used to evaluate the proposed model. Finally, limited service desk resources were allocated to obtain the values of the performance indicators under different resource allocation scenarios in order to determine the optimal allocation scheme. Under limited resource allocation, this scheme enables users to maximize the performance of the application layer firewall.	[Xuan, Shichang; Yang, Wu; Dong, Hui; Zhang, Jiangchuan] Harbin Engn Univ, Informat Secur Res Ctr, Harbin, Peoples R China	Harbin Engineering University	Yang, W (corresponding author), Harbin Engn Univ, Informat Secur Res Ctr, Harbin, Peoples R China.	yangwu@hrbeu.edu.cn		xuan, shichang/0000-0003-0332-0686	Fundamental Research Funds for the Central Universities [HEUCF160605]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the Fundamental Research Funds for the Central Universities (HEUCF160605). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Fundamental Research Funds for the Central Universities (HEUCF160605). The authors wish to thank the editor and anonymous reviewers for their valuable comments and feedback, which helped to improve this article.	Al-Shaer E, 2005, IEEE J SEL AREA COMM, V23, P2069, DOI 10.1109/JSAC.2005.854119; Al-Shaer E S, 2004, IEEE T NETW SERV MAN, V1, P2, DOI [10.1109/TNSM.2004.4623689, DOI 10.1109/TNSM.2004.4623689]; Bovet D., 2005, UNDERSTANDING LINUX; Choo KKR, 2011, COMPUT SECUR, V30, P719, DOI 10.1016/j.cose.2011.08.004; El-Atawy A, 2007, IEEE INFOCOM 2007 26; Firdhous M, 2011, 17 AS PAC C COMM; Gouda MG, 2007, COMPUT NETW, V51, P1106, DOI 10.1016/j.comnet.2006.06.015; Gross D, 2008, FUNDAMENTALS QUEUEIN; Hamed HH, 2006, ADAPTIVE STAT OPTIMI; Jain R., 1990, ART COMPUTER SYSTEMS; Khazaei H, 2012, IEEE T PARALL DISTR, V23, P936, DOI 10.1109/TPDS.2011.199; Kikuchi S, 2011, CLOUD COMP CLOUD 201; Kleinrock L, 1975, QUEUEING SYST; Leffler SJ, 1989, DESIGN IMPLEMENTATIO, P1; Liu AX, 2008, IEEE T PARALL DISTR, V19, P1237, DOI 10.1109/TPDS.2007.70802; Mayer A, 2000, SEC PRIV 2000 S P 20; Misherghi Ghassan, 2008, IEEE Transactions on Network and Service Management, V5, P227, DOI 10.1109/TNSM.2009.041104; Osanaiye O, 2016, J NETW COMPUT APPL, V67, P147, DOI 10.1016/j.jnca.2016.01.001; Osanaiye O, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0623-3; Peng J, 2016, ASTROTURFIN IN PRESS; Peng J, 2016, IEEE TRUSTC IN PRESS; Peng J., 2016, J NETW COMPUT APPL; Peng J, 2016, J NETW COMPUT APPL, V72, P14, DOI 10.1016/j.jnca.2016.06.012; Prokhorenko V, 2013, INTENT BASED EXTENSI; Prokhorenko V, 2016, APPL MATH COMPUT, V285, P59, DOI 10.1016/j.amc.2016.03.026; Prokhorenko V, 2016, J NETW COMPUT APPL, V60, P95, DOI 10.1016/j.jnca.2015.11.017; Qian J, 2001, INT FED INFO PROC, V64, P197; Salah K, 2014, AEU-INT J ELECTRON C, V68, P623, DOI 10.1016/j.aeue.2014.01.006; Salah K, 2011, APPL MATH COMPUT, V217, P9635, DOI 10.1016/j.amc.2011.04.048; Salah K, 2010, GLOB TEL C GLOBECOM; Salah K, 2013, IEEE CLOUD; Salah K, 2013, CLOUD NETW CLOUD NET; Salah K, 2012, IEEE INT CONF CL NET; Salah K, 2012, IEEE T NETW SERV MAN, V9, P12, DOI 10.1109/TNSM.2011.122011.110151; Takagi H, 1991, QUEUEING ANAL FDN PE; Xiong K, 2009, 2009 C SERV 1; Yang B, 2013, J SUPERCOMPUT, V65, P426, DOI 10.1007/s11227-011-0551-2; Yuan L, 2006, 2006 IEEE S SEC PRIV; Zapechnikov S, 2015, P 8 INT C SEC INF NE	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167280	10.1371/journal.pone.0167280	http://dx.doi.org/10.1371/journal.pone.0167280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893803	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400108
J	Li, SJ; Cao, WJ; Sun, XH				Li, Shengjie; Cao, Wenjun; Sun, Xinghuai			Role of Platelet Parameters on Neovascular Glaucoma: A Retrospective Case-Control Study in China	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; RETINAL VEIN OCCLUSION; ENDOTHELIAL GROWTH-FACTOR; DISTRIBUTION WIDTH; VOLUME; COUNT; ACTIVATION; INDEXES; ASSOCIATION; DETERMINANTS	Purpose Retinal vein occlusion (RVO) and diabetic retinopathy (DR) are two major sight-threatening diseases which may lead to neovascular glaucoma (NVG). The aim of this study was to explore the association between platelet parameters and NVG. Methods A total of 185 subjects were enrolled for the study from January, 2012 to December, 2015 at the Eye-ENT Hospital of Fudan University. Patients include those with NVG secondary to RVO (RVO group, n = 38), patients with NVG secondary to DR (DR group, n = 47), diabetics mellitus without retinopathy (DM group, n = 52), and healthy individuals (control group, n = 48). A complete ophthalmological examination including visual field examination, A-scan ultrasound, Fundus photography, and measurement of platelet parameters were performed for NVG subjects. Results There was no statistical difference in the mean age and gender among the RVO, DR, and control groups (p>0.05). The mean level of platelet distribution width (PDW) was higher (p<0.001) in the RVO group (15.16 +/- 2.13fl) and DR group (16.17 +/- 1.66fl) when compared with the control group (13.77 +/- 2.99fl). The mean plateletcrit (PCT) value of the RVO group (0.229 +/- 0.063%) was also higher (p = 0.049) than the control group (0.199 +/- 0.045). In the DR group, mean platelet volume (MPV) value (10.72 +/- 1.57fl) was significantly higher (p = 0.002) than the control group (9.75 +/- 0.89fl). A similar trend was observed when platelet parameters were compared among the 3 groups with respect to age. The mean level of PDW was significantly higher (p<0.001) in the DR group (16.17 +/- 1.66fl) compared with the DM group (13.80 +/- 3.32fl). Stepwise multiple logistic regression analysis revealed that PDW (OR = 1.44, 95% CI = 1.149-1.805, p = 0.002) and MPV (OR = 1.503, 95% CI = 1.031-2.192, p = 0.034) were associated with the DR group, PDW (OR = 1.207, 95% CI = 1.010-1.443, p = 0.039) and PCT (OR = 1.663, 95% CI = 1.870-2.654, p = 0.036) were associated with the RVO group. Conclusion Our results suggest that increased PDW and MPV are associated with the NVG secondary to DR group, elevated PDW and PCT are associated with the RVO group. It indicates that platelets might be an important factor in the onset and/or development of NVG.	[Li, Shengjie; Cao, Wenjun] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Cao, Wenjun; Sun, Xinghuai] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Cao, WJ (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China.; Cao, WJ; Sun, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China.	wgkiyk@aliyun.com; xhsun@shmu.edu.cn	Li, Shengjie/AAU-7902-2021	Cao, Wenjun/0000-0001-6383-9012	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [81020108017]; National Health and Family Planning Commission, China [201302015]; National Major Scientific Equipment program; Ministry of Science and Technology, China [2012YQ12008003]; State Key Program of National Natural Science Foundation of China [81430007]; New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning [2013SY058]	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission, China; National Major Scientific Equipment program; Ministry of Science and Technology, China(Ministry of Science and Technology, China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning	This research project was supported by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (81020108017), the National Health and Family Planning Commission, China (201302015), the National Major Scientific Equipment program, the Ministry of Science and Technology, China (2012YQ12008003), the State Key Program of National Natural Science Foundation of China (81430007), and the New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning (2013SY058).; This research project was supported by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (81020108017), the National Health and Family Planning Commission, China(201302015), the National Major Scientific Equipment program, the Ministry of Science and Technology, China (2012YQ12008003), the State Key Program of National Natural Science Foundation of China (81430007), and the New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning (2013SY058). The sponsor or funding organization had no role in the design or conduct of this research.	AABERG TM, 1981, OPHTHALMOLOGY, V88, P639; Akpinar I, 2014, J CARDIOL, V63, P112, DOI 10.1016/j.jjcc.2013.07.010; Aksoy Y, 2013, INDIAN J OPHTHALMOL, V61, P686, DOI 10.4103/0301-4738.119414; Ates O., 2009, EUR J MED, V6, P99, DOI DOI 10.29333/EIGM/82648; Beer PM, 2006, RETINA-J RET VIT DIS, V26, P871, DOI 10.1097/01.iae.0000233327.68433.02; Chen SD, 2015, ACTA OPHTHALMOL, V93, pE556, DOI 10.1111/aos.12624; Citirik M, 2015, EYE, V29, P376, DOI 10.1038/eye.2014.298; CLARKSON JG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1087; Daly ME, 2011, HAEMATOL-HEMATOL J, V96, P10, DOI 10.3324/haematol.2010.035287; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Du J, 2016, INT J LAB HEMATOL, V38, P233, DOI 10.1111/ijlh.12474; ERNE P, 1988, THROMB HAEMOSTASIS, V59, P259; Han JS, 2013, PLATELETS, V24, P590, DOI 10.3109/09537104.2012.748187; HAVER VM, 1981, J LAB CLIN MED, V97, P187; Higashide T, 2015, PLOS ONE, V10; Jindal S, 2011, HEMATOLOGY, V16, P86, DOI 10.1179/102453311X12902908412110; Kamisli O, 2013, CLIN APPL THROMB-HEM, V19, P29, DOI 10.1177/1076029612453196; Khandekar MM, 2006, J CLIN PATHOL, V59, P146, DOI 10.1136/jcp.2004.025387; Kodiatte Thomas Alex, 2012, J Lab Physicians, V4, P5, DOI 10.4103/0974-2727.98662; Latorre R, 2016, LIVER INT, V36, P232, DOI 10.1111/liv.12908; Leoncini G, 2007, THROMB HAEMOSTASIS, V97, P218, DOI 10.1160/TH06-05-0257; Nakano S, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1205895; OMALLEY T, 1995, STROKE, V26, P995, DOI 10.1161/01.STR.26.6.995; Onder HI, 2013, INDIAN J OPHTHALMOL, V61, P160, DOI 10.4103/0301-4738.111063; Ornek N, 2014, EUR REV MED PHARMACO, V18, P2778; Osselaer JC, 1997, CLIN CHEM, V43, P1072; Papanas N, 2004, PLATELETS, V15, P475, DOI 10.1080/0953710042000267707; Park Y, 2002, PLATELETS, V13, P301, DOI 10.1080/095371002220148332; Sahin A, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/236371; Sahin M, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1051572; Sahin M, 2016, ARQ BRAS OFTALMOL, V79, P12, DOI 10.5935/0004-2749.20160005; Sansanayudh N, 2016, EUR J INTERN MED, V30, P37, DOI 10.1016/j.ejim.2015.11.028; Tuzcu EA, 2014, GRAEF ARCH CLIN EXP, V252, P237, DOI 10.1007/s00417-013-2444-y; Tvedten H, 2008, VET CLIN PATH, V37, P266, DOI 10.1111/j.1939-165X.2008.00054.x; Ugur M, 2014, J CRIT CARE, V29, P978, DOI 10.1016/j.jcrc.2014.07.001; Ulu S, 2013, EUR ARCH OTO-RHINO-L, V270, P2875, DOI 10.1007/s00405-013-2348-9; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Varol E, 2011, SCAND J CLIN LAB INV, V71, P163, DOI 10.3109/00365513.2010.547596; Wakabayashi T, 2008, OPHTHALMOLOGY, V115, P1571, DOI 10.1016/j.ophtha.2008.02.026; Yazgan S, 2016, EYE CONTACT LENS, V42, P328, DOI 10.1097/ICL.0000000000000197; Yoshizumi MO, 1996, AM J OPHTHALMOL, V121, P728, DOI 10.1016/S0002-9394(14)70649-X; Zhong ZL, 2011, INT J OPHTHALMOL-CHI, V4, P182, DOI 10.3980/j.issn.2222-3959.2011.02.15	42	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166893	10.1371/journal.pone.0166893	http://dx.doi.org/10.1371/journal.pone.0166893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907042	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700050
J	Muanda, M; Ndongo, PG; Taub, LD; Bertrand, JT				Muanda, Mbadu; Ndongo, Parfait Gahungu; Taub, Leah D.; Bertrand, Jane T.			Barriers to Modern Contraceptive Use in Kinshasa, DRC	PLOS ONE			English	Article								Recent research from Kinshasa, DRC, has shown that only one in five married women uses modern contraception; over one quarter have an unmet need for family planning; and almost 400 health facilities across Kinshasa report that they provide modern contraception. This study addresses the question: with reasonable physical access and relatively high unmet need, why is modern contraceptive prevalence so low? To this end, the research team conducted 6 focus groups of women (non-users of any method, users of traditional methods, and users of modern methods) and 4 of husbands (of users of traditional methods and in non-user unions) in health zones with relatively strong physical access to FP services. Five key barriers emerged from the focus group discussions: fear of side effects (especially sterility), costs of the method, sociocultural norms (especially the dominant position of the male in family decision-making), pressure from family members to avoid modern contraception, and lack of information/misinformation. These findings are very similar to those from 12 other studies of sociocultural barriers to family planning in sub-Saharan Africa. Moreover, they have strong programmatic implications for the training of FP workers to counsel future clients and for the content of behavior change communication interventions.	[Muanda, Mbadu] Minist Hlth, Programme Natl Sante Adolescent, Natl Program Adolescent Hlth, Kinshasa, DEM REP CONGO; [Ndongo, Parfait Gahungu] Inst Super Dev Rural, Matadi, Kongo Cent, DEM REP CONGO; [Taub, Leah D.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Bertrand, Jane T.] Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Tulane University; Tulane University	Bertrand, JT (corresponding author), Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	bertrand@tulanae.edu			Bill and Melinda Gates Foundation [OPP1117997]; Bill & Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Bill and Melinda Gates Foundation (grant #OPP1117997; URL: http://www.gatesfoundation.org/). JTB and MM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article was developed under grant #OPP1117997 awarded to the Tulane University School of Public Health and Tropical Medicine by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The authors wish to thank Ms. Perri Sutton for her diligent oversight of the work under this grant.	Adongo PB, 2014, FRONT PUBLIC HEALTH, V2, P1; Adongo PB, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-16; [Anonymous], 2014, ENQ DEM SANT REP DEM; Aransiola JO, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-869; Barnes J., 2012, TOTAL MARKET INITIAT; Becker G., 1960, EC ANAL FERTILITY DE, P209; Bertrand J. T., 2016, ANAL SUPPLY DEMAND F; Chapman S, 2012, SEX HEALTH, V9, P44, DOI 10.1071/SH10165; Diamond-Smith N, 2012, CULT HEALTH SEX, V14, P421, DOI 10.1080/13691058.2012.664659; Farmer DB, 2015, GLOB HEALTH, V3, P242, DOI 10.9745/GHSP-D-14-00198; Gebremariam Alem, 2014, Int J Family Med, V2014, P878639, DOI 10.1155/2014/878639; Hennink M, 2005, AFRICAN POPULATION S, V20, P101; John NA, 2015, INT PERSPECT SEX R H, V41, P99, DOI 10.1363/4109915; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kayembe P, 2015, GLOB HEALTH-SCI PRAC, V3, P630, DOI 10.9745/GHSP-D-15-00298; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2015, KENY DEM HLTH SURV K; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Namey E, 2005, QUALITATIVE RES METH; Okwor EU, 2010, INT Q COMMUNITY HEAL, V30, P223, DOI 10.2190/IQ.30.3.d; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Pitorak H, 2014, HEALTH CARE WOMEN IN, V35, P234, DOI 10.1080/07399332.2012.736575; PMA, 2015, PMA2015 KINSH ROUND; Rossier C, 2014, POP ASS AM ANN M BOS; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; United Nations Department of Economic and Social Affairs Population Division, 2016, WORLD POP PROSP 2015; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	27	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167560	10.1371/journal.pone.0167560	http://dx.doi.org/10.1371/journal.pone.0167560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907138	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700195
J	Sohn, YS; Lee, SG; Lee, KH; Ku, B; Shine, HC; Cha, SS; Kim, YG; Lee, HS; Kang, SG; Oh, BH				Sohn, Young-Sik; Lee, Seong-Gyu; Lee, Kwang-Hoon; Ku, Bonsu; Shine, Ho-Chul; Cha, Sun-Shin; Kim, Yeon-Gil; Lee, Hyun Sook; Kang, Sung-Gyun; Oh, Byung-Ha			Identification of a Highly Conserved Hypothetical Protein TON_0340 as a Probable Manganese-Dependent Phosphatase	PLOS ONE			English	Article							IB RIBONUCLEOTIDE REDUCTASE; N-OXYGENASE AURF; CRYSTAL-STRUCTURE; SEQUENCE; DNA	A hypothetical protein TON_0340 of a Thermococcus species is a protein conserved in a variety of organisms including human. Herein, we present four different crystal structures of TON_0340, leading to the identification of an active-site cavity harboring a metal-binding site composed of six invariant aspartate and glutamate residues that coordinate one to three metal ions. Biochemical and mutational analyses involving many phosphorous compounds show that TON_0340 is a Mn2+-dependent phosphatase. Mg2+ binds to TON_0340 less tightly and activates the phosphatase activity less efficiently than Mn2+. Whereas Ca2+ and Zn2+ are able to bind to the protein, they are unable to activate its enzymatic activity. Since the active-site cavity is small and largely composed of nearly invariant stretches of 11 or 13 amino acids, the physiological substrates of TON_0340 and its homologues are likely to be a small and the same molecule. The Mn2+-bound TON_0340 structure provides a canonical model for the ubiquitously present TON_0340 homologues and lays a strong foundation for the elucidation of their substrate and biological function.	[Sohn, Young-Sik; Lee, Seong-Gyu; Lee, Kwang-Hoon; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Dept Biol Sci, Daejeon, South Korea; [Ku, Bonsu; Shine, Ho-Chul] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Cha, Sun-Shin] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, Kyungbuk, South Korea; [Lee, Hyun Sook; Kang, Sung-Gyun] Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Ctr, Ansan, South Korea; [Lee, Kwang-Hoon] Yuhan R&D Inst, Global Res Ctr, Yongin, Gyeonggi Do, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Pohang University of Science & Technology (POSTECH); Korea Institute of Ocean Science & Technology (KIOST)	Oh, BH (corresponding author), Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Dept Biol Sci, Daejeon, South Korea.	bhoh@kaist.ac.kr	Oh, Byung-Ha/C-2061-2011	Ku, Bonsu/0000-0003-1784-8975; Cha, Sun-Shin/0000-0002-0913-8706	Ministry of Oceans and Fisheries; Ministry of Oceans and Fisheries, Korea	Ministry of Oceans and Fisheries; Ministry of Oceans and Fisheries, Korea	This work was funded by Ministry of Oceans and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study made use of the Beamline 5C at the Pohang Accelerator Laboratory, Korea and the Beamline NW12A at Photon Factory, Japan. This research was a part of the project titled "Marine and Extreme Genome Research Center Program" funded by Ministry of Oceans and Fisheries, Korea.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; Bae SS, 2012, BIOTECHNOL LETT, V34, P75, DOI 10.1007/s10529-011-0732-3; Barynin VV, 2001, STRUCTURE, V9, P725, DOI 10.1016/S0969-2126(01)00628-1; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cha SS, 2012, ACTA CRYSTALLOGR D, V68, P1253, DOI 10.1107/S0907444912024420; Cheng KY, 2016, ELIFE, V5, DOI 10.7554/eLife.14294; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; Creekmore AL, 2007, MOL CELL ENDOCRINOL, V267, P106, DOI 10.1016/j.mce.2007.01.001; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006; Zocher G, 2007, J MOL BIOL, V373, P65, DOI 10.1016/j.jmb.2007.06.014	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167549	10.1371/journal.pone.0167549	http://dx.doi.org/10.1371/journal.pone.0167549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907125	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700189
J	Terry-Lorenzo, RT; Torres, VI; Wagh, D; Galaz, J; Swanson, SK; Florens, L; Washburn, MP; Waites, CL; Gundelfinger, ED; Reimer, RJ; Garner, CC				Terry-Lorenzo, Ryan T.; Torres, Viviana I.; Wagh, Dhananjay; Galaz, Jose; Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.; Waites, Clarissa L.; Gundelfinger, Eckart D.; Reimer, Richard J.; Garner, Craig C.			Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone Proteins Piccolo and Bassoon	PLOS ONE			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; NUCLEOTIDE-EXCHANGE FACTORS; DEVELOPING RAT-BRAIN; IDENTIFICATION TECHNOLOGY; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; SHOTGUN PROTEOMICS; PRECURSOR VESICLES; NEURITE OUTGROWTH	Synaptic vesicles (SVs) fuse with the plasma membrane at a precise location called the pre synaptic active zone (AZ). This fusion is coordinated by proteins embedded within a cytoskeletal matrix assembled at the AZ (CAZ). In the present study, we have identified a novel binding partner for the CAZ proteins Piccolo and Bassoon. This interacting protein, Trio, is a member of the Dbl family of guanine nucleotide exchange factors (GEFs) known to regulate the dynamic assembly of actin and growth factor dependent axon guidance and synaptic growth. Trio was found to interact with the C-terminal PBH 9/10 domains of Piccolo and Bassoon via its own N-terminal Spectrin repeats, a domain that is also critical for its localization to the CAZ. Moreover, our data suggest that regions within the C-terminus of Trio negatively regulate its interactions with Piccolo/Bassoon. These findings provide a mechanism for the presynaptic targeting of Trio and support a model in which Piccolo and Bassoon play a role in regulating neurotransmission through interactions with proteins, including Trio, that modulate the dynamic assembly of F-actin during cycles of synaptic vesicle exo- and endocytosis.	[Terry-Lorenzo, Ryan T.; Torres, Viviana I.; Wagh, Dhananjay; Galaz, Jose; Waites, Clarissa L.; Garner, Craig C.] Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Torres, Viviana I.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Reimer, Richard J.] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Reimer, Richard J.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garner, Craig C.] Charite, German Ctr Neurodegenerat Dis, Berlin, Germany; [Terry-Lorenzo, Ryan T.] Sunov Pharmaceut, Discovery & Preclin Res Dept, Marlborough, MA USA; [Galaz, Jose] Univ Bernardo O Higgins, Lab Bionanotecnol, Santiago, Chile; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Waites, Clarissa L.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA	Stanford University; Pontificia Universidad Catolica de Chile; Stowers Institute for Medical Research; Leibniz Institut fur Neurobiologie (LIN); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.; Universidad  Bernardo O'Higgins; University of Kansas; University of Kansas Medical Center; Columbia University	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	Craig-Curtis.Garner@dzne.de	Torres, Viviana/AAC-3329-2019	Torres, Viviana/0000-0002-1220-7709; Florens, Laurence/0000-0002-9310-6650; Garner, Craig/0000-0003-1970-5417	NIH [NS39471, NS353862]; Deutsches Zentrum fur Neurodegenerative Erkrankung (DZNE); Deutsche Forschungsgemeinschaft [SFB-958, SFB779]; Max Planck Award of the Alexander von Humboldt Foundation/Max Planck Society; Stowers Institute for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsches Zentrum fur Neurodegenerative Erkrankung (DZNE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Award of the Alexander von Humboldt Foundation/Max Planck Society; Stowers Institute for Medical Research	This work was supported by grants from the NIH (NS39471 and NS353862), Deutsches Zentrum fur Neurodegenerative Erkrankung (DZNE) and Deutsche Forschungsgemeinschaft (SFB-958) to CCG, NRSAs to CLW and RTTL, and a Max Planck Award of the Alexander von Humboldt Foundation/Max Planck Society and the Deutsche Forschungsgemeinschaft (SFB779) to EDG. SKS, LF and MPW are supported by the Stowers Institute for Medical Research.	Ackermann F, 2015, EMBO REP, V16, P923, DOI 10.15252/embr.201540434; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; BANKER G, 1998, CULTURING NERVE CELL; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Evergren E, 2007, J NEUROSCI RES, V85, P2648, DOI 10.1002/jnr.21176; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Florens Laurence, 2006, V328, P159; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GRAY EG, 1963, J ANAT, V97, P101; Gundelfinger Eckart D, 2015, Front Synaptic Neurosci, V7, P19, DOI 10.3389/fnsyn.2015.00019; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jose M, 2008, BIOPHYS J, V94, P1483, DOI 10.1529/biophysj.107.111674; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; KINDLER S, 1990, J BIOL CHEM, V265, P19679; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Ma XM, 2005, J COMP NEUROL, V482, P333, DOI 10.1002/cne.20404; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Schneggenburger R, 2015, NAT NEUROSCI, V18, P935, DOI 10.1038/nn.4044; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schroder MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058814; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun YJ, 2006, MOL CELL BIOL, V26, P6923, DOI 10.1128/MCB.02474-05; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Wagh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120093; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Waites CL, 2011, J NEUROSCI, V31, P14250, DOI 10.1523/JNEUROSCI.1835-11.2011; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Xin XN, 2004, J CELL SCI, V117, P4739, DOI 10.1242/jcs.01333; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Zhai R, 2000, MOL CELL NEUROSCI, V15, P417, DOI 10.1006/mcne.2000.0839; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	89	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167535	10.1371/journal.pone.0167535	http://dx.doi.org/10.1371/journal.pone.0167535			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907191	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700187
J	Bodez, D; Hocini, H; Tchitchek, N; Tisserand, P; Benhaiem, N; Barau, C; Kharoubi, M; Guellich, A; Guendouz, S; Radu, C; Couetil, JP; Ghaleh, B; Dubois-Rande, JL; Teiger, E; Hittinger, L; Levy, Y; Damy, T				Bodez, Diane; Hocini, Hakim; Tchitchek, Nicolas; Tisserand, Pascaline; Benhaiem, Nicole; Barau, Caroline; Kharoubi, Mounira; Guellich, Aziz; Guendouz, Soulef; Radu, Costin; Couetil, Jean-Paul; Ghaleh, Bijan; Dubois-Rande, Jean-Luc; Teiger, Emmanuel; Hittinger, Luc; Levy, Yves; Damy, Thibaud			Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study	PLOS ONE			English	Article							RANTES CHEMOKINE; HEART; TRANSPLANTATION; TITIN; CLASSIFICATION; PHENOTYPE; DIAGNOSIS	Aims Serial invasive endomyocardial biopsies (EMB) remain the gold standard for acute cellular rejection (ACR) diagnosis. However histological grading has several limitations. We aimed to explore the value of myocardial Gene Expression Profiling (GEP) for diagnosing and identifying predictive biomarkers of ACR. Methods A case-control study nested within a retrospective heart transplant patients cohort included 126 patients with median (IQR) age 50 (41-57) years and 111 (88%) males. Among 1157 EMB performed, 467 were eligible (i.e, corresponding to either ISHLT grade 0 or >= 3A), among which 36 were selected for GEP according to the grading: 0 (C-ISHLT, n = 13); rejection >= 3A (R-ISHLT, n = 13); 0 one month before ACR (BRISHLT, n = 10). Results We found 294 genes differentially expressed between C-ISHLT and R-ISHLT, mainly involved in immune activation, and inflammation. Hierarchical clustering showed a clear segregation of C-ISHLT and R-ISHLT groups and heterogeneity of GEP within R-ISHLT. All EMB presented immune activation, but some R-ISHLT EMB were strongly subject to inflammation, whereas others, closer to C-ISHLT,were characterized by structural modifications with lower inflammation level. We identified 15 probes significantly different between BRISHLT and C-ISHLT, including the gene of the muscular protein TTN. This result suggests that structural alterations precede inflammation in ACR. Linear Discriminant Analysis based on these 15 probes was able to identify the histological status of every 36 samples. Conclusion Myocardial GEP is a helpful method to accurately diagnose ACR, and predicts rejection one month before its histological occurrence. These results should be considered in cardiac allograft recipients' care.	[Bodez, Diane; Kharoubi, Mounira; Guellich, Aziz; Guendouz, Soulef; Dubois-Rande, Jean-Luc; Teiger, Emmanuel; Hittinger, Luc; Damy, Thibaud] Henri Mondor Teaching Hosp, AP HP, Dept Cardiol, Creteil, France; [Bodez, Diane; Hocini, Hakim; Tisserand, Pascaline; Barau, Caroline; Guellich, Aziz; Guendouz, Soulef; Couetil, Jean-Paul; Ghaleh, Bijan; Dubois-Rande, Jean-Luc; Teiger, Emmanuel; Hittinger, Luc; Levy, Yves; Damy, Thibaud] UPEC, Sch Med, Creteil, France; [Bodez, Diane; Hocini, Hakim; Tisserand, Pascaline; Barau, Caroline; Guellich, Aziz; Couetil, Jean-Paul; Ghaleh, Bijan; Dubois-Rande, Jean-Luc; Teiger, Emmanuel; Hittinger, Luc; Levy, Yves; Damy, Thibaud] UPEC, IMRB INSERM U955, F-94000 Creteil, France; [Bodez, Diane; Guellich, Aziz; Guendouz, Soulef; Dubois-Rande, Jean-Luc; Teiger, Emmanuel; Hittinger, Luc; Damy, Thibaud] Henri Mondor Teaching Hosp, DHU ATVB, Creteil, France; [Hocini, Hakim; Tisserand, Pascaline; Levy, Yves] Henri Mondor Teaching Hosp, VRI, Creteil, France; [Tchitchek, Nicolas] CEA, DSV IMETI, Immunol Viral Infect & Autoimmune Dis Res Unit, Fontenay Aux Roses, France; [Tchitchek, Nicolas] IDMIT Infrastruct, UMR1184, Fontenay Aux Roses, France; [Benhaiem, Nicole] Henri Mondor Teaching Hosp, AP HP, Dept Pathol, Creteil, France; [Barau, Caroline; Ghaleh, Bijan] Henri Mondor Teaching Hosp, AP HP, Platform Biol Resources, Creteil, France; [Kharoubi, Mounira; Guellich, Aziz; Guendouz, Soulef; Damy, Thibaud] Henri Mondor Teaching Hosp, GRC Amyloid Res Inst, Creteil, France; [Radu, Costin; Couetil, Jean-Paul] Henri Mondor Teaching Hosp, AP HP, Dept Cardiac Surg, Creteil, France; [Levy, Yves] Henri Mondor Teaching Hosp, AP HP, Clin Immunol, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Franche-Comte; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Damy, T (corresponding author), Henri Mondor Teaching Hosp, AP HP, Dept Cardiol, Creteil, France.; Levy, Y; Damy, T (corresponding author), UPEC, Sch Med, Creteil, France.; Levy, Y; Damy, T (corresponding author), UPEC, IMRB INSERM U955, F-94000 Creteil, France.; Damy, T (corresponding author), Henri Mondor Teaching Hosp, DHU ATVB, Creteil, France.; Levy, Y (corresponding author), Henri Mondor Teaching Hosp, VRI, Creteil, France.; Damy, T (corresponding author), Henri Mondor Teaching Hosp, GRC Amyloid Res Inst, Creteil, France.; Levy, Y (corresponding author), Henri Mondor Teaching Hosp, AP HP, Clin Immunol, Creteil, France.	yves.levy@aphp.fr; thibaud.damy@aphp.fr		TEIGER, emmanuel/0000-0001-7515-4344; Ghaleh, Bijan/0000-0003-0061-5462; Barau, Caroline/0000-0003-4289-3276; Tchitchek, Nicolas/0000-0003-3307-0446; Hittinger, Luc/0000-0003-1933-5815	non-profit organization AREMCAR (Association pour la Recherche de l'Etude des Maladies Vasculaires); Novartis	non-profit organization AREMCAR (Association pour la Recherche de l'Etude des Maladies Vasculaires); Novartis(Novartis)	This work was supported by the non-profit organization AREMCAR (Association pour la Recherche de l'Etude des Maladies Vasculaires) and with an institutional grant from Novartis to support the collection of the clinical data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzawi M, 1998, J HEART LUNG TRANSPL, V17, P881; Crespo-Leiro MG, 2012, TRANSPLANTATION, V94, P1172, DOI 10.1097/TP.0b013e31826e19e2; Deng MC, 2014, TRANSPLANTATION, V97, P708, DOI 10.1097/01.TP.0000443897.29951.cf; Frost RJA, 2007, CIRCULATION, V116, P1768, DOI 10.1161/CIRCULATIONAHA.107.696468; Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hidalgo C, 2013, TRENDS CARDIOVAS MED, V23, P165, DOI 10.1016/j.tcm.2012.10.005; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Hollander Z, 2010, TRANSPLANTATION, V90, P1388, DOI 10.1097/TP.0b013e3182003df6; Holweg CTJ, 2011, CIRCULATION, V123, P2236, DOI 10.1161/CIRCULATIONAHA.109.913921; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Hricik DE, 2013, AM J TRANSPLANT, V13, P2634, DOI 10.1111/ajt.12426; Khush KK, 2015, J HEART LUNG TRANSPL, V34, P970, DOI 10.1016/j.healun.2015.01.987; Lassner D, 2014, EUR HEART J, V35, P2186, DOI 10.1093/eurheartj/ehu101; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082153; Lund LH, 2014, J HEART LUNG TRANSPL, V33, P996, DOI 10.1016/j.healun.2014.08.003; Mehra MR, 2008, J HEART LUNG TRANSPL, V27, P297, DOI 10.1016/j.healun.2007.11.578; Meirovich YF, 2008, J HEART LUNG TRANSPL, V27, P31, DOI 10.1016/j.healun.2007.09.025; Mengel M, 2010, AM J TRANSPLANT, V10, P2105, DOI 10.1111/j.1600-6143.2010.03182.x; Michaels PJ, 2001, J HEART LUNG TRANSPL, V20, P407, DOI 10.1016/S1053-2498(00)00318-1; Mulligan MS, 2000, EXP MOL PATHOL, V69, P167, DOI 10.1006/exmp.2000.2327; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nicholson IC, 2012, CELL IMMUNOL, V275, P12, DOI 10.1016/j.cellimm.2012.04.002; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Reshef R, 2012, NEW ENGL J MED, V367, P135, DOI 10.1056/NEJMoa1201248; Rosenblum JM, 2010, J IMMUNOL, V184, P3450, DOI 10.4049/jimmunol.0903831; Sigdel TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138133; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderlund C, 2015, TRANSPLANT REV-ORLAN, V29, P181, DOI 10.1016/j.trre.2015.02.005; Song W, 2015, GENE, V569, P1, DOI 10.1016/j.gene.2015.06.029; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Tible M, 2013, J HEART LUNG TRANSPL, V32, P769, DOI 10.1016/j.healun.2013.05.012; Vassalli G, 2006, TRANSPLANTATION, V81, P240, DOI 10.1097/01.tp.0000194859.98504.9e	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167213	10.1371/journal.pone.0167213	http://dx.doi.org/10.1371/journal.pone.0167213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898719	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000040
J	Elya, C; Zhang, V; Ludington, WB; Eisen, MB				Elya, Carolyn; Zhang, Vivian; Ludington, William B.; Eisen, Michael B.			Stable Host Gene Expression in the Gut of Adult Drosophila melanogaster with Different Bacterial Mono-Associations	PLoS One			English	Article							LIFE-SPAN; IMMUNE HOMEOSTASIS; PERITROPHIC MATRIX; MICROBIOTA; DYSBIOSIS; INSIGHTS; GROWTH; WORLD	There is growing evidence that the microbes found in the digestive tracts of animals influence host biology, but we still do not understand how they accomplish this. Here, we evaluated how different microbial species commonly associated with laboratory-reared Drosophila melanogaster impact host biology at the level of gene expression in the dissected adult gut and in the entire adult organism. We observed that guts from animals associated from the embryonic stage with either zero, one or three bacterial species demonstrated indistinguishable transcriptional profiles. Additionally, we found that the gut transcriptional profiles of animals reared in the presence of the yeast Saccharomyces cerevisiae alone or in combination with bacteria could recapitulate those of conventionally-reared animals. In contrast, we found whole body transcriptional profiles of conventionally-reared animals were distinct from all of the treatments tested. Our data suggest that adult flies are insensitive to the ingestion of the bacteria found in their gut, but that prior to adulthood, different microbes impact the host in ways that lead to global transcriptional differences observable across the whole adult body.	[Elya, Carolyn; Zhang, Vivian; Ludington, William B.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Elya, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	elyac@berkeley.edu		Elya, Carolyn/0000-0002-9634-0303	MBE's Investigator Award from the Howard Hughes Medical Institute; National Institutes of Health Director's Early Independence Award [DP50 D017851-01]; Bowes Research Fellowship from the MCB Department at UC Berkeley; CE's Graduate Research Fellowship from the National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017851] Funding Source: NIH RePORTER	MBE's Investigator Award from the Howard Hughes Medical Institute; National Institutes of Health Director's Early Independence Award; Bowes Research Fellowship from the MCB Department at UC Berkeley; CE's Graduate Research Fellowship from the National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by MBE's Investigator Award from the Howard Hughes Medical Institute, the National Institutes of Health Director's Early Independence Award DP50 D017851-01 to WBL, the Bowes Research Fellowship from the MCB Department at UC Berkeley to WBL, and CE's Graduate Research Fellowship from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the MBE's Investigator Award from the Howard Hughes Medical Institute, WBL's Early Investigator Award from the National Institutes of Health and CE's Graduate Research Fellowship from the National Science Foundation. The authors would like to thank Edan Foley and members of MBE's research group for comments on an earlier draft of this manuscript. The authors also gratefully acknowledge reviewers William Etges and Nichole Broderick for their helpful feedback on the submitted version.	BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Broderick NA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0295; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Combe BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094729; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Day A, 2003, YEAST CELL SYNCHRONI, P55; Erkosar B, 2015, CELL HOST MICROBE, V18, P445, DOI 10.1016/j.chom.2015.09.001; Fast D, 2016, LACTOBACILLUS PLANTA, DOI [10.1101/049981, DOI 10.1101/049981]; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; HARTMAN JR, 1993, J EXP ZOOL, V267, P365, DOI 10.1002/jez.1402670403; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lee WJ, 2008, CELL HOST MICROBE, V4, P91, DOI 10.1016/j.chom.2008.07.007; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li HJ, 2016, CELL HOST MICROBE, V19, P240, DOI 10.1016/j.chom.2016.01.008; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Najarro MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1173; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ridley EV, 2013, APPL ENVIRON MICROB, V79, P3209, DOI 10.1128/AEM.00206-13; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; SANG JH, 1961, J EXP BIOL, V38, P793; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xu W, 2011, FOOD MICROBIOL, V28, P1175, DOI 10.1016/j.fm.2011.03.011; Yamada R, 2015, CELL REP, V10, P865, DOI 10.1016/j.celrep.2015.01.018	42	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167357	10.1371/journal.pone.0167357	http://dx.doi.org/10.1371/journal.pone.0167357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898741	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000058
J	He, H; Ye, A; Kim, H; Kim, J				He, Hongzhi; Ye, An; Kim, Hana; Kim, Joomyeong			PEG3 Interacts with KAP1 through KRAB-A	PLOS ONE			English	Article							ATP-CITRATE LYASE; IMPRINTED GENE; PROXIMAL CHROMOSOME-7; FINGER; MOUSE; METHYLATION; DOMAIN; HOMOLOG; PROTEIN; MOTIF	Peg3 (Paternally Expressed Gene 3) is an imprinted gene that encodes a zinc finger DNA-binding protein. Peg3 itself is localized in the middle of a KRAB-A (Kruppel-Associated Box) zinc finger gene cluster. The amino acid sequence encoded by its exon 7 also shows sequence similarity to that of KRAB-A, suggesting Peg3 as a KRAB-containing zinc finger gene. As predicted, the PEG3 protein was co-immunoprecipitated with KAP1, a co-repressor that interacts with KRAB-A. A series of follow-up experiments further demonstrated that the exon 7 of PEG3 is indeed responsible for its physical interaction with KAP1. ChIP and promoter assays also indicated that PEG3 likely controls its downstream genes through the KAP1-mediated repression mechanism. Overall, the current study identifies PEG3 as a KRAB-containing zinc finger protein that interacts with the co-repressor protein KAP1.	[He, Hongzhi; Ye, An; Kim, Hana; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Ryan Carl Kunz at Harvard Medical School for his help in tandem mass spectrometry. We also like to thank the members of JooKim Lab for their thoughtful feedback and discussion on the manuscript. This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).	Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Do Kim J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-108; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kim J, 2004, GENOMICS, V84, P47, DOI 10.1016/j.ygeno.2004.02.007; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2001, NATL FISH RES DEV I, V2001, P77; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim JY, 1999, HUM MOL GENET, V8, P847, DOI 10.1093/hmg/8.5.847; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liu H, 2014, GENOME BIOL EVOL, V6, P510, DOI 10.1093/gbe/evu030; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Shannon M, 1998, GENOMICS, V49, P112, DOI 10.1006/geno.1998.5230; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Trono D, 2015, COLD SH Q B, V80, P281, DOI 10.1101/sqb.2015.80.027573; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167541	10.1371/journal.pone.0167541	http://dx.doi.org/10.1371/journal.pone.0167541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898713	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000067
J	Santos, S; Almeida, I; Oliveiros, B; Castelo-Branco, M				Santos, Sara; Almeida, Ines; Oliveiros, Barbara; Castelo-Branco, Miguel			The Role of the Amygdala in Facial Trustworthiness Processing: A Systematic Review and Meta-Analyses of fMRI Studies	PLOS ONE			English	Review							SOCIAL COGNITION; ALE METAANALYSIS; 1ST IMPRESSIONS; NEURAL BASES; ACTIVATION; BRAIN; FACES; BIAS; HETEROGENEITY; RESPONSES	Background Faces play a key role in signaling social cues such as signals of trustworthiness. Although several studies identify the amygdala as a core brain region in social cognition, quantitative approaches evaluating its role are scarce. Objectives This review aimed to assess the role of the amygdala in the processing of facial trustworthiness, by analyzing its amplitude BOLD response polarity to untrustworthy versus trustworthy facial signals under fMRI tasks through a Meta-analysis of effect sizes (MA). Activation Likelihood Estimation (ALE) analyses were also conducted. Data sources Articles were retrieved from MEDLINE, ScienceDirect and Web-of-Science in January 2016. Following the PRISMA statement guidelines, a systematic review of original research articles in English language using the search string "(face OR facial) AND (trustworthiness OR trustworthy OR untrustworthy OR trustee) AND fMRI" was conducted. Study selection and data extraction The MA concerned amygdala responses to facial trustworthiness for the contrast Untrustworthy vs. trustworthy faces, and included whole-brain and ROI studies. To prevent potential bias, results were considered even when at the single study level they did not survive correction for multiple comparisons or provided non-significant results. ALE considered whole-brain studies, using the same methodology to prevent bias. A summary of the methodological options (design and analysis) described in the articles was finally used to get further insight into the characteristics of the studies and to perform a subgroup analysis. Data were extracted by two authors and checked independently. Data synthesis Twenty fMRI studies were considered for systematic review. An MA of effect sizes with 11 articles (12 studies) showed high heterogeneity between studies [Q(11) = 265.68, p <.0001; I-2 = 95.86%, 94.20% to 97.05%, with 95% confidence interval, CI]. Random effects analysis [RE(183) = 0.851,.422 to.969, 95% CI] supported the evidence that the (right) amygdala responds preferentially to untrustworthy faces. Moreover, two ALE analyses performed with 6 articles (7 studies) identified the amygdala, insula and medial dorsal nuclei of thalamus as structures with negative correlation with trustworthiness. Six articles/studies showed that posterior cingulate and medial frontal gyrus present positive correlations with increasing facial trustworthiness levels. Significant effects considering subgroup analysis based on methodological criteria were found for experiments using spatial smoothing, categorization of trustworthiness in 2 or 3 categories and paradigms which involve both explicit and implicit tasks. Limitations Significant heterogeneity between studies was found in MA, which might have arisen from inclusion of studies with smaller sample sizes and differences in methodological options. Studies using ROI analysis / small volume correction methods were more often devoted specifically to the amygdala region, with some results reporting uncorrected p-values based on mainly clinical a priori evidence of amygdala involvement in these processes. Nevertheless, we did not find significant evidence for publication bias. Conclusions and implications of key findings Our results support the role of amygdala in facial trustworthiness judgment, emphasizing its predominant role during processing of negative social signals in (untrustworthy) faces. This systematic review suggests that little consistency exists among studies' methodology, and that larger sample sizes should be preferred.	[Santos, Sara; Almeida, Ines; Oliveiros, Barbara; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci CNC IBILI, Visual Neurosci Lab, Coimbra, Portugal; [Oliveiros, Barbara; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci CNC IBILI, Lab Biostat & Med Informat, Coimbra, Portugal; [Castelo-Branco, Miguel] Brain Imaging Network Portugal, Inst Nucl Sci Appl Hlth ICNAS, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci CNC IBILI, Visual Neurosci Lab, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci CNC IBILI, Lab Biostat & Med Informat, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Brain Imaging Network Portugal, Inst Nucl Sci Appl Hlth ICNAS, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Almeida, Ines A. T./U-9150-2017; Oliveiros, Bárbara/AAR-4529-2020; Oliveiros, Bárbara/AHD-0826-2022	Castelo-Branco, Miguel/0000-0003-4364-6373; Almeida, Ines A. T./0000-0003-0230-3075; Oliveiros, Bárbara/0000-0001-7836-8161; Santos, Sara/0000-0002-7594-4765	Bial Foundation Grants [132/12, 133/12]; Foundation for Science and Technology (FCT) (Portugal) [UID/NEU/04539/2013, POCI-01-0145-FEDER-007440]; Projecto Operacional Regional do Centro - European Commission [QREN Centro-07-ST24-FEDER-002005]; program Mais Centro (Portugal); European Commission [FP7-HEALTH-2013-INNOVATION-1 - 602186 BRAINTRAIN]	Bial Foundation Grants(Bial Foundation); Foundation for Science and Technology (FCT) (Portugal)(Portuguese Foundation for Science and Technology); Projecto Operacional Regional do Centro - European Commission; program Mais Centro (Portugal); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by Bial Foundation Grants 132/12 and 133/12, Projeto UID/NEU/04539/2013, Strategic Project and POCI-01-0145-FEDER-007440 of the Foundation for Science and Technology (FCT) (Portugal), "Projecto Operacional Regional do Centro" (QREN Centro-07-ST24-FEDER-002005), funded by the European Commission and the program Mais Centro (Portugal), and FP7-HEALTH-2013-INNOVATION-1 - 602186 BRAINTRAIN, funded by the European Commission in their Seventh Framework Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Baas D, 2008, NEUROIMAGE, V40, P719, DOI 10.1016/j.neuroimage.2007.12.039; Bar M, 2006, EMOTION, V6, P269, DOI 10.1037/1528-3542.6.2.269; Baron SG, 2011, SOC COGN AFFECT NEUR, V6, P572, DOI 10.1093/scan/nsq086; Bos PA, 2012, NEUROIMAGE, V61, P730, DOI 10.1016/j.neuroimage.2012.04.002; BROTHERS L, 2002, SO NEUROSCI SER, P367; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Castle E, 2012, P NATL ACAD SCI USA, V109, P20848, DOI 10.1073/pnas.1218518109; Cosmides L, 2000, NEW COGNITIVE NEUROS, P1259; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cottrell CA, 2007, J PERS SOC PSYCHOL, V92, P208, DOI 10.1037/0022-3514.92.2.208; Doallo S, 2012, SOC COGN AFFECT NEUR, V7, P649, DOI 10.1093/scan/nsr031; Dzhelyova M, 2012, BRAIN RES, V1435, P81, DOI 10.1016/j.brainres.2011.11.043; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733; Freeman JB, 2014, J NEUROSCI, V34, P10573, DOI 10.1523/JNEUROSCI.5063-13.2014; Frith CD, 2007, CURRENT BIOL, V17; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goghari VM, 2011, PSYCHOL MED, V41, P1239, DOI 10.1017/S0033291710001972; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Haas BW, 2015, NEUROIMAGE, V107, P175, DOI 10.1016/j.neuroimage.2014.11.060; Habel U, 2007, NEUROPSYCHOLOGIA, V45, P2369, DOI 10.1016/j.neuropsychologia.2007.01.023; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harrison LA, 2015, PSYCHOL SCI, V26, P1543, DOI 10.1177/0956797615583804; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Killgore WDS, 2013, SOC NEUROSCI-UK, V8, P334, DOI 10.1080/17470919.2013.807300; Kim H, 2012, J COGNITIVE NEUROSCI, V24, P428, DOI 10.1162/jocn_a_00136; Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023; Kragel Pa, 2015, SOC COGN AFFECT NEUR; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Marzi T, 2014, SOC COGN AFFECT NEUR, V9, P63, DOI 10.1093/scan/nss102; Mattavelli G, 2012, NEUROPSYCHOLOGIA, V50, P2205, DOI 10.1016/j.neuropsychologia.2012.05.024; Mende-Siedlecki P, 2013, SOC COGN AFFECT NEUR, V8, P285, DOI 10.1093/scan/nsr090; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morawetz C, 2008, MAGN RESON IMAGING, V26, P45, DOI 10.1016/j.mri.2007.04.014; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pinkham AE, 2008, SCHIZOPHRENIA BULL, V34, P688, DOI 10.1093/schbul/sbn031; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Platek S. M., 2009, J SOCIAL EVOLUTIONAR, V3, P182, DOI [10.1037/h0099323, DOI 10.1037/H0099323]; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P289, DOI 10.1016/j.neuropsychologia.2008.07.018; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rule NO, 2013, J PERS SOC PSYCHOL, V104, P409, DOI 10.1037/a0031050; Ruz M, 2011, NEUROIMAGE, V54, P1685, DOI 10.1016/j.neuroimage.2010.08.039; Said CP, 2009, J COGNITIVE NEUROSCI, V21, P519, DOI 10.1162/jocn.2009.21041; Shotton K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006461.pub2; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Sterne JA., 2011, COCHRANE HDB SYSTEMA, P297; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Taylor K, 2014, COCHRANE DATABASE SY, V7; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Tsukiura T, 2013, SOC COGN AFFECT NEUR, V8, P515, DOI 10.1093/scan/nss025; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; van Rijn S, 2012, SOC COGN AFFECT NEUR, V7, P689, DOI 10.1093/scan/nsr041; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 1998, J NEUROSCI, V18, P411; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Yaffe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036626; Yang D, 2011, NEUROSCI LETT, V496, P147, DOI 10.1016/j.neulet.2011.03.066	82	28	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167276	10.1371/journal.pone.0167276	http://dx.doi.org/10.1371/journal.pone.0167276			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898705	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000045
J	Wang, SP; Zhang, XX; Zhang, YL				Wang, Shangping; Zhang, Xiaoxue; Zhang, Yaling			Efficiently Multi-User Searchable Encryption Scheme with Attribute Revocation and Grant for Cloud Storage	PLOS ONE			English	Article							MANAGEMENT	Cipher-policy attribute-based encryption (CP-ABE) focus on the problem of access control, and keyword-based searchable encryption scheme focus on the problem of finding the files that the user interested in the cloud storage quickly. To design a searchable and attribute based encryption scheme is a new challenge. In this paper, we propose an efficiently multi-user searchable attribute-based encryption scheme with attribute revocation and grant for cloud storage. In the new scheme the attribute revocation and grant processes of users are delegated to proxy server. Our scheme supports multi attribute are revoked and granted simultaneously. Moreover, the keyword searchable function is achieved in our proposed scheme. The security of our proposed scheme is reduced to the bilinear Diffie-Hellman (BDH) assumption. Furthermore, the scheme is proven to be secure under the security model of indistinguishability against selective ciphertext-policy and chosen plaintext attack (IND-sCP-CPA). And our scheme is also of semantic security under indistinguishability against chosen keyword attack (IND-CKA) in the random oracle model.	[Wang, Shangping; Zhang, Xiaoxue] Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China; [Zhang, Yaling] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology; Xi'an University of Technology	Zhang, XX (corresponding author), Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China.	iszhangxiaoxue@163.com		Wang, Shangping/0000-0002-8964-5328	National Natural Science Foundation of China [61572019, 61173192]; Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China [2016JZ001]; Research Foundation of Education Department of Shaanxi Province of China [2013JK1142]; Research Foundation of science and technology of Xi'an Beilin district of China [GX1407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China; Research Foundation of Education Department of Shaanxi Province of China; Research Foundation of science and technology of Xi'an Beilin district of China	This work is supported by the National Natural Science Foundation of China under grants 61572019, 61173192, the Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China under Grant No. 2016JZ001, the Research Foundation of Education Department of Shaanxi Province of China under grants 2013JK1142, and the Research Foundation of science and technology of Xi'an Beilin district of China under grants GX1407.	Attrapadung N, 2009, IM INT C CRYPT COD 2; Bao F, 2008, LECT NOTES COMPUT SC, V4991, P71; Bethencourt J, 2008, IEEE S 2007 SEC PRIV; Boneh D, 2004, LECT NOTES COMPUT SC, V3027, P506; Bringer J, 2009, IEEE ICC, P768; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Chen JH, 2011, J INF SCI ENG, V27, P437; Duquesne S, 2004, MATHIISCERNETIN, V22, P573; Emura K, 2009, LECT NOTES COMPUT SC, V5451, P13, DOI 10.1007/978-3-642-00843-6_2; Goyal V, 2015, BOUNDED CIPHERTEXT; Goyal V, 2006, P 13 ACM C COMP COMM, P89, DOI DOI 10.1145/1180405.1180418; Hu CY, 2012, J COMPUT, V7, P716, DOI 10.4304/jcp.7.3.716-723; Javanmardi S, 2015, INT J GRID UTIL COMP, V6, P57, DOI 10.1504/IJGUC.2015.066397; Jian Y, 2014, INT C COMP COMM NETW; Kaci A, 2014, IEEE INT C INF REUS; Kallahalla M, 2003, US C FIL STOR TECHN; Li Q, 2012, GLOB COMM C GLOBECOM; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Liu Z, 2013, INT C EM INT DAT WEB; Lv Z, 2014, IEEE INT C CLOUD COM; Lv Z, 2014, IEEE INT C TRUST SEC; Martinez-Vara P, 2009, CTR TELEMATICS INFOR, V13, P325; Naruse T, 2015, HUM-CENT COMPUT INFO, V5, DOI 10.1186/s13673-015-0027-0; Rhee HS, 2010, J SYST SOFTWARE, V83, P763, DOI 10.1016/j.jss.2009.11.726; Sahai A, 2005, LECT NOTES COMPUT SC, V3494, P457, DOI 10.1007/11426639_27; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Shojafar M, 2015, PEER PEER NETW APPL, V8, P120, DOI 10.1007/s12083-013-0236-0; Umar MM, 2016, SECURITY COMMUNICATI; Wang Q, 2014, INT C CLOUD COMP BIG; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Wu QX, 2014, CHINA COMMUN, V11, P93, DOI 10.1109/CC.2014.7022531; Wu QX, 2012, CHINA COMMUN, V9, P22; Xu Q, 2016, IEEE ACCESS, V4, P2840, DOI 10.1109/ACCESS.2016.2575863; Yang Y, 2011, IEEE INT C CLOUD COM; Yu S, 2010, ACM S INF APR; Zhang Y, 2013, INT C INT NETW COLL; Zhang Y, 2014, IEEE INTERNET THINGS, V1, P311, DOI 10.1109/JIOT.2014.2329462	37	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167157	10.1371/journal.pone.0167157	http://dx.doi.org/10.1371/journal.pone.0167157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898703	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000036
J	Wang, XB; Luo, FJ; Qian, Y; Ranzi, G				Wang, Xibin; Luo, Fengji; Qian, Ying; Ranzi, Gianluca			A Personalized Electronic Movie Recommendation System Based on Support Vector Machine and Improved Particle Swarm Optimization	PLOS ONE			English	Article								With the rapid development of ICT and Web technologies, a large an amount of information is becoming available and this is producing, in some instances, a condition of information overload. Under these conditions, it is difficult for a person to locate and access useful information for making decisions. To address this problem, there are information filtering systems, such as the personalized recommendation system (PRS) considered in this paper, that assist a person in identifying possible products or services of interest based on his/her preferences. Among available approaches, collaborative Filtering (CF) is one of the most widely used recommendation techniques. However, CF has some limitations, e.g., the relatively simple similarity calculation, cold start problem, etc. In this context, this paper presents a new regression model based on the support vector machine (SVM) classification and an improved PSO (IPSO) for the development of an electronic movie PRS. In its implementation, a SVM classification model is first established to obtain a preliminary movie recommendation list based on which a SVM regression model is applied to predict movies' ratings. The proposed PRS not only considers the movie's content information but also integrates the users' demographic and behavioral information to better capture the users' interests and preferences. The efficiency of the proposed method is verified by a series of experiments based on the MovieLens benchmark data set.	[Wang, Xibin; Qian, Ying] Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China; [Wang, Xibin; Qian, Ying] Chongqing Engn Res Ctr Software Qual Assurance Te, Chongqing, Peoples R China; [Luo, Fengji] Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia; [Luo, Fengji] Chongqing Univ, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; University of Sydney; Chongqing University	Luo, FJ (corresponding author), Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia.; Luo, FJ (corresponding author), Chongqing Univ, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China.	tracyluofengji@gmail.com		Ranzi, Gianluca/0000-0003-4603-8349	National Natural Science Foundation of China [61171060, 61379158]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1600437]; Visiting Scholarship of State Key Laboratory of Power Transmission Equipment AMP; System Security and New Technology (Chongqing University, China) [2007DA10512716401]; Australian Research Council [FT140100130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Research Program of Chongqing Municipal Education Commission; Visiting Scholarship of State Key Laboratory of Power Transmission Equipment AMP; System Security and New Technology (Chongqing University, China); Australian Research Council(Australian Research Council)	This work was supported in part by the National Natural Science Foundation of China under Grant Nos. 61171060 and 61379158, in part by the Scientific and Technological Research Program of Chongqing Municipal Education Commission under Grant No. KJ1600437, in part by a Visiting Scholarship of State Key Laboratory of Power Transmission Equipment & System Security and New Technology (Chongqing University, China) (2007DA10512716401), and in part by an Australian Research Council through its Future Fellowship scheme (FT140100130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported in part by the National Natural Science Foundation of China under Grant Nos. 61171060 and 61379158, in part by the Scientific and Technological Research Program of Chongqing Municipal Education Commission under Grant No. KJ1600437, in part by a Visiting Scholarship of State Key Laboratory of Power Transmission Equipment & System Security and New Technology (Chongqing University, China) (2007DA10512716401), and in part by an Australian Research Council through its Future Fellowship scheme (FT140100130).	Berti G, 2006, FUTURE GENER COMP SY, V22, P110, DOI 10.1016/j.future.2003.09.002; Billsus D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P46; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Deng WY, 2011, NEUROCOMPUTING, V74, P1848, DOI 10.1016/j.neucom.2010.07.034; Du WB, 2017, IEEE T CIRCUITS-II, V64, P467, DOI 10.1109/TCSII.2016.2595597; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Gu JR, 2011, EXPERT SYST APPL, V38, P3383, DOI 10.1016/j.eswa.2010.08.123; Hassan R., 2005, STRUCT DYNAM-US, V7, P1, DOI [DOI 10.2514/6.2005-1897, 10.2514/6.2005-1897]; Herlocker JL, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P230, DOI 10.1145/312624.312682; Hong WX, 2012, EXPERT SYST APPL, V39, P12398, DOI 10.1016/j.eswa.2012.04.082; Jiao LC, 2012, PATTERN RECOGN, V45, P4358, DOI 10.1016/j.patcog.2012.05.007; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Lee SK, 2010, INFORM SCIENCES, V180, P2142, DOI 10.1016/j.ins.2010.02.004; Li L, 2011, J COMPUT SCI TECH-CH, V26, P754, DOI 10.1007/s11390-011-0175-2; Li P., 2007, ADV NEURAL INFORM PR, P897; Liang X, 2009, NEUROCOMPUTING, V72, P3055, DOI 10.1016/j.neucom.2009.03.015; Luo FJ, 2014, IEEE T SMART GRID, V5, P1892, DOI 10.1109/TSG.2014.2314451; Pazzani M, 1997, MACH LEARN, V27, P313, DOI 10.1023/A:1007369909943; Pucci A., 2006, P INT MULT COMP SCI, V1, P189; Resnick P., 1994, Transcending Boundaries, CSCW '94. Proceedings of the Conference on Computer Supported Cooperative Work, P175, DOI 10.1145/192844.192905; Shang RH, 2016, PATTERN RECOGN, V55, P172, DOI 10.1016/j.patcog.2016.01.035; Shang RH, 2016, NEUROCOMPUTING, V171, P1242, DOI 10.1016/j.neucom.2015.07.068; Shang RH, 2012, IEEE T EVOLUT COMPUT, V16, P35, DOI 10.1109/TEVC.2010.2046328; Ungar L.H., 1998, AAAI WORKSH REC SYST, V1, P114; Yang LX, 2015, KNOWL-BASED SYST, V79, P80, DOI 10.1016/j.knosys.2015.01.006; Zhang T, 2002, J MACH LEARN RES, V2, P313, DOI 10.1162/153244302760200641; Zhang Y, 2007, P 30 ANN INT ACM SIG, P47, DOI [10.1145/1277741.1277752, DOI 10.1145/1277741.1277752]; Zheng Y, 2014, IEEE T POWER SYST, V29, P212, DOI 10.1109/TPWRS.2013.2278850	28	6	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0165868	10.1371/journal.pone.0165868	http://dx.doi.org/10.1371/journal.pone.0165868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898691	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000004
J	Cheng, YX; Luo, LZ; Sappington, TW; Jiang, XF; Zhang, L; Frolov, AN				Cheng, Yunxia; Luo, Lizhi; Sappington, Thomas W.; Jiang, Xingfu; Zhang, Lei; Frolov, Andrei N.			Onset of Oviposition Triggers Abrupt Reduction in Migratory Flight Behavior and Flight Muscle in the Female Beet Webworm, Loxostege sticticalis	PLOS ONE			English	Article							WING-DIMORPHIC CRICKET; LEPIDOPTERA-PYRALIDAE; EGG-PRODUCTION; HISTOLYSIS; INSECTS; REPRODUCTION; PERFORMANCE; DISPERSAL; BREAKDOWN; COTTON	Flight and reproduction are usually considered as two life history traits that compete for resources in a migratory insect. The beet webworm, Loxostege sticticalis L., manages the costs of migratory flight and reproduction through a trade-off in timing of these two life history traits, where migratory behavior occurs during the preoviposition period. To gain insight into how migratory flight and reproduction are coordinated in the female beet webworm, we conducted experiments beginning at the end of the preoviposition period. We used flight mills to test whether flight performance and supportive flight musculature and fuel are affected by the number of eggs oviposited, or by the age of mated and unmated females after onset of oviposition by the former. The results showed that flight distance, flight velocity, flight duration, and flight muscle mass decreased abruptly at the onset of oviposition, compared to that of virgin females of the same age which did not change over the next 7 d. These results indicate that onset of oviposition triggers a decrease in flight performance and capacity in female beet webworms, as a way of actively managing reallocation of resources away from migratory flight and into egg production. In addition to the abrupt switch, there was a gradual, linear decline in flight performance, flight muscle mass, and flight fuel relative to the number of eggs oviposited. The histolysis of flight muscle and decrease of triglyceride content indicate a progressive degradation in the ability of adults to perform additional migratory flights after onset of oviposition. Although the results show that substantial, albeit reduced, long-duration flights remain possible after oviposition begins, additional long-distance migratory flights probably are not launched after the initiation of oviposition.	[Cheng, Yunxia; Luo, Lizhi; Jiang, Xingfu; Zhang, Lei] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Sappington, Thomas W.] Iowa State Univ, Genet Lab, Corn Insects & Crop Genet Res Unit, USDA,ARS, Ames, IA USA; [Frolov, Andrei N.] All Russian Inst Plant Protect, St Petersburg, Russia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Iowa State University; United States Department of Agriculture (USDA); All-Russian Institute of Plant Protection	Luo, LZ; Jiang, XF (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	lzluo@ippcaas.cn; xfjiang@ippcaas.cn	Frolov, Andrey N./K-3409-2014	Frolov, Andrey N./0000-0002-6942-9951	National Natural Science Foundation of China [31301656, 31371947]; National Department of Public Benefit Research Project of China [201303057, 201403031]; International Science AMP; Technology Cooperation Program of China [2014DFR31250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department of Public Benefit Research Project of China; International Science AMP; Technology Cooperation Program of China	This work was funded by the National Natural Science Foundation of China (31301656; 31371947), the National Department of Public Benefit Research Project of China (201303057; 201403031), and the International Science & Technology Cooperation Program of China (2014DFR31250). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMES NJ, 1991, PHYSIOL ENTOMOL, V16, P131, DOI 10.1111/j.1365-3032.1991.tb00549.x; BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Chen Yang, 2012, Acta Entomologica Sinica, V55, P176; Cheng YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031562; Cheng YX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev135; [程云霞 Cheng Yunxia], 2013, [植物保护, Plant Protection], V39, P26; Cotto O, 2014, AM NAT, V183, P384, DOI 10.1086/675064; Denno R.F., 1981, INSECT LIFE HIST PAT, DOI 10.1007/978-1-4612-5941-1; DINGLE H, 1972, SCIENCE, V175, P1327, DOI 10.1126/science.175.4028.1327; DIXON AFG, 1993, J ANIM ECOL, V62, P182, DOI 10.2307/5492; EDWARDS FJ, 1969, J INSECT PHYSIOL, V15, P2013, DOI 10.1016/0022-1910(69)90069-9; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Gu HN, 2006, ECOL ENTOMOL, V31, P68, DOI 10.1111/j.0307-6946.2006.00761.x; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1631, DOI 10.1016/j.jinsphys.2010.06.006; Jiang Xing-Fu, 2002, Acta Entomologica Sinica, V45, P275; Jiang XF, 2010, ENVIRON ENTOMOL, V39, P232, DOI 10.1603/EN08315; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; JOHNSON B, 1957, J INSECT PHYSIOL, V1, P248, DOI 10.1016/0022-1910(57)90040-9; Johnson C.G., 1969, MIGRATION DISPERSAL; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; Kong HL, 2010, ENVIRON ENTOMOL, V39, P1579, DOI 10.1603/EN09314; Lorenz MW, 2007, J INSECT PHYSIOL, V53, P819, DOI 10.1016/j.jinsphys.2007.03.011; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P332; Luo Lizhi, 1995, Acta Entomologica Sinica, V38, P284; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; Ronce O, 2000, EVOL ECOL, V14, P233, DOI 10.1023/A:1011068005057; Ronce Ophelie, 2004, P227, DOI 10.1016/B978-012323448-3/50012-X; SAPPINGTON TW, 1992, ENVIRON ENTOMOL, V21, P677, DOI 10.1093/ee/21.4.677; Song W, 2016, PLANT PROT, V42, P23; Spurgeon DW, 1998, ENVIRON ENTOMOL, V22, P251; Stjernholm F, 2008, EUR J ENTOMOL, V105, P87, DOI 10.14411/eje.2008.012; TANAKA S, 1991, J INSECT PHYSIOL, V37, P517, DOI 10.1016/0022-1910(91)90028-X; Tanaka S, 2001, J INSECT PHYSIOL, V47, P83, DOI 10.1016/S0022-1910(00)00094-9; TANAKA S, 1993, J INSECT PHYSIOL, V39, P493, DOI 10.1016/0022-1910(93)90081-2; Xie DS, 2012, ENVIRON ENTOMOL, V41, P1199, DOI 10.1603/EN11068; ZAIDI ZS, 1985, B ZOOL, V52, P305, DOI 10.1080/11250008509440532; Zera AJ, 2001, J INSECT PHYSIOL, V47, P1147, DOI 10.1016/S0022-1910(01)00096-8; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121821; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	42	12	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166859	10.1371/journal.pone.0166859	http://dx.doi.org/10.1371/journal.pone.0166859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893835	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400050
J	Montaseri, S; Ganjtabesh, M; Zare-Mirakabad, F				Montaseri, Soheila; Ganjtabesh, Mohammad; Zare-Mirakabad, Fatemeh			Evolutionary Algorithm for RNA Secondary Structure Prediction Based on Simulated SHAPE Data	PLOS ONE			English	Article							SOFTWARE	Background Non-coding RNAs perform a wide range of functions inside the living cells that are related to their structures. Several algorithms have been proposed to predict RNA secondary structure based on minimum free energy. Low prediction accuracy of these algorithms indicates that free energy alone is not sufficient to predict the functional secondary structure. Recently, the obtained information from the SHAPE experiment greatly improves the accuracy of RNA secondary structure prediction by adding this information to the thermodynamic free energy as pseudo-free energy. Method In this paper, a new method is proposed to predict RNA secondary structure based on both free energy and SHAPE pseudo-free energy. For each RNA sequence, a population of secondary structures is constructed and their SHAPE data are simulated. Then, an evolutionary algorithm is used to improve each structure based on both free and pseudo-free energies. Finally, a structure with minimum summation of free and pseudo-free energies is considered as the predicted RNA secondary structure. Results and Conclusions Computationally simulating the SHAPE data for a given RNA sequence requires its secondary structure. Here, we overcome this limitation by employing a population of secondary structures. This helps us to simulate the SHAPE data for any RNA sequence and consequently improves the accuracy of RNA secondary structure prediction as it is confirmed by our experiments. The source code and web server of our proposed method are freely available at http://mostafa.utacdr/ESD-Fold/.	[Montaseri, Soheila; Ganjtabesh, Mohammad] Univ Tehran, Dept Comp Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Zare-Mirakabad, Fatemeh] Amirkabir Univ Technol, Dept Comp Sci, Fac Math & Comp Sci, Tehran, Iran	University of Tehran; Amirkabir University of Technology	Ganjtabesh, M (corresponding author), Univ Tehran, Dept Comp Sci, Sch Math Stat & Comp Sci, Tehran, Iran.	mgtabesh@ut.ac.ir	Zare-Mirakabad, Fatemeh/T-2862-2019; Zare-Mirakabad, Fatemeh/AAH-7191-2021	Zare-Mirakabad, Fatemeh/0000-0003-2849-3778				Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kladwang W, 2011, BIOCHEMISTRY-US, V50, P8049, DOI [10.1021/bi4200524n, 10.1021/bi200524n]; Leonard CW, 2013, BIOCHEMISTRY-US, V52, P588, DOI 10.1021/bi300755u; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathuriya A, 2009, 24 ANN ACM S APPL CO; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Storz G, 2006, COLD SPRING HARB MON, V43, P567; Sukosd Z, 2013, NUCLEIC ACIDS RES, V41, P2807, DOI 10.1093/nar/gks1283; Thulasi P, 2010, BIOCHEMISTRY-US, V49, P9058, DOI 10.1021/bi101164s; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1994, Methods Mol Biol, V25, P267	19	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166965	10.1371/journal.pone.0166965	http://dx.doi.org/10.1371/journal.pone.0166965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893832	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400064
J	Song, DL; Wilson, B; Zhao, LL; Bhuyan, R; Bandyopadhyay, M; Lyubarsky, A; Yu, C; Li, YF; Kanu, L; Miwa, T; Song, WC; Finnemann, SC; Rohrer, B; Dunaief, JL				Song, Delu; Wilson, Brooks; Zhao, Liangliang; Bhuyan, Rupak; Bandyopadhyay, Mausumi; Lyubarsky, Arkady; Yu, Chen; Li, Yafeng; Kanu, Levi; Miwa, Takashi; Song, Wen-Chao; Finnemann, Silvia C.; Rohrer, Barbel; Dunaief, Joshua L.			Retinal Pre-Conditioning by CD59a Knockout Protects against Light-Induced Photoreceptor Degeneration	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; PIGMENT EPITHELIAL-CELLS; COMPLEMENT REGULATORY PROTEINS; CHELATOR DEFERIPRONE PROTECTS; DECAY-ACCELERATING FACTOR; FACTOR-H DEFICIENCY; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FUNCTIONAL-CHARACTERIZATION; OXIDATIVE STRESS	Complement dysregulation plays a key role in the pathogenesis of age-related macular degeneration (AMD), but the specific mechanisms are incompletely understood. Complement also potentiates retinal degeneration in the murine light damage model. To test the retinal function of CD59a, a complement inhibitor, CD59a knockout (KO) mice were used for light damage (LD) experiments. Retinal degeneration and function were compared in WT versus KO mice following light damage. Gene expression changes, endoplasmic reticulum (ER) stress, and glial cell activation were also compared. At baseline, the ERG responses and rhodopsin levels were lower in CD59aKO compared to wild-type (WT) mice. Following LD, the ERG responses were better preserved in CD59aKO compared to WT mice. Correspondingly, the number of photoreceptors was higher in CD59aKO retinas than WT controls after LD. Under normal light conditions, CD59aKO mice had higher levels than WT for GFAP immunostaining in Muller cells, mRNA and protein levels of two ER-stress markers, and neurotrophic factors. The reduction in photon capture, together with the neurotrophic factor upregulation, may explain the structural and functional protection against LD in the CD59aKO.	[Song, Delu; Zhao, Liangliang; Bhuyan, Rupak; Lyubarsky, Arkady; Li, Yafeng; Kanu, Levi; Dunaief, Joshua L.] Univ Penn, Perelman Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Wilson, Brooks; Bandyopadhyay, Mausumi; Rohrer, Barbel] Med Univ South Carolina, Dept Ophthalmol, 171 Ashley Ave, Charleston, SC 29425 USA; [Zhao, Liangliang] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun, Jilin, Peoples R China; [Yu, Chen; Finnemann, Silvia C.] Fordham Univ, Dept Biol Sci, Ctr Canc Genet Dis & Gene Regulat, Bronx, NY 10458 USA; [Miwa, Takashi; Song, Wen-Chao] Univ Penn, Perelman Sch Med, Dept Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Rohrer, Barbel] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA	University of Pennsylvania; Pennsylvania Medicine; Medical University of South Carolina; Jilin University; Fordham University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Dunaief, JL (corresponding author), Univ Penn, Perelman Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.; Rohrer, B (corresponding author), Med Univ South Carolina, Dept Ophthalmol, 171 Ashley Ave, Charleston, SC 29425 USA.; Rohrer, B (corresponding author), Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA.	rohrer@musc.edu; jdunaief@upenn.edu	Yu, Chen/GPG-1530-2022	Yu, Chen/0000-0001-9651-9875; Song, Delu/0000-0002-9030-7211; Kanu, Levi/0000-0001-6428-4696	NIH [EY015240, CO6RR015455]; Research to Prevent Blindness; FM Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; National Center for Advancing Translational Sciences of the NIH [KL2TR001879]; National Institutes of Health [NIH R01EY019320, R01EY013295]; Department for Veteran Affairs merit award [RX000444]; Beckman Initiative for Macular Research; Research to Prevent Blindness (RPB), New York, NY; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001879] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320, R01EY013295, P30EY001583, R01EY015240] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); FM Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department for Veteran Affairs merit award; Beckman Initiative for Macular Research; Research to Prevent Blindness (RPB), New York, NY(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in the laboratory of J.D. by NIH EY015240, Research to Prevent Blindness, the FM Kirby Foundation, the Paul and Evanina Bell Mackall Foundation Trust, a gift in memory of Dr. Lee F. Mauger, and grant KL2TR001879 from the National Center for Advancing Translational Sciences of the NIH; in the laboratory of B.R. in part by the National Institutes of Health (NIH R01EY019320), a Department for Veteran Affairs merit award RX000444, the Beckman Initiative for Macular Research, an unrestricted grant to MUSC from Research to Prevent Blindness (RPB), New York, NY; and in the laboratory of S.C.F. by grants from the National Institutes of Health (R01EY013295) and the Beckman Initiative for Macular Research. B.R.'s animal studies were conducted in a facility constructed with support from the NIH CO6RR015455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in the laboratory of J.L.D. by NIH EY015240, Research to Prevent Blindness, the FM Kirby Foundation, the Paul and Evanina Bell Mackall Foundation Trust, a gift in memory of Dr. Lee F. Mauger, and grant KL2TR001879 from the National Center for Advancing Translational Sciences of the NIH; in the laboratory of B.R. in part by the National Institutes of Health (NIH R01EY019320), a Department for Veteran Affairs merit award RX000444, the Beckman Initiative for Macular Research, an unrestricted grant to MUSC from Research to Prevent Blindness (RPB), New York, NY; and in the laboratory of S.C.F. by grants from the National Institutes of Health (R01EY013295) and the Beckman Initiative for Macular Research. B.R.'s animal studies were conducted in a facility constructed with support from the NIH C06RR015455.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Bandyopadhyay M, 2010, MOL VIS, V16, P1178; Bayer AU, 2001, VISION RES, V41, P2173, DOI 10.1016/S0042-6989(01)00103-1; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORA NS, 1993, INVEST OPHTH VIS SCI, V34, P3579; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Chollangi S, 2009, NEUROBIOL DIS, V34, P535, DOI 10.1016/j.nbd.2009.03.012; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Ebrahimi KB, 2014, ADV EXP MED BIOL, V801, P259, DOI 10.1007/978-1-4614-3209-8_33; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Hadziahmetovic M, 2012, INVEST OPHTH VIS SCI, V53, P5231, DOI 10.1167/iovs.12-10204; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Herrmann P, 2015, NEUROBIOL AGING, V36, P2637, DOI 10.1016/j.neurobiolaging.2015.05.019; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kunchithapautham K, 2011, J BIOL CHEM, V286, P23717, DOI 10.1074/jbc.M110.214593; Liu CD, 1998, J NEUROSCI, V18, P1337; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; MEDOF ME, 1985, P NATL ACAD SCI USA, V82, P2980, DOI 10.1073/pnas.82.9.2980; Miwa T, 2002, BLOOD, V99, P3707, DOI 10.1182/blood.V99.10.3707; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; NICHOLSONWELLER A, 1983, P NATL ACAD SCI-BIOL, V80, P5066, DOI 10.1073/pnas.80.16.5066; Noell W K, 1966, Invest Ophthalmol, V5, P450; Ohlsson M, 2006, NEUROSCI LETT, V394, P179, DOI 10.1016/j.neulet.2005.10.037; PANGBURN MK, 1983, P NATL ACAD SCI-BIOL, V80, P5430, DOI 10.1073/pnas.80.17.5430; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; Powell MB, 1997, J IMMUNOL, V158, P1692; Qian YM, 2000, J IMMUNOL, V165, P2528, DOI 10.4049/jimmunol.165.5.2528; Radu RA, 2014, J BIOL CHEM, V289, P9113, DOI 10.1074/jbc.M114.548669; Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282; ROSSE WF, 1985, CLIN HAEMATOL, V14, P105; Schnabolk G, 2014, EXP EYE RES, V129, P18, DOI 10.1016/j.exer.2014.10.005; Sethna Saumil, 2013, Methods Mol Biol, V935, P245, DOI 10.1007/978-1-62703-080-9_17; SHAHINFAR S, 1991, CURR EYE RES, V10, P47, DOI 10.3109/02713689109007610; Song DL, 2014, AM J PATHOL, V184, P2721, DOI 10.1016/j.ajpath.2014.06.010; Song DL, 2014, INVEST OPHTH VIS SCI, V55, P4525, DOI 10.1167/iovs.14-14568; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Sulewski M., 2015, ARVO; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Torres PMM, 2001, J NEUROIMMUNOL, V117, P43, DOI 10.1016/S0165-5728(01)00303-4; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; Vogt SD, 2006, EXP EYE RES, V83, P834, DOI 10.1016/j.exer.2006.04.002; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wilson RB, 2007, INVEST OPHTH VIS SCI, V48, P2877, DOI 10.1167/iovs.06-1079; Wong P, 2001, CURR EYE RES, V23, P157, DOI 10.1076/ceyr.23.3.157.5463; Woodell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067894; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yu MZ, 2012, INVEST OPHTH VIS SCI, V53, P7684, DOI 10.1167/iovs.12-10069	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166348	10.1371/journal.pone.0166348	http://dx.doi.org/10.1371/journal.pone.0166348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893831	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400022
J	Costa, CP; Elias-Neto, M; Falcon, T; Dallacqua, RP; Martins, JR; Bitondi, MMG				Costa, Claudineia Pereira; Elias-Neto, Moyses; Falcon, Tiago; Dallacqua, Rodrigo Pires; Martins, Juliana Ramos; Gentile Bitondi, Marcia Maria			RNAi-Mediated Functional Analysis of Bursicon Genes Related to Adult Cuticle Formation and Tanning in the Honeybee, Apis mellifera	PLOS ONE			English	Article							ECDYSIS BEHAVIOR; WING EXPANSION; MANDUCA-SEXTA; CELL-DEATH; PROTEIN; HORMONE; RECEPTOR; EXPRESSION; SCLEROTIZATION; IDENTIFICATION	Bursicon is a heterodimeric neurohormone that acts through a G protein-coupled receptor named rickets (rk), thus inducing an increase in cAMP and the activation of tyrosine hydroxylase, the rate-limiting enzyme in the cuticular tanning pathway. In insects, the role of bursicon in the post-ecdysial tanning of the adult cuticle and wing expansion is well characterized. Here we investigated the roles of the genes encoding the bursicon subunits during the adult cuticle development in the honeybee, Apis mellifera. RNAi-mediated knockdown of AmBurs a and AmBurs beta bursicon genes prevented the complete formation and tanning (melanization/sclerotization) of the adult cuticle. A thinner, much less tanned cuticle was produced, and ecdysis toward adult stage was impaired. Consistent with these results, the knockdown of bursicon transcripts also interfered in the expression of genes encoding its receptor, AmRk, structural cuticular proteins, and enzymes in the melanization/sclerotization pathway, thus evidencing roles for bursicon in adult cuticle formation and tanning. Moreover, the expression of AmBurs a, AmBurs beta and AmRk is contingent on the declining ecdysteroid titer that triggers the onset of adult cuticle synthesis and deposition. The search for transcripts of AmBurs a, AmBurs beta and candidate targets in RNA-seq libraries prepared with brains and integuments strengthened our data on transcript quantification through RT-qPCR. Together, our results support our premise that bursicon has roles in adult cuticle formation and tanning, and are in agreement with other recent studies pointing for roles during the pharate-adult stage, in addition to the classical post-ecdysial ones.	[Costa, Claudineia Pereira; Falcon, Tiago; Martins, Juliana Ramos] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Costa, Claudineia Pereira; Elias-Neto, Moyses; Gentile Bitondi, Marcia Maria] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Dallacqua, Rodrigo Pires] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul	Bitondi, MMG (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil.	mmgbit@usp.br	Lopes, Tiago F/G-3409-2016; Lopes, Tiago Falcon/U-5883-2019; Costa, Claudineia/G-7267-2017; Martins, Juliana Ramos/AAD-4694-2021; Bitondi, Marcia MG/E-8014-2012; Elias-Neto, Moysés/B-6437-2012; Dallacqua, Rodrigo P/I-6592-2012; Martins, Juliana Ramos/F-6726-2012	Lopes, Tiago F/0000-0002-8936-0381; Costa, Claudineia/0000-0002-5458-4502; Martins, Juliana Ramos/0000-0002-7185-6477; Bitondi, Marcia MG/0000-0002-5619-6378; 	FAPESP (Sao Paulo Research Foundation, Brazil) [2010/16380-9, 2014/13136-0]; CNPq (National Counsel of Technological and Scientific Development Process) [134995/2010-4]; FAPESP [2009/15635-6]	FAPESP (Sao Paulo Research Foundation, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Counsel of Technological and Scientific Development Process); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided to MMGB (Processes 2010/16380-9; 2014/13136-0) by FAPESP (Sao Paulo Research Foundation, Brazil). FAPESP (Process 2009/15635-6) and CNPq (National Counsel of Technological and Scientific Development Process 134995/2010-4) provided fellowships to CPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034510; An SH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-424; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Andrews S., 2010, FASTQC QUALITY CONTR; Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Bai H, 2010, DEV BIOL, V344, P248, DOI 10.1016/j.ydbio.2010.05.003; Baker JD, 2002, J EXP BIOL, V205, P2555; Chung JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046299; COTTRELL CB, 1962, J EXP BIOL, V39, P395; Cunha AD, 2015, J INSECT PHYSL, V51, P1135; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dong SZ, 2015, ARCH INSECT BIOCHEM, V89, P87, DOI 10.1002/arch.21227; Elias-Neto M, 2009, APIDOLOGIE, V40, P29, DOI 10.1051/apido:2008064; Eriksen KK, 2000, GENOME RES, V10, P924, DOI 10.1101/gr.10.7.924; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; FRAENKEL G., 1965, J INSECT PHYSIOL, V11, P513, DOI 10.1016/0022-1910(65)90137-X; FRAENKEL G, 1966, SCIENCE, V151, P91, DOI 10.1126/science.151.3706.91; Garcia-Hughes G, 2015, MECH DEVELOP, V138, P349, DOI 10.1016/j.mod.2015.07.008; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HASSON C, 1987, ARCH INSECT BIOCHEM, V5, P13, DOI 10.1002/arch.940050103; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Henrich VC, 2012, INSECT ENDOCRINOLOGY, P177; Hepburn H.R., 1985, P1; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Jarosch A, 2011, J INSECT PHYSIOL, V57, P851, DOI 10.1016/j.jinsphys.2011.03.013; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Lahr EC, 2012, J NEUROSCI, V32, P6819, DOI 10.1523/JNEUROSCI.5301-11.2012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKE M, 1969, Tissue and Cell, V1, P555, DOI 10.1016/S0040-8166(69)80021-2; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Loveall BJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-92; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; MESSNER B, 1991, ZOOL JAHRB ALLG ZOOL, V95, P31; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Soares MPM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-576; Peabody NC, 2008, J NEUROSCI, V28, P14379, DOI 10.1523/JNEUROSCI.2842-08.2008; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; SELIGMAN M, 1969, J INSECT PHYSIOL, V15, P553, DOI 10.1016/0022-1910(69)90254-6; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Soares MPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020513; Song Q., 2012, INSECT ENDOCRINOLOGY, P93; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; THOMPSON PR, 1978, J APICULT RES, V17, P32, DOI 10.1080/00218839.1978.11099896; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Loy T, 2007, GEN COMP ENDOCR, V153, P59, DOI 10.1016/j.ygcen.2006.12.004; Veverytsa L, 2011, DEVELOPMENT, V138, P3147, DOI 10.1242/dev.064105; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X	68	13	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167421	10.1371/journal.pone.0167421	http://dx.doi.org/10.1371/journal.pone.0167421			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907116	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700150
J	Lee, YS; Song, JS; Hwang, M; Lim, B; Joung, B; Pak, HN				Lee, Young-Seon; Song, Jun-Seop; Hwang, Minki; Lim, Byounghyun; Joung, Boyoung; Pak, Hui-Nam			A New Efficient Method for Detecting Phase Singularity in Cardiac Fibrillation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; VENTRICULAR-FIBRILLATION; FOCAL IMPULSE; MECHANISMS; ROTORS; LOCALIZATION; ARRHYTHMIA; DYNAMICS; ABLATION; BREAKUP	Background The point of phase singularity (PS) is considered to represent a spiral wave core or a rotor in cardiac fibrillation. Computational efficiency is important for detection of PS in clinical electrophysiology. We developed a novel algorithm for highly efficient and robust detection of PS. Methods In contrast to the conventional method, which calculates PS based on the line integral of the phase around a PS point equal to +/- 2 pi (the Iyer-Gray method), the proposed algorithm (the location-centric method) looks for the phase discontinuity point at which PS actually occurs. We tested the efficiency and robustness of these two methods in a two-dimensional mathematical model of atrial fibrillation (AF), with and without remodeling of ionic currents. Results 1. There was a significant association, in terms of the Hausdorff distance (3.30 +/- 0.0 mm), between the PS points measured using the Iyer-Gray and location-centric methods, with almost identical PS trajectories generated by the two methods. 2. For the condition of electrical remodeling of AF (0.3 x I-CaL), the PS points calculated by the two methods were satisfactorily co-localized (with the Hausdorff distance of 1.64 +/- 0.09 mm). 3. The proposed location-centric method was substantially more efficient than the Iyer-Gray method, with a 28.6-fold and 28.2-fold shorter run times for the control and remodeling scenarios, respectively. Conclusion We propose a new location-centric method for calculating PS, which is robust and more efficient compared with the conventionally used method.	[Lee, Young-Seon; Song, Jun-Seop; Hwang, Minki; Lim, Byounghyun; Joung, Boyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Seoul, South Korea	Yonsei University; Yonsei University Health System	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Seoul, South Korea.	hnpak@yuhs.ac	Lee, Young-Seon/L-3636-2013; Pak, Hui-Nam/C-4266-2015	Lee, Young-Seon/0000-0003-1396-2172; Song, Jun-Seop/0000-0002-5886-4210; Pak, Hui-Nam/0000-0002-3256-3620; Joung, Boyoung/0000-0001-9036-7225	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2059391]; Korea Health 21 RD Project [A085136]; Ministry of Education [2014R1A1A2059391]	Korea Health 21 R&D Project, Ministry of Health and Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health 21 RD Project; Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], the Basic Science Research Program run by the National Research Foundation of Korea (NRF) (http://www.nrf.re krinteng_cms/) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.kr/nrf.eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants (A085136) from the Korea Health 21 R&D Project and the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (NRF-2013R1A2A2A01014634) and the Ministry of Education (2014R1A1A2059391).	Arevalo HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11437; Bayer JD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00108; Berenfeld O, 2014, CARDIOL CLIN, V32, P495, DOI 10.1016/j.ccl.2014.07.001; Bray MA, 2001, J CARDIOVASC ELECTR, V12, P716, DOI 10.1046/j.1540-8167.2001.00716.x; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gray RA, 2009, CHAOS, V19, DOI 10.1063/1.3204256; Haissaguerre M, 2006, CIRCULATION, V113, P616, DOI 10.1161/CIRCULATIONAHA.105.546648; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Hwang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149695; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; Keener JP, 2009, MATH PHYSL; Krummen DE, 2015, J THORAC DIS, V7, P142, DOI 10.3978/j.issn.2072-1439.2014.11.15; Kuklik P, 2015, IEEE T BIO-MED ENG, V62, P296, DOI 10.1109/TBME.2014.2350029; Lee YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150779; Liu YB, 2003, J CARDIOVASC ELECTR, V14, P1103, DOI 10.1046/j.1540-8167.2003.03218.x; McDowell KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117110; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Moreno J, 2004, REV ESP CARDIOL, V57, P69; Nakagawa H, 1998, CIRCULATION, V98, P458, DOI 10.1161/01.CIR.98.5.458; Narayan SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046034; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Pak HN, 2003, AM J PHYSIOL-HEART C, V285, pH2704, DOI 10.1152/ajpheart.00366.2003; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Qu ZL, 2000, ANN BIOMED ENG, V28, P755, DOI 10.1114/1.1289474; Quintanilla JG, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.002481; Roes SD, 2009, CIRC-CARDIOVASC IMAG, V2, P183, DOI 10.1161/CIRCIMAGING.108.826529; Umapathy K, 2010, CIRC-ARRHYTHMIA ELEC, V3, P105, DOI 10.1161/CIRCEP.110.853804; Ustrell X, 2010, CURR CARDIOL REV, V6, P175, DOI 10.2174/157340310791658721; Valderrabano M, 2003, CIRCULATION, V108, P354, DOI 10.1161/01.CIR.0000080322.67408.B4; Winfree A.T., 1987, TIME BREAKS 3 DIMENS, V14; Zahid S, 2016, CARDIOVASC RES, V110, P443, DOI 10.1093/cvr/cvw073; Zipes DP, 2014, CARDIAC ELECTROPHYSI, Vxxvi; Zou RQ, 2002, CHAOS, V12, P764, DOI 10.1063/1.1497505	42	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167567	10.1371/journal.pone.0167567	http://dx.doi.org/10.1371/journal.pone.0167567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907144	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700197
J	Montana, G; Lampiasi, N				Montana, Giovanna; Lampiasi, Nadia			Substance P Induces HO-1 Expression in RAW 264.7 Cells Promoting Switch towards M2-Like Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTORS; HEME OXYGENASE-1 EXPRESSION; HUMAN MONOCYTES; CYTOKINE PRODUCTION; GENE-EXPRESSION; CARBON-MONOXIDE; UP-REGULATION; TNF-ALPHA; INHIBITION	Substance P (SP) is a neuropeptide that mediates many physiological as well as inflammatory responses. Recently, SP has been implicated in the resolution of inflammation through induction of M2 macrophages phenotype. The shift between M1-like and M2-like, allowing the resolution of inflammatory processes, also takes place by means of hemeoxygenase-1 (HO-1). HO-1 is induced in response to oxidative stress and inflammatory stimuli and modulates the immune response through macrophages polarisation. SP induces HO-1 expression in human periodontal ligament (PDL), the latter potentially plays a role in cytoprotection. We demonstrated that SP promotes M2-like phenotype from resting as well as from M1 macrophages. Indeed, SP triggers the production of interleukine-10 (IL-10), interleukine-4 (IL-4) and arginase-1 (Arg1) without nitric oxide (NO) generation. In addition, SP increases HO-1 expression in a dose- and time-dependent manner. Here we report that SP, without affecting cell viability, significantly reduces the production of pro-inflammatory cytokines and enzymes, such as tumor necrosis factor-alpha (TNF-alpha), interleukine-6 (IL-6), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and ameliorates migration and phagocytic properties in LPS-stimulated RAW 264.7 cells. M2-like conversion required retention of NF-kappa B p65 into the cytoplasm and HO-1 induced expression. Silencing of the HO-1 mRNA expression reversed the induction of pro-inflammatory cytokines in RAW 264.7 stimulated by LPS and down-regulated anti-inflammatory hallmarks of M2 phenotype. In conclusion, our data show that SP treatment might be associated with anti-inflammatory effects in LPS-stimulated RAW 264.7 cells by suppressing NF-kappa B activation and inducing HO-1 expression.	[Montana, Giovanna; Lampiasi, Nadia] CNR, Ist Biomed & Immunol Mol Alberto Monroy, Via Ugo La Malfa, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Lampiasi, N (corresponding author), CNR, Ist Biomed & Immunol Mol Alberto Monroy, Via Ugo La Malfa, Palermo, Italy.	lampiasi@ibim.cnr.it	Lampiasi, Nadia/AAR-8451-2020; Lampiasi, Nadia/AAC-8751-2019	Lampiasi, Nadia/0000-0002-6831-4781; Lampiasi, Nadia/0000-0002-6831-4781; Montana, Giovanna/0000-0003-3368-4114				Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Amoruso A, 2008, BRIT J PHARMACOL, V154, P144, DOI 10.1038/bjp.2008.50; Azzolina A, 2003, BBA-MOL CELL RES, V1643, P75, DOI 10.1016/j.bbamcr.2003.09.003; Camara NOS, 2005, FREE RADICAL BIO MED, V38, P426, DOI 10.1016/j.freeradbiomed.2004.11.019; Canton J, 2014, J LEUKOCYTE BIOL, V96, P729, DOI 10.1189/jlb.1MR0114-021R; Castagliuolo I, 2002, BRIT J PHARMACOL, V136, P271, DOI 10.1038/sj.bjp.0704697; Chinetti G, 2003, CURR OPIN LIPIDOL, V14, P459, DOI 10.1097/00041433-200310000-00006; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; FAN TPD, 1993, BRIT J PHARMACOL, V110, P43, DOI 10.1111/j.1476-5381.1993.tb13769.x; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Ho WZ, 1997, J IMMUNOL, V159, P5654; Hong HS, 2014, BIOCHEM BIOPH RES CO, V453, P179, DOI 10.1016/j.bbrc.2014.09.090; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Janelsins BM, 2009, BLOOD, V113, P3017, DOI 10.1182/blood-2008-06-163121; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang MH, 2012, NEUROREPORT, V23, P786, DOI 10.1097/WNR.0b013e3283572206; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Lampiasi N, 2014, BBA-MOL CELL RES, V1843, P2662, DOI 10.1016/j.bbamcr.2014.07.010; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008; Liu W, 2001, J CELL BIOCHEM, V83, P271, DOI 10.1002/jcb.1234; LOTZ M, 1987, SCIENCE, V235, P893, DOI 10.1126/science.2433770; Lucrezi JD, 2014, INT IMMUNOPHARMACOL, V21, P44, DOI 10.1016/j.intimp.2014.04.007; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Ndisang JF, 2010, AM J PHYSIOL-REG I, V298, pR211, DOI 10.1152/ajpregu.91000.2008; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Rameshwar P, 1997, CLIN IMMUNOL IMMUNOP, V85, P129, DOI 10.1006/clin.1997.4446; Reddy SA, 2015, INT IMMUNOPHARMACOL, V24, P440, DOI 10.1016/j.intimp.2014.12.037; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Sun J, 2008, AM J PHYSIOL-CELL PH, V295, pC679, DOI 10.1152/ajpcell.00042.2008; Sun J, 2009, FASEB J, V23, P997, DOI 10.1096/fj.08-121756; Sung J, 2014, NUTR RES PRACT, V8, P352, DOI 10.4162/nrp.2014.8.4.352; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tu TH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/290708; ZICHE M, 1990, BRIT J PHARMACOL, V100, P11, DOI 10.1111/j.1476-5381.1990.tb12043.x	49	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167420	10.1371/journal.pone.0167420	http://dx.doi.org/10.1371/journal.pone.0167420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907187	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700149
J	Persinger, MA; Rouleau, N; Murugan, NJ; Tessaro, LWE; Costa, JN				Persinger, Michael A.; Rouleau, Nicolas; Murugan, Nirosha J.; Tessaro, Lucas W. E.; Costa, Justin N.			When Is the Brain Dead? Living-Like Electrophysiological Responses and Photon Emissions from Applications of Neurotransmitters in Fixed Post-Mortem Human Brains	PLOS ONE			English	Article							GAMMA OSCILLATIONS; MEMORY IMPAIRMENT; THETA; CORTEX; CONSCIOUSNESS; ACTIVATION; REGION; RAT; CA1	The structure of the post-mortem human brain can be preserved by immersing the organ within a fixative solution. Once the brain is perfused, cellular and histological features are maintained over extended periods of time. However, functions of the human brain are not assumed to be preserved beyond death and subsequent chemical fixation. Here we present a series of experiments which, together, refute this assumption. Instead, we suggest that chemical preservation of brain structure results in some retained functional capacity. Patterns similar to the living condition were elicited by chemical and electrical probes within coronal and sagittal sections of human temporal lobe structures that had been maintained in ethanol-formalin-acetic acid. This was inferred by a reliable modulation of frequency-dependent microvolt fluctuations. These weak microvolt fluctuations were enhanced by receptor-specific agonists and their precursors (i.e., nicotine, 5-HTP, and L-glutamic acid) as well as attenuated by receptor-antagonists (i.e., ketamine). Surface injections of 10 nM nicotine enhanced theta power within the right parahippocampal gyrus without any effect upon the ipsilateral hippocampus. Glutamate-induced high-frequency power densities within the left parahippocampal gyrus were correlated with increased photon counts over the surface of the tissue. Heschl's gyrus, a transverse convexity on which the primary auditory cortex is tonotopically represented, retained frequency-discrimination capacities in response to sweeps of weak (2 mu V) square-wave electrical pulses between 20 Hz and 20 kHz. Together, these results suggest that portions of the post-mortem human brain may retain latent capacities to respond with potential life-like and virtual properties.	[Persinger, Michael A.; Rouleau, Nicolas; Murugan, Nirosha J.] Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada; [Persinger, Michael A.; Tessaro, Lucas W. E.] Laurentian Univ, Human Studies Program, Sudbury, ON, Canada; [Persinger, Michael A.; Costa, Justin N.] Laurentian Univ, Dept Biol, Sudbury, ON, Canada; [Persinger, Michael A.; Rouleau, Nicolas; Murugan, Nirosha J.; Tessaro, Lucas W. E.; Costa, Justin N.] Laurentian Univ, Behav Neurosci Program, Sudbury, ON, Canada	Laurentian University; Laurentian University; Laurentian University; Laurentian University	Persinger, MA (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Human Studies Program, Sudbury, ON, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Behav Neurosci Program, Sudbury, ON, Canada.	mpersinger@laurentian.ca		Tessaro, Lucas/0000-0002-4876-9615				Accardo A, 1997, BIOL CYBERN, V77, P339, DOI 10.1007/s004220050394; Baars BJ, 2012, PHYS LIFE REV, V9, P285, DOI 10.1016/j.plrev.2012.07.001; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Carhart-Harris RL, 2016, P NATL ACAD SCI USA, V113, P4853, DOI 10.1073/pnas.1518377113; Costa J, 2016, NEURO MED, V7, P49; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; Dotta BT, 2012, NEUROSCI LETT, V513, P151, DOI 10.1016/j.neulet.2012.02.021; Egert U, 1998, BRAIN RES PROTOC, V2, P229, DOI 10.1016/S1385-299X(98)00013-0; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Grene MG, 1978, SPINOZA COLLECTION C; Hameroff S, 2014, PHYS LIFE REV, V11, P39, DOI 10.1016/j.plrev.2013.08.002; HARRISON PTC, 1984, LAB ANIM, V18, P325, DOI 10.1258/002367784780865324; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUMMEL E, 1986, ASTRON ASTROPHYS, V166, P97; JENSEN JV, 1988, BRIT J HIST SCI, V21, P161, DOI 10.1017/S0007087400024742; Kiernan J.A., 2000, MICROSC TODAY, V1, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; Kobayashi M, 1999, NEUROSCI RES, V34, P103, DOI 10.1016/S0168-0102(99)00040-1; Mach E., 1919, SCI MECH CRITICAL HI; Merker B, 2013, NEUROSCI BIOBEHAV R, V37, P401, DOI 10.1016/j.neubiorev.2013.01.013; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Pazos A, 1991, RECEPTORS HUMAN NERV, P74; Persinger, 2011, J CONSCIOUS EXPLOR R, V2, P1463; Persinger MA, 2007, INT J NEUROSCI, V117, P157, DOI 10.1080/00207450500535784; Persinger M.A., 2010, J CONSCIOUSNESS EXPL, V1, P808; PERSINGER MA, 1979, BEHAV NEURAL BIOL, V25, P380, DOI 10.1016/S0163-1047(79)90448-5; Persinger MA., 2013, WORLD J NEURO, V3, P10, DOI [10.4236/wjns.2013.31002, DOI 10.4236/WJNS.2013.31002]; Persinger MA, 2015, J SIGNAL INFORM PROC, V6, P153, DOI DOI 10.4236/JSIP.2015.62015; Persinger MA, 2015, J SYS INTEGRAT NEURO, V1, P55; Persinger MA, 2014, NAT HAZARDS, V70, P501, DOI 10.1007/s11069-013-0827-3; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Rouleau N, 2016, EPILEPSY BEHAV, V60, P181, DOI 10.1016/j.yebeh.2016.04.028; Saroka KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146595; Saroka KS, 2014, NEUROSCI LETT, V560, P126, DOI 10.1016/j.neulet.2013.11.024; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SERAFETINIDES EA, 1965, NEUROPSYCHOLOGIA, V3, P69, DOI 10.1016/0028-3932(65)90019-9; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Tagliazucchi E, 2016, CURR BIOL, V26, P1043, DOI 10.1016/j.cub.2016.02.010; Tang RD, 2014, J PHOTOCH PHOTOBIO B, V139, P71, DOI 10.1016/j.jphotobiol.2013.12.008; Tegmark M, 2000, PHYS REV E, V61, P4194, DOI 10.1103/PhysRevE.61.4194; Wijdicks EFM, 2010, NEUROLOGY, V75, P77, DOI 10.1212/WNL.0b013e3181e62194; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	49	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167231	10.1371/journal.pone.0167231	http://dx.doi.org/10.1371/journal.pone.0167231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907050	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700098
J	Zhang, B; Xia, Y; Wen, XH; Wang, XH; Yang, YF; Zhou, JZ; Zhang, Y				Zhang, Bing; Xia, Yu; Wen, Xianghua; Wang, Xiaohui; Yang, Yunfeng; Zhou, Jizhong; Zhang, Yu			The Composition and Spatial Patterns of Bacterial Virulence Factors and Antibiotic Resistance Genes in 19 Wastewater Treatment Plants	PLOS ONE			English	Article							ACTIVATED-SLUDGE; DIVERSITY; PATHOGENS; DISSEMINATION; GEOCHIP; COMMUNITIES; TEMPERATURE; MECHANISMS; MICROARRAY; REMOVAL	Bacterial pathogenicity and antibiotic resistance are of concern for environmental safety and public health. Accumulating evidence suggests that wastewater treatment plants (WWTPs) are as an important sink and source of pathogens and antibiotic resistance genes (ARGs). Virulence genes (encoding virulence factors) are good indicators for bacterial pathogenic potentials. To achieve a comprehensive understanding of bacterial pathogenic potentials and antibiotic resistance in WWTPs, bacterial virulence genes and ARGs in 19 WWTPs covering a majority of latitudinal zones of China were surveyed by using GeoChip 4.2. A total of 1610 genes covering 13 virulence factors and 1903 genes belonging to 11 ARG families were detected respectively. The bacterial virulence genes exhibited significant spatial distribution patterns of a latitudinal biodiversity gradient and a distance-decay relationship across China. Moreover, virulence genes tended to coexist with ARGs as shown by their strongly positive associations. In addition, key environmental factors shaping the overall virulence gene structure were identified. This study profiles the occurrence, composition and distribution of virulence genes and ARGs in current WWTPs in China, and uncovers spatial patterns and important environmental variables shaping their structure, which may provide the basis for further studies of bacterial virulence factors and antibiotic resistance in WWTPs.	[Zhang, Bing; Xia, Yu; Wen, Xianghua; Wang, Xiaohui; Yang, Yunfeng; Zhou, Jizhong] Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing, Peoples R China; [Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA USA; [Zhang, Yu] Chinese Acad Sci, State Key Lab Environm Aquat Chem, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China	Tsinghua University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Wen, XH (corresponding author), Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing, Peoples R China.	xhwen@tsinghua.edu.cn	wen, xianghua/A-7551-2015; Zhang, Bing/AAH-8513-2021; 吴, 昊/AAB-1620-2020	Zhang, Bing/0000-0002-1213-5151; 	NSFC [51678335]; State Key Joint Laboratory of Environment Simulation and Pollution Control [15L03ESPC]; Tsinghua University Initiative Scientific Research Program [20161080112]	NSFC(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control; Tsinghua University Initiative Scientific Research Program	This study was supported by the NSFC (51678335), State Key Joint Laboratory of Environment Simulation and Pollution Control (15L03ESPC) and Tsinghua University Initiative Scientific Research Program (No.20161080112).	Berglund Bjorn, 2015, Infection Ecology & Epidemiology, V5, P28564, DOI 10.3402/iee.v5.28564; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Chan YK, 2013, P NATL ACAD SCI USA, V110, P8990, DOI 10.1073/pnas.1300643110; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies JE, 1997, CIBA F SYMP, V207, P15; Dowle EJ, 2013, HEREDITY, V110, P501, DOI 10.1038/hdy.2013.4; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Handzlik J, 2013, ANTIBIOTICS-BASEL, V2, P28, DOI 10.3390/antibiotics2010028; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Ju F, 2016, WATER RES, V91, P1, DOI 10.1016/j.watres.2015.11.071; Koczura R, 2012, SCI TOTAL ENVIRON, V414, P680, DOI 10.1016/j.scitotenv.2011.10.036; Koleff P, 2001, ECOGRAPHY, V24, P341, DOI 10.1034/j.1600-0587.2001.240312.x; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Lee DY, 2006, J MICROBIOL METH, V65, P453, DOI 10.1016/j.mimet.2005.09.008; Lee YJ, 2013, ISME J, V7, P1974, DOI 10.1038/ismej.2013.88; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lindberg R, 2004, CHEMOSPHERE, V57, P1479, DOI 10.1016/j.chemosphere.2004.09.015; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Miller SM, 2008, APPL ENVIRON MICROB, V74, P2200, DOI 10.1128/AEM.01962-07; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Toze S, 1997, MICROBIAL PATHOGENS; Tu Qichao, 2014, Mol Ecol Resour, V14, P914, DOI 10.1111/1755-0998.12239; Wang X, 2016, APPL ENVIRON MICROB; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Yang YF, 2014, ISME J, V8, P430, DOI 10.1038/ismej.2013.146; Yildiz FH, 2007, RES MICROBIOL, V158, P195, DOI 10.1016/j.resmic.2006.12.005; Zhang T, 2015, APPL MICROBIOL BIOT, V99, P5033, DOI 10.1007/s00253-015-6556-7; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhang Y, 2013, WATER RES, V47, P6298, DOI 10.1016/j.watres.2013.08.003; Zhao MX, 2014, ISME J, V8, P2045, DOI 10.1038/ismej.2014.46; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 2015, MBIO, V6, DOI 10.1128/mBio.02288-14; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	47	18	18	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167422	10.1371/journal.pone.0167422	http://dx.doi.org/10.1371/journal.pone.0167422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907117	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700151
J	Zhu, D; Wang, Y; Yang, XR; Yang, DY; Guo, K; Guo, YY; Jing, XX; Pan, CW				Zhu, Dan; Wang, Yan; Yang, Xianrong; Yang, Dayong; Guo, Kai; Guo, Yuanyuan; Jing, Xinxia; Pan, Chen-Wei			Pre- and Postcycloplegic Refractions in Children and Adolescents	PLOS ONE			English	Article							AGE-RELATED CATARACT; AXIAL LENGTH; ERRORS; MYOPIA; AUTOREFRACTION; REPEATABILITY; CYCLOPLEGIA; PREVALENCE; SINGAPORE	Purpose To determine the difference between cycloplegic and non-cycloplegic refractive error and its associated factors in Chinese children and adolescents with a high prevalence of myopia. Methods A school-based study including 1565 students aged 6 to 21 years was conducted in 2013 in Ejina, Inner Mongolia, China. Comprehensive eye examinations were performed. Pre-and postcycloplegic refractive error were measured using an auto-refractor. For cycloplegic refraction, one drop of topical 1.0% cyclopentolate was administered to each eye twice with a 5-minute interval and a third drop was administered 15 minutes after the second drop if the pupil size was less than 6 mm or if the pupillary light reflex was still present. Results Two drops of cyclopentolate were found to be sufficient in 59% of the study participants while the other 41% need an additional drop. The prevalence of myopia was 89.5% in participants aged over 12 years and 68.6% in those aged 12 years or younger (P<0.001). When myopia was defined as spherical equivalent (SE) of less than -0.5 diopter (D), the prevalence estimates were 76.7% (95% confidence interval [CI] 74.6-78.8) and 54.1% (95%Cl 51.6-56.6) before and after cycloplegic refraction, respectively. When hyperopia was defined as SE of more than 0.5D, the prevalence was only 2.8% (95%CI 1.9-3.6) before cycloplegic refraction while it was 15.5% (95%Cl 13.7-17.3) after cycloplegic refraction. Increased difference between cycloplegic and non-cycloplegic refractive error was associated with decreased intraocular pressures (P = 0.01). Conclusions Lack of cycloplegia in refractive error measurement was associated with significant misclassifications in both myopia and hyperopia among Chinese children and adolescents. Decreased intraocular pressure was related to a greater difference between cycloplegic and non-cycloplegic refractive error.	[Zhu, Dan; Wang, Yan; Yang, Xianrong; Yang, Dayong; Guo, Kai; Guo, Yuanyuan; Jing, Xinxia] Inner Mongolia Med Univ, Affiliated Hosp, Dept Ophthalmol, Hohhot, Inner Mongolia, Peoples R China; [Pan, Chen-Wei] Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Suzhou, Peoples R China	Inner Mongolia Medical University; Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613; Zhu, Dan/0000-0002-8402-8929	National Natural Science Foundation of China [81560165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant no. 81560165). The sponsor or funding organization had no role in the design or conduct of this research.; This study was funded by the National Natural Science Foundation of China (Grant No. 81560165). The sponsor or funding organization had no role in the design or conduct of this research.	Bailey MD, 2005, J CATARACT REFR SURG, V31, P1025, DOI 10.1016/j.jcrs.2004.12.040; Bullimore MA, 1998, OPTOMETRY VISION SCI, V75, P617, DOI 10.1097/00006324-199808000-00028; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P2456, DOI 10.1167/iovs.10-5441; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; Fotouhi A, 2012, ACTA OPHTHALMOL, V90, P380, DOI 10.1111/j.1755-3768.2010.01983.x; Guo K, 2015, INVEST OPHTH VIS SCI, V56, P1769, DOI 10.1167/iovs.14-15737; Holden B.A., 2016, OPHTHALMOLOGY; Hu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117482; Jenssen F, 2012, J GLAUCOMA, V21, P45, DOI 10.1097/IJG.0b013e31820277a9; MAUGER RR, 1984, AM J OPTOM PHYS OPT, V61, P28; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2015, ACTA OPHTHALMOL; Pan C-W, 2015, OPTOM VIS SCI; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P4498, DOI 10.1167/iovs.13-12271; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Read SA, 2010, BRIT J OPHTHALMOL, V94, P332, DOI 10.1136/bjo.2009.166355; Rudnicka AR, 2016, BR J OPHTHALMOL; Sanfilippo PG, 2014, ACTA OPHTHALMOL, V92, pE458, DOI 10.1111/aos.12388; Yang DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109355; Zhang MZ, 2000, OPTOMETRY VISION SCI, V77, P302, DOI 10.1097/00006324-200006000-00010; Zhao JL, 2004, OPTOMETRY VISION SCI, V81, P49, DOI 10.1097/00006324-200401000-00010	24	26	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167628	10.1371/journal.pone.0167628	http://dx.doi.org/10.1371/journal.pone.0167628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907165	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700214
J	Choi, SY; Piao, ZH; Jin, L; Kim, JH; Kim, GR; Ryu, Y; Lin, MQ; Kim, HS; Kee, HJ; Jeong, MH				Choi, Sin Young; Piao, Zhe Hao; Jin, Li; Kim, Jung Ha; Kim, Gwi Ran; Ryu, Yuhee; Lin, Ming Quan; Kim, Hyung-Seok; Kee, Hae Jin; Jeong, Myung Ho			Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; CARDIAC-HYPERTROPHY; NEPHROPATHY; INHIBITION; INJURY; RATS	Piceatannol, a resveratrol metabolite, is a phenolic compound found in red wine and grapes. We investigated the effect of piceatannol on renal fibrosis and histone deacetylase (HDAC) expression in a mouse model of unilateral ureteral obstruction (UUO). Fibrosis was established by UUO and piceatannol was intraperitoneally injected for 2 weeks. Piceatannol suppressed extracellular matrix (ECM) protein deposition including collagen type I and fibronectin as well as connective tissue growth factor (CTGF) and a-smooth muscle actin (a-SMA) in UUO kidneys. However, the expressions of epithelial-mesenchymal transition (EMT) marker genes, such as N-cadherin and E-cadherin, were not changed in the kidneys after UUO. Masson's trichrome staining and fluorescence immunostaining showed that piceatannol administration attenuated collagen deposition in UUO kidneys. HDAC1, HDAC4, HDAC5, HDAC6, and HDAC10 protein expression was upregulated in UUO kidneys, whereas that of HDAC8 was downregulated. Piceatannol treatment significantly reduced HDAC4 and HDAC5 protein expression. Further, piceatannol attenuated phosphorylation of p38 mitogen-activated protein kinase (p38-MAPK) in UUO kidneys, but not that of transforming growth factor beta1-Smad2/3. These results suggest that class I HDACs and class IIa/b HDACs are involved in renal fibrosis development. Piceatannol may be a beneficial therapeutic agent for treating renal fibrosis via reduction of HDAC4 and HDAC5 protein expression or suppression of the p38-MAPK signaling pathway.	[Choi, Sin Young; Jin, Li; Kim, Jung Ha; Kim, Gwi Ran; Ryu, Yuhee; Lin, Ming Quan; Kim, Hyung-Seok; Kee, Hae Jin; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea; [Piao, Zhe Hao] Jilin Univ, Hosp 2, Changchun, Peoples R China; [Jin, Li] Jilin Univ, Jilin Hosp, Changchun, Jilin, Peoples R China; [Lin, Ming Quan] Yanbian Univ Hosp, Jilin Yanbian, Peoples R China; [Kim, Hyung-Seok] Chonnam Natl Univ, Sch Med, Dept Forens Med, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Jilin University; Jilin University; Yanbian University; Chonnam National University	Kee, HJ; Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea.	sshjkee@empas.com; myungho@chollian.net	Kee, Hae Jin/ABC-9979-2021	Kee, Hae Jin/0000-0002-9774-4828	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1527]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01056798]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1527). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01056798). The funders had no role in study design, data collection and analysis,	Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi S. Y., 2016, J CELL MOL MED; Choi SY, 2015, VASC PHARMACOL, V72, P130, DOI 10.1016/j.vph.2015.04.006; Kanasaki Keizo, 2013, Front Endocrinol (Lausanne), V4, P7, DOI 10.3389/fendo.2013.00007; Kee HJ, 2013, KIDNEY BLOOD PRESS R, V37, P229, DOI 10.1159/000350148; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Khan S, 2015, EXP MOL PATHOL, V98, P230, DOI 10.1016/j.yexmp.2015.01.003; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Liu N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00121; Ma N, 2016, CURR TOP MED CHEM, V16, P415, DOI 10.2174/1568026615666150813145629; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Nakatsuji S, 1998, VET PATHOL, V35, P352, DOI 10.1177/030098589803500504; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Takenaka M, 2009, PROSTAG LEUKOTR ESS, V80, P263, DOI 10.1016/j.plefa.2009.03.002; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	17	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167340	10.1371/journal.pone.0167340	http://dx.doi.org/10.1371/journal.pone.0167340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902771	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100075
J	Habicht, ME; Bianucci, R; Buckley, SA; Fletcher, J; Bouwman, AS; Ohrstrom, LM; Seiler, R; Galassi, FM; Hajdas, I; Vassilika, E; Boni, T; Henneberg, M; Ruhli, FJ				Habicht, Michael E.; Bianucci, Raffaella; Buckley, Stephen A.; Fletcher, Joann; Bouwman, Abigail S.; Ohrstrom, Lena M.; Seiler, Roger; Galassi, Francesco M.; Hajdas, Irka; Vassilika, Eleni; Boni, Thomas; Henneberg, Maciej; Ruhli, Frank J.			Queen Nefertari, the Royal Spouse of Pharaoh Ramses II: A Multidisciplinary Investigation of the Mummified Remains Found in Her Tomb (QV66)	PLOS ONE			English	Article							STATURE; MUMMIES; BONES; URBAN	Queen Nefertari, the favourite Royal Consort of Pharaoh Ramses II (Ancient Egypt, New Kingdom, 19th Dynasty c. 1250 BC) is famous for her beautifully decorated tomb in the Valley of the Queens. Her burial was plundered in ancient times yet still many objects were found broken in the debris when the tomb was excavated. Amongst the found objects was a pair of mummified legs. They came to the Egyptian Museum in Turin and are henceforth regarded as the remains of this famous Queen, although they were never scientifically investigated. The following multidisciplinary investigation is the first ever performed on those remains. The results (radiocarbon dating, anthropology, paleopathology, genetics, chemistry and Egyptology) all strongly speak in favour of an identification of the remains as Nefertari's, although different explanations-albeit less likely-are considered and discussed. The legs probably belong to a lady, a fully adult individual, of about 40 years of age. The materials used for embalming are consistent with Ramesside mummification traditions and indeed all objects within the tomb robustly support the burial as of Queen Nefertari.	[Habicht, Michael E.; Bouwman, Abigail S.; Ohrstrom, Lena M.; Seiler, Roger; Galassi, Francesco M.; Boni, Thomas; Ruhli, Frank J.] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Bianucci, Raffaella] Univ Turin, Dept Publ Hlth & Paediat Sci, Legal Med Sect, Turin, Italy; [Bianucci, Raffaella] Fac Med Marseille, Lab Anthropol Bioculturelle Droit Et & Sante Ades, UMR 7258, Marseille, France; [Buckley, Stephen A.; Fletcher, Joann] Univ York, Dept Archaeol, York, N Yorkshire, England; [Buckley, Stephen A.; Fletcher, Joann] Univ York, Dept Archaeol, BioArCh, York, N Yorkshire, England; [Buckley, Stephen A.; Fletcher, Joann] Univ York, Dept Biol, BioArCh, York, N Yorkshire, England; [Buckley, Stephen A.; Fletcher, Joann] Univ York, Dept Chem, BioArCh, York, N Yorkshire, England; [Ohrstrom, Lena M.] Univ Zurich Hosp, Dept Radiol, Zurich, Switzerland; [Hajdas, Irka] Swiss Fed Inst Technol, Lab Ionenstrahlphys LIP, Ion Beam Phys, Zurich, Switzerland; [Vassilika, Eleni] Fdn Museo Egizio Turin, Turin, Italy; [Henneberg, Maciej] Univ Adelaide, Sch Med, Adelaide, SA, Australia	University of Zurich; University of Turin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of York - UK; University of York - UK; University of York - UK; University of York - UK; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Adelaide	Ruhli, FJ (corresponding author), Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland.	frank.ruehli@iem.uzh.ch	Bianucci, Raffaella/AAW-1433-2020; Habicht, Michael/AAF-4033-2020; Hajdas, Irka/C-6696-2011	Hajdas, Irka/0000-0003-2373-2725; Henneberg, Maciej/0000-0003-1941-2286; Galassi, Francesco Maria/0000-0001-8902-3142; Habicht, Michael/0000-0002-0193-9672	Swiss National Science Funded "Canopic Jar Project"	Swiss National Science Funded "Canopic Jar Project"	The study is part of the Swiss National Science Funded "Canopic Jar Project," also including investigation of mummies from Ancient Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bietak M, 2003, SCI VERSUS ARCHAEOLO, P22; Buckley SA, 2001, NATURE, V413, P837, DOI 10.1038/35101588; Colombini MP, 2000, STUD CONSERV, V45, P19, DOI 10.2307/1506680; CONNAN J, 1991, RECHERCHE, V22, P1503; Convert World, 2014, CONV WORLD SHOE SIZ; Dodson Aidan, 2004, COMPLETE ROYAL FAMIL; Friedrich WL, 2006, SCIENCE, V312, P548, DOI 10.1126/science.1125087; Gautschy R, 2016, NEW ASTRONOMICALLY B; Grilletto R, 1991, MAT ANTROPOLOGICI ZO; Habicht ME, 2015, AM J PHYS ANTHROPOL, DOI [10.1002/ajpa.22728, DOI 10.1002/ATPA.22728]; Hajdas I., 2014, TREATISE GEOCHEMISTR, P37; Hajdas I., 2008, EISZEITALTER GEGENWA, V57; Hari R, 1979, AEGYPTUS, V59, P3; Harrell JA, 2002, ARCHAEOMETRY, V44, P285, DOI 10.1111/1475-4754.t01-1-00060; Henneberg M, 1998, AM J HUM BIOL, V10, P73, DOI 10.1002/(SICI)1520-6300(1998)10:1<73::AID-AJHB9>3.0.CO;2-D; HENNEBERG M, 1995, AM J PHYS ANTHROPOL, V96, P1, DOI 10.1002/ajpa.1330960102; Henneberg M., 1998, CHORA METAPONTO NECR; Krishan Kewal, 2013, Foot (Edinb), V23, P54, DOI 10.1016/j.foot.2012.12.002; Kruttli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086251; Leblanc C, 1993, BIFAO, V93, P313; Leblanc C, 1993, NEFERTARI VALLE REGI; McDonald J.K., 1996, HOUSE ETERNITY TOMB; Nissenbaum A, 2013, ARCHAEOMETRY, V55, P563, DOI 10.1111/j.1475-4754.2012.00713.x; Pawar Rohini M, 2012, Foot (Edinb), V22, P31, DOI 10.1016/j.foot.2011.10.002; Pearson K, 1899, PHIL T R SOC LOND A, V192, P169, DOI [DOI 10.1098/RSTA.1899.0004, 10.1098/rsta.1899.0004]; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Reimer P. J., 2013, RADIOCARBON, V55; RULLKOTTER J, 1988, NATURWISSENSCHAFTEN, V75, P618, DOI 10.1007/BF00366476; Schiaparelli E, 1904, INVENTARIO MANOSCRIT; Schlogl HA, 2000, RAMSES, VII; Siddiqi N., 2013, EGYPT J FORENSIC SCI, V3, P8; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Synal HA, 2007, NUCL INSTRUM METH B, V259, P7, DOI 10.1016/j.nimb.2007.01.138; TROTTER M, 1977, AM J PHYS ANTHROPOL, V47, P355, DOI 10.1002/ajpa.1330470216; TROTTER M, 1958, AM J PHYS ANTHROPOL, V16, P79, DOI 10.1002/ajpa.1330160106; Vassilika E, 2012, MASTERPIECES MUSEO E; Veldmeijer A. J., 2011, TUTANKHAMUNS FOOTWEA; Veldmeijer AJ, 2009, HORIZON STUDIES EGYP, P554; Vogelsang-Eastwood Gillian M., 1995, KLEIDER PHARAOS VERW; Wacker L, 2010, NUCL INSTRUM METH B, V268, P931, DOI 10.1016/j.nimb.2009.10.067; Wasef S, 2015, J ARCHAEOL SCI-REP, V4, P355, DOI 10.1016/j.jasrep.2015.09.020; Willeitner J, 2010, ABU SIMBEL FELSENTEM; Willeitner J, 1997, GEMAHLIN RAMSES, VII; Zoffili E, 1992, KLEIDUNG SCHMUCK ALT	44	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							0166571	10.1371/journal.pone.0166571	http://dx.doi.org/10.1371/journal.pone.0166571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EE3FV	27902731	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000389474100028
J	Johnston, O; Johnston, F; Todd, J; Williamson, G				Johnston, Olivia; Johnston, Fay; Todd, John; Williamson, Grant			Community-Wide Distribution of a Catalytic Device to Reduce Winter Ambient Fine Particulate Matter from Residential Wood Combustion: A Field Study	PLOS ONE			English	Article							AIR-POLLUTION; EMISSIONS; SMOKE	Residential wood combustion is the main source of elevated concentrations of fine particulate matter (PM2.5) during winter in many towns of Tasmania, Australia. A commercially available firebox catalyst in Australia has previously been shown to reduce visible smoke emissions and the manufacturer reports reductions in particle emissions generated from individual wood heaters in laboratory settings. This study aimed to evaluate the potential for community-wide distribution of the catalyst to improve the ambient winter air quality in the field. The study was set in four rural towns in northern Tasmania with similar topography, population size, and proportion of houses using wood heaters for space heating. Hourly PM2.5 concentrations and meteorological conditions were monitored in all locations by fixed stations from May-September, 2013 and 2014. In June 2014, residents of one town, Perth, were offered a free catalyst for placement in their fireboxes. A general linear model evaluated the impact of the intervention using an indicator variable adjusted for hourly conditions of weather. Almost 80% of wood heater owners in Perth accepted a catalytic device. However, no significant changes in ambient PM2.5 concentrations were associated with the catalyst trial. Future community-level research should address maintenance of the catalyst in the firebox, and the adequacy of conditions that facilitate catalysed combustion in individual heaters.	[Johnston, Olivia] Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia; [Johnston, Fay; Williamson, Grant] Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia; [Todd, John] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA 6027, Australia; [Williamson, Grant] Univ Tasmania, Sch Biol Sci, Private Bag 55, Hobart, Tas 7001, Australia	University of Tasmania; University of Tasmania; Menzies Institute for Medical Research; Edith Cowan University; University of Tasmania	Johnston, O (corresponding author), Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia.	Olivia.Johnston@utas.edu.au	Williamson, Grant/J-7514-2014	Williamson, Grant/0000-0002-3469-7550; Johnston, Fay Helena/0000-0002-5150-8678	National Health and Medical Research Council (NHMRC) via the Centre for Air Quality Research and Evaluation; Fay Johnston	National Health and Medical Research Council (NHMRC) via the Centre for Air Quality Research and Evaluation(National Health and Medical Research Council (NHMRC) of Australia); Fay Johnston	This research was supported by the National Health and Medical Research Council (NHMRC) via the Centre for Air Quality Research and Evaluation. Funding was received by Fay Johnston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, COMMUNITY INTERVENTI; Bergauff M, 2008, INT J ENVIRON AN CH, V88, P473, DOI 10.1080/03067310701809110; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carno J, 1996, FUEL, V75, P959, DOI 10.1016/0016-2361(96)00047-6; Department of Environment and Heritage, 2004, NAT WOODH AUD PROGR; EPA Tasmania, 2016, BURN BRIGHT WINT; Government of Tasmania, 2007, ENV MAN POLL CONTR D; Hine DW, 2011, J ENVIRON PSYCHOL, V31, P282, DOI 10.1016/j.jenvp.2011.05.003; Hukkanen A, 2012, ATMOS ENVIRON, V50, P16, DOI 10.1016/j.atmosenv.2012.01.016; John I, 2012, 22 ENV PROT AUTH; John I, 2015, 31 ENV PROT AUTH; Johnston FH, 2013, BMJ-BRIT MED J, V346, P11; Kaivosoja T, 2012, CHEMOSPHERE, V88, P278, DOI 10.1016/j.chemosphere.2012.02.027; McGowan JA, 2002, AUST NZ J PUBL HEAL, V26, P23, DOI 10.1111/j.1467-842X.2002.tb00266.x; Noonan CW, 2012, OCCUP ENVIRON MED, V69, P354, DOI 10.1136/oemed-2011-100394; Sanhueza PA, 2009, J AIR WASTE MANAGE, V59, P1481, DOI 10.3155/1047-3289.59.12.1481; Smartburn Australia, 2016, DOES SMARTB WORK; Smith E. P., 2013, ENCY ENV, V1, P141, DOI DOI 10.1002/9780470057339.VAB001.PUB2; Todd J, 2013, P CASANZ C SYDN CLEA	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166677	10.1371/journal.pone.0166677	http://dx.doi.org/10.1371/journal.pone.0166677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902719	gold, Green Published			2022-12-27	WOS:000389474100031
J	Liu, J; Ando, H				Liu, Juan; Ando, Hiroshi			Metal Sounds Stiffer than Drums for Ears, but Not Always for Hands: Low-Level Auditory Features Affect Multisensory Stiffness Perception More than High-Level Categorical Information	PLOS ONE			English	Article							INTEGRATION; OBJECT; PSYCHOMECHANICS; CORTEX; SIZE	Most real-world events stimulate multiple sensory modalities simultaneously. Usually, the stiffness of an object is perceived haptically. However, auditory signals also contain stiff-ness-related information, and people can form impressions of stiffness from the different impact sounds of metal, wood, or glass. To understand whether there is any interaction between auditory and haptic stiffness perception, and if so, whether the inferred material category is the most relevant auditory information, we conducted experiments using a force-feedback device and the modal synthesis method to present haptic stimuli and impact sound in accordance with participants' actions, and to modulate low-level acoustic parameters, i.e., frequency and damping, without changing the inferred material categories of sound sources. We found that metal sounds consistently induced an impression of stiffer surfaces than did drum sounds in the audio-only condition, but participants haptically perceived surfaces with modulated metal sounds as significantly softer than the same surfaces with modulated drum sounds, which directly opposes the impression induced by these sounds alone. This result indicates that, although the inferred material category is strongly associated with audio-only stiffness perception, low-level acoustic parameters, especially damping, are more tightly integrated with haptic signals than the material category is. Frequency played an important role in both audio-only and audio-haptic conditions. Our study provides evidence that auditory information influences stiffness perception differently in unisensory and multisensory tasks. Furthermore, the data demonstrated that sounds with higher frequency and/or shorter decay time tended to be judged as stiffer, and contact sounds of stiff objects had no effect on the haptic perception of soft surfaces. We argue that the intrinsic physical relationship between object stiffness and acoustic parameters may be applied as prior knowledge to achieve robust estimation of stiffness in multisensory perception.	[Liu, Juan] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan; Osaka Univ, Osaka, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Liu, J (corresponding author), Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan.	juanliu@nict.go.jp						Adelstein BD, 2003, 5 INT C MULT INT; Avanzini F, 2006, COMPUT ANIMAT VIRT W, V17, P411, DOI 10.1002/cav.144; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Carello C, 1998, PSYCHOL SCI, V9, P211, DOI 10.1111/1467-9280.00040; Chaigne A, 1997, J ACOUST SOC AM, V101, P539, DOI 10.1121/1.418117; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; DiFranco D. E., 1997, Proceedings of the ASME Dynamic Systems and Control Division, P17; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; FREED DJ, 1990, J ACOUST SOC AM, V87, P311, DOI 10.1121/1.399298; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Giordano BL, 2014, SPRINGER SERIES TOUC, P49; Giordano BL, 2010, J EXP PSYCHOL HUMAN, V36, P462, DOI 10.1037/a0018388; Grassi M, 2013, ACTA PSYCHOL, V143, P96, DOI 10.1016/j.actpsy.2013.02.005; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; James T. W., 2012, NEURAL BASEMULTISE; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; Kunkler-Peck AJ, 2000, J EXP PSYCHOL HUMAN, V26, P279, DOI 10.1037/0096-1523.26.1.279; Kurihara Y, 2013, ACM SIGGRAPH AS 2013; Lakatos S, 1997, PERCEPT PSYCHOPHYS, V59, P1180, DOI 10.3758/BF03214206; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lederman SJ, 2003, 11 S HAPT INT VIRT E; Lederman SJ, 2002, 10 S HAPT INT VIRT E; Liu J, 2008, IEEE C HUM SYST INT; Lutfi RA, 1997, J ACOUST SOC AM, V102, P3647, DOI 10.1121/1.420151; Lutfi RA, 2001, J ACOUST SOC AM, V110, P1010, DOI 10.1121/1.1385903; McAdams S, 2004, J ACOUST SOC AM, V115, P1306, DOI 10.1121/1.1645855; McAdams S, 2010, J ACOUST SOC AM, V128, P1401, DOI 10.1121/1.3466867; Menon S, 2014, 36 ANN C IEEE ENG ME; Morse PM, 1948, VIBRATION SOUND, P172; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Quesada FJ, 2006, IEEE MELECON 2006 MA; Rocchesso D, 2001, 2001 INT C AUD DISPL; Rodgers KM, 2008, CEREB CORTEX, V18, P2941, DOI 10.1093/cercor/bhn054; Sato S, 1985, TOUKEITEKI KANNOU KE, P263; SCHEFFE H, 1952, J AM STAT ASSOC, V47, P381, DOI 10.2307/2281310; Senna I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091688; Servos P, 2001, COGNITIVE BRAIN RES, V12, P307, DOI 10.1016/S0926-6410(01)00041-6; Stein BE, 2014, NAT REV NEUROSCI, V15, P520, DOI 10.1038/nrn3742; Tajadura-Jimenez A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00689; Tajadura-Jimenez A, 2015, IEEE MULTIMEDIA, V22, P48, DOI 10.1109/MMUL.2015.14; van den Doel K, 1998, PRESENCE-TELEOP VIRT, V7, P382, DOI 10.1162/105474698565794; van den Doel K., 1998, THESIS; Weisenberger JM, 2004, 12 INT S HAPT INT VI; Wildes R.P., 1988, NATURAL COMPUTATION, P356	47	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167023	10.1371/journal.pone.0167023	http://dx.doi.org/10.1371/journal.pone.0167023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902718	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100044
J	Liu, YC; Gau, JP; Lin, PY; Liu, CJL; Liu, CJ; Liu, JH; Fan, NW				Liu, Yao-Chung; Gau, Jyh-Pyng; Lin, Pei-Yu; Liu, Catherine Jui-Ling; Liu, Chia-Jen; Liu, Jin-Hwang; Fan, Nai-Wen			Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; RISK-FACTORS; OCULAR FINDINGS; GVHD; EYE; CRITERIA; BLOOD; SCORE	Background To investigate the incidence, risk factors and survival of conjunctival acute graft-versus-host disease (aGVHD) in adult patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) Methods This retrospective study included a total of 139 patients undergoing allogeneic HSCT between January 2012 and December 2014 at a tertiary referral hospital. Patients with ocular complaints after allogeneic HSCT or first donor lymphocyte infusion were evaluated by ophthalmologists. The risk factors for conjunctival aGVHD were analyzed using the Cox proportional hazards model. The overall survival was evaluated using Kaplan-Meier estimates. Results Thirteen (9.4%) patients developed conjunctival aGVHD, including eight patients with pseudomembranous conjunctivitis. The cumulative incidence of conjunctival aGVHD was 2.1 cases per 10,000 person-day. The median age at HSCT was 47 years (range, 18 to 66) in all patients and 42 years (range, 24 to 58) in the 13 patients with conjunctival aGVHD. Median time of follow-up after allogeneic HSCT was 353 days (range, 11 to 1184). In univariate analysis, grades II-IV skin aGVHD (P = 0.002) and advanced systemic aGVHD except skin aGVHD (overall grades III-IV) (P = 0.001) were significant predictors for conjunctival aGVHD. In multivariate analysis, grades II-IV skin aGVHD was a significant risk factor (P=0.04). The severity of conjunctival aGVHD was generally correlated with the systemic aGVHD (P=0.001). Overall survival was significantly shorter in patients with grades II-IV aGVHD compared to those with grade 0-I (P=0.01). Survival in patients with conjunctival aGVHD did not differ significantly from those without this complication (P = 0.94). In the subgroup analysis of patients with grades III-IV aGVHD, survival was significantly longer in patients with conjunctival involvement than those without (P=0.03). Conclusions The severity of conjunctival aGVHD is correlated with systemic aGVHD, but not with inferior overall survival.	[Liu, Yao-Chung; Gau, Jyh-Pyng; Liu, Chia-Jen; Liu, Jin-Hwang] Taipei Vet Gen Hosp, Div Hematol, Dept Med, Taipei, Taiwan; [Liu, Yao-Chung; Gau, Jyh-Pyng; Lin, Pei-Yu; Liu, Catherine Jui-Ling; Liu, Chia-Jen; Liu, Jin-Hwang; Fan, Nai-Wen] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Lin, Pei-Yu; Liu, Catherine Jui-Ling; Fan, Nai-Wen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Fan, Nai-Wen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Fan, NW (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.; Fan, NW (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Fan, NW (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	nwfan@vghtpe.gov.tw	Fan, Nai-Wen/ACB-0737-2022		Taipei Veterans General Hospital [V105B-009]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported in part by grants from Taipei Veterans General Hospital (V105B-009).	Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Bacigalupo A, 2007, BRIT J HAEMATOL, V137, P87, DOI 10.1111/j.1365-2141.2007.06533.x; BRAY LC, 1991, BRIT J OPHTHALMOL, V75, P611, DOI 10.1136/bjo.75.10.611; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; Chiang CC, 2007, CORNEA, V26, P861, DOI 10.1097/ICO.0b013e3180645cd7; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Dai E, 2007, CORNEA, V26, P756, DOI 10.1097/ICO.0b013e318059b55f; Elborai Y, 2012, IMMUNOTHERAPY-UK, V4, P947, DOI [10.2217/IMT.12.95, 10.2217/imt.12.95]; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; FRANKLIN RM, 1983, OPHTHALMOLOGY, V90, P4; Gratwohl A, 2012, BONE MARROW TRANSPL, V47, P749, DOI 10.1038/bmt.2011.110; Hessen M, 2012, CURR OPIN ALLERGY CL, V12, P540, DOI 10.1097/ACI.0b013e328357b4b9; HIRST LW, 1983, ARCH OPHTHALMOL-CHIC, V101, P580, DOI 10.1001/archopht.1983.01040010580010; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1343, DOI 10.1001/archopht.1989.01070020413046; Jacobs R, 2012, BONE MARROW TRANSPL, V47, P1470, DOI 10.1038/bmt.2012.56; Janin A, 1996, HUM PATHOL, V27, P307, DOI 10.1016/S0046-8177(96)90074-X; Kerty E, 1999, OPHTHALMOLOGY, V106, P1334, DOI 10.1016/S0161-6420(99)00720-4; Kim SK, 2006, CURR OPIN OPHTHALMOL, V17, P344, DOI 10.1097/01.icu.0000233952.09595.d8; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Liu YC, 2015, BRIT J HAEMATOL, V169, P737, DOI 10.1111/bjh.13357; Migita K, 1997, TRANSPLANTATION, V63, P583, DOI 10.1097/00007890-199702270-00017; Na KS, 2015, BONE MARROW TRANSPL, V50, P1459, DOI 10.1038/bmt.2015.187; Nassiri Nariman, 2013, J Ophthalmic Vis Res, V8, P351; Saboo US, 2015, OPHTHALMOLOGY, V122, P1669, DOI 10.1016/j.ophtha.2015.04.011; Shikari H, 2013, SURV OPHTHALMOL, V58, P233, DOI 10.1016/j.survophthal.2012.08.004; Tabbara KF, 2009, OPHTHALMOLOGY, V116, P1624, DOI 10.1016/j.ophtha.2009.04.054; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; Westeneng AC, 2010, CORNEA, V29, P758, DOI 10.1097/ICO.0b013e3181ca321c	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167129	10.1371/journal.pone.0167129	http://dx.doi.org/10.1371/journal.pone.0167129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902756	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100054
J	Zhu, DQ; Wang, SS; Lawless, J; He, JC; Zheng, ZG				Zhu, Dongqing; Wang, Shanshan; Lawless, John; He, Jianchen; Zheng, Zhengui			Dose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis	PLOS ONE			English	Article							SCUTELLARIA-BAICALENSIS; TUMOR ANGIOGENESIS; IN-VITRO; THERAPEUTIC ANGIOGENESIS; ANTICANCER ACTIVITY; RADIX-SCUTELLARIAE; OVARIAN-CANCER; GROWTH; EXPRESSION; WOGONIN	Huang Qin (root of Scutellaria baicalensis) is a widely used herb in different countries for adjuvant therapy of inflammation, diabetes, hypertension, different kinds of cancer and virus related diseases. Baicalin is the main flavonoid in this herb and has been extensively studied for 30 years. The angiogenic effect of herb Huang Qin extract and baicalin was found 13 years ago, however, the results were controversial with pro-angiogenic effect in some studies and anti-angiogenic effect in others. In this paper, the angiogenic effect of baicalin, its aglycone form baicalein and aqueous extract of Huang Qin was studied in chick embryo chorioallantoic membrane (CAM) model. Dose dependent dual effect was found in both aqueous extract and baicalin, but not in baicalein, in which only inhibitory effect was observed. In order to reveal the cellular and molecular mechanism of how baicalin and baicalein affect angiogenesis, cell proliferation and programmed cell death assays were performed in treated CAM. In addition, quantitative PCR array including 84 angiogenesis related genes was used to detect high and low dosage of baicalin and baicalein responsive genes. Low dose baicalin increased cell proliferation in developing blood vessels through upregulation of multiple angiogenic genes expression, but high dose baicalin induced cell death, performing inhibitory effect on angiogenesis. Both high and low dose of baicalein down regulated the expression of multiple angiogenic genes, decreased cell proliferation, and leads to inhibitory effects on angiogenesis.	[Zhu, Dongqing; Wang, Shanshan; Lawless, John; Zheng, Zhengui] Southern Illinois Univ Carbondale, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Zhu, Dongqing] Jiangsu Food & Pharmaceut Sci Coll, Dept Pharm, Huaian, Jiangsu, Peoples R China; [He, Jianchen] Shanghai Univ Tradit Chinese Med, Sch Basic Med Sci, Shanghai, Peoples R China	Southern Illinois University System; Southern Illinois University; Jiangsu Food & Pharmaceutical Science College; Shanghai University of Traditional Chinese Medicine	Zheng, ZG (corresponding author), Southern Illinois Univ Carbondale, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.; He, JC (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Basic Med Sci, Shanghai, Peoples R China.	hejc@shutcm.edu.cn; zzheng@siu.edu		Zheng, Zhengui/0000-0003-0997-2976	School of Medicine at Southern Illinois University	School of Medicine at Southern Illinois University	ZZ was supported by the School of Medicine at Southern Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bai Y, 2014, CELL TISSUE RES, V356, P109, DOI 10.1007/s00441-013-1781-9; Bassino E, 2016, NAT PROD RES, V2, P1; Bisht M, 2010, INDIAN J PHARMACOL, V42, P2, DOI 10.4103/0253-7613.62395; Bochorakova H, 2003, PHYTOTHER RES, V17, P640, DOI 10.1002/ptr.1216; Bokhari AA, 2015, J CELL BIOCHEM, V116, P1797, DOI 10.1002/jcb.25138; Bonham M, 2005, CLIN CANCER RES, V11, P3905, DOI 10.1158/1078-0432.CCR-04-1974; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chan FL, 2000, CANCER LETT, V160, P219, DOI 10.1016/S0304-3835(00)00591-7; Chen JC, 2013, INT J MOL SCI, V14, P6012, DOI 10.3390/ijms14036012; Chen SS, 2012, DISCOV MED, V13, P7; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chong HC, 2014, MOL THER, V22, P1593, DOI 10.1038/mt.2014.102; Chung H, 2015, BIOCHEM BIOPH RES CO, V458, P707, DOI 10.1016/j.bbrc.2015.02.032; Cohen MH, 2007, ONCOLOGIST, V12, P356, DOI 10.1634/theoncologist.12-3-356; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Deveza L, 2012, THERANOSTICS, V2, P801, DOI 10.7150/thno.4419; El Sayed KA, 2005, MINI-REV MED CHEM, V5, P971, DOI 10.2174/138955705774575291; El-Kenawi AE, 2013, BRIT J PHARMACOL, V170, P712, DOI 10.1111/bph.12344; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Fogel JL, 2012, JOVE-J VIS EXP, DOI 10.3791/4254; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gao J, 2008, J PHARM PHARM SCI, V11, P77; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Gu YX, 2016, INSTRUM SCI TECHNOL, V44, P593, DOI 10.1080/10739149.2016.1177541; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hehlgans T, 2002, CANCER RES, V62, P4034; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Huang Y, 2015, MOL CARCINOG; ISHIMARU K, 1995, PHYTOCHEMISTRY, V40, P279, DOI 10.1016/0031-9422(95)00200-Q; Jo H, 2015, BMB REP, V48, P271, DOI 10.5483/BMBRep.2015.48.5.131; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kim EH, 2009, J ETHNOPHARMACOL, V126, P320, DOI 10.1016/j.jep.2009.08.027; Kren V, 2001, CURR MED CHEM, V8, P1303, DOI 10.2174/0929867013372193; Li GH, 2016, NEURAL REGEN RES, V11, P1015, DOI 10.4103/1673-5374.184506; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Liu JJ, 2003, INT J CANCER, V106, P559, DOI 10.1002/ijc.11267; Liu W, 2015, BIOMED RES-INDIA, V26, P13; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Lu N, 2008, LIFE SCI, V82, P956, DOI 10.1016/j.lfs.2008.02.013; Miocinovic R, 2005, INT J ONCOL, V26, P241; Padwal M., 2016, NEPHROL DIAL TRANSPL; Reizis A, 2005, J EXP BIOL, V208, P2483, DOI 10.1242/jeb.01662; Ribatti D, 2008, ONCOL REP, V19, P1109; Rosing H, 2000, J LIQ CHROMATOGR R T, V23, P329, DOI 10.1081/JLC-100101455; Sagar S M, 2006, Curr Oncol, V13, P99; Sagar S M, 2006, Curr Oncol, V13, P14; Sato D, 2013, MOL CLIN ONCOL, V1, P105, DOI 10.3892/mco.2012.14; Scheck Adrienne C, 2006, BMC Complement Altern Med, V6, P27, DOI 10.1186/1472-6882-6-27; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Shang DD, 2015, ONCOL REP, V33, P2077, DOI 10.3892/or.2015.3786; Shang XF, 2010, J ETHNOPHARMACOL, V128, P279, DOI 10.1016/j.jep.2010.01.006; Shao ZH, 1999, J MOL CELL CARDIOL, V31, P1885, DOI 10.1006/jmcc.1999.1021; Silvestre JS, 2002, ARCH MAL COEUR VAISS, V95, P189; Soikkeli J, 2010, AM J PATHOL, V177, P387, DOI 10.2353/ajpath.2010.090748; Song XM, 2013, TOXICOL APPL PHARM, V271, P144, DOI 10.1016/j.taap.2013.04.031; Tang W, 2004, PHYTOMEDICINE, V11, P277, DOI 10.1078/0944711041495173; TPCoPR C, 2005, PHARMACOPOEIA PEOPLE; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Vale PR, 2001, REV ESP CARDIOL, V54, P1210, DOI 10.1016/S0300-8932(01)76480-9; Waisundara VY, 2008, AM J CHINESE MED, V36, P517, DOI 10.1142/S0192415X08005953; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang SS, 2004, LIFE SCI, V74, P2467, DOI 10.1016/j.lfs.2003.03.005; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yance DR, 2006, INTEGR CANCER THER, V5, P9, DOI 10.1177/1534735405285562; Yang Li-xin, 2002, Zhongguo Zhongyao Zazhi, V27, P166; Ye F, 2002, J ALTERN COMPLEM MED, V8, P567, DOI 10.1089/107555302320825075; Yin Hui-Fu, 2014, Zhongguo Zhong Yao Za Zhi, V39, P3757; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296; Zhang X, 2016, J ETHNOPHARMACOL, V186, P91, DOI 10.1016/j.jep.2016.03.057; Zheng ZG, 2015, P NATL ACAD SCI USA, V112, pE7194, DOI 10.1073/pnas.1515981112; Zhou M, 2014, VASC PHARMACOL, V60, P110, DOI 10.1016/j.vph.2014.01.010	76	23	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167125	10.1371/journal.pone.0167125	http://dx.doi.org/10.1371/journal.pone.0167125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902752	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100053
J	Basaran, M; Uzun, O; Cornelis, W; Gabriels, D; Erpul, G				Basaran, Mustafa; Uzun, Oguzhan; Cornelis, Wim; Gabriels, Donald; Erpul, Gunay			Potential Use of BEST (R) Sediment Trap in Splash - Saltation Transport Process by Simultaneous Wind and Rain Tests	PLOS ONE			English	Article							AEOLIAN SAND TRANSPORT; DRIVEN RAIN; FIELD CALIBRATION; NORTHERN ENGLAND; BLANKET PEAT; TUNNEL; EROSION; SOIL; DETACHMENT; EFFICIENCY	The research on wind-driven rain (WDR) transport process of the splash-saltation has increased over the last twenty years as wind tunnel experimental studies provide new insights into the mechanisms of simultaneous wind and rain (WDR) transport. The present study was conducted to investigate the efficiency of the BEST (R) sediment traps in catching the sand particles transported through the splash-saltation process under WDR conditions. Experiments were conducted in a wind tunnel rainfall simulator facility with water sprayed through sprinkler nozzles and free-flowing wind at different velocities to simulate the WDR conditions. Not only for vertical sediment distribution, but a series of experimental tests for horizontal distribution of sediments was also performed using BEST (R) collectors to obtain the actual total sediment mass flow by the splash-saltation in the center of the wind tunnel test section. Total mass transport (kg m(-2)) were estimated by analytically integrating the exponential functional relationship using the measured sediment amounts at the set trap heights for every run. Results revealed the integrated efficiency of the BEST (R) traps at 6, 9, 12 and 15 m s(-1) wind velocities under 55.8, 50.5, 55.0 and 50.5 mm h(-1) rain intensities were, respectively, 83, 106, 105, and 102%. Results as well showed that the efficiencies of BEST r did not change much as compared with those under rainless wind condition.	[Basaran, Mustafa; Uzun, Oguzhan] Erciyes Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Kayseri, Turkey; [Erpul, Gunay] Ankara Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Ankara, Turkey; [Cornelis, Wim; Gabriels, Donald] Univ Ghent, Dept Soil Management, ICE, Ghent, Belgium	Erciyes University; Ankara University; Ghent University	Basaran, M (corresponding author), Erciyes Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Kayseri, Turkey.	mbasaran@erciyes.edu.tr	uzun, oğuzhan/AAC-3311-2019; Basaran, Mustafa/AAQ-3724-2020	Basaran, Mustafa/0000-0001-5689-657X; Cornelis, Wim/0000-0002-6605-6723				ANDERSON RS, 1988, SCIENCE, V241, P820, DOI 10.1126/science.241.4867.820; Bagnold R., 1941, PHYS BLOWN SAND DESE; Basaran M, 2011, GEOMORPHOLOGY, V130, P343, DOI 10.1016/j.geomorph.2011.04.016; Bielders CL, 2002, GEODERMA, V109, P19, DOI 10.1016/S0016-7061(02)00138-6; Buschiazzo DE, 2007, J ARID ENVIRON, V69, P29, DOI 10.1016/j.jaridenv.2006.08.013; Cornelis WM, 2004, SOIL SCI SOC AM J, V68, P41, DOI 10.2136/sssaj2004.0041; Cornelis WM, 2004, SOIL SCI SOC AM J, V68, P32, DOI 10.2136/sssaj2004.0032; Cornelis WM, 2003, EARTH SURF PROC LAND, V28, P1033, DOI 10.1002/esp.1023; Cortes C, 2007, PROG ENERG COMBUST, V33, P409, DOI 10.1016/j.pecs.2007.02.001; DELIMA JLMP, 1990, J HYDROL, V115, P407, DOI 10.1016/0022-1694(90)90218-M; DEPLOEY J, 1980, ASSESSMENT EROSION, P143; Dong ZB, 2004, GEOMORPHOLOGY, V59, P119, DOI 10.1016/j.geomorph.2003.09.010; Erpul G, 2008, CATENA, V72, P413, DOI 10.1016/j.catena.2007.07.008; Erpul G, 2005, EARTH SURF PROC LAND, V30, P241, DOI 10.1002/esp.1178; Erpul G, 2004, GEOMORPHOLOGY, V59, P31, DOI 10.1016/j.geomorph.2003.09.003; Erpul G, 2004, EARTH SURF PROC LAND, V29, P955, DOI 10.1002/esp.1077; Erpul G, 2003, J HYDROL, V276, P184, DOI 10.1016/S0022-1694(03)00070-2; Erpul G, 2003, T ASAE, V46, P51, DOI 10.13031/2013.12548; Erpul G, 2002, CATENA, V47, P227, DOI 10.1016/S0341-8162(01)00182-5; Erpul G, 1998, SOIL TILL RES, V45, P455, DOI 10.1016/S0933-3630(97)00030-5; Erpul G, 2009, GEOMORPHOLOGY, V104, P191, DOI 10.1016/j.geomorph.2008.08.012; Erpul G, 2009, EARTH SURF PROC LAND, V34, P1270, DOI 10.1002/esp.1814; Erpul G., 2000, INT AGROPHYS, V14, P1; Erpul G., 1996, THESIS; Erpul G., 2001, THESIS; Evans M, 2005, EARTH SURF PROC LAND, V30, P557, DOI 10.1002/esp.1153; Finney R L., 1996, CALCULUS ANAL GEOMET; Foulds SA, 2007, EARTH SURF PROC LAND, V32, P481, DOI 10.1002/esp.1422; Foulds SA, 2007, GEOMORPHOLOGY, V83, P183, DOI 10.1016/j.geomorph.2006.07.001; FRYREAR DW, 1986, J SOIL WATER CONSERV, V41, P117; Gabriels D, 1997, SOIL TECHNOL, V10, P1, DOI 10.1016/S0933-3630(96)00012-8; GILLETTE DA, 1977, SOIL SCI, V123, P97, DOI 10.1097/00010694-197702000-00004; Goossens D, 2000, ATMOS ENVIRON, V34, P1043, DOI 10.1016/S1352-2310(99)00376-3; Goossens D, 2000, GEOMORPHOLOGY, V35, P233, DOI 10.1016/S0169-555X(00)00041-6; Gu ZM, 2007, PHYS LETT A, V368, P435, DOI 10.1016/j.physleta.2007.04.049; Hagen LJ, 2010, AEOLIAN RES, V1, P147, DOI 10.1016/j.aeolia.2009.08.002; Hoffmann C, 2008, CATENA, V75, P182, DOI 10.1016/j.catena.2008.06.003; LEATHERMAN SP, 1978, SEDIMENTOLOGY, V25, P303, DOI 10.1111/j.1365-3091.1978.tb00315.x; LEE JA, 1987, EARTH SURF PROCESSES, V12, P331, DOI 10.1002/esp.3290120311; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Li FR, 2003, CATENA, V53, P255, DOI 10.1016/S0341-8162(03)00039-0; Li ZS, 2003, GEOMORPHOLOGY, V52, P243, DOI 10.1016/S0169-555X(02)00259-3; NEUMAN CM, 1994, BOUND-LAY METEOROL, V68, P35, DOI 10.1007/BF00712663; PEDERSEN HS, 1995, CATENA, V24, P39, DOI 10.1016/0341-8162(94)00024-9; Pietravalle S, 2001, AGR FOREST METEOROL, V109, P171, DOI 10.1016/S0168-1923(01)00267-2; Poortinga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074007; Roney JA, 2006, ATMOS ENVIRON, V40, P7668, DOI 10.1016/j.atmosenv.2006.08.015; SHARON D, 1980, J HYDROL, V46, P165, DOI 10.1016/0022-1694(80)90041-4; Singh U., 1994, THESIS; SPAAN W P, 1991, Soil Technology, V4, P51, DOI 10.1016/0933-3630(91)90039-P; STERK G, 1993, 3 WAG AGR U DEP IRR; Stout JE, 1996, SOIL SCI, V161, P616, DOI 10.1097/00010694-199609000-00006; Temur C, 2012, J ENVIRON SCI HEAL B, V47, P842, DOI 10.1080/03601234.2012.693878; Visser, 2004, TROPICAL RESOURCE MA, P195; Wilson G R, 1994, THESIS; Wilson S. J., 1980, Soil erosion., P217; Youssef F, 2008, ENVIRON GEOL, V55, P741, DOI 10.1007/s00254-007-1027-9; Youssef F, 2012, GEOMORPHOLOGY, V159, P178, DOI 10.1016/j.geomorph.2012.03.023; Zobeck TM, 2006, J HAZARD MATER, V132, P26, DOI 10.1016/j.jhazmat.2005.11.090; [No title captured]	60	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166924	10.1371/journal.pone.0166924	http://dx.doi.org/10.1371/journal.pone.0166924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898716	Green Published, gold			2022-12-27	WOS:000389474000023
J	Park, S; Kim, M				Park, SangWook; Kim, Minhyuk			Numerical Exposure Assessment Method for Low Frequency Range and Application to Wireless Power Transfer	PLOS ONE			English	Article							BATTERY CHARGING PLATFORM; TRANSMISSION	In this paper, a numerical exposure assessment method is presented for a quasi-static analysis by the use of finite-difference time-domain (FDTD) algorithm. The proposed method is composed of scattered field FDTD method and quasi-static approximation for analyzing of the low frequency band electromagnetic problems. The proposed method provides an effective tool to compute induced electric fields in an anatomically realistic human voxel model exposed to an arbitrary non-uniform field source in the low frequency ranges. The method is verified, and excellent agreement with theoretical solutions is found for a dielectric sphere model exposed to a magnetic dipole source. The assessment method serves a practical example of the electric fields, current densities, and specific absorption rates induced in a human head and body in close proximity to a 150-kHz wireless power transfer system for cell phone charging. The results are compared to the limits recommended by the International Commission on Non-Ionizing Radiation Protection (ICNIRP) and the IEEE standard guidelines.	[Park, SangWook] Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea; [Kim, Minhyuk] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea	Seoul National University (SNU)	Park, S (corresponding author), Korea Automot Technol Inst, Reliabil & Safety R&D Div, EMI EMC R&D Ctr, Cheonan, South Korea.	parksw@katech.re.kr			Ministry of Trade, Industry and Energy of Korea [10052912]	Ministry of Trade, Industry and Energy of Korea	This work was supported by a grant "Development of Induction/magnetic resonance type 6.6kW, 90% EV Wireless Charger (No. 10052912)" from the Ministry of Trade, Industry and Energy of Korea, http://english.motie.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant "Development of Induction/magnetic resonance type 6.6kW, 90% EV Wireless Charger (No. 10052912)" from the Ministry of Trade, Industry and Energy of Korea.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; [Anonymous], 2005, C951 IEEE, V1; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Choi B, 2004, IEEE T IND ELECTRON, V51, P140, DOI 10.1109/TIE.2003.822039; Christ A, 2013, IEEE T ELECTROMAGN C, V55, P265, DOI 10.1109/TEMC.2012.2219870; Dawson T. W., 1996, Applied Computational Electromagnetics Society Journal, V11, P63; Deford J, 1985, ELECTROMAGN COMPAT I; DeMoerloose J, 1997, RADIO SCI, V32, P329, DOI 10.1029/96RS03690; Dimbylow P, 1996, P INT WORK VOX PHANT; Elliott GAJ, 2006, IEEE T MAGN, V42, P3389, DOI 10.1109/TMAG.2006.879619; Gabriel C, 1996, ENV HEAL; Gandhi O, 1995, P INT WORK VOX PHANT; GREEN AW, 1994, IEE CONF PUBL, P694; Harrington RF, 1996, FIELD COMPUTATION MO; Hirata A, 2010, IEICE T ELECT C; Hui SYR, 2014, IEEE T POWER ELECTR, V29, P4500, DOI 10.1109/TPEL.2013.2249670; Hui SYR, 2005, IEEE T POWER ELECTR, V20, P620, DOI 10.1109/TPEL.2005.846550; HURLEY WG, 1979, IEEE T MAGN, V15, P1174, DOI 10.1109/TMAG.1979.1145874; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Jang YT, 2003, IEEE T IND ELECTRON, V50, P520, DOI 10.1109/TIE.2003.812472; Kissin MLG, 2009, IEEE T IND ELECTRON, V56, P2393, DOI 10.1109/TIE.2009.2020076; Kunz K. S., 1993, FINITE DIFFERENCE TI; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Laakso I, 2012, PHYS MED BIOL, V57, P4991, DOI 10.1088/0031-9155/57/15/4991; Lin JC, 2013, IEEE ANTENN PROPAG M, V55, P250, DOI 10.1109/MAP.2013.6529362; Liu X, 2007, IEEE T POWER ELECTR, V22, P2202, DOI 10.1109/TPEL.2007.909301; Mason PA, 2000, NATO ASI 3 HIGH TECH, V82, P141; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; Park SW, 2013, IEEE T MICROW THEORY, V61, P3461, DOI 10.1109/TMTT.2013.2274053; Park SW, 2015, J ELECTROMAGN ENG SC, V15, P129, DOI 10.5515/JKIEES.2015.15.3.129; Schuder J, 1961, I RADIO ENGRS INT CO; Shojafar M, 2015, IEEE INT CONF COMM, P1800, DOI 10.1109/ICCW.2015.7247442; Song H, 2014, IEEE T MAGN, V50, P3, DOI DOI 10.1109/; Stratton J. A., 2007, ELECTROMAGNETIC THEO; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; The Institute of Electrical and Electronics Engineers (IEEE), 2002, C956 IEEE	36	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166720	10.1371/journal.pone.0166720	http://dx.doi.org/10.1371/journal.pone.0166720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898688	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000016
J	Aspvik, NP; Viken, H; Zisko, N; Ingebrigtsen, JE; Wisloff, U; Stensvold, D				Aspvik, Nils Petter; Viken, Hallgeir; Zisko, Nina; Ingebrigtsen, Jan Erik; Wisloff, Ulrik; Stensvold, Dorthe			Are Older Adults Physically Active Enough - A Matter of Assessment Method? The Generation 100 Study	PLOS ONE			English	Article							RELATIVE INTENSITY; SEDENTARY BEHAVIOR; OXYGEN-UPTAKE; AGE; ACCELEROMETRY; LIFE; GUIDELINES; CAPACITY; DECLINE; FITNESS	Introduction Physical activity (PA) is beneficial for general health. As a result, adults around the world are recommended to undertake regular PA of either absolute or relative intensity. Traditionally, adherence to PA recommendation is assessed by accelerometers that record absolute intensity thresholds. Since ageing often results in a decrease in cardiorespiratory fitness (CRF), older adults (aged > 65 years) might be more susceptible to not meeting the PA recommendation when measured in absolute terms. The aim of the present study was to compare the adherence to the PA recommendation using both absolute and relative thresholds. Additionally, we aimed to report the reference values for overall PA in a large sample of Norwegian older adults. Methods PA was assessed for 7 days using the Actigraph GT3X+ accelerometer in 1219 older adults (624 females) aged 70-77 years. Overall PA was measured as counts per minute (CPM) and steps. Absolute and relative moderate-to-vigorous PA (MVPA) thresholds were applied to quantify adherence to PA recommendation. The relative MVPA thresholds were developed specifically for the Generation 100 population sample. CRF was directly measured as peak oxygen uptake (VO2peak). Results Proportions meeting PA recommendation were 29% and 71% when utilizing absolute and relative MVPA, respectively. More females met the relative PA recommendation compared to males. Overall PA was higher among the youngest age group. Older adults with medium- and high levels of CRF were more physically active, compared to those with the lowest levels of CRF. Conclusion This is the first study to compare adherence to PA recommendation, using absolute and relative intensity thresholds among older adults. The present study clearly illustrates the consequences of using different methodological approaches to surveillance of PA across age, gender and CRF in a population of older adults.	[Aspvik, Nils Petter; Ingebrigtsen, Jan Erik] Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, Fac Social Sci & Technol Management, Trondheim, Norway; [Viken, Hallgeir; Zisko, Nina; Wisloff, Ulrik; Stensvold, Dorthe] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Viken, Hallgeir; Stensvold, Dorthe] Liaison Comm Cent Norway Reg Hlth Author & Norweg, Trondheim, Norway; [Wisloff, Ulrik] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Queensland	Stensvold, D (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway.; Stensvold, D (corresponding author), Liaison Comm Cent Norway Reg Hlth Author & Norweg, Trondheim, Norway.	dorthe.stensvold@ntnu.no	Stensvold, Dorthe/HGE-7694-2022	stensvold, dorthe/0000-0002-8942-1316; Wisloff, Ulrik/0000-0002-7211-3587; Zisko, Nina/0000-0002-0044-7246	Liaison Committee; K.G. Jebsen Foundation; Research Council of Norway	Liaison Committee; K.G. Jebsen Foundation; Research Council of Norway(Research Council of Norway)	The Generation 100 study was funded by The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), The K.G. Jebsen Foundation, and The Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amara CE, 2000, EXP PHYSIOL, V85, P877, DOI 10.1017/S0958067000020662; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Bento T, 2012, REV SAUDE PUBL, V46, P561, DOI 10.1590/S0034-89102012005000022; Berkemeyer K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0316-z; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Hall KS, 2014, MED SCI SPORT EXER, V46, P2335, DOI 10.1249/MSS.0000000000000356; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2014, BRIT J SPORT MED, V48, P239, DOI 10.1136/bjsports-2013-092993; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Lohne-Seiler H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-284; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Orsini N, 2006, MED SCI SPORT EXER, V38, P240, DOI 10.1249/01.mss.0000185086.19220.b3; Ozemek C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-53; Pedisic Z, 2014, BR J SPORTS MED; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Stensvold D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007519; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Viken H, 2016, J AGING PHYS ACTIV, V24, P369, DOI 10.1123/japa.2015-0148; Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS79, DOI 10.1080/02701367.2000.11082790; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2011, NIH PUBL; Zisko N, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0093-1	38	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167012	10.1371/journal.pone.0167012	http://dx.doi.org/10.1371/journal.pone.0167012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893785	Green Published, gold			2022-12-27	WOS:000389472400069
J	Bhattacharjee, N; Khanra, R; Dua, TK; Das, S; De, B; Zia-Ul-Haq, M; De Feo, V; Dewanjee, S				Bhattacharjee, Niloy; Khanra, Ritu; Dua, Tarun K.; Das, Susmita; De, Bratati; Zia-Ul-Haq, M.; De Feo, Vincenzo; Dewanjee, Saikat			Sansevieria roxburghiana Schult. & Schult. F. (Family: Asparagaceae) Attenuates Type 2 Diabetes and Its Associated Cardiomyopathy	PLOS ONE			English	Article							HIGH-FAT DIET; OXIDATIVE STRESS; ANTIDIABETIC ACTIVITY; ENHYDRA-FLUCTUANS; CAFFEIC ACID; ANTIOXIDANT; RAT; INHIBITION; EXTRACT; MODEL	Background Sansevieria roxburghiana Schult. & Schult. F. (Family: Asparagaceae) rhizome has been claimed to possess antidiabetic activity in the ethno-medicinal literature in India. Therefore, present experiments were carried out to explore the protective role of edible (aqueous) extract of S. roxburghiana rhizome (SR) against experimentally induced type 2 diabetes mellitus (T2DM) and its associated cardiomyopathy in Wistar rats. Methods SR was chemically characterized by GC-MS analysis. Antidiabetic activity of SR (50 and 100 mg/kg, orally) was measured in high fat diets (ad libitum) + low-single dose of streptozotocin (35 mg/kg, intraperitoneal) induced type 2 diabetic (T2D) rat. Fasting blood glucose level was measured at specific intermissions. Serum biochemical and inflammatory markers were estimated after sacrificing the animals. Besides, myocardial redox status, expressions of signal proteins (NF-kappa B and PKCs), histological and ultrastructural studies of heart were performed in the controls and SR treated T2D rats. Results Phytochemical screening of the crude extract revealed the presence of phenolic compounds, sugar alcohols, sterols, amino acids, saturated fatty acids within SR. T2D rats exhibited significantly (p < 0.01) higher fasting blood glucose level with respect to control. Alteration in serum lipid profile (p < 0.01) and increased levels of lactate dehydrogenase (p < 0.01) and creatine kinase (p < 0.01) in the sera revealed the occurrence of hyperlipidemia and cell destruction in T2D rats. T2DM caused significant (p < 0.05-0.01) alteration in the biochemical markers in the sera. T2DM altered the redox status (p < 0.05-0.01), decreased (p < 0.01) the intracellular NAD and ATP concentrations in the myocardial tissues of experimental rats. While investigating the molecular mechanism, activation PKC isoforms was observed in the selected tissues. T2D rats also exhibited an up-regulation in nuclear NF-kappa B (p65) in the cardiac tissues. So, oral administration of SR (50 and 500 mg/kg) could reduce hyperglycemia, hyperlipidemia, membrane disintegration, oxidative stress, vascular inflammation and prevented the activation of oxidative stress induced signaling cascades leading to cell death. Histological and ultra-structural studies of cardiac tissues supported the protective characteristics of SR. Conclusions From the present findings it can be concluded that, SR could offer protection against T2DM and its associated cardio-toxicity via multiple mechanisms viz. hypoglycemic, antioxidant and anti-inflammatory actions.	[Bhattacharjee, Niloy; Khanra, Ritu; Dua, Tarun K.; Dewanjee, Saikat] Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata, India; [Das, Susmita; De, Bratati] Univ Calcutta, Dept Bot, Phytochem & Pharmacognosy Res Lab, Kolkata, India; [Zia-Ul-Haq, M.] Women Univ, Lahore Coll, Off Res Innovat & Commercializat, Lahore, Pakistan; [De Feo, Vincenzo] Univ Salerno, Dept Pharm, Salerno, Italy	Jadavpur University; University of Calcutta; University of Salerno	Dewanjee, S (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata, India.; De Feo, V (corresponding author), Univ Salerno, Dept Pharm, Salerno, Italy.	defeo@unisa.it; s.dewanjee@yahoo.com	De Feo, Vincenzo/AAF-2293-2019; KHANRA, RITU/AAV-4351-2021; Dua, Tarun Kumar/AAM-4891-2020; Dewanjee, Saikat/U-9778-2017	De Feo, Vincenzo/0000-0002-1070-3207; Dua, Tarun Kumar/0000-0001-5136-7564; DAS, SUSMITA/0000-0002-2782-8014; Dewanjee, Saikat/0000-0001-9085-4226	Department of Science and Technology (DST), New Delhi, India [1690-2012]	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India))	The financial support of the Department of Science and Technology (DST), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Niloy Bhattacharjee [Department of Science and Technology-Inspire fellowship Ref. No.: DST/INSPIRE Fellowship/2012 [1690-2012] dated 25th February, 2013].; The financial support of the Department of Science and Technology (DST), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Niloy Bhattacharjee [Department of Science and Technology-Inspire fellowship Ref. No.: DST/INSPIRE Fellowship/2012 [1690-2012] dated 25th February, 2013]. Authors are thankful to Jadavpur University, Kolkata, India for providing necessary facilities for this study. Finally, all authors would like to express their sincere gratitude to all the reviewers for their valuable comments to improve the quality of this manuscript.	Ahmad FK, 2005, CURR DRUG TARGETS, V6, P487, DOI 10.2174/1389450054021990; Ambika S., 2013, BIOMEDICINE AGING PA, V3, P253, DOI DOI 10.1016/j.biomag.2013.09.004; [Anonymous], 2009, INT J DIABETES METAB; Baghirova S, 2015, METHODSX, V2, P440, DOI 10.1016/j.mex.2015.11.001; Bastaki S., 2005, INT J DIABETES METAB, V13, P111; Bennett WL, 2011, COMP EFFECTIVENESS R; Bhandari U, 2013, FRONT LIFE SCI, V7, P186, DOI 10.1080/21553769.2014.881304; Bhattacharjee N, 2016, EUR J PHARMACOL, V791, P8, DOI 10.1016/j.ejphar.2016.08.022; Bhattacharya S, 2013, TOXICOL APPL PHARM, V267, P16, DOI 10.1016/j.taap.2012.12.005; Bolner A, 2011, CLIN LAB, V57, P859; Byeon SE, 2013, FREE RADICAL BIO MED, V57, P105, DOI 10.1016/j.freeradbiomed.2012.12.013; CARLSON EC, 1981, J ULTRA MOL STRUCT R, V77, P241, DOI 10.1016/S0022-5320(81)80022-6; Cheng Dong, 2005, Nutr Metab (Lond), V2, P29, DOI 10.1186/1743-7075-2-29; Choi J, 2004, PLANTA MED, V70, P1027, DOI 10.1055/s-2004-832642; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Das S, 2016, EUR FOOD RES TECHNOL, V242, P733, DOI 10.1007/s00217-015-2581-0; Dewanjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139831; Dewanjee S, 2009, FOOD CHEM TOXICOL, V47, P2679, DOI 10.1016/j.fct.2009.07.038; DHIMAN AK, 2006, AYURVEDIC DRUG PLANT; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dua TK, 2016, REDOX REP, V21, P147, DOI 10.1179/1351000215Y.0000000021; Dua TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148757; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0598-6; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0430-3; Eggli, 2007, ILLUSTRATED HDB SUCC, P158; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Haldar Pallab K., 2010, Diabetologia Croatica, V39, P115; Harini Ranganathan, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P79; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163; Kalofoutis Christos, 2007, Exp Clin Cardiol, V12, P17; Khanra R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0364-1; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; KIRTIKAR KR, 1935, INDIAN MED PLANTS, V4; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Li A, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/691594; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Lim EJ, 2008, BIOMOL THER, V16, P231, DOI 10.4062/biomolther.2008.16.3.231; Lin KT, 1997, BIOCHEM BIOPH RES CO, V230, P115, DOI 10.1006/bbrc.1996.5897; Makni M, 2011, EUR J PHARMACOL, V668, P133, DOI 10.1016/j.ejphar.2011.07.001; Manna P, 2012, BIOCHIMIE, V94, P786, DOI 10.1016/j.biochi.2011.11.010; Matsumura H., 1980, METHOD ENZYMOL, V69, P465, DOI DOI 10.1016/S0076-6879(80)69045-4; Mohammed A, 2016, J ETHNOPHARMACOL, V180, P131, DOI 10.1016/j.jep.2016.01.009; Mortan JF, 1981, ATLAS MED PLANTS MID; Nair Preetha, 1997, Indian Journal of Experimental Biology, V35, P451; Narasimhan A, 2015, APPL PHYSIOL NUTR ME, V40, P769, DOI 10.1139/apnm-2015-0002; NAYAK SS, 1981, CLIN CHIM ACTA, V109, P267; Nualkaew S., 2015, Journal of Medicinal Plants Research, V9, P629; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Patel BM, 2014, EUR J PHARMACOL, V728, P128, DOI 10.1016/j.ejphar.2014.01.063; Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743; Philip D., 2011, ASIAN J PHARM CLIN R, V4, P130; PHS (Public Health Service), 1986, PUBL HLTH SERV POL H; Pulliah T, 2019, ENCY WORLD MED PLANT, V2; Raghu KG, 2009, J TRACE ELEM MED BIO, V23, P61, DOI 10.1016/j.jtemb.2008.10.001; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Schulze C, 2014, MOL NUTR FOOD RES, V58, P1795, DOI 10.1002/mnfr.201400016; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Sulyman AO, 2016, J ETHNOPHARMACOL, V182, P122, DOI 10.1016/j.jep.2016.02.002; Szabo C, 2002, DRUG NEWS PERSPECT, V15, P197, DOI 10.1358/dnp.2002.15.4.840052; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Van de Laar FA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003639.pub2; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Venn-Watson SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132117; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; ZHANG YY, 1995, J NUTR, V125, P446; Zheng T, 2012, J ETHNOPHARMACOL, V139, P814, DOI 10.1016/j.jep.2011.12.025	72	11	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167131	10.1371/journal.pone.0167131	http://dx.doi.org/10.1371/journal.pone.0167131			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893829	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400090
J	Boeddha, NP; Driessen, GJ; Cnossen, MH; Hazelzet, JA; Emonts, M				Boeddha, Navin P.; Driessen, Gertjan J.; Cnossen, Marjon H.; Hazelzet, Jan A.; Emonts, Marieke			Circadian Variation of Plasminogen-Activator Inhibitor-1 Levels in Children with Meningococcal Sepsis	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; CASE-FATALITY; PROTEIN-C; MORTALITY; PAI-1; FIBRINOLYSIS; POLYMORPHISM; DISEASE; GENE	Objective To study whether the circadian variation of plasminogen-activator-inhibitor-1 (PAI-1) levels, with high morning levels, is associated with poor outcome of children with meningococcal sepsis presenting in the morning hours. Design Retrospective analysis of prospectively collected clinical and laboratory data. Setting Single center study at Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. Subjects 184 patients aged 3 weeks to 18 years with meningococcal sepsis. In 36 of these children, PAI-1 levels at admission to the PICU were measured in plasma by ELISA. Interventions None. Measurements and main results Circadian variation was studied by dividing one day in blocks of 6 hours. Patients admitted between 6:00 am and 12:00 am had increased illness severity scores and higher PAI-1 levels (n = 9, median 6912 ng/mL, IQR 5808-15600) compared to patients admitted at night (P = 0.019, n = 9, median 3546 ng/mL, IQR 1668-6118) or in the afternoon (P = 0.007, n = 7, median 4224 ng/mL, IQR 1804-5790). In 184 patients, analysis of circadian variation in relation to outcome showed more deaths, amputations and need for skin grafts in patients admitted to the PICU between 6:00 am and 12:00 am than patients admitted during the rest of the day (P = 0.009). Conclusions Circadian variation of PAI-1 levels is present in children with meningococcal sepsis and is associated with illness severity, with a peak level in the morning. Whether circadian variation is an independent risk factor for morbidity and mortality in meningococcal sepsis needs to be explored in future studies.	[Boeddha, Navin P.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands; [Boeddha, Navin P.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Boeddha, Navin P.; Driessen, Gertjan J.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Div Pediat Infect Dis & Immunol, Dept Pediat, Rotterdam, Netherlands; [Cnossen, Marjon H.] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Div Pediat Hematol, Dept Pediat, Rotterdam, Netherlands; [Hazelzet, Jan A.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Emonts, Marieke] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Paediat Infect Dis & Immunol Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Emonts, Marieke] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Hazelzet, JA (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	j.a.hazelzet@erasmusmc.nl	Driessen, Gertjan/AAI-9711-2020; Hazelzet, Jan A/L-2888-2015	Cnossen, Marjon H./0000-0003-1557-2995	European Union's seventh Framework program under EC-GA [279185]; Baxter Bioscience, Vienna, Austria	European Union's seventh Framework program under EC-GA; Baxter Bioscience, Vienna, Austria	Research leading to these results has received funding from the European Union's seventh Framework program under EC-GA no. 279185 (EUCLIDS). Also, research has been supported, in part, by an unrestricted grant from Baxter Bioscience, Vienna, Austria, in 2000. We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2001, CRIT CARE MED, V29, P1164, DOI 10.1097/00003246-200106000-00015; BRANDTZAEG P, 1990, THROMB RES, V57, P271, DOI 10.1016/0049-3848(90)90326-8; Couto-Alves A, 2013, CRIT CARE, V17, DOI 10.1186/cc12609; de Kleijn ED, 2003, CRIT CARE MED, V31, P1839, DOI 10.1097/01.CCM.0000072121.61120.D8; GLADSON CL, 1989, BLOOD, V74, P173; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; HALSTENSEN A, 1987, SCAND J INFECT DIS, V19, P35, DOI 10.3109/00365548709032375; Henry M, 1998, ARTERIOSCL THROM VAS, V18, P84, DOI 10.1161/01.ATV.18.1.84; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Khemani R, 2009, INTENS CARE MED, V35, P327, DOI 10.1007/s00134-008-1280-8; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Lewis MR, 2001, THROMB HAEMOSTASIS, V86, P1495, DOI 10.1055/s-0037-1616754; Lorente L, 2014, THROMB RES, V134, P182, DOI 10.1016/j.thromres.2014.04.013; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Scheer FAJL, 2014, BLOOD, V123, P590, DOI 10.1182/blood-2013-07-517060; Smith I, 2006, EPIDEMIOL INFECT, V134, P103, DOI 10.1017/S0950268805004553; van der Bom JG, 2003, BLOOD, V101, P1841, DOI 10.1182/blood-2002-07-2181; Zeerleder S, 2005, CHEST, V128, P2864, DOI 10.1378/chest.128.4.2864	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167004	10.1371/journal.pone.0167004	http://dx.doi.org/10.1371/journal.pone.0167004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893784	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400067
J	Hagerman, GF; Noel, NCL; Cao, SY; Duval, MG; Oel, P; Allison, WT				Hagerman, Gordon F.; Noel, Nicole C. L.; Cao, Sylvia Y.; DuVal, Michele G.; Oel, Phillip; Allison, W. Ted			Rapid Recovery of Visual Function Associated with Blue Cone Ablation in Zebrafish	PLOS ONE			English	Article							TELEOST RETINA; PHOTORECEPTOR DEVELOPMENT; SENSITIVE CONES; CELL-DEATH; STEM-CELLS; REGENERATION; ROD; TRANSPLANTATION; DEGENERATION; RESTORATION	Hurdles in the treatment of retinal degeneration include managing the functional rewiring of surviving photoreceptors and integration of any newly added cells into the remaining second-order retinal neurons. Zebrafish are the premier genetic model for such questions, and we present two new transgenic lines allowing us to contrast vision loss and recovery following conditional ablation of specific cone types: UV or blue cones. The ablation of each cone type proved to be thorough (killing 80% of cells in each intended cone class), specific, and cell-autonomous. We assessed the loss and recovery of vision in larvae via the optomotor behavioural response (OMR). This visually mediated behaviour decreased to about 5% or 20% of control levels following ablation of UV or blue cones, respectively (P<0.05). We further assessed ocular photoreception by measuring the effects of UV light on body pigmentation, and observed that photoreceptor deficits and recovery occurred (p<0.01) with a timeline coincident to the OMR results. This corroborated and extended previous conclusions that UV cones are required photoreceptors for modulating body pigmentation, addressing assumptions that were unavoidable in previous experiments. Functional vision recovery following UV cone ablation was robust, as measured by both assays, returning to control levels within four days. In contrast, robust functional recovery following blue cone ablation was unexpectedly rapid, returning to normal levels within 24 hours after ablation. Ablation of cones led to increased proliferation in the retina, though the rapid recovery of vision following blue cone ablation was demonstrated to not be mediated by blue cone regeneration. Thus rapid visual recovery occurs following ablation of some, but not all, cone subtypes, suggesting an opportunity to contrast and dissect the sources and mechanisms of outer retinal recovery during cone photoreceptor death and regeneration.	[Hagerman, Gordon F.; Noel, Nicole C. L.; Cao, Sylvia Y.; DuVal, Michele G.; Oel, Phillip; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Allison, WT (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.; Allison, WT (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014	Allison, W. Ted/0000-0002-8461-4864; Noel, Nicole C. L./0000-0001-9094-6745; DuVal, Michele/0000-0001-6975-8117	University of Alberta Undergraduate Research Initiative; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; NSERC; Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates [201500066] Funding Source: researchfish	University of Alberta Undergraduate Research Initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	NCLN was supported by the University of Alberta Undergraduate Research Initiative (http://www.uri.ualberta.ca). MGD was supported by MD/PhD Studentships from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and from Alberta Innovates Health Solutions. SYC was funded by Studentships from Alberta Innovates Health Solutions (http://www.aihealthsolutions.ca) and NSERC. APO was supported by a CGSM Studentship from NSERC. Research was funded by Operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC http://www.nserc-crsng.gc.ca) to WTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2006, VISUAL NEUROSCI, V23, P25, DOI 10.1017/S0952523806231031; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Biehlmaier O, 2001, CELL TISSUE RES, V306, P199, DOI 10.1007/s004410100447; CAMERON DA, 1995, J NEUROSCI, V15, P2255, DOI 10.1523/JNEUROSCI.15-03-02255.1995; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; DuVal MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092991; DuVal MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089183; Duval MG, 2013, MOL VIS, V19, P1082; Easter SS, 2000, NEUROSCIENTIST, V6, P454, DOI 10.1177/107385840000600608; Engstrom K, 1960, ACTA ZOOLOGICA, V41, P227; ENGSTROM KJELL, 1963, ACTA ZOOL, V44, P179; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; Fleisch VC, 2013, NEUROBIOL DIS, V55, P11, DOI 10.1016/j.nbd.2013.03.007; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Kim JW, 2016, DEV CELL, V37, P520, DOI 10.1016/j.devcel.2016.05.023; Krauss A, 2003, VISION RES, V43, P1273, DOI 10.1016/S0042-6989(03)00090-7; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lakowski J, 2015, STEM CELLS, V33, P2469, DOI 10.1002/stem.2051; Lorach H, 2015, INVEST OPHTH VIS SCI, V56, P4644, DOI 10.1167/iovs.14-16011; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mensinger AF, 1999, VISUAL NEUROSCI, V16, P241, DOI 10.1017/S0952523899162059; Mensinger AF, 2007, VISUAL NEUROSCI, V24, P299, DOI 10.1017/S0952523807070265; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Mueller KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087372; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Ogawa Y, 2015, P BIOL SCI, V282; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; RAYMOND PA, 1988, J NEUROBIOL, V19, P431, DOI 10.1002/neu.480190504; Raymond PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085325; Risner ML, 2006, VISION RES, V46, P2625, DOI 10.1016/j.visres.2005.12.014; Sher A, 2013, J NEUROSCI, V33, P6800, DOI 10.1523/JNEUROSCI.1044-12.2013; Shiraki T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1498, DOI 10.1039/c0pp00199f; Snelson CD, 2008, DEV DYNAM, V237, P3538, DOI 10.1002/dvdy.21607; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Takechi M, 2008, J BIOL CHEM, V283, P31625, DOI 10.1074/jbc.M806226200; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123; White DT, 2013, METHODS, V62, P232, DOI 10.1016/j.ymeth.2013.03.017; Yoshimatsu T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4699	55	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166932	10.1371/journal.pone.0166932	http://dx.doi.org/10.1371/journal.pone.0166932			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893779	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400059
J	Karbiener, M; Jarvis, JC; Perkins, JD; Lanmuller, H; Schmoll, M; Rode, HS; Gerstenberger, C; Gugatschka, M				Karbiener, Michael; Jarvis, Jonathan C.; Perkins, Justin D.; Lanmueller, Hermann; Schmoll, Martin; Rode, Hanna S.; Gerstenberger, Claus; Gugatschka, Markus			Reversing Age Related Changes of the Laryngeal Muscles by Chronic Electrostimulation of the Recurrent Laryngeal Nerve	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; PARALYZED CANINE LARYNX; VOICE; MANAGEMENT; DYSPHONIA; ISOFORMS; YOUNG	Age related atrophy of the laryngeal muscles -mainly the thyroarytenoid muscle (TAM)leads to a glottal gap and consequently to a hoarse and dysphonic voice that significantly affects quality of life. The aim of our study was to reverse this atrophy by inducing muscular hypertrophy by unilateral functional electrical stimulation (FES) of the recurrent laryngeal nerve (RLN) in a large animal model using aged sheep (n = 5). Suitable stimulation parameters were determined by fatiguing experiments of the thyroarytenoid muscle in an acute trial. For the chronic trial an electrode was placed around the right RLN and stimulation was delivered once daily for 29 days. We chose a very conservative stimulation pattern, total stimulation time was two minutes per day, or 0.14% of total time. Overall, the mean muscle fiber diameter of the stimulated right TAM was significantly larger than the non-stimulated left TAM (30 mu m +/- 1.1 mu m vs. 28 mu m +/- 1.1 mu m, p<0.001). There was no significant shift in fiber type distribution as judged by immunohistochemistry. The changes of fiber diameter could not be observed in the posterior cricoarytenoid muscle (PCAM). FES is a possible new treatment option for reversing the effects of age related laryngeal muscle atrophy.	[Karbiener, Michael; Gerstenberger, Claus; Gugatschka, Markus] Med Univ Graz, ENT Univ Hosp, Dept Phoniatr, Graz, Austria; [Jarvis, Jonathan C.; Schmoll, Martin] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England; [Perkins, Justin D.; Rode, Hanna S.] Royal Vet Coll, Dept Vet Clin Sci, London, England; [Lanmueller, Hermann; Schmoll, Martin] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Medical University of Graz; Liverpool John Moores University; University of London; University of London Royal Veterinary College; Medical University of Vienna	Gugatschka, M (corresponding author), Med Univ Graz, ENT Univ Hosp, Dept Phoniatr, Graz, Austria.	markus.gugatschka@medunigraz.at		Schmoll, Martin/0000-0001-6354-3879; Gugatschka, Markus/0000-0001-8091-8812; Gerstenberger, Claus/0000-0002-6756-2986	Austrian Research Promotion Agency [848458]	Austrian Research Promotion Agency	This study was funded by the Austrian Research Promotion Agency (Grant Nr.: 848458; https://www.ffg.at/).	Andreasen CM, 2015, BONE, V75, P32, DOI 10.1016/j.bone.2015.02.014; Bloch I, 2001, LARYNGOSCOPE, V111, P2022, DOI 10.1097/00005537-200111000-00029; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Cheetham J, 2015, ARTIF ORGANS, V39, P876, DOI 10.1111/aor.12624; Chen PH, 2009, DYSPHAGIA, V24, P1, DOI 10.1007/s00455-008-9156-1; Chen RL, 2008, J GERONTOL A-BIOL, V63, P141, DOI 10.1093/gerona/63.2.141; Chen RL, 2010, J NEUROCHEM, V113, P1230, DOI 10.1111/j.1471-4159.2010.06689.x; Connor NP, 2002, ANN OTO RHINOL LARYN, V111, P579, DOI 10.1177/000348940211100703; Davids T, 2012, LARYNGOSCOPE, V122, P332, DOI 10.1002/lary.22397; Eurostat Statistics Explained, 2015, EUROSTAT STAT EXPLAI; Forster G, 2013, EUR ARCH OTO-RHINO-L, V270, P225, DOI 10.1007/s00405-012-2141-1; Martins RHG, 2015, LARYNGOSCOPE, V125, P2518, DOI 10.1002/lary.25398; Hagen P, 1996, SOUTHERN MED J, V89, P204, DOI 10.1097/00007611-199602000-00009; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Johns MM, 2011, OTOLARYNG HEAD NECK, V145, P1, DOI 10.1177/0194599811404640; Kletzien H, 2016, LARYNGOSCOPE, V126, P672, DOI 10.1002/lary.25520; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luschei ES, 1999, J NEUROPHYSIOL, V81, P2131, DOI 10.1152/jn.1999.81.5.2131; McMullen CA, 2011, J SPEECH LANG HEAR R, V54, P845, DOI 10.1044/1092-4388(2010/10-0127); Nomura K, 2010, LARYNGOSCOPE, V120, P2399, DOI 10.1002/lary.21065; Paniello RC, 2015, LARYNGOSCOPE, V125, pE67, DOI 10.1002/lary.24947; Paniello RC, 2000, ANN OTO RHINOL LARYN, V109, P447, DOI 10.1177/000348940010900502; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; RAMIG LA, 1983, J SPEECH HEAR RES, V26, P22, DOI 10.1044/jshr.2601.22; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; RODENO MT, 1993, ACTA OTO-LARYNGOL, V113, P445, DOI 10.3109/00016489309135842; Roy N, 2007, LARYNGOSCOPE, V117, P628, DOI 10.1097/MLG.0b013e3180306da1; Sauermann S, 2007, BIOMED TECH, V52, P267, DOI 10.1515/BMT.2007.046; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P962, DOI 10.1177/000348940211101102; Tulloch LK, 2011, EQUINE VET J, V43, P500, DOI 10.1111/j.2042-3306.2010.00329.x; Van Daele DJ, 2010, J COMMUN DISORD, V43, P327, DOI 10.1016/j.jcomdis.2010.04.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verdonck-de Leeuw Irma M, 2004, J Voice, V18, P193, DOI 10.1016/j.jvoice.2003.10.002; Wu YZ, 2000, ARCH OTOLARYNGOL, V126, P874, DOI 10.1001/archotol.126.7.874; Zealear DL, 2009, LARYNGOSCOPE, V119, P1737, DOI 10.1002/lary.20587; Ziegler A, 2014, LARYNGOSCOPE, V124, P1869, DOI 10.1002/lary.24548	39	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167367	10.1371/journal.pone.0167367	http://dx.doi.org/10.1371/journal.pone.0167367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893858	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400114
J	Zhang, W; Liu, C; Hai, B; Du, GH; Wang, H; Leng, HJ; Xu, YS; Song, CL				Zhang, Wen; Liu, Can; Hai, Bao; Du, Guohong; Wang, Hong; Leng, Huijie; Xu, Yingsheng; Song, Chunli			A Convenient In Vivo Model Using Small Interfering RNA Silencing to Rapidly Assess Skeletal Gene Function	PLOS ONE			English	Article							BONE-FORMATION; DELIVERY; MICE; INJECTION; INHIBITION; METABOLISM; PHYSIOLOGY; MINIPIGS; INSULIN; RODENTS	It is difficult to study bone in vitro because it contains various cell types that engage in crosstalk. Bone biologically links various organs, and it has thus become increasingly evident that skeletal physiology must be studied in an integrative manner in an intact animal. We developed a model using local intraosseous small interfering RNA (siRNA) injection to rapidly assess the effects of a target gene on the local skeletal environment. In this model, 160-g male Sprague-Dawley rats were treated for 1-2 weeks. The left tibia received intraosseous injection of a parathyroid hormone 1 receptor (Pth1r) or insulin-like growth factor 1 receptor (Igf-1r) siRNA transfection complex loaded in poloxamer 407 hydrogel, and the right tibia received the same volume of control siRNA. All the tibias received an intraosseous injection of recombinant human parathyroid hormone (1-34) (rhPTH (1-34)) or insulin-like growth factor-1 (IGF-1). Calcein green and alizarin red were injected 6 and 2 days before euthanasia, respectively. IGF-1R and PTH1R expression levels were detected via RT-PCR assays and immunohistochemistry. Bone mineral density (BMD), microstructure, mineral apposition rates (MARs), and strength were determined by dual-energy X-ray absorptiometry, micro-CT, histology and biomechanical tests. The RT-PCR and immunohistochemistry results revealed that IGF-1R and PTH1R expression levels were dramatically diminished in the siRNA-treated left tibias compared to the right tibias (both p<0.05). Using poloxamer 407 hydrogel as a controlled-release system prolonged the silencing effect of a single dose of siRNA; the mRNA expression levels of IGF-1R were lower at two weeks than at one week (p<0.01). The BMD, bone microstructure parameters, MAR and bone strength were significantly decreased in the left tibias compared to the right tibias (all p<0.05). This simple and convenient local intraosseous siRNA injection model achieved gene silencing with very small quantities of siRNA over a short treatment period(<= 7 days).	[Zhang, Wen; Liu, Can; Hai, Bao; Du, Guohong; Wang, Hong; Leng, Huijie; Song, Chunli] Peking Univ, Hosp 3, Dept Orthopaed, Beijing, Peoples R China; [Zhang, Wen; Liu, Can; Hai, Bao; Wang, Hong; Leng, Huijie; Song, Chunli] Beijing Key Lab Spinal Dis, Beijing, Peoples R China; [Xu, Yingsheng] Peking Univ, Hosp 3, Dept Neurol, Beijing, Peoples R China	Peking University; Peking University	Song, CL (corresponding author), Peking Univ, Hosp 3, Dept Orthopaed, Beijing, Peoples R China.; Song, CL (corresponding author), Beijing Key Lab Spinal Dis, Beijing, Peoples R China.	schl@bjmu.edu.cn	Leng, Huijie/AGQ-9574-2022	Leng, Huijie/0000-0002-4436-061X	National Natural Science Foundation of China [81641079, 81171693, 81672133]; National High Technology Research and Development Program of China (863 Program) [2015AA020304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Project Nos. 81641079, 81171693 and 81672133) and the National High Technology Research and Development Program of China (863 Program, Project No. 2015AA020304). Dr. CLS and Dr. YSX received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Manasi, 2010, Curr Osteoporos Rep, V8, P205, DOI 10.1007/s11914-010-0028-x; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hattori S, 2014, J NUTR SCI VITAMINOL, V60, P152, DOI 10.3177/jnsv.60.152; Hoskins SL, 2012, RESUSCITATION, V83, P107, DOI 10.1016/j.resuscitation.2011.07.041; Kaleagasioglu F, 2015, KNEE SURG SPORTS TRA; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; LI XJ, 1995, BONE, V17, pS243, DOI 10.1016/8756-3282(95)00298-R; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Maria CS, 2016, SEMIN CELL DEV BIOL, V49, P11, DOI 10.1016/j.semcdb.2015.12.004; Massarwi M, 2013, AM J EMERG MED, V31, P1255, DOI 10.1016/j.ajem.2013.05.020; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Murray DB, 2012, ANN EMERG MED, V60, P424, DOI 10.1016/j.annemergmed.2012.05.013; Pan M, 2015, BMB REP, V48, P147, DOI 10.5483/BMBRep.2015.48.3.089; Peer D, 2011, GENE THER, V18, P1127, DOI 10.1038/gt.2011.56; Pillai O, 2003, J CONTROL RELEASE, V89, P127, DOI 10.1016/S0168-3659(03)00094-4; Qing FZ, 2016, J ORTHOP RES, V34, P1147, DOI 10.1002/jor.23128; Ripamonti U, 2010, BIOMATERIALS, V31, P6400, DOI 10.1016/j.biomaterials.2010.04.037; Rosen C, 2012, BONE, V50, P429, DOI 10.1016/j.bone.2011.10.006; Ruehe B, 2011, J ORAL IMPLANTOL, V37, P3, DOI 10.1563/AAID-JOI-D-09-00090; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tan J, 2016, OSTEOPOROSIS INT, V27, P757, DOI 10.1007/s00198-015-3230-y; Tan J, 2015, MED SCI MONITOR, V21, P1428, DOI 10.12659/MSM.892247; Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8; Ueda Y, 2016, IMMUNOBIOLOGY, V221, P1080, DOI 10.1016/j.imbio.2016.06.007; van't Hof RJ, 2000, P NATL ACAD SCI USA, V97, P7993, DOI 10.1073/pnas.130511497; Wang YC, 2013, INT J NANOMED, V8, P3805, DOI 10.2147/IJN.S48950; Wu SY, 2009, AAPS J, V11, P639, DOI 10.1208/s12248-009-9140-1; Yang N, 2014, J BONE MINER METAB, V32, P252, DOI 10.1007/s00774-013-0496-z	38	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167222	10.1371/journal.pone.0167222	http://dx.doi.org/10.1371/journal.pone.0167222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893850	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400104
J	Zhao, S; Tong, YH; Wang, ZT; Tan, SH				Zhao, Shuai; Tong, Yunhai; Wang, Zitian; Tan, Shaohua			Identifying Key Drivers of Return Reversal with Dynamical Bayesian Factor Graph	PLOS ONE			English	Article							STOCK-MARKET; PRICE; PREDICTION; INDEX; AUTOCORRELATIONS; OVERREACTION; LIQUIDITY; NETWORKS; MOMENTUM; BEHAVIOR	In the stock market, return reversal occurs when investors sell overbought stocks and buy oversold stocks, reversing the stocks' price trends. In this paper, we develop a new method to identify key drivers of return reversal by incorporating a comprehensive set of factors derived from different economic theories into one unified dynamical Bayesian factor graph. We then use the model to depict factor relationships and their dynamics, from which we make some interesting discoveries about the mechanism behind return reversals. Through extensive experiments on the US stock market, we conclude that among the various factors, the liquidity factors consistently emerge as key drivers of return reversal, which is in support of the theory of liquidity effect. Specifically, we find that stocks with high turnover rates or high Amihud illiquidity measures have a greater probability of experiencing return reversals. Apart from the consistent drivers, we find other drivers of return reversal that generally change from year to year, and they serve as important characteristics for evaluating the trends of stock returns. Besides, we also identify some seldom discussed yet enlightening inter-factor relationships, one of which shows that stocks in Finance and Insurance industry are more likely to have high Amihud illiquidity measures in comparison with those in other industries. These conclusions are robust for return reversals under different thresholds.	[Zhao, Shuai; Tong, Yunhai; Wang, Zitian; Tan, Shaohua] Peking Univ, Sch Elect Engn & Comp Sci, Minist Educ, Key Lab Machine Percept, Beijing, Peoples R China	Peking University	Zhao, S; Tong, YH (corresponding author), Peking Univ, Sch Elect Engn & Comp Sci, Minist Educ, Key Lab Machine Percept, Beijing, Peoples R China.	zhaoshuai2013@pku.edu.cn; yhtong@pku.edu.cn			Consulting Project of the Chinese Academy of Engineering [2016-XY-12]; Project of Beijing Technology Plan [Z161100001116060]	Consulting Project of the Chinese Academy of Engineering; Project of Beijing Technology Plan	This work is supported by the Consulting Project of the Chinese Academy of Engineering numbered as 2016-XY-12, and the Project of Beijing Technology Plan numbered as Z161100001116060.	Amihud Y, 2002, J FINANC MARK, V5, P31, DOI 10.1016/S1386-4181(01)00024-6; Avramov D, 2006, J FINANC, V61, P2365, DOI 10.1111/j.1540-6261.2006.01060.x; Blitz D, 2013, J FINANC MARK, V16, P477, DOI 10.1016/j.finmar.2012.10.005; BOUDOUKH J, 1994, REV FINANC STUD, V7, P539, DOI 10.1093/rfs/7.3.539; Choudhry T, 2015, INT J FINANC ECON, V20, P61, DOI 10.1002/ijfe.1494; Chu XJ, 2016, APPL ECON, V48, P1915, DOI 10.1080/00036846.2015.1109048; Conrad J, 1997, J BUS ECON STAT, V15, P379; Cooper M, 1999, REV FINANC STUD, V12, P901, DOI 10.1093/rfs/12.4.901; D'Mello R, 2003, J FINANC MARK, V6, P73, DOI 10.1016/S1386-4181(02)00023-X; Da Z, 2011, DECOMPOSING SHORT TE; Da Z, 2014, MANAGE SCI, V60, P658, DOI 10.1287/mnsc.2013.1766; de Groot W, 2012, J BANK FINANC, V36, P371, DOI 10.1016/j.jbankfin.2011.07.015; de Oliveira FA, 2013, EXPERT SYST APPL, V40, P7596, DOI 10.1016/j.eswa.2013.06.071; DEBONDT WFM, 1985, J FINANC, V40, P793, DOI 10.1111/j.1540-6261.1985.tb05004.x; DEBONDT WFM, 1987, J FINANC, V42, P557, DOI 10.1111/j.1540-6261.1987.tb04569.x; DEBONDT WFM, 1990, AM ECON REV, V80, P52; FAMA EF, 1993, J FINANC ECON, V33, P3, DOI 10.1016/0304-405X(93)90023-5; GEIGER D, 1990, NETWORKS, V20, P507, DOI 10.1002/net.3230200504; George TJ, 2007, J FINANC, V62, P2865, DOI 10.1111/j.1540-6261.2007.01295.x; GIVOLY D, 1983, J FINANC, V38, P171, DOI 10.2307/2327645; Grinblatt M, 2004, J FINANC ECON, V71, P51, DOI 10.1016/S0304-405X(03)00180-6; Gupta Anu, 2012, Progress in VLSI Design and Test. Proceedings 16th International Symposium, VDAT 2012, P1, DOI 10.1007/978-3-642-31494-0_1; Gutierrez RC, 2008, J FINANC, V63, P415, DOI 10.1111/j.1540-6261.2008.01320.x; Hameed A, 2015, J FINANC QUANT ANAL, V50, P89, DOI 10.1017/S0022109014000404; Heiberger RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135311; Hirschey M, 2003, J PORTFOLIO MANAGE, V29, P78, DOI 10.3905/jpm.2003.319886; Hojsgaard S, 2015, BAYESIAN NETWORKS R, P1; Hong H, 1999, J FINANC, V54, P2143, DOI 10.1111/0022-1082.00184; JEGADEESH N, 1990, J FINANC, V45, P881, DOI 10.2307/2328797; JEGADEESH N, 1995, J FINANC INTERMED, V4, P116, DOI 10.1006/jfin.1995.1006; KAUL G, 1990, J FINANC ECON, V28, P67, DOI 10.1016/0304-405X(90)90048-5; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; LEHMANN BN, 1990, Q J ECON, V105, P1, DOI 10.2307/2937816; Malin M, 2013, J INT FINANC MARK I, V25, P1, DOI 10.1016/j.intfin.2013.01.002; Nagel S, 2012, REV FINANC STUD, V25, P2005, DOI 10.1093/rfs/hhs066; Neuberg LG, 2003, ECONOMET THEOR, V19, P675, DOI 10.1017/S026646603004109; Otchere I., 2003, J BEHAV FINANC, V4, P157, DOI [10.1207/S15427579JPFM0403_5, DOI 10.1207/S15427579JPFM0403_5]; Patel J., 2007, PROFIT PRICES ALL YO; Patel J, 2015, EXPERT SYST APPL, V42, P2162, DOI 10.1016/j.eswa.2014.10.031; Patel J, 2015, EXPERT SYST APPL, V42, P259, DOI 10.1016/j.eswa.2014.07.040; Pearl J, 2014, PROBABILISTIC REASON; Qian XY, 2008, PHYSICA A, V387, P503, DOI 10.1016/j.physa.2007.09.029; Qian XY, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062816; Rather AM, 2015, EXPERT SYST APPL, V42, P3234, DOI 10.1016/j.eswa.2014.12.003; Rhee S.G., 1995, J BUSINESS FINANCE A, V22, P1035, DOI [10.1111/j.1468-5957.1995.tb00892.x, DOI 10.1111/J.1468-5957.1995.TB00892.X]; ROLL R, 1984, J FINANC, V39, P1127, DOI 10.2307/2327617; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Shi HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137892; Subrahmanyam A, 2005, FINANC REV, V40, P11, DOI 10.1111/j.0732-8516.2005.00091.x; Tang GYN, 2014, APPL ECON, V46, P1335, DOI 10.1080/00036846.2013.872767; Ticknor JL, 2013, EXPERT SYST APPL, V40, P5501, DOI 10.1016/j.eswa.2013.04.013; Tsamardinos I., 2003, P FLAIRS C, P376; Verma T., 1991, P 6 UAI C UAI 90, P255; Wang LL, 2015, EXPERT SYST APPL, V42, P6267, DOI 10.1016/j.eswa.2015.01.035; Wang Z, 2008, J ECON DYN CONTROL, V32, P3939, DOI 10.1016/j.jedc.2008.04.005; Zbikowski K., 2014, EXPERT SYSTEMS APPL, V42, P1797; Zhang XZ, 2014, NEUROCOMPUTING, V142, P48, DOI 10.1016/j.neucom.2014.01.057	57	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167050	10.1371/journal.pone.0167050	http://dx.doi.org/10.1371/journal.pone.0167050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893780	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400076
J	Brazdova, M; Tichy, V; Helma, R; Bazantova, P; Polaskova, A; Krejci, A; Petr, M; Navratilova, L; Ticha, O; Nejedly, K; Bennink, ML; Subramaniam, V; Babkova, Z; Martinek, T; Lexa, M; Adamik, M				Brazdova, Marie; Tichy, Vlastimil; Helma, Robert; Bazantova, Pavla; Polaskova, Alena; Krejci, Aneta; Petr, Marek; Navratilova, Lucie; Ticha, Olga; Nejedly, Karel; Bennink, Martin L.; Subramaniam, Vinod; Babkova, Zuzana; Martinek, Tomas; Lexa, Matej; Adamik, Matej			p53 Specifically Binds Triplex DNA In Vitro and in Cells	PLOS ONE			English	Article							C-TERMINAL DOMAIN; SUPPRESSOR PROTEIN P53; HIGH-AFFINITY; GENE-EXPRESSION; MUTANT P53; H-DNA; SEQUENCE; IDENTIFICATION; MODULATION; REQUIRES	Triplex DNA is implicated in a wide range of biological activities, including regulation of gene expression and genomic instability leading to cancer. The tumor suppressor p53 is a central regulator of cell fate in response to different type of insults. Sequence and structure specific modes of DNA recognition are core attributes of the p53 protein. The focus of this work is the structure-specific binding of p53 to DNA containing triplex-forming sequences in vitro and in cells and the effect on p53-driven transcription. This is the first DNA binding study of full-length p53 and its deletion variants to both intermolecular and intramolecular T.A.T triplexes. We demonstrate that the interaction of p53 with intermolecular T.A.T triplex is comparable to the recognition of CTG-hairpin non-B DNA structure. Using deletion mutants we determined the C-terminal DNA binding domain of p53 to be crucial for triplex recognition. Furthermore, strong p53 recognition of intramolecular T.A.T triplexes (H-DNA), stabilized by negative superhelicity in plasmid DNA, was detected by competition and immunoprecipitation experiments, and visualized by AFM. Moreover, chromatin immunoprecipitation revealed p53 binding T.A.T forming sequence in vivo. Enhanced reporter transactivation by p53 on insertion of triplex forming sequence into plasmid with p53 consensus sequence was observed by luciferase reporter assays. In-silico scan of human regulatory regions for the simultaneous presence of both consensus sequence and T.A.T motifs identified a set of candidate p53 target genes and p53-dependent activation of several of them (ABCG5, ENOX1, INSR, MCC, NFAT5) was confirmed by RT-qPCR. Our results show that T.A.T triplex comprises a new class of p53 binding sites targeted by p53 in a DNA structure-dependent mode in vitro and in cells. The contribution of p53 DNA structure-dependent binding to the regulation of transcription is discussed.	[Brazdova, Marie; Tichy, Vlastimil; Helma, Robert; Bazantova, Pavla; Polaskova, Alena; Petr, Marek; Navratilova, Lucie; Ticha, Olga; Nejedly, Karel; Adamik, Matej] Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Vvi, Brno, Czech Republic; [Krejci, Aneta; Babkova, Zuzana] Univ Vet & Pharmaceut Sci Brno, Dept Mol Biol & Pharmaceut Biotechnol, Fac Pharm, Brno, Czech Republic; [Bennink, Martin L.; Subramaniam, Vinod] Univ Twente, Fac Sci & Technol, Biophys Engn Grp, Enschede, Netherlands; [Martinek, Tomas] Brno Univ Technol, Fac Informat Technol, Dept Comp Syst, Brno, Czech Republic; [Lexa, Matej] Masaryk Univ, Fac Informat, Dept Informat Technol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Veterinary Sciences Brno; University of Twente; Brno University of Technology; Masaryk University Brno	Brazdova, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Vvi, Brno, Czech Republic.	maruska@ibp.cz	Subramaniam, Vinod/B-4197-2010; Lexa, Matej/S-7256-2019; Brazdova, Marie/H-1924-2014; Lexa, Matej/A-1772-2011; Tichy, Vlastimil/H-1913-2014; Bazantova, Pavla/J-2102-2017	Subramaniam, Vinod/0000-0001-6712-7266; Lexa, Matej/0000-0002-4213-5259; Adamik, Matej/0000-0003-0683-5853; Bazantova, Pavla/0000-0002-4221-1370; Soldanova, Zuzana/0000-0002-7757-776X	Czech Science Foundation [13-36108S, 204/06/P369, 15-02891S]; University of Veterinary and Pharmaceutical Sciences Brno [IGAVFU Brno 316/2016/FaF]; IT4Innovations excellence in science project [IT41 XS - LQ1602]; Czech Academy of Sciences [RV068081707]	Czech Science Foundation(Grant Agency of the Czech Republic); University of Veterinary and Pharmaceutical Sciences Brno; IT4Innovations excellence in science project; Czech Academy of Sciences(Czech Academy of Sciences)	This work was supported by the Czech Science Foundation (13-36108S and 204/06/P369 to MB, 15-02891S to ML), University of Veterinary and Pharmaceutical Sciences Brno (IGAVFU Brno 316/2016/FaF to AK), IT4Innovations excellence in science project (IT41 XS - LQ1602 to TM) and by the Czech Academy of Sciences (RV068081707 to VT, MB, RH, PB, AP, MP, LN, MA).	Adamik M, 2016, BIOCHIMIE; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Bacolla A, 2006, NUCLEIC ACIDS RES, V34, P2663, DOI 10.1093/nar/gkl354; Bacolla A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005696; BAKALKIN G, 1995, NUCLEIC ACIDS RES, V23, P362, DOI 10.1093/nar/23.3.362; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Brazdova M, 2002, NUCLEIC ACIDS RES, V30, P4966, DOI 10.1093/nar/gkf616; Brazdova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059567; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Buske FA, 2013, BIOINFORMATICS, V29, P1895, DOI 10.1093/bioinformatics/btt315; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Buzek J, 1999, J BIOMOL STRUCT DYN, V17, P41; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Cherny DI, 2005, BIOPHYS CHEM, V114, P261, DOI 10.1016/j.bpc.2004.12.042; Cobb AM, 2013, ANAL BIOCHEM, V442, P51, DOI 10.1016/j.ab.2013.07.033; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Dudenhoffer C, 1998, MOL CELL BIOL, V18, P5332, DOI 10.1128/MCB.18.9.5332; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; Fojta M, 2003, BIOCHEM PHARMACOL, V65, P1305, DOI 10.1016/S0006-2952(03)00078-9; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; FOX KR, 1990, NUCLEIC ACIDS RES, V18, P5387, DOI 10.1093/nar/18.18.5387; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Goni JR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-63; Guieysse AL, 1997, J MOL BIOL, V267, P289, DOI 10.1006/jmbi.1997.0884; Hamppa S, 2016, P NATL ACAD SCI USA, V113, pE4311, DOI 10.1073/pnas.1605828113; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kim E, 2003, BIOCHEM CELL BIOL, V81, P141, DOI 10.1139/o03-046; Kim H, 2012, J MOL BIOL, V415, P843, DOI 10.1016/j.jmb.2011.12.001; KIYAMA R, 1991, P NATL ACAD SCI USA, V88, P10450, DOI 10.1073/pnas.88.23.10450; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kudoh T, 2010, EXP CELL RES, V316, P2849, DOI 10.1016/j.yexcr.2010.06.025; Kusic J, 2010, MOL BIOL REP, V37, P2317, DOI 10.1007/s11033-009-9735-8; Lacroix L, 1999, BIOCHEMISTRY-US, V38, P1893, DOI 10.1021/bi982290q; Laptenko O, 2016, TRENDS BIOCHEM SCI, P6808, DOI [10.1128/MCB.22.19.6797-6808.2002, DOI 10.1128/MCB.22.19.6797-6808.2002]; Laptenko O, 2015, MOL CELL, V57, P1034, DOI 10.1016/j.molcel.2015.02.015; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Lexa M, 2014, BIOINFORMATICS 2014: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P80; Lexa M, 2011, BIOINFORMATICS, V27, P2510, DOI 10.1093/bioinformatics/btr439; Liu XF, 2016, EMBO REP, V17, P349, DOI 10.15252/embr.201540505; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Nejedly K, 2007, BIOPHYS CHEM, V125, P237, DOI 10.1016/j.bpc.2006.08.007; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Palecek E, 2004, ONCOGENE, V23, P2119, DOI 10.1038/sj.onc.1207324; PALECEK E, 1991, CRIT REV BIOCHEM MOL, V26, P151, DOI 10.3109/10409239109081126; Palecek E, 1997, ONCOGENE, V15, P2201, DOI 10.1038/sj.onc.1201398; Palecek E, 1999, ONCOGENE, V18, P3617, DOI 10.1038/sj.onc.1202710; PECINKA P, 1995, J BIOMOL STRUCT DYN, V13, P29; Petr M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160232; Quante T, 2012, CELL CYCLE, V11, P3290, DOI 10.4161/cc.21646; REED M, 1995, P NATL ACAD SCI USA, V92, P9455, DOI 10.1073/pnas.92.21.9455; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Sebest P, 2015, INT J MOL SCI, V16, P3163, DOI 10.3390/ijms16023163; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; Subramanian D, 2005, BIOCHEMISTRY-US, V44, P2536, DOI 10.1021/bi048700u; Szak ST, 1999, J BIOL CHEM, V274, P3904, DOI 10.1074/jbc.274.6.3904; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tebaldi T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1643-9; Tiwari MK, 2016, NUCLEIC ACIDS RES, V44, P7742, DOI 10.1093/nar/gkw515; Tutton S, 2016, EMBO J, V35, P193, DOI 10.15252/embj.201490880; van Noort SJT, 1998, BIOPHYS J, V74, P2840, DOI 10.1016/S0006-3495(98)77991-3; Vasquez KM, 2002, Q REV BIOPHYS, V35, P89, DOI 10.1017/S0033583502003773; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Walter K, 2005, J BIOL CHEM, V280, P42497, DOI 10.1074/jbc.M507038200; Wang B, 2014, CELL DEATH DIFFER, V21, P521, DOI 10.1038/cdd.2013.132; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang GL, 2008, JNCI-J NATL CANCER I, V100, P1815, DOI 10.1093/jnci/djn385; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zotchev SB, 2000, NUCLEIC ACIDS RES, V28, P4005, DOI 10.1093/nar/28.20.4005	86	13	13	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167439	10.1371/journal.pone.0167439	http://dx.doi.org/10.1371/journal.pone.0167439			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907175	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700156
J	Fratini, A; Bonci, T; Bull, AMJ				Fratini, Antonio; Bonci, Tecla; Bull, Anthony M. J.			Whole Body Vibration Treatments in Postmenopausal Women Can Improve Bone Mineral Density: Results of a Stimulus Focussed Meta-Analysis	PLOS ONE			English	Article							MUSCLE STRENGTH; MUSCULOSKELETAL; TRANSMISSION; EXERCISE; THERAPY; RISK	Whole body vibration treatment is a non-pharmacological intervention intended to stimulate muscular response and increase bone mineral density, particularly for postmenopausal women. The literature related to this topic is controversial, heterogeneous, and unclear despite the prospect of a major clinical effect. The aim of this study was to identify and systematically review the literature to assess the effect of whole body vibration treatments on bone mineral density (BMD) in postmenopausal women with a specific focus on the experimental factors that influence the stimulus. Nine studies fulfilled the inclusion criteria, including 527 postmenopausal women and different vibration delivery designs. Cumulative dose, amplitudes and frequency of treatments as well as subject posture during treatment vary widely among studies. Some of the studies included an associated exercise training regime. Both randomized and controlled clinical trials were included. Whole body vibration was shown to produce significant BMD improvements on the hip and spine when compared to no intervention. Conversely, treatment associated with exercise training resulted in negligible outcomes when compared to exercise training or to placebo. Moreover, side-alternating platforms were more effective in improving BMD values than synchronous platforms and mechanical oscillations of magnitude higher than 3 g and/or frequency lower than 25 Hz were also found to be effective. Treatments with a cumulative dose over 1000 minutes in the follow-up period were correlated to positive outcomes. Our conclusion is that whole body vibration treatments in elderly women can reduce BMD decline. However, many factors (e.g., amplitude, frequency and subject posture) affect the capacity of the vibrations to propagate to the target site; the adequate level of stimulation required to produce these effects has not yet been defined. Further biomechanical analyses to predict the propagation of the vibration waves along the body and assess the stimulation levels are required.	[Fratini, Antonio; Bonci, Tecla] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Bull, Anthony M. J.] Imperial Coll London, Dept Bioengn, London, England	Aston University; Imperial College London	Fratini, A (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England.	a.fratini@aston.ac.uk	Fratini, Antonio/N-3802-2019; Bonci, Tecla/W-5767-2019	Fratini, Antonio/0000-0001-8894-461X; Bonci, Tecla/0000-0002-8255-4730; Bull, Anthony M J/0000-0002-4473-8264				Alshurafa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049163; Beck BR, 2010, AM J PHYS MED REHAB, V89, P997, DOI 10.1097/PHM.0b013e3181f71063; Bemben DA, 2010, BONE, V47, P650, DOI 10.1016/j.bone.2010.06.019; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Cesarelli M, 2010, EURASIP J ADV SIG PR, P2010; Crombie IK, 2004, AGE AGEING, V33, P287, DOI 10.1093/ageing/afh089; El Maghraoui A, 2008, QJM-INT J MED, V101, P605, DOI 10.1093/qjmed/hcn022; Fesus G, 2008, DEMOGRAPHIC CHALLENG; Fratini A, 2014, COMPUT METH PROG BIO, V113, P314, DOI 10.1016/j.cmpb.2013.10.009; Fratini A, 2009, MED ENG PHYS, V31, P1166, DOI 10.1016/j.medengphy.2009.07.014; Gusi N, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-92; Haaland Derek A, 2009, BMC Geriatr, V9, P28, DOI 10.1186/1471-2318-9-28; Harazin B, 1998, J SOUND VIB, V215, P775, DOI 10.1006/jsvi.1998.1675; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Karakiriou SK, 2012, EUR J SPORT SCI, V12, P81, DOI 10.1080/17461391.2010.536581; Kiiski J, 2008, J BONE MINER RES, V23, P1318, DOI [10.1359/jbmr.080315, 10.1359/JBMR.080315]; Lai CL, 2013, CLIN INTERV AGING, V8, P1603, DOI 10.2147/CIA.S53591; Lau RWK, 2011, CLIN REHABIL, V25, P975, DOI 10.1177/0269215511405078; Lorenzen C, 2010, COCHRANE LIB; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Rauch F, 2010, J MUSCULOSKEL NEURON, V10, P193; Ruan XY, 2008, CHINESE MED J-PEKING, V121, P1155, DOI 10.1097/00029330-200807010-00001; Santin-Medeiros F, 2015, NUTR HOSP, V31, P1654, DOI 10.3305/nh.2015.31.4.8441; Slatkovska L, 2010, OSTEOPOROSIS INT, V21, P1969, DOI 10.1007/s00198-010-1228-z; Srinivasan B, 2012, OSTEOPOROSIS INT, V23, P155, DOI 10.1007/s00198-011-1822-8; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; von Stengel S, 2011, MED SCI SPORT EXER, V43, P1071, DOI 10.1249/MSS.0b013e318202f3d3; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	33	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166774	10.1371/journal.pone.0166774	http://dx.doi.org/10.1371/journal.pone.0166774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907000	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700039
J	Konagaya, Y; Miyakawa, R; Sato, M; Matsugami, A; Watanabe, S; Hayashi, F; Kigawa, T; Nishimura, C				Konagaya, Yuta; Miyakawa, Rina; Sato, Masumi; Matsugami, Akimasa; Watanabe, Satoru; Hayashi, Fumiaki; Kigawa, Takanori; Nishimura, Chiaki			Effect of Glu12-His89 Interaction on Dynamic Structures in HIV-1 p17 Matrix Protein Elucidated by NMR	PLOS ONE			English	Article							AMIDE PROTON-EXCHANGE; TRIPLE-RESONANCE NMR; ROTATIONAL DIFFUSION; PLASMA-MEMBRANE; SALT BRIDGES; BACKBONE DYNAMICS; GAG POLYPROTEIN; BINDING DOMAIN; TYPE-1; RELAXATION	To test the existence of the salt bridge and stability of the HIV-1 p17 matrix protein, an E12A (mutated at helix 1) was established to abolish possible electrostatic interactions. The chemical shift perturbation from the comparison between wild type and E12A suggested the existence of an electrostatic interaction in wild type between El 2 and H89 (located in helix 4). Unexpectedly, the studies using urea denaturation indicated that the E12A substitution slightly stabilized the protein. The dynamic structure of E12A was examined under physiological conditions by both amide proton exchange and relaxation studies. The quick exchange method of amide protons revealed that the residues with faster exchange were located at the mutated region, around A12, compared to those of the wild-type protein. In addition, some residues at the region of helix 4, including H89, exhibited faster exchange in the mutant. In contrast, the average values of the kinetic rate constants for amide proton exchange for residues located in all loop regions were slightly lower in E12A than in wild type. Furthermore, the analyses of the order parameter revealed that less flexible structures existed at each loop region in E12A. Interestingly, the structures of the regions including the alphal-2 loop and helix 5 of E12A exhibited more significant conformational exchanges with the NMR time-scale than those of wild type. Under lower pH conditions, for further destabilization, the helix 1 and alpha2-3 loop in E12A became more fluctuating than at physiological pH. Because the El 2A mutant lacks the activities for trimer formation on the basis of the analytical ultra-centrifuge studies on the sedimentation distribution of p17 (Fledderman et al. Biochemistry 49, 9551-9562, 2010), it is possible that the changes in the dynamic structures induced by the absence of the E12-H89 interaction in the p17 matrix protein contributes to a loss of virus assembly.	[Konagaya, Yuta; Miyakawa, Rina; Sato, Masumi; Nishimura, Chiaki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo, Japan; [Matsugami, Akimasa; Hayashi, Fumiaki] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Watanabe, Satoru; Kigawa, Takanori] RIKEN Quantitat Biol Ctr, Lab Biomol Struct & Dynam, Yokohama, Kanagawa, Japan	RIKEN; RIKEN	Nishimura, C (corresponding author), Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo, Japan.	cnishimura@thu.ac.jp	Kigawa, Takanori/A-7679-2010; watanabe, satoru s/E-9501-2012	Kigawa, Takanori/0000-0003-0146-9719; watanabe, satoru s/0000-0001-5329-9278	 [23107726];  [16K08204]; Grants-in-Aid for Scientific Research [16K08204] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (23107726) on Innovative Areas (Molecular Science of Fluctuations toward Biological Functions) and for Scientific Research C (16K08204) in Japan.	Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2013, J BIOL CHEM, V288, P666, DOI 10.1074/jbc.M112.399865; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Cannon PM, 1997, J VIROL, V71, P3474, DOI 10.1128/JVI.71.5.3474-3483.1997; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dolcetti R, 2015, P NATL ACAD SCI USA, V112, P14331, DOI 10.1073/pnas.1514748112; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Ellenrieder AD, 2004, BIOL CHEM, V385, P303, DOI 10.1515/BC.2004.026; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Goh GKM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-126; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; MATTHEWS S, 1994, NATURE, V370, P666, DOI 10.1038/370666a0; Morikawa Y, 1998, J VIROL, V72, P7659, DOI 10.1128/JVI.72.9.7659-7663.1998; Nayek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093862; Nishimura C, 2005, P NATL ACAD SCI USA, V102, P4765, DOI 10.1073/pnas.0409538102; Nishimura C, 2003, J MOL BIOL, V334, P293, DOI 10.1016/j.jmb.2003.09.042; Nishimura C, 2010, J MOL BIOL, V396, P1319, DOI 10.1016/j.jmb.2009.12.040; Ohori Y, 2014, BBA-PROTEINS PROTEOM, V1844, P520, DOI 10.1016/j.bbapap.2013.12.010; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Osborne MJ, 2001, J BIOMOL NMR, V19, P209, DOI 10.1023/A:1011283809984; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STONE MJ, 1993, BIOCHEMISTRY-US, V32, P426, DOI 10.1021/bi00053a007; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Taylor JE, 2012, BIOPHYS J, V103, P541, DOI 10.1016/j.bpj.2012.06.042; Tsan P, 2000, J AM CHEM SOC, V122, P5603, DOI 10.1021/ja993654k; Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009; Vlach J, 2014, J BIOL CHEM, V289, P8697, DOI 10.1074/jbc.M113.543694; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wu ZB, 2004, P NATL ACAD SCI USA, V101, P11587, DOI 10.1073/pnas.0404649101; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z	62	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167176	10.1371/journal.pone.0167176	http://dx.doi.org/10.1371/journal.pone.0167176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907055	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700087
J	Lee, J; Baek, SH; Ahn, SY; Chin, HJ; Na, KY; Chae, DW; Kim, S				Lee, Jeonghwan; Baek, Seon Ha; Ahn, Shin Young; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong			Pre-Stage Acute Kidney Injury Can Predict Mortality and Medical Costs in Hospitalized Patients	PLOS ONE			English	Article							WORSENING RENAL-FUNCTION; LENGTH-OF-STAY; SERUM CREATININE; MINIMAL CHANGES; DIALYSIS; INCREASES; FAILURE; DISEASE; DEFINITIONS; THERAPY	The significance of minimal increases in serum creatinine below the levels indicative of the acute kidney injury (AKI) stage is not well established. We aimed to investigate the influence of pre-stage AKI (pre-AKI) on clinical outcomes. We enrolled a total of 21,261 patients who were admitted to the Seoul National University Bundang Hospital from January 1, 2013 to December 31, 2013. Pre-AKI was defined as a 25-50% increase in peak serum creatinine levels from baseline levels during the hospital stay. In total, 5.4% of the patients had pre-AKI during admission. The patients with pre-AKI were predominantly female (55.0%) and had a lower body weight and lower baseline levels of serum creatinine (0.63 +/- 0.18 mg/dl) than the patients with AKI and the patients without AKI (P < 0.001). The patients with pre-AKI had a higher prevalence of diabetes mellitus (25.1%) and malignancy (32.6%). The adjusted hazard ratio of in-hospital mortality for pre-AKI was 2.112 [95% confidence interval (CI), 1.143 to 3.903]. In addition, patients with pre-AKI had an increased length of stay (7.7 +/- 9.7 days in patients without AKI, 11.4 +/- 11.4 days in patients with pre-AKI, P < 0.001) and increased medical costs (4,061 +/- 4,318 USD in patients without AKI, 4,966 +/- 5,099 USD in patients with pre-AKI, P < 0.001) during admission. The adjusted hazard ratio of all-cause mortality for pre-AKI during the follow-up period of 2.0 +/- 0.6 years was 1.473 (95% CI, 1.228 to 1.684). Although the adjusted hazard ratio of pre-AKI for overall mortality was not significant among the patients admitted to the surgery department or who underwent surgery, pre-AKI was significantly associated with mortality among the non-surgical patients (adjusted HR 1.542 [95% CI, 1.330 to 1.787]) and the patients admitted to the medical department (adjusted HR 1.384 [95% CI, 1.153 to 1.662]). Pre-AKI is associated with increased mortality, longer hospital stay, and increased medical costs during admission. More attention should be paid to the clinical significance of pre-AKI.	[Lee, Jeonghwan] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Baek, Seon Ha; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Ahn, Shin Young] Korea Univ, Guro Hosp, Med Ctr, Dept Internal Med, Seoul, South Korea	Hallym University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	sejoong2@snu.ac.kr	Lee, Jeonghwan/C-5214-2011; Kim, Sejoong/J-5356-2015	Lee, Jeonghwan/0000-0003-3199-635X; Kim, Sejoong/0000-0002-7238-9962	Young Investigator Research Grant from the Korean Society of Nephrology (Kyowa Hakko Kirin) [06-2014-151]; SNUBH Research Fund [02-2014-058]	Young Investigator Research Grant from the Korean Society of Nephrology (Kyowa Hakko Kirin); SNUBH Research Fund	This study was supported by the Young Investigator Research Grant (no 06-2014-151) from the Korean Society of Nephrology (Kyowa Hakko Kirin 2014) and was Supported by grant no 02-2014-058 from the SNUBH Research Fund. The sponsors of this study played no role in its design, or in the collection, analysis, or interpretation of data, or the writing of the report.	Baek SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156444; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Garner AE, 2012, ANN CLIN BIOCHEM, V49, P59, DOI 10.1258/acb.2011.011125; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Jin DC, 2015, KIDNEY INT SUPPL, V5, P8, DOI 10.1038/kisup.2015.3; Jin DC, 2015, KOREAN J INTERN MED, V30, P17, DOI 10.3904/kjim.2015.30.1.17; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kork F, 2015, ANESTHESIOLOGY, V123, P1301, DOI 10.1097/ALN.0000000000000891; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liotta M, 2014, AM J CARDIOL, V113, P70, DOI 10.1016/j.amjcard.2013.09.012; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Siew ED, 2013, CLIN J AM SOC NEPHRO, V8, P10, DOI 10.2215/CJN.00200112; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zavada J, 2010, NEPHROL DIAL TRANSPL, V25, P3911, DOI 10.1093/ndt/gfp766	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167038	10.1371/journal.pone.0167038	http://dx.doi.org/10.1371/journal.pone.0167038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907046	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700069
J	Gonzalez, RP; Comba, PC; Esteban, MR; Sanchez, JJA; Afonso, JH; Perez, MDR; Rodriguez, IM; Diaz, BB; Elosua, R; de Leon, AC				Pimienta Gonzalez, Raquel; Couto Comba, Patricia; Rodriguez Esteban, Marcos; Aleman Sanchez, Jose Juan; Hernandez Afonso, Julio; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Elosua, Roberto; Cabrera de Leon, Antonio			Incidence, Mortality and Positive Predictive Value of Type 1 Cardiorenal Syndrome in Acute Coronary Syndrome	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; 11TH CONSENSUS CONFERENCE; MYOCARDIAL-INFARCTION; HEART-FAILURE; RENAL-FUNCTION; OUTCOMES; GUIDELINES; PATHOPHYSIOLOGY; DETERIORATION; PATHOGENESIS	Objectives To determine whether the risk of cardiovascular mortality associated with cardiorenal syndrome subtype 1 (CRS1) in patients who were hospitalized for acute coronary syndrome (ACS) was greater than the expected risk based on the sum of its components, to estimate the predictive value of CRS1, and to determine whether the severity of CRS1 worsens the prognosis. Methods Follow-up study of 1912 incident cases of ACS for 1 year after discharge. Cox regression models were estimated with time to event (in-hospital death, and readmission or death during the first year after discharge) as the dependent variable. Results The incidence of CRS1 was 9.2/1000 person-days of hospitalization (95% CI = 8.1-10.5), but these patients accounted for 56.6% (95% CI = 47.4-65.) of all mortality. The positive predictive value of CRS1 was 29.6% (95% CI = 23.9-36.0) for in-hospital death, and 51.4% (95% CI = 44.8-58.0) for readmission or death after discharge. The risk of in-hospital death from CRS1 (RR = 18.3; 95% CI = 6.3-53.2) was greater than the sum of risks associated with either acute heart failure (RR = 7.6; 95% CI = 1.8-31.8) or acute kidney injury (RR = 2.8; 95% CI = 0.9-8.8). The risk of events associated with CRS1 also increased with syndrome severity, reaching a RR of 10.6 (95% CI = 6.2-18.1) for in-hospital death at the highest severity level. Conclusions The effect of CRS1 on in-hospital mortality is greater than the sum of the effects associated with each of its components, and it increases with the severity of the syndrome. CRS1 accounted for more than half of all mortality, and its positive predictive value approached 30% in-hospital and 50% after discharge.	[Pimienta Gonzalez, Raquel; Couto Comba, Patricia; Rodriguez Esteban, Marcos; Hernandez Afonso, Julio] Hosp Univ Nuestra Senora de la Candelaria, Serv Cardiol, Santa Cruz De Tenerife, Spain; [Aleman Sanchez, Jose Juan; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Cabrera de Leon, Antonio] Unidad Invest Atenc Primaria, Santa Cruz De Tenerife, Spain; [Aleman Sanchez, Jose Juan; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Cabrera de Leon, Antonio] Hosp Univ Nuestra Senora de la Candelaria, Santa Cruz De Tenerife, Spain; [Aleman Sanchez, Jose Juan; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Elosua, Roberto; Cabrera de Leon, Antonio] Inst Salud Carlos III, Red Invest Cardiovasc, Madrid, Spain; [Elosua, Roberto] IMIM, Epidemiol Cardiovasc & Genet, Barcelona, Spain; [Cabrera de Leon, Antonio] Univ La Laguna, Area Med Prevent & Salud Publ, San Cristobal la Laguna, Spain	Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universidad de la Laguna	de Leon, AC (corresponding author), Unidad Invest Atenc Primaria, Santa Cruz De Tenerife, Spain.; de Leon, AC (corresponding author), Hosp Univ Nuestra Senora de la Candelaria, Santa Cruz De Tenerife, Spain.; de Leon, AC (corresponding author), Inst Salud Carlos III, Red Invest Cardiovasc, Madrid, Spain.; de Leon, AC (corresponding author), Univ La Laguna, Area Med Prevent & Salud Publ, San Cristobal la Laguna, Spain.	acableo@gobiernodecanarias.org	Marcelino-Rodríguez, Itahisa/AAH-1469-2021; Marcelino-RodrÃguez, Itahisa/AGE-3176-2022; Hernandez Afonso, Julio/I-2223-2017	Marcelino-Rodríguez, Itahisa/0000-0003-3645-3207; ELOSUA, ROBERTO/0000-0001-8235-0095; Hernandez Afonso, Julio/0000-0002-0982-1759	Canary Islands Health Service; Spanish Government (Institute de Salud Carlos III FEDER) [RD12/0042/0031, 0013]	Canary Islands Health Service; Spanish Government (Institute de Salud Carlos III FEDER)	This study was supported by the Canary Islands Health Service and the Spanish Government (Institute de Salud Carlos III, RD12/0042/0031 and 0013. FEDER).	Ali SF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000171; Cho E, 2013, NEPHROL DIAL TRANSPL, V28, P2766, DOI 10.1093/ndt/gft376; Eren Z, 2012, CARDIORENAL MED, V2, P168, DOI 10.1159/000337714; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Gillespie CD, 2009, MMWR SURVEILL SUMM S, V62; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; Ismail Y, 2012, SEMIN NEPHROL, V32, P18, DOI 10.1016/j.semnephrol.2011.11.003; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kellum JA, 2002, KIDNEY INT, V62, P1855, DOI 10.1046/j.1523-1755.2002.00613.x; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Marana I, 2014, NEPHROL THER, V10, P203, DOI 10.1016/j.nephro.2014.02.006; Marui A, 2015, AM J CARDIOL, V115, P1063, DOI 10.1016/j.amjcard.2015.01.544; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ronco C, 2010, CONTRIB NEPHROL, V164, P33, DOI 10.1159/000313718; Roubille F, 2014, BLOOD PURIFICAT, V37, P20, DOI 10.1159/000361061; Roy AK, 2013, CARDIORENAL MED, V3, P26, DOI 10.1159/000347037; Shacham Y, 2015, CAN J CARDIOL, V31, P1240, DOI 10.1016/j.cjca.2015.03.031; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Virzi GM, 2014, CARDIORENAL MED, V4, P103, DOI 10.1159/000362650	27	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167166	10.1371/journal.pone.0167166	http://dx.doi.org/10.1371/journal.pone.0167166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907067	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700085
J	Xia, F; Su, XY; Wang, W; Zhang, CX; Ning, ZL; Lee, I				Xia, Feng; Su, Xiaoyan; Wang, Wei; Zhang, Chenxin; Ning, Zhaolong; Lee, Ivan			Bibliographic Analysis of Nature Based on Twitter and Facebook Altmetrics Data	PLOS ONE			English	Article							RESEARCH IMPACT; CITATIONS; TWEETS	This paper presents a bibliographic analysis of Nature articles based on altmetrics. We assess the concern degree of social users on the Nature articles through the coverage analysis of Twitter and Facebook by publication year and discipline. The social media impact of a Nature article is examined by evaluating the mention rates on Twitter and on Facebook. Moreover, the correlation between tweets and citations is analyzed by publication year, discipline and Twitter user type to explore factors affecting the correlation. The results show that Twitter users have a higher concern degree on Nature articles than Facebook users, and Nature articles have higher and faster-growing impact on Twitter than on Facebook. The results also show that tweets and citations are somewhat related, and they mostly measure different types of impact. In addition, the correlation between tweets and citations highly depends on publication year, discipline and Twitter user type.	[Xia, Feng; Su, Xiaoyan; Wang, Wei; Zhang, Chenxin; Ning, Zhaolong] Dalian Univ Technol, Sch Software, Dalian 116621, Peoples R China; [Lee, Ivan] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5095, Australia	Dalian University of Technology; University of South Australia	Ning, ZL (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116621, Peoples R China.	zhaologning@dlut.edu.cn	Ning, Zhaolong/ABI-3626-2022; Xia, Feng/Y-2859-2019; Lee, Ivan/F-4131-2013; Wang, Wei/GYU-4649-2022	Ning, Zhaolong/0000-0002-7870-5524; Xia, Feng/0000-0002-8324-1859; Lee, Ivan/0000-0002-2826-6367; Wang, Wei/0000-0002-1717-5785				Bornmann L, 2016, SCIENTOMETRICS, V107, P1405, DOI 10.1007/s11192-016-1893-6; Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005; Bornmann L, 2014, J INFORMETR, V8, P935, DOI 10.1016/j.joi.2014.09.007; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; Darling ES, 2013, IDEAS ECOL EVOL, V6, DOI 10.4033/iee.2013.6.6.f; de Winter JCF, 2015, SCIENTOMETRICS, V102, P1773, DOI 10.1007/s11192-014-1445-x; Erdt M, 2016, SCIENTOMETRICS, V109, P1117, DOI 10.1007/s11192-016-2077-0; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Fenner M., 2014, OPENING SCI EVOLVING, P179, DOI [10.1007/978-3-319-00026-8_12, DOI 10.1007/978-3-319-00026-8_12]; Hammarfelt B, 2014, SCIENTOMETRICS, V101, P1419, DOI 10.1007/s11192-014-1261-3; Haustein S, 2014, SCIENTOMETRICS, V101, P1145, DOI 10.1007/s11192-013-1221-3; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Jung H, 2016, FRONTIERS RES METRIC, V1, P6, DOI [10.3389/frma.2016.00006, DOI 10.3389/FRMA.2016.00006]; Kousha K, 2014, J ASSOC INF SCI TECH, V65, P1615, DOI 10.1002/asi.23070; Ortega JL, 2015, J INFORMETR, V9, P39, DOI 10.1016/j.joi.2014.11.004; Patel A, 2016, BRIT J GEN PRACT, V66, pE59, DOI 10.3399/bjgp16X683353; Piwowar Heather, 2013, Bulletin of the American Society for Information Science and Technology, V39, P10; Priem J., 2010, P AM SOC INFORM SCI, V47, P1, DOI [10.1002/meet.14504701201, DOI 10.1002/MEET.14504701201]; Priem J, ALTMETRICS MANIFESTO; Priem J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048753; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Thelwall M, 2015, J ASSOC INF SCI TECH, V66, P876, DOI 10.1002/asi.23236; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Tonia T, 2016, INT J PUBLIC HEALTH, V61, P513, DOI 10.1007/s00038-016-0831-y; Wouters P., 2012, USERS NARCISSISM CON; Yu MC, 2016, COMPUT HUM BEHAV, V55, P1001, DOI 10.1016/j.chb.2015.11.007; Zahedi Z, 2014, SCIENTOMETRICS, V101, P1491, DOI 10.1007/s11192-014-1264-0	28	58	58	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165997	10.1371/journal.pone.0165997	http://dx.doi.org/10.1371/journal.pone.0165997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906981	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000389482700013
J	Yang, X; Zeng, ZX; Wang, RD; Sun, XS				Yang, Xin; Zeng, Zhenxiang; Wang, Ruidong; Sun, Xueshan			Bi-Objective Flexible Job-Shop Scheduling Problem Considering Energy Consumption under Stochastic Processing Times	PLOS ONE			English	Article							MATHEMATICAL-MODELS; UNCERTAINTY	This paper presents a novel method on the optimization of bi-objective Flexible Job-shop Scheduling Problem (FJSP) under stochastic processing times. The robust counterpart model and the Non-dominated Sorting Genetic Algorithm II (NSGA-II) are used to solve the bi-objective FJSP with consideration of the completion time and the total energy consumption under stochastic processing times. The case study on GM Corporation verifies that the NSGA-II used in this paper is effective and has advantages to solve the proposed model comparing with HPSO and PSO+SA. The idea and method of the paper can be generalized widely in the manufacturing industry, because it can reduce the energy consumption of the energy-intensive manufacturing enterprise with less investment when the new approach is applied in existing systems.	[Yang, Xin; Zeng, Zhenxiang] Hebei Univ Technol, Sch Econ & Management, Tianjin, Peoples R China; [Yang, Xin; Sun, Xueshan] Tianjin Univ Technol, ZhongHuan Informat Coll, Tianjin, Peoples R China; [Wang, Ruidong] Tianjin Univ Technol, Dept Math, Tianjin, Peoples R China	Hebei University of Technology; Tianjin University of Technology; Tianjin University of Technology	Yang, X; Zeng, ZX (corresponding author), Hebei Univ Technol, Sch Econ & Management, Tianjin, Peoples R China.	wing.lps@163.com; xzeng@hebut.edu.cn			Science technology Support Plan of Hebei Province [14210102D]	Science technology Support Plan of Hebei Province	This research was funded by a Science technology Support Plan of Hebei Province (Grant Number: 14210102D) http://www.hensf.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabani AB, 2011, APPL SOFT COMPUT, V11, P4954, DOI 10.1016/j.asoc.2011.06.004; Bonfill A, 2008, COMPUT CHEM ENG, V32, P1689, DOI 10.1016/j.compchemeng.2007.08.014; Ciro GC, 2016, IFAC PAPERSONLINE, V49, P1272, DOI 10.1016/j.ifacol.2016.07.690; Demir Y, 2013, APPL MATH MODEL, V37, P977, DOI 10.1016/j.apm.2012.03.020; Dou H, 2016, PERS UBIQUIT COMPUT, V20, P681, DOI 10.1007/s00779-016-0941-9; Dou H, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P210, DOI 10.1109/IIKI.2015.52; Fang K., 2011, GLOCALIZED SOLUTIONS, P305, DOI DOI 10.1007/978-3-642-19692-8_53; Fattahi P, 2007, J INTELL MANUF, V18, P331, DOI 10.1007/s10845-007-0026-8; Gutowski T, 2005, J CLEAN PROD, V13, P1, DOI 10.1016/j.jclepro.2003.10.004; He C., 2013, LECT NOTES ELECT ENG, V211, P393, DOI [10.1007/978-3-642-34522-7_42, DOI 10.1007/978-3-642-34522-7_42]; Honkomp SJ, 1997, COMPUT CHEM ENG, V21, pS1055; Hosseinabadi AAR, 2015, ANN OPER RES, V229, P451, DOI 10.1007/s10479-014-1770-8; Janak SL, 2007, COMPUT CHEM ENG, V31, P171, DOI 10.1016/j.compchemeng.2006.05.035; Jiang D, 2016, IEEE INTERNET THINGS; Lei D, 2012, INT J ADV MANUF TECH, V60, P291, DOI 10.1007/s00170-011-3600-3; Lei DM, 2011, COMPUT IND ENG, V61, P1200, DOI 10.1016/j.cie.2011.07.010; Li L., 2011, THESIS; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Mehmood A, 2014, NETWORK PROTOCOLS AL, V6; Mouzon G, 2007, INT J PROD RES, V45, P4247, DOI 10.1080/00207540701450013; Navaz S, 2012, INT J SCI RES PUBLIC, V2, P1; Ozguven C, 2010, APPL MATH MODEL, V34, P1539, DOI 10.1016/j.apm.2009.09.002; Peng Y, 2016, INT J GRID DISTRIB, V9, P161, DOI 10.14257/ijgdc.2016.9.4.15; Pooranian Z, 2015, J COMB OPTIM, V30, P413, DOI 10.1007/s10878-013-9644-6; Pooranian Z, 2013, INFORM-J COMPUT INFO, V37, P157; Shamshirband S, 2015, ANN OPER RES, V229, P743, DOI 10.1007/s10479-015-1855-z; Sun YC, 2017, J NETW COMPUT APPL, V83, P204, DOI 10.1016/j.jnca.2015.10.018; Sun ZY, 2017, WIREL NETW, V23, P1201, DOI 10.1007/s11276-016-1213-3; Tang Qiu-hua, 2015, Computer Integrated Manufacturing Systems, V21, P1002, DOI 10.13196/j.cims.2015.04.015; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; XIONG Rui, 1998, J TSINGHUA U SCI TEC, V38, P55; Xu Zhen-hao, 2004, Computer Integrated Manufacturing Systems, V10, P1247; Yu Xiaoyi, 2008, China Mechanical Engineering, V19, P2319; Zheng J., 2007, MULTI OBJECTIVE EVOL, P2	34	10	11	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167427	10.1371/journal.pone.0167427	http://dx.doi.org/10.1371/journal.pone.0167427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907163	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700153
J	Zakataeva, NP; Romanenkov, DV; Yusupova, YR; Skripnikova, VS; Asahara, T; Gronskiy, SV				Zakataeva, Natalia P.; Romanenkov, Dmitriy V.; Yusupova, Yuliya R.; Skripnikova, Victoria S.; Asahara, Takayuki; Gronskiy, Sergey V.			Identification, Heterologous Expression, and Functional Characterization of Bacillus subtilis YutF, a HAD Superfamily 5'-Nucleotidase with Broad Substrate Specificity	PLOS ONE			English	Article							GENERAL ENZYMATIC SCREENS; ESCHERICHIA-COLI; DEHALOGENASE SUPERFAMILY; CYTOPLASMIC 5'-NUCLEOTIDASES; PHOSPHATASE; REGULATOR; SEQUENCE; NUCLEOTIDE; PROTEINS; USHA	5'-nucleotidases (EC 3.1.3.5) catalyze the hydrolytic dephosphorylation of 5'-ribonucleotides and 5'-deoxyribonucleotides as well as complex nucleotides, such as uridine 5'-diphosphoglucose (UDP-glucose), nicotinamide adenine dinucleotide and flavin adenine dinucleotide, to their corresponding nucleosides plus phosphate. These enzymes have been found in diverse species in intracellular and membrane-bound, surface-localized forms. Soluble forms of 5'-nucleotidases belong to the ubiquitous haloacid dehalogenase superfamily (HADSF) and have been shown to be involved in the regulation of nucleotide, nucleoside and nicotinamide adenine dinucleotide (NAD(+)) pools. Despite the important role of 5'-nucleotidases in cellular metabolism, only a few of these enzymes have been characterized in the Gram-positive bacterium Bacillus subtilis, the workhorse industrial microorganism included in the Food and Drug Administration's GRAS (generally regarded as safe) list. In the present study, we report the identification of a novel 5'-nucleotidase gene from B. subtilis, yutF, which comprises 771 bp encoding a 256-amino-acid protein belonging to the IIA subfamily of the HADSF. The gene product is responsible for the major p-nitrophenyl phosphatase activity in B. subtilis. The yutF gene was overexpressed in Escherichia coli, and its product fused to a polyhistidine tag was purified and biochemically characterized as a soluble 5'-nucleotidase with broad substrate specificity. The recombinant YutF protein was found to hydrolyze various purine and pyrimidine 5'-nucleotides, showing preference for 5'nucleoside monophosphates and, specifically, 5'-XMP. Recombinant YutF also exhibited phosphohydrolase activity toward nucleotide precursors, ribose-5-phosphate and 5-phosphoribosyl- 1-pyrophosphate. Determination of the kinetic parameters of the enzyme revealed a low substrate specificity (Km values in the mM concentration range) and modest catalytic efficiencies with respect to substrates. An initial study of the regulation of yutF expression showed that the yutF gene is a component of the yutDEF transcription unit and that YutF overproduction positively influences yutDEF expression.	[Zakataeva, Natalia P.; Romanenkov, Dmitriy V.; Yusupova, Yuliya R.; Skripnikova, Victoria S.; Gronskiy, Sergey V.] Ajinomoto Genet Res Inst, Moscow, Russia; [Asahara, Takayuki] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan	Ajinomoto Co Inc; Ajinomoto Co Inc	Zakataeva, NP (corresponding author), Ajinomoto Genet Res Inst, Moscow, Russia.	natalia_zakataeva@agri.ru		Zakataeva, Natalia/0000-0002-0976-9874	Ajinomoto-Genetika Research Institute, Moscow, Russia; Research Institute for Bioscience Products & Fine Chemicals Ajinomoto Co., Inc, Kawasaki, Kanagawa, Japan; Ajinomoto Co., Inc	Ajinomoto-Genetika Research Institute, Moscow, Russia; Research Institute for Bioscience Products & Fine Chemicals Ajinomoto Co., Inc, Kawasaki, Kanagawa, Japan; Ajinomoto Co., Inc	Ajinomoto-Genetika Research Institute, Moscow, Russia and Research Institute for Bioscience Products & Fine Chemicals Ajinomoto Co., Inc, Kawasaki, Kanagawa, Japan are research centers of Ajinomoto Co., Inc. Ajinomoto Co., Inc provided support in the form of salaries for authors NPZ DVR YRY VSS TA SVG, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin VV, 1999, FEMS MICROBIOL LETT, V178, P47, DOI 10.1016/S0378-1097(99)00343-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTONIEWSKI C, 1990, J BACTERIOL, V172, P86, DOI 10.1128/JB.172.1.86-93.1990; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Biswas T, 2009, J BIOL CHEM, V284, P30594, DOI 10.1074/jbc.M109.012278; Bogan KL, 2010, NEW J CHEM, V34, P845, DOI 10.1039/b9nj00758j; Borowiec A, 2006, ACTA BIOCHIM POL, V53, P269; BURNS DM, 1986, NUCLEIC ACIDS RES, V14, P4325, DOI 10.1093/nar/14.10.4325; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cariani L, 2004, ANAL BIOCHEM, V324, P79, DOI 10.1016/j.ab.2003.09.008; Chambert R, 2003, J BIOCHEM, V134, P655, DOI 10.1093/jb/mvg189; DEMAIN AL, 1967, J BACTERIOL, V94, P66, DOI 10.1128/JB.94.1.66-74.1967; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Godinho LM, 2011, FEBS J, V278, P2511, DOI 10.1111/j.1742-4658.2011.08177.x; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Immormino RM, 2015, BIOCHEMISTRY-US, V54, P3514, DOI 10.1021/acs.biochem.5b00286; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; OZAKI H, 1979, J BIOCHEM-TOKYO, V85, P1083, DOI 10.1093/oxfordjournals.jbchem.a132416; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PLUMBRIDGE J, 1993, MOL MICROBIOL, V10, P973, DOI 10.1111/j.1365-2958.1993.tb00969.x; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Rittmann D, 2005, APPL ENVIRON MICROB, V71, P4339, DOI 10.1128/AEM.71.8.4339-4344.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Sarge S, 2015, CHEMBIOCHEM, V16, P2466, DOI 10.1002/cbic.201500352; Smirnov SV, 2015, Patent WO, pA1, Patent No. 2015056813; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Srinivasan B, 2014, FEBS J, V281, P1613, DOI 10.1111/febs.12727; Srinivasan Bharath, 2007, In Silico Biology, V7, P187; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wang L, 2014, ENZYME MICROB TECH, V58-59, P75, DOI 10.1016/j.enzmictec.2014.03.003; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Zakataeva NP, 2012, APPL MICROBIOL BIOT, V93, P2023, DOI 10.1007/s00253-011-3687-3; Zakataeva NP, 2010, APPL MICROBIOL BIOT, V85, P1201, DOI 10.1007/s00253-009-2276-1; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	49	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167580	10.1371/journal.pone.0167580	http://dx.doi.org/10.1371/journal.pone.0167580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907199	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700203
J	Lheure, C; Grange, PA; Ollagnier, G; Morand, P; Desire, N; Sayon, S; Corvec, S; Raingeaud, J; Marcelin, AG; Calvez, V; Khammari, A; Batteux, F; Dreno, B; Dupin, N				Lheure, Coralie; Grange, Philippe Alain; Ollagnier, Guillaume; Morand, Philippe; Desire, Nathalie; Sayon, Sophie; Corvec, Stephane; Raingeaud, Joel; Marcelin, Anne-Genevieve; Calvez, Vincent; Khammari, Amir; Batteux, Frederic; Dreno, Brigitte; Dupin, Nicolas			TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; HUMAN KERATINOCYTES; SEQUENCE ALIGNMENT; EXPRESSION; PROTEINS; PATHOGEN; IDENTIFICATION; PERFORMANCE; INFECTIONS; INDUCTION	Background Propionibacterium acnes (P. acnes) is an anaerobic, Gram-positive bacteria encountered in inflammatory acne lesions, particularly in the pilosebaceous follicle. P. acnes triggers a strong immune response involving keratinocytes, sebocytes and monocytes, the target cells during acne development. Lipoteicoic acid and peptidoglycan induce the inflammatory reaction, but no P. acnes surface protein interacting with Toll-like receptors has been identified. P. acnes surface proteins have been extracted by lithium stripping and shown to induce CXCL8 production by keratinocytes. Methodology and principal findings Far-western blotting identified two surface proteins, of 24.5- and 27.5-kDa in size, specifically recognized by TLR2. These proteins were characterized, by LC-MS/MS, as CAMP factor 1 devoid of its signal peptide sequence, as shown by N-terminal sequencing. Purified CAMP factor 1 induces CXCL8 production by activating the CXCL8 gene promoter, triggering the synthesis of CXCL8 mRNA. Antibodies against TLR2 significantly decreased the CXCL8 response. For the 27 P. acnes strains used in this study, CAMP1-TLR2 binding intensity was modulated and appeared to be strong in type IB and II strains, which produced large amounts of CXCL8, whereas most of the type IA(1) and IA(2) strains presented little or no CAMP1-TLR2 binding and low levels of CXCL8 production. The nucleotide sequence of CAMP factor displays a major polymorphism, defining two distinct genetic groups corresponding to CAMP factor 1 with 14 amino-acid changes from strains phylotyped II with moderate and high levels of CAMP1-TLR2 binding activity, and CAMP factor 1 containing 0, 1 or 2 amino-acid changes from strains phylotyped IA(1), IA(2), or IB presenting no, weak or moderate CAMP1-TLR2 binding. Conclusions Our findings indicate that CAMP factor 1 may contribute to P. acnes virulence, by amplifying the inflammation reaction through direct interaction with TLR2.	[Lheure, Coralie; Grange, Philippe Alain; Ollagnier, Guillaume; Batteux, Frederic; Dupin, Nicolas] Univ Sorbonne Paris Descartes, INSERM, Inst Cochin, Fac Med,Lab Dermatol,CNR Syphilis, Paris, France; [Morand, Philippe] Grp Hosp Paris, AP HP, CNR Streptocoques, Ctr Cochin,Hotel Dieu Broca,Serv Bacteriol, Paris, France; [Desire, Nathalie; Sayon, Sophie; Marcelin, Anne-Genevieve; Calvez, Vincent] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Desire, Nathalie; Sayon, Sophie; Marcelin, Anne-Genevieve; Calvez, Vincent] Grp Hosp Pitie Salpetriere, AP HP, Lab Virol, Paris, France; [Corvec, Stephane] CHU Nantes, Hyg Hosp, Serv Bacteriol, Nantes, France; [Raingeaud, Joel] Inst Gustave Roussy, UMR8126, Villejuif, France; [Khammari, Amir; Dreno, Brigitte] CHU, Serv Dermatol, CIC, Hotel Dieu, Nantes, France; [Batteux, Frederic] Grp Hosp Paris, AP HP, Ctr Cochin, Hotel Dieu Broca,Serv Immunol Biol, Paris, France; [Dupin, Nicolas] Grp Hosp Paris, AP HP, Ctr Cochin, Hotel Dieu Broca,Serv Dermatol Venereol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Dupin, N (corresponding author), Univ Sorbonne Paris Descartes, INSERM, Inst Cochin, Fac Med,Lab Dermatol,CNR Syphilis, Paris, France.; Dupin, N (corresponding author), Grp Hosp Paris, AP HP, Ctr Cochin, Hotel Dieu Broca,Serv Dermatol Venereol, Paris, France.	nicolas.dupin@aphp.fr	Morand, Philippe/C-1213-2016; Batteux, Frederic/O-7889-2017; Marcelin, Anne-Genevieve/D-8272-2014; CORVEC, Stephane/K-7655-2015; Grange, Philippe/W-3442-2017	Morand, Philippe/0000-0003-0306-8759; Batteux, Frederic/0000-0002-1265-7996; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Lheure, Coralie/0000-0002-9694-8386; Dupin, Nicolas/0000-0002-6237-4951; CORVEC, Stephane/0000-0003-3176-8111; Grange, Philippe/0000-0001-8151-748X	Societe Frangaise de Dermatologie et de Pathologie Sexuellement Transmissible	Societe Frangaise de Dermatologie et de Pathologie Sexuellement Transmissible	This work was supported by the Societe Frangaise de Dermatologie et de Pathologie Sexuellement Transmissible.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aubin GG, 2014, MED MALADIES INFECT, V44, P241, DOI 10.1016/j.medmal.2014.02.004; Barnard E, 2015, J CLIN MICROBIOL, V53, P1149, DOI 10.1128/JCM.02460-14; Beylot C, 2014, J EUR ACAD DERMATOL, V28, P271, DOI 10.1111/jdv.12224; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruggemann H, 2005, SEMIN CUTAN MED SURG, V24, P67, DOI 10.1016/j.sder.2005.03.001; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Collier CN, 2008, J AM ACAD DERMATOL, V58, P56, DOI 10.1016/j.jaad.2007.06.045; Dreno B, 2015, J EUR ACAD DERMATOL, V29, P3, DOI 10.1111/jdv.13190; Portillo ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804391; Fluegge K, 2004, EUR J CLIN MICROBIOL, V23, P818, DOI 10.1007/s10096-004-1229-y; FRASER G., 1962, RES VET SCI, V3, P104; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Grange PA, 2009, J DERMATOL SCI, V56, P106, DOI 10.1016/j.jdermsci.2009.08.001; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hauck Y, 2015, INFECT GENET EVOL, V33, P233, DOI 10.1016/j.meegid.2015.05.009; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Horneff JG, 2014, ORTHOP CLIN N AM, V45, P515, DOI 10.1016/j.ocl.2014.06.004; Jahns AC, 2012, BRIT J DERMATOL, V167, P50, DOI 10.1111/j.1365-2133.2012.10897.x; Jasson F, 2013, EXP DERMATOL, V22, P587, DOI 10.1111/exd.12206; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; JURGENS D, 1987, J EXP MED, V165, P720, DOI 10.1084/jem.165.3.720; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; KARCHOUDHURY TK, 1978, J CLIN MICROBIOL, V8, P238; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Lalani T, 2007, SCAND J INFECT DIS, V39, P840, DOI 10.1080/00365540701367793; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Lee CW, 2015, BIOMOL THER, V23, P564, DOI 10.4062/biomolther.2015.053; Liu PF, 2011, VACCINE, V29, P3230, DOI 10.1016/j.vaccine.2011.02.036; Lo CW, 2011, J INVEST DERMATOL, V131, P401, DOI 10.1038/jid.2010.319; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Mak TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-640; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070897; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raingeaud J, 2005, FEBS LETT, V579, P3953, DOI 10.1016/j.febslet.2005.06.019; RUHLMANN J, 1988, FEBS LETT, V235, P262, DOI 10.1016/0014-5793(88)81275-4; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Suh DH, 2015, BRIT J DERMATOL, V172, P13, DOI 10.1111/bjd.13634; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Walti LN, 2013, J INFECTION, V66, P424, DOI 10.1016/j.jinf.2012.12.010; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8	65	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167237	10.1371/journal.pone.0167237	http://dx.doi.org/10.1371/journal.pone.0167237			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902761	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100062
J	McLean, M; Cuetos-Bueno, J; Nedlic, O; Luckymiss, M; Houk, P				McLean, Matthew; Cuetos-Bueno, Javier; Nedlic, Osamu; Luckymiss, Marston; Houk, Peter			Local Stressors, Resilience, and Shifting Baselines on Coral Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; PHASE-SHIFTS; FISH; FUTURE; DEGRADATION; CONSERVATION; ASSEMBLAGES; CASCADES; IMPACTS	Understanding how and why coral reefs have changed over the last twenty to thirty years is crucial for sustaining coral-reef resilience. We used a historical baseline from Kosrae, a typical small island in Micronesia, to examine changes in fish and coral assemblages since 1986. We found that natural gradients in the spatial distribution of fish and coral assemblages have become amplified, as island geography is now a stronger determinant of species abundance patterns, and habitat forming Acropora corals and large-bodied fishes that were once common on the leeward side of the island have become scarce. A proxy for fishing access best predicted the relative change in fish assemblage condition over time, and in turn, declining fish condition was the only factor correlated with declining coral condition, suggesting overfishing may have reduced ecosystem resilience. Additionally, a proxy for watershed pollution predicted modern coral assemblage condition, suggesting pollution is also reducing resilience in densely populated areas. Altogether, it appears that unsustainable fishing reduced ecosystem resilience, as fish composition has shifted to smaller species in lower trophic levels, driven by losses of large predators and herbivores. While prior literature and anecdotal reports indicate that major disturbance events have been rare in Kosrae, small localized disturbances coupled with reduced resilience may have slowly degraded reef condition through time. Improving coral-reef resilience in the face of climate change will therefore require improved understanding and management of growing artisanal fishing pressure and watershed pollution.	[McLean, Matthew; Cuetos-Bueno, Javier; Houk, Peter] Univ Guam, Marine Lab, Mangilao, GU 96923 USA; [Nedlic, Osamu; Luckymiss, Marston] Kosrae Conservat & Safety Off, Tofol, Kosrae State, Micronesia	University of Guam	McLean, M (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	mcleamj@gmail.com		McLean, Matthew/0000-0001-6518-6043	Micronesia Conservation Trust; National Fish and Wildlife Foundation's Coral Reef Conservation Fund [0302.14.043741]; Kosrae Village Ecolodge; Pacific Treelodge	Micronesia Conservation Trust; National Fish and Wildlife Foundation's Coral Reef Conservation Fund; Kosrae Village Ecolodge; Pacific Treelodge	This work was funded by Micronesia Conservation Trust (http://ourmicronesia.org/; grant number: N/A), awarded to PH; and National Fish and Wildlife Foundation's Coral Reef Conservation Fund (http://www.nfwf.org/Pages/default.aspx; grant number: 0302.14.043741), awarded to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Kosrae Safety and Conservation Organization, Kosrae Department of Resources and Economic Affairs Division of Marine Resources, and Kosrae Island Resource Management Authority provided invaluable support in planning, logistics, and data collection. Unparalleled hospitality and support were provided by the Kosrae Village Ecolodge and the Pacific Treelodge. We are also grateful to Dr. Alexander Kerr who assisted with statistical procedures. Lastly we thank two anonymous reviewers whose comments greatly improved the quality of this paper.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; DOWNING JA, 1990, CAN J FISH AQUAT SCI, V47, P1929, DOI 10.1139/f90-217; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; George A, 2008, STATE CORAL REEF ECO; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Gurney GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080137; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houk P, 2014, CORAL REEF DISTURBAN; Houk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130823; Houk P, 2013, MAR ECOL PROG SER, V488, P23, DOI 10.3354/meps10410; Houk P, 2013, BIOSCIENCE, V63, P297, DOI 10.1525/bio.2013.63.4.10; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes R.E., 1975, Elsevier oceanogr Ser, V12, P13; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334; McClenachan L, 2012, CONSERV LETT, V5, P349, DOI 10.1111/j.1755-263X.2012.00253.x; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Saenz-Agudelo P, 2011, P ROYAL SOC B; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; USACE, 1989, KOSR COAST RES INV; van Nes EH, 2004, AM NAT, V164, P255, DOI 10.1086/422204; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Wilkinson CR, 1999, MAR FRESHWATER RES, V50, P867, DOI 10.1071/MF99121; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	67	18	18	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166319	10.1371/journal.pone.0166319	http://dx.doi.org/10.1371/journal.pone.0166319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902715	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100020
J	Szentagotai-Tatar, A; Miu, AC				Szentagotai-Tatar, Aurora; Miu, Andrei C.			Individual Differences in Emotion Regulation, Childhood Trauma and Proneness to Shame and Guilt in Adolescence	PLOS ONE			English	Article							SELF-CONSCIOUS EMOTIONS; REGULATION STRATEGIES; DEPRESSION; STRESS; CHILDREN; ANXIETY; ANTECEDENTS; EVENTS; PRIDE	Dispositional shame and guilt have been associated with psychopathology and an increasing number of studies have traced this relation back to adolescence. This developmental period is thought to be characterized by maturational changes in emotion regulation, which also play an important role in vulnerability to psychopathology, but little is known about the links between emotion regulation and dispositional shame and guilt. The current study investigated the relations between individual differences in the habitual use of a wide range of emotion regulation strategies and proneness to shame and guilt in a large sample of adolescents (N = 706), aged 13 to 17 years. History of childhood trauma was also assessed. Our results showed that emotion regulation independently explained about 20% of the variance of shame-proneness and guilt-proneness. Higher use of maladaptive (e.g., Self-Blaming, Catastrophizing) and lower use of adaptive (e.g., Refocus on Planning, Positive Reappraisal) emotion regulation strategies were positively associated with shame-proneness. In contrast, lower use of maladaptive (e.g., Catastrophizing, Blaming Others) and higher use of adaptive (e.g., Refocus on Planning, Positive Reappraisal) emotion regulation strategies were associated with guilt-proneness, independent of the influence of childhood trauma, which also explained a relatively minor portion of guilt-proneness. Although there were age differences (i.e., rumination was used more by older adolescents, and the influence of emotion regulation on depression and anxiety symptoms increased with age) and sex differences (i.e., girls reported higher use of Putting into Perspective and Other Blaming compared to boys) in emotion regulation, age and sex were not significantly associated with proneness to shame and guilt. The positive relations with maladaptive emotion regulation underscores the dysfunctional nature of shame-proneness. Future studies could use longitudinal measures to establish that emotion regulation drives dispositional shame and guilt, and also investigate whether emotion regulation optimization is able to normalize proneness to shame and guilt and reduce risk for psychopathology.	[Szentagotai-Tatar, Aurora] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Cluj, Romania; [Miu, Andrei C.] Univ Babes Bolyai, Cognit Neurosci Lab, Dept Psychol, Cluj Napoca, Cluj, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Szentagotai-Tatar, A (corresponding author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Cluj, Romania.	auraszentagotai@psychology.ro	Miu, Andrei C./C-5184-2011	Miu, Andrei C./0000-0002-6459-5010	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by grants from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro/), grant number PNII-ID-PCCE-2011-2-0045. Although the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, provided funding for the collection of data and the manuscript preparation, they had no role in the study design, the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	Alessandri SM, 1996, CHILD DEV, V67, P1857, DOI 10.1111/j.1467-8624.1996.tb01832.x; Arndt JE, 2013, PERS INDIV DIFFER, V55, P147, DOI 10.1016/j.paid.2013.02.022; Bennett DS, 2010, CHILD MALTREATMENT, V15, P305, DOI 10.1177/1077559510379634; Berking M, 2008, J COUNS PSYCHOL, V55, P485, DOI 10.1037/a0013589; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Carnuta M, 2015, PSYCHONEUROENDOCRINO, V51, P176, DOI 10.1016/j.psyneuen.2014.09.026; Casey BJ, 2015, ANNU REV PSYCHOL, V66, P295, DOI 10.1146/annurev-psych-010814-015156; Claesson K, 2002, CLIN PSYCHOL PSYCHOT, V9, P277, DOI 10.1002/cpp.331; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen TR, 2011, J PERS SOC PSYCHOL, V100, P947, DOI 10.1037/a0022641; de Hooge IE, 2008, J PERS SOC PSYCHOL, V95, P933, DOI 10.1037/a0011991; Dickerson SS, 2004, PSYCHOSOM MED, V66, P124, DOI 10.1097/01.PSY.0000097338.75454.29; Donatelli J.L., 2007, J CHILD FAM STUD, V16, DOI [10.1007/s10826-006-9130-1, DOI 10.1007/S10826-006-9130-1]; Else-Quest NM, 2012, PSYCHOL BULL, V138, P947, DOI 10.1037/a0027930; Ferguson TJ, 2000, GENET SOC GEN PSYCH, V126, P319; Garnefski N, 2005, J ADOLESCENCE, V28, P619, DOI 10.1016/j.adolescence.2004.12.009; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Garnefski N, 2007, EUR CHILD ADOLES PSY, V16, P1, DOI 10.1007/s00787-006-0562-3; Gausel N, 2016, MOTIV EMOTION, V40, P118, DOI 10.1007/s11031-015-9513-y; Gavazzi IG, 2011, EUR J DEV PSYCHOL, V8, P311, DOI 10.1080/17405629.2010.491303; Heth JT, 2002, PERS INDIV DIFFER, V33, P883; Howell AJ, 2012, PERS INDIV DIFFER, V53, P917, DOI 10.1016/j.paid.2012.06.021; Hoyt WT, 2008, REHABIL PSYCHOL, V53, P321, DOI 10.1037/a0013021; Hughes EK, 2011, J PSYCHOPATHOL BEHAV, V33, P335, DOI 10.1007/s10862-011-9220-2; Lagattuta K. H., 2007, SELF CONSCIOUS EMOTI, P91; Lewis M., 2007, SELF CONSCIOUS EMOTI, P134; Lickel B, 2014, EMOTION, V14, P1049, DOI 10.1037/a0038235; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; MacDermott ST, 2010, J PSYCHOPATHOL BEHAV, V32, P301, DOI 10.1007/s10862-009-9154-0; Martin RC, 2005, PERS INDIV DIFFER, V39, P1249, DOI 10.1016/j.paid.2005.06.004; Mills RSL, 2005, DEV REV, V25, P26, DOI 10.1016/j.dr.2004.08.001; Muris P, 2014, CLIN CHILD FAM PSYCH, V17, P19, DOI 10.1007/s10567-013-0137-z; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olthof T, 2004, COGNITION EMOTION, V18, P383, DOI 10.1080/02699930341000077; Orth U, 2010, J PERS SOC PSYCHOL, V99, P1061, DOI 10.1037/a0021342; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Perte A, 2011, MANUAL PENTRU SCALEL; Perte A, 2011, COGNITION BRAIN BEHA, VXV, P111; Rahim M, 2015, PEERJ, V3, DOI 10.7717/peerj.737; Roos S, 2014, DEV PSYCHOL, V50, P941, DOI 10.1037/a0033904; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sheppes G, 2015, ANNU REV CLIN PSYCHO, V11, P379, DOI 10.1146/annurev-clinpsy-032814-112739; Stotz SJ, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.25863; Stuewig J, 2005, CHILD MALTREATMENT, V10, P324, DOI 10.1177/1077559505279308; Stuewig J, 2010, J RES PERS, V44, P91, DOI 10.1016/j.jrp.2009.12.005; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Szentagotai-Tatar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134716; Tangney J. P., 1991, TEST SELF CONSCIOUS; Tangney J. P., 2012, HDB SELF IDENTITY, P446, DOI DOI 10.4135/9781446263402; Tangney J.P., 2003, SHAME GUILT; Tangney JP, 1996, BEHAV RES THER, V34, P741, DOI 10.1016/0005-7967(96)00034-4; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Thabrew H, 2012, ADV PSYCHOSOM MED, V32, P35, DOI 10.1159/000330002; Tilghman-Osborne C, 2012, J ABNORM CHILD PSYCH, V40, P607, DOI 10.1007/s10802-011-9591-6; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Walter J. L., 2006, N AM J PSYCHOL, V8, P321, DOI DOI 10.1037/A0033904; Webb M, 2007, CHILD ABUSE NEGLECT, V31, P1143, DOI 10.1016/j.chiabu.2007.09.003	57	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167299	10.1371/journal.pone.0167299	http://dx.doi.org/10.1371/journal.pone.0167299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898709	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000049
J	Ardente, NC; Ferreguetti, AC; Gettinger, D; Leal, P; Mendes-Oliveira, AC; Martins-Hatano, F; Bergallo, HG				Ardente, Natalia Carneiro; Ferreguetti, Atilla Colombo; Gettinger, Donald; Leal, Pricila; Mendes-Oliveira, Ana Cristina; Martins-Hatano, Fernanda; Bergallo, Helena Godoy			Diversity and Impacts of Mining on the Non-Volant Small Mammal Communities of Two Vegetation Types in the Brazilian Amazon	PLOS ONE			English	Article							SPECIES-DIVERSITY; ATLANTIC FOREST; RODENT; POPULATIONS; RICHNESS; ECOLOGY; ISLAND	The Carajas National Forest contains some of the largest iron ore deposits in the world. The majority of the minerals are found below a plant community known as Savana Metalofila, or "Canga", which represents only 3% of the landscape within the Carajas National Forest (CNF). The aim of our study was to understand the diversity of community of non-volant small mammals in the two predominant vegetation types: Ombrophilous Forest and Canga, and to examine how mining impacts these communities. Sampling was conducted from January 2010 to August 2011 in 11 sampling sites divided by the total area of Canga and 12 sampling sites in the forest, totalizing 23 sites. Of these, 12 sites (Canga and Forest) were considered impacted areas located close to the mine (<< 900 meters) and 11 sites (Canga and Forest), serving as controls, which were at least 7,000 meters from the mine. We recorded 28 species, 11 from the Order Didelphimorphia and 17 from the Order Rodentia. The two forest types shared 68.42% of the species found in the CNF. A gradient analysis (Non-metric multidimensional scaling) revealed that the first axis clearly separated the non flying small mammal communities by vegetation type. Occupancy models showed that the detectability of species was affected by the distance from the mining activities. Of all the small mammals analyzed, 10 species were positively affected by the distance from mining in areas impacted (e.g. more likely to be detected farther from mining areas) and detectability was lower in impacted areas. However, three species were negatively affected by the distance from mining, with higher detectability in the impacted areas, and seven species showed no effect of their proximity to mining operations. To date, there are no studies in Brazil about the impact of mining on mammals or other vertebrates. This study reveals that the effect of mining may go beyond the forest destruction caused by the opening of the mining pits, but also may negatively affect sensitive wildlife species.	[Ardente, Natalia Carneiro; Ferreguetti, Atilla Colombo; Bergallo, Helena Godoy] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Ecol Mamiferos, Rio De Janeiro, Brazil; [Gettinger, Donald] Univ Nebraska, Harold W Manter Lab Parasitol, Lincoln, NE USA; [Leal, Pricila; Martins-Hatano, Fernanda] Univ Fed Rural Amazonia Biol, Dept Biol Anim, Belem, Para, Brazil; [Mendes-Oliveira, Ana Cristina] Fed Univ Para, Inst Ciencias Biol, Lab Ecol & Zool Vertebrados, Campus Basico,Rua Augusto Correa, Belem, Para, Brazil	Universidade do Estado do Rio de Janeiro; University of Nebraska System; University of Nebraska Lincoln; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Para	Ardente, NC (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Ecol Mamiferos, Rio De Janeiro, Brazil.	natalia_ardente@hotmail.com	Ardente, Natalia/AAF-4404-2020; Ferreguetti, Atilla/D-1163-2019; Bergallo, Helena Godoy/F-9257-2011; de Oliveira, Ana Cristina Mendes/I-2680-2012	Ferreguetti, Atilla/0000-0002-5139-8835; Bergallo, Helena Godoy/0000-0001-9771-965X; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	VALE; Universidade Federal Rural da Amazonia	VALE; Universidade Federal Rural da Amazonia	This work was supported by VALE - www.vale.com Universidade Federal Rural da Amazonia - https://portal.ufra.edu.br/. The funders had no role in study design, data collection and analysis.	Ab'Saber A, 1986, GEOMORFOLOGIA; Abu Baker M, 2011, J ARID ENVIRON, V75, P14, DOI 10.1016/j.jaridenv.2010.08.005; ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alencar A, 2004, DESMATAMENTO AMAZONI; Alho C.J.R., 1982, Pymatuning Laboratory of Ecology Special Publications, V6, P143; ALHO CJR, 1986, MAMMALIA, V50, P447, DOI 10.1515/mamm.1986.50.4.447; Ardente Natalia, 2013, Check List, V9, P1104; BERGALLO HD, 1994, STUD NEOTROP FAUNA E, V29, P197, DOI 10.1080/01650529409360932; Bernarde Paulo Sergio, 2003, Biociencias (Porto Alegre), V11, P183; Bramble W. C., 1949, Journal of Forestry, V47, P477; Brown JH, 2000, AM NAT, V156, P314, DOI 10.1086/303385; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chamblin H, 2002, SMALL MAMMAL COMMUNI; Chamblin HD, 2004, AM MIDL NAT, V151, P346, DOI 10.1674/0003-0031(2004)151[0346:AWNMUO]2.0.CO;2; Chiarello AG, 2000, CONSERV BIOL, V14, P1649, DOI 10.1046/j.1523-1739.2000.99071.x; Core R, 2012, R LANG ENV STAT COMP; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Da Silva MFF, 1996, ACTA AMAZONICA, V26, P16; DAFONSECA GAB, 1990, BIOL CONSERV, V53, P265, DOI 10.1016/0006-3207(90)90097-9; De Capita M.E, 1975, Ohio Journal of Science, V75, P305; Díaz M. Mónica, 2004, Mastozool. neotrop., V11, P185; EMMONS LH, 1984, BIOTROPICA, V16, P210, DOI 10.2307/2388054; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fearnside PM, 2010, GRUP EST ESTR AM GEE; Figueiredo MDL, 2004, J TROP ECOL, V20, P225, DOI 10.1017/S0266467403001093; Graipel Maurício E., 2006, Mastozool. neotrop., V13, P31; HINGTGEN TM, 1984, J RANGE MANAGE, V37, P438, DOI 10.2307/3899632; IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis, 2004, PLAN MAN US MULT FLO; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lacher TE, 2001, BIOTROPICA, V33, P171; Lambert TD, 2000, J MAMMAL, V81, P70, DOI 10.1644/1545-1542(2000)081&lt;0070:MUBATF&gt;2.0.CO;2; Lambert TD, 2006, J MAMMAL, V87, P766, DOI 10.1644/05-MAMM-A-261R1.1; Larkin JL, 2008, SOUTHEAST NAT, V7, P401, DOI 10.1656/1528-7092-7.3.401; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Magnus Luíza Z, 2012, Mastozool. neotrop., V19, P163; Malcolm J. R., 1991, THESIS U FLORIDA; Malcolm Jay R., 1997, P207; Malygin VM, 2005, ZOOL ZH, V84, P492; MARES M A, 1989, Annals of Carnegie Museum, V58, P1; Mazerolle MJ, 2003, BIOL CONSERV, V113, P215, DOI 10.1016/S0006-3207(02)00360-9; MMA-Ministe A rio do Meio Ambiente, 2000, SIST NAC UN CONS; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Ochoa J, 2000, BIOTROPICA, V32, P146, DOI 10.1646/0006-3606(2000)032[0146:EDLEND]2.0.CO;2; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paglia A.P., 2012, OCCAS PAP CONSERV BI; Reis EJ, 2001, PARCERIAS ESTRATEGIC, V12, P276; Ribeiro R, 2005, REV BRAS ZOOL, V22, P898, DOI 10.1590/S0101-81752005000400014; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ripley EA., 1996, ENV EFFECTS MINING; Santos-Filho M, 2012, BRAZ J BIOL, V72, P265; Silva MFF, 1991, ACTA BOTO BRAS, V6, P107; Steele B. B., 1982, Reclamation and Revegetation Research, V1, P367; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; YAHNER RH, 1988, CONSERV BIOL, V2, P333, DOI 10.1111/j.1523-1739.1988.tb00197.x	56	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167266	10.1371/journal.pone.0167266	http://dx.doi.org/10.1371/journal.pone.0167266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893798	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400107
J	Chen, CH; Hsu, CM; Lin, CL; Chou, AK; Jeng, LB				Chen, Chien-Hua; Hsu, Che-Ming; Lin, Cheng-Li; Chou, An-Kuo; Jeng, Long-Bin			The Development of Diabetes after Subtotal Gastrectomy with Billroth II Anastomosis for Peptic Ulcer Disease	PLOS ONE			English	Article							SLEEVE GASTRECTOMY; GASTRIC BYPASS; RISK; SURGERY; HYPERTENSION; ASSOCIATION; PREVALENCE; MELLITUS	Purpose A duodenal bypass after a Roux-en-Y gastric bypass operation for obesity can ameliorate the development of diabetes mellitus (DM). We attempted to determine the subsequent risk of developing DM after subtotal gastrectomy with Billroth II anastomosis (SGBIIA) for peptic ulcer disease (PUD). Methods We identified 662 patients undergoing SGBIIA for PUD between 2000 and 2011 from the Longitudinal Health Insurance Database as the study cohort, and we randomly selected 2647 controls from the peptic ulcer population not undergoing SGBIIA and were frequencymatched by age, sex, and index year for the control cohort. All patient cases in both cohorts were followed until the end of 2011 to measure the incidence of DM. We analyzed DM risk by using a Cox proportional hazards regression model. Results The patients who underwent SGBIIA demonstrated a lower cumulative incidence of DM compared with the control cohort (log-rank test, P<.001 and 6.73 vs 12.6 per 1000 persony). The difference in the DM risk between patients with and without SGBIIA increased gradually with the follow-up duration. Age and sex did not affect the subsequent risk of developing DM, according to the multivariable Cox regression model. Nevertheless, the SGBIIA cohort exhibited a lower DM risk after we adjusted for the comorbidities of hypertension, hyperlipidemia, and coronary artery disease (adjusted hazard ratio (aHR): 0.56, 95% confidence interval (CI): 0.40-0.78). The incidence rate ratio (IRR) of DM in the SGBIIA cohort was lower than that in the control cohort for all age groups (age <= 49 y, IRR: 0.40, 95% CI: 0.16-0.99; age 50-64 y, IRR: 0.54, 95% CI: 0.31-0.96; age. 65 y, IRR: 0.57, 95% CI: 0.36-0.91). Moreover, the IRR of DM was significantly lower in the SGBIIA cohort with comorbidities (IRR: 0.50, 95% CI: 0.31-0.78) compared with those without a comorbidity (IRR: 0.65, 95% CI: 0.40-1.04). Conclusion The findings of this population-based cohort study revealed that SGBIIA was associated with a reduced risk of DM development, and the inverse association was greater in the presence of a comorbidity.	[Chen, Chien-Hua; Hsu, Che-Ming] Show Chwan Mem Hosp, Ctr Digest Dis, Changhua, Taiwan; [Chen, Chien-Hua] Hungkuang Univ, Taichung, Taiwan; [Chen, Chien-Hua] Chung Chou Univ Sci & Technol, Yuanlin Township, Changhua County, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Chou, An-Kuo] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chou, An-Kuo] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan	Show Chwan Memorial Hospital; Hungkuang University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Jeng, LB (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Jeng, LB (corresponding author), China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan.	otc.Jeng@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST-105-2325B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST-105-2325B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.r This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Chen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003481; Chen YK, 2014, J GASTROENTEROL, V49, P923, DOI 10.1007/s00535-013-0846-6; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Chu X, 2013, DIABETES, V62, P561, DOI 10.2337/db12-0139; Chung WS, 2014, ANN RHEUM DIS, V73, P1774, DOI 10.1136/annrheumdis-2013-203380; Cohen Ricardo V, 2012, Surg Obes Relat Dis, V8, pe66, DOI 10.1016/j.soard.2011.07.007; Cummings S, 2008, J AM DIET ASSOC, V108, pS40, DOI 10.1016/j.jada.2008.01.017; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; FRANSSILAKALLUNKI A, 1992, AM J CLIN NUTR, V56, P247; Gill RS, 2010, SURG OBES RELAT DIS, V6, P707, DOI 10.1016/j.soard.2010.07.011; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gupta Sanjay, 2005, BMC Surg, V5, P15; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Knuth D. E, 1981, ART COMPUTER PROGRAM, V2; Lee CW, 2011, SURG CLIN N AM, V91, P1001, DOI 10.1016/j.suc.2011.06.008; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Liao CH, 2014, J PSYCHOSOM RES, V77, P541, DOI 10.1016/j.jpsychores.2014.08.005; Lockrey Gregory, 2011, Journal of Pharmacy Practice and Research, V41, P58; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; MCGEE GS, 1987, ARCH SURG-CHICAGO, V122, P555; Mugo MN, 2007, HYPERTENSION DIABETE; National Diabetes Clearinghouse, 2011, NAT DIAB STAT 2011; Ng EKW, 2000, ANN SURG, V231, P153, DOI 10.1097/00000658-200002000-00001; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Rutti S, 2009, ENDOCRINOLOGY, V150, P4521, DOI 10.1210/en.2009-0252; Schwesinger WH, 2001, J GASTROINTEST SURG, V5, P438, DOI 10.1016/S1091-255X(01)80074-3; Thorsen K, 2013, WORLD J GASTROENTERO, V19, P347, DOI 10.3748/wjg.v19.i3.347; Wang FW, 2011, WORLD J GASTROENTERO, V17, P1199, DOI 10.3748/wjg.v17.i9.1199; Wysocki A, 2011, WORLD J SURG, V35, P811, DOI 10.1007/s00268-010-0917-2; Yang SH, 2010, NEW ENGL J MED, V362, P2425	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167321	10.1371/journal.pone.0167321	http://dx.doi.org/10.1371/journal.pone.0167321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893867	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400112
J	Lopez-Gresa, MP; Lison, P; Yenush, L; Conejero, V; Rodrigo, I; Belles, JM				Lopez-Gresa, M. Pilar; Lison, Purificacion; Yenush, Lynne; Conejero, Vicente; Rodrigo, Ismael; Belles, Jose Maria			Salicylic Acid Is Involved in the Basal Resistance of Tomato Plants to Citrus Exocortis Viroid and Tomato Spotted Wilt Virus	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ACIBENZOLAR-S-METHYL; PATHOGEN PSEUDOMONAS-SYRINGAE; DISEASE RESISTANCE; GENTISIC ACID; DEFENSE RESPONSES; BACTERIAL SPOT; HYPERSENSITIVE RESPONSE; NICOTIANA-ATTENUATA; ETHYLENE PRODUCTION	Tomato plants expressing the NahG transgene, which prevents accumulation of endogenous salicylic acid (SA), were used to study the importance of the SA signalling pathway in basal defence against Citrus Exocortis Viroid (CEVd) or Tomato Spotted Wilt Virus (TSWV). The lack of SA accumulation in the CEVd- or TSWV-infected NahG tomato plants led to an early and dramatic disease phenotype, as compared to that observed in the corresponding parental Money Maker. Addition of acibenzolar-S-methyl, a benzothiadiazole (BTH), which activates the systemic acquired resistance pathway downstream of SA signalling, improves resistance of NahG tomato plants to CEVd and TSWV. CEVd and TSWV inoculation induced the accumulation of the hydroxycinnamic amides p-coumaroyltyramine, feruloyltyramine, caffeoylputrescine, and feruloylputrescine, and the defence related proteins PR1 and P23 in NahG plants earlier and with more intensity than in Money Maker plants, indicating that SA is not essential for the induction of these plant defence metabolites and proteins. In addition, NahG plants produced very high levels of ethylene upon CEVd or TSWV infection when compared with infected Money Maker plants, indicating that the absence of SA produced additional effects on other metabolic pathways. This is the first report to show that SA is an important component of basal resistance of tomato plants to both CEVd and TSWV, indicating that SA-dependent defence mechanisms play a key role in limiting the severity of symptoms in CEVd- and TSWV-infected NahG tomato plants.	[Lopez-Gresa, M. Pilar; Lison, Purificacion; Yenush, Lynne; Conejero, Vicente; Rodrigo, Ismael; Belles, Jose Maria] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Lison, P (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain.	plison@ibmcp.upv.es	Rodrigo, Ismael/H-4423-2015; Lisón, Purificación/H-7731-2015; Gresa, María Pilar López/N-8830-2013; Yenush, Lynne/J-8815-2014	Rodrigo, Ismael/0000-0002-8994-6112; Lisón, Purificación/0000-0002-1662-8084; Gresa, María Pilar López/0000-0001-9251-0160; Yenush, Lynne/0000-0001-8589-7002	Spanish Ministry of Economy and Competitiveness [BIO2012-33419]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grant BIO2012-33419 from the Spanish Ministry of Economy and Competitiveness received by JMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfoka GH, 2000, CROP PROT, DOI DOI 10.1094/MPMI.2001.14.6.785; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Baysal O, 2003, PLANT PATHOL, V52, P747, DOI 10.1111/j.1365-3059.2003.00936.x; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Belles JM, 2006, PLANTA, V223, P500, DOI 10.1007/s00425-005-0109-8; BELLES JM, 1989, J PHYTOPATHOL, V125, P198, DOI 10.1111/j.1439-0434.1989.tb01061.x; Belles JM, 1999, MOL PLANT MICROBE IN, V12, P227, DOI 10.1094/MPMI.1999.12.3.227; BELLES JM, 1989, J PHYTOPATHOL, V127, P81, DOI 10.1111/j.1439-0434.1989.tb04506.x; BELLES JM, 1991, J PHYTOPATHOL, V132, P245, DOI 10.1111/j.1439-0434.1991.tb00117.x; Benhamou N, 1998, PLANT PHYSIOL, V118, P1203, DOI 10.1104/pp.118.4.1203; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; Brading PA, 2000, PLANT J, V23, P305, DOI 10.1046/j.1365-313x.2000.00778.x; Branch C, 2004, MOL PLANT MICROBE IN, V17, P351, DOI 10.1094/MPMI.2004.17.4.351; Campos L, 2014, MOL PLANT MICROBE IN, V27, P1159, DOI 10.1094/MPMI-04-14-0104-R; Campos L, 2014, PLANT PHYSIOL BIOCH, V77, P35, DOI 10.1016/j.plaphy.2014.01.016; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Cavalcanti FR, 2006, PHYSIOL MOL PLANT P, V68, P198, DOI 10.1016/j.pmpp.2006.11.001; Conejero V., 1990, NATO ASI SERIES VOL, P233; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Dufour MC, 2013, PLANT PATHOL, V62, P370, DOI 10.1111/j.1365-3059.2012.02628.x; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Fayos J, 2006, PHYTOCHEMISTRY, V67, P142, DOI 10.1016/j.phytochem.2005.10.014; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez G, 2008, PLANT PHYSIOL, V148, P414, DOI 10.1104/pp.108.120808; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Hagel JM, 2005, PLANTA, V221, P904, DOI 10.1007/s00425-005-1484-x; Halim VA, 2007, MOL PLANT MICROBE IN, V20, P1346, DOI 10.1094/MPMI-20-11-1346; Huang CH, 2012, PLANT DIS, V96, P221, DOI 10.1094/PDIS-03-11-0183; Jang SM, 2004, PLANT PHYSIOL, V135, P346, DOI 10.1104/pp.103.038372; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kachroo P, 2000, PLANT CELL, V12, P677, DOI 10.1105/tpc.12.5.677; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Belles JM, 2008, PLANT SCI, V174, P524, DOI 10.1016/j.plantsci.2008.02.008; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; MARTINTANGUY J, 1985, PLANT GROWTH REGUL, V3, P381, DOI 10.1007/BF00117595; Nachappa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075909; Nakahara KS, 2014, CURR OPIN PLANT BIOL, V20, P88, DOI 10.1016/j.pbi.2014.05.004; Newman MA, 2001, MOL PLANT MICROBE IN, V14, P785, DOI 10.1094/MPMI.2001.14.6.785; Nombela G, 2005, J ECON ENTOMOL, V98, P2266, DOI 10.1603/0022-0493-98.6.2266; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; O'Donnell PJ, 2001, PLANT J, V25, P315, DOI 10.1046/j.1365-313x.2001.00968.x; Obradovic A, 2005, PLANT DIS, V89, P712, DOI 10.1094/PD-89-0712; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Rayapuram C, 2007, PLANT J, V52, P700, DOI 10.1111/j.1365-313X.2007.03267.x; Roberts PD, 2008, CROP PROT, V27, P1519, DOI 10.1016/j.cropro.2008.06.007; RODRIGO I, 1993, PLANT PHYSIOL, V102, P939, DOI 10.1104/pp.102.3.939; Rohilla R, 2002, PEST MANAG SCI, V58, P63, DOI 10.1002/ps.423; Sanchez G, 2010, MOL PLANT MICROBE IN, V23, P394, DOI 10.1094/MPMI-23-4-0394; Scarponi L, 2001, PEST MANAG SCI, V57, P262, DOI 10.1002/ps.285; SEMANCIK JS, 1988, J GEN VIROL, V69, P3059, DOI 10.1099/0022-1317-69-12-3059; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Sherwood J. L., 2001, ENCY PLANT PATHOLOGY, P1034; Soler S, 1999, CAN J PLANT PATHOL, V21, P317, DOI 10.1080/07060669909501167; Tebayashi SI, 2007, BIOSCI BIOTECH BIOCH, V71, P1521, DOI 10.1271/bbb.70033; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Trejo-Saavedra DL, 2013, BIOL RES, V46, P333, DOI 10.4067/S0716-97602013000400004; Uehara T, 2010, PLANT CELL PHYSIOL, V51, P1524, DOI 10.1093/pcp/pcq109; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; VERA P, 1988, PLANT SCI, V55, P223, DOI 10.1016/0168-9452(88)90065-9; Verberne MC, 2003, PLANT J, V35, P27, DOI 10.1046/j.1365-313X.2003.01778.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Zacares L, 2007, MOL PLANT MICROBE IN, V20, P1439, DOI 10.1094/MPMI-20-11-1439	71	37	42	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166938	10.1371/journal.pone.0166938	http://dx.doi.org/10.1371/journal.pone.0166938			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893781	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400061
J	Plestilova, L; Neidhart, M; Russo, G; Frank-Bertoncelj, M; Ospelt, C; Ciurea, A; Kolling, C; Gay, RE; Michel, BA; Vencovsky, J; Gay, S; Jungel, A				Plestilova, Lenka; Neidhart, Michel; Russo, Giancarlo; Frank-Bertoncelj, Mojca; Ospelt, Caroline; Ciurea, Adrian; Kolling, Christoph; Gay, Renate E.; Michel, Beat A.; Vencovsky, Jiri; Gay, Steffen; Juengel, Astrid			Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis	PLOS ONE			English	Article							SYNOVIAL FIBROBLASTS; DNA HYPOMETHYLATION; CANCER; TISSUE; PIRNAS; CELLS; GENE	Objective The PIWIL (P-element induced wimpy testis like protein) subfamily of argonaute proteins is essential for Piwi-interacting RNA (piRNA) biogenesis and their function to silence transposons during germ-line development. Here we explored their presence and regulation in rheumatoid arthritis (RA). Methods The expression of PIWIL genes in RA and osteoarthritis (OA) synovial tissues and synovial fibroblasts (SF) was analysed by Real-time PCR, immunofluorescence and Western blot. The expression of piRNAs was quantified by next generation small RNA sequencing (NGS). The regulation of PIWI/piRNAs, proliferation and methylation of LINE-1 after silencing of PIWIL genes were studied. Results PIWIL2 and 4 mRNA were similarly expressed in synovial tissues and SF from RA and OA patients. However, on the protein level only PIWIL4 was strongly expressed in SF. Using NGS up to 300 piRNAs were identified in all SF without significant differences in expression levels between RA and OASF. Of interest, the analysis of the co-expression of the detected piRNAs revealed a less tightly regulated pattern of piRNA-823, -4153 and -16659 expression in RASF. In RASF and OASF, stimulation with TNF alpha+IL1 beta/TLR-ligands further significantly increased the expression levels of PIWIL2 and 4 mRNA and piRNA-16659 was significantly (4-fold) induced upon Poly(I:C) stimulation. Silencing of PIWIL2/4 neither affect LINE-1 methylation/expression nor proliferation of RASF. Conclusion We detected a new class of small regulatory RNAs (piRNAs) and their specific binding partners (PIWIL2/4) in synovial fibroblasts. The differential regulation of co-expression of piRNAs in RASF and the induction of piRNA/Piwi-proteins by innate immune stimulators suggest a role in inflammatory processes.	[Plestilova, Lenka; Neidhart, Michel; Frank-Bertoncelj, Mojca; Ospelt, Caroline; Gay, Renate E.; Gay, Steffen; Juengel, Astrid] Univ Zurich Hosp, Ctr Expt Rheumatol, Zurich, Switzerland; [Russo, Giancarlo] Funct Genom Ctr Zurich, Zurich, Switzerland; [Ciurea, Adrian; Michel, Beat A.] Univ Zurich Hosp, Dept Rheumatol, Zurich, Switzerland; [Kolling, Christoph] Schulthess Clin, Zurich, Switzerland; [Vencovsky, Jiri] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Vencovsky, Jiri] Charles Univ Prague, Fac Med 1, Clin Rheumatol, Prague, Czech Republic	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Schulthess Clinic; Charles University Prague; Institute of Rheumatology; Charles University Prague	Jungel, A (corresponding author), Univ Zurich Hosp, Ctr Expt Rheumatol, Zurich, Switzerland.	astrid.juengel@usz.ch	Russo, Giancarlo/GQY-5601-2022; Vencovsky, Jiri/G-6094-2017; Bertoncelj, Mojca Frank/AAC-6042-2021; Frank-Bertoncelj, Mojca/G-6649-2017	Vencovsky, Jiri/0000-0002-0851-0713; Bertoncelj, Mojca Frank/0000-0002-7257-2468; Ciurea, Adrian/0000-0002-7870-7132; Kolling, Christoph/0000-0003-2802-7638; Ospelt, Caroline/0000-0002-9151-4650; Neidhart, Michel/0000-0002-9656-5967	FP7 OSTEOIMMUNE [289150]; OPO Stiftung; EU-funded IMI BTCure; Institute Arthritis Research (IAR); MHCR Project [023728]	FP7 OSTEOIMMUNE; OPO Stiftung; EU-funded IMI BTCure; Institute Arthritis Research (IAR); MHCR Project	This work was supported by: FP7 OSTEOIMMUNE 289150, http://www.osteoimune.eu/; OPO Stiftung, http://www.opostiftung.chi; EU-funded IMI BTCure, http://www.ropaeuicontentibtcure; Institute Arthritis Research (IAR), http://wwwiar-suissechi; EU-funded EuroTEAM, http://www.team-arthritis.Hi; and MHCR Project for conceptual development of research organization 023728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aradi B, 2015, ARTHRITIS RHEUMATOLO; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bamezai S, 2012, STEM CELLS, V30, P2603, DOI 10.1002/stem.1237; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; Cui L, 2011, CLIN BIOCHEM, V44, P1050, DOI 10.1016/j.clinbiochem.2011.06.004; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Greither T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-272; He XX, 2015, NUCLEIC ACIDS RES, V43, P3712, DOI 10.1093/nar/gkv214; Kang HJ, 2014, MOL BIOL REP, V41, P6729, DOI 10.1007/s11033-014-3558-y; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martinez VD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10423; Neidhart M, 2000, ARTHRITIS RHEUM-US, V43, P2634, DOI 10.1002/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1; Neidhart M, 2010, ARTHRITIS RHEUM-US, V62, P2673, DOI 10.1002/art.27567; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Ng KW, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0491-9; Pan Y, 2012, CELL TISSUE RES, V350, P177, DOI 10.1007/s00441-012-1447-z; Peng L, 2015, TUMOUR BIOL; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Su C, 2012, FEBS LETT, V586, P1356, DOI 10.1016/j.febslet.2012.03.053; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Varet H, SARTOOLS DESEQ2 EDGE; Zhong FD, 2015, NUCLEIC ACIDS RES, V43, P10474, DOI 10.1093/nar/gkv954	27	15	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166920	10.1371/journal.pone.0166920	http://dx.doi.org/10.1371/journal.pone.0166920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893851	Green Published, gold, Green Accepted			2022-12-27	WOS:000389472400057
J	Zang, X; Tang, HL; Min, JE; Gu, DN; Montaner, JSG; Wu, ZY; Nosyk, B				Zang, Xiao; Tang, Houlin; Min, Jeong Eun; Gu, Diane; Montaner, Julio S. G.; Wu, Zunyou; Nosyk, Bohdan			Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REDUCING HETEROSEXUAL TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; PLASMA VIRAL LOAD; QUALITY-OF-LIFE; UNITED-STATES; BRITISH-COLUMBIA; COMBINATION PREVENTION; RANDOMIZED-TRIAL; INFECTION	Background In Guangxi Zhuang Autonomous Region, China, an estimated 80% of newly-identified anti-retroviral therapy (ART)-eligible patients are not engaged in ART. Delayed ART uptake ultimately translates into high rates of HIV morbidity, mortality, and transmission. To enhance HIV testing receipt and subsequent treatment uptake in Guangxi, the Chinese Center for Disease Control and Prevention (CDC) executed a cluster-randomized trial to assess the effectiveness and cost-effectiveness of a streamlined HIV testing algorithm (the One4All intervention) in 12 county-level hospitals. Objective To determine the incremental cost-effectiveness of the One4All intervention delivered at county hospitals in Guangxi, China, compared to the current standard of care (SOC). Perspective Health System. Time Horizon 1-, 5- and 25-years. Methods We adapted a dynamic, compartmental HIV transmission model to simulate HIV transmission and progression in Guangxi, China and identify the economic impact and health benefits of implementing the One4All intervention in all Guangxi hospitals. The One4All intervention algorithm entails rapid point-of-care HIV screening, CD4 and viral load testing of individuals presenting for HIV screening, with same-day results and linkage to counselling. We populated the model with data from the One4All trial (CTN-0056), China CDC HIV registry and published reports. Model outcomes were HIV incidence, mortality, costs, quality-adjusted life years (QALYs), and the incremental cost-effectiveness ratio (ICER) of the One4All intervention compared to SOC. Results The One4All testing intervention was more costly than SOC (CNY 2,182 vs. CNY 846), but facilitated earlier ART access, resulting in delayed disease progression and mortality. Over a 25-year time horizon, we estimated that introducing One4All in Guangxi would result in 802 averted HIV cases and 1629 averted deaths at an ICER of CNY 11,678 per QALY gained. Sensitivity analysis revealed that One4All remained cost-effective at even minimal levels of effectiveness. Results were robust to changes to a range of parameters characterizing the HIV epidemic over time. Conclusions The One4All HIV testing strategy was highly cost-effective by WHO standards, and should be prioritized for widespread implementation in Guangxi, China. Integrating the intervention within a broader combination prevention strategy would enhance the public health response to HIV/AIDS in Guangxi.	[Zang, Xiao; Min, Jeong Eun; Montaner, Julio S. G.; Nosyk, Bohdan] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Zang, Xiao; Nosyk, Bohdan] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Tang, Houlin; Gu, Diane; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Montaner, Julio S. G.] Univ British Columbia, Div AIDS, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of British Columbia	Nosyk, B (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.; Nosyk, B (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	bnosyk@cfenet.ubc.ca	tang, houlin/HGA-1502-2022		National Institutes of Health, National Institute on Drug Abuse Clinical Trials Network [CTN-0056 (U10DA013045)]; National Health and Family Planning Commission of the People's Republic of China [131-16-000-105-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse Clinical Trials Network; National Health and Family Planning Commission of the People's Republic of China; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes of Health, National Institute on Drug Abuse Clinical Trials Network, study number CTN-0056 (U10DA013045), and by the National Health and Family Planning Commission of the People's Republic of China (131-16-000-105-01). The funder had no direct role in the conduct of the analysis or the decision to submit the manuscript for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2016, HIV AIDS DAT HUB AS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bove J, 2015, J ACQUIR IMMUNE DEFI; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Cayley WE, 2004, AM FAM PHYSICIAN, V70, P1268; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Chen L, 2014, STUDY HIV AIDS EPIDE; Chen Y, 2012, CHINESE J AIDS STD, V18, P86; Chen Yi, 2013, Disease Surveillance, V28, P643; Cheng Gang, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P135; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Ciaranello AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117751; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Des Jarlais DC, 2010, DRUG ALCOHOL DEPEN, V109, P154, DOI 10.1016/j.drugalcdep.2009.12.028; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Eaton JW, 2014, P NATL ACAD SCI USA, V111, P16202, DOI 10.1073/pnas.1323007111; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Giannou F.K., 2015, EXPERT REV PHARM OUT, V7167, P1; Guangxi Zhuang Autonomous Region Bureau of Statistics, 2012, TAB 2010 POP CENS GU; HIV Modelling Consortium Treatment, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001259; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; HOMER JB, 1991, INTERFACES, V21, P26, DOI 10.1287/inte.21.3.26; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Huang YLA, 2015, APPL HEALTH ECON HEA, V13, P149, DOI 10.1007/s40258-014-0142-5; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; International Advisory Panel on HIV Care Continuum Optimization, 2015, J Int Assoc Provid AIDS Care, V14 Suppl 1, pS3, DOI 10.1177/2325957415613442; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Li JH, 2012, AIDS, V26, P2069, DOI 10.1097/QAD.0b013e3283574e54; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mastro T D, 1996, AIDS, V10 Suppl A, pS75, DOI 10.1097/00002030-199601001-00011; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; Mo Y, 2010, RES DRUG PROBLEMS GU; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; National Center for AIDS/STD Control and Prevention China CDC, 2012, AN HIV AIDS TEST TRE; NCAIDS N China CDC, 2011, CHINESE J AIDS STD; Nosyk B, 2014, CURR HIV-AIDS REP, V11, P468, DOI 10.1007/s11904-014-0227-7; Nosyk B, 2014, PHARMACOECONOMICS; Nosyk B, 2015, CONT CLIN TRIALS B, V45, P9; Nosyk B, 2015, LANCET HIV, V2, pE393, DOI 10.1016/S2352-3018(15)00127-7; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Nosyk B, 2013, JAIDS-J ACQ IMM DEF, V63, P653, DOI 10.1097/QAI.0b013e3182976891; Nosyk B, 2013, AIDS, V27, P1159, DOI 10.1097/QAD.0b013e32835f1d68; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Region SBoGZA, 2015, GUANGX STAT YB 2015; Rodger ABT., 2014, C RETR OPP INF 2014; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2013, DRUG ALCOHOL DEPEN, V128, P90, DOI 10.1016/j.drugalcdep.2012.08.009; She Y, 2010, J CHONGQING MED U, V135, P1902; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; UNAIDS, 2014, 90 90 90 AMB TREATM; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Wang SH, 2011, ASIA-PAC J PUBLIC HE, V23, P620, DOI 10.1177/1010539511412576; Wang X, 2015, J APPL PREV MED, V21, P171; Wang X, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-192; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei Liu, 2006, Subst Abus, V27, P53; Wood E., 2009, BMJ-BRIT MED J, V338, P1191; World Health Organization, 2015, CHOOS INT AR COST EF; Wu Z, LANCET UNPUB; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu Y, 2008, RES PSYCHOL PHYSL CH; Yang Hong-mei, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P393; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	85	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167308	10.1371/journal.pone.0167308	http://dx.doi.org/10.1371/journal.pone.0167308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893864	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400111
J	Balansky, R; La Maestra, S; Micale, RT; Iltcheva, M; Kirov, K; De Flora, S				Balansky, Roumen; La Maestra, Sebastiano; Micale, Rosanna T.; Iltcheva, Marietta; Kirov, Krassimir; De Flora, Silvio			Modulation by Ethanol of Cigarette Smoke Clastogenicity in Cells of Adult Mice and of Transplacentally Exposed Fetuses	PLOS ONE			English	Article							TOBACCO-SMOKE; MICRONUCLEUS TEST; DNA-ADDUCTS; RAT-LIVER; ALCOHOL; CARCINOGENESIS; LUNG; ACETALDEHYDE; CONSUMPTION; PROTECTION	Cigarette smoke (CS) and ethanol (EtOH) are known to synergize in the causation of cancers of the upper aerodigestive tract and of the liver. Little is known about possible interactions between these agents in other organs. These premises prompted us to evaluate the clastogenic effects resulting from the inhalation for 3 weeks of mainstream CS and oral administration of EtOH, which were tested either individually or in combination in cells of adult BDF1 mice and their fetuses. CS exerted clastogenic effects in haematopoietic cells of adult male mice by increasing the frequency of micronucleated erythroid cells both in bone marrow and in peripheral blood as well as the frequency of micronucleated and polynucleated pulmonary alveolar macrophages. Likewise, exposure to CS of pregnant mice resulted in a clastogenic damage in maternal bone marrow cells and in the liver and peripheral blood of their fetuses. Under all experimental conditions, EtOH was consistently devoid of clastogenic effects when given alone. In adult mice, EtOH exhibited a mild stimulating effect on the clastogenicity of CS in haematopoietic cells, while an opposite effect was observed in the respiratory tract, where EtOH attenuated the cytogenetic alterations induced by CS in pulmonary alveolar macrophages. At variance with the mild synergism observed in haematopoietic cells of adult mice, EtOH inhibited the clastogenicity of CS in the liver and peripheral blood cells of transplacentally exposed fetuses. Therefore, the effects of EtOH in CS-exposed mice show different trends depending both on the life stage and on the cells analyzed.	[Balansky, Roumen; Iltcheva, Marietta; Kirov, Krassimir] Natl Oncol Ctr, Sofia, Bulgaria; [La Maestra, Sebastiano; Micale, Rosanna T.; De Flora, Silvio] Univ Genoa, Dept Hlth Sci, Genoa, Italy	National Oncology Center - Bulgaria; University of Genoa	De Flora, S (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	sdf@unige.it	Micale, Rosanna Tindara/AAH-5665-2019	Micale, Rosanna Tindara/0000-0003-4361-2624; LA MAESTRA, SEBASTIANO/0000-0003-4939-2124	Bulgarian Ministry of Education and Science (National Research Fund); Hasumi International Research Foundation - Bulgaria	Bulgarian Ministry of Education and Science (National Research Fund); Hasumi International Research Foundation - Bulgaria	This work was supported by the Bulgarian Ministry of Education and Science (National Research Fund) and by the Hasumi International Research Foundation - Bulgaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balansky R, 2016, TOXICOLOGY; BALANSKY RB, 1992, CANCER LETT, V64, P123, DOI 10.1016/0304-3835(92)90072-4; BALANSKY RM, 1989, MUTAT RES, V223, P1, DOI 10.1016/0165-1218(89)90056-6; BALANSKY RM, 1993, CANCER LETT, V72, P183, DOI 10.1016/0304-3835(93)90127-U; BALANSKY RM, 1988, MUTAT RES, V208, P237, DOI 10.1016/0165-7992(88)90067-X; BALANSKY RM, 1987, MUTAT RES, V188, P13, DOI 10.1016/0165-1218(87)90109-1; Balansky RM, 1999, CARCINOGENESIS, V20, P1491, DOI 10.1093/carcin/20.8.1491; BALANSKY RM, 1995, CANCER LETT, V94, P91, DOI 10.1016/0304-3835(95)03829-L; Balansky R, 2007, CARCINOGENESIS, V28, P2236, DOI 10.1093/carcin/bgm122; Balansky R, 2012, INT J CANCER, V130, P1001, DOI 10.1002/ijc.26103; Balbo S, 2015, ADV EXP MED BIOL, V815, P71, DOI 10.1007/978-3-319-09614-8_5; Carpenter SP, 1997, J PHARMACOL EXP THER, V282, P1028; De Flora S, 2016, TRENDS PHARMACOL SCI, V37, P120, DOI 10.1016/j.tips.2015.11.003; De Flora S, 2012, INT J CANCER, V131, P2763, DOI 10.1002/ijc.27814; DEFLORA S, 1995, MUTAGENESIS, V10, P47; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dhouib H, 2015, PATHOL BIOL, V63, P258, DOI 10.1016/j.patbio.2015.10.001; Florek E, 2008, PHARMACOL REP, V60, P985; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; GREEN GM, 1977, AM REV RESPIR DIS, V115, P479; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Howard LA, 2001, J PHARMACOL EXP THER, V299, P542; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents, 2012, IARC MON EV CARC RIS, V100; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; International Agency for Research on Cancer World Health Organization, 2010, IARC MON EV CARC RIS, V96; Izzotti A, 1998, FASEB J, V12, P753, DOI 10.1096/fasebj.12.9.753; KORTE A, 1981, TOXICOLOGY, V20, P237, DOI 10.1016/0300-483X(81)90054-8; KRISTIANSEN E, 1990, FOOD CHEM TOXICOL, V28, P35, DOI 10.1016/0278-6915(90)90133-8; Linhart K, 2014, REDOX BIOL, V3, P56, DOI 10.1016/j.redox.2014.08.009; MAVOURNIN KH, 1990, MUTAT RES, V239, P29, DOI 10.1016/0165-1110(90)90030-F; Navasumrit P, 2001, MUTAT RES-FUND MOL M, V479, P81, DOI 10.1016/S0027-5107(01)00156-7; Przyblowska M, 2013, PHARM REP, V65, P906; Riedel F, 2003, BEST PRACT RES CL GA, V17, P543, DOI 10.1016/S1521-6918(03)00019-2; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Schoedel KA, 2003, BIOCHIM BIOPHYS ACTA, V17, P283; Seitz HK, 2015, ADV EXP MED BIOL, V815, P59, DOI 10.1007/978-3-319-09614-8_4; STICH HF, 1983, INT J CANCER, V31, P305, DOI 10.1002/ijc.2910310309; Trosko JE, 2006, CONTRIB MICROBIOL, V13, P45, DOI 10.1159/000092965	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167239	10.1371/journal.pone.0167239	http://dx.doi.org/10.1371/journal.pone.0167239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907070	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700101
J	Hsu, YC; Chang, CW; Lee, HL; Chuang, CC; Chiu, HC; Li, WY; Horng, JT; Fu, E				Hsu, Yung-Chuang; Chang, Cheng-Wei; Lee, Hsin-Lin; Chuang, Chuan-Chung; Chiu, Hsien-Chung; Li, Wan-Yun; Horng, Jorng-Tzong; Fu, Earl			Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan	PLOS ONE			English	Article							CLINICAL COMORBIDITY INDEX; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; NATIONWIDE COHORT; OXIDATIVE STRESS; ROOT-CARIES; MERCURY; HEALTH; PREVALENCE; NEURODEGENERATION	The impact of dental amalgam on the development of Parkinson's disease (PD) is still uncertain, although a positive association between dental amalgam and PD has been found in a few case-control studies. The patients with amalgam fillings restored between 2000 and 2008 were identified by using the National Health Insurance Research Database (NHIRD) in Taiwan. The same number of patients who had no new amalgam filling restored was matched by sex, age, and treatment date. Both cohorts were followed up from the treatment date until the date of diagnosis of PD, death, or the end of the year 2008. The individuals who received amalgam fillings had a significantly higher risk of PD afterward (adjusted hazard ratio [HR]=1.583, 95% confidence interval [CI]=1.122-2.234, p=0.0089) than those who did not. In the individuals who received amalgam fillings, being diagnosed with diabetes or hyperlipidemia demonstrated a significantly lower HR of PD occurrence than in the patients without diabetes or hyperlipidemia (HR=0.449, 95% CI=0.254-0.794, p=0.0059; HR=0.445, 95% CI=0.260-0.763, p=0.0032) after adjusting for comorbidities and Charlson-Deyo Comorbidity Index (CCI) scores. Meanwhile, hypertension increased the hazard risk of PD (HR=1.645, 95% CI=1.098-2.464, p=0.0159). The patients exposed to dental amalgam fillings were 1.583 times more likely to have PD afterward compared to their non-exposed counterparts after adjusting for comorbidities and CCI scores.	[Hsu, Yung-Chuang; Lee, Hsin-Lin; Chuang, Chuan-Chung; Chiu, Hsien-Chung; Fu, Earl] Tri Serv Gen Hosp, Dept Dent, Taipei, Taiwan; [Hsu, Yung-Chuang; Lee, Hsin-Lin; Chuang, Chuan-Chung; Chiu, Hsien-Chung; Fu, Earl] Natl Def Med Ctr, Taipei, Taiwan; [Chang, Cheng-Wei] Hsing Wu Univ, Dept Informat Management, New Taipei, Taiwan; [Li, Wan-Yun; Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli, Taiwan; [Horng, Jorng-Tzong] Asia Univ Taiwan, Dept Biomed Informat, Populat Hlth & Clin Informat Res Grp, Taichung, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Central University; Asia University Taiwan	Fu, E (corresponding author), Tri Serv Gen Hosp, Dept Dent, Taipei, Taiwan.; Fu, E (corresponding author), Natl Def Med Ctr, Taipei, Taiwan.	dentalab@tpts5.seed.net.tw		Fu, Earl/0000-0003-0637-0208				Allam MF, 2005, NEUROL RES, V27, P206, DOI 10.1179/016164105X22057; Aschner M, 2007, BRAZ J MED BIOL RES, V40, P285, DOI 10.1590/S0100-879X2007000300001; Bates MN, 2004, INT J EPIDEMIOL, V33, P894, DOI 10.1093/ije/dyh164; Brailsford SR, 2001, J DENT RES, V80, P1828, DOI 10.1177/00220345010800091101; Bratel J, 1997, EUR J ORAL SCI, V105, P234, DOI 10.1111/j.1600-0722.1997.tb00206.x; Burt B A, 1992, Clin Geriatr Med, V8, P447; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Correa MB, 2012, J DENT, V40, P703, DOI 10.1016/j.jdent.2012.04.020; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; FERRACANE J L, 1992, General Dentistry, V40, P223; Garton BJ, 2012, AUST DENT J, V57, P114, DOI 10.1111/j.1834-7819.2012.01690.x; Glaser V, 2010, NEUROTOXICOLOGY, V31, P454, DOI 10.1016/j.neuro.2010.05.012; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Hsu YT, 2015, AM J GERIAT PSYCHIAT, V23, P934, DOI 10.1016/j.jagp.2014.10.011; Hu SW, 2002, BRIT DENT J, V193, P411, DOI 10.1038/sj.bdj.4801577; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Jawed M, 2011, J DIABETES COMPLICAT, V25, P183, DOI 10.1016/j.jdiacomp.2010.07.001; Langworth S, 1997, J DENT RES, V76, P1397, DOI 10.1177/00220345970760071001; Leistevuo J, 2001, CARIES RES, V35, P163, DOI 10.1159/000047450; Liu WM, 2016, J FORMOS MED ASSOC, V115, P531, DOI 10.1016/j.jfma.2015.05.014; Lopez-Real A, 2005, J NEUROSCI RES, V81, P865, DOI 10.1002/jnr.20598; Lu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085781; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Nabi S, 2014, TOXIC EFFECT MERCURY, P308, DOI [10.1016/j.cden.2004.10.004, DOI 10.1016/J.CDEN.2004.10.004]; NGIM CH, 1989, NEUROEPIDEMIOLOGY, V8, P128, DOI 10.1159/000110175; Papapetropoulos S, 2004, EUR J NEUROL, V11, P231, DOI 10.1046/j.1468-1331.2003.00748.x; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Rodriguez-Farre E, 2016, REGUL TOXICOL PHARM; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Satoh H, 2000, IND HEALTH, V38, P153, DOI 10.2486/indhealth.38.153; Saunders Ralph H Jr, 2005, Dent Clin North Am, V49, P293; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; Tang CF, 2016, ACTA NEUROL SCAND, V134, P148, DOI 10.1111/ane.12524; Teunissen CE, 2003, NEUROBIOL AGING, V24, P893, DOI 10.1016/S0197-4580(03)00005-8; Timonen P, 2010, J DENT RES, V89, P1068, DOI 10.1177/0022034510376542; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Zorzon M, 2002, ACTA NEUROL SCAND, V105, P77, DOI 10.1034/j.1600-0404.2002.1o040.x	45	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166552	10.1371/journal.pone.0166552	http://dx.doi.org/10.1371/journal.pone.0166552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906991	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700029
J	Jobarteh, K; Shiraishi, RW; Malimane, I; Gudo, PS; Decroo, T; Auld, AF; Macome, V; Couto, A				Jobarteh, Kebba; Shiraishi, Ray W.; Malimane, Inacio; Gudo, Paula Samo; Decroo, Tom; Auld, Andrew F.; Macome, Vania; Couto, Aleny			Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; MORTALITY; ADHERENCE; THERAPY	Background High rates of attrition are stymying Mozambique's national HIV Program's efforts to achieve 80% treatment coverage. In response, Mozambique implemented a national pilot of Community Adherence and Support Groups (CASG). CASG is a model in which antiretroviral therapy (ART) patients form groups of up to six patients. On a rotating basis one CASG group member collects ART medications at the health facility for all group members, and distributes those medications to the other members in the community. Patients also visit their health facility bi-annually to receive clinical services. Methods A matched retrospective cohort study was implemented using routinely collected patient level data in 68 health facilities with electronic data systems and CASG programs. A total of 129,938 adult ART patients were registered in those facilities. Of the 129,938 patients on ART, 6,760 were CASG members. A propensity score matched analysis was performed to assess differences in mortality and loss to follow-up (LTFU) between matched CASG and non-CASG members. Propensity scores were estimated using a random-effects logistic regression model. The following covariates where included in the model: sex, educational status, WHO stage, year of ART initiation, age, CASG eligibility, CD4 cell count category, weight, and employment status. Results Non-CASG participants had higher LTFU rates (HR 2.356; p = 0.04) than matched CASG participants; however, there were no significant mortality differences between CASG and non-CASG participants. Compared with the full cohort of non-CASG members, CASG members were more likely to be female (74% vs. 68%), tended to have a lower median CD4 counts at ART initiation (183 cells/m3 vs. 200cells/m3) and be less likely to have a second ary school education (15% vs. 23%). Conclusion ART patients enrolled in CASG were significantly less likely to be LTFU compared to matched patients who did not join CASG. CASG appears to be an effective strategy to decrease LTFU in Mozambique's national ART program.	[Jobarteh, Kebba; Malimane, Inacio; Gudo, Paula Samo] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Maputo, Mozambique; [Shiraishi, Ray W.; Auld, Andrew F.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Decroo, Tom] Operat Ctr Brussels, Med Sans Frontieres, Dept Med, Brussels, Belgium; [Macome, Vania; Couto, Aleny] Mozamb Minist Hlth, Maputo, Mozambique	Centers for Disease Control & Prevention - USA; Doctors Without Borders	Jobarteh, K (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Maputo, Mozambique.	kebba@mac.com	Decroo, Tom/AAV-7208-2020	Decroo, Tom/0000-0002-1205-1484; Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163				Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Decroo T, 2013, INT STD RES REV, V12, P49; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gifford AL, 2002, JAIDS-J ACQ IMM DEF, V31, pS163, DOI 10.1097/00126334-200212153-00016; Joint United Nations Program on HIV/AIDS, 2014, JOINT UN PROGR HIV A, P14; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Leuven E, 2014, PSMATCH2 STATA MODUL; Lunt M., 2012, MPBALCHK STATA MODUL; Lunt M., 2012, PBALCHK STATA MODULE; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; MISAU, 2010, INQ NAC PREV RISC CO; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; National Program on HIV AIDS STIs, 2015, NAT PROGR HIV AIDS S; National Program on HIV AIDS STIs, 2011, NAT PROGR HIV AIDS S; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; The United National Development Program. Human Development Index Trends, 1980, HUM DEV IND TRENDS 1; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organization, 2009, WHOHTMNTDWHOPES20094	25	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166444	10.1371/journal.pone.0166444	http://dx.doi.org/10.1371/journal.pone.0166444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907084	Green Published, gold			2022-12-27	WOS:000389482700027
J	Kappas, I; Vittas, S; Pantzartzi, CN; Drosopoulou, E; Scouras, ZG				Kappas, Ilias; Vittas, Spiros; Pantzartzi, Chrysoula N.; Drosopoulou, Elena; Scouras, Zacharias G.			A Time-Calibrated Mitogenome Phylogeny of Catfish (Teleostei: Siluriformes)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; OTOPHYSAN FISHES OSTARIOPHYSI; DNA GENOME; MOLECULAR PHYLOGENETICS; EVOLUTIONARY HISTORY; COMPLETE SEQUENCE; ORIGIN; BIOGEOGRAPHY; NUCLEAR; INTERRELATIONSHIPS	A very significant part of the world's freshwater ichthyofauna is represented by ancient, exceptionally diverse and cosmopolitan ray-finned teleosts of the order Siluriformes. Over the years, catfish have been established as an exemplary model for probing historical biogeography at various scales. Yet, several tantalizing gaps still exist in their phylogenetic history, timeline and mode of diversification. Here, we re-examine the phylogeny of catfish by assembling and analyzing almost all publicly available mitogenome data. We constructed an ingroup matrix of 62 full-length mitogenome sequences from 20 catfish families together with four cypriniform outgroups, spanning 15,557 positions in total. Partitioned maximum likelihood analyses and Bayesian relaxed clock dating using fossil age constraints provide some useful and novel insights into the evolutionary history of this group. Loricarioidei are recovered as the first siluriform group to diversify, rendering Neotropics the cradle of the order. The next deepest clade is the South American Diplomystoidei placed as a sister group to all the remaining Siluroidei. The two multifamilial clades of "Big Asia" and "Big Africa" are also recovered, albeit nodal support for the latter is poor. Within "Big Asia", Bagridae are clearly polyphyletic. Other interfamilial relationships, including Clariidae + Heteropneustidae, Doradidae + Auchenipteridae and Ictaluridae + Cranoglanididae are robustly resolved. Our chronogram shows that siluriforms have a Pangaean origin, at least as far back as the Early Cretaceous. The inferred timeline of the basal splits corroborates the "Out-of-South America" hypothesis and accords well with the fossil record. The divergence of Siluroidei most likely postdated the final separation of Africa and South America. An appealing case of phylogenetic affinity elaborated by biogeographic dispersal is exemplified by the Early Paleogene split between the Southeast Asian Cranoglanididae and Ictaluridae, with the latter radiating into North America's freshwater realm by Eocene. The end of Cretaceous probably concludes the major bout of diversification at the family level while with the dawn of the Cenozoic a prolific radiation is evident at the generic level.	[Kappas, Ilias; Vittas, Spiros; Pantzartzi, Chrysoula N.; Drosopoulou, Elena; Scouras, Zacharias G.] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece; [Vittas, Spiros] Eurogenet MSA, Thessaloniki, Greece; [Pantzartzi, Chrysoula N.] Inst Mol Genet, Dept Transcript Regulat, Prague, Czech Republic	Aristotle University of Thessaloniki; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Scouras, ZG (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece.	scouras@bio.auth.gr	Kappas, Ilias/AAB-5286-2021; DROSOPOULOU, ELENA/N-2176-2015; Drosopoulou, Elena/AAX-6493-2020; Pantzartzi, Chrysoula/C-2683-2017	Kappas, Ilias/0000-0002-8564-7035; Drosopoulou, Elena/0000-0001-9805-0572; Vittas, Spiros/0000-0003-2879-6074				Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], 1981, ECLOGAE GEOL HELV; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Betancur-R R., 2013, PLOS CURR; Betancur-R R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-175; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Bruton MN, 1996, AQUAT LIVING RESOUR, V9, P35, DOI 10.1051/alr:1996040; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Cavender T.M., 1991, Fish and Fisheries Series, P34; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diogo R, 2004, ANIM BIOL, V54, P331, DOI 10.1163/1570756042729546; Diogo R, 2009, GONORYNCHIFORMES OST, P407; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eschmeyer WN, CATALOG FISHES GENER; FAO, 2012, FISH STAT 2012; Fara E, 2010, SER TELEOST FISH BIO, P173, DOI 10.1201/b10194-7; Ferraris Jr CJ, 2007, ZOOTAXA 0308, V1418, P628, DOI DOI 10.11646/ZOOTAXA.1418.1.1; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Gayet M, 2003, CATFISHES, VOLS 1-2, P491; Gayet M, 1999, GEOBIOS-LYON, V32, P235, DOI 10.1016/S0016-6995(99)80037-0; GRANDE L, 1986, PALAEONTOLOGY, V29, P113; Grande L., 1991, J VERTEBRATE PA S001, V1, P1, DOI DOI 10.1080/02724634.1991.10011424; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Jia XY, 2013, MITOCHONDR DNA, V24, P645, DOI 10.3109/19401736.2013.772164; Jia XY, 2013, MITOCHONDR DNA, V24, P373, DOI 10.3109/19401736.2013.763234; Jia XY, 2013, MITOCHONDR DNA, V24, P323, DOI 10.3109/19401736.2012.760075; Jondeung A, 2007, GENE, V387, P49, DOI 10.1016/j.gene.2006.08.001; Kartavtsev YP, 2007, GENE, V396, P13, DOI 10.1016/j.gene.2007.01.027; Kim SK, 2011, MITOCHONDR DNA, V22, P44, DOI 10.3109/19401736.2011.597388; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li Q, 2014, MITOCHONDR DNA, V25, P120, DOI 10.3109/19401736.2013.792057; Liang HW, 2014, MITOCHONDR DNA, V25, P179, DOI 10.3109/19401736.2013.792065; Liang HW, 2014, MITOCHONDR DNA, V25, P169, DOI 10.3109/19401736.2013.792060; Liang HW, 2013, MITOCHONDR DNA, V24, P222, DOI 10.3109/19401736.2012.752471; Liang HW, 2012, MITOCHONDR DNA, V23, P280, DOI 10.3109/19401736.2012.683185; Liang HW, 2012, MITOCHONDR DNA, V23, P170, DOI 10.3109/19401736.2012.668899; Liu J, 2009, SCI CHINA SER D, V52, P189, DOI 10.1007/s11430-009-0022-2; Lukoschek V, 2012, SYST BIOL, V61, P22, DOI 10.1093/sysbio/syr075; Lundberg J.G., 1975, U MICHIGAN MUSEUM PA, V11, P1; Lundberg JG, 2007, P ACAD NAT SCI PHILA, V156, P39, DOI 10.1635/0097-3157(2007)156[39:DOARFT]2.0.CO;2; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Mo T., 1991, Theses Zoologicae, V17, P1; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Patterson C., 1993, P621; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith G.R., 1993, P778; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sytchevskaya E.K., 1986, T SOVMESTNAYA SOVETS, V29, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vittas S, 2011, J BIOL RES-THESSALON, V15, P25; Waldbieser GC, 2003, DNA SEQUENCE, V14, P265, DOI 10.1080/1042517031000149057; Wan Q, 2013, MITOCHONDR DNA, V24, P333, DOI 10.3109/19401736.2012.760079; Wang H, 2015, MITOCHONDR DNA, V26, P631, DOI 10.3109/19401736.2013.834437; Wang JL, 2011, MOL BIOL REP, V38, P2507, DOI 10.1007/s11033-010-0388-4; Wang XY, 2013, MITOCHONDR DNA, V24, P1, DOI 10.3109/19401736.2012.710222; Wei M, 2015, MITOCHONDR DNA, V26, P633, DOI 10.3109/19401736.2013.836511; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zeng Q, 2012, MITOCHONDR DNA, V23, P355, DOI 10.3109/19401736.2012.690755; Zhao HP, 2014, MITOCHONDR DNA, V25, P342, DOI 10.3109/19401736.2013.800492; Zhou CJ, 2012, MITOCHONDR DNA, V23, P414, DOI 10.3109/19401736.2012.710211	73	27	29	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166988	10.1371/journal.pone.0166988	http://dx.doi.org/10.1371/journal.pone.0166988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907107	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700059
J	Kasahara, K; Kinoshita, K				Kasahara, Kota; Kinoshita, Kengo			IBiSA_Tools: A Computational Toolkit for Ion-Binding State Analysis in Molecular Dynamics Trajectories of Ion Channels	PLOS ONE			English	Article							POTASSIUM CHANNEL; CONDUCTION; ENERGETICS	Ion conduction mechanisms of ion channels are a long-standing conundrum. Although the molecular dynamics (MD) method has been extensively used to simulate ion conduction dynamics at the atomic level, analysis and interpretation of MD results are not straightforward due to complexity of the dynamics. In our previous reports, we proposed an analytical method called ion-binding state analysis to scrutinize and summarize ion conduction mechanisms by taking advantage of a variety of analytical protocols, e.g., the complex network analysis, sequence alignment, and hierarchical clustering. This approach effectively revealed the ion conduction mechanisms and their dependence on the conditions, i.e., ion concentration and membrane voltage. Here, we present an easy-to-use computational toolkit for ion-binding state analysis, called IBISA_tools. This toolkit consists of a C++ program and a series of Python and R scripts. From the trajectory file of MD simulations and a structure file, users can generate several images and statistics of ion conduction processes. A complex network named ion-binding state graph is generated in a standard graph format (graph modeling language; GML), which can be visualized by standard network analyzers such as Cytoscape. As a tutorial, a trajectory of a 50 ns MD simulation of the Kv1.2 channel is also distributed with the toolkit. Users can trace the entire process of ion-binding state analysis step by step. The novel method for analysis of ion conduction mechanisms of ion channels can be easily used by means of IBISA_tools. This software is distributed under an open source license at the following URL: http://wwwsitsumei.acjp/ktkshr/ibisatools/	[Kasahara, Kota] Ritsumeikan Univ, Coll Life Sci, Shiga, Japan; [Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi, Japan; [Kinoshita, Kengo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Ritsumeikan University; Tohoku University; Tohoku University; Tohoku University	Kasahara, K (corresponding author), Ritsumeikan Univ, Coll Life Sci, Shiga, Japan.	ktkshr@fc.ritsumei.ac.jp	Kinoshita, Kengo/E-9688-2011	Kinoshita, Kengo/0000-0003-3453-2171; Kasahara, Kota/0000-0003-0207-6271	Japan Society for Promotion of Science [22136005, 15H02773, 16K18526]; Japan Agency for Medical Research and Development; HPCI System Research Projects [hp130061, hp140032, hp150015]; Grants-in-Aid for Scientific Research [16K18526] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); HPCI System Research Projects; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for Promotion of Science, [http://www.jsps.go.jp/english/index.html (grant numbers: 22136005, 15H02773, and 16K18526), and Japan Agency for Medical Research and Development (the project name is "the Platform Project for Supporting in Drug Discovery and Life Science Research"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The supercomputing resources were provided by the Human Genome Center (the University of Tokyo) and the HPCI System Research Projects (project IDs: hp130061, hp140032, and hp150015).	Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Diaz-Franulic I, 2015, J GEN PHYSIOL, V146, P133, DOI 10.1085/jgp.201411353; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gumbart J, 2012, BIOPHYS J, V102, P795, DOI 10.1016/j.bpj.2012.01.021; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kasahara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150716; Kasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056342; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Nelson PH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3580562; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sack JT, 2015, J GEN PHYSIOL, V146, P123, DOI 10.1085/jgp.201511469; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865	27	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167524	10.1371/journal.pone.0167524	http://dx.doi.org/10.1371/journal.pone.0167524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907142	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700182
J	Meng, QJ; Ren, MM; Li, YG; Song, X				Meng, Qingjun; Ren, Mingming; Li, Yanguang; Song, Xiang			LncRNA-RMRP Acts as an Oncogene in Lung Cancer	PLOS ONE			English	Article							NONCODING RNA ANRIL; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-PROLIFERATION; POOR-PROGNOSIS; MICRORNA-206 FUNCTIONS; ADENOCARCINOMA CELLS; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; A549 CELLS; EXPRESSION	Accumulating studies have demonstrated that long noncoding RNAs (lncRNAs) act a crucial role in the development of tumors. However, the role of lncRNAs in lung cancer remains largely unknown. In this study, we demonstrated that theexpression of RMRP was upregulated in lung adenocarcinoma tissues compared to the matched adjacent normal tissues. Moreover, of 35 lung adenocarcinoma samples, RMRP expression was upregulated in 25 cases (25/35; 71.4%) compared to the adjacent normal tissues. We also showed that RMRP expression was upregulated in lung adenocarcinoma cell lines (A549, SPC-A1, H1299 and H23) compared to the bronchial epithelial cell line (16HBE). Ectopic expression of RMRP promoted lung adenocarcinoma cell proliferation, colony formation and invasion. In addition, overexpression of RMRP inhibited the miR-206 expression in the H1299 cell and increased the KRAS, FMNL2 and SOX9 expression, which were the target genes of miR-206. Re-expression of miR-206 reversed the RMRP-induced the H1299 cell proliferation and migration. Our data proved that RMRP acted as an oncogene LncRNA to promote the expression of KRAS, FMNL2 and SOX9 by inhibiting miR-206 expression in lung cancer. These data suggested that RMRP might serve as a therapeutic target in lung adenocarcinoma.	[Meng, Qingjun; Ren, Mingming; Li, Yanguang; Song, Xiang] CangZhou Cent Hosp, Dept Thorac Surg, Cangzhou, Hebei, Peoples R China		Song, X (corresponding author), CangZhou Cent Hosp, Dept Thorac Surg, Cangzhou, Hebei, Peoples R China.	xiaoxil1@163.com						Cai X, 2015, J ORTHOPAEDIC RES OF; Chen Q., 2016, ONCOTARGET; Chen QY, 2015, MOL BIOSYST, V11, P2290, DOI 10.1039/c4mb00734d; Cui YZ, 2013, BIOSCI TRENDS, V7, P259, DOI 10.5582/bst.2013.v7.6.259; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077070; Falcone D, 2013, CELL PROLIFERAT, V46, P172, DOI 10.1111/cpr.12018; Hu X, 2015, TUMOUR BIOL J INT SO; Hua L, 2015, INT J CLIN EXP PATHO, V8, P3076; Keklikoglou I, 2015, ONCOGENE, V34, P4867, DOI 10.1038/onc.2014.408; Li CY, 2013, CELL PROLIFERAT, V46, P272, DOI 10.1111/cpr.12034; Lin L, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0247-7; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Lu L, 2015, TOXICOL APPL PHARM, V289, P276, DOI 10.1016/j.taap.2015.09.016; Ma J., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1007/S11064-015-1803-Y; Ma YX, 2015, MOL MED REP, V11, P625, DOI 10.3892/mmr.2014.2688; Naemura M, 2015, ANTICANCER RES, V35, P5377; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Nakayama I, 2013, INT J ONCOL, V43, P63, DOI 10.3892/ijo.2013.1935; Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492; Plaimee P, 2014, CELL PROLIFERAT, V47, P564, DOI 10.1111/cpr.12140; Postiglione I, 2013, CELL PROLIFERAT, V46, P382, DOI 10.1111/cpr.12040; Qi P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-122; Ren XL, 2016, J CANCER RES CLIN, V142, P581, DOI 10.1007/s00432-015-2053-8; Rosenbluh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026270; Sabarinathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082699; Saito M, 2014, CLIN CANCER RES, V20, P4784, DOI 10.1158/1078-0432.CCR-14-1096; Shao Y, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9336; Song HJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-225; Tang Y, 2015, FEBS LETT, V589, P3189, DOI 10.1016/j.febslet.2015.08.046; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Tsay JCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118132; Wang D, 2015, ONCOTARGET; Wei JL, 2015, MOL MED REP, V11, P571, DOI 10.3892/mmr.2014.2675; Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357; Xie X, 2015, TUMOUR BIOL J INT SO; Yu X, 2015, ONCOL LETT, V10, P1953, DOI 10.3892/ol.2015.3553; Zhang C, 2012, ADV ENG FORUM, V2-3, P7, DOI 10.4028/www.scientific.net/AEF.2-3.7; Zhang HH, 2014, ONCOL REP, V31, P1473, DOI 10.3892/or.2014.2973; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081408; Zhang J, 2015, CLIN TRANSL ONCOL, V17, P209, DOI 10.1007/s12094-014-1213-7; Zhang JS, 2014, ACTA BIOCH BIOPH SIN, V46, P1, DOI 10.1093/abbs/gmt117; Zhang YJ, 2015, INT J CLIN EXP MED, V8, P9107; Zhang ZY, 2015, ONCOTARGET, V6, P1462, DOI 10.18632/oncotarget.2808; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15972	44	56	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0164845	10.1371/journal.pone.0164845	http://dx.doi.org/10.1371/journal.pone.0164845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906963	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700006
J	Spring, O; Zipper, R				Spring, Otmar; Zipper, Reinhard			Asexual Recombinants of Plasmopara halstedii Pathotypes from Dual Infection of Sunflower	PLOS ONE			English	Article							DOWNY MILDEW; PHYTOPHTHORA; HYBRIDIZATION; INOCULATION; HYBRIDS	Genetically homogenous strains of Plasmopara halstedii differing in host specificity and fungicide tolerance were used to test the hypothesis that asexual genetic recombination occurs and may account for the high genotype diversity of this homothallic reproducing oomycete, which causes downy mildew in sunflower. Dual inoculation of sunflower seedlings with single zoospore strains of complementary infection characteristics caused sporulation under conditions where inoculation with each strain alone failed to infect. PCR-based investigation with strain-specific primers proved the presence of genetic traits from both progenitors in single sporangia collected from sporangiophores of such infections. Sister zoospores released from these sporangia revealed the genotype of the one or the other parental strain thus indicating heterokaryology of sporangia. Moreover, some zoospores showed amplification products of both parents, which suggests that the generally mononucleic spores derived from genetic recombination. The possibility of parasexual genetic exchange in the host-independent stage of infection and the evolutionary consequences are discussed.	[Spring, Otmar; Zipper, Reinhard] Univ Hohenheim, Inst Bot, Stuttgart, Germany	University Hohenheim	Spring, O (corresponding author), Univ Hohenheim, Inst Bot, Stuttgart, Germany.	spring@uni-hohenheim.de						[Anonymous], STRUCTURE DYNAMICF; Bertier L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085385; Choi YJ, 2015, PLOS ONE, V7; DICK MW, 1995, CAN J BOT, V73, pS712, DOI 10.1139/b95-314; ERSEK T, 1995, PHYTOPATHOLOGY, V85, P1343, DOI 10.1094/Phyto-85-1343; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; Gu YH, 1998, CURR GENET, V34, P120, DOI 10.1007/s002940050375; Gulya T.J., 2007, ADV DOWNY MILDEW RES, V3, P121; Hammer T, 2006, MITT BIOL BUNDESANST, V400, P206; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; Judelson HS, 1998, MYCOL RES, V102, P1245, DOI 10.1017/S0953756298006388; May KJ, 2003, AUSTRALAS PLANT PATH, V32, P353, DOI 10.1071/AP03037; Michelmore R, 2008, EUR J PLANT PATHOL, V122, P19, DOI 10.1007/s10658-008-9305-2; Nechwatal J, 2009, PLANT PATHOL, V58, P261, DOI 10.1111/j.1365-3059.2008.01955.x; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Roca MG, 2004, MYCOL RES, V108, P1320, DOI 10.1017/S0953756204000838; Rozynek B., 2000, Helia, V23, P27; Rozynek B, 2001, J PHYTOPATHOL, V149, P309, DOI 10.1046/j.1439-0434.2001.00618.x; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Spring O., 2000, Helia, V23, P19; Spring O, 1997, J PHYTOPATHOL, V145, P189, DOI 10.1111/j.1439-0434.1997.tb00384.x; Spring O, 1998, J PHYTOPATHOL, V146, P577, DOI 10.1111/j.1439-0434.1998.tb04757.x; Spring O, 2006, MYCOL RES, V110, P657, DOI 10.1016/j.mycres.2006.03.009; Spring O, 2011, EUR J PLANT PATHOL, V131, P519, DOI 10.1007/s10658-011-9827-x; Tourvieille LD, P 15 INT SUNFL C 200, V2, P61; Truck T, 2010, J PLANT DIS PROTECT, V3, P143; VIRANYI F, 1991, MYCOL RES, V95, P199, DOI 10.1016/S0953-7562(09)81012-5; Viranyi F, 2011, EUR J PLANT PATHOL, V129, P207, DOI 10.1007/s10658-010-9683-0	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167015	10.1371/journal.pone.0167015	http://dx.doi.org/10.1371/journal.pone.0167015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907026	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700064
J	Pease, BS; Nielsen, CK; Holzmueller, EJ				Pease, Brent S.; Nielsen, Clayton K.; Holzmueller, Eric J.			Single-Camera Trap Survey Designs Miss Detections: Impacts on Estimates of Occupancy and Community Metrics	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; ILLINOIS OZARK HILLS; SAMPLING DESIGN; IMPERFECT DETECTION; NORTH-AMERICA; FOREST; MODELS; RATES; LOCATION; TRAILS	The use of camera traps as a tool for studying wildlife populations is commonplace. However, few have considered how the number of detections of wildlife differ depending upon the number of camera traps placed at cameras-sites, and how this impacts estimates of occupancy and community composition. During December 2015-February 2016, we deployed four camera traps per camera-site, separated into treatment groups of one, two, and four camera traps, in southern Illinois to compare whether estimates of wildlife community metrics and occupancy probabilities differed among survey methods. The overall number of species detected per camera-site was greatest with the four-camera survey method (P<0.0184). The four-camera survey method detected 1.25 additional species per camerasite than the one-camera survey method, and was the only survey method to completely detect the ground-dwelling silvicolous community. The four-camera survey method recorded individual species at 3.57 additional camera-sites (P = 0.003) and nearly doubled the number of camera-sites where white-tailed deer (Odocoileus virginianus) were detected compared to one-and two-camera survey methods. We also compared occupancy rates estimated by survey methods; as the number of cameras deployed per camera-site increased, occupancy estimates were closer to naive estimates, detection probabilities increased, and standard errors of detection probabilities decreased. Additionally, each survey method resulted in differing top-ranked, species-specific occupancy models when habitat covariates were included. Underestimates of occurrence and misrepresented community metrics can have significant impacts on species of conservation concern, particularly in areas where habitat manipulation is likely. Having multiple camera traps per site revealed significant shortcomings with the common one-camera trap survey method. While we realize survey design is often constrained logistically, we suggest increasing effort to at least two camera traps facing opposite directions per camera-site in habitat association studies, and to utilize camera-trap arrays when restricted by equipment availability.	[Pease, Brent S.; Nielsen, Clayton K.; Holzmueller, Eric J.] Southern Illinois Univ, Dept Forestry, Carbondale, IL 62901 USA; [Nielsen, Clayton K.] Southern Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Pease, BS (corresponding author), Southern Illinois Univ, Dept Forestry, Carbondale, IL 62901 USA.	bpease1@siu.edu			McIntire Stennis Formula Grant through the National Institute of Food and Agriculture	McIntire Stennis Formula Grant through the National Institute of Food and Agriculture	This work was funded by the McIntire Stennis Formula Grant through the National Institute of Food and Agriculture (httn://nfa.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ARCGIS E REL 10; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Blake John G, 2014, Mastozool. neotrop., V21, P17; Braczkowski AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151033; BURNHAM KP, 2002, MODEL SELECTION MULT, pR26; Claridge AW, 2014, CAMERA TRAPPING: WILDLIFE MANAGEMENT AND RESEARCH, P205; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fralish JS, 1997, CONSERVATION HIGHLY, pxvi; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; Kery M, 2016, APPL HIERARCHICAL MO, V1; Kery M., 2016, APPL HIERARCHICAL MO, V1; Krishnappa YS, 2014, ECOL INFORM, V24, P11, DOI 10.1016/j.ecoinf.2014.06.004; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Network T., 2008, TERRESTRIAL VERTEBRA; Nielsen CK, 2001, AM MIDL NAT, V146, P43, DOI 10.1674/0003-0031(2001)146[0043:SOOBLR]2.0.CO;2; Nielsen CK, 2009, NORTHEAST NAT, V16, P153, DOI 10.1656/045.016.0114; [NOAA] NOaAA, 2010, NAT CLIM DAT CTR WOR; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Ozier TB, 2006, AM MIDL NAT, V155, P253, DOI 10.1674/0003-0031(2006)155[253:CCASCI]2.0.CO;2; Ramsey David S.L., 2015, Journal of Wildlife Management, V79, P491; RCore Team, 2020, R LANG ENV STAT COMP; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Srbek-Araujo AC, 2013, BIOTA NEOTROP, V13, P51, DOI 10.1590/S1676-06032013000200005; Stokeld D, 2015, WILDLIFE RES, V42, P642, DOI 10.1071/WR15083; Trolliet F, 2014, BIOTECHNOL AGRON SOC, V18, P446; van de Gevel S, 2003, US FOR SERV T R NC, V234, P246; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Welbourne DJ, 2016, REMOTE SENS ECOL CON, V2, P77, DOI 10.1002/rse2.20	45	29	31	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166689	10.1371/journal.pone.0166689	http://dx.doi.org/10.1371/journal.pone.0166689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902733	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100032
J	Inzaule, SC; Hamers, RL; Kityo, C; De Wit, TFR; Roura, M				Inzaule, Seth C.; Hamers, Raph L.; Kityo, Cissy; Rinke de Wit, Tobias F.; Roura, Maria			Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study	PLOS ONE			English	Article								Background Long-term success of HIV antiretroviral therapy requires near-perfect adherence, maintained throughout one's lifetime. However, perceptions towards ART and patterns of adherence may change during the life course. We assessed challenges to long-term adherence in adolescents and adults in three regional HIV treatment centers in Uganda. Methods We conducted 24 in-depth interviews and 2 focus group discussions with a total of 33 health-care providers and expert clients (HIV patients on long-term ART who assist with adherence support of fellow patients). Interview topics included experiences with patients on long-term treatment with either declining adherence or persistent poor adherence. Transcribed texts were coded and analyzed based on the social-ecological framework highlighting differences and commonalities between adolescents and adults. Results The overarching themes in adolescents were unstructured treatment holidays, delays in disclosure of HIV status by caretakers, stigma, which was mainly experienced in boarding schools, and diminishing or lack of clinical support. In particular, there was minimal support for early and gradual disclosure for caretakers to the infected children, diminishing clinical support for young adults during transition to adult-based care and declining peer-to-peer support group activities. The predominating theme in adults was challenges with treatment access among temporary economic migrants. Common themes to adults and adolescents were challenges with disclosure in intimate relationships, treatment related factors including side effects, supply of single tablets in place of fixed-dose combined drugs, supply of drug brands with unfavorable taste and missed opportunities for counseling due to shortage of staff. Conclusion Adherence counseling and support should be adapted differently for adolescents and adults and to the emerging life course challenges in long-term treated patients. Programs should also address constraints experienced by temporary economic migrants to ensure continuity of treatment within the host country.	[Inzaule, Seth C.; Hamers, Raph L.; Rinke de Wit, Tobias F.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Inzaule, Seth C.; Hamers, Raph L.; Rinke de Wit, Tobias F.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hamers, Raph L.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, Amsterdam, Netherlands; [Kityo, Cissy] Joint Clin Res Ctr, Kampala, Uganda; [Roura, Maria] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Joint Clinic Research Center - United Arab Emirates; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Inzaule, SC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands.; Inzaule, SC (corresponding author), Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.	s.inzaule@aighd.org	Roura, Maria/K-6668-2014	Roura, Maria/0000-0001-9556-1940; Hamers, Raph/0000-0002-5007-7896	European Union through the Trans Global Health programme, part of the Erasmus Mundus Joint Doctorate Programme; Joint Clinical Research Centre (JCRC); RRC Mbale; RRC Fort Portal; Amsterdam Institute for Global Health and Development; Barcelona Centre for International Health Research (CRESIB) Hospital	European Union through the Trans Global Health programme, part of the Erasmus Mundus Joint Doctorate Programme; Joint Clinical Research Centre (JCRC); RRC Mbale; RRC Fort Portal; Amsterdam Institute for Global Health and Development; Barcelona Centre for International Health Research (CRESIB) Hospital	This work was supported by a grant from the European Union through the Trans Global Health programme, part of the Erasmus Mundus Joint Doctorate Programme.; The authors acknowledge the support of the study participants; The authors also acknowledge the support of the Joint Clinical Research Centre (JCRC), RRC Mbale, RRC Fort Portal, Amsterdam Institute for Global Health and Development, and Barcelona Centre for International Health Research (CRESIB) Hospital.	Adefolalu AO, 2013, DISEASES; Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; [Anonymous], 2014, HIV AIDS PREV CONTR; Bangsberg DR, 2013, ANTIVIRAL THERAPY; Bijker R, 2015, C RETR OPP INF CROI; Boender T. S., 2015, CLIN INFECT DIS; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bronfenbrenner U., 1977, AM PSYCHOL; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Cambiano V, 2010, AIDS; CHIVA, 2010, CHIVA GUID TRANS AD; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; DHHS, 2016, GUIDELINES USE ANTIR; Etard JF, 2007, TROP MED INT HLTH; Fair CD, 2012, AIDS PATIENT CARE ST; Feeney ER, 2011, OPEN CARDIOVASC MED; Fox MP, 2010, TROP MED INT HLTH; Funck-Brentano I, 2005, AIDS; Global Commission on HIV and the Law, 2012, RISKS RIGHTS HLTH; Gupta RK, 2009, LANCET INFECT DIS; Gusdal AK, 2011, AIDS CARE; Hardon AP, 2007, AIDS CARE; Havlir D V, 2004, CLIN INFECT DIS; Hazra R, 2010, ANN REV MED; Hudelson C, 2015, AIDS CARE; Kasedde S, 2013, CURR HIV AIDS REP; Kyakuwa M, 2012, MED ANTHR; Lima VD, 2009, J ACQUIR IMMUNE DEFI; Mbonye M, 2013, BMC PUBLIC HLTH; Mbonye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078243; Merten S, 2010, TROP MED INT HLTH; Mutumba M, 2015, J ASS NURSES AIDS CA; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; Nachega JB, 2009, J ACQUIR IMMUNE DEFI; Ortego C, 2011, AIDS BEHAV; Roura M, 2009, AIDS PATIENT CARE ST; Russell S, 2016, SOCIOL HLTH ILLN; Russell S, 2016, QUAL HLTH RES; Seeley J, 2009, CULT HLTH SEX; Taylor BS, 2011, MT SINAI J MED; Tesoriero J, 2003, J ACQUIR IMMUNE DEFI; UNAIDS, 2015, AIDS CHANG EV MDG6 1; UNICEF, 2014, LOST TRANS CURR ISS; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Williams PL, 2008, AM J EPIDEMIOL; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; World Health Organization, 2011, GUID HIV DISCL COUNS; Zelinsky W., 1971, GEOGR REV	49	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167492	10.1371/journal.pone.0167492	http://dx.doi.org/10.1371/journal.pone.0167492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898736	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000066
J	Saito, K; Ueta, M; Maekawa, K; Sotozono, C; Kinoshita, S; Saito, Y				Saito, Kosuke; Ueta, Mayumi; Maekawa, Keiko; Sotozono, Chie; Kinoshita, Shigeru; Saito, Yoshiro			Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens Johnson Syndrome/Toxic Epidermal Necrolysis	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; ERYTHEMA MULTIFORME; SHOTGUN LIPIDOMICS; IMMUNE-RESPONSE; BLOOD-PLASMA; INFLAMMATION; MANIFESTATIONS; SUSCEPTIBILITY; PHOSPHOLIPIDS	Stevens-Johnson syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), are drug-induced acute inflammatory vesiculobullous reactions of the skin and mucous membranes, including the ocular surface. Even after recovery from skin symptoms, some SJS/TEN patients continue to suffer with severe ocular complications (SOCs). Therefore, this study aims to understand the pathophysiology of chronic SOCs. Because plasma lipid profiling has emerged as a useful tool to understand pathophysiological alterations in the body, we performed plasma lipid profiling of 17 patients who suffered from SJS/TEN-associated chronic SOCs. A lipidomics approach yielded 386 lipid molecules and demonstrated that plasma levels of inflammatory oxylipins increased in patients with SJS/TEN-associated chronic SOCs. In addition, oxidized phosphatidylcholines and ether-type diacylglycerols increased in the patients with chronic SOCs, while phosphoglycerolipids decreased. When we compared these lipidomic profiles with those of patients with atopic dermatitis, we found that patients with chronic SOCs, specifically, had decreased levels of ether-type phosphatidylcholines (ePCs) containing arachidonic acid (AA), such as PC(18:0e/20:4) and PC (20:0e120:4). To confirm our finding, we recruited additional patients, who suffered from SOC associated with SJS/TEN (up to 51 patients), and validated the decreased plasma levels of AA-containing ePCs. Our study provides insight into the alterations of plasma lipidomic profiles in chronic SOCs and into the pathophysiology of SJS/TEN-associated chronic SOCs.	[Saito, Kosuke; Maekawa, Keiko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan; [Ueta, Mayumi; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kamigyo Ku, Kyoto, Japan; [Sotozono, Chie] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, Kyoto, Japan	National Institute of Health Sciences - Japan; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Saito, Y (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan.; Ueta, M (corresponding author), Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kamigyo Ku, Kyoto, Japan.	mueta@koto.kpu-m.ac.jp; yoshiro@nihs.go.jp	Saito, Kosuke/AAI-2878-2020		Japan Society for the Promotion of Science [26670758]; Japan Agency for Medical Research and development [16ak0101029j0003]; Grants-in-Aid for Scientific Research [26293122, 16H05488, 16K11327] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, MU SK, 26670758 "Core-to-Core Program, A. Advanced Research Networks", (www.jsps.go.jp) and Japan Agency for Medical Research and development, YS, 16ak0101029j0003, (www.amed.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkers CR, 2005, TRENDS PHARMACOL SCI, V26, P252, DOI 10.1016/j.tips.2005.03.005; BETZ M, 1991, J IMMUNOL, V146, P108; Caproni M, 2006, BRIT J DERMATOL, V155, P722, DOI 10.1111/j.1365-2133.2006.07398.x; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Lappas M, 2015, DIABETOLOGIA, V58, P1436, DOI 10.1007/s00125-015-3587-7; Li S, 2016, EXPERT REV PROTEOMIC, V13, P451, DOI 10.1080/14789450.2016.1177462; Mandal A, 1997, J BIOL CHEM, V272, P20306, DOI 10.1074/jbc.272.32.20306; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Mirzaian M, 2015, J LIPID RES, V56, P936, DOI 10.1194/jlr.M057232; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nagamachi M, 2007, J EXP MED, V204, P2865, DOI 10.1084/jem.20070773; Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Sales S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27710; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Sotozono C, 2015, AM J OPHTHALMOL, V160, P228, DOI 10.1016/j.ajo.2015.05.002; Surma MA, 2015, EUR J LIPID SCI TECH, V117, P1540, DOI 10.1002/ejlt.201500145; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Ueta M, 2015, J ALLERGY CLIN IMMUN, V135, P1538, DOI 10.1016/j.jaci.2014.12.1916; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04862; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Ueta M, 2012, PROG RETIN EYE RES, V31, P551, DOI 10.1016/j.preteyeres.2012.05.003; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Wei Y, 2012, INVEST OPHTH VIS SCI, V53, P2845, DOI 10.1167/iovs.11-8684; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; YETIV JZ, 1980, SOUTH MED J, V73, P599, DOI 10.1097/00007611-198005000-00015; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167402	10.1371/journal.pone.0167402	http://dx.doi.org/10.1371/journal.pone.0167402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898730	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474000060
J	Arnold, WD; Duque, S; Iyer, CC; Zaworski, P; McGovern, VL; Taylor, SJ; von Herrmann, KM; Kobayashi, DT; Chen, KS; Kolb, SJ; Paushkin, SV; Burghes, AHM				Arnold, W. David; Duque, Sandra; Iyer, Chitra C.; Zaworski, Phillip; McGovern, Vicki L.; Taylor, Shannon J.; von Herrmann, Katharine M.; Kobayashi, Dione T.; Chen, Karen S.; Kolb, Stephen J.; Paushkin, Sergey V.; Burghes, Arthur H. M.			Normalization of Patient-Identified Plasma Biomarkers in SMN Delta 7 Mice following Postnatal SMN Restoration	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON PROTEIN; MOUSE MODEL; COPY NUMBER; SINGLE NUCLEOTIDE; DETERMINING GENE; NATURAL-HISTORY; SURVIVAL; PHENOTYPE; SEVERITY	Introduction and Objective Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disorder. SMA is caused by homozygous loss of the SMN1 gene and retention of the SMN2 gene resulting in reduced levels of full length SMN protein that are insufficient for motor neuron function. Various treatments that restore levels of SMN are currently in clinical trials and biomarkers are needed to determine the response to treatment. Here, we sought to investigate in SMA mice a set of plasma analytes, previously identified in patients with SMA to correlate with motor function. The goal was to determine whether levels of plasma markers were altered in the SMN Delta 7 mouse model of SMA and whether postnatal SMN restoration resulted in normalization of the biomarkers. Methods SMN Delta 7 and control mice were treated with antisense oligonucleotides (ASO) targeting ISS-N1 to increase SMN protein from SMN2 or scramble ASO (sham treatment) via intracerebroventricular injection on postnatal day 1 (P1). Brain, spinal cord, quadriceps muscle, and liver were analyzed for SMN protein levels at P12 and P90. Ten plasma biomarkers (a subset of biomarkers in the SMA-MAP panel available for analysis in mice) were analyzed in plasma obtained at P12, P30, and P90. Results Of the eight plasma biomarkers assessed, 5 were significantly changed in sham treated SMN Delta 7 mice compared to control mice and were normalized in SMN Delta 7 mice treated with ASO. Conclusion This study defines a subset of the SMA-MAP plasma biomarker panel that is abnormal in the most commonly used mouse model of SMA. Furthermore, some of these markers are responsive to postnatal SMN restoration. These findings support continued clinical development of these potential prognostic and pharmacodynamic biomarkers.	[Arnold, W. David; Kolb, Stephen J.; Burghes, Arthur H. M.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Arnold, W. David] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA; [Duque, Sandra] Katholieke Univ Leuven, VIB Ctr Biol Dis, Dept Human Genet, Leuven, Belgium; [Iyer, Chitra C.; McGovern, Vicki L.; Kolb, Stephen J.; Burghes, Arthur H. M.] Ohio State Univ, Wexner Med Ctr, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Zaworski, Phillip; Taylor, Shannon J.] PharmOptima, Portage, MI USA; [von Herrmann, Katharine M.; Kobayashi, Dione T.; Chen, Karen S.; Paushkin, Sergey V.] SMA Fdn, New York, NY USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Flanders Institute for Biotechnology (VIB); KU Leuven; University System of Ohio; Ohio State University	Burghes, AHM (corresponding author), Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA.; Burghes, AHM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	burghes.1@osu.edu	Iyer, Chitra/K-5482-2019; Arnold, W. David/AAM-5649-2020	McGovern, Vicki/0000-0003-3979-9596; Burghes, Arthur/0000-0001-9031-1555; Arnold, W. David/0000-0001-9889-7036; kobayashi, dione/0000-0002-5541-7175	NIH-NICHD [HD060586, 5K12HD001097-17, U01NS079163]; Marshal Heritage Foundation; SMA Foundation; PharmOptima; Spinal Muscular Atrophy Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060586, K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS079163] Funding Source: NIH RePORTER	NIH-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Marshal Heritage Foundation; SMA Foundation; PharmOptima; Spinal Muscular Atrophy Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The studies described here were supported by NIH-NICHD grant HD060586, the Marshal Heritage Foundation, and the SMA Foundation. WDA was supported by a NIH-NICHD (5K12HD001097-17). SJK was supported by NIH-NINDS (U01NS079163). PharmOptima provided support in the form of salaries for PZ and ST. The Spinal Muscular Atrophy Foundation provided support in the form of salaries for KVH, DK, KC and SP and supported the cost of the biomarker and SMN levels performed at PharmOptima. PharmOptima had no additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are specified in the author contributions section. Competing interests: PZ and ST are employees of PharmOptima, Inc. KC and SP are employees of the Spinal Muscular Atrophy Foundation. KVH and DK were employees of the Spinal Muscular Atrophy Foundation at the time of this research. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Arnold W, 2016, NEUROBIOL DIS, V87, P116, DOI 10.1016/j.nbd.2015.12.014; Arnold W.D., 2013, ANN NEUROL; Arnold WD, 2015, JOVE-J VIS EXP, DOI 10.3791/52899; Arnold WD, 2015, MUSCLE NERVE, V51, P157, DOI 10.1002/mus.24497; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Bernal S, 2010, J MED GENET, V47, P640, DOI 10.1136/jmg.2010.079004; Bogdanik LP, 2015, P NATL ACAD SCI USA, V112, pE5863, DOI 10.1073/pnas.1509758112; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Bromberg MB, 2002, MUSCLE NERVE, V25, P445, DOI 10.1002/mus.10050; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chen YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17632; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Duque SI, 2015, ANN NEUROL, V77, P399, DOI 10.1002/ana.24332; Elsheikh B, 2009, MUSCLE NERVE, V40, P652, DOI 10.1002/mus.21350; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Harris VK, 2013, MULT SCLER J, V19, P1462, DOI 10.1177/1352458513477923; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Kobayashi DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060113; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McGovern VL, 2015, HUM MOL GENET; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ng KW, 2015, J NEUROL SCI, V358, P178, DOI 10.1016/j.jns.2015.08.1532; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Rutkove SB, 2014, PEDIATR NEUROL, V51, P88, DOI 10.1016/j.pediatrneurol.2014.02.015; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tiziano FD, 2011, INT J MOL SCI, V12, P24, DOI 10.3390/ijms12010024; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Zaworski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150640; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	63	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167077	10.1371/journal.pone.0167077	http://dx.doi.org/10.1371/journal.pone.0167077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907033	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700072
J	Gilbert, JA; Shenoi, SV; Moll, AP; Friedland, GH; Paltiel, AD; Galvani, AP				Gilbert, Jennifer A.; Shenoi, Sheela V.; Moll, Anthony P.; Friedland, Gerald H.; Paltiel, A. David; Galvani, Alison P.			Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; DRUG-RESISTANT TUBERCULOSIS; HIV-ASSOCIATED TUBERCULOSIS; ANTIRETROVIRAL THERAPY; TREATMENT OUTCOMES; MYCOBACTERIUM-TUBERCULOSIS; EPIDEMICS; MODEL; TB; TRANSMISSION	South Africa has one of the highest burdens of TB worldwide, driven by the country's widespread prevalence of HIV, and further complicated by drug resistance. Active case finding within the community, particularly in rural areas where healthcare access is limited, can significantly improve diagnosis and treatment coverage in high-incidence settings. We evaluated the potential health and economic consequences of implementing community-based TB/HIV screening and linkage to care. Using a dynamic model of TB and HIV transmission over a time horizon of 10 years, we compared status quo TB/HIV control to community-based TB/HIV screening at frequencies of once every two years, one year, and six months. We also considered the impact of extending IPT from 36 months for TST positive and 12 months for TST negative or unknown patients (36/12) to lifetime use for all HIV-infected patients. We conducted a probabilistic sensitivity analysis to assess the effect of parameter uncertainty on the cost-effectiveness results. We identified four strategies that saved the most life years for a given outlay: status quo TB/HIV control with 36/12 months of IPT and TB/HIV screening strategies at frequencies of once every two years, one year, and six months with lifetime IPT. All of these strategies were very cost-effective at a threshold of $6,618 per life year saved (the per capita GDP of South Africa). Community-based TB/HIV screening with linkage to care is therefore very cost-effective in rural South Africa.	[Gilbert, Jennifer A.; Friedland, Gerald H.; Galvani, Alison P.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Gilbert, Jennifer A.; Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA; [Shenoi, Sheela V.; Moll, Anthony P.; Friedland, Gerald H.] Yale Univ Sch Med, Infect Dis Sect, Dept Med, AIDS Program, New Haven, CT USA; [Moll, Anthony P.] Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Paltiel, A. David] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Gilbert, JA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.	jennifer.gilbert@aya.yale.edu	Shenoi, Sheela/Z-2641-2019; Shenoi, Sheela/GRY-6103-2022	Shenoi, Sheela/0000-0001-7654-4344; Paltiel, A. David/0000-0002-4861-3290	National Institute on Drug Abuse [R01DA015612, R01DA025932]; Gilead Foundation [157201]; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention [1U01GH000524-01]; National Institute of Mental Health [R01MH105203]; National Institutes of Health [2U01GM087719, 5U01GM105627]; National Institute of Allergy and Infectious Diseases [1K23AI089260]; National Institutes of Health's Fogarty International Clinical Research Program [R24TW007988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Gilead Foundation(Gilead Sciences); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health's Fogarty International Clinical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JAG and ADP were supported by the National Institute on Drug Abuse (R01DA015612, http://www.drugabuse.gov). GHF was supported by the National Institute on Drug Abuse (R01DA025932, http://www.drugabuse.gov). GHF and SVS were supported by the Gilead Foundation (157201, http://www.gilead.com). GHF, APM, APG, and SVS were supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention (1U01GH000524-01, http://www.cdc.gov). ADP was supported by the National Institute of Mental Health (R01MH105203, http://www.nimh.nih.gov). APG was supported by the National Institutes of Health (2U01GM087719 and 5U01GM105627, http://nih.gov). SVS was supported by the National Institute of Allergy and Infectious Diseases (1K23AI089260, http://www.niaid.nih.gov) and the National Institutes of Health's Fogarty International Clinical Research Program (R24TW007988, http://nih.gov).	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2014, NAT TUB MAN GUID; [Anonymous], 2013, S AFR ANT TREATM GUI; [Anonymous], 2011, MULT RES TUB POL FRA; [Anonymous], 2003, LAB MED, DOI DOI 10.1046/J.1439-0477.2003.03049.X; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Basu S, 2009, INT J TUBERC LUNG D, V13, P652; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Chehab JC, 2012, INT J TUBERC LUNG D, V16, P903, DOI 10.5588/ijtld.11.0722; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cleary S, 2005, S AFRICAN HLTH REV 2; CLEARY S, 2004, COST EFFECTIVENESS A; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gilbert JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126267; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Group ISS, 2015, N ENGL J MED; Group TAS, 2015, N ENGL J MED; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1159, DOI 10.5588/ijtld.13.0571; Health Systems Trust, 2015, BACT COV RAT; Health Systems Trust, 2011, DET INT RAT NEW SM C; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Johnson L., 2011, S AFR J HIV MED, V13, P22; Kompala T, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1627-8; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; MARTIN DJ, 1995, J ACQ IMMUN DEF SYND, V8, P386; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Mills HL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005260; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Osoti AO, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1053-2; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Republic of South Africa Department of Health, 2014, NAT CONS GUID PREV M; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Smith JA, 2015, LANCET HIV, V2, pE159, DOI 10.1016/S2352-3018(15)00016-8; South Africa Department of Health, 2006, THE KZN OUTBR; Statistics South Africa, 2014, MID POP EST 2014; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Tabana H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135048; Upadhya D, 2016, INT J STD AIDS, V27, P662, DOI 10.1177/0956462415592789; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, ANT THER HIV INF AD; WHO, 2014, GLOB TUB REP 2014; WHO, 2014, WHO TB BURD EST; WHO, 2008, EPI SEM 2008; World Bank, 2013, GDP PER CAP CURR; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, REC 36 MONTHS IS PRE; World Health Organization, 2001, MACR HLTH INV HLTH E; Yaesoubi R, 2013, P NATL ACAD SCI US	81	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165614	10.1371/journal.pone.0165614	http://dx.doi.org/10.1371/journal.pone.0165614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906986	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700009
J	Hossain, MI; Haque, R; Mondal, D; Mahfuz, M; Ahmed, AMS; Islam, MM; Guerrant, RL; Petri, WA; Ahmed, T				Hossain, Md. Iqbal; Haque, Rashidul; Mondal, Dinesh; Mahfuz, Mustafa; Ahmed, A. M. Shamsir; Islam, M. Munirul; Guerrant, Richard L.; Petri, William A., Jr.; Ahmed, Tahmeed			Undernutrition, Vitamin A and Iron Deficiency Are Associated with Impaired Intestinal Mucosal Permeability in Young Bangladeshi Children Assessed by Lactulose/Mannitol Test	PLOS ONE			English	Article							AMPEROMETRIC DETECTION; MALNOURISHED CHILDREN; PERSISTENT DIARRHEA; BARRIER FUNCTION; MANNITOL; IMPACT; GROWTH; MALNUTRITION; SUPPLEMENTATION; GASTROENTERITIS	Background Lactulose/mannitol (L:M) test has been used as a non-invasive marker of intestinal mucosal -integrity and -permeability (enteropathy). We investigated the association of enteropathy with anthropometrics, micronutrient-status, and morbidity in children. Methods The urine and blood samples were collected from 925 children aged 6-24 months residing in Mirpur slum of Dhaka, Bangladesh during November 2009 to April 2013. L:M test and micronutrient status were assessed in the laboratory of International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b) following standard procedure. Results Mean +/- SD age of the children was 13.2 +/- 5.2 months and 47.8% were female. Urinary-lactulose recovery was 0.264 +/- 0.236, mannitol recovery was 3.423 +/- 3.952, and L:M was 0.109 +/- 0.158. An overall negative correlation (Spearman's-rho) of L:M was found with age (r(s) = -0.087; p = 0.004), weight-for-age (r(s) = -0.077; p = 0.010), weight-for-length (r(s) = -0.060; p = 0.034), mid-upper-arm-circumference (r(s) = -0.098; p = 0.001) and plasma-retinol (r(s) = -0.105; p = 0.002); and a positive correlation with plasma alpha-1-acid glycoprotein (r(s) = 0.066; p = 0.027). However, most of the correlations were not very strong. Approximately 44% of children had enteropathy as reflected by L:M of >= 0.09. Logistic regression analysis revealed that younger age (infancy) (adjusted odds ratio (AOR) = 1.35; p = 0.027), diarrhea (AOR = 4.00; p = 0.039) or fever (AOR = 2.18; p = 0.003) within previous three days of L:M test were the risk factors of enteropathy (L:M of >= 0.09). Conclusions Enteropathy (high L:M) is associated with younger age, undernutrition, low vitamin A and iron status, and infection particularly diarrhea and fever.	[Hossain, Md. Iqbal; Haque, Rashidul; Mondal, Dinesh; Mahfuz, Mustafa; Ahmed, A. M. Shamsir; Islam, M. Munirul; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Hossain, Md. Iqbal; Ahmed, Tahmeed] Brac Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Guerrant, Richard L.; Petri, William A., Jr.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Virginia	Hossain, MI (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Hossain, MI (corresponding author), Brac Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	ihossain@icddrb.org	Petri, William A./D-3639-2019; Mahfuz, Mustafa/H-5923-2017; Petri, William/AAL-3642-2020	Mahfuz, Mustafa/0000-0002-4090-785X; Petri, William/0000-0002-7268-1218	University of Virginia (UVA); MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC); Bill & Melinda Gates Foundation; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)	University of Virginia (UVA); MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)	This research protocol was funded by University of Virginia (UVA) with support from MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC) with overall support from the Bill & Melinda Gates Foundation. icddr,b acknowledges with gratitude the commitment of UVA, FNIH, FIC and BMGF to its research efforts. icddr,b also gratefully acknowledges the following donors who provide unrestricted support: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UKAid).; This research protocol was funded by University of Virginia (UVA) with support from MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC) with overall support from the Bill & Melinda Gates Foundation. icddr,b acknowledges with gratitude the commitment of UVA, FNIH, FIC and BMGF to its research efforts. icddr,b also gratefully acknowledges the following donors who provided unrestricted support: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UKAid).	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; AGGETT PJ, 1990, NESTLE NUTR WORKS SE, V19, P155; Bao YD, 1996, J CHROMATOGR B, V685, P105, DOI 10.1016/0378-4347(96)00159-4; Barboza MS, 1999, BRAZ J MED BIOL RES, V32, P1499, DOI 10.1590/S0100-879X1999001200008; BEHRENS RH, 1987, AM J CLIN NUTR, V45, P1433, DOI 10.1093/ajcn/45.6.1433; BERANT M, 1992, J PEDIATR GASTR NUTR, V14, P17, DOI 10.1097/00005176-199201000-00004; Boaz RT, 2013, INDIAN PEDIATR, V50, P152, DOI 10.1007/s13312-013-0030-3; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Brown K H, 1991, Infect Dis Clin North Am, V5, P297; BROWN KH, 1979, AM J CLIN NUTR, V32, P1962, DOI 10.1093/ajcn/32.9.1962; BUTZNER JD, 1985, PEDIATR RES, V19, P476, DOI 10.1203/00006450-198505000-00014; Campbell DI, 2003, J NUTR, V133, P1332; FLEMING SC, 1990, CLIN CHEM, V36, P797; Ford RP, 1985, J PEDIAT GASTROENTER, V4, P474; Goto K, 1999, J PEDIATR GASTR NUTR, V28, P282, DOI 10.1097/00005176-199903000-00013; Goto R, 2009, T ROY SOC TROP MED H, V103, P520, DOI 10.1016/j.trstmh.2008.07.020; ISOLAURI E, 1989, J PEDIATR GASTR NUTR, V8, P466, DOI 10.1097/00005176-198905000-00008; JUBY LD, 1989, GASTROENTEROLOGY, V96, P79, DOI 10.1016/0016-5085(89)90767-1; Lima AAM, 2005, J PEDIATR GASTR NUTR, V40, P28, DOI 10.1097/00005176-200501000-00006; Louis-Auguste J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-15; Lunn PG, 2000, P NUTR SOC, V59, P147, DOI 10.1017/S0029665100000173; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; MENZIES IS, 1979, LANCET, V2, P1107; MENZIES IS, 1984, FALK S, V36, P527; NOONE C, 1986, EUR J CLIN INVEST, V16, P217, DOI 10.1111/j.1365-2362.1986.tb01332.x; Ramakrishna BS, 2006, POSTGRAD MED J, V82, P779, DOI 10.1136/pgmj.2006.048579; ROY SK, 1992, J PEDIATR GASTR NUTR, V15, P289, DOI 10.1097/00005176-199210000-00010; SULLIVAN PB, 1991, J PEDIATR GASTR NUTR, V12, P195, DOI 10.1097/00005176-199102000-00010; SULLIVAN PB, 1992, J PEDIATR GASTR NUTR, V14, P208, DOI 10.1097/00005176-199202000-00016; UKABAM SO, 1986, T ROY SOC TROP MED H, V80, P204, DOI 10.1016/0035-9203(86)90010-6; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; Willumsen JF, 1997, J PEDIATR GASTR NUTR, V24, P235, DOI 10.1097/00005176-199703000-00001	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0164447	10.1371/journal.pone.0164447	http://dx.doi.org/10.1371/journal.pone.0164447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906964	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700003
J	Kim, WT; Shin, S; Hwang, HJ; Kim, MK; Jung, HS; Park, H; Ryu, CJ				Kim, Won-Tae; Shin, Saemina; Hwang, Hyo Jeong; Kim, Min Kyu; Jung, Han-Sung; Park, Hwangseo; Ryu, Chun Jeih			Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; BAP31; RECOGNITION; SEQUENCE; DATABASE; COMPLEX; EXPORT; IGD	Previously, we showed that B-cell receptor associated protein 31 (BAP31), an endoplasmic reticulum (ER) membrane chaperone, is also expressed on the cell surface by two monoclonal antibodies (MAbs) 297-D4 and 144-A8. Both MAbs recognize the same linear epitope on the C-terminal domain of BAP31, although they were independently established. Here, flow cytometric analysis showed that 144-A8 had additional binding properties to some cells, as compared to 297-D4. Quantitative antigen binding assays also showed that 144-A8 had higher antigen binding capacity than 297-D4. Affinity measurement revealed that 144A8 had 1.54-fold higher binding affinity than 297-D4. Analysis of the heavy- and light-chain variable region sequences of two MAbs revealed that both MAbs belonged to the same heavy chain (Igh-V3660 VH3) and light chain subgroup (IGKV21) with just two amino acid differences in each framework region, indicating that both MAbs arise from the same germ line origin. Seven amino acid differences were found between the complementarity determining regions (CDRs) of the two MAbs. Molecular modeling of the epitope-paratope complexes revealed that the epitope appeared to reside in closer proximity to the CDRs of 144-A8 than to those of 297-D4 with the stronger hydrogen bond interactions with the former than the latter. More interestingly, an additional hydrophobic interaction appeared to be established between the leucine residue of epitope and the paratope of 144-A8, due to the substitution of H-Tyr101 for H-Phe101 in 144-A8. Thus, the different binding specificity and affinity of 144-A8 appeared to be due to the different hydrogen bonds and hydrophobic interaction induced by the alterations of amino acids in CDRs of 144-A8. The results provide molecular insights into how the binding specificities and affinities of antibodies evolve with the same epitope in different microenvironments.	[Kim, Won-Tae; Shin, Saemina; Hwang, Hyo Jeong; Kim, Min Kyu; Park, Hwangseo; Ryu, Chun Jeih] Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Anticanc Med Dev, Seoul, South Korea; [Jung, Han-Sung] Yonsei Univ, Dept Oral Biol, Div Anat & Dev Biol, Oral Sci Res Ctr,PLUS Project BK21,Coll Dent, Seoul, South Korea; [Jung, Han-Sung] Univ Hong Kong, Fac Dent, Oral Biosci, Hong Kong, Hong Kong, Peoples R China	Sejong University; Yonsei University; Yonsei University Health System; University of Hong Kong	Park, H; Ryu, CJ (corresponding author), Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Anticanc Med Dev, Seoul, South Korea.	hspark@sejong.ac.kr; cjryu@sejong.ac.kr	Jung, Han-Sung/I-3848-2012	Jung, Han-Sung/0000-0003-2795-531X	National Research Foundation of Korea [2016918220, 2016008610, 2016903249]; Biomedical Technology Development Project - Ministry of Science, ICT & Future Planning (MSIP) of Korea [NRF-2015M3A9B5030322]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3266]	National Research Foundation of Korea(National Research Foundation of Korea); Biomedical Technology Development Project - Ministry of Science, ICT & Future Planning (MSIP) of Korea; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported in part by the National Research Foundation of Korea (2016918220, 2016008610, and 2016903249 to CJR). This research was also supported in part by Biomedical Technology Development Project funded by Ministry of Science, ICT & Future Planning (MSIP) of Korea (NRF-2015M3A9B5030322 to HP). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3266 to HSJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choi HS, 2008, CELL TISSUE RES, V333, P197, DOI 10.1007/s00441-008-0632-6; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Kim Jum-Ji, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P136, DOI 10.1089/mab.2012.0092; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Kim WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130670; Kim WT, 2014, STEM CELLS, V32, P2626, DOI 10.1002/stem.1765; Kim WT, 2014, STEM CELLS, DOI [10.1038/emboj.2010.346, DOI 10.1038/EMBOJ.2010.346PMID]; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Quistgaard EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071111; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawicki MW, 1999, MOL IMMUNOL, V36, P423, DOI 10.1016/S0161-5890(99)00062-0; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Wang B, 2011, EMBO J, V30, P451, DOI 10.1038/emboj.2010.352; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167527	10.1371/journal.pone.0167527	http://dx.doi.org/10.1371/journal.pone.0167527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907150	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700183
J	Lan, XQ; Lederman, R; Eng, JM; Shoshtari, SSM; Saleem, MA; Malhotra, A; Singhal, PC				Lan, Xiqian; Lederman, Rivka; Eng, Judith M.; Shoshtari, Seyedeh Shadafarin Marashi; Saleem, Moin A.; Malhotra, Ashwani; Singhal, Pravin C.			Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ACETYLCHOLINE-RECEPTORS; CIGARETTE-SMOKING; RENAL-FUNCTION; CARDIOVASCULAR MORBIDITY; DIABETIC-NEPHROPATHY; NMDA RECEPTORS; ROS PRODUCTION; RISK-FACTOR; INJURY	Background Cigarette smoking plays an important role in the progression of chronic kidney disease (CKD). Nicotine, one of the major components of cigarette smoking, has been demonstrated to increase proliferation of renal mesangial cells. In this study, we examined the effect of nicotine on podocyte injury. Methods To determine the expression of nicotinic acetylcholine receptors (nAChR subunits) in podocytes, cDNAs and cell lysate of cultured human podocytes were used for the expression of nAChR mRNAs and proteins, respectively; and mouse renal cortical sections were subjected to immunofluorescant staining. We also studied the effect of nicotine on podocyte nephrin expression, reactive oxygen species (ROS) generation (via DCFDA loading followed by fluorometric analysis), proliferation, and apoptosis (morphologic assays). We evaluated the effect of nicotine on podocyte downstream signaling including phosphorylation of ERK1/2, JNK, and p38 and established causal relationships by using respective inhibitors. We used nAChR antagonists to confirm the role of nicotine on podocyte injury. Results Human podocytes displayed robust mRNA and protein expression of nAChR in vitro studies. In vivo studies, mice renal cortical sections revealed co-localization of nAChRs along with synaptopodin. In vitro studies, nephrin expression in podocyte was decreased by nicotine. Nicotine stimulated podocyte ROS generation; nonetheless, antioxidants such as N-acetyl cysteine (NAC) and TEMPOL (superoxide dismutase mimetic agent) inhibited this effect of nicotine. Nicotine did not modulate proliferation but promoted apoptosis in podocytes. Nicotine enhanced podocyte phosphorylation of ERK1/2, JNK, and p38, and their specific inhibitors attenuated nicotine-induced apoptosis. nAChR antagonists significantly suppressed the effects of nicotine on podocyte. Conclusions Nicotine induces podocyte apoptosis through ROS generation and associated downstream MAPKs signaling. The present study provides insight into molecular mechanisms involved in smoking associated progression of chronic kidney disease.	[Lan, Xiqian; Lederman, Rivka; Eng, Judith M.; Shoshtari, Seyedeh Shadafarin Marashi; Malhotra, Ashwani; Singhal, Pravin C.] Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, New York, NY 11549 USA; [Saleem, Moin A.] Southmead Hosp, Acad Renal Unit, Bristol, Avon, England	Hofstra University; Northwell Health; Southmead Hospital	Lan, XQ; Singhal, PC (corresponding author), Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, New York, NY 11549 USA.	xlan@northwell.edu; psinghal@northwell.edu		Saleem, Moin/0000-0002-9808-4518; Singhal, Pravin/0000-0002-6898-358X	NIH [RO1DK 098074, RO1DK084910, RO1DK083931]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants RO1DK 098074, RO1DK084910, and RO1DK083931 (PCS).	Agrawal S, 2014, KIDNEY INT, V86, P1150, DOI 10.1038/ki.2014.196; Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anderson M, 2011, AM J PHYSIOL-CELL PH, V300, pC22, DOI 10.1152/ajpcell.00268.2010; Arany I, 2012, AM J PHYSIOL-RENAL, V302, pF722, DOI 10.1152/ajprenal.00338.2011; Arany I, 2011, AM J PHYSIOL-RENAL, V301, pF125, DOI 10.1152/ajprenal.00041.2011; Asanuma Katsuhiko, 2015, Nihon Rinsho Meneki Gakkai Kaishi, V38, P26, DOI 10.2177/jsci.38.26; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Calderon LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143277; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Dryer SE, 2015, NEPHROL DIAL TRANSPL, V30, P1630, DOI 10.1093/ndt/gfv028; Dyck RF, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-57; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gergalova G, 2014, INT J BIOCHEM CELL B, V49, P26, DOI 10.1016/j.biocel.2014.01.001; Gu YQ, 2016, BIOCHEM BIOPH RES CO, V472, P573, DOI 10.1016/j.bbrc.2016.03.044; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hong Tao, 2015, Sichuan Da Xue Xue Bao Yi Xue Ban, V46, P173; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Hua W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127507; Ishizaka N, 2008, HYPERTENS RES, V31, P485, DOI 10.1291/hypres.31.485; Jaimes EA, 2009, AM J NEPHROL, V29, P319, DOI 10.1159/000163593; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jain G, 2013, BIOCHEM PHARMACOL, V86, P1215, DOI 10.1016/j.bcp.2013.07.014; Kim CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152591; Kim EY, 2012, MOL PHARMACOL, V82, P728, DOI 10.1124/mol.112.079376; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Lan XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055748; Lan XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050783; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Li XZ, 2015, SCI CHINA LIFE SCI, V58, P649, DOI 10.1007/s11427-015-4844-1; Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5; Lipovsek M, 2014, MOL BIOL EVOL, V31, P3250, DOI 10.1093/molbev/msu258; Liu YP, 2013, AM J NEPHROL, V38, P430, DOI 10.1159/000355970; Medapalli RK, 2011, CURR OPIN NEPHROL HY, V20, P306, DOI 10.1097/MNH.0b013e328345359a; Menzel S, 2011, PEDIATR NEPHROL, V26, P1775, DOI 10.1007/s00467-010-1725-5; Mercado C, 2007, CURR HYPERTENS REP, V9, P66, DOI 10.1007/s11906-007-0012-8; Miyamoto Y, 2011, NITRIC OXIDE-BIOL CH, V25, P344, DOI 10.1016/j.niox.2011.06.006; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Nordman JC, 2014, MOL PHARMACOL, V85, P50, DOI 10.1124/mol.113.088484; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Patel J, 2003, AM J PHYSIOL-RENAL, V285, pF861, DOI 10.1152/ajprenal.00134.2003; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Qiao D, 2005, TOXICOL APPL PHARM, V206, P17, DOI 10.1016/j.taap.2004.11.003; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Roshanravan H, 2016, DIABETES, V65, P3139, DOI 10.2337/db16-0209; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saurus P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.125; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schneider NG, 2001, CLIN PHARMACOKINET, V40, P661, DOI 10.2165/00003088-200140090-00003; Sciaccaluga M, 2015, FASEB J, V29, P3389, DOI 10.1096/fj.14-268102; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; Shi JX, 2016, MOL BIOSYST, V12, P1445, DOI 10.1039/c5mb00722d; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tammimaki A, 2012, NEUROPHARMACOLOGY, V63, P1002, DOI 10.1016/j.neuropharm.2012.07.022; Toyonaga J, 2011, NEPHROL DIAL TRANSPL, V26, P2475, DOI 10.1093/ndt/gfq750; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Vashistha H, 2009, RENAL FAILURE, V31, P303, DOI 10.1080/08860220902780101; Weber ML, 2008, AM J PHYSIOL-RENAL, V294, pF1388, DOI 10.1152/ajprenal.00389.2007; Xiang T, 2016, ONCOL REP, V35, P205, DOI 10.3892/or.2015.4363; Zanetti F, 2014, FREE RADICAL BIO MED, V76, P173, DOI 10.1016/j.freeradbiomed.2014.08.002; Zhang YJ, 2013, CELL SIGNAL, V25, P2769, DOI 10.1016/j.cellsig.2013.08.044; Zheng R, 2012, PHYTOTHER RES, V26, P892, DOI 10.1002/ptr.3656; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278	71	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167071	10.1371/journal.pone.0167071	http://dx.doi.org/10.1371/journal.pone.0167071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907022	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700071
J	Mohammad, M; Na, M; Welin, A; Svensson, MND; Ali, A; Jin, T; Pullerits, R				Mohammad, Majd; Na, Manli; Welin, Amanda; Svensson, Mattias N. D.; Ali, Abukar; Jin, Tao; Pullerits, Rille			RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic Arthritis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; RHEUMATOID-ARTHRITIS; EXPERIMENTAL-MODELS; RECEPTOR; EXPRESSION; DISEASE; ENDPRODUCTS; CONTRIBUTE; PROMOTES; RISK	Background Septic arthritis is a serious joint disease often caused by Staphylococcus aureus (S. aureus). Receptor for Advanced Glycation End products (RAGE) has an important role in several infections. We sought to investigate the role of RAGE in staphylococcal septic arthritis and sepsis in mice. Methods Wild-type (WT) and RAGE deficient (RAGE(-/-)) mice were intra-articularly or intravenously inoculated with an arthritic or septic dose of S. aureus LS-1 strain. Clinical arthritis, weight development and mortality were monitored for 14 days. Serum levels of cytokines, kidney bacterial loads as well as micro-CT and histopathology of the joints were assessed. Results RAGE(-/-) mice with septic arthritis had significantly lower IL-17A and higher bone mineral density (BMD) compared to the control group. However, no significant differences between the groups were observed regarding the weight loss, the severity and frequency of arthritis, and bacterial loads in the kidneys. In mice with sepsis, the overall mortality rate was similar in RAGE(-/-) (39%) and in WT mice (45%). However, RAGE(-/-) mice with sepsis had significantly higher bacterial load in their kidneys compared to the WT controls. In line with data from hematogenous S. aureus arthritis, RAGE deficiency had no impact on arthritis severity in local joint infection. Conclusions Our results indicate that lack of RAGE has no significant impact on septic arthritis. However, RAGE(-/-) mice had significantly higher BMD compared to WT mice, which coincided with lower IL-17A in RAGE(-/-) mice. In sepsis, RAGE deficiency impairs bacterial kidney clearance.	[Mohammad, Majd; Na, Manli; Welin, Amanda; Svensson, Mattias N. D.; Ali, Abukar; Jin, Tao; Pullerits, Rille] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Svensson, Mattias N. D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA USA	University of Gothenburg; University of California System; University of California San Diego	Mohammad, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	majd.mohammad@rheuma.gu.se	Pullerits, Rille/AAD-2050-2019; Jin, Tao/K-3323-2015; Svensson, Mattias N.D./A-9827-2012; Na, Manli/AAM-9864-2020; Pullerits, Rille/ABC-0141-2022	Pullerits, Rille/0000-0002-5383-9817; Jin, Tao/0000-0001-9039-0628; Svensson, Mattias N.D./0000-0001-8077-9824; Ali, Abukar/0000-0002-1963-3356; Na, Manli/0000-0002-7306-8941; Mohammad, Majd/0000-0002-3672-2991	Swedish Medical Research Council; Goteborg Medical Society; Swedish Medical Society; Rune and Ulla Amlovs Foundation; Tore Nilsons Foundation; Goteborg Association against Rheumatism; Swedish Association against Rheumatism; Nanna Svartz Foundation; Stiftelsen Clas Groschinskys Minnesfond; Lundberg Foundation; University of Gothenburg	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Goteborg Medical Society; Swedish Medical Society; Rune and Ulla Amlovs Foundation; Tore Nilsons Foundation; Goteborg Association against Rheumatism; Swedish Association against Rheumatism; Nanna Svartz Foundation; Stiftelsen Clas Groschinskys Minnesfond; Lundberg Foundation(European Commission); University of Gothenburg	This work was supported by the Swedish Medical Research Council, the Goteborg Medical Society, the Swedish Medical Society, the Rune and Ulla Amlovs Foundation, the Tore Nilsons Foundation, the Goteborg Association against Rheumatism, the Swedish Association against Rheumatism, the Nanna Svartz Foundation, the Stiftelsen Clas Groschinskys Minnesfond, the Lundberg Foundation, and the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2013, CRIT CARE, V17, DOI 10.1186/cc13162; Achouiti A, 2013, J INNATE IMMUN, V5, P603, DOI 10.1159/000348739; Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; BRETT J, 1993, AM J PATHOL, V143, P1699; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; Galloway JB, 2011, ANN RHEUM DIS, V70, P1810, DOI 10.1136/ard.2011.152769; Hein GE, 2006, CLIN CHIM ACTA, V371, P32, DOI 10.1016/j.cca.2006.03.017; Henningsson L, 2010, INFECT IMMUN, V78, P3783, DOI 10.1128/IAI.00385-10; Hou FF, 2004, J AM SOC NEPHROL, V15, P1889, DOI 10.1097/01.asn.0000131526.99506.f7; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Krishnamurthy A, 2016, ANN RHEUM DIS, V75, P721, DOI 10.1136/annrheumdis-2015-208093; Kwiecinski J, 2013, J INFECT DIS, V208, P990, DOI 10.1093/infdis/jit288; Lee Eun Ji, 2013, Genomics & Informatics, V11, P224, DOI 10.5808/GI.2013.11.4.224; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Soria LM, 2009, REUMATOL CLIN, V5, P18, DOI 10.1016/S1699-258X(09)70199-8; Stern D, 2002, ADV DRUG DELIVER REV, V54, P1615, DOI 10.1016/S0169-409X(02)00160-6; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Tarkowski A, 2006, BEST PRACT RES CL RH, V20, P1029, DOI 10.1016/j.berh.2006.08.001; Toscano MG, 2011, JOVE-J VIS EXP, DOI 10.3791/2860; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Verdrengh M, 2006, J INFECT DIS, V194, P1597, DOI 10.1086/508751; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167287	10.1371/journal.pone.0167287	http://dx.doi.org/10.1371/journal.pone.0167287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907047	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700111
J	Ogier, JC; Duvic, B; Lanois, A; Givaudan, A; Gaudriault, S				Ogier, Jean-Claude; Duvic, Bernard; Lanois, Anne; Givaudan, Alain; Gaudriault, Sophie			A New Member of the Growing Family of Contact-Dependent Growth Inhibition Systems in Xenorhabdus doucetiae	PLOS ONE			English	Article							TOXIN DELIVERY-SYSTEMS; VI SECRETION SYSTEM; CDI; PHOTORHABDUS; BACTERIOCIN; GENE; PATHOGENICITY; BIOSYNTHESIS; PATHOGENESIS; ACTIVATION	Xenorhabdus is a bacterial symbiont of entomopathogenic Steinernema nematodes and is pathogenic for insects. Its life cycle involves a stage inside the insect cadaver, in which it competes for environmental resources with microorganisms from soil and the insect gut. Xenorhabdus is, thus, a useful model for identifying new interbacterial competition systems. For the first time, in an entomopathogenic bacterium, Xenorhabdus doucetiae strain FRM16, we identified a cdi-like locus. The cdi loci encode contact-dependent inhibition (CDI) systems composed of proteins from the two-partner secretion (TPS) family. CdiB is the outer membrane protein and CdiA is the toxic exoprotein. An immunity protein, CdiI, protects bacteria against inhibition. We describe here the growth inhibition effect of the toxic C-terminus of CdiA from X. doucetiae FRM16, CdiA-CTFRM16, following its production in closely and distantly related enterobacterial species. CdiA-CTFRM16 displayed Mg2+-dependent DNase activity, in vitro. CdiA-CT (FRM16)-mediated growth inhibition was specifically neutralized by CdiI(FRM16). Moreover, the cdi(FRM16) locus encodes an ortholog of toxin-activating proteins C that we named CdiC(FRM16). In addition to E. coli, the cdiBCAI-type locus was found to be widespread in environmental bacteria interacting with insects, plants, rhizospheres and soils. Phylogenetic tree comparisons for CdiB, CdiA and CdiC suggested that the genes encoding these proteins had co-evolved. By contrast, the considerable variability of CdiI protein sequences suggests that the cdiI gene is an independent evolutionary unit. These findings further characterize the sparsely described cdiBCAI-type locus.	[Ogier, Jean-Claude; Duvic, Bernard; Lanois, Anne; Givaudan, Alain; Gaudriault, Sophie] Univ Montpellier, DGIMI, INRA, Montpellier, France	INRAE; Universite de Montpellier	Ogier, JC; Gaudriault, S (corresponding author), Univ Montpellier, DGIMI, INRA, Montpellier, France.	Jean-Claude.Ogier@umontpellier.fr; sophie.gaudriault@umontpellier.fr	Duvic, Bernard/ABG-5094-2020; , Gaudriault/AAK-9152-2021	, Gaudriault/0000-0003-2789-4959; Duvic, Bernard/0000-0002-7618-7719	Institut National de la Recherche Agronomique from the department "Sante des Plantes et Environnement" [010-1133-01]; Universite Montpellier [2011]	Institut National de la Recherche Agronomique from the department "Sante des Plantes et Environnement"; Universite Montpellier	This work was supported by 1) Institut National de la Recherche Agronomique: grant no 010-1133-01 from the department "Sante des Plantes et Environnement"; 2) Universite Montpellier: grant no 2011.	Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2011, VIRULENCE, V2, P356, DOI 10.4161/viru.2.4.16463; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Bisch G, 2015, J INVERTEBR PATHOL, V124, P15, DOI 10.1016/j.jip.2014.10.002; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Chapelle M, 2009, MOL IMMUNOL, V47, P261, DOI 10.1016/j.molimm.2009.09.028; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Crawford JM, 2011, ORG LETT, V13, P5144, DOI 10.1021/ol2020237; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Fuchs SW, 2011, ORG BIOMOL CHEM, V9, P3130, DOI 10.1039/c1ob05097d; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gualtieri M, 2009, J ANTIBIOT, V62, P295, DOI 10.1038/ja.2009.31; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Hayes C. S., 2014, COLD SPRING HARB PER, V4; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jubelin G, 2011, ENVIRON MICROBIOL, V13, P1271, DOI 10.1111/j.1462-2920.2011.02427.x; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mercy C, 2016, PLOS ONE, V11; Morales-Soto N, 2011, J BACTERIOL, V193, P3624, DOI 10.1128/JB.00092-11; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; Ogier JC, 2014, GENOME BIOL EVOL, V6, P1495, DOI 10.1093/gbe/evu119; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Reimer D, 2014, J NAT PROD, V77, P1976, DOI 10.1021/np500390b; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Reimer D, 2009, CHEMBIOCHEM, V10, P1997, DOI 10.1002/cbic.200900187; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Ruhe ZC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006145; Ruhe ZC, 2013, MBIO, V4, DOI 10.1128/mBio.00480-13; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Seth-Smith HMB, 2012, J BACTERIOL, V194, P1494, DOI 10.1128/JB.06403-11; Singh J, 2008, J BACTERIOL, V190, P3877, DOI 10.1128/JB.00209-08; THALER JO, 1995, APPL ENVIRON MICROB, V61, P2049, DOI 10.1128/AEM.61.5.2049-2052.1995; Trent MS, 1998, BIOCHEMISTRY-US, V37, P4644, DOI 10.1021/bi971588y; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; Willett JLE, 2015, J MOL BIOL, V427, P3754, DOI 10.1016/j.jmb.2015.09.010; Willett JLE, 2015, P NATL ACAD SCI USA, V112, P11341, DOI 10.1073/pnas.1512124112; Zheng J, 2011, PLOS ONE, V6	49	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167443	10.1371/journal.pone.0167443	http://dx.doi.org/10.1371/journal.pone.0167443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907104	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700159
J	Rosell-Negre, P; Bustamante, JC; Fuentes-Claramonte, P; Costumero, V; Llopis-Llacer, JJ; Barros-Loscertales, A				Rosell-Negre, Patricia; Bustamante, Juan-Carlos; Fuentes-Claramonte, Paola; Costumero, Victor; Llopis-Llacer, Juan-Jose; Barros-Loscertales, Alfonso			Reward Contingencies Improve Goal-Directed Behavior by Enhancing Posterior Brain Attentional Regions and Increasing Corticostriatal Connectivity in Cocaine Addicts	PLOS ONE			English	Article							IMPAIRED INHIBITORY CONTROL; STROOP-LIKE TASK; COGNITIVE CONTROL; PREFRONTAL CORTEX; DECISION-MAKING; DORSAL STRIATUM; PSYCHOPHYSIOLOGICAL INTERACTIONS; DEFICIT/HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY; RESPONSE-INHIBITION	The dopaminergic system provides the basis for the interaction between motivation and cognition. It is triggered by the possibility of obtaining rewards to initiate the neurobehavioral adaptations necessary to achieve them by directing the information from motivational circuits to cognitive and action circuits. In drug addiction, the altered dopamine (DA) modulation of the meso-cortico-limbic reward circuitry, such as the prefrontal cortex (PFC), underlies the disproportionate motivational value of drug use at the expense of other non drug reinforcers and the user's loss of control over his/her drug intake. We examine how the magnitude of the reward affects goal-directed processes in healthy control (HC) subjects and abstinent cocaine dependent (ACD) patients by using functional magnetic resonance imaging (fMRI) during a counting Stroop task with blocked levels of monetary incentives of different magnitudes ((sic)0, (sic)0.01, (sic)0.5, (sic)1 or (sic)1.5). Our results showed that increasing reward magnitude enhances (1) performance facilitation in both groups; (2) left dorsolateral prefrontal cortex (DLPFC) activity in HC and left superior occipital cortex activity in ACD; and (3) left DLPFC and left putamen connectivity in ACD compared to HC. Moreover, we observed that (4) dorsal striatal and pallidum activity was associated with craving and addiction severity during the parametric increases in the monetary reward. In conclusion, the brain response to gradients in monetary value was different in HC and ACD, but both groups showed improved task performance due to the possibility of obtaining greater monetary rewards.	[Rosell-Negre, Patricia; Fuentes-Claramonte, Paola; Costumero, Victor; Barros-Loscertales, Alfonso] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castello De La, Spain; [Bustamante, Juan-Carlos] Univ Zaragoza, Dept Psicol & Sociol, Zaragoza, Zaragoza, Spain; [Fuentes-Claramonte, Paola] FIDMAG Germanes Hosp Res Fdn Barcelona, Cataluna, Spain; [Llopis-Llacer, Juan-Jose] Conselleria Sanitat, Hosp Gen Univ, Unidad Conductas Adict, Castellon De La Plana, Spain	Universitat Jaume I; University of Zaragoza	Barros-Loscertales, A (corresponding author), Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castello De La, Spain.	barros@uji.es	Fuentes-Claramonte, Paola/AAC-1196-2021; Costumero, Víctor/A-5784-2019; Barrós-Loscertales, Alfonso/AAA-5611-2019; Barros-Loscertales, Alfonso/D-7069-2013	Fuentes-Claramonte, Paola/0000-0002-1428-7976; Costumero, Víctor/0000-0002-8743-5239; Barrós-Loscertales, Alfonso/0000-0002-2456-6653; Rosell Negre, Patricia/0000-0002-2440-8495	Spanish Ministry of Economy and Competitiveness [PSI2012-33054]; Spanish National Drug Strategy [20111040]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish National Drug Strategy	This research has been supported by Grants PSI2012-33054 from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/), and by 20111040 from the Spanish National Drug Strategy (http://www.pnsd.msssi.gob.es/) to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Adams ZW, 2011, PSYCHOL ASSESSMENT, V23, P427, DOI 10.1037/a0022112; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Arias-Carrion Oscar, 2010, Int Arch Med, V3, P24, DOI 10.1186/1755-7682-3-24; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Ashburner J, SPM8 MANUAL FIL METH; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Brewer JA, 2008, BIOL PSYCHIAT, V64, P998, DOI 10.1016/j.biopsych.2008.05.024; Bustamante J. C, 2012, SUBSTANCE ABUSE ASSE; Bustamante JC, 2014, ADDICT BIOL, V19, P885, DOI 10.1111/adb.12041; Carmona S, 2012, HUM BRAIN MAPP, V33, P2350, DOI 10.1002/hbm.21368; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Cools R, 2007, J NEUROSCI, V27, P5506, DOI 10.1523/JNEUROSCI.0601-07.2007; Cools R, 2015, CURR OPIN BEHAV SCI, V4, P152, DOI 10.1016/j.cobeha.2015.05.007; Crunelle CL, 2012, BRAIN BEHAV, V2, P499, DOI 10.1002/brb3.65; Engelmann JB, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.004.2009; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fowler Joanna S, 2007, Sci Pract Perspect, V3, P4; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Garavan H, 2012, PREV MED, V55, pS17, DOI 10.1016/j.ypmed.2012.05.018; Gilbert Alison M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P540, DOI 10.3758/CABN.4.4.540; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goldstein RZ, 2008, PSYCHOPHYSIOLOGY, V45, P705, DOI 10.1111/j.1469-8986.2008.00670.x; Goldstein RZ, 2007, DRUG ALCOHOL DEPEN, V87, P233, DOI 10.1016/j.drugalcdep.2006.08.022; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Goldstein RZ, 2007, PSYCHIAT INTERPE JAN, P43; Gonzalez-Saiz F, 2009, EUR ADDICT RES, V15, P87, DOI 10.1159/000189787; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hester R, 2013, DRUG ALCOHOL DEPEN, V133, P86, DOI 10.1016/j.drugalcdep.2013.05.027; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Hyatt CJ, 2012, REWARD RELATED DORSA, V7, P1; Ichihara-Takeda S, 2008, J COGNITIVE NEUROSCI, V20, P563, DOI 10.1162/jocn.2008.20047; Ikemoto S, 2014, NEUROPHARMACOLOGY, V76, P329, DOI 10.1016/j.neuropharm.2013.04.031; Ivanov I, 2012, BRAIN BEHAV, V2, P741, DOI 10.1002/brb3.80; Jasinska AJ, 2014, NEUROSCI BIOBEHAV R, V38, P1, DOI 10.1016/j.neubiorev.2013.10.013; Jia Z, 2012, INITIAL STUDY NEURAL, V70, P553; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kampman KM, 1998, ADDICT BEHAV, V23, P449, DOI 10.1016/S0306-4603(98)00011-2; Konova AB, 2012, EUR J NEUROSCI, V36, P2979, DOI 10.1111/j.1460-9568.2012.08211.x; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Kriegeskorte N, 2009, CIRCULAR ANAL SYSTEM, P1; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Li CSR, 2008, NEUROPSYCHOPHARMACOL, V33, P1798, DOI 10.1038/sj.npp.1301568; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McFarland K, 2001, J NEUROSCI, V21, P8655; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Mitchell Marci R., 2013, PRELIMINARY INVESTIG, V39, P1; Modesto-Lowe V, 1997, DRUG ALCOHOL DEPEN, V49, P9, DOI 10.1016/S0376-8716(97)00134-8; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; Moeller SJ, 2014, J PSYCHIATR RES, V58, P55, DOI 10.1016/j.jpsychires.2014.07.016; Moeller SJ, 2014, CEREB CORTEX, V24, P643, DOI 10.1093/cercor/bhs345; Moeller SJ, 2010, BRAIN, V133, P1484, DOI 10.1093/brain/awq066; Garcia MAM, 2008, PSICOTHEMA, V20, P545; Noel X, 2013, CURR OPIN NEUROBIOL, V23, P632, DOI 10.1016/j.conb.2013.01.018; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; Panadero A, 2015, CONSCIOUS COGN, V31, P35, DOI 10.1016/j.concog.2014.09.016; Petty NM, 2002, J CONSULT CLIN PSYCH, V70, P398, DOI 10.1037//0022-006X.70.2.398; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Preacher K. J., 2002, CALCULATION TEST DIF; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rogers RE, 2010, DRUG RELATED ACTIVIT, V22, P544; Root DH, 2010, SYNAPSE, V64, P704, DOI 10.1002/syn.20792; Ruiz MJ, 2015, PSYCHOPHARMACOLOGY, V232, P1717, DOI 10.1007/s00213-014-3806-9; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Small DM, 2005, CEREB CORTEX, V15, P1855, DOI 10.1093/cercor/bhi063; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Staudinger MR, 2011, CEREB CORTEX, V21, P2578, DOI 10.1093/cercor/bhr041; Stefanik MT, 2013, J NEUROSCI, V33, P13654, DOI 10.1523/JNEUROSCI.1570-13.2013; Stitzer ML, 2010, DRUG ALCOHOL DEPEN, V107, P76, DOI 10.1016/j.drugalcdep.2009.09.006; Stoppel CM, 2011, BRAIN RES, V1383, P218, DOI 10.1016/j.brainres.2011.01.095; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Tau GZ, 2014, NEUROPSYCHOPHARMACOL, V39, P545, DOI 10.1038/npp.2013.189; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Tomasi D, 2007, PSYCHIAT RES-NEUROIM, V155, P189, DOI 10.1016/j.pscychresns.2007.03.002; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Vadhan NP, 2009, DRUG ALCOHOL DEPEN, V102, P95, DOI 10.1016/j.drugalcdep.2009.02.003; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Watanabe M, 2007, CEREB CORTEX, V17, pI101, DOI 10.1093/cercor/bhm067; Weiland BJ, 2013, DRUG ALCOHOL DEPEN, V128, P130, DOI 10.1016/j.drugalcdep.2012.08.019; Wilcox CE, 2011, DRUG ALCOHOL DEPEN, V115, P137, DOI 10.1016/j.drugalcdep.2011.01.009; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Worhunsky PD, 2013, PSYCHOL ADDICT BEHAV, V27, P477, DOI 10.1037/a0029092; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033	107	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167400	10.1371/journal.pone.0167400	http://dx.doi.org/10.1371/journal.pone.0167400			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907134	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700144
J	Vazquez, N; Chacon, M; Rodriguez-Barrientos, CA; Merayo-Lloves, J; Naveiras, M; Baamonde, B; Alfonso, JF; Zambrano-Andazol, I; Riestra, AC; Meana, A				Vazquez, Natalia; Chacon, Manuel; Rodriguez-Barrientos, Carlos A.; Merayo-Lloves, Jesus; Naveiras, Miguel; Baamonde, Begona; Alfonso, Jose F.; Zambrano-Andazol, Iriana; Riestra, Ana C.; Meana, Alvaro			Human Bone Derived Collagen for the Development of an Artificial Corneal Endothelial Graft. In Vivo Results in a Rabbit Model	PLOS ONE			English	Article							CELL SHEET TRANSPLANTATION; TISSUE; MEMBRANE; PROTEIN; EXPRESSION; HYDROGELS; PRIMATE; SURGERY; CULTURE; CARRIER	Corneal keratoplasty (penetrating or lamellar) using cadaveric human tissue, is nowadays the main treatment for corneal endotelial dysfunctions. However, there is a worldwide shortage of donor corneas available for transplantation and about 53% of the world's population have no access to corneal transplantation. Generating a complete cornea by tissue engineering is still a tough goal, but an endothelial lamellar graft might be an easier task. In this study, we developed a tissue engineered corneal endothelium by culturing human corneal endothelial cells on a human purified type I collagen membrane. Human corneal endothelial cells were cultured from corneal rims after corneal penetrating keratoplasty and type I collagen was isolated from remnant cancellous bone chips. Isolated type I collagen was analyzed by western blot, liquid chromatography -mass spectrometry and quantified using the exponentially modified protein abundance index. Later on, collagen solution was casted at room temperature obtaining an optically transparent and mechanically manageable membrane that supports the growth of human and rabbit corneal endothelial cells which expressed characteristic markers of corneal endothelium: zonula ocluddens-1 and Na+/ K+ ATPase. To evaluate the therapeutic efficiency of our artificial endothelial grafts, human purified type I collagen membranes cultured with rabbit corneal endothelial cells were transplanted in New Zealand white rabbits that were kept under a minimal immunosuppression regimen. Transplanted corneas maintained transparency for as long as 6 weeks without obvious edema or immune rejection and maintaining the same endothelial markers that in a healthy cornea. In conclusion, it is possible to develop an artificial human corneal endothelial graft using remnant tissues that are not employed in transplant procedures. This artificial endothelial graft can restore the integrality of corneal endothelium in an experimental model of endothelial dysfunction. This strategy could supply extra endothelial tissue and compensate the deficit of cadaveric grafts for corneal endothelial transplantation.	[Vazquez, Natalia; Chacon, Manuel; Rodriguez-Barrientos, Carlos A.; Merayo-Lloves, Jesus; Naveiras, Miguel; Baamonde, Begona; Alfonso, Jose F.; Zambrano-Andazol, Iriana; Riestra, Ana C.; Meana, Alvaro] Univ Oviedo, Inst Univ Fernandez Vega, Oviedo, Spain; [Baamonde, Begona] Hosp Univ Cent Asturias, Oviedo, Spain; [Meana, Alvaro] FJD, IIS, CIBER Rare Dis CIBERer, Madrid, Spain	University of Oviedo; Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz	Vazquez, N (corresponding author), Univ Oviedo, Inst Univ Fernandez Vega, Oviedo, Spain.	natalia.vazquez@fio.as	Meana, Alvaro/D-9710-2019; Chacon, Manuel/D-8923-2019; Naveiras, Miguel/AAJ-3867-2021; Vázquez, Natalia/D-9744-2019; Arbaiza, Begoña Baamonde/ABG-8969-2020	Meana, Alvaro/0000-0001-9434-6042; Chacon, Manuel/0000-0003-3391-299X; Vázquez, Natalia/0000-0002-3410-2190; Naveiras, Miguel/0000-0003-1812-7029	Fundacion Mutua Madrilena, Government of Asturias (FEDER-EU) [FC-15-GRUPIN 14-141]; Telefonica	Fundacion Mutua Madrilena, Government of Asturias (FEDER-EU); Telefonica	This work was supported by Fundacion Mutua Madrilena, Government of Asturias (FEDER-EU - FC-15-GRUPIN 14-141) and Telefonica. The funders had no role in the study design, data collection analysis, decision to publish or preparation of the manuscript.	Bae I, 2008, FOOD CHEM, V108, P49, DOI 10.1016/j.foodchem.2007.10.039; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Bednarz J, 1998, IN VITRO CELL DEV-AN, V34, P149; BIGAR F, 1992, CURR OPIN OPHTHALMOL, V3, P473, DOI 10.1097/00001433-199208000-00007; BIGAR F, 1982, OPHTHALMOLOGY, V89, P596; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; JUMBLATT MM, 1980, TRANSPLANTATION, V29, P499, DOI 10.1097/00007890-198006000-00013; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Laemmli UK, 1970, GROUP, V227, P680, DOI DOI 10.1038/227680A0; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9; Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172; Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034; MCCULLEY JP, 1980, OPHTHALMOLOGY, V87, P194; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 2004, CORNEA, V23, P286, DOI 10.1097/00003226-200404000-00011; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Morikubo S, 2004, ARCH OPHTHALMOL-CHIC, V122, P966, DOI 10.1001/archopht.122.7.966; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P312; Okumura N, 2016, NAT PUBL GR; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038; Ozcelik B, 2013, ACTA BIOMATER, V9, P6594, DOI 10.1016/j.actbio.2013.01.020; Pietrzak WS, 2011, CELL TISSUE BANK, V12, P81, DOI 10.1007/s10561-009-9168-6; Potaros T., 2009, Kasetsart Journal, Natural Sciences, V43, P584; Satue M, 2015, Arch Soc Esp Oftalmol, V90, P356, DOI 10.1016/j.oftal.2015.01.004; Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029; SCHWARTZ BD, 1981, INVEST OPHTH VIS SCI, V20, P467; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Vazquez N, 2015, HISTOL HISTOPATHOL, V30, P813, DOI 10.14670HH-11-585; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yoeruek E, 2009, CORNEA, V28, P416, DOI 10.1097/ICO.0b013e31818c2c36; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Yoshida J, 2014, INVEST OPHTH VIS SCI, V55, P4975, DOI 10.1167/iovs.14-14211; Zhang J., 2015, ADV MAT SCI ENG, V1, P1; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	50	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167578	10.1371/journal.pone.0167578	http://dx.doi.org/10.1371/journal.pone.0167578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907157	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700201
J	Wu, N; Yu, YD; Li, T; Ji, XJ; Jiang, L; Zong, JJ; Huang, H				Wu, Na; Yu, Yadong; Li, Tao; Ji, Xiaojun; Jiang, Ling; Zong, Jiajun; Huang, He			Investigating the Influence of MoS2 Nanosheets on E-coli from Metabolomics Level	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; GRAPHENE; TOXICITY; NANOPARTICLES; CYTOTOXICITY; EXFOLIATION; REVEAL; WS2	Molybdenum disulfide, a type of two-dimensional layered material with unique properties, has been widely used in many fields. However, an exact understanding of its toxicity remains elusive, let alone its effects on the environmental microbial community. In this study, we utilized metabolomics technology to explore the effects of different concentrations of molybdenum disulfide nanosheets on Escherichia coli for the first time. The results showed that with increasing concentration of molybdenum disulfide nanosheets, the survival rate of Escherichia coli was decreased and the release of lactic dehydrogenase was increased. At the same time, intracellular concentrations of reactive oxygen species were dramatically increased. In addition, metabolomics analysis showed that high concentrations of molybdenum disulfide nanosheets (100, 1000 mu g/mL) could significantly affect the metabolic profile of Escherichia coli, including glycine, serine and threonine metabolism, protein biosynthesis, urea cycle and pyruvate metabolism. These results will be beneficial for molybdenum disulfide toxicity assessment and further applications.	[Wu, Na; Li, Tao; Ji, Xiaojun; Zong, Jiajun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Yu, Yadong] Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing, Peoples R China; [Jiang, Ling] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China; [Huang, He] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University	Yu, YD (corresponding author), Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing, Peoples R China.; Huang, H (corresponding author), Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China.	yadongyu@njtech.edu.cn; biotech@njtech.edu.cn	Ji, Xiao-Jun/E-6447-2012	Ji, Xiao-Jun/0000-0002-6450-0229	National Natural Science Foundation of China [21506096]; National High Technology Research and Development Program of China [2013AA020302]; Key Laboratory of Agro-Products Processing, Ministry of Agriculture [2015011]; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS [SKLBNPC15429]; Six Talent Peaks Project in Jiangsu Province [2015-JY-009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Laboratory of Agro-Products Processing, Ministry of Agriculture; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS(Chinese Academy of Sciences); Six Talent Peaks Project in Jiangsu Province	This work was financially supported by the National Natural Science Foundation of China (No. 21506096) and National High Technology Research and Development Program of China (2013AA020302), Key Laboratory of Agro-Products Processing, Ministry of Agriculture (2015011), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), and the Six Talent Peaks Project in Jiangsu Province (2015-JY-009). This funding was mainly used in the study design, date analysis, and decision to publish.; This work was financially supported by the National Natural Science Foundation of China (No. 21506096) and National High Technology Research and Development Program of China (2013AA020302), Key Laboratory of Agro-Products Processing, Ministry of Agriculture (2015011), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), and the Six Talent Peaks Project in Jiangsu Province (2015-JY-009).	Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x; Bertolazzi S, 2011, ACS NANO, V5, P9703, DOI 10.1021/nn203879f; Chng ELK, 2014, NANOSCALE, V6, P14412, DOI 10.1039/c4nr04907a; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dutta T, 2015, RSC ADV, V5, P80192, DOI 10.1039/c5ra14061g; Huang KJ, 2013, ELECTROCHIM ACTA, V109, P587, DOI 10.1016/j.electacta.2013.07.168; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kalantar-zadeh K, 2016, ACS SENSORS, V1, P5, DOI 10.1021/acssensors.5b00142; Karpeta-Kaczmarek J, 2016, ARTHROPOD STRUCT DEV, V45, P253, DOI 10.1016/j.asd.2016.02.002; Karwowska E, 2015, INT J APPL CERAM TEC, V12, P885, DOI 10.1111/ijac.12297; King LA, 2013, J MATER CHEM A, V1, P8935, DOI 10.1039/c3ta11633f; Late DJ, 2013, ACS NANO, V7, P4879, DOI 10.1021/nn400026u; Lee C, 2010, ACS NANO, V4, P2695, DOI 10.1021/nn1003937; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Li H, 2012, ADV FUNCT MATER, V22, P1385, DOI 10.1002/adfm.201102111; Li J, 2013, OMICS, V17, P269, DOI 10.1089/omi.2012.0088; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x; Lv MY, 2015, BIOANALYSIS, V7, P1527, DOI 10.4155/bio.15.83; Lyon DY, 2006, ENVIRON SCI TECHNOL, V40, P4360, DOI 10.1021/es0603655; Molina Sanchez A, 2011, PHYS REV B, VB 84; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Qureshi N, 2015, APPL NANOSCI, V5, P331, DOI 10.1007/s13204-014-0322-5; Rapoport L, 2005, J MATER CHEM, V15, P1782, DOI 10.1039/b417488g; Ratnasekhar C, 2015, NANOTOXICOLOGY, V9, P994, DOI 10.3109/17435390.2014.993345; REED LJ, 1990, J BIOL CHEM, V265, P8971; Ristic BZ, 2014, BIOMATERIALS, V35, P4428, DOI 10.1016/j.biomaterials.2014.02.014; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Shah P, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/31/315102; Sharma VK, 2015, CHEM SOC REV, V44, P8410, DOI 10.1039/c5cs00236b; Siegel G, 2015, APL MATER, V3, DOI DOI 10.1021/NN203879F; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Spohn P, 2009, ENVIRON POLLUT, V157, P1134, DOI 10.1016/j.envpol.2008.08.013; Subbaiah YPV, 2016, ADV FUNCT MATER, V26, P2046, DOI 10.1002/adfm.201504202; Teo WZ, 2014, CHEM-EUR J, V20, P9627, DOI 10.1002/chem.201402680; Thurston TR, 1999, J PHYS CHEM B, V103, P11, DOI 10.1021/jp982337h; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]; Wang C, 2014, APPL MICROBIOL BIOT, V98, P9735, DOI 10.1007/s00253-014-6143-3; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/NNANO.2012.193, 10.1038/nnano.2012.193]; Wang XS, 2013, J AM CHEM SOC, V135, P5304, DOI 10.1021/ja4013485; Winchester A, 2014, ACS APPL MATER INTER, V6, P2125, DOI 10.1021/am4051316; Winnik FM, 2013, ACCOUNTS CHEM RES, V46, P672, DOI 10.1021/ar3000585; Wu HH, 2011, ACS NANO, V5, P1276, DOI 10.1021/nn102941b; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yan DH, 2011, LANGMUIR, V27, P13206, DOI 10.1021/la2008107; Yang X, 2014, NANOSCALE, V6, P10126, DOI 10.1039/c4nr01965b; Zhao LJ, 2016, ENVIRON SCI TECHNOL, V50, P2000, DOI 10.1021/acs.est.5b05011; Zhu CF, 2013, J AM CHEM SOC, V135, P5998, DOI 10.1021/ja4019572	51	34	34	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167245	10.1371/journal.pone.0167245	http://dx.doi.org/10.1371/journal.pone.0167245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907068	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700102
J	Yoshizawa, H; Senda, D; Natori, Y; Tanaka, R; Mizuno, H; Hayashi, A				Yoshizawa, Hidekazu; Senda, Daiki; Natori, Yuhei; Tanaka, Rica; Mizuno, Hiroshi; Hayashi, Ayato			End-to-Side Neurorrhaphy as Schwann Cells Provider to Acellular Nerve Allograft and Its Suitable Application	PLOS ONE			English	Article							P16(INK4A) EXPRESSION; NEUROTROPHIC FACTORS; EPINEURIAL WINDOW; TRANSGENIC MICE; DONOR NERVE; STEM-CELLS; REGENERATION; RECONSTRUCTION; SYSTEM; REPAIR	Axonal regeneration relies on support from proliferating host Schwann cells (SCs), and previous studies on acellular nerve allografts (ANGs) suggest that axons can regenerate into ANGs within a limited distance. Numerous studies have demonstrated that the supplementation of ANGs with exogenous factors, such as cultured SCs, stem cells, and growth factors, promote nerve regeneration in ANGs. However, there are several problems associated with their utilization. In this study, we investigated whether end-to-side (ETS) neurorrhaphy, which is an axonal provider, could be useful as an SC provider to support axonal elongation in ANGs. We found that ETS neurorrhaphy effectively promoted SC migration into ANGs when an epineurium window combined with partial neurectomy was performed, and the effectiveness increased when it was applied bilaterally. When we transplanted ANGs containing migrated SCs via ETS neurorrhaphy (hybrid ANGs) to the nerve gap, hybrid ANGs increased the number of regenerated axons and facilitated rapid axonal elongation, particularly when ETS neurorrhaphy was applied to both edges of the graft. This approach may represent a novel application of ETS neurorrhaphy and lead to the development of hybrid ANGs, making ANGs more practical in a clinical setting.	[Yoshizawa, Hidekazu; Senda, Daiki; Natori, Yuhei; Tanaka, Rica; Mizuno, Hiroshi; Hayashi, Ayato] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan	Juntendo University	Hayashi, A (corresponding author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.	ayhayasi@juntendo.ac.jp			JSPS KAKENHI [24592720]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant [Grant-in-Aid for Scientific Research (C)] Number 24592720 (https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-245927201) awarded to Dr. Ayato Hayashi.	Bangaru MLY, 2012, J MOL NEUROSCI, V46, P497, DOI 10.1007/s12031-011-9628-x; Beris AE, 2009, INT REV NEUROBIOL, V87, P269, DOI 10.1016/S0074-7742(09)87013-X; Brenner MJ, 2007, PLAST RECONSTR SURG, V120, P215, DOI 10.1097/01.prs.0000264094.06272.67; Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; DEMEDINACELI L, 1995, J NEUROSCI METH, V58, P29, DOI 10.1016/0165-0270(94)00156-B; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Fox IK, 2005, MICROSURG, V25, P502, DOI 10.1002/micr.20152; Fox IK, 2005, MUSCLE NERVE, V31, P59, DOI 10.1002/mus.20231; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P27, DOI 10.1111/j.1365-2990.1986.tb00679.x; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; Hayashi A, 2004, PLAST RECONSTR SURG, V114, P129, DOI 10.1097/01.PRS.0000129075.96217.92; Hayashi A, 2008, EXP NEUROL, V211, P539, DOI 10.1016/j.expneurol.2008.02.031; Hayashi A, 2007, EXP NEUROL, V207, P128, DOI 10.1016/j.expneurol.2007.06.004; Ilha J, 2008, NEUROREHAB NEURAL RE, V22, P355, DOI 10.1177/1545968307313502; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Kalantarian B, 1998, J RECONSTR MICROSURG, V14, P459, DOI 10.1055/s-2007-1000208; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu HF, 2014, MICROSURG, V34, P136, DOI 10.1002/micr.22167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Magill CK, 2007, EXP NEUROL, V207, P64, DOI 10.1016/j.expneurol.2007.05.028; Matsuda K, 2005, J RECONSTR MICROSURG, V21, P581, DOI 10.1055/s-2005-922439; Matsuda K, 2008, J PLAST RECONSTR AES, V61, P1357, DOI 10.1016/j.bjps.2008.04.013; Matsuda K, 2015, J PLAST RECONSTR AES, V68, P1054, DOI 10.1016/j.bjps.2015.04.005; Matsumoto M, 1999, J RECONSTR MICROSURG, V15, P281, DOI 10.1055/s-2007-1000102; Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c; Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889; Moore AM, 2011, MUSCLE NERVE, V44, P221, DOI 10.1002/mus.22033; Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3; NADIM W, 1990, NEUROPATH APPL NEURO, V16, P411, DOI 10.1111/j.1365-2990.1990.tb01277.x; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Poppler LH, 2016, TISSUE ENG PT A, V22, P949, DOI [10.1089/ten.tea.2016.0003, 10.1089/ten.TEA.2016.0003]; Saheb-Al-Zamani M, 2013, EXP NEUROL, V247, P165, DOI 10.1016/j.expneurol.2013.04.011; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.TEB.2012.0275, 10.1089/ten.teb.2012.0275]; Ueda K, 2007, J RECONSTR MICROSURG, V23, P181, DOI 10.1055/s-2007-974654; Viterbo F, 1992, Rev Paul Med, V110, P267; Walker JC, 2004, J NEUROTRAUM, V21, P217, DOI 10.1089/089771504322778677; Walsh S, 2009, NEUROSCIENCE, V164, P1097, DOI 10.1016/j.neuroscience.2009.08.072; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953	53	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167507	10.1371/journal.pone.0167507	http://dx.doi.org/10.1371/journal.pone.0167507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907118	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700174
J	Cooke, CR				Cooke, Colin R.			Risk of Death Influences Regional Variation in Intensive Care Unit Admission Rates among the Elderly in the United States	PLOS ONE			English	Article							OF-LIFE CARE; MEDICARE BENEFICIARIES; EMERGENCY-DEPARTMENTS; END; HOSPITALS; MORTALITY; COSTS; ASSOCIATION; SERVICES; QUALITY	Rationale The extent to which geographic variability in ICU admission across the United States is driven by patients with lower risk of death is unknown. Objectives To determine whether patients at low to moderate risk of death contribute to geographic variation in ICU admission. Methods Retrospective cohort of hospitalizations among Medicare beneficiaries (age > 64 years) admitted for ten common medical and surgical diagnoses (2004 to 2009). We examined population-adjusted rates of ICU admission per 100 hospitalizations in 304 health referral regions (HRR), and estimated the relative risk of ICU admission across strata of regional ICU and risk of death, adjusted for patient and regional characteristics. Measurement and Main Results ICU admission rates varied nearly two-fold across HRR quartiles (quartile 1 to 4: 13.6, 17.3, 20.0, and 25.2 per 100 hospitalizations, respectively). Observed mortality for patients in regions (quartile 4) with the greatest ICU use was 17% compared to 21% in regions with lowest ICU use (quartile 1) (p<0.001). After adjusting for patient and regional characteristics, including regional differences in ICU, skilled nursing, and long-term acute care bed capacity, individuals' risk of death modified the relationship between regional ICU use and an individual's risk of ICU admission (p for interaction<0.001). Region was least important in predicting ICU admission among patients with high (quartile 4) risk of death (RR 1.27, 95% CI 1.22-1.31, for high versus low ICU use regions), and most important for patients with moderate (quartile 2; RR 1.63, 95% CI 1.53-1.72, quartile 3; RR 1.56 95% CI 1.47-1.65) and low (quartile 1) risk of death (RR 1.50, 95% CI 1.41-1.59). Conclusions There is wide variation in in ICU use by geography, independent of ICU beds and physician supply, for patients with low and moderate risks of death.	[Cooke, Colin R.] Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Cooke, Colin R.] Univ Michigan, Inst Healthcare Policy & Innovat, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Cooke, Colin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cooke, CR (corresponding author), Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.; Cooke, CR (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA.; Cooke, CR (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.	cookecr@umich.edu		Cooke, Colin/0000-0001-9713-5371	Agency for Healthcare Research and Quality [K08HS020672]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The Agency for Healthcare Research and Quality supported the work (K08HS020672).	Admon AJ, 2014, CHEST, V146, P1452, DOI 10.1378/chest.14-0059; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], 2015, DARTMOUTH ATLAS HEAL; Aronowitz RA, 1998, J GEN INTERN MED, V13, P495, DOI 10.1046/j.1525-1497.1998.00142.x; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Barnato AE, 2012, INTENS CARE MED, V38, P1886, DOI 10.1007/s00134-012-2661-6; Birkmeyer NJO, 2008, MED CARE, V46, P893, DOI 10.1097/MLR.0b013e31817925b0; Chen LM, 2012, ARCH INTERN MED, V172, P1220, DOI 10.1001/archinternmed.2012.2606; Curtis JR, 2012, AM J RESP CRIT CARE, V186, P587, DOI 10.1164/rccm.201206-1020CP; DETSKY AS, 1981, NEW ENGL J MED, V305, P667, DOI 10.1056/NEJM198109173051204; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; ERICKSON GM, 1985, MED CARE, V23, P1003, DOI 10.1097/00005650-198508000-00008; Escher M, 2004, BRIT MED J, V329, P425, DOI 10.1136/bmj.329.7463.425; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gershengorn HB, 2012, CRIT CARE MED, V40, P2009, DOI 10.1097/CCM.0b013e31824e9eae; Gooch RA, 2014, JAMA; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hutchings A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4353; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Jenq G, 2013, JAMA-J AM MED ASSOC, V309, P489, DOI 10.1001/jama.2013.73; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Luce JM, 2002, AM J RESP CRIT CARE, V165, P750, DOI 10.1164/ajrccm.165.6.2109045; Mullins PM, 2013, ACAD EMERG MED, V20, P479, DOI 10.1111/acem.12134; Newhouse J.P., 2013, VARIATION HLTH CARE; Preeshagul I, 2014, J GEN INTERN MED, V29, pS241; Research Data Assistance Center, MEDPAR INT CAR UN IC; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Safavi KC, 2013, CIRCULATION, V127, P923, DOI 10.1161/CIRCULATIONAHA.112.001088; Seferian EG, 2008, CRIT CARE MED, V36, P2779, DOI 10.1097/CCM.0b013e318186ab1b; Seymour CW, 2012, HEALTH SERV RES, V47, P2060, DOI 10.1111/j.1475-6773.2012.01402.x; Sjoding MW, 2015, AM J RESP CRIT CARE; Stelfox HT, 2012, ARCH INTERN MED, V172, P467, DOI 10.1001/archinternmed.2011.2315; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Valley TS, 2015, JAMA-J AM MED ASSOC, V314, P1272, DOI 10.1001/jama.2015.11068; Wallace DJ, 2015, AM J RESP CRIT CARE, V191, P410, DOI 10.1164/rccm.201409-1746OC; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; Wennberg JE, 2006, CARE PATIENTS SEVERE	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166933	10.1371/journal.pone.0166933	http://dx.doi.org/10.1371/journal.pone.0166933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898697	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000024
J	Garcia-Bardon, A; Thal, SC				Garcia-Bardon, Andreas; Thal, Serge C.			Normalization with Corresponding Naive Tissue Minimizes Bias Caused by Commercial Reverse Transcription Kits on Quantitative Real-Time PCR Results	PLoS One			English	Article							POLYMERASE-CHAIN-REACTION; MESSENGER-RNA; RT-PCR; QUANTIFICATION; EXPRESSION; GENES; BRAIN; SELECTION; ASSAYS; MICE	Real-time reverse transcription polymerase chain reaction (PCR) is the gold standard for expression analysis. Designed to improve reproducibility and sensitivity, commercial kits are commonly used for the critical step of cDNA synthesis. The present study was designed to determine the impact of these kits. mRNA from mouse brains were pooled to create serial dilutions ranging from 0.0625 mu g to 2 mu g, which were transcribed into cDNA using four different commercial reverse-transcription kits. Next, we transcribed mRNA from brain tissue after acute brain injury and naive mice into cDNA for qPCR. Depending on tested genes, some kits failed to show linear results in dilution series and revealed strong variations in cDNA yield. Absolute expression data in naive and trauma settings varied substantially between these kits. Normalization with a housekeeping gene failed to reduce kit-dependent variations, whereas normalization eliminated differences when naive samples from the same region were used. The study shows strong evidence that choice of commercial cDNA synthesis kit has a major impact on PCR results and, consequently, on comparability between studies. Additionally, it provides a solution to overcome this limitation by normalization with data from naive samples. This simple step helps to compare mRNA expression data between different studies and groups.	[Garcia-Bardon, Andreas; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany	Johannes Gutenberg University of Mainz	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Garcia-Bardon, Andreas/0000-0002-6229-1099	German Research Foundation [DFG TH1430/3-1]; Federal Ministry of Education and Research [BMBF 01EO1003]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was financially supported by a grant from the German Research Foundation (DFG TH1430/3-1) to SCT and by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dana Pieter for her excellent technical assistance. This work was financially supported by a grant from the German Research Foundation (DFG TH1430/3-1) to SCT and by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT. The authors would also like to thank Sandra Schmidt for her linguistic assistance.	Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Haberhausen G, 1998, J CLIN MICROBIOL, V36, P628, DOI 10.1128/JCM.36.3.628-633.1998; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Leite GM, 2012, J MICROBIOL METH, V88, P413, DOI 10.1016/j.mimet.2012.01.011; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Singh H B, 2006, J Commun Dis, V38, P274; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Thellin O, 1998, Dev Immunol, V6, P295, DOI 10.1155/1998/85209	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167209	10.1371/journal.pone.0167209	http://dx.doi.org/10.1371/journal.pone.0167209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898720	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000038
J	Luo, KW; Gao, LD; Hu, SX; Zhang, H; Deng, ZH; Huang, W; Sun, QL; Zhang, F; Zhang, SY; Chen, Y				Luo, Kai-Wei; Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Deng, Zhi-Hong; Huang, Wei; Sun, Qian-Lai; Zhang, Fan; Zhang, Si-Yu; Chen, Yu			Hand, Foot, and Mouth Disease in Hunan Province, China, 2009-2014: Epidemiology and Death Risk Factors	PLOS ONE			English	Article							HUMAN ENTEROVIRUS 71; CLINICAL CHARACTERISTICS; OUTBREAK; SHENZHEN; THAILAND; CHILDREN; HENAN; JAPAN; A16	Hand, foot, and mouth disease (HFMD) is an arising public health problem in Asia, including China. Epidemiological data is necessary to enable judicious public health responses and interventions. We analyzed the epidemiological and laboratory data of 759,301 HFMD cases reported to the Hunan Provincial Center for Disease Control and Prevention from 1 January 2009 to 31 December 2014. Univariate and multivariable conditional logistic regression analyses were used to identify risk factors of fatality in HFMD. The incidence of HFMD was highest among children aged 1-3 years, compared with other age groups. Of the total HFMD cases, 7,222 (0.95%) were considered severe and 338 (0.04%) were fatal. Enterovirus-A71 was the major cause of severe and fatal cases (65.75% and 88.78%, respectively). For severe cases, the median time from symptom onset to diagnosis was 0.5 days (interquartile range [IQR] 0-1.5 days); the median time from diagnosis to severe illness was 2 days (IQR 1-3 days). For fatal cases, the median time from symptom onset to diagnosis was 0.5 days (IQR 0-1.5 days); the median time from diagnosis to death was 1.5 days (IQR 0.5-2.5 days). In multivariable analysis, the abuse of antibiotic, glucocorticoid and pyrazolone in village clinics at basic medical institutions were identified as independent risk factors for HFMD fatal cases. In conclusion, our results suggest that the future direction to control and respond to HFMD is intensive surveillance of enterovirus-A71 and improving the ability to diagnose disease and treat patients, especially in basic medical institutions.	[Luo, Kai-Wei; Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Deng, Zhi-Hong; Huang, Wei; Sun, Qian-Lai; Zhang, Fan; Zhang, Si-Yu; Chen, Yu] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China		Luo, KW (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	hncdclkw@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Chinese Preventive Medicine Association [20101801]; Health and Family Planning Commission of Hunan Province [C2015-62]	Chinese Preventive Medicine Association; Health and Family Planning Commission of Hunan Province	This work was supported by the Chinese Preventive Medicine Association (Grant number: 20101801,http://www.cpma.org.cn/) and the Health and Family Planning Commission of Hunan Province (Grant number: C2015-62,http://www.hunanwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; [Anonymous], [No title captured]; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen SY, 2011, J INF SCI ENG, V27, P715; Chen ZR, 2015, ARCH VIROL, V160, P315, DOI 10.1007/s00705-014-2294-x; CZERNIAWSKAMYSIK G, 1981, ALLERGY, V36, P381, DOI 10.1111/j.1398-9995.1981.tb01842.x; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980; Gao LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100003; He LY, 2014, EUR J CLIN MICROBIOL, V33, P1429, DOI 10.1007/s10096-014-2085-z; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Hubiche T, 2014, PEDIATR INFECT DIS J, V33, pE92, DOI 10.1097/INF.0000000000000120; Kadurugamuwa JL, 2011, AM J INFECT CONTROL, V39, P788, DOI 10.1016/j.ajic.2011.01.015; Li W, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-440; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Lu B, 2014, LANCET INFECT DIS, V14, P1041, DOI 10.1016/S1473-3099(14)70972-7; Lu J, 2014, CLIN MICROBIOL INFEC, V20, pO442, DOI 10.1111/1469-0691.12468; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Ma HL, 2010, PEDIATR INFECT DIS J, V29, P524, DOI 10.1097/INF.0b013e3181cdd178; Mauleekoonphairoj J, 2015, VIRUS GENES, V51, P290, DOI 10.1007/s11262-015-1239-0; Mou J, 2014, EPIDEMIOL INFECT, V142, P776, DOI 10.1017/S0950268813001453; Nadel S, 2013, CRIT CARE MED, V41, P1821, DOI 10.1097/CCM.0b013e318291cb2d; National Bureau of Statistics of China, NAT CENS CHIN 2014; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Pan Jiahua, 2012, Indian J Dermatol, V57, P316, DOI 10.4103/0019-5154.97683; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; The Ministry of Health of China, 2010, HAND FOOT MOUTH DIS; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu XN, 2014, JPN J INFECT DIS, V67, P95, DOI 10.7883/yoken.67.95; Xie Z., 2014, J EPIDEMIOL, V35, P1109; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yan Yan, 2013, Bing Du Xue Bao, V29, P176; Zha J, 2015, J MED VIROL, V87, P2000, DOI 10.1002/jmv.24272; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zheng S, 2014, EPIDEMIOL INFECT, V142, P1751, DOI 10.1017/S0950268813002586; Zhou H, 2012, CHINESE MED J-PEKING, V125, P1261, DOI 10.3760/cma.j.issn.0366-6999.2012.07.013	38	10	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167269	10.1371/journal.pone.0167269	http://dx.doi.org/10.1371/journal.pone.0167269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898715	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000043
J	Smith, AD; Zhang, Y; Barber, RC; Minshall, CT; Huebinger, RM; Allen, MS				Smith, Ashley D.; Zhang, Yan; Barber, Robert C.; Minshall, Christian T.; Huebinger, Ryan M.; Allen, Michael S.			Common Lung Microbiome Identified among Mechanically Ventilated Surgical Patients	PLoS One			English	Article							PNEUMONIA; DIVERSITY; DIAGNOSIS; DISEASE	The examination of the pulmonary microbiome in patients with non-chronic disease states has not been extensively examined. Traditional culture based screening methods are often unable to identify bacteria from bronchoalveolar lavage samples. The advancement of next-generation sequencing technologies allows for a culture-independent molecular based analysis to determine the microbial composition in the lung of this patient population. For this study, the Ion Torrent PGM system was used to assess the microbial complexity of culture negative bronchoalveolar lavage samples. A group of samples were identified that all displayed high diversity and similar relative abundance of bacteria. This group consisted of Hydrogenophaga, unclassified Bacteroidetes, Pedobacter, Thauera, and Acinetobacter. These bacteria may be representative of a common non-pathogenic pulmonary microbiome associated within this population of patients.	[Smith, Ashley D.] Univ North Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX USA; [Smith, Ashley D.; Zhang, Yan; Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Ctr Biosafety & Biosecur, Ft Worth, TX 76107 USA; [Zhang, Yan; Barber, Robert C.; Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76107 USA; [Minshall, Christian T.; Huebinger, Ryan M.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Southwestern Medical Center Dallas	Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Ctr Biosafety & Biosecur, Ft Worth, TX 76107 USA.; Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76107 USA.; Huebinger, RM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	Ryan.Huebinger@UTSouthwestern.edu; Michael.Allen@unthsc.edu	Smith, Ashley/GZB-0298-2022; Zhang, Yan/L-1738-2015	Zhang, Yan/0000-0001-5784-4659; Allen, Michael/0000-0003-2293-8078	UNTHSC	UNTHSC	This work was supported in part by a grant from UNTHSC to MSA.; The authors thank personnel and staff at Parkland Memorial Hospital for samples. Work was supported in part by a grant from UNTHSC to MSA and ADS.	Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; Alex WI, 2012, AM THOR SOC INT C AM, pA4045; Cabello H, 1997, EUR RESPIR J, V10, P1137, DOI 10.1183/09031936.97.10051137; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Gholoobi A, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.8939; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Kelly BJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0151-8; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Nair GB, 2015, INTENS CARE MED, V41, P34, DOI 10.1007/s00134-014-3564-5; Nair GB, 2013, CRIT CARE CLIN, V29, P521, DOI 10.1016/j.ccc.2013.03.007; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Pascual A, 2010, INT J MICROBIOL, V2010; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Smith AD, 2013, BIO SYST, V2, P116; Smith AD, 2013, BIOL SYSTEMS, V2, P5; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401	32	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166313	10.1371/journal.pone.0166313	http://dx.doi.org/10.1371/journal.pone.0166313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898681	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000008
J	Zhu, H; Xia, W; Mo, XB; Lin, X; Qiu, YH; Yi, NJ; Zhang, YH; Deng, FY; Lei, SF				Zhu, Hong; Xia, Wei; Mo, Xing-Bo; Lin, Xiang; Qiu, Ying-Hua; Yi, Neng-Jun; Zhang, Yong-Hong; Deng, Fei-Yan; Lei, Shu-Feng			Gene-Based Genome-Wide Association Analysis in European and Asian Populations Identified Novel Genes for Rheumatoid Arthritis	PLOS ONE			English	Article							HLA-DMA; SUSCEPTIBILITY LOCI; RECOGNITION; IMMUNITY; PADI4	Objective Rheumatoid arthritis (RA) is a complex autoimmune disease. Using a gene-based association research strategy, the present study aims to detect unknown susceptibility to RA and to address the ethnic differences in genetic susceptibility to RA between European and Asian populations. Methods Gene-based association analyses were performed with KGG 2.5 by using publicly available large RA datasets (14,361 RA cases and 43,923 controls of European subjects, 4,873 RA cases and 17,642 controls of Asian Subjects). For the newly identified RA-associated genes, gene set enrichment analyses and protein-protein interactions analyses were carried out with DAVID and STRING version 10.0, respectively. Differential expression verification was conducted using 4 GEO datasets. The expression levels of three selected 'highly verified' genes were measured by ELISA among our in-house RA cases and controls. Results A total of 221 RA-associated genes were newly identified by gene-based association study, including 71'overlapped', 76 'European-specific' and 74 'Asian-specific' genes. Among them, 105 genes had significant differential expressions between RA patients and health controls at least in one dataset, especially for 20 genes including 11 'overlapped' (ABCF1, FLOT1, HLA-F, IER3, TUBB, ZKSCAN4, BTN3A3, HSP90AB1, CUTA, BRD2, HLA-DMA), 5 'European-specific' (PHTF1, RPS18, BAK1, TNFRSF14, SUOX) and 4 'Asian-specific' (RNASET2, HFE, BTN2A2, MAPK13) genes whose differential expressions were significant at least in three datasets. The protein expressions of two selected genes FLOT1 (P value = 1.70E-02) and HLA-DMA (P value = 4.70E-02) in plasma were significantly different in our in-house samples. Conclusion Our study identified 221 novel RA-associated genes and especially highlighted the importance of 20 candidate genes on RA. The results addressed ethnic genetic background differences for RA susceptibility between European and Asian populations and detected a long list of overlapped or ethnic specific RA genes. The study not only greatly increases our understanding of genetic susceptibility to RA, but also provides important insights into the ethno-genetic homogeneity and heterogeneity of RA in both ethnicities.	[Zhu, Hong; Xia, Wei; Mo, Xing-Bo; Lin, Xiang; Qiu, Ying-Hua; Deng, Fei-Yan; Lei, Shu-Feng] Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China; [Zhu, Hong; Xia, Wei; Mo, Xing-Bo; Zhang, Yong-Hong; Deng, Fei-Yan; Lei, Shu-Feng] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China; [Zhu, Hong] Soochow Univ, Dept Child & Adolescent Hlth, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China; [Yi, Neng-Jun] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Soochow University - China; Soochow University - China; Soochow University - China; University of Alabama System; University of Alabama Birmingham	Lei, SF (corresponding author), Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China.; Lei, SF (corresponding author), Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China.	leisf@suda.edu.cn	Mo, Xingbo/I-7112-2013	Mo, Xingbo/0000-0001-8956-4918	Natural Science Foundation of China [81401343, 81473046, 31401079, 31271336]; Colleges and Universities in Jiangsu Province plans to graduate research and innovation [KYLX_1270]; Soochow University [Q413900112]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Colleges and Universities in Jiangsu Province plans to graduate research and innovation; Soochow University; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by Natural Science Foundation of China (81401343, 81473046, 31401079 and 31271336), http://www.nsfc.gov.cn, the Colleges and Universities in Jiangsu Province plans to graduate research and innovation (KYLX_1270), http://jyt.njau.edu.cn, the Startup Fund from Soochow University (Q413900112), http://www.suda.edu.cn/, and the Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro-Benito M, 2015, J IMMUNOL, V194, P803, DOI 10.4049/jimmunol.1401389; Boudjema A, 2012, TISSUE ANTIGENS, V79, P155, DOI 10.1111/j.1399-0039.2011.01822.x; Douroudis K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-11; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kennedy RB, 2014, HUM GENET, V133, P1407, DOI 10.1007/s00439-014-1471-z; Kim JH, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/634289; Kisand K, 2012, GENE, V497, P285, DOI 10.1016/j.gene.2012.01.089; Kochi Y, 2010, NAT REV RHEUMATOL, V6, P290, DOI 10.1038/nrrheum.2010.23; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Lei SF, 2014, SCAND J RHEUMATOL, V43, P426, DOI 10.3109/03009742.2014.894121; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Liu Xiaofeng, 2014, BMC Proc, V8, pS46, DOI 10.1186/1753-6561-8-S1-S46; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Manuel A, 2000, GENOMICS, V64, P216, DOI 10.1006/geno.1999.6079; Messal N, 2011, EUR J IMMUNOL, V41, P3443, DOI 10.1002/eji.201141404; Mo XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121811; Morel J, 2004, ANN RHEUM DIS, V63, P1581, DOI 10.1136/ard.2003.012294; Moxley G, 2001, EUR J IMMUNOGENET, V28, P539, DOI 10.1046/j.1365-2370.2001.00258.x; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Qiu YH, 2014, J DIABETES INVEST, V5, P649, DOI 10.1111/jdi.12228; Song LB, 2012, GASTROENTEROLOGY, V143, P995, DOI 10.1053/j.gastro.2012.06.033; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tang Guo-ping, 2014, Zhejiang Da Xue Xue Bao Yi Xue Ban, V43, P466; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Van der Sluis S, 2015, BIOINFORMATICS, V31, P1007, DOI 10.1093/bioinformatics/btu783; Woetzel D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4526; Yamashiro H, 2010, J LEUKOCYTE BIOL, V88, P757, DOI 10.1189/jlb.0309156	42	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167212	10.1371/journal.pone.0167212	http://dx.doi.org/10.1371/journal.pone.0167212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898717	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000039
J	Wadman, RI; Stam, M; Jansen, MD; van der Weegen, Y; Wijngaarde, CA; Harschnitz, O; Sodaar, P; Braun, KPJ; Dooijes, D; Lemmink, HH; van den Berg, LH; van der Pol, WL				Wadman, Renske I.; Stam, Marloes; Jansen, Marc D.; van der Weegen, Yana; Wijngaarde, Camiel A.; Harschnitz, Oliver; Sodaar, Peter; Braun, Kees P. J.; Dooijes, Dennis; Lemmink, Henny H.; van den Berg, Leonard H.; van der Pol, W. Ludo			A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls	PLOS ONE			English	Article							MOTOR-NEURON PROTEIN; PERIPHERAL-BLOOD; MONONUCLEAR-CELLS; NATURAL-HISTORY; GENOTYPE-PHENOTYPE; CLINICAL-TRIALS; GENE-EXPRESSION; VALPROIC ACID; DOUBLE-BLIND; SURVIVAL	Background Clinical trials to test safety and efficacy of drugs for patients with spinal muscular atrophy (SMA) are currently underway. Biomarkers that document treatment-induced effects are needed because disease progression in childhood forms of SMA is slow and clinical outcome measures may lack sensitivity to detect meaningful changes in motor function in the period of 1-2 years of follow-up during randomized clinical trials. Objective To determine and compare SMN protein and mRNA levels in two cell types (i.e. PBMCs and skin-derived fibroblasts) from patients with SMA types 1-4 and healthy controls in relation to clinical characteristics and SMN2 copy numbers. Materials and methods We determined SMN1, SMN2-full length (SMN2-FL), SMN2-delta7 (SMN2-Delta 7), GAPDH and 18S mRNA levels and SMN protein levels in blood and fibroblasts from a total of 150 patients with SMA and 293 healthy controls using qPCR and ELISA. We analyzed the association with clinical characteristics including disease severity and duration, and SMN2 copy number. Results SMN protein levels in PBMCs and fibroblasts were higher in controls than in patients with SMA (p<0.01). Stratification for SMA type did not show differences in SMN protein (p>0.1) or mRNA levels (p>0.05) in either cell type. SMN2 copy number was associated with SMN protein levels in fibroblasts (p = 0.01), but not in PBMCs (p = 0.06). Protein levels in PBMCs declined with age in patients (p<0.01) and controls (p<0.01)(power 1-beta = 0.7). Ratios of SMN2-Delta 7/SMN2-FL showed a broad range, primarily explained by the variation in SMN2-Delta 7 levels, even in patients with a comparable SMN2 copy number. Levels of SMN2 mRNA did not correlate with SMN2 copy number, SMA type or age in blood (p = 0.7) or fibroblasts (p = 0.09). Paired analysis between blood and fibroblasts did not show a correlation between the two different tissues with respect to the SMN protein or mRNA levels. Conclusions SMN protein levels differ considerably between tissues and activity is age dependent in patients and controls. SMN protein levels in fibroblasts correlate with SMN2 copy number and have potential as a biomarker for disease severity.	[Wadman, Renske I.; Stam, Marloes; Jansen, Marc D.; van der Weegen, Yana; Wijngaarde, Camiel A.; Harschnitz, Oliver; Sodaar, Peter; van den Berg, Leonard H.; van der Pol, W. Ludo] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Braun, Kees P. J.] Univ Med Ctr Utrecht, Dept Neurol & Child Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Dooijes, Dennis] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands; [Lemmink, Henny H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen	Wadman, RI; van der Pol, WL (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	R.I.Wadman@umcutrecht.nl; W.L.vanderPol@umcutrecht.nl		Jansen, Marc/0000-0001-7567-8519; Harschnitz, Oliver/0000-0001-6496-881X	Prinses Beatrix Spierfonds [WAR008]; Stichting Spieren voor Spieren; Dutch patient organization for neuromuscular diseases	Prinses Beatrix Spierfonds; Stichting Spieren voor Spieren; Dutch patient organization for neuromuscular diseases	This study was funded by the Prinses Beatrix Spierfonds (WAR008; https://www. prinsesbeatrixspierfonds.nl/onderzoek/) and Stichting Spieren voor Spieren (https.//www. spierenvoorspieren.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the patients with SMA who participated in this study and the support of the Dutch patient organization for neuromuscular diseases (VSN).	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Also-Rallo E, 2011, EUR J HUM GENET, V19, P1059, DOI 10.1038/ejhg.2011.89; Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Arakawa M, 2014, BIOCHEM BIOPH RES CO, V453, P368, DOI 10.1016/j.bbrc.2014.09.087; Arakawa R, 2016, PEDIATR NEUROL, V61, P70, DOI 10.1016/j.pediatrneurol.2016.05.009; Barnes MG, 2010, BIOPRESERV BIOBANK, V8, P153, DOI 10.1089/bio.2010.0009; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Boyer JG, 2014, HUM MOL GENET, V23, P4249, DOI 10.1093/hmg/ddu142; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chen TH, 2010, NEUROLOGY, V75, P2190, DOI 10.1212/WNL.0b013e3182020332; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Cobben JM, 2008, NEUROMUSCULAR DISORD, V18, P541, DOI 10.1016/j.nmd.2008.05.008; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; Deymeer F, 2008, NEUROLOGY, V71, P644, DOI 10.1212/01.wnl.0000324623.89105.c4; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Dubowitz V, 1991, Neuromuscul Disord, V1, P77, DOI 10.1016/0960-8966(91)90051-S; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Garbes L, 2013, HUM MOL GENET, V22, P398, DOI 10.1093/hmg/dds437; Giavazzi A, 2006, J NEUROPATH EXP NEUR, V65, P267, DOI 10.1097/01.jnen.0000205144.54457.a3; Glanzman AM, 2011, J CHILD NEUROL, V26, P1499, DOI 10.1177/0883073811420294; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hauke J, 2009, HUM MOL GENET, V18, P304, DOI 10.1093/hmg/ddn357; Hunter G, 2014, NEUROMUSCULAR DISORD, V24, P973, DOI 10.1016/j.nmd.2014.05.013; Hunter G, 2014, HUM MOL GENET, V23, P2235, DOI 10.1093/hmg/ddt612; Jong YJ, 2000, J NEUROL SCI, V173, P147, DOI 10.1016/S0022-510X(99)00325-1; Kissel JT, 2014, MUSCLE NERVE, V49, P187, DOI 10.1002/mus.23904; Kissel JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021296; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Kobayashi DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050763; Kobayashi DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024269; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Man NT, 2008, NEUROLOGY, V71, P1757, DOI 10.1212/01.wnl.0000313038.34337.b1; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Patrizi AL, 1999, EUR J HUM GENET, V7, P301, DOI 10.1038/sj.ejhg.5200286; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Petit F, 2011, MUSCLE NERVE, V43, P26, DOI 10.1002/mus.21832; Piepers S, 2008, J NEUROL, V255, P1400, DOI 10.1007/s00415-008-0929-0; Piepers S, 2011, J NEUROL NEUROSUR PS, V82, P850, DOI 10.1136/jnnp.2009.200253; Rindt H, 2015, HUM MOL GENET, V24, P4094, DOI 10.1093/hmg/ddv148; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rudnik-Schoneborn S, 2009, CLIN GENET, V76, P168, DOI 10.1111/j.1399-0004.2009.01200.x; Shahabuddin S, 1998, CLIN DIAGN LAB IMMUN, V5, P632, DOI 10.1128/CDLI.5.5.632-635.1998; Simard LR, 2007, NEUROLOGY, V68, P451, DOI 10.1212/01.wnl.0000252934.70676.ab; Steinkellner H, 2015, ASSAY DRUG DEV TECHN, V13, P167, DOI 10.1089/adt.2015.635; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012140; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Tiziano FD, 2013, EUR J HUM GENET, V21, P630, DOI 10.1038/ejhg.2012.233; Tiziano FD, 2010, J MED GENET, V47, P856, DOI 10.1136/jmg.2010.080366; Tiziano FD, 2010, EUR J HUM GENET, V18, P52, DOI 10.1038/ejhg.2009.116; Torrecilla E, 2010, BRIT J NUTR, V104, P1650, DOI 10.1017/S0007114510002710; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vezain M, 2007, EUR J HUM GENET, V15, P1054, DOI 10.1038/sj.ejhg.5201885; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318; Zaworski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150640; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; Zhao DY, 2016, NATURE, V529, P48, DOI 10.1038/nature16469	72	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167087	10.1371/journal.pone.0167087	http://dx.doi.org/10.1371/journal.pone.0167087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893852	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400082
J	Yu, Y				Yu, Yan			Four Decades of Obesity Trends among Non-Hispanic Whites and Blacks in the United States: Analyzing the Influences of Educational Inequalities in Obesity and Population Improvements in Education	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ABDOMINAL OBESITY; PHYSICAL-ACTIVITY; US ADULTS; HEALTH; ASSOCIATION; AMERICANS; MORTALITY	Both obesity (body mass index >= 30) and educational attainment have increased dramatically in the United States since the 1970s. This study analyzed the influences of educational inequalities in obesity and population improvements in education on national obesity trends between 1970 and 2010. For non-Hispanic white and black males and females aged 25-74 years, educational differences in the probability of being obese were estimated from the 1971-2012 National Health and Nutrition Examination Surveys, and population distributions of age and educational groups, from the 1970 Census and 2010 American Community Survey. In the total population, obesity increased from 15.7% to 38.8%, and there were increases in the greater obese probabilities of non-college graduates relative to four-year college graduates. The increase in obesity would have been lower by 10% (2.2 percentage points) if educational inequalities in obesity had stayed at their 1970 values and lower by one third (7.9 points) if obesity inequalities had been eliminated. Obesity inequalities were larger for females than males and for whites than blacks, and obesity did not differ by education among black males. As a result, the impact of obesity inequalities on the obesity trend was largest among white females (a 47% reduction in the obesity increase if obesity inequalities had been eliminated), and virtually zero among black males. On the other hand, without educational improvements, the obesity increase would have been 9% more in the total population, 23% more among white females and not different in the other three subpopulations. Results indicate that obesity inequalities made sizable contributions to the obesity trends, and the obesity reductions associated with educational improvements were more limited.	[Yu, Yan] Univ Canberra, Hlth Res Inst, Bruce, ACT, Australia; [Yu, Yan] Australian Natl Univ, Sch Demog, Acton, ACT, Australia	University of Canberra; Australian National University	Yu, Y (corresponding author), Univ Canberra, Hlth Res Inst, Bruce, ACT, Australia.; Yu, Y (corresponding author), Australian Natl Univ, Sch Demog, Acton, ACT, Australia.	yan.yu@canberra.edu.au			Australian Research Council Centre of Excellence in Population Ageing Research [CE 1000 1029]	Australian Research Council Centre of Excellence in Population Ageing Research(Australian Research Council)	The work was supported by the Australian Research Council (http://www.arc.gov.au/) Centre of Excellence in Population Ageing Research (project number CE 1000 1029). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	An RP, 2015, ANN EPIDEMIOL, V25, P637, DOI 10.1016/j.annepidem.2015.06.004; [Anonymous], 2008, SOCIOECONOMIC STATUS; [Anonymous], 2006, AN REP GUID; [Anonymous], 2011, WORLD C SOC DET HLT; Cole SR, 2001, COMPUT METH PROG BIO, V64, P65, DOI 10.1016/S0169-2607(00)00088-2; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Goesling B, 2007, SOC FORCES, V85, P1621, DOI 10.1353/sof.2007.0068; Goldstein JR, 2001, AM SOCIOL REV, V66, P506, DOI 10.2307/3088920; Gottschalk P, 2005, REV INCOME WEALTH, P231; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Heckman JJ, 2001, AM ECON REV, V91, P145, DOI 10.1257/aer.91.2.145; Himes CL, 2005, GEND ISSUES, V22, P45, DOI 10.1007/s12147-005-0014-2; Hout M., 1993, PERSISTENT INEQUALIT; Krieger N, 2014, INT J EPIDEMIOL, V43, P1294, DOI 10.1093/ije/dyu047; Leon-Munoz LM, 2014, CLIN NUTR, V33, P836, DOI 10.1016/j.clnu.2013.10.013; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Martin SP, 2006, DEMOGR RES, V15, P537, DOI 10.4054/DemRes.2006.15.20; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; MURPHY KM, 1989, ED RES, V0018; National Center for Health Statistics, 1981, VITAL HLTH STAT SERI, V1; National Center for Health Statistics, 1973, VITAL HLTH STAT SERI, V1; National Center for Health Statistics, 1994, VITAL HLTH STAT SERI, V1; NCD Risk Factor Collaboration (NCD-RisC), 1975, LANCET, V2016, P1377; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ruggles S, 2010, INTEGRATED PUBLIC US; Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x; SEWELL WH, 1967, SOCIOL EDUC, V40, P1, DOI 10.2307/2112184; Smith JP, 2007, J HUM RESOUR, V42, P739; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; U.S. Department of Health and Human Services, 2014, SOCIAL DETERMINANTS; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; WHO, 2000, OB PREV MAN GLOB EP; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Xie B, 2003, PREV MED, V36, P30, DOI 10.1006/pmed.2002.1131; Yu Y, 2016, BIODEMOGR SOC BIOL, V62, P143, DOI 10.1080/19485565.2015.1108835; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.307; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167193	10.1371/journal.pone.0167193	http://dx.doi.org/10.1371/journal.pone.0167193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893853	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400098
J	Zhao, H; Ruberu, K; Li, HY; Garner, B				Zhao, Hua; Ruberu, Kalani; Li, Hongyun; Garner, Brett			Cell Type-Specific Modulation of Cobalamin Uptake by Bovine Serum	PLOS ONE			English	Article							TRANSCOBALAMIN-II; IMMUNOHISTOCHEMICAL QUANTIFICATION; CULTURED FIBROBLASTS; TRANSPORT PROTEIN; SURFACE RECEPTOR; BINDING PROTEIN; INBORN-ERRORS; IN-VITRO; VITAMIN-B12; EXPRESSION	Tracking cellular Co-57-labelled cobalamin (Co-57-Cbl) uptake is a well-established method for studying Cbl homeostasis. Previous studies established that bovine serum is not generally permissive for cellular Cbl uptake when used as a supplement in cell culture medium, whereas supplementation with human serum promotes cellular Cbl uptake. The underlying reasons for these differences are not fully defined. In the current study we address this question. We extend earlier observations by showing that fetal calf serum inhibits cellular Co-57-Cbl uptake by HT1080 cells (a fibrosarcoma-derived fibroblast cell line). Furthermore, we discovered that a simple heat-treatment protocol (95 degrees C for 10 min) ameliorates this inhibitory activity for HT1080 cell Co-57-Cbl uptake. We provide evidence that the very high level of haptocorrin in bovine serum (as compared to human serum) is responsible for this inhibitory activity. We suggest that bovine haptocorrin competes with cell-derived transcobalamin for Cbl binding, and that cellular Cbl uptake may be minimised in the presence of large amounts of bovine haptocorrin that are present under routine in vitro cell culture conditions. In experiments conducted with AG01518 cells (a neonatal foreskin-derived fibroblast cell line), overall cellular Co-57-Cbl uptake was 86% lower than for HT1080 cells, cellular TC production was below levels detectable by western blotting, and heat treatment of fetal calf serum resulted in only a modest increase in cellular Co-57-Cbl uptake. We recommend a careful assessment of cell culture protocols should be conducted in order to determine the potential benefits that heat-treated bovine serum may provide for in vitro studies of mammalian cell lines.	[Zhao, Hua; Ruberu, Kalani; Li, Hongyun; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Zhao, Hua; Ruberu, Kalani; Li, Hongyun; Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Zhao, Hua] Univ New South Wales, Prince Wales Clin Sch, Lowy Canc Ctr, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of New South Wales Sydney	Garner, B (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.; Garner, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	brettg@uow.edu.au	; Li, Hongyun/G-2301-2011	Ruberu, Kalani/0000-0003-2575-5242; Li, Hongyun/0000-0003-3332-3132	National Health and Medical Research Council (NHMRC) of Australia [1065982]; NHMRC Senior Research Fellowship [1109831]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council (NHMRC) of Australia (Grant ID #1065982). BG is supported by an NHMRC Senior Research Fellowship (Grant ID #1109831), NHMRC: http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Health and Medical Research Council (NHMRC) of Australia (Grant ID #1065982). BG is supported by an NHMRC Senior Research Fellowship (Grant ID # 1109831).	Abuyaman O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073110; Allen R H, 1975, Prog Hematol, V9, P57; ALLISON AC, 1961, BIOCHIM BIOPHYS ACTA, V49, P566, DOI 10.1016/0006-3002(61)90253-0; Alpers DH, 2016, BIOCHIMIE, V126, P52, DOI 10.1016/j.biochi.2015.11.006; AMAGASAKI T, 1990, BLOOD, V76, P1380; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; BERLINER N, 1981, METABOLISM, V30, P230, DOI 10.1016/0026-0495(81)90146-3; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Carmel R, 2009, BRIT J HAEMATOL, V147, P386, DOI 10.1111/j.1365-2141.2009.07855.x; Chlon TM, 2008, J NUTR, V138, P1323, DOI 10.1093/jn/138.7.1323; DIGIROLAMO PM, 1975, ARCH BIOCHEM BIOPHYS, V168, P386, DOI 10.1016/0003-9861(75)90267-2; EVANS VJ, 1956, CANCER RES, V16, P87; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; FRATERSCHRODER M, 1985, BIOCHIM BIOPHYS ACTA, V845, P421, DOI 10.1016/0167-4889(85)90207-1; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; LI N, 1994, BIOCHEM J, V301, P585, DOI 10.1042/bj3010585; Liu YW, 2002, WOUND REPAIR REGEN, V10, P336, DOI 10.1046/j.1524-475X.2002.10510.x; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; McLean GR, 1997, BLOOD, V89, P235, DOI 10.1182/blood.V89.1.235.235_235_242; MELLMAN I, 1978, J CLIN INVEST, V62, P952, DOI 10.1172/JCI109224; Moras E, 2007, MOL GENET METAB, V90, P140, DOI 10.1016/j.ymgme.2006.08.014; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Park Hyo Jin, 2009, Immune Netw, V9, P138, DOI 10.4110/in.2009.9.4.138; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; Quadros EV, 2013, BIOCHIMIE, V95, P1008, DOI 10.1016/j.biochi.2013.02.004; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; QUADROS EV, 1995, BBA-GEN SUBJECTS, V1244, P395, DOI 10.1016/0304-4165(95)00037-C; Quadros EV, 1999, AM J PHYSIOL-GASTR L, V277, pG161, DOI 10.1152/ajpgi.1999.277.1.G161; ROSENBERG LE, 1975, P NATL ACAD SCI USA, V72, P4617, DOI 10.1073/pnas.72.11.4617; Seetharam Bellur, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006422; SENNETT C, 1981, ANNU REV BIOCHEM, V50, P1053, DOI 10.1146/annurev.bi.50.070181.005201; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sysel AM, 2015, ONCOTARGET, V6, P2331, DOI 10.18632/oncotarget.3206; Sysel AM, 2013, ANTICANCER RES, V33, P4203; Arigony ALV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597282; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Watkins D, 2013, BIOCHIMIE, V95, P1019, DOI 10.1016/j.biochi.2013.01.013; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x; Zhao H, 2015, J ALZHEIMERS DIS, V43, P1017, DOI 10.3233/JAD-140681; Zhao H, 2014, BIOSCIENCE REP, V34, P43, DOI 10.1042/BSR20130130; Zhao H, 2013, J NEUROSCI METH, V217, P67, DOI 10.1016/j.jneumeth.2013.04.008; Zhao H, 2011, CELL MOL LIFE SCI, V68, P3963, DOI 10.1007/s00018-011-0861-9	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167044	10.1371/journal.pone.0167044	http://dx.doi.org/10.1371/journal.pone.0167044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893837	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400074
J	Chao, CM; Chen, CC; Huang, HL; Chuang, YC; Lai, CC; Tang, HJ				Chao, Chien-Ming; Chen, Chi-Chung; Huang, Hui-Ling; Chuang, Yin-Ching; Lai, Chih-Cheng; Tang, Hung-Jen			Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; BACTERIAL-INFECTIONS; IMIPENEM-CILASTATIN; IN-VITRO; EFFICACY; SAFETY; MULTICENTER; SURVEILLANCE	In this study, we retrospectively reviewed the clinical experience of patients receiving doripenem-containing regimens for the treatment of healthcare-associated infections (HCAIs) in a tertiary care center and assessed the clinical usefulness of doripenem therapy in this clinical setting. In this retrospective study, the medical records of all adult patients who had ever received doripenem-containing therapy for the treatment of HCAIs were reviewed between September 1, 2012 and August 31, 2014, and the following data were extracted: age, gender, type of infection, disease severity, underlying comorbidities or conditions, and laboratory results. Additionally, we also extracted data regarding the rates of mortality and clinical and microbiological response. A total of 184 adult patients with HCAIs who had received doripenem-containing therapy were included in this study. Respiratory tract infections (n = 91, 49.5%) were the most common type of infection, followed by urinary tract infections, intra-abdominal infections and skin and soft tissue infections. The mean APACHE II score was 14.5. The rate of clinical success was 78.2%, and the overall in-hospital mortality rate was only 13.0%. Among patients, in-hospital mortality was independently and significantly associated with APACHE II score (odds ratio (OR), 1.2825; 95% CI, 1.1123-1.4788) and achieving clinical success (OR, 0.003; 95% CI, 0.0003-0.409). In conclusion, the overall in hospital mortality rate was low and the clinical success rate was high among HCAI patients receiving doripenem treatment. These results suggest that doripenem may be judiciously used for the treatment of patients with HCAIs.	[Chao, Chien-Ming; Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chen, Chi-Chung; Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Hui-Ling; Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital	Tang, HJ (corresponding author), Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan.; Tang, HJ (corresponding author), Chi Mei Med Ctr, Dept Med, Tainan, Taiwan.	8409d1@gmail.com	chen, chen/GRY-7085-2022; CHEN, CHEN/HDM-6657-2022					Baldwin CM, 2008, DRUGS, V68, P803, DOI 10.2165/00003495-200868060-00006; Boncagni F, 2015, MINERVA ANESTESIOL, V81, P765; Castanheira M, 2009, DIAGN MICR INFEC DIS, V63, P426, DOI 10.1016/j.diagmicrobio.2009.01.026; Chastre J, 2008, CRIT CARE MED, V36, P1089, DOI 10.1097/CCM.0b013e3181691b99; Chen ZJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-217; Dabar G, 2015, INT J INFECT DIS, V37, P80, DOI 10.1016/j.ijid.2015.05.024; Dong SX, 2012, J MICROBIOL IMMUNOL, V45, P459, DOI 10.1016/j.jmii.2012.08.022; Fritsche TR, 2005, CLIN MICROBIOL INFEC, V11, P974, DOI 10.1111/j.1469-0691.2005.01271.x; Hagihara M, 2012, DIAGN MICR INFEC DIS, V72, P258, DOI 10.1016/j.diagmicrobio.2011.11.011; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jones RN, 2004, J ANTIMICROB CHEMOTH, V54, P144, DOI 10.1093/jac/dkh298; Kamidono S A S, 2005, JPN J CHEMOTHER S1, V53, P244; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Kollef MH, 2012, CRIT CARE, V16, DOI [10.1186/cc11862, 10.1186/cc11853]; Kuo SC, 2011, J MICROBIOL IMMUNOL, V44, P45, DOI 10.1016/j.jmii.2011.01.009; Lee H, 2011, MICROB DRUG RESIST, V17, P37, DOI 10.1089/mdr.2010.0034; Livermore DM, 2009, DIAGN MICR INFEC DIS, V63, P455, DOI 10.1016/j.diagmicrobio.2009.02.012; Lo Tze Shien, 2009, Infect Drug Resist, V2, P41; Lucasti C, 2008, CLIN THER, V30, P868, DOI 10.1016/j.clinthera.2008.04.019; Mushtaq S, 2004, ANTIMICROB AGENTS CH, V48, P3086, DOI 10.1128/AAC.48.8.3086-3092.2004; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P383, DOI [10.1586/ERI.13.14, 10.1586/eri.13.14]; Qu XY, 2015, BRAZ J INFECT DIS, V19, P156, DOI 10.1016/j.bjid.2014.10.010; Rea-Neto A, 2008, CURR MED RES OPIN, V24, P2113, DOI 10.1185/03007990802179255 ; Rodloff AC, 2006, J ANTIMICROB CHEMOTH, V58, P916, DOI 10.1093/jac/dkl354; Saito A., 2005, J CHEMOTHERAPY, V53, P185, DOI [10.11250/chemotherapy1995.53.supplement1_185, DOI 10.11250/CHEMOTHERAPY1995.53.SUPPLEMENT1_185]; Tan CK, 2010, J INFECTION, V61, P34, DOI 10.1016/j.jinf.2010.04.007; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Vazquez JA, 2012, CURR MED RES OPIN, V28, P1921, DOI 10.1185/03007995.2012.748653	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167522	10.1371/journal.pone.0167522	http://dx.doi.org/10.1371/journal.pone.0167522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907197	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700181
J	Glaser, DE; Turner, WS; Madfis, N; Wong, L; Zamora, J; White, N; Reyes, S; Burns, AB; Gopinathan, A; McCloskey, KE				Glaser, Drew E.; Turner, William S.; Madfis, Nicole; Wong, Lian; Zamora, Jose; White, Nicholas; Reyes, Samuel; Burns, Andrew B.; Gopinathan, Ajay; McCloskey, Kara E.			Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells	PLOS ONE			English	Article							INDUCED PLURIPOTENT STEM; IN-VITRO; VASCULAR PROGENITORS; SIGNALING PATHWAYS; CD34(+) CELLS; DIFFERENTIATION; VEGF; ANGIOGENESIS; MOUSE; PROLIFERATION	Embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells are attractive in vitro models of vascular development, therapeutic angiogenesis, and tissue engineering. However, distinct ESC and iPS cell lines respond differentially to the same microenvironmental factors. Developing improved/optimized differentiation methodologies tailored/applicable in a number of distinct iPS and ESC lines remains a challenge in the field. Currently published methods for deriving endothelial cells (EC) robustly generate high numbers of endothlelial progenitor cells (EPC) within a week, but their maturation to definitive EC is much more difficult, taking up to 2 months and requiring additional purification. Therefore, we set out to examine combinations/levels of putative EC induction factors-utilizing our stage-specific chemically-defined derivation methodology in 4 ESC lines including: kinetics, cell seeding density, matrix signaling, as well as medium treatment with vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF). The results indicate that temporal development in both early and late stages is the most significant factor generating the desired cells. The generation of early Flk-1(+)/KDR+ vascular progenitor cells (VPC) from pluripotent ESC is directed predominantly by high cell seeding density and matrix signaling from fibronectin, while VEGF supplementation was NOT statistically significant in more than one cell line, especially with fibronectin matrix which sequesters autocrine VEGF production by the differentiating stem cells. Although some groups have shown that the GSK3-kinase inhibitor (CHIR) can facilitate EPC fate, it hindered the generation of KDR+ cells in our preoptimized medium formulations. The methods summarized here significantly increased the production of mature vascular endothelial (VE)-cadherin+ EC, with up to 93% and 57% purity from mouse and human ESC, respectively, before VE-cadherin+ EC purification.	[Glaser, Drew E.; Turner, William S.; Wong, Lian; White, Nicholas; Reyes, Samuel; McCloskey, Kara E.] Univ Calif Merced, Sch Engn, Merced, CA 95340 USA; [Glaser, Drew E.; Wong, Lian; McCloskey, Kara E.] Univ Calif Merced, Grad Program Biol Engn & Small Scale Technol, Merced, CA 95340 USA; [Madfis, Nicole] Univ Calif Merced, Grad Program Quantitat & Syst Biol, Merced, CA USA; [Zamora, Jose; Gopinathan, Ajay] Univ Calif Merced, Dept Phys, Merced, CA USA; [Zamora, Jose; Burns, Andrew B.] Univ Calif Merced, Dept Mol & Cellular Biol, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced	McCloskey, KE (corresponding author), Univ Calif Merced, Sch Engn, Merced, CA 95340 USA.; McCloskey, KE (corresponding author), Univ Calif Merced, Grad Program Biol Engn & Small Scale Technol, Merced, CA 95340 USA.	kmccloskey@ucmerced.edu		Gopinathan, Ajay/0000-0002-9369-8780	California Institute for Regenerative Medicine (CIRM) New Faculty Award [RN2-00921-1]; Basic Biology Award [RB5-07414]; NSF Integrative Graduate Education and Research Traineeship (IGERT) Award [0965918]; NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award [0939511]; James S. McDonnell Foundation Award; NSF [DMS-1616926, EF-1038697]; NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced [NSF-HRD-1547848]; Division Of Mathematical Sciences [1616926] Funding Source: National Science Foundation	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Basic Biology Award; NSF Integrative Graduate Education and Research Traineeship (IGERT) Award; NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award; James S. McDonnell Foundation Award; NSF(National Science Foundation (NSF)); NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded through a California Institute for Regenerative Medicine (CIRM) New Faculty Award (# RN2-00921-1) and Basic Biology Award (#RB5-07414), as well as, NSF Integrative Graduate Education and Research Traineeship (IGERT) Award # 0965918, and NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award # 0939511. Statistics and computational modeling work by Ajay Gopinathan was supported by a James S. McDonnell Foundation Award, NSF grant DMS-1616926 and NSF grant EF-1038697. AG also acknowledges support from the NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced (NSF-HRD-1547848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded through a California Institute for Regenerative Medicine (CIRM) New Faculty Award (# RN2-00921-1) and Basic Biology Award (#RB5-07414), as well as, NSF Integrative Graduate Education and Research Traineeship (IGERT) Award # 0965918, and NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award # 0939511. Statistics and computational modeling work by Ajay Gopinathan was supported by a James S. McDonnell Foundation Award, NSF grant DMS-1616926 and NSF grant EF-1038697. AG also acknowledges support from the NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced (NSF-HRD-1547848).	[Anonymous], [No title captured]; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Blancas A, 2011, STEM CELLS DEV; Blancas AA, 2013, STEM CELLS DEV, V22, P1398, DOI 10.1089/scd.2012.0376; Blancas AA, 2011, STEM CELLS DEV, V20, P2153, DOI 10.1089/scd.2010.0432; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; Glaser DE, 2014, STEM CELLS CLONING, V7, P79, DOI 10.2147/SCCAA.S69554; Glaser DE, 2011, J VASC RES, V48, P415, DOI 10.1159/000324752; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Guo SF, 2010, CELL PHYSIOL BIOCHEM, V26, P679, DOI 10.1159/000322335; Hirashima M, 2003, BLOOD, V101, P2261, DOI 10.1182/blood-2002-01-0003; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Huang PP, 2007, THROMB HAEMOSTASIS, V98, P1335, DOI 10.1160/TH07-02-0137; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Joo HJ, 2011, BLOOD, V118, P2094, DOI 10.1182/blood-2010-12-323907; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kohler EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085549; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lee SH, 2013, MOL NUTR FOOD RES, V57, P225, DOI 10.1002/mnfr.201200489; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Levenberg S, 2010, NAT PROTOC, V5, P1115, DOI 10.1038/nprot.2010.31; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; McCloskey Kara E., 2006, V330, P287; McCloskey KE, 2006, J VASC RES, V43, P411, DOI 10.1159/000094791; McCloskey KE, 2003, ENDOTHELIUM-J ENDOTH, V10, P329, DOI 10.1080/10623320390272325; McCloskey KE, 2005, TISSUE ENG, V11, P497, DOI 10.1089/ten.2005.11.497; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Orlova VV, 2014, NAT PROTOC, V9, P1514, DOI 10.1038/nprot.2014.102; Orlova VV, 2014, ARTERIOSCL THROM VAS, V34, P177, DOI 10.1161/ATVBAHA.113.302598; Pandian RP, 2003, ARCH BIOCHEM BIOPHYS, V420, P169, DOI 10.1016/j.abb.2003.09.008; Pimton P, 2011, CELL ADHES MIGR, V5, P73, DOI 10.4161/cam.5.1.13704; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Purpura KA, 2008, STEM CELLS, V26, P2832, DOI 10.1634/stemcells.2008-0237; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007040; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41; Zhang S, 2014, BIOMATERIALS, V35, P3786, DOI 10.1016/j.biomaterials.2014.01.037	59	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166663	10.1371/journal.pone.0166663	http://dx.doi.org/10.1371/journal.pone.0166663			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907001	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700032
J	Martins, RL; Simoes, RC; Rabelo, ED; Farias, ALF; Rodrigues, ABL; Ramos, RD; Fernandes, JB; Santos, LD; de Almeida, SSMD				Martins, Rosany Lopes; Simoes, Ranggel Carvalho; Rabelo, Erica de Menezes; Ferreira Farias, Ana Luzia; Lobato Rodrigues, Alex Bruno; Ramos, Ryan da Silva; Fernandes, Joao Batista; Santos, Lourivaldo da Silva; da Silva de Almeida, Sheylla Susan Moreira			Chemical Composition, an Antioxidant, Cytotoxic and Microbiological Activity of the Essential Oil from the Leaves of Aeollanthus suaveolens Mart. ex Spreng	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; MEDICINAL-PLANTS; BRINE SHRIMP; BIOASSAY	Aeollanthus suaveolens species popularly known as catinga de mulata belongs to the Lamiaceae family. In the Amazon region, it is used in folk medicine for the treatment of gastritis, convulsions of epileptic origin, stomach pain and diarrhea in the form of tea and juice. Essential oils have analgesic, anti-inflammatory, and antimicrobial activity. This study evaluated the chemical composition of the A. suaveolens essential oil, and its cytotoxic, antimicrobial and antioxidant activity on Artemia salina Leach. The plant species was collected in Fazendinha district in the city of Macapa-AP. The essential oil obtained from the process was performed by hydrodistillation and identification of components by gas chromatography coupled with mass spectrometer. The antioxidant activity was evaluated by the kidnapping method of 2,2-diphenyl -1-picrilhidrazil radical, while the cytotoxic activity was assessed using saline A. and the microbiological activity was carried out by microdilution method with Escherichia coli, Salmonella sp. and Staphylococcus aureus bacteria. In a chromatographic analysis, the major constituents found in the essential oil of A. suaveolens were (E) -beta-farnesene (37.615%), Linalool (33.375%), alpha-Santalene (3.255%) and linalyl acetate (3.222%). The results showed that the Escherichia coli and Salmonella sp. bacteria were more susceptible to MIC 50 mg.mL(-1) when compared with the Staphylococcus aureus bacterium MIC 100 mg.mL(-1). With respect to MBC concentration of 100 mg.mL(-1) it was sufficient to inhibit the growth of E. coli. The essential oil did not show antioxidant activity, however, has a high cytotoxic activity against the A. salina, LC50 8.90 mu g.mL(-1).	[Martins, Rosany Lopes; Simoes, Ranggel Carvalho; Rabelo, Erica de Menezes; Ferreira Farias, Ana Luzia; Lobato Rodrigues, Alex Bruno; Ramos, Ryan da Silva; da Silva de Almeida, Sheylla Susan Moreira] Univ Fed Amapa, Lab Pharmacognosy & Phytochem, Macapa, Amapa, Brazil; [Fernandes, Joao Batista] Univ Fed Sao Carlos, Dept Chem, Sao Carlos, SP, Brazil; [Santos, Lourivaldo da Silva] Fed Univ Para, Chem Lab, Belem, Para, Brazil	Fundacao Universidade Federal do Amapa; Universidade Federal de Sao Carlos; Universidade Federal do Para	de Almeida, SSMD (corresponding author), Univ Fed Amapa, Lab Pharmacognosy & Phytochem, Macapa, Amapa, Brazil.	sheyllasusan@yahoo.com.br	Santos, Lourivaldo S/A-2934-2013; Rodrigues, Alex/AAM-3606-2020; MARTINS, ROSANY L/W-7477-2018; Santos, Lourivaldo S/B-5555-2014; Almeida, Sheylla Susan Moreira da Silva de/AAX-9891-2021; Ramos, Ryan/X-5824-2019	Rodrigues, Alex/0000-0003-2170-1773; MARTINS, ROSANY L/0000-0001-7708-6576; Santos, Lourivaldo S/0000-0001-6698-1743; Almeida, Sheylla Susan Moreira da Silva de/0000-0002-7687-8288; Ramos, Ryan/0000-0003-1802-1320; Simoes, Ranggel/0000-0003-4119-2953	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the CAPES for granting master's scholarship and the Postgraduate Diploma in Pharmaceutical Sciences program and the Research Program SUS (PPSUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RP, 2012, IDENTIFICATION ESSEN, P469; Almeida NR, 2011, MOLECULES, V16, P2726, DOI 10.3390/molecules16032726; Alves TMD, 2000, MEM I OSWALDO CRUZ, V95, P367, DOI 10.1590/S0074-02762000000300012; Andrade MA, 2012, REV CIENC AGRON, V43, P399, DOI 10.1590/S1806-66902012000200025; ANVISA Farmacopeia Brasileira, 2010, FARMACOPEIA BRASILEI, V2, P1; Araujo M. G. F., 2010, Revista de Ciencias Farmaceuticas Basica e Aplicada, V31, P205; Ayres M, 2008, BIOESTAT 2008 5 0 AP; Azevedo MV, 2007, ACTA BOT BRAS, V21, P263; Barreiro EJ, 2007, FARMACOGNOSIA PLANTA, P147; Boscardin DMP, 2012, EVID-BASED COMPL ALT, V2012, P342; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Cristani M, 2007, J AGR FOOD CHEM, V55, P6300, DOI 10.1021/jf070094x; do Amarante Cristine Bastos, 2011, Acta Amazonica, V41, P431, DOI 10.1590/S0044-59672011000300015; Donsi F, 2016, J BIOTECHNOL, V233, P106, DOI 10.1016/j.jbiotec.2016.07.005; Franz CM, 2010, FLAVOUR FRAG J, V25, P112, DOI 10.1002/ffj.1983; Freitas Rosangela Correia, 2014, Revista de Ciencias Farmaceuticas Basica e Aplicada, V35, P113; Godoi AA, 2011, REV BRAS FARM, V92, P198; Harley RM, 2012, PHYTOTAXA, V58, P1; Harley RM, 2004, FA GE VAS P, V7, P167; Lôbo K.M.S, 2010, Rev. bras. plantas med., V12, P227, DOI 10.1590/S1516-05722010000200016; Lopes-Lutz D, 2008, PHYTOCHEMISTRY, V69, P1732, DOI 10.1016/j.phytochem.2008.02.014; Lu YR, 2001, FOOD CHEM, V75, P197, DOI 10.1016/S0308-8146(01)00198-4; Mc laughlin JL., 1985, REV SOC VENEZ QUIM, V18, P13; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Nascimento CJ, 2011, REV BRAS FARM, V92, P327; Oliveira ASC, 2003, ESTUDO MORFOLOGICO C; Ootani AM, 2013, J BIOTEC BIODIVERS, V4, P162; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Rashed NK, 2013, AERIAL PARTS BIOMED, V2013, P2; Silveira MS, 2014, FOOD SCI TECHNOL, V59, P86; Simionatto E, 2007, QUIM NOVA, V30, P1923, DOI 10.1590/S0100-40422007000800024; Sousa CMDM, 2007, QUIM NOVA, V30, P351, DOI 10.1590/S0100-40422007000200021; Tepe B, 2005, FOOD CHEM, V90, P685, DOI 10.1016/j.foodchem.2004.04.030; Trevisan MTS, 2006, J AGR FOOD CHEM, V54, P4378, DOI 10.1021/jf060181+; Tucker AO, 2001, J ESSENT OIL RES, V13, P198, DOI 10.1080/10412905.2001.9699662; Yunes RA, 2007, QUIMICA PRODUTOS NAT, P209	36	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166684	10.1371/journal.pone.0166684	http://dx.doi.org/10.1371/journal.pone.0166684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907002	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700034
J	Mercado, E				Mercado, Eduardo, III			Acoustic Signaling by Singing Humpback Whales (Megaptera novaeangliae): What Role Does Reverberation Play?	PLOS ONE			English	Article							SOUND-TRANSMISSION; SONG; COMMUNICATION; DISTANCE; CLASSIFICATION; VOCALIZATION; CONSTRAINTS; ADAPTATIONS; BIRDSONG; HABITAT	When humpback whales (Megaptera novaeangliae) sing in coastal waters, the units they produce can generate reverberation. Traditionally, such reverberant acoustic energy has been viewed as an incidental side-effect of high-amplitude, long-distance, sound transmission in the ocean. An alternative possibility, however, is that reverberation actually contributes to the structure and function of songs. In the current study, this possibility was assessed by analyzing reverberation generated by humpback whale song units, as well as the spectral structure of unit sequences, produced by singers from different regions. Acoustical analyses revealed that: (1) a subset of units within songs generated narrowband reverberant energy that in some cases persisted for periods longer than the interval between units; (2) these highly reverberant units were regularly repeated throughout the production of songs; and (3) units occurring before and after these units often contained spectral energy peaks at non-overlapping, adjacent frequencies that were systematically related to the bands of reverberant energy generated by the units. These findings strongly suggest that some singing humpback whales not only produce sounds conducive to long-duration reverberation, but also may sequentially structure songs to avoid spectral overlap between units and ongoing reverberation. Singer-generated reverberant energy that is received simultaneously with directly transmitted song units can potentially provide listening whales with spatial cues that may enable them to more accurately determine a singer's position.	[Mercado, Eduardo, III] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Mercado, Eduardo, III] SUNY Buffalo, Evolut Ecol & Behav Program, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mercado, E (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.; Mercado, E (corresponding author), SUNY Buffalo, Evolut Ecol & Behav Program, Buffalo, NY 14260 USA.	emiii@buffalo.edu			National Science Foundation [0718004]; Cetamada of Madagascar; NSF [0718004]	National Science Foundation(National Science Foundation (NSF)); Cetamada of Madagascar; NSF(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant No, 0718004, nsf.gov, EM; Cetamada of Madagascar, Travel Grant, cetamada.org, EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NSF Grant No, 0718004 and a travel fellowship from Cetamada of Madagascar. I thank Jennifer Schneider and Patchouly Banks for their help in collecting song recordings off the coast of Rincon, as well as Herve Glotin, Marc Lammers, Christina Perazio, David Rothenberg, and Olivier Adam, for providing recordings of humpback whale songs collected in earlier studies, and for permission to include those recordings in the current analyses.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2001, HEARING WHALES DOLPH; Barker NKS, 2009, ETHOLOGY, V115, P897, DOI 10.1111/j.1439-0310.2009.01674.x; Barth M, 2015, ROUTL STUD SUSTAIN, P1; Bass AH, 2003, SPR HDB AUD, V16, P15; Branstetter B., 2006, INT J COMP PSYCHOL, V19, P26; CATO D H, 1991, Memoirs of the Queensland Museum, V30, P277; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Desharnais F, 1997, IEEE J OCEANIC ENG, V22, P309, DOI 10.1109/48.585950; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; ELLIS DD, 1993, IEEE J OCEANIC ENG, V18, P474, DOI 10.1109/48.262297; ELLIS DD, 1995, J ACOUST SOC AM, V97, P2804, DOI 10.1121/1.411910; Ellison WT., 1987, REP INT WHALING COMM, V37, P329; Eriksen N, 2005, BEHAVIOUR, V142, P305, DOI 10.1163/1568539053778283; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Garland EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079422; Garland EC, 2013, J ACOUST SOC AM, V133, P560, DOI 10.1121/1.4770232; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Green S., 1979, SOCIAL BEHAV COMMUNI, P73, DOI DOI 10.1007/978-1-4615-9116-0_3; Green SR, 2011, BEHAV PROCESS, V86, P284, DOI 10.1016/j.beproc.2010.12.014; GUINEE LN, 1988, ETHOLOGY, V79, P295; Guinee LN., 1983, COMMUNICATION BEHAV; HELWEG DA, 1992, MARINE MAMMAL SENSORY SYSTEMS, P459; Holland J, 1998, J ACOUST SOC AM, V103, P2154, DOI 10.1121/1.421361; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Lardner B, 2002, NATURE, V420, P475, DOI 10.1038/420475a; LePage KD, 1998, SR301 SACLANT UND RE; MacKay MM, 2016, CAN J ZOOL, V94, P517, DOI 10.1139/cjz-2015-0198; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Mercado E, 2000, OCEANS 2000 MTS/IEEE - WHERE MARINE SCIENCE AND TECHNOLOGY MEET, VOLS 1-3, CONFERENCE PROCEEDINGS, P1743, DOI 10.1109/OCEANS.2000.882192; Mercado E, 1999, J ACOUST SOC AM, V106, P3004, DOI 10.1121/1.428120; Mercado E, 2013, P M AC, V19, P1; Mercado E, 2007, J ACOUST SOC AM, V121, P2499, DOI 10.1121/1.2717495; Mercado E, 2010, J ACOUST SOC AM, V127, P2678, DOI 10.1121/1.3309453; Mobley J, 2001, ABUNDANCE HUMPBACK W; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Naguib M, 2003, J ACOUST SOC AM, V113, P1749, DOI 10.1121/1.1539050; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Ou H, 2013, J ACOUST SOC AM, V133, P301, DOI 10.1121/1.4770251; Pace F, 2010, APPL ACOUST, V71, P1107, DOI 10.1016/j.apacoust.2010.05.016; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; Payne K., 1983, COMMUNICATION BEHAV, P9; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Payne R., 1983, COMMUNICATION BEHAV, P333; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Perazio CE, MADAGASCAR IN PRESS; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Rothenberg D., 2015, MAUI ONE MADAGASCAR; Rothenberg D, 2008, LEONARDO MUSIC J, V18, P47, DOI 10.1162/lmj.2008.18.47; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Tyack PL, 2000, SPR HDB AUD, V12, P156; Tyack PL, 1997, PERSP ETHOL, V12, P251; Tyack PL, 2000, CETACEAN SOCIETIES, P270; URICK RJ, 1970, J ACOUST SOC AM, V48, P392, DOI 10.1121/1.1912140; WASER PM, 1977, Z TIERPSYCHOL, V43, P239; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; WINN HE, 1981, BEHAV ECOL SOCIOBIOL, V8, P41, DOI 10.1007/BF00302842; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631	63	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167277	10.1371/journal.pone.0167277	http://dx.doi.org/10.1371/journal.pone.0167277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907182	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700108
J	Rouger, C; Pagie, S; Derbre, S; Le Ray, AM; Richomme, P; Charreau, B				Rouger, Caroline; Pagie, Sylvain; Derbre, Severine; Le Ray, Anne-Marie; Richomme, Pascal; Charreau, Beatrice			Prenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial Cells	PLOS ONE			English	Article							MHC CLASS-I; IMMUNE-RESPONSE; CYCLOSPORINE-A; HLA-E; MICA; INHIBITION; EXPRESSION; COUMARINS; STATINS; CALCINEURIN	Endothelial cells (ECs) are key players in inflammation and immune responses involved in numerous pathologies. Although attempts were experimentally undertaken to prevent and control EC activation, drug leads and probes still remain necessary. Natural products (NPs) from Clusiaceous and Calophyllaceous plants were previously reported as potential candidates to prevent endothelial dysfunction. The present study aimed to identify more precisely the molecular scaffolds that could limit EC activation. Here, 13 polyphenols belonging to 5 different chemical types of secondary metabolites (i.e., mammea coumarins, a biflavonoid, a pyranochromanone acid, a polyprenylated polycyclic acylphloroglucinol (PPAP) and two xanthones) were tested on resting and cytokine-activated EC cultures. Quantitative and qualitative changes in the expression of both adhesion molecules (VCAM-1, ICAM-1, E-selectin) and major histocompatibility complex (MHC) molecules have been used to measure their pharmaceutical potential. As a result, we identified 3 mammea coumarins that efficiently reduce (up to >90% at 10 mu M) both basal and cytokine-regulated levels of MHC class I, class II, MICA and HLA-E on EC surface. They also prevented VCAM-1 induction upon inflammation. From a structural point of view, our results associate the loss of the free prenyl group substituting mammea coumarins with a reduced cellular cytotoxicity but also an abrogation of their anti-inflammatory potential and a reduction of their immunosuppressive effects. A PPAP, guttiferone J, also triggers a strong immunomodulation but restricted to HLA-E and MHC class II molecules. In conclusion, mammea coumarins with a free prenyl group and the PPAP guttiferone J emerge as NPs able to drastically decrease both VCAM-1 and a set of MHC molecules and to potentially reduce the immunogenicity of the endothelium.	[Rouger, Caroline; Derbre, Severine; Le Ray, Anne-Marie; Richomme, Pascal] Univ Angers, QUASAV SFR4207, SONAS EA921, Campus Vegetal, Beaucouze, France; [Pagie, Sylvain; Charreau, Beatrice] INSERM UMR1064, Ctr Rech Transplantat & Immunol, IHU CESTI, LabEx IGO, Nantes, France; [Pagie, Sylvain; Charreau, Beatrice] LabEx Transplantex, Nantes, France; [Pagie, Sylvain; Charreau, Beatrice] CHU Nantes, ITUN, Nantes, France; [Pagie, Sylvain; Charreau, Beatrice] Univ Nantes, LUNAM, Fac Med, Nantes, France	Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite	Derbre, S (corresponding author), Univ Angers, QUASAV SFR4207, SONAS EA921, Campus Vegetal, Beaucouze, France.; Charreau, B (corresponding author), INSERM UMR1064, Ctr Rech Transplantat & Immunol, IHU CESTI, LabEx IGO, Nantes, France.; Charreau, B (corresponding author), LabEx Transplantex, Nantes, France.; Charreau, B (corresponding author), CHU Nantes, ITUN, Nantes, France.; Charreau, B (corresponding author), Univ Nantes, LUNAM, Fac Med, Nantes, France.	sevenne.derbre@univ-angers.fr; beatrice.Charreau@univ-nantes.fr	CHARREAU, Beatrice/AAK-8186-2020; DERBRE, Séverine/AAJ-4904-2021	CHARREAU, Beatrice/0000-0001-5870-4615; DERBRE, Séverine/0000-0002-3953-5745; Rouger, Caroline/0000-0002-6442-6567; LE RAY, ANNE-MARIE/0000-0003-0542-6169	Ministere de l'Enseignement Superieur et de la Recherche; Pays de la Loire Region; French government [ANR-10-IBHU-005, ANR-11-LABX-0016-01, ANR-11-LABX-0070]; Nantes Metropole; "Fondation Centaure" (RTRS)	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Pays de la Loire Region(Region Pays de la Loire); French government; Nantes Metropole(Region Pays de la Loire); "Fondation Centaure" (RTRS)	This work was supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche (C.R.), by "PROVASC" and "HYPROTEC", grants from the Pays de la Loire Region (S.P.). It was realized in the context of the IHU-Cesti, LabEx IGO and LabEx Transplantex projects which received French government financial support managed by the National Research Agency (ANR) via the "Investment Into The Future" programs ANR-10-IBHU-005, ANR-11-LABX-0016-01 and ANR-11-LABX-0070. The IHU-Cesti project is also supported by Nantes Metropole and the Pays de la Loire Region. This study was also supported by the "Fondation Centaure" (RTRS) which supports a French transplantation research network.	Aird WC, 2008, PHARMACOL REP, V60, P139; Dang BT, 2014, FITOTERAPIA, V96, P65, DOI 10.1016/j.fitote.2014.04.005; Bedi O, 2016, N-S ARCH PHARMACOL, V389, P695, DOI 10.1007/s00210-016-1252-4; Belliard Guillaume, 2005, Nephrol Ther, V1, P221, DOI 10.1016/j.nephro.2005.06.008; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cechinel V, 2009, CHEM BIODIVERS, V6, P313, DOI 10.1002/cbdv.200800082; Cen JR, 2015, BIOCHIMIE, V111, P119, DOI 10.1016/j.biochi.2015.02.004; Cen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066503; Chauveau A, 2014, J INNATE IMMUN, V6, P89, DOI 10.1159/000351605; Choi J, 2004, ANNU REV IMMUNOL, V22, P683, DOI 10.1146/annurev.immunol.22.012703.104639; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Dang BT, 2015, MOLECULES, V20, P17735, DOI 10.3390/molecules201017735; Dang BT, 2015, PHYTOCHEM LETT, V11, P61, DOI 10.1016/j.phytol.2014.11.011; de Melo MS, 2014, EVID-BASED COMPL ALT, V2014, DOI [10.1155/2014/960258, DOI 10.1155/2014/960258]; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dzoyem JP, 2015, PHYTOCHEM LETT, V14, P153, DOI 10.1016/j.phytol.2015.10.003; Ferchichi L, 2012, PHYTOCHEMISTRY, V78, P98, DOI 10.1016/j.phytochem.2012.02.006; Gavlovsky PJ, 2016, HUM IMMUNOL; Gomez-Verjan J, 2015, SCIENTOMETRICS, V105, P1019, DOI 10.1007/s11192-015-1715-2; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Guilet D, 2001, J NAT PROD, V64, P563, DOI 10.1021/np000517o; Hay AE, 2004, LIFE SCI, V75, P3077, DOI 10.1016/j.lfs.2004.07.009; Khachigian LM, 1997, AM J PATHOL, V151, P1225; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Magadula J. J., 2012, Journal of Pharmaceutical and Scientific Innovation (JPSI), V1, P31; Merza J, 2006, PLANTA MED, V72, P87, DOI 10.1055/s-2005-873185; Morel C, 1999, HETEROCYCLES, V51, P2183; Muraro M, 2007, CELL IMMUNOL, V249, P63, DOI 10.1016/j.cellimm.2007.11.005; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Peng LQ, 2011, IUBMB LIFE, V63, P14, DOI 10.1002/iub.408; Pich C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00062; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Raad I, 2006, BIOORGAN MED CHEM, V14, P6979, DOI 10.1016/j.bmc.2006.06.026; Reyes-Chilpa R, 2004, LIFE SCI, V75, P1635, DOI 10.1016/j.lfs.2004.03.017; Rouger C, 2015, J NAT PROD, V78, P2187, DOI 10.1021/acs.jnatprod.5b00222; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schmitt EK, 2016, J IND MICROBIOL BIOT, V43, P249, DOI 10.1007/s10295-015-1691-9; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Singh P, 2009, ANN NY ACAD SCI, V1173, P746, DOI 10.1111/j.1749-6632.2009.04646.x; Survase SA, 2011, BIOTECHNOL ADV, V29, P418, DOI 10.1016/j.biotechadv.2011.03.004; Tilkin-Mariame AF, 2005, FASEB J, V19, P1513, DOI 10.1096/fj.04-3482fje; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zhang YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146944; Zou Y, 2010, TISSUE ANTIGENS, V76, P171, DOI 10.1111/j.1399-0039.2010.01527.x; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	47	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167361	10.1371/journal.pone.0167361	http://dx.doi.org/10.1371/journal.pone.0167361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907087	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700128
J	Sahyoun, R; Guidetti, P; Di Franco, A; Planes, S				Sahyoun, Rita; Guidetti, Paolo; Di Franco, Antonio; Planes, Serge			Patterns of Fish Connectivity between a Marine Protected Area and Surrounding Fished Areas	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; BREAM DIPLODUS-VULGARIS; POPULATION-STRUCTURE; LARVAL CONNECTIVITY; GENETIC PATCHINESS; MEDITERRANEAN SEA; MICROSATELLITE MARKERS; RESERVE NETWORKS; SELF-RECRUITMENT; WHITE SEA	Patterns of connectivity and self-recruitment are recognized as key factors shaping the dynamics of marine populations. Connectivity is also essential for maintaining and restoring natural ecological processes with genetic diversity contributing to the adaptation and persistence of any species in the face of global disturbances. Estimates of connectivity are crucial to inform the design of both marine protected areas (MPAs) and MPA networks. Among several approaches, genetic structure is frequently used as a proxy for patterns of connectivity. Using 8 microsatellite loci, we investigated genetic structure of the two-banded sea bream Diplodus vulgaris, a coastal fish that is both commercially and ecologically important. Adults were sampled in 7 locations (stretches of coastline approximately 8 km long) and juveniles in 14 sites (similar to 100 to 200 m of coastline) along 200 km of the Apulian Adriatic coast (SW Adriatic Sea), within and outside an MPA (Torre Guaceto MPA, Italy). Our study found similar genetic diversity indices for both the MPA and the surrounding fished areas. An overall lack of genetic structure among samples suggests high gene flow (i.e. connectivity) across a scale of at least 200 km. However, some local genetic divergences found in two locations demonstrate some heterogeneity in processes renewing the population along the Apulian Adriatic coast. Furthermore, two sites appeared genetically divergent, reinforcing our observations within the genetic makeup of adults and confirming heterogeneity in early stage genetics that can come from either different supply populations or from chaotic genetic patchiness occurring under temporal variation in recruitment and in the reproductive success. While the specific role of the MPA is not entirely known in this case, these results confirm the presence of regional processes and the key role of connectivity in maintaining the local population supply.	[Sahyoun, Rita; Di Franco, Antonio; Planes, Serge] PSL Res Univ, EPHE, UPVD, CNRS,USR 3278,CRIOBE, Perpignan, France; [Guidetti, Paolo; Di Franco, Antonio] Univ Cote dAzur, CNRS, ECOMERS, Parc Valrose,Ave Valrose, Nice, France; [Guidetti, Paolo; Di Franco, Antonio] CoNISMa Consorzio Nazl Interuniv Sci Mare, Piazzale Flaminio, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CoNISMa	Sahyoun, R (corresponding author), PSL Res Univ, EPHE, UPVD, CNRS,USR 3278,CRIOBE, Perpignan, France.	rita.sahyoun@gmail.com	PLANES, Serge/ABF-1360-2021; Di Franco, Antonio/A-8796-2010	Di Franco, Antonio/0000-0003-3411-7015	Total Foundation	Total Foundation(Total SA)	This study has been done in the framework of the project entitled 'Designing networks of marine protected areas in the Mediterranean context', funded by Total Foundation (http://fondation.total.com/fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Alos J, 2012, FISH RES, V115, P82, DOI 10.1016/j.fishres.2011.11.025; Arculeo M, 2003, FISH RES, V63, P339, DOI 10.1016/S0165-7836(03)00102-4; Arnaud-Haond S, 2008, MAR BIOL, V155, P147, DOI 10.1007/s00227-008-1013-0; Artegiani A, 1997, J PHYS OCEANOGR, V27; Aspillaga E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159813; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Benzie JAH, 2006, MAR ECOL PROG SER, V314, P197, DOI 10.3354/meps314197; Bernal-Ramirez JH, 2003, MAR BIOL, V142, P567, DOI 10.1007/s00227-002-0972-9; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Carreras-Carbonell J, 2007, MAR BIOL, V151, P719, DOI 10.1007/s00227-006-0513-z; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cornuet JM, 1999, GENETICS, V153, P1989; Di Franco A, 2015, BIOL CONSERV, V192, P361, DOI 10.1016/j.biocon.2015.10.015; Di Franco A, 2013, MAR ECOL PROG SER, V476, P227, DOI 10.3354/meps10117; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Gonzalez-Wanguemert M, 2012, J SEA RES, V68, P41, DOI 10.1016/j.seares.2011.12.005; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gruss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019960; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hartland DL, 1989, PRINCIPLES POPULATIO; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; Johnson MS, 1982, MAR BIOL; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KRUSKAL W, 1978, SCIENCE, V199, P1026, DOI 10.1126/science.199.4333.1026; La Mesa G, 2011, FISH RES, V111, P24, DOI 10.1016/j.fishres.2011.06.008; Larson RJ, 1999, CAL COOP OCEAN FISH, V40, P94; Lenfant P, 1996, J FISH BIOL, V49, P613, DOI 10.1111/j.1095-8649.1996.tb00058.x; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Mitarai S, 2008, J MARINE SYST, V69, P295, DOI 10.1016/j.jmarsys.2006.02.017; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Pritchard JK, 2000, GENETICS, V155, P945; Pujolar JM, 2013, DIVERS DISTRIB, V19, P1531, DOI 10.1111/ddi.12114; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roques S, 2007, CONSERV GENET, V8, P1255, DOI 10.1007/s10592-006-9254-2; Roques S, 2007, MOL ECOL NOTES, V7, P661, DOI 10.1111/j.1471-8286.2006.01667.x; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 2012, PLOS ONE, V7; Sala-Bozano M, 2009, MOL ECOL, V18, P4811, DOI 10.1111/j.1365-294X.2009.04404.x; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x	77	10	11	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167441	10.1371/journal.pone.0167441	http://dx.doi.org/10.1371/journal.pone.0167441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907100	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700157
J	Winther, M; Holdfeldt, A; Gabl, M; Wang, JM; Forsman, H; Dahlgren, C				Winther, Malene; Holdfeldt, Andre; Gabl, Michael; Wang, Ji Ming; Forsman, Huamei; Dahlgren, Claes			Formylated MHC Class lb Binding Peptides Activate Both Human and Mouse Neutrophils Primarily through Formyl Peptide Receptor 1	PLOS ONE			English	Article							CLASS-IB MOLECULE; STAPHYLOCOCCUS-AUREUS; RESPIRATORY BURST; LIGAND; RESPONSES; H2-M3; FPR; TUBERCULOSIS; INFLAMMATION; RECOGNITION	Two different immune recognition systems have evolved in parallel to recognize peptides starting with an N-formylated methionine, and recognition similarities/differences between these two systems have been investigated. A number of peptides earlier characterized in relation to the H2-M3 complex that presents N-formylated peptides to cytotoxic T cells, have been characterized in relation to the formyl peptide receptors expressed by phagocytic neutrophils in both men (FPRs) and mice (Fprs). FPR1/Fpr1 was identified as the preferred receptor for all fMet-containing peptides examined, but there was no direct correlation between H2-M3 binding and the neutrophil activation potencies. Similarly, there was no direct correlation between the activities induced by the different peptides in human and mouse neutrophils, respectively. The formyl group was important in both H2-M3 binding and FPR activation, but FPR2 was the preferred receptor for the non-formylated peptide. The structural requirements differed between the H2-M3 and FPR/Fpr recognition systems and these data suggest that the two recognition systems have different evolutionary traits.	[Winther, Malene; Holdfeldt, Andre; Gabl, Michael; Forsman, Huamei; Dahlgren, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Wang, Ji Ming] Frederick Natl Lab Canc Res, Ctr Canc Res, Frederick, MD USA	University of Gothenburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dahlgren, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	Claes.Dahlgren@microbio.gu.se		de Winther, Menno/0000-0002-4038-6636	Swedish research council; King Gustaf the Vth 80-year foundation; Clas Groschinsky foundation; Ake Wiberg foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska university hospital	Swedish research council(Swedish Research CouncilEuropean Commission); King Gustaf the Vth 80-year foundation; Clas Groschinsky foundation; Ake Wiberg foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska university hospital	The research was supported by grants from the Swedish research council, The King Gustaf the Vth 80-year foundation, the Clas Groschinsky foundation, the Ake Wiberg foundation, from IngaBritt and Arne Lundbergs foundation, and the Sahlgrenska university hospital through the national ALF-agreement. The funding agencies had no influence on the study design, data collection and analysis, or writing and submission of the report.; We thank the members of the Phagocyte Research Group at the Sahlgrenska Academy for critically discussing the results and the manuscript. The research was supported by grants from the Swedish research council, The King Gustaf the Vth 80-year foundation, the Clas Groschinsky foundation, the Ake Wiberg foundation, from IngaBritt and Arne Lundbergs foundation and, the Sahlgrenska university hospital through the national ALF-agreement. The funding agencies had no influence on the study design, data collection and analysis, or writing and submission of the report.	Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Arterburn JB, 2009, CURR TOP MED CHEM, V9, P1227, DOI 10.2174/156802609789753608; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J., 2014, INFLAMM CELL SIGNAL, V1, P1; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213; Colmone A, 2006, MICROBES INFECT, V8, P2277, DOI 10.1016/j.micinf.2006.03.020; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren C, 2016, BIOCH PHARM; Forsman H, 2015, BBA-MOL CELL RES, V1853, P192, DOI 10.1016/j.bbamcr.2014.10.021; Forsman H, 2012, J IMMUNOL, V189, P629, DOI 10.4049/jimmunol.1101616; Forsman H, 2012, INFECT IMMUN, V80, P1987, DOI 10.1128/IAI.05906-11; Fu HM, 2008, J IMMUNOL METHODS, V331, P50, DOI 10.1016/j.jim.2007.11.005; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; Hazeldine J, 2015, INJURY, V46, P975, DOI 10.1016/j.injury.2015.03.028; He HQ, 2014, J BIOL CHEM, V289, P2295, DOI 10.1074/jbc.M113.509216; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Holdfeldt A, 2016, J BIOL CHEM; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Jones RM, 2012, CURR MED CHEM, V19, P1519; Karlsson J, 2009, CELL CALCIUM, V45, P431, DOI 10.1016/j.ceca.2009.02.002; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Mir SA, 2013, VACCINE, V31, P3818, DOI 10.1016/j.vaccine.2013.04.005; Movitz C, 2010, J BIOL CHEM, V285, P14338, DOI 10.1074/jbc.M109.080465; Schepetkin IA, 2014, CURR MED CHEM, V21, P1478, DOI 10.2174/0929867321666131218095521; Skovbakke SL, 2016, BIOCHEM PHARMACOL, V119, P56, DOI 10.1016/j.bcp.2016.09.004; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; VYAS JM, 1992, J IMMUNOL, V149, P3605; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167529	10.1371/journal.pone.0167529	http://dx.doi.org/10.1371/journal.pone.0167529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907124	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700184
J	Berressem, D; Koch, K; Franke, N; Klein, J; Eckert, GP				Berressem, Dirk; Koch, Konrad; Franke, Nicole; Klein, Jochen; Eckert, Gunter P.			Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke - A Pilot Study	PLOS ONE			English	Article							FATTY-ACIDS; CEREBRAL-ISCHEMIA; MITOCHONDRIAL DYSFUNCTION; EICOSAPENTAENOIC ACID; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; BRAIN ISCHEMIA; CELL-DEATH; TRANSIENT; INJURY	Single long-chain omega-3 fatty acids (e.g. docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA)) are known for their neuroprotective properties associated with ischemic stroke. This pilot study aimed to test the effectiveness of an acute treatment with a long-chain omega-3 lipid emulsion (Omegaven 10%(R), OGV) that contains fish oil (DHA 18 mg/ml; EPA 21 mg/ml) and a-tocopherol (0.2 mg/ml) in a transient middle cerebral artery occlusion (MCAO) model of ischemic stroke in mice. For this purpose, female CD-1 mice were anesthetized and subjected to 90 minutes of MCAO. To reflect a clinically relevant situation for an acute treatment, either after induction of stroke or after reperfusion, a single dose of OGV was injected intravenously into the tail vein (5 ml/kg b.w.). A neurological severity score was used to assess motor function and neurological outcome. Stroke-related parameters were determined 24 hours after MCAO. Microdialysis was used to collect samples from extracellular space of the striatum. Mitochondrial function was determined in isolated mitochondria or dissociated brain cells. Inflammation markers were measured in brain homogenate. According to control experiments, neuroprotective effects could be attributed to the long-chain omega-3 content of the emulsion. Intravenous injection of OGV reduced size and severity of stroke, restored mitochondrial function, and prevented excitotoxic glutamate release. Increases of pro-inflammatory markers (COX-2 and IL-6) were attenuated. Neurological severity scoring and neurochemical data demonstrated that acute OGV treatment shortly after induction of stroke was most efficient and able to improve short-term neurological outcome, reflecting the importance of an acute treatment to improve the outcome. Summarising, acute treatment of stroke with a single intravenous dose of OGV provided strong neuroprotective effects and was most effective when given immediately after onset of ischemia. As OGV is an approved fishoil emulsion for parenteral nutrition in humans, our results may provide first translational data for a possible early management of ischemic stroke with administration of OGV to prevent further brain damage.	[Berressem, Dirk; Koch, Konrad; Franke, Nicole; Klein, Jochen; Eckert, Gunter P.] Goethe Univ Frankfurt, Dept Pharmacol, Frankfurt, Germany; [Eckert, Gunter P.] Justus Liebig Univ Giessen, Inst Nutr Sci, Giessen, Germany	Goethe University Frankfurt; Justus Liebig University Giessen	Berressem, D (corresponding author), Goethe Univ Frankfurt, Dept Pharmacol, Frankfurt, Germany.	dberressem@gmx.net	Klein, Jochen/B-9730-2008	Klein, Jochen/0000-0001-6971-3381	Fresenius Kabi Deutschland GmbH, Bad Homburg, Deutschland	Fresenius Kabi Deutschland GmbH, Bad Homburg, Deutschland	This study was partly supported by Fresenius Kabi Deutschland GmbH, Bad Homburg, Deutschland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amusquivar E, 2008, LIPIDS, V43, P713, DOI 10.1007/s11745-008-3180-7; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Blondeau N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/519830; Borow KM, 2015, ATHEROSCLEROSIS, V242, P357, DOI 10.1016/j.atherosclerosis.2015.07.035; Bourourou M, 2016, NEUROPHARMACOLOGY, V108, P60, DOI 10.1016/j.neuropharm.2016.04.040; Byrne J, 2011, J THORAC CARDIOV SUR, V141, P803, DOI 10.1016/j.jtcvs.2010.04.030; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Eady TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077237; Eady Tiffany N, 2012, Exp Transl Stroke Med, V4, P19, DOI 10.1186/2040-7378-4-19; Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Emon ST, 2011, TURK NEUROSURG, V21, P197, DOI 10.5137/1019-5149.JTN.3523-10.2; Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004; Gercek A, JPEN J PARENTER ENTE, V31, P161; Gesellschaft fur Versuchstierkunde (GV-SOLAS), 2010, TIER VER TIERSCH EMP, P4; Hagl S, 2013, PHARMACOL RES, V76, P17, DOI 10.1016/j.phrs.2013.06.008; Harvey KA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0005-6; Hong SH, 2014, J NEUROL SCI, V338, P135, DOI 10.1016/j.jns.2013.12.033; Horn T, 2013, NEUROCHEM INT, V62, P251, DOI 10.1016/j.neuint.2012.12.017; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kilian M, 2009, PANCREAS, V38, P436, DOI 10.1097/MPA.0b013e318198283b; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Lang D, 2011, BRAIN RES, V1425, P155, DOI 10.1016/j.brainres.2011.10.005; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Larsson SC, 2012, EUR J EPIDEMIOL, V27, P895, DOI 10.1007/s10654-012-9748-9; Lin Y, 2015, NEUROSCIENCE, V301, P471, DOI 10.1016/j.neuroscience.2015.06.024; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Maldonado NJ, 2014, CRIT CARE CLIN, V30, P673, DOI 10.1016/j.ccc.2014.06.002; Molina CA, 2011, STROKE, V42, pS16, DOI 10.1161/STROKEAHA.110.598763; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NAKAHARA I, 1991, J NEUROCHEM, V57, P839, DOI 10.1111/j.1471-4159.1991.tb08227.x; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pascoe MC, 2015, NEUROPSYCH DIS TREAT, V11, P153, DOI 10.2147/NDT.S72925; Pastor-Clerigues A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115404; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schwarzkopf TM, 2015, NEUROSCIENCE, V300, P201, DOI 10.1016/j.neuroscience.2015.05.014; Schwarzkopf TM, 2013, PHARMAZIE, V68, P584, DOI 10.1691/ph.2013.6513; Schwarzkopf TM, 2013, BRAIN RES, V1529, P178, DOI 10.1016/j.brainres.2013.07.003; Serhan CN., 2008, RESOLVINS PROTECTINS, P1; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; SUN DD, 1994, J NEUROCHEM, V62, P1921; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tanaka K, 2008, STROKE, V39, P2052, DOI 10.1161/STROKEAHA.107.509455; U.S. Department of Health and Human Services Food and Drug Administration, GUID IND EST MAX SAF; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wachira JK, 2014, BRIT J NUTR, V111, P1652, DOI 10.1017/S000711451300425X; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Williams JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056233; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11	65	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167329	10.1371/journal.pone.0167329	http://dx.doi.org/10.1371/journal.pone.0167329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902774	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100072
J	Gamma, A; Schleifer, R; Weinmann, W; Buadze, A; Liebrenz, M				Gamma, Alex; Schleifer, Roman; Weinmann, Wolfgang; Buadze, Anna; Liebrenz, Michael			Could Google Trends Be Used to Predict Methamphetamine-Related Crime? An Analysis of Search Volume Data in Switzerland, Germany, and Austria	PLOS ONE			English	Article							RISE; HEALTH	Objective To compare the time trends of Google search interest in methamphetamine and criminal offences related to this drug. Methods Google Trends data for the search term "meth" was compared to methamphetamine-related crime statistics (incl. use, possession, and dealing) in Switzerland, Germany, and Austria for the years 2004-2016. Google data was availably monthly. Crime data was available yearly, and monthly values were imputed. Results On the country level, internet search trends for "meth" roughly paralleled relevant criminal activity. State-level data, which was available for Austria, showed more heterogeneity. Cross-correlations for yearly data almost always peaked at a lag time of 0 and coefficients were mostly between 0.7 and 1.0 on the country level, and between 0.5 to 1.0 on the state level. Monthly cross-correlations based on imputed values were substantially lower, ranging from 0 to 0.6. Conclusions These results encourage the further evaluation by law enforcement authorities of Google search activity as a possible predictor of methamphetamine-related crime. However, several limitations, in particular the crude temporal resolution of available crime data, precluded a detailed assessment of the relationship between internet search trends and the development of methamphetamine-related crime in central Europe.	[Gamma, Alex; Schleifer, Roman; Liebrenz, Michael] Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland; [Weinmann, Wolfgang] Univ Bern, Inst Forens Med, Dept Forens Toxicol & Chem, Bern, Switzerland; [Buadze, Anna] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland	University of Bern; University of Bern; University of Zurich	Gamma, A (corresponding author), Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland.	Alexander.Gamma@fpd.unibe.ch		Buadze, Ana/0000-0002-8683-6807; Liebrenz, Michael/0000-0001-8040-2744				Ayers JW, 2016, AM J PREV MED, V50, pE173, DOI 10.1016/j.amepre.2015.12.008; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; BKA, 2013, BUND DEUTSCHL; Bramness JG, 2015, FORENSIC SCI INT, V246, P92, DOI 10.1016/j.forsciint.2014.11.010; Bruggisser M, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13115; Bundesamt fur Sport BASPO, 2014, SPORT SCHWEIZ 2014 O, P60; Cartier J, 2006, J INTERPERS VIOLENCE, V21, P435, DOI 10.1177/0886260505285724; Chomchai C, 2015, CURR OPIN PSYCHIATR, V28, P269, DOI 10.1097/YCO.0000000000000168; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Csemy L, 2002, EUR ADDICT RES, V8, P159, DOI 10.1159/000066134; Dobkin C, 2009, AM ECON REV, V99, P324, DOI 10.1257/aer.99.1.324; European Monitoring Centre for Drugs and Drug Addiction, 2014, EXPL METH TRENDS EUR; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gizzi MC, 2010, INT J OFFENDER THER, V54, P915, DOI 10.1177/0306624X09351825; Griffiths P, 2008, DRUG ALCOHOL REV, V27, P236, DOI 10.1080/09595230801932588; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Logan B K, 2002, Forensic Sci Rev, V14, P133; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; Martin I, 2009, EUR ADDICT RES, V15, P32, DOI 10.1159/000173007; Maxwell JC, 2008, DRUG ALCOHOL REV, V27, P229, DOI 10.1080/09595230801919460; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; Milin S, 2015, 18 ANN C EUR ASS SUB; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Pietsch J, 2013, FORENSIC SCI INT, V233, P51, DOI 10.1016/j.forsciint.2013.08.023; R Core Team, 2013, R LANG ENV STAT COMP; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Senna MC, 2010, FORENSIC SCI INT, V198, P11, DOI 10.1016/j.forsciint.2010.02.014; Stata Statistical Software, STAT STAT SOFTW REL; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Thanos PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155457; UN Office on Drugs and Crime, 2016, WORLD DRUG REP	34	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166566	10.1371/journal.pone.0166566	http://dx.doi.org/10.1371/journal.pone.0166566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902717	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100027
J	Huang, YC; Cheng, WY; Luo, SD; Luo, Y; Ma, CC; He, TL				Huang, Yuecheng; Cheng, Wuyi; Luo, Sida; Luo, Yun; Ma, Chengchen; He, Tailin			Features of the Asynchronous Correlation between the China Coal Price Index and Coal Mining Accidental Deaths	PLOS ONE			English	Article							COMPLEX NETWORK ANALYSIS; VISIBILITY GRAPH; TIME-SERIES; DYNAMICS	The features of the asynchronous correlation between accident indices and the factors that influence accidents can provide an effective reference for warnings of coal mining accidents. However, what are the features of this correlation? To answer this question, data from the China coal price index and the number of deaths from coal mining accidents were selected as the sample data. The fluctuation modes of the asynchronous correlation between the two data sets were defined according to the asynchronous correlation coefficients, symbolization, and sliding windows. We then built several directed and weighted network models, within which the fluctuation modes and the transformations between modes were represented by nodes and edges. Then, the features of the asynchronous correlation between these two variables could be studied from a perspective of network topology. We found that the correlation between the price index and the accidental deaths was asynchronous and fluctuating. Certain aspects, such as the key fluctuation modes, the subgroups characteristics, the transmission medium, the periodicity and transmission path length in the network, were analyzed by using complex network theory, analytical methods and spectral analysis method. These results provide a scientific reference for generating warnings for coal mining accidents based on economic indices.	[Huang, Yuecheng; Cheng, Wuyi; Luo, Yun; He, Tailin] China Univ Geosci, Ctr Safety Res, Beijing, Peoples R China; [Huang, Yuecheng; Cheng, Wuyi; Luo, Yun; Ma, Chengchen; He, Tailin] China Univ Geosci, Sch Engn & Technol, Beijing, Peoples R China; [Ma, Chengchen] Univ Manchester, Sch Environm Educ & Dev, Manchester, Lancs, England; [Luo, Sida] Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences; University of Manchester; Beihang University	Huang, YC (corresponding author), China Univ Geosci, Ctr Safety Res, Beijing, Peoples R China.; Huang, YC (corresponding author), China Univ Geosci, Sch Engn & Technol, Beijing, Peoples R China.	huangyc@cugb.edu.cn		Luo, Sida/0000-0002-5673-6100	National Key Technology RAMP;D Program of China [2015BAK16603]	National Key Technology RAMP;D Program of China	The paper is supported by the National Key Technology R&D Program of China (Grant No. 2015BAK16603). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; An HZ, 2014, PHYSICA A, V393, P382, DOI 10.1016/j.physa.2013.08.055; Bae J, 2014, PHYSICA A, V395, P549, DOI 10.1016/j.physa.2013.10.047; Burt Ronald S, 1992, STRUCTURAL HOLES SOC; Chen WD, 2010, ACTA PHYS SIN-CH ED, V59, P4514, DOI 10.7498/aps.59.4514; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cui XJ, 2006, J SAFETY SCI TECHNOL, V1, P50; Donner RV, 2012, ACTA GEOPHYS, V60, P589, DOI 10.2478/s11600-012-0032-x; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gao CJ, 2006, CROSS CULTURAL COMMU, V1, P23; Gao XY, 2014, ENERGY, V73, P380, DOI 10.1016/j.energy.2014.06.028; Gao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061091; Gao XY, 2012, ACTA PHYS SINICA, V61, P1321; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28151; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Lacasa L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30001; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Li HL, 2014, EXPERT SYST APPL, V41, P2842, DOI 10.1016/j.eswa.2013.10.019; Munnix MC, 2010, PHYSICA A, V389, P767, DOI 10.1016/j.physa.2009.10.033; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Qi AB, 2011, FUTURE DEV, V2, P29; SEIDMAN SB, 1978, J MATH SOCIOL, V6, P139, DOI 10.1080/0022250X.1978.9989883; SEIDMAN SB, 1978, SOC NETWORKS, V1, P65, DOI 10.1016/0378-8733(78)90013-8; Sun XR, 2014, CHAOS, V24, DOI 10.1063/1.4868261; [汤凌霄 TANG Lingxiao], 2006, [中国工业经济, China Industrial Economy], P53; van Beeck EF, 2000, INT J EPIDEMIOL, V29, P503, DOI 10.1093/ije/29.3.503; WACKERBAUER R, 1994, CHAOS SOLITON FRACT, V4, P133, DOI 10.1016/0960-0779(94)90023-X; Wang N, 2012, PHYSICA A, V391, P6543, DOI 10.1016/j.physa.2012.07.054; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xiang RX, 2012, CHAOS, V22, DOI 10.1063/1.3673789; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Yang LF, 2015, J XUZHOU I TECHNOLOG, V5, P63; Yang Y, 2009, PHYSICA A, V388, P4431, DOI 10.1016/j.physa.2009.07.016; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhou YW, 2014, PHYSICA A, V416, P21, DOI 10.1016/j.physa.2014.08.047	43	2	2	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167198	10.1371/journal.pone.0167198	http://dx.doi.org/10.1371/journal.pone.0167198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902748	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100059
J	Karacic, S; Osborne, JF				Karacic, Steven; Osborne, James F.			Eastern Mediterranean Economic Exchange during the Iron Age: Portable X-Ray Fluorescence and Neutron Activation Analysis of Cypriot-Style Pottery in the Amuq Valley, Turkey	PLOS ONE			English	Article							CERAMIC PROVENANCE	Two markers of regional exchange in the Eastern Mediterranean during the first millennium BCE are the White Painted and Bichrome Wares from Cypruss Cypro-Geometric and Cypro-Archaic periods. Although these ceramics are often assumed to be imports from Cyprus, excavations in southern Turkey at sites such as Tarsus-Gozlukule, Kilise Tepe, Sirkeli Hoyuk, and Kinet Hoyuk suggest that at least some of this pottery was produced locally, requiring a major revision of our understanding of economic interaction in the Eastern Mediterranean. We employ a combination of portable x-ray fluorescence and neutron activation analysis to investigate the White Painted and Bichrome Wares recovered from Tell Tayinat, Catal Hoyuk, and Tell Judaidah, three sites in the Amuq Valley of southeastern Anatolia. Our results demonstrate that a clear geochemical distinction exists between imported and local versions of this pottery. Through comparison with legacy datasets, we locate the likely origin of the imported pottery in the Circum-Troodos sediments of central and southern Cyprus. The secondary and tertiary settlements of Catal Hoyuk and Tell Judaidah had access only to this imported material. In contrast, the inhabitants of Tell Tayinat, capital city of the region, consumed both imported and locally produced White Painted and Bichrome Wares. This pattern cannot be explained in purely economic terms whereby the frequency of imports decreases as distance from the point of production increases. Instead, we suggest that elite feasting practices drove demand, resulting in either local potters producing Cypriot-style pottery or Cypriot potters settling in the vicinity of Tell Tayinat. These findings offer new insights into the relationship between historically attested Iron Age kingdoms in southern Turkey and Cyprus and complicate our understanding of exchange in the Eastern Mediterranean during the Iron Age.	[Karacic, Steven] Florida State Univ, Dept Class, Tallahassee, FL 32306 USA; [Osborne, James F.] Univ Chicago, Oriental Inst, Dept Near Eastern Languages & Civilizat, Chicago, IL 60637 USA	State University System of Florida; Florida State University; University of Chicago	Karacic, S (corresponding author), Florida State Univ, Dept Class, Tallahassee, FL 32306 USA.	skaracic@fsu.edu			United States National Science Foundation [1415403]; National Geographic Society [9485-14]	United States National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society)	The United States National Science Foundation (www.nsf.gov) grant 1415403 provided partial funding for neutron activation analysis conducted at the Archaeometry Laboratory at the University of Missouri Research Reactor. The National Geographic Society (www.nationalgeographic.com) grant 9485-14 supported the collection of the portable x-ray fluorescence data. The funders had no role in the study design,data analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the help they received for this study from the staff of the Oriental Institute Museum, especially Laura D'Alessandro, Jack Green, Helen McDonald, and Alison Whyte. The authors also wish to thank Daniel J. Pullen of Florida State University and Peter Grave from the University of New England for their suggestions for the improvement of this paper. Neutron activation analysis was conducted in the Archaeometry Laboratory at the University of Missouri Research Reactor (MURR) with support in part by a grant from the US National Science Foundation (#1415403). Permission to analyze sherds from catal Hoyiik and Tell Judaidah was generously provided by Lynn Swartz Dodd and Marina Pucci. Funding was provided by the National Geographic Society (Grant #9485-14) to support the collection of the pXRF data.	[Anonymous], 2004, ANATOLICA, DOI DOI 10.2143/ANA.30.0.2015518; ARNOLD DE, 1991, AM ANTHROPOL, V93, P70, DOI 10.1525/aa.1991.93.1.02a00040; Bishop R.L., 1982, ADV ARCHAEOL METH TH, V5, P275; Braidwood R.J., 1960, ORIENTAL I PUBLICATI, VLXI; Braidwood RJ, 1937, MOUNDS PLAIN ANTIOCH; Bryce Trevor, 2012, WORLD NEO HITTITE KI; Bunnens G., 2000, ESSAYS SYRIA IRON AG; Casana J, 2007, AM J ARCHAEOL, V111, P195, DOI 10.3764/aja.111.2.195; Dias MI, 2008, MICROCHEM J, V88, P136, DOI 10.1016/j.microc.2007.11.009; Forster N, 2011, X-RAY SPECTROM, V40, P389, DOI 10.1002/xrs.1360; Gjerstad E, 1948, SWEDISH CYPRUS EXPED, V4; Glascock MD, 2004, HYPERFINE INTERACT, V154, P95, DOI 10.1023/B:HYPE.0000032025.37390.41; Glascock MD, 2003, MEAS SCI TECHNOL, V14, P1516, DOI 10.1088/0957-0233/14/9/304; Grave P, 2013, OPEN CONTEXT; Grave P, 2008, J ARCHAEOL SCI, V35, P1974, DOI 10.1016/j.jas.2008.01.001; Grave P, 2014, ANTIQUITY, V88, P1180, DOI 10.1017/S0003598X0011539X; Grave P, 2012, J ARCHAEOL METHOD TH, V19, P377, DOI 10.1007/s10816-011-9119-y; Haines R. C., 1971, EXCAVATIONS PLAIN AN; Hanfmann G.M.A., 1963, EXCAVATIONS GO ZLU K, VIII, P18; HANSEN C., 2007, EXCAVATIONS KILISE T, P343; Hein A, 2002, ANALYST, V127, P542, DOI 10.1039/b109603f; Hodos T., 2005, ANATOL STUD, V55, P61, DOI DOI 10.1017/S006615460000065X; Hrouda B., 1997, ISTANBULER MITTEILUN, V47, P91; Hunt AMW, 2015, J ARCHAEOL SCI, V53, P626, DOI 10.1016/j.jas.2014.11.031; Iakovou M., 2004, B AM SCH ORIENT RES, V336, P61; Karacic S, 2016, ARCHAEOMETRY, V58, P23, DOI 10.1111/arcm.12233; Kealhofer L, 2013, J ARCHAEOL SCI, V40, P1918, DOI 10.1016/j.jas.2012.10.019; Kearsley R.A., 1989, PENDENT SEMICIRCLE S; Knappett C., 2007, EXCAVATIONS KILISE T, V30, P241; Mitchell D, 2012, J ARCHAEOL SCI, V39, P2921, DOI 10.1016/j.jas.2012.04.044; Niehr H, 2014, HB ORIENT ST SECT 1, V106, P1, DOI 10.1163/9789004229433; Osborne JF, 2013, J ANTHROPOL ARCHAEOL, V32, P774, DOI 10.1016/j.jaa.2013.05.004; OSBORNE JF, U CHICAGOS EXCAVATIO; Pamir H., 2005, AMUQ VALLEY REGIONAL, V1, P67; Perlman I, 1971, SCI ARCHAEOL, P182; Pucci M., EXCAVATIONS PLAIN AN; Rice P., 1987, POTTERY ANAL SOURCEB; ROAF M, 1994, ANTIQUITY, V68, P770, DOI 10.1017/S0003598X00047463; Saltz DL, 1978, GREEK GEOMETRIC POTT; Schreiber N., 2003, CYPROPHOENICIAN POTT; Sinopoli C.M., 1991, APPROACHES ARCHAEOLO; Speakman RJ, 2011, J ARCHAEOL SCI, V38, P3483, DOI 10.1016/j.jas.2011.08.011; Sterba JH, 2009, J ARCHAEOL SCI, V36, P1582, DOI 10.1016/j.jas.2009.03.022; Tadmor H., 2011, ROYAL INSCRIPTIONS T; Taylor JDP, 1959, CYPRIOT SYRIAN POTTE, V21, P62; Wallis NJ, 2010, J ARCHAEOL SCI, V37, P2598, DOI 10.1016/j.jas.2010.05.020; Wilkinson TJ., 2000, AM J ARCHAEOL, V104, P168; Woolley C.L., 1938, J HELLENIC STUD, V58, P133; Woolley L., 1938, J HELLENIC STUD, V58, P1, DOI DOI 10.2307/626431; YELLIN J, 1989, ISRAEL EXPLOR J, V39, P219; Yener K.A., 2005, AMUQ VALLEY REGIONAL, P1; Yener K. A., 2000, ANATOLICA, V26, P31, DOI DOI 10.2143/ANA.26.0.2015494; Zedeno M. Nieves, 1994, SOURCING PREHISTORIC, V58	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166399	10.1371/journal.pone.0166399	http://dx.doi.org/10.1371/journal.pone.0166399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EE3FV	27902729	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100024
J	Lega, T; Weiher, P; Obuchowski, M; Nidzworski, D				Lega, Tomasz; Weiher, Paulina; Obuchowski, Michal; Nidzworski, Dawid			Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis	PLOS ONE			English	Article							SURFACE DISPLAY; PROTEIN	Effective vaccination against influenza virus infection is a serious problem mainly due to antigenic variability of the virus. Among many of investigated antigens, the extracellular domain of the M2 protein (M2e) features high homology in all strains of influenza A viruses and antibodies against M2e and is protective in animal models; this makes it a potential candidate for generation of a universal influenza vaccine. However, due to the low immunogenicity of the M2e, formulation of a vaccine based on this antigen requires some modification to induce effective immune responses. In this work we evaluated the possible use of Bacillus subtilis spores as a carrier of the Influenza A M2e antigen in mucosal vaccination. A tandem repeat of 4 consensus sequences coding for human-avian-swine-human M2e (M2eH-A-S-H) peptide was fused to spore coat proteins and stably exposed on the spore surface, as demonstrated by the immunostaining of intact, recombinant spores. Oral immunization of mice with recombinant endospores carrying M2eH-A-S-H elicited specific antibody production without the addition of adjuvants. Bacillus subtilis endospores can serve as influenza antigen carriers. Recombinant spores constructed in this work showed low immunogenicity although were able to induce antibody production. The System of influenza antigen administration presented in this work is attractive mainly due to the omitting time-consuming and cost-intensive immunogen production and purification. Therefore modification should be made to increase the immunogenicity of the presented system.	[Lega, Tomasz] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland; [Lega, Tomasz; Weiher, Paulina; Nidzworski, Dawid] Med Univ Gdansk, Gdansk, Poland; [Weiher, Paulina; Nidzworski, Dawid] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccine, Gdansk, Poland; [Obuchowski, Michal] Med Univ Gdansk, Intercollegiate Fac Biotechnol UG GUMed, Dept Med Biotechnol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Lega, T (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland.; Lega, T (corresponding author), Med Univ Gdansk, Gdansk, Poland.	tomasz.lega@biotech.ug.edu.pl	Obuchowski, Michał/N-1118-2019; Obuchowski, Michał/F-5836-2011	Obuchowski, Michał/0000-0001-5410-2350; Obuchowski, Michał/0000-0001-5410-2350; Nidzworski, Dawid/0000-0003-0533-0837	Polish National Center for Research and Development [LIDER/016/489/L-4/12/NCBR/2013]; Foundation for Polish Science grant [START 74.2015]; Foundation for Polish Science (FNP)	Polish National Center for Research and Development; Foundation for Polish Science grant; Foundation for Polish Science (FNP)(Foundation for Polish Science)	The research was supported by the Polish National Center for Research and Development grant no LIDER/016/489/L-4/12/NCBR/2013 and Foundation for Polish Science grant no START 74.2015.; The research was supported by the Polish National Center for Research and Development grant no LIDER/016/489/L-4/12/NCBR/2013; Supported by the Foundation for Polish Science (FNP)	Alvarez P, 2013, VACCINE, V21, P31; Amuguni H, 2012, HUM VACC IMMUNOTHER, V8, P7; ANAGNOSTOPOULOS C, 1961, P NATL ACAD SCI USA, V47, P378, DOI 10.1073/pnas.47.3.378; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Deng L, 2015, VACCINES-BASEL, V3, P105, DOI 10.3390/vaccines3010105; Duc H, 2007, VACCINE, V25, P2; Graeme E. Price, 2014, J VIROL, V88, P11; Green MR, 2012, MOL CLONING LAB MANU, V1; Han T, 2011, ANN NY ACAD SCI, V1217, P13; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; Hinc K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-22; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Imamura D, 2011, J BACTERIOL, V193, P4075, DOI 10.1128/JB.05310-11; Imamura D, 2010, J BACTERIOL, V192, P518, DOI 10.1128/JB.01103-09; Isticato R, 2001, J BACTERIOL, V183, P6294, DOI 10.1128/JB.183.21.6294-6301.2001; Iwanicki A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-30; Julkowska D, 2005, J BACTERIOL, V187, P65, DOI 10.1128/JB.187.1.65-76.2005; Kammoun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059198; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liu WL, 2004, VACCINE, V23, P366, DOI 10.1016/j.vaccine.2004.05.028; Liu XB, 2012, J ENERG MATER, V30, P30, DOI 10.1080/07370652.2010.538946; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Monroe A, 2006, J BACTERIOL, V188, P7609, DOI 10.1128/JB.01116-06; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Negri A, 2013, J MED MICROBIOL, V62, P1379, DOI 10.1099/jmm.0.057372-0; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NICHOLSON WL, 1990, J BACTERIOL, V172, P7, DOI 10.1128/JB.172.1.7-14.1990; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Setlow P., 2006, J APPL MICROBIOL, V101, P3; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Woodcock DM, 1989, NUCLEIC ACIDS RES, V17, P9, DOI DOI 10.1093/NAR/17.9.3469; Young-Tae L, 2014, CLIN EXP VACCINE RES, V3, P1; Yuan G, 1995, J BACTERIOL, V177, P19; Zhang ZH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-89; Zheng M, 2015, HUM VACC IMMUNOTHER, V11, P2	39	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167225	10.1371/journal.pone.0167225	http://dx.doi.org/10.1371/journal.pone.0167225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902762	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100060
J	Mizutani, Y; Niizuma, Y; Yoda, K				Mizutani, Yuichi; Niizuma, Yasuaki; Yoda, Ken			How Do Growth and Sibling Competition Affect Telomere Dynamics in the First Month of Life of Long-Lived Seabird?	PLOS ONE			English	Article							OXIDATIVE STRESS; PREDICTS FITNESS; BROOD SIZE; TRADE-OFF; LENGTH; ANTIOXIDANTS; AGE; BIRD; WILD; TESTOSTERONE	Telomeres are nucleotide sequences located at the ends of chromosomes that promote genome stability. Changes in telomere length (dynamics) are related to fitness or life expectancy, and telomere dynamics during the development phase are likely to be affected by growth and stress factors. Here, we examined telomere dynamics of black-tailed gull chicks (Larus crassirostris) in nests with and without siblings. We found that the initial telomere lengths of singletons at hatching were longer than those of siblings, indicating that singletons are higher-quality chicks than siblings in terms of telomere length. Other factors likely affecting individual quality (i.e., sex, laying date, laying order of eggs, and clutch size) were not related to telomere lengths. Within broods, initial telomere lengths were longer in older chicks than in younger chicks, suggesting that maternal effects, which vary with laying sequence, influence the initial lengths. Additionally, telomeres of chicks with a sibling showed more attrition between hatching and fledging than those of singleton chicks, suggesting that being raised with siblings can cause a sustained competitive environment that leads to telomere loss. High growth rates were associated with a low degree of telomere shortening observed in older siblings, perhaps because slower growth reflects higher food stress and/or higher aerobic metabolism from increased begging effort. Our results show that developmental telomere attrition was an inevitable consequence in two-chick nests in the pre- and post-hatching microenvironments due to the combination of social stress within the nest and maternal effects. The results of our study shed light on telomere dynamics in early life, which may represent an important physiological undercurrent of life-history traits.	[Mizutani, Yuichi; Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi, Japan; [Niizuma, Yasuaki] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi, Japan	Nagoya University; Meijo University	Mizutani, Y (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi, Japan.	yuichi-san@nagoya-u.jp			Japan Society for the Promotion of Science [24681006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by the Japan Society for the Promotion of Science (24681006) [https://www.jsps.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2013, FUNCT ECOL, V27, P342, DOI 10.1111/1365-2435.12041; Asghar M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2263; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaulieu M, 2009, BEHAV ECOL, V20, P878, DOI 10.1093/beheco/arp076; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Boonekamp JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3287; Braasch A, 2014, GEN COMP ENDOCR, V204, P95, DOI 10.1016/j.ygcen.2014.05.007; Costantini D., 2014, OXIDATIVE STRESS HOR; Cotton PA, 1999, AM NAT, V153, P412, DOI 10.1086/303178; Dantzer B, 2015, EXP GERONTOL, V71, P38, DOI 10.1016/j.exger.2015.08.012; DeKogel CH, 1997, J ANIM ECOL, V66, P167; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Foote CG, 2011, J ZOOL, V283, P203, DOI 10.1111/j.1469-7998.2010.00774.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Grant JD, 2001, BIOTECHNIQUES, V31, P1314, DOI 10.2144/01316bc02; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Haussmann MF, 2007, EXP GERONTOL, V42, P610, DOI 10.1016/j.exger.2007.03.004; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2003, EXP GERONTOL, V38, P787, DOI 10.1016/S0531-5565(03)00109-8; Heidinger BJ, 2016, FUNCT ECOL; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Herborn KA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3151; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; Iseki Kenichi, 2002, Japanese Journal of Ornithology, V51, P108, DOI 10.3838/jjo.51.108; Johnstone RA, 2003, BEHAV ECOL, V14, P780, DOI 10.1093/beheco/arg024; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kazama K, 2007, P INT S OR EV NAT DI, P215; Kazama K, 2012, J ETHOL, V30, P279, DOI 10.1007/s10164-011-0324-7; Kim SY, 2013, J EVOLUTION BIOL, V26, P1341, DOI 10.1111/jeb.12136; Kim SY, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0211; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lloyd JD, 2003, P ROY SOC B-BIOL SCI, V270, P735, DOI 10.1098/rspb.2002.2289; Mathevon N, 2004, P ROY SOC B-BIOL SCI, V271, pS145, DOI 10.1098/rsbl.2003.0117; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Mizutani Y, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0511; Mizutani Yuichi, 2009, Japanese Journal of Ornithology, V58, P192; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1610; Nettle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083617; Noguera JC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0938; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Pariser EC, 2012, BEHAV ECOL SOCIOBIOL, V66, P519, DOI 10.1007/s00265-011-1300-5; Parolini M, 2015, FUNCT ECOL, V29, P1070, DOI 10.1111/1365-2435.12412; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pauliny A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-257; R Core Team, 2021, R LANGUAGE ENV STAT; Reed WL, 2011, INTEGR COMP BIOL, V51, P73, DOI 10.1093/icb/icr032; Reichert S, 2015, HEREDITY, V114, P10, DOI 10.1038/hdy.2014.60; Reichert S, 2015, J EXP BIOL, V218, P491, DOI 10.1242/jeb.109942; Rodriguez-Girones MA, 2001, ANIM BEHAV, V61, P733, DOI 10.1006/anbe.2000.1660; Royle NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4914, DOI 10.1098/rspb.2012.1701; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Rubolini D, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-24; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Smiseth PT, 2002, ANIM BEHAV, V63, P577, DOI 10.1006/anbe.2001.1944; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Tomita N, 2011, ORNITHOL SCI, V10, P21, DOI 10.2326/osj.10.21; Torok J, 2007, BEHAV ECOL SOCIOBIOL, V61, P541, DOI 10.1007/s00265-006-0282-1; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Watson H, 2015, J EXP BIOL, V218, P668, DOI 10.1242/jeb.104265; WERSCHKUL DF, 1979, IBIS, V121, P97, DOI 10.1111/j.1474-919X.1979.tb05022.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; Zeichner SL, 1999, BLOOD, V93, P2824	78	15	15	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167261	10.1371/journal.pone.0167261	http://dx.doi.org/10.1371/journal.pone.0167261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902754	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100065
J	Noh, JW; Kwon, YD; Park, J; Oh, IH; Kim, J				Noh, Jin-Won; Kwon, Young Dae; Park, Jumin; Oh, In-Hwan; Kim, Jinseok			Relationship between Physical Disability and Depression by Gender: A Panel Regression Model	PLOS ONE			English	Article							LATE-LIFE; FUNCTIONAL DISABILITY; RISK-FACTORS; PREVALENCE; SYMPTOMS; ANXIETY	Background Depression in persons with physical disabilities may be more common than in the general population. The purpose of this study was to examine the relationship between physical disability and depression by gender among adults, using a large, nationally representative sample. Methods This study used data from the Korean Longitudinal Study of Aging, Wave one through four, and ran a series of random effect panel regression models to test the relationship between physical disability status and depression by gender. We tested the moderating effect of gender on the relationship between disability status and depression level by examining the significance of the cross-product term between disability status and gender. Results After controlling for self-rated health, marital status, employment status, education, and age, subjects who were female or diagnosed as having any disability presented higher levels of depression scores. Further, the difference in terms of their depression level measured by Center for Epidemiologic Studies Short Depression Scale (CES-D 10) scores between those who were diagnosed as having any disability and those who were not was greater for females than for their male counterparts. Conclusion This study reaffirmed that disability is the risk factor of depression, using longitudinal data. In addition, female gender is the effect modifier rather than the risk factor. The effect of gender in the non-disability group, mostly composed of older persons, is limited. On the contrary, the female disability group showed more depressive symptoms than the male disability group. The gender difference in the disability group and the role of culture on these differences need further research.	[Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Seongnam, South Korea; [Noh, Jin-Won] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Park, Jumin] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Kim, Jinseok] Seoul Womens Univ, Dept Social Welf, Seoul, South Korea	Eulji University; University of Groningen; Catholic University of Korea; Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Kyung Hee University; Seoul Women's University	Kim, J (corresponding author), Seoul Womens Univ, Dept Social Welf, Seoul, South Korea.	jskim@swu.ac.kr	Oh, In Hwan/AAI-9070-2020; Kwon, Young Dae/T-1591-2017	Oh, In Hwan/0000-0002-5450-9887; Kwon, Young Dae/0000-0002-8781-6832; Noh, Jin-Won/0000-0001-5172-4023	Seoul Women's University	Seoul Women's University	This work was supported by a research grant from Seoul Women's University (2016).; This work was supported by a research grant from Seoul Women's University (2016).	Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Chevarley FM, 2006, WOMEN HEALTH ISS, V16, P297, DOI 10.1016/j.whi.2006.10.002; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Franklin DJ, 2000, DEPRESSION INFORM TR; Girgus JS, 2015, CURR OPIN PSYCHOL, V4, P53, DOI 10.1016/j.copsyc.2015.01.019; Hermans H, 2013, J AFFECT DISORDERS, V144, P94, DOI 10.1016/j.jad.2012.06.011; Hsiao C, 2007, TEST-SPAIN, V16, P1, DOI 10.1007/s11749-007-0046-x; Hughes R, 2001, TOPICS SPINAL CORD I, V7, P16, DOI DOI 10.1310/HPKX-D0PV-MNFV-N349; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Marcus M, 2012, WHO DEP MENTAL HLTH; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; McGrath E., 1990, WOMEN DEPRESSION RIS; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Nosek MA, 2003, REHABIL COUNS BULL, V46, P224, DOI 10.1177/003435520304600403; Pachana NA, 2012, INT PSYCHOGERIATR, V24, P145, DOI 10.1017/S1041610211001372; Papadopoulos FC, 2005, INT J GERIATR PSYCH, V20, P350, DOI 10.1002/gps.1288; Park JH, 2012, J AFFECT DISORDERS, V138, P34, DOI 10.1016/j.jad.2011.12.038; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Pirkis J, 2009, J AFFECT DISORDERS, V115, P54, DOI 10.1016/j.jad.2008.08.014; Regan CO, 2013, INT J GERIATR PSYCH, V28, P1280, DOI 10.1002/gps.3955; Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Takkinen S, 2004, AGING MENT HEALTH, V8, P187, DOI 10.1080/13607860410001669714; TURNER RJ, 1990, J NERV MENT DIS, V178, P343, DOI 10.1097/00005053-199006000-00001; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010; Wild B, 2012, INT J GERIATR PSYCH, V27, P375, DOI 10.1002/gps.2728; World Health Organization, DEPR FACT SHEET; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Zeiss AM, 1996, PSYCHOL AGING, V11, P572, DOI 10.1037/0882-7974.11.4.572	31	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166238	10.1371/journal.pone.0166238	http://dx.doi.org/10.1371/journal.pone.0166238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902709	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100015
J	Rastegar-Pouyani, S; Khazaei, N; Wee, P; Mohammadnia, A; Yaqubi, M				Rastegar-Pouyani, Shima; Khazaei, Niusha; Wee, Ping; Mohammadnia, Abdulshakour; Yaqubi, Moein			Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate	PLOS ONE			English	Article							NEURAL STEM-CELLS; HEPATOCYTE-LIKE CELLS; MOUSE FIBROBLASTS; DIRECT CONVERSION; DEFINED FACTORS; DOPAMINERGIC-NEURONS; LIVER DEVELOPMENT; SINGLE FACTOR; EZH2; CARDIOMYOCYTES	Direct reprogramming using defined sets of transcription factors (TFs) is a recent strategy for generating induced hepatocytes (iHeps) from fibroblasts for use in regenerative medicine and drug development. Comprehensive studies detailing the regulatory role of TFs during this reprogramming process could help increase its efficiency. This study aimed to find the TFs with the greatest influences on the generation of iHeps from fibroblasts, and to further understand their roles in the regulation of the gene expression program. Here, we used systems biology approaches to analyze high quality expression data sets in combination with TF-binding sites data and protein-protein interactions data during the direct reprogramming of fibroblasts to iHeps. Our results revealed two main patterns for differentially expressed genes (DEGs): up-regulated genes were categorized as hepatic-specific pattern, and down-regulated genes were categorized as mesoderm-and fibroblast-specific pattern. Interestingly, hepatic-specific genes co-expressed and were regulated by hepatic-specific TFs, specifically Hnf4a and Foxa2. Conversely, the mesoderm-and fibroblast-specific pattern was mainly silenced by polycomb repressive complex 2 (PRC2) members, including Suz12, Mtf2, Ezh2, and Jarid2. Independent analysis of both the gene and core regulatory network of DE-TFs showed significant roles for Hnf4a, Foxa2, and PRC2 members in the regulation of the gene expression program and in biological processes during the direct conversion process. Altogether, using systems biology approaches, we clarified the role of Hnf4a and Foxa2 as hepatic-specific TFs, and for the first time, introduced the PRC2 complex as the main regulator that favors the direct reprogramming process in cooperation with hepatic-specific factors.	[Rastegar-Pouyani, Shima; Khazaei, Niusha] NIGEB, Inst Med Biotechnol, Tehran, Iran; [Wee, Ping] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Wee, Ping] Univ Alberta, Signal Transduct Res Grp, Fac Med & Dent, Edmonton, AB, Canada; [Mohammadnia, Abdulshakour] McGill Univ, Dept Human Genet, Div Hematol & Oncol, Fac Med, Montreal, PQ, Canada; [Yaqubi, Moein] McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada; [Yaqubi, Moein] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	University of Alberta; University of Alberta; McGill University; McGill University; McGill University	Mohammadnia, A (corresponding author), McGill Univ, Dept Human Genet, Div Hematol & Oncol, Fac Med, Montreal, PQ, Canada.; Yaqubi, M (corresponding author), McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada.; Yaqubi, M (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	Abdulshakour.mohammadnia@mail.mcgill.com; Moein.yaqubi@mail.mcgill.ca		Mohammadnia, Abdulshakour/0000-0003-1982-3958; Khazaei, Niusha/0000-0002-2756-3386				Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bae WK, 2015, FASEB J, V29, P1653, DOI 10.1096/fj.14-261537; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bernard D, 2010, AGING-US, V2, P317, DOI 10.18632/aging.100153; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blazejczyk M, 2007, A STATISTICAL DATA A; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chistiakov DA, 2012, CELLS TISSUES ORGANS, V196, P291, DOI 10.1159/000335697; Crespo I, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-140; Crespo I, 2013, STEM CELLS, V31, P2127, DOI 10.1002/stem.1473; D'Alessio AC, 2015, STEM CELL REP, V5, P1; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Ding X, 2014, STEM CELLS DEV, P19; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fragola G, 2013, PLOS GENET, P9; Gordillo M, 2015, DEVELOPMENT, V142, P2094, DOI 10.1242/dev.114215; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Khazaie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150518; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15706; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Koike H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104776; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lim KT, 2016, CELL REP, V15, P814, DOI 10.1016/j.celrep.2016.03.071; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Mohammadnia A, 2016, J CELL PHYSIOL, V231, P1994, DOI 10.1002/jcp.25308; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nicolas C, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4010002; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schmidt R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-251; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vuong LM, 2015, MOL CELL BIOL, V35, P3471, DOI 10.1128/MCB.00030-15; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Yaqubi M, 2015, PREDICTING INVOLVEME, P1, DOI [10.1186/s13287-015-0045-x, DOI 10.1186/S13287-015-0045-X]; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005; Zhu S, 2014, CELL RES, V24, P126, DOI 10.1038/cr.2013.156	83	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167081	10.1371/journal.pone.0167081	http://dx.doi.org/10.1371/journal.pone.0167081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902735	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100049
J	Yamamoto, K; Iwase, T; Terasaki, H				Yamamoto, Kentaro; Iwase, Takeshi; Terasaki, Hiroko			Long-Term Changes in Intraocular Pressure after Vitrectomy for Rhegmatogenous Retinal Detachment, Epi-Retinal Membrane, or Macular Hole	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PROLIFERATIVE DIABETIC-RETINOPATHY; NUCLEAR CATARACT; RISK-FACTORS; LENS; COMPLICATIONS; MECHANISM; SURGERY	Purpose To determine the long-term changes in the intraocular pressure (IOP) following vitrectomy for rhegmatogenous retinal detachment (RRD), epiretinal membrane (ERM), and macular hole (MH), and to investigate the relationship between the retinal disease and the incidence of late-onset IOP elevation. Methods This was a retrospective, observational, comparative study. We reviewed the medical records of 54 eyes of 54 RRD patients, 117 eyes of 117 ERM patients, and 75 eyes of 75 MH patients who underwent 20-, 23- or 25-gauge vitrectomy. The IOPs before surgery and 1, 3, 6, and 12 months following vitrectomy, and also at the final visit (average, 23.95 months) were evaluated. We defined a significant increase in the IOP as an increase of >= 4 mmHg from the preoperative IOP, and this increase was taken to be a 'death' event for the Kaplan-Meier survival analyses. Results The mean follow-up period was not significantly different among the groups. The mean IOP at 3 (P = 0.001) and 12 (P = 0.011) months following the vitrectomy and at the final visit (P = 0.002) were significantly higher than that before the vitrectomy in the RRD group. The mean IOP in the RRD group was significant higher than that in the ERM group at 1 (P = 0.005), 3 (P = 0.009), and 12 (P = 0.013) months following vitrectomy, and at the final visit (P = 0.032). Kaplan-Meier survival analyses showed that the RRD group had a significantly higher risk of an IOP increase following vitrectomy than the other groups (P < 0.001 by log-rank test). Multivariate logistic regression analyses showed that a preoperative diagnosis of RRD was the only risk factor that was significantly associated with a postoperative IOP elevation after excluding eyes with a low preoperative IOP (odds ratio, 3.208; P = 0.003). Conclusions A late-onset IOP elevation following vitrectomy was observed only in eyes that underwent RRD surgery. The elevation was probably caused by the specific characteristics and surgical procedures of RRD. Clinicians should pay more attention to the IOP elevation for long times after vitrectomy especially in eyes with RRD.	[Yamamoto, Kentaro; Iwase, Takeshi; Terasaki, Hiroko] Nagoya Univ Hosp, Dept Ophthalmol, Nagoya, Aichi, Japan	Nagoya University	Iwase, T (corresponding author), Nagoya Univ Hosp, Dept Ophthalmol, Nagoya, Aichi, Japan.	TsuyoshiIwase@aol.com			Grants-in-Aid for Scientific Research [26462635] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barbazetto IA, 2004, EXP EYE RES, V78, P917, DOI 10.1016/j.exer.2004.01.003; Brazitikos P D, 2000, Semin Ophthalmol, V15, P65; Chang S, 2006, AM J OPHTHALMOL, V141, P1033, DOI 10.1016/j.ajo.2006.02.014; Chen CJ, 1998, OPHTHALMOLOGY, V105, P94, DOI 10.1016/S0161-6420(98)91470-1; Chen PP, 1997, OPHTHALMIC SURG LAS, V28, P37; Cheng MA, 2001, ANESTHESIOLOGY, V95, P1351, DOI 10.1097/00000542-200112000-00012; Fujikawa M, 2014, GRAEF ARCH CLIN EXP, V252, P389, DOI 10.1007/s00417-013-2475-4; HAN DP, 1989, OPHTHALMOLOGY, V96, P1357; Hasegawa Y, 2012, JPN J OPHTHALMOL, V56, P46, DOI 10.1007/s10384-011-0094-3; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; Hunt K, 2004, J NEUROSURG ANESTH, V16, P287, DOI 10.1097/00008506-200410000-00005; KALRA L, 1988, CHEST, V93, P739, DOI 10.1378/chest.93.4.739; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654, DOI 10.1001/archopht.1991.01080050068031; Ki-I Y, 2013, JPN J OPHTHALMOL, V57, P57, DOI 10.1007/s10384-012-0207-7; Koreen L, 2012, RETINA-J RET VIT DIS, V32, P160, DOI 10.1097/IAE.0b013e318217fffb; Lalezary M, 2011, RETINA-J RET VIT DIS, V31, P679, DOI 10.1097/IAE.0b013e3181ff0d5a; Luk FOJ, 2009, RETINA-J RET VIT DIS, V29, P218, DOI 10.1097/IAE.0b013e31818ba9ca; Mi CW, 2015, RETINA-J RET VIT DIS, V35, P2543, DOI 10.1097/IAE.0000000000000641; PALMQUIST BM, 1988, ACTA OPHTHALMOL, V66, P671; Sayed KM, 2011, J MED INVESTIG, V58, P29; SMIDDY WE, 1995, OPHTHALMOLOGY, V102, P1688; Toyokawa N, 2015, AM J OPHTHALMOL, V159, P727, DOI 10.1016/j.ajo.2015.01.010; Yu AL, 2010, GRAEF ARCH CLIN EXP, V248, P1407, DOI 10.1007/s00417-010-1409-7	24	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167303	10.1371/journal.pone.0167303	http://dx.doi.org/10.1371/journal.pone.0167303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898707	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000050
J	Kumar, AS; Sowpati, DT; Mishra, RK				Kumar, Amitha Sampath; Sowpati, Divya Tej; Mishra, Rakesh K.			Single Amino Acid Repeats in the Proteome World: Structural, Functional, and Evolutionary Insights	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; DYNAMIC MUTATIONS; PROTEINS; DISEASE; GLUTAMINE; REGIONS; TANDEM; RUNS	Microsatellites or simple sequence repeats (SSR) are abundant, highly diverse stretches of short DNA repeats present in all genomes. Tandem mono/tri/hexanucleotide repeats in the coding regions contribute to single amino acids repeats (SAARs) in the proteome. While SSRs in the coding region always result in amino acid repeats, a majority of SAARs arise due to a combination of various codons representing the same amino acid and not as a consequence of SSR events. Certain amino acids are abundant in repeat regions indicating a positive selection pressure behind the accumulation of SAARs. By analysing 22 proteomes including the human proteome, we explored the functional and structural relationship of amino acid repeats in an evolutionary context. Only similar to 15% of repeats are present in any known functional domain, while similar to 74% of repeats are present in the disordered regions, suggesting that SAARs add to the functionality of proteins by providing flexibility, stability and act as linker elements between domains. Comparison of SAAR containing proteins across species reveals that while shorter repeats are conserved among orthologs, proteins with longer repeats, >15 amino acids, are unique to the respective organism. Lysine repeats are well conserved among orthologs with respect to their length and number of occurrences in a protein. Other amino acids such as glutamic acid, proline, serine and alanine repeats are generally conserved among the orthologs with varying repeat lengths. These findings suggest that SAARs have accumulated in the proteome under positive selection pressure and that they provide flexibility for optimal folding of functional/structural domains of proteins. The insights gained from our observations can help in effective designing and engineering of proteins with novel features.	[Kumar, Amitha Sampath; Sowpati, Divya Tej; Mishra, Rakesh K.] CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Mishra, RK (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	mishra@ccmb.res.in	Mishra, Rakesh K/F-3496-2010	Mishra, Rakesh K/0000-0001-6636-7380	Department of Biotechnology (Government of India); Council of Scientific and Industrial Research (CSIR) [BSC0121, BSC0118]	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	We thank the Department of Biotechnology (Government of India) and Council of Scientific and Industrial Research (CSIR) for financial assistance through grants, Center of Excellence, Genesis (BSC0121) and EpiHeD (BSC0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GREEN H, 1994, P NATL ACAD SCI USA, V91, P4298, DOI 10.1073/pnas.91.10.4298; Hancock JM, 2005, GENE, V345, P113, DOI 10.1016/j.gene.2004.11.023; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Huntley MA, 2004, GENETICS, V166, P1141, DOI 10.1534/genetics.166.3.1141; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; King DG, 2012, ADV EXP MED BIOL, V769, P10; Kumar RP, 2010, BIOESSAYS, V32, P165, DOI 10.1002/bies.200900111; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Luo H, 2014, BRIEF BIOINFORM, V15, P582, DOI 10.1093/bib/bbt003; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Nithianantharajah J, 2007, BIOESSAYS, V29, P525, DOI 10.1002/bies.20589; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ramamoorthy S, 2014, GENE, V551, P167, DOI 10.1016/j.gene.2014.08.052; Richards RI, 2001, HUM MOL GENET, V10, P2187, DOI 10.1093/hmg/10.20.2187; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Sawaya SM, 2012, ADV EXP MED BIOL, V769, P41; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Veitia RA, 2004, GENOMICS, V83, P502, DOI 10.1016/j.ygeno.2003.09.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	42	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166854	10.1371/journal.pone.0166854	http://dx.doi.org/10.1371/journal.pone.0166854			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893794	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400049
J	Lopez, FJ; Alonso, R; Luque, D				Lopez, Francisco J.; Alonso, Rafael; Luque, David			Rapid Top-Down Control of Behavior Due to Propositional Knowledge in Human Associative Learning	PLOS ONE			English	Article							REACTION-TIME-TASK; RETRIEVAL MODELS; CONTINGENCY; INTERFERENCE; COGNITION; BLOCKING; JUDGMENT; OUTCOMES; RULE	Propositional and associative processes have been proposed to explain human associative learning. Our main objective in this study was to evaluate whether propositional knowledge may gain control over behavior even under high time-pressure conditions, as suggested by propositional single-process models. In the experiment reported, different groups of participants had to learn a series of cue-outcome relationships on a trial-by-trial basis under different time pressure conditions. Later, a simple verbal instruction indicated that one of the cues had reversed its contingency (informed condition). The other cue had also changed its contingency, though in an unanticipated way (uninformed condition) whilst other contingencies did not change (no-change condition). The results showed that, in the absence of instructions, interference (i.e., uninformed vs. no-change effect) was greater in the high time than in the low time-pressure group. This result indicates that those responses which were previously relevant are more difficult to inhibit when there is little time to respond. However, time pressure had no detectable effect on the use of the verbal instruction, since an equivalent instruction advantage (i.e., uninformed vs. informed effect) was obtained in both time pressure groups. These results reveal that propositional knowledge can override those cue-outcome relationships that were learnt trial-by-trial even under conditions of high cognitive demand. This pattern of results is consistent with a propositional single-process model of associative learning.	[Lopez, Francisco J.; Alonso, Rafael] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Lopez, Francisco J.; Alonso, Rafael] Univ Malaga, Malaga, Spain; [Luque, David] UNSW Australia, Sch Psychol, Sydney, NSW, Australia	Universidad de Malaga; Universidad de Malaga; University of New South Wales Sydney	Lopez, FJ (corresponding author), Inst Invest Biomed Malaga IBIMA, Malaga, Spain.; Lopez, FJ (corresponding author), Univ Malaga, Malaga, Spain.	frjlopez@uma.es	Luque, David/B-3776-2011; , DL/AAS-6678-2020; Lopez, Francisco/AAZ-2947-2021; López, Francisco/B-9295-2011	Luque, David/0000-0002-3457-9204; , DL/0000-0002-3457-9204; Lopez, Francisco/0000-0003-3884-4025; López, Francisco/0000-0003-3884-4025	Junta de Andalucia [P11-SEJ-7898]; Spanish Ministry of Science and Innovation [PSI2011-24662, PSI2014-56061-P]	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants P11-SEJ-7898 from Junta de Andalucia and PSI2011-24662 and PSI2014-56061-P from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants P11-SEJ-7898 from Junta de Andalucia and PSI201124662 and PSI2014-56061-P from the Spanish Ministry of Science and Innovation.	ALLOY LB, 1984, PSYCHOL REV, V91, P112, DOI 10.1037/0033-295X.91.1.112; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Boddez Y, OXFORD HDB IN PRESS; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cobos PL, 2013, J EXP PSYCHOL-ANIM B, V39, P299, DOI 10.1037/a0033528; Cobos PL, 2016, J EXPT PSYCHOL LEARN; Cohen-Kdoshay O, 2009, EXP PSYCHOL, V56, P128, DOI 10.1027/1618-3169.56.2.128; De Houwer J, 2006, LEARN MOTIV, V37, P176, DOI 10.1016/j.lmot.2005.12.002; De Houwer J, 2003, Q J EXP PSYCHOL-B, V56, P345, DOI 10.1080/02724990244000296; De Houwer J, 2010, EXP PSYCHOL, V57, P61, DOI 10.1027/1618-3169/a000008; De Houwer J, 2009, LEARN BEHAV, V37, P1, DOI 10.3758/LB.37.1.1; DICKINSON A, 1984, Q J EXP PSYCHOL-A, V36, P29, DOI 10.1080/14640748408401502; Dickinson A., 1980, CONT ANIMAL LEARNING; Eisenberg Daniel, 2015, J MENT HEALTH, V20, P222, DOI [10.3109/10673229.2012.712839, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; Gillan CM, 2014, BIOL PSYCHIAT, V75, P631, DOI 10.1016/j.biopsych.2013.02.002; Gonzalez-Martin E, 2012, J EXP PSYCHOL-ANIM B, V38, P419, DOI 10.1037/a0029517; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Lopez FJ, 2005, MEM COGNITION, V33, P1388, DOI 10.3758/BF03193371; Lopez FJ, 2008, CAMB HANDB PSYCHOL, P589; Love J, 2015, JASP VERSION 0 6 6 C; Luque D, 2013, LEARN BEHAV, V41, P61, DOI 10.3758/s13420-012-0085-3; Mertens G, 2016, BIOL PSYCHOL, V113, P91, DOI 10.1016/j.biopsycho.2015.11.014; Mertens G, 2016, COGNITION EMOTION, V30, P968, DOI 10.1080/02699931.2015.1038219; Mitchell CJ, 2009, BEHAV BRAIN SCI, V32, P183, DOI 10.1017/S0140525X09000855; Moris J, 2014, J EXP PSYCHOL GEN, V143, P77, DOI 10.1037/a0030919; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Shanks DR, 2010, ANNU REV PSYCHOL, V61, P273, DOI 10.1146/annurev.psych.093008.100519; Sternberg DA, 2012, PSYCHOL SCI, V23, P59, DOI 10.1177/0956797611429577; Townsend J.T., 1978, COGNITIVE THEORY, V3, P200; Van Dessel P, 2016, J EXP SOC PSYCHOL, V63, P1, DOI 10.1016/j.jesp.2015.11.002; Van Dessel P, 2015, EXP PSYCHOL, V62, P161, DOI 10.1027/1618-3169/a000282	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167115	10.1371/journal.pone.0167115	http://dx.doi.org/10.1371/journal.pone.0167115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893814	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400088
J	Novitsky, V; Moyo, S; Wang, R; Gaseitsiwe, S; Essex, M				Novitsky, Vlad; Moyo, Sikhulile; Wang, Rui; Gaseitsiwe, Simani; Essex, M.			Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD PHYLOGENIES; DUAL INFECTION; SEQUENCE ALIGNMENT; TYPE-1 SUPERINFECTION; VIRUS; LOAD; GAG; MEN; IDENTIFICATION; REPLICATION	Background A single viral variant is transmitted in the majority of HIV infections. However, about 20% of heterosexually transmitted HIV infections are caused by multiple viral variants. Detection of transmitted HIV variants is not trivial, as it involves analysis of multiple viral sequences representing intra-host HIV-1 quasispecies. Methodology We distinguish two types of multiple virus transmission in HIV infection: (1) HIV transmission from the same source, and (2) transmission from different sources. Viral sequences representing intra-host quasispecies in a longitudinally sampled cohort of 42 individuals with primary HIV-1C infection in Botswana were generated by single-genome amplification and sequencing and spanned the V1C5 region of HIV-1C env gp120. The Maximum Likelihood phylogeny and distribution of pairwise raw distances were assessed at each sampling time point (n = 217; 42 patients; median 5 (IQR: 4-6) time points per patient, range 2-12 time points per patient). Results Transmission of multiple viral variants from the same source (likely from the partner with established HIV infection) was found in 9 out of 42 individuals (21%; 95 CI 10-37%). HIV super-infection was identified in 2 patients (5%; 95% CI 1-17%) with an estimated rate of 3.9 per 100 person-years. Transmission of multiple viruses combined with HIV super-infection at a later time point was observed in one individual. Conclusions Multiple HIV lineages transmitted from the same source produce a monophyletic clade in the inferred phylogenetic tree. Such a clade has transiently distinct sub-clusters in the early stage of HIV infection, and follows a predictable evolutionary pathway. Over time, the gap between initially distinct viral lineages fills in and initially distinct sub-clusters converge. Identification of cases with transmission of multiple viral lineages from the same source needs to be taken into account in cross-sectional estimation of HIV recency in epidemiological and population studies.	[Novitsky, Vlad; Wang, Rui; Essex, M.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Novitsky, Vlad; Moyo, Sikhulile; Gaseitsiwe, Simani; Essex, M.] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Moyo, Sikhulile] Univ Stellenbosch, Div Med Virol, Tygerberg, South Africa; [Wang, Rui] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Stellenbosch University; Harvard University; Brigham & Women's Hospital	Essex, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA USA.; Essex, M (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.	messex@hsph.harvard.edu	Wang, Rui/X-1699-2019; Moyo, Sikhulile/E-1464-2015	Wang, Rui/0000-0001-5007-193X; Moyo, Sikhulile/0000-0003-3821-4592	NIH/NIAID [R01 A1057027, R37 AI051164]; Oak Foundation [OUSA-12-025]; NIH/FIC [D43 TW009610]; Stellenbosch University, Division of Medical Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051164] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oak Foundation; NIH/FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Stellenbosch University, Division of Medical Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary HIV-1C infection study in Botswana (Tshedimoso Study) was supported and funded by the NIH/NIAID (R01 A1057027). SM was supported by the Oak Foundation Fellowship (Grant # OUSA-12-025), by the NIH/FIC (D43 TW009610), and by Stellenbosch University, Division of Medical Virology. RW was supported by the NIH/NIAID (R37 AI051164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; [Anonymous], 2021, LANG ENV STAT COMP; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Castro E, 2014, AIDS, V28, P1840, DOI 10.1097/QAD.0000000000000342; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornelissen M, 2016, AIDS RES HUMAN RETRO; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Gottlieb GS, 2007, CLIN INFECT DIS, V45, P501, DOI 10.1086/520024; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Janes H, 2015, NAT MED, V21, P1139, DOI 10.1038/nm.3932; Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Kraft CS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-22; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Masharsky AE, 2010, J INFECT DIS, V201, P1697, DOI 10.1086/652702; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2013, INFECT GENET EVOL, V19, P361, DOI 10.1016/j.meegid.2013.02.023; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2007, CLIN INFECT DIS, V45, pE68, DOI 10.1086/520683; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ping LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071557; Redd AD, 2015, AIDS, V29, P1567, DOI 10.1097/QAD.0000000000000740; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Ronen K, 2014, AIDS, V28, P2281, DOI 10.1097/QAD.0000000000000422; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sheward DJ, 2015, J INFECT DIS, V212, P904, DOI 10.1093/infdis/jiv136; Sterrett S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu056; Tully DC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005619; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633	55	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166746	10.1371/journal.pone.0166746	http://dx.doi.org/10.1371/journal.pone.0166746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893822	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400042
J	Tran, TD; Nguyen, H; Fisher, J				Thach Duc Tran; Hau Nguyen; Fisher, Jane			Attitudes towards Intimate Partner Violence against Women among Women and Men in 39 Low- and Middle-Income Countries	PLOS ONE			English	Article							PREVALENCE; VICTIMIZATION; HEALTH	Background Violence against women perpetrated by an intimate partner (IPV) is prevalent in low-and middle-income countries (LAMIC). The aim was to describe the attitudes of women and men towards perpetration of physical violence to women by an intimate partner, in a large group of low-and middle-income countries. Methods and Findings We used data from Round Four of the UNICEF Multiple Indicator Cluster Surveys. Attitudes towards IPV against women were assessed by a study-specific scale asking if 'wife beating' is justified in any of five circumstances. Overall, data from 39 countries (all had data from women and 13 countries also had data from men) were included in the analyses. The proportions of women who held attitudes that 'wife-beating' was justified in any of the five circumstances varied widely among countries from 2.0% (95% CI 1.7;2.3) in Argentina to 90.2% (95% CI 88.9;91.5) in Afghanistan. Similarly, among men it varied from 5.0% (95% CI 4.0;6.0) in Belarus to 74.5% (95% CI 72.5;76.4) in the Central African Republic. The belief that 'wife-beating' is acceptable was most common in Africa and South Asia, and least common in Central and Eastern Europe and Latin America and the Caribbean. In general this belief was more common among people in disadvantaged circumstances, including being a member of a family in the lowest household wealth quintile, living in a rural area and having limited formal education. Young adults were more likely to accept physical abuse by a man of his intimate partner than those who were older, but people who had never partnered were less likely to have these attitudes. Conclusions Violence against women is an international priority and requires a multicomponent response. These data provide evidence that strategies should include major public education programs to change attitudes about the acceptability of IPV against women, and that these should be addressed to women and girls as well as to boys and men.	[Thach Duc Tran] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Thach Duc Tran; Hau Nguyen; Fisher, Jane] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic, Australia	Monash University	Tran, TD (corresponding author), Res & Training Ctr Community Dev, Hanoi, Vietnam.; Tran, TD (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic, Australia.	thach.tran@monash.edu	TRAN, THACH DUC/H-7734-2014; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Fisher, Jane/0000-0002-1959-6807	Monash University; Australian National Health and Medical Research Council; Jean Hailes Professorial Fellowship; L and H Hecht Trust	Monash University(Monash University); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jean Hailes Professorial Fellowship; L and H Hecht Trust	TDT is supported by a Bridging Postdoctoral Research Fellowship from Monash University and an Early Career Fellowship from the Australian National Health and Medical Research Council. JF is supported by a Professorial Fellowship from Monash University and the Jean Hailes Professorial Fellowship which is funded by the L and H Hecht Trust, managed by Perpetual Trustees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Caldwell JE, 2012, PSYCHOL VIOLENCE, V2, P42, DOI 10.1037/a0026296; Carter J, 2015, LANCET, V385, pE40, DOI 10.1016/S0140-6736(14)62217-0; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Fisher J, 2013, INT HEALTH, V5, P29, DOI 10.1093/inthealth/ihs012; Fisher J, 2012, J AFFECT DISORDERS, V140, P97, DOI 10.1016/j.jad.2012.03.029; Flood M, 2009, TRAUMA VIOLENCE ABUS, V10, P125, DOI 10.1177/1524838009334131; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garcia-Moreno C, 2013, KEY ISSUES MENT HEAL, V178, P1, DOI 10.1159/000343777; Glick P, 2002, PSYCHOL WOMEN QUART, V26, P292, DOI 10.1111/1471-6402.t01-1-00068; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Hindin MJ, 2003, B WORLD HEALTH ORGAN, V81, P501; Huang GP, 2010, J INTERPERS VIOLENCE, V25, P863, DOI 10.1177/0886260509336959; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Khawaja M, 2008, J FAM VIOLENCE, V23, P211, DOI 10.1007/s10896-007-9146-3; Krause KH, 2015, J INTERPERS VIOLENCE; Mckinney CM, 2009, ANN EPIDEMIOL, V19, P25, DOI 10.1016/j.annepidem.2008.08.008; Neville HA, 2004, PSYCHOL WOMEN QUART, V28, P83, DOI 10.1111/j.1471-6402.2004.00125.x; O'Leary KD, 2012, PREV SCI, V13, P329, DOI 10.1007/s11121-011-0237-2; Pavlou M., 2001, PSYCHIAT PSYCHOL LAW, V8, P76, DOI [10.1080/13218710109525006, DOI 10.1080/13218710109525006]; Peterman A, 2015, J ADOLESCENT HEALTH, V57, P624, DOI 10.1016/j.jadohealth.2015.08.008; Rani M, 2009, J INTERPERS VIOLENCE, V24, P1371, DOI 10.1177/0886260508322182; Sayem AM, 2012, J BIOSOC SCI, V44, P641, DOI 10.1017/S0021932012000223; Tran TD, 2016, B WORLD HEALTH ORGAN, V94, P122, DOI 10.2471/BLT.15.160036; Tjaden P, 2000, EXTENT NATURE CONSEQ; Tran TD, 2016, CHILD CARE IN PRESS; UNDP, 2011, HUM DEV REP 2011 SUS; UNDP, 2015, HUM DEV IND HDI; Uthman OA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-223; Uthman OA, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-14; Waltermaurer E, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-44; West A, 2002, J INTERPERS VIOLENCE, V17, P972, DOI 10.1177/0886260502017009004; Yount KM, 2011, SOC SCI RES, V40, P873, DOI 10.1016/j.ssresearch.2010.12.009	34	113	114	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167438	10.1371/journal.pone.0167438	http://dx.doi.org/10.1371/journal.pone.0167438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893861	Green Published, gold			2022-12-27	WOS:000389472400117
J	Chen, M; Lu, XG; Liao, B; Li, ZJ; Cai, LJ; Gu, CL				Chen, Min; Lu, Xingguo; Liao, Bo; Li, Zejun; Cai, Lijun; Gu, Changlong			Uncover miRNA-Disease Association by Exploiting Global Network Similarity	PLOS ONE			English	Article							HUMAN MICRORNA; INTERACTOME; PRIORITIZATION; GENES; WALKING; CANCER	Identification of miRNA-disease association is a fundamental challenge in human health clinic. However, the known miRNA-disease associations are rare and experimental verification methods are expensive and time-consuming. Therefore, there is a strong incentive to develop computational methods. In this paper, we calculate the similarity score for each miRNAs pair by integrating miRNA functional similarity and miRNA family information. We use the disease phenotype similarity data to construct the disease similarity network. Then we introduce a new miRNA-disease association prediction method (NETwork Group Similarity, NetGS) to explore the global network similarity, capturing the relationship between the disease and other diseases, the similarity between the potential disease-related miRNA and other miRNAs. Finally based on the consistency of diffusion profiles we get the miRNAdisease association scores. NetGS is tested by the leave-one-out cross validation and achieves an AUC value of 0.8450, which improves the prediction accuracy. NetGS can also be applied to solve the new miRNA-disease association and obtain reliable accuracy. Moreover, we use NetGS to predict new causing miRNAs of three cancers including breast cancer, lung cancer and Hepatocellular cancer. And the top predictions have been confirmed in the online databases. The encouraging results indicate that NetGS might play an essential role for future scientific research.	[Chen, Min; Lu, Xingguo; Liao, Bo; Li, Zejun; Cai, Lijun; Gu, Changlong] Hunan Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Chen, Min; Li, Zejun] Hunan Inst Technol, Sch Comp & Informat Sci, Hengyang, Peoples R China	Hunan University; Hunan Institute of Technology	Liao, B (corresponding author), Hunan Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	dragonbw@163.com			Program for National Nature Science Foundation of China [61672214, 61300128, 61472127]	Program for National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Program for National Nature Science Foundation of China (61672214, 61300128 and 61472127), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work is supported by the Program for National Nature Science Foundation of China (61672214, 61300128 and 61472127), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen HL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-12; Chen X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05501; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Chen Y, 2011, BIOINFORMATICS, V27, pI167, DOI 10.1093/bioinformatics/btr213; Cheung TH, 2012, CELL CYCLE, V11, P2876, DOI 10.4161/cc.21278; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Mookherjee S., 2009, ARXIV09014211; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Weidhaas J, 2010, LANCET ONCOL, V11, P106, DOI 10.1016/S1470-2045(09)70386-9; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Xuan P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070204, 10.1371/annotation/a076115e-dd8c-4da7-989d-c1174a8cd31e]; Yakhini Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-120; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhu J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S5	29	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166509	10.1371/journal.pone.0166509	http://dx.doi.org/10.1371/journal.pone.0166509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907011	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700028
J	Erel, R; Yermiyahu, U; Yasuor, H; Chamus, DC; Schwartz, A; Ben-Gal, A; Dag, A				Erel, Ran; Yermiyahu, Uri; Yasuor, Hagai; Chamus, Dan Cohen; Schwartz, Amnon; Ben-Gal, Alon; Dag, Arnon			Phosphorous Nutritional Level, Carbohydrate Reserves and Flower Quality in Olives	PLOS ONE			English	Article							OLEA-EUROPAEA L.; OVARY STARCH RESERVES; FRUIT-SET; WATER DEFICITS; FLORAL QUALITY; POLLEN; INFLORESCENCE; CULTIVARS; POLLINATION; BIOLOGY	The olive tree is generally characterized by relatively low final fruit set consequential to a significant rate of undeveloped pistils, pistil abortion, and flower and fruitlet abscission. These processes are acknowledged to be governed by competition for resources between the developing vegetative and reproductive organs. To study the role of phosphorus (P) nutritional level on reproductive development, trees were grown under four levels of P for three years in large containers. Phosphorus nutritional level was positively related to rate of reproductive bud break, inflorescence weight, rate of hermaphrodite flowers, pistil weight, fruitlet persistence, fruit set and the consequential total number of fruits. The positive impact of P nutrition on the productivity parameters was not related to carbohydrate reserves or to carbohydrate transport to the developing inflorescence. Phosphorous deficient trees showed significant impairment of assimilation rate, and yet, carbohydrates were accumulated in inflorescences at levels comparable to or higher than trees receiving high P. In contrast to female reproductive organs, pollen viability was consistently higher in P deficient trees, possibly due to the enhanced carbohydrate availability. Overall, the positive effect of P on female reproductive development was found to be independent of the total carbohydrate availability. Hence, P is speculated to have a direct influence on reproductive processes.	[Erel, Ran; Yermiyahu, Uri; Yasuor, Hagai; Chamus, Dan Cohen; Ben-Gal, Alon; Dag, Arnon] Agr Res Org Israel, Gilat Res Ctr, Bet Dagan, Israel; [Schwartz, Amnon] Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel	Hebrew University of Jerusalem	Erel, R (corresponding author), Agr Res Org Israel, Gilat Res Ctr, Bet Dagan, Israel.	ranerel@volcani.agri.gov.il	Ben-Gal, Alon/F-5190-2013	Ben-Gal, Alon/0000-0003-4105-7807; Erel, Ran/0000-0003-1780-3291				Alcaraz ML, 2010, PHYSIOL PLANTARUM, V140, P395, DOI 10.1111/j.1399-3054.2010.01410.x; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Ben-Gal A, 2011, IRRIGATION SCI, V29, P253, DOI 10.1007/s00271-010-0237-1; BERTIN R I, 1982, Evolutionary Theory, V6, P25; Beutel J., 1983, BULLETIN, V1879, P15; Bustan A, 2011, TREE PHYSL; CLEMENT C, 1994, SEX PLANT REPROD, V7, P347, DOI 10.1007/BF00230513; Cuevas J, 2004, ANN BOT-LONDON, V93, P547, DOI 10.1093/aob/mch079; Cuevas J., 1995, Advances in Horticultural Science, V9, P92; CUEVAS J, 1994, SCI HORTIC-AMSTERDAM, V59, P123, DOI 10.1016/0304-4238(94)90079-5; Dag A, 2009, CROP PASTURE SCI, V60, P427, DOI 10.1071/CP08143; De la Rosa R, 2000, HORTSCIENCE, V35, P1223, DOI 10.21273/HORTSCI.35.7.1223; DROSSOPOULOS JB, 1988, ANN BOT-LONDON, V62, P321, DOI 10.1093/oxfordjournals.aob.a087664; Erel R, 2008, J AM SOC HORTIC SCI, V133, P639, DOI 10.21273/JASHS.133.5.639; Erel R, 2014, TREE PHYSIOL, V34, P1102, DOI 10.1093/treephys/tpu081; Erel R, 2013, SCI HORTIC-AMSTERDAM, V159, P8, DOI 10.1016/j.scienta.2013.04.036; Fernandez-Escobar R, 2008, ENVIRON EXP BOT, V64, P113, DOI 10.1016/j.envexpbot.2008.04.007; Fernandez-Escobar R., 2010, OLIVE GROWING, P267; Ferrara G, 2012, 6 INT S OL GROW 2012; Granot D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00044; Grattan SR, 2006, AGR WATER MANAGE, V85, P133, DOI 10.1016/j.agwat.2006.04.001; Hartmann H, 1950, P AM SOC HORT SCI; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Jean D, 2001, PHYSIOL PLANTARUM, V112, P379, DOI 10.1034/j.1399-3054.2001.1120311.x; Kelly G, 2013, PLANT J, V75, P977, DOI 10.1111/tpj.12258; Kitsaki CK, 1999, J PLANT GROWTH REGUL, V18, P1, DOI 10.1007/PL00007040; Lavee S., 2002, Oliva, P25; Lavee S., 1990, Advances in Horticultural Science, V4, P135; Lavee S, 1996, SCI HORTIC-AMSTERDAM, V66, P149, DOI 10.1016/S0304-4238(96)00941-7; Lavee S, 1999, SCI HORTIC-AMSTERDAM, V82, P181, DOI 10.1016/S0304-4238(99)00057-6; Lavee S., 1996, WORLD OLIVE ENCY, P59; Lawson T, 2014, NEW PHYTOL, V203, P1064, DOI 10.1111/nph.12945; Levin AG, 2005, AUST J AGR RES, V56, P827, DOI 10.1071/AR04094; Alcaraz ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078467; Lynch Jonathan P., 2008, V7, P83; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Martins P. C., 2006, Advances in Horticultural Science, V20, P262; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreno-Alias I, 2013, SCI HORTIC-AMSTERDAM, V154, P17, DOI 10.1016/j.scienta.2013.02.014; Moriana A, 2003, J AM SOC HORTIC SCI, V128, P425, DOI 10.21273/JASHS.128.3.0425; Olive Lavee S., 1986, CRC HDB FRUIT SET DE, P261; Perica S, 2012, FLOWER STERILITY GER, V87, P237; Pinillos V, 2009, HORTSCIENCE, V44, P499, DOI 10.21273/HORTSCI.44.2.499; Pinney K, 1989, INT S OL GROW, V286; RALLO L, 1985, J AM SOC HORTIC SCI, V110, P303; Rapoport HF, 2012, ENVIRON EXP BOT, V77, P227, DOI 10.1016/j.envexpbot.2011.11.021; RAPOPORT HF, 1991, J AM SOC HORTIC SCI, V116, P720, DOI 10.21273/JASHS.116.4.720; Rapoport HF, 2006, P 2 INT SEM REC ADV; Reale L, 2006, SEX PLANT REPROD, V19, P151, DOI 10.1007/s00497-006-0032-6; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Rodriguez D, 1998, PLANT SOIL, V200, P227, DOI 10.1023/A:1004310217694; Rojo J, 2015, TREES-STRUCT FUNCT, P1; Rosati A, 2010, SCI HORTIC-AMSTERDAM, V126, P200, DOI 10.1016/j.scienta.2010.07.010; Ruiz R, 2001, ANN BOT-LONDON, V87, P805, DOI 10.1006/anbo.2001.1415; Selak GV, 2012, J HORTIC SCI BIOTECH, V87, P237; Selak GV, 2014, TREES-STRUCT FUNCT, V28, P1497, DOI 10.1007/s00468-014-1053-7; Selak GV, 2014, SCI HORTIC-AMSTERDAM, V165, P36, DOI 10.1016/j.scienta.2013.10.041; Selak GV, 2011, HORTSCIENCE, V46, P186, DOI 10.21273/HORTSCI.46.2.186; STITT M, 1989, PHYSIOL PLANTARUM, V77, P633, DOI 10.1111/j.1399-3054.1989.tb05402.x; STONE JL, 1995, AM J BOT, V82, P1186, DOI 10.2307/2446073; STUTTE GW, 1986, J AM SOC HORTIC SCI, V111, P27; Ulger S, 2004, PLANT GROWTH REGUL, V42, P89, DOI 10.1023/B:GROW.0000014897.22172.7d; Uriu K, 1959, P AM SOC HORT SCI; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vishnevetsky J, 2000, PHYSIOL PLANTARUM, V108, P361, DOI 10.1034/j.1399-3054.2000.108004361.x; Wissuwa M, 2005, J EXP BOT, V56, P1943, DOI 10.1093/jxb/eri189; Zamski E., 1996, PHOTOASSIMILATE DIST; Zipori I, 2015, IRRIGATION SCI, P1	70	26	27	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167591	10.1371/journal.pone.0167591	http://dx.doi.org/10.1371/journal.pone.0167591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907133	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700207
J	Johnson, TW; Wu, Y; Nathoo, N; Rogers, JA; Yong, VW; Dunn, JF				Johnson, Thomas W.; Wu, Ying; Nathoo, Nabeela; Rogers, James A.; Yong, V. Wee; Dunn, Jeff F.			Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis	PLOS ONE			English	Article							NF-KAPPA-B; CLINICALLY ISOLATED SYNDROMES; INDUCIBLE-FACTOR; PROLYL HYDROXYLATION; INCREASED EXPRESSION; CORTICAL ATROPHY; IRON DEPOSITION; WHITE-MATTER; LESION LOAD; MS PATIENTS	Background Multiple sclerosis (MS) has a significant inflammatory component and may have significant gray matter (GM) pathophysiology. Brain oxygenation is a sensitive measurement of the balance between metabolic need and oxygen delivery. There is evidence that inflammation and hypoxia are interdependent. In this paper, we applied novel, implanted PO2 sensors to measure hypoxia in cortical and cerebellar GM, in an inflammation-induced mouse model of MS. Objective Quantify oxygenation in cortical and cerebellar GM in the awake, unrestrained experimental autoimmune encephalomyelitis (EAE) mouse model and to relate the results to symptom level and disease time-course. Methods C57BL/6 mice were implanted with a fiber-optic sensor in the cerebellum (n = 13) and cortex (n = 24). Animals were induced with stimulation of the immune response and sensitization to myelin oligodendrocyte glycoprotein (MOG). Controls did not have MOG. We measured PO2 in awake, unrestrained animals from pre-induction (baseline) up to 36 days post-induction for EAE and controls. Results There were more days with hypoxia than hyperoxia (cerebellum: 34/67 vs. 18/67 days; cortex: 85/112 vs. 22/112) compared to time-matched controls. The average decline in PO2 on days that were significantly lower than time-matched controls was -8.8 +/- 6.0 mmHg (mean +/- SD) for the cerebellum and -8.0 4.6 for the cortex. Conversely, the average increase in PO2 on days that were significantly hyperoxic was +3.2 +/- 2.8 mmHg (mean +/- SD) for the cerebellum and +0.8 +/- 2.1 for the cortex. Cortical hypoxia related to increased behavioral deficits. Evidence for hypoxia occurred before measurable behavioral deficits. Conclusions A highly inflammatory condition primed to a white matter (WM) autoimmune response correlates with significant hypoxia and increased variation in oxygenation in GM of both cerebellum and cortex in the mouse EAE model of MS.	[Johnson, Thomas W.; Wu, Ying; Nathoo, Nabeela; Dunn, Jeff F.] Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada; [Rogers, James A.; Yong, V. Wee] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Dunn, JF (corresponding author), Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada.	dunnj@ucalgary.ca	Nathoo, Nabeela/AAC-6098-2022	Nathoo, Nabeela/0000-0001-6446-1146; Yong, V. Wee/0000-0002-2600-3563	Canada Foundation for Innovation [PP780226]; MS Society of Canada [RT757368]; Canadian Institutes of Health Research [CRH-120244]; Alberta Innovates: Health Solutions CRIO Team Grant [20140144]; National Institute of Biomedical Imaging and Bioengineering [R21 EB021397]; Alberta Innovates [201300669] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB021397] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); MS Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates: Health Solutions CRIO Team Grant; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alberta Innovates; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding for this research was provided by the Natural Science and Engineering Research Council of Canada (RGPIN/386056-2010; www.nserc-crsng.gc.ca), Canada Foundation for Innovation (PP780226; www.innovation.ca), MS Society of Canada (RT757368; www.endmsnetwork.ca), Canadian Institutes of Health Research (CRH-120244; www.cihr.ca), Alberta Innovates: Health Solutions CRIO Team Grant (20140144; www.aihealthsolutions.ca), and the National Institute of Biomedical Imaging and Bioengineering (R21 EB021397; www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Agrawal SM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-64; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Blinkenberg M, 2000, NEUROLOGY, V54, P558, DOI 10.1212/WNL.54.3.558; BROOKS DJ, 1984, J NEUROL NEUROSUR PS, V47, P1182, DOI 10.1136/jnnp.47.11.1182; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Calabrese M, 2011, NEUROLOGY, V77, P257, DOI 10.1212/WNL.0b013e318220abd4; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; Derache N, 2006, J NEUROL SCI, V245, P103, DOI 10.1016/j.jns.2005.09.017; Desai RA, 2016, ANN NEUROL, V79, P591, DOI 10.1002/ana.24607; Dunn JF, 1985, METABOLIC ADJUSTMENT; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Ge YL, 2012, J CEREBR BLOOD F MET, V32, P403, DOI 10.1038/jcbfm.2011.191; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Griffiths JR, 1999, BRIT J RADIOL, V72, P627, DOI 10.1259/bjr.72.859.10624317; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Inglese M, 2008, J CEREBR BLOOD F MET, V28, P164, DOI 10.1038/sj.jcbfm.9600504; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; LENIGERFOLLERT E, 1976, PFLUG ARCH EUR J PHY, V366, P39, DOI 10.1007/BF02486558; Lindsey J. William, 2005, P1; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MacKenzie-Graham A, 2006, NEUROIMAGE, V32, P1016, DOI 10.1016/j.neuroimage.2006.05.006; MacKenzie-Graham A, 2012, NEUROIMAGE, V60, P95, DOI 10.1016/j.neuroimage.2011.11.099; MacKenzie-Graham A, 2009, NEUROIMAGE, V48, P637, DOI 10.1016/j.neuroimage.2009.06.073; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; McMahon JM, 2012, MULT SCLER J, V18, P1437, DOI 10.1177/1352458512438455; Mhaille AN, 2008, J NEUROPATH EXP NEUR, V67, P200, DOI 10.1097/NEN.0b013e318165b239; Michaelis L, 1913, BIOCHEM Z, V49, P333; Nathoo N, 2013, MULT SCLER J, V19, P721, DOI 10.1177/1352458512460602; Ortiz-Prado E, 2010, J NEUROSCI METH, V193, P217, DOI 10.1016/j.jneumeth.2010.08.019; Papadopoulos D, 2006, EXP NEUROL, V197, P373, DOI 10.1016/j.expneurol.2005.10.033; Paulesu E, 1996, NEUROIMAGE, V4, P87, DOI 10.1006/nimg.1996.0032; Rashid W, 2004, J NEUROL NEUROSUR PS, V75, P1288, DOI 10.1136/jnnp.2003.026021; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sun X, 1998, Ann Nucl Med, V12, P89; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Xia YF, 2001, BIOCHEM BIOPH RES CO, V289, P851, DOI 10.1006/bbrc.2001.6067; Yang R, 2015, SCI REPORTS; Zhou J, 2003, AM J PHYSIOL-CELL PH, V284, pC439, DOI 10.1152/ajpcell.00294.2002	61	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167196	10.1371/journal.pone.0167196	http://dx.doi.org/10.1371/journal.pone.0167196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907119	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700089
J	Kiontke, A; Oliveira-Birkmeier, A; Opitz, A; Birkemeyer, C				Kiontke, Andreas; Oliveira-Birkmeier, Ariana; Opitz, Andreas; Birkemeyer, Claudia			Electrospray Ionization Efficiency Is Dependent on Different Molecular Descriptors with Respect to Solvent pH and Instrumental Configuration	PLOS ONE			English	Article							PRESSURE CHEMICAL-IONIZATION; MASS-SPECTROMETRY; AROMATIC-AMINES; GAS-PHASE; DROPLETS; MODEL; ELUENT; MATRIX; SCALE; IONS	Over the past decades, electrospray ionization for mass spectrometry (ESI-MS) has become one of the most commonly employed techniques in analytical chemistry, mainly due to its broad applicability to polar and semipolar compounds and the superior selectivity which is achieved in combination with high resolution separation techniques. However, responsiveness of an analytical method also determines its suitability for the quantitation of chemical compounds; and in electrospray ionization for mass spectrometry, it can vary significantly among different analytes with identical solution concentrations. Therefore, we investigated the ESI-response behavior of 56 nitrogen-containing compounds including aromatic amines and pyridines, two compound classes of high importance to both, synthetic organic chemistry as well as to pharmaceutical sciences. These compounds are increasingly analyzed employing ESI mass spectrometry detection due to their polar, basic character. Signal intensities of the peaks from the protonated molecular ion (MH+) were acquired under different conditions and related to compound properties such as basicity, polarity, volatility and molecular size exploring their quantitative impact on ionization efficiency. As a result, we found that though solution basicity of a compound is the main factor initially determining the ESI response of the protonated molecular ion, other factors such as polarity and vaporability become more important under acidic solvent conditions and may nearly outweigh the importance of basicity under these conditions. Moreover, we show that different molecular descriptors may become important when using different types of instruments for such investigations, a fact not detailed so far in the available literature.	[Kiontke, Andreas; Oliveira-Birkmeier, Ariana; Birkemeyer, Claudia] Univ Leipzig, Inst Analyt Chem, Linnestr, Leipzig, Germany; [Opitz, Andreas] Univ Leipzig, Inst Linguist, Beethovenstr, Leipzig, Germany; [Oliveira-Birkmeier, Ariana] Astellas Pharma GmbH, Munich, Germany	Leipzig University; Leipzig University; Astellas Pharmaceuticals	Birkemeyer, C (corresponding author), Univ Leipzig, Inst Analyt Chem, Linnestr, Leipzig, Germany.	birkemeyer@chemie.uni.leipzig.de	Opitz, Andreas/AAJ-6731-2021; Birkemeyer, Claudia/L-8687-2015	Opitz, Andreas/0000-0002-1494-7591; Birkemeyer, Claudia/0000-0002-8538-8838; Kiontke, Andreas/0000-0002-0297-797X	German Research Foundation (DFG); Universitat Leipzig; Deutsche Bundesstiftung Umwelt (DBU) [20015/375]; European Fund for Structural Development EFRE ("Europe funds Saxony") [2592-2014]; German Academic Exchange Service (DAAD "Rise" program)	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig; Deutsche Bundesstiftung Umwelt (DBU); European Fund for Structural Development EFRE ("Europe funds Saxony"); German Academic Exchange Service (DAAD "Rise" program)(Deutscher Akademischer Austausch Dienst (DAAD))	The author(s) acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. This work was financed by the Deutsche Bundesstiftung Umwelt (DBU grant No. 20015/375), the European Fund for Structural Development EFRE ("Europe funds Saxony", grant No. 2592-2014), the German Academic Exchange Service (DAAD "Rise" program 2016) and the University of Leipzig." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. ing. Susan Billig, Ramona Oehme, Elisabeth Klinge, and Carolin Oswald (all University of Leipzig, Germany) and Aigerim Galyamova (Penn State University, USA) for technical assistance. In addition, we thank Prof. em. Berger, Prof. Belder and Prof. Reemtsma (University of Leipzig, Germany) for kind and constant support. The author(s) acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. This work was financed by the Deutsche Bundesstiftung Umwelt (DBU grant No. 20015/375), the European Fund for Structural Development EFRE ("Europe funds Saxony", grant No. 2592-2014), the German Academic Exchange Service (DAAD "Rise" program 2016) and the University of Leipzig.	Abburi R, 2012, EUR J MASS SPECTROM, V18, P301, DOI 10.1255/ejms.1187; ASHTON DS, 1993, ORG MASS SPECTROM, V28, P721, DOI 10.1002/oms.1210280612; Caetano S, 2005, ANAL CHIM ACTA, V550, P92, DOI 10.1016/j.aca.2005.06.069; Cech NB, 2000, ANAL CHEM, V72, P2717, DOI 10.1021/ac9914869; Cech NB, 2001, ANAL CHEM, V73, P208, DOI 10.1021/ac0006019; Chalcraft KR, 2009, ANAL CHEM, V81, P2506, DOI 10.1021/ac802272u; CHENG ZL, 1992, J AM SOC MASS SPECTR, V3, P281, DOI 10.1016/1044-0305(92)87055-4; Cole RB, 2000, J MASS SPECTROM, V35, P763, DOI 10.1002/1096-9888(200007)35:7<763::AID-JMS16>3.0.CO;2-#; Constantopoulos TL, 1999, J AM SOC MASS SPECTR, V10, P625, DOI 10.1016/S1044-0305(99)00031-8; DELAMORA JF, 1994, J FLUID MECH, V260, P155, DOI 10.1017/S0022112094003472; DOLE M, 1968, J CHEM PHYS, V49, P2240, DOI 10.1063/1.1670391; Ehrmann BM, 2008, J AM SOC MASS SPECTR, V19, P719, DOI 10.1016/j.jasms.2008.01.003; Enke CG, 1997, ANAL CHEM, V69, P4885, DOI 10.1021/ac970095w; Gabelica V, 2004, INT J MASS SPECTROM, V231, P189, DOI 10.1016/j.ijms.2003.10.010; Girod M, 2012, PHYS CHEM CHEM PHYS, V14, P9389, DOI [10.1039/c2cp23341j, 10.1039/c2cp23341]; Golubovic J, 2016, J CHROMATOGR A, V1438, P123, DOI 10.1016/j.chroma.2016.02.021; Henriksen T, 2005, J AM SOC MASS SPECTR, V16, P446, DOI 10.1016/j.jasms.2004.11.021; Hiraoka K., 1995, J MASS SPECTROM SOC, V43, P127; IKONOMOU MG, 1990, ANAL CHEM, V62, P957, DOI 10.1021/ac00208a012; IRIBARNE JV, 1976, J CHEM PHYS, V64, P2287, DOI 10.1063/1.432536; Kebarle P, 2000, ANAL CHIM ACTA, V406, P11, DOI 10.1016/S0003-2670(99)00598-X; KEBARLE P, 1993, ANAL CHEM, V65, pA972, DOI 10.1021/ac00070a001; Kostiainen R, 2009, J CHROMATOGR A, V1216, P685, DOI 10.1016/j.chroma.2008.08.095; Leito I, 2008, RAPID COMMUN MASS SP, V22, P379, DOI 10.1002/rcm.3371; Liigand J, 2014, J AM SOC MASS SPECTR, V25, P1853, DOI 10.1007/s13361-014-0969-x; Mandra VJ, 2015, RAPID COMMUN MASS SP, V29, P1661, DOI 10.1002/rcm.7263; Mansoori BA, 1997, RAPID COMMUN MASS SP, V11, P1120, DOI 10.1002/(SICI)1097-0231(19970630)11:10<1120::AID-RCM976>3.3.CO;2-H; NAKAGAKI R, 1993, J PHYS ORG CHEM, V6, P261, DOI 10.1002/poc.610060503; Olumee Z, 1998, J PHYS CHEM A, V102, P9154, DOI 10.1021/jp982027z; Oss M, 2010, ANAL CHEM, V82, P2865, DOI 10.1021/ac902856t; Peng L, 2008, J CHROMATOGR A, V1179, P131, DOI 10.1016/j.chroma.2007.11.048; RADOMSKI JL, 1979, ANNU REV PHARMACOL, V19, P129, DOI 10.1146/annurev.pa.19.040179.001021; Raji MA, 2009, INT J MASS SPECTROM, V279, P100, DOI 10.1016/j.ijms.2008.10.013; Raji MA, 2009, RAPID COMMUN MASS SP, V23, P2221, DOI 10.1002/rcm.4141; Rauha JP, 2001, J MASS SPECTROM, V36, P1269, DOI 10.1002/jms.231; Richter G, 2008, ANAL BIOCHEM, V376, P157, DOI 10.1016/j.ab.2008.01.029; Schmidt A, 2001, ANAL CHEM, V73, P6040, DOI 10.1021/ac010451h; Stewart R., 1985, PROTON APPL ORGANIC; TANG L, 1993, ANAL CHEM, V65, P3654, DOI 10.1021/ac00072a020; Van Berkel GJ, 1998, J ANAL ATOM SPECTROM, V13, P603, DOI 10.1039/a800373d; Vaschetto ME, 1999, J MOL STRUC-THEOCHEM, V468, P209, DOI 10.1016/S0166-1280(98)00624-1; Voyksner RD, 1999, ANAL CHEM, V71, P1441, DOI 10.1021/ac980995s; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; YAMASHITA M, 1984, J PHYS CHEM-US, V88, P4451, DOI 10.1021/j150664a002; Yang XJ, 2013, ANALYST, V138, P659, DOI 10.1039/c2an36022e; Yen TY, 1996, J AM SOC MASS SPECTR, V7, P1106, DOI 10.1016/S1044-0305(96)00073-6; Yidong Li, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining Workshops (ICDMW 2010), P491, DOI 10.1109/ICDMW.2010.112; Zhou SL, 2000, J AM SOC MASS SPECTR, V11, P961, DOI 10.1016/S1044-0305(00)00174-4; Zhou SL, 2001, J AM SOC MASS SPECTR, V12, P206, DOI 10.1016/S1044-0305(00)00213-0	49	50	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167502	10.1371/journal.pone.0167502	http://dx.doi.org/10.1371/journal.pone.0167502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907110	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700171
J	Laranjeira, FO; da Silva, EN; Pereira, MG				Laranjeira, Fernanda O.; da Silva, Everton Nunes; Pereira, Mauricio G.			Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil	PLOS ONE			English	Article							NATIONWIDE MULTICENTER; NPH INSULIN; TASK-FORCE; TYPE-1; CARE; REIMBURSEMENT; METAANALYSIS; ADOLESCENTS; PRINCIPLES; GLARGINE	Background Long-acting insulin analogues for type 1 diabetes (T1D) treatment have been available on the Brazilian market since 2002. However, the population cannot access the analogues through the public health system. Objective To estimate the incremental budget impact of long-acting insulin analogues coverage for T1D patients in the Brazilian public health system compared to NPH insulin. Methods We performed a budget impact analysis of a five-year period. The eligible population was projected using epidemiological data from the International Diabetes Federation estimates for patients between 0-14 and 20-79 years old. The prevalence of T1D was estimated in children, and the same proportion was applied to the 15-19-year-old group due to a gap in epidemiological information. We considered 4,944 new cases per year and a 34.61/100,000 inhabitants mortality rate. Market share for long-acting insulin analogues was assumed as 20% in the first year, reaching 40% in the fifth year. The mean daily dose was taken from clinical trials. We calculated the bargaining power of the Ministry of Health by dividing the price paid for human insulin in the last purchase by the average regulated price. We performed univariate and multivariate sensitivity analyses. Results The incremental budget impact of long-acting insulin analogues was US$ 28.6 million in the first year, and reached US$ 58.7 million in the fifth year. The total incremental budget impact was US$ 217.9 million over the five-year period. The sensitivity analysis showed that the percentage of T1D among diabetic adults and the insulin analogue price were the main factors that affected the budget impact. Conclusions The cost of the first year of long-acting insulin analogue coverage would correspond to 0.03% of total public health expenditure. The main advantage of this study is that it identifies potential bargaining power because it features more realistic profiles of resource usage, once centralized purchasing is established as an economically sustainable strategy. Clinical guidelines restricting the use of insulin analogues would make the decision towards insulin analogue coverage more affordable.	[Laranjeira, Fernanda O.; da Silva, Everton Nunes; Pereira, Mauricio G.] Univ Brasilia, Brasilia, DF, Brazil	Universidade de Brasilia	Laranjeira, FO (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	flaranjeira.oliveira@gmail.com		Silva, Everton/0000-0001-8747-4185	Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education	Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education	FOL received a PhD scholarship by Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	[Anonymous], 2015, INS AN DIAB MELL TIP; Araujo S, 2014, DIRETRIZES SOC BRASI; Bachle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070567; Banerjee S, 2007, SHORT ACTING INSULIN; BETZ JL, 1995, DIABETES EDUCATOR, V21, P195, DOI 10.1177/014572179502100306; Brazilian society of diabetes, CLIN GUID US INS AN; de Souza ALC, 2014, APPL HEALTH ECON HEA, V12, P19, DOI 10.1007/s40258-013-0073-6; Cammarota S, 2014, NUTR METAB CARDIOVAS, V24, P10, DOI 10.1016/j.numecd.2013.04.002; Chalkidou K, 2010, HLTH EC POLICY LAW C, V4, P1; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Cobas RA, 2013, B WORLD HEALTH ORGAN, V91, P434, DOI 10.2471/BLT.12.110387; Drummond M, 2011, EUR J HEALTH ECON, V12, P263, DOI 10.1007/s10198-010-0274-y; Ferraes Alide Marina Biehl, 2007, Rev. Adm. Pública, V41, P475; Ferreira-Da-Silva AL, 2012, CAD SAUDE PUBLICA, V28, P1223, DOI 10.1590/S0102-311X2012000700002; Frier BM, 2013, DIABETES OBES METAB, V15, P978, DOI 10.1111/dom.12106; Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008; Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-67; Grunberger G, 2014, DIABETES CARE, V37, P1767, DOI 10.2337/dc14-0031; Hartman I, 2008, CLIN MED RES, V6, P54, DOI 10.3121/cmr.2008.793; Haukka J, 2013, PHARMACOEPIDEM DR S, V22, P1326, DOI 10.1002/pds.3534; Holcombe JH, 2002, CLIN THER, V24, P629, DOI 10.1016/S0149-2918(02)85138-4; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holden SE, 2012, DIABETES MANAGE, V2, P173; Home PD, 2005, DIABETES-METAB RES, V21, P545, DOI 10.1002/dmrr.572; Instituto Brasileiro de Geografia e Estatistica, 2015, HOUS BUDG SURV 2008; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Kostev Karel, 2013, J Diabetes Sci Technol, V7, P736; Leite EB, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0061-0; Mattos PE, 2012, ARQ BRAS ENDOCRINOL, V56, P39, DOI 10.1590/S0004-27302012000100007; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Ministerio da Saude. Secretaria de Tecnologia e Insumos Estrategicos. Departamento de e Insumos Estrategicos, 2014, SPEC COMP PHARM CAR; Monami M, 2009, DIABETES OBES METAB, V11, P372, DOI 10.1111/j.1463-1326.2008.00976.x; National Health Surveillance Agency, 2015, CAM REG MERC MED LIS; National Institute for Clinical Excellence, 2002, GUID US LONG ACT INS, P53; National Institute of Health and Care Excellence, 2015, TYP 1 DIAB DIAGN MAN; Negrato CA, 2010, J ENDOCRINOL INVEST, V33, P373, DOI [10.3275/6439, 10.1007/BF03346606]; Orlewska E, 2011, VALUE HEALTH, V14, pA475, DOI 10.1016/j.jval.2011.08.1326; Orlewska E, 2009, VALUE HEALTH, V12, pA414, DOI 10.1016/S1098-3015(10)75044-0; Palmer AJ, 2007, CURR MED RES OPIN, V23, P895, DOI 10.1185/030079907X182194; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Schober E, 2001, DIABETES CARE, V24, P2005, DOI 10.2337/diacare.24.11.2005; do Amaral SMS, 2011, REV SAUDE PUBL, V45, P799, DOI 10.1590/S0034-89102011005000016; Shah A, 2012, VALUE HEALTH, V15, pA190, DOI 10.1016/j.jval.2012.03.1027; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501; Tran K, 2007, LONG ACTING INSULIN; Tricco AC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5459; Vieira FS, 2013, SAUDE SOC-SAO PAULO, V22, P73, DOI 10.1590/S0104-12902013000100008; World Health Organization, 2014, WHO GLOB HLTH EXP AT; Zangheline F, 2014, REV ELETRON FARM, VXI, P15	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167039	10.1371/journal.pone.0167039	http://dx.doi.org/10.1371/journal.pone.0167039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907034	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700070
J	Mylenko, M; Boland, S; Penkov, S; Sampaio, JL; Lombardot, B; Vorkel, D; Verbavatz, JM; Kurzchalia, TV				Mylenko, Mykola; Boland, Sebastian; Penkov, Sider; Sampaio, Julio L.; Lombardot, Benoit; Vorkel, Daniela; Verbavatz, Jean-Marc; Kurzchalia, Teymuras V.			NAD(+) Is a Food Component That Promotes Exit from Dauer Diapause in Caenorhabditis elegans	PLOS ONE			English	Article							IMAGE-ANALYSIS; C. ELEGANS; PHEROMONE; METABOLISM; SEROTONIN; BACTERIA; BEHAVIOR; RENALASE; MUTANTS; LARVA	The free-living soil nematode Caenorhabditis elegans adapts its development to the availability of food. When food is scarce and population density is high, worms enter a developmentally arrested non-feeding diapause stage specialized for long-term survival called the dauer larva. When food becomes available, they exit from the dauer stage, resume growth and reproduction. It has been postulated that compound(s) present in food, referred to as the "food signal", promote exit from the dauer stage. In this study, we have identified NAD(+) as a component of bacterial extract that promotes dauer exit. NAD(+), when dissolved in alkaline medium, causes opening of the mouth and ingestion of food. We also show that to initiate exit from the dauer stage in response to NAD(+) worms require production of serotonin. Thus, C. elegans can use redox cofactors produced by dietary organisms to sense food.	[Mylenko, Mykola; Boland, Sebastian; Penkov, Sider; Sampaio, Julio L.; Lombardot, Benoit; Vorkel, Daniela; Verbavatz, Jean-Marc; Kurzchalia, Teymuras V.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	kurzchalia@mpi-cbg.de	Sampaio, Julio/S-3810-2019; Mylenko, Mykola/T-8790-2018; Boland, Sebastian/AAL-4065-2020; Boland, Sebastian/AAJ-3560-2020	Boland, Sebastian/0000-0002-6694-2039; Verbavatz, Jean-Marc/0000-0002-4654-1174; Sampaio, Julio/0000-0002-2881-7827; Mylenko, Mykola/0000-0002-2662-2137	MPI-CBG internal grants	MPI-CBG internal grants	This study was funded by MPI-CBG internal grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; ALBERT PS, 1983, J COMP NEUROL, V219, P461, DOI 10.1002/cne.902190407; [Anonymous], 2015, ACD CHEMSKETCH FREEW; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Beaupre BA, 2013, J AM CHEM SOC, V135, P13980, DOI 10.1021/ja407384h; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chase Daniel L, 2007, WormBook, P1; Entchev EV, 2015, ELIFE, V4, DOI 10.7554/eLife.06259; Erkut C, 2011, CURR BIOL, V21, P1331, DOI 10.1016/j.cub.2011.06.064; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; GBEWONYO K, 1994, BIO-TECHNOL, V12, P51, DOI 10.1038/nbt0194-51; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; HOLM S, 1979, SCAND J STAT, V6, P65; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; JOHNSON RW, 1988, J AM CHEM SOC, V110, P2257, DOI 10.1021/ja00215a041; JOHNSON SL, 1970, J BIOL CHEM, V245, P4519; Kiyama Y, 2012, J EXP BIOL, V215, P1178, DOI 10.1242/jeb.067199; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Mann H.B., 1947, TEST WHETHER ONE 2 R, P50; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Penkov S, 2014, NAT CHEM BIOL, V10, P281, DOI [10.1038/NCHEMBIO.1460, 10.1038/nchembio.1460]; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; R Core Team, 2013, R LANG ENV STAT COMP; Riddle DL, 1997, LIFE HIST EVOLUTION; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sobol RW, 2014, DNA REPAIR, V23, P1, DOI 10.1016/j.dnarep.2014.10.007; SULSTON JE, 1974, GENETICS, V77, P95; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Voet D., 2010, BIOCHEMISTRY	45	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167208	10.1371/journal.pone.0167208	http://dx.doi.org/10.1371/journal.pone.0167208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907064	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700092
J	Yap, R; Wilkins, S; Staples, M; Oliva, K; McMurrick, PJ				Yap, Raymond; Wilkins, Simon; Staples, Margaret; Oliva, Karen; McMurrick, Paul J.			The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; ADVERSE OUTCOMES; CHRONIC WOUNDS; MELLITUS; HYPERGLYCEMIA; MANAGEMENT; RISK	There are approximately 1.3 million patients in Australia with diabetes. Conflicting reports exist in the literature as to the effect of diabetes on the outcomes of colorectal cancer patients. We hypothesized that patients with diabetes would have poorer perioperative outcomes, and that diabetes was an independent risk factor for both 30-day mortality and perioperative morbidity. The aim of this study was to assess the impact of diabetes on perioperative colorectal cancer surgery outcomes, as compared to a diabetes-free reference population, and to examine factors affecting perioperative risk. We conducted an analysis of a prospectively collected, clinician-led colorectal cancer database of patients from 2010-2015. Patients with diabetes were compared to patients without diabetes on a range of perioperative outcomes. Pearson chi-squared tests, Wilcoxon rank sum tests and t-tests were employed for univariate analyses. Confounding factors were controlled for by separate logistic and linear regression analyses. The Huber-White Sandwich Estimator was used to calculate robust standard errors. A total of 1725 patients were analysed over 1745 treatment episodes in the study period with 267 patients (268 episodes) with diabetes studied. Diabetes contributed to medical, surgical complications, and increased length of inpatient stay in univariate analyses. Multivariable analysis adjusted for variables independently associated with each outcome revealed that diabetes was an independent contributor to an increased risk of surgical complications, with no significant effect on medical complications, return to the operating room, 30-day mortality, or readmission within 30 days. In this study, where overall baseline morbidity and mortality levels are low, the effect of diabetes alone on perioperative surgical outcomes appears to be overstated with control of associated perioperative risk factors such as cardiac, renal and respiratory factors being more important.	[Yap, Raymond; Wilkins, Simon; Oliva, Karen; McMurrick, Paul J.] Cabrini Monash Univ, Dept Surg, Cabrini Hosp, Malvern, Vic, Australia; [Wilkins, Simon] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Staples, Margaret] Cabrini Hosp, Monash Dept Clin Epidemiol, Malvern, Vic, Australia	Cabrini Health; Monash University; Monash University; Cabrini Health; Monash University	Yap, R (corresponding author), Cabrini Monash Univ, Dept Surg, Cabrini Hosp, Malvern, Vic, Australia.	ryap@cabrini.com.au	Wilkins, Simon/D-1174-2009	Wilkins, Simon/0000-0001-7712-4114				Anand N, 2010, J GEN INTERN MED, V25, P809, DOI 10.1007/s11606-010-1336-7; Ata A, 2010, AM SURGEON, V76, P697; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Brem H, 2007, MOL MED, V13, P30, DOI 10.2119/2006-00054.Brem; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Coursin DB, 2004, CRIT CARE MED, V32, pS116, DOI 10.1097/01.CCM.0000115623.52021.C0; Fransgaard T, 2016, COLORECTAL DIS, V18, pO22, DOI 10.1111/codi.13158; Frisch A, 2010, DIABETES CARE, V33, P1783, DOI 10.2337/dc10-0304; Heriot A., 2015, AUSTR COLORECTAL SUR; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; McConnell YJ, 2009, J GASTROINTEST SURG, V13, P508, DOI 10.1007/s11605-008-0734-1; McMurrick PJ, 2014, DIS COLON RECTUM, V57, P167, DOI 10.1097/DCR.0000000000000041; Mejia J, 2014, EUR J ANAESTH, V31, P205, DOI 10.1097/00003643-201406001-00588; Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9; MOWAT AG, 1971, NEW ENGL J MED, V284, P621, DOI 10.1056/NEJM197103252841201; Rogers W., 1994, STATA TECHNICAL B, V3, P1, DOI DOI 10.1016/J.SCITOTENV.2014.04.059; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770	21	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167271	10.1371/journal.pone.0167271	http://dx.doi.org/10.1371/journal.pone.0167271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907053	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700106
J	Zhang, H; Zhu, NX; Huang, K; Cai, BZ; Zeng, Y; Xu, YM; Liu, Y; Yuan, YP; Lin, CM				Zhang, Huan; Zhu, Ning-Xia; Huang, Keng; Cai, Bo-Zhi; Zeng, Yang; Xu, Yan-Ming; Liu, Yang; Yuan, Yan-Ping; Lin, Chang-Min			iTRAQ-Based Quantitative Proteomic Comparison of Early- and Late-Passage Human Dermal Papilla Cell Secretome in Relation to Inducing Hair Follicle Regeneration	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WNT SIGNALING PATHWAY; TGF-BETA ACTIVITY; MATRIX METALLOPROTEINASES; CANCER; PROGENITORS; PROGRESSION; MODULATION; PREDICTION; BIGLYCAN	Alopecia is an exceedingly prevalent problem that lacks effective therapy. Recently, research has focused on early-passage dermal papilla cells (DPCs), which have hair inducing activity both in vivo and in vitro. Our previous study indicated that factors secreted from early-passage DPCs contribute to hair follicle (HF) regeneration. To identify which factors are responsible for HF regeneration and why late-passage DPCs lose this potential, we collected 48-h-culture medium (CM) from both of passage 3 and 9 DPCs, and subcutaneously injected the DPC-CM into NU/NU mice. Passage 3 DPC-CM induced HF regeneration, based on the emergence of a white hair coat, but passage 9 DPC-CM did not. In order to identify the key factors responsible for hair induction, CM from passage 3 and 9 DPCs was analyzed by iTRAQ-based quantitative proteomic technology. We identified 1360 proteins, of which 213 proteins were differentially expressed between CM from early-passage vs. late-passage DPCs, including SDF1, MMP3, biglycan and LTBP1. Further analysis indicated that the differentially-expressed proteins regulated the Wnt, TGF-beta and BMP signaling pathways, which directly and indirectly participate in HF morphogenesis and regeneration. Subsequently, we selected 19 proteins for further verification by multiple reaction monitoring (MRM) between the two types of CM. These results indicate DPC-secreted proteins play important roles in HF regeneration, with SDF1, MMP3, biglycan, and LTBP1 being potential key inductive factors secreted by dermal papilla cells in the regeneration of hair follicles.	[Zhang, Huan; Zeng, Yang; Liu, Yang; Yuan, Yan-Ping; Lin, Chang-Min] Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China; [Zhu, Ning-Xia] Shantou Univ, Affiliated Hosp 1, Dept Cardiol, Coll Med, Shantou, Guangdong, Peoples R China; [Huang, Keng] Shantou Univ, Affiliated Hosp 2, Emergency Dept, Coll Med, Shantou, Guangdong, Peoples R China; [Cai, Bo-Zhi] Shantou Univ, Affiliated Hosp 1, Tissue Engn Lab, Coll Med, Shantou, Guangdong, Peoples R China; [Xu, Yan-Ming] Shantou Univ, Coll Med, Lab Canc Biol & Epigenet, Dept Cell Biol & Genet, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Lin, CM (corresponding author), Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China.	cocolin@126.com	Xu, yanming/Q-4931-2019		National Science Foundation of China [81372084, 81171832, 81501685]; Guangdong Province Outstanding Young Teacher Training Program [Yq2013078]; Guangdong Scientific Research Funding Program [2014A020211024]; National Science Foundation of Guangdong Province [2016A030310078]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Outstanding Young Teacher Training Program; Guangdong Scientific Research Funding Program; National Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Science Foundation of China (http://www.nsfc.gov.cn) (Nos. 81372084 to KH, 81171832 to CML and 81501685 to NXZ), the Guangdong Province Outstanding Young Teacher Training Program (http://www.gdhed.edu.cn) (No. Yq2013078 to CML), the Guangdong Scientific Research Funding Program (http://www.gdstc.gov.cn) (No. 2014A020211024 to CML), and by the National Science Foundation of Guangdong Province (http://pro.gdstc.gov.cn/) (No.2016A030310078 to NXZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmadani A, 2009, DIFFERENTIATION, V77, P395, DOI 10.1016/j.diff.2008.10.015; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; Blavier L, 2010, CANCER BIOL THER, V10, P198, DOI 10.4161/cbt.10.2.12193; Chen DM, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0198-9; Balana ME, 2015, WORLD J STEM CELLS, V7, P711, DOI 10.4252/wjsc.v7.i4.711; Fujie T, 2001, J DERMATOL SCI, V25, P206, DOI 10.1016/S0923-1811(00)00130-4; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Guo R, 2015, IN VITRO CELL DEV-AN, V51, P578, DOI 10.1007/s11626-014-9862-y; Hamada K, 2006, BRIT J DERMATOL, V154, P609, DOI 10.1111/j.1365-2133.2006.07144.x; Hu TH, 2014, CANCER LETT, V354, P417, DOI 10.1016/j.canlet.2014.08.012; Inamatsu M, 1998, J INVEST DERMATOL, V111, P767, DOI 10.1046/j.1523-1747.1998.00382.x; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kessenbrock K, 2013, CELL STEM CELL, V13, P300, DOI 10.1016/j.stem.2013.06.005; Li X, 2014, J PROTEOMICS, V98, P138, DOI 10.1016/j.jprot.2013.12.025; Lin CM, 2008, ARCH DERMATOL RES, V300, P531, DOI 10.1007/s00403-008-0852-3; Lin CM, 2009, CHIN J TRAUMATOL, V12, P49, DOI 10.3760/cma.j.issn.1008-1275.2009.01.010; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Malgouries S, 2008, BRIT J DERMATOL, V158, P234, DOI 10.1111/j.1365-2133.2007.08339.x; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Plikus MV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015198; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Tritschler I, 2009, INT J CANCER, V125, P530, DOI 10.1002/ijc.24443; Upton PD, 2013, AM J RESP CELL MOL, V49, P1135, DOI 10.1165/rcmb.2012-0470OC; Wang H, 2015, J BIOMECH, V48, P432, DOI 10.1016/j.jbiomech.2014.12.032; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Won CH, 2012, BMB REP, V45, P253, DOI 10.5483/BMBRep.2012.45.4.253; Yan H, 2010, BIOCHEM BIOPH RES CO, V391, P1187, DOI 10.1016/j.bbrc.2009.12.015; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yu L, 2005, J DERMATOL SCI, V37, P58, DOI 10.1016/j.jdermsci.2004.10.001; Zhang FL, 2014, J PROTEOMICS, V102, P125, DOI 10.1016/j.jprot.2014.03.007; Zhang PP, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414556850	37	11	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167474	10.1371/journal.pone.0167474	http://dx.doi.org/10.1371/journal.pone.0167474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907131	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700164
J	Makowska, A; Eble, M; Prescher, K; Hoss, M; Kontny, U				Makowska, Anna; Eble, Michael; Prescher, Kirsten; Hoss, Mareike; Kontny, Udo			Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IN-VITRO; INHIBITION; APOPTOSIS; HYDROXYCHLOROQUINE; TEMOZOLOMIDE; 5-FLUOROURACIL; CHEMOTHERAPY; CONTRIBUTES; INDUCTION	Background Treatment of nasopharyngeal carcinoma requires the application of high dosages of radiation, leading to severe long-term complications in the majority of patients. Sensitizing tumor cells to radiation could be a means to increase the therapeutic window of radiation. Nasopharyngeal carcinoma cells display alterations in autophagy and blockade of autophagy has been shown to sensitize them against chemotherapy. Methods We investigated the effect of chloroquine, a known inhibitor of autophagy, on sensitization against radiation-induced apoptosis in a panel of five nasopharyngeal carcinoma cell lines and a SV40-transformed nasoepithelial cell line. Autophagy was measured by immunoblot of autophagy-related proteins, immunofluorescence of autophagosomic microvesicles and electron microscopy. Autophagy was blocked by siRNA against autophagy-related proteins 3, 5, 6 and 7 (ATG3, ATG5, ATG6 and ATG7). Results C hloroquine sensitized four out of five nasopharyngeal cancer cell lines towards radiation-induced apoptosis. The sensitizing effect was based on the blockade of autophagy as inhibition of ATG3, ATG5, ATG6 and ATG7 by specific siRNA could substitute for the effect of chloroquine. No sensitization was seen in nasoepithelial cells. Conclusion Chloroquine sensitizes nasopharyngeal carcinoma cells but not nasoepithelial cells towards radiation-induced apoptosis by blocking autophagy. Further studies in a mouse-xenograft model are warranted to substantiate this effect in vivo.	[Makowska, Anna; Kontny, Udo] Rhein Westfal TH Aachen, Fac Med, Div Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany; [Eble, Michael; Prescher, Kirsten] Rhein Westfal TH Aachen, Fac Med, Dept Radiat Oncol, Aachen, Germany; [Hoss, Mareike] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Electron Microscop Facil, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Kontny, U (corresponding author), Rhein Westfal TH Aachen, Fac Med, Div Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany.	ukontny@ukaachen.de						Al Dhaheri Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109630; Alam MM, 2016, APOPTOSIS, V21, P1191, DOI 10.1007/s10495-016-1277-7; [Anonymous], 1978, Sci Sin, V21, P127; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Buehrlen M, 2012, CANCER-AM CANCER SOC, V118, P4892, DOI 10.1002/cncr.27395; Casanova M, 2012, CANCER-AM CANCER SOC, V118, P2718, DOI 10.1002/cncr.26528; Cheuk DKL, 2011, CANCER-AM CANCER SOC, V117, P197, DOI 10.1002/cncr.25376; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Du HL, 2012, ONCOL REP, V27, P143, DOI 10.3892/or.2011.1464; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Hori YS, 2015, J NEURO-ONCOL, V122, P11, DOI 10.1007/s11060-014-1686-9; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Lakhter AJ, 2013, J INVEST DERMATOL, V133, P2247, DOI 10.1038/jid.2013.56; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; LI Jing-gang, 2009, J NATURAL RESOURCE, V5, DOI DOI 10.2514/1.52476.31; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mo N, 2014, ONCOL REP, V32, P1905, DOI 10.3892/or.2014.3427; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rodemann H, 2011, RADIOTHER ONCOL, V99, P287, DOI [10.1016/j.radonc.2011.06.002, DOI 10.1016/J.RADONC.2011.06.002]; Rodriguez-Galindo C, 2005, CANCER-AM CANCER SOC, V103, P850, DOI 10.1002/cncr.20823; Rojas-Puentes LL, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-209; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Sloman S. A., 2014, MEM COGNITION, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100819; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Song LL, 2013, ONCOL LETT, V6, P1031, DOI 10.3892/ol.2013.1498; Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004; Tsai WL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-856; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509; Zhang Y, 2015, CURR MED RES OPIN, V31, P1009, DOI 10.1185/03007995.2015.1025731; Zhao XG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126147; Zhou ZR, 2013, ONCOL REP, V29, P2498, DOI 10.3892/or.2013.2382; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	50	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166766	10.1371/journal.pone.0166766	http://dx.doi.org/10.1371/journal.pone.0166766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902742	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100039
J	Prause, N; Siegle, GJ; Deblieck, C; Wu, A; Iacoboni, M				Prause, Nicole; Siegle, Greg J.; Deblieck, Choi; Wu, Allan; Iacoboni, Marco			EEG to Primary Rewards: Predictive Utility and Malleability by Brain Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST-STIMULATION; STRIATAL DOPAMINE RELEASE; RISKY SEXUAL-BEHAVIOR; INDIVIDUAL-DIFFERENCES; NEURAL ACTIVITY; TIME-COURSE; BLOOD-FLOW; AROUSAL; MOTOR	Theta burst stimulation (TBS) is thought to affect reward processing mechanisms, which may increase and decrease reward sensitivity. To test the ability of TBS to modulate response to strong primary rewards, participants hypersensitive to primary rewards were recruited. Twenty men and women with at least two opposite-sex, sexual partners in the last year received two forms of TBS. Stimulations were randomized to avoid order effects and separated by 2 hours to reduce carryover. The two TBS forms have been demonstrated to inhibit (continuous) or excite (intermittent) the left dorsolateral prefrontal cortex using different pulse patterns, which links to brain areas associated with reward conditioning. After each TBS, participants completed tasks assessing their reward responsiveness to monetary and sexual rewards. Electroencephalography (EEG) was recorded. They also reported their number of orgasms in the weekend following stimulation. This signal was malleable by TBS, where excitatory TBS resulted in lower EEG alpha relative to inhibitory TBS to primary rewards. EEG responses to sexual rewards in the lab (following both forms of TBS) predicted the number of orgasms experienced over the forthcoming weekend. TBS may be useful in modifying hypersensitivity or hyposensitivity to primary rewards that predict sexual behaviors. Since TBS altered the anticipation of a sexual reward, TBS may offer a novel treatment for sexual desire problems.	[Prause, Nicole] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Siegle, Greg J.] Univ Pittsburgh, Western Psychiat Inst & Clin, 3811 Ohara St, Pittsburgh, PA 15213 USA; [Deblieck, Choi; Wu, Allan; Iacoboni, Marco] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of California System; University of California Los Angeles	Prause, N (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.	nicole.prause@gmail.com						Ahn HM, 2013, BRAIN STIMUL, V6, P310, DOI 10.1016/j.brs.2012.05.013; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Beck SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009251; Benning S, 2001, PSYCHOPHYSIOLOGY, V38, pS24; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Binson D, 1998, PUBLIC OPIN QUART, V62, P190, DOI 10.1086/297840; Bobrov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020674; Both S, 2008, J SEX MED, V5, P1386, DOI 10.1111/j.1743-6109.2008.00815.x; Both S, 2008, J SEX MED, V5, P100, DOI 10.1111/j.1743-6109.2007.00643.x; BOWERS MB, 1971, AM J PSYCHIAT, V127, P1691, DOI 10.1176/ajp.127.12.1691; Bowman CH, 2003, BRAIN COGNITION, V53, P207, DOI 10.1016/S0278-2626(03)00111-8; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Catania JA, 2005, ANN BEHAV MED, V29, P86, DOI 10.1207/s15324796abm2902_2; Chistyakov AV, 2010, INT J NEUROPSYCHOPH, V13, P387, DOI 10.1017/S1461145710000027; Cho SS, 2010, BRAIN STIMUL, V3, P170, DOI 10.1016/j.brs.2009.10.002; Crosby R, 2008, INT J STD AIDS, V19, P590, DOI 10.1258/ijsa.2008.008120; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Derefinko KJ, 2014, ARCH SEX BEHAV, V43, P1149, DOI 10.1007/s10508-014-0327-x; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Diekhof EK, 2008, BRAIN RES REV, V59, P164, DOI 10.1016/j.brainresrev.2008.07.004; Donamayor N, 2012, NEUROIMAGE, V62, P17, DOI 10.1016/j.neuroimage.2012.04.038; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fortenberry JD, 2005, HEALTH PSYCHOL, V24, P252, DOI 10.1037/0278-6133.24.3.252; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Georgiadis JR, 2006, EUR J NEUROSCI, V24, P3305, DOI 10.1111/j.1460-9568.2006.05206.x; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; GILLAN P, 1979, PSYCHOPHYSIOLOGY, V16, P471, DOI 10.1111/j.1469-8986.1979.tb01507.x; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grov C, 2013, AIDS BEHAV, V17, P773, DOI 10.1007/s10461-012-0345-4; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hallschmid M, 2002, CLIN NEUROPHYSIOL, V113, P1059, DOI 10.1016/S1388-2457(02)00142-6; Herbenick D, 2009, J SEX MED, V6, P1857, DOI 10.1111/j.1743-6109.2009.01318.x; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubl D, 2008, NEUROSCIENCE, V151, P921, DOI 10.1016/j.neuroscience.2007.10.049; Iacono WG, 2006, PSYCHOPHYSIOLOGY, V43, P465, DOI 10.1111/j.1469-8986.2006.00422.x; JANSSEN E, 1994, J CONSULT CLIN PSYCH, V62, P1222, DOI 10.1037/0022-006X.62.6.1222; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; KAFKA MP, 1991, J CLIN PSYCHIAT, V52, P60; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Ko JH, 2013, HUM BRAIN MAPP, V34, P1591, DOI 10.1002/hbm.22006; KOLIN EA, 1964, J CONSULT PSYCHOL, V28, P477; Kruger THC, 2005, WORLD J UROL, V23, P130, DOI 10.1007/s00345-004-0496-7; Laan E, 2002, ANUNAL MEETING OF TH; Lega BC, 2011, NEUROREPORT, V22, P795, DOI 10.1097/WNR.0b013e32834b2975; Leicht G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083414; LEVIN RJ, 1985, ARCH SEX BEHAV, V14, P439, DOI 10.1007/BF01542004; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Luber B, 2014, NEUROIMAGE, V85, P961, DOI 10.1016/j.neuroimage.2013.06.007; Marcus BS, 2011, J SEX MED, V8, P3398, DOI 10.1111/j.1743-6109.2010.02132.x; Mastropasqua C, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00097; Mishra BR, 2010, ADDICTION, V105, P49, DOI 10.1111/j.1360-0443.2009.02777.x; Moll JL, 2011, J SEX MED, V8, P956, DOI 10.1111/j.1743-6109.2010.02190.x; Mori N, 2007, J ENG MECH, V133, P122, DOI 10.1061/(ASCE)0733-9399(2007)133:1(122); Nauczyciel C, 2011, PSYCHIAT RES, V186, P232, DOI 10.1016/j.psychres.2010.06.012; Norris CJ, 2010, BIOL PSYCHOL, V84, P422, DOI 10.1016/j.biopsycho.2010.03.011; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Oei NYL, 2012, NEUROPSYCHOPHARMACOL, V37, P1729, DOI 10.1038/npp.2012.19; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; Paterson LQP, 2013, THE JOURNAL OF SEXUA; Pogarell O, 2006, J PSYCHIATR RES, V40, P307, DOI 10.1016/j.jpsychires.2005.09.001; Politi E, 2008, AM J ADDICTION, V17, P345, DOI 10.1080/10550490802139283; Prause N, 2014, SOCIAL COGNITIVE AND; Prause N, 2014, PSYCHOPHYSIOLOGY, V51, P226, DOI 10.1111/psyp.12173; Prause N, 2012, SEX RELATSH THER, V27, P17, DOI 10.1080/14681994.2012.660141; Pripfl J, 2014, BRAIN STIMUL, V7, P226, DOI 10.1016/j.brs.2013.11.003; Rizk S, 2013, EUR J NEUROSCI, V38, P3230, DOI 10.1111/ejn.12334; Rosenbaum MS, 2013, J HOMOSEXUAL, V60, P505, DOI 10.1080/00918369.2013.760305; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rowland D L, 1994, Int J Impot Res, V6, P153; Rowland DL, 2004, INT J IMPOT RES, V16, P270, DOI 10.1038/sj.ijir.3901156; Rowland DL, 1996, J ABNORM PSYCHOL, V105, P194, DOI 10.1037/0021-843X.105.2.194; ROWLAND DL, 1992, ARCH SEX BEHAV, V21, P387, DOI 10.1007/BF01542027; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Santesso DL, 2008, NEUROIMAGE, V42, P807, DOI 10.1016/j.neuroimage.2008.05.032; Schaefer HS, 2006, BIOL PSYCHIAT, V60, P974, DOI 10.1016/j.biopsych.2006.03.024; Schober JM, 2004, BJU INT, V94, P589, DOI 10.1111/j.1464-410X.2004.05006.x; Schober JM, 2009, BJU INT, V103, P1096, DOI 10.1111/j.1464-410X.2008.08166.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2016, DOPAMINE REWARD PRED; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Semple SJ, 2006, J ADDICT DIS, V25, P105, DOI 10.1300/J069v25n04_10; Sescousse G, 2013, BRAIN, V136, P2527, DOI 10.1093/brain/awt126; Shankman SA, 2011, INT J PSYCHOPHYSIOL, V79, P287, DOI 10.1016/j.ijpsycho.2010.11.004; Simons RF, 2003, MEDIA PSYCHOL, V5, P283, DOI 10.1207/S1532785XMEP0503_03; SOBOTKA SS, 1992, ELECTROEN CLIN NEURO, V83, P236, DOI 10.1016/0013-4694(92)90117-Z; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; STEINMETZ H, 1990, AM J NEURORADIOL, V11, P1123; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Storholm ED, 2011, ARCH SEX BEHAV, V40, P1301, DOI 10.1007/s10508-010-9712-2; Stoy M, 2012, J PSYCHOPHARMACOL, V26, P677, DOI 10.1177/0269881111416686; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; Stuart B, 2010, J BIOSOC SCI, V42, P27, DOI 10.1017/S0021932009990289; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Urban NBL, 2012, PSYCHOPHARMACOLOGY, V221, P67, DOI 10.1007/s00213-011-2543-6; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; van Lankveld JJDM, 2008, BIOL PSYCHOL, V79, P200, DOI 10.1016/j.biopsycho.2008.04.016; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Wing VC, 2013, BRAIN STIMUL, V6, P221, DOI 10.1016/j.brs.2012.06.008; Wischnewski M, 2015, BRAIN STIMUL, V8, P685, DOI 10.1016/j.brs.2015.03.004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wu CC, 2014, NEUROIMAGE, V84, P279, DOI [10.1016/J.neuroimage.2013.08.055, 10.1016/j.neuroimage.2013.08.055]; Zangen A, 2002, NEUROREPORT, V13, P2401, DOI 10.1097/00001756-200212200-00005	131	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165646	10.1371/journal.pone.0165646	http://dx.doi.org/10.1371/journal.pone.0165646			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902711	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100007
J	Rechetelo, J; Grice, A; Reside, AE; Hardesty, BD; Moloney, J				Rechetelo, Juliana; Grice, Anthony; Reside, April Elizabeth; Hardesty, Britta Denise; Moloney, James			Movement Patterns, Home Range Size and Habitat Selection of an Endangered Resource Tracking Species, the Black-Throated Finch (Poephila cincta cincta)	PLOS ONE			English	Article							GRANIVOROUS BIRDS; RADIO-TRANSMITTERS; NORTHERN AUSTRALIA; BREEDING BIOLOGY; SPARROWS; BEHAVIOR; PASSERINES; RETENTION; MAMMALS; RATES	Understanding movement patterns and home range of species is paramount in ecology; it is particularly important for threatened taxa as it can provide valuable information for conservation management. To address this knowledge gap for a range-restricted endangered bird, we estimated home range size, daily movement patterns and habitat use of a granivorous subspecies in northeast Australia, the black-throated finch (Poephila cincta cincta; BTF) using radio-tracking and re-sighting of colour banded birds. Little is known about basic aspects of its ecology including movement patterns and home range sizes. From 2011 - 2014 we colour-banded 102 BTF and radio-tracked 15 birds. We generated home ranges (calculated using kernel and Minimum Convex Polygons techniques of the 15 tracked BTF). More than 50% of the re-sightings occurred within 200 m of the banding site (n = 51 out of 93 events) and within 100 days of capture. Mean home-range estimates with kernel (50%, 95% probability) and Minimum Convex Polygons were 10.59 ha, 50.79 ha and 46.27 ha, respectively. Home range size differed between two capture sites but no seasonal differences were observed. BTF home ranges overlapped four habitat types among eight available. Habitat selection was different from random at Site 1 (chi(2) = 373.41, df = 42, p<0.001) and Site 2 (chi(2) = 1896.1, df = 45, p<0.001); however, the preferred habitats differed between the two sites. BTF moved further than expected on the basis of current knowledge, with three individuals being resighted over 15 km from the banding location. However, BTF maintain small home ranges over short time-frames. Occasional long-distance movements may be related to resource bottleneck periods. Daily movement patterns differed between sites, which is likely linked to the fact that the sites differ in the spatial distribution of resources. The work provides information about home range sizes and local movement of BTF that will be valuable for targeting effective management and conservation strategies for this endangered granivore.	[Rechetelo, Juliana; Reside, April Elizabeth; Moloney, James] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Rechetelo, Juliana; Hardesty, Britta Denise] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Grice, Anthony] CSIRO, Land & Water Flagship, Townsville, Qld, Australia; [Rechetelo, Juliana] Univ Parana, Ornithol Lab, Matinhos, Parana, Brazil; [Grice, Anthony] James Cook Univ, Townsville, Qld, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Rechetelo, J (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Rechetelo, J (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.; Rechetelo, J (corresponding author), Univ Parana, Ornithol Lab, Matinhos, Parana, Brazil.	jurechetelo@gmail.com	Hardesty, Britta Denise/A-3189-2011; Rechetelo, Juliana/AAE-3692-2022; Reside, April/H-4940-2011	Hardesty, Britta Denise/0000-0003-1948-5098; Rechetelo, Juliana/0000-0002-3191-5268; Reside, April/0000-0002-0760-9527	Black-throated finch Trust; James Moloney and Anthony Grice; Bird Life Australia; Juliana Rechetelo WildLife Queensland; Juliana Rechetelo College of Marine & Environmental Sciences; James Cook University -Juliana Rechetelo Tropical Landscapes Joint Venture (JCU and SCIRO)	Black-throated finch Trust; James Moloney and Anthony Grice; Bird Life Australia; Juliana Rechetelo WildLife Queensland; Juliana Rechetelo College of Marine & Environmental Sciences; James Cook University -Juliana Rechetelo Tropical Landscapes Joint Venture (JCU and SCIRO)	Funded by Black-throated finch Trust- no grant number- James Moloney and Anthony Grice; Bird Life Australia -no grant number- Juliana Rechetelo WildLife Queensland no grant number Juliana Rechetelo College of Marine & Environmental Sciences, James Cook University -Juliana Rechetelo Tropical Landscapes Joint Venture (JCU and SCIRO)-scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Anich NM, 2009, J FIELD ORNITHOL, V80, P206, DOI 10.1111/j.1557-9263.2009.00210.x; [Anonymous], 2001, RADIO TRACKING ANIMA; [Anonymous], 2014, R LANG ENV STAT COMP; Baldwin HQ, 2010, WILSON J ORNITHOL, V122, P139, DOI 10.1676/08-160.1; Barg JJ, 2005, J ANIM ECOL, V74, P139, DOI 10.1111/j.1365-2656.2004.00906.x; Beyer H. L, 2012, GEOSPATIAL MODELLING; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; BirdLife International, 2015, IUCN RED LIST BIRDS; Brandt MJ, 2008, IBIS, V150, P495, DOI 10.1111/j.1474-919X.2008.00811.x; Brandt MJ, 2007, TRADE OFFS RISKS PRE; BTFRT, 2007, NAT REC PLAN BLACK T; Bureau of Meteorology, 2015, CLIM STAT AUSTR LOC; Calenge C, 2006, ECOLOGY, V87, P2349, DOI 10.1890/0012-9658(2006)87[2349:EOSRFA]2.0.CO;2; Calladine J, 327 BTO; Clarke MF, 1997, EMU, V97, P283, DOI 10.1071/MU97041; Crowley G, 1999, AUST J ECOL, V24, P208, DOI 10.1046/j.1442-9993.1999.00964.x; Crowley G.M., 2003, MANAGEMENT GUIDELINE; DAVIES SJJF, 1984, J ARID ENVIRON, V7, P183; Dean WRJ, 1997, J BIOGEOGR, V24, P769, DOI 10.1046/j.1365-2699.1997.00163.x; Department of the Environment, 2015, PEOPH CINCT CINCT SP; Diemer KM, 2014, WILSON J ORNITHOL, V126, P39, DOI 10.1676/13-098.1; EVANS SM, 1985, IBIS, V127, P348, DOI 10.1111/j.1474-919X.1985.tb05076.x; EVANS SM, 1987, EMU, V87, P124, DOI 10.1071/MU9870124; Franklin DC, 2005, WILDLIFE RES, V32, P399, DOI 10.1071/WR05052; Franklin DC, 2000, J BIOGEOGR, V27, P829, DOI 10.1046/j.1365-2699.2000.00446.x; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Garnett ST, 2000, ACTION PLAN AUSTR BI; Garnett ST, 2009, BIODIVERS CONSERV, P189; Ginter DL, 2005, WILSON BULL, V117, P63, DOI 10.1676/04-017; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gordon CE, 2000, AUK, V117, P748, DOI 10.1642/0004-8038(2000)117[0748:MPOWGS]2.0.CO;2; Grice AC, 2013, WILDLIFE SOC B, V37, P478, DOI 10.1002/wsb.314; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Higgins P.J., 2006, VOLUME 7 BOATBILL ST; Isles NL, 2007, PATTERNS FORAGING BE; JENKINS SH, 1981, AM NAT, V118, P126, DOI 10.1086/283807; JOHNSON GD, 1991, J FIELD ORNITHOL, V62, P486; KEAST ALLEN, 1958, EMU, V58, P219; Lewis M., 2007, TEMPORAL DIMENSIONS, P218, DOI [10.1007/978-0-387-45447-4_13, DOI 10.1007/978-0-387-45447-4_13]; Manly B. F. J., 2002, RESOURCE SELECTION A, V2; Maute K. L., 2011, THESIS; Milenkaya O, 2011, EMU, V111, P312, DOI 10.1071/MU10088; Millspaugh Joshua J., 2001, P383, DOI 10.1016/B978-012497781-5/50016-5; Mitchell DF, 1996, FORAGING ECOLOGY BLA; Morrison M.L., 1998, WILDLIFE HABITAT REL; MORTON SR, 1983, AUST J ECOL, V8, P235; O'Malley C., 2006, NATL RECOVERY PLAN G; Protection DoEaH, 2014, ENV MAPS DAT ONL; Queensland Government, 2014, MAT SERV MOD; Remnant Vegetation in Queensland, 2013, REMN VEG QUEENSL AN; Rivera JHV, 2003, J FIELD ORNITHOL, V74, P141, DOI 10.1648/0273-8570-74.2.141; Sattler P., 1999, CONSERVATION STATUS; Smith N.M.., 2002, WEEDS WETDRY TROPICS; Smolinsky JA, 2013, BEHAV ECOL SOCIOBIOL, V67, P2041, DOI 10.1007/s00265-013-1614-6; Tidemann Sonia C., 1993, Victorian Naturalist (South Yarra), V110, P238; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9; WOINARSKI JCZ, 1992, EMU, V92, P33, DOI 10.1071/MU9920033; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; Zann RA., 1996, ZEBRA FINCH SYNTHESI	63	18	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167254	10.1371/journal.pone.0167254	http://dx.doi.org/10.1371/journal.pone.0167254			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902764	Green Published, Green Accepted, gold			2022-12-27	WOS:000389474100064
J	Rechenberg, DK; Galicia, JC; Peters, OA				Rechenberg, Dan-Krister; Galicia, Johnah C.; Peters, Ove A.			Biological Markers for Pulpal Inflammation: A Systematic Review	PLOS ONE			English	Review							HUMAN DENTAL PULPS; GENE-RELATED PEPTIDE; GINGIVAL CREVICULAR FLUID; INFLAMED HUMAN PULP; ENDOTHELIAL GROWTH-FACTOR; ODONTOBLAST-LIKE CELLS; NECROSIS-FACTOR-ALPHA; IRREVERSIBLE PULPITIS; SUBSTANCE-P; UP-REGULATION	Background and Objective Pulpitis is mainly caused by an opportunistic infection of the pulp space with commensal oral microorganisms. Depending on the state of inflammation, different treatment regimes are currently advocated. Predictable vital pulp therapy depends on accurate determination of the pulpal status that will allow repair to occur. The role of several players of the host response in pulpitis is well documented: cytokines, proteases, inflammatory mediators, growth factors, antimicrobial peptides and others contribute to pulpal defense mechanisms; these factors may serve as biomarkers that indicate the status of the pulp. Therefore, the aim of this systematic review was to evaluate the presence of biomarkers in pulpitis. Methods The electronic databases of MEDLINE, EMBASE, Scopus and other sources were searched for English and non-English articles published through February 2015. Two independent reviewers extracted information regarding study design, tissue or analyte used, outcome measures, results and conclusions for each article. The quality of the included studies was assessed using a modification of the Newcastle-Ottawa-Scale. Results and Conclusions From the initial 847 publications evaluated, a total of 57 articles were included in this review. In general, irreversible pulpitis was associated with different expression of various biomarkers compared to normal controls. These biomarkers were significantly expressed not only in pulp tissue, but also in gingival crevicular fluid that can be collected non-invasively, and in dentin fluid that can be analyzed without extirpating the entire pulpal tissue. Such data may then be used to accurately differentiate diseased from healthy pulp tissue. The interplay of pulpal biomarkers and their potential use for a more accurate and biologically based diagnostic tool in endodontics is envisaged.	[Rechenberg, Dan-Krister] Univ Zurich, Ctr Dent Med, Dept Prevent Dent Periodontol & Cariol, Zurich, Switzerland; [Galicia, Johnah C.; Peters, Ove A.] Univ Pacific, Dept Endodont, Arthur A Dugoni Sch Dent, San Francisco, CA USA	University of Zurich; University of the Pacific	Rechenberg, DK (corresponding author), Univ Zurich, Ctr Dent Med, Dept Prevent Dent Periodontol & Cariol, Zurich, Switzerland.	dan.rechenberg@zzm.uzh.ch	Peters, Ove/AAU-7644-2020	Peters, Ove/0000-0001-5222-8718; Galicia, Johnah/0000-0003-1908-5801; Rechenberg, Dan-Krister/0000-0002-7509-764X	Department of Preventive Dentistry, Periodontology, and Cariology, University of Zurich Center for Dental Medicine	Department of Preventive Dentistry, Periodontology, and Cariology, University of Zurich Center for Dental Medicine	This research was supported by institutional funds of the Department of Preventive Dentistry, Periodontology, and Cariology, University of Zurich Center for Dental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elmeguid A, 2013, J ENDODONT, V39, P865, DOI 10.1016/j.joen.2012.12.035; Accorsi-Mendonca T, 2013, J ENDODONT, V39, P879, DOI 10.1016/j.joen.2012.11.011; Adachi T, 2007, J DENT RES, V86, P1217, DOI 10.1177/154405910708601215; AHLQUIST ML, 1994, ENDOD DENT TRAUMATOL, V10, P201; Allareddy V, 2014, J AM DENT ASSOC, V145, P331, DOI 10.14219/jada.2014.7; Anderson LM, 2002, J ENDODONT, V28, P651, DOI 10.1097/00004770-200209000-00006; Artese L, 2002, J ENDODONT, V28, P20, DOI 10.1097/00004770-200201000-00005; Avellan NL, 2008, ACTA ODONTOL SCAND, V66, P18, DOI 10.1080/00016350701810658; Awawdeh L, 2002, INT ENDOD J, V35, P30, DOI 10.1046/j.1365-2591.2002.00451.x; Barthel CR, 2000, J ENDODONT, V26, P525, DOI 10.1097/00004770-200009000-00010; Baume R., 1877, LEHRBUCH ZAHNHEILKUN; Bergenholtz G, 1981, J Endod, V7, P100, DOI 10.1016/S0099-2399(81)80122-7; Bhattacharyya S, 2013, AM J PATHOL, V182, P192, DOI 10.1016/j.ajpath.2012.09.007; Bodor C, 2007, INT ENDOD J, V40, P128, DOI 10.1111/j.1365-2591.2006.01196.x; Bolanos O R, 1981, J Endod, V7, P268, DOI 10.1016/S0099-2399(81)80005-2; Bostanci N, 2007, J CLIN PERIODONTOL, V34, P370, DOI 10.1111/j.1600-051X.2007.01061.x; Botero TM, 2006, J ENDODONT, V32, P951, DOI 10.1016/j.joen.2006.03.018; Bowles WR, 2003, J ENDODONT, V29, P265, DOI 10.1097/00004770-200304000-00009; Byers M R, 1992, Proc Finn Dent Soc, V88 Suppl 1, P499; Carrouel F, 2013, J ENDODONT, V39, P1008, DOI 10.1016/j.joen.2013.04.020; Caviedes-Bucheli J, 2007, INT ENDOD J, V40, P106, DOI 10.1111/j.1365-2591.2006.01189.x; Caviedes-Bucheli J, 2006, INT ENDOD J, V39, P394, DOI 10.1111/j.1365-2591.2006.01093.x; Caviedes-Bucheli J, 2005, INT ENDOD J, V38, P712, DOI 10.1111/j.1365-2591.2005.01006.x; Caviedes-Bucheli J, 2004, J ENDODONT, V30, P201, DOI 10.1097/00004770-200404000-00004; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P945, DOI 10.1016/j.joen.2008.05.011; Caviedes-Bucheli J, 2008, J ENDODONT, V34, P773, DOI 10.1016/j.joen.2008.03.010; COFFEY CT, 1970, ORAL SURG ORAL MED O, V30, P835, DOI 10.1016/0030-4220(70)90348-8; COHEN JS, 1985, J ENDODONT, V11, P330, DOI 10.1016/S0099-2399(85)80039-X; COOTAUCO CJ, 1993, J DENT RES, V72, P1485, DOI 10.1177/00220345930720110501; Di Maio FD, 2004, J DENT RES, V83, P312, DOI 10.1177/154405910408300408; Dong Y, 1999, Zhonghua Kou Qiang Yi Xue Za Zhi, V34, P236; Dong YC, 2013, J ENDODONT, V39, P223, DOI 10.1016/j.joen.2012.11.020; Dummer P M, 1980, Int Endod J, V13, P27, DOI 10.1111/j.1365-2591.1980.tb00834.x; ElSalhy M, 2013, INT ENDOD J, V46, P573, DOI 10.1111/iej.12030; Esposito P, 2003, EUR J ORAL SCI, V111, P454, DOI 10.1034/j.1600-0722.2003.00062.x; Esposito R, 2003, INT ENDOD J, V36, P599, DOI 10.1046/j.1365-2591.2003.00692.x; Evcil M Sinan, 2006, J Pain Palliat Care Pharmacother, V20, P15; Farges JC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/230251; Farges JC, 2011, IMMUNOBIOLOGY, V216, P513, DOI 10.1016/j.imbio.2010.08.006; Galicia JC, 2014, GENES IMMUN, V15, P333, DOI 10.1038/gene.2014.24; Ge J, 1996, Zhonghua Kou Qiang Yi Xue Za Zhi, V31, P201; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; Goh FG, 2010, J IMMUNOL, V184, P2655, DOI 10.4049/jimmunol.0903359; Goldberg M, 2008, PHARMACOL RES, V58, P137, DOI 10.1016/j.phrs.2008.05.013; Gomes MS, 2013, J ENDODONT, V39, P1205, DOI 10.1016/j.joen.2013.06.014; Graves DT, 2011, J ORAL MICROBIOL, V3; Griffiths GS, 2003, PERIODONTOL, V31, P32; Guven G, 2007, J ENDODONT, V33, P18, DOI 10.1016/j.joen.2006.07.014; Gusman H, 2002, EUR J ORAL SCI, V110, P353, DOI 10.1034/j.1600-0722.2002.21347.x; HAHN CL, 1991, ARCH ORAL BIOL, V36, P147, DOI 10.1016/0003-9969(91)90077-8; Horst OV, 2009, J DENT RES, V88, P333, DOI 10.1177/0022034509334846; Huang FM, 2009, INT ENDOD J, V42, P627, DOI 10.1111/j.1365-2591.2009.01567.x; Huang FM, 2005, INT ENDOD J, V38, P328, DOI 10.1111/j.1365-2591.2005.00951.x; Huang FM, 2007, J DENT SCI, V2, P152; Huang GTJ, 1999, ORAL SURG ORAL MED O, V88, P214, DOI 10.1016/S1079-2104(99)70118-6; IZUMI T, 1995, ARCH ORAL BIOL, V40, P609, DOI 10.1016/0003-9969(95)00024-J; Jiang HW, 2008, J ENDODONT, V34, P1351, DOI 10.1016/j.joen.2008.07.023; Jiang HW, 2006, J ENDODONT, V32, P747, DOI 10.1016/j.joen.2006.01.010; Karapanou V, 2008, J ENDODONT, V34, P148, DOI 10.1016/j.joen.2007.10.022; Keller JF, 2011, INNATE IMMUN-LONDON, V17, P29, DOI 10.1177/1753425909348527; Khabbaz MG, 2001, ORAL SURG ORAL MED O, V91, P587, DOI 10.1067/moe.2001.113831; Kokkas AB, 2007, INT ENDOD J, V40, P198, DOI 10.1111/j.1365-2591.2007.01215.x; Lepinski AM, 2000, J ENDODONT, V26, P744, DOI 10.1097/00004770-200012000-00020; Levin LG, 2009, J ENDODONT, V35, P1645, DOI 10.1016/j.joen.2009.09.032; [李男男 Li Nannan], 2011, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V37, P312; Mantyla P, 2003, J PERIODONTAL RES, V38, P436, DOI 10.1034/j.1600-0765.2003.00677.x; Mejare IA, 2012, INT ENDOD J, V45, P597, DOI 10.1111/j.1365-2591.2012.02016.x; Mente J, 2016, J ENDODONT, V42, P190, DOI 10.1016/j.joen.2015.10.020; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Michaelson PL, 2002, INT ENDOD J, V35, P829, DOI 10.1046/j.1365-2591.2002.00579.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moreland LW., 2004, RHEUMATOLOGY IMMUNOL; Mutoh N, 2007, J ENDODONT, V33, P1183, DOI 10.1016/j.joen.2007.05.018; Nakanishi T, 2005, J ENDODONT, V31, P84, DOI 10.1097/01.don.0000143414.22112.57; NAKANISHI T, 1995, J ENDODONT, V21, P131, DOI 10.1016/S0099-2399(06)80438-3; Nakanishi T, 2001, J ENDODONT, V27, P385, DOI 10.1097/00004770-200106000-00003; Nakanishi T, 2011, JPN DENT SCI REV, V47, P161, DOI 10.1016/j.jdsr.2011.02.001; da Silva LPN, 2008, MICRON, V39, P797, DOI 10.1016/j.micron.2008.01.018; Silva ACO, 2009, J APPL ORAL SCI, V17, P527, DOI 10.1590/S1678-77572009000500031; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; Paris S, 2009, J ENDODONT, V35, P520, DOI 10.1016/j.joen.2008.12.015; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Piattelli A, 2004, INT ENDOD J, V37, P114, DOI 10.1111/j.0143-2885.2004.00758.x; Rauschenberger CR, 1997, J ENDODONT, V23, P366, DOI 10.1016/S0099-2399(97)80184-7; Rechenberg DK, 2014, CYTOKINE, V69, P116, DOI 10.1016/j.cyto.2014.05.014; Rechenberg DK., 2014, ENDOD TOPICS, V30, P51, DOI [DOI 10.1111/ETP.12057, 10.1111/etp.12057]; Ricucci D, 2014, J ENDODONT, V40, P1932, DOI 10.1016/j.joen.2014.08.010; SELTZER SAMUEL, 1963, ORAL SURG ORAL MED AND ORAL PATHOL, V16, P846, DOI 10.1016/0030-4220(63)90323-2; Shi B, 2012, ANN RHEUM DIS, V71, P1411, DOI 10.1136/annrheumdis-2011-200899; Simon S, 2013, INT ENDOD J, V46, P79, DOI 10.1111/j.1365-2591.2012.02113.x; Smith AJ, 2002, CARIES RES, V36, P223, DOI 10.1159/000063930; Sorsa T, 2010, ORAL DIS, V16, P39, DOI 10.1111/j.1601-0825.2009.01603.x; Spoto G, 2004, Int J Immunopathol Pharmacol, V17, P21; Spoto G, 2004, Int J Immunopathol Pharmacol, V17, P11; Spoto G, 2001, J ENDODONT, V27, P394, DOI 10.1097/00004770-200106000-00005; Spoto G, 2001, J ENDODONT, V27, P180, DOI 10.1097/00004770-200103000-00010; Staquet M-J, 2011, Adv Dent Res, V23, P296, DOI 10.1177/0022034511405390; STASHENKO P, 1990, ENDOD DENT TRAUMATOL, V6, P89; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Suwanchai A, 2012, INT ENDOD J, V45, P372, DOI 10.1111/j.1365-2591.2011.01986.x; Taba Mario Jr, 2005, Dent Clin North Am, V49, P551, DOI 10.1016/j.cden.2005.03.009; The Pew Center on the States, 2012, PWE CHILDR DINT CAMP; Trowbridge H O, 1981, J Endod, V7, P52, DOI 10.1016/S0099-2399(81)80242-7; Tsai CH, 2005, J ENDODONT, V31, P860, DOI 10.1097/01.don.0000164851.55389.4e; Tulunoglu O, 1998, J Clin Pediatr Dent, V22, P341; Varvara G, 2005, INT ENDOD J, V38, P195, DOI 10.1111/j.1365-2591.2005.00936.x; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Vongsavan N, 2000, ARCH ORAL BIOL, V45, P931, DOI 10.1016/S0003-9969(00)00079-0; Walton R E, 1978, J Endod, V4, P167, DOI 10.1016/S0099-2399(78)80171-X; Wells GA, 2003, 11 INT COCHR C BARC, VO-63, P26; Zehnder M, 2003, CYTOKINE, V22, P84, DOI 10.1016/S1043-4666(03)00116-9; Zehnder M, 2014, J DENT, V42, P1027, DOI 10.1016/j.jdent.2014.01.014; Zehnder M, 2011, J ENDODONT, V37, P17, DOI 10.1016/j.joen.2010.10.003; Zhong S, 2012, J ENDODONT, V38, P746, DOI 10.1016/j.joen.2012.02.020	114	87	91	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167289	10.1371/journal.pone.0167289	http://dx.doi.org/10.1371/journal.pone.0167289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898727	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474000048
J	Zhao, JY; Chi, YL; Xu, YC; Jia, DY; Yao, K				Zhao, Jiayuan; Chi, Yuanlong; Xu, Yingchao; Jia, Dongying; Yao, Kai			Co-Metabolic Degradation of beta-Cypermethrin and 3-Phenoxybenzoic Acid by Co-Culture of Bacillus licheniformis B-1 and Aspergillus oryzae M-4	PLOS ONE			English	Article							MICROBIAL-DEGRADATION; PYRETHROID INSECTICIDES; GALLIC ACID; EXPOSURE; COMETABOLISM; PESTICIDES; BACTERIA	The degradation efficiency of organic contaminants and their associated metabolites by co-culture of microbes is mainly limited by toxic intermediates from co-metabolic degradation. In this study, we investigated the degradation of beta-cypermethrin (beta-CY) and 3-phenoxybenzoic acid (3-PBA) by co-culture of Bacillus licheniformis B-1 and Aspergillus oryzae M-4, as well as the influences of beta-CY and 3-PBA metabolites on their degradation and the growth of strains B-1 and M-4. Our results indicated that 100 mg/L beta-CY was degraded by 78.85%, and 3-PBA concentration was 0.05 mg/L after 72 h. Compared with using only strain B-1, the half-life (t(1/2)) of beta-CY by using the two strains together was shortened from 84.53 h to 38.54 h, and the yield coefficient of 3-PBA was decreased from 0.846 to 0.001. At 100 mg/L of 3-PBA and gallic acid, beta-CY and 3-PBA degradation were only 17.68% and 40.45%, respectively. As the toxic intermediate derived from co-metabolic degradation of beta-CY by strain B-1, 3-PBA was efficiently degraded by strain M-4, and gallic acid, as the toxic intermediate from co-metabolic degradation of 3-PBA by strain M-4, was efficiently degraded by strain B-1. These results provided a promising approach for efficient biodegradation of beta-CY and 3-PBA.	[Zhao, Jiayuan; Chi, Yuanlong; Xu, Yingchao; Jia, Dongying; Yao, Kai] Sichuan Univ, Coll Light Ind Text & Food Engn, Chengdu 610065, Sichuan, Peoples R China	Sichuan University	Yao, K (corresponding author), Sichuan Univ, Coll Light Ind Text & Food Engn, Chengdu 610065, Sichuan, Peoples R China.	yaokai555@126.com			National Natural Science Foundation of China [31371775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (31371775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08784; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050456; Deng Weiqin, 2015, Weishengwu Xuebao, V55, P1081; Deng WQ, 2015, APPL MICROBIOL BIOT, V99, P8187, DOI 10.1007/s00253-015-6690-2; Fenlon KA, 2007, J ENVIRON MONITOR, V9, P510, DOI 10.1039/b700668c; Halden RU, 1999, APPL ENVIRON MICROB, V65, P3354; Han Y, 2008, CHEMOSPHERE, V72, P785, DOI 10.1016/j.chemosphere.2008.03.058; Heudorf U, 2004, INT ARCH OCC ENV HEA, V77, P67, DOI 10.1007/s00420-003-0470-5; Hladik ML, 2012, J ENVIRON MONITOR, V14, P1838, DOI 10.1039/c2em10946h; Ji GX, 2011, REPROD TOXICOL, V31, P171, DOI 10.1016/j.reprotox.2010.10.005; Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7; Kolaczinski JH, 2004, FOOD CHEM TOXICOL, V42, P697, DOI 10.1016/j.fct.2003.12.008; Kong WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21558; KUMAR RA, 1992, J FERMENT BIOENG, V74, P159, DOI 10.1016/0922-338X(92)90076-7; Liu FF, 2014, J AGR FOOD CHEM, V62, P8256, DOI 10.1021/jf502835n; Liu SL, 2012, J CHROMATOGR SCI, V50, P469, DOI 10.1093/chromsci/bms030; Luo W, 2014, WATER SCI TECHNOL, V69, P1971, DOI 10.2166/wst.2014.108; McCoy MR, 2012, J AGR FOOD CHEM, V60, P5065, DOI 10.1021/jf2051653; NGOC H T, 2013, BIORESOURCE TECHNOLO, V146, P721; Ngoc Han T, 2010, J WATER ENV TECHNOL, V8, P125; Nzila A, 2013, ENVIRON POLLUT, V178, P474, DOI 10.1016/j.envpol.2013.03.042; Perry MJ, 2007, REPROD TOXICOL, V23, P113, DOI 10.1016/j.reprotox.2006.08.005; Sinha C, 2004, INT J DEV NEUROSCI, V22, P31, DOI 10.1016/j.ijdevneu.2003.10.005; Tang J, 2013, FRESEN ENVIRON BULL, V22, P1564; Van Eerd LL, 2003, WEED SCI, V51, P472, DOI 10.1614/0043-1745(2003)051[0472:PMIPAM]2.0.CO;2; Yang S, 2013, BIORESOURCE TECHNOL, V141, P97, DOI 10.1016/j.biortech.2013.01.173; Zhang YP, 2016, BIOMED CHROMATOGR, V30, P142, DOI 10.1002/bmc.3528; Zhao JY, 2015, J AGR FOOD CHEM, V63, P10729, DOI 10.1021/acs.jafc.5b04485	28	21	24	8	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166796	10.1371/journal.pone.0166796	http://dx.doi.org/10.1371/journal.pone.0166796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898684	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000018
J	Chung, J; Lee, WK; Cha, ES; Lee, JE; Kim, JH; Ryu, YH				Chung, Jin; Lee, Won Kyung; Cha, Eun-Suk; Lee, Jee Eun; Kim, Jeoung Hyun; Ryu, Young Hoon			Shear-Wave Elastography for the Differential Diagnosis of Breast Papillary Lesions	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; BI-RADS CLASSIFICATION; SONOGRAPHIC FEATURES; BENIGN PAPILLOMA; MASSES; ULTRASOUND; US; PERFORMANCE; MANAGEMENT; EXCISION	Objective To evaluate the diagnostic performance of shear-wave elastography (SWE) for the differential diagnosis of breast papillary lesions. Methods This study was an institutional review board-approved retrospective study, with a waiver of informed consent. A total of 79 breast papillary lesions in 71 consecutive women underwent ultrasound and SWE prior to biopsy. Ultrasound features and quantitative SWE parameters were recorded for each lesion. All lesions were surgically excised or excised using an ultra-sound-guided vacuum-assisted method. The diagnostic performances of the quantitative SWE parameters were compared using the area under the receiver operating characteristic curve (AUC). Results Of the 79 lesions, six (7.6%) were malignant and 12 (15.2%) were atypical. Orientation, margin, and the final BI-RADS ultrasound assessments were significantly different for the papillary lesions (p < 0.05). All qualitative SWE parameters were significantly different (p < 0.05). The AUC values for SWE parameters of benign and atypical or malignant papillary lesions ranged from 0.707 to 0.757 (sensitivity, 44.4-94.4%; specificity, 42.6-88.5%). The maximum elasticity and the mean elasticity showed the highest AUC (0.757) to differentiate papillary lesions. Conclusion SWE provides additional information for the differential diagnosis of breast papillary lesions. Quantitative SWE features were helpful to differentiate breast papillary lesions.	[Chung, Jin; Lee, Won Kyung; Cha, Eun-Suk; Lee, Jee Eun; Kim, Jeoung Hyun] Ewha Womans Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Chung, Jin] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ryu, Young Hoon] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, J (corresponding author), Ewha Womans Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Chung, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.	aqua0724@ewha.ac.kr						American College of Radiology ACR BI-RADS_Ultrasound, 2013, ACR BREAST IMAGING R; Au FWF, 2014, AM J ROENTGENOL, V203, pW328, DOI 10.2214/AJR.13.11693; Barr RG, 2012, J ULTRAS MED, V31, P773; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Chang JM, 2011, AM J ROENTGENOL, V196, P723, DOI 10.2214/AJR.10.4615; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Cho N, 2008, KOREAN J RADIOL, V9, P111, DOI 10.3348/kjr.2008.9.2.111; Choi JJ, 2012, JPN J RADIOL, V30, P422, DOI 10.1007/s11604-012-0070-y; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Hawley JR, 2015, CLIN IMAG, V39, P576, DOI 10.1016/j.clinimag.2015.01.017; Jagmohan P, 2013, DIAGN INTERV RADIOL, V19, P471, DOI 10.5152/dir.2013.13041; Kim MY, 2013, KOREAN J RADIOL, V14, P559, DOI 10.3348/kjr.2013.14.4.559; Kim TH, 2008, J ULTRAS MED, V27, P75, DOI 10.7863/jum.2008.27.1.75; Ko KH, 2012, ANN SURG ONCOL, V19, P908, DOI 10.1245/s10434-011-2050-3; Lam WWM, 2006, AM J ROENTGENOL, V186, P1322, DOI 10.2214/AJR.04.1908; Lee BE, 2015, EUR J RADIOL, V84, P1236, DOI 10.1016/j.ejrad.2015.04.005; Lee EJ, 2013, EUR RADIOL, V23, P1803, DOI 10.1007/s00330-013-2782-5; Lee SH, 2014, ULTRASONOGRAPHY, V33, P3, DOI 10.14366/usg.13012; Park HY, 2014, ULTRASOUND MED BIOL, V40, P1058, DOI 10.1016/j.ultrasmedbio.2013.12.021; Shin HJ, 2008, AM J ROENTGENOL, V190, P630, DOI 10.2214/AJR.07.2664; Skerl K, 2015, CLIN RADIOL, V70, P1421, DOI 10.1016/j.crad.2015.08.010; Sohn YM, 2013, J ULTRAS MED, V32, P303; Sohn YM, 2009, J ULTRAS MED, V28, P413, DOI 10.7863/jum.2009.28.4.413; Ueng SH, 2009, ARCH PATHOL LAB MED, V133, P893, DOI 10.1043/1543-2165-133.6.893; Vinnicombe SJ, 2014, EUR RADIOL, V24, P921, DOI 10.1007/s00330-013-3079-4; Yi A, 2012, EUR RADIOL, V22, P1033, DOI 10.1007/s00330-011-2341-x; Yoon J H, 2012, Ultraschall Med, V33, pE145, DOI 10.1055/s-0032-1313208; Yoon JH, 2013, EUR RADIOL, V23, P2432, DOI 10.1007/s00330-013-2854-6; Youk JH, 2013, EUR RADIOL, V23, P2695, DOI 10.1007/s00330-013-2873-3; Youk JH, 2012, ANN SURG ONCOL, V19, P922, DOI 10.1245/s10434-011-2033-4; Youk JH, 2011, RADIOLOGY, V258, P81, DOI 10.1148/radiol.10100728; Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167118	10.1371/journal.pone.0167118	http://dx.doi.org/10.1371/journal.pone.0167118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893857	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400089
J	Nieto, RLM; Mehaffy, C; Creissen, E; Troudt, JL; Troy, A; Bielefeldt-Ohmann, H; Burgos, M; Izzo, A; Dobos, KM				Luisa Maria Nieto, R.; Mehaffy, Carolina; Creissen, Elizabeth; Troudt, JoLynn; Troy, Amber; Bielefeldt-Ohmann, Helle; Burgos, Marcos; Izzo, Angelo; Dobos, Karen M.			Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC	PLOS ONE			English	Article							CATALASE-PEROXIDASE GENE; DRUG-RESISTANCE; BEIJING GENOTYPE; EXPRESSION; MUTATIONS; STRAINS; CELLS; LUNG; DIFFERENTIATION; PERSISTENCE	In the last decade, there were 10 million new tuberculosis cases per year globally. Around 9.5% of these cases were caused by isoniazid resistant (INHr) Mycobacterium tuberculosis (Mtb) strains. Although isoniazid resistance in Mtb is multigenic, mutations in the catalase-peroxidase (katG) gene predominate among the INHr strains. The effect of these drug-resis-tance-conferring mutations on Mtb fitness and virulence is variable. Here, we assessed differences in bacterial growth, immune response and pathology induced by Mtb strains harboring mutations at the N-terminus of the katG gene. We studied one laboratory and one clinically isolated Mtb clonal pair from different genetic lineages. The INHr strain in each pair had one and two katG mutations with significantly reduced levels of the enzyme and peroxidase activity. Both strains share the V1A mutation, while the double mutant clinical INHr had also the novel E3V katG mutation. Four groups of C57BL/6 mice were infected with one of the Mtb strains previously described. We observed a strong reduction in virulence (reduced bacterial growth), lower induction of proinflammatory cytokines and significantly reduced pathology scores in mice infected with the clinical INHr strain compared to the infection caused by its INHs progenitor strain. On the other hand, there was a subtle reduction of bacteria growth without differences in the pathology scores in mice infected with the laboratory INHr strain. Our results also showed distinct alkyl-hydroperoxidase C (AhpC) levels in the katG mutant strains, which could explain the difference in the virulence profile observed. The difference in the AhpC levels between clonal strains was not related to a genetic defect in the gene or its promoter. Cumulatively, our results indicate that the virulence, pathology and fitness of INHr strains could be negatively affected by multiple mutations in katG, lack of the peroxidase activity and reduced AhpC levels.	[Luisa Maria Nieto, R.; Mehaffy, Carolina; Creissen, Elizabeth; Troudt, JoLynn; Troy, Amber; Izzo, Angelo; Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Burgos, Marcos] Univ New Mexico, Dept Med, Div Infect Dis, Albuquerque, NM 87131 USA	Colorado State University; University of Queensland; University of Queensland; University of New Mexico	Dobos, KM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Karen.Dobos@colostate.edu	Izzo, Angelo A/F-1229-2017; LM, Nieto/N-4646-2013; Dobos, Karen/D-1170-2017	Izzo, Angelo A/0000-0003-3208-2330; LM, Nieto/0000-0003-1566-5876; Dobos, Karen/0000-0001-7115-8524	ATCC [2010-0516-0005]; Colombian government scholarship "Francisco Jose de Caldas 512" scholarship for PhD students (Colciencias agency) [HHSN2722010000091, HHSN27200004]; NIH/NIAID IDIQ	ATCC; Colombian government scholarship "Francisco Jose de Caldas 512" scholarship for PhD students (Colciencias agency); NIH/NIAID IDIQ	This work was possible due to funding from the ATCC (fund number 2010-0516-0005) awarded to KMD, the Colombian government scholarship "Francisco Jose de Caldas 512" scholarship for PhD students (Colciencias agency) awarded to LMNR, and the NIH/NIAID IDIQ Contract No. HHSN2722010000091 Task Order HHSN27200004, Task A58, awarded to MI. Mouse studies performed at CSU were funded under this same NIH/NIAID IDIQ Contract entitled "Testing of mutant mycobacteria in established advanced small animal models" to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Almeida D, 2009, ANTIMICROB AGENTS CH, V53, P4178, DOI 10.1128/AAC.00830-09; Barry CE, 1998, DRUG RESIST UPDATE, V1, P128, DOI 10.1016/S1368-7646(98)80028-9; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Cade CE, 2010, PROTEIN SCI, V13, DOI 10.1146/annurev.immunol.19.1.93; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Caraway M., 2011, THESIS; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chindelevitch L, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004475; Datta G, 2016, TUBERCULOSIS, V98, P50, DOI 10.1016/j.tube.2016.02.004; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Jacobs Jr WR, 2014, MICROBIOLOGY SPECTRU, V2; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kruh-Garcia NA, 2014, J PROTEOMICS, V97, P141, DOI 10.1016/j.jprot.2013.07.005; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Njuma OJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P27, DOI 10.1016/j.abb.2013.11.007; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Peters JS, 2016, FRONTIERS MICROBIOLO, P7; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Sandy J, 2002, J MOL BIOL, V318, P1071, DOI 10.1016/S0022-2836(02)00141-9; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Taylor JL, 2012, IMMUNOL CELL BIOL, V90, P945, DOI 10.1038/icb.2012.34; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2014, GLOB TUB REP; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	47	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166807	10.1371/journal.pone.0166807	http://dx.doi.org/10.1371/journal.pone.0166807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893795	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400046
J	Smith, GC; Delahay, RJ; McDonald, RA; Budgey, R				Smith, Graham C.; Delahay, Richard J.; McDonald, Robbie A.; Budgey, Richard			Model of Selective and Non-Selective Management of Badgers (Meles meles) to Control Bovine Tuberculosis in Badgers and Cattle	PLOS ONE			English	Article							SEVERITY; PROGRESSION; IMPACT	Bovine tuberculosis (bTB) causes substantial economic losses to cattle farmers and taxpayers in the British Isles. Disease management in cattle is complicated by the role of the European badger (Meles meles) as a host of the infection. Proactive, non-selective culling of badgers can reduce the incidence of disease in cattle but may also have negative effects in the area surrounding culls that have been associated with social perturbation of badger populations. The selective removal of infected badgers would, in principle, reduce the number culled, but the effects of selective culling on social perturbation and disease outcomes are unclear. We used an established model to simulate non-selective badger culling, non-selective badger vaccination and a selective trap and vaccinate or remove (TVR) approach to badger management in two distinct areas: South West England and Northern Ireland. TVR was simulated with and without social perturbation in effect. The lower badger density in Northern Ireland caused no qualitative change in the effect of management strategies on badgers, although the absolute number of infected badgers was lower in all cases. However, probably due to differing herd density in Northern Ireland, the simulated badger management strategies caused greater variation in subsequent cattle bTB incidence. Selective culling in the model reduced the number of badgers killed by about 83% but this only led to an overall benefit for cattle TB incidence if there was no social perturbation of badgers. We conclude that the likely benefit of selective culling will be dependent on the social responses of badgers to intervention but that other population factors including badger and cattle density had little effect on the relative benefits of selective culling compared to other methods, and that this may also be the case for disease management in other wild host populations.	[Smith, Graham C.; Delahay, Richard J.; Budgey, Richard] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, Cornwall, England	Animal & Plant Health Agency UK; University of Exeter	Budgey, R (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	richard.budgey@apha.gsi.gov.uk	McDonald, Robbie A/A-2931-2012; Smith, Graham C/J-2593-2013; Budgey, Richard/A-4861-2016; McDonald, Robbie/AAK-2718-2020; Delahay, Richard/GSI-4663-2022	McDonald, Robbie A/0000-0002-6922-3195; Smith, Graham C/0000-0002-9897-6794; Budgey, Richard/0000-0002-9938-2584; McDonald, Robbie/0000-0002-6922-3195; 	Department for Food, Environment and Rural Affairs; Department of Agriculture and Rural Development Northern Ireland	Department for Food, Environment and Rural Affairs; Department of Agriculture and Rural Development Northern Ireland	Funding organisations were: 1. Department for Food, Environment and Rural Affairs, and 2. Department of Agriculture and Rural Development Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, VET REC, V176, P32, DOI 10.1136/vr.h24; [Anonymous], 2012, VET REC, V171, P361, DOI 10.1136/vr.e6782; [Anonymous], 2012, VET REC, V171, P285, DOI 10.1136/vr.e6219; [Anonymous], 2012, W MORNING NEWS; AUBERT M, 1994, VET REC, V134, P55, DOI 10.1136/vr.134.3.55; Bielby J, 2014, P NATL ACAD SCI USA, V111, P9193, DOI 10.1073/pnas.1401503111; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Carter Stephen P., 2009, P121, DOI 10.1007/978-4-431-77134-0_7; Central Science Laboratory, 2006, INT ACT PIL AR PAP A; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Corner LAL, 2008, RES VET SCI, V85, P238, DOI 10.1016/j.rvsc.2007.11.010; DARDNI, 2013, TEST VACC REM TVR WI; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Graham J, 2013, EPIDEMIOL INFECT, V141, P1429, DOI 10.1017/S0950268812003019; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Independent Scientific Group, 2007, BOVINE TB THE SCIENT; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Lachish S, 2010, CONSERV BIOL, V24, P841, DOI 10.1111/j.1523-1739.2009.01429.x; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; Smith GC, 1997, J APPL ECOL, V34, P1375, DOI 10.2307/2405255; Smith GC, 2001, J APPL ECOL, V38, P509, DOI 10.1046/j.1365-2664.2001.00609.x; Smith GC, 2001, J APPL ECOL, V38, P520, DOI 10.1046/j.1365-2664.2001.00610.x; Smith GC, 2013, SIMULATION MODEL TO; Smith GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039250; Tosa MI, 2016, J WILDLIFE MANAGEMEN; Welsh Assembly Government, 2009, BADG CONTR BACKGR 20; Wilkinson D, 2004, J APPL ECOL, V41, P492, DOI 10.1111/j.0021-8901.2004.00898.x; Wilkinson D, 2009, J WILDLIFE DIS, V45, P1062, DOI 10.7589/0090-3558-45.4.1062; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326	35	12	12	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167206	10.1371/journal.pone.0167206	http://dx.doi.org/10.1371/journal.pone.0167206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893809	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000389472400100
J	Bin, LH; Deng, LH; Yang, HW; Zhu, LQ; Wang, X; Edwards, MG; Richers, B; Leung, DYM				Bin, Lianghua; Deng, Liehua; Yang, Hengwen; Zhu, Leqing; Wang, Xiao; Edwards, Michael G.; Richers, Brittany; Leung, Donald Y. M.			Forkhead Box C1 Regulates Human Primary Keratinocyte Terminal Differentiation	PLOS ONE			English	Article							SKIN BARRIER; CORNIFIED ENVELOPE; FOXC1; GENE; ABCA12; PATHOGENESIS; EXPRESSION; MUTATIONS; PROTEINS	The epidermis serves as a critical protective barrier between the internal and external environment of the human body. Its remarkable barrier function is established through the keratinocyte (KC) terminal differentiation program. The transcription factors specifically regulating terminal differentiation remain largely unknown. Using a RNA-sequencing (RNA-seq) profiling approach, we found that forkhead box c1 (FOXC1) was significantly up-regulated in human normal primary KC during the course of differentiation. This observation was validated in human normal primary KC from several different donors and human skin biopsies. Silencing FOXC1 in human normal primary KC undergoing differentiation led to significant down-regulation of late terminal differentiation genes markers including epidermal differentiation complex genes, keratinization genes, sphingolipid/ceramide metabolic process genes and epidermal specific cell-cell adhesion genes. We further demonstrated that FOXC1 works down-stream of ZNF750 and KLF4, and upstream of GRHL3. Thus, this study defines FOXC1 as a regulator specific for KC terminal differentiation and establishes its potential position in the genetic regulatory network.	[Bin, Lianghua; Deng, Liehua; Yang, Hengwen; Zhu, Leqing; Wang, Xiao] Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, Int Immunol Ctr, Guangzhou, Guangdong, Peoples R China; [Bin, Lianghua; Deng, Liehua; Yang, Hengwen; Zhu, Leqing; Wang, Xiao] Jinan Univ, Key Lab Antibody Engn Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Bin, Lianghua; Richers, Brittany; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Edwards, Michael G.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO USA; [Leung, Donald Y. M.] Guangzhou Med Univ, Guangdong Prov Key Lab Allergy & Clin Immunol, State Key Clin Specialty Allergy, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Guangzhou Medical University	Bin, LH (corresponding author), Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, Int Immunol Ctr, Guangzhou, Guangdong, Peoples R China.; Bin, LH (corresponding author), Jinan Univ, Key Lab Antibody Engn Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Bin, LH (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	Binl@njhealth.org	yang, hengwen/GQH-7922-2022	yang, hengwen/0000-0002-6418-1985; Bin, Lianghua/0000-0002-3786-0106	National Natural Science Foundation of China [81371718]; NIH [R01 AR41256]; Overall Atopic Dermatitis Research Network (NIH/NIAID) [1U19 AI 117673-01]; Edelstein Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041256] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Overall Atopic Dermatitis Research Network (NIH/NIAID); Edelstein Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Natural Science Foundation of China (No. 81371718)(LB); NIH grants R01 AR41256 (DL); Overall Atopic Dermatitis Research Network (NIH/NIAID 1U19 AI 117673-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Lianghua Bin is the advisory board member of Astellas Pharma Inc. The authors wish to thank the Edelstein Family Foundation for their generous support of this work.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2014, BBA-MOL CELL BIOL L, V1841, P435, DOI 10.1016/j.bbalip.2013.08.009; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Cui CY, 2016, J INVEST DERMATOL; Czarnowicki T, 2014, J ALLER CL IMM-PRACT, V2, P371, DOI 10.1016/j.jaip.2014.03.006; Furio L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005389; Jung M, 2014, J DERMATOL SCI, V76, P231, DOI 10.1016/j.jdermsci.2014.09.004; Kalinin AE, 2004, J BIOL CHEM, V279, P22773, DOI 10.1074/jbc.M313660200; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lay K, 2016, P NATL ACAD SCI USA, V113, pE1506, DOI 10.1073/pnas.1601569113; Lee WH, 2005, J INVEST DERMATOL, V125, P995, DOI 10.1111/j.0022-202X.2005.23887.x; Lopez-Pajares V, 2015, DEV CELL, V32, P693, DOI 10.1016/j.devcel.2015.01.028; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Mattiuzzo NR, 2011, EXP DERMATOL, V20, P113, DOI 10.1111/j.1600-0625.2010.01188.x; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Somerville TDD, 2015, CANCER CELL, V28, P329, DOI 10.1016/j.ccell.2015.07.017; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Stawczyk-Macieja M, 2015, POSTEP DERM ALERGOL, V32, P123, DOI 10.5114/pdia.2014.44003; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112; Zhou Y, 2002, GENOMICS, V80, P465, DOI 10.1006/geno.2002.6860	33	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167392	10.1371/journal.pone.0167392	http://dx.doi.org/10.1371/journal.pone.0167392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907090	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700141
J	Campbell, N; Eley, DS; McAllister, L				Campbell, Narelle; Eley, Diann S.; McAllister, Lindy			How Do Allied Health Professionals Construe the Role of the Remote Workforce? New Insight into Their Recruitment and Retention	PLOS ONE			English	Article							NORTHERN BRITISH-COLUMBIA; CHARACTER INVENTORY; PERSONALITY-TRAITS; MEDICAL-STUDENTS; PSYCHOBIOLOGICAL MODEL; EXPLORING TEMPERAMENT; SPECIALTY CHOICE; DOCTORS; CLONINGERS; VALIDITY	Purpose Allied health workforce recruitment and retention in remote areas is a global problem. Using case studies from the Australian allied health workforce, this paper adds new information by combining personality trait information with a detailed understanding of how the cases construe the demands of remote work, which may be useful in addressing this problem. Methods Four cases (two urban, two remote) are presented from a mixed methods study (n = 562), which used (1) the Temperament and Character Inventory to investigate personality traits of allied health professionals; and (2) repertory grid interviews to reveal quantitatively and qualitatively how the cases construed their Ideal work role compared with their Currentand a Remote role. Cases also self-assessed their fit ('suited' or 'not suited') with remote. Findings Differences in the way cases construed their fit with remote work was related to prior experience. However all were satisfied with their work, perceiving their Current role as similar to their Ideal. All saw remote work as requiring generalist expertise and a reliance on relationships. Personality traits, especially Novelty Seeking and Harm Avoidance, fit with how allied health professionals perceived their role. Conclusions The combination of two distinct lines of investigation, illustrates what more can be revealed about allied health professional's career choices by taking into account the fit or lack of fit between their personality tendencies, their construing of remote work and their life circumstances. Understanding the combined influence of perceptions and traits on an individual toward or away from remote work may enhance recruitment and retention internationally.	[Campbell, Narelle; Eley, Diann S.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [McAllister, Lindy] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia; [Campbell, Narelle] Flinders Univ S Australia, Northern Terr Med Program, Darwin, NT, Australia	University of Queensland; University of Sydney; Flinders University South Australia	Campbell, N (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.; Campbell, N (corresponding author), Flinders Univ S Australia, Northern Terr Med Program, Darwin, NT, Australia.	narelle.campbell@uqconnect.edu.au	Eley, Diann S/C-3331-2008; Campbell, Narelle/AAQ-2485-2020	Eley, Diann S/0000-0001-7256-9325; Campbell, Narelle/0000-0003-1088-1828				Adamson B., 2003, FOCUS HLTH PROFESSIO, V5, P34; Australian Institute of Health and Welfare, 2014, AUSTR HLTH 2014; Ball L, 2015, J HUM NUTR DIET, V28, P502, DOI 10.1111/jhn.12265; Barrett P., 2005, EUCLIDEAN DISTANCE R; Brandstrom S, 2003, PSYCHOL REP, V93, P995; Campbell N, 2012, RURAL REMOTE HEALTH, V12; Campbell N, 2014, AUST HEALTH REV, V38, P86, DOI 10.1071/AH13109; Campbell N, 2013, AUST J RURAL HEALTH, V21, P240, DOI 10.1111/ajr.12047; Chisholm M, 2011, AUST J RURAL HEALTH, V19, P81, DOI 10.1111/j.1440-1584.2011.01188.x; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cordina M, 2012, INT J CLIN PHARM-NET, V34, P876, DOI 10.1007/s11096-012-9686-3; Daniels ZM, 2007, J RURAL HEALTH, V23, P62, DOI 10.1111/j.1748-0361.2006.00069.x; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; Dodd Jenny, 2009, J Allied Health, V38, P215; Dominelli Angela, 2006, J Allied Health, V35, pe316; Eley D, 2011, J CLIN NURS, V20, P563, DOI 10.1111/j.1365-2702.2009.03122.x; Eley D, 2009, MED TEACH, V31, pE79, DOI 10.1080/01421590802335892; Eley D, 2009, J RURAL HEALTH, V25, P43, DOI 10.1111/j.1748-0361.2009.00197.x; Eley DS, 2014, J RURAL HEALTH, V30, P164, DOI 10.1111/jrh.12039; Eley DS, 2013, PEERJ, V1, DOI 10.7717/peerj.216; Eley DS, 2011, INT J NURS PRACT, V17, P380, DOI 10.1111/j.1440-172X.2011.01952.x; Fossati A, 2007, COMPR PSYCHIAT, V48, P380, DOI 10.1016/j.comppsych.2007.02.003; Grice JW, 2002, BEHAV RES METH INS C, V34, P338, DOI 10.3758/BF03195461; Grucza RA, 2007, J PERS ASSESS, V89, P167, DOI 10.1080/00223890701468568; Hardin EE, 2014, J COUNS PSYCHOL, V61, P634, DOI 10.1037/cou0000039; Health Workforce Australia, 2014, HLTH WORKF NUMB; Howard AF, 2014, J RURAL HEALTH, V30, P311, DOI 10.1111/jrh.12064; Jankowicz D., 2004, EASY GUIDE REPERTORY; Jones MP, 2013, AUST J RURAL HEALTH, V21, P80, DOI 10.1111/ajr.12013; Kelly G. A., 1991, PSYCHOL PERSONAL CON, V1; Kluger MT, 1999, ANAESTHESIA, V54, P926, DOI 10.1046/j.1365-2044.1999.01112.x; Lowe S., 2007, FRAMEWORK CATEGORIZA; Lysack C, 2001, J Allied Health, V30, P75; Malhi GS, 2011, AUST NZ J PSYCHIAT, V45, P861, DOI 10.3109/00048674.2011.604301; Manahan CM, 2009, RURAL REMOTE HEALTH, V9; Mason J., 2013, REV AUSTR GOVT HLTH; McDaniel BL., 2005, PERSONAL CONSTRUCT T, V2, P18; Neimeyer G. J., 1992, J CAREER DEV, V18, P163, DOI DOI 10.1177/089484539201800301; Parker G, 2003, ACTA PSYCHIAT SCAND, V108, P359, DOI 10.1034/j.1600-0447.2003.00149.x; Richardson JD, 2009, HEALTH CARE MANAG, V28, P218, DOI 10.1097/HCM.0b013e3181b3e9c7; Slagle Derek R, 2012, J Health Care Finance, V38, P91; Taber BJ, 2011, J VOCAT BEHAV, V78, P202, DOI 10.1016/j.jvb.2010.09.006; Thomas Y, 2007, INT J THER REHABIL, V14, P216, DOI 10.12968/ijtr.2007.14.5.23539; Vaidya NA, 2004, TEACH LEARN MED, V16, P150, DOI 10.1207/s15328015tlm1602_6; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Winter DA, 2013, CLIN CHILD PSYCHOL P, V18, P276, DOI 10.1177/1359104512454264; Woods SA, 2010, J APPL PSYCHOL, V95, P1045, DOI 10.1037/a0020600; Zuckerman M, 1996, PERS INDIV DIFFER, V21, P283, DOI 10.1016/0191-8869(96)00042-6	49	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167256	10.1371/journal.pone.0167256	http://dx.doi.org/10.1371/journal.pone.0167256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907073	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700104
J	Ding, Y; Vrionis, HA; Schneider, J; Berezuk, A; Khursigara, CM; Jarrell, KF				Ding, Yan; Vrionis, Helen A.; Schneider, James; Berezuk, Alison; Khursigara, Cezar M.; Jarrell, Ken F.			Complementation of an aglB Mutant of Methanococcus maripaludis with Heterologous Oligosaccharyltransferases	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; ARCHAEON SULFOLOBUS-ACIDOCALDARIUS; ASPARAGINE-LINKED OLIGOSACCHARIDE; TERMINAL GLOBULAR DOMAIN; N-GLYCOSYLATION; HALOFERAX-VOLCANII; PROTEIN GLYCOSYLATION; HYPERTHERMOPHILIC ARCHAEON; STRUCTURAL ELUCIDATION; CRYSTAL-STRUCTURE	The oligosaccharyltransferase is the signature enzyme for N-linked glycosylation in all domains of life. In Archaea, this enzyme termed AglB, is responsible for transferring lipid carrier-linked glycans to select asparagine residues in a variety of target proteins including archaellins, S-layer proteins and pilins. This study investigated the ability of a variety of AglBs to compensate for the oligosaccharyltransferase activity in Methanococcus maripaludis deleted for aglB, using archaellin FIaB2 as the reporter protein since all archaellins in Mc. maripaludis are modified at multiple sites by an N-linked tetrasaccharide and this modification is required for archaellation. In the Mc. maripaludis Delta aglB strain FIaB2 runs as at a smaller apparent molecular weight in western blots and is nonarchaellated. We demonstrate that AglBs from Methanococcus voltae and Methanothermococcus the rmolithotrophicus functionally replaced the oligosaccharyltransferase activity missing in the Mc. maripaludis Delta aglB strain, both returning the apparent molecular weight of FIaB2 to wildtype size and restoring archaellation. This demonstrates that AglB from Mc. voltae has a relaxed specificity for the linking sugar of the transferred glycan since while the N-linked glycan present in Mc. voltae is similar to that of Mc. maripaludis, the Mc. voltae glycan uses N-acetylglucosamine as the linking sugar. In Mc. maripaludis that role is held by N-acetylgalactosamine. This study also identifies aglB from Mtc. thermolithotrophicus for the first time by its activity. Attempts to use AglB from Methanocaldococcus jannaschii, Haloferax volcanii or Sulfolobus acidocaldarius to functionally replace the oligosaccharyltransferase activity missing in the Mc. maripaludis Delta aglB strain were unsuccessful.	[Ding, Yan; Vrionis, Helen A.; Schneider, James; Jarrell, Ken F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Berezuk, Alison; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada	Queens University - Canada; University of Guelph	Jarrell, KF (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jarrellk@queensu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for the project was supplied by two separate grants from Natural Sciences and Engineering Research Council of Canada (NSERC), one to KFJ and the other to CMK. NSERC website http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Albers SV, 2015, MICROBE, V10, P283, DOI DOI 10.1128/MICR0BE.10.283.1; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Calo D, 2011, MICROB BIOTECHNOL, V4, P461, DOI 10.1111/j.1751-7915.2011.00250.x; Calo D, 2010, APPL ENVIRON MICROB, V76, P5684, DOI 10.1128/AEM.00681-10; Chaban B, 2007, MOL MICROBIOL, V66, P596, DOI 10.1111/j.1365-2958.2007.05913.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130482; Chong PLG, 2012, ARCHAEA, V2012, DOI 10.1155/2012/138439; Cohen-Rosenzweig C, 2014, APPL ENVIRON MICROB, V80, P486, DOI 10.1128/AEM.03191-13; Cohen-Rosenzweig C, 2012, J BACTERIOL, V194, P6909, DOI 10.1128/JB.01716-12; Ding Y, 2016, MOL MICROBIOL, V102, P54, DOI 10.1111/mmi.13444; Ding Y, 2016, MICROBIOL-SGM, V162, P339, DOI 10.1099/mic.0.000221; Ding Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116402; Ding Y, 2013, J BACTERIOL, V195, P4094, DOI 10.1128/JB.00668-13; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Esquivel RN, 2016, J BIOL CHEM, V291, P10602, DOI 10.1074/jbc.M115.693556; FERRANTE G, 1990, BIOCHEM CELL BIOL, V68, P274, DOI 10.1139/o90-038; Fujinami D, 2015, CARBOHYD RES, V413, P55, DOI 10.1016/j.carres.2015.05.010; Fujinami D, 2014, CARBOHYD RES, V387, P30, DOI 10.1016/j.carres.2014.01.021; GRANT WD, 1985, J GEN MICROBIOL, V131, P3277; Guan ZQ, 2016, FEBS LETT, V590, P3168, DOI 10.1002/1873-3468.12341; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P607, DOI 10.1016/j.bbalip.2011.06.022; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; HEDRICK DB, 1991, J LIPID RES, V32, P659; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2011, J BIOL CHEM, V286, P13255, DOI 10.1074/jbc.M110.213900; Ihssen J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-67; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jain S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00641; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Jarrell Ken F, 2010, Int J Microbiol, V2010, P470138, DOI 10.1155/2010/470138; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kaminski L, 2013, MOL PHYLOGENET EVOL, V68, P327, DOI 10.1016/j.ympev.2013.03.024; Kaminski L, 2013, BIOCHEM SOC T, V41, P432, DOI 10.1042/BST20120142; Kandiba L, 2016, GLYCOBIOLOGY, V26, P745, DOI 10.1093/glycob/cww014; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; KOSTYUKOVA AS, 1992, CAN J MICROBIOL, V38, P1162, DOI 10.1139/m92-190; Langworthy TA, 1985, ARCHAEBACTERIA, V8, P459; Larkin A, 2013, NAT CHEM BIOL, V9, P367, DOI 10.1038/nchembio.1249; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Lie TJ, 2005, J BIOL CHEM, V280, P5236, DOI 10.1074/jbc.M411778200; Lie TJ, 2003, MOL MICROBIOL, V47, P235, DOI 10.1046/j.1365-2958.2003.03293.x; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Matsumoto S, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-11; Matsumoto S, 2012, BIOCHEMISTRY-US, V51, P4157, DOI 10.1021/bi300076u; Meyer BH, 2015, BIOCHIMIE, V118, P294, DOI 10.1016/j.biochi.2014.10.018; Meyer BH, 2014, MICROBIOLOGYOPEN, V3, P531, DOI 10.1002/mbo3.185; Meyer BH, 2013, BIOCHEM SOC T, V41, P384, DOI 10.1042/BST20120296; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Nair Divya B., 2015, Life-Basel, V5, P85, DOI 10.3390/life5010085; Ng SYM, 2006, J MOL MICROB BIOTECH, V11, P167, DOI 10.1159/000094053; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Peyfoon E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/754101; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Siu S, 2015, J BACTERIOL, V197, P1668, DOI 10.1128/JB.00040-15; SPROTT GD, 1991, J BACTERIOL, V173, P3907, DOI 10.1128/JB.173.12.3907-3910.1991; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Taguchi Y, 2016, J BIOL CHEM, V291, P11042, DOI 10.1074/jbc.M115.713156; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; WIELAND F, 1985, J BIOL CHEM, V260, P5180	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167611	10.1371/journal.pone.0167611	http://dx.doi.org/10.1371/journal.pone.0167611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907170	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700211
J	Grandellis, C; Fantino, E; Garcia, MNM; Bialer, MG; Santin, F; Capiati, DA; Ulloa, RM				Grandellis, Carolina; Fantino, Elisa; Garcia, Maria Noelia Muniz; Bialer, Magali Graciela; Santin, Franco; Capiati, Daniela Andrea; Ulloa, Rita Maria			StCDPK3 Phosphorylates In Vitro Two Transcription Factors Involved in GA and ABA Signaling in Potato: StRSG1 and StABF1	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; REPRESSION OFSHOOT GROWTH; DROUGHT STRESS TOLERANCE; ABSCISIC-ACID; SUBSTRATE-SPECIFICITY; SEED-GERMINATION; GENE; EXPRESSION; TUBERIZATION; ACTIVATOR	Calcium-dependent protein kinases, CDPKs, decode calcium (Ca2+) transients and initiate downstream responses in plants. In order to understand how CDPKs affect plant physiology, their specific target proteins must be identified. In tobacco, the bZIP transcription factor (R) under bar epression of (S) under bar hoot (G) under bar rowth (NtRSG) that modulates gibberellin (GA) content is a specific target of NtCDPK1. StCDPK3 from potato is homologous (88% identical) to NtCDPK1 even in its N-terminal variable domain. In this work, we observe that NtRSG is also phosphorylated by StCDPK3. The potato RSG family of transcription factors is composed of three members that share similar features. The closest homologue to NtRSG, which was named StRSG1, was amplified and sequenced. qRT-PCR data indicate that StRSG1 is mainly expressed in petioles, stems, lateral buds, and roots. In addition, GA treatment affected StRSG1 expression. StCDPK3 transcripts were detected in leaves, petioles, stolons, roots, and dormant tubers, and transcript levels were modified in response to GA. The recombinant StRSG1-GST protein was produced and tested as a substrate for StCDPK3 and StCDPK1. 6xHisStCDPK3 was able to phosphorylate the potato StRSG1 in a Ca2+-dependent way, while 6xHisStCDPK1 could not. StCDPK3 also interacts and phosphorylates the transcription factor StABF1 (ABRE binding factor 1) involved in ABA signaling, as shown by EMSA and phosphorylation assays. StABF1 transcripts were mainly detected in roots, stems, and stolons. Our data suggest that StCDPK3 could be involved in the cross-talk between ABA and GA signaling at the onset of tuber development.	[Grandellis, Carolina; Fantino, Elisa; Garcia, Maria Noelia Muniz; Bialer, Magali Graciela; Santin, Franco; Capiati, Daniela Andrea; Ulloa, Rita Maria] Natl Res Council CONICET, Inst Genet Engn & Mol Biol INGEBI, 2do Piso, Buenos Aires, DF, Argentina; [Capiati, Daniela Andrea; Ulloa, Rita Maria] Univ Buenos Aires, Sch Exact & Nat Sci, Dept Biochem, Buenos Aires, DF, Argentina; [Grandellis, Carolina] Rosario IBR Ocampo 210 Bis CONICET, Inst Mol & Cellular Biol, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ulloa, RM (corresponding author), Natl Res Council CONICET, Inst Genet Engn & Mol Biol INGEBI, 2do Piso, Buenos Aires, DF, Argentina.; Ulloa, RM (corresponding author), Univ Buenos Aires, Sch Exact & Nat Sci, Dept Biochem, Buenos Aires, DF, Argentina.	rulloa@dna.uba.ar		Capiati, Daniela/0000-0002-7169-2003; Grandellis, Carolina/0000-0002-1092-5045; Muniz Garcia, Maria Noelia/0000-0003-3794-5617	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP-CONICET) [00037]; Universidad de Buenos Aires, UBA (UBACYT) [20020120100115]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP-CONICET); Universidad de Buenos Aires, UBA (UBACYT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP-CONICET 00037) and Universidad de Buenos Aires, UBA (UBACYT 20020120100115). RU and DC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenstock J, 2016, TRENDS BIOCH SCI; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Curran A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00036; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fukazawa J, 2010, PLANT J, V62, P1035, DOI 10.1111/j.1365-313X.2010.04215.x; Giammaria V, 2011, PLANTA, V233, P593, DOI 10.1007/s00425-010-1319-2; Grandellis C, 2016, FUNCT INTEGR GENOMIC; Grandellis C, 2012, PLANTA, V236, P1831, DOI 10.1007/s00425-012-1732-9; Gravino M, 2015, PLANT J, V84, P1073, DOI 10.1111/tpj.13057; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Hartmann A, 2011, PLANT PHYSIOL, V155, P776, DOI 10.1104/pp.110.168252; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Huang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075850; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Ishida S, 2008, PLANT CELL, V20, P3273, DOI 10.1105/tpc.107.057489; Ito T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977721; Ito T, 2011, PLANT SIGNAL BEHAV, V6, P924, DOI 10.4161/psb.6.7.15604; Ito T, 2010, PLANT CELL, V22, P1592, DOI 10.1105/tpc.109.073577; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jiang SS, 2013, PLANT PHYSIOL BIOCH, V71, P112, DOI 10.1016/j.plaphy.2013.07.004; Kagaya Y, 2002, PLANT CELL, V14, P3177, DOI 10.1105/tpc.005272; Kanchiswamy CN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-97; Kawamoto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08341; Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; KUMAR D, 1972, NEW PHYTOL, V71, P639, DOI 10.1111/j.1469-8137.1972.tb01274.x; Li A, 2014, PLANT SIGNAL BEHAV, V3, P654; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Machackova I, 1998, PHYSIOL PLANTARUM, V102, P272, DOI 10.1034/j.1399-3054.1998.1020215.x; Mair A, 2015, ELIFE, V4, DOI 10.7554/eLife.05828; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; MENZEL CM, 1983, ANN BOT-LONDON, V52, P697, DOI 10.1093/oxfordjournals.aob.a086627; Garcia MNM, 2014, PLANTA, V239, P615, DOI 10.1007/s00425-013-2001-2; Garcia MNM, 2012, PLANTA, V235, P761, DOI 10.1007/s00425-011-1540-7; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Raices M, 2003, CELL MOL BIOL, V49, P959; Raices M, 2003, J EXP BOT, V54, P2589, DOI 10.1093/jxb/erg282; Raices M, 2003, PLANT MOL BIOL, V52, P1011, DOI 10.1023/A:1025478315648; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Roumeliotis E, 2013, J PLANT PHYSIOL, V170, P1228, DOI 10.1016/j.jplph.2013.04.003; Gargantini P, 2009, PLANT MOL BIOL, V70, P153, DOI 10.1007/s11103-009-9462-5; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Santin F, 2016, PHYSL PLANT; Schoonheim PJ, 2009, PLANT CELL ENVIRON, V32, P439, DOI 10.1111/j.1365-3040.2009.01932.x; Schulz P, 2013, PLANT PHYSIOL, V163, P523, DOI 10.1104/pp.113.222539; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shu K, 2016, J EXP BOT, V67, P195, DOI 10.1093/jxb/erv459; Shu K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003577; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; SMITH OE, 1969, AM POTATO J, V46, P185, DOI 10.1007/BF02863046; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vreugdenhil D, 2004, AM J POTATO RES, V81, P275, DOI 10.1007/BF02871769; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Xu X, 1998, J EXP BOT, V49, P573, DOI 10.1093/jexbot/49.320.573; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhang HF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-211; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	73	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167389	10.1371/journal.pone.0167389	http://dx.doi.org/10.1371/journal.pone.0167389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907086	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700139
J	Gupta, R; Reneaux, M; Karmeshu				Gupta, Rahul; Reneaux, Melissa; Karmeshu			Role of Heterogeneous Macromolecular Crowding and Geometrical Irregularity at Central Excitatory Synapses in Shaping Synaptic Transmission	PLOS ONE			English	Article							CENTRAL GLUTAMATERGIC SYNAPSES; EXTRACELLULAR-MATRIX; DIFFUSION-COEFFICIENTS; QUANTAL TRANSMISSION; DENDRITIC SPINES; RAT HIPPOCAMPUS; AMPA RECEPTORS; CA1 SYNAPSES; CLEFT; TRANSMITTER	Besides the geometrical tortousity due to the extrasynaptic structures, macromolecular crowding and geometrical irregularities constituting the cleft composition at central excitatory synapses has a major and direct role in retarding the glutamate diffusion within the cleft space. However, the cleft composition may not only coarsely reduce the overall diffusivity of the glutamate but may also lead to substantial spatial variation in the diffusivity across the cleft space. Decrease in the overall diffusivity of the glutamate may have straightforward consequences to the glutamate transients in the cleft. However, how spatial variation in the diffusivity may further affect glutamate transients is an intriguing aspect. Therefore, to understand the role of cleft heterogeneity, the present study adopts a novel approach of glutamate diffusion which considers a gamma statistical distribution of the diffusion coefficient of glutamate (Dglut) across the cleft space, such that its moments discernibly capture the dual impacts of the cleft composition, and further applies the framework of superstatistics. The findings reveal a power law behavior in the glutamate transients, akin to the long-range anomalous subdiffusion, which leads to slower decay profile of cleft glutamate at higher intensity of cleft heterogeneity. Moreover, increase in the cleft heterogeneity is seen to eventually cause slower-rising excitatory postsynaptic currents with higher amplitudes, lesser noise, and prolonged duration of charge transfer across the postsynaptic membrane. Further, with regard to the conventional standard diffusion approach, the study suggests that the effective Dglut essentially derives from the median of the Dglut distribution and does not necessarily need to be the mean Dglut. Together, the findings indicate a strong implication of cleft heterogeneity to the metabolically cost-effective tuning of synaptic response during the phenomenon of plasticity at individual synapses and also provide an additional factor of variability in transmission across identical synapses.	[Gupta, Rahul; Reneaux, Melissa; Karmeshu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Karmeshu] Jawaharlal Nehru Univ, Sch Comp & Syst Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Karmeshu (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.; Karmeshu (corresponding author), Jawaharlal Nehru Univ, Sch Comp & Syst Sci, New Delhi 110067, India.	karmeshu@mail.jnu.ac.in			Council of Scientific and Industrial Research (CSIR), India [09/ 263(1057)/2015-EMR-I]; CSIR, India [09/263(0991)/2013-EMR-I]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	RG received funding from Council of Scientific and Industrial Research (CSIR), India (grant no. 09/ 263(1057)/2015-EMR-I and URL: www.csirhrdg.res.in) for this research. MR also acknowledges the Senior Research Fellowship (SRF) provided by CSIR, India under the Grant No. 09/263(0991)/2013-EMR-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Beck C, 2003, PHYSICA A, V322, P267, DOI 10.1016/S0378-4371(03)00019-0; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Budisantoso T, 2013, J PHYSIOL-LONDON, V591, P219, DOI 10.1113/jphysiol.2012.241398; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cohen EGD, 2004, PHYSICA D, V193, P35, DOI 10.1016/j.physd.2004.01.007; Cory Sean M., 2006, Critical Reviews in Neurobiology, V18, P61; Diamond JS, 1997, J NEUROSCI, V17, P4672; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Freche D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025122; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRIS KM, 1992, J NEUROSCI, V12, P2685; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; Kessler JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070791; Kleinle J, 1996, BIOPHYS J, V71, P2413, DOI 10.1016/S0006-3495(96)79435-3; Lachamp P, 2002, J NEUROBIOL, V52, P336, DOI 10.1002/neu.10091; Lacks DJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041912; LAND BR, 1984, P NATL ACAD SCI-BIOL, V81, P1594, DOI 10.1073/pnas.81.5.1594; LERNER IV, 1993, NUCL PHYS A, V560, P274, DOI 10.1016/0375-9474(93)90096-G; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Namiki S, 2007, EUR J NEUROSCI, V25, P2249, DOI 10.1111/j.1460-9568.2007.05511.x; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okubo Y, 2011, J PHYSIOL-LONDON, V589, P481, DOI 10.1113/jphysiol.2010.199539; Postlethwaite M, 2007, J PHYSIOL-LONDON, V579, P69, DOI 10.1113/jphysiol.2006.123612; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; RAMBOURG A, 1967, J CELL BIOL, V32, P27, DOI 10.1083/jcb.32.1.27; Ronen I, 2006, MAGN RESON IMAGING, V24, P61, DOI 10.1016/j.mri.2005.10.023; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusakov DA, 2011, TRENDS NEUROSCI, V34, P359, DOI 10.1016/j.tins.2011.03.002; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schikorski T, 1997, J NEUROSCI, V17, P5858; Scimemi A, 2009, MOL NEUROBIOL, V40, P289, DOI 10.1007/s12035-009-8087-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stylianopoulos T, 2010, BIOPHYS J, V99, P1342, DOI 10.1016/j.bpj.2010.06.016; Trommershauser J, 1999, J THEOR BIOL, V198, P101, DOI 10.1006/jtbi.1999.0905; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Ventriglia F, 2011, BIOSYSTEMS, V104, P14, DOI 10.1016/j.biosystems.2010.12.008; WADE WF, 1989, J CELL BIOL, V109, P3325, DOI 10.1083/jcb.109.6.3325; Wang RB, 2007, COGN NEURODYNAMICS, V1, P203, DOI 10.1007/s11571-007-9015-z; Yamashita T, 2003, J NEUROSCI, V23, P3633; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	58	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167505	10.1371/journal.pone.0167505	http://dx.doi.org/10.1371/journal.pone.0167505			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907112	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700173
J	Itoh, T; Hibi, T; Suzuki, F; Sugimoto, I; Fujiwara, A; Inaka, K; Tanaka, H; Ohta, K; Fujii, Y; Taketo, A; Kimoto, H				Itoh, Takafumi; Hibi, Takao; Suzuki, Fumiko; Sugimoto, Ikumi; Fujiwara, Akihiro; Inaka, Koji; Tanaka, Hiroaki; Ohta, Kazunori; Fujii, Yutaka; Taketo, Akira; Kimoto, Hisashi			Crystal Structure of Chitinase ChiW from Paenibacillus sp str. FPU-7 Reveals a Novel Type of Bacterial Cell-Surface-Expressed Multi-Modular Enzyme Machinery	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; X-RAY-DIFFRACTION; SP STRAIN FPU-7; BETA-1,3-GLUCANASE LIC16A; CLOSTRIDIUM-THERMOCELLUM; CATALYTIC DOMAINS; VIRULENCE FACTOR; HIGH-RESOLUTION; PROTEIN; CRYSTALLIZATION	The Gram-positive bacterium Paenibacillus sp. str. FPU-7 effectively hydrolyzes chitin by using a number of chitinases. A unique chitinase with two catalytic domains, ChiW, is expressed on the cell surface of this bacterium and has high activity towards various chitins, even crystalline chitin. Here, the crystal structure of ChiW at 2.1 angstrom resolution is presented and describes how the enzyme degrades chitin on the bacterial cell surface. The crystal structure revealed a unique multi-modular architecture composed of six domains to function efficiently on the cell surface: a right-handed beta-helix domain (carbohydrate-binding module family 54, CBM-54), a Gly-Ser-rich loop, 1st immunoglobulin-like (Ig-like) fold domain, 1st beta/alpha-barrel catalytic domain (glycoside hydrolase family 18, GH-18), 2nd Ig-like fold domain and 2nd beta/alpha-barrel catalytic domain (GH-18). The structure of the CBM-54, flexibly linked to the catalytic region of ChiW, is described here for the first time. It is similar to those of carbohydrate lyases but displayed no detectable carbohydrate degradation activities. The CBM-54 of ChiW bound to cell wall polysaccharides, such as chin, chitosan, beta-1,3-glucan, xylan and cellulose. The structural and biochemical data obtained here also indicated that the enzyme has deep and short active site clefts with endo-acting character. The affinity of CBM-54 towards cell wall polysaccharides and the degradation pattern of the catalytic domains may help to efficiently decompose the cell wall chitin through the contact surface. Furthermore, we clarify that other Gram-positive bacteria possess similar cell-surface-expressed multi-modular enzymes for cell wall polysaccharide degradation.	[Itoh, Takafumi; Hibi, Takao; Suzuki, Fumiko; Sugimoto, Ikumi; Fujiwara, Akihiro; Kimoto, Hisashi] Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan; [Inaka, Koji] Maruwa Foods & Biosci Inc, Yamato Koriyama, Nara, Japan; [Tanaka, Hiroaki] Confocal Sci Inc, Chiyoda Ku, Tokyo, Japan; [Ohta, Kazunori] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan; [Fujii, Yutaka] Univ Fukui, Fac Med, Dept Mol Biol & Chem, Fukui, Fukui, Japan; [Taketo, Akira] Fukui Univ Technol, Dept Environm & Biotechnol Frontier Engn, Fukui, Fukui, Japan	Fukui Prefectural University; Japan Aerospace Exploration Agency (JAXA); University of Fukui	Itoh, T; Kimoto, H (corresponding author), Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan.	ito-t@fpu.ac.jp; kimoto@fpu.ac.jp		Tanaka, Hiroaki/0000-0001-8814-740X; Fujii, Yutaka/0000-0001-6357-3795; Hibi, Takao/0000-0003-4394-4426	High-Quality Protein Crystal Growth Experiment on JEM; FPU Promotion of Community Fund; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [25850234, 26450099, 16K08114]	High-Quality Protein Crystal Growth Experiment on JEM; FPU Promotion of Community Fund; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by the "High-Quality Protein Crystal Growth Experiment on JEM" promoted by JAXA (Japan Aerospace Exploration Agency). This work was also supported by a grant from the FPU Promotion of Community Fund, by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, Japan and by a Grant-in-Aid for Young Scientists (B) (TI, Grant Number 25850234) and Scientific Research (C) (HK, Grand Number 26450099; TI, Grant Number 16K08114) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berisio R, PROTEIN PEPT LETT, V19, P1045; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Cheng YM, 2009, APPL MICROBIOL BIOT, V81, P1051, DOI 10.1007/s00253-008-1617-9; CLARKE ND, 1994, P NATL ACAD SCI USA, V91, P11084, DOI 10.1073/pnas.91.23.11084; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dembek M, 2012, J BIOL CHEM, V287, P1538, DOI 10.1074/jbc.M111.302463; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARCIARUIZ JM, 1994, ACTA CRYSTALLOGR D, V50, P484, DOI 10.1107/S0907444993014350; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Itoh T, 2014, BIOSCI BIOTECH BIOCH, V78, P624, DOI 10.1080/09168451.2014.891935; Itoh T, 2014, ACTA CRYSTALLOGR F, V70, P350, DOI 10.1107/S2053230X14002325; Itoh T, 2013, APPL ENVIRON MICROB, V79, P7482, DOI 10.1128/AEM.02483-13; Kielak AM, 2013, APPL ENVIRON MICROB, V79, P263, DOI 10.1128/AEM.02546-12; Kislitsyn YA, 2015, ACTA CRYSTALLOGR F, V71, P217, DOI 10.1107/S2053230X15000539; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Manjeet K, 2013, MICROBIOL RES, V168, P461, DOI 10.1016/j.micres.2013.01.006; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Matsumoto T, 1999, P JPN ACAD B-PHYS, V75, P269, DOI 10.2183/pjab.75.269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; ROBYT JF, 1972, ANAL BIOCHEM, V45, P510, DOI 10.1016/0003-2697(72)90213-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Takahashi S, 2013, J SYNCHROTRON RADIAT, V20, P968, DOI 10.1107/S0909049513021596; Tanaka H, 2004, J SYNCHROTRON RADIAT, V11, P45, DOI 10.1107/S0909049503023446; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuji H, 2010, FEBS J, V277, P2683, DOI [10.1111/j.1742-464X.2010.07685.x, 10.1111/j.1742-4658.2010.07685.x]; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	58	19	20	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167310	10.1371/journal.pone.0167310	http://dx.doi.org/10.1371/journal.pone.0167310			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907169	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700117
J	Li, TS; Xu, YF; Liu, LZ; Huang, ML; Wang, Z; Tong, ZX; Zhang, H; Guo, F; Chen, CF				Li, Tiansen; Xu, Yafang; Liu, Laizhen; Huang, Meiling; Wang, Zhen; Tong, Zhixia; Zhang, Hui; Guo, Fei; Chen, Chuangfu			Brucella Melitensis 16M Regulates the Effect of AIR Domain on Inflammatory Factors, Autophagy, and Apoptosis in Mouse Macrophage through the ROS Signaling Pathway	PLOS ONE			English	Article							SELECTIVE AUTOPHAGY; IN-VITRO; MATURATION; SECRETION; ACTIVATION; EXPRESSION; IL-1-BETA; INFECTION; PARTNERS; RECEPTOR	Brucellosis is a highly contagious zoonosis caused by Brucella. Brucella can invade and persist inside host cells, which results in chronic infection. We constructed AIR interference and overexpression lentiviruses to acquire AIR interference, overexpression, and rescue stable expression cell lines. We also established a Brucella melitensis 16M-infected macrophage model, which was treated with either the vehicle control or NAC (ROS scavenger N-acetylcysteine (NAC) for 0, 3, 6, 12, and 24 h. Confocal laser microscopy, transmission electron microscopy, fluorescence quantitative PCR, flow cytometry, ELISA, and Western blot were used to detect inflammation, cell autophagy and apoptosis-related protein expression levels, ROS levels, and the distribution of mitochondria. It was found that after interference and overexpression of AIR, ROS release was significantly changed, and mitochondria became abnormally aggregated. B. melitensis 16M activated the NLRP3/AIM2 inflammatory complex, and induced RAW264.7 cells to secrete IL-1 beta and IL-18 through the ROS pathway. B. melitensis 16M also altered autophagy-related gene expression, increased autophagy activity, and induced cell apoptosis through the ROS pathway. The results showed that after B. melitensis 16M infection, ROS induced apoptosis, inflammation, and autophagy while AIR inhibited autophagosome maturation and autophagy initiation. Autophagy negatively regulated the activation of inflammasomes and prevented inflammation from occurring. In addition, mitophagy could promote cell apoptosis.	[Li, Tiansen; Xu, Yafang; Liu, Laizhen; Wang, Zhen; Tong, Zhixia; Zhang, Hui; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China; [Huang, Meiling] Shihezi Univ, Coll Life Sci, Shihezi, Xinjiang, Peoples R China; [Guo, Fei] Shihezi Univ, Coll Med, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China.; Guo, F (corresponding author), Shihezi Univ, Coll Med, Shihezi, Xinjiang, Peoples R China.	119783783@qq.com; chen_chuangfu@163.com			National Natural Science Foundation of China [31460650, 31572491, 31360610, 31201863, 81360239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31460650,31572491,31360610,31201863, 81360239). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00030; BENNETT BL, 1947, J BACTERIOL, V54, P93; Brezden A., 2016, J AM CHEM SOC; Carrasco E, 2016, METHODS; Carrasco-Pozo C, 2016, REDOX BIOL, V9, P229, DOI 10.1016/j.redox.2016.08.007; Castaneda-Ramirez A, 2012, VIRULENCE, V3, P434, DOI 10.4161/viru.21251; Celli J, 2015, CELL MICROBIOL, V17, P951, DOI 10.1111/cmi.12452; Chen DD, 2012, AUTOPHAGY, V8, P985, DOI 10.4161/auto.20255; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Miraglia MC, 2016, J IMMUNOL, V196, P3794, DOI 10.4049/jimmunol.1500908; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Espinoza MB, 2016, J CELL BIOCH; Del Giudice MG, 2016, J BIOL CHEM, V291, P12383, DOI 10.1074/jbc.M116.730994; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Han J, 2016, J CELL BIOCH; Im YB, 2016, VET RES, V47, DOI 10.1186/s13567-016-0311-7; Ke YH, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/fcimb.2015.00072, 10.3389/famb.2015.00072]; Kerrinnes T, 2015, ANTIMICROB AGENTS CH, V59, P6717, DOI 10.1128/AAC.00792-15; Kim JH, 2015, BMB REP, V48, P129, DOI 10.5483/BMBRep.2015.48.3.048; Kim JH, 2015, AUTOPHAGY, V11, P75, DOI 10.4161/15548627.2014.984276; Lee WS, 2016, INT IMMUNOPHARMACOL, V40, P146, DOI 10.1016/j.intimp.2016.08.021; Ma QL, 2015, INT J CLIN EXP MED, V8, P17530; Marquardt N, 2016, J IMMUNOL; Martinvalet D, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.992639; Miller C, 2016, J MOL BIOL; Nuber S, 2016, P NATL ACAD SCI US; Ogawa M, 2011, AUTOPHAGY, V7, P1389, DOI 10.4161/auto.7.11.17151; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Osman AY, 2016, MICROB PATHOG; Otani K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32587; Viglietti AIP, 2016, INFECT IMMUN, V84, P11, DOI 10.1128/IAI.01049-15; Reddy SS, 2016, TOXICOL APPL PHARM; Sun XL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0643-2; Yu QQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006175; Zhang YQ, 2016, INT J MOL MED; Zhang Y, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2015-6	36	10	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167486	10.1371/journal.pone.0167486	http://dx.doi.org/10.1371/journal.pone.0167486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907115	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700166
J	Richter, FR; Yeung, N				Richter, Franziska R.; Yeung, Nick			ERP Correlates of Encoding Success and Encoding Selectivity in Attention Switching	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVITY; PROCESSING RESOURCES; COGNITIVE CONTROL; EPISODIC MEMORY; TASK; EVENT; PARADIGM; RECOLLECTION; PERFORMANCE	Long-term memory encoding depends critically on effective processing of incoming information. The degree to which participants engage in effective encoding can be indexed in electroencephalographic (EEG) data by studying event-related potential (ERP) subsequent memory effects. The current study investigated ERP correlates of memory success operationalised with two different measures-memory selectivity and global memory-to assess whether previously observed ERP subsequent memory effects reflect focused encoding of task-relevant information (memory selectivity), general encoding success (global memory), or both. Building on previous work, the present study combined an attention switching paradigm-in which participants were presented with compound object-word stimuli and switched between attending to the object or the word across trials with a later recognition memory test for those stimuli, while recording their EEG. Our results provided clear evidence that subsequent memory effects resulted from selective attentional focusing and effective top-down control (memory selectivity) in contrast to more general encoding success effects (global memory). Further analyses addressed the question of whether successful encoding depended on similar control mechanisms to those involved in attention switching. Interestingly, differences in the ERP correlates of attention switching and successful encoding, particularly during the poststimulus period, indicated that variability in encoding success occurred independently of prestimulus demands for top-down cognitive control. These results suggest that while effects of selective attention and selective encoding co-occur behaviourally their ERP correlates are at least partly dissociable.	[Richter, Franziska R.; Yeung, Nick] Univ Oxford, Dept Expt Psychol, Oxford, England; [Richter, Franziska R.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Oxford; University of Cambridge	Richter, FR (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.; Richter, FR (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	frr28@cam.ac.uk		Richter, Franziska Rebekka/0000-0002-1917-0435; Yeung, Nick/0000-0003-1905-2129	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD)	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD)	FRR was supported by a doctoral scholarship from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD). Other than this scholarship, the authors received no specific funding for this work.; F. R. R. was supported by a Doctoral Scholarship from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD).	BOWER GH, 1969, J VERB LEARN VERB BE, V8, P323, DOI 10.1016/S0022-5371(69)80124-6; Chiu YC, 2016, J EXP PSYCHOL HUMAN, V42, P1, DOI 10.1037/xhp0000181; Chiu YC, 2015, J NEUROSCI, V35, P11936, DOI 10.1523/JNEUROSCI.0519-15.2015; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Dunlosky J., 2008, METACOGNITION; Elchlepp H, 2012, HUM BRAIN MAPP, V33, P1137, DOI 10.1002/hbm.21277; Evans LH, 2015, NEUROIMAGE; Evans LH, 2015, PSYCHOL SCI; FABIANI M, 1995, J EXP PSYCHOL LEARN, V21, P224, DOI 10.1037/0278-7393.21.1.224; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; Falkenstein M, 2003, PSYCHOPHYSIOLOGY, V40, P914, DOI 10.1111/1469-8986.00109; Fernandez G, 1998, PSYCHOPHYSIOLOGY, V35, P709, DOI 10.1017/S0048577298970500; Galli G, 2013, CORTEX, V49, P2239, DOI 10.1016/j.cortex.2012.10.011; Galli G, 2012, COGN NEUROSCI-UK, V3, P160, DOI 10.1080/17588928.2012.670105; Guo CY, 2004, NEUROSCI LETT, V356, P79, DOI 10.1016/j.neulet.2003.09.049; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Karayanidis F., 2014, TASK SWITCHING COGNI, P200, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0009; Karayanidis F, 2011, PSYCHOPHYSIOLOGY, V48, P559, DOI 10.1111/j.1469-8986.2010.01115.x; KARIS D, 1984, COGNITIVE PSYCHOL, V16, P177, DOI 10.1016/0010-0285(84)90007-0; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Krebs RM, 2015, CEREB CORTEX, V25, P833, DOI 10.1093/cercor/bht283; Longman CS, 2014, J EXP PSYCHOL HUMAN, V40, P1580, DOI 10.1037/a0036552; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Otten LJ, 2010, J COGNITIVE NEUROSCI, V22, P1212, DOI 10.1162/jocn.2009.21298; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Padovani T, 2013, BRAIN BEHAV, V3, P464, DOI 10.1002/brb3.150; Padovani T, 2011, J COGNITIVE NEUROSCI, V23, P4008, DOI 10.1162/jocn_a_00096; PALLER KA, 1988, BIOL PSYCHOL, V26, P269, DOI 10.1016/0301-0511(88)90023-3; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Poljac E, 2012, JOURNAL OF AUTISM AN; Poljac E, 2014, CEREBRAL CORTEX; Richter F.R., 2014, TASK SWITCHING COGNI, P237, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0010; Richter F. R., 2013, THESIS; Richter FR, 2015, Q J EXP PSYCHOL, V68, P1124, DOI 10.1080/17470218.2014.976579; Richter FR, 2012, PSYCHOL SCI, V23, P1256, DOI 10.1177/0956797612444613; Roediger HL, 2014, MEMORY, V22, P76, DOI 10.1080/09658211.2013.795974; Rugg M.D., 1995, OX PSYCH S, P133; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schott B, 2002, J COGNITIVE NEUROSCI, V14, P578, DOI 10.1162/08989290260045828; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SOMMER W, 1991, ELECTROEN CLIN NEURO, V79, P457, DOI 10.1016/0013-4694(91)90165-Z; Uncapher MR, 2009, J NEUROSCI, V29, P8270, DOI 10.1523/JNEUROSCI.1043-09.2009; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Yonelinas AP, 2010, HIPPOCAMPUS, V20, P1178, DOI 10.1002/hipo.20864	55	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167396	10.1371/journal.pone.0167396	http://dx.doi.org/10.1371/journal.pone.0167396			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907075	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700143
J	Sun, Y; Guo, WW; Wang, F; Yang, YK; Dai, XF; Liu, XX; Bai, ZH				Sun, Yang; Guo, Wenwen; Wang, Fen; Yang, Yankun; Dai, Xiaofeng; Liu, Xiuxia; Bai, Zhonghu			Transcriptome and Multivariable Data Analysis of Corynebacterium glutamicum under Different Dissolved Oxygen Conditions in Bioreactors	PLOS ONE			English	Article							GLYCOLYTIC FLUX; SACCHAROMYCES-CEREVISIAE; ACID BIOSYNTHESIS; ESCHERICHIA-COLI; METABOLIC FLUX; ORGANIC-ACIDS; RNA-SEQ; ATP; DEPRIVATION; SECRETION	Dissolved oxygen (DO) is an important factor in the fermentation process of Corynebacterium glutamicum, which is a widely used aerobic microbe in bio-industry. Herein, we described RNA-seq for C. glutamicum under different DO levels (50%, 30% and 0%) in 5 L bioreactors. Multivariate data analysis (MVDA) models were used to analyze the RNA-seq and metabolism data to investigate the global effect of DO on the transcriptional distinction of the substance and energy metabolism of C. glutamicum. The results showed that there were 39 and 236 differentially expressed genes (DEGs) under the 50% and 0% DO conditions, respectively, compared to the 30% DO condition. Key genes and pathways affected by DO were analyzed, and the result of the MVDA and RNA-seq revealed that different DO levels in the fermenter had large effects on the substance and energy metabolism and cellular redox balance of C. glutamicum. At low DO, the glycolysis pathway was up-regulated, and TCA was shunted by the up-regulation of the glyoxylate pathway and over-production of amino acids, including valine, cysteine and arginine. Due to the lack of electron-acceptor oxygen, 7 genes related to the electron transfer chain were changed, causing changes in the intracellular ATP content at 0% and 30% DO. The metabolic flux was changed to rebalance the cellular redox. This study applied deep sequencing to identify a wealth of genes and pathways that changed under different DO conditions and provided an overall comprehensive view of the metabolism of C. glutamicum. The results provide potential ways to improve the oxygen tolerance of C. glutamicum and to modify the metabolic flux for amino acid production and heterologous protein expression.	[Sun, Yang; Guo, Wenwen; Wang, Fen; Yang, Yankun; Dai, Xiaofeng; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China; [Sun, Yang; Guo, Wenwen; Wang, Fen; Yang, Yankun; Dai, Xiaofeng; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Sun, Yang; Guo, Wenwen; Wang, Fen; Yang, Yankun; Dai, Xiaofeng; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, XX; Bai, ZH (corresponding author), Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China.; Liu, XX; Bai, ZH (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China.; Liu, XX; Bai, ZH (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China.	liuxiuxia@jiangnan.edu.cn; baizhonghu@jiangnan.edu.cn	Yang, Yankun/AAJ-3032-2020; Bai, Zhihui/O-5303-2019	Yang, Yankun/0000-0003-4815-6832; Bai, Zhihui/0000-0002-3818-527X	National Basic Research Program of China (973 Program) [2013CB733602]; Fundamental Research Funds for the Central Universities [JUSRP51401A]; National Natural Science Foundation of China [31570034]; Natural Science Foundation of Jiangsu Province [BK20150148]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was financially supported by the National Basic Research Program of China (973 Program) (grant number 2013CB733602, http://www.973.gov.cn/ , ZHB), the Fundamental Research Funds for the Central Universities (grant numbers JUSRP51401A, htttp://kjc.jiangnan.edu.cn/, YKY), the National Natural Science Foundation of China (grant number 31570034, http://www.nsfc.gov.cn/, YKY), and the Natural Science Foundation of Jiangsu Province (grant number BK20150148, http://jstd.gov.cn/, XXL)	An SJ, 2013, PROTEIN EXPRES PURIF, V89, P251, DOI 10.1016/j.pep.2013.04.003; Becker J, 2012, CURR OPIN BIOTECH, V23, P631, DOI 10.1016/j.copbio.2011.11.012; Boccard J, 2013, ANAL CHIM ACTA, V769, P30, DOI 10.1016/j.aca.2013.01.022; Bueno E, 2012, ANTIOXID REDOX SIGN, V16, P819, DOI 10.1089/ars.2011.4051; Bylesjo Max, 2015, Methods Mol Biol, V1277, P137, DOI 10.1007/978-1-4939-2377-9_11; Chen Y, 2015, J IND MICROBIOL BIOT, V42, P577, DOI 10.1007/s10295-014-1536-y; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; Ehira S, 2008, APPL ENVIRON MICROB, V74, P5146, DOI 10.1128/AEM.00944-08; Guimaraes LC, 2012, COMPUT BIOL MED, V42, P538, DOI 10.1016/j.compbiomed.2012.01.006; Il'chenko AP, 1998, MICROBIOLOGY+, V67, P241; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Kalinowski J, 2011, J BIOTECHNOL, V154, P99, DOI 10.1016/j.jbiotec.2011.05.007; Kim HJ, 2012, APPL MICROBIOL BIOT, V94, P1079, DOI 10.1007/s00253-011-3779-0; Koch-Koerfges A, 2012, BBA-BIOENERGETICS, V1817, P370, DOI 10.1016/j.bbabio.2011.10.006; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Koebmann BJ, 2002, MOL BIOL REP, V29, P41, DOI 10.1023/A:1020398117281; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Larsson C, 2000, YEAST, V16, P797, DOI 10.1002/1097-0061(20000630)16:9<797::AID-YEA553>3.3.CO;2-X; Li HW, 2016, MOL BIOSYST, V12, P102, DOI 10.1039/c5mb00627a; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; [刘巽浩 Liu Xunhao], 2015, [作物杂志, Crops], P1; Madala NE, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-254; Melanie Spornraft, 2015, Biomol Detect Quantif, V5, P15, DOI 10.1016/j.bdq.2015.08.001; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MILLER WM, 1987, J CELL PHYSIOL, V132, P524, DOI 10.1002/jcp.1041320315; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakayama K, 1978, Adv Exp Med Biol, V105, P649; Neshat A, 2014, J BIOTECHNOL, V190, P55, DOI 10.1016/j.jbiotec.2014.05.033; Patek M, 2011, J BIOTECHNOL, V154, P101, DOI 10.1016/j.jbiotec.2011.01.017; Rathore AS, 2015, BIOTECHNOL PROGR, V31, P1586, DOI 10.1002/btpr.2155; Suberu J, 2016, J PHARMACEUT BIOMED, V117, P522, DOI 10.1016/j.jpba.2015.10.003; Umakoshi M, 2011, J BIOSCI BIOENG, V112, P595, DOI 10.1016/j.jbiosc.2011.08.011; Vasco-Cardenas MF, 2013, J PROTEOMICS, V85, P65, DOI 10.1016/j.jprot.2013.04.019; Wang ZX, 2014, APPL MICROBIOL BIOT, V98, P5589, DOI 10.1007/s00253-014-5763-y; Wendisch VF, 2006, CURR OPIN MICROBIOL, V9, P268, DOI 10.1016/j.mib.2006.03.001; Wieschalka S, 2013, MICROB BIOTECHNOL, V6, P87, DOI 10.1111/1751-7915.12013; Xu H, 2009, BIOCHEM ENG J, V43, P41, DOI 10.1016/j.bej.2008.08.007; Yamamoto S, 2011, APPL MICROBIOL BIOT, V90, P1051, DOI 10.1007/s00253-011-3144-3; Yim SS, 2014, APPL MICROBIOL BIOT, V98, P273, DOI 10.1007/s00253-013-5315-x; Yu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020092; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0; Zhou JW, 2009, BIOTECHNOL ADV, V27, P94, DOI 10.1016/j.biotechadv.2008.10.005; Zupke C, 1995, APPL MICROBIOL BIOT, V44, P27	43	17	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167156	10.1371/journal.pone.0167156	http://dx.doi.org/10.1371/journal.pone.0167156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907077	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700083
J	Tollefsrud, MM; Myking, T; Sonstebo, JH; Lygis, V; Hietala, AM; Heuertz, M				Tollefsrud, Mari Mette; Myking, Tor; Sonstebo, Jorn Henrik; Lygis, Vaidotas; Hietala, Ari Mikko; Heuertz, Myriam			Genetic Structure in the Northern Range Margins of Common Ash, Fraxinus excelsior L.	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; LONG-DISTANCE DISPERSAL; POPULATION-STRUCTURE; POSTGLACIAL RECOLONIZATION; COMPUTER-PROGRAM; SEED DISPERSAL; HYMENOSCYPHUS-PSEUDOALBIDUS; CONTRASTING PATTERNS; FRAGMENTED LANDSCAPE; MICROSATELLITE LOCI	During post glacial colonization, loss of genetic diversity due to leading edge effects may be attenuated in forest trees because of their prolonged juvenile phase, allowing many migrants to reach the colonizing front before populations become reproductive. The northern range margins of temperate tree taxa in Europe are particularly suitable to study the genetic processes that follow colonization because they have been little affected by northern refugia. Here we examined how post glacial range dynamics have shaped the genetic structure of common ash (Fraxinus excelsior L.) in its northern range compared to its central range in Europe. We used four chloroplast and six nuclear microsatellites to screen 42 populations (1099 trees), half of which corresponded to newly sampled populations in the northern range and half of which represented reference populations from the central range obtained from previously studies. We found that northern range populations of common ash have the same chloroplast haplotypes as south-eastern European populations, suggesting that colonization of the northern range took place along a single migration route, a result confirmed by the structure at the nuclear microsatellites. Along this route, diversity strongly decreased only in the northern range, concomitantly with increasing population differentiation and complex population substructures, a pattern consistent with a leading edge colonization model. Our study highlights that while diversity is maintained in the central range of common ash due to broad colonizing fronts and high levels of gene flow, it profoundly decreases in the northern range, where colonization was unidirectional and probably involved repeated founder events and population fluctuations. Currently, common ash is threatened by ash dieback, and our results on northern populations will be valuable for developing gene conservation strategies.	[Tollefsrud, Mari Mette; Myking, Tor; Sonstebo, Jorn Henrik; Hietala, Ari Mikko] Norwegian Inst Bioecon Res, As, Norway; [Lygis, Vaidotas] Nat Res Ctr, Inst Bot, Vilnius, Lithuania; [Heuertz, Myriam] INIA Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Heuertz, Myriam] Univ Bordeaux, BIOGECO, INRA, Cestas, France	Norwegian Institute of Bioeconomy Research; Nature Research Center - Lithuania; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); INRAE; UDICE-French Research Universities; Universite de Bordeaux	Tollefsrud, MM (corresponding author), Norwegian Inst Bioecon Res, As, Norway.	mari.mette.tollefsrud@nibio.no	Lygis, Vaidotas/I-6242-2019; Sønstebø, Jørn Henrik/Q-1144-2019; Heuertz, Myriam/A-7831-2011	Lygis, Vaidotas/0000-0001-5121-2052; Hietala, Ari Mikko/0000-0002-3195-6318; Heuertz, Myriam/0000-0002-6322-3645; Sonstebo, Jorn Henrik/0000-0002-3204-1283	Research Council of Norway [Ash die back in Norway causes, impact and control] [203822/E40]; Spanish Ministry of Science and Innovation, Ramon y Cajal program [RYC2009-04537]; Norges Forskningsrad [203822/E40]	Research Council of Norway [Ash die back in Norway causes, impact and control]; Spanish Ministry of Science and Innovation, Ramon y Cajal program; Norges Forskningsrad	This study was supported by the Research Council of Norway [Ash die back in Norway causes, impact and control, 203822/E40 to MMT, TM, JHS, AMH and MH] and the Spanish Ministry of Science and Innovation, Ramon y Cajal program [RYC2009-04537 to MH]. Norges Forskningsrad 203822/E40 to MMT, TM, JHS, AMH and MH. Spanish Ministry of Science and Innovation, Ramon y Cajal program RYC2009-04537 to MH.	Austerlitz F, 2000, GENETICS, V154, P1309; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Baral HO, 2014, IMA FUNGUS, V5, P79, DOI 10.5598/imafungus.2014.05.01.09; Beatty GE, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0879-5; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Brachet S, 1999, MOL ECOL, V8, P160; Brewer S, 2016, J MAPS; BREWER S, 2002, RECOLONISATION POSTG; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; Campagne P, 2012, MOL ECOL RESOUR, V12, P975, DOI 10.1111/1755-0998.12015; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chhatre VE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097291; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Comps B, 2001, GENETICS, V157, P389; Cornille A, 2013, MOL ECOL, V22, P2249, DOI 10.1111/mec.12231; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dobrowolska D, 2011, FORESTRY, V84, P133, DOI 10.1093/forestry/cpr001; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrazzini D, 2007, ANN FOREST SCI, V64, P159, DOI 10.1051/forest:2006100; Gerard PR, 2013, J BIOGEOGR, V40, P835, DOI 10.1111/jbi.12021; Giesecke T, 2005, VEG HIST ARCHAEOBOT, V14, P133, DOI 10.1007/s00334-005-0070-2; Gonzalez-Martinez SC, 2010, MOL PHYLOGENET EVOL, V55, P805, DOI 10.1016/j.ympev.2010.03.001; GOUDET J., 2001, FSTAT VERSION 2 9 3; Gross A, 2014, MOL ECOL, V23, P2943, DOI 10.1111/mec.12792; Gross A, 2014, MOL PLANT PATHOL, V15, P5, DOI 10.1111/mpp.12073; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hampe A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1070; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Havrdova A, 2015, MOL ECOL, V24, P4759, DOI 10.1111/mec.13348; Henriksen S, 2015, NORGE ARTSDATABANKEN; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Heuertz M, 2004, EVOLUTION, V58, P976; Heuertz M, 2003, MOL ECOL, V12, P2483, DOI 10.1046/j.1365-294X.2003.01923.x; Heuertz M, 2001, MOL ECOL, V10, P1615, DOI 10.1046/j.1365-294X.2001.01300.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hoban SM, 2010, MOL ECOL, V19, P4876, DOI 10.1111/j.1365-294X.2010.04834.x; Holliday JA, 2012, P ROY SOC B-BIOL SCI, V279, P1675, DOI 10.1098/rspb.2011.1805; Holtken AM, 2003, SILVAE GENET, V52, P206; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JS, 2002, FOREST ECOL MANAG, V156, P167, DOI 10.1016/S0378-1127(01)00641-7; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kowalski T, 2009, FOREST PATHOL, V39, P304, DOI 10.1111/j.1439-0329.2008.00589.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; LeCorre V, 1997, GENET RES, V69, P117, DOI 10.1017/S0016672397002668; Lefort F, 1999, MOL ECOL, V8, P1088, DOI 10.1046/j.1365-294X.1999.00655_8.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lesser MR, 2013, ECOL LETT, V16, P380, DOI 10.1111/ele.12053; Liepelt S, 2009, REV PALAEOBOT PALYNO, V153, P139, DOI 10.1016/j.revpalbo.2008.07.007; Lygis V, 2014, EUR J FOREST RES, V133, P501, DOI 10.1007/s10342-014-0780-z; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; McKinney LV, 2014, PLANT PATHOL, V63, P485, DOI 10.1111/ppa.12196; Mimura M, 2007, AM J BOT, V94, P991, DOI 10.3732/ajb.94.6.991; Morand ME, 2002, MOL ECOL, V11, P377, DOI 10.1046/j.1365-294X.2002.01461.x; Morand-Prieur ME, 2002, MOL ECOL, V11, P613, DOI 10.1046/j.1365-294X.2002.01453.x; Myking T, 2009, FORESTRY, V82, P529, DOI 10.1093/forestry/cpp022; Nadeau S, 2015, AM J BOT, V102, P1342, DOI 10.3732/ajb.1500160; Naess R., 1999, TRE NATURENS VAKREST; Naydenov K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-233; Nei M., 1987, MOL EVOLUTIONARY GEN; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Persson H, 2004, PLANT SYST EVOL, V244, P157, DOI 10.1007/s00606-003-0073-3; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PLIURA A, 2003, TECHNICAL GUIDELINES; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Solbraa K, 1996, VEIEN BOEREKRAFTIG S; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Sumegi P, 2013, QUATERN INT, V293, P34, DOI 10.1016/j.quaint.2012.07.032; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Thomas PA, 2016, J ECOL, V104, P1158, DOI 10.1111/1365-2745.12566; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; Tollefsrud MM, 2015, J BIOGEOGR, V42, P1431, DOI 10.1111/jbi.12484; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Vilas A, 2015, MOL ECOL, V24, P4419, DOI 10.1111/mec.13334; WALLANDER E, 2001, EVOLUTION WIND POLLI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	103	10	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167104	10.1371/journal.pone.0167104	http://dx.doi.org/10.1371/journal.pone.0167104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907032	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700077
J	Tryfinopoulou, K; Kesanopoulos, K; Xirogianni, A; Marmaras, N; Papandreou, A; Papaevangelou, V; Tsolia, M; Jasir, A; Tzanakaki, G				Tryfinopoulou, Kyriaki; Kesanopoulos, Konstantinos; Xirogianni, Athanasia; Marmaras, Nektarios; Papandreou, Anastasia; Papaevangelou, Vassiliki; Tsolia, Maria; Jasir, Aftab; Tzanakaki, Georgina			Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015)	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; CONJUGATE VACCINES; HERD-IMMUNITY; RISK-FACTORS; DISEASE; ADOLESCENTS; POPULATION; EUROPE; EPIDEMIOLOGY; PREVALENCE	Purpose The aim of the study was to estimate the meningococcal carriage rate and to identify the genotypic characteristics of the strains isolated from healthy military recruits and university students in order to provide data that might increase our understanding on the epidemiology of meningococcus and obtain information which helps to evaluate the potential effects on control programs such as vaccination., Methods A total of 1420 oropharyngeal single swab samples were collected from military recruits and university students on voluntary basis, aged 18-26 years. New York City Medium was used for culture and the suspected N. meningitidis colonies were identified by Gram stain, oxidase and rapid carbohydrate utilization tests. Further characterisation was carried out by molecular methods (multiplex PCR, MLST, WGS). Results The overall carriage rate was of 12.7%; 15% and 10.4% for recruits and university students respectively. MenB (39.4%) was the most prevalent followed by MenY (12.8%) and MenW (4.4%). Among the initial 76 Non Groupable (NG) isolates, Whole Genome Sequence Analysis (WGS) revealed that 8.3% belonged to MenE, 3.3% to MenX and 1.1% to MenZ, while, 53 strains (29.4%) were finally identified as capsule null. Genetic diversity was found among the MenB isolates, with 41/44 cc and 35 cc predominating. Conclusion Meningococcal carriage rate in both groups was lower compared to our previous studies (25% and 18% respectively) with predominance of MenB isolates. These findings, help to further our understanding on the epidemiology of meningococcal disease in Greece. Although the prevalence of carriage seems to have declined compared to our earlier studies, the predominant MenB clonal complexes (including 41/44cc and 35cc) are associated with invasive meningococcal disease.	[Tryfinopoulou, Kyriaki; Kesanopoulos, Konstantinos; Xirogianni, Athanasia; Marmaras, Nektarios; Papandreou, Anastasia; Tzanakaki, Georgina] Natl Sch Publ Hlth, NMRL, Dept Publ Hlth, Athens, Greece; [Tryfinopoulou, Kyriaki; Jasir, Aftab] European Ctr Dis Prevent & Control, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden; [Papaevangelou, Vassiliki] ATTIKON Natl Kapodistrian Univ Athens, Univ Gen Hosp, Dept Paediat 3, Athens, Greece; [Tsolia, Maria] Univ Athens, Sch Med, Dept Paediat 2, Aglaia Kyriakou Childrens Hosp, Athens, Greece	National & Kapodistrian University of Athens; European Centre for Disease Prevention & Control; Athens Medical School; National & Kapodistrian University of Athens	Tzanakaki, G (corresponding author), Natl Sch Publ Hlth, NMRL, Dept Publ Hlth, Athens, Greece.	gtzanakaki@esdy.edu.gr	Xirogianni, Athanasia/ABG-6686-2022; Tryfinopoulou, Kyriaki/W-8519-2019; Tzanakaki, Georgina/AAZ-6598-2021	Xirogianni, Athanasia/0000-0002-2959-8216; 	GSK; Ministries of Defence and Education	GSK(GlaxoSmithKline); Ministries of Defence and Education	The principal investigator of this study (GT) has received funding from GSK while, the rest of the authors received no funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MLST data were obtained from the WGS data carried out at University of Oxford (Dept. of Zoology). The authors would like to thank Prof Martin Maiden and Dr Holly Bracher for their great help on assembling, annotation and curation of the data and Dr Arnold Bosman and Prof Michael Catchpole (ECDC) for critical reviewing of the manuscript. The authors also would like to thank the Ministries of Defence and Education for their permission and support.	Ala'Aldeen DAA, 2011, EMERG INFECT DIS, V17, P1761, DOI 10.3201/eid1709.101762; BLACKWELL CC, 1992, EPIDEMIOL INFECT, V108, P441, DOI 10.1017/S0950268800049943; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Broker M, 2015, HUM VACC IMMUNOTHER, V11, P2281, DOI 10.1080/21645515.2015.1051276; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; CAUGANT DA, 1992, EPIDEMIOL INFECT, V109, P241, DOI 10.1017/S0950268800050196; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; de Moraes JC, 2015, PEDIATR INFECT DIS J, V34, P1197, DOI 10.1097/INF.0000000000000853; Drakopoulou Z, 2008, FEMS IMMUNOL MED MIC, V53, P178, DOI 10.1111/j.1574-695X.2008.00406.x; Dyet KH, 2006, EPIDEMIOL INFECT, V134, P377, DOI 10.1017/S0950268805004954; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Jeppesen CA, 2015, J INFECTION, V71, P43, DOI 10.1016/j.jinf.2015.02.006; Kafetzis DA, 2007, CLIN MICROBIOL INFEC, V13, P550, DOI 10.1111/j.1469-0691.2007.01704.x; Kremastinou J, 1999, FEMS IMMUNOL MED MIC, V23, P13, DOI 10.1111/j.1574-695X.1999.tb01716.x; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Moreno J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135497; OLCEN P, 1981, SCAND J INFECT DIS, V13, P105, DOI 10.3109/inf.1981.13.issue-2.05; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Sakou II, 2011, EUR J PEDIATR, V170, P1419, DOI 10.1007/s00431-011-1456-z; Sakou II, 2009, VACCINE, V27, P4408, DOI 10.1016/j.vaccine.2009.05.047; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; Stuart J, 1989, LANSET, V334, P723; Taha MK, 2014, LANCET, V384, P2088, DOI 10.1016/S0140-6736(14)60935-1; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Tsolia M, 2015, MENINGOCOCCAL DIS GR; Tsolia MN, 2006, EUR J CLIN MICROBIOL, V25, P449, DOI 10.1007/s10096-006-0155-6; Tzanakaki G, NATL MENINGITIS REFE; Tzanakaki G, 2007, INT J ANTIMICROB AG, V29, P621, DOI 10.1016/j.ijantimicag.2006.11.031; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167404	10.1371/journal.pone.0167404	http://dx.doi.org/10.1371/journal.pone.0167404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907129	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700146
J	Wang, HT; Huang, C; Zhao, WX; Dai, BS; Shen, C; Zhang, BB; Li, DG; Lin, ZX				Wang, Hantao; Huang, Cong; Zhao, Wenxia; Dai, Baosheng; Shen, Chao; Zhang, Beibei; Li, Dingguo; Lin, Zhongxu			Identification of QTL for Fiber Quality and Yield Traits Using Two Immortalized Backcross Populations in Upland Cotton	PLOS ONE			English	Article							ENVIRONMENT INTERACTIONS CONTRIBUTE; GOSSYPIUM-HIRSUTUM; PARTIAL DOMINANCE; GENE-EXPRESSION; CELL ELONGATION; EPISTASIS; HETEROSIS; LOCI; MAP; CONSTRUCTION	Two immortalized backcross populations (DHBCF(1)s and JMBCF(1)s) were developed using a recombinant inbred line (RIL) population crossed with the two parents DH962 and Jimian5 (as the males), respectively. The fiber quality and yield component traits of the two backcross populations were phenotyped at four environments (two locations, two years). One hundred seventy-eight quantitative trait loci (QTL) were detected including 76 for fiber qualities and 102 for yield components, explaining 4.08-17.79% of the phenotypic variation (PV). Among the 178 QTL, 22 stable QTL were detected in more than one environment or population. A stable QTL, qFL-c10-1, was detected in the previous F-2 population, a RIL population in 3 environments and the current two BCF1 populations in this study, explaining 5.79-37.09% of the PV. Additionally, 117 and 110 main-effect QTL (M-QTL) and 47 and 191 digenic epistatic QTL (E-QTL) were detected in the DHBCF(1)s and JMBCF(1)s populations, respectively. The effect of digenic epistasis played a more important role on lint percentage, fiber length and fiber strength. These results obtained in the present study provided more resources to obtain stable QTL, confirming the authenticity and reliability of the QTL for molecular marker-assisted selection breeding and QTL cloning.	[Wang, Hantao; Huang, Cong; Zhao, Wenxia; Dai, Baosheng; Shen, Chao; Zhang, Beibei; Lin, Zhongxu] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Wang, Hantao] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Li, Dingguo] Yangtze Univ, Coll Agr, Inst Crop Genet & Breeding, Jingzhou, Hubei, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Yangtze University	Lin, ZX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.; Li, DG (corresponding author), Yangtze Univ, Coll Agr, Inst Crop Genet & Breeding, Jingzhou, Hubei, Peoples R China.	lidingguo654456@126.com; linzhongxu@mail.hzau.edu.cn	shen, chao/GZL-3987-2022; Wang, Han/GPW-9809-2022	Shen, Chao/0000-0001-5483-3348	Fundamental Research Funds for the Central Universities [2014PY015]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the Fundamental Research Funds for the Central Universities (Grant No. 2014PY015).	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; CHURCHILL GA, 1994, GENETICS, V138, P963; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Fang DD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-397; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Islam MS, 2014, MOL BREEDING, V34, P373, DOI 10.1007/s11032-014-0040-4; Jia YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095882; Li Y, 2016, PLANT BIOTECHNOL J, V14, P951, DOI 10.1111/pbi.12450; Li YJ, 2010, PLANT CELL REP, V29, P193, DOI 10.1007/s00299-009-0812-1; Li ZK, 2001, GENETICS, V158, P1737; Liang QZ, 2014, J GENET, V93, P63, DOI 10.1007/s12041-014-0341-8; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Meredith WR, 2005, CROP SCI, V45, P807, DOI 10.2135/cropsci2005.0807; Nie XH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2662-x; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Qin HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118073; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Shang LG, 2016, THEOR APPL GENET, V129, P1429, DOI 10.1007/s00122-016-2714-2; Shang LG, 2016, PLANT BREEDING, V135, P224, DOI 10.1111/pbr.12352; Shang LG, 2016, G3-GENES GENOM GENET, V6, P499, DOI 10.1534/g3.115.025809; Shao QS, 2014, EUPHYTICA, V198, P43, DOI 10.1007/s10681-014-1082-8; Shen XL, 2006, CROP SCI, V20; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Tan ZY, 2015, EUPHYTICA, V203, P615, DOI 10.1007/s10681-014-1288-9; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Tang WX, 2014, PLANT MOL BIOL, V85, P613, DOI 10.1007/s11103-014-0208-7; Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130742; Wang HT, 2015, DNA RES, V22, P147, DOI 10.1093/dnares/dsu047; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Xia Z, 2014, J INTEGR AGR, V13, P299, DOI 10.1016/S2095-3119(13)60508-0; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430	48	23	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166970	10.1371/journal.pone.0166970	http://dx.doi.org/10.1371/journal.pone.0166970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907098	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700057
J	Yeom, SJ; Lee, DH; Kim, YJ; Lee, J; Kwon, KK; Han, GH; Kim, H; Kim, HS; Lee, SG				Yeom, Soo-Jin; Lee, Dae-Hee; Kim, Yu Jung; Lee, Jeongmin; Kwon, Kil Koang; Han, Gui Hwan; Kim, Haseong; Kim, Hak-Sung; Lee, Seung-Goo			Long-Term Stable and Tightly Controlled Expression of Recombinant Proteins in Antibiotics-Free Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHROMOSOMAL INTEGRATION; PLASMID SELECTION; GENE-EXPRESSION; EFFICIENT; DNA; REPLICATION; SYSTEMS	Plasmid-based gene expression is a fundamental tool in the field of biotechnology. However, overexpression of genes of interest with multi-copy plasmids often causes detrimental effects on host cells. To overcome this problem, chromosomal integration of target genes has been used for decades; however, insufficient protein expression occurred with this method. In this study, we developed a novel cloning and expression system named the chromosomal vector (ChroV) system, that has features of stable and high expression of target genes on the F' plasmid in the Escherichia coli JM109(DE3) strain. We used an RMT cluster (KCTC 11994BP) containing a silent cat gene from a previous study to clone a gene into the F' plasmid. The ChroV system was applied to clone two model targets, GFPuv and carotenoids gene clusters (4 kb), and successfully used to prove the inducible tightly regulated protein expression in the F' plasmid. In addition, we verified that the expression of heterologous genes in ChroV system maintained stably in the absence of antibiotics for 1 week, indicating ChroV system is applicable to antibiotics-free production of valuable proteins. This protocol can be widely applied to recombinant protein expression for antibiotics-free, stable, and genome-based expression, providing a new platform for recombinant protein synthesis in E. coli. Overall, our approach can be widely used for the economical and industrial production of proteins in E. coli.	[Yeom, Soo-Jin; Lee, Dae-Hee; Kim, Yu Jung; Lee, Jeongmin; Kwon, Kil Koang; Han, Gui Hwan; Kim, Haseong; Lee, Seung-Goo] KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon, South Korea; [Lee, Dae-Hee; Lee, Seung-Goo] UST, Biosyst & Bioengn, Daejeon, South Korea; [Kim, Yu Jung; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, SG (corresponding author), KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon, South Korea.; Lee, SG (corresponding author), UST, Biosyst & Bioengn, Daejeon, South Korea.	sglee@kribb.re.kr	Lee, Seung-Goo/AAR-9823-2021; LEE, DAE-HEE/O-5243-2018; Lee, Seung-Goo/AAS-1613-2021; Yeom, Soojin/AAE-3558-2022; Kim, Hak-Sung/C-1929-2011	Lee, Seung-Goo/0000-0003-4539-9812; LEE, DAE-HEE/0000-0002-0423-9057; Yeom, Soo-Jin/0000-0001-7307-237X	Intelligent Synthetic Biology Center of the Global Frontier Project [2011-0031944]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning [20133030000300]; C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3D3A1A01064875]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of the Global Frontier Project; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning; C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of the Global Frontier Project (2011-0031944), the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (20133030000300), C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015M3D3A1A01064875), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balbas P, 2001, MOL BIOTECHNOL, V19, P1, DOI 10.1385/MB:19:1:001; Balbas P, 2001, MOL BIOTECHNOL, V19, P251, DOI 10.1385/MB:19:3:251; Bryant JA, 2014, NUCLEIC ACIDS RES, V42, P11383, DOI 10.1093/nar/gku828; Cho SH, 2005, J BIOTECHNOL, V119, P197, DOI 10.1016/j.jbiotec.2005.03.008; Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; Gu PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09684; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hiraga S, 1985, Basic Life Sci, V30, P469; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jones KL, 1998, BIOTECHNOL BIOENG, V59, P659, DOI 10.1002/(SICI)1097-0290(19980920)59:6<659::AID-BIT1>3.3.CO;2-1; Kato Y, 2015, PEERJ, V3, DOI 10.7717/peerj.1247; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; KEASLING JD, 1991, J BACTERIOL, V173, P2673, DOI 10.1128/jb.173.8.2673-2680.1991; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; Kofoid E, 2003, J BACTERIOL, V185, P660, DOI 10.1128/JB.185.2.660-663.2003; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; LEE JJ, 2013, PLOS COMPUT BIOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0079979; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Palomares LA, 2004, RECOMBINANT GENE EXP; Preston Andrew, 2003, Methods Mol Biol, V235, P19; Rao XC, 2004, PROTEIN EXPRES PURIF, V36, P11, DOI 10.1016/j.pep.2004.01.020; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Sibley MH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1085; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; Willenbrock H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-252; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zucca S, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-12	34	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166890	10.1371/journal.pone.0166890	http://dx.doi.org/10.1371/journal.pone.0166890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907029	gold, Green Published			2022-12-27	WOS:000389482700048
J	Cermak, S; Kosicek, M; Mladenovic-Djordjevic, A; Smiljanic, K; Kanazir, S; Hecimovic, S				Cermak, Stjepko; Kosicek, Marko; Mladenovic-Djordjevic, Aleksandra; Smiljanic, Kosara; Kanazir, Selma; Hecimovic, Silva			Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins	PLOS ONE			English	Article							C-DISEASE; BRAIN; BETA; MOUSE; NEURODEGENERATION; EXPRESSION; CELLS; APP	Proper function of lysosomes is particularly important in neurons, as they cannot dilute accumulated toxic molecules and aggregates by cell division. Thus, impairment of lysosomal function plays an important role in neuronal degeneration and in the pathogenesis of numerous neurodegenerative diseases. In this work we analyzed how inhibition and/or loss of the major lysosomal proteases, the cysteine cathepsins B and L (CtsB/L), affects lysosomal function, cholesterol metabolism and degradation of the key Alzheimer's disease (AD) proteins. Here, we show that cysteine CtsB/L, and not the aspartyl cathepsin D (CtsD), represent a major lysosomal protease(s) that control lysosomal function, intracellular cholesterol trafficking and AD-like amyloidogenic features. Intriguingly, accumulation of free cholesterol in late endosomes/lysosomes upon CtsB/L inhibition resembled a phenotype characteristic for the rare neurodegenerative disorder Niemann-Pick type C (NPC). CtsB/L inhibition and not the inhibition of CtsD led to lysosomal impairment assessed by decreased degradation of EGF receptor, enhanced LysoTracker staining and accumulation of several lysosomal proteins LC3II, NPC1 and NPC2. By measuring the levels of NPC1 and ABCA1, the two major cholesterol efflux proteins, we showed that CtsB/L inhibition or genetic depletion caused accumulation of the NPC1 in lysosomes and downregulation of ABCA1 protein levels and its expression. Furthermore, we revealed that CtsB/L are involved in degradation of the key Alzheimer's proteins: amyloid-beta peptides (A beta) and C-terminal fragments of the amyloid precursor protein (APP) and in degradation of beta-secretase (BACE1). Our results imply CtsB/L as major regulators of lysosomal function and demonstrate that CtsB/L may play an important role in intracellular cholesterol trafficking and in degradation of the key AD proteins. Our findings implicate that enhancing the activity or levels of CtsB/L could provide a promising and a common strategy for maintaining lysosomal function and for preventing and/or treating neurodegenerative diseases.	[Cermak, Stjepko; Kosicek, Marko; Hecimovic, Silva] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Mladenovic-Djordjevic, Aleksandra; Smiljanic, Kosara; Kanazir, Selma] Sinisa Stankovic Univ Belgrade, Inst Biol Res, Dept Neurobiol, Mol Neurobiol Lab, Belgrade, Serbia	Rudjer Boskovic Institute; University of Belgrade	Hecimovic, S (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	silva.hecimovic@irb.hr	Kanazir, Selma/E-5495-2015; Hecimovic, Silva/T-8091-2017	Kanazir, Selma/0000-0002-7229-5296; Smiljanic, Kosara/0000-0002-6790-5491; Hecimovic, Silva/0000-0001-6077-433X; Mladenovic, Aleksandra/0000-0001-9011-5634	Swiss National Science Foundation grant SCOPES [IZ73Z0_152496]; Ministry of Education, Science and Technological Development of the Republic of Serbia [ON173056]	Swiss National Science Foundation grant SCOPES; Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was funded by the Unity Through Knowledge grant (to S.H.), by the Swiss National Science Foundation grant SCOPES (IZ73Z0_152496, to A.M.-D. and S.H.) and by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No ON173056 to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; BIEDLER JL, 1978, CANCER RES, V38, P3751; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; Hannaford J, 2013, OBESITY, V21, P1586, DOI 10.1002/oby.20136; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hook G, 2007, BIOL CHEM, V388, P979, DOI 10.1515/BC.2007.117; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Hook VYH, 2006, CELL MOL NEUROBIOL, V26, P449, DOI 10.1007/s10571-006-9047-7; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Koike M, 2000, J NEUROSCI, V20; Macias-Vidal J, 2016, PROTEOMICS, V16, P150, DOI 10.1002/pmic.201500110; Malnar M, 2014, NEUROBIOL DIS, V72, P37, DOI 10.1016/j.nbd.2014.05.033; Malnar M, 2012, BBA-MOL BASIS DIS, V1822, P1270, DOI 10.1016/j.bbadis.2012.04.002; Malnar M, 2010, BBA-MOL BASIS DIS, V1802, P682, DOI 10.1016/j.bbadis.2010.05.006; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakanishi H, 2003, AGEING RES REV, V2, P367, DOI 10.1016/S1568-1637(03)00027-8; Riemenschneider M, 2006, HUM MUTAT, V27, P532, DOI 10.1002/humu.20326; Schechter I, 2011, BIOL CHEM, V392, P555, DOI 10.1515/BC.2011.054; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Tholen S, 2014, CELL MOL LIFE SCI, V71, P899, DOI 10.1007/s00018-013-1406-1; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zheng XY, 2012, J BIOL CHEM, V287, P6084, DOI 10.1074/jbc.C111.328575	31	60	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167428	10.1371/journal.pone.0167428	http://dx.doi.org/10.1371/journal.pone.0167428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902765	Green Published, gold			2022-12-27	WOS:000389474100081
J	Gurariy, G; Killebrew, KW; Berryhill, ME; Caplovitz, GP				Gurariy, Gennadiy; Killebrew, Kyle W.; Berryhill, Marian E.; Caplovitz, Gideon P.			Induced and Evoked Human Electrophysiological Correlates of Visual Working Memory Set-Size Effects at Encoding	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; DELTA OSCILLATIONS; NEURAL MEASURES; PARIETAL LOBE; CAPACITY; ATTENTION; PSYCHOPHYSICS; INFORMATION; PHASE	The ability to encode, store, and retrieve visually presented objects is referred to as visual working memory (VWM). Although crucial for many cognitive processes, previous research reveals that VWM strictly capacity limited. This capacity limitation is behaviorally observable in the set size effect: the ability to successfully report items in VWM asymptotes at a small number of items. Research into the neural correlates of set size effects and VWM capacity limits in general largely focus on the maintenance period of VWM. However, we previously reported that neural resources allocated to individual items during VWM encoding correspond to successful VWM performance. Here we expand on those findings by investigating neural correlates of set size during VWM encoding. We hypothesized that neural signatures of encoding-related VWM capacity limitations should be differentiable as a function of set size. We tested our hypothesis using High Density Electroencephalography (HD-EEG) to analyze frequency components evoked by flickering target items in VWM displays of set size 2 or 4. We found that set size modulated the amplitude of the 1st and 2nd harmonic frequencies evoked during successful VWM encoding across frontal and occipital-parietal electrodes. Frontal sites exhibited the most robust effects for the 2nd harmonic (set size 2 > set size 4). Additionally, we found a set-size effect on the induced power of delta-band (1-4 Hz) activity (set size 2 > set size 4). These results are consistent with a capacity limited VWM resource at encoding that is distributed across to-be-remembered items in a VWM display. This resource may work in conjunction with a task-specific selection process that determines which items are to be encoded and which are to be ignored. These neural set size effects support the view that VWM capacity limitations begin with encoding related processes.	[Gurariy, Gennadiy; Killebrew, Kyle W.; Berryhill, Marian E.; Caplovitz, Gideon P.] Univ Nevada, Reno Dept Psychol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Gurariy, G (corresponding author), Univ Nevada, Reno Dept Psychol, Reno, NV 89557 USA.	ggurariy@unr.edu		Berryhill, Marian/0000-0002-8218-6587	National Science Foundation [NSF 1632848, NSF 1632849]; National Institutes of Health [1P20GM103650, R15EY022775]; NATIONAL EYE INSTITUTE [R15EY022775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation under grants: NSF 1632848 and NSF 1632849 and the National Institutes of Health under grants: 1P20GM103650 and R15EY022775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbach E, 1961, INFORMATION THEORY, P196; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bastiaansen M, 2003, CORTEX, V39, P967, DOI 10.1016/S0010-9452(08)70873-6; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Caplovitz GP, 2008, CONSCIOUS COGN, V17, P877, DOI 10.1016/j.concog.2007.08.006; Cohen JR, 2014, CEREB CORTEX, V24, P593, DOI 10.1093/cercor/bhs339; Cooper PS, 2015, NEUROIMAGE, V108, P354, DOI 10.1016/j.neuroimage.2014.12.028; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Cusack R, 2009, PSYCHON B REV, V16, P641, DOI 10.3758/PBR.16.4.641; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Eroglu C., 1992, EVOKED POTENTIALS EN; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fernandez T, 2002, ADV CLIN NEUROPHYSIO; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gazzaley A, 2011, NEUROPSYCHOLOGIA, V49, P1410, DOI 10.1016/j.neuropsychologia.2010.12.022; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killebrew K, 2015, NEUROPSYCHOLOGIA, V73, P12, DOI 10.1016/j.neuropsychologia.2015.04.032; Kim YJ, 2011, J COGNITIVE NEUROSCI, V23, P1875, DOI 10.1162/jocn.2010.21536; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; LaRocque JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00005; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Ma LS, 2012, HUM BRAIN MAPP, V33, P1850, DOI 10.1002/hbm.21329; Majerus S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069278; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miller R., 1991, CORTICO HIPPOCAMPAL; Missonnier P, 2006, J NEURAL TRANSM, V113, P1477, DOI 10.1007/s00702-005-0443-9; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterson DJ, 2014, NEUROPSYCHOLOGIA, V63, P145, DOI 10.1016/j.neuropsychologia.2014.08.020; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Phillips W., 1974, PERCEPT PSYCHOPHYS, V16, P193; Prada L, 2014, PSYCHOPHYSIOLOGY, V51, P658, DOI 10.1111/psyp.12210; PYLYSHYN Z, 1987, B PSYCHONOMIC SOC, V25, P332; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Schon K, 2016, CEREB CORTEX, V26, P1965, DOI 10.1093/cercor/bhv013; Schon K, 2009, CEREB CORTEX, V19, P2561, DOI 10.1093/cercor/bhp006; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sligte IG, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00175; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; STERNBERG S, 1969, AM SCI, V57, P421; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Townsend JT, 2004, PERCEPT PSYCHOPHYS, V66, P953, DOI 10.3758/BF03194987; Tsubomi H, 2013, J NEUROSCI, V33, P8257, DOI 10.1523/JNEUROSCI.5348-12.2013; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wendelken C, 2008, NEUROPSYCHOLOGIA, V46, P665, DOI 10.1016/j.neuropsychologia.2007.09.015; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	77	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167022	10.1371/journal.pone.0167022	http://dx.doi.org/10.1371/journal.pone.0167022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902738	Green Published, gold			2022-12-27	WOS:000389474100043
J	Rahman, S; Campbell, CMP; Rollison, DE; Wang, W; Waterboer, T; Michel, A; Pawlita, M; Villa, LL; Ponce, EL; Borenstein, AR; Giuliano, AR				Rahman, Shams; Campbell, Christine M. Pierce; Rollison, Dana E.; Wang, Wei; Waterboer, Tim; Michel, Angelika; Pawlita, Michael; Villa, Luisa L.; Lazcano Ponce, Eduardo; Borenstein, Amy R.; Giuliano, Anna R.			Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study	PLOS ONE			English	Article							ANAL HUMAN-PAPILLOMAVIRUS; HIGH-RISK HPV; VACCINATION RECOMMENDATIONS; ADVISORY-COMMITTEE; NATURAL-HISTORY; UNITED-STATES; INFECTION; POPULATION; PREVALENCE; SEROPOSITIVITY	Background Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. Recently a 9-valent HPV (9vHPV) prophylactic vaccine was licensed. Seroprevalence prior to vaccine dissemination is needed for monitoring vaccine effectiveness over time. Few studies have assessed the seroprevalence of 9vHPV types in men. Objectives To investigate the seroprevalence of 9vHPV vaccine types and associated risk factors among men residing in Brazil, Mexico, and the United States. Methods Six hundred men were randomly selected from the HPV Infection in Men (HIM) Study. Archived serum specimens collected at enrollment were tested for antibodies against nine HPV types (6, 11, 16, 18, 31, 33, 45, 52 and 58) using a glutathione S-transferase (GST) L1-based multiplex serologic assay. Socio-demographic, lifestyle and sexual behavior data at enrollment were collected through a questionnaire. Binomial proportions were used to estimate seroprevalence and logistic regression was used to examine factors associated with seropositivity of type-specific and grouped (i.e. 9vHPV, high-risk 9vHPV, low risk 9vHPV, and five-additional) HPV types. Results Overall, 28.3% of men were seropositive for at least one of the 9vHPV vaccine types, 14.0% for at least one of the seven high-risk types (16, 18, 31, 33, 45, 52 and 58) and 11.2% for at least one of the five high-risk types (31, 33, 45, 52 and 58) not included in the quadrivalent HPV vaccine, and 17.4% for at least one of the low-risk types (6/11). In multivariate analyses, odds ratios adjusted (AOR) for country of residence, age, marital status, smoking, number of anal sex lifetime partners, compared to men with no anal sex lifetime partners, men with >= 2 partners were more likely to be seropositive for grouped HPV [(9vHPV: AOR 2.52; 95% confidence interval (CI) 1.40-4.54), (high-risk 9vHPV: AOR 2.18; 95%Cl: 1.05-4.50) and (low-risk 9vHPV: AOR 2.12; 95%Cl: 1.12-4.03)], and individual HPV types 6, 16, 33 and 58 with AORs ranging from 2.19 to 7.36. Compared to men aged 18-30 years, men older than 30 years were significantly more likely to be seropositive for any high-risk 9vHPV, in addition to individual types 18 and 45; and compared to never smokers, current smokers were more likely to be seropositive to 9vHPV, low-risk 9vHPV and HPV 6. In contrast, married men were less likely to be seropositive to any high-risk 9vHPV and individual HPV types 18 and 31 when compared to single men. Conclusions These data indicate that exposure to the nine HPV types included in the 9vHPV vaccine is common in men and that seropositivity to 9vHPV vaccine types is associated with older age and the lifetime number of anal sex partners. Nine valent HPV vaccination of males and females has the potential to prevent HPV related diseases and transmission in both sexes.	[Rahman, Shams; Campbell, Christine M. Pierce; Rollison, Dana E.; Giuliano, Anna R.] H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL 33682 USA; [Rahman, Shams; Wang, Wei; Borenstein, Amy R.] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Waterboer, Tim; Michel, Angelika; Pawlita, Michael] German Canc Res Ctr, Mol Diagnost Oncogen Infect Div, Heidelberg, Germany; [Waterboer, Tim; Michel, Angelika; Pawlita, Michael] German Canc Res Ctr, Infect Inflammat & Canc Res Program, Heidelberg, Germany; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Lazcano Ponce, Eduardo] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Universidade de Sao Paulo; Instituto Nacional de Salud Publica	Giuliano, AR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL 33682 USA.	anna.giuliano@moffitt.org	VILLA, LUISA/AAH-4761-2019; Borenstein, Amy/AAN-8884-2021	VILLA, LUISA/0000-0003-4074-2335; Rahman, Shams/0000-0001-5856-7753; Pawlita, Michael/0000-0002-4720-8306	National Cancer Institute, National Institutes of Health (R03) [CA176743]; National Cancer Institute, National Institutes of Health (R01) [CA098803]	National Cancer Institute, National Institutes of Health (R03); National Cancer Institute, National Institutes of Health (R01)	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (R03: CA176743, PI: Anna R. Giuliano), and the HIM Study cohort infrastructure was supported through a grant from the National Cancer Institute, National Institutes of Health (R01: CA098803, PI: Anna R. Giuliano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Wkly Epidemiol Rec, V89, P465; [Anonymous], 2007, IARC MON EV CARC RIS; Ault Kevin A, 2006, Infect Dis Obstet Gynecol, V2006 Suppl, P40470; Bruni L., HUMAN PAPILLOMAVIRUS; Clifford GM, 2007, CANCER EPIDEM BIOMAR, V16, P1874, DOI 10.1158/1055-9965.EPI-07-0349; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dunne EF, 2009, SEX TRANSM DIS, V36, P671, DOI 10.1097/OLQ.0b013e3181bc094b; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Heiligenberg M, 2013, J INFECT DIS, V208, P1081, DOI 10.1093/infdis/jit295; Heiligenberg M, 2010, SEX TRANSM DIS, V37, P672, DOI 10.1097/OLQ.0b013e3181e71069; Hernandez BY, 2008, CANCER-AM CANCER SOC, V113, P2883, DOI 10.1002/cncr.23743; Introcaso CE, 2014, SEX TRANSM INFECT, V90, P505, DOI 10.1136/sextrans-2013-051490; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Liu G, 2016, J INFECT DIS, V213, P191, DOI 10.1093/infdis/jiv403; Lu B, 2010, EPIDEMIOLOGIC FACTOR; Lu BB, 2012, CANCER EPIDEM BIOMAR, V21, P1542, DOI 10.1158/1055-9965.EPI-12-0483; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Masel J, 2015, SEX TRANSM DIS, V42, P253, DOI 10.1097/OLQ.0000000000000277; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Newall AT, 2008, CLIN INFECT DIS, V46, P1647, DOI 10.1086/587895; Nyitray AG, 2011, J INFECT DIS, V204, P1711, DOI 10.1093/infdis/jir637; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Scherpenisse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048807; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Strickler HD, 1999, INT J CANCER, V80, P339, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;339::AID-IJC1&gt;3.0.CO;2-F; Syrjanen S, 2015, EUR J CLIN MICROBIOL, V34, P237, DOI 10.1007/s10096-014-2223-7; Thompson DL, 2004, J INFECT DIS, V190, P1563, DOI 10.1086/423817; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Villa L, 2014, BMC P S4, V8, pO7; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Weaver BA, 2006, J AM OSTEOPATH ASSOC, V106, pS2; WHO, 2009, WEEKL EP REC HUM PAP, P118; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167; Zhang CY, 2015, SEX TRANSM INFECT, V91, P506, DOI 10.1136/sextrans-2014-051936	44	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167173	10.1371/journal.pone.0167173	http://dx.doi.org/10.1371/journal.pone.0167173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902759	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100058
J	Khalil, U; Alamgir; Ali, A; Khan, DM; Khan, SA; Khan, Z				Khalil, Umair; Alamgir; Ali, Amjad; Khan, Dost Muhammad; Khan, Sajjad Ahmad; Khan, Zardad			Unit Root Testing and Estimation in Nonlinear ESTAR Models with Normal and Non-Normal Errors	PLOS ONE			English	Article							REAL EXCHANGE-RATES; HETEROSKEDASTICITY	Exponential Smooth Transition Autoregressive (ESTAR) models can capture non-linear adjustment of the deviations from equilibrium conditions which may explain the economic behavior of many variables that appear non stationary from a linear viewpoint. Many researchers employ the Kapetanios test which has a unit root as the null and a stationary nonlinear model as the alternative. However this test statistics is based on the assumption of normally distributed errors in the DGP. Cook has analyzed the size of the nonlinear unit root of this test in the presence of heavy-tailed innovation process and obtained the critical values for both finite variance and infinite variance cases. However the test statistics of Cook are oversized. It has been found by researchers that using conventional tests is dangerous though the best performance among these is a HCCME. The over sizing for LM tests can be reduced by employing fixed design wild bootstrap remedies which provide a valuable alternative to the conventional tests. In this paper the size of the Kapetanios test statistic employing hetroscedastic consistent covariance matrices has been derived and the results are reported for various sample sizes in which size distortion is reduced. The properties for estimates of ESTAR models have been investigated when errors are assumed non-normal. We compare the results obtained through the fitting of nonlinear least square with that of the quantile regression fitting in the presence of outliers and the error distribution was considered to be from t-distribution for various sample sizes.	[Khalil, Umair; Khan, Dost Muhammad; Khan, Sajjad Ahmad; Khan, Zardad] Abdul Wali Khan Univ Mardan, Dept Stat, Mardan, Pakistan; [Alamgir] Univ Peshawar, Dept Stat, Peshawar, Pakistan; [Ali, Amjad] Islamia Coll Peshawar, Dept Stat, Peshawar, Pakistan	University of Peshawar; University of Peshawar	Khalil, U (corresponding author), Abdul Wali Khan Univ Mardan, Dept Stat, Mardan, Pakistan.	umairkhalil@awkum.edu.pk	Khan, Sajjad Ahmad/AAE-5527-2020; Khan, Dost Muhammad/AAA-7465-2020	Khan, Sajjad Ahmad/0000-0001-6630-7222; Khan, Dost Muhammad/0000-0002-3919-8136				Berka M., 2002, GEN EQUILIBRIU UNPUB; Cook S., 2008, EC B, V3, P1; DIXIT A, 1989, Q J ECON, V104, P205, DOI 10.2307/2937845; DUMAS B, 1992, REV FINANC STUD, V5, P153, DOI 10.1093/rfs/5.2.153; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1982, CBMS NFS REGIONAL C, V38; EICKER F, 1963, ANN MATH STAT, V34, P447, DOI 10.1214/aoms/1177704156; Goncalves S, 2004, J ECONOMETRICS, V123, P89, DOI 10.1016/j.jeconom.2003.10.030; Granger C. W. J., 1993, MODELLING NONLINEAR; Kapetanios G, 2003, J ECONOMETRICS, V112, P359, DOI 10.1016/S0304-4076(02)00202-6; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; MacKinnon JG., 1985, J EC, V29, P305, DOI DOI 10.1016/0304-4076(83)90119-7; MARTIN RD, 1986, ANN STAT, V14, P781, DOI 10.1214/aos/1176350027; Michael P, 1997, J POLIT ECON, V105, P862, DOI 10.1086/262096; Ohanian LE, 1997, J MONEY CREDIT BANK, V29, P783, DOI 10.2307/2953667; Pavlidis EG, 2010, STUD NONLINEAR DYN E, V14; Potter S. M., 1999, J ECON SURV, V13, P5; SERCU P, 1995, J FINANC, V50, P1309, DOI 10.2307/2329354; Skalin J, 2002, MACROECON DYN, V6, P202, DOI 10.1017/S1365100502031024; Taylor MP, 2001, INT ECON REV, V42, P1015, DOI 10.1111/1468-2354.00144; TERASVIRTA T, 1994, J AM STAT ASSOC, V89, P208, DOI 10.2307/2291217; TERASVIRTA T, 1992, J APPL ECONOM, V7, pS119, DOI 10.1002/jae.3950070509; Terasvirta T, 1998, STAT TEXTB MONOG, V155, P507; Van Dijk D, 1999, J BUS ECON STAT, V17, P217; Wei, 1997, BIGGER THEY ARE HARD; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	26	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166990	10.1371/journal.pone.0166990	http://dx.doi.org/10.1371/journal.pone.0166990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898702	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000028
J	Caetano-Anolles, K; Rhodes, JS; Garland, T; Perez, SD; Hernandez, AG; Southey, BR; Rodriguez-Zas, SL				Caetano-Anolles, Kelsey; Rhodes, Justin S.; Garland, Theodore, Jr.; Perez, Sam D.; Hernandez, Alvaro G.; Southey, Bruce R.; Rodriguez-Zas, Sandra L.			Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS NEURONS; GENE-EXPRESSION; HIPPOCAMPAL NEUROGENESIS; CONDITIONED PREFERENCE; DOPAMINE-RECEPTORS; FIRING PATTERNS; MESSENGER-RNA; BASAL GANGLIA; DENTATE GYRUS; TARGET GENES	The role of the cerebellum in motivation and addictive behaviors is less understood than that in control and coordination of movements. High running can be a self-rewarding behavior exhibiting addictive properties. Changes in the cerebellum transcriptional networks of mice from a line selectively bred for High voluntary running (H) were profiled relative to an unselected Control (C) line. The environmental modulation of these changes was assessed both in activity environments corresponding to 7 days of Free (F) access to running wheel and to Blocked (B) access on day 7. Overall, 457 genes exhibited a significant (FDR-adjusted P-value < 0.05) genotype-by-environment interaction effect, indicating that activity genotype differences in gene expression depend on environmental access to running. Among these genes, network analysis highlighted 6 genes (Nrgn, Drd2, Rxrg, Gda, Adora2a, and Rab40b) connected by their products that displayed opposite expression patterns in the activity genotype contrast within the B and F environments. The comparison of network expression topologies suggests that selection for high voluntary running is linked to a predominant dysregulation of hub genes in the F environment that enables running whereas a dysregulation of ancillary genes is favored in the B environment that blocks running. Genes associated with locomotor regulation, signaling pathways, reward-processing, goalfocused, and reward-dependent behaviors exhibited significant genotype-by-environment interaction (e.g. Pak6, Adora2a, Drd2, and Arhgap8). Neuropeptide genes including Adcyap1, Cck, Sst, Vgf, Npy, Nts, Penk, and Tac2 and related receptor genes also exhibited significant genotype-by-environment interaction. The majority of the 183 differentially expressed genes between activity genotypes (e.g. Drd1) were under-expressed in C relative to H genotypes and were also under-expressed in B relative to F environments. Our findings indicate that the high voluntary running mouse line studied is a helpful model for understanding the molecular mechanisms in the cerebellum that influence locomotor control and reward-dependent behaviors.	[Caetano-Anolles, Kelsey; Southey, Bruce R.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rhodes, Justin S.; Perez, Sam D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Rhodes, Justin S.] Univ Illinois, Ctr Nutr Learning & Memory, Urbana, IL 61801 USA; [Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Hernandez, Alvaro G.] Univ Illinois, Roy J Carver Biotechnol Ctr, High Throughput Sequencing & Genotyping Unit, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Riverside; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Stat, Urbana, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA.	rodrgzzs@illinois.edu		Rodriguez-Zas, Sandra/0000-0003-1122-4758; Southey, Bruce/0000-0002-8959-7709; Caetano-Anolles, Kelsey/0000-0001-6310-6679	NIH [R21 DA027548, P30 DA018310]; USDA NIFA [ILLU-538-632, ILLU-538-909]; NSF [IOS-1121273]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH R21 DA027548 to SRZ, NIH P30 DA018310 to BRS and SRZ, USDA NIFA ILLU-538-632 to KCA, USDA NIFA ILLU-538-909 to SRZ, and NSF IOS-1121273 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alliey-Rodriguez N, 2011, PSYCHIAT GENET, V21, P190, DOI 10.1097/YPG.0b013e3283457a31; American Psychiatric A, 2013, DIAGN STAT MAN MENT, VFifth; Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Aoyama S, 2000, J NEUROSCI, V20, P5848, DOI 10.1523/JNEUROSCI.20-15-05848.2000; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Belke TW, 2007, J EXP ANAL BEHAV, V88, P199, DOI 10.1901/jeab.2007.62-06; BENINGER RJ, 1989, NEUROSCI BIOBEHAV R, V13, P113, DOI 10.1016/S0149-7634(89)80019-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bough KJ, 2014, NEUROPSYCHOPHARMACOL, V39, P202, DOI 10.1038/npp.2013.210; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Brown JD, 2015, PSYCHOPHARMACOLOGY, V232, P673, DOI 10.1007/s00213-014-3698-8; Brown RM, 2008, J PHARM PHARMACOL, V60, P1409, DOI 10.1211/jpp/60.11.0001; BROWN RR, 1991, ADV EXP MED BIOL, V294, P425; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Carbo-Gas M, 2014, PHYSIOL BEHAV, V132, P24, DOI 10.1016/j.physbeh.2014.04.044; Carbo-Gas M, 2014, ADDICT BIOL, V19, P61, DOI 10.1111/adb.12042; CARELLI RM, 1993, BRAIN RES, V626, P14, DOI 10.1016/0006-8993(93)90557-4; Caston J, 1998, BRAIN RES, V808, P232, DOI 10.1016/S0006-8993(98)00847-6; CHANG JY, 1994, J NEUROSCI, V14, P1224, DOI 10.1523/JNEUROSCI.14-03-01224.1994; Chapter MC, 2010, PHARMACOL THERAPEUT, V125, P39, DOI 10.1016/j.pharmthera.2009.07.006; Chehadeh SEH, 2014, AM J PHYSIOL-ENDOC M, V307, pE1009, DOI 10.1152/ajpendo.00364.2014; Chen JL, 2014, INT J DEV NEUROSCI, V35, P35, DOI 10.1016/j.ijdevneu.2014.03.006; Claghorn GC, 2016, PHYSIOL BEHAV, V161, P145, DOI 10.1016/j.physbeh.2016.04.033; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; COUCEYRO P, 1994, MOL PHARMACOL, V46, P667; DAHHAOUI M, 1992, BEHAV NEURAL BIOL, V58, P180, DOI 10.1016/0163-1047(92)90440-F; Dale CS, 2005, MEM I OSWALDO CRUZ, V100, P105, DOI 10.1590/S0074-02762005000900017; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Delis F, 2008, CEREBELLUM, V7, P242, DOI 10.1007/s12311-008-0005-4; Dierssen M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00058; Fernandez-Castillo N, 2012, GENES BRAIN BEHAV, V11, P38, DOI 10.1111/j.1601-183X.2011.00735.x; FRANKLIN KBJ, 1983, PHARMACOL BIOCHEM BE, V18, P747, DOI 10.1016/0091-3057(83)90018-7; Gaiteri C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00095; Garcia-Fuster MJ, 2003, N-S ARCH PHARMACOL, V368, P421, DOI 10.1007/s00210-003-0801-9; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gelman JS, 2010, AAPS J, V12, P279, DOI 10.1208/s12248-010-9186-0; Gibbons TE, 2014, BEHAV BRAIN RES, V272, P131, DOI 10.1016/j.bbr.2014.05.049; Gong HL, 2013, J HISTOCHEM CYTOCHEM, V61, P857, DOI 10.1369/0022155413505601; Gonzalez-Pena D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157727; Gonzalez-Pena D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150858; HARBER VJ, 1984, SPORTS MED, V1, P154, DOI 10.2165/00007256-198401020-00004; Hart AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042646; Heck A, 2014, NEURON, V81, P1203, DOI 10.1016/j.neuron.2014.01.010; Hoffmann HM, 2012, ADDICT BIOL, V17, P565, DOI 10.1111/j.1369-1600.2011.00353.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito M, 2014, AIMS NEUROSCI, V1, P89, DOI 10.3934/Neuroscience.2014.1.89; Ivlieva N.Yu., 2011, NEUROSCI BEHAV PHYSI, V41, P715, DOI [10.1007/s11055-011-9477-7, DOI 10.1007/S11055-011-9477-7]; Joshi S, 2006, CELL MOL LIFE SCI, V63, P2859, DOI 10.1007/s00018-006-6333-y; Keeney BK, 2012, PHARMACOL BIOCHEM BE, V101, P528, DOI 10.1016/j.pbb.2012.02.017; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim EH, 2013, J ETHNOPHARMACOL, V148, P474, DOI 10.1016/j.jep.2013.04.041; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Kim YS, 2009, J NEUROSCI, V29, P8530, DOI 10.1523/JNEUROSCI.0468-09.2009; Kohman RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022654; Kolb EM, 2013, J EXP BIOL, V216, P515, DOI 10.1242/jeb.076000; Kolb EM, 2013, PHYSIOL BEHAV, V112, P49, DOI 10.1016/j.physbeh.2013.02.010; Konu O, 2004, MOL BRAIN RES, V121, P102, DOI 10.1016/j.molbrainres.2003.11.012; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KORNETSKY C, 1981, BRAIN RES, V209, P496, DOI 10.1016/0006-8993(81)90177-3; Kovacic P, 2005, MED HYPOTHESES, V64, P350, DOI 10.1016/j.mehy.2004.06.028; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Landoltl H, 2012, EDITOR GENETICS ADEN; Leuenberger A, 2006, IMPULSE PREMIER J UN; Levran O, 2015, CNS NEUROSCI THER, V21, P898, DOI 10.1111/cns.12450; Lim S, 2012, J GAMBL STUD, V28, P481, DOI 10.1007/s10899-011-9261-1; Liu J, 2015, DEVELOPMENT, V142, P1113, DOI 10.1242/dev.117424; Majdak P, 2014, BEHAV GENET, V44, P516, DOI 10.1007/s10519-014-9667-5; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MALDONADO R, 1993, PHARMACOL BIOCHEM BE, V45, P239, DOI 10.1016/0091-3057(93)90112-7; Malisch JL, 2009, BEHAV GENET, V39, P192, DOI 10.1007/s10519-008-9246-8; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mathes WF, 2010, BEHAV BRAIN RES, V210, P155, DOI 10.1016/j.bbr.2010.02.016; Miquel Marta, 2009, Curr Drug Abuse Rev, V2, P26; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; Negishi T, 2012, J NEUROPATH EXP NEUR, V71, P468, DOI 10.1097/NEN.0b013e3182561327; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Neveu I, 2002, NEUROSCIENCE, V113, P767, DOI 10.1016/S0306-4522(02)00256-7; Nixon SE, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500109; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Novak G, 2013, SYNAPSE, V67, P179, DOI 10.1002/syn.21628; PENNEY JB, 1983, ANNU REV NEUROSCI, V6, P73, DOI 10.1146/annurev.ne.06.030183.000445; Peoples LL, 1998, J NEUROSCI, V18, P7588; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V114, P477, DOI 10.1007/BF02249339; Podder A, 2014, J THEOR BIOL, V357, P169, DOI 10.1016/j.jtbi.2014.05.011; Poleszak E, 2002, POL J PHARMACOL, V54, P359; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Ruegsegger GN, 2016, NEUROSCI LETT, V618, P83, DOI 10.1016/j.neulet.2016.02.037; Salatino-Oliveira A, 2015, AM J MED GENET B, V168, P162, DOI 10.1002/ajmg.b.32293; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Scarr E, 2012, SCHIZOPHR RES, V138, P94, DOI 10.1016/j.schres.2012.02.011; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Short JL, 2006, NEUROPSYCHOPHARMACOL, V31, P525, DOI 10.1038/sj.npp.1300852; Singec I, 2003, J COMP NEUROL, V459, P278, DOI 10.1002/cne.10600; Sorensen G, 2013, PHARMACOL BIOCHEM BE, V105, P151, DOI 10.1016/j.pbb.2013.02.010; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussman S, 2011, EVAL HEALTH PROF, V34, P3, DOI 10.1177/0163278710380124; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Tang Liang, 2005, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V21, P137; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Thoma P, 2008, CEREBELLUM, V7, P433, DOI 10.1007/s12311-008-0046-8; Tobon KE, 2015, EUR J NEUROSCI, V42, P1849, DOI 10.1111/ejn.12933; Tomasi D, 2015, HUM BRAIN MAPP, V36, P120, DOI 10.1002/hbm.22617; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Valverde O, 2000, J NEUROSCI, V20, P9284; Vuckovic MG, 2010, MOVEMENT DISORD, V25, P2777, DOI 10.1002/mds.23407; Wang Ju, 2011, Front Psychiatry, V2, P5, DOI 10.3389/fpsyt.2011.00005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Waters RP, 2013, BRAIN RES, V1508, P9, DOI 10.1016/j.brainres.2013.01.033; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Yalachkov Y, 2010, BEHAV BRAIN RES, V207, P215, DOI 10.1016/j.bbr.2009.09.015; Zeyda T, 2001, BRAIN RES, V906, P107, DOI 10.1016/S0006-8993(01)02563-X; Zhang H, 2008, MOL PSYCHIATR, V13, P531, DOI 10.1038/sj.mp.4002035	131	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167095	10.1371/journal.pone.0167095	http://dx.doi.org/10.1371/journal.pone.0167095			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893846	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400084
J	Ching, B; Woo, JM; Hiong, KC; Boo, MV; Wong, WP; Chew, SF; Ip, YK				Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Voltage-Gated Na+ Channel Isoforms and Their mRNA Expression Levels and Protein Abundance in Three Electric Organs and the Skeletal Muscle of the Electric Eel Electrophorus electricus	PLOS ONE			English	Article							SENSITIVE SODIUM-CHANNEL; CYTOCHEMICAL-LOCALIZATION; CHARGE MOVEMENT; BETA-1 SUBUNITS; EVOLUTION; INACTIVATION; GENE; ACETYLCHOLINESTERASE; PHOSPHORYLATION; PURIFICATION	This study aimed to obtain the coding cDNA sequences of voltage-gated Na+ channel (scn) alpha-subunit (scna) and beta-subunit (scnb) isoforms from, and to quantify their transcript levels in, the main electric organ (EO), Hunter's EO, Sach's EO and the skeletal muscle (SM) of the electric eel, Electrophorus electricus, which can generate both high and low voltage electric organ discharges (EODs). The full coding sequences of two scna (scn4aa and scn4ab) and three scnb (scn1b, scn2b and scn4b) were identified for the first time (except scn4aa) in E. electricus. In adult fish, the scn4aa transcript level was the highest in the main EO and the lowest in the Sach's EO, indicating that it might play an important role in generating high voltage EODs. For scn4ab/Scn4ab, the transcript and protein levels were unexpectedly high in the EOs, with expression levels in the main EO and the Hunter's EO comparable to those of scn4aa. As the key domains affecting the properties of the channel were mostly conserved between Scn4aa and Scn4ab, Scn4ab might play a role in electrogenesis. Concerning scnb, the transcript level of scn4b was much higher than those of scn1b and scn2b in the EOs and the SM. While the transcript level of scn4b was the highest in the main EO, protein abundance of Scn4b was the highest in the SM. Taken together, it is unlikely that Scna could function independently to generate EODs in the EOs as previously suggested. It is probable that different combinations of Scn4aa/Scn4ab and various Scnb isoforms in the three EOs account for the differences in EODs produced in E. electricus. In general, the transcript levels of various scn isoforms in the EOs and the SM were much higher in adult than in juvenile, and the three EOs of the juvenile fish could be functionally indistinct.	[Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Kent Ridge, Singapore; [Ip, Yuen K.] Natl Univ Singapore, Trop Marine Sci Inst, Kent Ridge, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore, Singapore	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Kent Ridge, Singapore.; Ip, YK (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Kent Ridge, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	tobacco company	tobacco company	The funders prefer to remain annonymous. None of the research costs or authors' salaries were funded, in whole or in part, by a tobacco company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The identity of the donor is not relevant to editors or reviewers' assessment of the validity of the work. The donor has no competing interests in relation to this work.	AGNEW WS, 1978, P NATL ACAD SCI USA, V75, P2606, DOI 10.1073/pnas.75.6.2606; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Albert J. S., 2005, PHYSL FISHES, P431; ARIYASU RG, 1987, J NEUROCYTOL, V16, P511, DOI 10.1007/BF01668505; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BARCHI RL, 1983, J NEUROCHEM, V40, P1377, DOI 10.1111/j.1471-4159.1983.tb13580.x; BENDA P, 1970, NATURE, V225, P1149, DOI 10.1038/2251149a0; BENESKI DA, 1980, P NATL ACAD SCI-BIOL, V77, P639, DOI 10.1073/pnas.77.1.639; Bennett MVL, 1971, FISH PHYSIOL, P346; Berra TM., 2001, FRESHWATER FISH DIST; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BLOOM FE, 1966, J CELL BIOL, V29, P475, DOI 10.1083/jcb.29.3.475; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catania K, 2014, SCIENCE, V346, P1231, DOI 10.1126/science.1260807; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chopra SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-113; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; ELLISMAN MH, 1982, P NATL ACAD SCI-BIOL, V79, P6707, DOI 10.1073/pnas.79.21.6707; FRITZ LC, 1983, J NEUROSCI, V3, P2300; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; GORDON RD, 1988, J NEUROSCI, V8, P3742; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; GRUNDFEST H, 1960, BIOL BULL, V119, P284; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hunter J., 1775, JOHN HUNTER FRS PHIL, V65, P395; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Isom LL, CELL; JAMES WM, 1989, BIOCHEMISTRY-US, V28, P6001, DOI 10.1021/bi00440a042; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keynes KD, 1961, BIOELECTROGENESIS, P14; KEYNES RD, 1953, J PHYSIOL-LONDON, V119, P315, DOI 10.1113/jphysiol.1953.sp004849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu H, 2007, DEV NEUROBIOL, V67, P1289, DOI 10.1002/dneu.20404; MACHADO RD, 1980, CELL TISSUE RES, V213, P69, DOI 10.1007/BF00236921; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; Miyazaki H, 2007, BIOCHEM BIOPH RES CO, V361, P43, DOI 10.1016/j.bbrc.2007.06.170; NAKAMURA Y, 1965, J GEN PHYSIOL, V49, P321, DOI 10.1085/jgp.49.2.321; Namadurai S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140192; Nelson ME, 2011, CURR BIOL, V21, pR528, DOI 10.1016/j.cub.2011.03.045; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Ortega H., 1986, SMITHS CONTR ZOOL, V437, P1, DOI DOI 10.5479/SI.00810282.437; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Paul C, 2016, J MOL EVOL, V83, P61, DOI 10.1007/s00239-016-9754-8; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peters Colin H, 2014, Handb Exp Pharmacol, V221, P1, DOI 10.1007/978-3-642-41588-3_1; RECIOPINTO E, 1987, J GEN PHYSIOL, V90, P375, DOI 10.1085/jgp.90.3.375; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSENBERG RL, 1984, P NATL ACAD SCI-BIOL, V81, P5594, DOI 10.1073/pnas.81.17.5594; Ruben PC, 2014, HDB EXP PHARM, V221; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; Smith RD, 1997, J NEUROSCI, V17, P6086; Stamatakis A, 2014, BIOINFORMATICS; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SZABO T, 1966, ANAT REC, V155, P103, DOI 10.1002/ar.1091550112; Thompson A, 2014, MOL BIOL EVOL, V31, P1941, DOI 10.1093/molbev/msu145; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yu FH, 2003, J NEUROSCI, V23, P7577; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	78	6	6	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167589	10.1371/journal.pone.0167589	http://dx.doi.org/10.1371/journal.pone.0167589			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907137	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700205
J	Chung, WY; Chiang, PS; Luo, ST; Lin, TY; Tsao, KC; Lee, MS				Chung, Wan-Yu; Chiang, Pai-Shan; Luo, Shu-Ting; Lin, Tzou-Yien; Tsao, Kuo-Chien; Lee, Min-Shi			A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; EMERGENCE; RESPONSES; CHILDREN	Traditional methods for detection and serotyping of enterovirus infections are virus isolation and immunofluorescence assay (VI-IFA), which are labor-intensive and time-consuming. Recently, VP1 gene has been targeted to develop a CODEHOP-based RT-PCR (VP1CODEHOP) for the same purpose. In this study, we conducted a 5-year enterovirus surveillance comparing the VI-IFA and VP1-CODEHOP tests. Throat swabs were collected from 431 pediatric patients and 208(48%) and 250(58%) were tested positive by the VI-IFA and VP1-CODEHOP tests, respectively. Among the 47 cases who had inconsistent results between the VI-IFA and VP1-CODEHOP tests and provided paired sera for serological verifications, correct diagnosis for the VI-IFA and VP1-CODEHOP were 5(11%) and 40(85%) cases, respectively. Therefore, the VP1-CODEHOP is more reliable for detection of human enteroviruses than the VI-IFA. Based on serological verifications for the eight cases who had inconsistent serotypes between the two tests and provided paired sera, five and two showed consistent serotypes with the VP1-CODEHOP and VI-IFA tests, respectively. CVA16, CVA6 and EV71 were the most prevalent serotypes in northern Taiwan, 2008 similar to 2012. Moreover, variant CVA2, CVA6 and EV71 viruses were further identified based on phylogenetic analysis of partial VP1 sequences. In conclusion, the VP1-CODEHOP test could be used as the primary method for enterovirus surveillance to support decision-making for outbreak control.	[Chung, Wan-Yu; Chiang, Pai-Shan; Luo, Shu-Ting; Lee, Min-Shi] NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Lin, Tzou-Yien] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan	National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lee, MS (corresponding author), NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	minshi.lee@hotmail.com			National Health Research Institutes	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chia MY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003044; Chia MY, 2014, PEDIATR NEONATOL, V55, P243, DOI 10.1016/j.pedneo.2013.07.007; Chiang PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048269; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Chung WH, 2013, J INFECT DIS, V208, P1968, DOI 10.1093/infdis/jit383; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080942; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116322; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438; Pallansch M., 2007, FIELDS VIROL, P839; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; Tsao LY, 2006, PEDIATR INT, V48, P5, DOI 10.1111/j.1442-200X.2006.02157.x; Vuorinen T, 2003, CLIN INFECT DIS, V37, P452, DOI 10.1086/376635; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; World Health Organization, 2015, GUID ENT SURV SUPP P, P40; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yip CCY, 2013, EMERG INFECT DIS, V19, P1285, DOI 10.3201/eid1908.121498; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167532	10.1371/journal.pone.0167532	http://dx.doi.org/10.1371/journal.pone.0167532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907198	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700186
J	DeVries, A; Talley, P; Sweet, K; Kline, S; Stinchfield, P; Tosh, P; Danila, R				DeVries, Aaron; Talley, Pamela; Sweet, Kristin; Kline, Susan; Stinchfield, Patricia; Tosh, Pritish; Danila, Richard			Development and Implementation of the Ebola Traveler Monitoring Program and Clinical Outcomes of Monitored Travelers during October - May 2015, Minnesota	PLOS ONE			English	Article							UNITED-STATES; VIRUS DISEASE; SIERRA-LEONE; DIAGNOSIS	Background In October 2014, the United States began actively monitoring all persons who had traveled from Guinea, Liberia, and Sierra Leone in the previous 21 days. State public health departments were responsible for monitoring all travelers; Minnesota has the largest Liberian population in the United States. The MDH Ebola Clinical Team (ECT) was established to assess travelers with symptoms of concern for Ebola virus disease (EVD), coordinate access to healthcare at appropriate facilities including Ebola Assessment and Treatment Units (EATU), and provide guidance to clinicians. Methods Minnesota Department of Health (MDH) began receiving traveler information collected by U. S. Customs and Border Control and Centers for Disease Control and Prevention staff on October 21, 2014 via encrypted electronic communication. All travelers returning from Liberia, Sierra Leone, and Guinea during 10/21/14-5/15/15 were monitored by MDH staff in the manner recommended by CDC based on the traveler's risk categorization as "low (but not zero)", "some" and "high" risk. When a traveler reported symptoms or a temperature >= 100.4 degrees F at any time during their 21-day monitoring period, an ECT member would speak to the traveler and perform a clinical assessment by telephone or via video-chat. Based on the assessment the ECT member would recommend 1) continued clinical monitoring while at home with frequent telephone follow-up by the ECT member, 2) outpatient clinical evaluation at an outpatient site agreed upon by all parties, or 3) inpatient clinical evaluation at one of four Minnesota EATUs. ECT members assessed and approved testing for Ebola virus infection at MDH. Traveler data, calls to the ECT and clinical outcomes were logged on a secure server at MDH. Results During 10/21/14-5/15/15, a total of 783 travelers were monitored; 729 (93%) traveled from Liberia, 30 (4%) Sierra Leone, and 24 (3%) Guinea. The median number monitored per week was 59 (range 45-143). The median age was 35 years; 136 (17%) were aged <18 years. Thirteen of 256 women of reproductive age (5%) were pregnant. The country of passport issuance was known for 720 of the travelers. The majority of monitored travelers (478 [66%]) used a non-U.S. passport including 442 (61%) Liberian nationals. A total of 772 (99%) travelers were "low (but not zero)" risk; 11 (1%) were "some" risk. Among monitored travelers, 43 (5%) experienced illness symptoms; 29 (67%) had a symptom consistent with EVD. Two were tested for Ebola virus disease and had negative results. Most frequently reported symptoms were fever (20/43, 47%) and abdominal pain (12/43, 28%). During evaluation, 16 (37%) of 43 travelers reported their symptoms began prior to travel; chronic health conditions in 24 travelers including tumors/cancer, pregnancy, and orthopedic conditions were most common. Infectious causes in 19 travelers included upper respiratory infection, malaria, and gastrointestinal infections. Discussion Prior to 2014, no similar active monitoring program for travelers had been performed in Minnesota; assessment and management of symptomatic travelers was a new activity for MDH. Ensuring safe entrance into healthcare was particularly challenging for children, and pregnant women, as well as those without an established connection to healthcare. Unnecessary inpatient evaluations were successfully avoided by close clinical follow-up by phone. Before similar monitoring programs are considered in the future, careful thought must be given to necessary resources and the impact on affected populations, public health, and the healthcare system.	[DeVries, Aaron] Minneapolis VA Med Ctr, Infect Dis Sect, Minneapolis, MN USA; [DeVries, Aaron] Univ Minnesota, Sch Med & Publ Hlth, Minneapolis, MN USA; [Talley, Pamela] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA USA; [Talley, Pamela; Sweet, Kristin; Danila, Richard] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN 55164 USA; [Kline, Susan] Univ Minnesota, Sch Med, Div Infect Dis, Minneapolis, MN 55455 USA; [Stinchfield, Patricia] Childrens Hosp & Clin Minnesota, St Paul, MN USA; [Tosh, Pritish] Mayo Clin, Div Infect Dis, Rochester, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; Children's Hospitals & Clinics of Minnesota; Mayo Clinic	Danila, R (corresponding author), Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN 55164 USA.	richard.danila@state.mn.us	amsalu, ribka/G-8780-2019	DeVries, Aaron/0000-0001-9211-0722	Hospital Preparedness Program (HPP); Public Health Emergency Preparedness (PHEP) [CDC-RFA-TP12-12010302SUPP15, CDC-RFA-TP12-120102CONT14]; Domestic Ebola Supplement to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)-Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments [CK14-1401PPHFSUPP15]	Hospital Preparedness Program (HPP); Public Health Emergency Preparedness (PHEP); Domestic Ebola Supplement to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)-Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments	Funded in part by the Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) Cooperative Agreements / PHEP Supplemental for Ebola Preparedness and Response Activities CDC-RFA-TP12-12010302SUPP15 and CDC-RFA-TP12-120102CONT14; and the Domestic Ebola Supplement to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)-Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments CK14-1401PPHFSUPP15. Funds did not go to individuals but went to the Minnesota Department of Health as an agency, which employed ASD, KS, and RND at the time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MMWR-MORBID MORTAL W, V64, P121; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074; Cardile AP, 2015, MMWR-MORBID MORTAL W, V64, P690; Centers for Disease Control and Prevention, FACT SHEET SCREEN MO; Centers for Disease Control and Prevention, EB CARE KIT; Centers for Disease Control and Prevention, INT US GUID MON MOV; Chung WM, 2015, ANN INTERN MED, V163, P164, DOI 10.7326/M15-0968; Department of Homeland Security, DHSS COORD RESP EB; Kraemer JD, 2015, HEALTH SECUR, V13, P295, DOI 10.1089/hs.2015.0016; O'Shea MK, 2015, CLIN INFECT DIS, V61, P795, DOI 10.1093/cid/civ399; Stehling-Ariza T, 2015, MMWR-MORBID MORTAL W, V64, P685; U. S. Department of Homeland Security, DHSS COORD RESP EB; WHO, 2015, EB SIT REP	16	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166797	10.1371/journal.pone.0166797	http://dx.doi.org/10.1371/journal.pone.0166797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907013	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700041
J	Feng, GL; Wu, YP				Feng, Guo-Lin; Wu, Yong-Ping			Signal of Acceleration and Physical Mechanism of Water Cycle in Xinjiang, China	PLOS ONE			English	Article							VAPOR TRANSPORT; CLIMATE-CHANGE; PATTERNS; FLOODS	Global warming accelerates water cycle with features of regional difference. However, little is known about the physical mechanism behind the phenomenon. To reveal the links between water cycle and climatic environment, we analyzed the changes of water cycle elements and their relationships with climatic and environmental factors. We found that when global warming was significant during the period of 1986-2003, the precipitation in Tarim mountains as well as Xinjiang increased rapidly except for Tarim plains, which indicated that there existed a signal of acceleration for water cycle in Xinjiang. The speed of water cycle is mainly affected by altitude, latitude, longitude, slope direction, and the most fundamental element is temperature. Moreover, according to Clausius-Kela Bai Lung relation, we found that the climate change induced the increase of temperature and accelerated the local water cycle only for the wet places. Our results provide a possible physical mechanisms of water cycle and thus well link the climate change to water circulation.	[Feng, Guo-Lin; Wu, Yong-Ping] Yangzhou Univ, Coll Phys Sci & Technol, Yangzhou 225002, Jiangsu, Peoples R China; [Feng, Guo-Lin] China Meteorol Adm, Natl Climate Ctr, Beijing 100081, Peoples R China; [Wu, Yong-Ping] Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA	Yangzhou University; China Meteorological Administration; University of California System; University of California Riverside	Wu, YP (corresponding author), Yangzhou Univ, Coll Phys Sci & Technol, Yangzhou 225002, Jiangsu, Peoples R China.; Wu, YP (corresponding author), Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA.	wuypyz@126.com			National Natural Science Foundation of China [41530531, 41375078, 41375079, 41201062, 41271083]; Major National Scientific Research Programs of China [2013CB430204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Scientific Research Programs of China	The research is funded by the National Natural Science Foundation of China (under grants 41530531, 41375078, 41375079, 41201062, 41271083), and Major National Scientific Research Programs of China (grant nos: 2013CB430204).	Apurv T, 2015, J HYDROL, V527, P281, DOI 10.1016/j.jhydrol.2015.04.056; Boos WR, 2012, J CLIMATE, V25, P992, DOI 10.1175/JCLI-D-11-00010.1; Skansi MD, 2013, GLOBAL PLANET CHANGE, V100, P295, DOI 10.1016/j.gloplacha.2012.11.004; Falconer K., 2004, FRACTAL GEOMETRY MAT; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huang J, 2012, ATMOS CHEM PHYS, V12, P5391, DOI 10.5194/acp-12-5391-2012; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/nclimate2837, 10.1038/NCLIMATE2837]; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kendall M. G., 1975, RANK CORRELATION MET; Kerr RA, 2012, SCIENCE, V336, P405, DOI 10.1126/science.336.6080.405; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Schmitz JT, 1996, J CLIMATE, V9, P1621, DOI 10.1175/1520-0442(1996)009<1621:WVTAWT>2.0.CO;2; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Smith TM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023402; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Trenberth KE, 1999, J CLIMATE, V12, P1368, DOI 10.1175/1520-0442(1999)012<1368:AMRROA>2.0.CO;2; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Vormoor K, 2016, J HYDROL, V538, P33, DOI 10.1016/j.jhydrol.2016.03.066; Wang B.Q., 1995, ACTA SEISMOLOGICA SI, V8, P653; Wu YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26470; Wu YP, 2015, APPL MATH COMPUT, V268, P478, DOI 10.1016/j.amc.2015.06.059; Wu YP, 2012, ECOL COMPLEX, V9, P63, DOI 10.1016/j.ecocom.2011.12.002; Zhang Q, 2016, GLOBAL PLANET CHANGE, V139, P44, DOI 10.1016/j.gloplacha.2015.10.005; Zhou TJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005413	28	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167387	10.1371/journal.pone.0167387	http://dx.doi.org/10.1371/journal.pone.0167387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907078	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700138
J	Feng, K; Hu, WZ; Jiang, AL; Sarengaowa; Xu, YP; Zou, Y; Yang, L; Wang, X				Feng, Ke; Hu, Wenzhong; Jiang, Aili; Sarengaowa; Xu, Yongping; Zou, Yu; Yang, Liu; Wang, Xin			A Dual Filtration-Based Multiplex PCR Method for Simultaneous Detection of Viable Escherichia coli O157:H7, Listeria monocytogenes, and Staphylococcus aureus on Fresh-Cut Cantaloupe	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE TREATMENT; POLYMERASE-CHAIN-REACTION; SALMONELLA SPP.; RAPID DETECTION; IMMUNOMAGNETIC SEPARATION; VIBRIO-PARAHAEMOLYTICUS; MICROBIAL QUALITY; DEAD CELLS; FOOD; O157-H7	Fresh-cut cantaloupe is particularly susceptible to contamination with pathogenic bacteria, such as Escherichia coli O157: H7, Listeria monocytogenes, and Staphylococcus aureus. Therefore, development of rapid, yet accurate detection techniques is necessary to ensure food safety. In this study, a multiplex PCR system and propidium monoazide (PMA) concentration were optimized to detect all viable pathogens in a single tube. A dual filtration system utilized a filtration membrane with different pore sizes to enrich pathogens found on fresh-cut cantaloupe. The results revealed that an optimized multiplex PCR system has the ability to effectively detect three pathogens in the same tube. The viable pathogens were simultaneously detected for PMA concentrations above 10 mu g/ml. The combination of a nylon membrane (15 mu m) and a micro pore filtration membrane (0.22 mu m) formed the dual filtration system used to enrich pathogens. The achieved sensitivity of PMA-mPCR based on this dual filtration system was 2.6 x 10(3) cfu/g for L. monocytogenes, 4.3 x 10 cfu/g for E. coli O157:H7, and 3.1 x 10(2) cfu/g for S. aureus. Fresh-cut cantaloupe was inoculated with the three target pathogens using concentrations of 10(3), 10(2), 10, and 1 cfu/g. After 6-h of enrichment culture, assay sensitivity increased to 1 cfu/g for each of these pathogens. Thus, this technique represents an efficient and rapid detection tool for implementation on fresh-cut cantaloupe.	[Feng, Ke; Sarengaowa; Xu, Yongping] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Feng, Ke; Hu, Wenzhong; Jiang, Aili; Sarengaowa; Zou, Yu; Yang, Liu; Wang, Xin] Dalian Nationalities Univ, Coll Life Sci, Dalian, Peoples R China; [Jiang, Aili] Dalian Nationalities Univ, Coll Life Sci, Engn Ctr quick Detect Foodborne Pathogen Microorg, Dalian, Peoples R China	Dalian University of Technology; Dalian Minzu University; Dalian Minzu University	Hu, WZ (corresponding author), Dalian Nationalities Univ, Coll Life Sci, Dalian, Peoples R China.	wenzhongh@sina.com	Xu, Yongping/AAH-3987-2020	Xu, Yongping/0000-0002-3946-9223	Ministry of Science and Technology of the People's Republic of China [2016YFD0400903]; National Natural Science Foundation of China [31471923]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by Ministry of Science and Technology of the People's Republic of China - 2016YFD0400903, and by the National Natural Science Foundation of China - 31471923.	Yanez MA, 2011, J MICROBIOL METH, V85, P124, DOI 10.1016/j.mimet.2011.02.004; Alvarado-Casillas S, 2007, J FOOD PROTECT, V70, P655, DOI 10.4315/0362-028X-70.3.655; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Alves J, 2016, LWT-FOOD SCI TECHNOL, V72, P175, DOI 10.1016/j.lwt.2016.04.051; Bae S, 2009, WATER RES, V43, P4850, DOI 10.1016/j.watres.2009.06.053; Beaulieu JC, 2007, J AM SOC HORTIC SCI, V132, P720, DOI 10.21273/JASHS.132.5.720; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Bhaduri S, 2001, MOL CELL PROBE, V15, P267, DOI 10.1006/mcpr.2001.0370; BOBBITT JA, 1992, J MICROBIOL METH, V16, P215, DOI 10.1016/0167-7012(92)90006-P; Bonetta S, 2011, ENVIRON MONIT ASSESS, V177, P493, DOI 10.1007/s10661-010-1650-x; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Cadirci O, 2010, MEAT SCI, V84, P553, DOI 10.1016/j.meatsci.2009.10.011; Chen SY, 2011, APPL ENVIRON MICROB, V77, P4008, DOI 10.1128/AEM.00354-11; Chiang YC, 2012, J MICROBIOL METH, V88, P110, DOI 10.1016/j.mimet.2011.10.021; Danyluk MD, 2014, FOOD MICROBIOL, V38, P52, DOI 10.1016/j.fm.2013.08.001; DELROSARIO BA, 1995, J FOOD PROTECT, V58, P105, DOI 10.4315/0362-028X-58.1.105; Donhauser SC, 2011, ANAL CHEM, V83, P3153, DOI 10.1021/ac2002214; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; D'Urso OF, 2009, FOOD MICROBIOL, V26, P311, DOI 10.1016/j.fm.2008.12.006; Ferretti R, 2001, APPL ENVIRON MICROB, V67, P977, DOI 10.1128/AEM.67.2.977-978.2001; Germini A, 2009, FOOD CONTROL, V20, P733, DOI 10.1016/j.foodcont.2008.09.010; Gil MI, 2006, J AGR FOOD CHEM, V54, P4284, DOI 10.1021/jf060303y; Gilbert C, 2003, MOL CELL PROBE, P17; Hagren V, 2008, INT J FOOD MICROBIOL, V125, P158, DOI 10.1016/j.ijfoodmicro.2008.03.037; Hahm BK, 2015, J MICROBIOL METH, V117, P64, DOI 10.1016/j.mimet.2015.07.016; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; John EG, 2015, FOOD CONTROL, V19, P1; Kawasaki S, 2005, J FOOD PROTECT, V68, P551, DOI 10.4315/0362-028X-68.3.551; Klerks MM, 2004, J MICROBIOL METH, V59, P337, DOI 10.1016/j.mimet.2004.07.011; Lee HJ, 2009, BIOSENS BIOELECTRON, V24, P3550, DOI 10.1016/j.bios.2009.05.010; Luo JF, 2010, APPL MICROBIOL BIOT, V86, P377, DOI 10.1007/s00253-009-2373-1; Martin B, 2004, LETT APPL MICROBIOL, V39, P290, DOI 10.1111/j.1472-765X.2004.01580.x; Millan-Sango D, 2015, FOOD RES INT, V67, P145, DOI 10.1016/j.foodres.2014.11.001; Morin NJ, 2004, CLIN CHEM, V50, P2037, DOI 10.1373/clinchem.2004.036814; Muhterem-Uyar M, 2015, FOOD CONTROL, V51, P94, DOI 10.1016/j.foodcont.2014.10.042; Mukhopadhyay A, 2007, J MICROBIOL METH, V68, P193, DOI 10.1016/j.mimet.2006.07.009; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Park YS, 2006, J MICROBIOL, V44, P92; Richards GM, 2005, INT J FOOD MICROBIOL, V103, P1, DOI 10.1016/j.ijfoodmicro.2004.05.023; Richards GM, 2005, INT J FOOD MICROBIOL, V97, P327, DOI 10.1016/j.ijfoodmicro.2004.05.002; Rodgers SL, 2004, J FOOD PROTECT, V67, P721, DOI 10.4315/0362-028X-67.4.721; Rueckert A, 2005, J APPL MICROBIOL, V99, P1246, DOI 10.1111/j.1365-2672.2005.02728.x; Saroj SD, 2008, MOL CELL PROBE, V22, P201, DOI 10.1016/j.mcp.2008.02.002; Seinige D, 2014, APPL ENVIRON MICROB, V80, P2186, DOI 10.1128/AEM.03962-13; Toh PS, 2000, FOOD CONTROL, V11, P447, DOI 10.1016/S0956-7135(00)00008-6; Ukuku DO, 2006, J FOOD PROTECT, V69, P1835, DOI 10.4315/0362-028X-69.8.1835; Ukuku DO, 2006, J FOOD PROTECT, V69, P1623, DOI 10.4315/0362-028X-69.7.1623; Ukuku DO, 2004, J FOOD PROTECT, V67, P432, DOI 10.4315/0362-028X-67.3.432; Ukuku DO, 2002, J FOOD PROTECT, V65, P924, DOI 10.4315/0362-028X-65.6.924; Valimaa AL, 2015, FOOD CONTROL, V55, P103, DOI 10.1016/j.foodcont.2015.02.037; Vasanth D, 2011, J MEMBRANE SCI, V379, P154, DOI 10.1016/j.memsci.2011.05.050; Wan CX, 2012, INT J FOOD SCI TECH, V47, P2460, DOI 10.1111/j.1365-2621.2012.03123.x; Wang SS, 2006, J MICROBIOL METH, V64, P1, DOI 10.1016/j.mimet.2005.04.023; Yang YJ, 2013, FOOD MICROBIOL, V34, P418, DOI 10.1016/j.fm.2013.01.004; Zhang ZH, 2014, FOOD CONTROL, V35, P401, DOI 10.1016/j.foodcont.2013.07.035; Zhu RG, 2012, J MICROBIOL METH, V90, P262, DOI 10.1016/j.mimet.2012.05.019	59	19	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166874	10.1371/journal.pone.0166874	http://dx.doi.org/10.1371/journal.pone.0166874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906992	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700047
J	Kawoos, U; Gu, M; Lankasky, J; McCarron, RM; Chavko, M				Kawoos, Usmah; Gu, Ming; Lankasky, Jason; McCarron, Richard M.; Chavko, Mikulas			Effects of Exposure to Blast Overpressure on Intracranial Pressure and Blood-Brain Barrier Permeability in a Rat Model	PLOS ONE			English	Article							CLOSED-HEAD INJURY; SHOCK-WAVES; MOUSE MODEL; TIME-COURSE; IN-VITRO; INFLAMMATION; DYSFUNCTION; DISRUPTION; MILD; PATHOPHYSIOLOGY	Exposure to blast overpressure (BOP) activates a cascade of pathological processes including changes in intracranial pressure (ICP) and blood-brain barrier (BBB) permeability resulting in traumatic brain injury (TBI). In this study the effect of single and multiple exposures at two intensities of BOP on changes in ICP and BBB permeability in Sprague-Dawley rats was evaluated. Animals were exposed to a single or three repetitive (separated by 0.5 h) BOPs at 72 kPa or 110 kPa. ICP was monitored continuously via telemetry for 6 days after exposure to BOP. The alteration in the permeability of BBB was determined by extravasation of Evans Blue (EB) into brain parenchyma. A significant increase in ICP was observed in all groups except the single 72 kPa BOP group. At the same time a marked increase in BBB permeability was also seen in various parts of the brain. The extent of ICP increase as well as BBB permeability change was dependent on intensity and frequency of blast.	[Kawoos, Usmah; Gu, Ming; Lankasky, Jason; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [McCarron, Richard M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center	Kawoos, U (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA.	Usmah.kawoos.ctr@mail.mil			Office of Naval Research (ONR) [601152N.0000.000.A1308]	Office of Naval Research (ONR)(Office of Naval Research)	This work was supported by Office of Naval Research (ONR) Work Unit 601152N.0000.000.A1308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Guild SJ, 2015, J APPL PHYSIOL, V119, P576, DOI 10.1152/japplphysiol.00165.2015; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jamali S, 1998, BRAIN INJURY, V12, P525, DOI 10.1080/026990598122485; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Paxinos G, 1998, ACTA NEUROBIOLOGIAE; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	46	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167510	10.1371/journal.pone.0167510	http://dx.doi.org/10.1371/journal.pone.0167510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907158	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700176
J	La, T; Phillips, ND; Hampson, DJ				La, Tom; Phillips, Nyree D.; Hampson, David J.			An Investigation into the Etiological Agents of Swine Dysentery in Australian Pig Herds	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MALLARDS ANAS-PLATYRHYNCHOS; DUPLEX PCR ASSAY; BRACHYSPIRA-HYODYSENTERIAE; SERPULINA-HYODYSENTERIAE; ANTIMICROBIAL SUSCEPTIBILITY; HAMPSONII; SEQUENCE; PILOSICOLI; STRAIN	Swine dysentery (SD) is a mucohemorrhagic colitis, classically seen in grower/finisher pigs and caused by infection with the anaerobic intestinal spirochete Brachyspira hyodysenteriae. More recently, however, the newly described species Brachyspira hampsonii and Brachyspira suanatina have been identified as causing SD in North America and/or Europe. Furthermore, there have been occasions where strains of B. hyodysenteriae have been recovered from healthy pigs, including in multiplier herds with high health status. This study investigated whether cases of SD in Australia may be caused by the newly described species; how isolates of B. hyodysenteriae recovered from healthy herds compared to isolates from herds with disease; and how contemporary isolates compare to those recovered in previous decades, including in their plasmid gene content and antimicrobial resistance profiles. In total 1103 fecal and colon samples from pigs in 97 Australian herds were collected and tested. Of the agents of SD only B. hyodysenteriae was found, being present in 34 (35.1%) of the herds, including in 14 of 24 (58%) herds that had been considered to be free of SD. Multilocus sequence typing applied to 96 isolates from 30 herds and to 53 Australian isolates dating from the 1980s through the early 2000s showed that they were diverse, distinct from those reported in other countries, and that the 2014/16 isolates generally were different from those from earlier decades. These findings provided evidence for ongoing evolution of B. hyodysenteriae strains in Australia. In seven of the 20 herds where multiple isolates were available, two to four different sequence types (STs) were identified. Isolates with the same STs also were found in some herds with epidemiological links. Analysis of a block of six plasmid virulence-associated genes showed a lack of consistency between their presence or absence and their origin from herds currently with or without disease; however, significantly fewer isolates from the 2000s and from 2014/16 had this block of genes compared to isolates from the 1980s and 1990s. It is speculated that loss of these genes may have been responsible for the occurrence of milder disease occurring in recent years. In addition, fewer isolates from 2014/16 were susceptible to the antimicrobials lincomycin, and to a lesser extent tiamulin, than those from earlier Australian studies. Four distinct multi-drug resistant strains were identified in five herds, posing a threat to disease control.	[La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia	Murdoch University	Hampson, DJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia.	d.hampson@murdoch.edu.au	Hampson, David/AAE-3666-2019; Hampson, David J/A-9464-2008	Hampson, David J/0000-0002-7729-0427	CRC for High Integrity Australian Pork ("The Pork CRC") [2A-111]	CRC for High Integrity Australian Pork ("The Pork CRC")	This work was funded by CRC for High Integrity Australian Pork ("The Pork CRC"), project number 2A-111 to DJ H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achacha M, 1996, CAN J VET RES, V60, P45; Atyeo RF, 1999, EPIDEMIOL INFECT, V123, P133, DOI 10.1017/S0950268899002691; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; Costa MO, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-129; Durmic Z, 1998, J APPL MICROBIOL, V85, P574, DOI 10.1046/j.1365-2672.1998.853539.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Hampson DJ, 2016, VET MICROBIOL, V191, P15, DOI 10.1016/j.vetmic.2016.05.016; Hampson DJ, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0002-1; HAMPSON DJ, 1992, VET REC, V131, P318, DOI 10.1136/vr.131.14.318; Hampson DJ, 2012, DIS SWINE, P680; Hampson DJ, 2008, REPORT PREPARED CO O, P1; Hansen CF, 2010, J ANIM SCI, V88, P3327, DOI 10.2527/jas.2009-2719; Hansen CF, 2011, BRIT J NUTR, V106, P1506, DOI 10.1017/S000711451100208X; Jacobson M, 2004, J MED MICROBIOL, V53, P273, DOI 10.1099/jmm.0.05323-0; Jansson DS, 2011, SYST APPL MICROBIOL, V34, P566, DOI 10.1016/j.syapm.2011.10.001; Jansson DS, 2004, J MED MICROBIOL, V53, P293, DOI 10.1099/jmm.0.05488-0; Martinez-Lobo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082626; JENSEN NS, 1993, VET MICROBIOL, V36, P221, DOI 10.1016/0378-1135(93)90090-T; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Karlsson M, 1999, FEMS MICROBIOL LETT, V172, P255, DOI 10.1111/j.1574-6968.1999.tb13476.x; Karlsson M, 2002, VET MICROBIOL, V84, P123, DOI 10.1016/S0378-1135(01)00444-8; La T, 2003, J CLIN MICROBIOL, V41, P3372, DOI 10.1128/JCM.41.7.3372-3375.2003; La T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160362; La T, 2014, VET RES, V45, DOI 10.1186/s13567-014-0131-6; La T, 2011, VET MICROBIOL, V153, P150, DOI 10.1016/j.vetmic.2011.02.053; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; Lobert S, 2016, TIERAERZTL PRAX G N, V44, P13, DOI 10.15653/TPG-150674; Lysons RJ, 1982, P 7 INT PIG VET SOC, P40; Mahu M, 2014, VET REC, V174, DOI 10.1136/vr.101868; Mahu M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0353-x; Mirajkar NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107176; Mirajkar NS, 2016, J CLIN MICROBIOL; Mushtaq M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0537-y; Osorio J, 2013, RES VET SCI, V95, P861, DOI 10.1016/j.rvsc.2013.07.014; Osorio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039082; Phillips ND, 2007, P 4 INT C COL SPIR I, P19; Phillips ND, 2006, VET MICROBIOL, V116, P239, DOI 10.1016/j.vetmic.2006.03.020; Phillips ND, 2009, VET MICROBIOL, V134, P294, DOI 10.1016/j.vetmic.2008.08.006; Pluske JR, 1996, J NUTR, V126, P2920; Pringle M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-54; Rasback T, 2007, ENVIRON MICROBIOL, V9, P983, DOI 10.1111/j.1462-2920.2006.01220.x; Rohde J, 2014, VET MICROBIOL, V168, P432, DOI 10.1016/j.vetmic.2013.11.016; Rohde J, 2012, VET MICROBIOL, V158, P211, DOI 10.1016/j.vetmic.2012.02.008; Ronne H, 1990, P INT PIG VET SOC C, P126; Rubin JE, 2013, MICROB ECOL, V66, P813, DOI 10.1007/s00248-013-0273-5; Rubin JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057146; Rugna G, 2015, VET J, V203, P115, DOI 10.1016/j.tvjl.2014.10.033; Siba PM, 1996, EPIDEMIOL INFECT, V116, P207, DOI 10.1017/S0950268800052456; Stege H, 2000, PREV VET MED, V46, P279, DOI 10.1016/S0167-5877(00)00148-3; Thomsen LE, 2007, VET MICROBIOL, V119, P152, DOI 10.1016/j.vetmic.2006.09.004; Thomson JR, 2003, P 2 INT C COL SPIR I; van Duijkeren E, 2014, J ANTIMICROB CHEMOTH, V69, P2022, DOI 10.1093/jac/dku123; Wilberts BL, 2014, VET PATHOL, V51, P1096, DOI 10.1177/0300985813516646; Wilberts BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114741	56	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167424	10.1371/journal.pone.0167424	http://dx.doi.org/10.1371/journal.pone.0167424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907102	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700152
J	Mukui, IN; Ng'ang'a, L; Williamson, J; Wamicwe, JN; Vakil, S; Katana, A; Kim, AA				Mukui, Irene N.; Ng'ang'a, Lucy; Williamson, John; Wamicwe, Joyce N.; Vakil, Shobha; Katana, Abraham; Kim, Andrea A.			Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012	PLOS ONE			English	Article							DRUG-USERS; ADHERENCE; ART; SUPPRESSION; INFECTION; OUTCOMES; RISK	Introduction Understanding the levels and associated factors of non-adherence to antiretroviral therapy (ART) is crucial in designing interventions to improve adherence and health outcomes of ART. We assessed non-adherence to ART among HIV-infected persons reporting ART use in a nationally representative survey in Kenya. Methods The Kenya AIDS Indicator Survey 2012 was a population-based, household survey of persons aged 18 months-64 years conducted in 2012-2013. Self-reported information was collected on demographics, sexual behaviour, HIV status, and ART use. Blood was collected for HIV testing, and if HIV infected, CD4 and viral load testing. HIV-positive specimens were tested for the presence of antiretroviral (ARV) drugs using a qualitative ARV assay using liquid chromatography-tandem mass spectrometry. HIV-positive persons who reported receiving ART but did not have the ARV biomarker present were defined as being non-adherent to their ARV medication. We restricted our analysis to HIV-infected persons aged 15-64 years who reported receiving ART and had laboratory-confirmed results from ARV testing. Multivariate logistic regression was used to identify variables associated with non-adherence. Results A total of 648 (5.6%; CI 4.9-6.3) tested HIV-positive of whom 559 (86.3%) had sufficient volume of blood to be tested for ARV drugs. Of those, 271 (47.7%; CI 41.8-53.6) self-reported HIV-positive status during the interview and 186 (69.1%; CI 62.2-76.0) of those reported taking ART. The ARV biomarker was absent in 18 of 186 individuals (9.4%; CI 4.9-13.8) who thus were defined as being non-adherent to ART. Non-adherence was associated with being aged 15-29 years (AOR 8.39; CI 2.26-31.22, p = 0.002) compared to aged 30-64 years, rural residence (AOR 5.87; CI 1.39-25.61, p = 0.016) compared with urban residence and taking recreational drugs in the past 30 days (AOR 5.89; CI 1.30-26.70, p = 0.022). Conclusion Overall, less than 10% of Kenyans aged 15-64 years on ART were not adhering to their HIV medication, highlighting the success of the Kenyan national ART program. Our findings, however, point to the need for targeted interventions particularly for young persons, those in rural areas to improve adherence outcomes, as well as delivery of treatment programs that include psychosocial support as a preventative measure to minimize substance abuse and the risk of treatment failure.	[Mukui, Irene N.; Wamicwe, Joyce N.; Vakil, Shobha] Minist Hlth, Natl AIDS & STI Control Programme, Dept Prevent & Promot Hlth Serv, Nairobi, Kenya; [Ng'ang'a, Lucy; Williamson, John; Katana, Abraham; Kim, Andrea A.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Nairobi, Kenya		Mukui, IN (corresponding author), Minist Hlth, Natl AIDS & STI Control Programme, Dept Prevent & Promot Hlth Serv, Nairobi, Kenya.	njahira2004@yahoo.com	Mukui, Irene/GYE-0151-2022	Mukui, Irene/0000-0002-3699-1841	National AIDS and STI Control Programme (NASCOP); Kenya National Bureau of Statistics, (KNBS); National Public Health Laboratory Services (NPHLS); National AIDS Control Council (NACC); National Council for Population and Development (NCPD); Kenya Medical Research Institute (KEMRI); U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta); United States Agency for International Development (USAID/Kenya); University of California, San Francisco (UCSF); Joint United Nations Team on HIV/AIDS; Japan International Cooperation Agency (JICA); Elizabeth Glaser Paediatric AIDS Foundation (EGPAF); Liverpool Voluntary Counselling and Testing (LVCT); African Medical and Research Foundation (AMREF); World Bank; Global Fund; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) [PS001805, GH000069, PS001814]; Joint United Nations Team for HIV/AIDS	National AIDS and STI Control Programme (NASCOP); Kenya National Bureau of Statistics, (KNBS); National Public Health Laboratory Services (NPHLS); National AIDS Control Council (NACC); National Council for Population and Development (NCPD); Kenya Medical Research Institute (KEMRI); U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID/Kenya)(United States Agency for International Development (USAID)); University of California, San Francisco (UCSF)(University of California System); Joint United Nations Team on HIV/AIDS; Japan International Cooperation Agency (JICA); Elizabeth Glaser Paediatric AIDS Foundation (EGPAF); Liverpool Voluntary Counselling and Testing (LVCT); African Medical and Research Foundation (AMREF); World Bank(The World Bank India); Global Fund; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Joint United Nations Team for HIV/AIDS	The second Kenya AIDS Indicator Survey (KAIS 2012) was supported by National AIDS and STI Control Programme (NASCOP), Kenya National Bureau of Statistics, (KNBS), National Public Health Laboratory Services (NPHLS), National AIDS Control Council (NACC), National Council for Population and Development (NCPD), Kenya Medical Research Institute (KEMRI), U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta), United States Agency for International Development (USAID/Kenya), University of California, San Francisco (UCSF), the United States Agency for International Development (USAID/Kenya), Joint United Nations Team on HIV/AIDS, Japan International Cooperation Agency (JICA), the Elizabeth Glaser Paediatric AIDS Foundation (EGPAF), Liverpool Voluntary Counselling and Testing (LVCT), the African Medical and Research Foundation (AMREF), the World Bank, and the Global Fund. This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreements [#PS001805, GH000069, and PS001814] through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA). This work was also funded in part by support from the Global Fund, World Bank, and the Joint United Nations Team for HIV/AIDS.	Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; [Anonymous], 2011, GUID ANT THER KEN; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Azar P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0913-0; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Bonolo PD, 2013, CLINICS, V68, P612, DOI 10.6061/clinics/2013(05)06; Boruett P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-242; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Elul B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053586; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Hansana V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-617; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Kim AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155498; Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316; KNBS, 2010, 2009 KEN POP HOUS CE; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Ministry of Health (MOH), 2014, KEN HIV EST REP 2014; Murri R, 2000, J ACQ IMMUN DEF SYND, V24, P123; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; National AIDS and STI Control Programme (NASCOP), 2012, NAT ARV STOCK STAT R; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nozaki I, 2011, AIDS CARE, V23, P831, DOI 10.1080/09540121.2010.542121; Obirikorang Christian, 2013, ISRN AIDS, V2013, P873939, DOI 10.1155/2013/873939; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rehle T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133255; Rudy BJ, 2010, AIDS PATIENT CARE ST, V24, P97, DOI 10.1089/apc.2009.0198; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Sidle J, 2007, 4 INT AIDS SOC C HIV; Sodergard B, 2006, J CLIN PHARM THER, V31, P605, DOI 10.1111/j.1365-2710.2006.00782.x; Spire B, 2008, ANTIVIR THER, V13, P697; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; UNAIDS, 2015, UND FAST TRACK; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wakibi SN, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-43; Waruiru W, 2014, JAIDS-J ACQ IMM DEF, V66, pS3, DOI 10.1097/QAI.0000000000000114; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; World Health Organization, 2016, CONS GUID US ANT DRU	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167465	10.1371/journal.pone.0167465	http://dx.doi.org/10.1371/journal.pone.0167465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907114	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700163
J	Polez, S; Origi, D; Zahariev, S; Guarnaccia, C; Tisminetzky, SG; Skoko, N; Baralle, M				Polez, Sulena; Origi, Domenico; Zahariev, Sotir; Guarnaccia, Corrado; Tisminetzky, Sergio G.; Skoko, Natasa; Baralle, Marco			A Simplified and Efficient Process for Insulin Production in Pichia pastoris	PLOS ONE			English	Article							RECOMBINANT HUMAN INSULIN; SECRETORY EXPRESSION; ORGANIC-SOLVENTS; MINI-PROINSULIN; PRECURSOR; YEAST; PURIFICATION; TECHNOLOGY; SEMISYNTHESIS; ENZYMES	A significant barrier to insulin is affordability. In this manuscript we describe improvements to key steps in the insulin production process in Pichia pastoris that reduce cost and time. The strategy for recovery and processing of human insulin precursor has been streamlined to two steps from bioreactor to the transpeptidation reaction. In the first step the insulin precursor secreted during the methanol induction phase is recovered directly from the culture broth using Tangential Flow Filtration with a Prostak (TM) module eliminating the laborious and time-consuming multi-step clarification, including centrifugation. In the second step the protein is applied at very high loadings on a cation exchange resin and eluted in a mixture of water and ethanol to obtain a concentrated insulin precursor, suitable for use directly in the transpeptidation reaction. Overall the yield from insulin precursor to human insulin was 51% and consisted of three purification chromatography steps. In addition we describe a method for recovery of the excess of H-Thr(tBu)-OtBu from the transpeptidation reaction mixture, one of the more costly reagents in the process, along with its successful reuse.	[Polez, Sulena; Zahariev, Sotir; Guarnaccia, Corrado; Tisminetzky, Sergio G.; Skoko, Natasa; Baralle, Marco] ICGEB, Trieste, Italy; [Origi, Domenico] Merck SpA, Proc Solut, Biomfg Sci Network, Milan, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Skoko, N; Baralle, M (corresponding author), ICGEB, Trieste, Italy.	skoko@icgeb.org; barallem@icgeb.org		Baralle, Marco/0000-0002-0417-1013				Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Babu PVC, 2008, J CHROMATOGR B, V861, P218, DOI 10.1016/j.jchromb.2007.10.008; Besnard L, 2016, BIOTECHNOL ADV, V34, P1, DOI 10.1016/j.biotechadv.2015.11.005; Castro GR, 1999, ENZYME MICROB TECH, V25, P689, DOI 10.1016/S0141-0229(99)00099-X; FIELD RW, 1995, J MEMBRANE SCI, V100, P259, DOI 10.1016/0376-7388(94)00265-Z; Gurramkonda C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-31; KEMPKEN R, 1995, BIOTECHNOL BIOENG, V46, P132, DOI 10.1002/bit.260460206; Kjeldsen T, 1996, REMOVABLE SPACER PEP; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Kohlbau H-J., 2003, HOUBEN WEYL METHODS; Liu HF, 2013, PROCESS BIOCHEM, V48, P965, DOI 10.1016/j.procbio.2013.04.004; Mansur M, 2005, BIOTECHNOL LETT, V27, P339, DOI 10.1007/s10529-005-1007-7; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; Meehl MA, 2014, CURR OPIN BIOTECH, V30, P120, DOI 10.1016/j.copbio.2014.06.007; Mollerup I., 2002, INSULIN PURIFICATION; MORIHARA K, 1986, BIOCHEM J, V240, P803, DOI 10.1042/bj2400803; Muniandi K.M., 2013, INT J BIOTECH MOL BI, V4, P28; Pais JM, 2003, BIOTECHNOL LETT, V25, P251, DOI 10.1023/A:1022398917213; Pais-Chanfrau JA, 2004, BIOTECHNOL LETT, V26, P1269, DOI 10.1023/B:BILE.0000044871.80632.f9; Rich J. O., 2001, METH BIOTEC, V15; ROSE K, 1983, BIOCHEM J, V211, P671, DOI 10.1042/bj2110671; Routledge SJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-17; Simon LM, 2001, BIOCHEM BIOPH RES CO, V280, P1367, DOI 10.1006/bbrc.2001.4282; Sundaran B, 2002, J BIOSCI BIOENG, V94, P93, DOI 10.1263/jbb.94.93; Urmann M, 2010, MABS-AUSTIN, V2, P395, DOI 10.4161/mabs.12303; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Walsh G, 2005, APPL MICROBIOL BIOT, V67, P151, DOI 10.1007/s00253-004-1809-x; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; Xie T, 2008, PREP BIOCHEM BIOTECH, V38, P308, DOI 10.1080/10826060802165147; Yavorsky D, 2003, PHARMACEUTICAL TECHN; Zhu T, 2009, J APPL MICROBIOL, V107, P954, DOI 10.1111/j.1365-2672.2009.04279.x	31	13	14	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167207	10.1371/journal.pone.0167207	http://dx.doi.org/10.1371/journal.pone.0167207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907132	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700091
J	Sobas, EM; Reinoso, R; Cuadrado-Asensio, R; Fernandez, I; Maldonado, MJ; Pastor, JAC				Sobas, Eva M.; Reinoso, Roberto; Cuadrado-Asensio, Ruben; Fernandez, Itziar; Maldonado, Miguel J.; Pastor, Jose A. C.			Reliability of Potential Pain Biomarkers in the Saliva of Healthy Subjects: Inter-Individual Differences and Intersession Variability	PLOS ONE			English	Article							ALPHA-AMYLASE; CORTISOL CONCENTRATIONS; RATING-SCALES; SURGERY; STRESS; VARIABLES; RESPONSES; SYSTEM	Aim Salivary cortisol, alpha-amylase (sAA), secretory IgA (sIgA), testosterone, and soluble fraction of receptor II of TNF alpha (sTNF alpha RII) could serve as objective pain measures, but the normal variability of these potential biomarkers is unknown. Patients & Methods Saliva was collected with the passive secretion method from 34, pain-free subjects in two single samples at least 24 hours apart. Biomarker variation and intersession reliability were assessed with the intraclass correlation coefficient (ICC). Also, we calculated the within-subject standard deviation (S-w) and the reproducibility (2.77 x S-w) of intersession measures. Results Salivary cortisol, sAA, sIgA, testosterone, and sTNF alpha RII yielded the following ICCs: 0.53, 0.003, 0.88, 0.42 and 0.83, respectively. We found no statistically significant systematic differences between sessions in any biomarker except for testosterone, which showed a decrease on the second day (p<0.001). The reproducibility for salivary cortisol, sAA, sIgA, testosterone, and sTNF alpha RII were 0.46 ng/ml, 12.88 U/ml, 11.7 mu g/ml, 14.54 pg/ml and 18.29 pg/ml, respectively. Cortisol, testosterone and TNF alpha RII measurement variability showed a positive correlation with the magnitude (p<0.002), but no relationship was found for sAA and sIgA. Conclusions Salivary sIgA and sTNF alpha RII show a remarkable good reproducibility and, therefore, could be useful as pain biomarkers. When using the passive secretion method, intersession variations in salivary sIgA of more than 11.7 mu g/ml may reflect true biomarker change. In the case of sTNF alpha RII this will depend of the magnitude. The estimates herein provided should help investigators and clinicians differentiate actual biomarker modification from measurement variability.	[Sobas, Eva M.; Reinoso, Roberto; Cuadrado-Asensio, Ruben; Fernandez, Itziar; Maldonado, Miguel J.; Pastor, Jose A. C.] Univ Valladolid, Inst Univ Oftalmobiol Aplicada IOBA, Valladolid, Spain; [Sobas, Eva M.] Univ Valladolid, Escuela Enfermeria, Valladolid, Spain; [Reinoso, Roberto] Vis I D, Valladolid, Spain; [Cuadrado-Asensio, Ruben; Maldonado, Miguel J.; Pastor, Jose A. C.] Univ Valladolid, Fac Med, Dept Cirugia Oftalmol Otorrinolaringol & Fisioter, Valladolid, Spain; [Reinoso, Roberto; Fernandez, Itziar] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valladolid, Spain; [Pastor, Jose A. C.] Hosp Clin Univ, Dept Ophthalmol, Valladolid, Spain	Universidad de Valladolid; Universidad de Valladolid; Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de la Laguna	Sobas, EM (corresponding author), Univ Valladolid, Inst Univ Oftalmobiol Aplicada IOBA, Valladolid, Spain.; Sobas, EM (corresponding author), Univ Valladolid, Escuela Enfermeria, Valladolid, Spain.	eva@ioba.med.uva.es	Jimeno, J Carlos Pastor/AAP-1156-2020; Tapia, Roberto Reinoso/AAI-3259-2021; Fernández, Itziar/AAF-9590-2020; Cuadrado-Asensio, Rubén/G-8374-2017	Jimeno, J Carlos Pastor/0000-0001-5934-7306; Fernández, Itziar/0000-0002-5077-4448; Cuadrado-Asensio, Rubén/0000-0002-8507-306X; Maldonado, Miguel J./0000-0002-1021-3275; Reinoso, Roberto/0000-0003-0476-4975				[Anonymous], 2014, R LANG ENV STAT COMP; Bell RF, 2001, ACTA ANAESTH SCAND, V45, P576, DOI 10.1034/j.1399-6576.2001.045005576.x; Beltzer EK, 2010, PHYSIOL BEHAV, V101, P289, DOI 10.1016/j.physbeh.2010.05.016; Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Bland M., 2000, INTRO MED STAT, P269; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Choi JC, 2012, ANAESTHESIA, V67, P1146, DOI 10.1111/j.1365-2044.2012.07267.x; Clark P, 2003, J RHEUMATOL, V30, P1584; Campos MJD, 2010, MED SCI MONITOR, V16, pCR405; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; DOMZAL T, 1983, PAIN, V17, P67, DOI 10.1016/0304-3959(83)90128-8; Englbrecht M, 2012, J RHEUMATOL, V39, P3, DOI 10.3899/jrheum.120335; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Golatowski C, 2013, CLIN CHIM ACTA, V419, P42, DOI 10.1016/j.cca.2013.01.013; Goodin BR, 2012, PSYCHOPHYSIOLOGY, V49, P118, DOI 10.1111/j.1469-8986.2011.01280.x; Goodin BR, 2012, PAIN MED, V13, P29, DOI 10.1111/j.1526-4637.2011.01293.x; Hanson D, 2010, INFANT BEHAV DEV, V33, P289, DOI 10.1016/j.infbeh.2010.03.003; Harmon AG, 2008, HORM BEHAV, V54, P592, DOI 10.1016/j.yhbeh.2008.05.019; Hirose Noriya, 2009, Masui, V58, P1360; Hirshoren N, 2002, J CLIN ENDOCR METAB, V87, P1569, DOI 10.1210/jc.87.4.1569; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Hsieh Shu-Feng, 2016, J Tradit Complement Med, V6, P269, DOI 10.1016/j.jtcme.2015.07.004; Izawa S, 2009, WILD ENVIRON MED, V20, P239, DOI 10.1580/07-WEME-OR-123R2.1; Kanegane Kazue, 2009, J Oral Sci, V51, P515; Lund Irene, 2005, BMC Med Res Methodol, V5, P31, DOI 10.1186/1471-2288-5-31; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Marchi A, 2009, CLIN DRUG INVEST, V29, P41, DOI 10.2165/0044011-200929001-00006; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039375; McLean SA, 2005, ARTHRITIS RHEUM-US, V52, P3660, DOI 10.1002/art.21372; Muller MJ, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-8; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Perroni F, 2009, ERGONOMICS, V52, P484, DOI 10.1080/00140130802707873; Petrelluzzi KFS, 2008, STRESS, V11, P390, DOI 10.1080/10253890701840610; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Robles TF, 2012, J ORAL MAXIL SURG, V70, P2256, DOI 10.1016/j.joms.2012.03.005; Schielzeth H, 2011, RPTR REPEATABILITY G; Shibata M, 2013, EARLY HUM DEV, V89, P503, DOI 10.1016/j.earlhumdev.2013.03.006; Singla NK, 2014, PAIN, V155, P441, DOI 10.1016/j.pain.2013.09.002; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Teson M, 2013, INVEST OPHTH VIS SCI, V54, P2093, DOI 10.1167/iovs.12-11361; Tornhage CJ, 2006, J PEDIATR ENDOCR MET, V19, P843; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186; Torres-Harding S, 2008, J APPL BIOBEHAV RES, V13, P157, DOI 10.1111/j.1751-9861.2008.00033.x; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x	48	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166976	10.1371/journal.pone.0166976	http://dx.doi.org/10.1371/journal.pone.0166976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907037	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700058
J	Takamatsu, S; Yamamoto, K; Maeda, Y; Kawamura, M; Shibata, S; Sato, Y; Terashima, K; Shimizu, Y; Tameshige, Y; Sasaki, M; Asahi, S; Kondou, T; Kobayashi, S; Matsui, O; Gabata, T				Takamatsu, Shigeyuki; Yamamoto, Kazutaka; Maeda, Yoshikazu; Kawamura, Mariko; Shibata, Satoshi; Sato, Yoshitaka; Terashima, Kazuki; Shimizu, Yasuhiro; Tameshige, Yuji; Sasaki, Makoto; Asahi, Satoko; Kondou, Tamaki; Kobayashi, Satoshi; Matsui, Osamu; Gabata, Toshifumi			Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging	PLOS ONE			English	Article							RADIOTHERAPY; TOLERANCE; IRRADIATION; AGREEMENT; VOLUMES; INJURY	Background Proton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), and toxicity tends to be lower than for photon radiotherapy. Focal liver parenchymal damage in radiotherapy is described as the focal liver reaction (FLR); the threshold doses (TDs) for FLR in the background liver have been analyzed in stereotactic ablative body radiotherapy and brachytherapy. To develop a safer approach for PBT, both TD and liver volume changes are considered clinically important in predicting the extent of damage before treatment, and subsequently in reducing background liver damage. We investigated appearance time, TDs and volume changes regarding FLR after PBT for HCC. Material and Methods Patients who were treated using PBT and were followed up using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA MRI) after PBT were enrolled. Sixty-eight lesions in 58 patients were eligible for analysis. MRI was acquired at the end of treatment, and at 1, 2, 3 and 6 months after PBT. We defined the FLR as a clearly depicted hypointense area on the hepatobiliary phase of Gd-EOB-DTPA MRI, and we monitored TDs and volume changes in the FLR area and the residual liver outside of the FLR area. Results FLR was depicted in all lesions at 3 months after PBT. In FLR expressed as the 2-Gy equivalent dose (alpha/beta = 3 Gy), TDs did not differ significantly (27.0 +/- 6.4 CGE [10 fractions [Fr] vs. 30.5 +/- 7.3 CGE [20 Fr]). There were also no correlations between the TDs and clinical factors, and no significant differences between Child-Pugh A and B scores. The volume of the FLR area decreased and the residual liver volume increased, particularly during the initial 3 months. Conclusion This study established the FLR dose for liver with HCC, which might be useful in the prediction of remnant liver volume for PBT	[Takamatsu, Shigeyuki] Kanazawa Univ Hosp, Dept Radiotherapy, Kanazawa, Ishikawa, Japan; [Takamatsu, Shigeyuki; Yamamoto, Kazutaka; Maeda, Yoshikazu; Shibata, Satoshi; Sato, Yoshitaka; Shimizu, Yasuhiro; Tameshige, Yuji; Sasaki, Makoto] Fukui Prefectural Hosp, Proton Therapy Ctr, Fukui, Fukui, Japan; [Kawamura, Mariko] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan; [Terashima, Kazuki] Hyogo Ion Beam Med Ctr, Dept Radiol, Tatsuno, Hyogo, Japan; [Asahi, Satoko] Univ Fukui, Dept Radiol, Fukui, Fukui, Japan; [Kondou, Tamaki] Kanazawa Med Univ, Dept Diagnost & Therapeut Radiol, Kanazawa, Ishikawa, Japan; [Kobayashi, Satoshi; Matsui, Osamu; Gabata, Toshifumi] Kanazawa Univ, Dept Radiol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Nagoya University; University of Fukui; Kanazawa Medical University; Kanazawa University	Takamatsu, S (corresponding author), Kanazawa Univ Hosp, Dept Radiotherapy, Kanazawa, Ishikawa, Japan.; Takamatsu, S (corresponding author), Fukui Prefectural Hosp, Proton Therapy Ctr, Fukui, Fukui, Japan.	shigerad@staff.kanazawa-u.ac.jp	Kobayashi, Satoshi/C-4645-2015; Kawamura, Mariko/Q-5517-2019	Kobayashi, Satoshi/0000-0001-7759-399X; Kawamura, Mariko/0000-0001-9211-4934; Maeda, Yoshikazu/0000-0002-3040-5549; Shimizu, Yasuhiro/0000-0002-3979-953X; Takamatsu, Shigeyuki/0000-0002-0743-4413	JSPSKAKENHI [16K10273]	JSPSKAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPSKAKENHI Grant Number 16K10273.	[Anonymous], 2007, 78 ICRU, V2, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dionisi F, 2014, RADIOTHER ONCOL, V111, P1, DOI 10.1016/j.radonc.2014.02.001; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Fowler JF, 2009, INT J RADIAT ONCOL, V73, P1532, DOI 10.1016/j.ijrobp.2008.11.039; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Helmy A, 2006, ALIMENT PHARM THER, V23, P11, DOI 10.1111/j.1365-2036.2006.02742.x; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Imada H, 2010, RADIOTHER ONCOL, V96, P236, DOI 10.1016/j.radonc.2010.03.025; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lee NK, 2009, RADIOGRAPHICS, V29, P1707, DOI 10.1148/rg.296095501; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Olsen CC, 2009, INT J RADIAT ONCOL, V73, P1414, DOI 10.1016/j.ijrobp.2008.07.032; Qi WX, 2015, RADIOTHER ONCOL, V114, P289, DOI 10.1016/j.radonc.2014.11.033; Richter C, 2014, MED HYPOTHESES, V83, P477, DOI 10.1016/j.mehy.2014.08.004; Ruhl R, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-44; Sanuki N, 2014, INT J RADIAT ONCOL, V88, P306, DOI 10.1016/j.ijrobp.2013.10.045; Seidensticker M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-40; Son SH, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-61; Takeda A, 2014, J GASTROEN HEPATOL, V29, P372, DOI 10.1111/jgh.12350; Vander Borght S, 2005, J PATHOL, V207, P471, DOI 10.1002/path.1852; Yuan YD, 2013, RADIOTHER ONCOL, V106, P378, DOI 10.1016/j.radonc.2013.01.016; Zhu R, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/529314	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167155	10.1371/journal.pone.0167155	http://dx.doi.org/10.1371/journal.pone.0167155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907063	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700082
J	Xu, MC; Zhang, F; Wang, AX; Wang, C; Cao, Y; Zhang, M; Zhang, MM; Su, M; Zou, XP; Xu, GF; Zhuge, YZ				Xu, Mingcui; Zhang, Feng; Wang, Aixiu; Wang, Chen; Cao, Yu; Zhang, Ming; Zhang, Mingming; Su, Min; Zou, Xiaoping; Xu, Guifang; Zhuge, Yuzheng			Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Promotes Hepatic Stellate Cells Migration via Canonical NF-kappa B/MMP9 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; LIVER FIBROSIS; MATRIX METALLOPROTEINASES; TWEAK; INJURY; AXIS; ANGIOGENESIS; PROGRESSION; ACTIVATION; EXPRESSION	In the liver, the signal and function of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) have mainly been assessed in association with liver regeneration. However, the effects of TWEAK on liver fibrosis have not been fully elucidated. To investigate the effects of TWEAK on human hepatic stellate cells (HSCs) and to explore the relevant potential mechanisms, human HSCs line-LX-2 were cultured with TWEAK. Cell migration was detected by transwell assay; cell viability was evaluated by Cell Counting Kit-8; the expression of MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 gene was identified by quantitative real-time polymerase chain reaction and western blotting; the activity of matrix metalloproteinases (MMPs) was tested by enzyme-linked immuno sorbent assay; small interfering RNA transfection was applied for depletion of MMP9 and p65. The result of transwell assay revealed that TWEAK promoted LX-2 migration. Subsequently, our data testified that the expression and activity of MMP9 was induced by TWEAK in LX-2 cells, which enhanced the migration. Furthermore, our findings showed that TWEAK upregulated the phosphorylation of I kappa B alpha and p65 protein to increase MMP9 expression in LX-2 cells. Meanwhile, the alpha-smooth muscle actin, vimentin and desmin expression were upregulated following TWEAK treatment. The results in the present study revealed that TWEAK promotes HSCs migration via canonical NF-kappa B/MMP9 pathway, which possibly provides a molecular basis targeting TWEAK for the therapy of liver fibrosis.	[Xu, Mingcui; Zhang, Feng; Zhuge, Yuzheng] Nanjing Med Univ, Affiliated Drum Tower Clin Med Sch, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Wang, Aixiu; Wang, Chen; Cao, Yu; Zhang, Ming; Zhang, Mingming; Su, Min; Zou, Xiaoping; Xu, Guifang] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University	Zhuge, YZ (corresponding author), Nanjing Med Univ, Affiliated Drum Tower Clin Med Sch, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	yuzheng9111963@aliyun.com	wang, chen/GWM-9481-2022		National Natural Science Foundation of China [81570550]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81570550 http://www.nsfc.gov.cn/) to YZZG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berzal S, 2015, J CELL PHYSIOL, V230, P1580, DOI 10.1002/jcp.24905; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Burkly LC, 2014, SEMIN IMMUNOL, V26, P229, DOI 10.1016/j.smim.2014.02.006; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Castilho-Fernandes A, 2011, EXP MOL PATHOL, V91, P664, DOI 10.1016/j.yexmp.2011.09.002; Coito AJ, 2011, CURR OPIN ORGAN TRAN, V16, P34, DOI 10.1097/MOT.0b013e328342542e; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Garcia-Irigoyen O, 2015, HEPATOLOGY, V62, P166, DOI 10.1002/hep.27798; Henaut L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.220; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136453; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kato H, 2014, J HEPATOL, V60, P1032, DOI 10.1016/j.jhep.2013.12.022; Li XiaoXia, 2016, Journal of South China Agricultural University, V37, P1; Lopez-Dupla M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144789; Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084071; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Munch J, 2016, J CARD FAIL; Nakamura K, 2012, J HEPATOL, V57, P1037, DOI 10.1016/j.jhep.2012.07.004; Padrao AI, 2015, ARCH BIOCHEM BIOPHYS, V567, P13, DOI 10.1016/j.abb.2014.12.026; Pettersen I, 2013, INT J ONCOL, V42, P1239, DOI 10.3892/ijo.2013.1800; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Wilhelm A, 2016, J PATHOL, V239, P109, DOI 10.1002/path.4707; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yu GY, 2014, AM J RESP CRIT CARE, V190, P780, DOI 10.1164/rccm.201310-1903OC; Zhang F, 2014, INT IMMUNOPHARMACOL, V19, P193, DOI 10.1016/j.intimp.2014.01.021	34	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167658	10.1371/journal.pone.0167658	http://dx.doi.org/10.1371/journal.pone.0167658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907201	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700219
J	Donald, W; Pasay, C; Guintran, JO; Iata, H; Anderson, K; Nausien, J; Gresty, KJ; Waters, NC; Vestergaard, LS; Taleo, G; Cheng, Q				Donald, Wesley; Pasay, Cielo; Guintran, Jean-Olivier; Iata, Harry; Anderson, Karen; Nausien, Johnny; Gresty, Karryn J.; Waters, Norman C.; Vestergaard, Lasse S.; Taleo, George; Cheng, Qin			The Utility of Malaria Rapid Diagnostic Tests as a Tool in Enhanced Surveillance for Malaria Elimination in Vanuatu	PLOS ONE			English	Article							REACTIVE CASE DETECTION; SYMPTOMATIC MALARIA; AMPLIFICATION KIT; PLASMODIUM-VIVAX; INFECTIONS; PREVALENCE; PARASITE; ISLANDS; ZAMBIA; AREAS	Background As part of efforts to eliminate malaria, Vanuatu has piloted the implementation of enhanced malaria surveillance and response strategies since 2011. This involves passive case detection (PCD) in health facilities, proactive case detection (Pro-ACD) and reactive case detection (Re-ACD) in communities using malaria rapid diagnostic tests (RDTs). While RDTs improve case management, their utility for detection of malaria infections in ACDs in this setting is unclear. Methods The utility of malaria RDTs as diagnostic tools was evaluated in PCD, in five rounds of Pro-ACDs and five rounds of Re-ACDs conducted in Tafea and Torba Provinces between 2011 and 2014. The number of malaria infections detected by RDTs was compared to that detected by PCR from collected used-RDTs. Results PCD in Tafea Province (2013) showed a RDT-positive rate of 0.21% (2/939) and a PCR-positive rate of 0.44% (2/453), indicating less than 1% of suspected malaria cases in Tafea Province were due to malaria. In Pro-ACDs conducted in Tafea and Torba Provinces, RDT-positive rates in 2013 and 2014 were 0.14% (3/2145) and 0% (0/2823), respectively, while the corresponding PCR-positive rates were 0.72% (9/1242) and 0.79% (9/1141). PCR identified villages in both provinces appearing to be transmission foci with a small number of low-density infections, mainly P. falciparum infections. In five rounds of Re-ACD, RDTs did not identify any additional infections while PCR detected only one among 173 subjects screened. Conclusions PCD and Pro-ACDs demonstrate that both Tafea and Torba Provinces in Vanuatu has achieved very low malaria prevalence. In these low-transmission areas, conducting Pro-ACD and Re-ACDs using RDTs appears not cost-effective and may have limited impact on interrupting malaria transmission due to the small number of infections identified by RDTs and considerable operational resources invested. More sensitive, field deployable and affordable diagnostic tools will improve malaria surveillance in malaria elimination settings.	[Donald, Wesley; Iata, Harry; Nausien, Johnny; Taleo, George] Minist Hlth, Malaria & Vector Borne Dis Control, Port Vila, Vanuatu; [Pasay, Cielo; Anderson, Karen; Gresty, Karryn J.; Cheng, Qin] Australian Army Malaria Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia; [Pasay, Cielo; Anderson, Karen; Gresty, Karryn J.; Cheng, Qin] QIMR Berghofer Med Res Inst, Clin Trop Med, Brisbane, Qld, Australia; [Guintran, Jean-Olivier] WHO, Vanuatu Country Off, Port Vila, Vanuatu; [Waters, Norman C.] Walter Reed Army Inst Res, Malaria Vaccine Branch, Mil Malaria Res Program, Silver Spring, MD USA; [Vestergaard, Lasse S.] WHO, Western Pacific Reginal Off, Manila, Philippines	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; World Health Organization; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); WHO Western Pacific Regional Office; World Health Organization	Taleo, G (corresponding author), Minist Hlth, Malaria & Vector Borne Dis Control, Port Vila, Vanuatu.; Cheng, Q (corresponding author), Australian Army Malaria Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia.; Cheng, Q (corresponding author), QIMR Berghofer Med Res Inst, Clin Trop Med, Brisbane, Qld, Australia.	gtaleo@vanuatu.gov.au; qin.cheng@defence.gov.au	Cheng, Qin/AAO-2198-2020	Cheng, Qin/0000-0001-7776-4437	AusAID through the Pacific Malaria Initiative Supporting Centre, University of Queensland; Department of Defense, Global Emerging Infections Surveillance Program (DoD-GETS), United States	AusAID through the Pacific Malaria Initiative Supporting Centre, University of Queensland; Department of Defense, Global Emerging Infections Surveillance Program (DoD-GETS), United States	The work was partially funded by: AusAID through the Pacific Malaria Initiative Supporting Centre, University of Queensland and the Department of Defense, Global Emerging Infections Surveillance Program (DoD-GETS), United States.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; [Anonymous], 2012, MAL RAP DIAGN TEST P; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; Gueye CS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-358; Hamainza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-128; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Imwong M, 2015, J INFECT DIS; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-6; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Larsen DA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0895-9; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Morris U, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-106; National Malaria and Vector Borne Diseases Control Programme, 2010, MAL EL GUID; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P599, DOI 10.1046/j.1365-3156.2002.00902.x; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Program WGM, 2015, ROL MASS DRUG ADM MA; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; The Global Health Group and the Malaria Atlas Project, 2011, ATL MAL EL COUNTR 20; The Pacific Malaria Initiative Survey Group, 2010, MALARIA J, V9, P218, DOI 10.1186/1475-2875-9-218; Vallejo AF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1104-1; van Eijk AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1120-1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, DIS SURV MAL EL OP M; WHO-WPRO, 2012, PROGR MAL CONTR MOV; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; World Health Organization, 2015, WORLD MAL REP 2015 W	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167136	10.1371/journal.pone.0167136	http://dx.doi.org/10.1371/journal.pone.0167136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902755	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100055
J	Li, H; Li, L; Gu, J; Li, Y; Chen, XL; Yang, DZ				Li, Hui; Li, Lin; Gu, Jian; Li, Yu; Chen, Xiaoli; Yang, Dongzi			Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study	PLOS ONE			English	Article							LC-MS/MS; PHENOTYPE; ANDROSTENEDIONE; PCOS; TESTOSTERONE; PREVALENCE; PROFILES; CHINESE; SERUM; MEN	This hospital-based observational study aims to estimate differences in metabolic abnormalities between different polycystic ovary syndrome (PCOS) phenotypes and their distribution characteristics. The prevalence of metabolic abnormalities among different PCOS phenotypes, including diabetes mellitus (DM), metabolic syndrome (MS), pre-diabetes mellitus (pre-DM), insulin resistance (IR) and dyslipidemia were compared. A total of 2436 women who were >= 18 years old and who were hospitalized in Sun Yat-Sen University affiliated hospital from 1998 to 2015 in GuangZhou, China, were included in this study. PCOS phenotypes were recorded according to the 2003 Rotterdam criteria, including the polycystic ovary morphology (PCO), hyperandrogenism (HA) and ovulation dysfunction (OD) phenotype (PCO+HA+OD); the ovulation phenotype (PCO+HA); the non-PCO phenotype (HA+OD); and the non-HA phenotype (PCO+OD). Notably, 56% of the patients had the classic phenotype (PCO+HA+OD). Importantly, there was no significant difference in the prevalence of metabolic abnormalities or the distribution characteristics of the metabolic abnormalities among these four PCOS phenotypes. Our study supports the notion that metabolic abnormalities and the distribution characteristics of metabolic abnormalities should not be used to distinguish among the various clinical PCOS phenotypes.	[Li, Hui; Li, Lin; Li, Yu; Chen, Xiaoli; Yang, Dongzi] Sun Yat Sen Mem Hosp, Dept Reprod, Med Ctr, Guangzhou, Guangdong, Peoples R China; [Gu, Jian] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gynecol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, XL; Yang, DZ (corresponding author), Sun Yat Sen Mem Hosp, Dept Reprod, Med Ctr, Guangzhou, Guangdong, Peoples R China.	gzxiaolichen@163.com; yangdz@mail.sysu.edu.cn	LI, Cheer/AAW-2626-2020					Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Buttler RM, 2016, CLIN CHIM ACTA, V454, P112, DOI 10.1016/j.cca.2016.01.002; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Damgaard-Olesen A, 2016, CLIN CHIM ACTA, V454, P82, DOI 10.1016/j.cca.2015.12.042; de Paula Martins W, 2007, EUR J OBSTET GYN R B, V133, P203, DOI 10.1016/j.ejogrb.2006.10.038; Georgopoulos NA, 2014, HORM-INT J ENDOCRINO, V13, P213, DOI 10.1007/BF03401335; Guo M, 2012, HUM REPROD, V27, P1481, DOI 10.1093/humrep/des018; Ho HVT, 2016, EUR J CLIN NUTR, V70, P1239, DOI 10.1038/ejcn.2016.89; Huang R, 2015, ACTA OBSTET GYN SCAN, V94, P494, DOI 10.1111/aogs.12612; Huddleston HG, 2010, AM J OBSTET GYNECOL, V202, P413, DOI 10.1016/j.ajog.2009.12.020; Kim JJ, 2014, FERTIL STERIL, V101, P1424, DOI 10.1016/j.fertnstert.2014.01.049; de Guevara AL, 2014, FERTIL STERIL, V101, P1732, DOI 10.1016/j.fertnstert.2014.02.020; Ladson G, 2011, FERTIL STERIL, V96, P224, DOI 10.1016/j.fertnstert.2011.05.002; Lerchbaum E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108263; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Moran LJ, 2015, TRENDS ENDOCRIN MET, V26, P136, DOI 10.1016/j.tem.2014.12.003; National Institutes of Health, 2012, EV BAS METH WORKSH P; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Strauss Jrome III F., 2009, YAN JAFFES REPROD EN; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yin QQ, 2013, J OBSTET GYNAECOL RE, V39, P203, DOI 10.1111/j.1447-0756.2012.01907.x; Zhang S-D, 2014, J REPROD MED, V23, P100; Zhao Y, 2015, J CAPITAL MED U, V4; Zhao Y, 2013, STEROIDS, V78, P755, DOI 10.1016/j.steroids.2013.04.006	25	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167036	10.1371/journal.pone.0167036	http://dx.doi.org/10.1371/journal.pone.0167036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902723	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100045
J	Matsumoto, Y; Hannigan, B; Crews, D				Matsumoto, Yuiko; Hannigan, Brette; Crews, David			Temperature Shift Alters DNA Methylation and Histone Modification Patterns in Gonadal Aromatase (cyp19a1) Gene in Species with Temperature-Dependent Sex Determination	PLOS ONE			English	Article							EARED SLIDER TURTLE; RNA-POLYMERASE-II; TRACHEMYS-SCRIPTA; INCUBATION-TEMPERATURE; HUMAN GENOME; EXPRESSION; EMBRYOS; MARKS; DIFFERENTIATION; PROFILES	The environment surrounding the embryos has a profound impact on the developmental process and phenotypic outcomes of the organism. In species with temperature-dependent sex determination, gonadal sex is determined by the incubation temperature of the eggs. A mechanistic link between temperature and transcriptional regulation of developmental genes, however, remains elusive. In this study, we examine the changes in DNA methylation and histone modification patterns of the aromatase (cyp19a1) gene in embryonic gonads of red-eared slider turtles (Trachemys scripta) subjected to a temperature shift during development. Shifting embryos from a male-producing temperature (MPT) to a female-producing temperature (FPT) at the beginning of the temperature-sensitive period (TSP) resulted in an increase in aromatase mRNA expression while a shift from FPT to MPT resulted in decreased expression. DNA methylation levels at CpG sites in the promoter of the aromatase gene were high (70-90%) at the beginning of TSP, but decreased in embryos that were incubated at constant FPT and those shifted from MPT to the FPT. This decrease in methylation in the promoter inversely correlated with the expected increase in aromatase expression at the FPT. The active demethylation under the FPT was especially prominent at the CpG site upstream of the gonad-specific TATA box at the beginning of TSP and spread downstream of the gene including exon1 as the gonad development progressed. In embryos incubated at FPT, the promoter region was also labeled by canonical transcriptional activation markers, H3K4me3 and RNA polymerase II. A transcriptional repression marker, H3K27me3, was observed in temperature-shifted gonads of both temperature groups, but was not maintained throughout the development in either group. Our findings suggest that DNA hypomethylation and H3K4me3 modification at the aromatase promoter may be a primary mechanism that releases a transcriptional block of aromatase to initiate a cascade of ovarian differentiation.	[Matsumoto, Yuiko; Crews, David] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Hannigan, Brette] Univ Texas Austin, Dept Pharm, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Matsumoto, Y (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	y_matsumoto@utexas.edu			National Science Foundation [201002064-005]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (grant 201002064-005) to D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; BULL JJ, 1981, J EXP ZOOL, V218, P435, DOI 10.1002/jez.1402180315; BULL JJ, 1981, HEREDITY, V47, P173, DOI 10.1038/hdy.1981.74; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; DESVAGES G, 1992, J STEROID BIOCHEM, V41, P851, DOI 10.1016/0960-0760(92)90437-N; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Ellis HL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099747; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gabriel WN, 2001, J EXP ZOOL, V290, P439, DOI 10.1002/jez.1087; Gilbert SF, 2001, DEV BIOL, V233, P1, DOI 10.1006/dbio.2001.0210; GRECO TL, 1994, ENDOCRINOLOGY, V135, P262, DOI 10.1210/en.135.1.262; Greenbaum E, 2011, STANDARDIZED SERIES, V80, P1350; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Matsumoto Y, 2014, ENDOCRINOLOGY, V155, P4168, DOI 10.1210/en.2014-1404; Matsumoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063599; Matsumoto Y, 2013, J MOL ENDOCRINOL, V50, P389, DOI 10.1530/JME-12-0260; Milnes MR, 2002, ENVIRON HEALTH PERSP, V110, P393, DOI 10.1289/ehp.02110s3393; Moczek AP, 2015, FRONT ECOL EVOL, V3, P553; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Mukaka MM, 2012, MALAWI MED J, V24, P69; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Parrott BB, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.111468; Piferrer F, 2005, FISH PHYSIOL BIOCHEM, V31, P215, DOI 10.1007/s10695-006-0027-0; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; Rhen T, 2007, SEX DEV, V1, P255, DOI 10.1159/000104775; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; Teves SS, 2011, GENE DEV, V25, P2387, DOI [10.1101/gad.177675.111, 10.1101/gad.178079.111]; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Warner DA, 2013, SCI REPORTS, V3; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WIBBELS T, 1991, J EXP ZOOL, V260, P371, DOI 10.1002/jez.1402600311; Yao HHC, 2004, MECH DEVELOP, V121, P1393, DOI 10.1016/j.mod.2004.06.001; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	47	28	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167362	10.1371/journal.pone.0167362	http://dx.doi.org/10.1371/journal.pone.0167362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902763	Green Published, gold			2022-12-27	WOS:000389474100078
J	MC Langemeijer, S; Mariani, N; Knops, R; Gilissen, C; Woestenenk, R; de Witte, T; Huls, G; van der Reijden, BA; Jansen, JH				MC Langemeijer, Saskia; Mariani, Niccolo; Knops, Ruth; Gilissen, Christian; Woestenenk, Rob; de Witte, Theo; Huls, Gerwin; van der Reijden, Bert A.; Jansen, Joop H.			Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROMES; BCL-2 FAMILY PROTEINS; BONE-MARROW BIOPSIES; BREAST-CANCER CELLS; EXCESSIVE APOPTOSIS; BIK GENE; BCL-2-RELATED PROTEINS; SURVIVIN EXPRESSION; PROGENITOR CELLS	Although the vast majority of patients with a myelodysplastic syndrome (MDS) suffer from cytopenias, the bone marrow is usually normocellular or hypercellular. Apoptosis of hematopoietic cells in the bone marrow has been implicated in this phenomenon. However, in MDS it remains only partially elucidated which genes are involved in this process and which hematopoietic cells are mainly affected. We employed sensitive real-time PCR technology to study 93 apoptosis-related genes and gene families in sorted immature CD34+ and the differentiating erythroid (CD71+) and monomyeloid (CD13/33+) bone marrow cells. Unsupervised cluster analysis of the expression signature readily distinguished the different cellular bone marrow fractions (CD34+, CD71+ and CD13/33+) from each other, but did not discriminate patients from healthy controls. When individual genes were regarded, several were found to be differentially expressed between patients and controls. Particularly, strong over-expression of BIK (BCL2-interacting killer) was observed in erythroid progenitor cells of low- and high-risk MDS patients (both p = 0.001) and TNFRSF4 (tumor necrosis factor receptor superfamily 4) was down-regulated in immature hematopoietic cells (p = 0.0023) of low- risk MDS patients compared to healthy bone marrow.	[MC Langemeijer, Saskia; Mariani, Niccolo; Knops, Ruth; Woestenenk, Rob; van der Reijden, Bert A.; Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr Radboudumc, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands; [MC Langemeijer, Saskia; Huls, Gerwin] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands; [Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [de Witte, Theo] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Nijmegen, Netherlands; [Huls, Gerwin] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen	Jansen, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr Radboudumc, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands.	joop.jansen@radboudumc.nl	Jansen, J.H./H-8054-2014; Woestenenk, Rob/C-6119-2016; de Witte, T.J.M./L-4762-2015; Knops, Ruth G.H.J.N./F-5280-2016; van der Reijden, Bert A/A-3543-2014; Gilissen, Christian/E-5246-2012	Jansen, J.H./0000-0001-9459-568X; Gilissen, Christian/0000-0003-1693-9699	"Dutch Organization for Scientific Research" (NWO) [92003420]; Dutch Cancer Society	"Dutch Organization for Scientific Research" (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by grants from the "Dutch Organization for Scientific Research" (NWO, 92003420) to SMCL and the "Dutch Cancer Society" (KWF) to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena V, 2003, GENE CHROMOSOME CANC, V38, P91, DOI 10.1002/gcc.10245; Bogdanovic AD, 1997, LEUKEMIA, V11, P656, DOI 10.1038/sj.leu.2400640; Bogenberger JM, 2014, LEUKEMIA, V28, P1657, DOI 10.1038/leu.2014.44; Boudard D, 2000, LEUKEMIA, V14, P2045, DOI 10.1038/sj.leu.2401959; Bouscary D, 1997, LEUKEMIA, V11, P839, DOI 10.1038/sj.leu.2400654; Bouscary D, 2000, EXP HEMATOL, V28, P784, DOI 10.1016/S0301-472X(00)00179-X; BOYD JM, 1995, ONCOGENE, V11, P1921; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Choi YC, 2015, EXP CELL RES, V339, P320, DOI 10.1016/j.yexcr.2015.10.012; Claessens YE, 2005, BLOOD, V105, P4035, DOI 10.1182/blood-2004-08-3166; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Economopoulou C, 2008, LEUKEMIA RES, V32, P61, DOI 10.1016/j.leukres.2007.04.012; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; Evangelisti C, 2015, BBA-MOL CELL RES, V1853, P14, DOI 10.1016/j.bbamcr.2014.09.023; Ferreira AF, 2015, ACTA HAEMATOL-BASEL, V133, P354, DOI 10.1159/000369446; Garcia N, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-93; Germing U, 2013, DTSCH ARZTEBL INT, V110, P783, DOI 10.3238/arztebl.2013.0783; Gianelli U, 2007, ANN HEMATOL, V86, P185, DOI 10.1007/s00277-006-0215-0; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Guerenne L, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0235-8; Huh YO, 2002, LEUKEMIA, V16, P2249, DOI 10.1038/sj.leu.2402704; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Invernizzi R, 2004, LEUKEMIA LYMPHOMA, V45, P2229, DOI 10.1080/10428190412331283251; Jensen SM, 2010, SEMIN ONCOL, V37, P524, DOI 10.1053/j.seminoncol.2010.09.013; Jilg S, 2016, LEUKEMIA, V30, P112, DOI 10.1038/leu.2015.179; Kitagawa M, 1997, LEUKEMIA, V11, P2049, DOI 10.1038/sj.leu.2400844; Kohlmann A, 2010, LEUKEMIA, V24, P1216, DOI 10.1038/leu.2010.73; Lan KL, 2007, CLIN EXP METASTAS, V24, P461, DOI 10.1007/s10585-007-9083-9; Lane PJL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00154; Lin CW, 2002, LEUKEMIA RES, V26, P551, DOI 10.1016/S0145-2126(01)00170-9; Lindberg EH, 2001, BRIT J HAEMATOL, V112, P714, DOI 10.1046/j.1365-2141.2001.02581.x; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Moran AE, 2013, CURR OPIN IMMUNOL, V25, P230, DOI 10.1016/j.coi.2013.01.004; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Parker JE, 1998, BRIT J HAEMATOL, V103, P1075; Pecci A, 2003, ACTA HAEMATOL-BASEL, V109, P29, DOI 10.1159/000067275; Poklepovic A, 2014, AUTOPHAGY, V10, P1478, DOI 10.4161/auto.29428; Rajapaksa R, 1996, BLOOD, V88, P4275; Raponi M, 2008, BLOOD, V111, P2589, DOI 10.1182/blood-2007-09-112730; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; RAZA A, 1995, AM J HEMATOL, V48, P143, DOI 10.1002/ajh.2830480302; Real PJ, 2006, FEBS LETT, V580, P5905, DOI 10.1016/j.febslet.2006.08.088; Esparza-Garrido RR, 2016, TUMOR BIOL, V37, P6749, DOI 10.1007/s13277-015-4494-8; Sawanobori M, 2003, LEUKEMIA RES, V27, P583, DOI 10.1016/S0145-2126(02)00095-4; Shetty V, 2002, BRIT J HAEMATOL, V116, P817, DOI 10.1046/j.0007-1048.2002.03366.x; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Suarez L, 2004, LEUKEMIA, V18, P1311, DOI 10.1038/sj.leu.2403386; Tefferi A, 2009, NAT REV CLIN ONCOL, V6, P627, DOI 10.1038/nrclinonc.2009.149; Theilgaard-Monch K, 2011, LEUKEMIA, V25, P909, DOI 10.1038/leu.2011.48; Tsimberidou AM, 2008, CANCER-AM CANCER SOC, V113, P1605, DOI 10.1002/cncr.23785; Tsoplou P, 1999, LEUKEMIA, V13, P1554, DOI 10.1038/sj.leu.2401538; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Viedma-Rodriguez R, 2015, TUMOR BIOL, V36, P6991, DOI 10.1007/s13277-015-3374-6; Viedma-Rodriguez R, 2013, INT J ONCOL, V43, P1777, DOI 10.3892/ijo.2013.2127; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; Webb GJ, 2016, CLIN REV ALLERG IMMU, V50, P312, DOI 10.1007/s12016-015-8498-3; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Xi Y, 2015, J CANCER, V6, P327, DOI 10.7150/jca.11185; Yamamoto K, 2004, LEUKEMIA RES, V28, P1203, DOI 10.1016/j.leukres.2004.03.020; Yoshida A, 2012, HAEMATOL-HEMATOL J, V97, P1372, DOI 10.3324/haematol.2011.055681; Zang DY, 2001, BLOOD, V98, P3058, DOI 10.1182/blood.V98.10.3058; Zou YY, 2002, CANCER RES, V62, P8	70	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165582	10.1371/journal.pone.0165582	http://dx.doi.org/10.1371/journal.pone.0165582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902785	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100005
J	Palmer, MV; Thacker, TC; Waters, WR				Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray			Differential Cytokine Gene Expression in Granulomas from Lungs and Lymph Nodes of Cattle Experimentally Infected with Aerosolized Mycobacterium bovis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; NECROSIS-FACTOR-ALPHA; CALMETTE-GUERIN; MESSENGER-RNA; TUBERCULOSIS; MICE; PROGRESSION; DELTA-RD1; RELEVANCE; PATHOLOGY	The hallmark lesion of tuberculosis in humans and animals is the granuloma. The granuloma represents a distinct host cellular immune response composed of epithelioid macrophages, lymphocytes, and multinucleated giant cells, often surrounding a caseous necrotic core. Within the granuloma, host-pathogen interactions determine disease outcome. Factors within the granulomas such as cytokines and chemokines drive cell recruitment, activity, function and ultimately the success or failure of the host's ability to control infection. Hence, an understanding of the granuloma-level cytokine response is necessary to understand tuberculosis pathogenesis. In-situ cytokine expression patterns were measured using a novel in situ hybridization assay, known as RNAScope (R) in granulomas of the lungs, tracheobronchial lymph nodes and caudal mediastinal lymph nodes of cattle experimentally infected with Mycobacterium bovis via aerosol exposure. In spite of microscopic morphological similarities, significant differences were seen between late stage granulomas of the lung compared to those of the tracheobronchial lymph nodes for IL-17A, IFN-gamma, TGF-beta, IL10 and IL22 but not for TNF-alpha. Additionally, significant differences were noted between granulomas from two different thoracic lymph nodes that both receive afferent lymphatics from the lungs (i.e., tracheobronchial and caudal mediastinal lymph nodes) for TNF-alpha, IL-17A, IFN-gamma, TGF-beta and IL-10 but not for IL-22. These findings show that granuloma morphology alone is not a reliable indicator of granuloma function as granulomas of similar morphologies can have disparate cytokine expression patterns. Moreover, anatomically distinct lymph nodes (tracheobronchial vs caudal mediastinal) differ in cytokine expression patterns even when both receive afferent lymphatics from a lung containing tuberculoid granulomas. These findings show that selection of tissue and anatomic location are critical factors in assessing host immune response to M. bovis and should be considered carefully.	[Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray] ARS, Infect Bacterial Dis Livestock Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Palmer, MV (corresponding author), ARS, Infect Bacterial Dis Livestock Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	mitchell.palmer@ars.usda.gov	Palmer, Mitchell/R-7091-2018	Palmer, Mitchell/0000-0002-5902-3333	US Department of Agriculture, Agricultural Research Service Project (CRIS) [3625-32000-104]	US Department of Agriculture, Agricultural Research Service Project (CRIS)	Research funds were provided by the US Department of Agriculture, Agricultural Research Service Project (CRIS# 3625-32000-104).	Aranday-Cortes E, 2013, TRANSBOUND EMERG DIS, V60, P525, DOI 10.1111/j.1865-1682.2012.01370.x; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Boddu-Jasmine HC, 2008, TUBERCULOSIS, V88, P610, DOI 10.1016/j.tube.2008.06.003; Cotran R.S., 1994, ROBBINS PATHOLOGIC B, V5th ed., P700; Cotran RS, 1994, ROBBINS PATHOLOGIC B, P51; DiFazio RM, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0043-3; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Johnson L, 2007, TUBERCULOSIS, V87, P71, DOI 10.1016/j.tube.2006.04.002; Johnson L, 2006, VET IMMUNOL IMMUNOP, V111, P219, DOI 10.1016/j.vetimm.2006.01.016; Langer AJ, 2014, ZOONOTIC TUBERCULOSIS: MYCOBACTERIUM BOVIS AND OTHER PATHOGENIC MYCOBACTERIA, 3RD EDITION, P21; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Mustafa T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-535; Myers R.K., 2012, PATHOLOGIC BASIS VET, V5th ed., P122; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Palmer MV, 2015, J COMP PATHOL, V153, P150, DOI 10.1016/j.jcpa.2015.06.004; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Palmer MV, 1999, AM J VET RES, V60, P310; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Saar LI, 1975, ANATOMY DOMESTIC ANI, P1024; Salguero FJ, 2016, TRANSBOUND EMERG DIS; Shu D, 2014, VET IMMUNOL IMMUNOP, V160, P81, DOI 10.1016/j.vetimm.2014.03.017; Sizemore C, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, pXV; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; Tubbs RR, 2013, AM J CLIN PATHOL, V140, P736, DOI 10.1309/AJCPJTWK07FSABRJ; USDA APHIS, 2007, BOV TUB ER UN METH R, P1; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Waters WR, 2014, J COMP PATHOL, V151, P410, DOI 10.1016/j.jcpa.2014.08.007; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; Waters WR, 2015, ILAR J, V56, P26, DOI 10.1093/ilar/ilv001; Waters WR, 2014, VET IMMUNOL IMMUNOP, V159, P113, DOI 10.1016/j.vetimm.2014.02.009; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Witchell J, 2010, VET IMMUNOL IMMUNOP, V138, P79, DOI 10.1016/j.vetimm.2010.07.004	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167471	10.1371/journal.pone.0167471	http://dx.doi.org/10.1371/journal.pone.0167471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902779	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474100085
J	Scott, CM; Joo, JE; O'Callaghan, N; Buchanan, DD; Clendenning, M; Giles, GG; Hopper, JL; Wong, EM; Southey, MC				Scott, Cameron M.; Joo, JiHoon Eric; O'Callaghan, Neil; Buchanan, Daniel D.; Clendenning, Mark; Giles, Graham G.; Hopper, John L.; Wong, Ee Ming; Southey, Melissa C.			Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry	PLOS ONE			English	Article							POPULATION-BASED ESTIMATE; PERIPHERAL-BLOOD DNA; SPORADIC BREAST; PROMOTER HYPERMETHYLATION; BRCA1 PROMOTER; REPAIR GENES; P53 GENES; MUTATIONS; ATM; VARIANTS	DNA methylation can mimic the effects of both germline and somatic mutations for cancer predisposition genes such as BRCA1 and p16(INK4a). Constitutional DNA methylation of the BRCA1 promoter has been well described and is associated with an increased risk of early-onset breast cancers that have BRCA1-mutation associated histological features. The role of methylation in the context of other breast cancer predisposition genes has been less well studied and often with conflicting or ambiguous outcomes. We examined the role of methylation in known breast cancer susceptibility genes in breast cancer predisposition and tumor development. We applied the Infinium HumanMethylation450 Beadchip (HM450K) array to blood and tumor-derived DNA from 43 women diagnosed with breast cancer before the age of 40 years and measured the methylation profiles across promoter regions of BRCA1, BRCA2, ATM, PALB2, CDH1, TP53, FANCM, CHEK2, MLH1, MSH2, MSH6 and PMS2. Prior genetic testing had demonstrated that these women did not carry a germline mutation in BRCA1, ATM, CHEK2, PALB2, TP53, BRCA2, CDH1 or FANCM. In addition to the BRCA1 promoter region, this work identified regions with variable methylation at multiple breast cancer susceptibility genes including PALB2 and MLH1. Methylation at the region of MLH1 in these breast cancers was not associated with microsatellite instability. This work informs future studies of the role of methylation in breast cancer susceptibility gene silencing.	[Scott, Cameron M.; Joo, JiHoon Eric; O'Callaghan, Neil; Wong, Ee Ming; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3010, Australia; [Buchanan, Daniel D.; Clendenning, Mark] Univ Melbourne, Dept Pathol, Colorectal Oncogen Grp, Genet Epidemiol Lab, Parkville, Vic, Australia; [Buchanan, Daniel D.; Giles, Graham G.; Hopper, John L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Cancer Council Victoria	Southey, MC (corresponding author), Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3010, Australia.	msouthey@unimelb.edu.au		Southey, Melissa/0000-0002-6313-9005; Buchanan, Daniel/0000-0003-2225-6675; Wong, Ee Ming/0000-0002-7288-7865	National Health and Medical Research Council of Australia; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); USA National Cancer Institute [UM1 CA164920]; Genetic Epidemiology Laboratory Honors Scholarship, Department of Pathology, The University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); USA National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genetic Epidemiology Laboratory Honors Scholarship, Department of Pathology, The University of Melbourne	The Australia site of Breast Cancer Family Registry was supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and grant UM1 CA164920 from the USA National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. JLH is a Senior Principle Research Fellow and MCS is a Senior Research Fellow of the NHMRC. CMS is a recipient of a Genetic Epidemiology Laboratory Honors Scholarship, Department of Pathology, The University of Melbourne.	Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Apicella C, 2007, CLIN GENET, V72, P87, DOI 10.1111/j.1399-0004.2007.00841.x; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Chmelarova M, 2013, CLIN TRANSL ONCOL, V15, P160, DOI 10.1007/s12094-012-0894-z; Deng GR, 1999, CANCER RES, V59, P2029; Dite GS, 2003, J NATL CANCER I, V95, P448, DOI 10.1093/jnci/95.6.448; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Jha AK, 2012, MOL BIOL REP, V39, P9145, DOI 10.1007/s11033-012-1787-5; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Joo JE, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-23; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Maksimovic J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv526; Mikeska T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-26; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Murata H, 2002, ONCOGENE, V21, P5696, DOI 10.1038/sj.onc.1205683; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neuhausen SL, 2009, BREAST CANCER RES TR, V116, P379, DOI 10.1007/s10549-008-0153-8; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Potapova A, 2008, CANCER RES, V68, P998, DOI 10.1158/0008-5472.CAN-07-2418; Poumpouridou N, 2016, CLIN BIOCHEM, V49, P253, DOI 10.1016/j.clinbiochem.2015.10.009; Ramalho EAVF, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-3; Smith LD, 2007, EUR J CANCER, V43, P823, DOI 10.1016/j.ejca.2007.01.011; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796; ten Broeke SW, 2015, J CLIN ONCOL, V33, P319, DOI 10.1200/JCO.2014.57.8088; Watanabe Y, 2013, GENES CELLS, V18, P1120, DOI 10.1111/gtc.12100; Williams LH, 2006, CLIN CANCER RES, V12, P6967, DOI 10.1158/1078-0432.CCR-06-1770; Wong Ee Ming, 2015, BMC Res Notes, V8, P543, DOI 10.1186/s13104-015-1487-z; Wong EM, 2011, CANCER PREV RES, V4, P23, DOI 10.1158/1940-6207.CAPR-10-0212; Wong EM, 2016, BREAST CANC RES TREA	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165436	10.1371/journal.pone.0165436	http://dx.doi.org/10.1371/journal.pone.0165436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902704	Green Published, gold			2022-12-27	WOS:000389474100004
J	Gomez-Gutierrez, P; Campos, PM; Vega, M; Perez, JJ				Gomez-Gutierrez, Patricia; Campos, Pedro M.; Vega, Miguel; Perez, Juan J.			Identification of a Novel Inhibitory Allosteric Site in p38 alpha	PLoS One			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASES; COMPLEX; SELECTIVITY; SUBSTRATE; DISEASE	In the present study, we report the discovery of a novel allosteric inhibitory site for p38 alpha, a subclass of the mitogen-activated protein kinases (MAPK) family. The putative site was discovered after inspection of the crystallographic structure of the p38 alpha-MK2 complex. MK2 (MAPK-activated protein kinase 2) is an interesting protein playing a dual role as modulator and substrate of p38 alpha. This intriguing behavior is due to the ability of the two proteins to form distinctive heterodimers when p38 alpha is phosphorylated or not. We hypothesized that the regulatory action of MK2 is due to its capability to keep p38 alpha in an inactive conformation and consequently, we investigated the atomic structure of the p38 alpha-MK2 complex to understand such regulatory behavior at the molecular level. After inspection of the complex structure, two peptides designed from the MK2 regulatory loop in contact with p38a with sequences Tyr(1)-Sere(2)-Asn(3)-His(4)-Gly(5)-Leu(6) (peptide-1) and [Phe(0)]-peptide-1 (peptide-2) in their zwitterionic form were investigated for their phosphorylation inhibitory capability in vitro. Since both peptides exhibited inhibitory capability of the p38 alpha kinase mediated phosphorylation of MEF2A, in a subsequent step we pursued the discovery of small molecule peptidomimetics. For this purpose we characterized in detail the peptide-p38 alpha interaction using molecular dynamics simulations, leading to the definition of a pharmacophore for the peptide-protein interaction. This hypothesis was used as query for a in silico screening, leading to the discovery of a fused ring compound with micromolar inhibitory activity. Site-directed mutagenesis studies support that the compound binds to the putative novel allosteric site in p38 alpha.	[Gomez-Gutierrez, Patricia; Campos, Pedro M.; Vega, Miguel] Allinky Biopharma, Madrid Sci Pk,7 Campus Cantoblanco, Madrid, Spain; [Gomez-Gutierrez, Patricia; Perez, Juan J.] Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Av Diagonal, Barcelona, Spain	Universitat Politecnica de Catalunya	Perez, JJ (corresponding author), Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Av Diagonal, Barcelona, Spain.	juan.jesus.perez@upc.edu	Campos, Pedro Manuel/AAD-3433-2020; Perez, Juan J/E-3710-2010	Campos, Pedro Manuel/0000-0002-4756-4087; Perez, Juan J/0000-0002-0748-8147				[Anonymous], MOE MOL OP ENV VERS; Bender A, 2009, J CHEM INF MODEL, V49, P108, DOI 10.1021/ci800249s; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Case DA, 2012, AMBER 12; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Gaestel M, 2009, PEPTIDES SIGNALING I; HALL HK, 1957, J AM CHEM SOC, V79, P5441, DOI 10.1021/ja01577a030; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krishna S, 2014, J CHEM INF MODEL, V54, P781, DOI 10.1021/ci5000032; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lipkus AH, 1999, J MATH CHEM, V26, P263, DOI 10.1023/A:1019154432472; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Perez JJ, 2005, CHEM SOC REV, V34, P143, DOI 10.1039/b209064n; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Tokunaga Y, 2014, NAT STRUCT MOL BIOL, V21, P704, DOI 10.1038/nsmb.2861; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Yang Y, 2011, J CHEM INF MODEL, V51, P3235, DOI 10.1021/ci200159g	30	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167379	10.1371/journal.pone.0167379	http://dx.doi.org/10.1371/journal.pone.0167379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898710	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000059
J	Subramanian, H; Doring, F; Kollert, S; Rukoyatkina, N; Sturm, J; Gambaryan, S; Stellzig-Eisenhauer, A; Meyer-Marcotty, P; Eigenthaler, M; Wischmeyer, E				Subramanian, Hariharan; Doering, Frank; Kollert, Sina; Rukoyatkina, Natalia; Sturm, Julia; Gambaryan, Stepan; Stellzig-Eisenhauer, Angelika; Meyer-Marcotty, Philipp; Eigenthaler, Martin; Wischmeyer, Erhard			PTH1R Mutants Found in Patients with Primary Failure of Tooth Eruption Disrupt G-Protein Signaling	PLOS ONE			English	Article							HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; MUTATIONS; CHONDRODYSPLASIA; RECEPTORS; CELLS	Aim Primary failure of tooth eruption (PFE) is causally linked to heterozygous mutations of the parathyroid hormone receptor (PTH1R) gene. The mutants described so far lead to exchange of amino acids or truncation of the protein that may result in structural changes of the expressed PTH1R. However, functional effects of these mutations have not been investigated yet. Materials and Methods In HEK293 cells, PTH1R wild type was co-transfected with selected PTH1R mutants identified in patients with PFE. The effects on activation of PTH-regulated intracellular signaling pathways were analyzed by ELISA and Western immunoblotting. Differential effects of wild type and mutated PTH1R on TRESK ion channel regulation were analyzed by electrophysiological recordings in Xenopus laevis oocytes. Results In HEK293 cells, activation of PTH1R wild type increases cAMP and in response activates cAMP-stimulated protein kinase as detected by phosphorylation of the vasodilator stimulated phosphoprotein (VASP). In contrast, the PTH1R mutants are functionally inactive and mutant PTH1R/Gly452Glu has a dominant negative effect on the signaling of PTH1R wild type. Confocal imaging revealed that wild type PTH1R is expressed on the cell surface, whereas PTH1R/Gly452Glu mutant is mostly retained inside the cell. Furthermore, in contrast to wild type PTH1R which substantially augmented K+ currents of TRESK channels, coupling of mutated PTH1R to TRESK channels was completely abolished. Conclusions PTH1R mutations affect intracellular PTH-regulated signaling in vitro. In patients with primary failure of tooth eruption defective signaling of PTH1R mutations is suggested to occur in dento-alveolar cells and thus may lead to impaired tooth movement.	[Subramanian, Hariharan; Rukoyatkina, Natalia; Eigenthaler, Martin] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Subramanian, Hariharan] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Doering, Frank; Kollert, Sina; Sturm, Julia; Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, AG Mol Electrophysiol, Wurzburg, Germany; [Rukoyatkina, Natalia; Gambaryan, Stepan] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Gambaryan, Stepan] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg, Russia; [Stellzig-Eisenhauer, Angelika; Meyer-Marcotty, Philipp; Eigenthaler, Martin] Univ Clin Wuerzburg, Dept Orthodont, Wurzburg, Germany; [Meyer-Marcotty, Philipp] Univ Clin Goettingen, Dept Orthodont, Gottingen, Germany	University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Saint Petersburg State University; University of Wurzburg; University of Gottingen	Eigenthaler, M (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany.; Eigenthaler, M (corresponding author), Univ Clin Wuerzburg, Dept Orthodont, Wurzburg, Germany.	M.Eigenthaler@medizin.uni-wuerzburg.de	Kollert, Sina/Q-8737-2017; Gambaryan, Stepan/I-3940-2016; meyer-marcotty, philipp/AAY-7610-2020; Rukoyatkina, Natalia/AAN-2227-2020	Gambaryan, Stepan/0000-0002-1470-0791; Doring, Frank/0000-0003-1017-1498; Rukoyatkina, Natalia/0000-0002-3920-206X	Interdisziplinares Zentrum fur Klinische Forschung des Universitatsklinikum Wurzburg [Z-4/113]; Open Access Publication Fund of the University of Wuerzburg	Interdisziplinares Zentrum fur Klinische Forschung des Universitatsklinikum Wurzburg; Open Access Publication Fund of the University of Wuerzburg	This work was supported by the Interdisziplinares Zentrum fur Klinische Forschung des Universitatsklinikum Wurzburg, grant Z-4/113. Publication was supported by the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Decker E, 2008, AM J HUM GENET, V83, P781, DOI 10.1016/j.ajhg.2008.11.006; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Doppler H, 2013, CELL ADHES MIGR, V7, P482, DOI 10.4161/cam.27351; Duchatelet S, 2005, HUM MOL GENET, V14, P1, DOI 10.1093/hmg/ddi001; Eigenthaler M, 1999, Rev Physiol Biochem Pharmacol, V135, P173, DOI 10.1007/BFb0033673; Frazier-Bowers SA, 2014, J DENT RES, V93, P134, DOI 10.1177/0022034513513588; Frazier-Bowers SA, 2009, ORTHOD CRANIOFAC RES, V12, P74, DOI 10.1111/j.1601-6343.2009.01440.x; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Hoogendam J, 2007, J CLIN ENDOCR METAB, V92, P1088, DOI 10.1210/jc.2006-0300; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; Kollert S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12548; Patterson EK, 2010, BONE, V46, P1180, DOI 10.1016/j.bone.2009.12.005; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Pilz P, 2014, J OROFAC ORTHOP, V75, P226, DOI 10.1007/s00056-014-0215-y; Prideaux M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125731; Roth H, 2014, CLIN ORAL INVEST, V18, P377, DOI 10.1007/s00784-013-1014-3; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shimomura-Kuroki J, 2016, ODONTOLOGY; Stellzig-Eisenhauer Angelika, 2013, Orthod Fr, V84, P241, DOI 10.1051/orthodfr/2013055; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Taylor CW, 2012, BIOCHEM SOC T, V40, P147, DOI 10.1042/BST20110615; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Yamaguchi T, 2011, J BONE MINER RES, V26, P1655, DOI 10.1002/jbmr.385	30	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167033	10.1371/journal.pone.0167033	http://dx.doi.org/10.1371/journal.pone.0167033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898723	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000030
J	Boeri, L; Ventimiglia, E; Capogrosso, P; Ippolito, S; Pecoraro, A; Paciotti, M; Scano, R; Galdini, A; Valsecchi, L; Papaleo, E; Montorsi, F; Salonia, A				Boeri, Luca; Ventimiglia, Eugenio; Capogrosso, Paolo; Ippolito, Silvia; Pecoraro, Angela; Paciotti, Marco; Scano, Roberta; Galdini, Alessandro; Valsecchi, Luca; Papaleo, Enrico; Montorsi, Francesco; Salonia, Andrea			Low Birth Weight Is Associated with a Decreased Overall Adult Health Status and Reproductive Capability - Results of a Cross-Sectional Study in Primary Infertile Patients	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ISCHEMIC-HEART-DISEASE; GIRLS BORN; INCREASED RISK; RETROSPECTIVE COHORT; BODY-COMPOSITION; GONADAL-FUNCTION; MEN; CANCER; APPROPRIATE	Individuals born with low birth weight (LBW) risk cardiometabolic complications later in life. However the impact of LBW on general health status and male reproductive function has been scantly analysed. We investigated the clinical and seminal impact of different birth weights (BW) in white-European men presenting for primary couple's infertility. Demographic, clinical, and laboratory data from 827 primary infertile men were compared with those of 373 consecutive fertile men. Patients with BW <= 2500, 2500-4200, and >= 4200gr were classified as having LBW, normal (NBW), and high BW (HBW), respectively. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Testicular volume was assessed with a Prader orchidometer. Semen analysis values were assessed based on 2010 WHO reference criteria. Descriptive statistics and regression models tested associations between semen parameters, clinical characteristics and BW categories. LBW, NBW and HBW were found in 71 (8.6%), 651 (78.7%) and 105 (12.7%) infertile men, respectively. LBW was more frequent in infertile patients than fertile men (p = 0.002). Infertile patients with LBW had a higher rate of comorbidities (p = 0.003), lower mean testicular volume (p = 0.007), higher FSH (p = 0.02) and lower tT levels (p = 0.04) compared to other BW groups. Higher rates of asthenozoospermia (p = 0.02) and teratozoospermia (p = 0.03) were also found in LBW men. At logistic regression models, LBW was univariably associated with pathologic progressive motility (p <= 0.02) and pathologic sperm morphology (p < 0.005). At multivariable logistic regression analysis, LBW achieved independent predictor status for both lower sperm motility and pathologic sperm morphology (all p <= 0.04). Only LBW independently predicted higher CCI values (p < 0.001). In conclusion, we found that LBW was more frequent in infertile than in fertile men. Infertile individuals with LBW showed a higher rate of comorbidities and significantly worse clinical, endocrine and semen parameters compared to other BW groups.	[Boeri, Luca; Ventimiglia, Eugenio; Capogrosso, Paolo; Ippolito, Silvia; Pecoraro, Angela; Paciotti, Marco; Scano, Roberta; Montorsi, Francesco; Salonia, Andrea] IRCCS Osped San Raffaele, URI, Div Expt Oncol, Unit Urol, Milan, Italy; [Ventimiglia, Eugenio; Capogrosso, Paolo; Montorsi, Francesco; Salonia, Andrea] Univ Vita Salute San Raffaele, Milan, Italy; [Galdini, Alessandro; Valsecchi, Luca; Papaleo, Enrico] IRCCS Osped San Raffaele, Dept Obstet & Gynaecol, Milan, Italy; [Papaleo, Enrico] IRCCS Osped San Raffaele, Infertil Unit, Unit Obstet Gynecol, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Salonia, A (corresponding author), IRCCS Osped San Raffaele, URI, Div Expt Oncol, Unit Urol, Milan, Italy.; Salonia, A (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	salonia.andrea@hsr.it	Salonia, Andrea/H-1025-2016; Boeri, Luca/AAC-4848-2022; Paciotti, Marco/AAX-4209-2021; Ippolito, Silvia/AAI-1361-2021; Pecoraro, Angela/V-4669-2019; Montorsi, Francesco/AAN-2473-2020; Ventimiglia, Eugenio/ABI-2333-2020; Papaleo, Enrico/AAN-9591-2021	Salonia, Andrea/0000-0002-0595-7165; Pecoraro, Angela/0000-0002-5184-2799; Papaleo, Enrico/0000-0003-0281-9143; Capogrosso, Paolo/0000-0003-2347-9504; Ventimiglia, Eugenio/0000-0003-3654-1629				[Anonymous], 2015, 2013 ACC AHA GUIDELI; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Chan KA, 2015, J ENDOCRINOL, V224, pR45, DOI 10.1530/JOE-14-0469; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cicognani A, 2002, J PEDIATR-US, V141, P376, DOI 10.1067/mpd.2002.126300; Eisenberg ML, 2015, FERTIL STERIL, V103, P66, DOI 10.1016/j.fertnstert.2014.10.017; Eisenberg ML, 2013, FERTIL STERIL, V100, P681, DOI 10.1016/j.fertnstert.2013.05.022; Faure C, 2015, FERTIL STERIL, V103, P6, DOI 10.1016/j.fertnstert.2014.11.027; Fisher JS, 1999, ENVIRON HEALTH PERSP, V107, P397, DOI 10.1289/ehp.99107397; Francois I, 1997, PEDIATR RES, V42, P899, DOI 10.1203/00006450-199712000-00029; Hernandez MI, 2006, J CLIN ENDOCR METAB, V91, P3377, DOI 10.1210/jc.2005-2368; Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P3391, DOI 10.1210/jc.87.7.3391; Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P1986, DOI 10.1210/jc.87.5.1986; Ibanez L, 2000, J CLIN ENDOCR METAB, V85, P2624, DOI 10.1210/jc.85.7.2624; Jensen RB, 2007, J CLIN ENDOCR METAB, V92, P1353, DOI 10.1210/jc.2006-2348; Kerkhof GF, 2009, J CLIN ENDOCR METAB, V94, P4243, DOI 10.1210/jc.2009-1036; Labayen I, 2008, OBESITY, V16, P1680, DOI 10.1038/oby.2008.258; Meas T, 2010, HUM REPROD, V25, P2354, DOI 10.1093/humrep/deq184; National Institute on Alcohol Abuse and Alcoholism, 1995, PHYS GUID HELP PAT A; Olsen J, 2000, INT J ANDROL, V23, P230, DOI 10.1046/j.1365-2605.2000.00239.x; Ozturk O, 2001, HUM REPROD, V16, P2238, DOI 10.1093/humrep/16.10.2238; Palatianou ME, 2014, HORM METAB RES, V46, P911, DOI 10.1055/s-0034-1395561; Ramlau-Hansen CH, 2010, FERTIL STERIL, V94, P610, DOI 10.1016/j.fertnstert.2009.01.142; Sadrzadeh S, 2003, HUM REPROD, V18, P2225, DOI 10.1093/humrep/deg409; Salonia A, 2009, EUR UROL, V56, P1025, DOI 10.1016/j.eururo.2009.03.001; Sharpe RM, 1998, BIOL REPROD, V59, P1084, DOI 10.1095/biolreprod59.5.1084; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; UNICEF, LOW BIRTH WEIGHT COU; Vanbillemont G, 2010, J CLIN ENDOCR METAB, V95, P1587, DOI 10.1210/jc.2009-2149; Ventimiglia E, 2015, FERTIL STERIL, V104, P48, DOI 10.1016/j.fertnstert.2015.04.020; Visentin S, 2014, ATHEROSCLEROSIS, V237, P391, DOI 10.1016/j.atherosclerosis.2014.09.027; Walsh TJ, 2010, CANCER-AM CANCER SOC, V116, P2140, DOI 10.1002/cncr.25075; Walsh TJ, 2009, ARCH INTERN MED, V169, P351, DOI 10.1001/archinternmed.2008.562; World Health Organization, 2010, LAB MAN EX PROC HUM; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166728	10.1371/journal.pone.0166728	http://dx.doi.org/10.1371/journal.pone.0166728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893825	Green Published, gold			2022-12-27	WOS:000389472400040
J	Liu, N; Wang, Z; Gan, WD; Xiong, L; Miao, BL; Chen, XC; Guo, HQ; Li, DM				Liu, Ning; Wang, Zhen; Gan, Weidong; Xiong, Lei; Miao, Baolei; Chen, Xiancheng; Guo, Hongqian; Li, Dongmei			Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E3; SOFT PART SARCOMA; BREAK-APART FISH; CLINICOPATHOLOGICAL FEATURES; TFE3; IMMUNOHISTOCHEMISTRY; EXPERIENCE; DIAGNOSIS; IMPACT; ADULTS	To investigate the clinical characteristics, treatments and prognosis of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions (Xp11.2 tRCC), the epidemiological features and treatment results of 34 cases of Xp11.2 tRCC, which were diagnosed by immunohistochemistry staining of TFE3 and fluorescence in situ hybridization at our center, were retrospectively reviewed. The 34 patients included 21 females and 13 males aged 3 to 64 years (median age: 27 years). Four patients were children or adolescents (<18 years of age), and 26 patients were young or middle-aged adults (18-45 years). Radical nephrectomy was performed on 25 patients. Laparoscopic nephron-sparing surgery was performed on 9 patients who presented with an isolated mass with a small diameter (<7 cm) and well-defined boundary on computed tomography imaging. Postoperative staging showed that 25 cases (73.53%) were at stage I/II, while 9 cases (26.47%) were at stage III/IV. All stage I/II patients received a favorable prognosis with a three-year overall survival rate of 100%, including the patients who underwent laparoscopic nephron-sparing surgery. With the exception of 2 children, the other 7 stage III/IV patients died or developed recurrence with a median follow-up of 29 months. On univariate analysis, maximum diameter, adjuvant treatment, TNM stage, lymph node metastasis, inferior vena cava tumor thrombosis and tumor boundary were identified as statistically significant factors impacting survival (P<0.05). Multivariate analysis indicated that TNM stage and inferior vena cava tumor thrombosis were independent prognostic factors (P<0.05). In conclusion, Xp11.2 tRCC is a rare subtype of renal cell carcinoma that mainly occurs in young females. Nephron-sparing surgery was confirmed effective preliminarily in the treatment of small Xp11.2 tRCCs with clear rims. Advanced TNM stage and inferior vena cava tumor thrombosis were associated with poor prognosis.	[Liu, Ning; Wang, Zhen; Gan, Weidong; Xiong, Lei; Miao, Baolei; Chen, Xiancheng; Guo, Hongqian] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Gan, WD (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Sch Med, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	gwd@nju.edu.cn; lidm@nju.edu.cn	冬梅, 李/AHI-8180-2022	冬梅, 李/0000-0003-3819-355X; Liu, Ning/0000-0002-7283-7294	National Natural Science Foundation of China [81572512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (ID:81572512). The website of the program is http://www.nsfcngov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2005, AM J SURG PATHOL, V29, P230, DOI 10.1097/01.pas.0000146007.54092.37; Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Carini M, 2006, J UROLOGY, V175, P2022, DOI 10.1016/S0022-5347(06)00275-8; Chen Xiancheng, 2014, Zhonghua Yi Xue Za Zhi, V94, P3675; CHEN XZ, 2015, MEDICINE, V94, DOI DOI 10.1097/MD; Cheng XM, 2015, INT J CLIN EXP PATHO, V8, P5403; Choueiri TK, 2010, CANCER-AM CANCER SOC, V116, P5219, DOI 10.1002/cncr.25512; Chowdhury T, 2013, J PEDIAT HEMATOL ONC, V35, pE1, DOI 10.1097/MPH.0b013e318266bf34; Eble JN, 2004, PATHOLOGY GENETICS T; Ellis CL, 2014, MODERN PATHOL, V27, P875, DOI 10.1038/modpathol.2013.208; Gaillot-Durand L, 2013, PATHOL RES PRACT, V209, P83, DOI 10.1016/j.prp.2012.10.013; Geller JI, 2008, CANCER-AM CANCER SOC, V112, P1607, DOI 10.1002/cncr.23331; Geller JI, 2004, CANCER-AM CANCER SOC, V101, P1575, DOI 10.1002/cncr.20548; Gorin MA, 2015, CLIN GENITOURIN CANC, V13, pE199, DOI 10.1016/j.clgc.2014.12.008; Green WM, 2013, AM J SURG PATHOL, V37, P1150, DOI 10.1097/PAS.0b013e31828a69ae; He J, 2015, FUTURE ONCOL, V11, P3243, DOI 10.2217/fon.15.177; Hirobe M, 2016, INT J UROL, V23, P140, DOI 10.1111/iju.13007; Hodge JC, 2014, MODERN PATHOL, V27, P113, DOI 10.1038/modpathol.2013.83; Klatte T, 2012, AM J CLIN PATHOL, V137, P761, DOI 10.1309/AJCPQ6LLFMC4OXGC; Komai Y, 2009, CLIN CANCER RES, V15, P1170, DOI 10.1158/1078-0432.CCR-08-1183; Kuroda N, 2012, HISTOL HISTOPATHOL, V27, P133, DOI 10.14670/HH-27.133; Lim B, 2015, KOREAN J UROL, V56, P212, DOI 10.4111/kju.2015.56.3.212; Malouf GG, 2010, ANN ONCOL, V21, P1834, DOI 10.1093/annonc/mdq029; Malouf GG, 2011, J UROLOGY, V185, P24, DOI 10.1016/j.juro.2010.08.092; Minervini Andrea, 2009, Arch Ital Urol Androl, V81, P65; Nelius T, 2011, CASE REP MED, V2011, DOI 10.1155/2011/432917; Nesbitt JC, 1997, ANN THORAC SURG, V63, P1592, DOI 10.1016/S0003-4975(97)00329-9; Qu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21677; Ramphal R, 2006, AM J CLIN PATHOL, V126, P349, DOI 10.1309/98YE9E442ARLX2X; Rao Q, 2013, AM J SURG PATHOL, V37, P804, DOI 10.1097/PAS.0b013e31827e17cb; Rao Q, 2010, INT J SURG PATHOL, V18, P458, DOI 10.1177/1066896910375565; Reuter VE., 2016, WHO CLASSIFICATION T; Song HC, 2014, J PEDIATR SURG, V49, P539, DOI 10.1016/j.jpedsurg.2013.10.005; Sukov WR, 2012, AM J SURG PATHOL, V36, P663, DOI 10.1097/PAS.0b013e31824dd972	36	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166897	10.1371/journal.pone.0166897	http://dx.doi.org/10.1371/journal.pone.0166897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893792	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400053
J	Perwitasari, O; Johnson, S; Yan, XZ; Register, E; Crabtree, J; Gabbard, J; Howerth, E; Shacham, S; Carlson, R; Tamir, S; Tripp, RA				Perwitasari, Olivia; Johnson, Scott; Yan, Xiuzhen; Register, Emery; Crabtree, Jackelyn; Gabbard, Jon; Howerth, Elizabeth; Shacham, Sharon; Carlson, Robert; Tamir, Sharon; Tripp, Ralph A.			Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NUCLEAR EXPORT SIGNAL; CRM1; PROTEIN; INHIBITOR; MORTALITY; VITRO	Influenza A virus (IAV) causes seasonal epidemics of respiratory illness that can cause mild to severe illness and potentially death. Antiviral drugs are an important countermeasure against IAV; however, drug resistance has developed, thus new therapeutic approaches are being sought. Previously, we demonstrated the antiviral activity of a novel nuclear export inhibitor drug, verdinexor, to reduce influenza replication in vitro and pulmonary virus burden in mice. In this study, in vivo efficacy of verdinexor was further evaluated in two animal models or influenza virus infection, mice and ferrets. In mice, verdinexor was efficacious to limit virus shedding, reduce pulmonary pro-inflammatory cytokine expression, and moderate leukocyte infiltration into the bronchoalveolar space. Similarly, verdinexor-treated ferrets had reduced lung pathology, virus burden, and inflammatory cytokine expression in the nasal wash exudate. These findings support the anti-viral efficacy of verdinexor, and warrant its development as a novel antiviral therapeutic for influenza infection.	[Perwitasari, Olivia; Johnson, Scott; Yan, Xiuzhen; Register, Emery; Crabtree, Jackelyn; Gabbard, Jon; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Howerth, Elizabeth] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Shacham, Sharon; Carlson, Robert; Tamir, Sharon] Karyopharm Therapeut, Newton, MA USA; [Gabbard, Jon] Univ Louisville, Ctr Predict Med, Louisville, KY 40292 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Louisville	Tripp, RA (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA.	ratripp@uga.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700006C]; Georgia Research Alliance	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance	This study is supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (HHSN266200700006C), and funding from the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2012, GASTROENTEROLOGY; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Boltz DA, 2010, DRUGS, V70, P1349, DOI 10.2165/11537960-000000000-00000; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Freundt EC, 2009, J VIROL, V83, P6631, DOI 10.1128/JVI.00367-09; Kuruvilla J, 2013, 55 ANN M AM SOC HEM; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Loregian A, 2014, CELL MOL LIFE SCI, V71, P3659, DOI 10.1007/s00018-014-1615-2; Mau-Sorensen M, 2013, GASTR CANC S JAN 24; McKimm-Breschkin Jennifer L, 2005, Treat Respir Med, V4, P107, DOI 10.2165/00151829-200504020-00004; Monto AS, 2003, VACCINE, V21, P1796, DOI 10.1016/S0264-410X(03)00075-6; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanchez V, 2007, J VIROL, V81, P11730, DOI 10.1128/JVI.02760-06; Savona M, 2013, 55 ANN M AM SOC HEM; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Szretter KJ, 2005, CURRENT PROTOCOLS MI; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	29	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167221	10.1371/journal.pone.0167221	http://dx.doi.org/10.1371/journal.pone.0167221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893810	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400103
J	Burger, P; Stacey, RJ; Bowden, SA; Hacke, M; Parnell, J				Burger, Pauline; Stacey, Rebecca J.; Bowden, Stephen A.; Hacke, Marei; Parnell, John			Identification, Geochemical Characterisation and Significance of Bitumen among the Grave Goods of the 7th Century Mound 1 Ship-Burial at Sutton Hoo (Suffolk, UK)	PLOS ONE			English	Article							MOLECULAR ARCHAEOLOGY; TRADE; BC; ASPHALT; ORIGIN; PERIOD	The 7th century ship-burial at Sutton Hoo is famous for the spectacular treasure discovered when it was first excavated in 1939. The finds include gold and garnet jewellery, silverware, coins and ceremonial armour of broad geographical provenance which make a vital contribution to understanding the political landscape of early medieval Northern Europe. Fragments of black organic material found scattered within the burial were originally identified as 'Stockholm Tar' and linked to waterproofing and maintenance of the ship. Here we present new scientific analyses undertaken to re-evaluate the nature and origin of these materials, leading to the identification of a previously unrecognised prestige material among the treasure: bitumen from the Middle East. Whether the bitumen was gifted as diplomatic gesture or acquired through trading links, its presence in the burial attests to the far-reaching network within which the elite of the region operated at this time. If the bitumen was worked into objects, either alone or in composite with other materials, then their significance within the burial would certainly have been strongly linked to their form or purpose. But the novelty of the material itself may have added to the exotic appeal. Archaeological finds of bitumen from this and earlier periods in Britain are extremely rare, despite the abundance of natural sources of bitumen within Great Britain. This find provides the first material evidence indicating that the extensively exploited Middle Eastern bitumen sources were traded northward beyond the Mediterranean to reach northern Europe and the British Isles.	[Burger, Pauline; Stacey, Rebecca J.; Hacke, Marei] British Museum, Dept Sci Res, London, England; [Bowden, Stephen A.; Parnell, John] Univ Aberdeen, Dept Geol & Petr Geol, Aberdeen, Scotland; [Burger, Pauline] Univ Cote dAzur, CNRS, Inst Chim Nice, UMR7272, F-06108 Nice, France; [Hacke, Marei] Swedish Natl Heritage Board, Conservat Sci, Visby, Sweden	Natural History Museum London; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur	Stacey, RJ (corresponding author), British Museum, Dept Sci Res, London, England.	rstacey@thebritishmuseum.ac.uk	Stacey, Rebecca/AAW-7380-2021; Hacke, Marei/HII-6525-2022	Stacey, Rebecca/0000-0002-5074-6180; Hacke, Marei/0000-0002-4534-534X; BURGER, Pauline/0000-0003-2109-5451	European Commission Research Executive Agency (REA) via the Marie Curie Actions - Intra-European Fellowships for Career Development funding scheme (FP7-MC-IEF) [253942]	European Commission Research Executive Agency (REA) via the Marie Curie Actions - Intra-European Fellowships for Career Development funding scheme (FP7-MC-IEF)	This research was supported by funding from the European Commission Research Executive Agency (REA) via the Marie Curie Actions - Intra-European Fellowships for Career Development funding scheme (FP7-MC-IEF), Grant Agreement No. 253942, awarded to PB and RJS for project AMPT (Ancient Maritime Pitch and Tar: a multi-disciplinary study of sources, technology and preservation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegineta P., 1834, MED WORKS PAULUS AEG, VI; [Anonymous], 2003, DOMESDAY BOOK COMPLE; Aquino Neto FR, 1983, GEOCHEMISTRY 1981, P659; Bessinger JB, 1958, SPECULUM, V33, P515; Blair J., 2000, ANGLOSAXON AGE VERY; BRINK S, 2008, THE VIKING WORLD; Bruce-Mitford R, 1979, SUTTON HOO SHIP BURI; Bruce-Mitford RLS, 1974, ASPECTS ANGLO SAXON, P114; Bruce-Mitford Rupert, 1983, SUTTON HOO SHIP BURI, V4; Bruce-Mitford Rupert, 1975, SUTTON HOO SHIP BURI, V1; Campbell James, 2000, ANGLOSAXON STATE; Care Evans A., 1995, SUTTON HOO SHIP BURI; Carver M., 2000, SUTTON HOO BURIAL GR; Carver M. O. H., 2005, 7 CENTURY PRINCELY B; Celsus, 1938, CELSUS MED, VII; Chadwick H. M., 1940, ANTIQUITY, V14, P76; Connan J, 1999, PHILOS T ROY SOC B, V354, P33, DOI 10.1098/rstb.1999.0358; Connan J, 2006, ORG GEOCHEM, V37, P1752, DOI 10.1016/j.orggeochem.2006.07.023; CONNAN J, 1992, GEOCHIM COSMOCHIM AC, V56, P2743, DOI 10.1016/0016-7037(92)90357-O; CONNAN J, 1992, MATER RES SOC SYMP P, V267, P683, DOI 10.1557/PROC-267-683; Connan J, 2005, ARAB ARCHAEOL EPIGR, V16, P21, DOI 10.1111/j.1600-0471.2005.00041.x; Connan J, 1998, ARAB ARCHAEOL EPIGR, V9, P141, DOI 10.1111/j.1600-0471.1998.tb00116.x; Connan J, 2004, ORG GEOCHEM, V35, P775, DOI 10.1016/j.orggeochem.2004.01.015; Connan J, 1998, BITUME MARI MARI 9; Connan J., 1996, BITUME SUSE COLLECTI; Connan J., 1992, MESOPOTAMIA, V27, P47; Connan J, 2006, ORG GEOCHEM, V37, P1768, DOI 10.1016/j.orggeochem.2006.08.015; Connan J, 2010, ARAB ARCHAEOL EPIGR, V21, P1, DOI 10.1111/j.1600-0471.2009.00321.x; Crabtree PJ, 2005, MEDIEVAL ARCHAEOLOGY; Crumlin-Pedersen O., 1990, MARITIME CELTS FRISI, P98; Davies O., 1948, ARCH CAMB, V100, P61; Dooijes R., 2009, HOLDING IT ALL TOGET, P8; Duff P, 1992, GEOLOGY ENGLAND WALE; EGLINTON G, 1967, SCI AM, V216, P32, DOI 10.1038/scientificamerican0167-32; EVERSHED RP, 1985, NATURE, V314, P528, DOI 10.1038/314528a0; Filmer-Sankey William, 1990, MARITIME CELTS FRISI, P126; Forbes R.J., 1936, BITUMEN PETROLEUM AN; GIFFORD E, 1995, INT J NAUT ARCHAEOL, V24, P121; Hines John, 2013, E ANGLIA ITS N SEA W, p[16, 39]; HUGGET J. W., 1988, MEDIEV ARCHAEOL, V32, P63; Kostyukevich Y, 2016, J MASS SPECTROM, V51, P430, DOI 10.1002/jms.3769; Lamm JP, 1983, VENDEL PERIOD STUDIE; Langenheim J.H., 2003, PLANT RESINS CHEM EV; LaRoche D., 2007, UNDERWATER ARCHAEOLO, P85; MILES JA, 1993, MAR PETROL GEOL, V10, P58, DOI 10.1016/0264-8172(93)90100-7; MOLDOWAN JM, 1984, GEOCHIM COSMOCHIM AC, V48, P2767, DOI 10.1016/0016-7037(84)90321-1; NISSENBAUM A, 1993, REV CHEM ENG, V9, P365; NISSENBAUM A, 1978, AAPG BULL, V62, P837; Nissenbaum A., 1980, ORG GEOCHEM, V2, P167, DOI DOI 10.1016/0146-6380(80)90007-8; NOONER DW, 1973, CHEM GEOL, V11, P189, DOI 10.1016/0009-2541(73)90016-8; Pestell T., 2011, HINTON, P556; Peters K.E., 2005, BIOMARKER GUIDE, V1; Peters K.E., 1994, PETROLEUM SYSTEM SOU, V60, P93; Phillips C.W, 1940, ANTIQ J, V20, P149; Philp R.P., 1985, FOSSIL FUEL BIOMARKE; RUBINSTEIN I, 1975, J CHEM SOC PERK T 1, P1833, DOI 10.1039/p19750001833; Schwartz M., 2000, PALEORIENT, V26, P83; Scull C., 2011, OXFORD HDB ANGLOSAXO, P848, DOI 10.1093/oxfordhb/9780199212149.013.0044; Stacey RJ, 2006, BRIT IRON AGE SWORDS, P131; Taylor M. V., 1926, JRS, V16, P216; Wagensonner K., CUNEIFORM DIGITAL LI; Williams G., 2013, E ANGLIA ITS N SEA W, P120	62	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166276	10.1371/journal.pone.0166276	http://dx.doi.org/10.1371/journal.pone.0166276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EE3JC	27906999	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700021
J	Grimes, L; Doyle, A; Miller, AL; Pyles, RB; Olah, G; Szabo, C; Hoskins, S; Eaves-Pyles, T				Grimes, Logan; Doyle, Allie; Miller, Aaron L.; Pyles, Richard B.; Olah, Gabor; Szabo, Csaba; Hoskins, Sarah; Eaves-Pyles, Tonyia			Intraluminal Flagellin Differentially Contributes to Gut Dysbiosis and Systemic Inflammation following Burn Injury	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NF-KAPPA-B; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; BOWEL-DISEASE; ANKYLOSING-SPONDYLITIS; BACTERIAL FLAGELLIN; BARRIER FUNCTION; IMMUNE-RESPONSE; THERMAL-INJURY	Burn injury is associated with a loss of gut barrier function, resulting in systemic dissemination of gut-derived bacteria and their products. The bacterial protein and TLR5 agonist, flagellin, induces non-specific innate immune responses. Because we detected flagellin in the serum of burn patients, we investigated whether gut-derived flagellin was a primary or secondary contributor to intestinal dysfunction and systemic inflammation following burn injury. The apical surface of polarized human intestinal epithelial cells (IECs), Caco-2BBe, were exposed to 50 or 500 ng of purified flagellin and 1 x 10(5) of an intestinal E. coli (EC) isolate as follows: 1) flagellin added 30 min prior to EC, 2) flagellin and EC added simultaneously, or 3) EC added 30 min prior to flagellin. Our results showed that luminal flagellin and EC modulated each other's biological actions, which influenced their ability to induce basolateral secretion of inflammatory cytokines and subsequent translocation of bacteria and their products. A low dose of flagellin accompanied by an enteric EC in the lumen, tempered inflammation in a dose-and time-dependent manner. However, higher doses of flagellin acted synergistically with EC to induce both intestinal and systemic inflammation that compromised barrier integrity, increasing systemic inflammation following burn injury, a process we have termed flagellemia. In a murine model of burn injury we found that oral gavage of flagellin (1 mu g/mouse) significantly affected the gut microbiome after burn injury. In these mice, flagellin disseminated out of the intestine into the serum and to distal organs (mesenteric lymph nodes and lungs) where it induced secretion of monocyte chemoattractant protein (MCP-1) and CXCL1/KC (mouse equivalent of human IL-8) at 24 and 48h post-burn. Our results illustrated that gut-derived flagellin alone or accompanied by a non-pathogenic enteric EC strain can function as an initiator of luminal and systemic inflammation following burn injury.	[Grimes, Logan; Doyle, Allie; Hoskins, Sarah; Eaves-Pyles, Tonyia] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA; [Grimes, Logan; Doyle, Allie; Hoskins, Sarah; Eaves-Pyles, Tonyia] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA; [Miller, Aaron L.; Pyles, Richard B.] Univ Texas Med Branch, Pediat, Galveston, TX 77555 USA; [Olah, Gabor; Szabo, Csaba] Univ Texas Med Branch, Anesthesiol, Galveston, TX 77555 USA; [Szabo, Csaba; Eaves-Pyles, Tonyia] Shriners Hosp Children, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Eaves-Pyles, T (corresponding author), Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA.; Eaves-Pyles, T (corresponding author), Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA.; Eaves-Pyles, T (corresponding author), Shriners Hosp Children, Galveston, TX 77550 USA.	tdeavesp@utmb.edu	Szabo, Csaba/ABG-2644-2021		Shriners Hospital for Children [85210]; NIAID T35 training grant [AI078878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T35AI078878] Funding Source: NIH RePORTER	Shriners Hospital for Children; NIAID T35 training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Shriners Hospital for Children 85210 to Dr. Tonyia Eaves-Pyles. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Shriners Hospitals for Children grant funding (85210). We would also like to thank NIAID T35 training grant (AI078878; PI L. Soong) for supporting Mr. Grimes during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. David Herndon for his input and expertise. Additionally, we are grateful to Ms. Mardelle Susman for her thorough review of this manuscript.	ALEXANDER JW, 1991, ANN SURG, V213, P558, DOI 10.1097/00000658-199106000-00005; ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012; BARON P, 1994, J SURG RES, V57, P197, DOI 10.1006/jsre.1994.1131; Bernstein CN, 2011, CAN J GASTROENTEROL, V25, P269, DOI 10.1155/2011/712350; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Costantini TW, 2009, J TRAUMA, V67, P1162, DOI 10.1097/TA.0b013e3181ba3577; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; Costello ME, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4228; Deitch E A, 2001, Curr Opin Crit Care, V7, P92, DOI 10.1097/00075198-200104000-00007; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Dotan I, 2010, DIGEST DIS, V28, P418, DOI 10.1159/000320396; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Eaves-Pyles T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024869; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; EavesPyles T, 1996, J TRAUMA, V41, P1013, DOI 10.1097/00005373-199612000-00012; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Foca A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/326032; Gentry M, 2007, INFECT IMMUN, P101128; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Liaudet L, 2003, SHOCK, V19, P131, DOI 10.1097/00024382-200302000-00008; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Liu G, 2009, NANOSCI TECH, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0020928; Maass DL, 2002, SHOCK, V17, P293, DOI 10.1097/00024382-200204000-00009; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Martin Rumbo, 2006, FEBS LETT; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Neely CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085623; Neville LF, 2005, INT J MOL MED, V16, P165; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rolli J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012687; Rolli J, 2010, CRIT CARE, V14, DOI 10.1186/cc9235; ROUMEN RMH, 1993, ARCH SURG-CHICAGO, V128, P453; Schoepfer AM, 2008, NEUROGASTROENT MOTIL, V20, P1110, DOI 10.1111/j.1365-2982.2008.01166.x; Sigman M, 2013, J BURN CARE RES, V34, P633, DOI 10.1097/BCR.0b013e318280e2f8; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Szabo C, 2003, CRIT CARE MED, V31, pS39, DOI 10.1097/00003246-200301001-00006; Takedatsu H, 2009, GUT, V58, P60, DOI 10.1136/gut.2008.156422; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Varedi M, 1999, AM J PHYSIOL-GASTR L, V277, pG175, DOI 10.1152/ajpgi.1999.277.1.G175; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Xiao Y, 2014, CELLULAR MOL IMMUNOL, V12, P730; Zagar A, 2015, MBIO, V6, P1; Zhang HS, 2014, APPL ENVIRON MICROB, V80, P7551, DOI 10.1128/AEM.02676-14	53	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166770	10.1371/journal.pone.0166770	http://dx.doi.org/10.1371/journal.pone.0166770			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907005	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700038
J	Hellweger, FL; van Sebille, E; Calfee, BC; Chandler, JW; Zinser, ER; Swan, BK; Fredrick, ND				Hellweger, Ferdi L.; van Sebille, Erik; Calfee, Benjamin C.; Chandler, Jeremy W.; Zinser, Erik R.; Swan, Brandon K.; Fredrick, Neil D.			The Role of Ocean Currents in the Temperature Selection of Plankton: Insights from an Individual-Based Model	PLOS ONE			English	Article							MARINE CYANOBACTERIA PROCHLOROCOCCUS; BIOGEOGRAPHIC PATTERNS; RESOURCE-ALLOCATION; GROWTH; DISTRIBUTIONS; COMMUNITIES; ENVIRONMENT; ADAPTATION; MICROBES; ECOTYPES	Biogeography studies that correlate the observed distribution of organisms to environmental variables are typically based on local conditions. However, in cases with substantial translocation, like planktonic organisms carried by ocean currents, selection may happen upstream and local environmental factors may not be representative of those that shaped the local population. Here we use an individual-based model of microbes in the global surface ocean to explore this effect for temperature. We simulate up to 25 million individual cells belonging to up to 50 species with different temperature optima. Microbes are moved around the globe based on a hydrodynamic model, and grow and die based on local temperature. We quantify the role of currents using the "advective temperature differential" metric, which is the optimum temperature of the most abundant species from the model with advection minus that from the model without advection. This differential depends on the location and can be up to 4 degrees C. Poleward-flowing currents, like the Gulf Stream, generally experience cooling and the differential is positive. We apply our results to three global datasets. For observations of optimum growth temperature of phytoplankton, accounting for the effect of currents leads to a slightly better agreement with observations, but there is large variability and the improvement is not statistically significant. For observed Prochlorococcus ecotype ratios and metagenome nucleotide divergence, accounting for advection improves the correlation significantly, especially in areas with relatively strong poleward or equatorward currents.	[Hellweger, Ferdi L.; Fredrick, Neil D.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [van Sebille, Erik] Imperial Coll London, Grantham Inst, London, England; [van Sebille, Erik] Imperial Coll London, Dept Phys, London, England; [van Sebille, Erik] Univ New South Wales, Climate Change Res Ctr, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia; [Calfee, Benjamin C.; Chandler, Jeremy W.; Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Swan, Brandon K.] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Swan, Brandon K.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA	Northeastern University; Imperial College London; Imperial College London; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of Tennessee System; University of Tennessee Knoxville; Bigelow Laboratory for Ocean Sciences	Hellweger, FL (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.	ferdi@coe.neu.edu	Swan, Brandon K/O-9824-2018; van Sebille, Erik/F-6781-2010	Swan, Brandon K/0000-0003-0465-1444; van Sebille, Erik/0000-0003-2041-0704	National Science Foundation (NSF) [DEB-1240894, OCE-1030518, OCE-1232982]; National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant; Australian Research Council [DE130101336]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant; Australian Research Council(Australian Research Council)	F.L.H. and N.D.F. were supported by grants from the National Science Foundation (NSF) (DEB-1240894) and National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant. E.v.S. was supported by the Australian Research Council (DE130101336). E.R.Z. was supported by the NSF (OCE-1030518). B.K.S. was supported by the NSF (OCE-1232982).; Two anonymous reviewers provided constructive criticism. F.L.H. and N.D.F. were supported by grants from the National Science Foundation (NSF) (DEB- 1240894) and National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant. E.v.S. was supported by the Australian Research Council (DE130101336). E.R.Z. was supported by the NSF (OCE-1030518). B.K.S. was supported by the NSF (OCE-1232982).	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; Berube PM, 2015, ISME J, V9, P1195, DOI 10.1038/ismej.2014.211; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Brown MV, 2014, MAR GENOM, V15, P17, DOI 10.1016/j.margen.2014.03.002; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Bucci V, 2012, AQUAT ECOL, V46, P101, DOI 10.1007/s10452-011-9384-6; Chandler JW, 2016, ENV MICROBIOLOGY REP; Chen BZ, 2014, MAR ECOL PROG SER, V505, P37, DOI 10.3354/meps10773; Clark JR, 2013, LIMNOL OCEANOGR, V58, P1008, DOI 10.4319/lo.2013.58.3.1008; del Giorgio PA, 2008, PHYSL STRUCTURE SING, P243; Doblin MA, 2016, P NATL ACAD SCI USA, V113, P5700, DOI 10.1073/pnas.1521093113; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; FALKOWSKI PG, 1981, MAR BIOL, V65, P69, DOI 10.1007/BF00397069; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hellweger FL, 2008, COMPUT GEOSCI-UK, V34, P144, DOI 10.1016/j.cageo.2006.12.006; Hellweger FL, 2014, SCIENCE, V345, P1346, DOI 10.1126/science.1254421; Hellweger FL, 2010, ECOL MODEL, V221, P1620, DOI 10.1016/j.ecolmodel.2010.03.015; Hellweger FL, 2009, ENVIRON MICROBIOL, V11, P1386, DOI 10.1111/j.1462-2920.2009.01866.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kamennaya NA, 2011, APPL ENVIRON MICROB, V77, P291, DOI 10.1128/AEM.01272-10; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Kirchman DL, 2016, ANNU REV MAR SCI, V8, P285, DOI 10.1146/annurev-marine-122414-033938; Lee Z., 2007, GEOPHYS RES, V112, pC3, DOI DOI 10.1029/2006JC003802; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levy M., 2014, LIMNOL OCEANOGR, V4, P67, DOI [DOI 10.1146/annurev-marine-120710-100912, 10.1215/21573689-2768549, DOI 10.1215/21573689-2768549]; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Moore L, 2005, AQUATIC MICROBIAL EC; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Nagai T, 2003, MAR ECOL PROG SER, V265, P17, DOI 10.3354/meps265017; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Pommier T, 2012, BIOL LETTERS, V8, P562, DOI 10.1098/rsbl.2011.0990; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SMAYDA THEODORE J., 1958, OIKOS, V9, P158, DOI 10.2307/3564763; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Swan BK, 2013, P NATL ACAD SCI; Thomas MK, 2016, GLOBAL ECOL BIOGEOGR, V25, P75, DOI 10.1111/geb.12387; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; van Sebille E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7521; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; WEYL PK, 1978, SCIENCE, V202, P475, DOI 10.1126/science.202.4367.475; Woods JD, 2005, PROG OCEANOGR, V67, P84, DOI 10.1016/j.pocean.2005.04.003; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205	58	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167010	10.1371/journal.pone.0167010	http://dx.doi.org/10.1371/journal.pone.0167010			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907181	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700062
J	Hotaling, NA; Jeon, J; Wade, MB; Luong, D; Palmer, XL; Bharti, K; Simon, CG				Hotaling, Nathan A.; Jeon, Jun; Wade, Mary Beth; Luong, Derek; Palmer, Xavier-Lewis; Bharti, Kapil; Simon, Carl G., Jr.			Training to Improve Precision and Accuracy in the Measurement of Fiber Morphology	PLOS ONE			English	Article							NANOFIBER; DIFFERENTIATION; DIAMETERJ; IMAGE; CELLS	An estimated $7.1 billion dollars a year is spent due to irreproducibility in pre-clinical data from errors in data analysis and reporting. Therefore, developing tools to improve measurement comparability is paramount. Recently, an open source tool, DiameterJ, has been deployed for the automated analysis of scanning electron micrographs of fibrous scaffolds designed for tissue engineering applications. DiameterJ performs hundreds to thousands of scaffold fiber diameter measurements from a single micrograph within a few seconds, along with a variety of other scaffold morphological features, which enables a more rigorous and thorough assessment of scaffold properties. Herein, an online, publicly available training module is introduced for educating DiameterJ users on how to effectively analyze scanning electron micrographs of fibers and the large volume of data that a DiameterJ analysis yields. The end goal of this training was to improve user data analysis and reporting to enhance reproducibility of analysis of nanofiber scaffolds. User performance was assessed before and after training to evaluate the effectiveness of the training modules. Users were asked to use DiameterJ to analyze reference micrographs of fibers that had known diameters. The results showed that training improved the accuracy and precision of measurements of fiber diameter in scanning electron micrographs. Training also improved the precision of measurements of pore area, porosity, intersection density, and characteristic fiber length between fiber intersections. These results demonstrate that the DiameterJ training module improves precision and accuracy in fiber morphology measurements, which will lead to enhanced data comparability.	[Hotaling, Nathan A.; Palmer, Xavier-Lewis; Simon, Carl G., Jr.] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA; [Hotaling, Nathan A.; Jeon, Jun; Bharti, Kapil] NEI, Unit Ocular & Stem Cell Translat Res, NIH, Bethesda, MD 20892 USA; [Wade, Mary Beth; Luong, Derek] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA	National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Ohio; University of Akron	Hotaling, NA (corresponding author), NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.; Hotaling, NA (corresponding author), NEI, Unit Ocular & Stem Cell Translat Res, NIH, Bethesda, MD 20892 USA.	Nathan.Hotaling@nih.gov	; Hotaling, Nathan/F-2763-2014	Luong, Derek/0000-0002-4108-2386; Simon, Carl/0000-0001-5209-3577; Palmer, Xavier-Lewis/0000-0002-1289-5302; Hotaling, Nathan/0000-0001-8423-6464				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; [Anonymous], 2016, 572511994 ISO; Bartneck M, 2013, MAT SCI ENG C-MATER, V33, P5109, DOI 10.1016/j.msec.2013.08.028; Baum E., 2013, KEY TOOLS TECHNOLOGY; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Buck S, 2015, SCIENCE, V348, P1403, DOI 10.1126/science.aac8041; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Errington TM, 2014, ELIFE, V3, DOI 10.7554/eLife.04333; Freedman DH, 2010, ATLANTIC; French A, 2015, STEM CELL TRANSL MED, V4, P217, DOI 10.5966/sctm.2014-0233; Goldstein J., 2012, PRACTICAL SCANNING E; Hotaling NA, 2015, DATA BRIEF, V5, P13, DOI 10.1016/j.dib.2015.07.012; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Joint Committee for Guides in Metrology, 2015, INT VOC METR BAS GEN, V200, P2012; Kaiser J, 2015, SCIENCE, V348, P1411, DOI 10.1126/science.348.6242.1411; Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; Lehrer J., 2010, NEW YORKER, V13, P229; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; NIH National Institutes of Health, RIG REPR; Pilehvar-Soltanahmadi Y, 2016, ARTIF CELL NANOMED B, V44, P1350, DOI 10.3109/21691401.2015.1036999; Porat Y., CYTOTHERAPY; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Simon CG, 2016, STEM CELL TRANSL MED, V5, P705, DOI 10.5966/sctm.2015-0269; Stanger JJ, 2014, POLYM TEST, V40, P4, DOI 10.1016/j.polymertesting.2014.08.002; Wadman M, 2013, NATURE, V500, P14, DOI 10.1038/500014a; Watt I.M., 1997, PRINCIPLES PRACTICE; Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042; Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167664	10.1371/journal.pone.0167664	http://dx.doi.org/10.1371/journal.pone.0167664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907145	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700221
J	Irwin, C; van Reenen, M; Mason, S; Mienie, LJ; Westerhuis, JA; Reinecke, CJ				Irwin, Cindy; van Reenen, Mari; Mason, Shayne; Mienie, Lodewyk J.; Westerhuis, Johan A.; Reinecke, Carolus J.			Contribution towards a Metabolite Profile of the Detoxification of Benzoic Acid through Glycine Conjugation: An Intervention Study	PLOS ONE			English	Article							LIVER-MITOCHONDRIA; N-ACYLTRANSFERASE; COA LIGASES; METABOLOMICS; NUTRITION	Benzoic acid is widely used as a preservative in food products and is detoxified in humans through glycine conjugation. Different viewpoints prevail on the physiological significance of the glycine conjugation reaction and concerns have been raised on potential public health consequences following uncontrolled benzoic acid ingestion. We performed a metabolomics study which used commercial benzoic acid containing flavored water as vehicle for designed interventions, and report here on the controlled consumption of the benzoic acid by 21 cases across 6 time points for a total of 126 time points. Metabolomics data from urinary samples analyzed by nuclear magnetic resonance spectroscopy were generated in a time-dependent cross-over study. We used ANOVA-simultaneous component analysis (ASCA), repeated measures analysis of variance (RM-ANOVA) and unfolded principal component analysis (unfolded PCA) to supplement conventional statistical methods to uncover fully the metabolic perturbations due to the xenobiotic intervention, encapsulated in the metabolomics tensor (three-dimensional matrices having cases, spectral areas and time as axes). Identification of the biologically important metabolites by the novel combination of statistical methods proved the power of this approach for metabolomics studies having complex data structures in general. The study disclosed a high degree of inter-individual variation in detoxification of the xenobiotic and revealed metabolic information, indicating that detoxification of benzoic acid through glycine conjugation to hippuric acid does not indicate glycine depletion, but is supplemented by ample glycine regeneration. The observations lend support to the view of maintenance of glycine homeostasis during detoxification. The study indicates also that time-dependent metabolomics investigations, using designed interventions, provide a way of interpreting the variation induced by the different factors of a designed experiment-an approach with potential to advance significantly our understanding of normal and pathophysiological perturbations of endogenous or exogenous origin.	[Irwin, Cindy; van Reenen, Mari; Mason, Shayne; Mienie, Lodewyk J.; Reinecke, Carolus J.] North West Univ, Fac Nat Sci, Ctr Human Metabol, Potchefstroom Campus, Potchefstroom, South Africa; [van Reenen, Mari; Westerhuis, Johan A.] North West Univ, Dept Stat, Fac Nat Sci, Potchefstroom Campus, Potchefstroom, South Africa; [Westerhuis, Johan A.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal, Amsterdam, Netherlands	North West University - South Africa; North West University - South Africa; University of Amsterdam	Reinecke, CJ (corresponding author), North West Univ, Fac Nat Sci, Ctr Human Metabol, Potchefstroom Campus, Potchefstroom, South Africa.	carools.reinecke@nwu.ac.za		Mienie, Japie/0000-0003-0860-5285; van Wyk, Mari/0000-0002-5856-3258; Mason, Shayne/0000-0002-2945-5768	Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa; National Research Foundation (NRF) of South Africa	Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	Research funding for the analytical and computational aspects of the project was provided by the Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa. CI received a post-graduate bursary from the National Research Foundation (NRF) of South Africa. The views and findings of this investigation are those of the authors and do not reflect or represent any policies of the NRF or TIA funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research funding for the analytical and computational aspects of the project was provided by the Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa. CI received a post-graduate bursary from the National Research Foundation (NRF) of South Africa. The views and findings of this investigation are those of the authors and do not reflect or represent any policies of the NRF or TIA funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antti H, 2002, J CHEMOMETR, V16, P461, DOI 10.1002/cem.733; APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; Badenhorst CPS, 2013, EXPERT OPIN DRUG MET, V9, P1139, DOI 10.1517/17425255.2013.796929; Beyoglu D, 2012, PHARMACOL THERAPEUT, V135, P151, DOI 10.1016/j.pharmthera.2012.05.003; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; CONTI A, 1977, DRUG METAB REV, V6, P1, DOI 10.3109/03602537708993764; Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039; Ellinger JJ, 2013, CURR METABOL, V1, P28, DOI 10.2174/2213235X11301010028; Fave G, 2011, METABOLOMICS, V7, P469, DOI 10.1007/s11306-011-0289-0; Fingerhut R, 2003, RAPID COMMUN MASS SP, V17, P717, DOI 10.1002/RCM.966; GATLEY SJ, 1977, BIOCHEM J, V166, P39, DOI 10.1042/bj1660039; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Jana S, 2009, CURR DRUG METAB, V10, P595, DOI 10.2174/138920009789375379; Knights KM, 2000, CURR DRUG METAB, V1, P49, DOI 10.2174/1389200003339261; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Mason S. P., 2010, THESIS; MCGUIRE DM, 1984, J BIOL CHEM, V259, P2034; NANDI DL, 1979, J BIOL CHEM, V254, P7230; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Park HW, 2011, J FOOD BIOCHEM, V35, P1034, DOI 10.1111/j.1745-4514.2010.00432.x; Powers R, 2009, MAGN RESON CHEM, V47, pS2, DOI 10.1002/mrc.2461; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; SCHACHTER D, 1954, J BIOL CHEM, V208, P263; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Smith RL, BIOCHEM PHARMACOL, DOI DOI 10.1016/J.BCP.2011.12.031; Tanaka I, 2004, NEUROSCI RES, V49, P165, DOI 10.1016/j.neures.2004.02.007; Vessey DA, 1999, BBA-GEN SUBJECTS, V1428, P455, DOI 10.1016/S0304-4165(99)00088-4; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Villez K, 2009, BIOSYST ENG, V103, P23, DOI 10.1016/j.biosystemseng.2009.01.014; Wen H, 2013, MOL CELL PROTEOMICS, V12, P575, DOI 10.1074/mcp.M112.021352; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Zimniak P, 2008, AGEING RES REV, V7, P281, DOI 10.1016/j.arr.2008.04.001; Zwanenburg G, 2011, J CHEMOMETR, V25, P561, DOI 10.1002/cem.1400	36	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167309	10.1371/journal.pone.0167309	http://dx.doi.org/10.1371/journal.pone.0167309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907139	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700116
J	Just, S; Raphel, L; Berger, IM; Buhler, A; Kessler, M; Rottbauer, W				Just, Steffen; Raphel, Linda; Berger, Ina M.; Buehler, Anja; Kessler, Mirjam; Rottbauer, Wolfgang			Tbx20 Is an Essential Regulator of Embryonic Heart Growth in Zebrafish	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MESSENGER-RNA; TBX20-RELATED GENES; PROLIFERATION; CELLS; DIFFERENTIATION; TRANSLATION; TERMINATION; EXPRESSION; DROSOPHILA	The molecular mechanisms that regulate cardiomyocyte proliferation during embryonic heart growth are not completely deciphered yet. In a forward genetic N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we identified the recessive embryonic-lethal zebrafish mutant line weiches herz (whz). Homozygous mutant whz embryos display impaired heart growth due to diminished embryonic cardiomyocyte proliferation resulting in cardiac hypoplasia and weak cardiac contraction. By positional cloning, we found in whz mutant zebrafish a missense mutation within the T-box 20 (Tbx20) transcription factor gene leading to destabilization of Tbx20 protein. Morpholino-mediated knock-down of Tbx20 in wild-type zebrafish embryos phenocopies whz, indicating that the whz phenotype is due to loss of Tbx20 function, thereby leading to significantly reduced cardiomyocyte numbers by impaired proliferation of heart muscle cells. Ectopic overexpression of wild-type Tbx20 in whz mutant embryos restored cardiomyocyte proliferation and heart growth. Interestingly, ectopic overexpression of Tbx20 in wild-type zebrafish embryos resulted, similar to the situation in the embryonic mouse heart, in significantly reduced proliferation rates of ventricular cardiomyocytes, suggesting that Tbx20 activity needs to be tightly fine-tuned to guarantee regular cardiomyocyte proliferation and embryonic heart growth in vivo.	[Just, Steffen; Berger, Ina M.; Buehler, Anja; Rottbauer, Wolfgang] Univ Ulm, Mol Cardiol, Dept Med 2, Ulm, Germany; [Raphel, Linda; Kessler, Mirjam; Rottbauer, Wolfgang] Univ Ulm, Dept Med 2, Ulm, Germany	Ulm University; Ulm University	Just, S; Rottbauer, W (corresponding author), Univ Ulm, Mol Cardiol, Dept Med 2, Ulm, Germany.; Rottbauer, W (corresponding author), Univ Ulm, Dept Med 2, Ulm, Germany.	steffen.just@uniklinik-ulm.de; wolfgang.rottbauer@uniklinik-ulm.de		Buhler, Anja/0000-0003-2927-2379	Deutsche Forschungsgemeinschaft (DFG) [RO2173/3-1, RO2173/3-2, JU2859/2-1]; German Federal Ministry of Education and Research (BMBF) [01ZX1407A]; Insight-DCM [01GS0108, 01GS0420, 01GS0836, 01GS1104, 01KU0901C]; European Union (EU-Inheritance); Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm; Boehringer Ingelheim Ulm University BioCenter (BIU)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Insight-DCM; European Union (EU-Inheritance)(European Commission); Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm; Boehringer Ingelheim Ulm University BioCenter (BIU)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) RO2173/3-1 (WR), RO2173/3-2 (WR), JU2859/2-1 (SJ) and the German Federal Ministry of Education and Research (BMBF) (e:Med-SYMBOL-HF grant #01ZX1407A) (SJ) as well as 01GS0108 (WR), 01GS0420 (WR), 01GS0836 (WR) and 01GS1104 (WR) (NGFNplus), and 01KU0901C (WR) Insight-DCM; the European Union (EU-Inheritance) (WR); the Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm (SJ) and the Boehringer Ingelheim Ulm University BioCenter (BIU) (WR/SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft (DFG) RO2173/3-1 (WR), RO2173/3-2 (WR), JU2859/2-1 (SJ) and the German Federal Ministry of Education and Research (BMBF) (e:Med-SYMBOL-HF grant #01ZX1407A) (SJ) as well as 01GS0108 (WR), 01GS0420 (WR), 01GS0836 (WR) and 01GS1104 (WR) (NGFNplus), and 01KU0901C (WR) Insight-DCM; the European Union (EU-Inheritance) (WR); the Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm (SJ) and the Boehringer Ingelheim Ulm University BioCenter (BIU) (WR/SJ).	Akimitsu N, 2008, J BIOCHEM, V143, P1, DOI 10.1093/jb/mvm204; Akimitsu N, 2007, EMBO J, V26, P2327, DOI 10.1038/sj.emboj.7601679; Buhler A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020187; Chakraborty S, 2012, DEV BIOL, V363, P234, DOI 10.1016/j.ydbio.2011.12.034; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Griffin TJ, 1998, ANAL BIOCHEM, V260, P56, DOI 10.1006/abio.1998.2686; Hamby Stephen E., 2011, Human Genomics, V5, P241; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hirth S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150323; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Just S, 2016, BIOCHEM BIOPH RES CO, V477, P581, DOI 10.1016/j.bbrc.2016.06.088; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Langenbacher AD, 2011, DEV BIOL, V353, P19, DOI 10.1016/j.ydbio.2011.02.011; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Qian L, 2005, DEV BIOL, V279, P509, DOI 10.1016/j.ydbio.2005.01.013; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Sahara M, 2015, EMBO J, V34, P710, DOI 10.15252/embj.201490563; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Soonpaa MH, 2013, BBA-MOL CELL RES, V1833, P799, DOI 10.1016/j.bbamcr.2012.10.029; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Szeto DP, 2002, DEVELOPMENT, V129, P5093; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torres-Torronteras J, 2011, HUM MUTAT, V32, pE2061, DOI 10.1002/humu.21447; Xiang FL, 2016, CIRCULATION, V133, P1081, DOI 10.1161/CIRCULATIONAHA.115.019357; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zebrowski DC, 2015, ELIFE, V4, DOI 10.7554/eLife.05563; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	36	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167306	10.1371/journal.pone.0167306	http://dx.doi.org/10.1371/journal.pone.0167306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907103	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700114
J	Kogelman, LJA; Fu, JY; Franke, L; Greve, JW; Hofker, M; Rensen, SS; Kadarmideen, HN				Kogelman, Lisette J. A.; Fu, Jingyuan; Franke, Lude; Greve, Jan Willem; Hofker, Marten; Rensen, Sander S.; Kadarmideen, Haja N.			Inter-Tissue Gene Co-Expression Networks between Metabolically Healthy and Unhealthy Obese Individuals	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE-EPSILON; PROTEIN-KINASE-C; ADIPOSE-TISSUE; SKELETAL-MUSCLE; INSULIN SENSITIVITY; DISEASE; EXPRESSION; LIVER; IL-6; IDENTIFICATION	Background Obesity is associated with severe co-morbidities such as type 2 diabetes and nonalcoholic steatohepatitis. However, studies have shown that 10-25 percent of the severely obese individuals are metabolically healthy. To date, the identification of genetic factors underlying the metabolically healthy obese (MHO) state is limited. Systems genetics approaches have led to the identification of genes and pathways in complex diseases. Here, we have used such approaches across tissues to detect genes and pathways involved in obesity-induced disease development. Methods Expression data of 60 severely obese individuals was accessible, of which 28 individuals were MHO and 32 were metabolically unhealthy obese (MUO). A whole genome expression profile of four tissues was available: liver, muscle, subcutaneous adipose tissue and visceral adipose tissue. Using insulin-related genes, we used the weighted gene co-expression network analysis (WGCNA) method to build within- and inter-tissue gene networks. We identified genes that were differentially connected between MHO and MUO individuals, which were further investigated by homing in on the modules they were active in. To identify potentially causal genes, we integrated genomic and transcriptomic data using an eQTL mapping approach. Results Both IL-6 and IL1B were identified as highly differentially co-expressed genes across tissues between MHO and MUO individuals, showing their potential role in obesity-induced disease development. WGCNA showed that those genes were clustering together within tissues, and further analysis showed different co-expression patterns between MHO and MUO subnetworks. A potential causal role for metabolic differences under similar obesity state was detected for PTPRE, IL-6R and SLC6A5. Conclusions We used a novel integrative approach by integration of co-expression networks across tissues to elucidate genetic factors related to obesity-induced metabolic disease development. The identified genes and their interactions give more insight into the genetic architecture of obesity and the association with co-morbidities.	[Kogelman, Lisette J. A.; Kadarmideen, Haja N.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Frederiksberg, Denmark; [Fu, Jingyuan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Groningen, Netherlands; [Greve, Jan Willem] Atrium Med Ctr Parkstad, Dept Gen Surg, Heerlen, Netherlands; [Hofker, Marten] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Pediat Mol Genet, Groningen, Netherlands; [Rensen, Sander S.] Maastricht Univ, Dept Surg, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands	University of Copenhagen; University of Groningen; University of Groningen; Atrium Medical Center; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Kadarmideen, HN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Frederiksberg, Denmark.	hajak@sund.ku.dk	Fu, Jingyuan/ABE-6868-2020; Rensen, Sander/J-3224-2019; Fu, Jingyuan/E-8980-2012; Fu, JY/GRR-6179-2022; Kogelman, Lisette/Y-5883-2019; Franke, Lude/P-7036-2016	Fu, Jingyuan/0000-0001-5578-1236; Rensen, Sander/0000-0001-5054-8400; Kogelman, Lisette/0000-0001-9782-7810; Franke, Lude/0000-0002-5159-8802; Kadarmideen, Haja/0000-0001-6294-382X	Biochild project; Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden) [0603-00457B]; EU [CIG-293511]	Biochild project; Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden); EU(European Commission)	Lisette J. A. Kogelman is funded by a post-doctoral fellowship within Biochild project (http://biochild.ku.dk/) with grant (0603-00457B) from the Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden). Haja N. Kadarmideen thanks EU-FP7 Marie Curie Actions - Career Integration Grant (CIG-293511) for partially funding his time spent on this research.; Lisette J.A. Kogelman was funded by a post-doctoral fellowship within Biochild project (http://biochild.ku.dk/) with grant (0603-00457B) from the Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden). Haja N. Kadarmideen thanks EU-FP7 Marie Curie Actions-Career Integration Grant (CIG-293511) for partially funding his time spent on this research. The authors thank Dr. Tom Michoel for fruitful discussions and input about the methodology regarding across-tissue network construction. Prof. Wim Buurman is thanked for his role in setting up the cohort of severely obese subjects.	Aga-Mizrachi S, 2008, ENDOCRINOLOGY, V149, P605, DOI 10.1210/en.2007-0908; Ahl S, 2015, J CLIN ENDOCR METAB, V100, P4172, DOI 10.1210/jc.2015-2765; Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Argiles JM, 2005, MED RES REV, V25, P49, DOI 10.1002/med.20010; Beretta Martina, 2015, Advances in Biological Regulation, V58, P1, DOI 10.1016/j.jbior.2014.11.004; Bing C, 2015, ADIPOCYTE, V4, P149, DOI 10.4161/21623945.2014.979661; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bogdanik LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030217; Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Eldor R, 2006, DIABETES RES CLIN PR, V74, pS3, DOI 10.1016/j.diabres.2006.06.004; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; John C, 2002, ENDOCRINOLOGY, V143, P3060, DOI 10.1210/en.143.8.3060; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Kogelman LJA, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-57; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Marques-Vidal P, 2012, EUR J CLIN NUTR, V66, P426, DOI 10.1038/ejcn.2011.170; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Mojtaba E, 2011, INT J BIOSCI, V1, P93; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Olson AL, 2013, HORM MOL BIOL CLIN I, V15, P115, DOI 10.1515/hmbci-2013-0019; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Wallerstedt E, 2010, DIABETOLOGIA, V53, P946, DOI 10.1007/s00125-010-1668-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wolfs MGM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-34; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011	50	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167519	10.1371/journal.pone.0167519	http://dx.doi.org/10.1371/journal.pone.0167519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907186	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700180
J	McDonald, KK; Cooper, S; Danielzak, L; Leask, RL				McDonald, Karli K.; Cooper, Scott; Danielzak, Lisa; Leask, Richard L.			Glycocalyx Degradation Induces a Proinflammatory Phenotype and Increased Leukocyte Adhesion in Cultured Endothelial Cells under Flow	PLOS ONE			English	Article							FLUID SHEAR-STRESS; NITRIC-OXIDE SYNTHASE; IN-VITRO; HEPARAN-SULFATE; VASCULAR ENDOTHELIUM; P-SELECTIN; EXPRESSION; ICAM-1; ATHEROSCLEROSIS; SURFACE	Leukocyte adhesion to the endothelium is an early step in the pathogenesis of atherosclerosis. Effective adhesion requires the binding of leukocytes to their cognate receptors on the surface of endothelial cells. The glycocalyx covers the surface of endothelial cells and is important in the mechanotransduction of shear stress. This study aimed to identify the molecular mechanisms underlying the role of the glycocalyx in leukocyte adhesion under flow. We performed experiments using 3-D cell culture models, exposing human abdominal aortic endothelial cells to steady laminar shear stress (10 dynes/cm(2) for 24 hours). We found that with the enzymatic degradation of the glycocalyx, endothelial cells developed a proinflammatory phenotype when exposed to uniform steady shear stress leading to an increase in leukocyte adhesion. Our results show an up-regulation of ICAM-1 with degradation compared to non-degraded controls (3-fold increase, p<0.05) and we attribute this effect to a de-regulation in NF-kappa B activity in response to flow. These results suggest that the glycocalyx is not solely a physical barrier to adhesion but rather plays an important role in governing the phenotype of endothelial cells, a key determinant in leukocyte adhesion. We provide evidence for how the destabilization of this structure may be an early and defining feature in the initiation of atherosclerosis.	[McDonald, Karli K.; Leask, Richard L.] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Cooper, Scott; Danielzak, Lisa; Leask, Richard L.] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada	McGill University; McGill University	Leask, RL (corresponding author), McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.; Leask, RL (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.	richard.leask@mcgill.ca		Leask, Richard/0000-0002-3649-5127	Canadian Institute of Health Research-Individual Grant [MOP-119292]; Natural Science and Engineering Research Council of Canada-Discovery Grant [RGPIN-261938-13]	Canadian Institute of Health Research-Individual Grant; Natural Science and Engineering Research Council of Canada-Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by Canadian Institute of Health Research-Individual Grant MOP-119292 (to RLL) and the Natural Science and Engineering Research Council of Canada-Discovery Grant RGPIN-261938-13 (to RLL).	ARISAKA T, 1995, ANN NY ACAD SCI, V748, P543; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; ASAKURA T, 1990, CIRC RES, V66, P1045, DOI 10.1161/01.RES.66.4.1045; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Davis ME, 2004, J BIOL CHEM, V279, P163, DOI 10.1074/jbc.M307528200; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Falanga A, 1996, BLOOD, V87, P613, DOI 10.1182/blood.V87.2.613.bloodjournal872613; Farcas MA, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-30; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z; Gimbrone MA, 1999, THROMB HAEMOSTASIS, V82, P722; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Hay DC, 2003, BBA-MOL CELL RES, V1642, P33, DOI 10.1016/S0167-4889(03)00084-3; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Imberti B, 2000, MICROVASC RES, V60, P182, DOI 10.1006/mvre.2000.2260; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOLLER A, 1993, CIRC RES, V72, P1276, DOI 10.1161/01.RES.72.6.1276; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Kunkel EJ, 1998, J IMMUNOL, V161, P2449; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Molteni R, 2009, BLOOD, V114, P1073, DOI 10.1182/blood-2008-10-183699; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; OBRIEN KD, 1993, J CLIN INVEST, V92, P945, DOI 10.1172/JCI116670; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Rizzo V, 1998, J BIOL CHEM, V273, P26323, DOI 10.1074/jbc.273.41.26323; Rossi J, 2011, ANN BIOMED ENG, V39, P402, DOI 10.1007/s10439-010-0145-9; Rossi J, 2010, EUR J PHARMACOL, V649, P268, DOI 10.1016/j.ejphar.2010.09.016; Rossi J, 2010, LIFE SCI, V87, P92, DOI 10.1016/j.lfs.2010.05.008; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Rouleau L, 2010, ANN BIOMED ENG, V38, P2791, DOI 10.1007/s10439-010-0032-4; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001217; Rouleau L, 2010, ANN BIOMED ENG, V38, P1451, DOI 10.1007/s10439-010-9934-4; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; TSUBOI H, 1995, BIOCHEM BIOPH RES CO, V206, P988, DOI 10.1006/bbrc.1995.1140; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; WALPOLA PL, 1995, ARTERIOSCL THROM VAS, V15, P2, DOI 10.1161/01.ATV.15.1.2; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zeng Y, 2014, AM J PHYSIOL-HEART C, V306, pH363, DOI 10.1152/ajpheart.00687.2013; Zeng Y, 2013, AM J PHYSIOL-HEART C, V305, pH811, DOI 10.1152/ajpheart.00764.2012; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168	56	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167576	10.1371/journal.pone.0167576	http://dx.doi.org/10.1371/journal.pone.0167576			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907146	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700200
J	Minagawa, K; Jamil, MO; Al-Obaidi, M; Pereboeva, L; Salzman, D; Erba, HP; Lamb, LS; Bhatia, R; Mineishi, S; Di Stasi, A				Minagawa, Kentaro; Jamil, Muhammad O.; Al-Obaidi, Mustafa; Pereboeva, Larisa; Salzman, Donna; Erba, Harry P.; Lamb, Lawrence S.; Bhatia, Ravi; Mineishi, Shin; Di Stasi, Antonio			In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia	PLOS ONE			English	Article							INDUCED KILLER-CELLS; SAFETY SWITCH; GEMTUZUMAB OZOGAMICIN; ON-TARGET; CASPASE-9; LYMPHOCYTES; DEATH; PHARMACOKINETICS; IMMUNOGLOBULIN; IMMUNOTHERAPY	Background Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose chemotherapy for patients at standard risk of relapse as assessed by cytogenetic and molecular analysis, or high-dose chemotherapy with allogeneic hematopoietic stem cell transplant for high-risk patients. Despite allogeneic hematopoietic stem cell transplant about 25% of patients still succumb to disease relapse, therefore, novel strategies are needed to improve the outcome of patients with acute myeloid leukemia. Methods and findings We developed an immunotherapeutic strategy targeting the CD33 myeloid antigen, expressed in similar to 85-90% of patients with acute myeloid leukemia, using chimeric antigen receptor redirected T-cells. Considering that administration of CAR T-cells has been associated with cytokine release syndrome and other potential off-tumor effects in patients, safety measures were here investigated and reported. We genetically modified human activated T-cells from healthy donors or patients with acute myeloid leukemia with retroviral supernatant encoding the inducible Caspase9 suicide gene, a Delta CD19 selectable marker, and a humanized third generation chimeric antigen receptor recognizing human CD33. Delta CD19 selected inducible Caspase9-CAR.CD33 T-cells had a 75 +/- 3.8% (average +/- standard error of the mean) chimeric antigen receptor expression, were able to specifically lyse CD33(+) targets in vitro, including freshly isolated leukemic blasts from patients, produce significant amount of tumor-necrosis-factor-alpha and interferon-gamma, express the CD107a degranulation marker, and proliferate upon antigen specific stimulation. Challenging Delta CD19 selected inducible Caspase9-CAR.CD33 T-cells with programmed-death-ligand-1 enriched leukemia blasts resulted in significant killing like observed for the programmed-death-ligand-1 negative leukemic blasts fraction. Since the administration of 10 nanomolar of a non-therapeutic dimerizer to activate the suicide gene resulted in the elimination of only 76.4 +/- 2.0% gene modified cells in vitro, we found that co-administration of the dimerizer with either the BCL-2 inhibitor ABT-199, the pan-BCL inhibitor ABT-737, or mafosfamide, resulted in an additive effect up to complete cell elimination. Conclusions This strategy could be investigated for the safety of CAR T-cell applications, and targeting CD33 could be used as a "bridge" therapy for patients coming to allogeneic hematopoietic stem cell transplant, as anti-leukemia activity from infusing CAR. CD33 T-cells has been demonstrated in an ongoing clinical trial. Albeit never performed in the clinical setting, our future plan is to investigate the utility of iC9-CAR. CD33 T-cells as part of the conditioning therapy for an allogeneic hematopoietic stem cell transplant for acute myeloid leukemia, together with other myelosuppressive agents, whilst the activation of the inducible Caspase9 suicide gene would grant elimination of the infused gene modified T-cells prior to stem cell infusion to reduce the risk of engraftment failure as the CD33 is also expressed on a proportion of the donor stem cell graft.	[Minagawa, Kentaro; Jamil, Muhammad O.; Al-Obaidi, Mustafa; Pereboeva, Larisa; Salzman, Donna; Erba, Harry P.; Lamb, Lawrence S.; Bhatia, Ravi; Mineishi, Shin; Di Stasi, Antonio] Univ Alabama Birmingham, Hematol Oncol, Birmingham, AL 35294 USA; [Mineishi, Shin] Penn State Hershey Med Ctr, Hematol Oncol, Hershey, PA USA	University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Di Stasi, A (corresponding author), Univ Alabama Birmingham, Hematol Oncol, Birmingham, AL 35294 USA.	adistasi@uabmc.edu		Minagawa, Kentaro/0000-0003-1740-7109; Lamb, Lawrence/0000-0001-7180-0994				Baev Denis V, 2014, Leuk Res Rep, V3, P79, DOI 10.1016/j.lrr.2014.06.001; Barese CN, 2015, STEM CELLS, V33, P91, DOI 10.1002/stem.1869; Bhatia S, 2014, HEMATOL-AM SOC HEMAT, P495, DOI 10.1182/asheducation-2014.1.495; Buckley SA, 2015, CURR HEMATOL MALIG R, V10, P65, DOI 10.1007/s11899-015-0250-9; Casucci M, 2013, BLOOD, V122, P3461, DOI 10.1182/blood-2013-04-493361; Chang EC, 2016, MOL THER, V24, P736, DOI 10.1038/mt.2015.217; Cheng SS, 2015, INT J BIOL MARKER, V30, pE364, DOI 10.5301/jbm.5000170; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dutour A, 2012, Adv Hematol, V2012, P683065, DOI 10.1155/2012/683065; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Finkelmeier F, 2016, EUR J CANCER, V59, P152, DOI 10.1016/j.ejca.2016.03.002; Gargett T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00235; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Gill S, 2014, BLOOD, V123, P2343, DOI 10.1182/blood-2013-09-529537; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Karlsson SCH, 2013, CANCER GENE THER, V20, P386, DOI 10.1038/cgt.2013.35; Kenderian SS, 2015, LEUKEMIA, V29, P1637, DOI 10.1038/leu.2015.52; Krupka C, 2016, LEUKEMIA, V30, P484, DOI 10.1038/leu.2015.214; Mardiros A, 2013, BLOOD, V122, P3138, DOI 10.1182/blood-2012-12-474056; Marin V, 2010, HAEMATOL-HEMATOL J, V95, P2144, DOI 10.3324/haematol.2010.026310; Maus MV, 2013, CANCER IMMUNOL RES, V1, P26, DOI 10.1158/2326-6066.CIR-13-0006; McMillan SJ, 2008, CARBOHYD RES, V343, P2050, DOI 10.1016/j.carres.2008.01.009; Minagawa K, 2015, PHARMACEUTICALS, V8, P230, DOI 10.3390/ph8020230; NAKAHATA T, 1994, LEUKEMIA LYMPHOMA, V13, P401, DOI 10.3109/10428199409049629; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pizzitola I, 2014, LEUKEMIA, V28, P1596, DOI 10.1038/leu.2014.62; Ritchie DS, 2013, MOL THER, V21, P2122, DOI 10.1038/mt.2013.154; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stasi R, 2008, EXPERT OPIN BIOL TH, V8, P527, DOI [10.1517/14712598.8.4.527, 10.1517/14712598.8.4.527 ]; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tettamanti S, 2013, BRIT J HAEMATOL, V161, P389, DOI 10.1111/bjh.12282; Thomas S, 2010, IMMUNOLOGY, V129, P170, DOI 10.1111/j.1365-2567.2009.03227.x; Wang L, 2015, ONCOTARGET, V6, P41228, DOI 10.18632/oncotarget.5682; Wang QS, 2015, MOL THER, V23, P184, DOI 10.1038/mt.2014.164; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhou XO, 2016, MOL THER, V24, P823, DOI 10.1038/mt.2015.234; Zhou XO, 2015, BLOOD, V125, P4103, DOI 10.1182/blood-2015-02-628354; Zhou XO, 2014, BLOOD, V123, P3895, DOI 10.1182/blood-2014-01-551671	48	60	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166891	10.1371/journal.pone.0166891	http://dx.doi.org/10.1371/journal.pone.0166891			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907031	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700049
J	Silva-Freitas, ML; Cota, GF; Machado-De-Assis, TS; Giacoia-Gripp, C; Rabello, A; Da-Cruz, AM; Santos-Oliveira, JR				Silva-Freitas, Maria Luciana; Cota, Glaucia Fernandes; Machado-de-Assis, Talia S.; Giacoia-Gripp, Carmem; Rabello, Ana; Da-Cruz, Alda M.; Santos-Oliveira, Joanna R.			Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; TIME; COINFECTION; DEPLETION; LESIONS; AIDS	The maintenance of chronic immune activation due to leishmaniasis or even due to microbial translocation is associated with immunosenescence and may contribute to frequent relapses. Our aim was to investigate whether patients with HIV-associated visceral leishmaniasis (VL/HIV) who experience a single episode of VL have different immunological behaviors in comparison to those who experience frequent relapses. VL/HIV patients were allocated to non-relapsing (NR, n = 6) and relapsing (R, n = 11) groups and were followed from the active phase of VL up to 12 months post-treatment (mpt). The patients were receiving highly active antiretroviral therapy (HAART) and secondary prophylaxis after VL therapy. During active VL, the two groups were similar in all immunological parameters, including the parasite load. At 6 and 12 mpt, the NR group showed a significant gain of CD4(+) T cells, a reduction of lymphocyte activation, and lower soluble CD14 and anti-Leishmania IgG3 levels compared to the R group. The viral load remained low, without correlation with the activation. The two groups showed elevated but similar percentages of senescent T cells. These findings suggest a decreased ability of the R group to downmodulate immune activation compared to the NR group. Such functional impairment of the effector response may be a useful indicator for predicting clinical prognosis and recommending starting or stopping secondary prophylaxis.	[Silva-Freitas, Maria Luciana; Da-Cruz, Alda M.; Santos-Oliveira, Joanna R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Rio De Janeiro, Brazil; [Cota, Glaucia Fernandes; Machado-de-Assis, Talia S.; Rabello, Ana] Fiocruz MS, Lab Pesquisas Clin & Polit Publ Doencas Infeccios, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Cota, Glaucia Fernandes; Machado-de-Assis, Talia S.] Hosp Eduardo de Menezes, Fundacao Hosp Estado Minas Gerais, FHEMIG, Belo Horizonte, MG, Brazil; [Giacoia-Gripp, Carmem] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol, Rio De Janeiro, Rio De Janeiro, Brazil; [Santos-Oliveira, Joanna R.] IFRJ, Inst Fed Educ Ciencia & Tecnol, Nucleo Ciencias Biomed Aplicadas, Rio De Janeiro, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Federal do Rio de Janeiro (IFRJ); Instituto Federal do Sertao Pernambucano	Santos-Oliveira, JR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Rio De Janeiro, Brazil.; Santos-Oliveira, JR (corresponding author), IFRJ, Inst Fed Educ Ciencia & Tecnol, Nucleo Ciencias Biomed Aplicadas, Rio De Janeiro, Rio De Janeiro, Brazil.	joannareisoliveira@gmail.com	Cota, Glaucia/ABC-5378-2020; Da-Cruz, Alda Maria/J-2152-2012	Cota, Glaucia/0000-0003-0538-7403; 	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/111.443/2013]; Instituto Oswaldo Cruze FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e tecnologico - CNPq	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Oswaldo Cruze FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by: 1- Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, http://www.faperj.br/ (E-26/111.443/2013) - JRSO; 2- Instituto Oswaldo Cruze FIOCRUZ - http://www.fiocruz.br/ioc/cgi/cgilua.exe/sys/start.htm?tpl=home (Fellowship - MLSF); 3- Conselho Nacional de Desenvolvimento Cientifico e tecnologico - CNPq, http://cnpq.br/ (Fellowship - AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2016, HIV AIDS-RES PALLIAT, V8, P75, DOI 10.2147/HIV.S96883; Alexandrino-de-Oliveira P, 2010, MEM I OSWALDO CRUZ, V105, P692, DOI 10.1590/S0074-02762010000500016; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Baba Chalamalasetty Sreenivasa, 2006, Indian J Gastroenterol, V25, P309; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Casado JL, 2015, HIV MED, V16, P240, DOI 10.1111/hiv.12206; Casado JL, 2001, EUR J CLIN MICROBIOL, V20, P202, DOI 10.1007/s100960100457; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054676; Cota GF, 2011, PLOS NEGLECT TROP D, V5, P1; Cota GF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002816; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239; Cruz I, 2006, INDIAN J MED RES, V123, P357; Da-Cruz AM, 2000, T ROY SOC TROP MED H, V94, P569, DOI 10.1016/S0035-9203(00)90090-7; de la Rosa R, 2001, CLIN INFECT DIS, V32, P633, DOI 10.1086/318708; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; del Giudice P, 2002, J INFECT DIS, V186, P1366, DOI 10.1086/344325; Demarchi IG, 2012, PARASITOL INT, V61, P538, DOI 10.1016/j.parint.2012.04.006; Fagundes-Silva GA, 2012, PARASITE IMMUNOL, V34, P486, DOI 10.1111/j.1365-3024.2012.01379.x; Gomes LI, 2012, EXP PARASITOL, V131, P175, DOI 10.1016/j.exppara.2012.03.021; Senent SG, 2009, GASTROENTEROL HEPATO, V32, P176, DOI 10.1016/j.gastrohep.2008.09.021; Hicks L, 2009, EUR J GASTROEN HEPAT, V21, P117, DOI 10.1097/MEG.0b013e32830e6fdb; Kaushal H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0653-6; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136; Luz KG, 2010, REV SOC BRAS MED TRO, V43, P393, DOI 10.1590/S0037-86822010000400011; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Medrano FJ, 1998, CLIN EXP IMMUNOL, V114, P403; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021; Okwor I, 2013, IMMUNOL RES, V56, P163, DOI 10.1007/s12026-013-8389-8; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Santos LO, 2013, J ANTIMICROB CHEMOTH, V68, P348, DOI 10.1093/jac/dks410; Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198; Santos-Oliveira JR, 2013, J INFECT DIS, V208, P57, DOI 10.1093/infdis/jit135; Santos-Oliveira JR, 2011, AM J TROP MED HYG, V85, P55, DOI 10.4269/ajtmh.2011.10-0398; Santos-Oliveira JR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-358; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Villanueva JL, 2000, EUR J CLIN MICROBIOL, V19, P798, DOI 10.1007/s100960000364; Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583; Zijlstra EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003258	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167512	10.1371/journal.pone.0167512	http://dx.doi.org/10.1371/journal.pone.0167512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907136	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700177
J	Lallawmsanga; Passari, AK; Mishra, VK; Leo, VV; Singh, BP; Meyyappan, GV; Gupta, VK; Uthandi, S; Upadhyay, RC				Lallawmsanga; Passari, Ajit Kumar; Mishra, Vineet Kumar; Leo, Vincent Vineeth; Singh, Bhim Pratap; Meyyappan, Geetha Valliammai; Gupta, Vijai Kumar; Uthandi, Sivakumar; Upadhyay, Ramesh Chandra			Antimicrobial Potential, Identification and Phylogenetic Affiliation of Wild Mushrooms from Two Sub-Tropical Semi-Evergreen Indian Forest Ecosystems	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; EDIBLE MUSHROOMS; AURICULARIA-AURICULA; GENETIC DIVERSITY; LENTINULA-EDODES; BIOACTIVE COMPOUNDS; CULTIVATED STRAINS; ANTIOXIDANT; CHINA; RAPD	The diversity of wild mushrooms was investigated from two protected forest areas in India and 231 mushroom specimens were morphologically identified. Among them, 76 isolates were screened for their antimicrobial potential against seven bacterial and fungal pathogens. Out of 76 isolates, 45 isolates which displayed significant antimicrobial activities were identified using ITS rRNA gene amplification and subsequently phylogenetically characterized using random amplified polymorphic DNA (RAPD) and inter-simple sequence repeat (ISSR) markers. Sequencing of the ITS rRNA region classified the isolates into 16 genera belonging to 11 families. In total, 11 RAPD and 10 ISSR primers were selected to evaluate genetic diversity based on their banding profile produced. In total 337 RAPD and 312 ISSR bands were detected, among which percentage of polymorphism ranges from 34.2% to 78.8% and 38.6% to 92.4% by using RAPD and ISSR primers respectively. Unweighted Pair-Group Method with Arithmetic Mean (UPGMA) trees of selected two methods were structured similarly, grouping the 46 isolates into two clusters which clearly showed a significant genetic distance among the different strains of wild mushroom, with an similarity coefficient ranges from 0.58 to 1.00 and 0.59 to 1.00 with RAPD and ISSR analysis respectively. This reporthas highlighted both DTR and MNP forests provide a habitat for diverse macrofungal species, therefore having the potential to be used for the discovery of antimicrobials. The report has also demonstrated that both RAPD and ISSR could efficiently differentiate wild mushrooms and could thus be considered as efficient markers for surveying genetic diversity. Additionally, selected six wild edible mushroom strains (Schizophyllum commune BPSM01, Panusgiganteus BPSM27, Pleurotussp. BPSM34, Lentinussp. BPSM37, Pleurotusdjamor BPSM41 and Lentinula sp. BPSM45) were analysed for their nutritional (proteins, carbohydrates, fat and ash content), antioxidant potential. The present findings also suggested that the wild edible mushroom strains do not have only nutritional values but also can be used as an accessible source of natural antioxidants.	[Lallawmsanga; Passari, Ajit Kumar; Mishra, Vineet Kumar; Leo, Vincent Vineeth; Singh, Bhim Pratap] Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Mizoram, India; [Gupta, Vijai Kumar] Natl Univ Ireland Galway, Dept Biochem, Mol Glycobiotechnol Grp, Galway, Ireland; [Meyyappan, Geetha Valliammai; Uthandi, Sivakumar] Tamil Nadu Agr Univ, Dept Agr Microbiol, Coimbatore, Tamil Nadu, India; [Upadhyay, Ramesh Chandra] ICAR Res Complex, Directorate Mushroom Res, Solan, Himachal Prades, India	Mizoram University; Ollscoil na Gaillimhe-University of Galway; Tamil Nadu Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Mushroom Research	Singh, BP (corresponding author), Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Mizoram, India.	bhimpratap@gmail.com	Uthandi, Sivakumar/C-3277-2018; Gupta, Vijai Kumar/O-2445-2014; Singh, Bhim Pratap/G-7268-2016; Passari, Ajit Kumar/X-9807-2019	Uthandi, Sivakumar/0000-0002-7116-1317; Gupta, Vijai Kumar/0000-0003-1565-5918; Singh, Bhim Pratap/0000-0002-9911-4125; Passari, Ajit Kumar/0000-0002-1150-8075; Leo, Vincent Vineeth/0000-0003-1700-2259; LALLAWMSANGA, LALLAWMSANGA/0000-0002-7179-7892	DBT sponsored NER-Twinning project, the Government of India, New Delhi [BT/320/NE/TBP/2012]	DBT sponsored NER-Twinning project, the Government of India, New Delhi	This work was supported by grants sanctioned to BPS from the DBT sponsored NER-Twinning project (No. BT/320/NE/TBP/2012), the Government of India, New Delhi. Authors are thankful to the Department of Biotechnology, for establishment of DBT-BIF centre and DBT-State Biotech Hub in the Department, which has beenused for the present study.	Acharya Krishnendu, 2004, Indian Journal of Experimental Biology, V42, P538; Agrahar-Murugkar D, 2005, FOOD CHEM, V89, P599, DOI 10.1016/j.foodchem.2004.03.042; Andrew E. E., 2013, Journal of Ecology and the Natural Environment, V5, P318; Angelini P, 2016, PLANT BIOSYST, V150, P540, DOI 10.1080/11263504.2014.987844; [Anonymous], 1994, NREL CAT TASK LAB AN; Barros L, 2007, EUR FOOD RES TECHNOL, V225, P151, DOI 10.1007/s00217-006-0394-x; Barua P, 1998, Anc Sci Life, V17, P190; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bhunia SK, 2010, CARBOHYD RES, V345, P2542, DOI 10.1016/j.carres.2010.09.015; Bisht NS, 2011, WOOD DECAYING FUNGI; Bolla K., 2011, International Journal of Agricultural Technology, V7, P957; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai M, 2015, INT J MED MUSHROOMS, V17, P591, DOI 10.1615/IntJMedMushrooms.v17.i6.90; Calvo-Bado L, 2000, APPL ENVIRON MICROB, V66, P728, DOI 10.1128/AEM.66.2.728-734.2000; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Chang S. T., 2003, Current Topics in Nutraceutical Research, V1, P257; Chang ST, 2004, MUSHROOMS CULTIVATIO, P189; Chiu SW, 1996, MYCOL RES, V100, P1393, DOI 10.1016/S0953-7562(96)80069-4; Chowdhury MMH, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0067-3; Das Sudip Kumar, 2015, Proceedings of the Indian National Science Academy Part B Biological Sciences, V85, P219, DOI 10.1007/s40011-014-0330-y; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; Du P, 2013, BIOCHEM SYST ECOL, V48, P199, DOI 10.1016/j.bse.2012.11.011; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dursun N, 2006, J SCI FOOD AGR, V86, P1087, DOI 10.1002/jsfa.2462; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandes A, 2016, LWT-FOOD SCI TECHNOL, V69, P91, DOI 10.1016/j.lwt.2016.01.037; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guan XJ, 2008, WORLD J MICROB BIOT, V24, P1617, DOI 10.1007/s11274-007-9647-5; Hrudayanath Thatoi, 2014, African Journal of Biotechnology, V13, P523; Hseu RS, 1996, APPL ENVIRON MICROB, V62, P1354, DOI 10.1128/AEM.62.4.1354-1363.1996; Ishikawa NK, 2001, BRAZ J MICROBIOL, V32, P206, DOI 10.1590/S1517-83822001000300008; Islam T, 2016, LWT-FOOD SCI TECHNOL, V72, P423, DOI 10.1016/j.lwt.2016.05.005; Jagadeesh R, 2010, INT J MICROBIOL RES, V1, P110; Jagadish LK, 2009, AFR J BIOTECHNOL, V8, P654; Jose Nayana, 2002, International Journal of Medicinal Mushrooms, V4, P329; Kanaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026654; Khaund P, 2014, J KOREAN SOC APPL BI, V57, P263, DOI 10.1007/s13765-013-4225-z; Kosanic M, 2016, J FOOD DRUG ANAL, V24, P477, DOI 10.1016/j.jfda.2016.01.008; Krishna G, 2015, J MYCOL, DOI [10.1155/2015/382476, DOI 10.1155/2015/382476]; Kristensen HL, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.7114; Kusari P, 2013, FUNGAL DIVERS, V60, P137, DOI 10.1007/s13225-012-0216-3; Largent DL, 1986, IDENTIFY MUSHROOMS G, P1; Lee JS, 2006, J MICROBIOL, V44, P29; Liang HH, 2008, J MICROBIOL, V46, P549, DOI 10.1007/s12275-008-0107-1; Mahendra Rai, 2005, Natural Product Radiance, V4, P246; Manjunathan J., 2010, International Journal of PharmTech Research, V2, P1910; Mattila P, 2000, NUTRITION, V16, P694, DOI 10.1016/S0899-9007(00)00341-5; Metuku RP, 2014, 3 BIOTECH, V4, P227, DOI 10.1007/s13205-013-0138-0; Miles LA, 2012, BIOCONTROL, V57, P697, DOI 10.1007/s10526-012-9442-6; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Moore AJ, 2001, APPL MICROBIOL BIOT, V55, P742, DOI 10.1007/s002530000588; Munkhgerell L., 2013, MONGOLIAN J CHEM, V14, P41, DOI DOI 10.5564/MJC.V14I0.197; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nowacka N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140355; Olukanni OD, 2006, AFR J BIOTECHNOL, V5, P1980; Osman M, 2014, J CHEM BIOPHYSCI B, V5, P545; Oyetayo VO, 2009, TROP J PHARM RES, V6, P809; Park HG, 2004, J MICROBIOL BIOTECHN, V14, P816; PATERSON AH, 1991, ADV AGRON, V46, P39; Rajaratnam S, 2012, EUROPEAN J EXPT BIOL, V2, P369; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Ramesh C, 2010, PHARMACOGN RES, V2, P107, DOI 10.4103/0974-8490.62953; Ramirez Lucia, 2000, International Microbiology, V3, P147; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reis FS, 2011, J FOOD SCI, V76, pC824, DOI 10.1111/j.1750-3841.2011.02251.x; Ro HS, 2007, MYCOL RES, V111, P710, DOI 10.1016/j.mycres.2007.03.016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; Smolskaite L, 2015, LWT-FOOD SCI TECHNOL, V60, P462, DOI 10.1016/j.lwt.2014.08.007; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Tambekar D. H., 2006, IJP - International Journal of Pharmacology, V2, P582; Tamrakar S, 2016, J NAT MED-TOKYO, V70, P769, DOI 10.1007/s11418-016-1013-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang LH, 2010, CURR MICROBIOL, V61, P132, DOI 10.1007/s00284-010-9587-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibuhwa DD, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-49; Udu-Ibiam OE, 2014, INT J SCI TECH RES, V3; Vialle A, 2009, MOL ECOL RESOUR, V9, P99, DOI 10.1111/j.1755-0998.2009.02637.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wong JY, 2009, J FOOD COMPOS ANAL, V22, P269, DOI 10.1016/j.jfca.2008.11.021; Yan PS, 2004, WORLD J MICROB BIOT, V20, P795, DOI 10.1007/s11274-004-5840-y; Yin YG, 2014, CURR MICROBIOL, V68, P397, DOI 10.1007/s00284-013-0489-0; Yu MY, 2008, CURR MICROBIOL, V56, P240, DOI 10.1007/s00284-007-9067-7; Yuan ZM, 1998, J NUTR SCI VITAMINOL, V44, P829, DOI 10.3177/jnsv.44.829; Zhang RY, 2007, APPL MICROBIOL BIOT, V74, P140, DOI 10.1007/s00253-006-0628-7; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	92	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166368	10.1371/journal.pone.0166368	http://dx.doi.org/10.1371/journal.pone.0166368			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902725	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100022
J	Almquist, ZW; Bagozzi, BE				Almquist, Zack W.; Bagozzi, Benjamin E.			The Spatial Properties of Radical Environmental Organizations in the UK: Do or Die!	PLOS ONE			English	Article							NETWORKS; DIFFUSION; EMERGENCE; MODELS	Radical environmental groups and their members have a wide and varied agenda which often encompasses both local and global issues. In their efforts to call attention to environmental problems, communicate with like-minded groups, and mobilize support for their activities, radical environmental organizations also produce an enormous amount of text, which can be used to estimate the complex communications and task-based networks that underlie these organizations. Moreover, the tactics employed to garnish attention for these groups' agenda can range from peaceful activities such as information dissemination to violent activities such as fire-bombing buildings. To obtain these varied objectives, radical environmental organizations must harness their networks, which have an important spatial component that structures their ability to communicate, coordinate and act on any given agenda item. Here, we analyze a network built from communications and information provided by the semi-annual "Do or Die" (DoD) magazine published in the UK over a 10 year period in the late 1990s and early 2000s. We first employ structural topic model methods to discover violent and nonviolent actors within the larger environmental community. Using this designation, we then compare the spatial structure of these groups, finding that violent groups are especially likely to engage in coordination and/or communication if they are sufficiently close, but exhibit a quickly decreasing probability of interaction over even a few kilometers. Further, violent and nonviolent groups each have a higher probability of coordination with their own group than across groups over even short distances. In these respects, we see that violent groups are especially local in their organization and that their geographic reach is likely very limited. This suggests that nonviolent environmental groups seek each other out over both large and short distances for communication and coordination, but violent groups tend to be highly localized.	[Almquist, Zack W.] Univ Minnesota, Sch Stat, Dept Sociol, St Paul, MN USA; [Almquist, Zack W.] Univ Minnesota, MPC, St Paul, MN USA; [Bagozzi, Benjamin E.] Univ Delaware, Dept Polit Sci & Int Relat, Newark, DE USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Delaware	Almquist, ZW (corresponding author), Univ Minnesota, Sch Stat, Dept Sociol, St Paul, MN USA.; Almquist, ZW (corresponding author), Univ Minnesota, MPC, St Paul, MN USA.	almquist@umn.edu		Almquist, Zack/0000-0002-1967-123X	Army Research Office [W911NF-14-1-0577]	Army Research Office	This work was supported by Army Research Office, Young Investigator Program, Award #W911NF-14-1-0577 (http://www.arl.army. mil/www/default.ctm?page=29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman GA, 2003, TERROR POLIT VIOLENC, V15, P143, DOI 10.1080/09546550390449935; Almquist ZW, 2015, GEOGR ANAL, V47, P50, DOI 10.1111/gean.12045; Almquist ZW, 2012, SOC NETWORKS, V34, P493, DOI 10.1016/j.socnet.2012.03.002; Almquist ZW, 2012, DEMOGR RES, V26, P593, DOI 10.4054/DemRes.2012.26.22; Almquist ZW, 2015, WORKING PAPER; [Anonymous], 1999, STUDIES CONFLICT TER, DOI 10.1080/105761099265748; Ansell Ch, 2003, SOCIAL MOVEMENTS NET; Asal V, 2008, J POLIT, V70, P437, DOI 10.1017/S0022381608080419; Backstrom L., 2010, PROCEEDINGS OF THE 1, P61, DOI [10.1145/1772690.1772698, DOI 10.1145/1772690.1772698]; Beaumont J, 2007, ENVIRON PLANN A, V39, P29; BLAU PM, 1977, AM J SOCIOL, V83, P26, DOI 10.1086/226505; Boessen A, 2014, AM J COMMUN PSYCHOL, V53, P447, DOI 10.1007/s10464-014-9639-1; Bossard JHS, 1932, AM J SOCIOL, V38, P219, DOI 10.1086/216031; Burris V., 2000, SOCIOL FOCUS, V33, DOI https://doi.org/10.1080/00380237.2000.10571166; Butts C. T., 2002, THESIS; Butts C.T., 2011, SAGE HDB GIS SOC RES, P222, DOI DOI 10.4135/9781446201046.N12; Butts CT, 2012, SOC NETWORKS, V34, P82, DOI 10.1016/j.socnet.2011.08.003; Butts CT, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P313; Caspi D, 2010, THESIS; Chalecki EL, 2002, GLOBAL ENVIRON POLIT, V2, P103, DOI [DOI 10.1162/152638002317261463, 10.1162/152638002317261463]; Chermak S, 2013, STUD CONFL TERROR, V36, P193, DOI 10.1080/1057610X.2013.755912; Cunningham D, 2003, SOC SCI HIST, V27, P327, DOI 10.1215/01455532-27-3-327; Fafchamps M, 2010, J EUR ECON ASSOC, V8, P203, DOI 10.1162/jeea.2010.8.1.203; Festinger L., 1950, SOCIAL PRESSURES INF; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1988, J SOC BIOL STRUCT, V11, P415, DOI 10.1016/0140-1750(88)90080-2; Gerstenfeld P.B., 2003, ANAL SOCIAL ISSUES P, V3, DOI [DOI 10.1111/J.1530-2415.2003.00013.X, https://doi.org/10.1111/j.1530-2415.2003.00013.x]; GOULD RV, 1991, AM SOCIOL REV, V56, P716, DOI 10.2307/2096251; Hagerstrand T., 1966, PAP REG SCI ASS, V16, P27, DOI [10.1007/BF01888934, DOI 10.1007/BF01888934]; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Haynes KE, 1984, SCI GEOGRAPHY, V2; HEDSTROM P, 1994, AM J SOCIOL, V99, P1157, DOI 10.1086/230408; Henry AD, 2011, P NATL ACAD SCI USA, V108, P8605, DOI 10.1073/pnas.1014486108; Hipp JR, 2009, CITY COMMUNITY, V8, P5, DOI 10.1111/j.1540-6040.2009.01267.x; Ho P, 2001, DEV CHANGE, V32, P893, DOI 10.1111/1467-7660.00231; Horowitz MC, 2010, INT ORGAN, V64, P33, DOI 10.1017/S0020818309990233; Joosse P, 2007, TERROR POLIT VIOLENC, V19, P351, DOI 10.1080/09546550701424042; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kenney M., 2007, PABLO OSAMA TRAFFICK; Kousis M, 1999, ENV MOVEMENTLOCAL, P149; Krivitsky P. N., 2008, J STAT SOFTWARE, V24; LATANE B, 1994, BEHAV SCI, V39, P1, DOI 10.1002/bs.3830390102; Leader SH, 2003, TERROR POLIT VIOLENC, V15, P37, DOI 10.1080/09546550390449872; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Marx GT, 2003, J SOC ISSUES, V59, P369, DOI 10.1111/1540-4560.00069; MCADAM D, 1986, AM J SOCIOL, V92, P64, DOI 10.1086/228463; MCPHERSON JM, 1991, SOC FORCES, V70, P19, DOI 10.2307/2580060; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Medina R, 2008, STUD GLOB JUSTICE, V4, P151; Medina RM, 2011, T GIS, V15, P577, DOI 10.1111/j.1467-9671.2011.001281.x; Moon IC, 2007, IEEE INTELL SYST, V22, P40, DOI 10.1109/MIS.2007.4338493; Perry B, 2009, INF COMMUN TECHNOL L, V18, P185, DOI 10.1080/13600830902814984; Pianta M, 2001, PARALLEL SUMMITS GLO; Plows A, 2001, EARTH LIBERATION FRO; Plows A., 2004, SOC MOVEMENT STUD, V3, P199, DOI 10.1080/1474283042000266128; Posner RA, 2008, U CHICAGO LAW REV, V75, P245; Raab J, 2003, J PUBL ADM RES THEOR, V13, P413, DOI 10.1093/jopart/mug029; Ramana P., 2011, MEASURES DEAL LEFT W; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Rootes C, 1997, TECHNOLOGY ENV US, P30; Rydgren J, 2005, EUR J POLIT RES, V44, P413, DOI 10.1111/j.1475-6765.2005.00233.x; Sageman M, 2004, UNDERSTANDING TERROR NETWORKS, P1; Saunders Clare, 2007, GRADUATE J SOCIAL SC, V1, P109; Schlosberg David., 1999, ENVIRON POLIT, V6, P122, DOI [10.1080/09644019908414441, DOI 10.1080/09644019908414441]; Smith B.L., 2009, CRIMINOL PUBLIC POL, V8, P475, DOI 10.1111/j.1745-9133.2009.00571.x; Smith BL, GEOSPATIAL ANAL TERR; Smith E. J., 2014, J GERONTOL B-PSYCHOL, V70, P91, DOI DOI 10.1093/GER0NB/GBU142; Spiro ES., 2016, SOCIUS, V2, P1, DOI DOI 10.1177/2378023116634340; Wall D., 1999, ENVIRON POLIT, V8, P81, DOI DOI 10.1080/; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zanini M, 2001, NETWORKS NETWARDS FU	72	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166609	10.1371/journal.pone.0166609	http://dx.doi.org/10.1371/journal.pone.0166609			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898689	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000013
J	Arensman, E; Bennardi, M; Larkin, C; Wall, A; McAuliffe, C; McCarthy, J; Williamson, E; Perry, IJ				Arensman, Ella; Bennardi, Marco; Larkin, Celine; Wall, Amanda; McAuliffe, Carmel; McCarthy, Jacklyn; Williamson, Eileen; Perry, Ivan J.			Suicide among Young People and Adults in Ireland: Method Characteristics, Toxicological Analysis and Substance Abuse Histories Compared	PLOS ONE			English	Article							GENDER-DIFFERENCES; BINGE DRINKING; AGED 15-24; ALCOHOL; ACCESS; BEHAVIORS; MORTALITY; PATTERNS; ISSUES; CHOICE	Objective Information on factors associated with suicide among young individuals in Ireland is limited. The aim of this study was to identify socio-demographic characteristics and circumstances of death associated with age among individuals who died by suicide. Methods The study examined 121 consecutive suicides (2007-2012) occurring in the southern eastern part of Ireland (Cork city and county). Data were obtained from coroners, family informants, and health care professionals. A comparison was made between 15-24-year-old and 25-34-year-old individuals. Socio-demographic characteristics of the deceased, methods of suicide, history of alcohol and drug abuse, and findings from toxicological analysis of blood and urine samples taken at post mortem were included. Pearson's chi(2) tests and binary logistic regression analysis were performed. Results Alcohol and/or drugs were detected through toxicological analysis for the majority of the total sample (79.5%), which did not differentiate between 15-24-year-old and 25-34-year-old individuals (74.1% and 86.2% respectively). Compared to 25-34-year-old individuals, 15-24-year-old individuals were more likely to engage in suicide by hanging (88.5%). Younger individuals were less likely to die by intentional drug overdose and carbon monoxide poisoning compared to older individuals. Younger individuals who died between Saturday and Monday were more likely to have had alcohol before dying. Substance abuse histories were similar in the two age groups. Conclusion Based on this research it is recommended that strategies to reduce substance abuse be applied among 25-34-year-old individuals at risk of suicide. The wide use of hanging in young people should be taken into consideration for future means restriction strategies.	[Arensman, Ella; Bennardi, Marco; Larkin, Celine; Wall, Amanda; McCarthy, Jacklyn; Williamson, Eileen] Univ Coll Cork, Natl Suicide Res Fdn, Cork, Ireland; [Arensman, Ella; Perry, Ivan J.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [McAuliffe, Carmel] St Patricks Mental Hlth Serv, Cork, Ireland	University College Cork; University College Cork	Bennardi, M (corresponding author), Univ Coll Cork, Natl Suicide Res Fdn, Cork, Ireland.	marco.bennardi@gmail.com	Bennardi, Marco/ABC-4493-2020	Bennardi, Marco/0000-0001-8934-5416; Arensman, Ella/0000-0003-0376-1203; Larkin, Celine/0000-0003-2961-0585; Perry, Ivan/0000-0002-4965-9792	National Office for Suicide Prevention; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 [316795]; EU	National Office for Suicide Prevention; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7; EU(European Commission)	The first phase of the Suicide Support and Information System (September 2008 - March 2011) was funded by the National Office for Suicide Prevention. The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007 2013 under REA grant agreement no 316795.; We would like to thank Dr. Carla Sabariego and Prof. Alarcos Cieza for their helpful suggestions provided at the meeting 'Scientific Paper Reviews' that was offered in the scope of the EU-funded project MARATONE.	Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; [Anonymous], 2011, IBM SPSS STAT WINDOW; Arensman E., 2013, 2 REPORT SUICIDE SUP; Arensman E, 2012, 1 REPORT SUICIDE SUP; Arnett J. J, 2014, ADOLESCENCE EMERGING; Aseltine RH, 2009, J AM ACAD CHILD PSY, V48, P262, DOI 10.1097/CHI.0b013e318195bce8; Baca-Garcia E, 2001, J CLIN PSYCHIAT; Barnes LS, 2001, SUICIDE LIFE-THREAT, V32, P68, DOI 10.1521/suli.32.1.5.68.24217; Bedford D, 2006, Ir Med J, V99, P80; Biddle L, 2006, BRIT J GEN PRACT, V56, P924; Biddle L, 2012, J AFFECT DISORDERS, V136, P702, DOI 10.1016/j.jad.2011.10.004; Biddle L, 2010, BRIT J PSYCHIAT, V197, P320, DOI 10.1192/bjp.bp.109.076349; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bowers L, 2010, J NERV MENT DIS, V198, P315, DOI 10.1097/NMD.0b013e3181da47e2; Callanan VJ, 2012, SOC PSYCH PSYCH EPID, V47, P857, DOI 10.1007/s00127-011-0393-5; Cantor CH, 1998, AUST NZ J PSYCHIAT, V32, P8, DOI 10.3109/00048679809062700; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Cherpitel CJ, 2004, ALCOHOL CLIN EXP RES, V28, p18S, DOI 10.1097/01.ALC.0000127411.61634.14; Conner KR, 2011, SUICIDE LIFE-THREAT, V41, P594, DOI 10.1111/j.1943-278X.2011.00057.x; Conwell Y, 2002, AM J GERIAT PSYCHIAT, V10, P407, DOI 10.1176/appi.ajgp.10.4.407; Corcoran P, 2015, INT J EPIDEMIOL; Davoren MP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006045; Economic UNDo, 2007, WORLD YOUTH REP 2007; Elnour AA, 2008, INJURY PREV, V14, P39, DOI 10.1136/ip.2007.016246; FARMER R, 1980, ACTA PSYCHIAT SCAND, V62, P436, DOI 10.1111/j.1600-0447.1980.tb00632.x; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Health-Service-Executive N-S-R-G Department-of-Health-and-Children, 2005, REACH OUT IR NAT STR; Hingson R., 2004, SOCIAL HLTH EC CONSE; Houston K, 2001, J AFFECT DISORDERS, V63, P159, DOI 10.1016/S0165-0327(00)00175-0; Kanchan T, 2009, J FORENSIC SCI, V54, P938, DOI 10.1111/j.1556-4029.2009.01054.x; KAPLAN MS, 1994, GERONTOLOGIST, V34, P59, DOI 10.1093/geront/34.1.59; Kuntsche E, 2006, ADDICT BEHAV, V31, P1844, DOI 10.1016/j.addbeh.2005.12.028; Kuntsche E, 2012, DRUG ALCOHOL DEPEN, V124, P319, DOI 10.1016/j.drugalcdep.2012.02.001; Lin J-J, 2010, BMC PUBLIC HEALTH, V10, P1; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Long J., 2014, ALCOHOL CONSUMPTION; Mahay J, 2007, J FAM ISSUES, V28, P706, DOI 10.1177/0192513X06297272; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Owens C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5801; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Pirkis J, 2001, Crisis, V22, P155, DOI 10.1027//0227-5910.22.4.155; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; Pompili M, 2010, INT J ENV RES PUB HE, V7, P1392, DOI 10.3390/ijerph7041392; ROSENBERG ML, 1988, J FORENSIC SCI, V33, P1445; Samaritans T., 2002, MEDIA GUIDELINES POR; Schaffer M, 2008, ARCH SUICIDE RES, V12, P124, DOI 10.1080/13811110701857111; Skibin L, 2005, FORENSIC SCI INT, V147, pS49, DOI 10.1016/j.forsciint.2004.09.083; Snider JE, 2006, SUICIDE LIFE-THREAT, V36, P511, DOI 10.1521/suli.2006.36.5.511; SOUTH SJ, 1993, J MARRIAGE FAM, V55, P357, DOI 10.2307/352807; Stack Steven, 2005, Arch Suicide Res, V9, P57, DOI 10.1080/13811110590512949; Uzun Ibrahim, 2007, J Forensic Leg Med, V14, P406, DOI 10.1016/j.jflm.2007.01.002; Varnik A, 2009, J AFFECT DISORDERS, V113, P216, DOI 10.1016/j.jad.2008.06.004; Walsh B, 2011, ECON SOC REV, V42, P27; World Health Organization, 2008, PREV SUIC RES MED PR; World-Health-Organization, 2014, PREV SUIC GLOB IMP; Wulfert E, 2002, J PERS, V70, P533	57	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166881	10.1371/journal.pone.0166881	http://dx.doi.org/10.1371/journal.pone.0166881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898722	Green Published, gold			2022-12-27	WOS:000389474000020
J	Brandl, C; Breinlich, V; Stark, KJ; Enzinger, S; Assenmacher, M; Olden, M; Grassmann, F; Graw, J; Heier, M; Peters, A; Helbig, H; Kuchenhoff, H; Weber, BHF; Heid, IM				Brandl, Caroline; Breinlich, Valentin; Stark, Klaus J.; Enzinger, Sabrina; Assenmacher, Matthias; Olden, Matthias; Grassmann, Felix; Graw, Jochen; Heier, Margit; Peters, Annette; Helbig, Horst; Kuechenhoff, Helmut; Weber, Bernhard H. F.; Heid, Iris M.			Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LONG-TERM INCIDENCE; SEVERITY SCALE; EYE DISEASE; 10-YEAR INCIDENCE; CATARACT-SURGERY; POOLED FINDINGS; PREVALENCE; MACULOPATHY; CLASSIFICATION	Age-related macular degeneration (AMD) is a vision impairing disease of the central retina characterized by early and late forms in individuals older than 50 years of age. However, there is little knowledge to what extent also younger adults are affected. We have thus set out to estimate the prevalence of early AMD features and late AMD in a general adult population by acquiring color fundus images in 2,840 individuals aged 25 to 74 years of the Cooperative Health Research in the Region of Augsburg project (KORA) in South Germany. Among the 2,546 participants with gradable images for each eye, 10.9% (n = 277) had early AMD features (applying the 9-step Age-Related Eye Disease Study Severity Scale), 0.2% (n = 6) had late AMD. Prevalence increased with age, reaching 26.3% for early AMD features and 1.9% for late AMD at the age 70+. However, signs of early AMD were found in subjects as young as 25 years, with the risk for early AMD features increasing linearly by years of age in men, and, less consistent with a linear increase, in women. Risk for early AMD features increased linearly by pack years of smoking in men, not in women, nor was there any association with other lifestyle or metabolic factors. By providing much sought-after prevalence estimates for AMD from Central Europe, our data underscores a substantial proportion of the adult population with signs of early AMD, including individuals younger than 50 years. This supports the notion that early AMD features in the young might be under-acknowledged.	[Brandl, Caroline; Stark, Klaus J.; Olden, Matthias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Brandl, Caroline; Helbig, Horst] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Brandl, Caroline; Breinlich, Valentin; Grassmann, Felix; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Enzinger, Sabrina; Assenmacher, Matthias; Kuechenhoff, Helmut] Ludwig Maximilians Univ Munchen, Stat Consulting Unit, StaBLab, Dept Stat, Munich, Germany; [Graw, Jochen] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Heier, Margit; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Heid, Iris M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany.; Heid, IM (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany.	iris.heid@klinik.uni-regensburg.de	Heier, Margit/AAT-5280-2020; Stark, Klaus/L-7367-2013; Peters, Annette/A-6117-2011	Stark, Klaus/0000-0002-7832-1942; Peters, Annette/0000-0001-6645-0985; Graw, Jochen/0000-0003-0298-9660; Kuchenhoff, Helmut/0000-0002-6372-2487; Grassmann, Felix/0000-0003-1390-7528; Brandl, Caroline/0000-0001-8223-6137; Assenmacher, Matthias/0000-0003-2154-5774; Weber, Bernhard H.F./0000-0002-8808-7723	German Federal Ministry of Education and Research (BMBF) [01ER1206, 01ER1507]; Helmholtz Zentrum Munchen German Research Center for Environmental Health; State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	The analytical work in this study is supported in part by grants from the German Federal Ministry of Education and Research (BMBF 01ER1206 and 01ER1507) to I.M.H. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Akuffo KO, 2015, BRIT J OPHTHALMOL, V99, P1037, DOI 10.1136/bjophthalmol-2014-305768; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Buitendijk GHS, 2013, OPHTHALMOLOGY, V120, P2644, DOI 10.1016/j.ophtha.2013.07.053; BUTLER JS, 1987, REV ECON STAT, V69, P644, DOI 10.2307/1935959; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Cougnard-Gregoire A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090973; Cugati S, 2006, OPHTHALMOLOGY, V113, P2020, DOI 10.1016/j.ophtha.2006.05.047; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Erke MG, 2014, ACTA OPHTHALMOL, V92, P662, DOI 10.1111/aos.12346; Erke MG, 2012, OPHTHALMOLOGY, V119, P1737, DOI 10.1016/j.ophtha.2012.03.016; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kaarniranta K, 2015, CURR EYE RES, V40, P226, DOI 10.3109/02713683.2014.925933; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Kim YJ, 2004, J R STAT SOC B, V66, P337, DOI 10.1046/j.1369-7412.2003.05316.x; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2014, OPHTHAL EPIDEMIOL, V21, P14, DOI 10.3109/09286586.2013.867512; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Korb CA, 2014, GRAEF ARCH CLIN EXP, V252, P1403, DOI 10.1007/s00417-014-2591-9; La TY, 2014, CURR EYE RES, V39, P1232, DOI 10.3109/02713683.2014.907431; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Meisinger C, 2005, DIABETOLOGIA, V48, P27, DOI 10.1007/s00125-004-1604-3; Neuner B, 2009, ADDICT BEHAV, V34, P938, DOI 10.1016/j.addbeh.2009.05.015; Risk factors associated with age-related macular degeneration, 2000, OPHTHALMOLOGY, P107; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2011, NEW ENGL J MED, V364, P1966, DOI 10.1056/NEJMe1103334; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Stratmann B, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-90; Tan JSL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1089, DOI 10.1001/archopht.125.8.1089; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; van Leeuwen R, 2003, EUR J EPIDEMIOL, V18, P845, DOI 10.1023/A:1025643303914; Velilla S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/895147; Vitale S, 2016, JAMA OPHTHALMOL, V134, P1041, DOI 10.1001/jamaophthalmol.2016.2383; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wang JJ, 2012, OPHTHALMOLOGY, V119, P2298, DOI 10.1016/j.ophtha.2012.07.003; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkler G, 1998, Z ERNAHRUNGSWISS, V37, P234, DOI 10.1007/s003940050022; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Wolfram C, 2012, WEISSBUCH SITUATION; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2006, AUST NZ J STAT, V48, P445, DOI 10.1111/j.1467-842X.2006.00450.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Ying GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1147, DOI 10.1001/archophthalmol.2009.189; YOUNG RW, 1988, SURV OPHTHALMOL, V32, P252, DOI 10.1016/0039-6257(88)90174-9; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645	61	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167181	10.1371/journal.pone.0167181	http://dx.doi.org/10.1371/journal.pone.0167181			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893849	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000389472400096
J	Qin, W; Zhang, XY; Yang, SN; Li, Y; Yuan, JL; Yang, L; Li, SJ; Hu, WL				Qin, Wei; Zhang, Xiaoyu; Yang, Shuna; Li, Yue; Yuan, Junliang; Yang, Lei; Li, Shujuan; Hu, Wenli			Risk Factors for Multiple Organ Dysfunction Syndrome in Severe Stroke Patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTENSIVE-CARE; MEDICAL COMPLICATIONS; PREDICTORS; INFARCTION; SURVIVAL; MORTALITY; FAILURE; PROJECT; SCORE	Background Severe stroke patients have poor clinical outcome which may be associated with development of multiple organ dysfunction syndrome (MODS). Therefore, the aim of our study was to investigate independent risk factors for development of MODS in severe stroke patients. Methods Ninety seven severe stroke patients were prospective recruited from Jan 2011 to Jun 2015. The development of MODS was identified by Sequential Organ Failure Assessment (SOFA) score (score >= 3, at least two organs), which was assessed on day 1, 4, 7, 10 and 14 after admission. Baseline characteristics, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Glasgow coma score (GCS) and cerebral imaging parameters were collected at admission. Cox regression was performed to determine predictors for the development of MODS. Medical complications after admission and in-hospital mortality were also investigated. Results 33 (34%) patients were in MODS group and 64 (66%) were in non-MODS group within 14 days after admission. Patients in MODS group had more smoker (51.5% vs 28.1%, p = 0.023), higher NIHSS score (23.48 +/- 6.12 vs 19.81 +/- 4.83, p = 0.004), higher APACHE II score (18.70 +/- 5.18 vs 15.64 +/- 4.36, p = 0.003) and lower GCS score (6.33 +/- 2.48 vs 8.14 +/- 2.73, p = 0.002). They also had higher rate of infarction in multi vascular territories (36.4% vs 10.9%, p = 0.003). The most common complication in all patients was pulmonary infection, while complication scores were comparable between two groups. Patients with MODS had higher in-hospital mortality (69.7% vs 9.4%, p = 0.000). In Cox regression, NIHSS score (RR = 1.084, 95% CI 1.019-1.153) and infarction in multi vascular territories (RR = 2.345 95% CI 1.105-4.978) were independent risk factors for development of MODS. Conclusions In acute phase of stroke, NIHSS score and infarction in multi vascular territories predicted MODS in severe stroke patients. Moreover, patients with MODS had higher in-hospital mortality, suggesting that early identification of MODS is critical important.	[Qin, Wei; Zhang, Xiaoyu; Yang, Shuna; Li, Yue; Yuan, Junliang; Yang, Lei; Li, Shujuan; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com	Zhang, xiaoyu/GXA-3206-2022					ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barber PA, 2003, CEREBROVASC DIS, V16, P230, DOI 10.1159/000071121; Bill O, 2013, J THROMB HAEMOST, V11, P92, DOI 10.1111/jth.12066; Chen YD, 2011, EUR NEUROL, V66, P204, DOI 10.1159/000330551; Fanshawe M, 2002, ANAESTH INTENS CARE, V30, P628, DOI 10.1177/0310057X0203000515; Gerriets T, 2004, CEREBROVASC DIS, V18, P90, DOI 10.1159/000078759; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Jeng JS, 2008, J NEUROL SCI, V270, P60, DOI 10.1016/j.jns.2008.01.015; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Kleiman DA, 2014, SURG INFECT, V15, P445, DOI 10.1089/sur.2012.071; Koh MG, 2000, STROKE, V31, P2062, DOI 10.1161/01.STR.31.9.2062; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Lam WWM, 2005, J NEUROL NEUROSUR PS, V76, P354, DOI 10.1136/jnnp.2003.035055; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Liu Hai-Bo, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P294; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; Ortega-Casarrubios M, 2007, NEUROLOGIA, V22, P426; Prosser J, 2007, STROKE, V38, P2295, DOI 10.1161/STROKEAHA.106.471813; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Ulvik A, 2007, CRIT CARE, V11, DOI 10.1186/cc6111; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Warlow CP, 2012, J NEUROL NEUROSUR PS, V83, P579, DOI 10.1136/jnnp-2011-301381; Yoo AJ, 2013, J STROKE CEREBROVASC, V22, P742, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.002	26	7	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167189	10.1371/journal.pone.0167189	http://dx.doi.org/10.1371/journal.pone.0167189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893797	Green Submitted, gold, Green Published			2022-12-27	WOS:000389472400097
J	Abugalieva, S; Didorenko, S; Anuarbek, S; Volkova, L; Gerasimova, Y; Sidorik, I; Turuspekov, Y				Abugalieva, Saule; Didorenko, Svetlana; Anuarbek, Shynar; Volkova, Lubov; Gerasimova, Yelena; Sidorik, Ivan; Turuspekov, Yerlan			Assessment of Soybean Flowering and Seed Maturation Time in Different Latitude Regions of Kazakhstan	PLOS ONE			English	Article							MAP-BASED CLONING; MATURITY; GENE; RESPONSES; E3; E2; E1	Soybean is still a minor crop in Kazakhstan despite an increase in planting area from 4,500 to 11,400 km(2) between 2006 and 2014. However, the Government's recently accepted crop diversification policy projects the expansion of soybean cultivation area to more than 40,000 km(2) by 2020. The policy is targeting significant expansion of soybean production in Southeastern, Eastern, and Northern regions of Kazakhstan. Successful realization of this policy requires a comprehensive characterization of plant growth parameters to identify optimal genotypes with appropriate adaptive phenotypic traits. In this study 120 soybean accessions from different parts of the World, including 18 accessions from Kazakhstan, were field tested in South-eastern, Eastern, and Northern regions of the country. These studies revealed positive correlation of yield with flowering time in Northern Kazakhstan, with seed maturity time in Eastern Kazakhstan, and with both these growth stages in South-eastern Kazakhstan. It was determined that in South-eastern, Eastern and Northern regions of Kazakhstan the majority of productive genotypes were in maturity groups MGI, MG0, and MG00, respectively. The accessions were genotyped for four major maturity genes (E1, E2, E3, and E4) in order to assess the relationship between E loci and agronomic traits. The allele composition of the majority of accessions was e1-as/e2/E3/E4 (specific frequencies 57.5%, 91.6%, 65.0%, and 63.3%, respectively). Accessions with dominant alleles in either E3 or E4 genes showed higher yield in all three regions, although the specific genotype associated with greatest productivity was different for each site. Genotype-environment interaction studies based on yield performances suggest that South-east and East regions formed one mega-environment, which was well separated from North Kazakhstan where significantly earlier time to maturation is required. The results provide important insights into the relationship between genetic and phenotypic patterns in new soybean growing territories in Kazakhstan.	[Abugalieva, Saule; Anuarbek, Shynar; Volkova, Lubov; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Didorenko, Svetlana] Kazakh Res Inst Agr, Almalybak Vil, Almaty Region, Kazakhstan; [Gerasimova, Yelena] East Kazakhstan Res Inst Agr, Solnechnyi Vil, Ust Kamenogorsk, Kazakhstan; [Sidorik, Ivan] Kostanaiskyi Res Inst Agr, Zarechnoe Vil, Kostanai Region, Kazakhstan	Institute of Plant Biology & Biotechnology in Kazakhstan; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Abugalieva, Saule/M-6690-2015; Turuspekov, Yerlan/C-3458-2011; Anuarbek, Shynar/AAO-1161-2020; Didorenko, Svetlana/AAO-9646-2020	Abugalieva, Saule/0000-0002-9748-507X; Turuspekov, Yerlan/0000-0001-8590-1745; Didorenko, Svetlana/0000-0002-2223-0718; Anuarbek, Shynar/0000-0002-8673-9820; Gerasimova, Elena/0000-0003-4069-3457	Ministry of Education and science of the Republic of Kazakhstan [1108/GF4]	Ministry of Education and science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	The study funded by grant number 1108/GF4 given by the Ministry of Education and science of the Republic of Kazakhstan. Website of the Ministry: http://edu.gov.kz/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugalieva S, 2013, BIOTECHNOLOGY THEORY, V3, P26; Abugalieva S., 2013, BIOTECHNOLOGY THEORY, V4, P13; Anuarbek S, 2015, KAZNU B BIOL SERIES, V3, P110; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; Duranti M, 2006, FITOTERAPIA, V77, P67, DOI 10.1016/j.fitote.2005.11.008; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Jia HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094139; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; SAINDON G, 1989, CROP SCI, V29, P1436, DOI 10.2135/cropsci1989.0011183X002900060021x; Shin JH, 2012, MOL BREEDING, V30, P1793, DOI 10.1007/s11032-012-9743-6; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xu ML, 2015, PLANT PHYSIOL, V168, P1735, DOI 10.1104/pp.15.00763; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]	21	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166894	10.1371/journal.pone.0166894	http://dx.doi.org/10.1371/journal.pone.0166894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907027	Green Submitted, Green Published, gold			2022-12-27	WOS:000389482700051
J	Araujo, A; Julious, S; Senn, S				Araujo, Artur; Julious, Steven; Senn, Stephen			Understanding Variation in Sets of N-of-1 Trials	PLOS ONE			English	Article							ORTHOGONAL BLOCK STRUCTURE; CROSS-OVER TRIALS; CLINICAL-TRIALS; RANDOMIZED EXPERIMENTS; LINEAR-MODELS; METAANALYSIS; METHODOLOGY; ADDITIVITY; VARIANCE; DESIGN	A recent paper in this journal by Chen and Chen has used computer simulations to examine a number of approaches to analysing sets of n-of-1 trials. We have examined such designs using a more theoretical approach based on considering the purpose of analysis and the structure as regards randomisation that the design uses. We show that different purposes require different analyses and that these in turn may produce quite different results. Our approach to incorporating the randomisation employed when the purpose is to test a null hypothesis of strict equality of the treatment makes use of Nelder's theory of general balance. However, where the purpose is to make inferences about the effects for individual patients, we show that a mixed model is needed. There are strong parallels to the difference between fixed and random effects meta-analyses and these are discussed.	[Araujo, Artur; Senn, Stephen] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Julious, Steven] Univ Sheffield, Sch Hlth & Related Res, Med Stat Grp, Sheffield, S Yorkshire, England	Luxembourg Institute of Health; University of Sheffield	Senn, S (corresponding author), Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg.	stephen.senn@lih.lu	Senn, Stephen/B-2903-2013; Araujo, Artur/AAW-2581-2020	Senn, Stephen/0000-0002-7558-8473; Araujo, Artur/0000-0003-1419-4208	European Union [602552]; Boehringer-Ingelheim	European Union(European Commission); Boehringer-Ingelheim(Boehringer Ingelheim)	SS and AA's work was funded by the European Union's FP7 programme grant number 602552 for the IDEAL project. AA has received additional funding from Boehringer-Ingelheim. The support of both funders is gratefully acknowledged The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin M, 1999, STAT MED, V18, P2343, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2343::AID-SIM260>3.0.CO;2-3; [Anonymous], 1908, BIOMETRIKA, V6, P1; Auerbach C., 2014, SSD R R PACKAGE ANAL; Bailey R. A., 2008, DESIGN COMP EXPT; BAILEY RA, 1981, J ROY STAT SOC A STA, V144, P214, DOI 10.2307/2981920; Bludowsky A, 2015, AUST NZ J STAT, V57, P517, DOI 10.1111/anzs.12136; Brown, 2006, APPL MIXED MODELS ME; Carlin B. P., 1996, BAYES EMPIRICAL BAYE; Chen X., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1061/(ASCE)MT.1943-5533.0000778; Cox D. R., 2003, COMPONENTS VARIANCE; COX DR, 1958, BIOMETRIKA, V45, P69, DOI 10.2307/2333046; Cushny AR, 1905, J PHYSIOL-LONDON, V32, P501; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan NH, 2013, J CLIN EPIDEMIOL, V66, pS21, DOI 10.1016/j.jclinepi.2013.04.006; Dugard P., 2012, SINGLE CASE SMALL N; Dworkin RH, 2014, PAIN, V155, P457, DOI 10.1016/j.pain.2013.09.019; Fisher R. A., 1930, ARRANGEMENT FIELD EX; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fisher RA, 1923, J AGR SCI, V13, P311, DOI 10.1017/S0021859600003592; Fisher RA, 1990, DESIGN EXPT; FLEISS JL, 1986, BIOMETRICS, V42, P449; FLEISS JL, 1989, CONTROL CLIN TRIALS, V10, P237, DOI 10.1016/0197-2456(89)90065-2; Galwey N. W., 2014, INTRO MIXED MODELLIN; GUYATT G, 1988, CAN MED ASSOC J, V139, P497; GUYATT GH, 1990, CONTROL CLIN TRIALS, V11, P88, DOI 10.1016/0197-2456(90)90003-K; Hersen M., 1976, SINGLE CASE EXPT DES; Jones B., 2014, DESIGN ANAL CROSS OV; Julious SA, 2010, INTRODUCTION TO STATISTICS IN EARLY PHASE TRIALS, P1, DOI 10.1002/9780470686164; Kalow W, 1998, PHARMACOGENETICS, V8, P283; Keene ON, 2007, PHARM STAT, V6, P89, DOI 10.1002/pst.250; KELLER JL, 1988, SCAND J GASTROENTERO, V23, P22, DOI 10.3109/00365528809099154; Krishef C. H., 1991, FUNDAMENTAL APPROACH; LASHNER BA, 1988, ANN INTERN MED, V108, P274, DOI 10.7326/0003-4819-108-2-274; Li J., 2013, EURASIP J ADV SIG PR, V2013, P1, DOI DOI 10.1145/2534393; Makubate B, 2010, STAT MED, V29, P3203, DOI 10.1002/sim.3981; Miller I., 2004, JE FREUNDS MATH STAT, V7th; NELDER JA, 1965, PROC R SOC LON SER-A, V283, P147, DOI 10.1098/rspa.1965.0012; NELDER JA, 1965, PROC R SOC LON SER-A, V283, P163, DOI 10.1098/rspa.1965.0013; NELDER JA, 1977, J ROY STAT SOC A STA, V140, P48, DOI 10.2307/2344517; Patterson S, 2006, INTERD STAT, P1; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; ROCHON J, 1990, J CLIN EPIDEMIOL, V43, P499, DOI 10.1016/0895-4356(90)90139-G; Senn S, 2004, STAT MED, V23, P3729, DOI 10.1002/sim.2074; Senn S, 2004, BMJ-BRIT MED J, V329, P966, DOI 10.1136/bmj.329.7472.966; SENN S, 1994, STAT MED, V13, P785, DOI 10.1002/sim.4780130802; SENN S, 1993, CONTROL CLIN TRIALS, V14, P1, DOI 10.1016/0197-2456(93)90045-F; Senn S, 2000, STAT MED, V19, P861, DOI 10.1002/(SICI)1097-0258(20000330)19:6<861::AID-SIM407>3.0.CO;2-F; Senn S, 2000, DRUG INF J, V34, P535, DOI 10.1177/009286150003400222; Senn S, 2002, CROSS OVER TRIALS CL; Senn S, 2015, STAT MED; SENN SJ, 1992, STAT MED, V11, P715, DOI 10.1002/sim.4780110603; SENN SJ, 1991, STAT MED, V10, P1361, DOI 10.1002/sim.4780100905; Senn SJ, 2012, SIGNIFICANCE, V9, P30, DOI DOI 10.1111/j.1740-9713.2012.00620.x; Senn S, 2006, STAT MED, V25, P3430, DOI 10.1002/sim.2706; Senn S, 2015, STAT METHODS MED RES, V24, P403, DOI 10.1177/0962280214520728; Senn S, 2014, STAT MED, V33, P2876, DOI 10.1002/sim.5965; Senn S, 2011, STAT PROBABIL LETT, V81, P842, DOI 10.1016/j.spl.2011.02.010; SHEINER LB, 1972, COMPUT BIOMED RES, V5, P441, DOI 10.1016/0010-4809(72)90051-1; Shelley JH, 1999, LANCET, V353, P1870, DOI 10.1016/S0140-6736(98)09152-1; Stoll S, 2009, J ROY SOC MED, V102, P493, DOI 10.1258/jrsm.2009.09k039; Verbeke G, 2009, SPRINGER SER STAT, P1; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vohra S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1738; Wilkinson G., 1973, APPL STAT, P392; Yates F, 1933, J AGR SCI, V23, P108, DOI 10.1017/S0021859600052916; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	67	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167167	10.1371/journal.pone.0167167	http://dx.doi.org/10.1371/journal.pone.0167167			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907056	Green Published, Green Accepted, gold			2022-12-27	WOS:000389482700086
J	de Mattos, CN; Kim, HS; Requiao, MG; Marasaldi, RF; Filomensky, TZ; Hodgins, DC; Tavares, H				de Mattos, Cristiana Nicoli; Kim, Hyoun S.; Requiao, Marinalva G.; Marasaldi, Renata F.; Filomensky, Tatiana Z.; Hodgins, David C.; Tavares, Hermano			Gender Differences in Compulsive Buying Disorder: Assessment of Demographic and Psychiatric Co-Morbidities	PLOS ONE			English	Article							METAANALYSIS; RELIABILITY; PREVALENCE; VALIDATION	Compulsive buying is a common disorder found worldwide. Although recent research has shed light into the prevalence, etiology and clinical correlates of compulsive buying disorder, less is known about gender differences. To address this empirical gap, we assessed potential gender differences in demographic and psychiatric co-morbidities in a sample of 171 compulsive buyers (20 men and 151 women) voluntarily seeking treatment in Sao Paulo, Brazil. A structured clinical interview confirmed the diagnosis of compulsive buying. Of the 171 participants, 95.9% (n = 164) met criteria for at least one co-morbid psychiatric disorder. The results found that male and female compulsive buyers did not differ in problem severity as assessed by the Compulsive Buying Scale. However, several significant demographic and psychiatric differences were found in a multivariate binary logistic regression. Specifically, male compulsive buyers were more likely to report being non-heterosexual, and reported fewer years of formal education. In regards to psychiatric co-morbidities, male compulsive buyers were more likely to be diagnosed with sexual addiction, and intermittent explosive disorder. Conversely, men had lower scores on the shopping subscale of the Shorter PROMIS Questionnaire. The results suggest that male compulsive buyers are more likely to present with co-morbid psychiatric disorders. Treatment planning for compulsive buying disorder would do well to take gender into account to address for potential psychiatric co-morbidities.	[de Mattos, Cristiana Nicoli; Requiao, Marinalva G.; Marasaldi, Renata F.; Filomensky, Tatiana Z.; Tavares, Hermano] Univ Sao Paulo, Inst Psychiat, Impulse Control Disorders Outpatient Unit, Sao Paulo, Brazil; [Kim, Hyoun S.; Hodgins, David C.] Univ Calgary, Addict Behav Lab, Calgary, AB, Canada	Universidade de Sao Paulo; University of Calgary	de Mattos, CN (corresponding author), Univ Sao Paulo, Inst Psychiat, Impulse Control Disorders Outpatient Unit, Sao Paulo, Brazil.	cristiana.mattos@usp.br	Kim, Hyoun S./G-6114-2015	Kim, Hyoun S./0000-0002-0804-0256; Hodgins, David/0000-0003-2737-5200	National Council for Development of Science and Technology (CNPq) of Brazil; Alberta Innovates [201500112] Funding Source: researchfish	National Council for Development of Science and Technology (CNPq) of Brazil; Alberta Innovates	This research was supported by a scholarship of National Council for Development of Science and Technology (CNPq) of Brazil-URL: http//cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376; Beck A. T., 1996, MANUAL BECK DEPRESSI, V1, P82; Beck A.T., 1990, BECK SCALE SUICIDE I; Black DW, 2007, WORLD PSYCHIATRY, V6, P14; Black Donald W, 2010, Dialogues Clin Neurosci, V12, P175; Black DW, 2001, CNS DRUGS, V15, P17, DOI 10.2165/00023210-200115010-00003; Black DW, 1996, J CLIN PSYCHIAT, V57, P50; Black DW, OXFORD HDB IMPULSE C; Bleuler E, 1924, TXB PSYCHIAT; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; Christo G, 2003, ADDICT BEHAV, V28, P225, DOI 10.1016/S0306-4603(01)00231-3; Dittmar H, 2005, BRIT J PSYCHOL, V96, P467, DOI 10.1348/000712605X53533; Dittmar H, 2004, SEX ROLES, V50, P423, DOI 10.1023/B:SERS.0000018896.35251.c7; Dittmar H., 2004, ADDICTIVE DISORDERS, P411; Ellard KK, 2010, COGN BEHAV PRACT, V17, P88, DOI 10.1016/j.cbpra.2009.06.002; FABER RJ, 1992, J CONSUM RES, V19, P459, DOI 10.1086/209315; Fong Timothy W, 2006, Psychiatry (Edgmont), V3, P51; Getty H A, 2000, J Gambl Stud, V16, P377, DOI 10.1023/A:1009480106531; Klimkiewicz A, 2015, PSYCHIAT POL; Kraepelin E, 1915, PSYCHIATRIE, P409; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Leite P, 2013, REV BRAS PSIQUIATR, V35, P38, DOI 10.1016/j.rbp.2012.10.004; Lorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.x; Otero-Lopez JM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-101; Maraz A, 2016, ADDICTION, V111, P408, DOI 10.1111/add.13223; MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P242; Miltenberger RG, 2003, J BEHAV THER EXP PSY, V34, P1, DOI 10.1016/S0005-7916(03)00002-8; Mueller A, 2010, PSYCHIAT RES, V180, P137, DOI 10.1016/j.psychres.2009.12.001; Mueller A, 2010, PSYCHIAT RES, V178, P348, DOI 10.1016/j.psychres.2010.04.021; Rojas AJ, 2016, J MENT HEALTH, P1; Shaffer HJ, 2004, HARVARD REV PSYCHIAT, V12, P367, DOI 10.1080/10673220490905705; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481	33	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167365	10.1371/journal.pone.0167365	http://dx.doi.org/10.1371/journal.pone.0167365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907082	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700130
J	Kirkeby, C; Graesboll, K; Nielsen, SS; Christiansen, LE; Toft, N; Halasa, T				Kirkeby, Carsten; Graesboll, Kaare; Nielsen, Soren Saxmose; Christiansen, Lasse Engbo; Toft, Nils; Halasa, Tariq			Adaptive Test Schemes for Control of Paratuberculosis in Dairy Cows	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; JOHNES-DISEASE CONTROL; CONTROL PROGRAM; HERDS; PREVALENCE; PROBABILITY; INFECTION	Paratuberculosis is a chronic infection that in dairy cattle causes reduced milk yield, weight loss, and ultimately fatal diarrhea. Subclinical animals can excrete bacteria (Mycobacterium avium ssp. paratuberculosis, MAP) in feces and infect other animals. Farmers identify the infectious animals through a variety of test-strategies, but are challenged by the lack of perfect tests. Frequent testing increases the sensitivity but the costs of testing are a cause of concern for farmers. Here, we used a herd simulation model using milk ELISA tests to evaluate the epidemiological and economic consequences of continuously adapting the sampling interval in response to the estimated true prevalence in the herd. The key results were that the true prevalence was greatly affected by the hygiene level and to some extent by the test-frequency. Furthermore, the choice of prevalence that will be tolerated in a control scenario had a major impact on the true prevalence in the normal hygiene setting, but less so when the hygiene was poor. The net revenue is not greatly affected by the test-strategy, because of the general variation in net revenues between farms. An exception to this is the low hygiene herd, where frequent testing results in lower revenue. When we look at the probability of eradication, then it is correlated with the testing frequency and the target prevalence during the control phase. The probability of eradication is low in the low hygiene herd, and a test-and-cull strategy should probably not be the primary strategy in this herd. Based on this study we suggest that, in order to control MAP, the standard Danish dairy farm should use an adaptive strategy where a short sampling interval of three months is used when the estimated true prevalence is above 1%, and otherwise use a long sampling interval of one year.	[Kirkeby, Carsten; Graesboll, Kaare; Toft, Nils; Halasa, Tariq] Tech Univ Denmark, Epidemiol Sect, DTU VET, Richard Petersens Plads, Denmark; [Nielsen, Soren Saxmose] Univ Copenhagen, Dept Large Anim Sci, Sect Anim Welf & Dis Control, Copenhagen, Denmark; Tech Univ Denmark, DTU Compute, Sect Dynam Syst, Dept Appl Math & Comp Sci, Richard Petersens Plads, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Kirkeby, C (corresponding author), Tech Univ Denmark, Epidemiol Sect, DTU VET, Richard Petersens Plads, Denmark.	ckir@vet.dtu.dk	Kirkeby, Carsten/GVS-8137-2022	Graesboll, Kaare/0000-0002-6258-8212; Halasa, Tariq/0000-0003-1112-0254; Christiansen, Lasse Engbo/0000-0001-5019-1931; Nielsen, Soren/0000-0003-2417-0787; Kirkeby, Carsten/0000-0001-9292-5526	Green Development and Demonstration Program (GUDP) under the Danish Directorate for Food, Fisheries and Agriculture [34009-13-0596]	Green Development and Demonstration Program (GUDP) under the Danish Directorate for Food, Fisheries and Agriculture	This project was funded by the Green Development and Demonstration Program (GUDP) under the Danish Directorate for Food, Fisheries and Agriculture, grant no. 34009-13-0596.	Al-Mamun MA, 2016, J THEOR BIOL, V408, P105, DOI 10.1016/j.jtbi.2016.08.014; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; COLLINS MT, 1994, J AM VET MED ASSOC, V204, P208; Dorshorst NC, 2006, PREV VET MED, V75, P92, DOI 10.1016/j.prevetmed.2006.02.002; Frossling J, 2013, PREV VET MED, V108, P47, DOI 10.1016/j.prevetmed.2012.07.010; Graesboll K, 2015, P 12 INT C PAR PARM, P139; Groenendaal H, 2003, J AM VET MED ASSOC, V223, P1757, DOI 10.2460/javma.2003.223.1757; Kennedy DJ, 2000, VET MICROBIOL, V77, P443, DOI 10.1016/S0378-1135(00)00329-1; Kirkeby C, FRONTIERS VET SCI, V3, P90, DOI [10.3389/fvets.2016.00090, DOI 10.3389/FVETS.2016.00090]; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; Lu Z, 2008, J THEOR BIOL, V254, P135, DOI 10.1016/j.jtbi.2008.05.008; McAloon CG, 2016, J DAIRY SCI, V99, P1449, DOI 10.3168/jds.2015-10156; Nielsen SS, 2006, J DAIRY SCI, V89, P4557, DOI 10.3168/jds.S0022-0302(06)72505-X; Nielsen S. S., 2014, CAB Reviews, V9, P1, DOI 10.1079/PAVSNNR20149012; Nielsen S.S., 2007, B INT DAIRY FED, V410, P23; Nielsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063009; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Robins J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0195-y; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; S. Economy, 2008, J DAIRY SCI, V91, P4599, DOI [10.3168/jds.2008-1257, DOI 10.3168/JDS.2008-1257]; Sergeant ESG, 2008, PREV VET MED, V85, P92, DOI 10.1016/j.prevetmed.2008.01.005; Sorge U, 2010, J DAIRY SCI, V93, P1491, DOI 10.3168/jds.2009-2447; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; Verdugo C, 2015, PREV VET MED, V121, P282, DOI 10.1016/j.prevetmed.2015.07.012; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x	26	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167219	10.1371/journal.pone.0167219	http://dx.doi.org/10.1371/journal.pone.0167219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907192	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700094
J	Schuster, C; Hardiman, O; Bede, P				Schuster, Christina; Hardiman, Orla; Bede, Peter			Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study	PLOS ONE			English	Article							WHITE-MATTER DEGENERATION; ALS	Background Despite significant advances in quantitative neuroimaging, the diagnosis of ALS remains clinical and MRI-based biomarkers are not currently used to aid the diagnosis. The objective of this study is to develop a robust, disease-specific, multimodal classification protocol and validate its diagnostic accuracy in independent, early-stage and follow-up data sets. Methods 147 participants (81 ALS patients and 66 healthy controls) were divided into a training sample and a validation sample. Patients in the validation sample underwent follow-up imaging longitudinally. After removing age-related variability, indices of grey and white matter integrity in ALS-specific pathognomonic brain regions were included in a cross-validated binary logistic regression model to determine the probability of individual scans indicating ALS. The following anatomical regions were assessed for diagnostic classification: average grey matter density of the left and right precentral gyrus, the average fractional anisotropy and radial diffusivity of the left and right superior corona radiata, inferior corona radiata, internal capsule, mesencephalic crus of the cerebral peduncles, pontine segment of the corticospinal tract, and the average diffusivity values of the genu, corpus and splenium of the corpus callosum. Results Using a 50% probability cut-off value of suffering from ALS, the model was able to discriminate ALS patients and HC with good sensitivity (80.0%) and moderate accuracy (70.0%) in the training sample and superior sensitivity (85.7%) and accuracy (78.4%) in the independent validation sample. Conclusions This diagnostic classification study endeavours to advance ALS biomarker research towards pragmatic clinical applications by providing an approach of automated individual-data interpretation based on group-level observations.	[Schuster, Christina; Hardiman, Orla; Bede, Peter] Trinity Coll Dublin, Inst Biomed Sci, Acad Unit Neurol, Quantitat Neuroimaging Grp, Dublin, Ireland	Trinity College Dublin	Bede, P (corresponding author), Trinity Coll Dublin, Inst Biomed Sci, Acad Unit Neurol, Quantitat Neuroimaging Grp, Dublin, Ireland.	bedepeter@hotmail.com	Hardiman, Orla/Y-3441-2019	Hardiman, Orla/0000-0003-2610-1291; Bede, Peter/0000-0003-0492-4772	Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant; Iris O'Brien Foundation; Perrigo Clinician-Scientist Research Fellowship; Health Research Board; Research Motor Neuron (RMN-Ireland) foundation; European Community's Seventh Framework Programme (FP7) [259867]; EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project	Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant; Iris O'Brien Foundation; Perrigo Clinician-Scientist Research Fellowship; Health Research Board; Research Motor Neuron (RMN-Ireland) foundation; European Community's Seventh Framework Programme (FP7); EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project	This work was supported by the Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant, The Iris O'Brien Foundation, The Perrigo Clinician-Scientist Research Fellowship, the Health Research Board and the Research Motor Neuron (RMN-Ireland) foundation. Professor Hardiman's research group has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no [259867] (EUROMOTOR), the EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant, The Iris O'Brien Foundation, The Perrigo Clinician-Scientist Research Fellowship, the Health Research Board and the Research Motor Neuron (RMN-Ireland) foundation. Professor Hardiman's research group has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no [259867] (EUROMOTOR), the EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project. The sponsors of the study had no role in study design, writing of the report, or decision to submit this work for publication.	Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Arbabshirani M.R., 2016, NEUROIMAGE; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bede P, 2015, J NEUROL NEUROSUR PS, V86, P468, DOI 10.1136/jnnp-2014-308172; Bede P., 2016, AMYOTROPHIC LATERAL, P1; Bede P, 2013, AMYOTROPHIC LATERAL; Bede P, 2014, NEUROIMAGE-CLIN, V4, P436, DOI 10.1016/j.nicl.2014.02.011; Bede P, 2013, NEUROLOGY, V81, P2107, DOI 10.1212/01.wnl.0000437313.80913.2c; Bede P, 2013, NEUROLOGY, V81, P361, DOI 10.1212/WNL.0b013e31829c5eee; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Bede P, 2012, AMYOTROPH LATERAL SC, V13, P407, DOI 10.3109/17482968.2011.649760; Ben Bashat D, 2011, AMYOTROPH LATERAL SC, V12, P398, DOI 10.3109/17482968.2011.582646; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cellura E, 2012, CLIN NEUROL NEUROSUR, V114, P550, DOI 10.1016/j.clineuro.2011.11.026; Chen SH, 2008, GENET EPIDEMIOL, V32, P152, DOI 10.1002/gepi.20272; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Foerster BR, 2013, ACAD RADIOL, V20, P1099, DOI 10.1016/j.acra.2013.03.017; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gupta PK, 2012, J NEUROL SCI, V312, P68, DOI 10.1016/j.jns.2011.08.021; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Koikkalainen J, 2016, NEUROIMAGE CLIN; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Machts J, 2015, NEUROLOGY, V85, P1301, DOI 10.1212/WNL.0000000000002017; McLaughlin RL, 2015, NEUROBIOL AGING, V36; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Muller H-P, 2016, J NEUROLOGY NEUROSUR; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pagani M, 2014, NEUROLOGY, V83, P1067, DOI 10.1212/WNL.0000000000000792; Schuster C, 2016, EUR J NEUROL, V23, P1361, DOI 10.1111/ene.13038; Schuster C, 2015, J NEUROL NEUROSUR PS, V86, P1089, DOI 10.1136/jnnp-2014-309888; Schuster C, 2014, NEUROBIOL AGING, V35, P240, DOI 10.1016/j.neurobiolaging.2013.07.020; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Turner MR, 2011, LANCET; Van Laere K, 2014, JAMA NEUROL, V71, P553, DOI 10.1001/jamaneurol.2014.62; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Welsh Robert C, 2013, Front Hum Neurosci, V7, P251, DOI 10.3389/fnhum.2013.00251; Wokke JH, 2000, AMYOTROPH LATERAL SC, V1, pS61, DOI 10.1080/14660820050515773	45	56	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167331	10.1371/journal.pone.0167331	http://dx.doi.org/10.1371/journal.pone.0167331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907080	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700120
J	Shevtsova, E; Shevtsov, A; Mukanov, K; Filipenko, M; Kamalova, D; Sytnik, I; Syzdykov, M; Kuznetsov, A; Akhmetova, A; Zharova, M; Karibaev, T; Tarlykov, P; Ramanculov, E				Shevtsova, Elena; Shevtsov, Alexandr; Mukanov, Kasim; Filipenko, Maxim; Kamalova, Dinara; Sytnik, Igor; Syzdykov, Marat; Kuznetsov, Andrey; Akhmetova, Assel; Zharova, Mira; Karibaev, Talgat; Tarlykov, Pavel; Ramanculov, Erlan			Epidemiology of Brucellosis and Genetic Diversity of Brucella abortus in Kazakhstan	PLOS ONE			English	Article							MELITENSIS; STRAIN; MLVA; REEMERGENCE; COUNTRIES; VACCINE; CATTLE; LOCI	Brucellosis is a major zoonotic infection in Kazakhstan. However, there is limited data on its incidence in humans and animals, and the genetic diversity of prevalent strains is virtually unstudied. Additionally, there is no detailed overview of Kazakhstan brucellosis control and eradication programs. Here, we analyzed brucellosis epidemiological data, and assessed the effectiveness of eradication strategies employed over the past 70 years to counteract this infection. We also conducted multiple loci variable-number tandem repeat analysis (MLVA) of Brucella abortus strains found in Kazakhstan. We analyzed official data on the incidence of animal brucellosis in Kazakhstan. The records span more than 70 years of anti-brucellosis campaigns, and contain a brief description of the applied control strategies, their effectiveness, and their impact on the incidence in humans. The MLVA-16 method was used to type 94 strains of B. abortus and serial passages of B. abortus 82, a strain used in vaccines. MLVA-8 and MLVA-11 analyses clustered strains into a total of four and seven genotypes, respectively; it is the first time that four of these genotypes have been described. MLVA-16 analysis divided strains into 28 distinct genotypes having genetic similarity coefficient that varies from 60 to100% and a Hunter & Gaston diversity index of 0.871. MST analysis reconstruction revealed clustering into "Kazakhstani-Chinese (Central Asian)", "European" and "American" lines. Detection of multiple genotypes in a single outbreak confirms that poorly controlled trade of livestock plays a crucial role in the spread of infection. Notably, the MLVA-16 profile of the B. abortus 82 strain was unique and did not change during 33 serial passages. MLVA genotyping may thus be useful for epidemiological monitoring of brucellosis, and for tracking the source(s) of infection. We suggest that countrywide application of MLVA genotyping would improve the control of brucellosis in Kazakhstan.	[Shevtsova, Elena; Shevtsov, Alexandr; Mukanov, Kasim; Filipenko, Maxim; Kamalova, Dinara; Tarlykov, Pavel] Natl Biotechnol Ctr, Astana, Kazakhstan; [Filipenko, Maxim] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Filipenko, Maxim] Novosibirsk State Univ, Novosibirsk, Russia; [Sytnik, Igor; Akhmetova, Assel; Zharova, Mira; Karibaev, Talgat] Natl Reference Ctr Vet, Astana, Kazakhstan; [Syzdykov, Marat; Kuznetsov, Andrey] Kazakh Sci Ctr Quarantine & Zoonot Dis, Alma Ata, Kazakhstan; [Ramanculov, Erlan] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan	National Center for Biotechnology (NCB); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Nazarbayev University	Shevtsov, A (corresponding author), Natl Biotechnol Ctr, Astana, Kazakhstan.	ncbshevtsov@gmail.com	Filipenko, Maksim/AAU-9552-2020; Alexandr, Shevtsov/P-2717-2017; Kuznetsov, Andrey/K-8824-2014; Ramankulov, Yerlan/AAG-7450-2019; Tarlykov, Pavel/C-2587-2012; Shevtsova, Elena/G-6288-2017; Kamalova, Dinara/ABB-6600-2020; Mukanov, Kasim/N-4118-2017	Filipenko, Maksim/0000-0002-8950-5368; Alexandr, Shevtsov/0000-0002-0307-1053; Kuznetsov, Andrey/0000-0003-2354-533X; Ramankulov, Yerlan/0000-0001-6786-3028; Tarlykov, Pavel/0000-0003-2075-307X; Shevtsova, Elena/0000-0002-7221-5866; Sytnik, Igor'/0000-0002-3439-7021; Kamalova, Dinara/0000-0002-8444-3305; Kamalova, Dinara/0000-0002-4570-8761; Ramanculov, Erlan/0000-0001-6791-4497	Ministry of Education and Science of the Republic of Kazakhstan [N0115RK01870]	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by funding received from the Ministry of Education and Science of the Republic of Kazakhstan, grant no. N0115RK01870. AS received the funding. (http://sc.edu.gov.kz/main/?L=2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Amato GAJ, 1995, MALTESE MED J, V7, P7; Amireyev SA, 1986, EPIDEMIOLOGIYA EPIZO; Beauvais W, 2015, ECOHEALTH, V30, P30; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; De Massis F, 2015, TRANSBOUND EMERG DIS, V62, P463, DOI 10.1111/tbed.12397; De Santis R, 2011, BMC MICROBIOL, V11, P1471; de Vegas EZS, 2006, INFECT CONT HOSP EP, V27, P397, DOI 10.1086/503177; Di Giannatale E., 2006, VET ITAL, V44, P383; Doganay Gizem D, 2013, Recent Pat Antiinfect Drug Discov, V8, P27; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Durusoy R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-71; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; Garcia-Yoldi D, 2007, VACCINE, V25, P2858, DOI 10.1016/j.vaccine.2006.09.063; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Garofolo G, 2013, J MICROBIOL METH, V92, P103, DOI 10.1016/j.mimet.2012.11.007; Godfroid J, 2002, REV SCI TECH OIE, V21, P277, DOI 10.20506/rst.21.2.1333; Godfroid J, 2002, VET MICROBIOL, V90, P135, DOI 10.1016/S0378-1135(02)00217-1; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Grushina T, 2003, BRUC 2003 INT RES C; Guigon G., 2008, Eurosurveillance, V13, P18863; Gwida M, 2012, COMP IMMUNOL MICROB, V35, P181, DOI 10.1016/j.cimid.2011.12.012; Gwida M, 2010, CROAT MED J, V51, P289, DOI 10.3325/cmj.2010.51.289; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ivanov Arkady V., 2011, Animal Health Research Reviews, V12, P113, DOI 10.1017/S1466252311000028; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Kineyev MA, 2005, PORODY KRUPNOGO ROGA; Kulakov YK, 2010, VACCINE, V1, P31; Kuznetsov VS, 1962, KAZAKHSKO KITAYSKIYE; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lundervold M, 2004, ACTA VET SCAND, V45, P211, DOI 10.1186/1751-0147-45-211; Mailles A, 2012, EUROSURVEILLANCE, V17, P2; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; Mezenchuk EA, 1941, IZVESTIYA KAZAKHSTAN, V1, P140; Mick V, 2014, PLOS ONE, V9; Millward James, 2021, EURASIAN CROSSROADS, V2nd; Minharro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081152; Mizanbayeva S, 2009, DIAGN MICR INFEC DIS, V65, P14, DOI 10.1016/j.diagmicrobio.2009.05.002; Neubauer H, 2010, Prilozi, V31, P209; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Nicoletti P, 2010, Prilozi, V31, P21; Norman FF, 2016, TRAVEL MED INFECT DI, V14, P182, DOI 10.1016/j.tmaid.2016.05.005; OIE, 2012, MANUAL DIAGNOSTIC TE; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pridorogin MI, 1914, KRUPNYY ROGATYY SKOT; Rementsova MM, 1962, BRUTSELLOZ DIKIKH ZH; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Shevtsov A, 2013, GENOME ANNOUNC, V1; Shevtsov A, 2015, INFECT GENET EVOL, V34, P173, DOI 10.1016/j.meegid.2015.07.008; Studentsov KP, 1975, BRUTSELLEZ ZHIVOTNYK; Sun YH, 2005, CURR PROTOC MICROBIO; Syzdykov M.S., 2014, GIGIYENA EPIDEMIOLOG, V72, P24; Tappe D, 2012, J MED MICROBIOL, V61, P1335, DOI 10.1099/jmm.0.038612-0; Tukana A, 2015, PREV VET MED, V122, P14, DOI 10.1016/j.prevetmed.2015.10.005; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05	57	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167496	10.1371/journal.pone.0167496	http://dx.doi.org/10.1371/journal.pone.0167496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907105	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700170
J	Tyndall, JDA; Sabherwal, M; Sagatova, AA; Keniya, MV; Negroni, J; Wilson, RK; Woods, MA; Tietjen, K; Monk, BC				Tyndall, Joel D. A.; Sabherwal, Manya; Sagatova, Alia A.; Keniya, Mikhail V.; Negroni, Jacopo; Wilson, Rajni K.; Woods, Matthew A.; Tietjen, Klaus; Monk, Brian C.			Structural and Functional Elucidation of Yeast Lanosterol 14 alpha-Demethylase in Complex with Agrochemical Antifungals	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; AZOLE RESISTANCE; MYCOSPHAERELLA-GRAMINICOLA; TRIAZOLE RESISTANCE; CYP51; CYTOCHROME-P450; FUNGICIDES; SENSITIVITY; MECHANISMS; MUTATIONS	Azole antifungals, known as demethylase inhibitors (DMIs), target sterol 14 alpha-demethylase (CYP51) in the ergosterol biosynthetic pathway of fungal pathogens of both plants and humans. DMIs remain the treatment of choice in crop protection against a wide range of fungal phytopathogens that have the potential to reduce crop yields and threaten food security. We used a yeast membrane protein expression system to overexpress recombinant hexahistidine-tagged S. cerevisiae lanosterol 14 alpha-demethylase and the Y140F or Y140H mutants of this enzyme as surrogates in order characterize interactions with DMIs. The whole-cell antifungal activity (MIC50 values) of both the R-and S-enantiomers of tebuconazole, prothioconazole (PTZ), prothioconazole-desthio, and oxo-prothioconazole (oxo-PTZ) as well as for fluquinconazole, prochloraz and a racemic mixture of difenoconazole were determined. In vitro binding studies with the affinity purified enzyme were used to show tight type II binding to the yeast enzyme for all compounds tested except PTZ and oxo-PTZ. High resolution X-ray crystal structures of ScErg11p6xHis in complex with seven DMIs, including four enantiomers, reveal triazole-mediated coordination of all compounds and the specific orientation of compounds within the relatively hydrophobic binding site. Comparison with CYP51 structures from fungal pathogens including Candida albicans, Candida glabrata and Aspergillus fumigatus provides strong evidence for a highly conserved CYP51 structure including the drug binding site. The structures obtained using S. cerevisiae lanosterol 14 alpha-demethylase in complex with these agrochemicals provide the basis for understanding the impact of mutations on azole susceptibility and a platform for the structure-directed design of the next-generation of DMIs.	[Tyndall, Joel D. A.] Univ Otago, New Zealands Natl Sch Pharm, Dunedin, New Zealand; [Sabherwal, Manya; Sagatova, Alia A.; Keniya, Mikhail V.; Wilson, Rajni K.; Woods, Matthew A.; Monk, Brian C.] Univ Otago, New Zealands Natl Ctr Dent, Sir John Walsh Res Inst, Dunedin, New Zealand; [Keniya, Mikhail V.; Monk, Brian C.] Univ Otago, New Zealands Natl Ctr Dent, Dept Oral Sci, Dunedin, New Zealand; [Negroni, Jacopo] Bayer SAS, Div Crop Sci, Dis Control Res, Lyon, France; [Tietjen, Klaus] Bayer AG, Div Crop Sci, Dis Control Res, Monheim, Germany	University of Otago; University of Otago; University of Otago; Bayer AG; Bayer AG	Tyndall, JDA (corresponding author), Univ Otago, New Zealands Natl Sch Pharm, Dunedin, New Zealand.; Monk, BC (corresponding author), Univ Otago, New Zealands Natl Ctr Dent, Sir John Walsh Res Inst, Dunedin, New Zealand.; Monk, BC (corresponding author), Univ Otago, New Zealands Natl Ctr Dent, Dept Oral Sci, Dunedin, New Zealand.	joel.tyndall@otago.ac.nz; brian.monk@otago.ac.nz	Sagatova, Alia/AAH-7119-2019; tyndall, joel/C-2803-2008	tyndall, joel/0000-0003-0783-1635; Keniya, Mikhail/0000-0001-5193-6982; Monk, Brian/0000-0003-2264-3480	Health Research Council; Bayer Crop Science	Health Research Council; Bayer Crop Science(Bayer AG)	This programme was funded by the Health Research Council and Bayer Crop Science, https://www.cropscince.bayer.com. The funding was provided to BM and used for this study. The commercial funders provided financial support in the form of authors' salaries and/or research materials. JN and KT had a minor role in data analysis, and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Bowyer P, 2014, PEST MANAG SCI, V70, P173, DOI 10.1002/ps.3567; Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12; Chen ZF, 2015, ENVIRON INT, V84, P142, DOI 10.1016/j.envint.2015.07.022; Chowdhary A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003633; Cools HJ, 2013, PEST MANAG SCI, V69, P150, DOI 10.1002/ps.3348; Dong FS, 2013, ENVIRON SCI TECHNOL, V47, P3386, DOI 10.1021/es304982m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faria-Ramos I, 2014, FEMS YEAST RES, V14, P1119, DOI 10.1111/1567-1364.12193; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Franceschini S, 2016, COMPOST SCI UTIL, V24, P20, DOI 10.1080/1065657X.2015.1046612; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Haas M., 2004, Pflanzenschutz-Nachrichten Bayer, V57, P207; Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310; Kakeya H, 2000, ANTIMICROB AGENTS CH, V44, P2985, DOI 10.1128/AAC.44.11.2985-2990.2000; Kjaerstad MB, 2010, REPROD TOXICOL, V30, P573, DOI 10.1016/j.reprotox.2010.07.009; Kuck K-H, 2012, MODERN CROP PRO TECT, P1; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Mullins JGL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020973; Parker Josie E., 2014, Journal of Chemical Biology, V7, P143, DOI 10.1007/s12154-014-0121-1; Parker JE, 2013, APPL ENVIRON MICROB, V79, P1639, DOI 10.1128/AEM.03246-12; Parker JE, 2011, APPL ENVIRON MICROB, V77, P1460, DOI 10.1128/AEM.01332-10; Price CL, 2015, PEST MANAG SCI, V71, P1054, DOI 10.1002/ps.4029; Price CL, 2015, APPL ENVIRON MICROB, V81, P3379, DOI 10.1128/AEM.03965-14; Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180; Russell PE, J AGR SCI, V143, P11; Sagatova AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26213; Sagatova AA, 2015, ANTIMICROB AGENTS CH, V59, P4982, DOI 10.1128/AAC.00925-15; Sanglard D, 1998, ANTIMICROB AGENTS CH, V42, P241, DOI 10.1093/jac/42.2.241; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Snelders E, 2011, FUNGAL GENET BIOL, V48, P1062, DOI 10.1016/j.fgb.2011.08.002; Stammler G, 2008, CROP PROT, V27, P1448, DOI 10.1016/j.cropro.2008.07.007; Tietjen K, 2016, MODERN FUNGICIDES AN, VVIII; Trosken E.-R, 2005, TOXICOLOGICAL EVALUA; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4225, DOI 10.1128/AAC.00316-10	44	37	38	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167485	10.1371/journal.pone.0167485	http://dx.doi.org/10.1371/journal.pone.0167485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907120	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700165
J	Broom, A; Wong, WKT; Kirby, E; Sibbritt, D; Karikios, D; Harrup, R; Lwin, Z				Broom, Alex; Wong, W. K. Tim; Kirby, Emma; Sibbritt, David; Karikios, Deme; Harrup, Rosemary; Lwin, Zarnie			A Qualitative Study of Medical Oncologists' Experiences of Their Profession and Workforce Sustainability	PLOS ONE			English	Article							PALLIATIVE CARE; CANCER-PATIENTS; BOUNDARIES; SHORTAGE; SOCIETY; WOMEN; WORK	Background Medical oncology is a steadily evolving field of medical practice and professional pathway for doctors, offering value, opportunity and challenge to those who chose this medical specialty. This study examines the experiences of a group of Australian medical oncologists, with an emphasis on their professional practice, career experiences, and existing and emerging challenges across career stages. Methods In-depth qualitative interviews were conducted with 22 medical oncologists, including advanced trainees, early-career consultants and senior consultants, focusing on: professional values and experiences; career prospects and pathways; and, the nexus of the characteristics of the profession and delivery of care. Results The following themes were emergent from the interviews: the need for professional reinvention and the pressure to perform; the importance, and often absence, of mentoring and feedback loops; the emotional labour of oncology; and, the impact of cascading workload volume on practice sustainability. Conclusions Understanding professional experiences, career trajectories and challenges at the work-force level are crucial for understanding what drives the oncological care day-to-day. The results indicate that there are considerable potential tensions between the realities of professional, workforce demands and expectations for patient care. Such tensions have real and significant consequences on individual medical oncologists with respect to their futures, aspirations, satisfaction with work, caring practices, interactions with patients and potentially therapeutic outcomes.	[Broom, Alex; Wong, W. K. Tim; Kirby, Emma] UNSW Australia, Sch Social Sci, Sydney, NSW, Australia; [Sibbritt, David] Univ Technol, Fac Hlth, Sydney, NSW, Australia; [Karikios, Deme] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Karikios, Deme] Nepean Hosp, Sydney, NSW, Australia; [Harrup, Rosemary] Royal Hobart Hosp, Hobart, Tas, Australia; [Lwin, Zarnie] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Lwin, Zarnie] Univ Queensland, Brisbane, Qld, Australia	University of New South Wales Sydney; University of Technology Sydney; University of Sydney; Nepean Hospital; Royal Hobart Hospital; Royal Brisbane & Women's Hospital; University of Queensland	Broom, A (corresponding author), UNSW Australia, Sch Social Sci, Sydney, NSW, Australia.	a.broom@unsw.edu.au	Sibbritt, David W/F-8070-2017	Sibbritt, David W/0000-0003-3561-9447; Kirby, Emma/0000-0001-9754-0342; Broom, Alexander/0000-0003-1258-1140				Augustin ID, 2014, J CLIN ANESTH, V26, P91, DOI 10.1016/j.jclinane.2013.01.020; Australian Medical Workforce Advisory Committee, 2001, AMWAC REPORT 2001 2; Baile WF, 2015, ONCOLOGIST, V20, P852, DOI 10.1634/theoncologist.2015-0250; Band PR, 2010, J CLIN ONCOL, V28, P3653, DOI 10.1200/JCO.2010.29.5261; Bascioni R, 2014, PALLIAT SUPPORT CARE, V12, P351, DOI 10.1017/S1478951513000291; Bidwell S, 2013, THE NEW ZEALAND MEDI, V126, P45; Blinman PL, 2012, MED J AUSTRALIA, V196, P58, DOI 10.5694/mja11.10363; Boutayeb Saber, 2013, ISRN Oncol, V2013, P341565, DOI 10.1155/2013/341565; Broom A, 2013, SOC SCI MED, V78, P9, DOI 10.1016/j.socscimed.2012.11.008; Bryman A., 2012, SOCIAL RES METHOD, V4th ed., P809; Burchell B, 2005, JOB INSECURITY AND W; Celenza A, 2012, EMERG MED AUSTRALAS, V24, P625, DOI 10.1111/j.1742-6723.2012.01607.x; Collinson DL, 2003, ORGANIZATION, V10, P527, DOI 10.1177/13505084030103010; de Azambuja E, 2014, ANN ONCOL, V25, P525, DOI 10.1093/annonc/mdt559; Draper C, 2007, EDUC PRIM CARE, V18, P338, DOI 10.1080/14739879.2007.11493559; Edwards N, 2002, BMJ-BRIT MED J, V324, P835, DOI 10.1136/bmj.324.7341.835; Erikson C, 2007, J ONCOL PRACT, V3, P79, DOI 10.1200/JOP.0723601; Fallowfield L, 2014, LANCET ONCOL, V15, P1423, DOI 10.1016/S1470-2045(14)71122-2; Girgis A, 2009, EUR J CANCER, V45, P393, DOI 10.1016/j.ejca.2008.09.029; Gordon R, 2009, J PAIN SYMPTOM MANAG, V38, P68, DOI 10.1016/j.jpainsymman.2009.04.002; Hilmer C, 2007, AM ECON REV, V97, P422, DOI 10.1257/aer.97.2.422; Hortobagyi GN, 2007, J CLIN ONCOL, V25, P1468, DOI 10.1200/JCO.2007.10.9397; Jacob SA, 2015, CLIN ONCOL-UK, V27, P77, DOI 10.1016/j.clon.2014.10.004; Koczwara B, 2012, MED J AUSTRALIA, V196, P32, DOI 10.5694/mja11.10356; Kuhlmann E., 2006, MODERNISING HEALTH C; LEVINSON W, 1991, WESTERN J MED, V154, P423; Levit L, 2010, J ONCOL PRACT, V6, P7, DOI 10.1200/JOP.091067; Loriot Y, 2010, ANN ONCOL, V21, P161, DOI 10.1093/annonc/mdp294; Miles Andrew, 2009, J Eval Clin Pract, V15, P1000, DOI 10.1111/j.1365-2753.2009.01351.x; Nancarrow SA, 2005, SOCIOL HEALTH ILL, V27, P897, DOI 10.1111/j.1467-9566.2005.00463.x; NETTLETON S, 2008, SOCIAL THEORY HLTH, V0006; Ogbonna E, 2004, ORGAN STUD, V25, P1185, DOI 10.1177/0170840604046315; Oh H, 2014, SOCIOL HEALTH ILL, V36, P580, DOI 10.1111/1467-9566.12087; Olver I, 2009, ASIA PACIFIC J CL S1, V5, pA1, DOI [10.1111/j.1743-7563.2009.01207.x, DOI 10.1111/J.1743-7563.2009.01207.X]; Pope C, 2007, QUALITATIVE RES HLTH, P1, DOI DOI 10.1002/9780470750841.CH1; Popescu RA, 2014, ANN ONCOL, V25, P9, DOI 10.1093/annonc/mdt522; Rubin G, LANCET ONCOLOGY, V16, P1231, DOI [10.1016/S1470-2045(15), DOI 10.1016/S1470-2045(15)]; Sennett R., 2011, THE CORROSION OF CHA; Shanafelt Tait D, 2005, J Support Oncol, V3, P157; Shanafelt TD, 2014, J CLIN ONCOL, V32, P2991, DOI 10.1200/JCO.2014.56.2827; Stokes H, 2007, INT J LIFELONG EDUC, V26, P495, DOI 10.1080/02601370701559573; Tadajewski M, 2016, J MARKET MANAG-UK, V32, P1, DOI 10.1080/0267257X.2015.1120508; Yoon JD, 2016, ACAD PSYCHIATR, P1, DOI DOI 10.1007/S40596-016-0487-1	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166302	10.1371/journal.pone.0166302	http://dx.doi.org/10.1371/journal.pone.0166302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902706	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474100018
J	Dickson, JM; Moberly, NJ; O'Dea, C; Field, M				Dickson, Joanne M.; Moberly, Nicholas J.; O'Dea, Christian; Field, Matt			Goal Fluency, Pessimism and Disengagement in Depression	PLOS ONE			English	Article							ADAPTIVE SELF-REGULATION; BEHAVIORAL ACTIVATION; AVOIDANCE GOALS; UNATTAINABLE GOALS; PERSONAL GOALS; MOTIVATION; SEVERITY; ANXIETY; REWARD	Despite the development of prominent theoretical models of goal motivation and its importance in daily life, research has rarely examined goal dysregulation processes in clinical depression. Here we aimed to investigate problematic aspects of goal regulation in clinically depressed adults, relative to controls. Depressed participants (n = 42) were recruited from two Improving Access to Psychological Therapy clinics in north-west England. Control participants (n = 51) were recruited from the same region. Participants generated personal approach goals (e.g., improve my marathon time) and avoidance goals (e.g., avoid getting upset over little things) and completed self-report measures of goal attainment likelihood and depressive symptoms. Participants also completed a measure of ease of disengagement from unattainable goals and re-engagement with new goals. Compared to controls, depressed participants reported fewer approach goals (but not more avoidance goals), rated their approach goal (rewarding) outcomes as less likely to happen and avoidance goal (threatening) outcomes as more likely to happen. Depressed participants also reported greater ease of disengagement from unattainable goals and more difficulty re-engaging with new goals than controls. Our findings extend current knowledge of the psychopathology of depression from a goal regulation perspective, suggesting that pessimism around goal pursuit accompanies fewer approach goal pursuits and a general tendency to disengage when difficulties are encountered.	[Dickson, Joanne M.] Edith Cowan Univ, Dept Psychol, Joondalup, WA, Australia; [Dickson, Joanne M.; Field, Matt] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England; [Moberly, Nicholas J.] Univ Exeter, Mood Disorders Ctr, Exeter, Devon, England; [O'Dea, Christian] Newhall Independent Hosp, Mental Hlth Care, Wrexham, Wales	Edith Cowan University; University of Liverpool; University of Exeter	Dickson, JM (corresponding author), Edith Cowan Univ, Dept Psychol, Joondalup, WA, Australia.; Dickson, JM (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England.	j.dickson@ecu.edu.au	Field, Matt/AAQ-1056-2020	Field, Matt/0000-0002-7790-5559; Dickson, Joanne/0000-0002-4626-8761; Moberly, Nicholas/0000-0001-8040-1418	University of Liverpool	University of Liverpool	The Doctoral Clinical Psychology programme at the University of Liverpool financially supported this research. However, the funder had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU; Carver CS, 2006, MOTIV EMOTION, V30, P105, DOI 10.1007/s11031-006-9044-7; CARVER CS, 1990, PSYCHOL REV, V97, P19, DOI 10.1037/0033-295X.97.1.19; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dickson JM, 2006, J ADOLESCENCE, V29, P177, DOI 10.1016/j.adolescence.2005.03.007; Dickson JM, 2004, COGNITIVE THER RES, V28, P415, DOI 10.1023/B:COTR.0000031809.20488.ee; Dickson JM, 2006, PERS INDIV DIFFER, V41, P1527, DOI 10.1016/j.paid.2006.06.005; Dickson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064512; Dickson JM, 2011, J ABNORM PSYCHOL, V120, P975, DOI 10.1037/a0023665; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Elliot A.J., 2007, PERSONAL PROJECT PUR, P97; FOWLES DC, 1994, NEBR SYM MOTIV, V41, P181; Grawe K., 2007, NEUROPSYCHOTHERAPY N; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Hadley SA, 2010, COGNITION EMOTION, V24, P1191, DOI 10.1080/02699930903122521; Henriques JB, 2000, COGNITION EMOTION, V14, P711, DOI 10.1080/02699930050117684; Johnson S. L., 2010, EMOTION REGULATION P, P204; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Klinger E, 1977, MEANING AND VOID INN; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lezak M., 1976, NEUROPSYCHOLOGICAL A; Mansell W, 2005, PSYCHOL PSYCHOTHER-T, V78, P141, DOI 10.1348/147608304X21400; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McEvoy P, 2013, J PSYCHIATR MENT HLT, V20, P890, DOI 10.1111/jpm.12032; McFarland BR, 2006, J AFFECT DISORDERS, V91, P229, DOI 10.1016/j.jad.2006.01.012; Miller GE, 2007, PSYCHOL SCI, V18, P773, DOI 10.1111/j.1467-9280.2007.01977.x; O'Connor RC, 2012, J AFFECT DISORDERS, V142, P248, DOI 10.1016/j.jad.2012.04.035; O'Connor RC, 2009, BEHAV RES THER, V47, P164, DOI 10.1016/j.brat.2008.11.001; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; PYSZCZYNSKI T, 1987, PSYCHOL BULL, V102, P122, DOI 10.1037/0033-2909.102.1.122; Sherdell L, 2012, J ABNORM PSYCHOL, V121, P51, DOI 10.1037/a0024945; Sherratt KAL, 2013, COGNITION EMOTION, V27, P1432, DOI 10.1080/02699931.2013.786680; Spielberg JM, 2011, COGNITIVE THER RES, V35, P359, DOI 10.1007/s10608-011-9364-0; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; The British Psychological Society (BPS), 2014, COD HUM RES ETH; Trew JL, 2011, CLIN PSYCHOL REV, V31, P1156, DOI 10.1016/j.cpr.2011.07.007; van den Elzen J, 2006, BEHAV THER, V37, P304, DOI 10.1016/j.beth.2006.02.005; Wallace ML, 2012, INT J GERIATR PSYCH, V27, P178, DOI 10.1002/gps.2706; Watkins E, 2011, CLIN PSYCHOL REV, V31, P260, DOI 10.1016/j.cpr.2010.05.004; Wrosch C, 2003, PERS SOC PSYCHOL B, V29, P1494, DOI 10.1177/0146167203256921; Wrosch C, 2011, J PERS SOC PSYCHOL, V100, P934, DOI 10.1037/a0022873; Wrosch C, 2003, SELF IDENTITY, V2, P1, DOI 10.1080/15298860309021	45	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166259	10.1371/journal.pone.0166259	http://dx.doi.org/10.1371/journal.pone.0166259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902708	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000389474100016
J	Stelmokas, J; Gabel, N; Flaherty, JM; Rayson, K; Tran, K; Anderson, JR; Bieliauskas, LA				Stelmokas, Julija; Gabel, Nicolette; Flaherty, Jennifer M.; Rayson, Katherine; Tran, Kathileen; Anderson, Jason R.; Bieliauskas, Linas A.			Delirium Detection and Impact of Comorbid Health Conditions in a Post-Acute Rehabilitation Hospital Setting	PLOS ONE			English	Article							COGNITIVE TEST BATTERY; VALIDATION; UTILITY; CARE	Misdiagnosis and under-detection of delirium may occur in many medical settings. This is important to address as delirium clearly increases risk of morbidity and mortality in such settings. This study assessed whether Veterans who screened positive on a delirium severity measure (Memorial Delirium Assessment Scale; MDAS) differed from those with and without corresponding medical documentation of delirium in terms of cognitive functioning, psychiatric/ medical history, and medication use. A medical record review of 266 inpatients at a VA post-acute rehabilitation unit found that 10.9% were identified as delirious according to the MDAS and/or medical records. Of the Veterans who screened positive on the MDAS (N = 19), 68.4% went undetected by medical screening. Undetected cases had a higher number of comorbid medical conditions as measured by the Age-Adjusted Charlson Index (AACI) scores (median = 9, SD = 3.15; U = 5.5, p = .003) than medically documented cases. For Veterans with a score of 7 or greater on the AACI, the general relative risk for delirium was 4.46. Delirium is frequently under-detected in a post-acute rehabilitation unit, particularly for Veterans with high comorbid illness. The relative risk of delirium is up to 4.46 for those with high medical burden, suggesting the need for more comprehensive delirium screening in these patients.	[Stelmokas, Julija; Rayson, Katherine; Bieliauskas, Linas A.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; [Gabel, Nicolette] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Flaherty, Jennifer M.] Eastern Virginia Med Sch, Dept Psychiat & Behav Sci, Norfolk, VA 23501 USA; [Tran, Kathileen; Bieliauskas, Linas A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Anderson, Jason R.] Kent State Univ, Kent, OH 44242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Eastern Virginia Medical School; University of Michigan System; University of Michigan; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Stelmokas, J (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA.	jstelmok@med.umich.edu						American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Collins N, 2010, AGE AGEING, V39, P131, DOI 10.1093/ageing/afp201; Detweiler MB, 2014, PSYCHIAT QUART, V85, P211, DOI 10.1007/s11126-013-9284-0; Eden BM, 1996, HEART LUNG, V25, P388, DOI 10.1016/S0147-9563(96)80082-3; Elie M, 2000, CAN MED ASSOC J, V163, P977; Hope Carol, 2014, BMC Res Notes, V7, P208, DOI 10.1186/1756-0500-7-208; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kakuma R, 2003, J AM GERIATR SOC, V51, P443, DOI 10.1046/j.1532-5415.2003.51151.x; Kishi Y, 2007, GEN HOSP PSYCHIAT, V29, P442, DOI 10.1016/j.genhosppsych.2007.05.006; Lawlor PG, 2000, CANCER, V88, P2859, DOI 10.1002/1097-0142(20000615)88:12<2859::AID-CNCR29>3.3.CO;2-K; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Powers JS, 2013, GERONTOLOGIST, V53, P1051, DOI 10.1093/geront/gns161; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Swigart SE, 2008, PSYCHOSOMATICS, V49, P104, DOI 10.1176/appi.psy.49.2.104; Tabet N, 2005, AGE AGEING, V34, P152, DOI 10.1093/ageing/afi031; Wechsler D., 1997, WECHSLER ADULT INTEL	21	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166754	10.1371/journal.pone.0166754	http://dx.doi.org/10.1371/journal.pone.0166754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902744	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100038
J	Forsblom, E; Ruotsalainen, E; Jarvinen, A				Forsblom, Erik; Ruotsalainen, Eeva; Jarvinen, Asko			Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study	PLOS ONE			English	Article							CEFAZOLIN; CARE	The objective was to compare the prognostic impact of first week treatment with anti-staphylococcal penicillin (ASP) versus cephalosporin in methicillin-sensitive Staphylococcus aureus bacteremia (MS-SAB). Altogether 580 patients were retrospectively followed and categorized according to first week treatment; 84% (488) received ASP (cloxacillin) and 16% (92) cephalosporin (cefuroxime or ceftriaxone). SAB management was optimized with formal bedside infectious disease specialist consultation in 88%, deep infection foci diagnosed in 77% and adjunctive rifampicin therapy given to 61% of patients. The total case fatality in 580 patients was 12% at 28 days and 18% at 90 days. When comparing effectiveness of first week ASP versus cephalosporin treatment there were no significant differences in 28-days (11% vs. 12%, OR; 1.05, 95% CI, 0.53-2.09) or 90-days (17% vs. 21% OR; 1.25, 95% CI, 0.72-2.19) outcome. In univariate analysis no prognostic impact of either first week ASP or cephalosporin treatment was observed for 28-days (OR; 0.96, 95% CI, 0.48-1.90 and OR; 1.05, 95% CI, 0.53-2.09) or 90-days (OR; 0.80, 95% CI, 0.46-1.39 and OR; 1.25, 95% CI, 0.72-2.19) outcome. Propensity-score adjusted Cox proportional regression analysis for first week treatment with cephalosporin demonstrated no significant prognostic impact at 28-days (HR 1.54, 95% CI 0.72-3.23) or 90-days (HR 1.56, 95% CI 0.88-2.86). In conclusion: There is a comparable effectiveness with respect to 28- and 90-days outcome for first week treatment with ASP versus cephalosporin in MS-SAB. The results indicate that the difference in prognostic impact between first week ASP and cephalosporin may be nonsignificant in patient cohorts with SAB management optimized by infectious disease specialist consultation.	[Forsblom, Erik] Univ Helsinki, Cent Hosp, Div Infect Dis, Inflammat Ctr, Helsinki, Finland; Univ Helsinki, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Forsblom, E (corresponding author), Univ Helsinki, Cent Hosp, Div Infect Dis, Inflammat Ctr, Helsinki, Finland.	erik.forsblom@helsinki.fi			Medical Society of Finland; foundation Medicinska Understodsforeningen Liv och Halsa; foundation Dorothea Olivia, Karl Walter och Jarl Walter Perklens minne	Medical Society of Finland; foundation Medicinska Understodsforeningen Liv och Halsa; foundation Dorothea Olivia, Karl Walter och Jarl Walter Perklens minne	The study has been supported by grants from The Medical Society of Finland and the foundations Medicinska Understodsforeningen Liv och Halsa and Dorothea Olivia, Karl Walter och Jarl Walter Perklens minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AD, 2015, J ANTIMICROB CHEMOTH, V70, P1539, DOI 10.1093/jac/dku560; Forsblom E, 2013, CLIN INFECT DIS, V56, P527, DOI 10.1093/cid/cis889; Forsblom E, 2011, J HOSP INFECT, V78, P102, DOI 10.1016/j.jhin.2011.03.010; Forsblom E, 2015, PLOS ONE, V13; Kaech C, 2006, CLIN MICROBIOL INFEC, V12, P345, DOI 10.1111/j.1469-0691.2005.01359.x; Lee S, 2011, ANTIMICROB AGENTS CH, V55, P5122, DOI 10.1128/AAC.00485-11; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Nannini EC, 2013, ANTIMICROB AGENTS CH, V57, P4276, DOI 10.1128/AAC.00856-13; Nannini EC, 2009, ANTIMICROB AGENTS CH, V53, P3437, DOI 10.1128/AAC.00317-09; Nissen JL, 2013, J ANTIMICROB CHEMOTH, V68, P1894, DOI 10.1093/jac/dkt108; Paul M, 2011, CLIN MICROBIOL INFEC, V17, P1581, DOI 10.1111/j.1469-0691.2010.03425.x; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Rasmussen JB, 2014, J ANTIMICROB CHEMOTH, V69, P506, DOI 10.1093/jac/dkt375; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ruotsalainen E, 2006, J INTERN MED, V259, P179, DOI 10.1111/j.1365-2796.2005.01598.x; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Vardakas KZ, 2014, INT J ANTIMICROB AG, V44, P486, DOI 10.1016/j.ijantimicag.2014.09.002	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167112	10.1371/journal.pone.0167112	http://dx.doi.org/10.1371/journal.pone.0167112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898714	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000033
J	Vella, S; Tavanti, E; Hattinger, CM; Fanelli, M; Versteeg, R; Koster, J; Picci, P; Serra, M				Vella, Serena; Tavanti, Elisa; Hattinger, Claudia Maria; Fanelli, Marilu; Versteeg, Rogier; Koster, Jan; Picci, Piero; Serra, Massimo			Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells	PLoS One			English	Article							CYCLIN-DEPENDENT KINASES; IN-VITRO; EMERGING DRUGS; R-ROSCOVITINE; CANCER CELLS; HIGH-GRADE; INHIBITOR; RESISTANCE; APOPTOSIS; LINES	Cyclin-dependent kinase 2 (CDK2) has been reported to be essential for cell proliferation in several human tumours and it has been suggested as an appropriate target to be considered in order to enhance the efficacy of treatment regimens based on the use of DNA damaging drugs. We evaluated the clinical impact of CDK2 overexpression on a series of 21 high-grade osteosarcoma (OS) samples profiled by using cDNA microarrays. We also assessed the in vitro efficacy of the CDKs inhibitor roscovitine in a panel of drug-sensitive and drug-resistant human OS cell lines. OS tumour samples showed an inherent overexpression of CDK2, and high expression levels at diagnosis of this kinase appeared to negatively impact on clinical outcome. CDK2 expression also proved to be relevant for in vitro OS cells growth. These findings indicated CDK2 as a promising candidate therapeutic marker for OS and therefore we assessed the efficacy of the CDKs-inhibitor roscovitine in both drug-sensitive and -resistant OS cell lines. All cell lines resulted to be responsive to roscovitine, which was also able to increase the activity of cisplatin and doxorubicin, the two most active DNA damaging drugs used in OS chemotherapy. Our results indicated that combined treatment with conventional OS chemotherapeutic drugs and roscovitine may represent a new candidate intervention approach, which may be considered to enhance tumour cell sensitivity to DNA damaging drugs.	[Vella, Serena; Tavanti, Elisa; Hattinger, Claudia Maria; Fanelli, Marilu; Picci, Piero; Serra, Massimo] Orthopaed Rizzoli Inst, Expt Oncol Lab, Bologna, Italy; [Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Serra, M (corresponding author), Orthopaed Rizzoli Inst, Expt Oncol Lab, Bologna, Italy.	massimo.serra@ior.it	Versteeg, Rogier/AAQ-1765-2020; Serra, Massimo/J-4878-2016; Koster, Jan/C-5934-2008; Hattinger, Claudia/Q-1212-2016	Serra, Massimo/0000-0003-0742-1177; Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Hattinger, Claudia/0000-0002-9316-5095	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) [IG2014 I.d.15851]; Istituto Ortopedico Rizzoli	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); Istituto Ortopedico Rizzoli	This study was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C. www.airc.it; grant to MS, IG2014 I.d.15851) and the Istituto Ortopedico Rizzoli (www.ior.it; 5 parts per thousand contributions to Rizzoli Institute). Dr. ET received a fellowship from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) to perform the research project "Pre-clinical validation of approaches targeting protein kinases in osteosarcoma". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza MSI, 2008, WORLD J GASTROENTERO, V14, P5162, DOI 10.3748/wjg.14.5162; Abbotts R, 2014, CANCER MANAG RES, V6, P77, DOI 10.2147/CMAR.S50497; Achille C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052356; Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Bruyere C, 2013, CURR OPIN CELL BIOL, V25, P772, DOI 10.1016/j.ceb.2013.08.004; Cicenas J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.61; Coley HM, 2007, GYNECOL ONCOL, V105, P462, DOI 10.1016/j.ygyno.2007.01.004; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ferrari S, 2015, EXPERT OPIN PHARMACO, V16, P2727, DOI 10.1517/14656566.2015.1102226; Fischer PM, 2003, EXPERT OPIN INV DRUG, V12, P955, DOI 10.1517/eoid.12.6.955.21792; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Han XF, 2014, CYTOTECHNOLOGY, V66, P567, DOI 10.1007/s10616-013-9604-0; Hattinger CM, 2015, EXPERT OPIN EMERG DR, V20, P495, DOI 10.1517/14728214.2015.1051965; Hattinger CM, 2015, HISTOPATHOLOGY, V67, P338, DOI 10.1111/his.12653; Hattinger CM, 2010, EXPERT OPIN EMERG DR, V15, P615, DOI 10.1517/14728214.2010.505603; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khalil HS, 2015, J BIOTECHNOL, V202, P40, DOI 10.1016/j.jbiotec.2015.02.032; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Le Tourneau C, 2010, EUR J CANCER, V46, P3243, DOI 10.1016/j.ejca.2010.08.001; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Messerschmitt PJ, 2008, CLIN ORTHOP RELAT R, V466, P2168, DOI 10.1007/s11999-008-0338-9; Mohapatra S, 2005, CANCER RES, V65, P7717, DOI 10.1158/0008-5472.CAN-05-0347; Mohapatra S, 2007, MOL CANCER RES, V5, P145, DOI 10.1158/1541-7786.MCR-06-0300; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pasello M, 2008, CANCER RES, V68, P6661, DOI 10.1158/0008-5472.CAN-07-5840; Pepper C, 2003, CELL CYCLE, V2, P53, DOI 10.4161/cc.2.1.249; Pitts TM, 2014, PHARMACOL THERAPEUT, V142, P258, DOI 10.1016/j.pharmthera.2013.12.010; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Senderowicz AM, 2003, CANCER BIOL THER, V2, pS84; Sero V, 2014, INVEST NEW DRUG, V32, P1167, DOI 10.1007/s10637-014-0158-6; SERRA M, 1993, ANTICANCER RES, V13, P323; Serra M, 2004, ANN ONCOL, V15, P151, DOI 10.1093/annonc/mdh004; Siemeister G, 2012, MOL CANCER THER, V11, P2265, DOI 10.1158/1535-7163.MCT-12-0286; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Tavanti E, 2013, BRIT J CANCER, V109, P2607, DOI 10.1038/bjc.2013.643; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wesierska-Gadek J, 2009, ANN NY ACAD SCI, V1171, P228, DOI 10.1111/j.1749-6632.2009.04726.x; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002	49	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166233	10.1371/journal.pone.0166233	http://dx.doi.org/10.1371/journal.pone.0166233			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898692	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000006
J	Weston, C; Klobusicky, J; Weston, J; Connor, J; Toms, SA; Marko, NF				Weston, Cody; Klobusicky, Joe; Weston, Jennifer; Connor, James; Toms, Steven A.; Marko, Nicholas F.			Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas	PLOS ONE			English	Article							PROTEASE MATRIPTASE-2 TMPRSS6; HYDROGEN-PEROXIDE; CANCER GENOMICS; FENTON REACTION; STEAP PROTEINS; DNA DAMAGE; HFE; GLIOBLASTOMA; CELLS; PROLIFERATION	Iron is a tightly regulated micronutrient with no physiologic means of elimination and is necessary for cell division in normal tissue. Recent evidence suggests that dysregulation of iron regulatory proteins may play a role in cancer pathophysiology. We use public data from The Cancer Genome Atlas (TCGA) to study the association between survival and expression levels of 61 genes coding for iron regulatory proteins in patients with World Health Organization Grade II-III gliomas. Using a feature selection algorithm we identified a novel, optimized subset of eight iron regulatory genes (STEAP3, HFE, TMPRSS6, SFXN1, TFRC, UROS, SLC11A2, and STEAP4) whose differential expression defines two phenotypic groups with median survival differences of 52.3 months for patients with grade II gliomas (25.9 vs. 78.2 months, p< 10(-3)), 43.5 months for patients with grade III gliomas (43.9 vs. 87.4 months, p = 0.025), and 54.0 months when considering both grade II and III gliomas (79.9 vs. 25.9 months, p < 10(-5)).	[Weston, Cody; Connor, James] Penn State Milton S Hershey Med Ctr, Coll Med, Hershey, PA USA; [Klobusicky, Joe] Geisinger Med Ctr, Dept Data Sci, Danville, PA 17822 USA; [Weston, Jennifer] Penn State Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA USA; [Toms, Steven A.; Marko, Nicholas F.] Geisinger Med Ctr, Dept Neurosurg, Danville, PA 17822 USA; [Marko, Nicholas F.] Penn State Sch Med, Dept Surg, Danville, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Weston, C (corresponding author), Penn State Milton S Hershey Med Ctr, Coll Med, Hershey, PA USA.	cweston@hmc.psu.edu			Geisinger Health System; Penn State University	Geisinger Health System; Penn State University	This project was funded entirely through internal organizational funds provided through Geisinger Health System and Penn State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikyol B, 2013, NEUROSCIENCE, V235, P119, DOI 10.1016/j.neuroscience.2013.01.014; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; CAZZOLA M, 1990, BLOOD, V75, P1903; Ceci A, 2002, BRIT J HAEMATOL, V118, P330, DOI 10.1046/j.1365-2141.2002.03554.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chirasani SR, 2009, J MOL MED, V87, P153, DOI 10.1007/s00109-008-0414-3; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Dayani PN, 2004, J NEURO-ONCOL, V67, P367, DOI 10.1023/B:NEON.0000024238.21349.37; di Montemuros FM, 2001, NEUROLOGY, V57, P1342, DOI 10.1212/WNL.57.7.1342; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gomes IM, 2012, MOL CANCER RES, V10, P573, DOI 10.1158/1541-7786.MCR-11-0281; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Isobe T, 2011, EXP CELL RES, V317, P2582, DOI 10.1016/j.yexcr.2011.07.022; Jacobsen A., CGDSR R BAS API ACCE; Jiang XP, 2010, ANTICANCER RES, V30, P759; Jin Y, 2015, EMBO MOL MED, V7, P315, DOI 10.15252/emmm.201404181; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Kennedy AE, 2014, LEUKEMIA RES, V38, P1055, DOI 10.1016/j.leukres.2014.06.016; Kim H, 2013, INT J NANOMED, V8, P57, DOI 10.2147/IJN.S40733; LAHAV M, 1985, CANCER LETT, V25, P305, DOI 10.1016/S0304-3835(15)30010-0; Lee SY, 2015, J NEURO-ONCOL, V122, P97, DOI 10.1007/s11060-014-1681-1; Lee SY, 2011, INT J CANCER, V129, P2104, DOI 10.1002/ijc.25888; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x; Roy CN, 2001, HUM MOL GENET, V10, P2181, DOI 10.1093/hmg/10.20.2181; Sakurai K, 2014, HEPATO-GASTROENTEROL, V61, P426, DOI 10.5754/hge13969; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Simon N, 2011, J STAT SOFTW, V39, P1; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weston CL, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-14; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	40	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166593	10.1371/journal.pone.0166593	http://dx.doi.org/10.1371/journal.pone.0166593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898674	Green Published, gold			2022-12-27	WOS:000389474000012
J	Lieutaud, T; Gadegbeku, B; Ndiaye, A; Chiron, M; Viallon, V				Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian			The Decrease in Traumatic Brain Injury Epidemics Deriving from Road Traffic Collision Following Strengthened Legislative Measures in France	PLOS ONE			English	Article							GLASGOW COMA SCALE; PROGNOSTIC VALUE; HEAD-INJURY; MORTALITY; CASUALTIES; SEVERITY; MODERATE; CRASHES; OUTCOMES; ENGLAND	Background Since 2002, France has been strengthening legislation on road traffic. This study is intended to evaluate the changes in Traumatic Brain Injury (TBI) incidence and mortality resulting from Road Traffic Collision (RTC) in the two 6-year periods before and after 2002. Methods We used a Registry of all RTC casualties in the Rho A ne Department of France. Each casualty was coded according to the Abbreviated Injury Scale (AIS). The study describes changes in demographic variables, TBI (AIS >= 2) incidence and mortality, other body lesions (AIS >= 3) associated with TBI, road user types, seatbelt and helmet wearing. Findings RTC casualty occurrences decreased by 21% (from 64,312 to 50,746) during the period after 2002. TBI occurrence accounted for 8.6% and 6.7% of all RTC in both periods. This corresponds to a reduction of TBI casualty incidence (-42%), which was much more pronounced than RTC casualty incidence (-25%) (p < 0.0001). Severe and critical TBI (AIS-4 and -5) incidences were reduced by half as much (-21%), compared to TBI incidence. TBI mortality rate (among population) and lethality (among TBI related to RTC casualties) decreased 56% and 23%, respectively. This reduction particularly affected car occupants and victims who deceased. TBI incidence decreased 43% in all 10-year age classes until 60 on average, this decrease declining with age in the period after 2002. After adjustment for age, sex, road user types, and severity of lesions at the head and other body regions, logistic regression analysis displayed a protective effect of the period following 2002, on the risk of death after RTC-related TBI. Interpretation The greater reductions in the incidence, severity and mortality of TBI when compared with the reduction of casualty incidence have mainly affected car users. These results should be attributable to the improvements in standards of care, primary safety of the car fleet and general road architecture safety. However, the increased reduction in the TBI epidemics in France, when compared to those observed in other developed countries for the same periods, suggests that the effects should be strongly attributable to changes in road user behaviour induced by law enforcement. The at-risk groups for TBI after RTC are now two-wheel users ( motorized or not) and individuals over 60 years of age.	[Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian] IFSTTAR, UMRESTTE, UMR T 9405, Bron, France; [Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian] Univ Lyon, Lyon, France; [Lieutaud, Thomas] Univ Lyon, Univ Claude Bernard Lyon 1, Team TIGER, INSERM,U10128,CNRS,UMR5292,Lyon Neurosci Res Ctr, Lyon, France	Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lieutaud, T (corresponding author), IFSTTAR, UMRESTTE, UMR T 9405, Bron, France.; Lieutaud, T (corresponding author), Univ Lyon, Lyon, France.; Lieutaud, T (corresponding author), Univ Lyon, Univ Claude Bernard Lyon 1, Team TIGER, INSERM,U10128,CNRS,UMR5292,Lyon Neurosci Res Ctr, Lyon, France.	thomas.lieutaud@gmail.com	Gadegbeku, Blandine/AAE-3618-2019	Gadegbeku, Blandine/0000-0001-6720-206X	Institut National de Veille sanitaire Ministere de l'equipement	Institut National de Veille sanitaire Ministere de l'equipement	This work was funded by Institut National de Veille sanitaire Ministere de l'equipement.	Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blomberg RD, 2009, J SAFETY RES, V40, P285, DOI 10.1016/j.jsr.2009.07.002; Braver ER, 2003, ACCIDENT ANAL PREV, V35, P295, DOI 10.1016/S0001-4575(01)00106-3; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clark DE, 2003, ACCIDENT ANAL PREV, V35, P965, DOI 10.1016/S0001-4575(02)00104-5; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Edwards P, 2005, LANCET, V365, P1957; Eksler V, 2008, PUBLIC HEALTH, V122, P826, DOI 10.1016/j.puhe.2007.10.003; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Hetland A, 2014, ANN PHARMACOTHER, V48, P494, DOI 10.1177/1060028014520882; Heyes Gavin J, 2014, Ulster Med J, V83, P55; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Laumon B, 1997, 41 ANN P ASS ADV AUT, P127; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Licaj I, 2011, ACCIDENT ANAL PREV, V43, P1617, DOI 10.1016/j.aap.2011.02.003; Lieutaud T, 2012, J NEUROTRAUM, V29, P479, DOI 10.1089/neu.2011.1880; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nash S., 2014, Annals of Physical and Rehabilitation Medicine, V57, P600, DOI 10.1016/j.rehab.2014.08.010; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pilkington P, 2005, BMJ-BRIT MED J, V330, P331, DOI 10.1136/bmj.38324.646574.AE; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Viallon V, 2013, ACCIDENT ANAL PREV, V52, P250, DOI 10.1016/j.aap.2012.12.024; Yeguiayan JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11375	41	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167082	10.1371/journal.pone.0167082	http://dx.doi.org/10.1371/journal.pone.0167082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893865	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400080
J	Shen, P; Murphy, DV; George, SJ; Lapis-Gaza, H; Xu, MG; Gleeson, DB				Shen, Pu; Murphy, Daniel Vaughan; George, Suman J.; Lapis-Gaza, Hazel; Xu, Minggang; Gleeson, Deirdre Bridget			Increasing the Size of the Microbial Biomass Altered Bacterial Community Structure which Enhances Plant Phosphorus Uptake	PLOS ONE			English	Article							HIGHLY WEATHERED SOIL; MULTIVARIATE-ANALYSIS; AGRICULTURAL SOILS; ORGANIC-MATTER; FRACTIONS; AVAILABILITY; RHIZOSPHERE; DIVERSITY; CROP; GRASSLAND	Agricultural production can be limited by low phosphorus (P) availability, with soil P being constrained by sorption and precipitation reactions making it less available for plant uptake. There are strong links between carbon (C) and nitrogen (N) availability and P cycling within soil P pools, with microorganisms being an integral component of soil P cycling mediating the availability of P to plants. Here we tested a conceptual model that proposes (i) the addition of readily-available organic substrates would increase the size of the microbial biomass thus exhausting the pool of easily-available P and (ii) this would cause the microbial biomass to access P from more recalcitrant pools. In this model it is hypothesised that the size of the microbial population is regulating access to less available P rather than the diversity of organisms contained within this biomass. To test this hypothesis we added mixtures of simple organic compounds that reflect typical root exudates at different C:N ratios to a soil microcosm experiment and assessed changes in soil P pools, microbial biomass and bacterial diversity measures. We report that low C:N ratio (C:N = 12.5:1) artificial root exudates increased the size of the microbial biomass while high C: N ratio (C:N = 50:1) artificial root exudates did not result in a similar increase in microbial biomass. Interestingly, addition of the root exudates did not alter bacterial diversity (measured via univariate diversity indices) but did alter bacterial community structure. Where C, N and P supply was sufficient to support plant growth the increase observed in microbial biomass occurred with a concurrent increase in plant yield.	[Shen, Pu; Murphy, Daniel Vaughan; George, Suman J.; Lapis-Gaza, Hazel; Gleeson, Deirdre Bridget] Univ Western Australia, Sch Earth & Environm, Fac Sci, Soil Biol & Mol Ecol Grp, Perth, WA, Australia; [Shen, Pu; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Shanghai, Peoples R China	University of Western Australia; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Gleeson, DB (corresponding author), Univ Western Australia, Sch Earth & Environm, Fac Sci, Soil Biol & Mol Ecol Grp, Perth, WA, Australia.	deirdre.gleeson@uwa.edu.au	; gleeson, deirdre/F-9894-2011	Murphy, Daniel/0000-0002-4686-9276; gleeson, deirdre/0000-0002-9069-7723	Grains Research and Development Corporation [UWA00150]; Australian Research Council [FT110100246]; University of Western Australia; China Scholarship Council [2011325039]	Grains Research and Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); University of Western Australia; China Scholarship Council(China Scholarship Council)	This work was funded by the Grains Research and Development Corporation (UWA00150; www.grdc.com.au), the Australian Research Council Future Fellowship Scheme (FT110100246; www.arc.gov.au) awarded to D.V.M, The University of Western Australia and a China Scholarship Council (2011325039) award to P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; BROOKES PC, 1984, SOIL BIOL BIOCHEM, V16, P169, DOI 10.1016/0038-0717(84)90108-1; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Bunemann EK, 2004, SOIL SCI SOC AM J, V68, P1645, DOI 10.2136/sssaj2004.1645; Bunemann EK, 2004, SOIL BIOL BIOCHEM, V36, P889, DOI [10.1016/j.soilbio.2004.02.002, 10.1016/S0038-0717(04)00052-5]; Carson JK, 2007, FEMS MICROBIOL ECOL, V61, P414, DOI 10.1111/j.1574-6941.2007.00361.x; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Certini G, 2004, SOIL BIOL BIOCHEM, V36, P1119, DOI 10.1016/j.soilbio.2004.02.022; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cleveland CC, 2014, OECOLOGIA, V174, P283, DOI 10.1007/s00442-013-2758-9; COLWELL J. D., 1963, AUSTRALIAN JOUR EXPTL AGRIC AND ANIMAL HUSB, V3, P190, DOI 10.1071/EA9630190; Condron L. M., 2005, Organic phosphorus in the environment, P295, DOI 10.1079/9780851998220.0295; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; Damon PM, 2007, AUST J AGR RES, V58, P816, DOI 10.1071/AR06402; Damon PM, 2014, SOIL BIOL BIOCHEM, V74, P127, DOI 10.1016/j.soilbio.2014.03.003; DeAngelis KM, 2011, APPL ENVIRON MICROB, V77, P6313, DOI 10.1128/AEM.05262-11; Ehlers K, 2010, SOIL BIOL BIOCHEM, V42, P558, DOI 10.1016/j.soilbio.2009.11.025; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gleeson DB, 2016, SCI TOTAL E IN PRESS; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; GRISWOLD BL, 1951, ANAL CHEM, V23, P192, DOI 10.1021/ac60049a041; Guo FM, 1998, SOIL SCI, V163, P822, DOI 10.1097/00010694-199810000-00006; Guppy CN, 2009, CROP PASTURE SCI, V60, P116, DOI 10.1071/CP07157; Hamdali H, 2008, APPL SOIL ECOL, V38, P12, DOI 10.1016/j.apsoil.2007.08.007; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Iyamuremye F, 1996, SOIL SCI, V161, P436, DOI 10.1097/00010694-199607000-00003; KRAFFCZYK I, 1984, SOIL BIOL BIOCHEM, V16, P315, DOI 10.1016/0038-0717(84)90025-7; Kwabiah AB, 2003, AGR ECOSYST ENVIRON, V100, P53, DOI 10.1016/S0167-8809(03)00171-3; Lapis-Gaza HR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0334-z; Lehmann J, 2001, PLANT SOIL, V237, P309, DOI 10.1023/A:1013320721048; Mander C, 2012, SOIL BIOL BIOCHEM, V44, P93, DOI 10.1016/j.soilbio.2011.09.009; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Mori H, 2014, DNA RES, V21, P217, DOI 10.1093/dnares/dst052; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Oberson A., 2005, Organic phosphorus in the environment, P133, DOI 10.1079/9780851998220.0133; Oberson A, 1999, NUTR CYCL AGROECOSYS, V55, P77, DOI 10.1023/A:1009813008445; Oberson A, 2011, SOIL BIOL, V26, P431, DOI 10.1007/978-3-642-15271-9_17; Olander LP, 2004, ECOSYSTEMS, V7, P404, DOI 10.1007/s10021-004-0264-y; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Pearse SJ, 2006, PLANT SOIL, V288, P127, DOI 10.1007/s11104-006-9099-y; Pii Y, 2015, BIOL FERT SOILS, V51, P403, DOI 10.1007/s00374-015-0996-1; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Ragot S, 2013, GEODERMA, V202, P30, DOI 10.1016/j.geoderma.2013.03.006; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444; Ryan PR, 2014, PHYSIOL PLANTARUM, V151, P230, DOI 10.1111/ppl.12150; SEELING B, 1993, PLANT SOIL, V148, P277, DOI 10.1007/BF00012865; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; SMECK NE, 1985, GEODERMA, V36, P185, DOI 10.1016/0016-7061(85)90001-1; Terrazas RA, 2016, ADV APPL MICROBIOL, V95, P1, DOI 10.1016/bs.aambs.2016.03.001; TIAN G, 1995, APPL SOIL ECOL, V2, P25, DOI 10.1016/0929-1393(94)00033-4; Uroz S, 2012, GEOMICROBIOL J, V29, P88, DOI 10.1080/01490451.2010.523764; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vu DT, 2008, PLANT SOIL, V304, P21, DOI 10.1007/s11104-007-9516-x; Wang Y, 2013, PLANT SOIL, V362, P231, DOI 10.1007/s11104-012-1289-1; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zhang TQ, 2004, SOIL SCI SOC AM J, V68, P519, DOI 10.2136/sssaj2004.0519; Ziadi N, 2013, ADV AGRON, V122, P85, DOI 10.1016/B978-0-12-417187-9.00002-4	68	3	3	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166062	10.1371/journal.pone.0166062	http://dx.doi.org/10.1371/journal.pone.0166062			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893833	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400016
J	Ye, WQ; Ramos, EH; Wong, BC; Belsham, DD				Ye, Wenqing; Ramos, Ernesto H.; Wong, Brian C.; Belsham, Denise D.			Beneficial Effects of Metformin and/or Salicylate on Palmitate- or TNF alpha-Induced Neuroinflammatory Marker and Neuropeptide Gene Regulation in Immortalized NPY/AgRP Neurons	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; I-KAPPA-B; INDUCED INSULIN-RESISTANCE; FOOD-INTAKE; TARGETED DISRUPTION; SODIUM-SALICYLATE; HUMAN OBESITY; EXPRESSION	Neuropeptide Y (NPY)/Agouti-related peptide (AgRP)-expressing neurons in the hypothalamus induce feeding and decrease energy expenditure. With consumption of a diet high in fat, there is an increase in circulating saturated free fatty acids, including palmitate, leading to the development of neuroinflammation and secretion of cytokines, such as TNF alpha, and in turn activation of the canonical IKK beta/NFkB cascade. We describe a model of palmitate- and TNF alpha-induced neuroinflammation in a functionally characterized, immortalized NPY/AgRP-expressing cell model, mHypoE-46, to study whether the anti-diabetic metformin alone or in combination with the anti-inflammatory agent salicylate can ameliorate these detrimental effects. Treatment with palmitate increased mRNA expression of feeding peptides Npy and Agrp, and inflammatory cytokines Tnfa and Il-6, whereas treatment with TNFa increased mRNA expression of Npy, Nfkb, Ikba, Tnfa, and Il-6. The effects of metformin and/or sodium salicylate on these genes were assessed. Metformin increased phosphorylation of AMPK and S6K, while sodium salicylate increased phospho-AMPK and decreased phospho-S6K, but neither had any effect on -phospho-ERK,-JNK or -p38 in the mHypoE-46 NPY/AgRP neurons. Furthermore, we utilized a pre-treatment and/or co-treatment paradigm to model potential clinical regimens. We determined co-treatment with metformin or sodium salicylate alone was successful in alleviating changes observed in feeding peptide mRNA regulation, whereas a preventative pre-treatment with metformin and sodium salicylate together was able to alleviate palmitate- and TNF alpha-induced induction of NPY and/or AgRP mRNA levels. These results highlight important differences in reactive versus preventative treatments on palmitate- and TNF alpha-induced neuroinflammation in NPY/AgRP neurons.	[Ye, Wenqing; Ramos, Ernesto H.; Wong, Brian C.; Belsham, Denise D.] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Fac Med, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Belsham, DD (corresponding author), Univ Toronto, Dept Physiol, Fac Med, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Fac Med, Dept Obstet & Gynaecol, Toronto, ON, Canada.	d.belsham@utoronto.ca			Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation and Canada Research Chairs Program; Endocrine Society Summer Studentship; Banting and Best Diabetes Centre (BBDC) Summer Studentship; Banting and Best Diabetes Centre (BBDC) Graduate Studentship	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation and Canada Research Chairs Program; Endocrine Society Summer Studentship; Banting and Best Diabetes Centre (BBDC) Summer Studentship; Banting and Best Diabetes Centre (BBDC) Graduate Studentship	This work was supported by Canadian Institutes for Health Research (CIHR) and Canada Foundation for Innovation and Canada Research Chairs Program (DDB). WY was supported by an Endocrine Society Summer Studentship, EHR was supported by a Banting and Best Diabetes Centre (BBDC) Summer Studentship, and BCW was supported by a Banting and Best Diabetes Centre (BBDC) Graduate Studentship.	Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; [Anonymous], 2016, SATURATED FATTY ACID; Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bjorntorp P, 1999, DIABETIC MED, V16, P373, DOI 10.1046/j.1464-5491.1999.00067.x; Cakir I, 2013, J BIOL CHEM, V288, P17675, DOI 10.1074/jbc.M113.475343; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; CHEN M, 1978, DIABETES, V27, P750, DOI 10.2337/diabetes.27.7.750; Colwell John A, 2003, Diabetes Care, V26 Suppl 1, pS87; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dhillon SS, 2012, MOL CELL ENDOCRINOL, V358, P116, DOI 10.1016/j.mce.2012.03.012; Duan Y, 2013, NEURAL REGEN RES, V8, P2379, DOI 10.3969/j.issn.1673-5374.2013.25.009; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Guan XM, 1998, NEUROREPORT, V9, P3415, DOI 10.1097/00001756-199810260-00015; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; HORI T, 1991, BRAIN RES BULL, V27, P309, DOI 10.1016/0361-9230(91)90117-3; Hotamisligil G.S., 2008, INT J OBES S7, V32, pS52; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang Q, 2015, ANALYST, V140, P197, DOI 10.1039/c4an01443j; Kas MJH, 2005, J MOL ENDOCRINOL, V35, P159, DOI 10.1677/jme.1.01819; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim HJ, 2013, AM J PHYSIOL-REG I, V305, pR499, DOI 10.1152/ajpregu.00099.2013; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lv WS, 2012, BRAIN RES, V1444, P11, DOI 10.1016/j.brainres.2012.01.028; de Morentin PBM, 2010, BBA-MOL CELL BIOL L, V1801, P350, DOI 10.1016/j.bbalip.2009.09.016; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Mayer CM, 2009, MOL CELL ENDOCRINOL, V307, P99, DOI 10.1016/j.mce.2009.02.031; Michel C, 2003, PHYSIOL BEHAV, V78, P357, DOI 10.1016/S0031-9384(02)01002-8; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Morton GJ, 2001, INT J OBESITY, V25, pS56, DOI 10.1038/sj.ijo.0801915; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozes ON, 1999, NATURE, V401, P82; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vidarsdottir S, 2007, DIABETES, V56, P2547, DOI 10.2337/db07-0193; Wang XK, 2012, EXP DIABETES RES, DOI 10.1155/2012/847246; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166973	10.1371/journal.pone.0166973	http://dx.doi.org/10.1371/journal.pone.0166973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893782	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400065
J	Augustyniak, M; Plachetka-Bozek, A; Kafel, A; Babczynska, A; Tarnawska, M; Janiak, A; Loba, A; Dziewiecka, M; Karpeta-Kaczmarek, J; Zawisza-Raszka, A				Augustyniak, Maria; Plachetka-Bozek, Anna; Kafel, Alina; Babczynska, Agnieszka; Tarnawska, Monika; Janiak, Agnieszka; Loba, Anna; Dziewiecka, Marta; Karpeta-Kaczmarek, Julia; Zawisza-Raszka, Agnieszka			Phenotypic Plasticity, Epigenetic or Genetic Modifications in Relation to the Duration of Cd-Exposure within a Microevolution Time Range in the Beet Armyworm	PLOS ONE			English	Article							SPODOPTERA-EXIGUA LARVAE; COMET ASSAY; DNA-DAMAGE; DROSOPHILA-MELANOGASTER; SOMATIC-CELLS; LEPIDOPTERA-NOCTUIDAE; CADMIUM; ZINC; POPULATION; REPAIR	In the case of the pests inhabiting metal polluted or fields where the use of pesticides is common, a natural selection of resistant individuals can occur. This may pose serious problems for humans, agriculture, as well as the economies of many countries. In this study, the hypothesis that multigenerational (120 generations) exposure to cadmium of a beet army worm population could be a selecting factor toward a more efficient DNA protection was verified. The hemocytes of individuals from two culture strains (control and Cd-exposed) were treated with H2O2 (a DNA-damaging agent) or PBS (reference). The level of DNA damage was assessed using the Comet assay immediately and 5, 15 and 30 min. after the treatment. The immediate result of the contact with H2O2 was that the level of DNA damage in the hemocytes of the insects from both strains increased significantly. However, in the cells of the Cd-exposed individuals, the level of DNA damage decreased over time, while in the cells from the control insects it remained at the same level with no evidence of repair. These results suggest that efficient defense mechanisms may exist in the cells of insects that have prolonged contact with cadmium. Some evolutionary and trade-off aspects of the phenomenon are discussed. In a wider context, comparing the results obtained in the laboratory with field studies may be beneficial for understanding basic mechanisms of the resistance of an organism. To summarize, the high potential for the repair of DNA damage that was observed in the insects from the cadmium strain may confirm the hypothesis that multigenerational exposure to that metal may possibly contribute to the selection of insects that have a wider tolerance to oxidative stress. However, our investigations of polymorphism using AFLP did not reveal differences between the two main insect strains.	[Augustyniak, Maria; Plachetka-Bozek, Anna; Kafel, Alina; Babczynska, Agnieszka; Tarnawska, Monika; Loba, Anna; Dziewiecka, Marta; Karpeta-Kaczmarek, Julia; Zawisza-Raszka, Agnieszka] Univ Silesia, Dept Anim Physiol & Ecotoxicol, Katowice, Poland; [Janiak, Agnieszka] Univ Silesia, Dept Genet, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Augustyniak, M (corresponding author), Univ Silesia, Dept Anim Physiol & Ecotoxicol, Katowice, Poland.	maria.augustyniak@us.edu.pl	Augustyniak, Maria/T-7320-2019; Babczyńska, Agnieszka/ABC-9525-2020; Kafel, Alina/AAH-1163-2019; Dziewięcka, Marta/AAN-8973-2020; Tarnawska, Monika/L-6718-2019	Augustyniak, Maria/0000-0003-1960-1669; Kafel, Alina/0000-0001-5111-3791; Dziewiecka, Marta/0000-0001-9321-2579; Babczynska, Agnieszka/0000-0002-0000-789X; Tarnawska, Monika/0000-0002-0286-1379; Janiak, Agnieszka/0000-0003-0225-7216	National Science Centre, Poland [DEC-2013/09/B/NZ9/01754]	National Science Centre, Poland(National Science Centre, Poland)	This project was supported by National Science Centre, Poland (decision DEC-2013/09/B/NZ9/01754).	Augustyniak M, 2016, REV MUTAT RES, V767, P67; Augustyniak M, 2008, J INSECT PHYSIOL, V54, P41, DOI 10.1016/j.jinsphys.2007.08.002; Augustyniak M, 2006, COMP BIOCHEM PHYS C, V144, P242, DOI 10.1016/j.cbpc.2006.09.003; Augustyniak M, 2014, CHEMOSPHERE, V96, P180, DOI 10.1016/j.chemosphere.2013.10.033; Avan H, J INSECT PHYSL, V130, P148; Bilbao C, 2002, MUTAT RES-FUND MOL M, V503, P11, DOI 10.1016/S0027-5107(02)00070-2; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; CALOW P, 1990, FUNCT ECOL, V4, P283, DOI 10.2307/2389587; Carmona ER, 2011, MUTAT RES-GEN TOX EN, V724, P35, DOI 10.1016/j.mrgentox.2011.05.008; Carmona ER, 2011, ENVIRON MOL MUTAGEN, V52, P165, DOI 10.1002/em.20604; Carmona ER, 2011, MUTAT RES-GEN TOX EN, V718, P33, DOI 10.1016/j.mrgentox.2010.10.008; Chandler LD, 1996, SOUTHWEST ENTOMOL, V21, P189; Collins AR, 2009, MUTAT RES-REV MUTAT, V681, P24, DOI 10.1016/j.mrrev.2007.10.002; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Decordier I, 2010, MUTAT RES-REV MUTAT, V705, P107, DOI 10.1016/j.mrrev.2010.05.002; Dhawan A, 2009, CELL BIOL TOXICOL, V25, P5, DOI 10.1007/s10565-008-9072-z; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Hendry AP, 2011, EVOL APPL, V4, P159, DOI 10.1111/j.1752-4571.2010.00165.x; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Imamura T, 2004, J STORED PROD RES, V40, P169, DOI 10.1016/S0022-474X(02)00095-4; Jha AN, 2008, MUTAGENESIS, V23, P207, DOI 10.1093/mutage/gen014; Jongsma MA, 1996, INSECT BIOCHEM MOLEC, V26, P185, DOI 10.1016/0965-1748(95)00082-8; Kafel A, 2003, ENVIRON INT, V28, P683, DOI 10.1016/S0160-4120(02)00111-3; Kafel A, 2012, ECOTOX ENVIRON SAFE, V78, P22, DOI 10.1016/j.ecoenv.2011.10.024; Kojic D, 2009, EUR J ENTOMOL, V106, P451, DOI 10.14411/eje.2009.056; Koo HN, 2011, J ASIA-PAC ENTOMOL, V14, P243, DOI 10.1016/j.aspen.2011.03.001; Kramarz P, 2003, ENVIRON POLLUT, V126, P1, DOI 10.1016/S0269-7491(03)00183-0; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; McAuslane HJ, 2000, ENTOMOL EXP APPL, V97, P283, DOI 10.1023/A:1004051527347; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Mouron SA, 2001, MUTAT RES-GEN TOX EN, V498, P47, DOI 10.1016/S1383-5718(01)00266-2; Nicotra AB, 2015, ECOL EVOL, V5, P634, DOI 10.1002/ece3.1329; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Polyakov A, 2004, P ROY SOC B-BIOL SCI, V271, pS156, DOI 10.1098/rsbl.2003.0112; Quintela M, 2014, PLOS ONE, V9, P1; Rojas E, 1999, J CHROMATOGR B, V722, P225, DOI 10.1016/S0378-4347(98)00313-2; Schulze E., 2005, PLANT ECOL, P5; Sestili P, 2005, DNA REPAIR, V4, P271, DOI 10.1016/j.dnarep.2004.09.007; Sharma K, 2016, BBA-GEN SUBJECTS, V1860, P1237, DOI 10.1016/j.bbagen.2016.03.004; Showler AT, 2001, J CHEM ECOL, V27, P2013, DOI 10.1023/A:1012238803311; Sliwinski T, 2007, MUTAT RES-GEN TOX EN, V634, P220, DOI 10.1016/j.mrgentox.2007.07.013; Steinberg CE, 2012, EXPERT OPIN ENV BIOL, DOI [10.4172/2325-9655.1000e104, DOI 10.4172/2325-9655.1000E104]; Wozniak K, 2002, MUTAT RES-GEN TOX EN, V514, P233, DOI 10.1016/S1383-5718(01)00344-8; Yun SH, 2014, RADIAT PHYS CHEM, V96, P44, DOI 10.1016/j.radphyschem.2013.08.008; Zheng SJ, 2000, EUPHYTICA, V114, P77, DOI 10.1023/A:1004089424419; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	48	19	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167371	10.1371/journal.pone.0167371	http://dx.doi.org/10.1371/journal.pone.0167371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907095	gold, Green Submitted, Green Published			2022-12-27	WOS:000389482700133
J	Blomstrom, AL; Fossum, C; Wallgren, P; Berg, M				Blomstrom, Anne-Lie; Fossum, Caroline; Wallgren, Per; Berg, Mikael			Viral Metagenomic Analysis Displays the Co-Infection Situation in Healthy and PMWS Affected Pigs	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; PORCINE CIRCOVIRUS TYPE-2; BOCA-LIKE VIRUS; INFECTIONS; MULTIPLE; TISSUE; PCV2; IDENTIFICATION; REPRODUCTION; DISCOVERY	The development of high-throughput sequencing technologies have allowed the possibility to investigate and characterise the entire microbiome of individuals, providing better insight to the complex interaction between different microorganisms. This will help to understand how the microbiome influence the susceptibility of secondary agents and development of disease. We have applied viral metagenomics to investigate the virome of lymph nodes from Swedish pigs suffering from the multifactorial disease postweaning multisystemic wasting syndrome (PMWS) as well as from healthy pigs. The aim is to increase knowledge of potential viruses, apart from porcine circovirus type 2 (PCV2), involved in PMWS development as well as to increase knowledge on the virome of healthy individuals. In healthy individuals, a diverse viral flora was seen with several different viruses present simultaneously. The majority of the identified viruses were small linear and circular DNA viruses, such as different circoviruses, anelloviruses and bocaviruses. In the pigs suffering from PMWS, PCV2 sequences were, as expected, detected to a high extent but other viruses were also identified in the background of PCV2. Apart from DNA viruses also RNA viruses were identified, among them were a porcine pestivirus showing high similarity to a recently (in 2015) discovered atypical porcine pestivirus in the US. Majority of the viruses identified in the background of PCV2 in PMWS pigs could also be identified in the healthy pigs. PCV2 sequences were also identified in the healthy pigs but to a much lower extent than in PMWS affected pigs. Although the method used here is not quantitative the very clear difference in amount of PCV2 sequences in PMWS affected pigs and healthy pigs most likely reflect the very strong replication of PCV2 known to be a hallmark of PMWS. Taken together, these findings illustrate that pigs appear to have a considerable viral flora consisting to a large extent of small single-stranded and circular DNA viruses. Future research on these types of viruses will help to better understand the role that these ubiquitous viruses may have on health and disease of pigs. We also demonstrate for the first time, in Europe, the presence of a novel porcine pestivirus.	[Blomstrom, Anne-Lie; Berg, Mikael] Swedish Univ Agr Sci, Virol Sect, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Fossum, Caroline] Swedish Univ Agr Sci, Immunol Sect, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Wallgren, Per] Natl Vet Inst SVA, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Blomstrom, AL (corresponding author), Swedish Univ Agr Sci, Virol Sect, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden.	Anne-Lie.Blomstrom@slu.se		Fossum, Caroline/0000-0003-4639-1652; Berg, Mikael/0000-0001-5779-3345; Blomstrom, Anne-Lie/0000-0003-4455-311X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [Formas-2014-862, Formas-2012-586]; SNP&SEQ Technology Platform in Uppsala - Uppsala University; Uppsala University Hospital; Science for Life Laboratory Uppsala; Swedish Research Council [80576801, 70374401]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); SNP&SEQ Technology Platform in Uppsala - Uppsala University; Uppsala University Hospital; Science for Life Laboratory Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning is greatly acknowledged for financial support (Formas-2014-862, Formas-2012-586). Also, the Swedish Farmers' Foundation for Agricultural Research is acknowledged. The authors would like to acknowledge support of the SNP&SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory Uppsala and the Swedish Research Council (contracts 80576801 and 70374401).	Alexandersen S, 2010, DIS SWINE, P610; ARTURSSON K, 1995, SCAND J IMMUNOL, V41, P121, DOI 10.1111/j.1365-3083.1995.tb03543.x; Balasch M, 1999, J COMP PATHOL, V121, P139, DOI 10.1053/jcpa.1999.0310; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2011, VET QUART, V31, P107, DOI 10.1080/01652176.2011.604971; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Brunborg IM, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-22; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Chae C, 2004, VET J, V168, P41, DOI 10.1016/j.tvjl.2003.09.018; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Ha Y, 2008, VET PATHOL, V45, P842, DOI 10.1354/vp.45-6-842; Hasslung F, 2005, VET MICROBIOL, V106, P49, DOI 10.1016/j.vetmic.2004.12.011; Hause BM, 2015, J GEN VIROL, V96, P2994, DOI 10.1099/jgv.0.000251; Jiang YH, 2014, J GEN VIROL, V95, P453, DOI 10.1099/vir.0.057042-0; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; McMenamy MJ, 2013, VET MICROBIOL, V164, P293, DOI 10.1016/j.vetmic.2013.03.009; Meng XJ, 2012, TRANSBOUNDARY EMERGI; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmusk S, 2008, VIRUS GENES, V36, P509, DOI 10.1007/s11262-008-0217-1; Wallgren P, 1999, J VET MED B, V46, P249; Wattrang E, 2002, VET MICROBIOL, V86, P281, DOI 10.1016/S0378-1135(02)00024-X; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zeng SL, 2011, J GEN VIROL, V92, P784, DOI 10.1099/vir.0.028340-0	31	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166863	10.1371/journal.pone.0166863	http://dx.doi.org/10.1371/journal.pone.0166863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907010	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700045
J	Lamos, C; Mihaljevic, C; Aulmann, S; Bruckner, T; Domschke, C; Wallwiener, M; Paringer, C; Fluhr, H; Schott, S; Dinkic, C; Brucker, J; Golatta, M; Gensthaler, L; Eichbaum, M; Sohn, C; Rom, J				Lamos, Cristina; Mihaljevic, Charlotte; Aulmann, Sebastian; Bruckner, Thomas; Domschke, Christoph; Wallwiener, Markus; Paringer, Carmen; Fluhr, Herbert; Schott, Sarah; Dinkic, Christine; Brucker, Janina; Golatta, Michael; Gensthaler, Lisa; Eichbaum, Michael; Sohn, Christof; Rom, Joachim			Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS-CELL CARCINOMA; HPV; RISK; WOMEN; CANCER; VULVA; HYSTERECTOMY; PREVALENCE; PREDICTION	Introduction Vaginal intraepithelial neoplasia (VAIN) is a pre-malignant lesion, potentially leading to vaginal cancer. It is a rare disease, representing less than 1% of all intraepithelial neoplasia of the female genital tract. Similar to cervical intraepithelial neoplasia (CIN), there are three different grades of VAIN. VAIN 1 is also known as a low-grade squamous intraepithelial lesion (LSIL), whereas VAIN 2 and VAIN 3 both represent high-grade squamous intraepithelial lesions (HSIL). Risk factors for the development of VAIN are similar to those for cervical neoplasia, i.e. promiscuity, starting sexual activity at an early age, tobacco consumption and infection with human papillomavirus (HPV). However, compared to other intraepithelial neoplasia such as CIN or VIN (vulvar intraepithelial neoplasia), there still is little understanding about the natural course of VAIN and its capacity for pro-or regression. Furthermore, there is controversial data about the HPV detection rate in VAIN lesions. Patients and Methods 67 patients with histologically confirmed VAIN, who were diagnosed between 2003 and 2011 at the University Women's Hospital of Heidelberg Germany, were included in this study. The biopsies of all participating patients were subjected to HPV genotyping. GP-E6/E7 Nested Multiplex PCR (NMPCR) was used to identify and genotype HPV. Eighteen pairs of type-specific nested PCR primers were assessed to detect the following "high-risk" HPV genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68, as well as the "low-risk" genotypes 6/11, 42, 43 and 44. The data was analyzed with the software SAS (Statistical Analysis System). Results All 67 cases were eligible for DNA analysis. The median age was 53 years. The largest group with 53% (n = 36) was formed by women, who were first diagnosed with VAIN between the age of 41 to 60 years. 50% (n = 37) of the patients presented a VAIN in the upper 1/3 of the vagina. 58 (87%) were diagnosed with HSIL (VAIN). The median age in patients with LSIL (VAIN) was 53 years and in patients with HSIL (VAIN) 53.5 years. 12 women (18%) had an immunosuppression. HPV positivity was confirmed in 37 patients (55%). Except for a single patient, who had a triple infection with HPV types 6/11, 16 and 68, only infections with one single HPV genotype were detected. An infection with the HPV genotypes 31, 39, 45, 51, 58, 59, 66, 42, 43 and 44 couldn't be found in any of the patients. In 28 patients with diagnosed VAIN, an infection with HPV 16 could be shown, 24 (86%) of them were diagnosed with a HSIL (VAIN). 16 (24%) women presented condylomata and 13 of them (81%) had a positive HPV status. However, only 47% of the women without condylomata presented a positive HPV status, resulting in a significant correlation (p = 0.0164) between condylomata and HPV infection. In 28 of all 67 patients (42%), recurrence of the neoplasia occurred. Conclusion HPV 16 is the main virus-type to be associated with the development of a VAIN. Also, HPV 16 infection, VIN or condylomata acuminata in the past medical history seemed to be significant factors for early relapse.	[Lamos, Cristina] Ludwigshafen Hosp, Dept Dermatol, Ludwigshafen, Germany; [Mihaljevic, Charlotte; Domschke, Christoph; Wallwiener, Markus; Paringer, Carmen; Fluhr, Herbert; Schott, Sarah; Dinkic, Christine; Brucker, Janina; Golatta, Michael; Sohn, Christof; Rom, Joachim] Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany; [Bruckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Gensthaler, Lisa] Univ Vienna, Vienna, Austria; [Eichbaum, Michael] Helios Dr Horst Schmidt Kliniken, Dept Gynecol & Obstet, Wiesbaden, Germany	Ludwigshafen Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Vienna	Rom, J (corresponding author), Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany.	joachim.rom@med.uni-heidelberg.de	Schott, Sarah/D-5242-2018; Golatta, Michael/AAH-8735-2021; Wallwiener, Markus/AAH-9038-2021; Fluhr, Herbert/AAS-6177-2020	Schott, Sarah/0000-0002-1714-1147; Golatta, Michael/0000-0002-2605-0060; Wallwiener, Markus/0000-0002-4139-9340	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO M, 1991, CANCER, V68, P195, DOI 10.1002/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L; AUDETLAPOINTE P, 1990, GYNECOL ONCOL, V36, P232, DOI 10.1016/0090-8258(90)90180-S; Aulmann S, 2008, J CLIN PATHOL, V61, P1034, DOI 10.1136/jcp.2008.056275; BELL J, 1984, OBSTET GYNECOL, V64, P699; Bosquet EG, 2008, EUR J GYNAECOL ONCOL, V29, P43; Chao A, 2011, INT J CANC; Chao A, 2011, INT J CANCER, V128, P653, DOI 10.1002/ijc.25384; Chiasson MA, 1997, OBSTET GYNECOL, V89, P690, DOI 10.1016/S0029-7844(97)00069-0; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Diakomanolis E, 2002, EUR J GYNAECOL ONCOL, V23, P457; Dittmer C, 2011, ARCH GYNECOL OBSTET, V284, P169, DOI 10.1007/s00404-011-1850-9; Dodge JA, 2001, GYNECOL ONCOL, V83, P363, DOI 10.1006/gyno.2001.6401; Ferenzcy AS, 2014, WHO CLASSIFICATION T, P210; Frega A, 2007, CANCER LETT, V249, P235, DOI 10.1016/j.canlet.2006.09.003; Gross G, 1997, CLIN DERMATOL, V15, P457, DOI 10.1016/S0738-081X(96)00152-6; Hampl M, 2007, J CANCER RES CLIN, V133, P235, DOI 10.1007/s00432-006-0162-0; Kalogirou D, 1997, EUR J GYNAECOL ONCOL, V18, P188; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; LENEHAN PM, 1986, OBSTET GYNECOL, V68, P333, DOI 10.1097/00006250-198609000-00008; Madsen BS, 2008, INT J CANCER, V122, P2827, DOI 10.1002/ijc.23446; Murta Eddie F. C., 2005, Archives of Gynecology and Obstetrics, V272, P261, DOI 10.1007/s00404-005-0022-1; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Petersen I, 2007, VIRCHOWS ARCH, V451, P701, DOI 10.1007/s00428-007-0437-0; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Schockaert S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.026; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; So KA, 2009, J GYNECOL ONCOL, V20, P232, DOI 10.3802/jgo.2009.20.4.232; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Spitzer M, 1999, Obstet Gynecol Surv, V54, P131, DOI 10.1097/00006254-199902000-00023; WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205	32	29	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167386	10.1371/journal.pone.0167386	http://dx.doi.org/10.1371/journal.pone.0167386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907089	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700137
J	Ruff, CB; Burgess, ML; Ketcham, RA; Kappelman, J				Ruff, Christopher B.; Burgess, M. Loring; Ketcham, Richard A.; Kappelman, John			Limb Bone Structural Proportions and Locomotor Behavior in AL288-1 ("Lucy")	PLOS ONE			English	Article							JOINT SURFACE-AREAS; AUSTRALOPITHECUS-AFARENSIS; LONG-BONE; POSTCRANIAL ROBUSTICITY; SKELETAL ALLOMETRY; BODY PROPORTIONS; EARLY HOMINID; SITE SIERRA; LOS HUESOS; HOMO	While there is broad agreement that early hominins practiced some form of terrestrial bipe-dality, there is also evidence that arboreal behavior remained a part of the locomotor repertoire in some taxa, and that bipedal locomotion may not have been identical to that of modern humans. It has been difficult to evaluate such evidence, however, because of the possibility that early hominins retained primitive traits (such as relatively long upper limbs) of little contemporaneous adaptive significance. Here we examine bone structural properties of the femur and humerus in the Australopithecus afarensis A.L. 288-1 ("Lucy", 3.2 Myr) that are known to be developmentally plastic, and compare them with other early hominins, modern humans, and modern chimpanzees. Cross-sectional images were obtained from micro-CT scans of the original specimens and used to derive section properties of the diaphyses, as well as superior and inferior cortical thicknesses of the femoral neck. A.L. 288-1 shows femoral/humeral diaphyseal strength proportions that are intermediate between those of modern humans and chimpanzees, indicating more mechanical loading of the forelimb than in modern humans, and by implication, a significant arboreal locomotor component. Several features of the proximal femur in A.L. 288-1 and other australopiths, including relative femoral head size, distribution of cortical bone in the femoral neck, and cross-sectional shape of the proximal shaft, support the inference of a bipedal gait pattern that differed slightly from that of modern humans, involving more lateral deviation of the body center of mass over the support limb, which would have entailed increased cost of terrestrial locomotion. There is also evidence consistent with increased muscular strength among australopiths in both the forelimb and hind limb, possibly reflecting metabolic trade-offs between muscle and brain development during hominin evolution. Together these findings imply significant differences in both locomotor behavior and ecology between australopiths and later Homo.	[Ruff, Christopher B.; Burgess, M. Loring] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA; [Ketcham, Richard A.; Kappelman, John] Univ Texas Austin, Dept Geol Sci, Austin, TX USA; [Kappelman, John] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	Johns Hopkins University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ruff, CB (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA.	cbruff@jhmi.edu	Ketcham, Richard/B-5431-2011	Ketcham, Richard/0000-0002-2748-0409	National Science Foundation [BCS-0642297, BCS-1316104, EAR 0646848, EAR-0948842, EAR-1258878]; Paleoanthropology Lab Fund; College of Liberal Arts UT Austin; Houston Museum of Natural Science; Geology Foundation of UT Austin; U.S. National Science Foundation [EAR-0948842, EAR-1258878, EAR-0646848]; NSF [BCS-0642297, BCS-1316104]; Direct For Social, Behav & Economic Scie [1316104] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Paleoanthropology Lab Fund; College of Liberal Arts UT Austin; Houston Museum of Natural Science; Geology Foundation of UT Austin; U.S. National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by the National Science Foundation (www.nsf.gov) BCS-0642297 and BCS-1316104 to C.B. Ruff, and EAR 0646848, EAR-0948842, and EAR-1258878 to R.A. Ketcham. Institutional support was provided by the University of Oulu and the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Authority for Research and Conservation of Cultural Heritage and the National Museum of Ethiopia of the Ministry of Tourism and Culture for permission to scan, study, and photograph Lucy; A. Admassu, K. Ayele, J. A. Bartsch, Y. Beyene, Y. Desta, R. Diehl, R. Flores, R. Harvey, G. Kebede, R. Lariviere, J. H. Mariam, S. M. Miller, L. Rebori, B. Roberts, J. Ten Barge, J. M. Sanchez, D. Slesnick, D. Van Tuerenhout, S. Wilson, M. Woldehan, and M. Yilma for facilitating and assisting with the scanning; T. Getachew and M. Endalamaw for assisting with the photography, and S. Mattox for the photograph in Extended Data Fig 3; A. Witzel for assistance with 3D printing; and Paleoanthropology Lab Fund, College of Liberal Arts UT Austin, and Houston Museum of Natural Science for financial and logistical support, and Owen-Coates Fund of the Geology Foundation of UT Austin for publication costs. The University of Texas High-Resolution X-ray CT Facility was supported by U.S. National Science Foundation grants EAR-0646848, EAR-0948842, and EAR-1258878 (www.nsf.gov). We would also like to thank L. Rodriguez and J. M. Carretero for making available unpublished data on several Atapuerca specimens and Gombore MK3; B. Holt, M. Niskanen, V. Sladek, and M. Berner for collaboration in obtaining the modern European comparative data set, which was supported by NSF (www.nsf.gov) grant BCS-0642297; J-A. Junno for collaboration on obtaining the chimpanzee comparative data set, which was supported by NSF grant (www.nsf.gov) BCS-1316104, with institutional support from the University of Oulu; and J-J. Hublin and C. Boesch for access to chimpanzee specimens in their care. The paper benefited from the comments of three anonymous reviewers.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Barak MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077687; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; de Castro JMB, 2012, AM J PHYS ANTHROPOL, V147, P604, DOI 10.1002/ajpa.22020; Bozek K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001871; Carretero JM, 1997, J HUM EVOL, V33, P357, DOI 10.1006/jhev.1997.0128; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Carrier D, 2004, FROM BIPED TO STRIDER, P135; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; CLARK WE, 1964, FOSSIL EVIDENCE HUMA; Cowgill LW, 2010, AM J PHYS ANTHROPOL, V143, P52, DOI 10.1002/ajpa.21289; de Sousa A, 2012, PROG BRAIN RES, V195, P293, DOI 10.1016/B978-0-444-53860-4.00014-3; DEMES B, 1994, J HUM EVOL, V26, P353, DOI 10.1006/jhev.1994.1023; Demissie S, 2007, BONE, V40, P743, DOI 10.1016/j.bone.2006.09.020; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; DeSilva JM, 2012, J HUM EVOL, V63, P487, DOI 10.1016/j.jhevol.2012.05.010; Di Vincenzo F, 2015, QUATERNARY SCI REV, V122, P207, DOI 10.1016/j.quascirev.2015.05.014; Dominguez-Rodrigo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080347; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; Dowthwaite JN, 2009, J MUSCULOSKEL NEURON, V9, P198; Eser P, 2009, J BONE MINER RES, V24, P1981, DOI [10.1359/JBMR.090521, 10.1359/jbmr.090521]; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Franciscus RG, 1992, B MEM SOC ANTHRO PAR, V4, P5, DOI [10.3406/bmsap.1992.2300, DOI 10.3406/BMSAP.1992.2300]; GODFREY L, 1991, J ZOOL, V223, P603, DOI 10.1111/j.1469-7998.1991.tb04391.x; GODFREY LR, 1995, AM J PHYS ANTHROPOL, V97, P11, DOI 10.1002/ajpa.1330970103; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Harmon EH, 2009, AM J PHYS ANTHROPOL, V139, P154, DOI 10.1002/ajpa.20966; HARTWIGSCHERER S, 1991, J HUM EVOL, V21, P439, DOI 10.1016/0047-2484(91)90094-C; HERMAN GT, 1979, PHYS MED BIOL, V24, P81, DOI 10.1088/0031-9155/24/1/008; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Jungers W.L., 1991, P215; JUNGERS WL, 1983, J HUM EVOL, V12, P673, DOI 10.1016/S0047-2484(83)80007-4; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Jungers WL, 2001, ADV PRIMATO, P371; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Ketcham RA, 2006, P SOC PHOTO-OPT INS, V6318, pO3180, DOI 10.1117/12.680939; KIMBEL WH, 1994, NATURE, V368, P449, DOI 10.1038/368449a0; Kivell TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9431; LANYON LE, 1980, J ZOOL, V192, P457; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; Latimer B., 1991, P169; Legendre P., 2014, LMODEL2 MODEL 2 REGR; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; MacLatchy LM, 1996, J HUM EVOL, V31, P455, DOI 10.1006/jhev.1996.0071; McHenry H.M., 1991, P133; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V49, P473, DOI 10.1002/ajpa.1330490407; Napier J. R., 1964, Archo Biol Liege (Suppl), V75, P673; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; O'Neill MC, 2008, J HUM EVOL, V54, P309, DOI 10.1016/j.jhevol.2007.08.008; Ohman JC., 1993, THESIS; Organ JM, 2006, J HUM EVOL, V51, P113, DOI 10.1016/j.jhevol.2006.01.007; Paciulli L. M., 1995, American Journal of Physical Anthropology, V0, P165; Pontzer H, 2016, NATURE, V533, P390, DOI 10.1038/nature17654; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Richmond B. G., 1998, THESIS; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff C, 2003, BONE, V33, P317, DOI 10.1016/S8756-3282(03)00161-3; Ruff C, 1998, PRIMATE LOCOMOTION, P449; Ruff C, 2003, J HUM EVOL, V45, P317, DOI 10.1016/j.jhevol.2003.08.006; Ruff CB, 1999, AM J PHYS ANTHROPOL, V109, P509, DOI 10.1002/(SICI)1096-8644(199908)109:4<509::AID-AJPA7>3.0.CO;2-X; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; RUFF CB, 1994, AM J PHYS ANTHROPOL, V93, P35, DOI 10.1002/ajpa.1330930103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Ruff CB, STERKFONTEIN HOMININ; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Ruff CB, 2016, AM ASS PHYS ANTHR; Ruff C, 2008, J HUM EVOL, V54, P383, DOI 10.1016/j.jhevol.2007.09.001; Ruff C, 2009, AM J PHYS ANTHROPOL, V138, P90, DOI 10.1002/ajpa.20907; Ruff CB, 2015, P NATL ACAD SCI USA, V112, P7147, DOI 10.1073/pnas.1502932112; Ruff CB, 2015, J HUM EVOL, V80, P147, DOI 10.1016/j.jhevol.2014.12.004; Ruff CB, 2015, J HUM EVOL, V80, P74, DOI 10.1016/j.jhevol.2014.09.005; Ruff CB, 2013, J HUM EVOL, V65, P693, DOI 10.1016/j.jhevol.2013.06.008; Ruff CB, 2013, AM J PHYS ANTHROPOL, V150, P512, DOI 10.1002/ajpa.22214; Ruff CB, 2012, AM J PHYS ANTHROPOL, V148, P601, DOI 10.1002/ajpa.22087; Sarringhaus LA, 2016, AM J PHYS ANTHROPOL, V160, P16, DOI 10.1002/ajpa.22930; Scholz MN, 2006, P R SOC B, V273, P2177, DOI 10.1098/rspb.2006.3568; Senut B., 1985, P193; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Squyres N, 2015, AM J PHYS ANTHROPOL, V158, P198, DOI 10.1002/ajpa.22789; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Sylvester AD, 2010, AM J PHYS ANTHROPOL, V142, P665, DOI 10.1002/ajpa.21299; Thorpe SKS, 1999, AM J PHYS ANTHROPOL, V110, P179, DOI 10.1002/(SICI)1096-8644(199910)110:2<179::AID-AJPA5>3.0.CO;2-Z; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; TSUTAKAWA RK, 1977, BIOMETRICS, V33, P215; Walker A., 1993, NARIOKOTOME HOMO ERE; Ward Carol V., 2013, P235; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; Warden SJ, 2014, P NATL ACAD SCI USA, V111, P5337, DOI 10.1073/pnas.1321605111; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WOLPOFF MH, 1983, NATURE, V304, P59, DOI 10.1038/304059a0; WOLPOFF MH, 1983, J HUM EVOL, V12, P443, DOI 10.1016/S0047-2484(83)80140-7; WOO SLY, 1981, J BONE JOINT SURG AM, V63, P780, DOI 10.2106/00004623-198163050-00013; Wood B., 1976, EARLIEST MAN ENV LAK, P490; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	122	49	49	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166095	10.1371/journal.pone.0166095	http://dx.doi.org/10.1371/journal.pone.0166095			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902687	gold, Green Submitted, Green Published			2022-12-27	WOS:000389474100012
J	Chan, Y; Zhu, BS; Jiang, HG; Zhang, JM; Luo, Y; Tang, WR				Chan, Ying; Zhu, Baosheng; Jiang, Hongguo; Zhang, Jinman; Luo, Ying; Tang, Wenru			Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome	PLoS One			English	Article							RECURRENT IMPLANTATION FAILURE; GENE POLYMORPHISM; MISSED ABORTION; PREGNANCY LOSS; P53; MDM2; APOPTOSIS; INHIBITOR; SELECTION; PATHWAY	To evaluate the association of the TP53 codon 72 (rs 1042522) alone or in combination with HDM2 SNP309 (rs 2279744) polymorphisms with human infertility and IVF outcome, we collected 1450 infertility women undergoing their first controlled ovarian stimulation for IVF treatment and 250 fertile controls in the case-control study. Frequencies, distribution, interaction of genes, and correlation with infertility and IVF outcome of clinical pregnancy were analyzed. We found a statistically significant association between TP53 codon 72 polymorphism and IVF outcome (52.10% vs. 47.40%, OR =0.83, 95%CI:0.71-0.96, p = 0.01). No significant difference was shown between TP53 codon 72, HDM2 SNP309 polymorphisms, human infertility, and between the combination of two genes polymorphisms and the clinical pregnancy outcome of IVF. The data support C allele as a protective factor for IVF pregnancy outcome. Further researches should be focused on the mechanism of these associations.	[Chan, Ying; Zhu, Baosheng; Zhang, Jinman] First Peoples Hosp Yunnan Prov, Genet Diag Ctr, Yunnan Prov Key Lab Birth Defects & Genet Dis, Kunming, Yunnan, Peoples R China; [Jiang, Hongguo; Luo, Ying; Tang, Wenru] Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology	Luo, Y; Tang, WR (corresponding author), Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China.	yingluo@kmust.edu.cn; twr@sina.com	Luo, Ying/AAQ-7666-2020		State Key Laboratory of Genetics Resources and Evolution [GREKF10-07]; Technological Leading Talent of Industries in Yunnan Province [L201201]	State Key Laboratory of Genetics Resources and Evolution; Technological Leading Talent of Industries in Yunnan Province	The study was supported by the State Key Laboratory of Genetics Resources and Evolution, grant GREKF10-07, and by the Technological Leading Talent of Industries in Yunnan Province, grant L201201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bennett WP, 1999, J PATHOL, V187, P8, DOI 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO;2-Y; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P877, DOI 10.1038/sj.cdd.4401938; DAMERON KM, 1994, COLD SPRING HARB SYM, V59, P483, DOI 10.1101/SQB.1994.059.01.053; Fang Y, 2011, HUM REPROD, V26, P1252, DOI 10.1093/humrep/der017; Fang Y, 2009, HUM REPROD, V24, P1346, DOI 10.1093/humrep/dep044; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goodman C, 2009, FERTIL STERIL, V92, P494, DOI 10.1016/j.fertnstert.2008.07.022; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Karthikeyan VJ, 2011, PREGNANCY HYPERTENS, V1, P191, DOI 10.1016/j.preghy.2011.07.002; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Lledo B, 2014, J ASSIST REPROD GEN, V31, P169, DOI 10.1007/s10815-013-0147-2; Paskulin DD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.116; Patounakis G, 2009, FERTIL STERIL, V92, P1290, DOI 10.1016/j.fertnstert.2008.07.1783; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Savion S, 2002, AM J REPROD IMMUNOL, V47, P118, DOI 10.1034/j.1600-0897.2002.1o027.x; Shi H, 2009, AM J HUM GENET, V84, P534, DOI 10.1016/j.ajhg.2009.03.009; Tofoski Gligor, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P95; Zhang RM, 2004, ANAL BIOCHEM, V331, P138, DOI 10.1016/j.ab.2004.03.009	24	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167147	10.1371/journal.pone.0167147	http://dx.doi.org/10.1371/journal.pone.0167147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898708	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000035
J	Deleuran, T; Vilstrup, H; Overgaard, S; Jepsen, P				Deleuran, Thomas; Vilstrup, Hendrik; Overgaard, Soren; Jepsen, Peter			No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study	PLoS One			English	Article							KNEE OSTEOARTHRITIS; SOCIOECONOMIC-STATUS; JOINT REGISTRY; HIP; REPLACEMENTS; MORTALITY; RELEVANCE; SURVIVAL; ENGLAND; WALES	Objective Chronic synovial inflammation causes primary osteoarthritis, but it is unknown whether chronic systemic inflammation does, too. Patients with cirrhosis have chronic systemic inflammation and therefore we examined the association between cirrhosis and primary osteoarthritis of the hip and knee. Methods In Danish healthcare databases we identified all residents over 60 years diagnosed with cirrhosis in 1994-2011, and for each of them we sampled five age- and gender-matched reference persons from the general population. We excluded everyone with risk factors for secondary osteoarthritis and computed incidence rates of primary osteoarthritis of the hip or knee. We used stratified Cox regression to estimate the hazard ratios of primary osteoarthritis for cirrhosis patients vs. reference persons in strata defined by gender, age, cirrhosis etiology, and ascites vs. no ascites. We also computed separate HRs for primary osteoarthritis of the hips or knees. Results We identified 10,049 cirrhosis patients. Their median age was 67 years, and 65% were men. Among the cirrhosis patients the crude incidence rate of primary osteoarthritis was 8.40 (95% CI: 7.30-9.63) per 1000 person-years. The rate was similar in the reference persons: 8.76 (95% CI: 8.43-9.12) per 1000 person-years. Accordingly, the hazard ratio for primary osteoarthritis for cirrhosis patients vs. reference persons was 0.99 (95% CI: 0.851.16), and we found the same null association in all patient strata and in both joints. Conclusion Cirrhosis, and thus chronic systemic inflammation, is not a risk factor for primary osteoarthritis.	[Deleuran, Thomas; Vilstrup, Hendrik; Jepsen, Peter] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark; [Deleuran, Thomas; Jepsen, Peter] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Overgaard, Soren] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Orthoped Surg & Traumatol, Odense, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital	Deleuran, T (corresponding author), Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark.; Deleuran, T (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	thomas.deleuran@clin.au.dk	Overgaard, Søren/AAX-9407-2020	Deleuran, Thomas/0000-0001-7319-975X; Jepsen, Peter/0000-0002-6641-1430; Overgaard, Soren/0000-0001-6829-4787	Aarhus University	Aarhus University	The study was supported by a PhD scolarship from Aarhus University.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Daghestani HN, 2015, ARTHRITIS RHEUMATOL, V67, P956, DOI 10.1002/art.39006; Deleuran T, 2014, ACTA ORTHOP, P1; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Hunt LP, 2014, LANCET, V384, P1429, DOI 10.1016/S0140-6736(14)60540-7; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Jepsen P, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-35; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Langholz B, 1996, STAT SCI, V11, P35; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pearce F, 2013, ARTHRIT CARE RES, V65, P1026, DOI 10.1002/acr.21954; Pedersen AB, 2004, ACTA ORTHOP SCAND, V75, P434, DOI 10.1080/00016470410001213-1; Pedersen AB, 2012, CLIN EPIDEMIOL, V4, P125, DOI DOI 10.2147/CLEP.S30050; Pedersen CB, 2006, DAN MED BULL, V53, P441; R. R Development Core Team, 2013, LANG ENV STAT COMP; Reyes C, 2015, OSTEOARTHR CARTILAGE, V23, P1323, DOI 10.1016/j.joca.2015.03.020; Stannus OP, 2013, ANN RHEUM DIS, V72, P535, DOI 10.1136/annrheumdis-2011-201047; Vestberg K, 1997, J Med Syst, V21, P11, DOI 10.1023/A:1022835207287	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167134	10.1371/journal.pone.0167134	http://dx.doi.org/10.1371/journal.pone.0167134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898694	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000034
J	Umare, A; Seyoum, B; Gobena, T; Mariyam, TH				Umare, Abdi; Seyoum, Berhanu; Gobena, Tesfaye; Mariyam, Tamirat Haile			Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; SURFACE-ANTIGEN; ADDIS-ABABA; SEROPREVALENCE; EPIDEMIOLOGY; PREVALENCE; ANTIBODY	Background Hepatitis B virus (HBV) infection is a serious public health problem worldwide. Reports have shown that 68,600 people die of HBV infection and more than 300,000 deaths due to liver cancer secondary to hepatitis B every year globally. Women who are infected with HBV can vertically transmit the infection to their infants. This study aims to determine the prevalence of HBV infection and associated factors among pregnant women. Methods and Findings A hospital-based cross-sectional study was conducted among pregnant women who attended antenatal care clinic (ANC) for routine pregnancy check-up between 18 March 2015 and 15 May 2015. Data were collected by face to face interview using a pre-tested questionnaire. Serum was withdrawn for each study subject and used to test for Hepatitis B Surface Antigen (HBsAg) by an enzyme linked immunosorbent assay (ELISA) test kit. Binary logistic regression analysis was used to examine the association between explanatory variables and outcome variable. The prevalence of HBV infection was found to be 6.9%. Interestingly, the history of abortion (AOR 10.9; 95% CI: 2.2-53.9), nose piercing (AOR 9.1; 95% CI: 1.34-61.79), surgical procedure (AOR 12.8; 95% CI: 1.68-97.06) and history of multiple sexual partners (AOR 16.8; 95% CI: 3.18-89.06) were significant predictors of HBV infection. Conclusions This study determined that the prevalence of HBV infection among pregnant women was 6.9%, implying that it is high-intermediate endemic area, which is important public health issue needs to be addressed. History of abortion, nose piercing, surgical procedures and multiple sexual partners were significantly associated with this viral infection. Accordingly we advocate that health education programs on the mode of HBV transmission, high-risk behaviors and methods of preventions should be instituted at antenatal care clinics to raise the awareness of mothers and limit the spread of infection. It is also advisable to implement nosocomial infection prevention strategies to prevent the transmissions of HBV through health care related activities such as surgical procedures. Furthermore, all pregnant women should be screened for HBV, treated if necessary to reduce their viral loads and their children vaccinated at birth with the single-dose hepatitis B vaccine to break the cycle of mother-to-child transmission.	[Umare, Abdi] Deder Hosp, Dept Lab Med, Deder, Ethiopia; [Seyoum, Berhanu] Haramaya Univ, Dept Microbiol Sci, Coll Hlth & Med Sci, Harar, Ethiopia; [Gobena, Tesfaye] Haramaya Univ, Dept Publ Hlth, Coll Hlth & Med Sci, Harar, Ethiopia; [Mariyam, Tamirat Haile] Ethiopian Red Cross Soc, Harar Branch, Blood Bank, Addis Ababa, Ethiopia	Haramaya University; Haramaya University	Umare, A (corresponding author), Deder Hosp, Dept Lab Med, Deder, Ethiopia.	umareabdi@gmail.com						Adibi P, 2012, INT J PREV MED, V3, P94; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; Desalegn Z, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0211-3; Duncan M. E., 1995, Ethiopian Journal of Health Development, V9, P31; Eke AC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-12; Elsheikh RM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-104; Federal Democratic Republic of Ethiopia, 2010, NAT EXP PROGR IMM CO; Gasim GI, 2013, J INFECT DEV COUNTR, V7, P566, DOI 10.3855/jidc.3243; GEBRESELASSIE L, 1983, ETHIOPIAN MED J, V21, P205; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; KEFENE H, 1988, J MED VIROL, V24, P75, DOI 10.1002/jmv.1890240110; Kolawole OM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-317; Mansour W, 2012, J MED VIROL, V84, P1186, DOI 10.1002/jmv.23336; Mohammed Awole, 2005, Ethiopian Journal of Health Development, V19, P45; Molla S, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0437-7; Murad EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-127; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Negero A, 2011, BMC RES NOTES, V4, P3; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Rabiu KA, 2010, ACTA OBSTET GYN SCAN, V89, P1024, DOI 10.3109/00016349.2010.482580; Ramos JM, 2011, J CLIN VIROL, V51, P83, DOI 10.1016/j.jcv.2011.01.010; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seid MGB., 2014, ADV LIFE SCI HLTH, V1, P109; Stewart RD, 2013, HEPATITIS B VACCINAT, P167; Tegegne Dessie, 2014, BMC Res Notes, V7, P239, DOI 10.1186/1756-0500-7-239; Tiruneh Moges, 2008, Ethiop Med J, V46, P359; Verma R, 2011, HUM VACCINES, V7, P1387, DOI 10.4161/hv.7.12.17878; World Health O, 2009, WKLY EPIDEMIOL REC, V84, P405, DOI DOI 10.1016/J.VACCINE.2009.10.110; World Health Organization, 2015, WC536 WHO; World Health Organization, 1990, WHOEPIGEN906; Yakasai IA., 2012, J BASIC CLIN REPROD, V1, P49; Yohanes T., 2016, HEPAT RES TREAT, V2016, P9290163, DOI DOI 10.1155/2016/9290163; Zenebe Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-118	33	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166936	10.1371/journal.pone.0166936	http://dx.doi.org/10.1371/journal.pone.0166936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898721	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000025
J	Czupryna, AM; Brown, JS; Bigambo, MA; Whelan, CJ; Mehta, SD; Santymire, RM; Lankester, FJ; Faust, LJ				Czupryna, Anna M.; Brown, Joel S.; Bigambo, Machunde A.; Whelan, Christopher J.; Mehta, Supriya D.; Santymire, Rachel M.; Lankester, Felix J.; Faust, Lisa J.			Ecology and Demography of Free-Roaming Domestic Dogs in Rural Villages near Serengeti National Park in Tanzania	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; RABIES CONTROL; EPIDEMIOLOGIC PARAMETERS; VACCINATION COVERAGE; COQUIMBO REGION; URBAN AREAS; POPULATION; DISEASE; AFRICA; MANAGEMENT	Free-roaming dogs (Canis lupus familiaris) are of public health and conservation concern because of their potential to transmit diseases, such as rabies, to both people and wildlife. Understanding domestic dog population dynamics and how they could potentially be impacted by interventions, such as rabies vaccination, is vital for such disease control efforts. For four years, we measured demographic data on 2,649 free-roaming domestic dogs in four rural villages in Tanzania: two villages with and two without a rabies vaccination campaign. We examined the effects of body condition, sex, age and village on survivorship and reproduction. Furthermore, we compared sources of mortality among villages. We found that adult dogs (> 12mos) had higher survival than puppies in all villages. We observed a male-biased sex ratio across all age classes. Overall survival in one non-vaccination village was lower than in the other three villages, all of which had similar survival probabilities. In all villages, dogs in poor body condition had lower survival than dogs in ideal body condition. Sickness and spotted hyena (Crocuta crocuta) predation were the two main causes of dog death. Within vaccination villages, vaccinated dogs had higher survivorship than unvaccinated dogs. Dog population growth, however, was similar in all the villages suggesting village characteristics and ownership practices likely have a greater impact on overall dog population dynamics than vaccination. Free-roaming domestic dogs in rural communities exist in the context of their human owners as well as the surrounding wildlife. Our results did not reveal a clear effect of vaccination programs on domestic dog population dynamics. An investigation of the role of dogs and their care within these communities could provide additional insight for planning and implementing rabies control measures such as mass dog vaccination.	[Czupryna, Anna M.; Brown, Joel S.; Whelan, Christopher J.; Santymire, Rachel M.; Faust, Lisa J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Czupryna, Anna M.; Bigambo, Machunde A.; Santymire, Rachel M.; Lankester, Felix J.; Faust, Lisa J.] Lincoln Pk Zoo, Serengeti Hlth Initiat, Chicago, IL USA; [Mehta, Supriya D.] Univ Illinois, Dept Epidemiol & Biostat, Chicago, IL USA; [Lankester, Felix J.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington State University	Czupryna, AM (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.; Czupryna, AM (corresponding author), Lincoln Pk Zoo, Serengeti Hlth Initiat, Chicago, IL USA.	aczupr3@uic.edu	Whelan, Christopher J/H-4856-2019	Whelan, Christopher J/0000-0001-7511-2603; Lankester, Felix/0000-0002-0802-0693	University of Illinois at Chicago Bodmer International Travel Award; University of Illinois at Chicago Elmer Hadley Award for Graduate Research; American Society of Mammalogists; University of Illinois at Chicago Chancellor's Supplemental Research Fellowship; Explorer's Club Fund for Exploration; Idea Wild; University of Illinois at Chicago Institute for Environmental Science and Policy Fellowship; Portage Park Animal Hospital; HomeAgain/Schering-Plough; Lincoln Park Zoo	University of Illinois at Chicago Bodmer International Travel Award; University of Illinois at Chicago Elmer Hadley Award for Graduate Research; American Society of Mammalogists; University of Illinois at Chicago Chancellor's Supplemental Research Fellowship; Explorer's Club Fund for Exploration; Idea Wild; University of Illinois at Chicago Institute for Environmental Science and Policy Fellowship; Portage Park Animal Hospital; HomeAgain/Schering-Plough; Lincoln Park Zoo	Anna Czupryna received funding for this research from the following institutions and awards: University of Illinois at Chicago Bodmer International Travel Award, University of Illinois at Chicago Elmer Hadley Award for Graduate Research, American Society of Mammalogists Grant in Aid of Research, University of Illinois at Chicago Chancellor's Supplemental Research Fellowship, Explorer's Club Fund for Exploration, Idea Wild, University of Illinois at Chicago Institute for Environmental Science and Policy Fellowship, Portage Park Animal Hospital, HomeAgain/Schering-Plough, and the Lincoln Park Zoo. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta-Jamett G, 2015, EUR J WILDLIFE RES, V61, P329, DOI 10.1007/s10344-014-0886-0; Acosta-Jamett G, 2010, PREV VET MED, V94, P272, DOI 10.1016/j.prevetmed.2010.01.002; [Anonymous], 2010, MICR EXC AN TOOLP; [Anonymous], 2016, SENAPA GIS LAYERS; APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Belsare AV, 2015, ECOL MODEL, V296, P102, DOI 10.1016/j.ecolmodel.2014.10.031; Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003; BERAN GW, 1982, COMP IMMUNOL MICROB, V5, P265, DOI 10.1016/0147-9571(82)90047-9; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Butler JRA, 2000, VET REC, V147, P442, DOI 10.1136/vr.147.16.442; Butler JRA, 1998, ECOLOGY DOMESTIC DOG; Caughley G., 2004, ANAL VERTEBRATE POPU; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Cleaveland S, 2007, CONSERV BIOL, V21, P612, DOI 10.1111/j.1523-1739.2007.00701.x; Cleaveland S, 2006, VET MICROBIOL, V117, P43, DOI 10.1016/j.vetmic.2006.04.009; Cleves M., 2008, INTRO SURVIVAL ANAL; Coleman PG, 2004, EMERG INFECT DIS, V10, P140; Conan A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004177; Concannon PW, 2011, ANIM REPROD SCI, V124, P200, DOI 10.1016/j.anireprosci.2010.08.028; COX DR, 1972, J R STAT SOC B, V34, P187; Crawley MJ, 2005, STAT INTRO USING R; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; Deem SL, 2016, CANINE DISTEMPER TER, V31, P441; ESRI, 2015, ARC GIS DESKT REL 10; Feng N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27518; Flores-Ibarra M, 2004, PREV VET MED, V62, P79, DOI 10.1016/j.prevetmed.2003.10.002; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Gilbert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110811; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Gsell AS, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-236; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Herron ME, 2014, J VET BEHAV, V9, P13, DOI 10.1016/j.jveb.2013.09.003; Hossain M, 2013, PREV VET MED, V111, P134, DOI 10.1016/j.prevetmed.2013.03.008; Kaare M., 2007, RABIES CONTROL RURAL; Kat P. W., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P229, DOI 10.1098/rspb.1995.0200; Kitala P, 2001, ACTA TROP, V78, P217, DOI 10.1016/S0001-706X(01)00082-1; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Knobel DL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-5; Knobel DL, 2013, FREE RANGING DOGS WI; Kongkaew W, 2004, PREV VET MED, V65, P105, DOI 10.1016/j.prevetmed.2004.05.009; Laflamme D, 1997, VET CLIN N AM-SMALL, V27, P1561, DOI 10.1016/S0195-5616(97)50139-2; Lankester F, 2014, SCIENCE, V345, P1562, DOI 10.1126/science.1256306; Lembo T, 2007, P ROY SOC B-BIOL SCI, V274, P2123, DOI 10.1098/rspb.2007.0664; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; MACDONALD DW, 1993, ONDERSTEPOORT J VET, V60, P351; Macpherson CNL, 2013, DOGS, ZOONOSES AND PUBLIC HEALTH, 2ND EDITION, P1, DOI 10.1079/9781845938352.0000; Matter H. C., 2000, Dogs, zoonoses and public health, P17, DOI 10.1079/9780851994369.0017; Morters MK, 2014, J APPL ECOL, V51, P1096, DOI 10.1111/1365-2664.12279; Morters MK, 2013, J ANIM ECOL, V82, P6, DOI 10.1111/j.1365-2656.2012.02033.x; Nagao Y, 2012, J VET MED SCI, V74, P699, DOI 10.1292/jvms.11-0509; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; Ortega-Pacheeo A, 2007, THERIOGENOLOGY, V67, P382, DOI 10.1016/j.theriogenology.2006.07.020; Pal SK, 2003, ACTA THERIOL, V48, P271, DOI 10.1007/BF03194167; Piccione G, 2005, J VET MED A, V52, P377, DOI 10.1111/j.1439-0442.2005.00758.x; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; Pulczer AS, 2013, PREV VET MED, V108, P209, DOI 10.1016/j.prevetmed.2012.07.012; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; Rinzin K, 2016, PREV VET MED, V126, P39, DOI 10.1016/j.prevetmed.2016.01.030; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sambo M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002510; Sen Majumder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143501; Sepulveda MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086152; StataCorp, 2011, STAT STAT SOFTW REL; Suzuki K, 2008, ZOONOSES PUBLIC HLTH, V55, P177, DOI 10.1111/j.1863-2378.2008.01114.x; Totton SC, 2010, THERIOGENOLOGY, V74, P1115, DOI 10.1016/j.theriogenology.2010.05.008; Townsend SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002372; Whitman KL, 2006, MODELLING MONITORING; Wiggs RB., 1997, VET DENT PRINCIPLES, P165; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Woodroffe R, 2011, J APPL ECOL, V48, P1345, DOI 10.1111/j.1365-2664.2011.02059.x; World Health Organization, 2013, WHO TECH REP SER; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	80	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							0167092	10.1371/journal.pone.0167092	http://dx.doi.org/10.1371/journal.pone.0167092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893866	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400083
J	Murrison, LB; Martinson, N; Moloney, RM; Msandiwa, R; Mashabela, M; Samet, JM; Golub, JE				Murrison, Liza Bronner; Martinson, Neil; Moloney, Rachael M.; Msandiwa, Regina; Mashabela, Mondiwana; Samet, Jonathan M.; Golub, Jonathan E.			Tobacco Smoking and Tuberculosis among Men Living with HIV in Johannesburg, South Africa: A Case-Control Study	PLOS ONE			English	Article							INFECTED ADULTS; RISK; PREVALENCE; ALCOHOL; TRANSMISSION; POPULATION; HEALTH; COMMUNITY; CESSATION; DISEASE	Setting Although there is ample evidence that smoking increases the risk of tuberculosis (TB), the magnitude of impact on TB risk among HIV-infected persons is poorly described. Given that a high proportion of patients with TB are co-infected with HIV in South Africa, the risks arising from the intersection of smoking, TB, and HIV/AIDS have key relevance for tobacco control policies. Objective To evaluate the association of pulmonary tuberculosis (PTB) with current tobacco smoking among men with HIV in South Africa. Design Case-control study of antiretroviral therapy naive men with confirmed HIV-infection in Johannesburg. Cases had laboratory-confirmed PTB and controls had no evidence of active TB. Participants were interviewed to collect detailed smoking histories. Results We enrolled 146 men diagnosed with PTB and 133 controls. Overall, 33% of participants were currently smoking, defined as smoking a cigarette within 2 months (34% cases vs. 32% controls, p = 0.27). Median CD4 count was lower (60 vs. 81 cells/mm3, P = 0.03) and median viral load was higher (173 vs. 67 copies/ul per thousand, P<0.001) among cases versus controls. In adjusted analyses, current smoking tripled the odds of PTB (aOR 3.2; 95% CI: 1.3-7.9, P = 0.01) and former smoking nearly doubled the odds of PTB (aOR 1.8; 95% CI 0.8-4.4, P = 0.18) compared to never smoking. Conclusions Males with HIV that smoke are at greater odds for developing PTB than non-smokers. Extensive smoking cessation programs are needed to reduce odds of TB and promote health among adults living with HIV.	[Murrison, Liza Bronner; Moloney, Rachael M.; Golub, Jonathan E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Murrison, Liza Bronner; Martinson, Neil; Golub, Jonathan E.] Johns Hopkins Sch Med, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil; Msandiwa, Regina; Mashabela, Mondiwana] Univ Witwatersrand, Perinatal HIV Res Unit, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Johannesburg, South Africa; [Martinson, Neil] Univ Witwatersrand, NRF DST Ctr Excellence Biomed TB Res, Johannesburg, South Africa; [Samet, Jonathan M.] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Witwatersrand; University of Witwatersrand; University of Southern California	Golub, JE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.; Golub, JE (corresponding author), Johns Hopkins Sch Med, Ctr TB Res, Baltimore, MD USA.	jgolub@jhmi.edu	Murrison, Liza/AAE-7682-2019	Bronner Murrison, Liza/0000-0002-8668-3898	Faculty Grant award from Center for TB Research at Johns Hopkins School of Medicine	Faculty Grant award from Center for TB Research at Johns Hopkins School of Medicine	This study was supported by a Faculty Grant award from the Center for TB Research at the Johns Hopkins School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work	Amoakwa K, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu120; [Anonymous], GLOB TOB CONTR; ASPA, 2014, HLTH CONSMOK 50 YE; BROWN KE, 1961, BRIT J DIS CHEST, V55, P150, DOI 10.1016/S0007-0971(61)80109-5; Brunet L, 2011, EUR RESPIR J, V38, P139, DOI 10.1183/09031936.00137710; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Jackson-Morris A, 2015, INT J TUBERC LUNG D, V19, P1003, DOI 10.5588/ijtld.14.0813; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; Lam C, 2013, INT J TUBERC LUNG D, V17, P1354, DOI 10.5588/ijtld.13.0016; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; LEWIS JG, 1963, BRIT J PREV SOC MED, V17, P149; Lifson AR, 2012, CURR HIV-AIDS REP, V9, P223, DOI 10.1007/s11904-012-0121-0; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Louwagie GMC, 2014, ADDICTION, V109, P1942, DOI 10.1111/add.12671; Moller V, 2010, SOC INDIC RES, V98, P217, DOI 10.1007/s11205-009-9546-2; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Murray EJ, 2009, INT J TUBERC LUNG D, V13, P767; National Institute on Alcohol Abuse and Alcoholism, 2016, ALC FACTS STAT; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Organization WH, 2016, GLOBAL TUBERCULOSIS; Peltzer K, 2014, SAJP-S AFR J PSYCHI, V20, P21, DOI [10.7196/sajp.482, 10.7196/SAJP.482]; Republic of South Africa Department of Health, 2008, NAT TUB MAN GUID; Shapiro AE, 2011, INT J TUBERC LUNG D, V15, P140; Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Stein L, 2008, BRIT J CANCER, V98, P1586, DOI 10.1038/sj.bjc.6604303; UNAIDS, 2014, UNAIDS HIV AND AIDS; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; Yen YF, 2014, INT J TUBERC LUNG D, V18, P492, DOI 10.5588/ijtld.13.0694	36	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167133	10.1371/journal.pone.0167133	http://dx.doi.org/10.1371/journal.pone.0167133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	27893799	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400091
J	Nielsen, HL; Kirk, KF; Bodilsen, J; Ejlertsen, T; Nielsen, H				Nielsen, Hans Linde; Kirk, Karina Frahm; Bodilsen, Jacob; Ejlertsen, Tove; Nielsen, Henrik			Azithromycin vs. Placebo for the Clinical Outcome in Campylobacter concisus Diarrhoea in Adults: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial	PLOS ONE			English	Article							INFECTION; DISEASE; SAMPLES	Campylobacter concisus has been associated with prolonged mild diarrhoea, but investigations regarding the efficacy of antimicrobial treatment have not been reported previously. We initiated a phase 3, single-centre, randomized, double-blinded, placebo-controlled study comparing the efficacy of 500 mg once-daily dose of azithromycin with a 500 mg once-daily dose of placebo for three days, for the treatment of C. concisus diarrhoea in adult patients with a follow-up period of ten days. If symptoms persisted at day ten, the patient was offered cross-over study treatment of three days and another ten-day follow-up period. The primary efficacy endpoint was the clinical response, defined as time to cessation of diarrhoea (<3 stools/day or reversal of accompanying symptoms). Our estimated sample size was 100 patients. We investigated a total of 10,036 diarrheic stool samples from 7,089 adult patients. Five-hundred and eighty-eight C. concisus positive patients were assessed for eligibility, of which 559 were excluded prior to randomization. The three main reasons for exclusion were duration of diarrhoea longer than 21 days (n = 124), previous antibiotic treatment (n = 113), and co-pathogens in stools (n = 87). Therefore, 24 patients completed the trial with either azithromycin (n = 12) or placebo (n = 12). Both groups presented symptoms of mild, prolonged diarrhoea with a mean duration of 18 days (95% CI: 16-19). One person in the azithromycin group and four from the placebo group chose to continue with crossover medication after the initial ten-day period. In the azithromycin group, there was a mean of seven days (95% CI: 5-9) to clinical cure and for the placebo group it was ten days (95% CI: 6-14) (OR-3 (95% CI: -7-1). We observed no differences in all examined outcomes between azithromycin treatment and placebo. However, due to unforeseen recruitment difficulties we did not reach our estimated sample size of 100 patients and statistical power to conclude on an effect of azithromycin treatment was not obtained.	[Nielsen, Hans Linde; Kirk, Karina Frahm; Bodilsen, Jacob; Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Nielsen, Hans Linde; Ejlertsen, Tove] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Kirk, Karina Frahm; Nielsen, Henrik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University	Nielsen, HL (corresponding author), Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark.; Nielsen, HL (corresponding author), Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark.	halin@rn.dk		Bodilsen, Jacob/0000-0002-7398-814X	Obel Family Foundation	Obel Family Foundation	This work was supported by grants from The Obel Family Foundation, http://www.obel.com/.	Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; Engberg J, 2016, DIAGNOSTIK BAKTERIEL; European Centers for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V, P20; Hansen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058825; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Nielsen HL, 2013, CLIN MICROBIOL INFEC, V19, P445, DOI 10.1111/j.1469-0691.2012.03852.x; Nielsen HL, 2012, CLIN MICROBIOL INFEC, V18, pE459, DOI 10.1111/j.1469-0691.2012.03990.x; Nielsen HL, 2015, DIAGN MICR INFEC DIS, V83, P11, DOI 10.1016/j.diagmicrobio.2015.05.008; Nielsen HL, 2013, PEDIATR INFECT DIS J, V32, P1194, DOI 10.1097/INF.0b013e31829f0aff; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Nielsen HL, 2016, CLIN MICROBIAL, V5, P230; Riddle MS, 2016, AM J GASTROENTEROL, V111, P602, DOI 10.1038/ajg.2016.126; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; Ternhag A, 2007, CLIN INFECT DIS, V44, P696, DOI 10.1086/509924; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166395	10.1371/journal.pone.0166395	http://dx.doi.org/10.1371/journal.pone.0166395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893820	Green Submitted, Green Published, gold			2022-12-27	WOS:000389472400023
J	Hanieh, H; Mohafez, O; Hairul-Islam, VI; Alzahrani, A; Ismail, MB; Thirugnanasambantham, K				Hanieh, Hamza; Mohafez, Omar; Hairul-Islam, Villianur Ibrahim; Alzahrani, Abdullah; Ismail, Mohammad Bani; Thirugnanasambantham, Krishnaraj			Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; METASTASIS; POLYPHENOLS; ACTIVATION; EXPRESSION; ANTITUMOR; AXIS; AHR; INFLAMMATION; MECHANISMS	Background Despite the remarkable progress to fight against breast cancer, metastasis remains the dominant cause of treatment failure and recurrence. Therefore, control of invasiveness potential of breast cancer cells is crucial. Accumulating evidences suggest Aryl hydrocarbon receptor (Ahr), a helix-loop-helix transcription factor, as a promising target to control migration and invasion in breast cancer cells. Thus, an Ahr-based exploration was performed to identify a new Ahr agonist with inhibitory potentials on cancer cell motility. Methods For prediction of potential interactions between Ahr and candidate molecules, bioinformatics analysis was carried out. The interaction of the selected ligand with Ahr and its effects on migration and invasion were examined in vitro using the MDA-MB-231 and T47D cell lines. The silencing RNAs were transfected into cells by electroporation. Expressions of microRNAs (miRNAs) and coding genes were quantified by real-time PCR, and the protein levels were detected by western blot. Results The in silico and in vitro results identified Flavipin as a novel Ahr agonist. It induces formation of Ahr/Ahr nuclear translocator (Arnt) heterodimer to promote the expression of cytochrome P450 family 1 subfamily A member 1 (Cyp1a1). Migration and invasion of MDA-MB-231 and T47D cells were inhibited with Flavipin treatment in an Ahr-dependent fashion. Interestingly, Flavipin suppressed the pro-metastatic factor SRY-related HMG-box4 (Sox4) by inducing miR-212/132 cluster. Moreover, Flavipin inhibited growth and adhesion of both cell lines by suppressing gene expressions of B-cell lymphoma 2 (BcI2) and integrina4 (ITGA4). Conclusion Taken together, the results introduce Flavipin as a novel Ahr agonist, and provide first evidences on its inhibitory effects on cancer cell motility, suggesting Flavipin as a candidate to control cell invasiveness in breast cancer patients.	[Hanieh, Hamza; Hairul-Islam, Villianur Ibrahim; Alzahrani, Abdullah; Ismail, Mohammad Bani] King Faisal Univ, Coll Sci, Dept Biol Sci, Hofuf Ahsaa, Saudi Arabia; [Mohafez, Omar] Coll Clin Pharm, Biomed Dept, Hofuf Ahsaa, Saudi Arabia; [Mohafez, Omar] Al Azhar Univ Assiut, Coll Pharm, Dept Biochem, Assiut, Egypt; [Hairul-Islam, Villianur Ibrahim; Thirugnanasambantham, Krishnaraj] Pondicherry Ctr Biol Sci, Pondicherry, India	King Faisal University; Egyptian Knowledge Bank (EKB); Al Azhar University; Assiut University	Hanieh, H (corresponding author), King Faisal Univ, Coll Sci, Dept Biol Sci, Hofuf Ahsaa, Saudi Arabia.	hhanieh@kfu.edu.sa	Thirugnanasambantham, Krishnaraj/N-7545-2017; Mohafez, Omar/AAA-4883-2022; Hanieh, Hamza/AAA-7867-2021; Alzahrani, Abdullah M/H-8384-2016; Villianur Ibrahim, Hairul-Islam/I-4689-2016	Thirugnanasambantham, Krishnaraj/0000-0002-5340-8806; Mohafez, Omar/0000-0001-5352-8210; Hanieh, Hamza/0000-0001-9230-3858; Alzahrani, Abdullah M/0000-0003-4372-4968; Villianur Ibrahim, Hairul-Islam/0000-0002-2444-5552; Bani Ismail, Mohammad/0000-0001-9278-7258	Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia [160030, 160036]	Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia	This work was funded by the Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia (Grants 160030 to HH and 160036 to AA).r This work was funded by the Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia (Grants 160030 to HH and 160036 to AA).	Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Chang CL, 2014, INT SYMP INTEGR CIRC, P1, DOI 10.1109/ISICIR.2014.7029491; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Chinen I, 2015, INT IMMUNOL, V27, P405, DOI 10.1093/intimm/dxv015; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Evans DGR, 2009, J MED GENET, V46, P811, DOI 10.1136/jmg.2009.067850; Fukasawa K, 2015, MOL CANCER THER, V14, P343, DOI 10.1158/1535-7163.MCT-14-0158; Gao X, 2016, BIOCH PHARM; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; Hamidullah, 2015, BIOCHIMIE, V119, P68, DOI 10.1016/j.biochi.2015.10.012; Hanieh H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0443-9; Hanieh H, 2013, EUR J IMMUNOL, V43, P2771, DOI 10.1002/eji.201343486; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; Hiyoshi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07095; Hockings JK, 2006, CANCER RES, V66, P2224, DOI 10.1158/0008-5472.CAN-05-1619; Hoye Anette M., 2012, Advances in Biological Regulation, V52, P326, DOI 10.1016/j.jbior.2012.03.004; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kattimani Vivekanand S, 2013, J Contemp Dent Pract, V14, P227; Kim EJ, 2009, J NUTR, V139, P2373, DOI 10.3945/jn.109.111864; Ko YS, 2016, PHYTOTHER RES, V30, P1180, DOI 10.1002/ptr.5626; Luo KW, 2014, PHYTOMEDICINE, V21, P1078, DOI 10.1016/j.phymed.2014.04.020; MADRIGAL C, 1995, CAN J BOT, V73, P425, DOI 10.1139/b95-043; Martinez V, 2008, BREAST CANCER RES TR, V110, P521, DOI 10.1007/s10549-007-9739-9; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Nasr T, 2014, EUR J MED CHEM, V76, P539, DOI 10.1016/j.ejmech.2014.02.026; Nguyen CH, 2016, HUM MOL GENET; Novikov O, 2016, MOL PHARM; Parks AJ, 2014, MOL PHARMACOL, V86, P593, DOI 10.1124/mol.114.093369; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Qu XL, 2014, EUR REV MED PHARMACO, V18, P1269; Rahimi M, 2010, CANCER LETT, V295, P59, DOI 10.1016/j.canlet.2010.02.014; Ronnekleiv-Kelly SM, 2016, CANCER LETT, V370, P91, DOI 10.1016/j.canlet.2015.10.014; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Shi ML, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0332-2; Sun F, 2015, CARCINOGENESIS, V36, P757, DOI 10.1093/carcin/bgv040; Thirugnanasambantham K, 2014, APPL BIOCHEM BIOTECH, V174, P130, DOI 10.1007/s12010-014-1038-4; Tiong CT, 2012, CARCINOGENESIS, V33, P1089, DOI 10.1093/carcin/bgs110; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Videira M, 2012, NANOMED-NANOTECHNOL, V8, P1208, DOI 10.1016/j.nano.2011.12.007; Wang YB, 2010, PHYTOMEDICINE, V17, P363, DOI 10.1016/j.phymed.2009.07.019; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Xiao Y, 2013, FEMS MICROBIOL LETT, V339, P130, DOI 10.1111/1574-6968.12065; Young SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120815; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080515	50	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167650	10.1371/journal.pone.0167650	http://dx.doi.org/10.1371/journal.pone.0167650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907195	Green Published, gold, Green Submitted			2022-12-27	WOS:000389482700217
J	Neves, LM; Teixeira-Neves, TP; Pereira-Filho, GH; Araujo, FG				Neves, Leonardo M.; Teixeira-Neves, Tatiana P.; Pereira-Filho, Guilherme H.; Araujo, Francisco G.			The Farther the Better: Effects of Multiple Environmental Variables on Reef Fish Assemblages along a Distance Gradient from River Influences	PLOS ONE			English	Article							RIO-DE-JANEIRO; COMMUNITY STRUCTURE; WAVE EXPOSURE; ROCKY REEF; CORAL-REEFS; SWIMMING PERFORMANCE; SOUTHEASTERN BRAZIL; TERRESTRIAL RUNOFF; STRUCTURE PATTERNS; TROPHIC STRUCTURE	The conservation and management of site-attached assemblages of coastal reefs are particularly challenging because of the tremendous environmental variation that exists at small spatial scales. In this sense, understanding the primary sources of variation in spatial patterns of the biota is fundamental for designing effective conservation policies. We investigated spatial variation in fish assemblages around the windward and leeward sides of coastal islands situated across a gradient of riverine influence (13 km in length). Specifically, relationships between rocky reef fish assemblages and benthic, topographic and physical predictors were assessed. We hypothesized that river induced disturbances may overcome local habitat features in modeling spatial patterns of fish distribution. Fish assemblages varied primarily due to the strong directional gradient of riverine influence (22.6% of the estimated components of variation), followed by topographic complexity (15%), wave exposure (9.9%), and benthic cover (8%). The trophic structure of fish assemblages changed from having a high abundance of invertebrate feeders in macroalgae-dominated reefs close to river mouths to a high proportion of herbivores, planktivores and invertebrate feeder species in reefs with large boulders covered by epilithic algal matrices, as the distance from rivers increased. This gradient led to an increase of 4.5-fold in fish richness and fish trophic group diversity, 11-fold in fish biomass and 10-fold in fish abundance. Our results have implications for the conservation and monitoring of assemblages patchily distributed at small spatial scales. The major role of distance from river influences on fish assemblages rather than benthic cover and topographic complexity suggest that managing land-based activities should be a conservation priority toward reef restoration.	[Neves, Leonardo M.; Teixeira-Neves, Tatiana P.; Araujo, Francisco G.] Univ Fed Rural Rio de Janeiro, Dept Biol Anim, Lab Ecol Peixes, Campus Seropedica, Seropedica, RJ, Brazil; [Neves, Leonardo M.] Univ Fed Rural Rio de Janeiro, Dept Ciencias Meio Ambiente, Campus Tres Rios, Seropedica, RJ, Brazil; [Pereira-Filho, Guilherme H.] Univ Fed Sao Paulo, Inst Mar, Lab Ecol & Conservacao Marinha, Campus Baixada Santista, Santos, SP, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal de Sao Paulo (UNIFESP)	Araujo, FG (corresponding author), Univ Fed Rural Rio de Janeiro, Dept Biol Anim, Lab Ecol Peixes, Campus Seropedica, Seropedica, RJ, Brazil.	gersonufrrj@gmail.com	Neves, Leonardo/AAN-1167-2020; Neves, Leonardo M/C-7799-2013; Pereira-Filho, Guilherme-Henrique/I-2946-2013	Neves, Leonardo/0000-0002-0269-6588; Neves, Leonardo M/0000-0002-0269-6588; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241	FAPERJ Foundation; CNPq - Brazilian council	FAPERJ Foundation(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq - Brazilian council	This work was supported by FAPERJ Foundation for the research of the Rio de Janeiro State, Brazil; and CNPq - Brazilian council for developing research.	Aburto-Oropeza O, 2001, MAR ECOL-P S Z N I, V22, P283, DOI 10.1046/j.1439-0485.2001.t01-1-01747.x; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2004, REV GEOCIENCIAS, V3, P53; [Anonymous], 1988, NMFSSEFC215 NOAA; Balata D, 2011, MAR BIOL, V158, P2459, DOI 10.1007/s00227-011-1747-y; Beger M, 2008, MAR ECOL PROG SER, V361, P1, DOI 10.3354/meps07481; Bejarano S, 2011, MAR BIOL, V158, P489, DOI 10.1007/s00227-010-1575-5; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; BOUCHONNAVARO Y, 1989, ENVIRON BIOL FISH, V25, P47, DOI 10.1007/BF00002200; Camilato V, 2010, J APPL ICHTHYOL, V26, P463, DOI 10.1111/j.1439-0426.2009.01343.x; Coni EOC, 2013, ENVIRON BIOL FISH, V96, P45, DOI 10.1007/s10641-012-0021-6; Chemello R, 2002, MAR BIOL, V140, P981, DOI 10.1007/s00227-002-0777-x; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; CLARKE RD, 1992, CORAL REEFS, V11, P199, DOI 10.1007/BF00301994; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cooney R., 2004, PRECAUTIONARY PRINCI; DENNY M, 1995, ECOL MONOGR, V65, P371, DOI 10.2307/2963496; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Dias CD, 2008, HYDROBIOLOGIA, V614, P65, DOI 10.1007/s10750-008-9537-3; EKLOV P, 1994, OECOLOGIA, V98, P344, DOI 10.1007/BF00324223; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Ferreira CEL, 2001, ENVIRON BIOL FISH, V61, P353, DOI 10.1023/A:1011609617330; Field CD, 1998, MAR POLLUT BULL, V37, P383; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Francisco CN, 2004, GEOCIENCIAS, V3, P53; Francisco-Ramos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078761; Fraschetti S, 2012, MAR ECOL PROG SER, V466, P21, DOI 10.3354/meps09937; Freret-Meurer NV, 2010, MAR POLLUT BULL, V60, P627, DOI 10.1016/j.marpolbul.2010.01.023; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Froese R., 2014, FISHBASE; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Fulton CJ, 2004, MAR BIOL, V144, P429, DOI 10.1007/s00227-003-1216-3; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; GEE JM, 1994, MAR ECOL PROG SER, V103, P141, DOI 10.3354/meps103141; Gibran FZ, 2012, NEOTROP ICHTHYOL, V10, P369, DOI 10.1590/S1679-62252012005000013; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; GOLBUU Y, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/981273; Golbuu Y, 2011, MAR POLLUT BULL, V62, P824, DOI 10.1016/j.marpolbul.2010.12.015; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Guerra JV, 2009, J COASTAL RES, P1350; Gusso-Choueri PK, 2015, ENVIRON SCI POLLUT R, V22, P18047, DOI 10.1007/s11356-015-4911-y; Hammond W, 2004, MAR BIOL, V144, P547, DOI 10.1007/s00227-003-1210-9; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Hauzy C, 2010, OECOLOGIA, V163, P625, DOI 10.1007/s00442-010-1585-5; Haywick DW, 1997, CORAL REEFS, V16, P39, DOI 10.1007/s003380050057; Hewitt AH, 2006, ENVIRON TOXICOL CHEM, V25, P2288, DOI 10.1897/05-569R.1; Ignacio BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013065; JACCARD J, 1990, MULTIVAR BEHAV RES, V25, P467, DOI 10.1207/s15327906mbr2504_4; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Karnauskas M, 2012, LIMNOL OCEANOGR, V57, P1403, DOI 10.4319/lo.2012.57.5.1403; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2085, DOI 10.1023/A:1021354914494; Letourneur Y, 1998, ENVIRON BIOL FISH, V51, P141, DOI 10.1023/A:1007489502060; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Luiz OJ, 2008, ZOOTAXA, P1; Macieira RM, 2009, J APPL ICHTHYOL, V25, P358, DOI 10.1111/j.1439-0426.2008.01118.x; Malcolm HA, 2011, AQUAT CONSERV, V21, P173, DOI 10.1002/aqc.1165; Mallela J, 2007, J FISH BIOL, V70, P523, DOI 10.1111/j.1095-8649.2007.01323.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCGEHEE MA, 1994, MAR ECOL PROG SER, V105, P243, DOI 10.3354/meps105243; McQuaid CD, 2000, MAR ECOL PROG SER, V206, P147, DOI 10.3354/meps206147; Medeiros PR, 2010, ENVIRON BIOL FISH, V87, P237, DOI 10.1007/s10641-010-9593-1; Mueller Erich, 1995, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P89; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2002, CORAL REEFS, V21, P105, DOI 10.1007/s00338-001-0200-y; Nemeth RS, 1998, ENVIRON BIOL FISH, V53, P129, DOI 10.1023/A:1007402104047; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nogueira CR, 1991, COASTAL ZONE 91 BEAC, V4, P3221; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Peterson AT, 2000, BIOL CONSERV, V93, P85, DOI 10.1016/S0006-3207(99)00074-9; Pinheiro HT, 2013, J MAR BIOL ASSOC UK, V93, P1175, DOI 10.1017/S0025315412001749; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; Roberts DE, 2006, MAR ECOL PROG SER, V321, P19, DOI 10.3354/meps321019; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Santin S, 2007, MAR BIOL, V151, P1683, DOI 10.1007/s00227-006-0586-8; Santos CSG, 2016, NAT CONSERV IN PRESS; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Semmens BX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008895; Sogard SM, 1997, B MAR SCI, V60, P1129; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Teixeira TP, 2012, HYDROBIOLOGIA, V684, P161, DOI 10.1007/s10750-011-0980-1; Teixeira-Neves TP, 2016, MAR POLLUT BULL, V109, P290, DOI 10.1016/j.marpolbul.2016.05.067; Teixeira-Neves TP, 2015, ENVIRON BIOL FISH, V98, P1645, DOI 10.1007/s10641-015-0390-8; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Tuya F, 2006, MAR ECOL PROG SER, V311, P15, DOI 10.3354/meps311015; Vinagre C, 2011, J SEA RES, V65, P362, DOI 10.1016/j.seares.2011.02.003; Wenger AS, 2012, J EXP MAR BIOL ECOL, V428, P43, DOI 10.1016/j.jembe.2012.06.004; Wenger AS, 2011, CORAL REEFS, V30, P879, DOI 10.1007/s00338-011-0773-z; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Yeager LA, 2011, OECOLOGIA, V167, P157, DOI 10.1007/s00442-011-1959-3; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	111	15	15	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166679	10.1371/journal.pone.0166679	http://dx.doi.org/10.1371/journal.pone.0166679			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907017	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700033
J	Noman, N; Inniss, M; Iba, H; Way, JC				Noman, Nasimul; Inniss, Mara; Iba, Hitoshi; Way, Jeffrey C.			Pulse Detecting Genetic Circuit - A New Design Approach	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; SWITCH; DNA; MECHANISM; REPRESSOR; NETWORKS; YEAST	A robust cellular counter could enable synthetic biologists to design complex circuits with diverse behaviors. The existing synthetic-biological counters, responsive to the beginning of the pulse, are sensitive to the pulse duration. Here we present a pulse detecting circuit that responds only at the falling edge of a pulse analogous to negative edge triggered electric circuits. As biological events do not follow precise timing, use of such a pulse detector would enable the design of robust asynchronous counters which can count the completion of events. This transcription-based pulse detecting circuit depends on the interaction of two co-expressed lambdoid phage-derived proteins: the first is unstable and inhibits the regulatory activity of the second, stable protein. At the end of the pulse the unstable inhibitor protein disappears from the cell and the second protein triggers the recording of the event completion. Using stochastic simulation we showed that the proposed design can detect the completion of the pulse irrespective to the pulse duration. In our simulation we also showed that fusing the pulse detector with a phage lambda memory element we can construct a counter which can be extended to count larger numbers. The proposed design principle is a new control mechanism for synthetic biology which can be integrated in different circuits for identifying the completion of an event.	[Noman, Nasimul] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW, Australia; [Inniss, Mara] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Iba, Hitoshi] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Informat & Commun Engn, Bunkyo Ku, Tokyo, Japan; [Way, Jeffrey C.] Wyss Inst Biol Inspired Engn, Boston, MA USA	University of Newcastle; Harvard University; Harvard Medical School; University of Tokyo	Noman, N (corresponding author), Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW, Australia.	nasimul.noman@newcastle.edu.au		Noman, Nasimul/0000-0002-8566-0870	Defense Advanced Research Projects Agency Grant [N66001-11-C-4203]; University of Tokyo	Defense Advanced Research Projects Agency Grant; University of Tokyo	This work was supported by Defense Advanced Research Projects Agency Grant N66001-11-C-4203 and funds from the University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; BERTRAND KP, 1983, GENE, V23, P149, DOI 10.1016/0378-1119(83)90046-X; Biliouris K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-9; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ewen C. D., 2014, NATURE REV MICROBIOL, V12, P381, DOI [10.1038/nrmicro3239, DOI 10.1038/NRMICRO3239]; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Inniss M. C., 2014, THESIS; ISACKSON PJ, 1985, P NATL ACAD SCI USA, V82, P6226, DOI 10.1073/pnas.82.18.6226; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Morelli MJ, 2009, P NATL ACAD SCI USA, V106, P8101, DOI 10.1073/pnas.0810399106; NELSON HCM, 1986, J MOL BIOL, V192, P27, DOI 10.1016/0022-2836(86)90461-4; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ray A, 1999, MOL CELL BIOL, V19, P31; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Subsoontorn P, 2012, PROCEDIA COMPUT SCI, V11, P43, DOI 10.1016/j.procs.2012.09.006; SUSSKIND MM, 1975, J MOL BIOL, V98, P413, DOI 10.1016/S0022-2836(75)80127-6; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tocci R. J., 2000, DIGITAL SYSTEMS PRIN; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039	26	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167162	10.1371/journal.pone.0167162	http://dx.doi.org/10.1371/journal.pone.0167162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907045	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700084
J	Garbarino, S; Durando, P; Guglielmi, O; Dini, G; Bersi, F; Fornarino, S; Toletone, A; Chiorri, C; Magnavita, N				Garbarino, Sergio; Durando, Paolo; Guglielmi, Ottavia; Dini, Guglielmo; Bersi, Francesca; Fornarino, Stefania; Toletone, Alessandra; Chiorri, Carlo; Magnavita, Nicola			Sleep Apnea, Sleep Debt and Daytime Sleepiness Are Independently Associated with Road Accidents. A Cross-Sectional Study on Truck Drivers	PLOS ONE			English	Article							VEHICLE ACCIDENTS; PROFESSIONAL DRIVERS; COMMERCIAL DRIVERS; UNITED-STATES; SHIFT-WORK; RISK; PERFORMANCE; DEPRIVATION; POPULATION; CRASHES	Background Recent research has found evidence of an association between motor vehicle accidents (MVAs) or near miss accidents (NMAs), and excessive daytime sleepiness (EDS) or its main medical cause, Obstructive Sleep Apnea (OSA). However, EDS can also be due to non-medical factors, such as sleep debt (SD), which is common among professional truck drivers. On the opposite side, rest breaks and naps are known to protect against accidents. Study Objectives To investigate the association of OSA, SD, EDS, rest breaks and naps, with the occurrence of MVAs and NMAs in a large sample of truck drivers. Methods 949 male truck drivers took part in a cross-sectional medical examination and were asked to complete a questionnaire about sleep and waking habits, risk factors for OSA and EDS. Results MVAs and NMAs were reported by 34.8% and 9.2% of participants, respectively. MVAs were significantly predicted by OSA (OR = 2.32 CI95% = 1.68-3.20), SD (OR = 1.45 CI95% = 1.29-1.63), EDS (OR = 1.73 CI95% = 1.15-2.61) and prevented by naps (OR = 0.59 CI95% = 0.44-0.79) or rest breaks (OR = 0.63 CI95% = 0.45-0.89). NMAs were significantly predicted by OSA (OR = 2.39 CI95% = 1.47-3.87) and SD (OR = 1.49 CI95% = 1.27-1.76) and prevented by naps (OR = 0.52 CI95% = 0.32-0.85) or rest breaks (OR = 0.49 CI95% = 0.29-0.82). Conclusions When OSA, SD or EDS are present, the risk of MVAs or NMAs in truck drivers is severely increased. Taking a rest break or a nap appear to be protective against accidents.	[Garbarino, Sergio; Guglielmi, Ottavia; Fornarino, Stefania] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Garbarino, Sergio; Durando, Paolo; Dini, Guglielmo; Bersi, Francesca; Toletone, Alessandra] Univ Genoa, Postgrad Sch Occupat Med, Dept Hlth Sci, Genoa, Italy; [Garbarino, Sergio; Durando, Paolo; Dini, Guglielmo; Bersi, Francesca; Toletone, Alessandra] IRCCS AOU San Martino 1ST, Occupat Med Unit, Genoa, Italy; [Chiorri, Carlo] Univ Genoa, Dept Educ Sci, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy	University of Genoa; University of Genoa; University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy.	nicolamagnavita@gmail.com	Garbarino, Sergio/X-5368-2018; Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021	Garbarino, Sergio/0000-0002-8508-552X; Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X	CNH-Iveco Industrial Corporation - European Union Road Safety Action [25171877]; Italian Ministry of Transport	CNH-Iveco Industrial Corporation - European Union Road Safety Action; Italian Ministry of Transport	Medical examinations were funded by the CNH-Iveco Industrial Corporation (Grant number 25171877) within the "CNH Iveco Industrial Check Stop Project", an international project for road safety, supported by the European Union Road Safety Action and the Italian Ministry of Transport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Print expenses will be covered with University funds from NM.; The study was funded by the CNH Iveco Industrial Corporation. Grant number 25171877. We thank Mrs. E. A. Wright who revised the English language of the manuscript.	Braeckman L, 2011, CHRONOBIOL INT, V28, P126, DOI 10.3109/07420528.2010.540363; Carter N, 2003, ACCIDENT ANAL PREV, V35, P613, DOI 10.1016/S0001-4575(02)00033-7; Catarino R, 2014, SLEEP BREATH, V18, P59, DOI 10.1007/s11325-013-0848-x; Chu HC, 2014, ACCIDENT ANAL PREV, V62, P130, DOI 10.1016/j.aap.2013.09.016; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; de Cordova PB, 2016, WORK, V53, P825, DOI 10.3233/WOR-162250; de Pinho RSN, 2006, CHRONOBIOL INT, V23, P963, DOI 10.1080/07420520600920759; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Garbarino S, 2008, G Ital Med Lav Ergon, V30, P291; Garbarino S, 2004, SLEEP, V27, P1295, DOI 10.1093/sleep/27.7.1295; Garbarino S, 2001, SLEEP, V24, P203; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; Haavisto ML, 2010, J SLEEP RES, V19, P444, DOI 10.1111/j.1365-2869.2010.00823.x; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Howard ME, 2014, ACCIDENT ANAL PREV, V62, P1, DOI 10.1016/j.aap.2013.09.003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson KD, 2014, J OCCUP ENVIRON MED, V56, P510, DOI 10.1097/JOM.0000000000000132; Kales SN, 2014, IND HEALTH, V52, P13, DOI 10.2486/indhealth.2013-0206; Karimi M, 2015, SLEEP, V38, P341, DOI 10.5665/sleep.4486; Liistro G, 2003, EUR RESPIR J, V21, P248, DOI 10.1183/09031936.03.00292403; Lim J, 2007, SLEEP, V30, P61, DOI 10.1093/sleep/30.1.61; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Mohebbi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031790; Perttula P, 2011, PSYCHOL REP, V108, P507, DOI 10.2466/06.13.22.PR0.108.2.507-514; Philip P, 2005, IND HEALTH, V43, P30, DOI 10.2486/indhealth.43.30; Pylkkonen M, 2015, ACCIDENT ANAL PREV, V80, P201, DOI 10.1016/j.aap.2015.03.031; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; Smolensky MH, 2011, ACCIDENT ANAL PREV, V43, P533, DOI 10.1016/j.aap.2009.12.004; Talmage JB, 2008, J OCCUP ENVIRON MED, V50, P324, DOI 10.1097/JOM.0b013e3181617ab8; Tefft BC, 2012, ACCIDENT ANAL PREV, V45, P180, DOI 10.1016/j.aap.2011.05.028; Transport T., 2006, SLEEP MED REV, V10, P347, DOI [10.1016/j.smrv.2006.04.002, DOI 10.1016/J.SMRV.2006.04.002]; Vignatelli L, 2003, NEUROL SCI, V23, P295, DOI 10.1007/s100720300004; Wong CKH, 2012, J OCCUP ENVIRON MED, V54, P989, DOI 10.1097/JOM.0b013e3182535d7d; Xie W, 2011, J OCCUP ENVIRON MED, V53, P169, DOI 10.1097/JOM.0b013e3182068ceb	36	82	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166262	10.1371/journal.pone.0166262	http://dx.doi.org/10.1371/journal.pone.0166262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902703	Green Published, gold			2022-12-27	WOS:000389474100017
J	Simmonds, MJ; Milne, N; Ong, K; Brotherton, E; McNamee, AP; Horobin, J; Sabapathy, S				Simmonds, Michael J.; Milne, Nikki; Ong, Kee; Brotherton, Emily; McNamee, Antony P.; Horobin, Jarod; Sabapathy, Surendran			Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PLASMA VISCOSITY; INSULIN-RESISTANCE; DIABETES-MELLITUS; CELL AGGREGATION; ASSOCIATION; PROGRESSION; PREVALENCE; RHEOLOGY	Classic features of polycystic ovary syndrome (PCOS) include derangement of metabolic and cardiovascular health, and vascular dysfunction is commonly reported. These comorbidities indicate impaired blood flow; however, other than limited reports of increased plasma viscosity, surprisingly little is known regarding the physical properties of blood in PCOS. We aimed to investigate whether haemorheology was impaired in women with PCOS. We thus measured a comprehensive haemorheological profile, in a case-control design, of lean women with PCOS and age-matched healthy controls. A clinical examination determined similar cardiovascular risk for the two groups. Whole blood and plasma viscosity was measured using a cone-plate viscometer. The magnitude and rate of red blood cell (RBC) aggregation was determined using a light-transmission aggregometer, and the degree of RBC deformability was measured via laser-diffraction ektacytometry. Plasma viscosity was significantly increased in women with PCOS. Blood viscosity was also increased for PCOS at lower-to-moderate shear rates in both native and standardised haematocrit samples. The magnitude of RBC aggregation-a primary determinant of low-shear blood viscosity-was significantly increased in PCOS at native and 0.4 L . L-1 haematocrit. No difference was detected between PCOS and CON groups for RBC deformability measurements. A novel measure indicating the effectiveness of oxygen transport by RBC (i.e., the haematocrit-to-viscosity ratio; HVR) was decreased at all shear rates in women with PCOS. In a group of young and lean women with PCOS with an unremarkable cardiovascular risk profile based on clinical data, significant haemorheological impairment was observed. The degree of haemorheological derangement observed in the present study reflects that of overt chronic disease, and provides an avenue for future therapeutic intervention in PCOS.	[Simmonds, Michael J.; Brotherton, Emily; McNamee, Antony P.; Horobin, Jarod; Sabapathy, Surendran] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Milne, Nikki] Bond Univ, Bond Inst Hlth & Sport, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Ong, Kee] Monash IVF, Southport, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Bond University	Simmonds, MJ (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	mike@thesimmonds.id.au	; Simmonds, Michael/U-9339-2017	Milne, Nikki/0000-0002-5121-9825; Simmonds, Michael/0000-0001-8145-6787; Sabapathy, Surendran/0000-0003-1267-6035; Horobin, Jarod/0000-0002-9684-1562				Alexy T, 2006, TRANSFUSION, V46, P912, DOI 10.1111/j.1537-2995.2006.00823.x; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Brown CD, 2005, KIDNEY INT, V67, P295, DOI 10.1111/j.1523-1755.2005.00082.x; Brun JF, 2004, CLIN HEMORHEOL MICRO, V30, P365; Burchall GF, 2015, SEMINARS THROMBOSIS; Caglar GS, 2011, FERTIL STERIL, V95, P310, DOI 10.1016/j.fertnstert.2010.06.092; Celik C, 2014, FERTIL STERIL, V101, P1123, DOI 10.1016/j.fertnstert.2013.12.050; Chang AY, 2015, CLIN ENDOCRINOLOGY; Cho YI, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0404-6; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; CROWELL JW, 1967, J APPL PHYSIOL, V22, P501, DOI 10.1152/jappl.1967.22.3.501; Desai V, 2014, J CLIN DIAGN RES, V8, pCC1, DOI 10.7860/JCDR/2014/8125.4530; El Bouhmadi A, 2000, CLIN HEMORHEOL MICRO, V22, P99; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Husstedt IW, 1997, EUR NEUROL, V37, P90, DOI 10.1159/000117416; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P199, DOI 10.1055/s-2007-994921; Luque-Ramirez M, 2007, HUM REPROD, V22, P3197, DOI 10.1093/humrep/dem324; Luque-Ramirez M, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0500-6; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, P1068, DOI 10.1210/jc.2010-2279; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Markantes G, 2011, GYNECOL ENDOCRINOL, V27, P971, DOI 10.3109/09513590.2011.569783; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Neu B, 2002, BIOPHYS J, V83, P2482, DOI 10.1016/S0006-3495(02)75259-4; Okoroh EM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.007; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Simmonds MJ, 2011, CLIN HEMORHEOL MICRO, V49, P231, DOI 10.3233/CH-2011-1473; Simmonds MJ, 2011, AUST J ZOOL, V59, P26, DOI 10.1071/ZO10083; Sloop Gregory, 2015, Ther Adv Cardiovasc Dis, V9, P19, DOI 10.1177/1753944714553226; Sprung VS, 2013, CLIN ENDOCRINOL, V78, P438, DOI 10.1111/j.1365-2265.2012.04490.x; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Vaya A, 2011, CLIN HEMORHEOL MICRO, V49, P493, DOI 10.3233/CH-2011-1499; Vervita V, 2009, GYNECOL ENDOCRINOL, V25, P640, DOI 10.1080/09513590903015486; Young MJ, 1996, CLIN SCI, V90, P183, DOI 10.1042/cs0900183	34	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167290	10.1371/journal.pone.0167290	http://dx.doi.org/10.1371/journal.pone.0167290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902766	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474100068
J	Tapia-McClung, H; Ibarra, HA; Rao, D				Tapia-McClung, Horacio; Ibarra, Helena Ajuria; Rao, Dinesh			Quantifying Human Visible Color Variation from High Definition Digital Images of Orb Web Spiders	PLOS ONE			English	Article							CAMOUFLAGE	Digital processing and analysis of high resolution images of 30 individuals of the orb web spider Verrucosa arenata were performed to extract and quantify human visible colors present on the dorsal abdomen of this species. Color extraction was performed with minimal user intervention using an unsupervised algorithm to determine groups of colors on each individual spider, which was then analyzed in order to quantify and classify the colors obtained, both spatially and using energy and entropy measures of the digital images. Analysis shows that the colors cover a small region of the visible spectrum, are not spatially homogeneously distributed over the patterns and from an entropic point of view, colors that cover a smaller region on the whole pattern carry more information than colors covering a larger region. This study demonstrates the use of processing tools to create automatic systems to extract valuable information from digital images that are precise, efficient and helpful for the understanding of the underlying biology.	[Tapia-McClung, Horacio] Lab Nacl Informat Avanzada AC, Xalapa, Veracruz, Mexico; [Ibarra, Helena Ajuria; Rao, Dinesh] Univ Veracruzana, INBIOTECA, Xalapa, Veracruz, Mexico	Universidad Veracruzana	Tapia-McClung, H (corresponding author), Lab Nacl Informat Avanzada AC, Xalapa, Veracruz, Mexico.	htapia@lania.edu.mx		Rao, Dinesh/0000-0002-1900-7742; Tapia-McClung, Horacio/0000-0002-9671-9751				[Anonymous], 2004, COMPUTATIONAL COLOUR, DOI DOI 10.1002/0470020326; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Beverido N, 2015, ETHOLOGY, V121, P187, DOI [10.1111/eth.12330, DOI 10.1111/ETH.12330]; Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002; de Ibarra NH, 2009, J COMP PHYSIOL A, V195, P319, DOI 10.1007/s00359-009-0412-0; Fan CM, 2009, BEHAV ECOL, V20, P808, DOI 10.1093/beheco/arp064; Freire FMC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.064502; Garcia JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125817; Garcia JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096646; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; Gonzalez R. C., 2006, PEARSON ED, V3rd, P8; Hyman J, 2008, WORKSH APPL SYST ALG; Kang C, 2015, BEHAV ECOL, V26, P45, DOI 10.1093/beheco/aru150; Kemp DJ, 2015, AM NAT, V185, P705, DOI 10.1086/681021; Kendal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072296; Marshall KLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135241; O'Hanlon JC, 2014, CURR ZOOL, V60, P90, DOI 10.1093/czoolo/60.1.90; Rao D, 2011, NATURWISSENSCHAFTEN, V98, P699, DOI 10.1007/s00114-011-0811-2; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115586; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Taylor CH, 2013, METHODS ECOL EVOL, V4, P771, DOI 10.1111/2041-210X.12063; Teasdale LC, 2013, J EVOLUTION BIOL, V26, P1035, DOI 10.1111/jeb.12115; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; Tsai DY, 2008, J DIGIT IMAGING, V21, P338, DOI 10.1007/s10278-007-9044-5; Tso I-Min, 2013, P319; Wolfram Research Inc., 2015, MATH VERS 10 3	27	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166371	10.1371/journal.pone.0166371	http://dx.doi.org/10.1371/journal.pone.0166371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902724	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100023
J	Twomey, C; Prina, AM; Baldwin, DS; Das-Munshi, J; Kingdon, D; Koeser, L; Prince, MJ; Stewart, R; Tulloch, AD; Cieza, A				Twomey, Conal; Prina, A. Matthew; Baldwin, David S.; Das-Munshi, Jayati; Kingdon, David; Koeser, Leonardo; Prince, Martin J.; Stewart, Robert; Tulloch, Alex D.; Cieza, Alarcos			Utility of the Health of the Nation Outcome Scales (HoNOS) in Predicting Mental Health Service Costs for Patients with Common Mental Health Problems: Historical Cohort Study	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; PROSPECTIVE-PAYMENT; CARE; COMMUNITY; HOSPITALIZATION; PSYCHIATRY; USERS; NEEDS; RISK	Background Few countries have made much progress in implementing transparent and efficient systems for the allocation of mental health care resources. In England there are ongoing efforts by the National Health Service (NHS) to develop mental health 'payment by results' (PbR). The system depends on the ability of patient 'clusters' derived from the Health of the Nation Outcome Scales (HoNOS) to predict costs. We therefore investigated the associations of individual HoNOS items and the Total HoNOS score at baseline with mental health service costs at one year follow-up. Methods An historical cohort study using secondary care patient records from the UK financial year 2012-2013. Included were 1,343 patients with 'common mental health problems', represented by ICD-10 disorders between F32-48. Costs were based on patient contacts with community-based and hospital-based mental health services. The costs outcome was transformed into 'high costs' vs 'regular costs' in main analyses. Results After adjustment for covariates, 11 HoNOS items were not associated with costs. The exception was 'self-injury' with an odds ratio of 1.41 (95% CI 1.10-2.99). Population attributable fractions (PAFs) for the contribution of HoNOS items to high costs ranged from 0.6% (physical illness) to 22.4% (self-injury). After adjustment, the Total HoNOS score was notassociated with costs (OR 1.03, 95% CI 0.99-1.07). However, the PAF (33.3%) demon that no competing interests exist. strated that it might account for a modest proportion of the incidence of high costs. Conclusions Our findings provide limited support for the utility of the self-injury item and Total HoNOS score in predicting costs. However, the absence of associations for the remaining HoNOS items indicates that current PbR clusters have minimal ability to predict costs, so potentially contributing to a misallocation of NHS resources across England. The findings may inform the development of mental health payment systems internationally, especially since the vast majority of countries have not progressed past the early stages of this development. Discrepancies between our findings with those from Australia and New Zealand point to the need for further international investigations.	[Twomey, Conal; Cieza, Alarcos] Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England; [Prina, A. Matthew; Das-Munshi, Jayati; Koeser, Leonardo; Prince, Martin J.; Stewart, Robert; Tulloch, Alex D.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Baldwin, David S.; Kingdon, David] Univ Southampton, Fac Med, Southampton, Hants, England; [Cieza, Alarcos] Ludwig Maximilians Univ Munchen, Dept Med Informat Biometry & Epidemiol IBE, Res Unit Biopsychosocial Hlth, Munich, Germany; [Cieza, Alarcos] Swiss Parapleg Res SPF, Nottwil, Switzerland	University of Southampton; University of London; King's College London; University of Southampton; University of Munich; Swiss Paraplegic Research	Twomey, C (corresponding author), Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England.	c.twomey@soton.ac.uk; robert.stewart@kcl.ac.uk	Kingdon, David/B-8200-2009; Stewart, Robert/B-1667-2010; Prince, Martin J/A-9170-2010; Prina, Matthew/B-4188-2013; Das-Munshi, Jayati/F-1910-2010	Kingdon, David/0000-0002-8913-0906; Stewart, Robert/0000-0002-4435-6397; Prince, Martin J/0000-0003-1379-7146; Prina, Matthew/0000-0001-6698-3263; Das-Munshi, Jayati/0000-0002-3913-6859; Tulloch, Alex/0000-0002-4657-6238; Baldwin, David/0000-0003-3343-0907	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 [316795]; MRC [MR/K021907/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF4-Das-Munshi] Funding Source: researchfish; Medical Research Council [MR/K021907/1] Funding Source: researchfish	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research is funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ (REA grant agreement No. 316795).	Alvarez LG, 2011, J HOSP INFECT, V79, P231, DOI 10.1016/j.jhin.2011.06.016; Andreas S, 2010, J SUBST ABUSE TREAT, V39, P32, DOI 10.1016/j.jsat.2010.03.011; Beecham J, 2001, MEASURING MENTAL HLT, P163; Bekas S, 2013, PSYCHIATR BULL, V37, P349, DOI 10.1192/pb.bp.112.041780; Berk ML, 2001, HEALTH AFFAIR, V20, P9, DOI 10.1377/hlthaff.20.2.9; Blozik E, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-198; BREWIN CR, 1987, PSYCHOL MED, V17, P971, DOI 10.1017/S0033291700000787; Burgess P., 1999, CASEMIX, V1, P4; Byrne SL, 2010, J AFFECT DISORDERS, V126, P206, DOI 10.1016/j.jad.2010.02.135; Callaly T, 2011, AUSTRALAS PSYCHIATRY, V19, P221, DOI 10.3109/10398562.2011.561845; Calver J, 2006, MED J AUSTRALIA, V184, P393, DOI 10.5694/j.1326-5377.2006.tb00289.x; Cotterill PG, 2004, HEALTH CARE FINANC R, V26, P85; Durbin A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006690; Eagar Kathy, 2004, World Psychiatry, V3, P172; Elphick M, 1996, J MENT HLTH ABINGDON, V5, P443; ENGLISH JT, 1986, AM J PSYCHIAT, V143, P131; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Goldney RD, 1998, AUST NZ J PSYCHIAT, V32, P199, DOI 10.3109/00048679809062729; Harrison-Read P, 2002, PSYCHOL MED, V32, P403, DOI 10.1017/S0033291702005305; Health and Social Care Information Centre Casemix Service, 2006, MENT HLTH CAS CLASS; Huang BY, 2000, J AM GERIATR SOC, V48, P1279, DOI 10.1111/j.1532-5415.2000.tb02602.x; Keene J, 2007, EUR J PUBLIC HEALTH, V17, P387, DOI 10.1093/eurpub/ckl248; Kingdon DG, 2012, BRIT J PSYCHIAT, V200, P162, DOI 10.1192/bjp.200.2.162; Kisely S, 2010, CAN J PSYCHIAT, V55, P431, DOI 10.1177/070674371005500706; LAVIK NJ, 1983, ACTA PSYCHIAT SCAND, V67, P404, DOI 10.1111/j.1600-0447.1983.tb09721.x; Lee KJ, 2014, RESPIROLOGY, V19, P162, DOI 10.1111/resp.12226; Lovaglio PG, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-20; Lovaglio PG, 2012, QUAL LIFE RES, V21, P1643, DOI 10.1007/s11136-011-0071-9; Macdonald AJD, 2011, BRIT J PSYCHIAT, V199, P178, DOI 10.1192/bjp.bp.110.090993; Mannion Russell, 2008, J Health Organ Manag, V22, P79, DOI 10.1108/14777260810862425; Mason A, 2011, J MENT HEALTH, V20, P234, DOI 10.3109/09638237.2011.562261; Monitor, 2015, OP CONS PROP CHANG L; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Pirkis Jane E, 2005, Health Qual Life Outcomes, V3, P76, DOI 10.1186/1477-7525-3-76; Prina AM, 2015, J PSYCHOSOM RES, V78, P25, DOI 10.1016/j.jpsychores.2014.11.002; Prina AM, 2014, GEN HOSP PSYCHIAT, V36, P33, DOI 10.1016/j.genhosppsych.2013.08.009; Sabariego C, 2011, J REHABIL MED, V43, P703, DOI 10.2340/16501977-0845; SCHUMACHER DN, 1986, NEW ENGL J MED, V315, P1331, DOI 10.1056/NEJM198611203152106; Self R, 2008, J MENT HEALTH, V17, P33, DOI 10.1080/09638230701505806; Sinclair JMA, 2011, SOC PSYCH PSYCH EPID, V46, P263, DOI 10.1007/s00127-010-0183-5; Speak B, 2015, AUSTRALAS PSYCHIATRY, V23, P66, DOI 10.1177/1039856214563851; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; TAUBE CA, 1988, AM J PSYCHIAT, V145, P19; Tulloch AD, 2016, EPIDEMIOL PSYCH SCI, V25, P181, DOI 10.1017/S2045796015000128; Tulloch AD, 2014, EPIDEMIOL PSYCH SCI, P1; Tulloch AD, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-121; Tulloch AD, 2012, BRIT J PSYCHIAT, V200, P161, DOI 10.1192/bjp.200.2.161; Twomey CD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007575; Wang RX, 2015, MENT HEALTH REV J, V20, P156, DOI 10.1108/MHRJ-03-2014-0008; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167103	10.1371/journal.pone.0167103	http://dx.doi.org/10.1371/journal.pone.0167103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902745	gold, Green Published, Green Accepted			2022-12-27	WOS:000389474100051
J	Urfer, M; Elzi, L; Dell-Kuster, S; Bassetti, S				Urfer, Milena; Elzi, Luigia; Dell-Kuster, Salome; Bassetti, Stefano			Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit	PLOS ONE			English	Article							POTENTIALLY INAPPROPRIATE MEDICATION; STOPP SCREENING TOOL; BEERS CRITERIA; OLDER PERSONS; COMMON OUTCOMES; RISK; PRESCRIPTIONS; PEOPLE; ADULTS; HOSPITALIZATION	Background Polypharmacy and inappropriate medication prescriptions are associated with increased morbidity and mortality. Most interventions proposed to improve appropriate prescribing are time and resource intensive and therefore hardly applicable in daily clinical practice. Objective To test the efficacy of an easy-to-use checklist aimed at supporting the therapeutic reasoning of physicians in order to reduce inappropriate prescribing and polypharmacy. Methods We assessed the efficacy and safety of a 5-point checklist to be used by all physicians on the internal medicine wards of a Swiss hospital by comparing outcomes in 450 consecutive patients aged >= 65 years hospitalized after the introduction of the checklist, and in 450 consecutive patients >= 65 years hospitalized before the introduction of the checklist. The main measures were the proportion of patients with prescription of potentially inappropriate medications (PIMs) at discharge, according to STOPP criteria, and the number of prescribed medications at discharge, before and after the introduction of the checklist. Secondary outcomes were the prevalence of polypharmacy (>= 5 drugs) and hyperpolypharmacy (>= 10 drugs), and the prevalence of potentially inappropriate prescribing omissions (PPOs) according to START criteria. Results At admission 59% of the 900 patients were taking >5 drugs, 13% >= 10 drugs, 37% had >= 1 PIM and 25% >= 1 PPO. The introduction of the checklist was associated with a significant reduction by 22% of the risk of being prescribed >= 1 PIM at discharge (adjusted risk ratios [RR] 0.78; 95% CI: 0.68-0.94), but not with a reduction of at least 20% of the number of drugs prescribed at discharge, nor with a reduction of the risk of PPOs at discharge. Conclusions The introduction of an easy-to-use 5-point checklist aimed at supporting therapeutic reasoning of physicians on internal medicine wards significantly reduced the risk of prescriptions of inappropriate medications at discharge.	[Urfer, Milena] Kantonsspital Olten, Div Internal Med, Olten, Switzerland; [Elzi, Luigia] Reg Hosp San Giovanni, Div Infect Dis, Bellinzona, Switzerland; [Dell-Kuster, Salome] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Bassetti, Stefano] Univ Basel Hosp, Div Internal Med, Basel, Switzerland; [Bassetti, Stefano] Univ Basel Hosp, Dept Clin Res, Basel, Switzerland	Kantonsspital Olten; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Basel; University of Basel; University of Basel	Bassetti, S (corresponding author), Univ Basel Hosp, Div Internal Med, Basel, Switzerland.; Bassetti, S (corresponding author), Univ Basel Hosp, Dept Clin Res, Basel, Switzerland.	stefano.bassetti@usb.ch	Dell-Kuster, Salome/H-4259-2017; Dell-Kuster, Salome/P-2653-2019	Dell-Kuster, Salome/0000-0001-7219-7138; Dell-Kuster, Salome/0000-0001-7219-7138				Bayoumi I, 2009, ANN PHARMACOTHER, V43, P1667, DOI 10.1345/aph.1M059; Blozik E, 2013, DRUG AGING, V30, P561, DOI 10.1007/s40266-013-0073-0; Carey EC, 2008, J AM GERIATR SOC, V56, P68, DOI 10.1111/j.1532-5415.2007.01496.x; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Cook TD, 2002, ACAD EMERG MED, V9, P1430; Dalleur O, 2014, DRUG AGING, V31, P291, DOI 10.1007/s40266-014-0157-5; Dalleur O, 2012, DRUG AGING, V29, P829, DOI 10.1007/s40266-012-0016-1; Dovjak P, 2012, Z GERONTOL GERIATR, V45, P468, DOI 10.1007/s00391-012-0362-y; Egger SS, 2006, DRUG AGING, V23, P823, DOI 10.2165/00002512-200623100-00005; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2008, AGE AGEING, V37, P673, DOI 10.1093/ageing/afn197; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Health FOoP, 2015, EV KVG REV BER SPIT, V13; Hubbard RE, 2015, MED J AUSTRALIA, V202, P373, DOI 10.5694/mja13.00172; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Price SD, 2014, ANN PHARMACOTHER, V48, P6, DOI 10.1177/1060028013504904; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Scott IA, 2012, AM J MED, V125, P529, DOI 10.1016/j.amjmed.2011.09.021; Sganga F, 2015, GERIATR GERONTOL INT; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Steinman MA, 2014, J GEN INTERN MED, V29, P1379, DOI 10.1007/s11606-014-2924-8; Topinkova E, 2012, DRUG AGING, V29, P477, DOI 10.2165/11632400-000000000-00000; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	35	35	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166359	10.1371/journal.pone.0166359	http://dx.doi.org/10.1371/journal.pone.0166359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902720	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474100021
J	Artinger, S; Vulkan, N				Artinger, Sabrina; Vulkan, Nir			Does Group Size Matter for Behavior in Online Trust Dilemmas?	PLoS One			English	Article							GENDER-DIFFERENCES; 5-FACTOR MODEL	How does group size influence behavior in online trust dilemmas? We investigate cooperation in groups of 4 to 100 players. While overall levels of cooperation are stable across group sizes, we find significant gender differences: women increase cooperation with group size and cooperate significantly more than men in large groups. These results are robust when controlling for risk aversion, age, and other individual differences. They highlight the importance of studying behavior and gender differences in large groups.	[Artinger, Sabrina] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Artinger, Sabrina; Vulkan, Nir] Univ Oxford, Said Business Sch, Oxford, England	Max Planck Society; University of Oxford	Artinger, S (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.; Artinger, S (corresponding author), Univ Oxford, Said Business Sch, Oxford, England.	sartinger@mpib-berlin.mpg.de			Said Foudation, Said Business School, University of Oxford NV SA; Max Planck Society, Max Planck Institute for Human Development, SA	Said Foudation, Said Business School, University of Oxford NV SA; Max Planck Society, Max Planck Institute for Human Development, SA	Funded by Said Foudation, Said Business School, University of Oxford NV SA, Max Planck Society, Max Planck Institute for Human Development, SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrow K. J., 1974, LIMITS ORG; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Cooper DJ, 2013, EUR ECON REV, V59, P126, DOI 10.1016/j.euroecorev.2013.01.003; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Eckel CC., 2008, HDB EXPT EC RESULTS, DOI 10.1016/S1574-0722(07)00113-8; Hergueux J, 2015, EXP ECON, V18, P251, DOI 10.1007/s10683-014-9400-5; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; John OP, 1991, TECHNICAL REPORT; Kelley H. H., 2003, ATLAS INTERPERSONAL, DOI [10.1017/CBO9780511499845, DOI 10.1017/CBO9780511499845]; Kelley H. H, 1978, INTERPERSONAL RELATI; Kim Y, 1996, GAME ECON BEHAV, V15, P203, DOI 10.1006/game.1996.0066; Lefcourt H., 2014, LOCUS CONTROL CURREN; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Poppe M, 2005, J ECON PSYCHOL, V26, P431, DOI 10.1016/j.joep.2004.12.006; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Van Lange PAM, 2012, HDB THEORIES SOCIAL, P251; Wit A, 1998, EUR J SOC PSYCHOL, V28, P249, DOI 10.1002/(SICI)1099-0992(199803/04)28:2<249::AID-EJSP868>3.0.CO;2-J	21	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166279	10.1371/journal.pone.0166279	http://dx.doi.org/10.1371/journal.pone.0166279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898667	Green Submitted, Green Published, gold			2022-12-27	WOS:000389474000007
J	Radosa, JC; Radosa, CG; Mavrova, R; Wagenpfeil, S; Hamza, A; Joukhadar, R; Baum, S; Karsten, M; Juhasz-Boess, I; Solomayer, EF; Radosa, MP				Radosa, Julia Caroline; Radosa, Christoph Georg; Mavrova, Russalina; Wagenpfeil, Stefan; Hamza, Amr; Joukhadar, Ralf; Baum, Sascha; Karsten, Maria; Juhasz-Boess, Ingolf; Solomayer, Erich-Franz; Radosa, Marc Philipp			Postoperative Quality of Life and Sexual Function in Premenopausal Women Undergoing Laparoscopic Myomectomy for Symptomatic Fibroids: A Prospective Observational Cohort Study	PLOS ONE			English	Article							FUNCTION INDEX FSFI; UTERINE FIBROIDS; HYSTERECTOMY; CLASSIFICATION; VALIDATION; ULTRASOUND; MANAGEMENT; LEIOMYOMA; OUTCOMES	Introduction Uterine leiomyomas are the most common benign gynecologic tumors. To date laparoscopy myomectomy is the gold standard for treatment of symptomatic fibroids in reproductive aged women. Detailed counseling about the effects of this procedure on postoperative sexuality and quality of life is important in these patients. However, available data on these subjects are limited and contradictory. The aim of this study was to assess sexual function and quality of life in premenopausal women undergoing laparoscopic myomectomy for symptomatic uterine fibroids. Material and Methods All premenopausal women who underwent laparoscopic myomectomy for symptomatic fibroids between April 2012 and August 2014 at a tertiary university center were enrolled in this prospective observational cohort study. Sexual function and quality of life were assessed for the pre- and postoperative (six months post-operatively) state using two validated questionnaires, the Female Sexual Function Index (FSFI) and the European Quality of Life Five-Dimension Scale (EQ-5D). Results Ninety-five of the 115 (83%) eligible patients completed the study. Overall a significant improvement in quality of life and sexual function was observed in the study cohort: Median FSFI (28 (18.7-35.2)) and EQ-5D scores (1 (0.61-1) after laparoscopic myomectomy were significantly higher than preoperative scores (21.2 (5.2-33.5); 0.9 (0.2-1); p <= 0.01). The number, position and localization of the largest fibroids were not correlated with pre- or postoperative sexual function or quality of life. Conclusion Laparoscopic myomectomy might have positive short-term effects on postoperative quality of life and sexual function in premenopausal women suffering from symptomatic fibroids.	[Radosa, Julia Caroline; Mavrova, Russalina; Hamza, Amr; Joukhadar, Ralf; Baum, Sascha; Juhasz-Boess, Ingolf; Solomayer, Erich-Franz] Saarland Univ Hosp, Dept Gynecol & Obstet, Homburg, Germany; [Radosa, Christoph Georg] Dresden Univ Hosp, Dept Radiol, Dresden, Germany; [Wagenpfeil, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Karsten, Maria] Charite, Dept Gynecol, Berlin, Germany; [Radosa, Marc Philipp] Jena Univ Hosp, Dept Gynecol & Obstet, Jena, Germany	Universitatsklinikum des Saarlandes; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Universitatsklinikum des Saarlandes; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Radosa, JC (corresponding author), Saarland Univ Hosp, Dept Gynecol & Obstet, Homburg, Germany.	Julia.radosa@uks.eu	Hamza, Amr/AAM-2842-2021; Radosa, Julia/AAH-8266-2019; Radosa, Christoph/AFT-9924-2022; Radosa, Marc P/M-8334-2016; Juhasz-Böss, Ingolf/F-4963-2014	Hamza, Amr/0000-0003-3630-0593; Radosa, Christoph/0000-0002-1127-4408; Juhasz-Böss, Ingolf/0000-0002-2178-6490; Karsten, Maria Margarete/0000-0001-7587-7550	German academic exchange services (DAAD) [91533303]	German academic exchange services (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was funded by a grant provided to Julia Caroline Radosa by the German academic exchange services (DAAD; grant number 91533303). URL of DAAD website: https://www.daad.de/de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therewas no additional external or internal funding received for this study.	[Anonymous], 1996, WHO TECH REP SER, V866, P1; Arleo Elizabeth Kagan, 2007, Int J Fertil Womens Med, V52, P111; Ayoubi JM, 2003, EUR J OBSTET GYN R B, V111, P179, DOI 10.1016/S0301-2115(03)00213-6; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bernardi TS, 2014, ARCH GYNECOL OBSTET, V290, P87, DOI 10.1007/s00404-014-3155-2; Borah BJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.017; Carranza-Mamane B, 2015, J OBSTET GYNAECOL CA, V37, P277, DOI 10.1016/S1701-2163(15)30318-2; Chen S, 2016, UTERINE PRESERVING I, P01; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Costantini E, 2013, INT UROGYNECOL J, V24, P1481, DOI 10.1007/s00192-012-2041-3; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Dilek S, 2010, J OBSTET GYNAECOL RE, V36, P364, DOI 10.1111/j.1447-0756.2009.01149.x; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; Ertunc D, 2009, J SEX MED, V6, P1032, DOI 10.1111/j.1743-6109.2008.01086.x; Ferrero S, 2006, FERTIL STERIL, V86, P1504, DOI 10.1016/j.fertnstert.2006.04.025; Griffin L, 2013, JSLS-J SOC LAPAROEND, V17, P407, DOI 10.4293/108680813X13693422521557; Hampton T, 2014, JAMA-J AM MED ASSOC, V312, P588, DOI 10.1001/jama.2014.10041; Jacobson GF, 2006, OBSTET GYNECOL, V107, P1278, DOI 10.1097/01.AOG.0000210640.86628.ff; Juhasz-Boss I, 2012, ARCH GYNECOL OBSTET, V286, P167, DOI 10.1007/s00404-012-2254-1; Marshburn PB, 2006, OBSTET GYN CLIN N AM, V33, P125, DOI 10.1016/j.ogc.2005.12.009; Meston CM, 2003, J SEX MARITAL THER, V29, P39, DOI 10.1080/713847100; Mukhopadhaya N, 2008, BEST PRACT RES CL OB, V22, P677, DOI 10.1016/j.bpobgyn.2008.01.012; Munro MG, 2011, INT J GYNECOL OBSTET, V113, P1, DOI 10.1016/j.ijgo.2011.01.001; Pitter MC, 2014, INTERACT J MED RES, V3, P12, DOI 10.2196/ijmr.3160; Radosa JC, 2014, J SEX MED, V11, P2342, DOI 10.1111/jsm.12623; Radosa JC, 2013, EUR J OBSTET GYN R B, V171, P122, DOI 10.1016/j.ejogrb.2013.08.014; Radosa MP, 2014, EUR J OBSTET GYN R B, V180, P35, DOI 10.1016/j.ejogrb.2014.05.029; Radosa MP, 2012, EUR J OBSTET GYN R B, V162, P192, DOI 10.1016/j.ejogrb.2012.02.024; Spies JB, 2010, OBSTET GYNECOL, V116, P641, DOI 10.1097/AOG.0b013e3181ed36b3; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; van Evert JS, 2010, GYNECOL SURG, V7, P9, DOI 10.1007/s10397-009-0529-8; Wang FL, 2014, J MINIM INVAS GYN, V21, P279, DOI 10.1016/j.jmig.2013.09.004; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Witting K, 2008, ARCH SEX BEHAV, V37, P912, DOI 10.1007/s10508-007-9287-8; Zimmermann A, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-6	36	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166659	10.1371/journal.pone.0166659	http://dx.doi.org/10.1371/journal.pone.0166659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FU	27898669	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000014
J	Wang, HJ; Liu, SQ; Zhang, B; Wei, WQ				Wang, Hongju; Liu, Siqing; Zhang, Bo; Wei, Wenqiang			Analysis of Synonymous Codon Usage Bias of Zika Virus and Its Adaption to the Hosts	PLOS ONE			English	Article							SELECTION; ADAPTATION; MUTATION; BIOLOGY; GENES; RNA	Zika virus (ZIKV) is a mosquito-borne virus (arbovirus) in the family Flaviviridae, and the symptoms caused by ZIKV infection in humans include rash, fever, arthralgia, myalgia, asthenia and conjunctivitis. Codon usage bias analysis can reveal much about the molecular evolution and host adaption of ZIKV. To gain insight into the evolutionary characteristics of ZIKV, we performed a comprehensive analysis on the codon usage pattern in 46 ZIKV strains by calculating the effective number of codons (ENc), codon adaptation index (CAI), relative synonymous codon usage (RSCU), and other indicators. The results indicate that the codon usage bias of ZIKV is relatively low. Several lines of evidence support the hypothesis that translational selection plays a role in shaping the codon usage pattern of ZIKV. The results from a correspondence analysis (CA) indicate that other factors, such as base composition, aromaticity, and hydrophobicity may also be involved in shaping the codon usage pattern of ZIKV. Additionally, the results from a comparative analysis of RSCU between ZIKV and its hosts suggest that ZIKV tends to evolve codon usage patterns that are comparable to those of its hosts. Moreover, selection pressure from Homo sapiens on the ZIKV RSCU patterns was found to be dominant compared with that from Aedes aegypti and Aedes albopictus. Taken together, both natural translational selection and mutation pressure are important for shaping the codon usage pattern of ZIKV. Our findings contribute to understanding the evolution of ZIKV and its adaption to its hosts.	[Wang, Hongju; Wei, Wenqiang] Henan Univ, Sch Med, Kaifeng, Peoples R China; [Liu, Siqing; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China	Henan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wei, WQ (corresponding author), Henan Univ, Sch Med, Kaifeng, Peoples R China.	weiwq168@163.com			Plant Foundation for Young Scientists of Henan University [CX0000A40557]; National Natural Science Foundation of China [31501701]	Plant Foundation for Young Scientists of Henan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Plant Foundation for Young Scientists of Henan University (CX0000A40557) and the National Natural Science Foundation of China (31501701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Plant Foundation for Young Scientists of Henan University (CX0000A40557), and the National Natural Science Foundation of China (31501701). We thank Yihui Yuan (Wuhan Institute of Virology, Chinese Academy of Sciences) for helpful discussions and editing of this manuscript.	Auewarakul P, 2005, VIRUS RES, V109, P33, DOI 10.1016/j.virusres.2004.10.004; Babbitt GA, 2014, NUCLEIC ACIDS RES, V42, P10915, DOI 10.1093/nar/gku811; BULMER M, 1991, GENETICS, V129, P897; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Chen Youhua, 2014, VirusDisease, V25, P285, DOI 10.1007/s13337-014-0191-2; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022; Das S, 2006, VIRUS RES, V117, P227, DOI 10.1016/j.virusres.2005.10.007; Doran TM, 2011, THESIS; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Freire CCdM, 2015, SPREAD PANDEMIC ZIKA; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hemert FV, 2015, VIROL J, V13, P1; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jung SK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-340; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kumar N, 2016, PLOS ONE, V11; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lara-Ramirez EE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/851425; Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68; Ma YP, 2015, J FISH DIS, V38, P665, DOI 10.1111/jfd.12316; Ma YP, 2014, ARCH VIROL, V159, P1841, DOI 10.1007/s00705-014-2000-z; Ma YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111950; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4; Plotkin JB, 2006, J MOL EVOL, V63, P635, DOI 10.1007/s00239-005-0233-x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862; Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4; Vicario S, 2006, BMC EVOL BIOL, V7, P1; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zeng ZY, 2014, J VIROL METHODS, V208, P102, DOI 10.1016/j.jviromet.2014.08.001; Zhou JH, 2013, PLOS ONE, V8, P1175	56	19	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166260	10.1371/journal.pone.0166260	http://dx.doi.org/10.1371/journal.pone.0166260			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893824	gold, Green Published, Green Submitted			2022-12-27	WOS:000389472400020
J	Choi, S; Ray, HE; Lai, SH; Alwood, JS; Globus, RK				Choi, Sungshin; Ray, Hami E.; Lai, San-Huei; Alwood, Joshua S.; Globus, Ruth K.			Preservation of Multiple Mammalian Tissues to Maximize Science Return from Ground Based and Spaceflight Experiments	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; PHENOL-CHLOROFORM EXTRACTION; FRESH-FROZEN TISSUE; SINGLE-STEP METHOD; WARM ISCHEMIA; RNA INTEGRITY; QUALITY; DEGRADATION; IMPACT	Background Even with recent scientific advancements, challenges posed by limited resources and capabilities at the time of sample dissection continue to limit the collection of high quality tissues from experiments that can be conducted only infrequently and at high cost, such as in space. The resources and time it takes to harvest tissues post-euthanasia, and the methods and duration of long duration storage, potentially have negative impacts on sample quantity and quality, thereby limiting the scientific outcome that can be achieved. Objectives The goals of this study were to optimize methods for both sample recovery and science return from rodent experiments, with possible relevance to both ground based and space-flight studies. The first objective was to determine the impacts of tissue harvest time post euthanasia, preservation methods, and storage duration, focusing on RNA quality and enzyme activities in liver and spleen as indices of sample quality. The second objective was to develop methods that will maximize science return by dissecting multiple tissues after long duration storage in situ at -80 degrees C. Methods Tissues of C57BI/6J mice were dissected and preserved at various time points post-euthanasia and stored at -80 degrees C for up to 11 months. In some experiments, tissues were recovered from frozen carcasses which had been stored at -80 degrees C up to 7 months. RNA quantity and quality was assessed by measuring RNA Integrity Number (RIN) values using an Agilent Bioanalyzer. Additionally, the quality of tissues was assessed by measuring activities of hepatic enzymes (catalase, glutathione reductase and GAPDH). Results Fresh tissues were collected up to one hour post-euthanasia, and stored up to 11 months at -80 degrees C, with minimal adverse effects on the RNA quality of either livers or RNAlater-preserved spleens. Liver enzyme activities were similar to those of positive controls, with no significant effect observed at any time point. Tissues dissected from frozen carcasses that had been stored for up to 7 months at -80 degrees C had variable results, depending on the specific tissue analyzed. RNA quality of liver, heart, and kidneys were minimally affected after 6-7 months of storage at -80 degrees C, whereas RNA degradation was evident in tissues such as small intestine, bone, and bone marrow when they were collected from the carcasses frozen for 2.5 months. Conclusion These results demonstrate that 1) the protocols developed for spaceflight experiments with on-orbit dissections support the retrieval of high quality samples for RNA expression and some protein analyses, despite delayed preservation post-euthanasia or prolonged storage, and 2) many additional tissues for gene expression analysis can be obtained by dissection even following prolonged storage of the tissue in situ at -80 degrees C. These findings have relevance both to high value, ground-based experiments when sample collection capability is severely constrained, and to spaceflight experiments that entail on-orbit sample recovery by astronauts.	[Choi, Sungshin; Lai, San-Huei] KBRwyle, Moffett Field, CA USA; [Ray, Hami E.] ASRC Fed Space & Def Inc, Moffett Field, CA USA; [Choi, Sungshin; Ray, Hami E.; Lai, San-Huei; Alwood, Joshua S.; Globus, Ruth K.] NASA, Space Biosci Div, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Globus, RK (corresponding author), NASA, Space Biosci Div, Ames Res Ctr, Moffett Field, CA 94035 USA.	ruth.k.globus@nasa.gov			NASA, a U.S. Government agency, (Space Biology Program); NASA (ISS Research Integration Office); NASA;  [NNA14AB82C]	NASA, a U.S. Government agency, (Space Biology Program); NASA (ISS Research Integration Office); NASA(National Aeronautics & Space Administration (NASA)); 	The funder, NASA, a U.S. Government agency, (Space Biology Program) provided support in the form of salaries for authors (RKG, SC, SL, JSA and HER), but did not have any additional role in the study design, data collection and analysis, and decisions in preparation of the manuscript. Funds for the supplies and materials needed to conduct the research were provided by NASA (ISS Research Integration Office). Funds for the laboratory space were provided by multiple NASA programs. These funding sources were supplied as directed funds to advance knowledge about the methods needed to conduct research on the ISS, and were not competed (as a grant would be). For authors that are not government employees (SC, SL, and HER), funding was provided as-needed salary support by implementation through the appropriate government services contractor companies under contract number NNA14AB82C. No commercial funds were involved in this activity, and no competing interest exists. The specific roles of these authors are articulated in the 'author contributions' section. Furthermore, KBRwyle and ASRC Federal Space and Defense, Inc. had no roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2004, ANAL BIOCHEM, V328, P101, DOI 10.1016/j.ab.2004.02.004; Botling J, 2009, DIAGN MOL PATHOL, V18, P44, DOI 10.1097/PDM.0b013e3181857e92; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Dastgheib S, 2014, IRAN J MED SCI, V39, P282; Ellis M, 2002, CLIN CANCER RES, V8, P1155; Ferl RJ, 2015, ASTROBIOLOGY, V15, P32, DOI 10.1089/ast.2014.1210; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; Griffin M, 2012, BIOTECHNIQUES, V52, P332, DOI 10.2144/0000113862; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; Gupta V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/475935; Hong Sang Hyun, 2010, J Korean Soc Coloproctol, V26, P316, DOI 10.3393/jksc.2010.26.5.316; Ibberson D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-102; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Inoue H, 2002, FORENSIC SCI INT, V130, P127, DOI 10.1016/S0379-0738(02)00352-3; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Miyatake Y, 2004, EXP MOL PATHOL, V77, P222, DOI 10.1016/j.yexmp.2004.07.004; Muyal JP, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-9; Paul AL, 2005, ACTA ASTRONAUT, V56, P623, DOI 10.1016/j.actaastro.2004.10.001; Salehi Z, 2014, BIOCH PHYSL, V3, P126, DOI DOI 10.4172/2168-9652.1000126; Schoor O, 2003, BIOTECHNIQUES, V35, P1192, DOI 10.2144/03356rr01; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Thompson KL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-57; Vincek V, 2003, LAB INVEST, V83, P137, DOI 10.1097/01.LAB.0000047490.26282.CF; Wolfe LM, 2014, PLACENTA, V35, P645, DOI 10.1016/j.placenta.2014.05.005	27	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167391	10.1371/journal.pone.0167391	http://dx.doi.org/10.1371/journal.pone.0167391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907194	Green Submitted, gold, Green Published			2022-12-27	WOS:000389482700140
J	Pulmanns, N; Mehlig, U; Nordhaus, I; Saint-Paul, U; Diele, K				Pulmanns, Nathalie; Mehlig, Ulf; Nordhaus, Inga; Saint-Paul, Ulrich; Diele, Karen			Mangrove Crab Ucides cordatus Removal Does Not Affect Sediment Parameters and Stipule Production in a One Year Experiment in Northern Brazil	PLOS ONE			English	Article							FIDDLER-CRABS; CAETE ESTUARY; CHASMAGNATHUS-GRANULATA; SULFUR BIOGEOCHEMISTRY; NUTRIENT STATUS; RIVER ESTUARY; SALT; FORESTS; BURROWS; CARBON	Mangrove crabs influence ecosystem processes through bioturbation and/or litter feeding. In Brazilian mangroves, the abundant and commercially important crab Ucides cordatus is the main faunal modifier of microtopography establishing up to 2 m deep burrows. They process more than 70% of the leaf litter and propagule production, thus promoting microbial degradation of detritus and benefiting microbe-feeding fiddler crabs. The accelerated nutrient turn-over and increased sediment oxygenation mediated by U. cordatus may enhance mangrove tree growth. Such positive feed-back loop was tested in North Brazil through a one year crab removal experiment simulating increased harvesting rates in a mature Rhizophora mangle forest. Investigated response parameters were sediment salinity, organic matter content, CO2 efflux rates of the surface sediment, and reduction potential. We also determined stipule fall of the mangrove tree R. mangle as a proxy for tree growth. Three treatments were applied to twelve experimental plots (13 m x 13 m each): crab removal, disturbance control and control. Within one year, the number of U. cordatus burrows inside the four removal plots decreased on average to 52% of the initial number. Despite this distinct reduction in burrow density of this large bioturbator, none of the measured parameters differed between treatments. Instead, most parameters were clearly influenced by seasonal changes in precipitation. Hence, in the studied R. mangle forest, abiotic factors seem to be more important drivers of ecosystem processes than factors mediated by U. cordatus, at least within the studied timespan of one year.	[Pulmanns, Nathalie; Nordhaus, Inga; Saint-Paul, Ulrich] Leibniz Ctr Trop Marine Ecol, Mangrove Ecol Grp, Dept Ecol, Bremen, Germany; [Mehlig, Ulf] Fed Univ Para, Lab Bot, Braganca Paulista, SP, Brazil; [Diele, Karen] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Diele, Karen] St Abbs Marine Stn, St Abbs, Berwick, Scotland	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Universidade Federal do Para; Edinburgh Napier University	Pulmanns, N (corresponding author), Leibniz Ctr Trop Marine Ecol, Mangrove Ecol Grp, Dept Ecol, Bremen, Germany.	nathalie.puelmanns@gmail.com	Mehlig, Ulf/A-2280-2013	Mehlig, Ulf/0000-0002-0142-4505	Leibniz Center for Tropical Marine Ecology [6201]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Institute do Estudos Costeiros (IECOS) of the Federal University of Para (UFPa)	Leibniz Center for Tropical Marine Ecology; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Institute do Estudos Costeiros (IECOS) of the Federal University of Para (UFPa)	NP and IN were funded by the Leibniz Center for Tropical Marine Ecology (project 6201, http://zmt-bremen.de). KD received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, http:// www.masts.ac.uk) and its support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. UM was funded by the Institute do Estudos Costeiros (IECOS) of the Federal University of Para (UFPa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2001, MAR GEOL, V179, P85, DOI 10.1016/S0025-3227(01)00195-5; Andreetta A, 2014, J SEA RES, V85, P524, DOI 10.1016/j.seares.2013.08.010; Araujo JMC, 2012, GEO-MAR LETT, V32, P289, DOI 10.1007/s00367-011-0268-5; Boeger WA, 2005, MEM I OSWALDO CRUZ, V100, P161, DOI 10.1590/S0074-02762005000200009; Bortolus A, 1999, MAR ECOL PROG SER, V178, P79, DOI 10.3354/meps178079; BOTO KG, 1983, MAR ECOL PROG SER, V11, P63, DOI 10.3354/meps011063; BOTO KG, 1984, ESTUARIES, V7, P61, DOI 10.2307/1351957; Botto F, 1999, J EXP MAR BIOL ECOL, V241, P263, DOI 10.1016/S0022-0981(99)00089-1; de Araujo MSLC, 2011, TROP OCEANOGR, V39, P155; de Magalhaes HF, 2011, BIOTA NEOTROP, V11, P45, DOI 10.1590/S1676-06032011000200005; Diele K, 2005, AQUAT LIVING RESOUR, V18, P169, DOI 10.1051/alr:2005018; Diele K, 2010, ECOL STUD-ANAL SYNTH, V211, P275, DOI 10.1007/978-3-642-13457-9_18; Diele K, 2010, ECOL STUD-ANAL SYNTH, V211, P287, DOI 10.1007/978-3-642-13457-9_19; Dittmann S, 1996, MAR ECOL PROG SER, V134, P119, DOI 10.3354/meps134119; DUKE NC, 1984, AUST J BOT, V32, P87, DOI 10.1071/BT9840087; DYE AH, 1986, MAR ECOL PROG SER, V32, P259, DOI 10.3354/meps032259; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; Fanjul E, 2007, MAR ECOL PROG SER, V341, P177, DOI 10.3354/meps341177; Ferreira TO, 2007, GEODERMA, V142, P36, DOI 10.1016/j.geoderma.2007.07.010; Gomes de Santa Fe UMG, 2013, ACTAPESCA ACTA FISH, V1, P29; Guerra RS, 2013, MYCOPATHOLOGIA, V175, P421, DOI 10.1007/s11046-013-9636-1; Heron SF, 2008, ESTUAR COAST SHELF S, V78, P135, DOI 10.1016/j.ecss.2007.11.018; Heron SF, 2003, ESTUAR COAST SHELF S, V58, P137, DOI 10.1016/S0272-7714(03)00068-4; Heron SF, 2001, ESTUAR COAST SHELF S, V52, P411, DOI 10.1006/ecss.2000.0761; HOFFMAN JA, 1984, J EXP MAR BIOL ECOL, V82, P161, DOI 10.1016/0022-0981(84)90101-1; Koch V, 2002, MAR ECOL PROG SER, V228, P119, DOI 10.3354/meps228119; Kostka JE, 2002, LIMNOL OCEANOGR, V47, P230, DOI 10.4319/lo.2002.47.1.0230; Krause G, 2010, ECOL STUD-ANAL SYNTH, V211, P19, DOI 10.1007/978-3-642-13457-9_3; Krause G, 2001, ECOTROPICA, V7, P93; Kristensen E, 2008, J SEA RES, V59, P30, DOI 10.1016/j.seares.2007.05.004; Kristensen E, 2006, LIMNOL OCEANOGR, V51, P1557, DOI 10.4319/lo.2006.51.4.1557; Lara Ruben J., 2006, Wetlands Ecology and Management, V14, P349, DOI 10.1007/s11273-005-4991-4; Leopold A, 2015, SCI TOTAL ENVIRON, V502, P617, DOI 10.1016/j.scitotenv.2014.09.066; Marchand C, 2004, MAR GEOL, V208, P361, DOI 10.1016/j.margeo.2004.04.015; Mehlig U, 2006, AQUAT BOT, V84, P158, DOI 10.1016/j.aquabot.2005.09.007; Mehlig U, 2010, ECOL STUD-ANAL SYNTH, V211, P71, DOI 10.1007/978-3-642-13457-9_6; Morrisey DJ, 1999, MAR ECOL PROG SER, V182, P231, DOI 10.3354/meps182231; Nascimento DM, 2016, OCEAN COAST MANAGE, V130, P50, DOI 10.1016/j.ocecoaman.2016.05.010; Nielsen OI, 2003, J EXP MAR BIOL ECOL, V289, P59, DOI 10.1016/S0022-0981(03)00041-8; Nordhaus I, 2006, ESTUAR COAST SHELF S, V67, P239, DOI 10.1016/j.ecss.2005.11.022; Nordhaus I, 2007, MAR BIOL, V151, P1665, DOI 10.1007/s00227-006-0597-5; Nordhaus I, 2009, J EXP MAR BIOL ECOL, V374, P104, DOI 10.1016/j.jembe.2009.04.002; PASSIOURA JB, 1992, FUNCT ECOL, V6, P476, DOI 10.2307/2389286; Penha-Lopes G, 2009, MAR POLLUT BULL, V58, P1694, DOI 10.1016/j.marpolbul.2009.06.015; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pinheiro MAA, 2006, BRAZILIAN ARCH BIOL; Popel F, 2000, MULLER J VLG CF; Pulmanns N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109532; R Core Team, 2012, R LANG ENV STAT COMP; Reise A, 2003, ESTIMATES BIOMASS PR; Ridd PV, 1996, ESTUAR COAST SHELF S, V43, P617, DOI 10.1006/ecss.1996.0091; ROBERTSON AI, 1986, J EXP MAR BIOL ECOL, V102, P237, DOI 10.1016/0022-0981(86)90179-6; Sarkar D, 2008, USE R, P1; Schmidt AJ, 2012, ANIM BEHAV, V84, P333, DOI 10.1016/j.anbehav.2012.04.023; Schories D, 2003, WETL ECOL MANAG, V11, P243, DOI 10.1023/A:1025011431984; Smith NF, 2009, MAR BIOL, V156, P2255, DOI 10.1007/s00227-009-1253-7; SMITH TJ, 1991, ESTUAR COAST SHELF S, V33, P419, DOI 10.1016/0272-7714(91)90081-L; SMITH TJ, 1987, ECOLOGY, V68, P266; Steubing L, 1992, PFLANZENOKOLOGISCHES; Stieglitz T, 2000, HYDROBIOLOGIA, V421, P69, DOI 10.1023/A:1003925502665; Tavares M, 2003, FAO SPECIES IDENTIFI, P327; Thomas CR, 2010, MAR ECOL PROG SER, V414, P167, DOI 10.3354/meps08708; Twilley RR, 1997, OECOLOGIA, V111, P109, DOI 10.1007/s004420050214; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOLANSKI E, 1981, AUST J MAR FRESH RES, V32, P681; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xin P, 2009, ADV WATER RESOUR, V32, P439, DOI 10.1016/j.advwatres.2008.12.008; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	73	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167375	10.1371/journal.pone.0167375	http://dx.doi.org/10.1371/journal.pone.0167375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907093	Green Published, Green Submitted, gold			2022-12-27	WOS:000389482700134
J	Zhan, QS; Ye, Z; Clarke, R; Rosenwaks, Z; Zaninovic, N				Zhan, Qiansheng; Ye, Zhen; Clarke, Robert; Rosenwaks, Zev; Zaninovic, Nikica			Direct Unequal Cleavages: Embryo Developmental Competence, Genetic Constitution and Clinical Outcome	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; HUMAN OOCYTES; MULTINUCLEATED BLASTOMERES; MORPHOKINETIC PARAMETERS; STAGE EMBRYOS; CENTROSOMES; ABNORMALITIES; IMPLANTATION; INHERITANCE; INSTABILITY	Objective To investigate the prevalence, developmental potential, chromosomal constitution and clinical outcome of embryos with direct unequal cleavages (DUC). Design A retrospective observational study. Setting Academic Institution. Participant 21,261 embryos from 3,155 cycles cultured in EmbryoScope. Results The total incidence of DUCs per embryo occupying the first three cleavages were 26.1%. Depending of the cell stage, DUC rate was 9.8% at first cleavage (DUC-1), 9.1% at second cleavage (DUC-2), and 3.7% at third cleavage (DUC-3) with 3.6% of embryos exhibiting multiple DUCs (DUC-Plus). The occurrence of DUCs was not correlated with female gamete age or source. The incidence of DUC-1 was significantly higher in embryos fertilized by epididymal and testicular sperm (13.6% and 11.4%, respectively) compared to ejaculated sperm (9.1%, all p<0.05). The total incidences of DUCs were strongly correlated with the onset of blastomere multinucleation (MNB) during the first three divisions. In MNB embryos, DUCs incidence are two to three times more likely to develop when compared to non-MNB embryos (OR = 3.11, 95% CI [2.64, 3.67] at 1 -cell stage, OR = 2.64, 95% CI [2.39, 2.91] at 2 -cell stage and OR = 2.51, 95% CI [1.84, 3.43] at 4 -cell stage). The blastocyst formation rates gradually decreased from 61.0% in non-DUC to 40.2% in DUC-3, 18.8% in DUC-2, 8.2% in DUC-1 and 5.6% in multiple DUC embryos (DUC-Plus). The known implantation rates (FH) for day 3 (D3) transfers were 12.42% (n = 3172) in Non-DUC embryos, 6.3% (n = 127) in DUC-3, and 2.7% (n = 260) in DUC-2 embryos. No live births resulted from either DUC-1 (n = 225) or DUC-Plus (n = 100) embryo transfers. For blastocyst transfers, lower implantation rates (33.3%) but similar live birth (LB) rates (40%) were observed if DUC blastocysts were transferred. Comparatively rates in Non-DUC blastocyst were 45.2% and 34.8%, respectively. The euploid rate gradually increased from DUC-1,-2,-3 to NonDUC (13.3%, 19.5%, 33.3%, 45.6%, p<0.001) for D3 biopsied embryos. Interestingly, the trend of decreased euploidy disappeared in DUC D5/6 biopsied embryos and similar rates were exemplified in DUC (D5 56.3%, D6 35.6%) vs. non-DUC (D5 51.4%, D6 33.8%) embryos. Conclusion Blastocyst formation, implantation potential and euploid rate were significantly reduced in DUC embryos. DUC embryos should be deselected for D3 transfers, but should be culture to blastocyst stage for possible ET.	[Zhan, Qiansheng; Ye, Zhen; Clarke, Robert; Rosenwaks, Zev; Zaninovic, Nikica] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA	Cornell University	Zaninovic, N (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA.	nizanin@med.cornell.edu						Aguilar J, 2016, FERTIL STERIL, V106, P291, DOI 10.1016/j.fertnstert.2016.03.036; Alikani M, 2005, HUM REPROD, V20, P3369, DOI 10.1093/humrep/dei242; Alikani M, 2000, HUM REPROD, V15, P2634, DOI 10.1093/humrep/15.12.2634; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P44, DOI 10.1016/j.fertnstert.2012.09.038; Chamayou S, 2013, J ASSIST REPROD GEN, V30, P703, DOI 10.1007/s10815-013-9992-2; Chatzimeletiou K, 2007, ZYGOTE, V15, P81, DOI 10.1017/S0967199406004059; Chatzimeletiou K, 2005, HUM REPROD, V20, P672, DOI 10.1093/humrep/deh652; Colls P, 2007, FERTIL STERIL, V88, P53, DOI 10.1016/j.fertnstert.2006.11.099; Desai N, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-54; Destouni A, 2016, GENOME RES, V26, P567, DOI 10.1101/gr.200527.115; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Gisselsson D, 2010, P NATL ACAD SCI USA, V107, P20489, DOI 10.1073/pnas.1006829107; Han YM, 1999, BIOL REPROD, V61, P1340, DOI 10.1095/biolreprod61.5.1340; Hlinka D, 2012, PHYSIOL RES, V61, P513, DOI 10.33549/physiolres.932287; Jackson KV, 1998, FERTIL STERIL, V70, P60, DOI 10.1016/S0015-0282(98)00100-9; Johnson GE, 2008, MUTAT RES-GEN TOX EN, V651, P56, DOI 10.1016/j.mrgentox.2007.10.019; Kalatova B, 2014, ACTA HISTOCHEMICA; Kligman I, 1996, HUM REPROD, V11, P1492; Klisch K, 1999, ANAT EMBRYOL, V200, P229, DOI 10.1007/s004290050275; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; Kroener LL, 2015, FERTIL STERIL, V103, P694, DOI 10.1016/j.fertnstert.2014.12.090; Lagalla C, 2015, HUM REPROD, V30, P3; Lammers J, 2014, REPROD BIOMED ONLINE, V28, P658, DOI 10.1016/j.rbmo.2014.01.009; Lemmen JG, 2008, REPROD BIOMED ONLINE, V17, P385, DOI 10.1016/S1472-6483(10)60222-2; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; Manandhar G, 2000, HUM REPROD, V15, P256, DOI 10.1093/humrep/15.2.256; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Moomjy M, 1999, MOL HUM REPROD, V5, P836, DOI 10.1093/molehr/5.9.836; MRAK RE, 1995, NEW ENGL J MED, V332, P718, DOI 10.1056/NEJM199503163321105; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; MUNNE S, 1993, HUM REPROD, V8, P1120, DOI 10.1093/oxfordjournals.humrep.a138204; Munne Santiago, 2002, Reprod Biomed Online, V4, P223; PICKERING SJ, 1995, HUM REPROD, V10, P1912, DOI 10.1093/oxfordjournals.humrep.a136206; Rubio I, 2012, FERTIL STERIL, V98, P1458, DOI 10.1016/j.fertnstert.2012.07.1135; Sathananthan AH, 1999, HUM REPROD UPDATE, V5, P553, DOI 10.1093/humupd/5.5.553; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; Sathananthan AH, 1998, J ASSIST REPROD GEN, V15, P129, DOI 10.1023/A:1023056804548; SCHATTEN G, 1991, P NATL ACAD SCI USA, V88, P6785, DOI 10.1073/pnas.88.15.6785; Schatten H, 2009, ENVIRON MOL MUTAGEN, V50, P620, DOI 10.1002/em.20493; Schatten H, 2009, MOL HUM REPROD, V15, P531, DOI 10.1093/molehr/gap049; Scott L, 2003, HUM REPROD UPDATE, V9, P237, DOI 10.1093/humupd/dmg023; Simerly C, 1999, MOL BIOL CELL, V10, P2955, DOI 10.1091/mbc.10.9.2955; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Staessen C, 1997, HUM REPROD, V12, P321, DOI 10.1093/humrep/12.2.321; TESARIK J, 1987, HUM REPROD, V2, P127, DOI 10.1093/oxfordjournals.humrep.a136496; Van Royen E, 2003, HUM REPROD, V18, P1062, DOI 10.1093/humrep/deg201; Veeck L.L., 2003, ATLAS HUMAN BLASTOCY, V1st, DOI 10.3109/9780203008935; Wirka KA, 2014, FERTIL STERIL, V101, P1637, DOI 10.1016/j.fertnstert.2014.02.050; Zaninovic N, 2016, FERTIL STERIL, pP; Zaninovic N. RB, 2006, CYCLE LIFE GAMETES S; Zhang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119285	53	55	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166398	10.1371/journal.pone.0166398	http://dx.doi.org/10.1371/journal.pone.0166398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907016	gold, Green Published, Green Submitted			2022-12-27	WOS:000389482700026
J	Kret, ME; Tomonaga, M				Kret, Mariska E.; Tomonaga, Masaki			Getting to the Bottom of Face Processing. Species-Specific Inversion Effects for Faces and Behinds in Humans and Chimpanzees (Pan Troglodytes)	PLOS ONE			English	Article							CONFIGURAL INFORMATION; SELECTIVE REGIONS; FACIAL COLOR; BODY; SKIN; ATTRACTIVENESS; PERCEPTION; SEARCH; BODIES; ERP	For social species such as primates, the recognition of conspecifics is crucial for their survival. As demonstrated by the 'face inversion effect', humans are experts in recognizing faces and unlike objects, recognize their identity by processing it configurally. The human face, with its distinct features such as eye-whites, eyebrows, red lips and cheeks signals emotions, intentions, health and sexual attraction and, as we will show here, shares important features with the primate behind. Chimpanzee females show a swelling and reddening of the anogenital region around the time of ovulation. This provides an important socio-sexual signal for group members, who can identify individuals by their behinds. We hypothesized that chimpanzees process behinds configurally in a way humans process faces. In four different delayed matching-to-sample tasks with upright and inverted body parts, we show that humans demonstrate a face, but not a behind inversion effect and that chimpanzees show a behind, but no clear face inversion effect. The findings suggest an evolutionary shift in socio-sexual signalling function from behinds to faces, two hairless, symmetrical and attractive body parts, which might have attuned the human brain to process faces, and the human face to become more behind-like.	[Kret, Mariska E.] Leiden Univ, Inst Psychol, Cognit Psychol Unit, Leiden, Netherlands; [Kret, Mariska E.] LIBC, Leiden, Netherlands; [Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan	Leiden University; Leiden University - Excl LUMC; Kyoto University	Kret, ME (corresponding author), Leiden Univ, Inst Psychol, Cognit Psychol Unit, Leiden, Netherlands.; Kret, ME (corresponding author), LIBC, Leiden, Netherlands.	m.e.kret@fsw.leidenuniv.nl	Kret, Mariska/B-4798-2010	Kret, Mariska/0000-0002-3197-5084	Japan Society for the Promotion of Science [pE10084, BR120105]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek [016-155-082]; Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen [UPS/BP/5215]; JSPS-KAKENHI [20002001, 23220006, 24000001, 15H05709]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen; JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (pE10084 and BR120105), the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (#016-155-082) and the Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen (UPS/BP/5215) awarded to MEK, and JSPS-KAKENHI (20002001, 23220006, 24000001 and 15H05709) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1983, CURR ANTHROPOL, V24, P25, DOI 10.1086/202933; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Dahl CD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01044; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; de Valk JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01240; de Waal FB., 1990, SOCIOSEXUAL BEHAV US, P378; de Waal FBM, 2008, ADV SCI LETT, V1, P99, DOI 10.1166/asl.2008.006; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Jones BC, 2015, PSYCHONEUROENDOCRINO, V56, P29, DOI 10.1016/j.psyneuen.2015.02.021; Kret ME, 2013, EXP BRAIN RES, V228, P399, DOI 10.1007/s00221-013-3557-6; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Kret M.E., 2015, FRONT PSYCHOL, V6; Kret ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104886; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; Kret ME, 2016, P NATL ACAD SCI US; Lafer-Sousa R, 2016, J NEUROSCI, V36, P1682, DOI 10.1523/JNEUROSCI.3164-15.2016; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P127, DOI 10.1007/4-431-30248-4_8; Minami T, 2015, NEUROSCIENCE, V311, P341, DOI 10.1016/j.neuroscience.2015.10.019; Mori Y, 2007, PRIMATES, V48, P97, DOI 10.1007/s10329-006-0030-1; Morris D., 1967, NAKED APE ZOOLOGISTS; Nakajima K, 2014, HUM BRAIN MAPP, V35, P4958, DOI 10.1002/hbm.22535; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rhodes G, 2005, P ROY SOC B-BIOL SCI, V272, P1379, DOI 10.1098/rspb.2005.3093; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Thornhill R., 2008, EVOLUTIONARY BIOL HU; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; Tomonaga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11437; Turati C, 2004, INFANCY, V6, P275, DOI 10.1207/s15327078in0602_8; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	45	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165357	10.1371/journal.pone.0165357	http://dx.doi.org/10.1371/journal.pone.0165357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902685	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474100003
J	Novais, SMA; Nunes, CA; Santos, NB; D'Amico, AR; Fernandes, GW; Quesada, M; Braga, RF; Neves, ACO				Novais, Samuel M. A.; Nunes, Cassio A.; Santos, Natalia B.; D'Amico, Ana R.; Fernandes, G. Wilson; Quesada, Mauricio; Braga, Rodrigo F.; Neves, Ana Carolina O.			Effects of a Possible Pollinator Crisis on Food Crop Production in Brazil	PLOS ONE			English	Article							HONEY-BEES; SERVICES; LANDSCAPE; ECOSYSTEM; DIVERSITY; RESPONSES; DECLINES; THREATS	Animal pollinators contribute to human food production and security thereby ensuring an important component of human well-being. The recent decline of these agents in Europe and North America has aroused the concern of a potential global pollinator crisis. In order to prioritize efforts for pollinator conservation, we evaluated the extent to which food production depends on animal pollinators in Brazil-one of the world's agriculture leaders-by comparing cultivated area, produced volume and yield value of major food crops that are pollinator dependent with those that are pollinator non-dependent. In addition, we valued the ecosystem service of pollination based on the degree of pollinator dependence of each crop and the consequence of a decline in food production to the Brazilian Gross Domestic Product and Brazilian food security. A total of 68% of the 53 major food crops in Brazil depend to some degree on animals for pollination. Pollinator non-dependent crops produce a greater volume of food, mainly because of the high production of sugarcane, but the cultivated area and monetary value of pollinator dependent crops are higher (59% of total cultivated area and 68% of monetary value). The loss of pollination services for 29 of the major food crops would reduce production by 16.55-51 million tons, which would amount to 4.86-14.56 billion dollars/year, and reduce the agricultural contribution to the Brazilian GDP by 6.46%-19.36%. These impacts would be largely absorbed by family farmers, which represent 74.4% of the agricultural labor force in Brazil. The main effects of a pollinator crisis in Brazil would be felt by the poorer and more rural classes due to their lower income and direct or exclusive dependence on this ecosystem service.	[Novais, Samuel M. A.; Santos, Natalia B.; D'Amico, Ana R.; Fernandes, G. Wilson; Neves, Ana Carolina O.] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Novais, Samuel M. A.; Quesada, Mauricio] Univ Nacl Autonoma Mexico, Lab Nacl Anal & Sintesis Ecol, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico; [Novais, Samuel M. A.; Quesada, Mauricio] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico; [Nunes, Cassio A.; Braga, Rodrigo F.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [D'Amico, Ana R.] Inst Chico Mendes Conservacao Biodiversidade ICMB, Rondonia, Brazil; [Fernandes, G. Wilson] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidade Federal de Minas Gerais; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal de Lavras; Stanford University	Novais, SMA (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil.; Novais, SMA (corresponding author), Univ Nacl Autonoma Mexico, Lab Nacl Anal & Sintesis Ecol, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico.; Novais, SMA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico.	snovaisbio@gmail.com	Nunes, Cássio Alencar/I-5528-2019; Fernandes, Geraldo/AAN-5602-2021	Nunes, Cássio Alencar/0000-0002-2783-0210; Fernandes, Geraldo/0000-0003-1559-6049; Novais, Samuel/0000-0003-3863-0860; Britto dos Santos, Natalia/0000-0002-3075-7085; Quesada, Mauricio/0000-0002-7776-9286	Universidad Nacional Autonoma de Mexico (PAPIIT) [1N212714-3]; CONACyT [2009-131008]; CONACyT-UNAM-UAGro-Laboratorio Nacional de Analisis y Sintesis Ecologica [2015-250996, 2016-271449]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq	Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-UNAM-UAGro-Laboratorio Nacional de Analisis y Sintesis Ecologica; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Universidad Nacional Autonoma de Mexico (PAPIIT #1N212714-3) and CONACyT (2009-131008) and CONACyT-UNAM-UAGro-Laboratorio Nacional de Analisis y Sintesis Ecologica (2015-250996 and 2016-271449 MQ). SMA Novais, CA Nunes, RF Braga, GW Fernandes and ACO Neves thank the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES), Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and CNPq for scholarships.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Ashworth L, 2009, BIOL CONSERV, V142, P1050, DOI 10.1016/j.biocon.2009.01.016; Assuncao J, 2013, DOES CREDIT AFFECT D; Barona E, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024002; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; CONAB, 2013, AC SAFR CAN DE AC SA; Connelly H, 2015, AGR ECOSYST ENVIRON, V211, P51, DOI 10.1016/j.agee.2015.05.004; De Aguiar WM, 2015, ENV ENTOMOL; De Marco P, 2004, BIODIVERS CONSERV, V13, P1245, DOI 10.1023/B:BIOC.0000019402.51193.e8; Dutch Soy Coalition, 2008, SOY BIG BUS BIG RESP; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Ferreira P. A., 2015, LANDSCAPE ECOL, V30, P1; Ferreira PA, 2013, ECOL INDIC, V31, P35, DOI 10.1016/j.ecolind.2012.07.025; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Giannini TC, 2015, APIDOLOGIE, V46, P209, DOI 10.1007/s13592-014-0316-z; Giannini T.C., 2015, J ECON ENTOMOL; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graesser J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034017; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herbert LT, 2014, J EXP BIOL, V217, P3457, DOI 10.1242/jeb.109520; IBGE, 2014, CONT NAC TRIM IND VO; IBGE, 2009, CENSOAGROPECUARIO 20; IBGE Banco de Dados Agregados, 2015, SIST IBGE REC AUTOMA; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM 2008 20; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; MAPA, 2014, INT COM AGR PRINC ME; MAPA, 2016, SIST AGR FIT; Melathopoulos AP, 2015, ECOL ECON, V109, P59, DOI 10.1016/j.ecolecon.2014.11.007; Munyuli M. B. Theodore, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P190, DOI 10.1080/21513732.2012.682361; *NAT RES COUNC, 2006, STAT POLL N AM; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pinheiro Jose Nunes, 2010, Oecologia Australis, V14, P266; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R Core Team, 2021, R LANGUAGE ENV STAT; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Williams I. H., 1994, Agricultural Zoology Reviews, VNo.6, P229; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; World Health Organization, 1990, WHO TECHN REP SER, V797, P98	62	30	30	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167292	10.1371/journal.pone.0167292	http://dx.doi.org/10.1371/journal.pone.0167292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902787	Green Published, gold, Green Submitted			2022-12-27	WOS:000389474100069
J	Taylor, M; Simpkin, AJ; Haycock, PC; Dudbridge, F; Zuccolo, L				Taylor, Michelle; Simpkin, Andrew J.; Haycock, Philip C.; Dudbridge, Frank; Zuccolo, Luisa			Exploration of a Polygenic Risk Score for Alcohol Consumption: A Longitudinal Analysis from the ALSPAC Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION ANALYSIS; DEPENDENCE; GENES; ADOLESCENCE; DEHYDROGENASE; HERITABILITY; METAANALYSIS; METABOLISM; BIOMARKERS	Background Uncertainty remains about the true extent by which alcohol consumption causes a number of health outcomes. Genetic variants, or combinations of variants built into a polygenic risk score (PGRS), can be used in an instrumental variable framework to assess causality between a phenotype and disease outcome of interest, a method known as Mendelian randomisation (MR). We aimed to identify genetic variants involved in the aetiology of alcohol consumption, and develop a PGRS for alcohol. Methods Repeated measures of alcohol consumption from mothers and their offspring were collected as part of the Avon Longitudinal Study of Parents and Children. We tested the association between 89 SNPs (identified from either published GWAS data or from functional literature) and repeated measures of alcohol consumption, separately in mothers (from ages 28-48) and offspring (from ages 15-21) who had ever reported drinking. We modelled log units of alcohol using a linear mixed model and calculated beta coefficients for each SNP separately. Cross-validation was used to determine an allelic score for alcohol consumption, and the AVENGEME algorithm employed to estimate variance of the trait explained. Results Following correction for multiple testing, one SNP (rs1229984) showed evidence for association with alcohol consumption (beta = -0.177, SE = 0.042, p = < 0.0001) in the mothers. No SNPs showed evidence for association in the offspring after correcting for multiple testing. The optimal allelic score was generated using p-value cut offs of 0.5 and 0.05 for the mothers and offspring respectively. These scores explained 0.3% and 0.7% of the variance. Conclusion Our PGRS explains a modest amount of the variance in alcohol consumption and larger sample sizes would be required to use our PGRS in an MR framework.	[Taylor, Michelle; Simpkin, Andrew J.; Haycock, Philip C.; Zuccolo, Luisa] Univ Bristol, Univ Bristol IEU, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Taylor, Michelle; Simpkin, Andrew J.; Haycock, Philip C.; Zuccolo, Luisa] Univ Bristol, Fac Med & Dent, Sch Social & Community Med, Bristol, Avon, England; [Taylor, Michelle] Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol, Bristol, Avon, England; [Dudbridge, Frank] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England	University of Bristol; University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Taylor, M (corresponding author), Univ Bristol, Univ Bristol IEU, MRC Integrat Epidemiol Unit, Bristol, Avon, England.; Taylor, M (corresponding author), Univ Bristol, Fac Med & Dent, Sch Social & Community Med, Bristol, Avon, England.; Taylor, M (corresponding author), Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol, Bristol, Avon, England.	michelle.taylor@bristol.ac.uk	Haycock, Philip/I-6188-2019	Haycock, Philip/0000-0001-5001-3350; Simpkin, Andrew/0000-0002-4975-444X; Zuccolo, Luisa/0000-0002-7049-3037	Wellcome Trust [102215/2/13/2]; Wellcome Trust PhD Studentship [097088/Z/11/Z]; UK MRC Population Health Scientist fellowship [G0902144]; UK Medical Research Council grant [MR/L011824/1]; CRUK Population Research Postdoctoral Fellowship [C52724/A20138]; UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol [MC_UU_12013/1]; UK MRC [K006215]; 23andMe; Medical Research Council [MC_UU_12013/1, MC_PC_15018, G9815508, MC_UU_12013/3, G0902144, MC_UU_12013/5, MR/K006215/1, MR/L011824/1] Funding Source: researchfish; MRC [MC_UU_12013/1, MR/K006215/1, MC_UU_12013/5, MC_UU_12013/3, MR/L011824/1, G0902144] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust PhD Studentship(Wellcome Trust); UK MRC Population Health Scientist fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK Population Research Postdoctoral Fellowship; UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 23andMe; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council and the Wellcome Trust (grant number: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. When conducting this research MT was supported by a Wellcome Trust PhD Studentship (grant number: 097088/Z/11/Z). LZ was funded by a UK MRC Population Health Scientist fellowship (grant number G0902144). AJS is funded by a UK Medical Research Council grant (grant number: MR/L011824/1). PH is supported by CRUK Population Research Postdoctoral Fellowship (grant number: C52724/A20138). MT, AS, PH and LZ work within the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (grant number: MC_UU_12013/1). FD receives funding from the UK MRC (grant number: K006215).; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and all authors will serve as guarantors for the contents of this paper. GWAS data was generated by Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute and LabCorp (Laboratory Corporation of American using support from 23andMe.	Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Bevilacqua L, 2009, CLIN PHARMACOL THER, V85, P359, DOI 10.1038/clpt.2009.6; BHF, 2015, CARD DIS STAT 2015 B; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Birley AJ, 2009, HUM MOL GENET, V18, P1533, DOI 10.1093/hmg/ddp060; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burgess S, 2016, J CLIN EPIDEMIOL, V69, P208, DOI 10.1016/j.jclinepi.2015.08.001; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Clarke TK, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.83; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Dick DM, 2003, ALCOHOL CLIN EXP RES, V27, P868, DOI 10.1097/01.ALC.0000065436.24221.63; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Edwards AL, 1957, SOCIAL DESIRABILITY, Ve1003348, DOI [10.1371/journal.pgen.1003348, DOI 10.1371/JOURNAL.PGEN.1003348]; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Glymour MM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4334; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Heron J, 2012, ALCOHOL ALCOHOLISM, V47, P169, DOI 10.1093/alcalc/agr156; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Hung CF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0334-3; Irons DE, 2007, DEV PSYCHOPATHOL, V19, P1181, DOI 10.1017/S0954579407000612; Kapoor M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.27; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lees R, 2012, ALCOHOL ALCOHOLISM, V47, P267, DOI 10.1093/alcalc/ags010; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; MacArthur GJ, 2012, J PUBLIC HEALTH-UK, V34, pI20, DOI 10.1093/pubmed/fds006; Melotti R, 2011, PEDIATRICS, V127, pE948, DOI 10.1542/peds.2009-3450; MIDANIK L, 1982, BRIT J ADDICT, V77, P357; Palla L, 2015, AM J HUM GENET, V97, P250, DOI 10.1016/j.ajhg.2015.06.005; Park BL, 2013, HUM GENET, V132, P657, DOI 10.1007/s00439-013-1281-8; Peterson K, 2004, ALCOHOL RES HEALTH, V28, P30; Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811; Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093; Rehm J., 2012, ALCOHOL CONSUMPTION; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Shen L, 2016, AM J EPIDEMIOL, V183, P147, DOI 10.1093/aje/kwv204; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; StataCorp, 2013, STATA STAT SOFTW REL; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Swan G E, 1990, J Subst Abuse, V2, P39; Taylor AE, 2015, SCI REPORTS, P5; Taylor AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26496; Treutlein J, 2011, CURR PSYCHIAT REP, V13, P147, DOI 10.1007/s11920-011-0176-4; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; Vink JM, 2014, ADDICTION, V109, P1141, DOI 10.1111/add.12491; Walter S, 2015, AM J MED GENET B, V168, P108, DOI 10.1002/ajmg.b.32286; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221	55	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167360	10.1371/journal.pone.0167360	http://dx.doi.org/10.1371/journal.pone.0167360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902751	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000389474100077
J	Antwi, GD; Bates, LA; King, R; Mahama, PR; Tagbor, H; Cairns, M; Newell, JN				Antwi, Gifty D.; Bates, Laura A.; King, Rebecca; Mahama, Princess R.; Tagbor, Harry; Cairns, Matt; Newell, James N.			Facilitators and Barriers to Uptake of an Extended Seasonal Malaria Chemoprevention Programme in Ghana: A Qualitative Study of Caregivers and Community Health Workers	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; KNOWLEDGE-BEHAVIOR GAP; SHARED DECISION-MAKING; SULFADOXINE-PYRIMETHAMINE; SENEGALESE CHILDREN; TRIAL; EFFICACY; IMPACT	Background Seasonal Malaria Chemoprevention (SMC) is currently recommended for children under five in areas where malaria transmission is highly seasonal. We explored children's caregivers' and community health workers' (CHWs) responses to an extended 5-month SMC programme. Methods Thirteen in-depth interviews and eight focus group discussions explored optimal and suboptimal 'uptake' of SMC to examine facilitators and barriers to caregivers' uptake. Results There did not appear to be major differences between caregivers of children with optimal and sub-optimal SMC uptake in terms of their knowledge of malaria, their perceptions of the effect of SMC on a child's health, nor their understanding of chemoprevention. Caregivers experienced difficulty in prioritising SMC for well children, perceiving medication being for treatment rather than prevention. Prior to the study, caregivers had become accustomed to rapid diagnostic testing (RDT) for malaria, and therefore blood testing for malaria during the baseline survey at the start of the SMC programme may have positively influenced uptake. Facilitators of uptake included caregivers' trust in and respect for administrators of SMC (including CHWs), access to medication and supportive (family) networks. Barriers to uptake related to poor communication of timings of community gatherings, travel distances, absence during SMC home deliveries, and limited demand for SMC due to lack of previous experience. Future delivery of SMC by trained CHWs would be acceptable to caregivers. Conclusion A combination of caregivers' physical access to SMC medication, the drug regimen, trust in the medical profession and perceived norms around malaria prevention all likely influenced caregivers' level of uptake. SMC programmes need to consider: 1) developing supportive, accessible and flexible modes of drug administration including home delivery and village community kiosks; 2) improving demand for preventive medication including the harnessing of learnt trust; and 3) developing community-based networks for users to support optimal uptake of SMC.	[Antwi, Gifty D.; Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Bates, Laura A.; King, Rebecca; Newell, James N.] Univ Leeds, Leeds Inst Hlth Sci, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Mahama, Princess R.] KNUST, Ctr Global Hlth Res, Kumasi, Ghana; [Cairns, Matt] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London, England	Kwame Nkrumah University Science & Technology; University of Leeds; Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine	Bates, LA (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England.	L.A.Bates@leeds.ac.uk	Tagbor, Harry/B-9312-2018	Tagbor, Harry/0000-0002-9300-665X; Acheampong, Princess Ruhama/0000-0002-3161-6487	Department for International Development [5245]; COMDIS-HSD; Medical Research Council [MR/K012126/1, MR/J012394/1] Funding Source: researchfish; Department for International Development (DFID) [201025] Funding Source: researchfish; MRC [MR/J012394/1] Funding Source: UKRI	Department for International Development; COMDIS-HSD; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Th grant number with Department for International Development is 5245 - 'Delivering effective health services'. Their websites can be found here: www.dfid.gov.uk http://r4d.dfid.gov.uk/. COMDIS-HSD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, T3 TEST TREAT TRACK; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Cantey PT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000728; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Coulter A, 1997, J Health Serv Res Policy, V2, P112; Dial NJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-47; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Edwards A, 2005, BRIT J GEN PRACT, V55, P6; Elkington H, 2004, RESP MED, V98, P439, DOI 10.1016/j.rmed.2003.11.006; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Ghana Statistical Service (GSS) GHSG and ICF International, 2015, GHAN DEM HLTH SURV 2; Gopichandran V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004115; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080051; Lin GA, 2014, CIRC-CARDIOVASC QUAL, V7, P328, DOI 10.1161/CIRCOUTCOMES.113.000322; Menaca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109707; Orish VN, 2016, TROPICAL DOCTOR, P1; Peters D, INT J HLTH PLANN MGM, V31, P227; Pitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032900; Rimal RN, 2000, HEALTH COMMUN, V12, P219, DOI 10.1207/S15327027HC1203_01; Sangare LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039712; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Tagbor H, 2015, TROPICAL MED INT HLT; Wegwarth O, 2014, VACCINE, V32, P1388, DOI 10.1016/j.vaccine.2013.12.038; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; Woolf SH, 2005, ANN INTERN MED, V143, P293, DOI 10.7326/0003-4819-143-4-200508160-00010; World Health Organisation, 2015, WORLD MAL PROGR; World Health Organisation, 2012, GLOB MAL PROGR WHO P	30	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166951	10.1371/journal.pone.0166951	http://dx.doi.org/10.1371/journal.pone.0166951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898699	Green Published, Green Accepted, gold			2022-12-27	WOS:000389474000027
J	Cui, ZH; Stevens, J; Truesdale, KP; Zeng, DL; French, S; Gordon-Larsen, P				Cui, Zhaohui; Stevens, June; Truesdale, Kimberly P.; Zeng, Donglin; French, Simone; Gordon-Larsen, Penny			Prediction of Body Mass Index Using Concurrently Self-Reported or Previously Measured Height and Weight	PLOS ONE			English	Article							ADOLESCENT OBESITY; VALIDITY; PREVALENCE; EQUATIONS; STATE	Objective To compare alternative models for the imputation of BMIM (measured weight in kilograms/measured height in meters squared) in a longitudinal study. Methods We used data from 11,008 adults examined at wave III (2001-2002) and wave IV (2007-2008) in the National Longitudinal Study of Adolescent to Adult Health. Participants were asked their height and weight before being measured. Equations to predict wave IV BMIM were developed in an 80% random subsample and evaluated in the remaining participants. The validity of models that included BMI constructed from previously measured height and weight (BMIPM) was compared to the validity of models that used BMI calculated from concurrently self-reported height and weight (BMISR). The usefulness of including demographics and perceived weight category in those models was also examined. Results The model that used BMISR, compared to BMIPM, as the only variable produced a larger R-2 (0.913 vs. 0.693), a smaller root mean square error (2.07 vs. 3.90 kg/m(2)) and a lower bias between normal-weight participants and those with obesity (0.98 vs. 4.24 kg/m(2)). The performance of the model containing BMISR alone was not substantially improved by the addition of demographics, perceived weight category or BMIPM. Conclusions Our work is the first to show that concurrent self-reports of height and weight may be more useful than previously measured height and weight for imputation of missing BMIM when the time interval between measures is relatively long. Other time frames and alternatives to inperson collection of self-reported data need to be examined.	[Cui, Zhaohui; Stevens, June; Truesdale, Kimberly P.; Gordon-Larsen, Penny] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA; [Stevens, June] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Zeng, Donglin] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [French, Simone] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Cui, ZH (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27514 USA.	cuiz@email.unc.edu		French, Simone/0000-0003-3413-5985	National Heart, Lung, And Blood Institute [1U01HL103561]; Eunice Kennedy Shriver National Institute of Child Health and Development [P01-HD31921]; Office of Behavioral and Social Sciences Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057194, P2CHD050924, P01HD031921] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Award Number 1U01HL103561 from the National Heart, Lung, And Blood Institute, the Eunice Kennedy Shriver National Institute of Child Health and Development and the Office of Behavioral and Social Sciences Research. The funder had no role in the design, analysis, or writing of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.; This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Burke G L, 1996, Ethn Health, V1, P327; Connor Gorber Sarah, 2008, Health Rep, V19, P71; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Harris KM, RES DESIGN; Hayes AJ, 2008, AUST NZ J PUBL HEAL, V32, P542, DOI 10.1111/j.1753-6405.2008.00306.x; Jain RB, 2010, INT J OBESITY, V34, P1655, DOI 10.1038/ijo.2010.80; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Paeratakul S, 2002, OBES RES, V10, P345, DOI 10.1038/oby.2002.48; Plankey MW, 1997, OBES RES, V5, P308, DOI 10.1002/j.1550-8528.1997.tb00556.x; Popkin BM, 1998, J NUTR, V128, P701, DOI 10.1093/jn/128.4.701; Pursey K, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2909; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schenker N, 2010, STAT MED, V29, P533, DOI 10.1002/sim.3809; Scribani M, 2014, JRSM OPEN, V5; Shields Margot, 2011, Health Rep, V22, P35; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Wen M, ETHN DIS, V22, P72; WHO Consultation on Obesity, 2000, OB PREV MAN GLOB EP, P9	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167288	10.1371/journal.pone.0167288	http://dx.doi.org/10.1371/journal.pone.0167288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898706	gold, Green Published, Green Submitted			2022-12-27	WOS:000389474000047
J	Estensoro, I; Ballester-Lozano, G; Benedito-Palos, L; Grammes, F; Martos-Sitcha, JA; Mydland, LT; Calduch-Giner, JA; Fuentes, J; Karalazos, V; Ortiz, A; Overland, M; Sitja-Bobadilla, A; Perez-Sanchez, J				Estensoro, Itziar; Ballester-Lozano, Gabriel; Benedito-Palos, Laura; Grammes, Fabian; Martos-Sitcha, Juan Antonio; Mydland, Liv-Torunn; Calduch-Giner, Josep Alvar; Fuentes, Juan; Karalazos, Vasileios; Ortiz, Alvaro; Overland, Margareth; Sitja-Bobadilla, Ariadna; Perez-Sanchez, Jaume			Dietary Butyrate Helps to Restore the Intestinal Status of a Marine Teleost (Sparus aurata) Fed Extreme Diets Low in Fish Meal and Fish Oil	PLoS One			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; MEAGER ARGYROSOMUS-REGIUS; ATLANTIC SALMON; SOYBEAN-MEAL; GROWTH-PERFORMANCE; INDUCED ENTERITIS; ALKALINE-PHOSPHATASE; COMBINED REPLACEMENT; DIGESTIVE ENZYMES	There is a constant need to find feed additives that improve health and nutrition of farmed fish and lessen the intestinal inflammation induced by plant-based ingredients. The objective of this study was to evaluate the effects of adding an organic acid salt to alleviate some of the detrimental effects of extreme plant-ingredient substitution of fish meal (FM) and fish oil (FO) in gilthead sea bream diet. Three experiments were conducted. In a first trial (T1), the best dose (0.4%) of sodium butyrate (BP-70 (R) NOREL) was chosen after a short (9 weeks) feeding period. In a second longer trial (T2) (8 months), four diets were used: a control diet containing 25% FM (T2-D1) and three experimental diets containing 5% FM (T2-D2, T2-D3, T2-D4). FO was the only added oil in D1, while a blend of plant oils replaced 58% and 84% of FO in T2-D2, and T2-D3 and T2-D4, respectively. The latter was supplemented with 0.4% BP-70. In a third trial (T3), two groups of fish were fed for 12 and 38 months with D1, D3 and D4 diets of T2. The effects of dietary changes were studied using histochemical, immunohistochemical, molecular and electrophysiological tools. The extreme diet (T2-D3) modified significantly the transcriptomic profile, especially at the anterior intestine, up-regulating the expression of inflammatory markers, in coincidence with a higher presence of granulocytes and lymphocytes in the submucosa, and changing genes involved in antioxidant defences, epithelial permeability and mucus production. Trans-epithelial electrical resistance (Rt) was also decreased (T3-D3). Most of these modifications were returned to control values with the addition of BP-70. None of the experimental diets modified the staining pattern of PCNA, FABP2 or ALPI. These results further confirm the potential of this additive to improve or reverse the detrimental effects of extreme fish diet formulations.	[Estensoro, Itziar; Sitja-Bobadilla, Ariadna] CSIC, IATS, Fish Pathol Grp, Castellon de La Plana, Spain; [Ballester-Lozano, Gabriel; Benedito-Palos, Laura; Martos-Sitcha, Juan Antonio; Calduch-Giner, Josep Alvar; Perez-Sanchez, Jaume] CSIC, IATS, Nutrigen & Fish Endocrinol Grp, Castellon de La Plana, Spain; [Grammes, Fabian; Mydland, Liv-Torunn; Overland, Margareth] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ass, Norway; [Fuentes, Juan] Univ Algarve, CCMar, Comparat Endocrinol & Integrat Biol, Faro, Portugal; [Karalazos, Vasileios] BioMar R&D, Grangemouth, Scotland; [Ortiz, Alvaro] Norel SA, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Norwegian University of Life Sciences; Universidade do Algarve	Perez-Sanchez, J (corresponding author), CSIC, IATS, Nutrigen & Fish Endocrinol Grp, Castellon de La Plana, Spain.	jaime.perez.sanchez@csic.es	Karalazos, Vasileios/AAI-7953-2020; Karalazos, Vasileios/AGR-7881-2022; Fuentes, Juan/I-6663-2013; Mydland, Liv Torunn/AAO-2783-2020; Calduch-Giner, Josep/K-8253-2014; Calduch-Giner, Josep/AAY-1475-2021; Sitjà-Bobadilla, Ariadna/J-2715-2014; sanchez, jaume perez/K-3231-2014; estensoro, itziar/AAX-4469-2020; Sánchez, Jaume Pérez/AAJ-6628-2021; Martos-Sitcha, Juan Antonio/L-6140-2014	Karalazos, Vasileios/0000-0002-4490-5499; Fuentes, Juan/0000-0003-0430-8734; Calduch-Giner, Josep/0000-0003-3124-5986; Calduch-Giner, Josep/0000-0003-3124-5986; Sitjà-Bobadilla, Ariadna/0000-0002-7473-3413; sanchez, jaume perez/0000-0003-2506-1523; estensoro, itziar/0000-0002-6218-2191; Sánchez, Jaume Pérez/0000-0003-2506-1523; Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Benedito-Palos, Laura/0000-0003-4726-4196; Grammes, Fabian/0000-0002-9551-9280	European Commission of the European Union, specific RTD Framework Programme 7, (FP7) [KBBE-2011-288925, 262336, 0044/03/04/14a, 652831, 0004/01-INTEBREAM]; Portuguese Foundation for Science and Technology (FCT) [PTDC/MARBIO/3034/2014]; FCT [UID/Multi/04326/2013]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2013-48560-R]; Generalitat Valenciana [PROMETEOII/2014/085]	European Commission of the European Union, specific RTD Framework Programme 7, (FP7); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work has been carried out with financial support from the European Commission of the European Union, specific RTD Framework Programme 7, (FP7/2007-2013) under grant projects ARRAINA (KBBE-2011-288925) to JPS, AO and VK, AQUAEXCEL (262336) under TNA project 0044/03/04/14a to FG, and AQUAEXCEL2020 (652831) under TNA project 0004/01-INTEBREAM to JF. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. JF was also funded by the Portuguese Foundation for Science and Technology (FCT) through Project PTDC/MARBIO/3034/2014. CCMar was supported by national funds from FCT through institutional project UID/Multi/04326/2013. Additional funding has been received by Spanish Ministry of Economy and Competitiveness (MINECO) project no. AGL2013-48560-R to JPS and ASB, and Generalitat Valenciana (PROMETE011/2014/085) to ASB. JAMS received a Postdoctoral Research Fellow (Juan de la Cierva-Formacion, Reference FJCI-2014-20161) from MINECO.	Andre M, 2000, INT J DEV BIOL, V44, P249; Martos-Sitcha JA, 2013, GEN COMP ENDOCR, V193, P221, DOI 10.1016/j.ygcen.2013.07.017; Baeza-Arino R, 2016, AQUAC RES, V47, P460, DOI 10.1111/are.12507; Bakke-McKellep AM, 2000, J FISH DIS, V23, P115, DOI 10.1046/j.1365-2761.2000.00218.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Ballester-Lozano GF, 2014, AQUACULT NUTR, V20, P421, DOI 10.1111/anu.12095; Beauvieux Marie-Christine, 2008, BMC Physiology, V8, P19, DOI 10.1186/1472-6793-8-19; Benedito-Palos L, 2007, AQUACULTURE, V267, P199, DOI 10.1016/j.aquaculture.2007.01.011; Benedito-Palos L, 2016, AQUACULTURE, V454, P8, DOI 10.1016/j.aquaculture.2015.12.008; Benedito-Palos L, 2009, AQUACULTURE, V288, P98, DOI 10.1016/j.aquaculture.2008.11.010; Boltana S, 2011, DEV COMP IMMUNOL, V35, P1195, DOI 10.1016/j.dci.2011.02.010; Castro C, 2016, FISH PHYSIOL BIOCHEM, V42, P203, DOI 10.1007/s10695-015-0130-1; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Ducasse-Cabanot S, 2007, ANIMAL, V1, P1272, DOI 10.1017/S1751731107000596; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; Fang CL, 2014, J ANIM PHYSIOL AN N, V98, P680, DOI 10.1111/jpn.12122; Firdaus-Nawi M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-611; Forlenza M, 2008, MOL IMMUNOL, V45, P1531, DOI 10.1016/j.molimm.2007.10.010; Gao YL, 2011, AQUACULTURE, V311, P233, DOI 10.1016/j.aquaculture.2010.11.048; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geurden I, 2009, COMP BIOCHEM PHYS A, V152, P552, DOI 10.1016/j.cbpa.2008.12.016; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Jiang Y, 2015, CAN J ANIM SCI, V95, P389, DOI [10.4141/CJAS-2014-183, 10.4141/cjas-2014-183]; Karalazos V, 2007, AQUACULT NUTR, V13, P256, DOI 10.1111/j.1365-2095.2007.00471.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Knudsen D, 2008, BRIT J NUTR, V100, P120, DOI 10.1017/S0007114507886338; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Liu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074581; Liu WS, 2014, BRIT J NUTR, V112, P15, DOI 10.1017/S0007114514000610; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Posadas R, 2011, INFLAMM BOWEL DIS, V17, P543, DOI 10.1002/ibd.21381; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Medale F, 2013, INRA PROD ANIM, V26, P303; Nascimento DS, 2007, MOL IMMUNOL, V44, P2277, DOI 10.1016/j.molimm.2006.11.006; Nasopoulou C, 2012, LWT-FOOD SCI TECHNOL, V47, P217, DOI 10.1016/j.lwt.2012.01.018; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Perez-Sanchez J, 2015, FISH SHELLFISH IMMUN, V44, P117, DOI 10.1016/j.fsi.2015.01.039; Regost C, 2003, AQUACULTURE, V217, P465, DOI 10.1016/S0044-8486(02)00259-4; Ribeiro L, 2015, AQUACULTURE, V447, P116, DOI 10.1016/j.aquaculture.2014.12.017; RIMOLDI S, 2015, J NUTR SCI, V4; Robles R, 2013, FISH PHYSIOL BIOCHEM, V39, P1567, DOI 10.1007/s10695-013-9809-3; Romarheim OH, 2013, AQUACULTURE, V402, P13, DOI 10.1016/j.aquaculture.2013.03.011; Romarheim OH, 2013, BRIT J NUTR, V109, P1062, DOI 10.1017/S0007114512002899; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; de Rodriganez MAS, 2013, FISH PHYSIOL BIOCHEM, V39, P1365, DOI 10.1007/s10695-013-9790-x; Simo-Mirabet P, 2016, AQ EUR AE 2016 ED SC, P166; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Terova G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160332; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; Venold FF, 2013, COMP BIOCHEM PHYS A, V164, P229, DOI 10.1016/j.cbpa.2012.09.009; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang L, 2014, DEV COMP IMMUNOL, V43, P54, DOI 10.1016/j.dci.2013.10.006; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Welch A, 2010, REV FISH SCI, V18, P235, DOI 10.1080/10641262.2010.504865; Zheng RG, 2009, EFFECT SODIUM BUTYRA	63	76	79	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166564	10.1371/journal.pone.0166564	http://dx.doi.org/10.1371/journal.pone.0166564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898676	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000389474000011
J	Silva, D; Olsen, KW; Bednarz, MN; Droste, A; Lenkeit, CP; Chaharbakhshi, E; Temple-Wood, ER; Jemc, JC				Silva, Diane; Olsen, Kenneth W.; Bednarz, Magdalena N.; Droste, Andrew; Lenkeit, Christopher P.; Chaharbakhshi, Edwin; Temple-Wood, Emily R.; Jemc, Jennifer C.			Regulation of Gonad Morphogenesis in Drosophila melanogaster by BTB Family Transcription Factors	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; AXON GUIDANCE GENE; POZ-DOMAIN; BALANCER CHROMOSOMES; MOLECULAR-DYNAMICS; CELL-MIGRATION; SALIVARY-GLAND; LOLA ENCODES; EXPRESSION; RIBBON	During embryogenesis, primordial germ cells (PGCs) and somatic gonadal precursor cells (SGPs) migrate and coalesce to form the early gonad. A failure of the PGCs and SGPs to form a gonad with the proper architecture not only affects germ cell development, but can also lead to infertility. Therefore, it is critical to identify the molecular mechanisms that function within both the PGCs and SGPs to promote gonad morphogenesis. We have characterized the phenotypes of two genes, longitudinals lacking (lola) and ribbon (rib), that are required for the coalescence and compaction of the embryonic gonad in Drosophila melanogaster. rib and lola are expressed in the SGPs of the developing gonad, and genetic interaction analysis suggests these proteins cooperate to regulate gonad development. Both genes encode proteins with DNA binding motifs and a conserved protein-protein interaction domain, known as the Broad complex, Tramtrack, Bric-a-brac (BTB) domain. Through molecular modeling and yeast-two hybrid studies, we demonstrate that Rib and Lola homoand heterodimerize via their BTB domains. In addition, analysis of the colocalization of Rib and Lola with marks of transcriptional activation and repression on polytene chromosomes reveals that Rib and Lola colocalize with both repressive and activating marks and with each other. While previous studies have identified Rib and Lola targets in other tissues, we find that Rib and Lola are likely to function via different downstream targets in the gonad. These results suggest that Rib and Lola act as dual-function transcription factors to cooperatively regulate embryonic gonad morphogenesis.	[Silva, Diane; Bednarz, Magdalena N.; Droste, Andrew; Lenkeit, Christopher P.; Chaharbakhshi, Edwin; Temple-Wood, Emily R.; Jemc, Jennifer C.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Olsen, Kenneth W.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Silva, Diane] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Bednarz, Magdalena N.] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA; [Droste, Andrew] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Lenkeit, Christopher P.; Temple-Wood, Emily R.] Midwestern Univ, Chicago Coll Osteopath Med, Downers Grove, IL 60515 USA; [Chaharbakhshi, Edwin] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA	Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; Central Michigan University; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; Loyola University Chicago	Jemc, JC (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jmierisch@luc.edu			Loyola University Chicago	Loyola University Chicago	DS KWO MNB AD CPL EC ERTW and JCJ were recipients of funding from Loyola University Chicago to support this research. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bartoletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049958; Bass BP, 2007, DEV BIOL, V304, P771, DOI 10.1016/j.ydbio.2007.01.029; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; BOYLE M, 1995, DEVELOPMENT, V121, P1815; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Cavarec L, 1997, MOL CELL BIOL, V17, P482, DOI 10.1128/MCB.17.1.482; Cheshire AM, 2008, DEV DYNAM, V237, P2874, DOI 10.1002/dvdy.21709; Crowner D, 2002, DEVELOPMENT, V129, P1317; Davies EL, 2013, DEV BIOL, V373, P310, DOI 10.1016/j.ydbio.2012.11.004; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Enuameh MS, 2013, GENOME RES, V23, P928, DOI 10.1101/gr.151472.112; Gates MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-37; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GODT D, 1993, DEVELOPMENT, V119, P799; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Henderson KD, 2000, DEV BIOL, V217, P362, DOI 10.1006/dbio.1999.9560; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; Horowitz H, 1996, DEVELOPMENT, V122, P1859; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Jack J, 1997, GENETICS, V147, P243; Jemc JC, 2012, DEV BIOL, V367, P114, DOI 10.1016/j.ydbio.2012.04.027; Jemc JC, 2011, GENESIS, V49, P753, DOI 10.1002/dvg.20784; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kerman BE, 2008, DEV BIOL, V320, P278, DOI 10.1016/j.ydbio.2008.05.541; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Loganathan R, 2016, DEV BIOL, V409, P234, DOI 10.1016/j.ydbio.2015.10.016; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ohsako T, 2003, GENE, V311, P59, DOI 10.1016/S0378-1119(03)00554-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rosbrook GO, 2012, ACTA CRYSTALLOGR D, V68, P26, DOI 10.1107/S0907444911048335; Sano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052649; Shim K, 2001, DEVELOPMENT, V128, P4923; Siggs OM, 2012, CELL CYCLE, V11, P3358, DOI 10.4161/cc.21277; SIMON J, 1990, EMBO J, V9, P3945, DOI 10.1002/j.1460-2075.1990.tb07615.x; Southall TD, 2014, DEV CELL, V28, P685, DOI 10.1016/j.devcel.2014.01.030; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Trappe R, 2002, BIOCHEM BIOPH RES CO, V296, P319, DOI 10.1016/S0006-291X(02)00850-1; Tripathy R, 2014, DEV BIOL, V392, P193, DOI 10.1016/j.ydbio.2014.05.026; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Zhang WG, 2003, J BIOL CHEM, V278, P11696, DOI 10.1074/jbc.M213269200; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	67	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0167283	10.1371/journal.pone.0167283	http://dx.doi.org/10.1371/journal.pone.0167283			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898696	Green Published, Green Submitted, gold			2022-12-27	WOS:000389474000046
J	Yuki, K; Awano-Tanabe, S; Ono, T; Shiba, D; Murata, H; Asaoka, R; Tsubota, K				Yuki, Kenya; Awano-Tanabe, Sachiko; Ono, Takeshi; Shiba, Daisuke; Murata, Hiroshi; Asaoka, Ryo; Tsubota, Kazuo			Risk Factors for Motor Vehicle Collisions in Patients with Primary Open-Angle Glaucoma: A Multicenter Prospective Cohort Study	PLOS ONE			English	Article							VISUAL-FIELD; OLDER DRIVERS; INVOLVEMENT; IMPAIRMENT	Purpose To identify the incidence rate of motor vehicle collisions (MVCs) in patients with no ocular pathology other than primary open-angle glaucoma (POAG) and determine the putative risk factors for MVCs in this group of patients. Methods We designed a prospective cohort study across three centers utilizing a consecutive sampling method to identify all patients with POAG between the ages of 40 and 80 years old. Patients with glaucoma were consecutively screened for eligibility. All study participants answered a questionnaire about motor vehicle collisions at baseline, and answered the questionnaire again every 12 months (+/- 1 month) after baseline for three years. A binocular integrated visual field was calculated for each patient by merging a patient's monocular Humphrey Field Analyzer (HFA) visual fields (VFs), using the 'best sensitivity' method. Patients with incident MVCs were defined as the "MVC+" group and patients without incident MVCs were defined as the "MVC+" group. Adjusted odds ratios for the incidence of MVCs were estimated with a logistic regression model. Results One hundred and ninety-one Japanese POAG patients were analyzed in this study. The age of the participants was 63.7 +/- 10.2 [mean +/- standard deviation]. A total of 28 participants experienced a MVC during the follow up period of three years (4.9% per year). Ten patients (5.2%) experienced a MVC in the first year, 13 patients (6.8%) in the second year, and 11 patients (5.8%) in the third year (some patients experienced multiple MVCs over different years). Best corrected visual acuity in the worst eye was significantly worse in the MVC+ group (0.03 +/- 0.01, mean +/- standard deviation, LogMar) compared with the MVC-group (0.01 +/- 0.003, p = 0.01), and was the only variable identified as a significant predictor of future MVCs in the multiple logistic regression model [odds ratio: 1.2, 95% confidence interval (CI): 1.1 to 1.4]. Conclusion Deterioration in visual acuity in the worst eye is a risk factor for future MVCs in patients with POAG.	[Yuki, Kenya; Awano-Tanabe, Sachiko; Ono, Takeshi; Shiba, Daisuke; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Murata, Hiroshi; Asaoka, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University; University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp						Anderson DR., 1999, AUTOMATED STATIC PER; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; Cross JM, 2009, BRIT J OPHTHALMOL, V93, P400, DOI 10.1136/bjo.2008.144584; Gracitelli CPB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138288; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hu PS, 1998, ACCIDENT ANAL PREV, V30, P569, DOI 10.1016/S0001-4575(98)00019-0; Huisingh C, 2015, INVEST OPHTH VIS SCI, V56, P132, DOI 10.1167/iovs.14-15194; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Kwon M, 2016, OPHTHALMOLOGY, V123, P109, DOI 10.1016/j.ophtha.2015.08.043; Marottoli RA, 1997, J GERONTOL A-BIOL, V52, pM184, DOI 10.1093/gerona/52A.3.M184; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; McGwin G, 2015, J GLAUCOMA, V24, P138, DOI 10.1097/IJG.0b013e3182a0761c; Ono T, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/497067; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Yuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115572	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2016	11	11							e0166943	10.1371/journal.pone.0166943	http://dx.doi.org/10.1371/journal.pone.0166943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FU	27898724	Green Submitted, gold, Green Published			2022-12-27	WOS:000389474000026
J	Bankoglu, EE; Tschopp, O; Schmitt, J; Burkard, P; Jahn, D; Geier, A; Stopper, H				Bankoglu, Ezgi Eyluel; Tschopp, Oliver; Schmitt, Johannes; Burkard, Philipp; Jahn, Daniel; Geier, Andreas; Stopper, Helga			Role of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEME OXYGENASE-1; SKELETAL-MUSCLE; KIDNEY-CELLS; LIFE-STYLE; OBESITY; GROWTH; CANCER	Type 2 diabetes (T2DM) and obesity are frequently associated with non-alcoholic fatty liver disease (NAFLD) and with an elevated cancer incidence. The molecular mechanisms of carcinogenesis in this context are only partially understood. High blood insulin levels are typical in early T2DM and excessive insulin can cause elevated reactive oxygen species (ROS) production and genomic instability. ROS are important for various cellular functions in signaling and host defense. However, elevated ROS formation is thought to be involved in cancer induction. In the molecular events from insulin receptor binding to genomic damage, some signaling steps have been identified, pointing at the PI3K/AKT pathway. For further elucidation Phosphatase and Tensin homolog (Pten), a tumour suppressor phosphatase that plays a role in insulin signaling by negative regulation of PI3K/AKT and its downstream targets, was investigated here. Dihydroethidium (DHE) staining was used to detect ROS formation in immortalized human hepatocytes. Comet assay and micronucleus test were performed to investigate genomic damage in vitro. In liver samples, DHE staining and western blot detection of HSP70 and HO-1 were performed to evaluate oxidative stress response. DNA double strand breaks (DSBs) were detected by immunohistostaining. Inhibition of PTEN with the pharmacologic inhibitor VO-OHpic resulted in increased ROS production and genomic damage in a liver cell line. Knockdown of Pten in a mouse model yielded increased oxidative stress levels, detected by ROS levels and expression of the two stress-proteins HSP70 and HO-1 and elevated genomic damage in the liver, which was significant in mice fed with a high fat diet. We conclude that PTEN is involved in oxidative stress and genomic damage induction in vitro and that this may also explain the in vivo observations. This further supports the hypothesis that the PI3K/AKT pathway is responsible for damaging effects of high levels of insulin.	[Bankoglu, Ezgi Eyluel; Burkard, Philipp; Stopper, Helga] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Tschopp, Oliver; Geier, Andreas] Univ Zurich Hosp, Clin Endocrinol & Diabetol, Zurich, Switzerland; [Schmitt, Johannes; Jahn, Daniel; Geier, Andreas] Univ Hosp Wuerzburg, Dept Med 2, Div Hepatol, Wurzburg, Germany	University of Wurzburg; University of Zurich; University Zurich Hospital; University of Wurzburg	Stopper, H (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany.	stopper@toxi.uni-wuerzburg.de	Tschopp, Oliver/H-7545-2018; Bankoglu, Ezgi Eyluel/ABA-2543-2021	Bankoglu, Ezgi Eyluel/0000-0001-7488-6228; Tschopp, Oliver/0000-0002-7733-7934; Burkard, Philipp/0000-0001-9748-7967	European Foundation for the Study of Diabetes in the frame of the "Research Program in Diabetes and Cancer"; Open Access Publication Fund of the University of Wuerzburg	European Foundation for the Study of Diabetes in the frame of the "Research Program in Diabetes and Cancer"; Open Access Publication Fund of the University of Wuerzburg	This work was supported by the European Foundation for the Study of Diabetes in the frame of the "Research Program in Diabetes and Cancer" to AG and OT. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Brunt KR, 2006, ARTERIOSCL THROM VAS, V26, P2027, DOI 10.1161/01.ATV.0000236204.37119.8d; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Dato S, 2013, INT J MOL SCI, V14, P16443, DOI 10.3390/ijms140816443; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Li YR, 2011, J PATHOL, V224, P90, DOI 10.1002/path.2855; MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50; Marti A, INT J OBES RELAT MET, V28, pS29; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Othman EM, 2014, FREE RADICAL BIO MED, V68, P247, DOI 10.1016/j.freeradbiomed.2013.12.010; Othman EM, 2013, MUTAT RES-FUND MOL M, V745, P34, DOI 10.1016/j.mrfmmm.2013.03.006; Othman EM, 2013, ENDOCRINOLOGY, V154, P1434, DOI 10.1210/en.2012-1768; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ramlo-Halsted BA, 1999, PRIMARY CARE, V26, P771, DOI 10.1016/S0095-4543(05)70130-5; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Schultze SM, 2015, LIVER INT, V35, P1354, DOI 10.1111/liv.12600; Soares JP, 2015, EXP GERONTOL, V62, P45, DOI 10.1016/j.exger.2015.01.001; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wang LL, 2012, J APPL PHYSIOL, V113, P1669, DOI 10.1152/japplphysiol.00658.2012; Weiss J, 2014, DTSCH ARZTEBL INT, V111, P447, DOI 10.3238/arztebl.2014.0447; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zou C, 2011, CARCINOGENESIS, V32, P1840, DOI 10.1093/carcin/bgr225	42	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0166956	10.1371/journal.pone.0166956	http://dx.doi.org/10.1371/journal.pone.0166956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893783	Green Published, Green Accepted, gold			2022-12-27	WOS:000389472400062
J	Barth, SM; Schreitmuller, CM; Proehl, F; Oehl, K; Lumpp, LM; Kowalewski, DJ; Di Marco, M; Sturm, T; Backert, L; Schuster, H; Stevanovic, S; Rammensee, HG; Planz, O				Barth, Sharon M.; Schreitmueller, Christian M.; Proehl, Franziska; Oehl, Kathrin; Lumpp, Leonie M.; Kowalewski, Daniel J.; Di Marco, Moreno; Sturm, Theo; Backert, Linus; Schuster, Heiko; Stevanovic, Stefan; Rammensee, Hans-Georg; Planz, Oliver			Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy	PLOS ONE			English	Article							PET DOGS; NEURAL-NETWORKS; MATRIX PEPTIDE; VIRAL PEPTIDES; CANCER-THERAPY; DOMESTIC DOGS; ANIMAL-MODEL; ANTIGEN; MOLECULES; HLA-A2	There are limitations in pre-clinical settings using mice as a basis for clinical development in humans. In cancer, similarities exist between humans and dogs; thus, the dog patient can be a link in the transition from laboratory research on mouse models to clinical trials in humans. Knowledge of the peptides presented on MHC molecules is fundamental for the development of highly specific T cell-based immunotherapies. This information is available for human MHC molecules but is absent for the canine MHC. In the present study, we characterized the binding motif of dog leukocyte antigen (DLA) class I allele DLA-88*50101, using human C1R and K562 transfected cells expressing the DLA-88*50101 heavy chain. MHC class I immunoaffinity-purification revealed 3720 DLA-88*50101 derived peptides, which enabled the determination of major anchor positions. The characterized binding motif of DLA-88*50101 was similar to HLA-A*02:01. Peptide binding analyses on HLA-A*02:01 and DLA-88*50101 via flow cytometry showed weak binding of DLA-88*50101 derived peptides to HLA-A*02:01, and vice versa. Our results present for the first time a detailed peptide binding motif of the canine MHC class I allelic product DLA-88*50101. These data support the goal of establishing dogs as a suitable animal model for the evaluation and development of T cell-based cancer immunotherapies, benefiting both dog and human patients.	[Barth, Sharon M.; Schreitmueller, Christian M.; Proehl, Franziska; Oehl, Kathrin; Lumpp, Leonie M.; Kowalewski, Daniel J.; Di Marco, Moreno; Backert, Linus; Schuster, Heiko; Stevanovic, Stefan; Rammensee, Hans-Georg; Planz, Oliver] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany; [Oehl, Kathrin; Schuster, Heiko] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland; [Kowalewski, Daniel J.] Immat Biotechnol GmbH, Tubingen, Germany; [Sturm, Theo] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Sturm, Theo] Univ Utrecht, Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Sturm, Theo] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Backert, Linus] Univ Tubingen, Appl Bioinformat, Ctr Bioinformat, Tubingen, Germany; [Backert, Linus] Univ Tubingen, Dept Comp Sci, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Zurich; University Zurich Hospital; Immatics Biotechnologies GmbH; Swiss Federal Institutes of Technology Domain; ETH Zurich; Utrecht University; Utrecht University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Planz, O (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany.	oliver.planz@uni-tuebingen.de						Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; BAROUCH D, 1995, J EXP MED, V182, P1847, DOI 10.1084/jem.182.6.1847; Berlin C, 2016, LEUKEMIA, V30, P1003, DOI 10.1038/leu.2016.1; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bukowski JA, 1998, J TOXICOL ENV HEAL A, V54, P579, DOI 10.1080/009841098158719; Burnett RC, 1997, TISSUE ANTIGENS, V49, P484, DOI 10.1111/j.1399-0039.1997.tb02783.x; BURNETT RC, 1995, J IMMUNOL, V155, P4278; Du JM, 2009, J MOL RECOGNIT, V22, P465, DOI 10.1002/jmr.964; Dutra AS, 1996, CYTOGENET CELL GENET, V74, P113, DOI 10.1159/000134395; EDWARDS PAW, 1982, EUR J IMMUNOL, V12, P641, DOI 10.1002/eji.1830120804; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Graumann MB, 1998, TISSUE ANTIGENS, V51, P374, DOI 10.1111/j.1399-0039.1998.tb02976.x; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Hardt C, 2006, TISSUE ANTIGENS, V67, P163, DOI 10.1111/j.1399-0039.2006.00497.x; HAYES HM, 1981, AM J EPIDEMIOL, V114, P229, DOI 10.1093/oxfordjournals.aje.a113186; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kennedy LJ, 2001, TISSUE ANTIGENS, V58, P55, DOI 10.1034/j.1399-0039.2001.580111.x; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Kowalewski Daniel J, 2013, Methods Mol Biol, V960, P145, DOI 10.1007/978-1-62703-218-6_12; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; LOZZIO BB, 1981, P SOC EXP BIOL MED, V166, P546; Marchetti S, 2007, BRIT J CANCER, V97, P577, DOI 10.1038/sj.bjc.6603925; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; MATSUI M, 1993, P NATL ACAD SCI USA, V90, P674, DOI 10.1073/pnas.90.2.674; MATSUI M, 1994, HUM IMMUNOL, V41, P160, DOI 10.1016/0198-8859(94)90010-8; Momburg F, 1996, J IMMUNOL, V156, P1756; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; OBST R, 1995, EUR J IMMUNOL, V25, P2170, DOI 10.1002/eji.1830250808; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parmiani G, 2014, HUM VACC IMMUNOTHER, V10, P3175, DOI 10.4161/hv.29418; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Rammensee HG, 2013, EXPERT REV VACCINES, V12, P1211, DOI 10.1586/14760584.2013.836911; Reif JS, 1998, AM J EPIDEMIOL, V147, P488, DOI 10.1093/oxfordjournals.aje.a009475; Ross P, 2012, TISSUE ANTIGENS, V80, P175, DOI 10.1111/j.1399-0039.2012.01889.x; Ross P, 2012, VET IMMUNOL IMMUNOP, V150, P206, DOI 10.1016/j.vetimm.2012.08.012; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Sant A, 2003, CURR OPIN IMMUNOL, V15, P66, DOI 10.1016/S0952-7915(02)00020-1; Scheidt WM, 2003, EVOLUTION COGNITION, V9, P57; Singh-Jasuja H, 2004, CANCER IMMUNOL IMMUN, V53, P187, DOI 10.1007/s00262-003-0480-x; STEVANOVIC S, 1993, ANAL BIOCHEM, V212, P212, DOI 10.1006/abio.1993.1314; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; TENG JMC, 1994, MOL IMMUNOL, V31, P459, DOI 10.1016/0161-5890(94)90065-5; TERHORST C, 1976, P NATL ACAD SCI USA, V73, P910, DOI 10.1073/pnas.73.3.910; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; Tsai KL, 2013, IMMUNOGENETICS, V65, P501, DOI 10.1007/s00251-013-0704-y; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; Venkataraman GM, 2007, TISSUE ANTIGENS, V70, P53, DOI 10.1111/j.1399-0039.2007.00839.x; Wagner JL, 2000, TISSUE ANTIGENS, V55, P564, DOI 10.1034/j.1399-0039.2000.550607.x; Xiao J, 2016, J IMMUNOL, P50801; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167017	10.1371/journal.pone.0167017	http://dx.doi.org/10.1371/journal.pone.0167017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893789	Green Published, gold, Green Submitted			2022-12-27	WOS:000389472400070
J	Chen, SY; Kaeppler, SM; Vogel, KP; Casler, MD				Chen, Shiyu; Kaeppler, Shawn M.; Vogel, Kenneth P.; Casler, Michael D.			Selection Signatures in Four Lignin Genes from Switchgrass Populations Divergently Selected for In Vitro Dry Matter Digestibility	PLOS ONE			English	Article							LOLIUM-PERENNE L.; FESCUE FESTUCA-ARUNDINACEA; TRANSGENIC DOWN-REGULATION; TERM ARTIFICIAL SELECTION; FERMENTABLE SUGAR YIELDS; ACID-O-METHYLTRANSFERASE; HERBAGE QUALITY TRAITS; CELL-WALL COMPOSITION; PANICUM-VIRGATUM L.; COMPREHENSIVE ANALYSIS	Switchgrass is undergoing development as a dedicated cellulosic bioenergy crop. Fermentation of lignocellulosic biomass to ethanol in a bioenergy system or to volatile fatty acids in a livestock production system is strongly and negatively influenced by lignification of cell walls. This study detects specific loci that exhibit selection signatures across switchgrass breeding populations that differ in in vitro dry matter digestibility (IVDMD), ethanol yield, and lignin concentration. Allele frequency changes in candidate genes were used to detect loci under selection. Out of the 183 polymorphisms identified in the four candidate genes, twenty-five loci in the intron regions and four loci in coding regions were found to display a selection signature. All loci in the coding regions are synonymous substitutions. Selection in both directions were observed on polymorphisms that appeared to be under selection. Genetic diversity and linkage disequilibrium within the candidate genes were low. The recurrent divergent selection caused excessive moderate allele frequencies in the cycle 3 reduced lignin population as compared to the base population. This study provides valuable insight on genetic changes occurring in short-term selection in the polyploid populations, and discovered potential markers for breeding switchgrass with improved biomass quality.	[Chen, Shiyu; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Kaeppler, Shawn M.; Casler, Michael D.] Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53726 USA; [Vogel, Kenneth P.] USDA ARS, Grain Forage & Bioenergy Res Unit, Lincoln, NE USA; [Vogel, Kenneth P.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Casler, Michael D.] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Casler, MD (corresponding author), Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53726 USA.; Casler, MD (corresponding author), USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA.	mdcasler@wisc.edu		Chen, Shiyu/0000-0003-0102-8112	U.S. Department of Energy Great Lakes Bioenergy Research Center in Madison, WI; USDA-ARS in Madison, WI; University of Wisconsin, Department of Agricultural Research Stations; U.S. Department of Energy Great Lakes Bioenergy Research Center in East Lansing, MI; USDA-ARS in Lincoln, NE;  [DE-FC02-07ER64494]	U.S. Department of Energy Great Lakes Bioenergy Research Center in Madison, WI; USDA-ARS in Madison, WI; University of Wisconsin, Department of Agricultural Research Stations; U.S. Department of Energy Great Lakes Bioenergy Research Center in East Lansing, MI; USDA-ARS in Lincoln, NE; 	This research was funded principally by the U.S. Department of Energy Great Lakes Bioenergy Research Center located in Madison, WI and East Lansing, MI and supported by Grant DE-FC02-07ER64494. Secondary funding was provided by USDA-ARS in Madison, WI and Lincoln, NE, and by the University of Wisconsin, Department of Agricultural Research Stations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal DD, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0206-5; Alarcon-Zuniga B, 2009, MOLECULAR BREEDING OF FORAGE AND TURF, P151, DOI 10.1007/978-0-387-79144-9_14; Andersen J. R., 2007, Proceedings of the XXVIIth EUCARPIA Symposium on improvement of fodder crops and amenity grasses, Copenhagen, Denmark, 19th to 23rd August 2007, P145; Andersen JR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-2; Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188; Baxter HL, 2014, PLANT BIOTECHNOL J, V12, P914, DOI 10.1111/pbi.12195; Beissinger TM, 2014, GENETICS, V196, P829, DOI 10.1534/genetics.113.160655; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenner EA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-27; Brummer EC, 2009, MOLECULAR BREEDING OF FORAGE AND TURF, P193, DOI 10.1007/978-0-387-79144-9_18; Casler MD, 1999, CROP SCI, V39, P12, DOI 10.2135/cropsci1999.0011183X003900010003x; Casler MD, 2014, CROP SCI, V54, P626, DOI 10.2135/cropsci2013.04.0239; Casler MD, 2011, PLANT GENOME-US, V4, P273, DOI 10.3835/plantgenome2011.10.0026; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen L, 2004, FUNCT PLANT BIOL, V31, P235, DOI 10.1071/FP03254; Chen L, 2003, PLANT BIOTECHNOL J, V1, P437, DOI 10.1046/j.1467-7652.2003.00040.x; Chen YS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-12; Cogan N, 2005, THEOR APPL GENET, V110, P364, DOI 10.1007/s00122-004-1848-9; Cogan NOI, 2006, MOL GENET GENOMICS, V276, P101, DOI 10.1007/s00438-006-0126-8; Costich DE, 2010, PLANT GENOME-US, V3, P130, DOI 10.3835/plantgenome2010.04.0010; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; EIA, BIOFUELS PRODUCTION; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Ge Y, 2012, IN VITRO CELL DEV-PL, V48, P430; GODSHALK EB, 1986, CROP SCI, V26, P943, DOI 10.2135/cropsci1986.0011183X002600050021x; Guo DM, 2010, J MOL EVOL, V71, P202, DOI 10.1007/s00239-010-9378-3; Han KJ, 2013, GCB BIOENERGY, V5, P358, DOI 10.1111/j.1757-1707.2012.01203.x; Hirsch CN, 2014, GENETICS, V198, P409, DOI 10.1534/genetics.114.167155; HOPKINS AA, 1993, CROP SCI, V33, P253, DOI 10.2135/cropsci1993.0011183X003300020007x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HM, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-8; Liu LL, 2014, BIOENERG RES, V7, P253, DOI 10.1007/s12155-013-9367-7; Lorenzana RE, 2010, CROP SCI, V50, P541, DOI 10.2135/cropsci2009.04.0182; Masatoshi N., 1987, MOLECULAR EVOLUTIONA; Naaz H, 2013, BIOTECHNOL APPL BIOC, V60, P170, DOI 10.1002/bab.1075; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parvathi K, 2001, PLANT J, V25, P193, DOI 10.1046/j.1365-313x.2001.00956.x; Pembleton LW, 2013, CROP PASTURE SCI, V64, P244, DOI 10.1071/CP12392; Pettersson ME, 2013, G3-GENES GENOM GENET, V3, P2305, DOI 10.1534/g3.113.008375; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sarath G, 2008, APPL BIOCHEM BIOTECH, V150, P1, DOI 10.1007/s12010-008-8168-5; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Somleva MN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-79; Team RC, 2015, R A LANGUAGE AND ENV; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; Truntzler M, 2010, THEOR APPL GENET, V121, P1465, DOI 10.1007/s00122-010-1402-x; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Vogel KP, 2013, CROP SCI, V53, P853, DOI 10.2135/cropsci2012.09.0542; Vogel KP, 2002, CROP SCI, V42, P1857, DOI 10.2135/cropsci2002.1857; VOGEL KP, 1981, CROP SCI, V21, P39, DOI 10.2135/cropsci1981.0011183X002100010011x; Wang M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045905; Wang YH, 2013, GENOME, V56, P659, DOI 10.1139/gen-2013-0134; Wang ZY, 2012, ANN BOT-LONDON, V110, P1317, DOI 10.1093/aob/mcs027; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; Wisser RJ, 2008, GENETICS, V180, P583, DOI 10.1534/genetics.108.090118; Xing Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-43; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Zhang YW, 2011, GENETICA, V139, P933, DOI 10.1007/s10709-011-9597-6; Zhong RQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134611; Zhu QH, 2013, G3-GENES GENOM GENET, V3, P1031, DOI 10.1534/g3.112.005447	70	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167005	10.1371/journal.pone.0167005	http://dx.doi.org/10.1371/journal.pone.0167005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FE	27893787	Green Published, Green Submitted, gold			2022-12-27	WOS:000389472400068
